FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Wan, GJ
   Yang, P
   Shi, XJ
   Wong, M
   Zhou, HF
   Huang, N
   Chu, PK
AF Wan, GJ
   Yang, P
   Shi, XJ
   Wong, M
   Zhou, HF
   Huang, N
   Chu, PK
TI In vitro investigation of hemocompatibility of hydrophilic SiNx : H
   films fabricated by plasma-enhanced chemical vapor deposition
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 32nd International Conference on Metallurgical Coatings and Thin Film
CY MAY 02-06, 2005
CL San Diego, CA
SP AVS Sci & Technol Soc, Adv Surface Engn Div
DE silicon nitride films; hemocompatibility; hydrophilicity; bioMEMS;
   plasma enhanced chemical vapor deposition
ID PLATELET-ADHESION; SILICON-NITRIDE; THIN-FILMS; SYSTEMS; MEMS; SURFACES;
   DEVICES
AB SiNx:H films with different N/Si ratios were synthesized by plasma-enhanced chemical vapor deposition (PECVD), aimed for BioMEMS or other biomedical applications. In vitro platelet adhesion tests were conducted to evaluate the hemocompatibility of the prepared films and the results were compared to low-temperature isotropic carbon (LTI-C) which is the most commonly used materials in commercial blood contacting biomedical devices such as artificial heart valves. Our results indicate that the SiN,:H films offer acceptable hemocompatibility compared to LTI-C and possess better characteristics. The hydrophilic property in terms of surface free energy is considered to contribute to the platelet adhesion and activation behavior. The thrombogenicity of the materials is investigated from the thermodynamic and kinetic points of view. Our results indicate that the Si-N bonds play a crucial role in determining the hydrophilic property of the film and consequently affect the blood/surface reactions and hemocompatibility of the films. (c) 2005 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Coll Mat Sci & Engn, Chengdu 610031, Peoples R China.
   Hong Kong Univ Sci & Technol, Dept Elect & Elect Engn, Kowloon, Hong Kong, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Wong, Man/D-1427-2014; Wan, Guojiang/A-6651-2013; Chu, Paul/B-5923-2013;
   Wan, GJ/A-3648-2009
OI Wong, Man/0000-0002-8823-2548; Wan, Guojiang/0000-0002-1636-5405; Chu,
   Paul/0000-0002-5581-4883; 
CR AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   BENMAKROHA Y, 1995, MED BIOL ENG COMPUT, V33, P811, DOI 10.1007/BF02523013
   BUSTARRET E, 1988, PHYS REV B, V38, P8171, DOI 10.1103/PhysRevB.38.8171
   Ciarlo DR, 2002, BIOMED MICRODEVICES, V4, P63, DOI 10.1023/A:1014275913962
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Galayev AA, 1997, ADV PERFORM MATER, V4, P161, DOI 10.1023/A:1008639428729
   Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   Hernandez PR, 1998, SENSOR ACTUAT B-CHEM, V46, P133, DOI 10.1016/S0925-4005(98)00099-9
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KANDA Y, 1981, ELECTRON LETT, V17, P558, DOI 10.1049/el:19810391
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Lattemann M, 2003, SURF COAT TECH, V174, P365, DOI 10.1016/S0257-8972(03)00695-9
   Molinari M, 2000, APPL PHYS LETT, V77, P3499, DOI 10.1063/1.1329163
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Rebello KJ, 2004, P IEEE, V92, P43, DOI 10.1109/JPROC.2003.820536
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   WANG RR, 1996, J BIOMED MATER RES, V46, P262
   Weisenberg BA, 2002, J BIOMED MATER RES, V60, P283, DOI 10.1002/jbm.10076
NR 26
TC 10
Z9 12
U1 1
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD NOV 21
PY 2005
VL 200
IS 5-6
BP 1945
EP 1949
DI 10.1016/j.surfcoat.2005.08.068
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 995JM
UT WOS:000234096600122
DA 2018-10-20
ER

PT J
AU Gheith, MK
   Sinani, VA
   Wicksted, JP
   Matts, RL
   Kotov, NA
AF Gheith, MK
   Sinani, VA
   Wicksted, JP
   Matts, RL
   Kotov, NA
TI Single-walled carbon nanotube polyelectrolyte multilayers and
   freestanding films as a biocompatible platformfor neuroprosthetic
   implants
SO ADVANCED MATERIALS
LA English
DT Article
ID FIELD-EMISSION; NEURONAL GROWTH; PULMONARY TOXICITY; CHEMICAL SENSORS;
   GAS-DETECTION; CELLS; FUNCTIONALIZATION; NEUROBLASTOMA; DNA;
   IMMOBILIZATION
AB Layer-by-layer (LBL) assembly has been Biomedical Materials I used to prepare single-walled carbon nanotube (SWNT) freestanding structures that can be used for implantable devices with unique mechanical and electrical properties (see Figure). The thin LBL membranes prepared are biocompatible and support extensive neurite outgrowth. The stretched fiber-like LBL freestanding films exhibit neuronal guiding. The SWNT structures described may potentially enable connectivity between neurons.
C1 Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Oklahoma State Univ, Dept Phys, Stillwater, OK 74078 USA.
   Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.
RP Kotov, NA (reprint author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
EM mgheith@rice.edu; kotov@umich.edu
OI Kotov, Nicholas/0000-0002-6864-5804
CR Bahr JL, 2002, J MATER CHEM, V12, P1952, DOI 10.1039/b201013p
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u
   Bianco A, 2003, ADV MATER, V15, P1765, DOI 10.1002/adma.200301646
   Bradley K, 2004, NANO LETT, V4, P253, DOI 10.1021/nl0349855
   Bradley K, 2003, APPL PHYS LETT, V83, P3821, DOI 10.1063/1.1619222
   Cai H, 2003, ANAL BIOANAL CHEM, V375, P287, DOI 10.1007/s00216-002-1652-9
   Chen RJ, 2004, J AM CHEM SOC, V126, P1563, DOI 10.1021/ja038702m
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   Chopra S, 2003, APPL PHYS LETT, V83, P2280, DOI 10.1063/1.1610251
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Davis JJ, 2003, CHEM-EUR J, V9, P3732, DOI 10.1002/chem.200304872
   DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179
   Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x
   Georgakilas V, 2002, CHEM COMMUN, P3050, DOI 10.1039/b209843a
   GHEITH MK, UNPUB
   GHEITH MK, 2004, 60 SW REG M AM CHEM
   Guo ZJ, 1998, ADV MATER, V10, P701, DOI 10.1002/(SICI)1521-4095(199806)10:9<701::AID-ADMA701>3.0.CO;2-4
   Hafner JH, 1999, J AM CHEM SOC, V121, P9750, DOI 10.1021/ja992761b
   Hamprecht B, 1977, Int Rev Cytol, V49, P99
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   Huang WJ, 2002, NANO LETT, V2, P311, DOI 10.1021/n1010095i
   Javey A, 2002, NAT MATER, V1, P241, DOI 10.1038/nmat769
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Koktysh DS, 2002, ADV FUNCT MATER, V12, P255, DOI 10.1002/1616-3028(20020418)12:4<255::AID-ADFM255>3.0.CO;2-1
   Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Lee NS, 2001, DIAM RELAT MATER, V10, P265, DOI 10.1016/S0925-9635(00)00478-7
   Li J, 2003, NANO LETT, V3, P929, DOI 10.1021/nl034220x
   Lu Q, 2004, NANO LETT, V4, P2473, DOI 10.1021/nl048326j
   LUSTGARTEN JH, 1991, J BIOMECH ENG-T ASME, V113, P184, DOI 10.1115/1.2891232
   Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747
   Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Niu CM, 1997, APPL PHYS LETT, V70, P1480, DOI 10.1063/1.118568
   Niyogi S, 2002, ACCOUNTS CHEM RES, V35, P1105, DOI 10.1021/ar010155r
   ODONNELL ME, 1982, J CELL PHYSIOL, V113, P405, DOI 10.1002/jcp.1041130308
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Popov VN, 2000, PHYS REV B, V61, P3078, DOI 10.1103/PhysRevB.61.3078
   Qi P., 2003, NANO LETT, V3, P347, DOI DOI 10.1021/NL034010K
   RINZLER AG, 1995, SCIENCE, V269, P1550, DOI 10.1126/science.269.5230.1550
   Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94
   Saito Y, 2000, CARBON, V38, P169, DOI 10.1016/S0008-6223(99)00139-6
   SCHUBERT D, 1971, DEV BIOL, V25, P514, DOI 10.1016/0012-1606(71)90004-2
   Seidman KJN, 1996, J NEUROCHEM, V66, P1011
   Shim M, 2002, NANO LETT, V2, P285, DOI 10.1021/nl015692j
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Sinani VA, 2003, NANO LETT, V3, P1177, DOI 10.1021/nl0255045
   Sinani VA, 2005, J AM CHEM SOC, V127, P3463, DOI 10.1021/ja045670+
   Star A, 2003, NANO LETT, V3, P459, DOI 10.1021/nl0340172
   SUPRONOWICZ PR, 2002, J BIOMED MATER RES, V5, P499
   Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0
   Tans SJ, 1998, NATURE, V393, P49
   WANG S, 2003, NAT MATER, V2, P186
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971
   Wong SS, 1998, NATURE, V394, P52
   Wong YM, 2003, SENSOR ACTUAT B-CHEM, V93, P327, DOI 10.1016/S0925-4005(03)00213-2
   Xue HG, 2003, SYNTHETIC MET, V135, P831, DOI 10.1016/S0379-6779(02)00919-0
   Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552
   Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877
   Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911
   Zorbas V, 2004, J AM CHEM SOC, V126, P7222, DOI 10.1021/ja049202b
NR 67
TC 117
Z9 119
U1 3
U2 54
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD NOV 18
PY 2005
VL 17
IS 22
BP 2663
EP +
DI 10.1002/adma.200500366
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 989CX
UT WOS:000233651600002
DA 2018-10-20
ER

PT J
AU Signori, F
   Chiellini, F
   Solaro, R
AF Signori, F
   Chiellini, F
   Solaro, R
TI New self-assembling biocompatible-biodegradable amphiphilic block
   copolymers
SO POLYMER
LA English
DT Article
DE amphiphilic block copolymers; biocompatible polymers; self-assembly line
ID TRIBLOCK COPOLYMERS; POLYMERIC NANOPARTICLES; BIOMEDICAL APPLICATIONS;
   POLY(ETHYLENE GLYCOL); EPSILON-CAPROLACTONE; WATER; RELEASE; MICELLES;
   OXIDE); DRUG
AB New biodegradable-biocompatible amphiphilic block copolymers were prepared in good yields by SnOct(2) catalyzed ring opening polymerization of epsilon-caprolactone initiated by monomethoxy-terminated poly(ethylene glycol) (MPEG). Coupling of the AB copolymers with hexamethylene diisocyanate afforded ABA (formally ABBA) block copolymers. Both AB and ABA copolymers were thoroughly characterized by IR and NMR spectroscopy, size exclusion chromatography, TGA and DSC thermal analysis. In particular, DSC measurements evidenced that the copolymer hydrophilic-lipophilic balance appreciably affected the state of adsorbed water. Polarized optical microscopy of bulk materials and pyrene fluorescence emission of polymer water solutions highlighted the copolymer tendency to phase separation and self-organization, respectively. Most of the prepared materials formed micelles in water and the copolymer structure appreciably affected their-critical micellar concentration. In vitro cytocompatibility tests confirmed the low toxicity of the prepared polymeric materials which enhances their potential for biomedical applications. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Pisa, Dipartimento Chim & Chim Ind, UdR INSTM Consortium, I-56126 Pisa, Italy.
RP Solaro, R (reprint author), Univ Pisa, Dipartimento Chim & Chim Ind, UdR INSTM Consortium, Via Risorgimento 35, I-56126 Pisa, Italy.
EM rosola@dcci.unipi.it
RI Chiellini, Federica/F-3233-2010; Signori, Francesca/G-1937-2010
OI Chiellini, Federica/0000-0003-4680-9975; Signori,
   Francesca/0000-0002-9211-5352
CR AHMAD MB, 1994, POLYM INT, V33, P273, DOI 10.1002/pi.1994.210330306
   Becher P., 1987, SURFACTANT SCI SERIE, V23, P435
   BENHAMED A, 2001, PHARM RES, V18, P232
   Bizzarri R, 2002, MACROMOLECULES, V35, P1215, DOI 10.1021/ma0111257
   Bogdanov B, 1998, POLYMER, V39, P1631, DOI 10.1016/S0032-3861(97)00444-8
   Cammas-Marion S, 2000, MACROMOL CHEM PHYSIC, V201, P355, DOI 10.1002/(SICI)1521-3935(20000201)201:3<355::AID-MACP355>3.0.CO;2-9
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Chiellini E, 2003, MACROMOL SYMP, V197, P345, DOI 10.1002/masy.200350730
   Chiellini E, 2001, J BIOACT COMPAT POL, V16, P441, DOI 10.1106/6CFL-4E8A-L7XR-MUF7
   CHIELLINI E, 1992, J CONTROL RELEASE, V22, P273, DOI 10.1016/0168-3659(92)90102-W
   Chiellini F, 2003, MACROMOL SYMP, V197, P369, DOI 10.1002/masy.200350732
   CHIELLINI F, 2001, MACROMOL RAPID COMM, V22, P1285
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   CHUNG TS, 2004, POLYMER, V45, P1592
   Covolan VL, 2004, MACROMOL SYMP, V218, P273, DOI 10.1002/masy.200451428
   Deng MX, 2004, J POLYM SCI POL CHEM, V42, P950, DOI 10.1002/pola.11052
   HERMAND MF, 1997, BIOCOMPATIBILITY ASS, P120
   HIGUCHI A, 1984, POLYM BULL, V11, P203
   Huang MH, 2003, MACROMOL CHEM PHYSIC, V204, P1994, DOI 10.1002/macp.200350054
   Huibers PDT, 1996, LANGMUIR, V12, P1462, DOI 10.1021/la950581j
   *ISO, 30993EN ISO
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   Lee JY, 2004, J CONTROL RELEASE, V94, P323, DOI 10.1016/j.conrel.2003.10.012
   Ma D. Z., 1997, POLYMER, V38, P1131
   Ma DZ, 1996, POLYMER, V37, P1575
   Montanaro L, 2001, BIOMATERIALS, V22, P59, DOI 10.1016/S0142-9612(00)00163-0
   NAKAMURA K, 1983, POLYMER, V24, P871, DOI 10.1016/0032-3861(83)90206-9
   Oh KT, 2004, J CONTROL RELEASE, V94, P411, DOI 10.1016/j.jcornel.2003.10.018
   Piao LH, 2003, POLYMER, V44, P2025, DOI 10.1016/S0032-3861(03)00087-9
   QUINN FX, 1988, MACROMOLECULES, V21, P3191, DOI 10.1021/ma00189a012
   Roesler Annette, 2001, Advanced Drug Delivery Reviews, V53, P95
   Shin ILG, 1998, J CONTROL RELEASE, V51, P1
   Shiomi T, 2001, POLYMER, V42, P3233, DOI 10.1016/S0032-3861(00)00597-8
   Shuai XT, 2003, MACROMOLECULES, V36, P5751, DOI 10.1021/ma034390w
   Signori F, 2003, MACROMOL SYMP, V197, P289, DOI 10.1002/masy.200350726
   Solaro R, 2003, J MATER SCI-MATER M, V14, P705, DOI 10.1023/A:1024963700223
   Solaro R, 1997, J BIOACT COMPAT POL, V12, P27, DOI 10.1177/088391159701200103
   Sosnik A, 2003, POLYMER, V44, P7033, DOI 10.1016/j.polymer.2003.09.012
   TANZI MC, 1994, J MATER SCI-MATER M, V5, P393, DOI 10.1007/BF00058971
   Tuominen J, 2002, BIOMACROMOLECULES, V3, P445, DOI 10.1021/bm0101522
   WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010
   WUNDERLICH B, 1976, MACROMOLECULAR PHYSI, V2, P218
   Yamamoto Y, 2001, J CONTROL RELEASE, V77, P27, DOI 10.1016/S0168-3659(01)00451-5
   Yang Z, 2003, LANGMUIR, V19, P943, DOI 10.1021/la026479l
   Zhang S, 2004, J POLYM SCI POL CHEM, V42, P3527, DOI 10.1002/pola.20078
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 48
TC 36
Z9 36
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD NOV 14
PY 2005
VL 46
IS 23
BP 9642
EP 9652
DI 10.1016/j.polymer.2005.07.071
PG 11
WC Polymer Science
SC Polymer Science
GA 978SQ
UT WOS:000232893700016
DA 2018-10-20
ER

PT J
AU Xie, ZG
   Guan, HL
   Chen, L
   Tian, HY
   Chen, XS
   Jing, XB
AF Xie, ZG
   Guan, HL
   Chen, L
   Tian, HY
   Chen, XS
   Jing, XB
TI Novel biodegradable poly(ethylene
   glycol)-block-poly(2-methyl-2carboxyl-propylene carbonate) copolymers:
   Synthesis, characterization, and micellization
SO POLYMER
LA English
DT Article
DE 2-methyl-2-carboxyl-propylene carbonate; block copolymer; micellization
ID TRANSFER RADICAL POLYMERIZATION; AMPHIPHILIC BLOCK-COPOLYMERS;
   DRUG-DELIVERY SYSTEMS; EPSILON-CAPROLACTONE; OXIDE) BLOCK;
   POLY(1,3-TRIMETHYLENE CARBONATE); POLY(GAMMA-BENZYL L-GLUTAMATE);
   TRIMETHYLENE CARBONATE; TRIBLOCK COPOLYMER; DIBLOCK COPOLYMER
AB A novel amphiphilic biodegradable poly(ethylene glycol)-poly(2-methyl-2-carboxyl-propylene carbonate) (MPEG-PMBC) block copolymer was successfully synthesized by ring-opening polymerization (ROP) of 2-methyl-2-carboxyl-propylene carbonate (MBC) with MPEG as a macroinitiator. C-13 NMR and GPC confirmed its structure. It could self-assemble into micelles in aqueous solution with the critical micelle concentration (cmc) as low as similar to 10(-3) g/l. The cmc decreased with increasing PMBC content. DLS analyses of the MPEG-PMBC micelles revealed their size of less than 100 nm and narrow size distribution. The micelle size depends much on the copolymer composition and micelle preparation conditions. The morphology of micelle observed by ESEM is spherical. The obtained polymeric micelles are expected to be used as biomedical materials such as drug delivery vehicles. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
   Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China.
RP Jing, XB (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Peoples R China.
EM xbjing@ciac.jl.cn
RI xie, zhigang/E-6501-2010
OI xie, zhigang/0000-0003-2974-1825
CR Allen C, 1998, BIOCONJUGATE CHEM, V9, P564, DOI 10.1021/bc9702157
   Arimura H, 2005, BIOMACROMOLECULES, V6, P720, DOI 10.1021/bm0494491
   Cammas S, 1996, MACROMOLECULES, V29, P3227, DOI 10.1021/ma951025z
   Cho CS, 1999, POLYMER, V40, P6769, DOI 10.1016/S0032-3861(99)00007-5
   Deng C, 2005, POLYMER, V46, P653, DOI 10.1016/j.polymer.2004.11.100
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   GAO ZS, 1993, MACROMOLECULES, V26, P7353, DOI 10.1021/ma00078a035
   Guan HL, 2005, POLYMER, V46, P2817, DOI 10.1016/j.polymer.2005.01.072
   Hagan SA, 1996, LANGMUIR, V12, P2153, DOI 10.1021/la950649v
   Hori Y, 1996, MACROMOLECULES, V29, P804, DOI 10.1021/ma951345i
   Jia YT, 2004, POLYM INT, V53, P312, DOI 10.1002/pi.1311
   Kang N, 2004, POLYMER, V45, P8967, DOI 10.1016/j.polymer.2004.10.081
   Khousakoun E, 2004, POLYMER, V45, P8303, DOI 10.1016/j.polymer.2004.10.020
   Kim C, 2000, MACROMOLECULES, V33, P7448, DOI 10.1021/ma000517v
   KIM C, 2002, POLYM J, V34, P230
   Kim KH, 2004, MACROMOL CHEM PHYSIC, V205, P1684, DOI 10.1002/macp.200400084
   Kita-Tokarczyk K, 2005, POLYMER, V46, P3540, DOI 10.1016/j.polymer.2005.02.083
   KRICHELDORF HR, 1991, MAKROMOL CHEM, V192, P2391
   Kurjata J, 2004, POLYMER, V45, P6111, DOI 10.1016/j.polymer.2004.06.062
   La SB, 1996, J PHARM SCI, V85, P85, DOI 10.1021/js950204r
   Lee JY, 2004, J CONTROL RELEASE, V94, P323, DOI 10.1016/j.conrel.2003.10.012
   Lei LC, 2004, POLYMER, V45, P4375, DOI 10.1016/j.polymer.2004.04.040
   Liu TB, 2004, POLYMER, V45, P7989, DOI 10.1016/j.polymer.2004.08.074
   Liu ZL, 2003, J POLYM SCI POL CHEM, V41, P4001, DOI 10.1002/pola.11001
   Luo LB, 2004, MACROMOLECULES, V37, P4008, DOI 10.1021/ma035910q
   NAGARAJAN R, 1989, MACROMOLECULES, V22, P4312, DOI 10.1021/ma00201a029
   Nasongkla N, 2004, ANGEW CHEM INT EDIT, V43, P6323, DOI 10.1002/anie.200460800
   Pai TSC, 2004, POLYMER, V45, P4383, DOI 10.1016/j.polymer.2004.04.041
   Park C, 2003, POLYMER, V44, P6725, DOI 10.1016/j.polymer.2003.08.011
   Raghunadh V, 2004, POLYMER, V45, P3149, DOI 10.1016/j.polymer.2004.03.042
   Soo PL, 2002, LANGMUIR, V18, P9996, DOI 10.1021/la026339b
   Storey RF, 2005, POLYMER, V46, P2141, DOI 10.1016/j.polymer.2004.12.041
   Tan BH, 2005, POLYMER, V46, P1347, DOI 10.1016/j.polymer.2004.11.070
   Tang DM, 2004, MACROMOL RAPID COMM, V25, P1241, DOI 10.1002/marc.200400100
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   Vandenberg EJ, 1999, MACROMOLECULES, V32, P3613, DOI 10.1021/ma9816822
   Wang LS, 2004, MACROMOL RAPID COMM, V25, P959, DOI 10.1002/marc.200300319
   WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010
   Yin M, 2005, POLYMER, V46, P3215, DOI 10.1016/j.polymer.2005.03.005
   Zeng FQ, 2004, BIOMACROMOLECULES, V5, P1810, DOI 10.1021/bm049836a
   Zhou Y, 2004, POLYMER, V45, P5459, DOI 10.1016/j.polymer.2004.06.016
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 42
TC 25
Z9 25
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD NOV 14
PY 2005
VL 46
IS 23
BP 10523
EP 10530
DI 10.1016/j.polymer.2005.08.025
PG 8
WC Polymer Science
SC Polymer Science
GA 978SQ
UT WOS:000232893700109
DA 2018-10-20
ER

PT J
AU Jayakumar, R
   Prabaharan, M
   Reis, RL
   Mano, JF
AF Jayakumar, R
   Prabaharan, M
   Reis, RL
   Mano, JF
TI Graft copolymerized chitosan - present status and applications
SO CARBOHYDRATE POLYMERS
LA English
DT Review
DE chitosan; grafting; grafting efficiency; drug delivery; biomedical
   applications
ID PARTIALLY DEACETYLATED CHITIN; CHEMICALLY-MODIFIED CHITOSAN; HIGHLY
   PHOSPHORYLATED DERIVATIVES; EPITHELIAL-CELLS CACO-2; IN-VITRO
   EVALUATION; L-LACTIC ACID; METAL-IONS; BETA-CYCLODEXTRIN;
   PHOTOCROSSLINKABLE CHITOSAN; DITHIOCARBAMATE CHITOSAN
AB Chitosan is a natural based polymer obtained by alkaline deacetylation of chitin, exhibiting excellent biological properties such as biodegradation in the human body, and immunological, antibacterial, and wound-healing activity. Chitosan has also been found to be a good candidate as a support material for gene delivery, cell culture and tissue engineering. However, practical use of chitosan has been mainly confined to the unmodified forms. For a breakthrough in utilization, graft copolymerization onto chitosan will be a key point, which will introduce desired properties and enlarge the field of the potential applications of chitosan by choosing various types of side chains. This article reviews the various methods such as free radical, radiation, enzymatic and cationic graft copolymerization onto chitosan, the factors influencing on the grafting parameters such as grafting percentage and grafting efficiency, and the properties of grafted chitosan. This review also screens the current applications of graft copolymerized chitosans in the field of drug delivery, tissue engineering, antibacterial, biomedical, metal adsorption and dye removal. (c) 2005 Published by Elsevier Ltd.
C1 Univ Minho, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Mano, JF (reprint author), Univ Minho, 3Bs Res Grp Biomat Biodegradables & Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM jmano@dep.uminho.pt
RI Mano, Joao/A-4418-2009; Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Mano, Joao/0000-0002-2342-3765; Group, 3Bs/0000-0002-5195-3456; Reis,
   Rui L./0000-0002-4295-6129; M, Prabaharan/0000-0001-5446-9320
CR Ahn JS, 2001, BIOMATERIALS, V22, P923, DOI 10.1016/S0142-9612(00)00256-8
   Alexandrova VA, 1999, MACROMOL SYMP, V144, P413, DOI 10.1002/masy.19991440138
   Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Aoki N, 2003, CARBOHYD POLYM, V52, P219, DOI 10.1016/S0144-8617(02)00308-9
   ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988
   Asakawa T, 2000, KAGAKU KOGAKU RONBUN, V26, P321, DOI 10.1252/kakoronbunshu.26.321
   BABA Y, 1992, CHEM LETT, P1905, DOI 10.1246/cl.1992.1905
   Baran ET, 2004, J MATER SCI-MATER M, V15, P161, DOI 10.1023/B:JMSM.0000011818.85273.cd
   BECKER T., 2000, REACT FUNCT POLYM, V44, P289
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   BERKOVICH LA, 1983, J POLYM SCI POL CHEM, V21, P1281, DOI 10.1002/pol.1983.170210505
   Bersch P.C., 1995, J MAT SCI MED, V6, P231
   BLAIR HS, 1987, J APPL POLYM SCI, V33, P641, DOI 10.1002/app.1987.070330226
   Caner H, 1998, EUR POLYM J, V34, P493
   Cardenas G, 2001, INT J BIOL MACROMOL, V28, P167, DOI 10.1016/S0141-8130(00)00156-2
   Chao AC, 2004, BIORESOURCE TECHNOL, V91, P157, DOI 10.1016/S0960-8524(03)00171-8
   Chen SP, 2001, J APPL POLYM SCI, V82, P2414, DOI 10.1002/app.2092
   Chen TH, 2000, BIOTECHNOL BIOENG, V70, P564, DOI 10.1002/1097-0290(20001205)70:5<564::AID-BIT11>3.0.CO;2-W
   CHIESSI E, 1991, J CHEM RES SYNOPSIS, V9, P248
   Choi K. S., 1990, POLLIMO, V14, P516
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   DINGILIAN EO, 1992, Patent No. 9208742
   Don TM, 2002, J APPL POLYM SCI, V86, P3057, DOI 10.1002/app.11329
   DORDICK JS, 1992, TRENDS BIOTECHNOL, V10, P287, DOI 10.1016/0167-7799(92)90246-R
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Furusaki E, 1996, CARBOHYD POLYM, V29, P29, DOI 10.1016/0144-8617(95)00133-6
   Guibal E, 2002, REACT FUNCT POLYM, V50, P149, DOI 10.1016/S1381-5148(01)00110-9
   Guibal E, 2000, J APPL POLYM SCI, V75, P119, DOI 10.1002/(SICI)1097-4628(20000103)75:1<119::AID-APP14>3.3.CO;2-5
   Guibal E, 2004, SEP PURIF TECHNOL, V38, P43, DOI 10.1016/j.seppur.2003.10.004
   GUILLEN MG, 1994, CARBOHYD RES, V258, P313
   GUILLEN MG, 1992, CARBOHYD RES, V233, P255
   Heras A, 2001, CARBOHYD POLYM, V44, P1, DOI 10.1016/S0144-8617(00)00195-8
   Hirano S., 1988, POLYM ENG SCI, V59, P897
   Hoffman A.S., 1997, POLYM PREPR AM CHEM, V38, P524
   HOLME KR, 1991, CAN J CHEM, V69, P585, DOI 10.1139/v91-088
   Hu SG, 2003, J APPL POLYM SCI, V88, P2797, DOI 10.1002/app.12055
   Hu Y, 2002, BIOMATERIALS, V23, P3193, DOI 10.1016/S0142-9612(02)00071-6
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   INOUE K, 1993, B CHEM SOC JPN, V66, P2915, DOI 10.1246/bcsj.66.2915
   INOUE K, 1995, SEPAR SCI TECHNOL, V30, P2477, DOI 10.1080/01496399508021396
   INOUE K, 1994, BIOTECHNOLOGY AND BIOACTIVE POLYMERS, P35
   Jilan W, 2001, RADIAT PHYS CHEM, V61, P149
   Juang RS, 1998, IND ENG CHEM RES, V37, P3463, DOI 10.1021/ie980046p
   Juang RS, 1997, IND ENG CHEM RES, V36, P5403, DOI 10.1021/ie970322k
   Jung BO, 1999, J APPL POLYM SCI, V72, P1713, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1713::AID-APP7>3.0.CO;2-T
   Kang DW, 1999, J APPL POLYM SCI, V73, P469, DOI 10.1002/(SICI)1097-4628(19990725)73:4<469::AID-APP2>3.3.CO;2-9
   Kang DW, 1996, POLYM-KOREA, V20, P989
   Kaplan DL, 1998, ACS SYM SER, V684, P2
   Kast CE, 2003, INT J PHARM, V256, P183, DOI 10.1016/S0378-5173(03)00076-0
   Kast CE, 2001, BIOMATERIALS, V22, P2345, DOI 10.1016/S0142-9612(00)00421-X
   Kawamura Y, 1997, WATER SCI TECHNOL, V35, P97, DOI 10.1016/S0273-1223(97)00119-4
   KAWAMURA Y, 1993, IND ENG CHEM RES, V32, P386, DOI 10.1021/ie00014a015
   Kim IY, 2002, J APPL POLYM SCI, V85, P2661, DOI 10.1002/app.10626
   Kim SY, 2000, J APPL POLYM SCI, V78, P1381, DOI 10.1002/1097-4628(20001114)78:7<1381::AID-APP90>3.0.CO;2-M
   Kim YH, 2001, BIOCONJUGATE CHEM, V12, P932, DOI 10.1021/bc015510c
   Kondo K, 1996, SEPAR SCI TECHNOL, V31, P1771, DOI 10.1080/01496399608000724
   Kondo K, 1997, J CHEM ENG JPN, V30, P846, DOI 10.1252/jcej.30.846
   Kotze AF, 1997, PHARMACEUT RES, V14, P1197, DOI 10.1023/A:1012106907708
   Kumar G, 1999, BIOTECHNOL BIOENG, V63, P154, DOI 10.1002/(SICI)1097-0290(19990420)63:2<154::AID-BIT4>3.3.CO;2-I
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumbar SG, 2003, J APPL POLYM SCI, V89, P2940, DOI 10.1002/app.12386
   Kumbar SG, 2003, J APPL POLYM SCI, V87, P1525, DOI 10.1002/app.11552
   Kurita K, 1998, CHEM LETT, P317, DOI 10.1246/cl.1998.317
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Kweon DK, 1999, J APPL POLYM SCI, V74, P458, DOI 10.1002/(SICI)1097-4628(19991010)74:2<458::AID-APP29>3.0.CO;2-6
   LAGOS A, 1988, J POLYM SCI POL CHEM, V26, P985, DOI 10.1002/pola.1988.080260403
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Li YP, 2003, POLYM INT, V52, P285, DOI 10.1002/pi.1082
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Liu YH, 2003, J APPL POLYM SCI, V89, P2283, DOI 10.1002/app.12102
   LUEBEN HL, 1996, PHARM RES, V13, P1668
   Mao C, 2004, MAT SCI ENG C-BIO S, V24, P479, DOI 10.1016/j.msec.2003.09.168
   Mao C, 2004, PROCESS BIOCHEM, V39, P1151, DOI 10.1016/S0032-9592(03)00225-5
   Martel B, 2001, J POLYM SCI POL CHEM, V39, P169, DOI 10.1002/1099-0518(20010101)39:1<169::AID-POLA190>3.0.CO;2-G
   MORI T, 1999, KICHIN KITOSAN KENKY, V5, P168
   MU Q, 2000, XIANDAI HUAGONG, V20, P14
   Muzzarelli C, 2002, TRENDS GLYCOSCI GLYC, V14, P223, DOI 10.4052/tigg.14.223
   Muzzarelli R., 1986, CHITIN NATURE TECHNO
   MUZZARELLI RAA, 1982, PURE APPL CHEM, V54, P2141, DOI 10.1351/pac198254112141
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   MUZZARELLI RAA, 1985, BIOTECHNOL BIOENG, V27, P1115, DOI 10.1002/bit.260270805
   MUZZARELLI RAA, 1982, CARBOHYD RES, V104, P235, DOI 10.1016/S0008-6215(00)82585-9
   MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P85, DOI 10.1016/0144-8617(85)90026-8
   MUZZARELLI RAA, 1984, CARBOHYD POLYM, V4, P137
   MUZZARELLI RAA, 1989, ELSEVIER APPL POLYM, P87
   Nagib S, 1999, HYDROMETALLURGY, V51, P73, DOI 10.1016/S0304-386X(98)00073-5
   Najjar AMK, 2000, J APPL POLYM SCI, V77, P2314, DOI 10.1002/1097-4628(20000906)77:10<2314::AID-APP25>3.0.CO;2-7
   Ng LT, 2001, J APPL POLYM SCI, V79, P466
   Ni CH, 1996, J APPL POLYM SCI, V59, P499
   NISHI N, 1987, INT J BIOL MACROMOL, V9, P109, DOI 10.1016/0141-8130(87)90035-3
   NISHI N, 1986, INT J BIOL MACROMOL, V8, P311, DOI 10.1016/0141-8130(86)90046-2
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Ouchi T, 1998, POLYMER, V39, P5171, DOI 10.1016/S0032-3861(97)10020-9
   Pedram M. Y, 2000, MACROMOLECULAR CHEM, V201, P923
   Pedram M.Y., 1996, J APPL POLYM SCI, V63, P1321
   PEDRAM MY, 1992, INT J POLYM MATER, V18, P25
   PEDRAM MY, 1995, J MACROMOL SCI CHEM, V32, P1037
   Peng CH, 1998, J APPL POLYM SCI, V70, P501, DOI 10.1002/(SICI)1097-4628(19981017)70:3<501::AID-APP11>3.3.CO;2-S
   Pourjavadi A, 2003, J APPL POLYM SCI, V90, P3115, DOI 10.1002/app.13054
   Pourjavadi A, 2003, J APPL POLYM SCI, V88, P2048, DOI 10.1002/app.11820
   Prashanth KVH, 2003, CARBOHYD POLYM, V54, P343, DOI 10.1016/S0144-8617(03)00191-7
   Radhakumary C, 2003, J MACROMOL SCI PURE, VA40, P715, DOI 10.1081/MA-120021421
   Ramos VM, 2003, CARBOHYD POLYM, V51, P425, DOI 10.1016/S0144-8617(02)00211-4
   RAVIKUMAR MNV, 2000, REACT FUNCT POLYM, V46, P1
   RETUERT J, 1993, POLYM BULL, V31, P559, DOI 10.1007/BF00297892
   Rodrigues CA, 1998, POLYMER, V39, P5121, DOI 10.1016/S0032-3861(97)10190-2
   Ruiz M, 2003, SOLVENT EXTR ION EXC, V21, P307, DOI 10.1081/SEI-120018952
   Ruiz M, 2002, SEPAR SCI TECHNOL, V37, P2385, DOI 10.1081/SS-120003519
   SAKAGUCHI T, 1979, NIPPON NOGEI KAGAKU, V53, P149
   SANFORD PA, 1989, CHITIN CHITOSAN SOUR, P51
   Sashiwa H, 1999, CARBOHYD POLYM, V39, P127, DOI 10.1016/S0144-8617(98)00167-2
   SAUCEDO I, 1992, ENVIRON TECHNOL, V13, P1101, DOI 10.1080/09593339209385250
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   SEO T, 1991, BIOTECHNOLOGY AND POLYMERS, P215
   SHANTHA KL, 1995, EUR POLYM J, V31, P377, DOI 10.1016/0014-3057(94)00177-4
   Shanthi C, 2001, CARBOHYD POLYM, V44, P123, DOI 10.1016/S0144-8617(00)00201-0
   Shigemasa Y, 1999, CARBOHYD POLYM, V39, P237, DOI 10.1016/S0144-8617(99)00007-7
   SHIGENO Y, 1982, J MACROMOL SCI CHEM, VA17, P571, DOI 10.1080/00222338208062409
   Shimizu Y, 2005, J APPL POLYM SCI, V96, P2423, DOI 10.1002/app.21707
   Singh DK, 1997, J APPL POLYM SCI, V66, P869, DOI 10.1002/(SICI)1097-4628(19971031)66:5<869::AID-APP7>3.0.CO;2-T
   Singh DK, 1998, CARBOHYD POLYM, V36, P251, DOI 10.1016/S0144-8617(97)00260-9
   Singh V, 2005, J APPL POLYM SCI, V95, P820, DOI 10.1002/app.21245
   Sreenivasan K, 1998, J APPL POLYM SCI, V69, P1051, DOI 10.1002/(SICI)1097-4628(19980808)69:6<1051::AID-APP1>3.0.CO;2-F
   Sridhari TR, 2000, INDIAN J CHEM TECHN, V7, P198
   Sugimoto M, 1998, CARBOHYD POLYM, V36, P49, DOI 10.1016/S0144-8617(97)00235-X
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun T, 2003, EUR POLYM J, V39, P189, DOI 10.1016/S0014-3057(02)00174-X
   Sun T, 2004, CARBOHYD POLYM, V58, P379, DOI 10.1016/j.carbpol.2004.06.042
   TAHLAWY KEL, 2001, J APPL POLYM SCI, V82, P683
   Tan SY, 1999, J APPL POLYM SCI, V71, P2069, DOI 10.1002/(SICI)1097-4628(19990321)71:12<2069::AID-APP17>3.3.CO;2-J
   Tang LG, 2001, J APPL POLYM SCI, V79, P1476, DOI 10.1002/1097-4628(20010222)79:8<1476::AID-APP150>3.0.CO;2-A
   Tasker RAR, 1998, LAB ANIM, V32, P270, DOI 10.1258/002367798780559220
   Terada N, 1999, CHEM LETT, P1285, DOI 10.1246/cl.1999.1285
   Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9
   Tojima T, 1999, CARBOHYD POLYM, V40, P17, DOI 10.1016/S0144-8617(99)00030-2
   Tojima T, 1998, J POLYM SCI POL CHEM, V36, P1965, DOI 10.1002/(SICI)1099-0518(199808)36:11<1965::AID-POLA33>3.3.CO;2-K
   TOKURA S, 1983, POLYM J, V15, P597, DOI 10.1295/polymj.15.597
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Vachoud L, 2001, ENZYME MICROB TECH, V29, P380, DOI 10.1016/S0141-0229(01)00404-5
   VALANTA C, 1998, J PHARM PHARMACOL, V50, P445
   Verma A. J., 2004, CARBOHYD POLYM, V55, P77
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Wang Yuting, 1999, Huanjing Kexue, V20, P55
   Weltrowski M, 1996, J APPL POLYM SCI, V59, P647, DOI 10.1002/(SICI)1097-4628(19960124)59:4<647::AID-APP10>3.0.CO;2-N
   Xie WM, 2002, CARBOHYD POLYM, V50, P35, DOI 10.1016/S0144-8617(01)00370-8
   Xie WM, 2002, POLYM BULL, V49, P47, DOI 10.1007/s00289-002-0076-1
   Xie WM, 2001, BIOORG MED CHEM LETT, V11, P1699, DOI 10.1016/S0960-894X(01)00285-2
   YALPANI M, 1991, MACROMOLECULES, V24, P6046, DOI 10.1021/ma00022a024
   Yamada K, 2000, BIOMACROMOLECULES, V1, P252, DOI 10.1021/bm0003009
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   YANG S, 1989, SYNTHETIC MET, V32, P191, DOI 10.1016/0379-6779(89)90841-2
   Yang ZK, 2003, J APPL POLYM SCI, V89, P924, DOI 10.1002/app.12015
   Yang ZK, 1999, J APPL POLYM SCI, V74, P3053, DOI 10.1002/(SICI)1097-4628(19991220)74:13<3053::AID-APP7>3.0.CO;2-6
   Yang ZK, 2002, J APPL POLYM SCI, V86, P2677, DOI 10.1002/app.11214
   Yang ZK, 2001, J APPL POLYM SCI, V82, P1838, DOI 10.1002/app.2026
   Yao FL, 2003, POLYMER, V44, P6435, DOI 10.1016/S0032-3861(03)000676-1
   Yoshikawa S, 1998, J APPL POLYM SCI, V68, P1883, DOI 10.1002/(SICI)1097-4628(19980613)68:11<1883::AID-APP21>3.0.CO;2-U
   Yu L, 2003, J APPL POLYM SCI, V90, P2855, DOI 10.1002/app.13011
   Zhang J, 2003, EUR POLYM J, V39, P847, DOI 10.1016/S0014-3057(02)00286-0
NR 163
TC 356
Z9 368
U1 8
U2 164
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD NOV 10
PY 2005
VL 62
IS 2
BP 142
EP 158
DI 10.1016/j.carbpol.2005.07.017
PG 17
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 985MS
UT WOS:000233382600007
DA 2018-10-20
ER

PT J
AU Zhu, SL
   Yang, XJ
   Fu, DH
   Zhang, LY
   Li, CY
   Cui, ZD
AF Zhu, SL
   Yang, XJ
   Fu, DH
   Zhang, LY
   Li, CY
   Cui, ZD
TI Stress-strain behavior of porous NiTi alloys prepared by powders
   sintering
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE powder metallurgy; shape memory alloy; porous NiTi alloy; mechanical
   property
ID SHAPE-MEMORY ALLOY; ELEMENTAL POWDERS; TINI; FABRICATION; IMPLANTS
AB Porous NiTi shape memory alloys have recently attracted extensive interests for their potential use as biomedical materials. Stress-strain behaviors of porous NiTi alloy fabricated by element powder sintering in argon atmosphere were investigated in this paper by compression and flexural tests. The results indicated that the ultimate compressive strength and the flexural strength of the porous NiTi alloy depended on the densities of the porous NiTi alloy and the sintering conditions. In compression experiments, the pre-strain could completely recover while it was less than 2%. The shape recovery of porous NiTi alloy rested with the unique SME of NiTi phase and pores structure. The pores have adverse effects on the shape recovery of NiTi alloy under the experiment conditions. (c) 2005 Elsevier B.V. All rights reserved.
C1 Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
   Tianjin Univ, Sch Mech Engn, Tianjin 300072, Peoples R China.
   Tianjin Med Univ, Sch Dent, Tianjin 300070, Peoples R China.
RP Cui, ZD (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM zdcui@tju.edu.cn
RI Zhu, Shengli/D-5281-2009
OI Zhu, Shengli/0000-0002-0190-2626
CR Bram M, 2002, MAT SCI ENG A-STRUCT, V337, P254, DOI 10.1016/S0921-5093(02)00028-X
   Chen MF, 2004, MAT SCI ENG C-BIO S, V24, P497, DOI 10.1016/j.msec.2003.11.001
   Chu CL, 2004, MAT SCI ENG A-STRUCT, V366, P114, DOI 10.1016/j.msea.2003.08.118
   DAVIES GJ, 1983, J MATER SCI, V18, P1899, DOI 10.1007/BF00554981
   Entchev PB, 2004, MECH MATER, V36, P893
   Helsen J.A., 1998, METALS BIOMATERIALS
   HEY JC, 1994, MAT SCI ENG A-STRUCT, V188, P291, DOI 10.1016/0921-5093(94)90384-0
   Hosoda H, 1998, INTERMETALLICS, V6, P291, DOI 10.1016/S0966-9795(97)00100-3
   Kujala S, 2004, BIOMATERIALS, V25, P353, DOI 10.1016/S0142-9612(03)00488-5
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li BY, 2000, INTERMETALLICS, V8, P643, DOI 10.1016/S0966-9795(99)00140-5
   Lipscomb I. P., 1996, APPL SHAPE MEMORY AL
   McNeese MD, 2000, MAT SCI ENG A-STRUCT, V280, P334, DOI 10.1016/S0921-5093(99)00550-X
   Qidwai MA, 2001, INT J SOLIDS STRUCT, V38, P8653, DOI 10.1016/S0020-7683(01)00118-4
   Smith LN, 1998, J MATER PROCESS TECH, V79, P94, DOI 10.1016/S0924-0136(97)00387-7
   Yuan B, 2004, MAT SCI ENG A-STRUCT, V382, P181, DOI 10.1016/j.msea.2004.04.068
   Zhu SL, 2004, MATER LETT, V58, P2369, DOI 10.1016/j.matlet.2004.02.017
NR 17
TC 74
Z9 79
U1 0
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD NOV 5
PY 2005
VL 408
IS 1-2
BP 264
EP 268
DI 10.1016/j.msea.2005.08.012
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 987NN
UT WOS:000233524700037
DA 2018-10-20
ER

PT J
AU Kannan, RY
   Salacinski, HJ
   Butler, PE
   Seifalian, AM
AF Kannan, RY
   Salacinski, HJ
   Butler, PE
   Seifalian, AM
TI Polyhedral oligomeric silsesquioxane nanocomposites: The next generation
   material for biomedical applications
SO ACCOUNTS OF CHEMICAL RESEARCH
LA English
DT Review
ID NONLINEAR-OPTICAL PROPERTIES; CARBON NANOTUBES; PHOTOCATALYTIC
   PROPERTIES; H-SILSESQUIOXANES; HYBRID COMPOSITES; POLYMERS; NANOSCALE;
   SILICA; NANOPARTICLES; DEFORMATION
AB The unique properties of nanocomposites have seen them creating the next revolution in materials science. Their quantal properties as a result of their size have given them unique physical characteristics, previously not possible because of classical physical laws. There is now evidence that these may also extend into the world of biology and medicine. In this Account, we look at the birth of a new generation of silica nanocomposites using polyhedral oligomeric silsesquioxanes, a promising nanoscale silica particle with particular use in cardiovascular interventional devices.
C1 UCL, BTEC, London, England.
   Royal Free Hampstead NHS Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, BTEC, Mortimer St, London, England.
EM A.Seifalian@UCL.AC.UK
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322; Butler,
   Peter/0000-0001-7419-1493
CR Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   Armstrong J, 2004, J PHYS-CONDENS MAT, V16, pS2483, DOI 10.1088/0953-8984/16/26/022
   Beyer G., 2002, PLAST ADDIT COMPD, V4, P22, DOI DOI 10.1016/S1464-391X(02)80151-9
   Chapman DL, 1913, PHILOS MAG, V25, P475, DOI 10.1080/14786440408634187
   Cheng WD, 2000, J PHYS CHEM B, V104, P6737, DOI 10.1021/jp000016b
   Chnari E, 2005, BIOMATERIALS, V26, P3749, DOI 10.1016/j.biomaterials.2004.09.038
   Choi J, 2001, J AM CHEM SOC, V123, P11420, DOI 10.1021/ja010720l
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Deng JJ, 2002, J AM CHEM SOC, V124, P15194, DOI 10.1021/ja027860v
   Dijkstra TW, 2002, J AM CHEM SOC, V124, P9856, DOI 10.1021/ja0122243
   Du H, 2002, CHEM MATER, V14, P4473, DOI 10.1021/cm010622z
   Fu BX, 2001, POLYMER, V42, P599, DOI 10.1016/S0032-3861(00)00389-X
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Ghosh B, 2004, J NANOSCI NANOTECHNO, V4, P849, DOI 10.1166/jnn.2004.113
   Giannelis EP, 1999, ADV POLYM SCI, V118, P108, DOI [10.1007/3-540-69711-X_3, DOI 10.1007/3-540-69711-X_]
   Gooding JJ, 2005, METH MOL B, V300, P225
   Haddad TS, 1999, ABSTR PAP AM CHEM S, V217, pU608
   Harrup M., 2002, FUNCTIONAL CONDENSAT, P43
   Hoet P. M., 2004, J NANOBIOTECHNOL, V2, P12, DOI DOI 10.1186/1477-3155-2-12
   Huang HZ, 2005, J COLLOID INTERF SCI, V282, P26, DOI 10.1016/j.jcis.2004.08.063
   Huang XY, 2003, J AM CHEM SOC, V125, P7049, DOI 10.1021/ja0343611
   Kannan R Y, 2004, Med J Malaysia, V59 Suppl B, P107
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Karajanagi SS, 2004, LANGMUIR, V20, P11594, DOI 10.1021/la047994h
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Lee A, 1998, MACROMOLECULES, V31, P4970, DOI 10.1021/ma9800764
   Lee SH, 2005, COLLOID SURFACE B, V40, P93, DOI 10.1016/j.colsurfb.2004.05.005
   Li J, 2005, METH MOL B, V300, P191
   LICHTENHAN JD, 1995, COMMENT INORG CHEM, V17, P115, DOI 10.1080/02603599508035785
   Lichtenhan JD, 1998, ABSTR PAP AM CHEM S, V215, pU410
   Liu Y, 1999, OPT EXPRESS, V4, P177, DOI 10.1364/OE.4.000177
   Liu YL, 2005, BIOMACROMOLECULES, V6, P368, DOI 10.1021/bm049531w
   Meng GW, 2004, J NANOSCI NANOTECHNO, V4, P712, DOI 10.1166/jnn.2004.100
   Merkel TC, 2002, SCIENCE, V296, P519, DOI 10.1126/science.1069580
   Moreau JJE, 2003, CHEM-EUR J, V9, P1594, DOI 10.1002/chem.200390183
   Muller B, 2001, J VAC SCI TECHNOL B, V19, P1715, DOI 10.1116/1.1392402
   NOVAK BM, 1993, ADV MATER, V5, P422, DOI 10.1002/adma.19930050603
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   POPE EJA, 1986, J NON-CRYST SOLIDS, V87, P185, DOI 10.1016/S0022-3093(86)80078-3
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   SAHATJIAN RA, 2003, Patent No. 2004032799
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   SALACINSKI HJ, 2004, Patent No. 04012027
   Sanchez C, 2001, CHEM MATER, V13, P3061, DOI 10.1021/cm01106le
   SANTIERRE PJ, 2002, Patent No. 2002098477
   Sato T, 1996, J CHEM SOC FARADAY T, V92, P5089, DOI 10.1039/ft9969205089
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Sheng YJ, 2004, J CHEM PHYS, V121, P9693, DOI 10.1063/1.1808124
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Song SP, 2004, J NANOSCI NANOTECHNO, V4, P817, DOI 10.1166/jnn.2004.093
   Suhr J, 2005, NAT MATER, V4, P134, DOI 10.1038/nmat1293
   Suresh S, 2004, J NANOSCI NANOTECHNO, V4, P250, DOI 10.1166/jnn.2004.033
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   Tiwari A, 2004, MATER RES INNOV, V8, P103, DOI 10.1080/14328917.2004.11784839
   TRAN HV, 2001, ABSTR PAP AM CHEM 2, V221, P283
   Van Zeghbroeck B., 2004, PRINCIPLES SEMICONDU
   VORONKOV MG, 1981, 3 IRIS M IRIS GRAZ A
   Wada K, 2005, CHEM COMMUN, P95, DOI 10.1039/b413921f
   Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340
   Wu JH, 2001, J MATER CHEM, V11, P3343, DOI 10.1039/b103838a
   Xiang KH, 1998, J PHYS CHEM B, V102, P8704, DOI 10.1021/jp981840r
   Xu HY, 2002, MACROMOLECULES, V35, P8788, DOI 10.1021/ma0202843
   Yang HG, 2005, J AM CHEM SOC, V127, P270, DOI 10.1021/ja045253x
   Yu J, 2004, J APPL POLYM SCI, V92, P749, DOI 10.1002/app.20013
   Zaremba CM, 1996, CHEM MATER, V8, P679, DOI 10.1021/cm9503285
   Zhang Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.195504
NR 67
TC 292
Z9 296
U1 4
U2 143
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0001-4842
EI 1520-4898
J9 ACCOUNTS CHEM RES
JI Accounts Chem. Res.
PD NOV
PY 2005
VL 38
IS 11
BP 879
EP 884
DI 10.1021/ar050055b
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 986HZ
UT WOS:000233442000005
PM 16285710
DA 2018-10-20
ER

PT J
AU Cioffi, M
   Gilliland, D
   Ceccone, G
   Chiesa, R
   Cigada, A
AF Cioffi, M
   Gilliland, D
   Ceccone, G
   Chiesa, R
   Cigada, A
TI Electrochemical release testing of nickel-titanium orthodontic wires in
   artificial saliva using thin layer activation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE nickel-titanium alloy; orthodontics; corrosion; fluoride; strain
ID SHAPE-MEMORY ALLOYS; CORROSION BEHAVIOR; ATMOSPHERIC CORROSION; DENTAL
   MATERIALS; SURFACE; METAL; BIOCOMPATIBILITY; RESISTANCE; NITINOL; STEEL
AB Alloys based on Ni-Ti intermetallics generally exhibit special shape memory and pseudoelastic properties, which make them desirable for use in the dental field as orthodontic wires. The possibility of nickel release from these materials is of high concern, because the allergenicity of this element. The aim of this study was to test pseudoelastic Ni-Ti wires in simulated physiological conditions, investigating the combined effect of strain and fluoridated media: the wires were examined both under strained (5% tensile strain) and unstrained conditions, in fluoridated artificial saliva at 37 degrees C. Real time electrochemical nickel release testing was performed using a novel application of a radiotracer based method, thin layer activation (TLA). TLA was validated, in unstrained conditions, against adsorptive stripping voltammetry methodology. Control tests were also performed in non-fluoridated artificial saliva. From our research it transpired that the corrosion behaviour of Ni-Ti alloy is highly affected by the fluoride content, showing a release of 4.79 +/- 0.10 mu g/cm(2)/day, but, differently from other biomaterials, it does not seem to be affected by elastic tensile strain. The application of the TLA method in the biomedical field appears a suitable technique to monitor in real time the corrosion behaviour of biomedical devices. (c) 2005 Actabio Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy.
   Commiss European Communities, Inst Hlth & Consumer Protect, I-21020 Ispra, Italy.
   Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, I-20131 Milan, Italy.
RP Cioffi, M (reprint author), Politecn Milan, Dipartimento Bioingn, Piazza Leonardo Da Vinci 32, I-20133 Milan, Italy.
EM margherita.cioffi@biomed.polimi.it
RI Chiesa, Roberto/N-2605-2013
OI Chiesa, Roberto/0000-0002-5317-6849; Cigada, Alberto/0000-0002-0925-5558
CR Achterberg EP, 1999, ANAL CHIM ACTA, V400, P381, DOI 10.1016/S0003-2670(99)00619-4
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   Baumann Michael A, 2004, Dent Clin North Am, V48, P55, DOI 10.1016/j.cden.2003.11.001
   Cisse O, 2002, J BIOMED MATER RES, V61, P339, DOI 10.1002/jbm.10114
   CRAGG AH, 1993, RADIOLOGY, V189, P775, DOI 10.1148/radiology.189.3.8234703
   Dai KR, 1996, BIO-MED MATER ENG, V6, P233
   Garcia-Alonso MC, 2002, CORROS SCI, V44, P129, DOI 10.1016/S0010-938X(01)00044-0
   Gil FJ, 1998, P I MECH ENG H, V212, P473, DOI 10.1243/0954411981534231
   Haanappel VAC, 2002, CORROS SCI, V44, P1411, DOI 10.1016/S0010-938X(01)00150-0
   Hensten-Pettersen A, 1998, EUR J ORAL SCI, V106, P707
   Huang HH, 2003, BIOMATERIALS, V24, P3585, DOI 10.1016/S0142-9612(03)00188-1
   Huang HH, 2002, BIOMATERIALS, V23, P59, DOI 10.1016/S0142-9612(01)00079-5
   HUANG HH, 2003, BIOMED MAT RES, V15, P829
   Hwang CJ, 2001, AM J ORTHOD DENTOFAC, V120, P383, DOI 10.1067/mod.2001.117911
   Ibe D M, 1998, J Orofac Orthop, V59, P29, DOI 10.1007/BF01321553
   Jia WY, 1999, J BIOMED MATER RES, V48, P488, DOI 10.1002/(SICI)1097-4636(1999)48:4<488::AID-JBM14>3.3.CO;2-4
   Kusy RP, 2000, AM J ORTHOD DENTOFAC, V117, P589, DOI 10.1016/S0889-5406(00)70210-1
   Laguzzi G, 2001, CORROS SCI, V43, P747, DOI 10.1016/S0010-938X(00)00075-5
   Leung VWH, 1997, J DENT, V25, P475, DOI 10.1016/S0300-5712(96)00068-1
   Newbrun E, 2001, J Dent Educ, V65, P1078
   PROFFIT WR, 1995, ORTODONZIA MODERNA, P266
   Rincic N, 2003, COLLEGIUM ANTROPOL, V27, P99
   Rondelli G, 2000, J BIOMED MATER RES, V51, P47, DOI 10.1002/(SICI)1097-4636(200007)51:1<47::AID-JBM7>3.3.CO;2-G
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Shin Ji-Soo, 2003, Aust Orthod J, V19, P13
   Stroosnijder MF, 2004, CORROS SCI, V46, P2355, DOI 10.1016/j.corsci.2004.01.014
   Stroosnijder MF, 1995, NATO ADV SCI INST SE, V283, P399
   Thompson SA, 2000, INT ENDOD J, V33, P297, DOI 10.1046/j.1365-2591.2000.00339.x
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
NR 31
TC 23
Z9 25
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2005
VL 1
IS 6
BP 717
EP 724
DI 10.1016/j.actbio.2005.07.008
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 008RC
UT WOS:000235057400013
PM 16701852
DA 2018-10-20
ER

PT J
AU Eder, C
   Falkner, E
   Mickel, M
   Chiari-Grisar, C
   Appl, H
   Schoffl, H
   Nehrer, S
   Losert, UM
AF Eder, C
   Falkner, E
   Mickel, M
   Chiari-Grisar, C
   Appl, H
   Schoffl, H
   Nehrer, S
   Losert, UM
TI A modified HET-CAM approach for biocompatibility testing of medical
   devices
SO ANIMAL WELFARE
LA English
DT Article
DE animal welfare; biocompatibility testing; chorionallantoic membrane;
   HET-CAM test; Three Rs; tissue engineering
ID CELLS
AB The implantation of new biomedical devices into living animals without any previous toxicity or biocompatibility evaluation is possible under current legislation. The HET-CAM (Hen Egg Test-Chorionallantoic Membrane) test offers a partially immunodeficient, borderline in vitro/in vivo test system that ailows the simulation of transplantation experiments to obtain biocompatibility data prior to animal testing. A collagen type I/III scaffold, designed for tissue regeneration, was tested for angiogenetic properties and biocompatibility patterns. A significant angiogenetic stimulus caused by the collagen scaffold material was observed. Altering biocompatibility patterns by incubation with the potentially hazardous chemicals acridine orange and ethidiurn bromide led to severe vessel thrombosis and a foreign body tissue response. CAM testing of biomaterials and tissue engineered products allows selection of the most suitable biomoterial and the elimination of unsuitable materials from animal experiments, leading to a refinement of testing procedures and a reduction in the number of animals required for biocompatibility testing.
C1 Med Univ Vienna, Dept Orthopaed Surg, Vienna, Austria.
   Ctr Alternat & Complementary Methods Anim Testing, Linz, Austria.
   Med Univ Vienna, Core Unit Biomed Res, Vienna, Austria.
   Karl Landsteiner Inst Appl Cardiovasc Res, Vienna, Austria.
RP Eder, C (reprint author), Med Univ Vienna, Dept Orthopaed Surg, Vienna, Austria.
EM eder@zet.or.at
CR BOHNSACK U, 2003, 109931 ISO
   Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   BRISCOE DM, 1999, TRANSPLANTATION, V67, P1950
   DAVIES JE, 2000, BONE ENG
   Djabari Z, 2002, INT J TISSUE REACT, V24, P117
   Falkner E, 2004, ATLA-ALTERN LAB ANIM, V32, P573
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404
   JUX C, 2003, J INTERVENTIONAL CAR, V6, P149
   Kalteis T, 2004, Z ORTHOP GRENZGEB, V142, P666, DOI 10.1055/s-2004-832317
   Kalweit S, 1987, Mol Toxicol, V1, P597
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   Romeis B., 1989, MIKROSKOPISCHE TECHN
   Russel W, 1959, PRINCIPLES HUMANE EX
   Spielmann H, 1995, Methods Mol Biol, V43, P199
   VANTIENHOVEN EAE, 2001, 640080 RIVM
   1989, REGULATING EXPT PROC
NR 17
TC 2
Z9 2
U1 0
U2 1
PU UNIV FEDERATION ANIMAL WELFARE
PI WHEATHAMPSTEAD
PA OLD SCHOOL, BREWHOUSE HILL, WHEATHAMPSTEAD AL4 8AN, HERTS, ENGLAND
SN 0962-7286
J9 ANIM WELFARE
JI Anim. Welf.
PD NOV
PY 2005
VL 14
IS 4
BP 297
EP 302
PG 6
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 978QU
UT WOS:000232888900005
DA 2018-10-20
ER

PT J
AU Haynie, DT
   Zhang, L
   Rudra, JS
   Zhao, WH
   Zhong, Y
   Palath, N
AF Haynie, DT
   Zhang, L
   Rudra, JS
   Zhao, WH
   Zhong, Y
   Palath, N
TI Polypeptide multilayer films
SO BIOMACROMOLECULES
LA English
DT Review
ID BY-LAYER MANIPULATION; SURFACTANT-LIKE PEPTIDES; ATOMIC-FORCE
   MICROSCOPY; IN-SITU ELLIPSOMETRY; ALPHA-AMINO-ACID; POLYELECTROLYTE
   MULTILAYERS; THIN-FILMS; SECONDARY STRUCTURE; WEAK POLYELECTROLYTES;
   CONJUGATED POLYMERS
AB Research on polypeptide multilayer films, coatings, and microcapsules is located at the intersection of several disciplines: synthetic polymer chemistry and physics, biomaterials science, and nanoscale engineering. The past few years have witnessed considerable growth in each of these areas. Unexplored territory has been found at the borders, and new possibilities for technology development are taking form from technological advances in polypeptide production, sequencing of the human genome, and the nature of peptides themselves. Most envisioned applications of polypeptide multilayers have a biomedical bent. Prospects seem no less positive, however, in fields ranging from food technology to environmental science. This review of the present state of polypeptide multilayer film research covers key points of polypeptides as materials, means of polymer production and film preparation, film characterization methods, focal points of current research in basic science, and the outlook for a few specific applications. In addition, it discusses how the study of polypeptide multilayer films could help to clarify the physical basis of assembly and stability of polyelectrolyte multilayers, and mention is made of similarities to protein folding studies.
C1 Louisiana Tech Univ, Bioanosyst Engn Lab, Ctr Appl Phys Studies, Coll Engn & Sci, Ruston, LA 71272 USA.
RP Haynie, DT (reprint author), Louisiana Tech Univ, Bioanosyst Engn Lab, Ctr Appl Phys Studies, Coll Engn & Sci, POB 10348, Ruston, LA 71272 USA.
EM haynie@latech.edu
CR Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Alberts B, 2002, MOL BIOL CELL
   Angeletti R H, 1999, J Biomol Tech, V10, P2
   Antipov AA, 2001, J PHYS CHEM B, V105, P2281, DOI 10.1021/jp002184+
   Antipov AA, 2004, ADV COLLOID INTERFAC, V111, P49, DOI 10.1016/j.cis.2004.07.006
   Anzai J, 1999, J CHEM SOC PERK T 2, P2413, DOI 10.1039/a907276d
   Anzai J, 2001, BUNSEKI KAGAKU, V50, P585, DOI 10.2116/bunsekikagaku.50.585
   AOKI T, 1995, J MEMBRANE SCI, V99, P117, DOI 10.1016/0376-7388(94)00199-9
   Arys X, 2000, SUPRAMOLECULAR POLYMERS, P505
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   BALKUNDI S, 2004, THESIS LOUISIANA TU
   BECKERLE M, 2002, FRONTIERS MOL BIOL
   BELL LN, 1995, BIOPOLYMERS, V35, P201, DOI 10.1002/bip.360350208
   Bellomo EG, 2004, NAT MATER, V3, P244, DOI 10.1038/nmat1093
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Beynon R., 2001, PROTEOLYTIC ENZYMES
   Bliznyuk VN, 1998, POLYMER, V39, P5249, DOI 10.1016/S0032-3861(98)00069-X
   Boulmedais F, 2003, LANGMUIR, V19, P440, DOI 10.1021/la0264522
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Boulmedais F, 2003, LANGMUIR, V19, P9873, DOI 10.1021/la0348259
   Boulmedais F, 2002, LANGMUIR, V18, P4523, DOI 10.1021/la0117505
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   BOWER CK, 1995, APPL ENVIRON MICROB, V61, P992
   Branden C., 1999, INTRO PROTEIN STRUCT
   Brown T. A., 2000, ESSENTIAL MOL BIOL P
   Brynda E, 1996, J COLLOID INTERF SCI, V183, P18, DOI 10.1006/jcis.1996.0514
   Burke SE, 2003, BIOMACROMOLECULES, V4, P1773, DOI 10.1021/bm034184w
   Burke SE, 2003, LANGMUIR, V19, P3297, DOI 10.1021/la026500i
   Burkoth TS, 1999, J AM CHEM SOC, V121, P7429, DOI 10.1021/ja991233x
   Canavan HE, 2005, LANGMUIR, V21, P1949, DOI 10.1021/la048546c
   Caruso F, 2000, CHEM-EUR J, V6, P413, DOI 10.1002/(SICI)1521-3765(20000204)6:3<413::AID-CHEM413>3.0.CO;2-9
   Caruso F, 1999, LANGMUIR, V15, P8276, DOI 10.1021/la990426v
   Caruso F, 1999, MACROMOLECULES, V32, P2317, DOI 10.1021/ma980674i
   Caruso F, 1998, J PHYS CHEM B, V102, P2011, DOI 10.1021/jp980198y
   Caruso F, 1999, CHEM MATER, V11, P3394, DOI 10.1021/cm9911058
   CATTY D, 1996, ANTIBODIES PRACTICAL
   Chan W. C., 2000, FMOC SOLID PHASE PEP
   Chang TMS, 2005, NAT REV DRUG DISCOV, V4, P221, DOI 10.1038/nrd1659
   CHASIN M, 1990, DRUGS PHARM SCI SERI
   Chen W, 1997, MACROMOLECULES, V30, P78, DOI 10.1021/ma961096d
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Cheng YF, 1999, J PHYS CHEM B, V103, P8726, DOI 10.1021/jp9920693
   CHEUNG JH, 1994, THIN SOLID FILMS, V244, P985, DOI 10.1016/0040-6090(94)90616-5
   Cheung JH, 1997, MACROMOLECULES, V30, P2712, DOI 10.1021/ma970047d
   Chiarelli PA, 2001, ADV MATER, V13, P1167, DOI 10.1002/1521-4095(200108)13:15<1167::AID-ADMA1167>3.0.CO;2-A
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Cho J, 2001, ADV MATER, V13, P1076, DOI 10.1002/1521-4095(200107)13:14<1076::AID-ADMA1076>3.0.CO;2-M
   Choi JY, 2001, J MACROMOL SCI PURE, V38, P1191, DOI 10.1081/MA-100108377
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001
   Chung AJ, 2002, LANGMUIR, V18, P1176, DOI 10.1021/la010873m
   Clark SL, 1997, MACROMOLECULES, V30, P7237, DOI 10.1021/ma970610s
   Clark SL, 1998, ADV MATER, V10, P1515, DOI 10.1002/(SICI)1521-4095(199812)10:18<1515::AID-ADMA1515>3.0.CO;2-E
   Clark SL, 2000, LANGMUIR, V16, P10206, DOI 10.1021/la000418a
   COOPER A, 1992, J MOL BIOL, V225, P939, DOI 10.1016/0022-2836(92)90094-Z
   COOPER TM, 1995, LANGMUIR, V11, P2713, DOI 10.1021/la00007a061
   Creighton T. E., 1993, PROTEINS STRUCTURES
   Dai JH, 2001, LANGMUIR, V17, P931, DOI 10.1021/la001363f
   Debreczeny M, 2003, J PHYS CHEM B, V107, P12734, DOI 10.1021/jp035037v
   DECHER G, 1992, PROG COLL POL SCI S, V89, P160
   DECHER G, 1994, BIOSENS BIOELECTRON, V9, P677, DOI 10.1016/0956-5663(94)80065-0
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1994, THIN SOLID FILMS, V244, P772, DOI 10.1016/0040-6090(94)90569-X
   Decher G., 1993, POLYM PREPR AM CHEM, V34, P745
   DECHER G, 2003, MULTILAYER THIN FILM, P1
   DECHER G, 2003, MULTILAYR THIN FILMS
   Delcorte A, 1997, LANGMUIR, V13, P5125, DOI 10.1021/la970105o
   Donath E, 1999, NACHR CHEM TECH LAB, V47, P400
   Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E
   Dubas ST, 2001, MACROMOLECULES, V34, P3736, DOI 10.1021/ma001720t
   Dubas ST, 1999, MACROMOLECULES, V32, P8153, DOI 10.1021/ma981927a
   DUKE CB, 2002, FRONTIERS SURFACE IN
   Eishabini-Riad A., 1997, THIN FILM TECHNOLOGY
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   FASMAN GD, 1970, BIOCHEMISTRY-US, V9, P3316, DOI 10.1021/bi00819a005
   FERREIRA M, 1995, MACROMOLECULES, V28, P7107, DOI 10.1021/ma00125a012
   FERREIRA M, 1994, THIN SOLID FILMS, V244, P806, DOI 10.1016/0040-6090(94)90575-4
   Fink A.L, 1998, FOLDING DESIGN, V3, P9
   Fitter J, 1999, BIOPHYS J, V76, P1034, DOI 10.1016/S0006-3495(99)77268-1
   Fleer G. J., 1983, ADSORPTION SOLUTION, P153
   FOU AC, 1995, MACROMOLECULES, V28, P7115, DOI 10.1021/ma00125a013
   Gergely C, 2004, LANGMUIR, V20, P5575, DOI 10.1021/la049932x
   Glinel K., 2003, MULTILAYER THIN FILM, P177
   GRANT GA, 2002, SYNTHETIC PEPTIDES
   Haller MF, 1998, J CONTROL RELEASE, V53, P1, DOI 10.1016/S0168-3659(97)00232-0
   Halthur TJ, 2004, LANGMUIR, V20, P1739, DOI 10.1021/la035475t
   Halthur TJ, 2004, J AM CHEM SOC, V126, P17009, DOI 10.1021/ja0464645
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   HAMMOND PT, 2000, CURR OPIN COLLOID IN, V4, P430
   Harrison PM, 1997, CURR OPIN STRUC BIOL, V7, P53, DOI 10.1016/S0959-440X(97)80007-3
   Haynie DT, 2005, LANGMUIR, V21, P1136, DOI 10.1021/la047833d
   Haynie DT, 2004, LANGMUIR, V20, P4540, DOI 10.1021/la036330p
   HAYNIE DT, 1993, PROTEINS, V16, P115, DOI 10.1002/prot.340160202
   HAYNIE DT, 2005, 230 FALL NAT M AM CH
   HAYNIE DT, IN PRESS J BIOMED MA
   HIGASHI N, 1995, J CHEM SOC CHEM COMM, P2119, DOI 10.1039/c39950002119
   Higashi N, 2001, LANGMUIR, V17, P4061, DOI 10.1021/la010127h
   Hiorth M, 2003, EUR J PHARM BIOPHARM, V56, P175, DOI 10.1016/S0939-6411(03)00065-1
   Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y
   Hoogeveen NG, 1996, J COLLOID INTERF SCI, V182, P146, DOI 10.1006/jcis.1996.0445
   Huang L, 2000, J APPL POLYM SCI, V78, P631, DOI 10.1002/1097-4628(20001017)78:3<631::AID-APP190>3.3.CO;2-M
   HUBBELL JA, 2004, Patent No. 6743521
   Hubsch E, 2005, LANGMUIR, V21, P3664, DOI 10.1021/la047258d
   Ichinose I, 1999, POLYM J, V31, P1065, DOI 10.1295/polymj.31.1065
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   IZQUIERDO A, 2005, LANGMUIR
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   JESSEL N, 2004, ADV MATER, V16, P1507
   Jessel N., 2004, ADV FUNCT MATER, V14, P174
   Jessel N., 2005, ADV FUNCT MATER, V15, P648
   Jessel NB, 2004, ADV FUNCT MATER, V14, P963, DOI 10.1002/adfm.200305089
   JIRGENSENS B, 1973, OPTICAL ACTIVITY PRO
   Joanny JF, 1999, EUR PHYS J B, V9, P117, DOI 10.1007/s100510050747
   Joly S, 2000, LANGMUIR, V16, P1354, DOI 10.1021/la991089t
   Kabanov VA, 2003, MULTILAYER THIN FILM, P47
   KARDINAHL S, 2000, BIOL CHEM, V381, P1069
   Kato N, 2002, MACROMOLECULES, V35, P9780, DOI 10.1021/ma0209388
   Keller SW, 1995, J AM CHEM SOC, V117, P12879, DOI 10.1021/ja00156a034
   Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X
   Kidchob T, 1997, J APPL POLYM SCI, V63, P453, DOI 10.1002/(SICI)1097-4628(19970124)63:4<453::AID-APP6>3.3.CO;2-Q
   KLITZING RV, 1995, LANGMUIR, V11, P3554
   Kolarik L, 1999, LANGMUIR, V15, P8265, DOI 10.1021/la990413h
   Kotov NA, 1999, NANOSTRUCT MATER, V12, P789, DOI 10.1016/S0965-9773(99)00237-8
   Kotov NA, 1997, J AM CHEM SOC, V119, P6821, DOI 10.1021/ja964409t
   Kugler R, 2002, MACROMOL CHEM PHYSIC, V203, P413
   Kuwajima K, 1996, J MOL BIOL, V264, P806, DOI 10.1006/jmbi.1996.0678
   Kuwata K, 1998, J MOL BIOL, V283, P731, DOI 10.1006/jmbi.1998.2117
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   Lappan U, 1999, POLYMER, V40, P4087, DOI 10.1016/S0032-3861(98)00647-8
   Laschewsky A, 1997, MACROMOL CHEM PHYSIC, V198, P3239, DOI 10.1002/macp.1997.021981021
   Laschewsky A, 1996, THIN SOLID FILMS, V284, P334, DOI 10.1016/S0040-6090(95)08336-7
   Laschewsky A, 1997, MACROMOLECULES, V30, P8304, DOI 10.1021/ma961771j
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lee NH, 2002, POLYMER, V43, P6255, DOI 10.1016/S0032-3861(02)00555-4
   Lee SS, 2001, MACROMOLECULES, V34, P5358, DOI 10.1021/ma0022304
   LI B, IN PRESS BIOTECHNOL
   LI B, IN PRESS ENCY CHEM P
   LI B, IN PRESS J NANOTECHN
   Li BY, 2004, BIOMACROMOLECULES, V5, P1667, DOI 10.1021/bm0496155
   Limjaroen P, 2003, J PLAST FILM SHEET, V19, P95, DOI 10.1177/8756087903039409
   Lloyd-Williams P., 1997, CHEM APPROACHES SYNT
   Losche M, 1998, MACROMOLECULES, V31, P8893, DOI 10.1021/ma980910p
   LOWACK K, 1995, MACROMOLECULES, V28, P2912, DOI 10.1021/ma00112a043
   Lvov Y, 2000, PROTEIN ARCHITECTURE, P125
   Lvov Y, 2001, ANAL CHEM, V73, P4212, DOI 10.1021/ac010118d
   Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015
   LVOV Y, 2000, PROTEIN ARCHITECTURE
   MARUYAMA A, 1990, MACROMOLECULES, V23, P2748, DOI 10.1021/ma00212a027
   MAY SR, 1983, INT C BURNS GEN MAY
   McAloney RA, 2001, LANGMUIR, V17, P6655, DOI 10.1021/la010136q
   Mendelsohn JD, 2000, LANGMUIR, V16, P5017, DOI 10.1021/la000075g
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Messina R, 2004, J POLYM SCI POL PHYS, V42, P3557, DOI 10.1002/polb.20203
   Messina R, 2004, MACROMOLECULES, V37, P621, DOI 10.1021/ma034689e
   Messina R, 2003, LANGMUIR, V19, P4473, DOI 10.1021/la026988n
   Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0
   Morikawa M, 2005, CHEM-EUR J, V11, P1574, DOI 10.1002/chem.200400751
   MOROZOVA LA, 1995, NAT STRUCT BIOL, V2, P871, DOI 10.1038/nsb1095-871
   Muller M, 2004, J ADHESION, V80, P521, DOI 10.1080/00218460490477189
   Muller M, 2003, J PHYS CHEM B, V107, P8189, DOI 10.1021/jp027812x
   Muller M, 2001, BIOMACROMOLECULES, V2, P262, DOI 10.1021/bm005628g
   MUTTER M, 1990, ANGEW CHEM INT EDIT, V29, P185, DOI 10.1002/anie.199001851
   Ngankam AP, 2004, LANGMUIR, V20, P3362, DOI 10.1021/la035479y
   Ohring M., 2001, MAT SCI THIN FILMS
   Okubo T, 1999, J COLLOID INTERF SCI, V213, P565, DOI 10.1006/jcis.1999.6171
   Okubo T, 1999, COLLOID POLYM SCI, V277, P813, DOI 10.1007/s003960050457
   OLENYCH SG, IN PRESS BIOMACROMOL
   PALATH N, 2005, THESIS LOUISIANA TU
   Panchagnula V, 2005, LANGMUIR, V21, P1118, DOI 10.1021/la047741o
   Panchagnula V, 2002, J AM CHEM SOC, V124, P12515, DOI 10.1021/ja020683d
   Park MK, 2001, LANGMUIR, V17, P7670, DOI 10.1021/la011006k
   Park SY, 2001, MACROMOLECULES, V34, P3384, DOI 10.1021/ma001601d
   Peyratout CS, 2004, ANGEW CHEM INT EDIT, V43, P3762, DOI 10.1002/anie.200300568
   Phillips TJ, 1998, ARCH DERMATOL, V134, P344, DOI 10.1001/archderm.134.3.344
   Phuvanartnuruks V, 1998, MACROMOLECULES, V31, P1906, DOI 10.1021/ma970876z
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   POLAND D, 1970, THEORY HELIX COIL TR
   Porcel CH, 2005, LANGMUIR, V21, P800, DOI 10.1021/la047570n
   Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245
   Raposo M, 1997, MACROMOLECULES, V30, P6095, DOI 10.1021/ma970228f
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   RIEHS T, 2003, COLLOID SURFACE A, V212, P79
   Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0
   Rmaile HH, 2003, J AM CHEM SOC, V125, P6602, DOI 10.1021/ja035251x
   Rmaile HH, 2002, LANGMUIR, V18, P8263, DOI 10.1021/la025624s
   Rubner M. F., 2003, MULTILAYER THIN FILM, P133
   Ruths J, 2000, LANGMUIR, V16, P8871, DOI 10.1021/la000257a
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Salloum DS, 2004, BIOMACROMOLECULES, V5, P1089, DOI 10.1021/bm034522t
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Santoso S, 2002, NANO LETT, V2, P687, DOI [10.1021/nl025563i, 10.1021/n1025563i]
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schlenoff J. B., 2003, MULTILAYER THIN FILM, P99
   Schlenoff JB, 2000, LANGMUIR, V16, P9968, DOI 10.1021/la001312i
   Schlenoff JB, 1996, BER BUNSEN PHYS CHEM, V100, P943, DOI 10.1002/bbpc.19961000641
   SCHMITT J, 1993, MACROMOLECULES, V26, P7058, DOI 10.1021/ma00077a052
   Schonhoff M, 2003, J PHYS-CONDENS MAT, V15, pR1781, DOI 10.1088/0953-8984/15/49/R01
   Schonhoff M, 2003, CURR OPIN COLLOID IN, V8, P86, DOI 10.1016/S1359-0294(03)00003-7
   Schwarz S, 1999, COLLOID SURFACE A, V159, P491, DOI 10.1016/S0927-7757(99)00289-7
   Schwinte P, 2002, BIOMACROMOLECULES, V3, P1135, DOI 10.1021/bm025547f
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879
   Stair JL, 2001, CHEM MATER, V13, P2641, DOI 10.1021/cm010166e
   Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486
   Stroeve P, 1996, THIN SOLID FILMS, V284, P708, DOI 10.1016/S0040-6090(95)08428-2
   Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Sukhorukov GB, 1998, COLLOID SURFACE A, V137, P253, DOI 10.1016/S0927-7757(98)00213-1
   Sukhorukov GB, 1999, J PHYS CHEM B, V103, P6434, DOI 10.1021/jp990095v
   Sukhorukov GB, 1998, POLYM ADVAN TECHNOL, V9, P759, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<759::AID-PAT846>3.0.CO;2-Q
   Sukhorukov GB, 1996, BER BUNSEN PHYS CHEM, V100, P948, DOI 10.1002/bbpc.19961000642
   SUN J, 1998, CHEM COMMUN, V17, P1853
   Tripathy S. K., 2002, HDB POLYELECTROLYTES, VI-II
   Tsukruk VV, 1997, LANGMUIR, V13, P2171, DOI 10.1021/la960603h
   van Ackern F, 1998, THIN SOLID FILMS, V327, P762, DOI 10.1016/S0040-6090(98)00782-2
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Voigt A, 1999, IND ENG CHEM RES, V38, P4037, DOI 10.1021/ie9900925
   von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+
   WANDELT K, 2006, HDB SURFACE INTERFAC
   Wang LY, 1997, MACROMOL RAPID COMM, V18, P509, DOI 10.1002/marc.1997.030180609
   Wang LY, 1999, LANGMUIR, V15, P1360, DOI 10.1021/la981181+
   Xie AF, 2001, J AM CHEM SOC, V123, P3175, DOI 10.1021/ja005818z
   YANG JJ, 1995, J MOL BIOL, V252, P483, DOI 10.1006/jmbi.1995.0513
   Yang SY, 2002, J AM CHEM SOC, V124, P2100, DOI 10.1021/ja017681y
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
   Zarge JI, 1997, J VASC SURG, V25, P840, DOI 10.1016/S0741-5214(97)70213-1
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang L, 2005, LANGMUIR, V21, P5439, DOI 10.1021/la0501381
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   Zheng B, 2005, J BIOMAT SCI-POLYM E, V16, P285, DOI 10.1163/1568562053654103
   ZHI ZI, IN PRESS ARTIF CELL
   Zhi ZL, 2004, MACROMOLECULES, V37, P8668, DOI 10.1021/ma049136y
   ZHONG Y, IN PRESS BIOTECHNOL
NR 238
TC 79
Z9 79
U1 3
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2005
VL 6
IS 6
BP 2895
EP 2913
DI 10.1021/bm050525p
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 985QD
UT WOS:000233392100002
PM 16283705
DA 2018-10-20
ER

PT J
AU Murakami, Y
   Maeda, M
AF Murakami, Y
   Maeda, M
TI DNA-responsive hydrogels that can shrink or swell
SO BIOMACROMOLECULES
LA English
DT Article
AB Molecule-responsive hydrogels are reputed to be smart materials because of their unique properties. We recently reported that hydrogels containing directly grafted single-stranded (ss) DNA or ssDNA-polyacrylamide conjugate in a semi-interpenetrating network (semi-IPN) manner that "only shrunk" by the addition of ssDNA samples. To date, however, no DNA-responsive hydrogels have been reported capable of "swelling" in response to specific DNAs. Smart materials capable of both shrinking and swelling in response to specific DNAs would be very useful in biochemical and biomedical applications. Here, we show a novel "shrinking or swelling" DNA-responsive mechanism. Novel hybrid hydrogels containing rationally designed ssDNA as the cross-linker were capable of shrinking or swelling in response to ssDNA samples and recognizing a single base difference in the samples. On the basis of the results presented in this paper, it is envisioned that these novel hybrid hydrogels could function and have potential in applications such as DNA-sensing devices and DNA-triggered actuators.
C1 RIKEN, Inst Phys & Chem Res, Bioengn Lab, Wako, Saitama 3510198, Japan.
RP Maeda, M (reprint author), RIKEN, Inst Phys & Chem Res, Bioengn Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM mizuo@riken.go.jp
RI Maeda, Mizuo/I-3498-2014; Murakami, Yoshihiko/C-9485-2013
CR ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   Kato N, 2003, MACROMOLECULES, V36, P961, DOI 10.1021/ma0214198
   KRAKAUER H, 1974, BIOCHEMISTRY-US, V13, P2579, DOI 10.1021/bi00709a017
   Lu ZR, 2003, MACROMOL BIOSCI, V3, P296, DOI 10.1002/mabi.200390039
   MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031
   Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700
   Miyata T, 1999, MACROMOLECULES, V32, P2082, DOI 10.1021/ma981659g
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Miyata T, 1996, MACROMOL CHEM PHYSIC, V197, P1135, DOI 10.1002/macp.1996.021970330
   Murakami Y, 2005, MACROMOLECULES, V38, P1535, DOI 10.1021/ma047803h
NR 10
TC 132
Z9 137
U1 3
U2 45
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2005
VL 6
IS 6
BP 2927
EP 2929
DI 10.1021/bm0504330
PG 3
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 985QD
UT WOS:000233392100006
PM 16283709
DA 2018-10-20
ER

PT J
AU Xie, YT
   Liu, XY
   Huang, AP
   Ding, CX
   Chu, PK
AF Xie, YT
   Liu, XY
   Huang, AP
   Ding, CX
   Chu, PK
TI Improvement of surface bioactivity on titanium by water and hydrogen
   plasma immersion ion implantation
SO BIOMATERIALS
LA English
DT Article
DE titanium; plasma immersion ion implantation; bioactivity;
   cytocompatibility; water; hydrogen
ID SIMULATED BODY-FLUID; APATITE FORMATION; CALCIUM; OXYGEN; SEPARATION;
   OXIDE; COATINGS; LAYERS; TI
AB We have investigated the surface bioactivity of titanium after water and hydrogen plasma immersion ion implantation. Plasma immersion ion implantation (PIII) excels in the surface treatment of components possessing a complicated shape such as medical implants. In addition, water and hydrogen PIII has been extensively studied as a method to fabricate silicon-on-insulator (SOI) substrates in the semiconductor industry and so it is relatively straightforward to transfer the technology to the biomedical field. In our investigation, water and hydrogen were plasma-implanted into titanium sequentially. Our objective is that water PIII introduces near-surface damages that trap hydrogen implanted in the subsequent step to improve the surface bioactivity while the desirable bulk properties of the materials are not compromised. Ti-OH functional groups can be detected on the (H2O + H-2)-implanted titanium surface by X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FTIR) spectroscopy. After incubation in simulated body fluids (SBF) for cytocompatibililty evaluation in vitro, bone-like hydroxyapatite was found to precipitate on the (H2O + H-2) implanted samples while no apatite was found on titanium samples plasma implanted with water or hydrogen alone. Human osteoblast cells were cultured on the (H2O + H-2)-implanted titanium surface and they exhibited good adhesion and growth. Our results suggest a practical means to improve the surface bioactivity and cytocompatibility of medical implants made of titanium. (c) 2005 Elsevier Ltd. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Liu, Xuanyong/J-2609-2018; Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR ALONSO J, 2002, MATER CHEM PHYS, V77, P938
   Bezrodna T, 2004, J MOL STRUCT, V700, P175, DOI 10.1016/j.molstruc.2003.12.057
   Chen J, 2001, APPL PHYS LETT, V78, P73, DOI 10.1063/1.1337642
   Chen P, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1852087
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   DESPINA DD, 2001, BIOMATERIALS, V22, P87
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   FERBER H, 1987, MATER SCI ENG, V90, P213, DOI 10.1016/0025-5416(87)90214-X
   Grook K, 1987, J BIOMED MATER RES, V21, P1375
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   HANAWA T, 1995, MATER T JIM, V36, P438, DOI 10.2320/matertrans1989.36.438
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Jallot E, 2003, J ADV MATER-COVINA, V35, P9
   Jill C., 1992, HDB XRAY PHOTOELECTR
   Kim KJ, 1996, J BIOMED MATER RES, V32, P3, DOI 10.1002/(SICI)1097-4636(199609)32:1<3::AID-JBM1>3.3.CO;2-6
   KOKUBO T, 2000, KEY ENG MATER, V192, P1
   Krupa D, 2005, BIOMATERIALS, V26, P2847, DOI 10.1016/j.biomaterials.2004.08.015
   LIU JB, 1995, APPL PHYS LETT, V67, P2361, DOI 10.1063/1.114345
   Liu JH, 2004, J POLYM RES-TAIWAN, V11, P43, DOI 10.1023/B:JPOL.0000021748.21432.d8
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   Loinaz A, 1998, SURF COAT TECH, V104, P262, DOI 10.1016/S0257-8972(98)00411-3
   Lu X, 1997, APPL PHYS LETT, V70, P1748, DOI 10.1063/1.118645
   Maitz MF, 2002, SURF COAT TECH, V158, P151, DOI 10.1016/S0257-8972(02)00189-5
   Manley Michael T., 1993, P1
   Min J, 1996, SURF COAT TECH, V85, P60, DOI 10.1016/0257-8972(96)02885-X
   OKABE Y, 1989, NUCL INSTRUM METH B, V39, P619, DOI 10.1016/0168-583X(89)90861-6
   OKABE Y, 1994, SURF COAT TECH, V66, P384, DOI 10.1016/0257-8972(94)90035-3
   Pham MT, 2000, J MATER SCI-MATER M, V11, P383, DOI 10.1023/A:1008938125348
   SCROCCO M, 1979, CHEM PHYS LETT, V61, P4536
   Soltani-Farshi M, 1998, SURF COAT TECH, V104, P299, DOI 10.1016/S0257-8972(98)00427-7
   Sumitomo Chemical Co, 1975, Patent Application, Patent No. 158745
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Yang P, 2002, SURF COAT TECH, V156, P284, DOI 10.1016/S0257-8972(02)00087-7
NR 38
TC 72
Z9 80
U1 5
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2005
VL 26
IS 31
BP 6129
EP 6135
DI 10.1016/j.biomaterials.2005.03.032
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 952BA
UT WOS:000230975100005
PM 15885768
DA 2018-10-20
ER

PT J
AU Taylor, JE
   Laity, PR
   Freeburn, S
   Wong, SS
   Norris, K
   Khunkamchoo, P
   Cable, M
   Andrews, G
   Johnson, AF
   Cameron, RE
AF Taylor, JE
   Laity, PR
   Freeburn, S
   Wong, SS
   Norris, K
   Khunkamchoo, P
   Cable, M
   Andrews, G
   Johnson, AF
   Cameron, RE
TI Effect of processing route and acetone pre-treatment on the biostability
   of pellethane materials used in medical device applications
SO BIOMATERIALS
LA English
DT Article
DE polyurethane; biocompatibility; haemocompatibility; oxidation
ID POLY(ETHERURETHANE UREA) ELASTOMERS; IN-VITRO STABILITY; POLYURETHANE
   ELASTOMERS; SOFT-SEGMENT; STRESS CRACKING; THERMOPLASTIC POLYURETHANES;
   BIOMEDICAL POLYURETHANES; BIODEGRADATION; DEGRADATION; MORPHOLOGY
AB Thermoplastic polyurethanes, such as Pellethane 2363 80A (TM) (Pel80A) and Pellethane 2363 55D (TM) (Pel55D) are widely used in the medical device industry because of their biological and mechanical properties. However, premature failure in such devices has been observed and attributed to environmental stress cracking (ESC). The current work investigates the possibility of reducing ESC via bulk morphology manipulation. This can be achieved through various processing routes such as solvent-casting (SC) and hot-press quenching (HPQ). The effect of stress on the bulk morphology of Pel55D and Pel80A was evaluated using small-angle X-ray scattering (SAXS) in conjunction with tensile testing. SC samples exhibited greater phase separation compared with HPQ samples. Alignment of hard segment domains became apparent around the point of yield. Onset of ESC with respect to SC and HPQ routines was determined using the Zhao-Stokes glass-wool test with optical (OM) and environment scanning electron microscopy (ESEM). Improvement in biostability of Pel80A was found in HPQ samples compared to those that were SC. A secondary objective of this work was to investigate the effect of acetone pre-treatment on surface morphology. High resolution imaging of acetone treated and untreated SC Pel80A showed significant differences in surface morphology. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci, Cambridge, England.
   Univ Leeds, Dept Chem, Leeds LS2 9JT, W Yorkshire, England.
   Ranier Technol Ltd, Cambridge, England.
RP Cameron, RE (reprint author), Univ Cambridge, Dept Mat Sci, Cambridge, England.
EM ree11@cam.ac.uk
OI Laity, Peter/0000-0001-8608-875X; Cameron, Ruth/0000-0003-1573-4923
CR Abouzahr S, 1985, PROCESSING STRUCTURE, P165
   Blundell DJ, 2002, POLYMER, V43, P5197, DOI 10.1016/S0032-3861(02)00386-5
   Casas J, 1999, J BIOMED MATER RES, V46, P475, DOI 10.1002/(SICI)1097-4636(19990915)46:4<475::AID-JBM5>3.0.CO;2-J
   CASTNER D G, 1990, Journal of Biomaterials Science Polymer Edition, V1, P191
   Chen JH, 1998, J BIOMED MATER RES, V41, P633, DOI 10.1002/(SICI)1097-4636(19980915)41:4<633::AID-JBM16>3.0.CO;2-F
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Fare S, 1999, J BIOMED MATER RES, V45, P62, DOI 10.1002/(SICI)1097-4636(199904)45:1<62::AID-JBM9>3.0.CO;2-F
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   HEPBURN C, 1982, POLYURETHANE ELASTOM, P128
   Jimenez G, 2000, EUR POLYM J, V36, P2039, DOI 10.1016/S0014-3057(99)00241-4
   Krakovsky I, 1997, POLYMER, V38, P3637, DOI 10.1016/S0032-3861(96)00897-X
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Laity PR, 2004, POLYMER, V45, P7273, DOI 10.1016/j.polymer.2004.08.033
   Laity PR, 2004, POLYMER, V45, P5215, DOI 10.1016/j.polymer.2004.05.032
   Martin DJ, 1996, J APPL POLYM SCI, V60, P557, DOI 10.1002/(SICI)1097-4628(19960425)60:4<557::AID-APP9>3.0.CO;2-N
   Martin DJ, 1996, J APPL POLYM SCI, V62, P1377
   Martin DJ, 2001, BIOMATERIALS, V22, P973, DOI 10.1016/S0142-9612(00)00262-3
   Martin DJ, 1999, J APPL POLYM SCI, V71, P937
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Roe R.-J., 2000, METHODS XRAY NEUTRON, P155
   Salacinski HJ, 2002, BIOMATERIALS, V23, P2231, DOI 10.1016/S0142-9612(01)00356-8
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   Schubert MA, 1997, J BIOMED MATER RES, V35, P319, DOI 10.1002/(SICI)1097-4636(19970605)35:3<319::AID-JBM6>3.0.CO;2-K
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   SZYCHER M, 1999, SZYCHERS HDB POLYURE, P128
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Takahashi A, 2002, J MATER SCI-MATER M, V13, P259, DOI 10.1023/A:1014054716444
   TYLER BJ, 1993, J BIOMED MATER RES, V27, P327, DOI 10.1002/jbm.820270306
   VANDERKAMP KWHJ, 1995, J BIOMED MATER RES, V29, P1303, DOI 10.1002/jbm.820291018
   Wiggins MJ, 2003, J BIOMED MATER RES A, V66A, P463, DOI 10.1002/jbm.a.10584
   Wiggins MJ, 2003, J BIOMED MATER RES A, V65A, P524, DOI 10.1002/jbm.a.10565
   WU YK, 1994, J BIOMED MATER RES, V28, P515, DOI 10.1002/jbm.820280414
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 40
TC 6
Z9 6
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2005
VL 26
IS 33
BP 6467
EP 6476
DI 10.1016/j.biomaterials.2005.04.009
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 954XW
UT WOS:000231189800007
PM 15935471
DA 2018-10-20
ER

PT J
AU Etienne, O
   Gasnier, C
   Taddei, C
   Voegel, JC
   Aunis, D
   Schaaf, P
   Metz-Boutigue, MH
   Bolcato-Bellemin, AL
   Egles, C
AF Etienne, O
   Gasnier, C
   Taddei, C
   Voegel, JC
   Aunis, D
   Schaaf, P
   Metz-Boutigue, MH
   Bolcato-Bellemin, AL
   Egles, C
TI Antifungal coating by biofunctionalized polyelectrolyte multilayered
   films
SO BIOMATERIALS
LA English
DT Article
DE antimicrobial; bioactivity; surface modifications; polyelectrolyte
   multilayer film; chromofungin; chromogranin A
ID ANTIMICROBIAL PEPTIDES; MOLECULAR-BASIS; RESISTANCE; PROTECTION;
   IMPLANTS; GROWTH
AB The surface of medical devices is a common site of bacterial and fungal adhesion. first step to the constitution of a resistant biofilm leading frequently to chronic infections. In order to prevent Such complications. several physical and chemical modifications of the device surface have been proposed. Here, we experiment a new type of topical antifungal coating using the layer-by-layer technique. The nanometric multilayer thin obtained by this technique is functionalized. by the insertion of a chromogranin A-derived antifungal peptide (CGA 47-66, chromofungin). We show that the embedded peptide keeps its antifungal activity by interacting with the fungal membrane and penetrating into the cell. In vitro studies demonstrate that Such an antifungal Coating is able to inhibit the growth of yeast Candida albicans by 65% and completely stop the proliferation of filamentous fungus Neurospora crassa. The cytotoxicity of such a coating was also assessed by growing human gingival fibroblasts at its surface, Finally the antifungal coating of poly(methylmethacrylate), a widely used material for biomedical devices, is successfully tested in tit in vivo oral candidiasis rat model. Taken together, these results assessed the functionalized multilayer films containing a new potent antifungal non-toxic peptide, as a novel and promising technique for local antifungal protection. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Inst Natl Sante & Rech Med, Unite 595, F-67085 Strasbourg, France.
   Univ Strasbourg 1, Fac Chirurgie Dent, F-67000 Strasbourg, France.
   Inst Natl Sante & Rech Med, Unite 575, F-67085 Strasbourg, France.
   Univ Strasbourg 1, CNRS, Inst Charles Sadron, UPR 22, F-67083 Strasbourg, France.
RP Egles, C (reprint author), Inst Natl Sante & Rech Med, Unite 595, 11 Rue Humann, F-67085 Strasbourg, France.
EM christophe.egles@odonto-ulp.u-strasbg.fr
RI ETIENNE, olivier/D-1601-2013; SCHAAF, Pierre/J-2751-2016; etienne,
   olivier/D-9542-2011
OI ETIENNE, olivier/0000-0001-8870-4659; SCHAAF,
   Pierre/0000-0001-7423-5492; EGLES, Christophe/0000-0003-0982-7752
CR Alarco AM, 2004, J IMMUNOL, V172, P5622, DOI 10.4049/jimmunol.172.9.5622
   Bolcato-Bellemin AL, 2000, J DENT RES, V79, P1712, DOI 10.1177/00220345000790091201
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   DECHER G, 1997, SCIENCE, V277, P5330
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   Jabra-Rizk MA, 2004, EMERG INFECT DIS, V10, P14, DOI 10.3201/eid1001.030119
   Kanno T, 1999, EXP PHYSIOL, V84, P1073
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186
   Lugardon K, 2001, J BIOL CHEM, V276, P35875, DOI 10.1074/jbc.M104670200
   Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3
   Lupetti A, 2002, EXPERT OPIN INV DRUG, V11, P309, DOI 10.1517/13543784.11.2.309
   Metz-Boutigue MH, 2003, TRENDS MICROBIOL, V11, P585, DOI 10.1016/j.tim.2003.10.001
   Nikawa H, 1998, J DENT, V26, P299, DOI 10.1016/S0300-5712(97)00026-2
   Pacor S, 2002, J ANTIMICROB CHEMOTH, V50, P339, DOI 10.1093/jac/dkf141
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Radford DR, 1999, CRIT REV ORAL BIOL M, V10, P99, DOI 10.1177/10454411990100010501
   Tunney MM, 1998, ANTIMICROB AGENTS CH, V42, P3002, DOI 10.1128/AAC.42.11.3002
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   Vodouhe C, 2005, BIOMATERIALS, V26, P545, DOI 10.1016/j.biomaterials.2004.02.057
NR 21
TC 99
Z9 104
U1 1
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2005
VL 26
IS 33
BP 6704
EP 6712
DI 10.1016/j.biomaterials.2005.04.068
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 954XW
UT WOS:000231189800032
PM 15992921
DA 2018-10-20
ER

PT J
AU Rautaray, D
   Sastry, M
AF Rautaray, D
   Sastry, M
TI Free-standing nanogold membranes as supports for the growth of calcium
   phosphate crystals
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
ID AQUEOUS CHLOROAURATE IONS; GOLD NANOPARTICLES; AMINO-ACID; SPONTANEOUS
   REDUCTION; ENZYMATIC-ACTIVITY; COLLOIDAL GOLD; HYDROXYAPATITE;
   STABILITY; PARTICLES; SYSTEM
AB Current strategies for bone tissue regeneration focus on the development of implantable matrices that mimic biological tissues. Inorganic composites are of special interest for bone substitute applications. It is necessary to create an artificial three-dimensional scaffold-like porous material with certain geometrical structure to induce bone growth. We report here the growth of calcium phosphate crystals on free-standing carboxylic acid functionalized gold nanoparticle membranes. The gold nanoparticle membrane is synthesized by the spontaneous reduction of aqueous chloroaurate ions by a diamine molecule at a liquid-liquid interface. This membrane is robust and malleable, and most importantly, the gold nanoparticles in the membrane may be functionalized with suitable ligands. In this study, the amino acids aspartic acid and cysteine together with an aromatic bifunctional molecule, anthranilic acid, were used to modify the surface of the gold nanoparticles in the membrane. The free carboxylic acid groups on the gold nanoparticles further to functionalization with these molecules were then used to bind Ca2+ ions and reacted with phosphate ions to yield calcium phosphate. The nature of the nanogold surface modifier directed the formation of either crystalline hydroxyapatite or amorphous calcium phosphate. The nanogold membrane thus suggests potential biomedical application as biocompatible implants and grafts.
C1 Natl Chem Lab, Nanosci Grp, Mat Chem Div, Pune 411008, Maharashtra, India.
RP Sastry, M (reprint author), Natl Chem Lab, Nanosci Grp, Mat Chem Div, Pune 411008, Maharashtra, India.
EM m.sastry@ncl.res.in
CR Bigi A, 2000, BIOMACROMOLECULES, V1, P752, DOI 10.1021/bm0055854
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   Cabanas MV, 2003, J MATER CHEM, V13, P1104, DOI 10.1039/b301435e
   Dolder JVD, 2003, BIOMATERIALS, V24, P1745
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Gole A, 2002, COLLOID SURFACE B, V25, P129, DOI 10.1016/S0927-7765(01)00301-0
   Gole A, 2001, LANGMUIR, V17, P1674, DOI 10.1021/la001164w
   Gole A, 2001, BIOCONJUGATE CHEM, V12, P684, DOI 10.1021/bc0001241
   Hirai T, 2000, LANGMUIR, V16, P955, DOI 10.1021/la990590i
   HUER AH, 1992, SCIENCE, V255, P1098
   Isobe T, 2002, J PHYS CHEM B, V106, P5169, DOI 10.1021/jp0138936
   Joshi VS, 2003, CRYST RES TECHNOL, V38, P817, DOI 10.1002/crat.200310100
   Keating CD, 1998, J PHYS CHEM B, V102, P9404, DOI 10.1021/jp982723z
   Kumar A, 2003, LANGMUIR, V19, P6277, DOI 10.1021/la034209c
   LEFF DV, 1995, J PHYS CHEM-US, V99, P7036, DOI 10.1021/j100018a041
   Liu Y, 1997, J PHYS CHEM B, V101, P3464, DOI 10.1021/jp962403k
   Lowenstam HA, 1989, BIOMINERALIZATION
   Mandal S, 2002, P INDIAN AS-CHEM SCI, V114, P513
   Mayya KS, 1997, LANGMUIR, V13, P3944, DOI 10.1021/la962140l
   Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003
   Pretto M, 2003, J AM CERAM SOC, V86, P1534, DOI 10.1111/j.1151-2916.2003.tb03510.x
   Rautaray D, 2004, CHEM MATER, V16, P988, DOI 10.1021/cm035004s
   Schnettler R, 2003, BIOMATERIALS, V24, P4603, DOI 10.1016/S0142-9612(03)00354-5
   Selvakannan P, 2004, J COLLOID INTERF SCI, V269, P97, DOI 10.1016/S0021-9797(03)00616-7
   Selvakannan PR, 2004, ADV MATER, V16, P966, DOI 10.1002/adma.200400116
   Selvakannan PR, 2003, LANGMUIR, V19, P3545, DOI 10.1021/la026906v
   SELVAKANNAN PR, 2002, J CHEM SOC CHEM COMM, P1334
   Xu GF, 2001, J AM CHEM SOC, V123, P2196, DOI 10.1021/ja002537i
   Zhao JG, 1996, BIOSENS BIOELECTRON, V11, P493, DOI 10.1016/0956-5663(96)86786-8
NR 29
TC 2
Z9 3
U1 1
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD NOV-DEC
PY 2005
VL 21
IS 6
BP 1759
EP 1767
DI 10.1021/bp050144n
PG 9
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 991CM
UT WOS:000233789900025
PM 16321063
DA 2018-10-20
ER

PT J
AU Kusterer, J
   Alekov, A
   Pasquarelli, A
   Muller, R
   Ebert, W
   Lehmann-Horn, F
   Kohn, E
AF Kusterer, J
   Alekov, A
   Pasquarelli, A
   Muller, R
   Ebert, W
   Lehmann-Horn, F
   Kohn, E
TI A diamond-on-silicon patch-clamp-system
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on New Diamond Science and Technology
CY MAY 11-14, 2005
CL Tsukuba, JAPAN
SP Japan New Diamond Forum, New Energy & Ind Technol Dev Org, Natl Inst Sci & Technol, Seki Technotron Corp
DE diamond film; nano-crystalline; microstructure; biomedical application
AB Here, we present a planar multi-patch-clamp-system based on a nano-crystalline diamond patch-membrane used for the investigation of ion channels in cell-membranes. In such a system the cell-membrane is electrically stimulated through a potential difference in the electrolyte across the patch-membrane. Usually, the patch-mernbrane material is a highly insulating dielectric. The use of diamond allows to add highly localized probes in close proximity to the clamping area for a localized analysis of the stimulation mechanism. The technological concept, realization and first electrical characteristics of the principle structure are discussed. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Ulm, Dept Elect Circuits & Dev, Ulm, Germany.
   Univ Ulm, Dept Appl Physiol, Ulm, Germany.
RP Kusterer, J (reprint author), Univ Ulm, EBS, Albert Einstein Allee 45, D-89081 Ulm, Germany.
EM joachim.kusterer@uni-ulm.de
CR Brueggemann A, 2004, Curr Drug Discov Technol, V1, P91, DOI 10.2174/1570163043484833
   Fertig N, 2002, APPL PHYS LETT, V81, P4865, DOI 10.1063/1.1531228
   Janischowsky K, 2003, DIAM RELAT MATER, V12, P336, DOI 10.1016/S0925-9635(02)00294-7
   Kiss L, 2003, ASSAY DRUG DEV TECHN, V1, P127, DOI 10.1089/154065803762851298
   *MOL DEV CORP, 2004, ION CHANN SCREEN SYS
   Muller R, 2005, DIAM RELAT MATER, V14, P504, DOI 10.1016/j.diamond.2005.01.005
   NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0
   Schroeder K, 2003, J BIOMOL SCREEN, V8, P50, DOI 10.1177/1087057102239667
NR 8
TC 6
Z9 6
U1 0
U2 1
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD NOV-DEC
PY 2005
VL 14
IS 11-12
BP 2139
EP 2142
DI 10.1016/j.diamond.2005.06.011
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 993VN
UT WOS:000233983600088
DA 2018-10-20
ER

PT J
AU Rui, H
   LeBaron, MJ
AF Rui, Hallgeir
   LeBaron, Matthew J.
TI Creating tissue microarrays by cutting-edge matrix assembly
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Article
DE cutting-edge matrix assembly; CEMA; microarray; tissue microarray
ID QUANTITATIVE-ANALYSIS; CANCER; EXPRESSION; SAMPLES
AB Tissue microarrays have become widely adopted for effective parallel in situ analysis of hundreds of tissues placed onto single slides. Traditionally, tissue core punches are transferred into predrilled holes within a scaffold block of paraffin or other material, and sectioned transversely by a microtome to generate array sections. While core-based arraying has greatly advanced tissue analyses, some of the limitations include restricted feature sizes and numbers, variable core depths of unpredictable tissue quality and inability to array thin-walled, stratified tissue samples such as intestines, vessels or skin. Overcoming these limitations, the authors have developed a practical arraying method that combines serial cuffing and edge-to-edge bonding of samples to assemble a scaffold-free array matrix - cuffing-edge matrix assembly. Using cuffing-edge matrix assembly, the authors have successfully placed more than 10,000 individual tissue pieces on a single histology glass slide. The potential biomedical utility and ongoing efforts to further develop the assembly technology and analysis of high-density cuffing-edge matrix assembly tissue microarrays is discussed.
C1 Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.
RP Rui, H (reprint author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, 3970 Reservoir Rd NW, Washington, DC 20057 USA.
EM ruih@georgetown.edu
FU NCI NIH HHS [1P30-CA-51008, R01-CA101841, T32-CA009686-08]; NIDDK NIH
   HHS [R01-DK52013]
CR BATTIFORA H, 1986, LAB INVEST, V55, P244
   Camp RL, 2003, CANCER RES, V63, P1445
   Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791
   Fejzo MS, 2001, AM J PATHOL, V159, P1645
   GALIL KA, 1984, J BIOMED MATER RES, V18, P609, DOI 10.1002/jbm.820180603
   Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844
   LeBaron MJ, 2005, NAT METHODS, V2, P511, DOI 10.1038/NMETH772
   Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1220/JCO.2004.11.046
   Rimm DL, 2005, NAT METHODS, V2, P492, DOI 10.1038/nmeth0705-492
   Rubin MA, 2004, AM J PATHOL, V164, P831, DOI 10.1016/S0002-9440(10)63171-9
   Simon R, 2002, ONCOGENE, V21, P2476, DOI 10.1038/sj/onc/1205304
   WAN WH, 1987, J IMMUNOL METHODS, V103, P121
NR 12
TC 11
Z9 13
U1 0
U2 0
PU FUTURE DRUGS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD NOV
PY 2005
VL 2
IS 6
BP 673
EP 680
DI 10.1586/17434440.2.6.673
PG 8
WC Engineering, Biomedical
SC Engineering
GA 089YS
UT WOS:000240918400008
PM 16293094
DA 2018-10-20
ER

PT J
AU Velten, T
   Ruf, HH
   Barrow, D
   Aspragathos, N
   Lazarou, P
   Jung, E
   Malek, CK
   Richter, M
   Kruckow, J
AF Velten, T
   Ruf, HH
   Barrow, D
   Aspragathos, N
   Lazarou, P
   Jung, E
   Malek, CK
   Richter, M
   Kruckow, J
TI Packaging of bio-MEMS: Strategies, technologies, and applications
SO IEEE TRANSACTIONS ON ADVANCED PACKAGING
LA English
DT Review
DE biomicroelectromechanical systems (bio-MEMS); bioaffinity; biosensor;
   gluing; joining; microsystems; point-of-care testing; wire-bonding
ID ON-A-CHIP; MICROFLUIDIC DEVICES; BIOMEDICAL APPLICATIONS; FABRICATION;
   SILICON; SYSTEMS; SU-8; BIOMEMS; GLASS; FILM
AB Biomicroelectromechanical systems (bio-MEMS) are MEMS which are designed for medical or biological applications. As with other MEMS, bio-MEMS frequently, have to be packaged to provide an interface to the macroscale world of the user. Bio-MEMS can be roughly divided in two groups. Bio-MEMS can be pure technical systems applied in a biological environment or technical systems which integrate biological materials as one functional component of the system. In both cases, the materials which have intimate contact to biological matter have to be biocompatible to avoid unintentional effects on the biological substances, which in case of medical implants, could harm the patient. In the case of biosensors, the use of nonbiocompatible materials could interfere with the biological subcomponents which would affect the sensor's performance. Bio-MEMS containing biological subcomponents require the use of "biocompatible" technologies for assembly and packaging; e.g., high temperatures occurring, for instance, during thermosonic wire bonding and other thermobonding processes would denature the bioaffinity layers on biosensor chips. This means that the use of selected or alternative packaging and assembly methods, or new strategies, is necessary for a wide range of bio-MEMS applications. This paper provides an overview of some of the strategies, technologies, and applications in the field of bio-MEMS packaging. It includes the following:
   strategies for the partitioning of subsystems within integrated microsystems for (bio)chemical analysis/synthesis;
   methods for microassembly of bio-MEMS;
   technologies for bonding of polymer bio-MEMS components;
   packaging of miniature medical devices;
   packaging of biosensors for in vitro applications;
   packaging of micropumps as a bio-MEMS component.
   The applications discussed are derived from different fields to demonstrate the plethora of bio-MEMS considerations. In commercial production, packaging is possibly the major cost factor of bio-MEMS-based products, and its development requires special attention.
C1 IBMT, D-66386 St Ingbert, Germany.
   Cardiff Univ, Cardiff Sch Engn, Cardiff CF24 3TF, S Glam, Wales.
   Univ Patras, Robot Grp Mech, Rion 26500, Greece.
   Univ Patras, Aeronaut Engn Dept, Rion 26500, Greece.
   Fraunhofer Inst Reliabil & Microintegrat, D-13355 Berlin, Germany.
   CNRS, UMR, FEMTO ST, F-25044 Besancon, France.
   IZM, D-80686 Munich, Germany.
RP Velten, T (reprint author), IBMT, D-66386 St Ingbert, Germany.
EM thomas.velten@ibmt.fraunhofer.de; barrow@cf.ac.uk;
   asprag@mech.upatras.gr; erju@izm.fhg.de; chantal.khan-malek@lpmo.edu;
   martin.richter@izm-m.fraunhofer.de
RI Barrow, David/A-3050-2010
OI Aspragathos, Nikos/0000-0002-7662-5942
CR BAHRS J, 2004, THESIS RES CTR KARLS
   BARGIEL S, 2005, IN PRESS EUROSENSORS
   Bashir R, 2004, ADV DRUG DELIVER REV, V56, P1565, DOI 10.1016/j.addr.2004.03.002
   BAUER T, 2002, P SOC PHOTO-OPT INS, V4633, P128
   Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   Bilenberg B, 2004, J MICROMECH MICROENG, V14, P814, DOI 10.1088/0960-1317/14/6/008
   Bohringer KF, 2003, J MICROMECH MICROENG, V13, pS1
   BOHRINGER KF, 1998, P IEEE INT C ROB AUT, V2, P1204
   Bouaidat S, 2004, SENSOR ACTUAT A-PHYS, V110, P390, DOI 10.1016/j.sna.2003.10.032
   BUNDGAARD F, 2004, P MUTAS MALM SWED, P372
   BUTLER JT, 1997, INT C SOL STAT SENS, P261
   Carlier J, 2004, J MICROMECH MICROENG, V14, P619, DOI 10.1088/0960-1317/14/4/024
   CEFAI JJ, 1994, J MICROMECH MICROENG, V4, P172, DOI 10.1088/0960-1317/4/4/002
   CHARTIER I, P SPIE, V5345, P7
   Chen S, 2003, INT J MATER PROD TEC, V18, P457, DOI 10.1504/IJMPT.2003.002502
   CHOU TK, 2001, P IEEE TRANSDUCERS C, P1050
   Chuang YJ, 2003, SENSOR ACTUAT A-PHYS, V103, P64, DOI 10.1016/S0924-4247(02)00325-4
   Cooley P, 2001, P SOC PHOTO-OPT INS, V4560, P177, DOI 10.1117/12.443057
   DROST S, 1996, P 2 INT S MIN TOT AN, P199
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Dziuban JA, 2004, SENSOR ACTUAT A-PHYS, V115, P318, DOI 10.1016/j.sna.2004.04.028
   EATON WP, 1994, APPL PHYS LETT, V65, P439, DOI 10.1063/1.112326
   FIEHM S, 1995, P TAS WORKSH, P289
   FLUITMAN JHJ, 1994, P WORKSHOP MICRO TOT, P73
   FRIIS P, 2004, P TAS, P354
   Fu C, 2003, J MICROMECH MICROENG, V13, pS96, DOI 10.1088/0960-1317/13/4/316
   FU C, 2002, P EUROSENSORS, V16, P149
   GALAMBOS P, 2001, P 2001 ASME C NEW YO, P1
   Gerlach A, 1999, MICROSYST TECHNOL, V6, P19, DOI 10.1007/s005420050169
   Guerin L. J., 1997, P TRANSD 97 CHIC IL, P1419
   Guillaudeu S, 2003, DIAM RELAT MATER, V12, P65, DOI 10.1016/S0925-9635(02)00286-8
   HAN A, 2003, P IEEE 12 INT C TRAN, P1315
   Han J., 2003, P 7 INT C MICR TOT A, P1113
   Harper CA, 1996, HDB PLASTICS ELASTOM
   Harrison C, 2004, J MICROMECH MICROENG, V14, P153, DOI 10.1088/0960-1317/14/1/021
   Helbo B, 2003, J MICROMECH MICROENG, V13, P307, DOI 10.1088/0960-1317/13/2/320
   Heuschkel MO, 1998, SENSOR ACTUAT B-CHEM, V48, P356, DOI 10.1016/S0925-4005(98)00071-9
   Huang HC, 2004, J CHROMATOGR A, V1027, P263, DOI 10.1016/j.chroma.2003.08.106
   Huang ZL, 2001, ELECTROPHORESIS, V22, P3924, DOI 10.1002/1522-2683(200110)22:18<3924::AID-ELPS3924>3.0.CO;2-4
   Jackman RJ, 2001, J MICROMECH MICROENG, V11, P263, DOI 10.1088/0960-1317/11/3/316
   JANTING J, 2004, P TAS, P378
   JOURDAIN A, 2003, P DTIP 2003 5 7 MAY, P239
   Kaneko K, 1997, IEEE INT CONF ROBOT, P710, DOI 10.1109/ROBOT.1997.620119
   KENTSCH J, 2004, P TAS, P19
   KIM HS, 2003, P 12 INT C SOL STAT, P790
   Klank H, 2002, LAB CHIP, V2, P242, DOI 10.1039/b206409j
   KOCH M, SENS ACTUATORS A, V74, P207
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Kricka LJ, 2001, CLIN CHIM ACTA, V307, P219, DOI 10.1016/S0009-8981(01)00451-X
   LAI J, 2003, P IEEE ICEPT, P168
   LAI S, 2002, BUSINESS BRIEFING ME, P1
   LANGEN H, ANN CIRP, V44, P173
   LEE HS, 2003, P 12 INT C SOL STAT, P1331
   Lee KB, 2004, SENSOR ACTUAT A-PHYS, V111, P44, DOI 10.1016/j.sna.2003.10.027
   LEI KF, 2003, P 12 INT C SOL STAT, P1335
   Li S, 2003, J MICROMECH MICROENG, V13, P732, DOI 10.1088/0960-1317/13/5/328
   Luo JC, 2000, 2000 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2000), VOLS 1-3, PROCEEDINGS, P1468, DOI 10.1109/IROS.2000.893227
   MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P249, DOI 10.1016/0925-4005(90)80210-Q
   Manz A, 1998, MICROSYSTEM TECHNOLO
   Mardanov S, 1999, COMPUT IND, V38, P93, DOI 10.1016/S0166-3615(98)00111-0
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   Metz S, 2001, LAB CHIP, V1, P29, DOI 10.1039/b103896f
   Misiakos K, 2004, ANAL CHEM, V76, P1366, DOI 10.1021/ac0353334
   Morrissey A, 1997, P SOC PHOTO-OPT INS, V3224, P161, DOI 10.1117/12.284511
   Niklaus F, 2003, SENSOR ACTUAT A-PHYS, V107, P273, DOI 10.1016/S0924-4247(03)00356-X
   Niklaus F, 2001, J MICROMECH MICROENG, V11, P100, DOI 10.1088/0960-1317/11/2/303
   Noh HS, 2004, J MICROMECH MICROENG, V14, P625, DOI 10.1088/0960-1317/14/4/025
   NOH HS, 2003, IEEE P TRANSD 12 INT, P798
   Oberhammer J, 2004, PROC IEEE MICR ELECT, P713, DOI 10.1109/MEMS.2004.1290684
   Oberhammer J, 2003, SENSOR ACTUAT A-PHYS, V105, P297, DOI 10.1016/S0924-4247(03)00202-4
   OH KW, 2001, MICROMECH MICROENG, V12, P187
   Pan CT, 2002, J MICROMECH MICROENG, V12, P611, DOI 10.1088/0960-1317/12/5/315
   PEROZZIELLO G, 2003, MICROSYSTEM ENG LAB, pCH9
   Roberts MA, 1997, ANAL CHEM, V69, P2035, DOI 10.1021/ac961038q
   Ruano JM, 2000, ANAL CHEM, V72, P1093, DOI 10.1021/ac9906983
   Schlautmann S, 2003, J MICROMECH MICROENG, V13, pS81, DOI 10.1088/0960-1317/13/4/313
   Schmidt M. A., 1994, SOL STAT SENS ACT WO, P127
   SCHUENEMANN M, 2004, IEEE P EL COMP TECHN, P853
   Shawgo RS, 2002, CURR OPIN SOLID ST M, V6, P329, DOI 10.1016/S1359-0286(02)00032-3
   SPIERINGS GACM, 1995, PHILIPS J RES, V49, P139, DOI 10.1016/0165-5817(95)82007-8
   Su YC, 2001, PROC IEEE MICR ELECT, P50, DOI 10.1109/MEMSYS.2001.906476
   Svasek P, 2004, SENSOR ACTUAT A-PHYS, V115, P591, DOI 10.1016/j.sna.2004.03.055
   Tanaka M, 2001, RIKEN REV, V34, P46
   TAVAKOLI M, 2002, BUSINESS BRIEFING ME, P1
   TOPPER M, 1998, P IMAPS
   Truckenmuller R, 2004, MICROSYST TECHNOL, V10, P372, DOI 10.1007/s00542-004-0422-3
   Truong TQ, 2004, J MICROMECH MICROENG, V14, P632, DOI 10.1088/0960-1317/14/4/026
   TSENG A, 2000, J MAT PROCESS MANUF, V8, P295
   TURMEZEI P, 2003, P IEEE TRANSDUCERS, V3, P107
   Uematsu I, 2004, J COLLOID INTERF SCI, V269, P336, DOI 10.1016/j.jcis.2003.08.069
   VANBRUSSEL H, 2000, ANN CIRP, V49, P452
   Verpoorte E, 2003, P IEEE, V91, P930, DOI 10.1109/JPROC.2003.813570
   Vulto P, 2005, LAB CHIP, V5, P158, DOI [10.1039/b411885e, 10.1039/b411885c]
   Weigl BH, 2003, ADV DRUG DELIVER REV, V55, P349, DOI 10.1016/S0169-409X(02)00223-5
   Witte R, 2003, P SOC PHOTO-OPT INS, V4979, P226, DOI 10.1117/12.478282
   Wu ZY, 2002, ELECTROPHORESIS, V23, P782, DOI 10.1002/1522-2683(200203)23:5<782::AID-ELPS782>3.0.CO;2-K
   WULFF K, 2001, THESIS U KARLSRUHE K
   Zhou Y, 1998, IEEE INT CONF ROBOT, P1220, DOI 10.1109/ROBOT.1998.677265
   Ziaie B, 2004, ADV DRUG DELIVER REV, V56, P145, DOI 10.1016/j.addr.2003.09.001
   Zimmermann S, 2004, SENSOR ACTUAT B-CHEM, V99, P163, DOI 10.1016/S0925-4005(03)00552-5
NR 101
TC 55
Z9 56
U1 4
U2 100
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1521-3323
J9 IEEE T ADV PACKAGING
JI IEEE Trans. Adv. Packag.
PD NOV
PY 2005
VL 28
IS 4
BP 533
EP 546
DI 10.1109/TADVP.2005.858427
PG 14
WC Engineering, Manufacturing; Engineering, Electrical & Electronic;
   Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 984EE
UT WOS:000233284500002
DA 2018-10-20
ER

PT J
AU Laske, TG
   Harlow, HJ
   Werder, JC
   Marshall, MT
   Iaizzo, PA
AF Laske, TG
   Harlow, HJ
   Werder, JC
   Marshall, MT
   Iaizzo, PA
TI High capacity implantable data recorders: System design and experience
   in canines and Denning Black Bears
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
ID HUMANS
AB Background: Implantable medical devices have increasingly large capacities for storing patient data as a diagnostic aid and to allow patient monitoring. Although these devices can store a significant amount of data, an increased ablility for data storage was required for chronic monitoring in recent physiological studies.
   Method of Approach: Novel high capacity implantable data recorders were designed for use in advanced physiological studies of canines and free-ranging black bears. These hermitically sealed titanium encased recorders were chronically, implanted and programmed to record intrabody broadband electrical activity to monitor electrocardiograms and electromyogroms, and single-axis acceleration to document relative activities.
   Results: Changes in cardiac T-wave morphology were characterized in the canines over a 6 month period, providing new physiological data for the design of algorithms and filtering schemes that could be employed to avoid inappropriate implantable defibrillator shocks. Unique characteristics of bear hibernation physiology were successfully identified in the black bears, including: heart rate, respiratory rate, gross body movement, and shiver. An unanticipated high rejection rate of these devices occurred in the bears, with five of six being externalized during the overwintering period, including two devices implanted in the peritoneal cavity.
   Conclusions: High capacity, implantable data recorders were designed and utilized for the collection of long-term physiological data in both laboratory and extreme field environments. The devices described were programmable to accommodate the diverse research protocols. Additionally, we have described substantial differences in the response of two species to a common device. Variations in the foreign hotly response of different mammals must be identified and taken into consideration when choosing tissue-contacting materials in the application of biomedical technology to physiologic research.
C1 Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA.
   Univ Minnesota, Dept Physiol, Minneapolis, MN 55455 USA.
   Medtronic Inc, Minneapolis, MN 55432 USA.
   Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.
RP Iaizzo, PA (reprint author), Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA.
CR Byrd CL, 2000, CLIN CARDIAC PACING, P669
   BYRD CL, 2000, CLIN CARDIAC PACING, P695
   Echols KN, 2004, URSUS, V15, P172, DOI 10.2192/1537-6176(2004)015<0172:EOSIFM>2.0.CO;2
   Harlow HJ, 2001, NATURE, V409, P997, DOI 10.1038/35059165
   HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620
   IAIZZO PA, 2005, HDB CARDIAC ANATOMY, pCH23
   Korte T, 2004, PACE, V27, P924, DOI 10.1111/j.1540-8159.2004.00560.x
   MARSHALL MT, 2003, PACE, V26, P1100
   Moody G. B., 1985, Computers in Cardiology (Cat. No.85CH2217-8), P113
NR 9
TC 10
Z9 12
U1 0
U2 3
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD NOV
PY 2005
VL 127
IS 6
BP 964
EP 971
DI 10.1115/1.2049340
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 981EH
UT WOS:000233069700012
PM 16438234
DA 2018-10-20
ER

PT J
AU Georgiev, DG
   Sultana, T
   Mian, A
   Auner, G
   Herfurth, H
   Witte, R
   Newaz, G
AF Georgiev, DG
   Sultana, T
   Mian, A
   Auner, G
   Herfurth, H
   Witte, R
   Newaz, G
TI Laser fabrication and characterization of sub-millimeter joints between
   polyimide and Ti-coated borosilicate glass
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID INTERFACE; DIFFUSION; XPS
AB Laser-fabricated joints of sub-millimeter widths between biocompatible, dissimilar materials have the potential for application as encapsulation of miniature implantable biomedical devices. In this work, we briefly describe the laser joining method of a very promising system, polyimide/titanium-coated borosilicate glass, and present results from characterization of such laser joints by means of mechanical failure (tensile) tests, optical and scanning electron microscopy, X-ray photoelectron spectroscopy (XPS) and Raman spectroscopy. Our results suggest that the formation of the joints is a result of the creation of strong chemical bonds between Ti-containing species and certain polymeric functional groups. Mechanical tensile strength failure testing showed that such joints experience some degradation as a result of soaking in physiological solutions. This degradation is limited and, even after relatively long-term exposure the joints retain considerable strength. (c) 2005 Springer Science+ Business Media, Inc.
C1 Wayne State Univ, Coll Engn, Ctr Smart Sensors & Integrated Microsyst, Detroit, MI 48202 USA.
   Fraunhofer Ctr Laser Technol, Plymouth, MI 48170 USA.
RP Georgiev, DG (reprint author), Wayne State Univ, Coll Engn, Ctr Smart Sensors & Integrated Microsyst, Detroit, MI 48202 USA.
EM dgeorgie@eng.wayne.edu
OI Mian, Ahsan/0000-0002-2033-6738
CR Bauer I, 2004, P SOC PHOTO-OPT INS, V5339, P454, DOI 10.1117/12.530239
   CALLEGARI AC, 1994, J VAC SCI TECHNOL A, V12, P185, DOI 10.1116/1.578918
   Faupel F, 1997, DEFECT DIFFUS FORUM, V143, P887, DOI 10.4028/www.scientific.net/DDF.143-147.887
   FURMAN BK, 1992, J VAC SCI TECHNOL A, V10, P2913, DOI 10.1116/1.577729
   FURUKAWA T, 1981, J AM CERAM SOC, V64, P443, DOI 10.1111/j.1151-2916.1981.tb09893.x
   Georgiev DG, 2004, APPL SURF SCI, V236, P71, DOI 10.1016/j.apsusc.2004.03.261
   Girardeaux C, 1996, J ELECTRON SPECTROSC, V77, P209, DOI 10.1016/0368-2048(95)02521-9
   GIRARDEAUX C, 1994, J ELECTRON SPECTROSC, V70, P11, DOI 10.1016/0368-2048(94)02218-O
   Marin N, 1997, NUCL INSTRUM METH B, V131, P109, DOI 10.1016/S0168-583X(97)00197-3
   MIAN A, UNPUB J MAT SCI MAT
   OHUCHI FS, 1986, J VAC SCI TECHNOL A, V4, P1039, DOI 10.1116/1.573450
   SHIH DY, 1991, J VAC SCI TECHNOL A, V9, P2963, DOI 10.1116/1.577157
NR 12
TC 25
Z9 25
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD NOV
PY 2005
VL 40
IS 21
BP 5641
EP 5647
DI 10.1007/s10853-005-1291-6
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 975WS
UT WOS:000232695400010
DA 2018-10-20
ER

PT J
AU Zheng, HY
   Lee, T
AF Zheng, HY
   Lee, T
TI Studies of CO2 laser peeling of glass substrates
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
AB Glass has been used as a substrate in micro-fluidics, biomedical and MEMS. Glass is difficult to machine due to its brittleness. Traditional mechanical techniques such as grinding, turning and drilling are associated with surface damage, micro-cracks, edge chips and rough surface as the material is removed by breaking and chipping into small glass fragments. Laser cutting by the melt and blow technique also causes thermal cracks and rough surfaces. In this paper, we report a new way of removing a continuous strip of a glass layer by laser peeling along the moving path of the beam. The formed groove is found crack free with a smooth bottom surface. The possible mechanism of forming the continuous glass strip in laser peeling is discussed.
C1 Singapore Inst Mfg Technol, Singapore 638075, Singapore.
RP Zheng, HY (reprint author), Singapore Inst Mfg Technol, 71 Nanyang Dr, Singapore 638075, Singapore.
EM hyzheng@simtech.a-star.edu.sg
CR Allcock G, 1995, J APPL PHYS, V78, P7295, DOI 10.1063/1.360378
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   HERMAN PR, 2003, C LAS EL OPT
   Mencik J., 1992, STRENGTH FRACTURE GL
   Nikumb S, 2005, THIN SOLID FILMS, V477, P216, DOI 10.1016/j.tsf.2004.08.136
   Tsai CH, 2003, J MATER PROCESS TECH, V136, P166, DOI 10.1016/S0924-0136(03)00134-1
   Zheng HY, 2004, APPL SURF SCI, V236, P114, DOI 10.1016/j.apsusc.2004.04.034
   ZHENG HY, 2005, INT J ADV MANUF TECH
NR 8
TC 28
Z9 28
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD NOV
PY 2005
VL 15
IS 11
BP 2093
EP 2097
DI 10.1088/0960-1317/15/11/014
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 990SP
UT WOS:000233763800015
DA 2018-10-20
ER

PT J
AU Kim, JM
   Oh, DH
   Yoon, J
   Cho, S
   Kim, N
   Cho, J
   Kwon, Y
   Cheon, C
   Kim, YK
AF Kim, JM
   Oh, DH
   Yoon, J
   Cho, S
   Kim, N
   Cho, J
   Kwon, Y
   Cheon, C
   Kim, YK
TI Silicon MEMS probe using a simple adhesive bonding process for
   permittivity measurement
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
ID RADIO-FREQUENCY PERMITTIVITY; ENDED COAXIAL LINE; BIOLOGICAL TISSUES; 20
   GHZ; LIQUIDS
AB We developed a silicon MEMS probe for permittivity measurements using an adhesive bonding process. Only two photolithographic masks are required to fabricate the probe, which can be implemented through simple bonding processes using silicon substrates and a benzo cyclo butene (BCB) adhesive layer. Undoped silicon substrates with thicknesses of 300 gm are used as the dielectric layers of the proposed probe. BCB layers, which have good electrical properties at high frequencies as well as adhesive properties for the bonding process, play the role of bonding materials between the two silicon substrates. The length of the probe is 30 mm, and the aperture located at the tip of the probe is 1.1 mm x 0.62 mm. The permittivity of 0.5% saline was measured, and the results agreed with the values obtained through the Cole-Cole equation. To validate the feasibility of this probe for practical biological applications, we also performed in vivo measurements of the muscle, skin and blood of mice. Due to the simple fabrication process, the cost of the probe can be reduced in comparison with the previous micromachined probe (Kim et al 2005 J. Micromech. Microeng. 15 543-50) as well as the conventional laser machined probe. Low cost leads to disposability, which is an important factor for practical biomedical applications; and thus, coupled with the probe's capabilities of MMIC integration and CMOS compatibility, this probe has excellent potential in the field of microwave permittivity measurements.
C1 Seoul Natl Univ, Sch Elect Engn & Comp Sci, Seoul, South Korea.
   Univ Seoul, Dept Elect & Comp Engn, Seoul, South Korea.
RP Kim, JM (reprint author), Seoul Natl Univ, Sch Elect Engn & Comp Sci, Seoul, South Korea.
CR ATHEY TW, 1982, IEEE T MICROW THEORY, V30, P82, DOI 10.1109/TMTT.1982.1131021
   Hagl DA, 2003, IEEE T MICROW THEORY, V51, P1194, DOI 10.1109/TMTT.2003.809626
   JEONG E, 2004, MTT S, V3, P1813
   Kim JM, 2005, J MICROMECH MICROENG, V15, P543, DOI 10.1088/0960-1317/15/3/015
   NYSHADHAM A, 1992, IEEE T MICROW THEORY, V40, P305, DOI 10.1109/22.120103
   Pozar D. M., 2005, MICROWAVE ENG
   STUCHLY MA, 1982, IEEE T MICROW THEORY, V30, P87, DOI 10.1109/TMTT.1982.1131022
   WEI YZ, 1991, IEEE T MICROW THEORY, V39, P526, DOI 10.1109/22.75296
   WEI YZ, 1989, REV SCI INSTRUM, V60, P3041, DOI 10.1063/1.1140601
NR 9
TC 2
Z9 2
U1 0
U2 1
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD NOV
PY 2005
VL 15
IS 11
BP N11
EP N16
DI 10.1088/0960-1317/15/11/N01
PG 6
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 990SP
UT WOS:000233763800031
DA 2018-10-20
ER

PT J
AU Trenholm, A
   Landry, S
   McLaughlin, K
   Deluzio, KJ
   Leighton, J
   Trask, K
   Leighton, RK
AF Trenholm, A
   Landry, S
   McLaughlin, K
   Deluzio, KJ
   Leighton, J
   Trask, K
   Leighton, RK
TI Comparative fixation of tibial plateau fractures using alpha-BSM (TM), a
   calcium phosphate cement, versus cancellous bone graft
SO JOURNAL OF ORTHOPAEDIC TRAUMA
LA English
DT Article
DE tibial plateau; fracture; bone graft substitute
ID AUTOLOGOUS BONE; SUBSTITUTE; DEFECTS
AB Objectives: To compare the compressive strength of a bone substitute material (alpha-BSM (TM)) to cancellous bone when used to fill a defect void in a cadaver model of a Schatzker II split depression fracture of the lateral tibial plateau.
   Design: Randomized, paired design.
   Setting: Biomedical engineering laboratory.
   Patients: Twenty-six human tibias were harvested from 13 cadavers. Three pairs of tibia fractured during preparation and were excluded. The remaining 10 matched pairs were randomized to fixation by using the bone substitute material or cancellous bone.
   Intervention: A split depression fracture of the lateral tibial plateau was created in each tibia by using reproducible methods. This fracture was stabilized with a stainless steel L-plate and screws and either alpha-BSM (TM) or cancellous bone to fill the defect void.
   Main Outcome Measurements: Stiffness of the elevated fragment in compression, total depression of the joint at 1000 N.
   Results: The alpha-BSM (TM) bone substitute displayed significantly greater stiffness than cancellous bone constructs in Schatzker II split depression fractures of the lateral tibial plateau (P < 0.0001). Plateau defects displaced significantly less at 1000N when using alpha-BSM (TM) in comparison to cancellous bone (P < 0.0001).
   Conclusions: In this cadaveric study, alpha-BSM (TM) is an effective bone substitute compared with cancellous bone graft for stabilizing split depression fractures of the lateral tibial plateau.
C1 Dalhousie Univ, Dept Orthopaed, Queen Elizabeth II Hlth Sci Ctr, Sch Biomed Engn, Halifax, NS B3H 3A7, Canada.
RP Leighton, RK (reprint author), Dalhousie Univ, Dept Orthopaed, Queen Elizabeth II Hlth Sci Ctr, Sch Biomed Engn, 1796 Summer St, Halifax, NS B3H 3A7, Canada.
EM r.k.leighton@ns.sympatico.ca
CR Beris Alexandros E., 1996, Bulletin Hospital for Joint Diseases, V55, P12
   Bloemers FW, 2003, J BIOMED MATER RES B, V66B, P526, DOI 10.1002/jbm.b.10045
   GOAD MEP, 1997, J BONE MINER RES S, V12, P518
   Haggard W.O., 2003, BONE GRAFT SUBSTITUT, P260
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.0.CO;2-J
   KNAACK D, 1997, J BONE MINER RES S, V12, P202
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LEE DD, 1999, CLIN ORTHOP RELAT R, V367, P396
   Linhart W, 2003, UNFALLCHIRURG, V106, P618, DOI 10.1007/s00113-003-0628-3
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   MORRISON J, 1968, BIOMED ENG NY, V4, P164
   Muller ME, 1995, MANUAL INTERNAL FIXA
   RUSSELL TA, 2004, 71 ANN M AM AC ORTH, P595
   Sarkar MR, 2001, J BIOMED MATER RES, V58, P329, DOI 10.1002/1097-4636(2001)58:3<329::AID-JBM1025>3.0.CO;2-9
   SCHIPPLEIN OD, 1991, J ORTHOPAED RES, V9, P113, DOI 10.1002/jor.1100090114
   SHORS EC, 2003, BONE GRAFT SUBSTITUT, P271
   Stuart M J, 1999, Am J Knee Surg, V12, P148
   URBAN RM, 2004, ORTHOPAEDICS S1, V27, P1113
   Welch RD, 2003, J BONE JOINT SURG AM, V85A, P222, DOI 10.2106/00004623-200302000-00007
   Wenisch S, 2003, UNFALLCHIRURG, V106, P387, DOI 10.1007/s00113-003-0578-9
   WIPPERMANN BW, 1999, 45 ORS M, P525
NR 21
TC 42
Z9 45
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA
SN 0890-5339
J9 J ORTHOP TRAUMA
JI J. Orthop. Trauma
PD NOV-DEC
PY 2005
VL 19
IS 10
BP 698
EP 702
DI 10.1097/01.bot.0000183455.01491.bb
PG 5
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 989NZ
UT WOS:000233682100004
PM 16314717
DA 2018-10-20
ER

PT J
AU Weissleder, R
   Kelly, K
   Sun, EY
   Shtatland, T
   Josephson, L
AF Weissleder, R
   Kelly, K
   Sun, EY
   Shtatland, T
   Josephson, L
TI Cell-specific targeting of nanoparticles by multivalent attachment of
   small molecules
SO NATURE BIOTECHNOLOGY
LA English
DT Article
ID QUANTUM DOTS; IN-VIVO; FLUORESCENT; PROBES; EXPRESSION; AGENTS
AB Nanomaterials with precise biological functions have considerable potential for use in biomedical applications. Here we investigate whether multivalent attachment of small molecules can increase specific binding affinity and reveal new biological properties of such nanomaterials. We describe the parallel synthesis of a library comprising 146 nanoparticles decorated with different synthetic small molecules. Using fluorescent magnetic nanoparticles, we rapidly screened the library against different cell lines and discovered a series of nanoparticles with high specificity for endothelial cells, activated human macrophages or pancreatic cancer cells. Hits from the last-mentioned screen were shown to target pancreatic cancer in vivo. The method and described materials could facilitate development of functional nanomaterials for applications such as differentiating cell lines, detecting distinct cellular states and targeting specific cell types.
C1 Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Charlestown, MA 02129 USA.
RP Weissleder, R (reprint author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Bldg 149,13th St,Room 5403, Charlestown, MA 02129 USA.
EM weissleder@helix.mgh.harvard.edu
OI /0000-0003-0828-4143
CR Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Boullier A, 2001, ANN NY ACAD SCI, V947, P214
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.040437101
   Gao XH, 2003, TRENDS BIOTECHNOL, V21, P371, DOI 10.1016/S0167-7799(03)00209-9
   Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i
   Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749
   Hogemann D, 2002, BIOCONJUGATE CHEM, V13, P116, DOI 10.1021/bc015549h
   Huber MM, 1998, BIOCONJUGATE CHEM, V9, P242, DOI 10.1021/bc970153k
   Josephson L, 2002, BIOCONJUGATE CHEM, V13, P554, DOI 10.1021/bc015555d
   Kang HW, 2002, BIOCONJUGATE CHEM, V13, P122, DOI 10.1021/bc0155521
   Kelly KA, 2004, ANAL BIOCHEM, V330, P181, DOI 10.1016/j.ab.2004.02.035
   Kelly KA, 2005, CIRC RES, V96, P327, DOI 10.1161/01.RES.0000155722.17881.dd
   Kircher MF, 2004, BIOCONJUGATE CHEM, V15, P242, DOI 10.1021/bc034151d
   Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030
   Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755
   Pham W, 2004, CHEMBIOCHEM, V5, P1148, DOI 10.1002/cbic.200400063
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Santra S, 2005, J AM CHEM SOC, V127, P1656, DOI 10.1021/ja0464140
   Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964
   SHEN T, 1993, MAGN RESON MED, V29, P599, DOI 10.1002/mrm.1910290504
   Tsapis N, 2002, P NATL ACAD SCI USA, V99, P12001, DOI 10.1073/pnas.182233999
   Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872
   Wu Y, 2004, NATURE, V430, P61, DOI 10.1038/nature02674
   Wunderbaldinger P, 2002, ACAD RADIOL, V9, pS304, DOI 10.1016/S1076-6332(03)80210-6
   Zorov DB, 2004, CIRC RES, V95, P239, DOI 10.1161/01.RES.0000137875.42385.8e
NR 29
TC 643
Z9 652
U1 9
U2 192
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1087-0156
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD NOV
PY 2005
VL 23
IS 11
BP 1418
EP 1423
DI 10.1038/nbt1159
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 984FN
UT WOS:000233288000038
PM 16244656
DA 2018-10-20
ER

PT J
AU Yoo, J
   Tang, L
   Perkins, TA
   Rowland, DJ
   Laforest, R
   Lewis, JS
   Welch, MJ
AF Yoo, J
   Tang, L
   Perkins, TA
   Rowland, DJ
   Laforest, R
   Lewis, JS
   Welch, MJ
TI Preparation of high specific activity (86)Y using a small biomedical
   cyclotron
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
DE (86)Y; electrodeposition; biomedical cyclotron; electrochemical
   separation
ID NON-HODGKINS-LYMPHOMA; DIETHYLENETRIAMINEPENTAACETIC ACID;
   MONOCLONAL-ANTIBODIES; Y-90; YTTRIUM-86; IN-111; PET;
   RADIOIMMUNOTHERAPY; PURIFICATION; PHARMACOKINETICS
AB (86)Y is an attractive PET radionuclide due to its intermediate half-life. (86)Y was produced via the (86)Sr(p,n) 86Y nuclear reaction. Enriched SrCO(3) or SrO was irradiated with 2-6 mu A of beam current for <4 It on a CS-I 5 cyclotron. It was shown that the SrO target could withstand at least 6 mu A of beam current, a significant improvement over a maximum of 2 mu A on the SrCO(3) target. Average yields of 4.5 mCi/mu A (.) It were achieved with SrO, which represent 71% of the theoretical yield, compared to 2.3 mCi/mu A (.) It with SrCO(3). The radioisotopic contaminants were (86m)Y (220%), (87)Y (0.27%), (87m)Y (0.43%) and (88)Y (0.024%). (86)Y was isolated in an electrochemical cell consisting of three Pt electrodes. The solution was electrolyzed at 2000 mA (40 min) using two Pt plate electrodes. A second electrolysis (230 mA for 20 min) was performed using one Pt plate and a Pt wire. On average, 97.1% of the (86)Y was recollected on the Pt wire after a second electrolysis. The (86)Y was collected from the Pt wire using 2.8 M HNO(3)/EtOH (3: 1). After evaporation, (86)Y was reconstituted in 100 mu l of 0.1 M HCl Target materials were recovered as SrCO(3) and then converted to SrO by thermal decomposition at 1150 degrees C. Specific activity of (86)Y was determined to be 29 +/- 19 mCi/mu g via titration of (86)Y(OAc)(3) With DOTA or DTPA. We have established techniques for the routine, economical production of high purity, high specific activity (86)Y on a small biomedical cyclotron that are translatable to other institutions. (c) 2005 Published by Elsevier Inc.
C1 Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
RP Lewis, JS (reprint author), Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
EM j.s.lewis@wustl.edu
RI Rowland, Douglas/F-3104-2014
OI Rowland, Douglas/0000-0001-8059-6905; Lewis, Jason/0000-0001-7065-4534
FU NCI NIH HHS [R24 CA86307]
CR Breeman WAP, 2003, EUR J NUCL MED MOL I, V30, P917, DOI 10.1007/s00259-003-1142-0
   Brouwers AH, 2004, J NUCL MED, V45, P327
   Buchholz HG, 2003, EUR J NUCL MED MOL I, V30, P716, DOI 10.1007/s00259-002-1112-y
   Carrasquillo JA, 1999, J NUCL MED, V40, P268
   Finn RD, 1999, AIP CONF PROC, V475, P991
   GAEHLE G, 2002, 17 INT C APPL ACC RE, P785
   Garmestani K, 2002, NUCL MED BIOL, V29, P599, DOI 10.1016/S0969-8051(02)00322-0
   Goldenberg DM, 2001, CRIT REV ONCOL HEMAT, V39, P195
   Grillo-Lopez Antonio J, 2002, Expert Rev Anticancer Ther, V2, P485, DOI 10.1586/14737140.2.5.485
   Hamaguchi H, 1958, BUNSEKI KAGAKU, V7, P243
   HERZOG H, 1993, J NUCL MED, V34, P2222
   Jamar F, 2003, EUR J NUCL MED MOL I, V30, P510, DOI 10.1007/s00259-003-1117-1
   Koudelkova M, 2003, J CHROMATOGR A, V990, P311, DOI 10.1016/S0021-9673(02)01703-X
   KOVACS Z, 1985, INT J APPL RADIAT IS, V36, P635, DOI 10.1016/0020-708X(85)90004-3
   KOZAK RW, 1989, CANCER RES, V49, P2639
   LANGE G, 1957, J INORG NUCL CHEM, V4, P146, DOI 10.1016/0022-1902(57)80060-8
   Lovqvist A, 2001, J NUCL MED, V42, P1281
   McCarthy DW, 1999, NUCL MED BIOL, V26, P351, DOI 10.1016/S0969-8051(98)00113-9
   McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6
   McQuade P, 2005, J MED CHEM, V48, P2985, DOI 10.1021/jm0490282
   PAISCHERF LH, 1720, CLIN RES RES, V6, P1720
   Pandey U, 2002, APPL RADIAT ISOTOPES, V57, P313, DOI 10.1016/S0969-8043(02)00103-3
   Park LS, 2004, NUCL MED BIOL, V31, P297, DOI 10.1016/S0969-8051(03)00141-0
   PENTLOW RS, 2000, CLIN POSITRON IMAGIN, V3, P85
   Reischl G, 2002, RADIOCHIM ACTA, V90, P225, DOI 10.1524/ract.2002.90.4_2002.225
   Roesch F, 1993, APPL RADIAT ISOTOPES, V44, P677
   Rosch F, 1999, EUR J NUCL MED, V26, P358, DOI 10.1007/s002590050398
   ROSELLI M, 1989, J NUCL MED, V30, P672
   Rowland D. J., 2001, Journal of Labelled Compounds and Radiopharmaceuticals, V44, pS1059
   Sheh Y, 2000, RADIOCHIM ACTA, V88, P169, DOI 10.1524/ract.2000.88.3-4.169
   Silverman DH, 2004, CANCER TREAT REV, V30, P165, DOI 10.1016/j.ctrv.2003.07.006
   STIMMEL JB, 1995, BIOCONJUGATE CHEM, V6, P219, DOI 10.1021/bc00032a010
   Szelagowski H, 1999, J APPL PHYS, V85, P193, DOI 10.1063/1.369468
   Venkatesh M, 2001, RADIOCHIM ACTA, V89, P413, DOI 10.1524/ract.2001.89.6.413
   Walrand S, 2003, EUR J NUCL MED MOL I, V30, P354, DOI 10.1007/s00259-002-1068-y
   Ziegler J F, 1985, STOPPING RANGE IONS
NR 36
TC 67
Z9 67
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0969-8051
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PD NOV
PY 2005
VL 32
IS 8
BP 891
EP 897
DI 10.1016/j.nucmedbio.2005.06.007
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 983RM
UT WOS:000233249800013
PM 16253815
DA 2018-10-20
ER

PT J
AU Ren, DW
   Yi, HF
   Wang, W
   Ma, XJ
AF Ren, DW
   Yi, HF
   Wang, W
   Ma, XJ
TI The enzymatic degradation and swelling properties of chitosan matrices
   with different degrees of N-acetylation
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE enzymatic degradation; chitosan matrices; N-acetylation; biomedical
   materials
ID MECHANICAL-PROPERTIES; ALGINATE-CHITOSAN; IN-VITRO; LYSOZYME; CARTILAGE;
   SCAFFOLD; FILMS; MICROCAPSULES; MICROSPHERES; DERIVATIVES
AB In the design of chitosan-based drug delivery systems and implantable scaffolds, the biodegradation rate of the chitosan matrix represents a promising strategy for drug delivery and the function of carriers. In this study, we have investigated the degradation of chitosan with different degrees of N-acetylation, with respect to weight loss, water absorption.. swelling behavior, molecular weight loss of bulk materials, and reducing sugar content in the media. Chitosan matrices were prepared by compression molding. The results revealed that the initial degradation rate, equilibrium water absorption, and swelling degree increased with decreasing degree of deacetylation (DD) and a dramatic rise began as DD of the chitosan matrix decreased to 62.4%. Chitosan matrices with DD of 52.6%, 56.1%, and 62.4% had the weight half-life of 9.8, 27.3, and more than 56 days, respectively, and the weight half-life of average molecular weight 8.4, 8.8, and 20.0 days, respectively. For chitosan matrices with DD of 71.7%, 81.7%, and 93.5%, both types of half-life exceeded 84 days because of the much slower degradation rate. The dimension of chitosan matrices during degradation was determined by the process of swelling and degradation. These findings may help to design chitosan-based biomedical materials with predetermined degradation timed from several days to months and proper swelling behaviors. (C) 2005 Elsevier Ltd. All rights reserved.
C1 Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Peoples R China.
   Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China.
RP Ma, XJ (reprint author), Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, 457 Zhongshan Rd, Dalian 116023, Peoples R China.
EM maxj@diep.ac.cn
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   AIBA S, 1991, INT J BIOL MACROMOL, V13, P40, DOI 10.1016/0141-8130(91)90008-I
   AIBA S, 1992, INT J BIOL MACROMOL, V14, P225, DOI 10.1016/S0141-8130(05)80032-7
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Broom ND, 1998, BIOMATERIALS, V19, P1179, DOI 10.1016/S0142-9612(98)00017-9
   Chang KLB, 2000, CARBOHYD POLYM, V43, P163, DOI 10.1016/S0144-8617(00)00145-4
   Chang KLB, 1997, CARBOHYD RES, V303, P327, DOI 10.1016/S0008-6215(97)00179-1
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   HENRY JB, 1991, CLIN DIAGNOSIS MANAG, P1371
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050
   KHOR E, 2001, CHITIN FULFILLING BI, P127
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   NORDTVEIT RJ, 1994, CARBOHYD POLYM, V23, P253, DOI 10.1016/0144-8617(94)90187-2
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Prashanth KVH, 2002, CARBOHYD POLYM, V50, P27
   ROBERTS GAF, 1992, CHITIN CHEM, P238
   SAMUELS RJ, 1981, J POLYM SCI POL PHYS, V19, P1081, DOI 10.1002/pol.1981.180190706
   TEMEL A, 1991, ANN OPHTHALMOL, V23, P191
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Yamaguchi I, 2003, BIOMATERIALS, V24, P2031, DOI 10.1016/S0142-9612(02)00633-6
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
   Yu WT, 2004, CHEM J CHINESE U, V25, P1381
NR 33
TC 181
Z9 188
U1 6
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
J9 CARBOHYD RES
JI Carbohydr. Res.
PD OCT 31
PY 2005
VL 340
IS 15
BP 2403
EP 2410
DI 10.1016/j.carres.2005.07.022
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 975FE
UT WOS:000232645600007
PM 16109386
DA 2018-10-20
ER

PT J
AU Bai, JM
   Wang, JP
AF Bai, JM
   Wang, JP
TI High-magnetic-moment core-shell-type FeCo-Au/Ag nanoparticles
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID SUPERPARAMAGNETIC IRON-OXIDE; BIOMEDICAL APPLICATIONS; CONTRAST AGENTS;
   GROWTH; MICROSCOPY; PARTICLES; CLUSTERS; MR
AB We developed a physical technique combining an on-line sputtering/evaporation process with an integrated nanocluster deposition process to prepare core-shell-type nanoparticles. High-magnetic-moment (Fe60Co40)(core)Au-shell and (Fe60Co40)(core)Ag-shell superparamagnetic nanoparticles with controllable particle size of 10-20 nm and Au/Ag shell thickness of 1-3 nm were prepared by using this method. Au shell is not only functional for the potential biocompatibility but also the key to prevent the oxidation of FeCo nanoparticles. Saturation magnetization of (Fe60Co40)(core)Au-shell nanoparticles was found three times higher than that of iron oxide nanoparticles. This technique enables us to control independently the dimensions of core and shell and select individually materials for core and shell for any other core-shell-type nanoparticles. (C) 2005 American Institute of Physics.
C1 Univ Minnesota, Dept Elect & Comp Engn, MINT Ctr, Minneapolis, MN 55455 USA.
RP Wang, JP (reprint author), Univ Minnesota, Dept Elect & Comp Engn, MINT Ctr, 200 Union St SE, Minneapolis, MN 55455 USA.
EM jpwang@umn.edu
CR ASIK JR, 1969, J APPL PHYS, V40, P1385, DOI 10.1063/1.1657680
   Bansmann J, 2005, SURF SCI REP, V56, P189, DOI 10.1016/j.surfrep.2004.10.001
   Bao YP, 2005, J MAGN MAGN MATER, V293, P15, DOI 10.1016/j.jmmm.2005.01.037
   Binns C, 2001, SURF SCI REP, V44, P1, DOI 10.1016/S0167-5729(01)00015-2
   Carpenter EE, 1999, IEEE T MAGN, V35, P3496, DOI 10.1109/20.800568
   Chen M, 2003, J APPL PHYS, V93, P7551, DOI 10.1063/1.1555312
   Chen XB, 2003, NANO LETT, V3, P799, DOI 10.1021/nl034243b
   Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016
   Cho SJ, 2005, CHEM MATER, V17, P3181, DOI 10.1021/cm0500713
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   Dumitrache F, 2004, DIAM RELAT MATER, V13, P362, DOI 10.1016/j.diamond.2003.10.022
   Gupta AK, 2004, BIOMATERIALS, V25, P3029, DOI 10.1016/j.biomaterials.2003.09.095
   GUPTA PK, 1989, LIFE SCI, V44, P175, DOI 10.1016/0024-3205(89)90593-6
   Gutierrez DG, 2004, APPL PHYS A, V79, P481
   *JCPDS INT CTR DIF, 1995, 441433 JCPDS INT CTR
   KENT TA, 1990, MAGNET RESON MED, V13, P434, DOI 10.1002/mrm.1910130310
   Kim DK, 2003, CHEM MATER, V15, P1617, DOI 10.1021/cm021349j
   Lyon JL, 2004, NANO LETT, V4, P719, DOI 10.1021/nl035253f
   Mehta RV, 1997, BIOTECHNOL TECH, V11, P493, DOI 10.1023/A:1018457915380
   Morel R, 2003, EUR PHYS J D, V24, P287, DOI 10.1140/epjd/e2003-00158-9
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Mornet S, 2005, NANO LETT, V5, P281, DOI 10.1021/nl048153y
   Nishimura K, 2002, J APPL PHYS, V91, P8555, DOI 10.1063/1.1452207
   QIU J, 2005, J APPL PHYS, V97
   Skumryev V, 2003, NATURE, V423, P850, DOI 10.1038/nature01687
   Tada M, 2003, J APPL PHYS, V93, P7566, DOI 10.1063/1.1558676
   WANG JP, 2004, PMRC, P247
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   Wu EX, 2004, NMR BIOMED, V17, P478, DOI 10.1002/nbm.923
   XU Y, 2005, J APPL PHYS, V97
   Zhou WL, 2001, EUR PHYS J D, V16, P289, DOI 10.1007/s100530170112
   Zhou WL, 2000, MATER RES SOC SYMP P, V581, P107
NR 32
TC 78
Z9 80
U1 0
U2 32
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD OCT 10
PY 2005
VL 87
IS 15
AR 152502
DI 10.1063/1.2089171
PG 3
WC Physics, Applied
SC Physics
GA 972GL
UT WOS:000232442200044
DA 2018-10-20
ER

PT J
AU Krief, S
   Hladik, CM
   Haxaire, C
AF Krief, S
   Hladik, CM
   Haxaire, C
TI Ethnomedicinal and bioactive properties of plants ingested by wild
   chimpanzees in Uganda
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Review
DE zoopharmacognosy; ethnomedicine; ethnoveterinary medicine; Pan
   troglodytes; apes diet; Uganda
ID SELF-MEDICATIVE BEHAVIOR; MEDICINAL-PLANTS; VERNONIA-AMYGDALINA;
   CHEMICAL ECOLOGY; NATIONAL-PARK; NEST MATERIAL; FOOD; ETHNOPHARMACOLOGY;
   PERSPECTIVE; NESTLINGS
AB Wild chimpanzees eat several plant species claimed by traditional healers to cure diseases. However, the behaviour leading apes to ingest these peculiar species is not clearly understood. Some of the items consumed by chimpanzees have low nutritional value, and there is a growing body of evidence suggesting that health might be improved or regulated by such ingestion. Observations concerning the diet and the health condition of wild chimpanzees (Pan troglodytes schweinfurthii) in the Kibale National Park (Uganda) are discussed in relation to the ethnomedicinal utilization of plant species reviewed in literature. Among the 163 plant parts known to be eaten by these chimpanzees, at least 35 (21.4%) are used in traditional medicine as treatments for intestinal parasites, skin infections, reproduction and respiratory diseases. Relationships with pharmacological properties are presented, taking into account the difficulties of interpreting ethnomedicinal data. In conclusion, a greater knowledge of ape's behaviour and health may provide a new complementary method to select plants for biomedical research. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Museum Natl Hist Nat, Dept Hommes Nat Soc, USM 0104, F-75231 Paris, France.
   Museum Natl Hist Nat, Dept Regulat Dev Divers Mol, USM 0502, F-75231 Paris, France.
   Univ Paris 05, Ctr Rech Psychotropes Sante Mentale, CESAMES, INSERM,CNRS,UMR 81 36, F-75270 Paris, France.
   Fac Med & Sci Sante, Dept Sci Humaines & Sociales, Brest, France.
RP Hladik, CM (reprint author), Museum Natl Hist Nat, Dept Hommes Nat Soc, USM 0104, 43 Rue Buffon, F-75231 Paris, France.
EM hladik@ccr.jussieu.fr
CR *ACCT, 1984, CONTR ET ETHN FLOR G, P294
   Akah PA, 1998, J ETHNOPHARMACOL, V62, P123, DOI 10.1016/S0378-8741(98)00060-9
   Ake-Assi YA., 1992, THESIS U C BERNARD L, P220
   Assi L. Ake, 1981, CONTRIBUTION IDENTIF, P139
   AUGE M, 1986, HOMME, V26, P81
   Baerts M., 1991, Annalen Economische Wetenschappen-Koninklijk Museum voor Midden-Afrika, V21
   BAERTS M, 2002, UTILIZATION QUELQUES
   Baker M, 1996, AM J PRIMATOL, V38, P263
   Bally P.R.O., 1937, KEW B, V1, P10
   BARNISH G, 1992, SLADEA PUBLICATION K, P96
   BOST R., 1961, MEM INST SCI MADAGASCAR SER B BIOL VEG, V10, P159
   Bouquet A., 1969, MEMOIRE ORSTOM
   Bouquet A., 1974, TRAVAUX DOCUMENTS OR, V32, P232
   Bruneton J, 1993, PHARMACOGNOSIE PHYTO, P915
   Carter CA, 1997, TETRAHEDRON, V53, P16959, DOI 10.1016/S0040-4020(97)10174-0
   CLARK L, 1988, OECOLOGIA, V77, P174, DOI 10.1007/BF00379183
   CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280
   CONKLIN NL, 1994, BIOCHEM SYST ECOL, V22, P137, DOI 10.1016/0305-1978(94)90004-3
   Cousins Don, 2002, African Study Monographs, V23, P65
   Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893
   CURASSON MG, 1938, B SERVICES ZOOTECHNI, V11, P13
   Danbury TC, 2000, VET REC, V146, P307, DOI 10.1136/vr.146.11.307
   Defour G, 1994, PLANTES MED TRADITIO
   DEWAAL F, 1982, CHIMPANZEE POLITICS
   ETKIN NL, 1991, J ETHNOPHARMACOL, V32, P25, DOI 10.1016/0378-8741(91)90100-R
   ETKIN NL, 1982, SOC SCI MED, V16, P1559, DOI 10.1016/0277-9536(82)90167-8
   ETKIN NL, 1981, J ETHNOPHARMACOL, V4, P75, DOI 10.1016/0378-8741(81)90021-0
   ETKIN NL, 1983, ANTHROPOL MED, P231
   ETKIN NL, 1988, CONTEXT MED DEV COUN, P236
   FARNSWORTH NR, 1985, B WORLD HEALTH ORGAN, V63, P965
   FARNSWORTH NR, 1990, CIBA F SYMP, V154, P2
   FAUTH PT, 1991, OECOLOGIA, V88, P22, DOI 10.1007/BF00328399
   FELLOWS LE, 1992, NEW DRUGS NATURAL SO
   GBILE Z O, 1990, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V23, P1033
   GILLET J, 1910, ANN MUSEE ROYAL CO 5, V4, P120
   GLANDER K E, 1982, Yearbook of Physical Anthropology, V25, P1
   Goodall J, 1986, CHIMPANZEES GOMBE PA, P673
   Gwinner H, 2000, ANIM BEHAV, V59, P301, DOI 10.1006/anbe.1999.1306
   Harjula R, 1980, MIRAU HIS PRACTICE S, P224
   HAXAIRE C, 1996, ALIMENTATION FORET T, P923
   HAXAIRE C, 1999, REMEDES JOUVENCE REM, P199
   HEINE B, 1988, BAND KOLNER BEITRAGE, P142
   HELMAN CG, 1981, SOC SCI MED-MED ANTH, V15, P521, DOI 10.1016/0160-7987(81)90026-0
   HEXAIRE C, 1979, THESIS U SCI TECHNIQ
   Hill M, 1992, Eur J Cancer Prev, V1, P339, DOI 10.1097/00008469-199208000-00001
   Hladik C. M., 1977, P481
   Hladik Claude Marcel, 1996, Evolutionary Anthropology, V5, P58, DOI 10.1002/(SICI)1520-6505(1996)5:2<58::AID-EVAN5>3.0.CO;2-S
   Hladik CM, 1977, PRIMATE ECOLOGY, P324
   HOLMSTEDT B, 1991, J ETHNOPHARMACOL, V32, P7, DOI 10.1016/0378-8741(91)90099-Y
   Huffman M. A., 1996, COMPOSITAE BIOL UTIL, V2, P351
   Huffman MA, 2004, PRIMATES, V45, P113, DOI 10.1007/s10329-003-0065-5
   HUFFMAN MA, 1989, PRIMATES, V30, P51, DOI 10.1007/BF02381210
   Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257
   Huffman MA, 2001, BIOSCIENCE, V51, P651, DOI 10.1641/0006-3568(2001)051[0651:SMBITA]2.0.CO;2
   Huffman MA, 1997, YEARB PHYS ANTHROPOL, V40, P171
   HUFFMAN MA, 1998, NATURAL MED RES 21 C, P113
   Huffman Michael A., 1993, African Study Monographs, V14, P227
   HUGHJONES S, 1993, MAN BIOSPH, V13, P533
   Janzen D.H., 1978, P73
   Johns T, 1999, ANNU REV ANTHROPOL, V28, P27, DOI 10.1146/annurev.anthro.28.1.27
   KALANDA K, 1995, REV MED PHARMACOPEES, V9, P59
   Karban R, 1997, ECOLOGY, V78, P603
   KARHAGOMBA IB, 1998, RECHERCHES AFRICAINE, P90
   Katende AB, 1995, USEFUL TREES SHRUBS
   KAYONGA A, 1987, CONTRIBUTION ETUDES, P121
   Kerharo J., 1974, PHARMACOPEE SENEGALA, P1012
   KLOOS H, 1987, PLANTS RECOGNIZED MO
   Kokwaro JO, 1976, MED PLANTS E AFRICA, P368
   Krief S, 2005, INT J PRIMATOL, V26, P467, DOI 10.1007/s10764-005-2934-9
   Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004
   Krief S., 2003, Bulletin de la Societe de Pathologie Exotique, V96, P80
   KRIEF S, 2004, PRIMATOLOGIE, V6, P151
   Krief S, 2003, THESIS MNHN PARIS, P375
   Lachaux B, 1988, PLACEBO MEDICAMENT Q
   LARRAT M, 2002, MED PHARM INDIGENES
   MAAS A, 1991, INVENTAIRE PRODUITS, P39
   MERKER M, 1910, MASAI ETHNOGRAPHISCH, P161
   MESFIN T, 1994, REV SCI TECH OIE, V13, P417, DOI 10.20506/rst.13.2.769
   Motte-Florac E., 1996, ALIMENTATION FORET T, P835
   NDAYITWAYEKO A, 1978, CONTRIBUTION ETUDE P, P129
   Nyakabwa M, 1990, AFR STUD MONOGR, V11, P101
   OATES JF, 1977, BIOCHEM SYST ECOL, V5, P317, DOI 10.1016/0305-1978(77)90032-1
   OHIGASHI H, 1994, J CHEM ECOL, V20, P541, DOI 10.1007/BF02059596
   OJINNAKA CM, 1980, PHYTOCHEMISTRY, V19, P2482, DOI 10.1016/S0031-9422(00)91061-6
   Polygenis-Bigendako M.-.J., 1990, THESIS U LIBRE BRUXE, P352
   Reynolds V, 1965, PRIMATE BEHAV, P368
   Rodman P.S., 1978, P465
   SAWYERR ES, 1983, SOLOMON ISLANDS, V1, P88
   Schaller G. B, 1963, MOUNTAIN GORILLA ECO, P1963
   STANER P, 1937, MEM I ROYAL COLONIAL, P228
   Sugiyama Yukimaru, 1992, African Study Monographs, V13, P127
   TANIGUCHI M, 1978, CHEM PHARM BULL, V26, P2910
   TESTA J, 1991, REV MED PHARM AFR, V5, P51
   TUTIN CEG, 1993, AM J PRIMATOL, V30, P195, DOI 10.1002/ajp.1350300305
   VANPUYVELDE L, 1985, J ETHNOPHARMACOL, V13, P209, DOI 10.1016/0378-8741(85)90008-X
   WATT JM, 1962, MED POISONOUS PLANTS
   WRANGHAM R W, 1983, Primates, V24, P276, DOI 10.1007/BF02381090
   Wrangham R. W., 1977, P503
   Wrangham Richard W., 1996, P45, DOI 10.1017/CBO9780511752414.006
   WRANGHAM RW, 1983, BIOTROPICA, V15, P217, DOI 10.2307/2387832
   WRANGHAM RW, 1995, AM J PRIMATOL, V37, P297, DOI 10.1002/ajp.1350370404
   WRANGHAM RW, 1991, PHILOS T ROY SOC B, V334, P171, DOI 10.1098/rstb.1991.0106
   WRANGHAM RW, 1994, CHIMPANZEE CULTURES, P424
NR 103
TC 44
Z9 46
U1 0
U2 28
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD OCT 3
PY 2005
VL 101
IS 1-3
BP 1
EP 15
DI 10.1016/j.jep.2005.03.024
PG 15
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 970LR
UT WOS:000232312200001
PM 15913933
DA 2018-10-20
ER

PT J
AU Holliday, R
   Corti, C
AF Holliday, R
   Corti, C
TI Gold as a biomedical material
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
AB An international program to develop now uses for gold is producing results in the biomedical sector.
C1 Ind Sector, World Gold Council, London, England.
RP Holliday, R (reprint author), Ind Sector, World Gold Council, London, England.
EM richard.holliday@gold.org
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 0882-7958
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD OCT
PY 2005
VL 163
IS 10
BP 74
EP 76
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 976XC
UT WOS:000232765900010
DA 2018-10-20
ER

PT J
AU Liepold, P
   Wieder, H
   Hillebrandt, H
   Friebel, A
   Hartwich, G
AF Liepold, P
   Wieder, H
   Hillebrandt, H
   Friebel, A
   Hartwich, G
TI DNA-arrays with electrical detection: A label-free low cost technology
   for routine use in life sciences and diagnostics
SO BIOELECTROCHEMISTRY
LA English
DT Article; Proceedings Paper
CT 1st Workshop on New Trends in Nucleic Acid Based Biosensors
CY OCT 25-28, 2003
CL Univ Florence, Florence, ITALY
HO Univ Florence
DE DNA-sensor; electrochemical readout; SNP-detection; biological
   applications
ID AMPLIFIED AMPEROMETRIC DETECTION; GRAPHITE-ELECTRODES; BIOSENSOR;
   HYBRIDIZATION; GOLD; RECOGNITION; INDICATOR; SENSORS; NANOPARTICLES;
   MONOLAYERS
AB Fast and highly parallel DNA analysis are essential for improved biomedical research and development. Currently fluorescence-based methods are state of the art in DNA microarray analysis. The necessity to modify the target DNA with labels is costly, laborious and requires skilled personnel. Moreover, false positive calls from unspecific adsorption are possible and it is difficult to discriminate perfect matching target sequences from those with a single mismatch. In this paper a new and simple electrochemical approach for hybridisation detection without the need of labelling the target DNA is described. The EDDA (Electrically Detected Displacement Assay) method uses a solution of short redox-labelled signalling oligonucteotides (oligonucleotides carrying a covalently attached redox active compound like ferrocene) to characterize the hybridisation state of label-free capture probe DNA immobilised on gold electrodes. The number of capture probes associated with signalling oligonucleotides is determined by chronocoulometry. This technique allows to separate the electrochemical response of capture probe associated signal probes from the response of freely diffusing signalling probes. In the absence of the complementary target sequences the redox-labelled signalling probes at the surface give rise to an instantaneous increase of the detection signal, while freely diffusing signalling probes show a significantly delayed response. Hybridisation with targets complementary to the capture probe displace the loosely associated signalling probes thereby decreasing the instantaneous signal. Besides an introduction to the EDDA technology, data validating the method for biological material will be presented and an outlook to the detection of single nucleotide polymorphisms (SNPs) is given. (c) 2005 Elsevier B.V. All rights reserved.
C1 FRIZ Biochem GmbH, D-81477 Munich, Germany.
RP Hartwich, G (reprint author), FRIZ Biochem GmbH, Staffelseestr 6, D-81477 Munich, Germany.
EM Gerhard.hartwich@frizbiochem.de
CR Aich P, 1999, J MOL BIOL, V294, P477, DOI 10.1006/jmbi.1999.3234
   Anne A, 1999, J AM CHEM SOC, V121, P10379, DOI 10.1021/ja991780i
   Bard A.J., 1980, ELECTROCHEMICAL METH
   Boon EM, 2000, NAT BIOTECHNOL, V18, P1096, DOI 10.1038/80301
   Campbell CN, 2002, ANAL CHEM, V74, P158, DOI 10.1021/ac015602v
   de-los-Santos-Alvarez P, 2004, ANAL BIOANAL CHEM, V378, P104, DOI 10.1007/s00216-003-2369-0
   de-Los-Santos-Alvarez P, 2002, ANAL CHEM, V74, P3342, DOI 10.1021/ac015749m
   Dequaire M, 2002, ANAL CHEM, V74, P4370, DOI 10.1021/ac025541g
   Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873
   Erdem A, 1999, ELECTROANAL, V11, P1372, DOI 10.1002/(SICI)1521-4109(199912)11:18<1372::AID-ELAN1372>3.3.CO;2-W
   Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316
   Fritzsche W, 2003, NANOTECHNOLOGY, V14, pR63, DOI 10.1088/0957-4484/14/12/R01
   Gooding JJ, 2002, ELECTROANAL, V14, P1149, DOI 10.1002/1521-4109(200209)14:17<1149::AID-ELAN1149>3.0.CO;2-8
   Hartwich G, 1999, J AM CHEM SOC, V121, P10803, DOI 10.1021/ja9920664
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Herne TM, 1997, J AM CHEM SOC, V119, P8916, DOI 10.1021/ja9719586
   Holmlin RE, 1997, ANGEW CHEM INT EDIT, V36, P2715
   Kelley SO, 1999, NUCLEIC ACIDS RES, V27, P4830, DOI 10.1093/nar/27.24.4830
   Kelley SO, 1997, J AM CHEM SOC, V119, P9861, DOI 10.1021/ja9714651
   Kerman K, 2004, MEAS SCI TECHNOL, V15, pR1, DOI 10.1088/0957-0233/15/2/R01
   Lee PS, 2000, CURR OPIN BIOTECH, V11, P171, DOI 10.1016/S0958-1669(00)00077-X
   Lemieux B, 1998, MOL BREEDING, V4, P277, DOI 10.1023/A:1009654300686
   Levicky R, 1998, J AM CHEM SOC, V120, P9787, DOI 10.1021/ja981897r
   Lucarelli F, 2002, BIOELECTROCHEMISTRY, V58, P113, DOI 10.1016/S1567-5394(02)00133-0
   Meric B, 2002, ELECTROANAL, V14, P1245, DOI 10.1002/1521-4109(200210)14:18<1245::AID-ELAN1245>3.0.CO;2-V
   MILLAN KM, 1993, ANAL CHEM, V65, P2317, DOI 10.1021/ac00065a025
   Napier ME, 1997, BIOCONJUGATE CHEM, V8, P906, DOI 10.1021/bc9701149
   Ozsoz M, 2003, ANAL CHEM, V75, P2181, DOI 10.1021/ac026212r
   Palecek E, 2002, CRIT REV ANAL CHEM, V32, P261, DOI 10.1080/10408340290765560
   Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003
   Peterlinz KA, 1997, J AM CHEM SOC, V119, P3401, DOI 10.1021/ja964326c
   Ramsay G, 1998, NAT BIOTECHNOL, V16, P40, DOI 10.1038/nbt0198-40
   RAND DAJ, 1971, J ELECTROANAL CHEM, V31, P29, DOI 10.1016/0368-1874(71)80004-7
   Shoemaker DD, 2002, CURR OPIN MICROBIOL, V5, P334, DOI 10.1016/S1369-5274(02)00327-2
   Steel AB, 1998, ANAL CHEM, V70, P4670, DOI 10.1021/ac980037q
   Steinmetz LM, 2000, BIOTECHNOL GENET ENG, V17, P109, DOI 10.1080/02648725.2000.10647990
   Turcu F, 2004, ANGEW CHEM INT EDIT, V43, P3482, DOI 10.1002/anie.200454228
   TURCU F, IN PRESS BSBE
   Wang J, 1998, ANAL CHIM ACTA, V375, P197, DOI 10.1016/S0003-2670(98)00503-0
   Wang J, 2002, ANAL CHIM ACTA, V469, P63, DOI 10.1016/S0003-2670(01)01399-X
   Wang J, 2001, ANAL CHEM, V73, P5576, DOI 10.1021/ac0107148
   Yu CJ, 2001, J AM CHEM SOC, V123, P11155, DOI 10.1021/ja010045f
   Zhang YC, 2003, ANAL CHEM, V75, P3267, DOI 10.1021/ac034445s
   Zhang YC, 2002, ANAL BIOANAL CHEM, V374, P1050, DOI 10.1007/s00216-002-1604-4
NR 44
TC 32
Z9 32
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1567-5394
J9 BIOELECTROCHEMISTRY
JI Bioelectrochemistry
PD OCT
PY 2005
VL 67
IS 2
BP 143
EP 150
DI 10.1016/j.bioelechem.2004.08.004
PG 8
WC Biochemistry & Molecular Biology; Biology; Biophysics; Electrochemistry
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Biophysics; Electrochemistry
GA 971DF
UT WOS:000232360800003
PM 16046192
DA 2018-10-20
ER

PT J
AU Fu, AH
   Gu, WW
   Larabell, C
   Alivisatos, AP
AF Fu, AH
   Gu, WW
   Larabell, C
   Alivisatos, AP
TI Semiconductor nanocrystals for biological imaging
SO CURRENT OPINION IN NEUROBIOLOGY
LA English
DT Review
ID QUANTUM DOTS; IN-VIVO; CDSE NANOCRYSTALS; LIVE CELLS; FLUORESCENCE;
   CYTOTOXICITY; MICROSCOPY; RECEPTORS; TRACKING; NANOPARTICLES
AB Conventional organic fluorophores suffer from poor photo stability, narrow absorption spectra and broad emission spectra. Semiconductor nanocrystals, however, are highly photo-stable with broad absorption spectra and narrow size-tunable emission spectra. Recent advances in the synthesis of these materials have resulted in the generation of bright, sensitive, extremely photo-stable and biocompatible semiconductor fluorophores. Commercial availability facilitates their application in a variety of unprecedented biological experiments, including multiplexed cellular imaging, long-term in vitro and in vivo labeling, deep tissue structure mapping and single particle investigation of dynamic cellular processes. Semiconductor nanocrystals are one of the first examples of nanotechnology enabling a new class of biomedical applications.
C1 Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.
   Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.
   Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RP Alivisatos, AP (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
EM alivis@uclink4.berkeley.edu
RI Alivisatos, Paul/N-8863-2015
OI Alivisatos, Paul/0000-0001-6895-9048
CR Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399
   Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506
   ALLVISATOS AP, 2005, ANNU REV BIOMED ENG, V7, P55
   Arya H, 2005, BIOCHEM BIOPH RES CO, V329, P1173, DOI 10.1016/j.bbrc.2005.02.043
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   Brokmann X, 2005, CHEM PHYS LETT, V406, P210, DOI 10.1016/j.cplett.2005.03.007
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Chen FQ, 2004, NANO LETT, V4, P1827, DOI 10.1021/nl049170q
   Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y
   Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Fu AH, 2004, J AM CHEM SOC, V126, P10832, DOI 10.1021/ja04647x
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003
   Gerion D, 2003, ANAL CHEM, V75, P4766, DOI 10.1021/ac034482j
   Grecco HE, 2004, MICROSC RES TECHNIQ, V65, P169, DOI 10.1002/jemt.20129
   Gueroui Z, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166108
   Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228
   Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562
   Hoshino A, 2004, NANO LETT, V4, P2163, DOI 10.1021/nl048715d
   Kaul Z, 2003, CELL RES, V13, P503, DOI 10.1038/sj.cr.7290194
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929
   Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028
   Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y
   Michalet X, 2001, SINGLE MOL, V2, P261, DOI 10.1002/1438-5171(200112)2:4<261::AID-SIMO261>3.0.CO;2-P
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Morgan NY, 2005, ACAD RADIOL, V12, P313, DOI 10.1016/j.acra.2004.04.023
   Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102
   Oh E, 2005, J AM CHEM SOC, V127, P3270, DOI 10.1021/ja0433323
   Pellegrino T, 2003, DIFFERENTIATION, V71, P542, DOI 10.1111/j.1432-0436.2003.07109006.x
   Pinaud F, 2004, J AM CHEM SOC, V126, P6115, DOI 10.1021/ja031691c
   Qu LH, 2002, J AM CHEM SOC, V124, P2049, DOI 10.1021/ja017002j
   Rosenthal SJ, 2002, J AM CHEM SOC, V124, P4586, DOI 10.1021/ja003486s
   Shiohara A, 2004, MICROBIOL IMMUNOL, V48, P669, DOI 10.1111/j.1348-0421.2004.tb03478.x
   Stroh M, 2005, NAT MED, V11, P678, DOI 10.1038/nm1247
   Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096
   Vu TQ, 2005, NANO LETT, V5, P603, DOI 10.1021/nl047977c
   Xiao Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh024
   Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s
NR 45
TC 135
Z9 140
U1 0
U2 45
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-4388
J9 CURR OPIN NEUROBIOL
JI Curr. Opin. Neurobiol.
PD OCT
PY 2005
VL 15
IS 5
BP 568
EP 575
DI 10.1016/j.conb.2005.08.004
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 979LM
UT WOS:000232943500012
PM 16150591
DA 2018-10-20
ER

PT J
AU Togawa, K
   Sanbonsugi, H
   Lapicki, A
   Abe, M
   Handa, H
   Sandhu, A
AF Togawa, K
   Sanbonsugi, H
   Lapicki, A
   Abe, M
   Handa, H
   Sandhu, A
TI High-sensitivity InSb thin-film micro-Hall sensor arrays for
   simultaneous multiple detection of magnetic beads for biomedical
   applications
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article; Proceedings Paper
CT International Magnetics Conference 2005
CY APR 04-08, 2005
CL Nagoya, JAPAN
SP IEEE Magnet Soc, Magnet Soc Japan
DE Hall effect devices; magnetic particles; magnetic sensors; nanostructure
   materials
ID PROBE MICROSCOPY
AB An InSb thin-film linear micro-Hall sensor array of eight sensors, each with a sensitivity of 10 nT/Hz(1/2) was developed for biomedical applications. The individual Hall sensors had an active area of 5 mu m x 5 mu m and were separated by a distance of 5 mu m. A combination of these Hall devices and a magnetization system incorporating both dc and ac bias magnetic fields, enabled the simultaneous detection of multiple 2.8 mu m diameter superparamagnetic beads.
C1 Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1528552, Japan.
   Tokyo Inst Technol, Dept Phys Elect, Tokyo 1528552, Japan.
   Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Tokyo 1528552, Japan.
   Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan.
   Tokyo Inst Technol, Dept Elect & Elect Engn, Quantum Nanoelect Res Ctr, Tokyo 1528552, Japan.
RP Togawa, K (reprint author), Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1528552, Japan.
RI Sandhu, Adarsh/A-1818-2011
CR Baselt DR, 1998, BIOSENS BIOELECTRON, V13, P731, DOI 10.1016/S0956-5663(98)00037-2
   Besse PA, 2002, APPL PHYS LETT, V80, P4199, DOI 10.1063/1.1483909
   Rife JC, 2003, SENSOR ACTUAT A-PHYS, V107, P209, DOI 10.1016/S0924-4247(03)00380-7
   Sandhu A, 2004, MICROELECTRON ENG, V73-4, P524, DOI 10.1016/j.mee.2004.03.029
   Sandhu A, 2004, JPN J APPL PHYS 2, V43, pL868, DOI 10.1143/JJAP.43.L868
   Sandhu A, 2004, JPN J APPL PHYS 1, V43, P777, DOI 10.1143/JJAP.43.777
   Sandhu A, 2002, ULTRAMICROSCOPY, V91, P97, DOI 10.1016/S0304-3991(02)00087-6
   SANDHU A, 2000, P 8 INT C FERR ICF 8, P390
   WOOD DK, 2004, SENS ACTUATORS A
NR 9
TC 17
Z9 18
U1 0
U2 11
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD OCT
PY 2005
VL 41
IS 10
BP 3661
EP 3663
DI 10.1109/TMAG.2005.854789
PG 3
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 975RN
UT WOS:000232679700357
DA 2018-10-20
ER

PT J
AU Lee, SW
   Kim, SJ
   Shim, IB
   Bae, S
   Kim, CS
AF Lee, SW
   Kim, SJ
   Shim, IB
   Bae, S
   Kim, CS
TI Mossbauer studies of nano-size controlled iron oxide for biomedical
   applications
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article; Proceedings Paper
CT International Magnetics Conference 2005
CY APR 04-08, 2005
CL Nagoya, JAPAN
SP IEEE Magnet Soc, Magnet Soc Japan
DE bio-medical applications; magnetite; Mossbauer spectroscopy;
   nanoparticles; superparamagnetism
ID NANOPARTICLES; MAGNETITE
AB We present the magnetic properties and the material characteristics of magnetite (Fe3O4), which was successfully prepared by using the reaction of iron(III) acetylacetonate [Fe(acac)(3)] with surfactants at high temperature (so called by "high temperature decomposition method"). According to the results of high resolution transmission electron microscopy (HRTEM) analysis, the prepared iron oxide particles had the average particle sizes between 4 and 6 nm and very uniform size distributions. The crystal structure analyzed by using both XRD and Mossbauer spectra confirmed that the prepared iron oxide nanoparticles only have single magnetite (Fe3O4) crystal phase. The typical superparamagnetic behaviors were observed from the prepared iron-oxide nanoparticles. In addition, they showed the saturation magnetization, MS of 59.5 emu/g for 4 nm, and of 59.7 emu/9 for 6 nm, respectively at room temperature under the externally applied magnetic field of 10 kOe. The measured Wssbauer spectrum at 4.2 K was fitted using two magnetic components: (1) hyperfine fields H-hf = 514 and 492 kOe, (2) isomer shifts delta = 0.35 and 0.73 mm/s. The fitted data apparently verified that the prepared iron oxide samples only have pure magnetite ([Fe3+](A) [Fe2+Fe3+](B)O-4).
C1 Kookmin Univ, Dept Phys, Seoul 136702, South Korea.
   Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117576, Singapore.
RP Lee, SW (reprint author), Kookmin Univ, Dept Phys, Seoul 136702, South Korea.
CR Cornell RM, 2003, IRON OXIDES
   Gupta AK, 2004, IEEE T NANOBIOSCI, V3, P66, DOI 10.1109/TNB.2003.820277
   GUPTA AK, 2005, SYNTH SURFACE ENG IR, V26, P3995
   Kim DK, 2001, J MAGN MAGN MATER, V225, P30, DOI 10.1016/S0304-8853(00)01224-5
   Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852
   Sun SH, 2002, J AM CHEM SOC, V124, P8204, DOI 10.1021/ja026501x
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   VANDIEPEN AM, 1977, PHYSICA B & C, V86, P955, DOI 10.1016/0378-4363(77)90757-4
   Woo K, 2004, CHEM MATER, V16, P2814, DOI 10.1021/cm049552x
NR 9
TC 8
Z9 8
U1 0
U2 13
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD OCT
PY 2005
VL 41
IS 10
BP 4114
EP 4116
DI 10.1109/TMAG.2005.855337
PG 3
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 975RN
UT WOS:000232679700507
DA 2018-10-20
ER

PT J
AU Lapicki, A
   Sanbonsugi, H
   Yamamura, T
   Matsushita, N
   Abe, M
   Narimatsu, H
   Handa, H
   Sandhu, A
AF Lapicki, A
   Sanbonsugi, H
   Yamamura, T
   Matsushita, N
   Abe, M
   Narimatsu, H
   Handa, H
   Sandhu, A
TI Functionalization of micro-Hall effect sensors for biomedical
   applications utilizing superparamagnetic beads
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article; Proceedings Paper
CT International Magnetics Conference 2005
CY APR 04-08, 2005
CL Nagoya, JAPAN
SP IEEE Magnet Soc, Magnet Soc Japan
DE Hall effect devices; magnetic particles; magnetic sensors; microsensors;
   nanostructured materials
ID TEMPERATURE
AB Fabrication of Hall sensors that are compatible with biological environments has been accomplished in an effort to provide an analytical tool for the detection, identification and quantification of deoxyribonuclaeic acid. Sensors are formed by InSb thin films grown on (100) GaAs wafers. Amorphous silicon nitride was deposited as waterproof sensor insulation, and topped by a gold overlayer serving as an interface for the immobilization of biomolecules. The key analytical processes utilize hybridization of complementary strands of oligonucleotides as a biorecognition mechanism, closing a chain sequence leading to attachment of magnetic beads, where the thiol-gold chemical reactivity produces bonding to the sensor surface.
C1 Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Tokyo 1528552, Japan.
   Tokyo Inst Technol, Dept Phys Elect, Tokyo 1528552, Japan.
   Tokyo Inst Technol, Dept Elect Engn, Tokyo 1528552, Japan.
   Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan.
RP Lapicki, A (reprint author), Tokyo Inst Technol, Quantum Nanoelect Res Ctr, Tokyo 1528552, Japan.
RI Matsushita, Nobuhiro/F-9416-2014; Sandhu, Adarsh/A-1818-2011
CR Abe M., 2004, Journal of the Magnetics Society of Japan, V28, P841
   EDELSTEIN RL, 2000, BIOSENS BIOELECTRON, V14, P10
   INGO GM, 1989, J VAC SCI TECHNOL A, V7, P3048, DOI 10.1116/1.576314
   NAOE M, 1980, IEEE T MAGN, V16, P646, DOI 10.1109/TMAG.1980.1060683
   Sandhu A, 2004, MICROELECTRON ENG, V73-4, P524, DOI 10.1016/j.mee.2004.03.029
   Sandhu A, 2004, JPN J APPL PHYS 2, V43, pL868, DOI 10.1143/JJAP.43.L868
NR 6
TC 7
Z9 7
U1 0
U2 7
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD OCT
PY 2005
VL 41
IS 10
BP 4134
EP 4136
DI 10.1109/TMAG.2005.855341
PG 3
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 975RN
UT WOS:000232679700512
DA 2018-10-20
ER

PT J
AU Kim, DH
   Lee, SH
   Im, KH
   Kim, KN
   Kim, KM
   Kim, KD
   Park, H
   Shim, IB
   Lee, YK
AF Kim, DH
   Lee, SH
   Im, KH
   Kim, KN
   Kim, KM
   Kim, KD
   Park, H
   Shim, IB
   Lee, YK
TI Biodistribution of chitosan-based magnetite suspensions for targeted
   hyperthermia in ICR mice
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article; Proceedings Paper
CT International Magnetics Conference 2005
CY APR 04-08, 2005
CL Nagoya, JAPAN
SP IEEE Magnet Soc, Magnet Soc Japan
DE biomedical materials; cancer; hyperthermia; magnetic liquids
ID DRUG-DELIVERY; MICROSPHERES; NANOPARTICLES
AB Magnetite and the chitosan-based magnetite suspensions were synthesized by spray-coprecipitation. In the 2 wt% chitosan-based magnetite suspension, the zeta-potential value was lower value at 5.6 mV relative to other concentrations of magnetic suspension. The chitosan-based magnetic suspension with a zeta potential close to zero showed increased circulation time in biodistribution of Institute of Cancer Research mice.
C1 Yonsei Univ, Coll Dent, Brain Korea Project Med Sci 21, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120752, South Korea.
   Yonsei Univ, Coll Dent, Human Identif Res Ctr, Dept Oral & Maxillofacial Radiol, Seoul 120752, South Korea.
   Kookmin Univ, Dept Phys Elect, Seoul 136702, South Korea.
RP Kim, DH (reprint author), Yonsei Univ, Coll Dent, Brain Korea Project Med Sci 21, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120752, South Korea.
OI Kim, Dong-Hyun/0000-0001-6815-3319
CR Denkbas EB, 2002, REACT FUNCT POLYM, V50, P225, DOI 10.1016/S1381-5148(01)00115-8
   DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233
   Hilger I, 2002, INVEST RADIOL, V37, P580, DOI 10.1097/00004424-200210000-00008
   Li JL, 2003, J BIOMED MATER RES A, V67A, P938, DOI 10.1002/jbm.a.10076
   LONNEMARK M, 1991, ACTA RADIOL, V32, P232, DOI 10.1177/028418519103200309
   Lorenzo-Lamosa ML, 1998, J CONTROL RELEASE, V52, P109, DOI 10.1016/S0168-3659(97)00203-4
   Masashige S., 2002, J BIOSCI BIOENG, V94, P606
   Roser M, 1998, EUR J PHARM BIOPHARM, V46, P255, DOI 10.1016/S0939-6411(98)00038-1
NR 8
TC 9
Z9 10
U1 0
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD OCT
PY 2005
VL 41
IS 10
BP 4158
EP 4160
DI 10.1109/TMAG.2005.854857
PG 3
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 975RN
UT WOS:000232679700520
DA 2018-10-20
ER

PT J
AU Liu, Y
   Sun, LZ
   Wang, G
AF Liu, Y
   Sun, LZ
   Wang, G
TI Tomography-based 3-D anisotropic elastography using boundary
   measurements
SO IEEE TRANSACTIONS ON MEDICAL IMAGING
LA English
DT Article
DE adjoint method; anisotropic biomaterial; breast imaging; elastography;
   finite-element method; tomography
ID MAGNETIC-RESONANCE-ELASTOGRAPHY; MODULUS RECONSTRUCTION; INVERSE
   PROBLEMS; ELASTIC MEDIUM; STRAIN IMAGES; TISSUE; DISPLACEMENT;
   VISUALIZATION; NONUNIQUENESS; RESOLUTION
AB While ultrasound- and magnetic resonance-based elastography techniques have proved to be powerful biomedical imaging tools, most approaches assume isotropic material properties. In this paper, a general framework is developed for tomography-based anisotropic elastography. An anatomically well-motivated piece-wise homogeneous model is proposed to represent a class of biological objects consisting of different regions. With established tomography modality, static displacements are measured on the entire external and internal boundaries, and the force distribution is recorded on part of the external surface. A principle is proposed to identify the anisotropic elastic moduli of the constituent regions with the obtained boundary measurements. The reconstruction procedure is optimization-based with minimizing an objective function that measures the difference between the predicted and observed displacements. Analytic gradients of the objective function with respect to the elastic moduli are calculated using an adjoint method, and are utilized to significantly improve the numerical efficiency. Simulations are performed to identify the elastic moduli in a breast phantom consisting of soft tissue and a hard tumor. For isotropic phantom, one set of the boundary measurements enables unique reconstruction results for the tissue and tumor. For anisotropic phantom, however, multiple sets of the measurements corresponding to different deformation modes become necessary.
C1 Univ Iowa, Dept Civil & Environm Engn, Seamans Ctr 4114, Iowa City, IA 52242 USA.
   Univ Iowa Hosp & Clin, Dept Radiol, Iowa City, IA 52242 USA.
RP Sun, LZ (reprint author), Univ Iowa, Dept Civil & Environm Engn, Seamans Ctr 4114, Iowa City, IA 52242 USA.
EM lizhi-sun@uiowa.edu
RI Sun, Lizhi/C-5205-2008
FU NIBIB NIH HHS [EB002667-01]
CR Barbone PE, 2004, INVERSE PROBL, V20, P283, DOI 10.1088/0266-5611/20/1/017
   Barbone PE, 2002, PHYS MED BIOL, V47, P2147, DOI 10.1088/0031-9155/47/12/310
   Cox SJ, 1997, MATH MECH SOLIDS, V2, P297, DOI 10.1177/108128659700200304
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Gao L, 1996, ULTRASOUND MED BIOL, V22, P959, DOI 10.1016/S0301-5629(96)00120-2
   Gennisson JL, 2003, J ACOUST SOC AM, V114, P536, DOI 10.1121/1.1579008
   Hajnal JV, 2001, MED IMAGE REGISTRATI
   Kallel F, 1996, IEEE T MED IMAGING, V15, P299, DOI 10.1109/42.500139
   Kang HB, 2003, INVERSE PROBL, V19, P703, DOI 10.1088/0266-5611/19/3/314
   KARDESTUNCER H, 1987, FINITE ELEMENT HDB
   LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116
   Liu HT, 2003, MED PHYS, V30, P2340, DOI 10.1118/1.1599953
   LIU Y, 2003, THESIS U PENNSYLVANI
   Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6
   MAZZUCATO AL, 2003, 2003009 MSRI
   McCracken PJ, 2005, MAGNET RESON MED, V53, P628, DOI 10.1002/mrm.20388
   MCKNIGHT AL, 2002, AM J ROENTGENOL, V178
   McLaughlin JR, 2004, INVERSE PROBL, V20, P25, DOI 10.1088/0266-5611/20/1/002
   McPherson CP, 1997, CANCER, V79, P1923, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1923::AID-CNCR13>3.0.CO;2-X
   Meinel JF, 2003, ACAD RADIOL, V10, P607, DOI 10.1016/S1076-6332(03)80078-8
   MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924
   Nakamura G, 1999, SIAM J APPL MATH, V59, P1879, DOI 10.1137/S0036139998337164
   Nakamura G, 1996, SIAM J APPL MATH, V56, P602, DOI 10.1137/S003613999426630X
   NAKAMURA G, 1995, SIAM J MATH ANAL, V26, P263, DOI 10.1137/S0036141093247494
   Oberai AA, 2004, PHYS MED BIOL, V49, P2955, DOI 10.1088/0031-9155/49/13/
   Oberai AA, 2003, INVERSE PROBL, V19, P297, DOI 10.1088/0266-5611/19/2/304
   Ophir J, 1997, INT J IMAG SYST TECH, V8, P89, DOI 10.1002/(SICI)1098-1098(1997)8:1<89::AID-IMA11>3.0.CO;2-G
   OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W
   Ophir J., 1999, J ENG MED, V213, P203
   Plewes DB, 2000, PHYS MED BIOL, V45, P1591, DOI 10.1088/0031-9155/45/6/314
   Rozvany G.I.N., 1995, APPL MECH REV, V48, P41, DOI DOI 10.1115/1.3005097
   Samani A, 2001, IEEE T MED IMAGING, V20, P271, DOI 10.1109/42.921476
   Samani A, 2001, IEEE T MED IMAGING, V20, P877, DOI 10.1109/42.952726
   Sarvazyan AP, 1995, ACOUST IMAGING, V21, P223, DOI DOI 10.1007/978-1-4615-1943-0_23
   Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317
   Sinkus R, 2005, MAGNET RESON MED, V53, P372, DOI 10.1002/mrm.20355
   SKOVORODA AR, 1995, IEEE T ULTRASON FERR, V42, P747, DOI 10.1109/58.393117
   SKOVORODA AR, 1994, IEEE T ULTRASON FERR, V41, P302, DOI 10.1109/58.285463
   Tanner C, 2002, PROC SPIE, V4684, P1807, DOI 10.1117/12.467155
   Taylor LS, 2000, PHYS MED BIOL, V45, P1477, DOI 10.1088/0031-9155/45/6/306
   WALPOLE LJ, 1984, P ROY SOC LOND A MAT, V391, P149, DOI 10.1098/rspa.1984.0008
   WANG Z, 2005, MRS SPRING M SAN FRA
   Weaver J, 2002, MED PHYS, V29, P1291
   Weaver JB, 2001, MED PHYS, V28, P1620, DOI 10.1118/1.1386776
   Wellman P., 1999, BREAST TISSUE STIFFN
   Zhu YN, 2003, IEEE T MED IMAGING, V22, P890, DOI 10.1109/TMI.2003.815065
NR 46
TC 33
Z9 33
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0278-0062
J9 IEEE T MED IMAGING
JI IEEE Trans. Med. Imaging
PD OCT
PY 2005
VL 24
IS 10
BP 1323
EP 1333
DI 10.1109/TMI.2005.857232
PG 11
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Engineering, Electrical & Electronic; Imaging Science &
   Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging
SC Computer Science; Engineering; Imaging Science & Photographic
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA 969LX
UT WOS:000232236800008
PM 16229418
DA 2018-10-20
ER

PT J
AU Khan, MA
   Shatalov, M
   Maruska, HP
   Wang, HM
   Kuokstis, E
AF Khan, MA
   Shatalov, M
   Maruska, HP
   Wang, HM
   Kuokstis, E
TI III-nitride UV devices
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF
   COMMUNICATIONS & REVIEW PAPERS
LA English
DT Review
DE MOCVD; AlGaN; AllnGaN; ultraviolet; epitaxy; growth; light-emitting
   diode
ID LIGHT-EMITTING-DIODES; CHEMICAL-VAPOR-DEPOSITION; QUANTUM-WELL LASER;
   METAL ULTRAVIOLET PHOTODETECTORS; I-N PHOTODIODES; SOLAR-BLIND
   PHOTODETECTORS; SHORT-PERIOD SUPERLATTICES; GAN AVALANCHE PHOTODIODES;
   LOW-DISLOCATION-DENSITY; ATOMIC-LAYER EPITAXY
AB The need for efficient, compact and robust solid-state UV optical sources and sensors had stimulated the development of optical devices based on III-nitride material system. Rapid progress in material growth, device fabrication and packaging enabled demonstration of high efficiency visible-blind and solar-blind photodetectors, deep-UV light-emitting diodes with emission from 400 to 250 nm, and UV laser diodes with operation wavelengths ranging from 340 to 350 run. Applications of these UV optical devices include flame sensing; fluorescence-based biochemical sensing; covert communications; air, water and food purification and disinfection; and biomedical instrumentation. This paper provides a review of recent advances in the development of UV optical devices. Performance of state-of-the-art devices as well as future prospects and challenges are discussed.
C1 Univ S Carolina, Dept Elect Engn, Columbia, SC 29028 USA.
RP Khan, MA (reprint author), Univ S Carolina, Dept Elect Engn, Columbia, SC 29028 USA.
EM asif@engr.sc.edu
CR Adivarahan V, 2004, APPL PHYS LETT, V85, P2175, DOI 10.1063/1.1796525
   Adivarahan V, 2004, APPL PHYS LETT, V85, P1838, DOI 10.1063/1.1784882
   Adivarahan V, 2004, APPL PHYS LETT, V84, P4762, DOI 10.1063/1.1756202
   Adivarahan V, 2002, APPL PHYS LETT, V81, P3666, DOI 10.1063/1.1519100
   Adivarahan V, 2002, JPN J APPL PHYS 2, V41, pL435, DOI 10.1143/JJAP.41.L435
   Adivarahan V, 2001, APPL PHYS LETT, V79, P4240, DOI 10.1063/1.1425453
   Adivarahan V, 2001, APPL PHYS LETT, V79, P1903, DOI 10.1063/1.1402159
   Akasaka T, 2004, APPL PHYS LETT, V84, P4104, DOI 10.1063/1.1753068
   AKASAKI I, 1991, J LUMIN, V48-9, P666
   AKASAKI I, 1995, JPN J APPL PHYS 2, V34, P1517
   AKASAKI I, 1994, J ELECTROCHEM SOC, V141, P2266, DOI 10.1149/1.2055104
   Akasaki I, 1998, SEMICONDUCT SEMIMET, V50, P459
   Akita K, 2004, JPN J APPL PHYS 1, V43, P8030, DOI 10.1143/JJAP.43.8030
   Allerman AA, 2004, J CRYST GROWTH, V272, P227, DOI 10.1016/j.jcrysgro.2004.08.035
   AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549
   Asano T, 2002, APPL PHYS LETT, V80, P3497, DOI 10.1063/1.1478157
   Bilenko Y, 2005, JPN J APPL PHYS 2, V44, pL98, DOI 10.1143/JJAP.44.L98
   Bochowski M, 2004, J CRYST GROWTH, V270, P409, DOI 10.1016/j.jcrysgro.2004.06.060
   Boroditsky M, 1999, APPL PHYS LETT, V75, P1036, DOI 10.1063/1.124588
   Brown JD, 2000, MRS INTERNET J N S R, V5, P1
   Bykhovski AD, 1997, J APPL PHYS, V81, P6332, DOI 10.1063/1.364368
   Campbell JC, 2001, PHYS STATUS SOLIDI A, V188, P283, DOI 10.1002/1521-396X(200111)188:1<283::AID-PSSA283>3.3.CO;2-8
   Carrano JC, 1999, IEEE CIRCUITS DEVICE, V15, P15, DOI 10.1109/101.795089
   Carrano JC, 2000, APPL PHYS LETT, V76, P924, DOI 10.1063/1.125631
   Carrano JC, 1997, ELECTRON LETT, V33, P1980, DOI 10.1049/el:19971322
   Carrano JC, 1998, J APPL PHYS, V83, P6148, DOI 10.1063/1.367484
   Carrano JC, 1998, APPL PHYS LETT, V73, P2405, DOI 10.1063/1.122448
   Carrano JC, 1998, ELECTRON LETT, V34, P692, DOI 10.1049/el:19980453
   Chen LC, 2004, JPN J APPL PHYS 1, V43, P3353, DOI 10.1143/JJAP.43.3353
   CHEN Q, 1995, ELECTRON LETT, V31, P1781, DOI 10.1049/el:19951190
   Chen Q, 1997, APPL PHYS LETT, V70, P2277, DOI 10.1063/1.118837
   Chitnis A, 2003, PHYS STATUS SOLIDI A, V200, P99, DOI 10.1002/pssa.200303420
   Chitnis A, 2003, APPL PHYS LETT, V82, P2565, DOI 10.1063/1.1569040
   Chitnis A, 2002, JPN J APPL PHYS 2, V41, pL320, DOI 10.1143/JJAP.41.L320
   Chitnis A, 2002, JPN J APPL PHYS 2, V41, pL450, DOI 10.1143/JJAP.41.L450
   Chitnis A, 2002, APPL PHYS LETT, V81, P2938, DOI 10.1063/1.1516631
   Chitnis A, 2002, APPL PHYS LETT, V81, P3491, DOI 10.1063/1.1518155
   Chitnis A, 2000, APPL PHYS LETT, V77, P3800, DOI 10.1063/1.1331084
   Cho JH, 2000, APPL PHYS LETT, V76, P1489, DOI 10.1063/1.126072
   Chowdhury U, 2003, J CRYST GROWTH, V248, P552, DOI 10.1016/S0022-0248(02)01877-8
   Ciplys D, 2001, P SOC PHOTO-OPT INS, V4453, P37, DOI 10.1117/12.447655
   Ciplys D, 2002, APPL PHYS LETT, V80, P2020, DOI 10.1063/1.1459485
   CIPLYS D, 2004, IN PRESS P IEEE SENS
   Collins CJ, 2002, APPL PHYS LETT, V80, P3754, DOI 10.1063/1.1480484
   Edmond J, 2004, J CRYST GROWTH, V272, P242, DOI 10.1016/j.jcrysgro.2004.08.056
   Fischer AJ, 2004, APPL PHYS LETT, V84, P3394, DOI 10.1063/1.1728307
   Gao HJ, 1999, ANNU REV MATER SCI, V29, P173, DOI 10.1146/annurev.matsci.29.1.173
   Gaska R, 2002, APPL PHYS LETT, V81, P4658, DOI 10.1063/1.1524034
   GASKA R, 2003, MAT RES SOC S P, V764
   Goepfert ID, 2000, J APPL PHYS, V88, P2030, DOI 10.1063/1.1305842
   Guo X, 2001, APPL PHYS LETT, V78, P3337, DOI 10.1063/1.1372359
   Han J, 1998, APPL PHYS LETT, V73, P1688, DOI 10.1063/1.122246
   Han J, 2001, APPL PHYS LETT, V78, P67, DOI 10.1063/1.1336812
   Han J, 2000, JPN J APPL PHYS 1, V39, P2372, DOI 10.1143/JJAP.39.2372
   Hanlon A, 2003, JPN J APPL PHYS 2, V42, pL628, DOI 10.1143/JJAP.42.L628
   He Y, 2004, APPL PHYS LETT, V84, P463, DOI 10.1063/1.1637960
   Hirano A, 2001, PHYS STATUS SOLIDI A, V188, P293
   Hirayama H, 2004, JPN J APPL PHYS 2, V43, pL1241, DOI 10.1143/JJAP.43.L1241
   Hirayama H, 2002, APPL PHYS LETT, V80, P207, DOI 10.1063/1.1433162
   Hirayama H, 2001, PHYS STATUS SOLIDI A, V188, P83
   Hu X, 2003, APPL PHYS LETT, V82, P1299, DOI 10.1063/1.1555282
   Hwang JH, 2002, APPL PHYS LETT, V81, P5192, DOI 10.1063/1.1534395
   Iida K, 2004, J CRYST GROWTH, V272, P270, DOI 10.1016/j.jcrysgro.2004.08.052
   Iida K, 2004, JPN J APPL PHYS 2, V43, pL499, DOI 10.1143/JJAP.43.L499
   Jain SC, 2000, J APPL PHYS, V87, P965, DOI 10.1063/1.371971
   Jeon SR, 2004, JPN J APPL PHYS 2, V43, pL1409, DOI 10.1143/JJAP.43.L1409
   Jiang H, 2004, JPN J APPL PHYS 2, V43, pL683, DOI 10.1143/JJAP.43.L683
   Jin SX, 2000, APPL PHYS LETT, V76, P631, DOI 10.1063/1.125841
   Kamiyama S, 2002, OPTO-ELECTRON REV, V10, P225
   Kamiyama S, 2002, PHYS STATUS SOLIDI A, V192, P296, DOI 10.1002/1521-396X(200208)192:2<296::AID-PSSA296>3.0.CO;2-Z
   Kamiyama S, 2001, J CRYST GROWTH, V223, P83, DOI 10.1016/S0022-0248(00)01017-4
   Kawaguchi Y, 2003, PHYS STATUS SOLIDI C, V0, P2107, DOI 10.1002/pssc.200303412
   KHAN MA, 1995, APPL PHYS LETT, V66, P2046, DOI 10.1063/1.113687
   KHAN MA, 1992, APPL PHYS LETT, V61, P2539, DOI 10.1063/1.108144
   Khan MA, 1996, APPL PHYS LETT, V68, P3022, DOI 10.1063/1.116684
   KHAN MA, 1992, APPL PHYS LETT, V60, P1366
   KHAN MA, 1992, APPL PHYS LETT, V60, P2917, DOI 10.1063/1.106819
   KHAN MA, 1993, APPL PHYS LETT, V63, P2455, DOI 10.1063/1.110473
   Khan MA, 2000, APPL PHYS LETT, V76, P1161, DOI 10.1063/1.125970
   Khan MA, 2001, JPN J APPL PHYS 2, V40, pL1308, DOI 10.1143/JJAP.40.L1308
   KHAN MA, 1993, APPL PHYS LETT, V63, P3470, DOI 10.1063/1.110123
   KHAN MA, 1995, P SOC PHOTO-OPT INS, V2397, P283, DOI 10.1117/12.206878
   KHAN MA, IEEE INT EL DEV M 20, P347
   Kim KH, 2004, APPL PHYS LETT, V85, P4777, DOI 10.1063/1.1819506
   Kim KH, 2003, APPL PHYS LETT, V83, P566, DOI 10.1063/1.1593212
   Kim ST, 1998, J CRYST GROWTH, V194, P37, DOI 10.1016/S0022-0248(98)00551-X
   Kinoshita A, 2000, APPL PHYS LETT, V77, P175, DOI 10.1063/1.126915
   Kipshidze G, 2003, J APPL PHYS, V93, P1363, DOI 10.1063/1.1535255
   Kipshidze G, 2002, APPL PHYS LETT, V80, P3682, DOI 10.1063/1.1480886
   Kneissl M, 2003, PHYS STATUS SOLIDI A, V200, P118, DOI 10.1002/pssa.200303390
   Kneissl M, 2004, APPL PHYS LETT, V84, P2485, DOI 10.1063/1.1691494
   Kneissl M, 2003, APPL PHYS LETT, V82, P4441, DOI 10.1063/1.1585135
   Kneissl M, 2003, APPL PHYS LETT, V82, P2386, DOI 10.1063/1.1568160
   Kozodoy P, 1999, APPL PHYS LETT, V74, P3681, DOI 10.1063/1.123220
   Kozodoy P, 1999, APPL PHYS LETT, V75, P2444, DOI 10.1063/1.125042
   KUGA Y, 1995, JPN J APPL PHYS 1, V34, P4085
   Kung P, 1995, APPL PHYS LETT, V67, P3792, DOI 10.1063/1.115385
   Kuokstis E, 2001, APPL PHYS LETT, V79, P4375, DOI 10.1063/1.1429753
   Kuryatkov V, 2003, APPL PHYS LETT, V83, P1319, DOI 10.1063/1.1603333
   LAMARRE P, 2001, MAT RES SOC S P, V639
   Lebedev V, 2004, PHYS STATUS SOLIDI C, V1, P233, DOI 10.1002/pssc.200303907
   Lee YB, 2002, JPN J APPL PHYS 2, V41, pL1037, DOI 10.1143/JJAP.41.LI037
   Lee YB, 2002, JPN J APPL PHYS 1, V41, P4450, DOI 10.1143/JJAP/41.4450
   LEFEBVFRE P, 1999, MRS INTERNET J NITRI
   Li J, 2001, APPL PHYS LETT, V79, P3245, DOI 10.1063/1.1418255
   Li T, 2000, ELECTRON LETT, V36, P1581, DOI 10.1049/el:20001110
   Lim BW, 1997, ELECTRON LETT, V33, P633, DOI 10.1049/el:19970377
   Lim BW, 1996, APPL PHYS LETT, V68, P3761, DOI 10.1063/1.115998
   Mair RA, 1997, APPL PHYS LETT, V71, P2898, DOI 10.1063/1.120209
   Malikova L, 1997, SOLID STATE COMMUN, V103, P273, DOI 10.1016/S0038-1098(97)00160-9
   Marinelli C, 2001, APPL PHYS LETT, V79, P4076, DOI 10.1063/1.1424061
   MARUSKA HP, 1973, APPL PHYS LETT, V22, P303, DOI 10.1063/1.1654648
   Masui S, 2003, JPN J APPL PHYS 2, V42, pL1318, DOI 10.1143/JJAP.42.L1318
   Mayes K, 2004, APPL PHYS LETT, V84, P1046, DOI 10.1063/1.1647273
   McClintock R, 2004, P SOC PHOTO-OPT INS, V5359, P434, DOI 10.1117/12.529348
   McClintock R, 2004, APPL PHYS LETT, V84, P1248, DOI 10.1063/1.1650550
   McIntosh FG, 1996, APPL PHYS LETT, V68, P40, DOI 10.1063/1.116749
   McIntosh KA, 1999, APPL PHYS LETT, V75, P3485, DOI 10.1063/1.125363
   McIntosh KA, 2000, APPL PHYS LETT, V76, P3938, DOI 10.1063/1.126827
   Mickevicius J, 2005, PHYS STATUS SOLIDI A, V202, P126, DOI 10.1002/pssa.200406903
   Monroy E, 2003, SEMICOND SCI TECH, V18, pR33, DOI 10.1088/0268-1242/18/4/201
   Morita D, 2004, JPN J APPL PHYS 1, V43, P5945, DOI 10.1143/JJAP.43.5945
   Morita D, 2002, JPN J APPL PHYS 2, V41, pL1434, DOI 10.1143/JJAP.41.L1434
   Motoki K, 2001, JPN J APPL PHYS 2, V40, pL140, DOI 10.1143/JJAP.40.L140
   Mukai T, 1998, JPN J APPL PHYS 2, V37, pL839, DOI 10.1143/JJAP.37.L839
   Munoz E, 2001, J PHYS-CONDENS MAT, V13, P7115, DOI 10.1088/0953-8984/13/32/316
   Nagahama S, 2000, JPN J APPL PHYS 2, V39, pL647, DOI 10.1143/JJAP.39.L647
   Nagahama S, 2002, JPN J APPL PHYS 1, V41, P5, DOI 10.1143/JJAP.41.5
   Nagahama S, 2001, JPN J APPL PHYS 2, V40, pL788, DOI 10.1143/JJAP.40.L788
   Nagahama S, 2001, JPN J APPL PHYS 2, V40, pL785, DOI 10.1143/JJAP.40.L785
   Nakamura S, 1996, APPL PHYS LETT, V68, P2105, DOI 10.1063/1.115599
   Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL217, DOI 10.1143/JJAP.35.L217
   Nakamura S, 1998, SEMICONDUCT SEMIMET, V50, P431
   NAKAMURA S, 1993, JPN J APPL PHYS 2, V32, pL8, DOI 10.1143/JJAP.32.L8
   Nakamura S, 1998, SCIENCE, V281, P956, DOI 10.1126/science.281.5379.956
   Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74
   Nakamura S, 1998, MATER RES SOC SYMP P, V482, P1145
   Nakamura S., 1997, BLUE LASER DIODE
   Nakarmi ML, 2004, APPL PHYS LETT, V85, P3769, DOI 10.1063/1.1809272
   Nakarmi ML, 2003, APPL PHYS LETT, V82, P3041, DOI 10.1063/1.1559444
   Nam OH, 1997, APPL PHYS LETT, V71, P2638, DOI 10.1063/1.120164
   Narukawa Y, 2002, JPN J APPL PHYS 2, V41, pL371, DOI 10.1143/JJAP.41.L371
   Nikishin SA, 2003, JPN J APPL PHYS 2, V42, pL1362, DOI 10.1143/JJAP.42.L1362
   Nishida T, 1999, PHYS STATUS SOLIDI A, V176, P45, DOI 10.1002/(SICI)1521-396X(199911)176:1<45::AID-PSSA45>3.0.CO;2-0
   Nishida T, 2004, APPL PHYS LETT, V84, P1002, DOI 10.1063/1.1646454
   Nishida T, 2001, APPL PHYS LETT, V78, P3927, DOI 10.1063/1.1377854
   Nishida T, 2001, APPL PHYS LETT, V79, P711, DOI 10.1063/1.1390485
   Nishida T, 2001, APPL PHYS LETT, V78, P399, DOI 10.1063/1.1338964
   Oder TN, 2004, APPL PHYS LETT, V84, P466, DOI 10.1063/1.1644050
   Oder TN, 2003, APPL PHYS LETT, V83, P1231, DOI 10.1063/1.1600839
   Osinsky A, 1998, APPL PHYS LETT, V72, P742, DOI 10.1063/1.120862
   Osinsky A, 1997, APPL PHYS LETT, V71, P2334, DOI 10.1063/1.120023
   Otsuka N, 2000, JPN J APPL PHYS 2, V39, pL445, DOI 10.1143/JJAP.39.L445
   Ozbay E, 2004, IEEE J SEL TOP QUANT, V10, P742, DOI 10.1109/JSTQE.2004.831681
   PANKOVE JI, 1974, J APPL PHYS, V45, P3892, DOI 10.1063/1.1663881
   Parish G, 1999, APPL PHYS LETT, V75, P247, DOI 10.1063/1.124337
   Peng H, 2004, APPL PHYS LETT, V85, P1436, DOI 10.1063/1.1784537
   QIU CH, 1995, APPL PHYS LETT, V66, P2712, DOI 10.1063/1.113497
   Razeghi M, 2002, P IEEE, V90, P1006, DOI 10.1109/JPROC.2002.1021565
   Rojo JC, 2002, J CRYST GROWTH, V240, P508
   Rojo JC, 2001, J CRYST GROWTH, V231, P317
   Saitoh T, 2003, APPL PHYS LETT, V82, P4426, DOI 10.1063/1.1586992
   Sandvik P, 2001, J CRYST GROWTH, V231, P366, DOI 10.1016/S0022-0248(01)01467-1
   Saxler A, 1999, APPL PHYS LETT, V74, P2023, DOI 10.1063/1.123744
   Schreiber P, 1999, P SOC PHOTO-OPT INS, V3629, P230, DOI 10.1117/12.344560
   Shan W, 1999, J APPL PHYS, V85, P8505, DOI 10.1063/1.370696
   Shatalov M, 2003, APPL PHYS LETT, V82, P167, DOI 10.1063/1.1536729
   Shatalov M, 2002, JPN J APPL PHYS 1, V41, P5083, DOI 10.1143/JJAP.41.5083
   Shatalov M, 2002, IEEE J SEL TOP QUANT, V8, P302, DOI 10.1109/2944.999185
   Shatalov M, 2002, IEEE ELECTR DEVICE L, V23, P452, DOI 10.1109/LED.2002.801295
   Shatalov M, 2001, APPL PHYS LETT, V78, P817, DOI 10.1063/1.1343493
   Shaw GA, 2001, P SOC PHOTO-OPT INS, V4396, P31, DOI 10.1117/12.438327
   Shur MS, 1999, SEMICONDUCT SEMIMET, V57, P407
   Shur MS, 2000, APPL PHYS LETT, V76, P3061, DOI 10.1063/1.126579
   Shur MS, 1997, MRS BULL, V22, P44
   Silveira E, 2004, APPL PHYS LETT, V84, P3501, DOI 10.1063/1.1738929
   Skierbiszewski C, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1846143
   STEVENS KS, 1995, APPL PHYS LETT, V66, P3518, DOI 10.1063/1.113783
   Sun WH, 2004, JPN J APPL PHYS 2, V43, pL1419, DOI 10.1143/JJAP.43.L1419
   Sun WH, 2004, APPL PHYS LETT, V85, P531, DOI 10.1063/1.1772864
   Tadatomo K, 2001, JPN J APPL PHYS 2, V40, pL583, DOI 10.1143/JJAP.40.L583
   Taguchi T, 2004, PHYS STATUS SOLIDI A, V201, P2730, DOI 10.1002/pssa.200405101
   Takano T, 2004, JPN J APPL PHYS 2, V43, pL1258, DOI 10.1143/JJAP.43.L1258
   Takano T, 2004, APPL PHYS LETT, V84, P3567, DOI 10.1063/1.1737061
   Tamulaitis G, 2000, APPL PHYS LETT, V77, P2136, DOI 10.1063/1.1314288
   Tarsa EJ, 2000, APPL PHYS LETT, V77, P316, DOI 10.1063/1.126962
   Teke A, 2003, SOLID STATE ELECTRON, V47, P1401, DOI 10.1016/S0038-1101(03)00068-6
   ULMER MP, 1995, P SOC PHOTO-OPT INS, V2397, P210, DOI 10.1117/12.206870
   Walker D, 1997, APPL PHYS LETT, V70, P949, DOI 10.1063/1.118450
   Walker D, 2000, APPL PHYS LETT, V76, P403, DOI 10.1063/1.125768
   Walker D, 1996, APPL PHYS LETT, V68, P2100, DOI 10.1063/1.115597
   Walker D, 1998, APPL PHYS LETT, V72, P3303, DOI 10.1063/1.121631
   Wang HL, 2002, APPL PHYS LETT, V81, P4703, DOI 10.1063/1.1530749
   Wang HM, 2002, APPL PHYS LETT, V81, P604, DOI 10.1063/1.1494858
   Wang T, 2002, APPL PHYS LETT, V81, P2508, DOI 10.1063/1.1510967
   Wong MM, 2001, PHYS STATUS SOLIDI A, V188, P333, DOI 10.1002/1521-396X(200111)188:1<333::AID-PSSA333>3.0.CO;2-X
   Wu S, 2004, JPN J APPL PHYS 2, V43, pL1035, DOI 10.1143/JJAP.43.L1035
   Xu GY, 1997, APPL PHYS LETT, V71, P2154, DOI 10.1063/1.119366
   Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700
   Yang B, 2000, ELECTRON LETT, V36, P1866, DOI 10.1049/el:20001301
   Yang B, 2000, IEEE J QUANTUM ELECT, V36, P1229, DOI 10.1109/3.890260
   Yasan A, 2003, APPL PHYS LETT, V83, P4701, DOI 10.1063/1.1633019
   Yasan A, 2002, APPL PHYS LETT, V81, P801, DOI 10.1063/1.1497709
   Yasan A, 2002, APPL PHYS LETT, V81, P2151, DOI 10.1063/1.1508414
   Zhang J, 2001, APPL PHYS LETT, V79, P925, DOI 10.1063/1.1392301
   Zhang J., UNPUB
   Zhang JP, 2004, APPL PHYS LETT, V85, P5532, DOI 10.1063/1.1831557
   Zhang JP, 2003, APPL PHYS LETT, V83, P3456, DOI 10.1063/1.1633321
   Zhang JP, 2003, J ELECTRON MATER, V32, P364, DOI 10.1007/s11664-003-0159-2
   Zhang JP, 2002, APPL PHYS LETT, V81, P4910, DOI 10.1063/1.1531835
   Zhang JP, 2002, APPL PHYS LETT, V81, P4392, DOI 10.1063/1.1528726
   Zhang JP, 2002, APPL PHYS LETT, V80, P3542, DOI 10.1063/1.1477620
   Zhang JP, 2001, JPN J APPL PHYS 2, V40, pL921, DOI 10.1143/JJAP.40.L921
   ZHANG W, 2003, PHYS STATUS SOLIDI, P1571
   ZHANG X, 1995, APPL PHYS LETT, V67, P2028, DOI 10.1063/1.114776
   Zhou JJ, 2004, J APPL PHYS, V95, P5925, DOI 10.1063/1.1699522
   Zhu TG, 2003, J CRYST GROWTH, V248, P548, DOI 10.1016/S0022-0248(02)01930-9
   Zhu TG, 2002, IEEE J SEL TOP QUANT, V8, P298, DOI 10.1109/2944.999184
   2005, COMPOUND SEMICON MAR, P12
NR 219
TC 313
Z9 321
U1 10
U2 266
PU JAPAN SOC APPLIED PHYSICS
PI TOKYO
PA KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO,
   102-0073, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Brief Commun. Rev. Pap.
PD OCT
PY 2005
VL 44
IS 10
BP 7191
EP 7206
DI 10.1143/JJAP.44.7191
PG 16
WC Physics, Applied
SC Physics
GA 976NC
UT WOS:000232739300002
OA Bronze
DA 2018-10-20
ER

PT J
AU Peleg, R
   Gotshal, H
   Soffer, T
   Freud, T
   Biderman, A
AF Peleg, R
   Gotshal, H
   Soffer, T
   Freud, T
   Biderman, A
TI Patterns of use of nonbiomedical medicine services by nonbiomedical
   medicine providers
SO JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
LA English
DT Article
ID ALTERNATIVE MEDICINE; UNITED-STATES; COMPLEMENTARY MEDICINE; PREVALENCE
AB Objectives: The aim of this study was to characterize the patterns of use of nonbiomedical medicine compared to biomedical medicine among providers of nonbiomedical medicine in order to assess the degree of confidence the providers have in nonbiomedical medicine.
   Materials and Methods: Anonymous, self-administered questionnaires were distributed among the providers of care in nonbiomedical medicine clinics in Israel.
   Results: Ninety-two (92) of 127 questionnaires were completed (73% response rate). Fifty-four percent (54%) were women and 76% were Israeli-born. Nineteen percent (19%) had M.D. degrees and 83% received training in nonbiomedical medicine in Israel. In the course of the 12 months preceding the survey, 62% of the providers were treated by nonbiomedical medicine techniques; of these, 54% chose these techniques as their first treatment of choice. The vast majority (97%) expressed satisfaction with the results of this treatment. Fifty-five percent (55%) stated that they would turn to both nonbiomedical and biomedical medicine in the future for acute medical problems; 28% declared that they would turn first to nonbiomedical medicine, compared to 14%, who said they would turn first to biomedical medicine. A similar result was seen for chronic medical problems. More than two thirds of those who turned to nonbiomedical medicine treatment asked for acupuncture. Eighty-seven percent (87%) of acupuncture providers also preferred this mode of treatment.
   Conclusions: Providers of nonbiomedical medicine care prefer to combine nonbiomedical and biomedical medicine treatment for their own acute and chronic medical problems. The preferred method of therapy was acupuncture. These patterns of use demonstrate that providers have confidence in these methods of treatment alongside biomedical medicine.
C1 Ben Gurion Univ Negev, Dept Family Med, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Sial Res Ctr, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.
   Clalit Hlth Serv, Complementary Med Clin, Beer Sheva, Israel.
   Ben Gurion Univ Negev, Fac Hlth Sci, Div Hlth Community, IL-84105 Beer Sheva, Israel.
RP Peleg, R (reprint author), Ben Gurion Univ Negev, Dept Family Med, POB 653, IL-84105 Beer Sheva, Israel.
EM pelegr@bgumail.bgu.ac.i
RI BIDERMAN, AYA/F-1793-2012; Freud, Tamar/D-7276-2016; Peleg,
   Roni/F-1904-2012
CR Cassidy CM, 1998, J ALTERN COMPLEM MED, V4, P17, DOI 10.1089/acm.1998.4.1-17
   EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406
   Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569
   Garaghan H., 1994, NATURE, V370, P591
   KAUFMAN M, 1996, HAREFUAH, V131, P46
   Kitai E, 1998, FAM PRACT, V15, P411, DOI 10.1093/fampra/15.5.411
   Leibovici L, 1996, Harefuah, V130, P109
   MacLennan AH, 1996, LANCET, V347, P569, DOI 10.1016/S0140-6736(96)91271-4
   OBERBAUM M, 2001, IMAJ, V5, P139
   PALINKAS LA, 2000, FAM PRACT, V49, P121
   SACHAR T, 2001, HAREFUAH, V140, P907
   Smeeth L, 2002, BRIT MED J, V324, P1168, DOI 10.1136/bmj.324.7347.1168
   Soffer T, 2001, ISRAEL MED ASSOC J, V3, P584
   Wood A.J.J., 2002, NEW ENGL J MED, V347, P2046
   Zollman C, 1999, BRIT MED J, V319, P1486, DOI 10.1136/bmj.319.7223.1486
NR 15
TC 1
Z9 1
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1075-5535
J9 J ALTERN COMPLEM MED
JI J. Altern. Complement Med.
PD OCT
PY 2005
VL 11
IS 5
BP 917
EP 921
DI 10.1089/acm.2005.11.917
PG 5
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 988QO
UT WOS:000233615900033
PM 16296927
DA 2018-10-20
ER

PT J
AU Aggarwal, P
   Phaneuf, MD
   Bide, MJ
   Sousa, KA
   LoGerfo, FW
AF Aggarwal, P
   Phaneuf, MD
   Bide, MJ
   Sousa, KA
   LoGerfo, FW
TI Development of an infection-resistant bifunctionalized Dacron
   biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; Ciprofloxacin; infection resistance; Dacron; antimicrobial
ID SURFACE-MODIFYING MACROMOLECULES; VASCULAR PROSTHETIC INFECTION; GRAFTS;
   PREVENTION; EFFICACY; PROTEIN
AB A novel infection-resistant biomaterial was created by applying the antibiotic Ciprofloxacin (Cipro) to a recently developed bifunctionalized polyethylene terephthalate ("polyester," Dacron) material using textile-dyeing technology. Dacron was modified via exposure to ethylenediamine (EDA) to create amine and carboxylic acid sites within the polymer backbone. Cipro was applied to the bifunctionalized Dacron construct under varied experimental conditions, with resulting antimicrobial activity determined via zone of inhibition. Dacron segments treated at a liquor ratio of 20:1, with 5% Cipro on weight of fabric (owf), at PH 8 for 4 h at 70 degrees C followed by autoclaving showed antimicrobial activity for 78 days (length of study). Segments treated similarly but without autoclaving lost activity within I day. Dyeing time and temperature did not significantly affect antibiotic release/ activity, but segments dyed at pHs higher or lower than 8 had less antimicrobial activity. The long-term infection resistance provided by this technique may answer major problems of infection from which implantable Dacron biomedical devices suffer. (c) 2005 Wiley Periodicals, Inc.
C1 Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   BioSurfaces, Ashland, MA 01721 USA.
   Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
RP Aggarwal, P (reprint author), Beth Israel Deaconess Med Ctr, 4 Blackfan Circle,Room 131, Boston, MA 02115 USA.
EM aggarwal@bu.edu
FU NHLBI NIH HHS [R41 HL078596]
CR AVRAMOVIC JR, 1991, AUST NZ J SURG, V61, P436, DOI 10.1111/j.1445-2197.1991.tb00258.x
   Bergamini TM, 1996, J SURG RES, V60, P3, DOI 10.1006/jsre.1996.0002
   BETHESDA MD, 1995, INF CONTR S INFL MED
   BIDE MJ, 1993, AATTC REV, V25, P15
   BIDE MJ, 1999, AATTC REV
   CHERVU A, 1991, J VASC SURG, V13, P897
   Dickinson RB, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P67
   GRECO RS, 1985, ARCH SURG-CHICAGO, V120, P71
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   Ho JY, 2000, J BIOMAT SCI-POLYM E, V11, P1085
   Jahangir AR, 2002, J BIOMED MATER RES, V60, P135, DOI 10.1002/jbm.10033
   Johnson A, 1989, THEORY COLORATION TE
   LizanGarcia M, 1997, INFECT CONT HOSP EP, V18, P310
   Manivannan G, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P1
   Marchant Roger E., 1994, P13
   Muller RJ, 2001, J BIOTECHNOL, V86, P87, DOI 10.1016/S0168-1656(00)00407-7
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   Nunn D. M., 1979, DYEING SYNTHETIC POL
   OZAKI CK, 1993, J SURG RES, V55, P543, DOI 10.1006/jsre.1993.1181
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   Phaneuf MD, 2001, ASAIO J, V47, P634, DOI 10.1097/00002480-200111000-00013
   PHANEUF MD, 1993, J BIOMED MATER RES, V27, P233, DOI 10.1002/jbm.820270213
   Risberg B, 2000, Lakartidningen, V97, P4280
   Shore J., 1990, COLORANTS AUXILIARIE
   SHUE WB, 1988, J VASC SURG, V8, P600, DOI 10.1067/mva.1988.avs0080600
   SUGARMAN B, 1982, INFECTION, V10, P9, DOI 10.1007/BF01640828
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   WHITE JV, 1991, J VASC SURG, V13, P753
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Zhang X, 2000, ANTIMICROBIAL/ANTI-INFECTIVE MATERIALS, P149
   ZHONG T, 2003, AATCC REV, V3, P24
NR 31
TC 6
Z9 6
U1 2
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT 1
PY 2005
VL 75A
IS 1
BP 224
EP 231
DI 10.1002/jbm.a.30427
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 963PP
UT WOS:000231816600025
PM 16078211
DA 2018-10-20
ER

PT J
AU Young, RJ
AF Young, RJ
TI The Manchester Conference Centre, Manchester, UK, 14-16 July 2004
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
AB Although natural polymers fibres such as hair, wool and silk have been exploited since antiquity, the development of synthetic polymers in the 20th century was driven by the need for man-made fibres. Because of this, polymer fibres have been the focus of intensive research for a many years and, by some people, the field is now perceived as being mature. This, however, is far from the case and in recent years there have been unparalleled developments in the preparation of new polymer- based fibres, new techniques of fibre characterisation and novel applications of polymer fibres. Moreover, polymer fibres are finding increasing use in high- performance composites where their high levels of stiffness and strength combined with low density give rise to materials with outstanding mechanical properties.
   This special section of the Journal of Materials Science contains twelve papers selected specially from a number presented at the Third International Conference 'Polymer Fibres 2004' held in Manchester in July 2004. At the conference there was a total of 38 oral presentations and 35 poster papers with delegates coming from 20 different countries.
   The main themes of the meeting were:
   Techniques
   Natural Fibres
   High Performance Fibres
   Composites
   Fibre Assemblies
   Nanostructured Fibres
   To set the scene in each area, a number of keynote presentations were made covering a number of different aspects of the subject:
   X- ray Diffraction from Single Polymer fibres - C. Riekel
   Silk: Secret of the Spider's Success - R. J. Young
   Fibers as Medical Devices - M. Jaffe
   M5: from Laboratory Curiosity to Semi- technical Demonstration - D. Sikkema
   Novel Composites by Hot Compaction - I. M. Ward
   Structural Mechanics of Fibre Assemblies - J. W. S. Hearle
   Carbon Nanotube Based Continuous Fibre - A. K. Windle
   The twelve papers in this issue are a representative selection of the research presentations under all of these themes. The first paper by Cho and Jeong is concerned with the estimation of fibre strength from the mechanical testing of the properties of fibre bundles. This is followed by a paper by Smole and co- workerswho have undertaken a detailed study of the characterisation of natural fibres obtained from different types of grass. The next two papers are concerned with the spinning of silk fibres using different approaches. The development of conductive polyester and polyamide fibres is described in the paper by Harlin and co- workers. The next three papers deal with the effect of surface modification upon the properties of fibres. Warren and co- workers describe how gas plasma can be used to modify the surface of polypropylene tape and Prasithphol and Young show how Raman spectroscopy can be used to determine the strength of the fibre- matrix interface in model Technora/ epoxy composites. The generation of functional nanostructures upon the surface of polypropylene fibres using plasmas is then described in the paper by Wei and co- workers. The next two papers are concerned with applications of non- wovens, firstly by Tyeo and co- workers for filtration and secondly by Kosuge and co- workers for sound absorption. The final two papers by Jeong and co- workers describe the development of polymer fibres with antibacterial properties for applications such as in the biomedical industry. Although it has not been possible to include all of the papers presented at the meeting it is hoped that a flavour of the exciting research developments in the field Polymer Fibres will be conveyed.
C1 Univ Manchester, Sch Mat, Ctr Mat Sci, Manchester M1 7HS, Lancs, England.
RP Young, RJ (reprint author), Univ Manchester, Sch Mat, Ctr Mat Sci, Manchester M1 7HS, Lancs, England.
EM robert.young@manchester.ac.uk
OI Young, Robert/0000-0001-6073-9489
NR 0
TC 0
Z9 0
U1 1
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD OCT
PY 2005
VL 40
IS 20
BP 5339
EP 5340
DI 10.1007/s10853-005-4259-7
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA 971RW
UT WOS:000232403100001
DA 2018-10-20
ER

PT J
AU Kim, H
   Camata, RP
   Vohra, YK
   Lacefield, WR
AF Kim, H
   Camata, RP
   Vohra, YK
   Lacefield, WR
TI Control of phase composition in hydroxyapatite/tetracalcium phosphate
   biphasic thin coatings for biomedical applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PLASMA-SPRAYED COATINGS; COATED POROUS TITANIUM; TRICALCIUM PHOSPHATE;
   PHYSICOCHEMICAL CHARACTERIZATION; LASER DEPOSITION; IMPLANTS; BONE;
   FILMS; HYDROXYLAPATITE; INTERFACE
AB Biphasic calcium phosphates comprising well-controlled mixtures of nonresorbable hydroxyapatite and other resorbable calcium phosphate phases often exhibit a combination of enhanced bioactivity and mechanical stability that is difficult to achieve in single-phase materials. This makes these biphasic bioceramics promising substrate materials for applications in bone tissue regeneration and repair. In this paper we report the synthesis of highly crystalline, biphasic coatings of hydroxyapatite/tetracalcium phosphate with control over the weight fraction of the constituent phases. The coatings were produced by pulsed laser deposition using ablation targets of pure crystalline hydroxyapatite. The fraction of tetracalcium phosphate phase in the coatings was controlled by varying the substrate temperature and the partial pressure of water vapor in the deposition chamber. A systematic study of phase composition in the hydroxyapatite/tetracalcium phosphate biphasic coatings was performed with X-ray diffraction. Tetracalcium phosphate in the coatings obtained at high substrate temperature is not formed by partial conversion of previously deposited hydroxyapatite. Instead, it is produced by nucleation and growth of tetracalcium phosphate itself from the ablation products of the hydroxyapatite target or by accretion of tetracalcium phosphate grains formed during ablation. This finding was confirmed by formation of calcium oxide, not tetracalcium phosphate, after annealing of pure hydroxyapatite coatings at high temperatures of 700-850 degrees C. (C) 2005 Springer Science + Business Media, Inc.
C1 Univ Alabama, Dept Phys, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Prosthodont & Biomat, Birmingham, AL 35294 USA.
RP Camata, RP (reprint author), Univ Alabama, Dept Phys, Birmingham, AL 35294 USA.
EM camata@uab.edu
FU NIDCR NIH HHS [R01 DE013952, R01 DE013952-07]; PHS HHS [2 R01D013952-04]
CR BERRY JL, 1986, J BIOMED MATER RES, V20, P65, DOI 10.1002/jbm.820200107
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   COOK SD, 1988, CLIN ORTHOP RELAT R, P303
   COTELL CM, 1992, J APPL BIOMATER, V3, P87, DOI 10.1002/jab.770030204
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DEBRUIJN JD, 1994, BIOMATERIALS, V15, P543, DOI 10.1016/0142-9612(94)90021-3
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DEGROOT K, 1993, MATER TECHNOL, V8, P12
   ESCHENROEDER HC, 1987, CLIN ORTHOP RELAT R, P234
   Fernandez-Pradas JM, 1998, THIN SOLID FILMS, V317, P393, DOI 10.1016/S0040-6090(97)00629-9
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   HALL MM, 1977, J APPL CRYSTALLOGR, V10, P66, DOI 10.1107/S0021889877012849
   HENCH L, 1993, INTRO BIOCERAMICS
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   Kim H, 2005, KEY ENG MAT, V284-286, P207, DOI 10.4028/www.scientific.net/KEM.284-286.207
   Kim H, 2003, MATER RES SOC SYMP P, V750, P71
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P909, DOI 10.1002/jbm.820280810
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   OONISHI H, 1989, J BONE JOINT SURG BR, V71, P213
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Zeng HT, 2000, J BIOMED MATER RES, V50, P248, DOI 10.1002/(SICI)1097-4636(200005)50:2<248::AID-JBM20>3.3.CO;2-9
NR 31
TC 50
Z9 51
U1 3
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2005
VL 16
IS 10
BP 961
EP 966
DI 10.1007/s10856-005-4430-3
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 965HM
UT WOS:000231941200009
PM 16167104
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zeng, QH
   Yu, AB
   Lu, GQ
   Paul, DR
AF Zeng, QH
   Yu, AB
   Lu, GQ
   Paul, DR
TI Clay-based polymer nanocomposites: Research and commercial development
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Review
DE polymers; nanocomposites; clay minerals; layered silicates; processing
   and characterization; materials properties; commercialization; drug
   delivery; biomaterials
ID LAYERED SILICATE NANOCOMPOSITES; IN-SITU POLYMERIZATION; NYLON 6/CLAY
   NANOCOMPOSITES; SYNDIOTACTIC POLYSTYRENE/MONTMORILLONITE NANOCOMPOSITES;
   UNSATURATED POLYESTER/MONTMORILLONITE NANOCOMPOSITES; POLY(ETHYLENE
   OXIDE)/MONTMORILLONITE NANOCOMPOSITES; POLYANILINE/NA+-MONTMORILLONITE
   NANOCOMPOSITES; DYNAMIC-MECHANICAL PROPERTIES; MELT INTERCALATION
   METHOD; DRUG-RELEASE BEHAVIOR
AB This paper reviews the recent research and development of clay-based polymer nanocomposites. Clay minerals, due to their unique layered structure, rich intercalation chemistry and availability at low cost, are promising nanoparticle reinforcements for polymers to manufacture low-cost, lightweight and high performance nanocomposites. We introduce briefly the structure, properties and surface modification of clay minerals, followed by the processing and characterization techniques of polymer nanocomposites. The enhanced and novel properties of such nanocomposites are then discussed, including mechanical, thermal, barrier, electrical conductivity, biodegradability among others. In addition, their available commercial and potential applications in automotive, packaging, coating and pigment, electrical materials, and in particular biomedical fields are highlighted. Finally, the challenges for the future are discussed in terms of processing, characterization and the mechanisms governing the behaviour of these advanced materials.
C1 Univ Queensland, ARC Ctr Funct Nanomat, Brisbane, Qld 4072, Australia.
   Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia.
   Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
RP Lu, GQ (reprint author), Univ Queensland, ARC Ctr Funct Nanomat, Brisbane, Qld 4072, Australia.
RI Lu, Gaoqing (Max)/A-2859-2008; Yu, Aibing/A-6054-2008; Zeng,
   Qinghua/G-2000-2011
OI Lu, Gaoqing (Max)/0000-0002-5223-1674; Yu, Aibing/0000-0002-5139-0657;
   Zeng, Qinghua/0000-0003-4572-4072; Family Name Deactivated, Given Names
   Deactivated/0000-0002-1456-6983
CR Akelah A, 1996, J MATER SCI, V31, P3589
   Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   ALEXANDRE M, 1999, PCT INT APPL, P15
   Ambrogi V, 2001, FARMACO, V56, P421, DOI 10.1016/S0014-827X(01)01054-0
   ARANDA P, 1992, ELECTROCHIM ACTA, V37, P1573, DOI 10.1016/0013-4686(92)80114-2
   Billingham J, 1997, VIB SPECTROSC, V14, P19, DOI 10.1016/S0924-2031(96)00074-4
   Biswas M, 2001, ADV POLYM SCI, V155, P167
   BLUMSTEIN A, 1965, J POLYM SCI PART A, V3, P2665, DOI 10.1002/pol.1965.100030721
   BURNSIDE SD, 1995, CHEM MATER, V7, P1597, DOI 10.1021/cm00057a001
   Chaiko DJ, 2003, CHEM MATER, V15, P1105, DOI 10.1021/cm020833j
   Chang JH, 2001, POLYM ENG SCI, V41, P2226, DOI 10.1002/pen.10918
   Chavarria F, 2004, POLYMER, V45, P8501, DOI 10.1016/j.polymer.2004.09.074
   Chen TK, 1999, J POLYM SCI POL CHEM, V37, P2225, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2225::AID-POLA37>3.0.CO;2-Z
   Chen W, 1999, J MATER SCI LETT, V18, P711, DOI 10.1023/A:1006648329483
   Cho JW, 2001, POLYMER, V42, P1083, DOI 10.1016/S0032-3861(00)00380-3
   Choi HJ, 1997, MACROMOL SYMP, V119, P149, DOI 10.1002/masy.19971190115
   Choi HJ, 2001, MACROMOL RAPID COMM, V22, P320, DOI 10.1002/1521-3927(20010301)22:5<320::AID-MARC320>3.0.CO;2-3
   Choi HK, 1999, POLYM-KOREA, V23, P456
   Choi WJ, 2004, POLYMER, V45, P6045, DOI 10.1016/j.polymer.2004.06.033
   Chung MJ, 2005, J APPL POLYM SCI, V95, P307, DOI 10.1002/app.21224
   Churochkina NA, 1998, POLYM GELS NETW, V6, P205, DOI 10.1016/S0966-7822(97)00014-2
   Cypes SH, 2003, J CONTROL RELEASE, V90, P163, DOI 10.1016/S0168-3659(03)00133-0
   Dai XH, 2004, MACROMOLECULES, V37, P5615, DOI 10.1021/ma049900g
   Delozier DM, 2002, POLYMER, V43, P813, DOI 10.1016/S0032-3861(01)00640-1
   Doh JG, 1998, POLYM BULL, V41, P511, DOI 10.1007/s002890050395
   Eastman MP, 1999, APPL CLAY SCI, V15, P173, DOI 10.1016/S0169-1317(99)00011-3
   Ergungor Z, 2002, MACROMOL SYMP, V185, P259, DOI 10.1002/1521-3900(200208)185:1<259::AID-MASY259>3.0.CO;2-0
   FAGUY PW, 1994, J MATER CHEM, V4, P771, DOI 10.1039/jm9940400771
   Fischer HR, 1999, ACTA POLYM, V50, P122, DOI 10.1002/(SICI)1521-4044(19990401)50:4<122::AID-APOL122>3.0.CO;2-X
   Fong H, 2002, POLYMER, V43, P775, DOI 10.1016/S0032-3861(01)00665-6
   Fornes TD, 2003, POLYMER, V44, P7545, DOI 10.1016/j.polymer.2003.09.034
   Fornes TD, 2003, POLYMER, V44, P3945, DOI 10.1016/S0032-3861(03)00344-6
   Fornes TD, 2002, POLYMER, V43, P5915, DOI 10.1016/S0032-3861(02)00400-7
   Fornes TD, 2001, POLYMER, V42, P9929, DOI 10.1016/S0032-3861(01)00552-3
   Fu XA, 2004, POLYM ENG SCI, V44, P345, DOI 10.1002/pen.20031
   Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104
   Gilman JW, 1999, APPL CLAY SCI, V15, P31, DOI 10.1016/S0169-1317(99)00019-8
   GILMAN JW, 1998, INT SAMPE S EXH, V43, P1053
   Gopakumar TG, 2002, POLYMER, V43, P5483, DOI 10.1016/S0032-3861(02)00403-2
   Gorrasi G, 2003, POLYMER, V44, P2271, DOI 10.1016/S0032-3861(03)00108-3
   Han B, 2004, J APPL POLYM SCI, V91, P2536, DOI 10.1002/app.13398
   Han B, 2003, EUR POLYM J, V39, P1641, DOI 10.1016/S0014-3057(03)00075-2
   Hasegawa N, 1998, J APPL POLYM SCI, V67, P87
   Hasegawa N, 2003, POLYMER, V44, P2933, DOI 10.1016/S0032-3861(03)00215-5
   Heinemann J, 1999, MACROMOL RAPID COMM, V20, P423, DOI 10.1002/(SICI)1521-3927(19990801)20:8<423::AID-MARC423>3.0.CO;2-N
   Hotta S, 2004, POLYMER, V45, P7639, DOI 10.1016/j.polymer.2004.08.059
   Hu Y, 2003, MACROMOL MATER ENG, V288, P272, DOI 10.1002/mame.200390017
   Hutchison JC, 1996, CHEM MATER, V8, P1597, DOI 10.1021/cm960039w
   Hyun YH, 2001, MACROMOLECULES, V34, P8084, DOI 10.1021/ma002191w
   Ivanyuk AV, 2004, POLYM SCI SER A+, V46, P1199
   Jeon HG, 1998, POLYM BULL, V41, P107, DOI 10.1007/s002890050339
   Jimenez G, 1997, J APPL POLYM SCI, V64, P2211, DOI 10.1002/(SICI)1097-4628(19970613)64:11<2211::AID-APP17>3.0.CO;2-6
   Kato M, 1997, J APPL POLYM SCI, V66, P1781, DOI 10.1002/(SICI)1097-4628(19971128)66:9<1781::AID-APP17>3.0.CO;2-Y
   Kawasumi M, 1997, MACROMOLECULES, V30, P6333, DOI 10.1021/ma961786h
   Kawasumi M, 2004, J POLYM SCI POL CHEM, V42, P819, DOI 10.1002/pola.10961
   Kawasumi M, 1998, MAT SCI ENG C-BIO S, V6, P135, DOI 10.1016/S0928-4931(98)00045-9
   Ke YC, 1999, J APPL POLYM SCI, V71, P1139, DOI 10.1002/(SICI)1097-4628(19990214)71:7<1139::AID-APP12>3.3.CO;2-5
   Kedzierski M, 2004, POLIMERY-W, V49, P801
   Kelly HM, 2004, INT J PHARM, V274, P167, DOI 10.1016/j.ijpharm.2004.01.019
   Kim HG, 2004, J APPL POLYM SCI, V92, P238, DOI 10.1002/app.13657
   Kim J, 2004, POLYM TEST, V23, P629, DOI 10.1016/j.polymertesting.2004.01.014
   Kim JW, 1999, MACROMOL RAPID COMM, V20, P450, DOI 10.1002/(SICI)1521-3927(19990801)20:8<450::AID-MARC450>3.3.CO;2-E
   Kim JY, 2003, J APPL POLYM SCI, V89, P3130, DOI 10.1002/app.12506
   Kim KY, 2003, POLYM-KOREA, V27, P377
   Kim SW, 2002, POLYM J, V34, P103, DOI 10.1295/polymj.34.103
   KOJIMA Y, 1993, J MATER SCI LETT, V12, P889, DOI 10.1007/BF00455608
   KOJIMA Y, 1993, J MATER RES, V8, P1185, DOI 10.1557/JMR.1993.1185
   KOMARNENI S, 2002, NANOPHASE NANOCOMPOS, V4
   Koo CM, 2005, J POLYM SCI POL PHYS, V43, P158, DOI 10.1002/polb.10564
   Kornmann X, 1998, POLYM ENG SCI, V38, P1351, DOI 10.1002/pen.10305
   Krishnamoorti R, 1997, MACROMOLECULES, V30, P4097, DOI 10.1021/ma960550a
   KRISHNAMOORTI R, 2001, POLYM NANOCOMPOSITES
   Lagaly G, 1999, APPL CLAY SCI, V15, P1
   LAN T, 1994, CHEM MATER, V6, P573, DOI 10.1021/cm00041a002
   LAN T, 1995, CHEM MATER, V7, P2144, DOI 10.1021/cm00059a023
   LAN T, 1994, CHEM MATER, V6, P2216, DOI 10.1021/cm00048a006
   Laus M, 1997, J MATER RES, V12, P3134, DOI 10.1557/JMR.1997.0409
   LeBaron PC, 1999, APPL CLAY SCI, V15, P11, DOI 10.1016/S0169-1317(99)00017-4
   Lee D, 2002, POLYM DEGRAD STABIL, V75, P555, DOI 10.1016/S0141-3910(01)00259-2
   Lee DC, 1996, J APPL POLYM SCI, V61, P1117, DOI 10.1002/(SICI)1097-4628(19960815)61:7<1117::AID-APP7>3.0.CO;2-P
   Lee DC, 1998, J APPL POLYM SCI, V68, P1997, DOI 10.1002/(SICI)1097-4628(19980620)68:12<1997::AID-APP14>3.0.CO;2-P
   Lee DK, 2000, MACROMOL RAPID COMM, V21, P1136, DOI 10.1002/1521-3927(20001101)21:16<1136::AID-MARC1136>3.0.CO;2-S
   Lee EC, 2004, POLYM ENG SCI, V44, P1773, DOI 10.1002/pen.20179
   Lee SR, 2002, POLYMER, V43, P2495, DOI 10.1016/S0032-3861(02)00012-5
   Lee WF, 2004, J APPL POLYM SCI, V94, P74, DOI 10.1002/app.20730
   Lee WF, 2003, J APPL POLYM SCI, V89, P3652, DOI 10.1002/app.12624
   Lepoittevin B, 2002, POLYMER, V43, P4017, DOI 10.1016/S0032-3861(02)00229-X
   Lepoittevin B, 2003, POLYMER, V44, P2033, DOI 10.1016/S0032-3861(03)00076-4
   Lepoittevin B, 2002, J MATER CHEM, V12, P3528, DOI 10.1039/b205787e
   Lepoittevin B, 2002, MACROMOLECULES, V35, P8385, DOI 10.1021/ma020300w
   Levis SR, 2003, INT J PHARM, V253, P145, DOI 10.1016/S0378-5173(02)00702-0
   Levis SR, 2002, INT J PHARM, V243, P125, DOI 10.1016/S0378-5173(02)00274-0
   LEVY R, 1975, J COLLOID INTERF SCI, V50, P442, DOI 10.1016/0021-9797(75)90167-8
   Liang GD, 2004, J APPL POLYM SCI, V91, P3974, DOI 10.1002/app.13612
   Liang L, 2000, LANGMUIR, V16, P9895, DOI 10.1021/la000279v
   Liang YR, 2005, POLYM TEST, V24, P12, DOI 10.1016/j.polymertesting.2004.08.004
   Liang ZM, 2003, POLYMER, V44, P1391, DOI 10.1016/S0032-3861(02)00911-4
   Liang ZM, 2004, EUR POLYM J, V40, P307, DOI 10.1016/j.europolymj.2003.09.020
   Liao B, 2001, POLYMER, V42, P10007, DOI 10.1016/S0032-3861(01)00563-8
   Lim ST, 2004, E-POLYMERS
   Lim ST, 2002, CHEM MATER, V14, P1839, DOI 10.1021/cm010377j
   Lin FH, 2002, BIOMATERIALS, V23, P1981, DOI 10.1016/S0142-9612(01)00325-8
   Lincoln DM, 2001, POLYMER, V42, P9975, DOI 10.1016/S0032-3861(01)00542-0
   Liu J, 2004, COLLOID POLYM SCI, V282, P291, DOI 10.1007/s00396-003-0978-y
   Liu LM, 1999, J APPL POLYM SCI, V71, P1133, DOI 10.1002/(SICI)1097-4628(19990214)71:7<1133::AID-APP11>3.0.CO;2-N
   Liu XH, 2000, ACTA POLYM SIN, P563
   Liu XH, 2002, POLYMER, V43, P1933, DOI 10.1016/S0032-3861(01)00759-5
   Liu XH, 2001, POLYMER, V42, P10013, DOI 10.1016/S0032-3861(01)00561-4
   Ma JS, 2001, J APPL POLYM SCI, V82, P1444, DOI 10.1002/app.1982
   Maiti P, 2002, CHEM MATER, V14, P4654, DOI 10.1021/cm020391b
   Maiti P, 2003, POLYM MAT SCI ENG, V88, P58
   Matsumura A, 2001, B CHEM SOC JPN, V74, P1153, DOI 10.1246/bcsj.74.1153
   Medellin-Rodriguez FJ, 2003, J MACROMOL SCI PHYS, VB42, P201, DOI 10.1081/MB-120015759
   Medellin-Rodriguez FJ, 2001, POLYMER, V42, P9015, DOI 10.1016/S0032-3861(01)00395-0
   MEHROTRA V, 1992, SOLID STATE IONICS, V51, P115, DOI 10.1016/0167-2738(92)90353-Q
   MEHROTRA V, 1991, SOLID STATE COMMUN, V77, P155, DOI 10.1016/0038-1098(91)90876-W
   MESSERSMITH PB, 1993, CHEM MATER, V5, P1064, DOI 10.1021/cm00032a005
   MESSERSMITH PB, 1995, J POLYM SCI POL CHEM, V33, P1047, DOI 10.1002/pola.1995.080330707
   Messersmith PB, 1997, MATER RES SOC SYMP P, V457, P507
   MESSERSMITH PB, 1994, CHEM MATER, V6, P1719, DOI 10.1021/cm00046a026
   Moon SY, 2004, EUR POLYM J, V40, P1615, DOI 10.1016/j.europolymj.2004.04.018
   Nah C, 2004, POLYM INT, V53, P891, DOI 10.1002/pi.1454
   Nam P.H., 2001, 1 WORLD C NAN CHIC I, P281
   National Science and Technology Council, 2000, SUBC NAN SCI ENG TEC, P88
   Noh MW, 1999, POLYM BULL, V42, P619, DOI 10.1007/s002890050510
   Ogata N, 1997, J POLYM SCI POL PHYS, V35, P389, DOI 10.1002/(SICI)1099-0488(19970130)35:2<389::AID-POLB14>3.0.CO;2-E
   Ogata N, 1997, J APPL POLYM SCI, V66, P573, DOI 10.1002/(SICI)1097-4628(19971017)66:3<573::AID-APP19>3.0.CO;2-W
   Okada A, 1995, MAT SCI ENG C-BIOMIM, V3, P109, DOI 10.1016/0928-4931(95)00110-7
   OKADA A, 1991, POLYM PREPR, V32, P540
   ONEIL CJ, 2003, ANTEC 2003 PLAST ANN, V3
   Oriakhi CO, 2000, J CHEM EDUC, V77, P1138, DOI 10.1021/ed077p1138
   Oriakhi CO, 1999, APPL CLAY SCI, V15, P109, DOI 10.1016/S0169-1317(99)00018-6
   ORIAKHI CO, 1995, MATER RES BULL, V30, P723, DOI 10.1016/0025-5408(95)00054-2
   Pantoustier N, 2002, POLYM ENG SCI, V42, P1928, DOI 10.1002/pen.11085
   PANTOUSTIER N, 2001, E-POLYMERS
   Parfitt R, 1970, CLAY MINER, V8, P305
   Park SH, 2001, POLYMER, V42, P5737, DOI 10.1016/S0032-3861(01)00071-4
   Pinnavaia T.J., 2000, POLYM CLAY NANOCOMPO
   Pluta M, 2002, J APPL POLYM SCI, V86, P1497, DOI 10.1002/app.11309
   Porter TL, 1997, RRD POLYM SCI, V1, P1
   RATTO JA, 1999, SO CLAY ANTEC, P1628
   Ray S, 2005, J POLYM SCI POL CHEM, V43, P304, DOI 10.1002/pola.20502
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Ray SS, 2003, MACROMOL MATER ENG, V288, P203, DOI 10.1002/mame.200390013
   Ray SS, 2003, MACROMOLECULES, V36, P2355, DOI 10.1021/ma021728y
   Ray SS, 2003, CHEM MATER, V15, P1456, DOI 10.1021/cm020953r
   Ray SS, 2003, POLYMER, V44, P857
   Ray SS, 2002, MACROMOL RAPID COMM, V23, P943, DOI 10.1002/1521-3927(200211)23:16<943::AID-MARC943>3.0.CO;2-F
   Ray SS, 2002, NANO LETT, V2, P1093, DOI [10.1021/nl0202152, 10.1021/n10202152]
   Ray SS, 2002, MACROMOLECULES, V35, P3104, DOI 10.1021/ma011613e
   Ray SS, 2002, NANO LETT, V2, P423, DOI 10.1021/nl020284g
   Ray SS, 2002, J NANOSCI NANOTECHNO, V2, P171, DOI 10.1166/jnn.2002.086
   RAY SS, 2002, POLYM PREPR JPN, V51, P155
   Reichert P, 1998, ACTA POLYM, V49, P116, DOI 10.1002/(SICI)1521-4044(199802)49:2/3<116::AID-APOL116>3.0.CO;2-T
   RUIZHITZKY E, 1995, ADV MATER, V7, P180, DOI 10.1002/adma.19950070218
   Runt J, 2001, ABSTR PAP AM CHEM S, V222, pU248
   Sanchez-Solis A, 2004, POLYM ENG SCI, V44, P1094, DOI 10.1002/pen.20102
   SCHERER C, 1999, NEW PLASTICS 99
   Schmidt D, 2002, CURR OPIN SOLID ST M, V6, P205, DOI 10.1016/S1359-0286(02)00049-9
   Shah RK, 2004, POLYMER, V45, P2991, DOI 10.1016/j.polymer.2004.02.058
   Shen ZQ, 2002, POLYM ENG SCI, V42, P2369, DOI 10.1002/pen.11123
   Shen ZQ, 2003, EUR POLYM J, V39, P1917, DOI 10.1016/S0014-3057(03)00097-1
   Sherman LM, 1999, PLAST TECHNOL, V45, P52
   Shi TJ, 2003, ACTA POLYM SIN, P559
   Shin SYA, 2003, POLYMER, V44, P5317, DOI 10.1016/S0032-3861(03)00564-0
   Simha R, 2001, COMPOS INTERFACE, V8, P345, DOI 10.1163/156855401753255431
   Strawhecker KE, 2003, CHEM MATER, V15, P844, DOI 10.1021/cm0212865
   Su SP, 2004, POLYM ADVAN TECHNOL, V15, P225, DOI 10.1002/pat.456
   Sun T, 2002, ADV MATER, V14, P128, DOI 10.1002/1521-4095(20020116)14:2<128::AID-ADMA128>3.0.CO;2-7
   Szanto Z, 1999, J RADIOANAL NUCL CH, V241, P45, DOI 10.1007/BF02347288
   Szanto Z, 1998, J CONTROL RELEASE, V56, P239, DOI 10.1016/S0168-3659(98)00092-3
   Tortora M, 2002, POLYMER, V43, P6147, DOI 10.1016/S0032-3861(02)00556-6
   Truss RW, 2003, POLYM INT, V52, P1790, DOI 10.1002/pi.1290
   Tseng CR, 2002, J APPL POLYM SCI, V86, P2492, DOI 10.1002/app.11020
   Tudor J, 1996, CHEM COMMUN, P2031, DOI 10.1039/cc9960002031
   Tyan HL, 1999, POLYMER, V40, P4877, DOI 10.1016/S0032-3861(98)00716-2
   USUKI A, 1993, J MATER RES, V8, P1174, DOI 10.1557/JMR.1993.1174
   USUKI A, 1993, J MATER RES, V8, P1179, DOI 10.1557/JMR.1993.1179
   Uthirakumar P, 2004, EUR POLYM J, V40, P2437, DOI 10.1016/j.eurpolymj.2004.06.013
   Utracki LA, 2003, MACROMOLECULES, V36, P2114, DOI 10.1021/ma0215464
   Vaia RA, 1999, APPL CLAY SCI, V15, P67, DOI 10.1016/S0169-1317(99)00013-7
   Vaia RA, 1997, MACROMOLECULES, V30, P8000, DOI 10.1021/ma9603488
   Vaia RA, 1996, CHEM MATER, V8, P2628, DOI 10.1021/cm960102h
   Vaia RA, 1997, J POLYM SCI POL PHYS, V35, P59
   VAIA RA, 1995, ADV MATER, V7, P154, DOI 10.1002/adma.19950070210
   VAIA RA, 1995, MACROMOLECULES, V28, P8080, DOI 10.1021/ma00128a016
   Vuluga Z, 2004, MATER PLAST, V41, P3
   Wang SF, 2003, J APPL POLYM SCI, V89, P2583, DOI 10.1002/app.11961
   Wang SF, 2003, COLLOID POLYM SCI, V281, P951, DOI 10.1007/s00396-002-0858-x
   Wang SF, 2003, MATER LETT, V57, P2675, DOI 10.1016/S0167-577X(02)01354-X
   Wang SJ, 1998, J APPL POLYM SCI, V69, P1557, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1557::AID-APP10>3.3.CO;2-8
   Wang Y, 2004, COMPOS PART B-ENG, V35, P111, DOI 10.1016/S1359-8368(03)00049-0
   Wang YZ, 1999, CHEM J CHINESE U, V20, P1143
   Wang Z, 1998, CHEM MATER, V10, P1820, DOI 10.1021/cm970784o
   Wang Z, 1998, CHEM MATER, V10, P3769, DOI 10.1021/cm980448n
   Wang ZM, 2003, J POLYM SCI POL PHYS, V41, P3173, DOI 10.1002/polb.10697
   Weimer MW, 1999, J AM CHEM SOC, V121, P1615, DOI 10.1021/ja983751y
   Weng WG, 2003, POLYMER, V44, P8119, DOI 10.1016/j.polymer.2003.10.028
   WOLF D, 1999, EUROFILLER 99
   WU JH, 1993, CHEM MATER, V5, P835, DOI 10.1021/cm00030a019
   Wu TM, 2003, POLYMER, V44, P2553, DOI 10.1016/S0032-3861(03)00106-X
   Wu TM, 2004, J MACROMOL SCI PHYS, VB43, P329, DOI 10.1081/MB-120029773
   Wu TM, 2003, J POLYM SCI POL PHYS, V41, P1730, DOI 10.1002/polb.10527
   Wu TM, 2002, POLYM ENG SCI, V42, P2295, DOI 10.1002/pen.11116
   Wu TM, 2002, POLYM ENG SCI, V42, P1141, DOI 10.1002/pen.11018
   Wu TM, 2000, MACROMOL CHEM PHYSIC, V201, P2820, DOI 10.1002/1521-3935(20001201)201:18<2820::AID-MACP2820>3.3.CO;2-W
   Xu RJ, 2003, J BIOMED MATER RES A, V64A, P114, DOI 10.1002/jbm.a.10377
   Xu RJ, 2001, MACROMOLECULES, V34, P337, DOI 10.1021/ma0013657
   Yang F, 2003, J APPL POLYM SCI, V89, P3680, DOI 10.1002/app.12639
   Yang F, 2003, CHEM J CHINESE U, V24, P711
   Yano K, 1997, J POLYM SCI POL CHEM, V35, P2289, DOI 10.1002/(SICI)1099-0518(199708)35:11<2289::AID-POLA20>3.0.CO;2-9
   YANO K, 1993, J POLYM SCI POL CHEM, V31, P2493, DOI 10.1002/pola.1993.080311009
   Yeh JM, 2004, J APPL POLYM SCI, V92, P1072, DOI 10.1002/app.13437
   Yeh JM, 2001, CHEM MATER, V13, P1131, DOI 10.1021/cm00938r
   Yoon PJ, 2003, POLYMER, V44, P5341, DOI 10.1016/S0032-3861(03)00523-8
   Yoon PJ, 2003, POLYMER, V44, P5323, DOI 10.1016/S0032-3861(03)00528-7
   Yoon PJ, 2002, POLYMER, V43, P6727, DOI 10.1016/S0032-3861(02)00638-9
   Yu ZZ, 2004, POLYM INT, V53, P1093, DOI 10.1002/pi.1498
   Zanetti M, 2001, POLYMER, V42, P4501, DOI 10.1016/S0032-3861(00)00775-8
   Zeng CC, 2001, MACROMOLECULES, V34, P4098, DOI 10.1021/ma010061x
   Zeng QH, 2002, NANOTECHNOLOGY, V13, P549, DOI 10.1088/0957-4484/13/5/301
   ZENG QH, 2000, CHEMECA 2000 OPPORTU
   ZENG QH, 2001, ACUN 3 TECHNOLOGY CO
   Zhang Q, 2003, CHINESE J POLYM SCI, V21, P359
   Zhang XQ, 2004, J APPL POLYM SCI, V92, P552, DOI 10.1002/app.20039
   Zhang YH, 2004, POLYMER, V45, P7579, DOI 10.1016/j.polymer.2004.08.032
   Zhang YQ, 2004, COMPOS SCI TECHNOL, V64, P1383, DOI 10.1016/j.compscitech.2003.10.014
   Zhao CG, 2005, POLYM DEGRAD STABIL, V87, P183, DOI 10.1016/j.polymdegradstab.2004.08.005
   Zhao HC, 2003, CHINESE J POLYM SCI, V21, P413
   ZHAO X, 1989, COLLOID POLYM SCI, V267, P899, DOI 10.1007/BF01410338
   Zhu J, 2001, CHEM MATER, V13, P3774, DOI 10.1021/cm000984r
   Zhu WP, 2004, J APPL POLYM SCI, V91, P431, DOI 10.1002/app.13096
   Zhu ZK, 1999, J APPL POLYM SCI, V73, P2063, DOI 10.1002/(SICI)1097-4628(19990912)73:11<2063::AID-APP1>3.0.CO;2-Q
   Zilg C, 1999, MACROMOL CHEM PHYSIC, V200, P661, DOI 10.1002/(SICI)1521-3935(19990301)200:3<661::AID-MACP661>3.3.CO;2-W
NR 234
TC 346
Z9 350
U1 10
U2 157
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD OCT
PY 2005
VL 5
IS 10
BP 1574
EP 1592
DI 10.1166/jnn.2005.411
PG 19
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 967ZJ
UT WOS:000232129900002
PM 16245517
DA 2018-10-20
ER

PT J
AU Cui, CX
   Liu, H
   Li, YC
   Sun, JB
   Wang, R
   Liu, SJ
   Greer, AL
AF Cui, CX
   Liu, H
   Li, YC
   Sun, JB
   Wang, R
   Liu, SJ
   Greer, AL
TI Fabrication and biocompatibility of nano-TiO2/titanium alloys
   biomaterials
SO MATERIALS LETTERS
LA English
DT Article
DE nanoparticles; biomaterial; simulated body fluid (SBF); biocompatibility
ID CALCIUM-PHOSPHATE COATINGS; SPRAYED HYDROXYAPATITE COATINGS; BIOMEDICAL
   APPLICATIONS; IMPLANTS
AB Using the process that titanium alloys were embedded by nanometer titanium dioxide powders and sintered in the high temperature furnace, the nano-TiO2/titanium alloys biomedical material was fabricated out. The particle size of TiO2 particles on the surface of Ti alloy was mainly 50-90 nm. The experimental results indicated that the films of nanocrystalline titanium oxide powders on the surface of Ti alloy were with an excellent biocompatibility. By cultivation in the simulated body fluid (SBF) for 7 days, the Ca phosphates were deposited on the specimen surface; and n (Ca)/n (P) atom ratio is about 1.6:1, which is similar to that of HA and human bone. (C) 2005 Elsevier B.V. All rights reserved.
C1 Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China.
   Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Cui, CX (reprint author), Hebei Univ Technol, Sch Mat Sci & Engn, Dingzigu,Rd 1,Hongqiao Dist, Tianjin 300130, Peoples R China.
EM Hutcui@hebut.edu.cn
RI Greer, Alan Lindsay/G-1977-2011; Greer, Lindsay/E-9433-2017
CR ASK M, 1988, APPL SURF SCI, V35, P283
   Dasarathy H, 1996, J BIOMED MATER RES, V31, P81, DOI 10.1002/(SICI)1097-4636(199605)31:1<81::AID-JBM10>3.0.CO;2-P
   DONACHIE MJ, 1988, TITANIUM TECHNICAL G, P29
   Haddow DB, 1998, J SOL-GEL SCI TECHN, V13, P261, DOI 10.1023/A:1008699421635
   HAMAN JD, 1995, J THERM SPRAY TECHN, V4, P179, DOI 10.1007/BF02646110
   HERO H, 1994, J BIOMED MATER RES, V28, P343, DOI 10.1002/jbm.820280308
   Jillavenkatesa A, 1998, J MATER SCI, V33, P4111, DOI 10.1023/A:1004436732282
   Kamitakahara M, 2003, BIOMATERIALS, V24, P1357, DOI 10.1016/S0142-9612(02)00513-6
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   KLEIN CPAT, 1994, J BIOMED MATER RES, V28, P909, DOI 10.1002/jbm.820280810
   Korkusuz F, 1999, Bull Hosp Jt Dis, V58, P86
   Kyeck S., 1999, Materials Science Forum, V308-311, P368
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   ONG JL, 1991, J AM CERAM SOC, V74, P2301, DOI 10.1111/j.1151-2916.1991.tb08301.x
   Pham MT, 1997, THIN SOLID FILMS, V310, P251, DOI 10.1016/S0040-6090(97)00330-1
   Ronold HJ, 2002, BIOMATERIALS, V23, P4211, DOI 10.1016/S0142-9612(02)00167-9
   Singh RK, 1996, MATER MANUF PROCESS, V11, P481, DOI 10.1080/10426919608947498
   Tsui YC, 1998, BIOMATERIALS, V19, P2031, DOI 10.1016/S0142-9612(98)00104-5
   WANG BC, 1993, SURF COAT TECH, V58, P107, DOI 10.1016/0257-8972(93)90181-M
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   Yamashita K, 1996, J AM CERAM SOC, V79, P3313, DOI 10.1111/j.1151-2916.1996.tb08111.x
NR 21
TC 45
Z9 47
U1 2
U2 72
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD OCT
PY 2005
VL 59
IS 24-25
BP 3144
EP 3148
DI 10.1016/j.matlet.2005.05.037
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 957JJ
UT WOS:000231365800041
DA 2018-10-20
ER

PT J
AU Jezewski, J
   Horoba, K
   Matonia, A
   Wrobel, J
AF Jezewski, J
   Horoba, K
   Matonia, A
   Wrobel, J
TI Quantitative analysis of contraction patterns in electrical activity
   signal of pregnant uterus as an alternative to mechanical approach
SO PHYSIOLOGICAL MEASUREMENT
LA English
DT Article
DE uterine contraction activity; electrohysterography; tocography;
   biomedical instrumentation
ID UTERINE ACTIVITY; ELECTROMYOGRAPHY; FETAL
AB Monitoring of uterine contraction activity is an important diagnostic too] used during both pregnancy and labour. The strain the pregnant uterus exerts on the maternal abdomen is measured via external tocography. However, limitation of this approach has caused the development of another technique-electrohysterography-which is based on the recording of electrical uterine activity. A computer-aided system is presented, which allows the recording of electrohysterographic signals from the maternal abdomen and their online analysis both in time and frequency domains. As a research material, we acquired 108 traces during a 24 h period before labour from a group of patients between 37 and 40 weeks of gestation. The comparison study between electrohysterography and tocography was carried out thanks to the possibility of simultaneous recording of mechanical and electrical uterine activities. The obtained results show that both methods demonstrate high agreement in relation to the number of contractions recognized as being consistent. However, their agreement in relation to the quantitative description of recognized patterns has appeared to be unacceptable to consider these methods as fully alternative. The appropriate way of further development of electrohysterography seems to be spectral analysis. Several spectral parameters describing electrophysiological properties of uterine muscle can be obtained by the use of electrohysterographic signals.
C1 Inst Med Technol & Equipment, Dept Biomed Informat, PL-41800 Zabrze, Poland.
RP Jezewski, J (reprint author), Inst Med Technol & Equipment, Dept Biomed Informat, 118 Roosevelt Str, PL-41800 Zabrze, Poland.
RI Jezewski, Janusz/B-8462-2011; Wrobel, Janusz/T-4670-2017
OI Jezewski, Janusz/0000-0001-7904-8258; Wrobel, Janusz/0000-0002-2995-2465
CR BLAND JM, 1986, LANCET, V1, P307
   DEVEDEUX D, 1993, AM J OBSTET GYNECOL, V169, P1636, DOI 10.1016/0002-9378(93)90456-S
   DUCHENE J, 1995, IEEE ENG MED BIOL, V14, P125, DOI 10.1109/51.376749
   Gondry Jean, 1993, Biomedical Instrumentation and Technology, V27, P318
   HARRISON A, 1995, P 3 EUR C ENG MED, P90
   HOROBA K, 1998, P 2 IMACS CESA, P776
   HOROBA K, 2002, P 12 NORD BALT C BIO, P160
   HOROBA K, 2001, P 23 INT C IEEE EMBS, P461
   Jezewski J, 2003, P ANN INT IEEE EMBS, V25, P3145, DOI 10.1109/IEMBS.2003.1280809
   LARKS SD, 1957, J APPL PHYSIOL, V10, P479
   Leman H, 1999, IEEE T BIO-MED ENG, V46, P1222, DOI 10.1109/10.790499
   Miles AM, 2001, AM J PERINAT, V18, P137, DOI 10.1055/s-2001-14522
   Pieri JF, 2001, MED BIOL ENG COMPUT, V39, P118, DOI 10.1007/BF02345275
   Radhakrishnan N, 2000, IEEE ENG MED BIOL, V19, P89
   RAMONDT J, 1986, MED BIOL ENG COMPUT, V24, P351, DOI 10.1007/BF02442687
   SIMS SM, 1982, J GEN PHYSIOL, V80, P353, DOI 10.1085/jgp.80.3.353
   SMYTH CN, 1957, J OBSTET GYNAECOL, V64, P59
   Snowden S, 2001, PHYSIOL MEAS, V22, P673, DOI 10.1088/0967-3334/22/4/303
   STEER CM, 1950, AM J OBSTET GYNECOL, V59, P25, DOI 10.1016/0002-9378(50)90337-1
   TROEDSSON MHT, 1993, J REPROD FERTIL, V99, P307
   WOLFS G, 1970, ARCH GYNAKOL, V208, P373, DOI 10.1007/BF00668252
NR 21
TC 50
Z9 50
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0967-3334
J9 PHYSIOL MEAS
JI Physiol. Meas.
PD OCT
PY 2005
VL 26
IS 5
BP 753
EP 767
DI 10.1088/0967-3334/26/5/014
PG 15
WC Biophysics; Engineering, Biomedical; Physiology
SC Biophysics; Engineering; Physiology
GA 975MK
UT WOS:000232666400015
PM 16088066
DA 2018-10-20
ER

PT J
AU Zhang, SG
   Gelain, F
   Zhao, XJ
AF Zhang, SG
   Gelain, F
   Zhao, XJ
TI Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell
   cultures
SO SEMINARS IN CANCER BIOLOGY
LA English
DT Review
DE beta-sheet structure; biological scaffolds; nanofibers and nanopores;
   ionic self-complementarity
ID COMPLEMENTARY OLIGOPEPTIDE; BASEMENT-MEMBRANE; BIOLOGICAL-MATERIALS;
   ENDOTHELIAL-CELLS; IN-VITRO; BREAST; DIFFERENTIATION; EXPRESSION;
   HYDROGEL; MATRICES
AB Biomedical researchers have become increasingly aware of the limitations of time-honored conventional 2D tissue cell cultures where most tissue cell studies have been carried out. They are now searching for 3D cell culture systems, something between a petri dish and a mouse. It has become apparent that 3D cell culture offers a more realistic micro- and local-environment where the functional properties of cells can be observed and manipulated that is not possible in animals. A newly designer self-assembling peptide scaffolds may provide an ideally alternative system. The important implications of 3D tissue cell cultures for basic cell biology, tumor biology, high-content drug screening, and regenerative medicine and beyond could be profound. (c) 2005 Elsevier Ltd. All rights reserved.
C1 MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   Fdn Ctr San Raffaele Monte Tabor, DIBIT, Stem Cell Res Inst, I-20132 Milan, Italy.
   Sichuan Univ, Inst Nanobiotechnol & Membrane Biol, Chengdu 610065, Peoples R China.
RP Zhang, SG (reprint author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM Shuguang@mit.edu
RI Gelain, Fabrizio/K-5069-2012
OI Gelain, Fabrizio/0000-0002-2624-5853
CR Alberts B, 2002, MOL BIOL CELL
   ATALA A, 2001, METHODS TISSUE ENG
   Ayad S., 1998, EXTRACELLULAR MATRIX
   Bissell M J, 1981, Int Rev Cytol, V70, P27, DOI 10.1016/S0074-7696(08)61130-4
   Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016
   Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x
   Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040
   Branden C., 1999, INTRO PROTEIN STRUCT
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Edelman DB, 2005, EXP NEUROL, V192, P1, DOI 10.1016/j.expneurol.2004.10
   GELAIN F, UNPUB DESIGNER SELF
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Kreis T, 1999, GUIDE BOOK EXTRACELL
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Lanza R, 2000, PRINCIPLES TISSUE EN
   LEE EYHP, 1985, P NATL ACAD SCI USA, V82, P1419, DOI 10.1073/pnas.82.5.1419
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   OLIVER C, 1987, J DENT RES, V66, P594, DOI 10.1177/00220345870660023901
   PALSSON B, 2003, TISSUE ENG PRINCIPLE
   PETSKO GA, 2003, PROTEIN STRUCTURE FU
   RATNER B, 1996, BIOMATERIALS SCI
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   SCOTT MP, 2003, MOL CELL BIOL, P34501
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   TIMPL R, 1979, J BIOL CHEM, V254, P9933
   WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yannas I., 2001, TISSUE ORGAN REGENER
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhau HE, 1997, IN VITRO CELL DEV-AN, V33, P375
NR 48
TC 235
Z9 261
U1 4
U2 99
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-579X
J9 SEMIN CANCER BIOL
JI Semin. Cancer Biol.
PD OCT
PY 2005
VL 15
IS 5
BP 413
EP 420
DI 10.1016/j.semcancer.2005.05.007
PG 8
WC Oncology
SC Oncology
GA 966KO
UT WOS:000232018800010
PM 16061392
DA 2018-10-20
ER

PT J
AU Fortin, MA
   Marion, F
   Stansfield, BL
   Paynter, RW
   Sarkissian, A
   Terreault, B
AF Fortin, MA
   Marion, F
   Stansfield, BL
   Paynter, RW
   Sarkissian, A
   Terreault, B
TI Efficiency of plasma-based ion implantation of radioisotopes (P-32)
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Plasma Surface Engineering
CY SEP 13-17, 2004
CL Garmisch Partenkirchen, GERMANY
SP European Joint Comm Plasma & Ion Surface Engn
DE radioactive ion-implantation; plasma-based ion implantation; P-32;
   radioactive implants; beta-ray dosimmetry
ID MUSCLE CELL-PROLIFERATION; BETA-RADIATION; ANEURYSMS; STENTS
AB Radioactive phosphorus (P-32) can be implanted in biomedical devices using plasma-based ion implantation (PBII). A pulsed ECR (2.45 GHz) coaxial argon plasma reactor has been developed in which the radioisotopes are implanted into a negatively biased target. A I ms microwave pulse creates the plasma, which sputters material from a sputter target. A fraction of the radioisotopes is then ionized and the ions are implanted into a negatively biased cylindrical titanium implant. The theory underlying plasma-based radioisotope ion implantation is described in this article and the calculations are compared to experimental results for different plasma conditions and sputtering target positions. This study confirms the importance of radioactive source positioning and the impact of high plasma densities when using a PBII reactor. Implantation efficiency rates of about 1% are measured, which is about 100 times higher than conventional beam-line ion implantation. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Quebec, INRS, EMT, Varennes, PQ J3X 1S2, Canada.
   Plasmaion Inc, Varennes, PQ J3X 1S2, Canada.
RP Fortin, MA (reprint author), Univ Quebec, INRS, EMT, 1650 Boul Lionel Boulet, Varennes, PQ J3X 1S2, Canada.
EM fortin@emt.inrs.ca
RI Paynter, Royston/G-9333-2011
CR FISCHELL TA, 1994, CIRCULATION, V90, P2956, DOI 10.1161/01.CIR.90.6.2956
   Fortin MA, 2004, REV SCI INSTRUM, V75, P5237, DOI 10.1063/1.1821621
   FORTIN MA, 2004, UNPUB PLASMA SOURCES
   HEHRLEIN C, 1995, CIRCULATION, V92, P1570, DOI 10.1161/01.CIR.92.6.1570
   Huttel E, 2002, REV SCI INSTRUM, V73, P825, DOI 10.1063/1.1429784
   LENNON MA, 1986, ATOMIC MOL DATA FU 2
   Raymond J, 2003, STROKE, V34, P2801, DOI 10.1161/01.STR.0000098651.14384.AB
   Raymond J, 2002, STROKE, V33, P421, DOI 10.1161/hs0202.104474
   Sarkissian AH, 1998, SURF COAT TECH, V98, P1336, DOI 10.1016/S0257-8972(97)00399-X
   Waksman R, 2000, CIRCULATION, V101, P1895, DOI 10.1161/01.CIR.101.16.1895
   Ziegler JF, 2000, STOPPING RANGE IONS
NR 11
TC 14
Z9 14
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD OCT 1
PY 2005
VL 200
IS 1-4
BP 996
EP 999
DI 10.1016/j.surfcoat.2005.02.177
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 970RR
UT WOS:000232327800220
DA 2018-10-20
ER

PT J
AU Polini, R
   Amar, M
   Ahmed, W
   Kumashiro, S
   Sein, H
   Colligon, S
AF Polini, R
   Amar, M
   Ahmed, W
   Kumashiro, S
   Sein, H
   Colligon, S
TI A study of diamond synthesis by hot filament chemical vapour deposition
   on nanocomposite coatings
SO THIN SOLID FILMS
LA English
DT Article
DE chemical vapour deposition (CVD); TiN/Si3N4; superhard coatings;
   nanocomposite; diamond
ID GAS-PHASE; NUCLEATION; GROWTH; TOOLS
AB Deposition of diamond films onto various substrates can result in significant technological advantages in terms of functionality and improved life and performance of components. Diamond is hard, wear resistant, chemically inert and biocompatible and considered as the ideal material for surfaces of cutting tools and biomedical components. However, it is well known that diamond deposition onto technologically important substrates such as Co-cemented carbides and steels is problematic due to carbon interaction with the substrate, low nucleation densities and poor adhesion. Several papers previously published in the relevant literature have reported the application of interlayer materials such as metal nitrides and carbides to provide bonding between diamond and hostile substrates. In this study, we have investigated for the first time the chemical vapour deposition (CVD) of polycrystalline diamond on TiN/SiNx nanocomposite interlayers deposited at relatively low temperatures. The nanocomposite layers were deposited at 70 degrees C or 400 degrees C on silicon substrates by using a dual ion beam deposition system. The results showed that a preliminary seeding pre-treatment with diamond suspension was necessary to achieve large diamond nucleation densities and that diamond nucleation was larger on narrocomposite films than on bare sc-Si submitted to same pretreatment and CVD process parameters. TiN/SiNx layers synthesized at 70 degrees C or 400 degrees C underwent different nanostructure modifications during diamond CVD. The data also showed that TiN/SiNx films obtained at 400 degrees C are preferable so far as their use as interlayers between hostile substrates and CVD diamond is concerned. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy.
   Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
RP Ahmed, W (reprint author), Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-00133 Rome, Italy.
EM w.ahmed@mmu.ac.uk
RI Polini, Riccardo/D-2289-2017
OI Polini, Riccardo/0000-0002-6551-0883; Ahmed, Waqar/0000-0003-4152-5172
CR CHEN X, 1993, J APPL PHYS, V74, P4168, DOI 10.1063/1.354420
   Colligon JS, 2004, PHILOS T ROY SOC A, V362, P103, DOI 10.1098/rsta.2003.1303
   Davis R. F., 1993, DIAMOND FILMS COATIN
   Endler I, 1996, DIAM RELAT MATER, V5, P299, DOI 10.1016/0925-9635(95)00352-5
   FAN WD, 1994, J MATER RES, V9, P2850, DOI 10.1557/JMR.1994.2850
   Faure C, 1999, DIAM RELAT MATER, V8, P830, DOI 10.1016/S0925-9635(98)00363-X
   HAUBNER R, 1993, DIAM RELAT MATER, V2, P1505, DOI 10.1016/0925-9635(93)90021-S
   IIJIMA S, 1991, J MATER RES, V6, P1491, DOI 10.1557/JMR.1991.1491
   Inspektor A, 1997, INT J REFRACT MET H, V15, P49, DOI 10.1016/S0263-4368(96)00045-5
   *JCPDS, 850879 JCPDS
   *JCPDS, 381420 JCPDS
   Jentsch HG, 2000, ADV ENG MATER, V2, P369, DOI 10.1002/1527-2648(200006)2:6<369::AID-ADEM369>3.0.CO;2-8
   LI S, 1992, PLASMA CHEM PLASMA P, V21, P287
   Liu H. M., 1995, DIAMOND CHEM VAPOR D
   MITSUDA Y, 1993, DIAM RELAT MATER, V2, P333, DOI 10.1016/0925-9635(93)90077-F
   MOLINARI E, 1992, APPL PHYS LETT, V61, P1287, DOI 10.1063/1.107567
   MOLINARI E, 1992, J MATER RES, V7, P1778, DOI 10.1557/JMR.1992.1778
   Nesladek M, 1995, THIN SOLID FILMS, V270, P184, DOI 10.1016/0040-6090(95)06914-3
   Rebouta L, 2000, SURF COAT TECH, V133, P234, DOI 10.1016/S0257-8972(00)00934-8
   Schwarz S, 2003, DIAM RELAT MATER, V12, P701, DOI 10.1016/S0925-9635(03)00061-X
   Silva S, 1999, DIAM RELAT MATER, V8, P1913, DOI 10.1016/S0925-9635(99)00156-9
   Veprek S, 2000, SURF COAT TECH, V133, P152, DOI 10.1016/S0257-8972(00)00957-9
NR 22
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD OCT 1
PY 2005
VL 489
IS 1-2
BP 116
EP 121
DI 10.1016/j.tsf.2005.04.119
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 958HN
UT WOS:000231435400019
DA 2018-10-20
ER

PT J
AU Zhang, EL
   Yang, K
AF Zhang, EL
   Yang, K
TI Coating of calcium phosphate on biometallic materials by electrophoretic
   deposition
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE hydroxyapatite coating; biomedical application; electrophoretic
   deposition
ID HYDROXYAPATITE COATINGS; TITANIUM-ALLOY; IMPLANTS; POWDERS
AB Although biometallic materials have been used as bone implant materials for a long time, they are still detected as foreign bodies by human immune system. Calcium phosphate coating, especially hydroxyapatite ( HA) coating attracts special attention due to its good biocompatibility. Being one of the effective methods used to deposit HA coating onto the metallic implant, the electrophoretic deposition (EPD) was reviewed in detail, including the process of EPD, the advantages and disadvantages, the important processing factors and the microstructure and mechanical properties of the coating. Research results on the processing and the coating show potential application of EPD process to the biomedical materials surface modification. In addition, the nanoparticulate HA coating as a new trend in HA coating was also introduced.
C1 Chinese Acad Sci, Met Res Inst, Shenyang 110016, Peoples R China.
RP Zhang, EL (reprint author), Chinese Acad Sci, Met Res Inst, Shenyang 110016, Peoples R China.
EM zhang_erlin2000@yahoo.com
RI Zhang, Erlin/N-6608-2014
OI Zhang, Erlin/0000-0002-6152-6546
CR Barrere F., 2001, KEY ENG MATER, P192
   CAHN RW, MAT SCI TECHNOLOGY C, V14
   [陈晓明 Chen Xiaoming], 2002, [材料科学与工程, Materials Science and Engineering], V20, P545
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   GAROR L, 1992, J ELECTROCHEM, V139, P1078
   Guipont V, 2002, MAT SCI ENG A-STRUCT, V325, P9, DOI 10.1016/S0921-5093(01)01414-9
   HELEN A, 1998, J MATER CHEM, P405
   KOKUBO T, 2003, BIOMATERIALS, V24, P2167
   Kong LB, 2002, J MATER SCI, V37, P1131, DOI 10.1023/A:1014355103125
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Ma J, 2003, J MATER SCI-MATER M, V14, P797, DOI 10.1023/A:1025092506583
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   MIZUGUCHI J, 1983, J ELECTROCHEM SOC, V130, P1819, DOI 10.1149/1.2120105
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   OSBORN JF, 1987, BIOMED TECH, V32, P177, DOI 10.1515/bmte.1987.32.7-8.177
   Ploska U, 2004, KEY ENG MAT, V254-2, P411, DOI 10.4028/www.scientific.net/KEM.254-256.411
   RUYS AJ, 1995, J MATER SCI LETT, V14, P744
   Sridhar TM, 2003, CORROS SCI, V45, P237, DOI 10.1016/S0010-938X(02)00091-4
   Sridhar TM, 2002, CORROS REV, V20, P255
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   Tsui YC, 1998, BIOMATERIALS, V19, P2031, DOI 10.1016/S0142-9612(98)00104-5
   Wang C X, 2002, SURFACE COATINGS TEC, V130, P39
   Wang CX, 2001, BIOMATERIALS, V22, P1619, DOI 10.1016/S0142-9612(00)00319-7
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   Wei M, 2001, J SOL-GEL SCI TECHN, V21, P39, DOI 10.1023/A:1011201414651
   Wei M, 1999, J BIOMED MATER RES, V45, P11, DOI 10.1002/(SICI)1097-4636(199904)45:1<11::AID-JBM2>3.0.CO;2-7
   Wei M, 1999, J MATER SCI-MATER M, V10, P401, DOI 10.1023/A:1008923029945
   Weng J, 1996, J BIOMED MATER RES, V30, P5
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
NR 32
TC 9
Z9 9
U1 0
U2 4
PU ALLERTON PRESS INC
PI NEW YORK
PA 18 WEST 27TH ST, NEW YORK, NY 10001 USA
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD OCT
PY 2005
VL 15
IS 5
BP 957
EP 964
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 983ER
UT WOS:000233214500001
DA 2018-10-20
ER

PT J
AU Majoros, IJ
   Thomas, TP
   Mehta, CB
   Baker, JR
AF Majoros, IJ
   Thomas, TP
   Mehta, CB
   Baker, JR
TI Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice
   for cancer therapy
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID FOLATE RECEPTOR; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; STARBURST
   DENDRIMERS; CELL-LINES; MACROMOLECULES; METHOTREXATE; PROTEINS;
   POLYMERS; TISSUES
AB Multifunctional cancer therapeutic nanodevices have been designed and synthesized using the poly(amidoamine) (PAMAM) dendrimer as a carrier. Partial acetylation of the generation 5 (G5) PAMAM dendrimer was utilized to neutralize a fraction of the primary amino groups, provide enhanced solubility of the dendrimer during the conjugation reaction of fluorescein isothiocyanate (FITC) (in dimethyl sulfoxide (DMSO)), and prevent nonspecific targeting interactions (in vitro and in vivo) during delivery. The remaining nonacetylated primary amino groups were utilized for conjugation of the functional molecules fluorescein isothiocyanate (FITC, an imaging agent), folic acid (FA, targets overexpressed folate receptors on specific cancer cells), and methotrexate (MTX, chemotherapeutic drug). The appropriate control nanodevices have been synthesized as well. The G5 PAMAM dendrimer molecular weight and number of primary amino groups were determined by gel permeation chromatography (GPC) and potentiometric titration for stoichiometric design of ensuing conjugation reactions. Additionally, dendrimer conjugates were characterized by multiple analytical methods including GPC, nuclear magnetic resonance spectroscopy (NMR), high performance liquid chromatography (HPLC), and UV spectroscopy. The fully characterized nanodevices can be used for the targeted delivery of chemotherapeutic and imaging agents to specific cancer cells. Here, we present a more extensive investigation of our previously reported synthesis of this material with improvements directed toward scale-up synthesis and clinical trials.
C1 Univ Michigan, Ctr Biol Nanotechnol, Ann Arbor, MI 48109 USA.
RP Majoros, IJ (reprint author), Univ Michigan, Ctr Biol Nanotechnol, 200 Zina Pl,4027 Kresge II, Ann Arbor, MI 48109 USA.
EM majoros@umich.edu
FU NCI NIH HHS [N01-CM-97065-32]
CR Badjic JD, 2004, J AM CHEM SOC, V126, P2288, DOI 10.1021/ja0395285
   Diallo MS, 2004, LANGMUIR, V20, P2640, DOI 10.1021/la036108k
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   Genestier L, 2000, IMMUNOPHARMACOLOGY, V47, P247, DOI 10.1016/S0162-3109(00)00189-2
   ISLAM MT, IN PRESS J CHROMAT B
   Kono K, 1999, BIOCONJUGATE CHEM, V10, P1115, DOI 10.1021/bc990082k
   Kukowska-Latallo JF, 2005, CANCER RES, V65, P5317, DOI 10.1158/0008-5472.CAN-04-3921
   Majoros IJ, 2003, MACROMOLECULES, V36, P5526, DOI 10.1021/ma021540e
   MAJOROS IJ, IN PRESS 2004 HDB TH
   MAJOROS IJ, 2004, UNPUB UV PROPERTIES
   Majoros IJ, 2004, J COMPUT THEOR NANOS, V1, P193, DOI 10.1166/jctn.2004.016
   Malik N, 2000, J CONTROL RELEASE, V68, P299, DOI 10.1016/S0168-3659(00)00283-2
   Malik N, 1999, ANTI-CANCER DRUG, V10, P767, DOI 10.1097/00001813-199909000-00010
   Mattei S, 1997, HELV CHIM ACTA, V80, P2391, DOI 10.1002/hlca.19970800810
   Paleos CM, 2004, BIOMACROMOLECULES, V5, P524, DOI 10.1021/bm030068h
   Patri AK, 2002, CURR OPIN CHEM BIOL, V6, P466, DOI 10.1016/S1367-5931(02)00347-2
   Pavlov GM, 1999, PROG COLL POL SCI S, V113, P150
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S
   Santo M, 1999, J PHYS ORG CHEM, V12, P293, DOI 10.1002/(SICI)1099-1395(199904)12:4<293::AID-POC88>3.3.CO;2-H
   Singh P, 1998, BIOCONJUGATE CHEM, V9, P54, DOI 10.1021/bc970048a
   Stiriba SE, 2002, ANGEW CHEM INT EDIT, V41, P1329, DOI 10.1002/1521-3773(20020415)41:8<1329::AID-ANIE1329>3.0.CO;2-P
   Thomas TP, 2005, J MED CHEM, V48, P3729, DOI 10.1021/jm040187v
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   Tomalia DA, 2000, SUPRAMOLECULAR POLYMERS, P359
   Tomalia DA, 1990, ANGEW CHEM, V102, P119
   Wang H, 2000, BLOOD, V96, P3529
   WEITMAN SD, 1992, CANCER RES, V52, P3396
NR 28
TC 303
Z9 324
U1 8
U2 118
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD SEP 22
PY 2005
VL 48
IS 19
BP 5892
EP 5899
DI 10.1021/jm0401863
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 967GS
UT WOS:000232080200004
PM 16161993
DA 2018-10-20
ER

PT J
AU Guilherme, MR
   Reis, AV
   Takahashi, SH
   Rubira, AF
   Feitosa, JPA
   Muniz, EC
AF Guilherme, MR
   Reis, AV
   Takahashi, SH
   Rubira, AF
   Feitosa, JPA
   Muniz, EC
TI Synthesis of a novel superabsorbent hydrogel by copolymerization of
   acrylamide and cashew gum modified with glycidyl methacrylate
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE cashew gum; acrylamide; methacrylated-polysaccharide; aqueous-DMSO;
   superabsorbent hydrogel
ID POLYACRYLAMIDE HYDROGELS; ANACARDIUM-OCCIDENTALE; EXUDATE
   POLYSACCHARIDE; RHEOLOGICAL PROPERTIES; SEMI-IPNS; TREE GUM; BEHAVIOR;
   WATER; RELEASE; POLY(N-ISOPROPYLACRYLAMIDE)
AB Novel superabsorbent hydrogels were manufactured using chemically modified cashew gum (CGMA) and acrylamide (AAm) as reactants. The route for the synthesis was feasible due to the incorporation of glycidyl methacrylate (GMA) into structure of cashew gum (CG) to form the cashew gum-methacrylated (CGMA), in an appropriate mixture water-DMSO, as solvent, and using TEMED as catalyst. Thereafter, the CGMA was copolymerized with AAm yielding (CGMA-co-AAm) hydrogels. The main characteristics of raw and the modified materials are reported in this paper. C-13 NMR, H-1 NMR and FTIR spectroscopies confirmed the incorporation of vinyl groups, from GMA, into CG structure. By the spectrophotometry analyses, it was found that, ca. 82% of GMA was incorporated to the CG after 24 h of reaction. The cross-linking of CGMA or co-polymerization of CGMA with acrylamide leads to a hydrogel formation. Their gelation was characterized by FT-IR analysis. Alkaline hydrolysis at 40 degrees C for 3 and 4.5 h increased the water uptake (WU) capacity. Hydrolyzed CGMA-co-AAm hydrogels present higher values of WU (up to 1500) and may be classified as water superabsorbent material. Applications in agriculture, as soil conditioner, and in biomedical field, as biomaterial (scaffold) are being investigated. (C) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Estadual Maringa, Dept Quim, GMPC, BR-87020 Maringa, Parana, Brazil.
   Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60455760 Fortaleza, Ceara, Brazil.
RP Muniz, EC (reprint author), Univ Estadual Maringa, Dept Quim, GMPC, Av Colombo,5790 Zona Sete, BR-87020 Maringa, Parana, Brazil.
EM ecmuniz@uem.br
RI Guilherme, Marcos/J-6008-2012
OI Muniz, Edvani/0000-0001-6685-1519; Guilherme, Marcos/0000-0002-4260-5660
CR Bajpai AK, 2003, CARBOHYD POLYM, V53, P271, DOI 10.1016/S0144-8617(03)00071-7
   Bell CL, 1995, ADV POLYM SCI, V122, P125
   BOURANIS DL, 1995, COMMUN SOIL SCI PLAN, V26, P2461, DOI 10.1080/00103629509369460
   Chatzoudis GK, 1999, COMMUN SOIL SCI PLAN, V30, P2465, DOI 10.1080/00103629909370387
   Chatzoudis GK, 1998, J AGR FOOD CHEM, V46, P2830, DOI 10.1021/jf970969f
   Chen J, 2000, CARBOHYD POLYM, V41, P259, DOI 10.1016/S0144-8617(99)00144-7
   DEPAULA RCM, 1995, CARBOHYD POLYM, V26, P177, DOI 10.1016/0144-8617(95)00006-S
   DRUBOVSKII SA, 1994, POLYM GELS NETW, V2, P49
   Ferreira L, 2000, CARBOHYD POLYM, V41, P15, DOI 10.1016/S0144-8617(99)00064-8
   Guilherme MR, 2003, POLYMER, V44, P4213, DOI 10.1016/S0032-3861(03)00370-7
   GUILHERME MR, 2004, Patent No. 0404265
   GUTOWSKA A, 1994, MACROMOLECULES, V27, P4167, DOI 10.1021/ma00093a018
   Kabiri K, 2003, EUR POLYM J, V39, P1341, DOI 10.1016/S0014-3057(02)00391-9
   Karadag E, 2002, EUR POLYM J, V38, P2133, DOI 10.1016/S0014-3057(02)00117-9
   Kwok AY, 2003, POLYMER, V44, P7335, DOI 10.1016/j.polymer.2003.09.026
   Mahdavinia GR, 2004, EUR POLYM J, V40, P1399, DOI 10.1016/j.europolymj.2004.01.039
   Menestrina JM, 1998, PHYTOCHEMISTRY, V47, P715, DOI 10.1016/S0031-9422(97)00666-3
   Mothe CG, 1999, FOOD HYDROCOLLOID, V13, P501, DOI 10.1016/S0268-005X(99)00035-1
   Mothe CG, 2000, THERMOCHIM ACTA, V357, P9, DOI 10.1016/S0040-6031(00)00358-0
   Muniz EC, 2000, J MEMBRANE SCI, V172, P287, DOI 10.1016/S0376-7388(00)00346-X
   Muniz EC, 2001, MACROMOLECULES, V34, P4480, DOI 10.1021/ma001192l
   Okay O, 2000, EUR POLYM J, V36, P393, DOI 10.1016/S0014-3057(99)00058-0
   Reis AV, 2003, INT J PHARM, V267, P13, DOI 10.1016/j.ijpharm.2003.08.001
   Sannino A, 2003, J BIOMED MATER RES A, V67A, P1016, DOI 10.1002/jbm.a.10149
   Sarubbo LA, 2000, J CHROMATOGR B, V743, P79, DOI 10.1016/S0378-4347(99)00516-2
   Silva DA, 2004, CARBOHYD POLYM, V58, P163, DOI 10.1016/j.carbpol.2004.06.034
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Zakaria MB, 1996, CARBOHYD POLYM, V29, P25, DOI 10.1016/0144-8617(95)00132-8
NR 29
TC 84
Z9 88
U1 4
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD SEP 21
PY 2005
VL 61
IS 4
BP 464
EP 471
DI 10.1016/j.carbpol.2005.06.017
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 969OZ
UT WOS:000232245100011
DA 2018-10-20
ER

PT J
AU Wei, X
   Xiao, TQ
   Liu, LX
   Du, GH
   Chen, M
   Luo, YY
   Xu, HJ
AF Wei, X
   Xiao, TQ
   Liu, LX
   Du, GH
   Chen, M
   Luo, YY
   Xu, HJ
TI Application of x-ray phase contrast imaging to microscopic
   identification of Chinese medicines
SO PHYSICS IN MEDICINE AND BIOLOGY
LA English
DT Article
ID SYNCHROTRON-RADIATION; COMPUTED-TOMOGRAPHY
AB In the last decade, x-ray phase contrast imaging (XPCI) has received considerable attention as a novel imaging technique, which has proved to be suitable for weakly absorbing materials such as biomedical samples and polymers. In this paper, the microstructures of traditional Chinese medicines (TCMs), which are used as judging criteria in the identification of TCMs, were investigated by XPCI based on a nano-focus x-ray tube.. The results demonstrated that XPCI is a promising new method for the identification of TCMs, with advantages such as nondestructivity, no special sample preparation and suitability for thick samples.
C1 Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China.
RP Wei, X (reprint author), Chinese Acad Sci, Shanghai Inst Appl Phys, POB 800-204, Shanghai 201800, Peoples R China.
EM tqxiao@sinap.ac.cn
CR Arfelli F, 2003, P SOC PHOTO-OPT INS, V5030, P274, DOI 10.1117/12.480162
   Besseghini S, 2004, MAT SCI ENG A-STRUCT, V378, P125, DOI 10.1016/j.msea.2004.01.054
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023
   DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0
   FITAGERALD R, 2000, PHYS TODAY, V53, P23
   Gao DC, 1999, P SOC PHOTO-OPT INS, V3659, P346, DOI 10.1117/12.349509
   Huang H. X., 1993, CHIN TRAD HERB DRUGS, V24, P656
   Hwu Y, 2002, J PHYS D APPL PHYS, V35, pR105, DOI 10.1088/0022-3727/35/13/201
   JI S, 2000, CHIN TRADITION PATEN, V22, P856
   Keyrilainen J, 2005, EUR J RADIOL, V53, P226, DOI 10.1016/j.ejard.2004.03.015
   MOMOSE A, 1995, NUCL INSTRUM METH A, V352, P622, DOI 10.1016/0168-9002(95)90017-9
   Pogany A, 1997, REV SCI INSTRUM, V68, P2774, DOI 10.1063/1.1148194
   Ren R. A., 1986, IDENTIFICATION TRADI
   ROCHA S, 2005, NUCL INSTRUM METH A, V548, P175
   Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073
   Stevenson AW, 2003, NUCL INSTRUM METH B, V199, P427, DOI 10.1016/S0168-583X(02)01557-4
   Takeda T, 2001, NUCL INSTRUM METH A, V467, P1322, DOI 10.1016/S0168-9002(01)00656-8
   Tsai WL, 2002, NATURE, V417, P139, DOI 10.1038/417139a
   Wang Xi-fang, 2003, Zhongguo Zhongyao Zazhi, V28, P924
   Webb MA, 1999, PLANT CELL, V11, P751
   Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0
   Xiao Tiqiao, 2003, Nuclear Techniques, V26, P743
   Xiao TQ, 2005, NUCL INSTRUM METH A, V548, P155, DOI 10.1016/j.nima.2005.03.083
   Yang C. P., 1997, PHARM BOT
   YEUNG E, 1998, BEGINNERS GUIDE STUD
   Yokosuka H, 2002, J SYNCHROTRON RADIAT, V9, P179, DOI 10.1107/S0909049502004211
NR 27
TC 10
Z9 19
U1 0
U2 20
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0031-9155
J9 PHYS MED BIOL
JI Phys. Med. Biol.
PD SEP 21
PY 2005
VL 50
IS 18
BP 4277
EP 4286
DI 10.1088/0031-9155/50/18/003
PG 10
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 972BC
UT WOS:000232427800003
PM 16148393
DA 2018-10-20
ER

PT J
AU Tjandra, W
   Yao, J
   Ravi, P
   Tam, KC
   Alamsjah, A
AF Tjandra, W
   Yao, J
   Ravi, P
   Tam, KC
   Alamsjah, A
TI Nanotemplating of calcium phosphate using a double-hydrophilic block
   copolymer
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID CRYSTAL-GROWTH MODIFIERS; ASSOCIATION BEHAVIOR; SELF-ORGANIZATION;
   AQUEOUS-MEDIUM; SUPERLATTICES; NANOPARTICLES; MINERALIZATION; TEMPLATE;
   DESIGN
AB Atom transfer radical polymerization technique was used to synthesize poly(ethylene oxide)-block-poly(methacrylic acid) (PEO-b-PMAA) copolymer, which was employed as a template for the controlled precipitation of calcium phosphate from aqueous solution at different pH values. The interactions between polymer and inorganic ions were studied using Ca2+ ion selective electrode, which indicated a possible weak interaction between Ca2+ and PEO segments, in addition to the interaction between Ca2+ and MAA segments. Two interesting superstructures consisting of an organized inorganic/organic hybrid material were characterized by electron microscopy. At pH similar to 4.0 a nested structure consisting of hybrid nanofilaments was obtained. The fibers originate from a core of a size similar to that of the primary polymer aggregates, suggesting that cooperative interactions at a local level between dissolving calcium phosphate clusters and disassembling polymer segments may be responsible for the highly anisotropic character of the secondary growth process. At pH similar to 9.0 fractal growth morphology was obtained through the mineralization process. Such calcium phosphate/polymer nanohybrids with complex morphologies are interesting and might also be useful as novel ceramic precursors, reinforcing fillers, or biomedical implants.
C1 Nanyang Technol Univ, Singapore MIT Alliance, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
   Zhejiang Univ, Dept Chem, Hangzhou 310027, Peoples R China.
RP Tam, KC (reprint author), Nanyang Technol Univ, Singapore MIT Alliance, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mkctam@ntu.edu.sg
RI Tam, Michael/G-4813-2010
OI Tam, Michael/0000-0002-7603-5635
CR Andres RP, 1996, SCIENCE, V273, P1690, DOI 10.1126/science.273.5282.1690
   Antonietti M, 1998, CHEM-EUR J, V4, P2493, DOI 10.1002/(SICI)1521-3765(19981204)4:12<2493::AID-CHEM2493>3.0.CO;2-V
   ARCHIBALD DD, 1993, NATURE, V364, P430, DOI 10.1038/364430a0
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Colfen H, 2001, MACROMOL RAPID COMM, V22, P219, DOI 10.1002/1521-3927(20010201)22:4<219::AID-MARC219>3.0.CO;2-G
   Colfen H, 1998, LANGMUIR, V14, P582, DOI 10.1021/la970765t
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dujardin E, 2001, CHEM COMMUN, P1264, DOI 10.1039/b102319p
   Estroff LA, 2001, CHEM MATER, V13, P3227, DOI 10.1021/cm010110k
   Galow TH, 2000, ADV MATER, V12, P576
   Li M, 1999, NATURE, V402, P393
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Mann S, 2000, ADV MATER, V12, P147, DOI 10.1002/(SICI)1521-4095(200001)12:2<147::AID-ADMA147>3.0.CO;2-U
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335
   PETYCHEVA A, 2002, COLLOID POLYM SCI, V280, P218
   Qi LM, 2000, ANGEW CHEM INT EDIT, V39, P604, DOI 10.1002/(SICI)1521-3773(20000204)39:3<604::AID-ANIE604>3.0.CO;2-B
   Qi LM, 2001, CHEM-EUR J, V7, P3526, DOI 10.1002/1521-3765(20010817)7:16<3526::AID-CHEM3526>3.0.CO;2-Z
   Ravi P, 2003, MACROMOLECULES, V36, P173, DOI 10.1021/ma021302j
   Sedlak M, 1998, MACROMOL CHEM PHYSIC, V199, P247, DOI 10.1002/(SICI)1521-3935(19980201)199:2<247::AID-MACP247>3.0.CO;2-9
   Shenton W, 1997, NATURE, V389, P585
   Solomatin SV, 2004, LANGMUIR, V20, P2066, DOI 10.1021/la034895f
   Wang ZL, 1998, ADV MATER, V10, P13, DOI 10.1002/(SICI)1521-4095(199801)10:1<13::AID-ADMA13>3.0.CO;2-W
   Yang PD, 2001, ADV MATER, V13, P427, DOI 10.1002/1521-4095(200103)13:6<427::AID-ADMA427>3.3.CO;2-3
   Yao J, 2004, LANGMUIR, V20, P2157, DOI 10.1021/la0355343
   Yao J, 2003, J MATER CHEM, V13, P3053, DOI 10.1039/b308801d
   Yu SH, 2002, ANGEW CHEM INT EDIT, V41, P2356, DOI 10.1002/1521-3773(20020703)41:13<2356::AID-ANIE2356>3.0.CO;2-U
   Yu SH, 2003, NANO LETT, V3, P379, DOI 10.1021/nl025722y
   Yu SH, 2002, CHEM-EUR J, V8, P2937, DOI 10.1002/1521-3765(20020703)8:13<2937::AID-CHEM2937>3.0.CO;2-I
NR 30
TC 54
Z9 55
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD SEP 20
PY 2005
VL 17
IS 19
BP 4865
EP 4872
DI 10.1021/cm050679b
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 964QC
UT WOS:000231894600017
DA 2018-10-20
ER

PT J
AU Habermehl, J
   Skopinska, J
   Boccafoschi, F
   Sionkowska, A
   Kaczmarek, H
   Laroche, G
   Mantovani, D
AF Habermehl, J
   Skopinska, J
   Boccafoschi, F
   Sionkowska, A
   Kaczmarek, H
   Laroche, G
   Mantovani, D
TI Preparation of ready-to-use, stockable and reconstituted collagen
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; collagen; FT-IR; mechanical properties
ID RAT TAIL TENDON; MECHANICAL-PROPERTIES; PRIMARY CULTURE; CROSS-LINKING;
   CELLS; STABILITY; SUBSTRATA; BEHAVIOR; GEL; GLUTARALDEHYDE
AB Collagen is a widely used material in biomedical applications. Although processes that prepare collagen and collagen-based materials that show suitable properties after extraction exist, a ready-to-use, easily stockable, with tailored collagen concentration has not yet been developed. Using rat tail tendons, acid soluble collagen solutions were prepared by two different methods. To improve cell viability of pure collagen films, solutions with physiological pH were also prepared by mixing with NaOH solution. Specimens in the form of thin sheets were then fabricated by solvent evaporation. Next, IR spectroscopy, tensile testing techniques as well as human fibroblast cell morphology and cytotoxicity were used to validate the significant variations in the processes. The results demonstrated that, during the synthesis of collagen stock solution, lyophilization and mechanical blending had little effect on the final properties and therefore offers a method for obtaining solutions with a more homogeneous and modifiable collagen concentration and longer storage time. Neutralizing the stock solution with aqueous NaOH prior to solvent evaporation provided films that had lower mechanical properties but significantly improved biological performance.
C1 Univ Laval, Lab Biomat & Bioengn, Quebec City, PQ G1K 7P4, Canada.
   Univ Hosp, Res Ctr, Quebec City, PQ G1K 7P4, Canada.
   Nicholas Copernicus Univ, Fac Chem, PL-87100 Torun, Poland.
   Univ Piemonte Orientale, Human Anat Lab, I-28100 Novara, Italy.
RP Mantovani, D (reprint author), Univ Laval, Lab Biomat & Bioengn, Quebec City, PQ G1K 7P4, Canada.
EM Diego.Mantovani@gmn.ulaval.ca
RI Skopinska-Wisniewska, Joanna/O-6445-2015; Kaczmarek, Halina/I-8746-2014;
   Sionkowska, Alina/I-5599-2014
OI Boccafoschi, Francesca/0000-0002-6734-5447; Mantovani,
   Diego/0000-0001-9672-895X
CR BARRY MA, 1993, CANCER RES, V53, P2349
   Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   BURJANADZE TV, 1982, BIOPOLYMERS, V21, P1695, DOI 10.1002/bip.360210902
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   DAVISON PF, 1989, CONNECT TISSUE RES, V18, P293, DOI 10.3109/03008208909019078
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505
   EHRMANN RL, 1956, J NATL CANCER I, V16, P1375
   Eliades G, 1997, DENT MATER, V13, P24, DOI 10.1016/S0109-5641(97)80005-X
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Feng Z, 2003, ARTIF ORGANS, V27, P84, DOI 10.1046/j.1525-1594.2003.07187.x
   Feng Zhonggang, 2003, J Artif Organs, V6, P192, DOI 10.1007/s10047-003-0230-z
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   HAYASHI T, 1973, J BIOCHEM-TOKYO, V73, P999, DOI 10.1093/oxfordjournals.jbchem.a130184
   Kaminska A, 1996, POLYM DEGRAD STABIL, V51, P19, DOI 10.1016/0141-3910(95)00159-X
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   MEZGHANI S, 1995, J POLYM SCI POL PHYS, V33, P2413, DOI 10.1002/polb.1995.090331712
   MICHALOPOULOS G, 1975, EXP CELL RES, V94, P70, DOI 10.1016/0014-4827(75)90532-7
   Nicolas FL, 1997, BIOMATERIALS, V18, P815, DOI 10.1016/S0142-9612(97)00003-3
   PAINTER PC, 1978, BIOPOLYMERS, V17, P2475, DOI 10.1002/bip.1978.360171014
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Prystupa DA, 1996, POLYM GELS NETW, V4, P87, DOI 10.1016/0966-7822(96)00003-2
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   RAO KP, 1988, COLLAGEN, V3, P63
   REID GG, 1993, J MATER SCI-MATER M, V4, P201, DOI 10.1007/BF00120393
   RENUGOPALAKRISHNAN V, 1989, MACROMOLECULES, V22, P4121, DOI 10.1021/ma00200a054
   SCHOR SL, 1980, J CELL SCI, V41, P159
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   Sionkowska A, 2004, INT J BIOL MACROMOL, V34, P9, DOI 10.1016/j.ijbiomac.2003.10.001
   Sionkowska A, 2004, J PHOTOCH PHOTOBIO A, V162, P545, DOI 10.1016/S1010-6030(03)00397-6
   Song J, 2000, IN VITRO CELL DEV-AN, V36, P600
   Usha R, 2000, J APPL POLYM SCI, V75, P1577
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WINDER SJ, 1992, J DAIRY RES, V59, P491, DOI 10.1017/S0022029900027151
NR 38
TC 40
Z9 40
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP 16
PY 2005
VL 5
IS 9
BP 821
EP 828
DI 10.1002/mabi.200500102
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 967GI
UT WOS:000232079100002
PM 16121339
DA 2018-10-20
ER

PT J
AU Check, J
   Karuppiah, KSK
   Sundararajan, S
AF Check, J
   Karuppiah, KSK
   Sundararajan, S
TI Comparison of the effect of surface roughness on the
   micro/nanotribological behavior of ultra-high-molecularweight
   polyethylene (UHMWPE) in air and bovine serum solution
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE ultra-high-molecular-weight polyethylene (UHMWPE); friction; surface
   roughness; wear; atomic force microscopy (AFM)
ID TOTAL JOINT REPLACEMENTS; WEIGHT POLYETHYLENE; FORCE MICROSCOPY; WEAR;
   FRICTION; CONTACT; NANOINDENTATION; STRESS; DEBRIS
AB Tribological properties of materials used in biomedical implants critically affect the performance of the implant. A UHMWPE cup paired with a ceramic ball is a popular combination for implants due to its relatively low wear rate. In this study we investigate the effect of surface roughness of UHMWPE on the friction behavior and onset of wear in a UHMWPE/silicon nitride interface in both dry air and bovine serum environments. Microscale multi-asperity contact is examined using a ball-on-flat reciprocating microtribometer. Nanoscale single-asperity contact and surface topography are examined using atomic force microscopy. Friction was found to increase with a decrease in surface roughness of the UHMWPE sample in air, which is due to an increase in real area of contact. This trend was seen to disappear or even reverse in serum. This is due to an increase in the interfacial shear stress of the UHMWPE surface when exposed to the serum. This increase is believed to be caused by an adhered layer of protein on the UHMWPE surface. (c) 2005 Wiley Periodicals, Inc.
C1 Iowa State Univ Sci & Technol, Dept Mech Engn, Ames, IA 50011 USA.
RP Sundararajan, S (reprint author), Iowa State Univ Sci & Technol, Dept Mech Engn, Ames, IA 50011 USA.
EM srirams@iastate.edu
CR Barbour PSM, 1997, J MATER SCI-MATER M, V8, P603, DOI 10.1023/A:1018515318630
   BARBOUR PSM, 1999, J ENG MED, V213, P455
   BHUSHAN B, 1995, WEAR, V181, P743
   Bhushan B., 1999, PRINCIPLES APPL TRIB
   BHUSHAN B, 1999, HDB MICRO NANO TRIBO
   Cooper J. R., 1993, Clinical Materials, V14, P295, DOI 10.1016/0267-6605(93)90016-Z
   FISHER J, 1994, WEAR, V175, P219, DOI 10.1016/0043-1648(94)90185-6
   HEUBERGER MP, 2004, BIOMATERIALS, V26, P1165
   Ho SP, 2003, P I MECH ENG H, V217, P357, DOI 10.1243/095441103770802522
   Ho SP, 2002, WEAR, V253, P1145, DOI 10.1016/S0043-1648(02)00220-X
   HOWIE DW, 1993, ORTHOP CLIN N AM, V24, P571
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   Lancaster JG, 1997, P I MECH ENG H, V211, P17, DOI 10.1243/0954411971534647
   Mazzucco D, 2003, WEAR, V254, P514, DOI 10.1016/S0043-1648(03)00135-2
   ONIONS RA, 1973, J PHYS D APPL PHYS, V6, P289, DOI 10.1088/0022-3727/6/3/302
   Park KD, 2003, J BIOMED MATER RES B, V65B, P272, DOI 10.1002/jbm.b.10006
   Revell PA, 1997, P I MECH ENG H, V211, P187, DOI 10.1243/0954411971534304
   RUAN JA, 1994, J TRIBOL-T ASME, V116, P378, DOI 10.1115/1.2927240
   Sawae Y, 1998, WEAR, V216, P213, DOI 10.1016/S0043-1648(97)00196-8
   SEMLITSCH M, 1997, J ENG MED, V211, P73
   Tortonese M, 1997, P SOC PHOTO-OPT INS, V3009, P53, DOI 10.1117/12.271229
   Villarrubia JS, 1997, J RES NATL INST STAN, V102, P425, DOI 10.6028/jres.102.030
   WANG A, 1995, WEAR, V181, P241, DOI 10.1016/0043-1648(94)07027-X
NR 23
TC 18
Z9 19
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2005
VL 74A
IS 4
BP 687
EP 695
DI 10.1002/jbm.a.30355
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 959JC
UT WOS:000231513000020
PM 16028238
DA 2018-10-20
ER

PT J
AU Zhu, C
   Hard, C
   Lin, CP
   Gitsov, I
AF Zhu, C
   Hard, C
   Lin, CP
   Gitsov, I
TI Novel materials for bioanalytical and biomedical applications:
   Environmental response and binding/release capabilities of amphiphilic
   hydrogels shape-persistent dendritic junctions
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article; Proceedings Paper
CT Polymer Networks Conference 2004
CY AUG, 2004
CL Bethesda, MD
DE binding and release; drug delivery systems; hydrogels; pH-sensitive
   indicators; poly(benzyl ether) dendrimers; poly(ethylene glycol);
   sensors
ID POLY(ETHYLENE GLYCOL); CONTROLLED-RELEASE; AQUEOUS-SOLUTION;
   ACRIDINE-ORANGE; METHYLENE BLUE; NUCLEIC-ACIDS; CROSS-LINKING; NETWORKS;
   POLY(N-ISOPROPYLACRYLAMIDE); COPOLYMERS
AB The binding and release capabilities of a hydrogel series, constructed of hydrophilic poly(ethylene glycol) segments and hydrophobic dendritic junctions [poly (benzyl ether)s], are evaluated in aqueous media. The environmental response of the amphiphilic networks is also tested in water at three pH values: 1.5, 7.0, and 10.1. The highest swelling ratio is observed under acidic conditions and varies between 3.7 and 6.5, depending on the crosslinking density and dendrimer generation. Gel specimens with embedded indicators react within 3-6 s with a clear color switch to the change in the pH of the surrounding medium. The experiments with model anionic and cationic indicators and stains show that the hydrogels have basic interiors. The gel binding capabilities depend on the water solubility of the substrate and on the size of the incorporated dendritic fragments. Model release studies have been performed at 37 degrees C and pHs 1.5, 7.0, and 10.1. The observed phenomena are explained by the transformations in the structure and charge that both the networks and the model compounds undergo with the changes in the pH of the aqueous medium. (c) 2005 Wiley Periodicals, Inc.
C1 SUNY Syracuse, Michael M Szwarc Polymer Res Inst, Syracuse, NY 13210 USA.
   SUNY Syracuse, Dept Chem, Coll Environm Sci & Forestry, Syracuse, NY 13210 USA.
RP Gitsov, I (reprint author), SUNY Syracuse, Michael M Szwarc Polymer Res Inst, Syracuse, NY 13210 USA.
EM igivanov@syr.edu
RI Gitsov, Ivan/A-6791-2009
OI Gitsov, Ivan/0000-0001-7433-8571
CR AKIO K, 2002, POLYM BIOMATER 2002, P133
   BLEARS DJ, 1966, J AM CHEM SOC, V88, P1084, DOI 10.1021/ja00957a058
   Da J, 2004, J POLYM SCI POL CHEM, V42, P360, DOI 10.1002/pola.10796
   DEITCH AD, 1964, J HISTOCHEM CYTOCHEM, V12, P451, DOI 10.1177/12.6.451
   Emami SH, 2003, J POLYM SCI POL CHEM, V41, P520, DOI 10.1002/pola.10593
   Flory P. J., 1953, PRINCIPLES POLYM CHE, P584
   FROST JK, 1979, HISTOCHEM CYTOCHEM, V27, P545
   GARVIN AJ, 1976, J HISTOCHEM CYTOCHEM, V24, P587, DOI 10.1177/24.4.58023
   Gitsov I, 2002, MACROMOLECULES, V35, P8418, DOI 10.1021/ma020935v
   GOLDEN JF, 1979, J HISTOCHEM CYTOCHEM, V27, P522, DOI 10.1177/27.1.374619
   GOLDEN JF, 1974, J HISTOCHEM CYTOCHEM, V22, P495, DOI 10.1177/22.7.495
   Graham Neil B., 1996, V178, P52
   Gudipati CS, 2004, J POLYM SCI POL CHEM, V42, P6193, DOI 10.1002/pola.20466
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   HEMSTREET GP, 1983, INT J CANCER, V31, P577, DOI 10.1002/ijc.2910310508
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Katime I, 2004, J POLYM SCI POL CHEM, V42, P2756, DOI 10.1002/pola.20112
   KUDELA V, 1985, ENCY POLYM SCI ENG, V7, P783
   Lowe TL, 1999, J APPL POLYM SCI, V73, P1031, DOI 10.1002/(SICI)1097-4628(19990808)73:6<1031::AID-APP22>3.0.CO;2-C
   Maitra U, 2001, ANGEW CHEM INT EDIT, V40, P2281, DOI 10.1002/1521-3773(20010618)40:12<2281::AID-ANIE2281>3.0.CO;2-L
   Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405
   Nedelcheva AN, 2004, J POLYM SCI POL CHEM, V42, P5736, DOI 10.1002/pola.20418
   Patrickios CS, 2003, CURR OPIN COLLOID IN, V8, P76, DOI 10.1016/S1359-0294(03)00005-0
   Rudzinski WE, 2002, DES MONOMERS POLYM, V5, P39, DOI 10.1163/156855502760151580
   Russell RJ, 1999, ANAL CHEM, V71, P4909, DOI 10.1021/ac990901u
   Tsanov TN, 2002, REACT FUNCT POLYM, V50, P243, DOI 10.1016/S1381-5148(01)00118-3
   XIA DW, 1992, CONT TOPICS POLYM SC, P229
   Yin XC, 2005, J POLYM SCI POL CHEM, V43, P1641, DOI 10.1002/pola.20523
   Zhan W, 2002, ANAL CHEM, V74, P4647, DOI 10.1021/ac020340y
   Zheng YJ, 2003, J PHYS CHEM B, V107, P483, DOI 10.1021/jp027119+
   Zhuo RX, 2003, J POLYM SCI POL CHEM, V41, P152, DOI 10.1002/pola.10570
NR 31
TC 43
Z9 43
U1 0
U2 18
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD SEP 15
PY 2005
VL 43
IS 18
BP 4017
EP 4029
DI 10.1002/pola.20898
PG 13
WC Polymer Science
SC Polymer Science
GA 959NG
UT WOS:000231524100001
DA 2018-10-20
ER

PT J
AU Liaw, DJ
   Chen, TP
   Huang, CC
AF Liaw, DJ
   Chen, TP
   Huang, CC
TI Novel active ester-bridged copolynorbornene materials containing
   terminal functional hydroxyl, amino, methacryloyl, or ammonium groups
   via ring-opening metathesis polymerization
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE ROMP; block copolymers; nanoparticles
ID NORBORNENE DERIVATIVES; BLOCK-COPOLYMERS; POLYMERS; ROUTE;
   POLYDISPERSITY; CATALYSTS; MONOMERS
AB Several random and block copolynorbornenes with side chains containing terminal hydroxyl, amino, methacryloyl or ammonium groups were derived from the functional alkyl ester-containing norbornenes by ring-opening metathesis polymerization (ROMP). The main chain of ROMP-type polynorbornene had a more important role for glass-transition temperature in comparison with vinyl addition polymerization. There is little effect on glass-transition temperature (about -39 degrees C) of polynorbornenes with different length of alkyl side chain. The organosoluble copolynorbornenes with active crosslinkable methylacryloyl side chains derived from functional hydroxyl group were prepared to improve the thermal stability of poly(methyl methacrylate) [decomposition temperature (T-d)(10%) = 325 degrees C in nitrogen] by forming networked AB crosslinked polymer (T-d(10%) = 367 degrees C in nitrogen). The sizes of nanometerscale polymeric micelles of block copolymers having hydrophobic alkyl ester and hydrophilic ammonium groups were measured in the range of 11-25 nm by scanning electron microscopy. These polymeric materials with various functional groups or amphiphilic architectures are accessible by ROMP, whose topology makes them particularly attractive for application potential such as biomedical and photoelectric materials. (c) 2005 Wiley Periodicals, Inc.
C1 Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 106, Taiwan.
RP Liaw, DJ (reprint author), Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 106, Taiwan.
EM liaw8484@yahoo.com.tw
CR ALLEN SG, 1989, COMPREHENSIVE POLYM, P451
   BOCK J, 1994, MACROMOLECULAR COMPL, P33
   BREUNIG S, 1992, MAKROMOL CHEM, V193, P2915
   Carlise JR, 2004, J POLYM SCI POL CHEM, V42, P2973, DOI 10.1002/pola.20134
   Carrillo A, 2004, J POLYM SCI POL CHEM, V42, P3352, DOI 10.1002/pola.20130
   Chung T. C., 2002, FUNCTIONALIZATION PO
   Dounis P, 1996, POLYMER, V37, P2547, DOI 10.1016/0032-3861(96)85371-7
   GAST AP, 1986, MACROMOLECULES, V19, P686, DOI 10.1021/ma00157a035
   GOETHALS EJ, 1989, TELECHELIC POLYM SYN
   Gratt J, 1997, MACROMOLECULES, V30, P3137, DOI 10.1021/ma961532w
   GRUBBS RH, 2003, HDB METATHESIS, V2, P145
   Holland MG, 2003, J POLYM SCI POL CHEM, V41, P2125, DOI 10.1002/pola.10761
   Kago K, 1999, LANGMUIR, V15, P4295, DOI 10.1021/la981220h
   KOMIYA Z, 1992, MACROMOLECULES, V25, P3609, DOI 10.1021/ma00040a001
   Liaw DJ, 2000, MACROMOLECULES, V33, P6925, DOI 10.1021/ma000025i
   Liaw DJ, 2005, MACROMOLECULES, V38, P3533, DOI 10.1021/ma048015v
   Liaw DJ, 1998, J POLYM SCI POL CHEM, V36, P1785, DOI 10.1002/(SICI)1099-0518(199808)36:11<1785::AID-POLA12>3.0.CO;2-A
   Liaw DJ, 1999, J MOL CATAL A-CHEM, V147, P23, DOI 10.1016/S1381-1169(99)00123-5
   MANDAL BK, 1991, MAKROMOL CHEM-RAPID, V12, P63
   Maughon BR, 2000, MACROMOLECULES, V33, P1929, DOI 10.1021/ma9907340
   MITCHELL AR, 1978, J ORG CHEM, V43, P2845, DOI 10.1021/jo00408a022
   MITCHELL JP, 1991, MACROMOLECULES, V24, P1220, DOI 10.1021/ma00005a043
   Miyamoto Y, 2004, J POLYM SCI POL CHEM, V42, P4248, DOI 10.1002/pola.20286
   NOOLANDI J, 1982, MACROMOLECULES, V15, P482, DOI 10.1021/ma00230a054
   NORMAN RO, 1993, PRINCIPLES ORGANIC S, P440
   REISER A, 1988, PHOTOREACTIVE POLYM
   Schuch H, 2000, MACROMOLECULES, V33, P1734, DOI 10.1021/ma991491e
   SCHWAB P, 1995, ANGEW CHEM INT EDIT, V34, P2039, DOI 10.1002/anie.199520391
   Son SU, 2003, J POLYM SCI POL CHEM, V41, P76, DOI 10.1002/pola.10561
   Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f
   Valenti DJ, 1998, MACROMOLECULES, V31, P2764, DOI 10.1021/ma9714833
   Yang HL, 2003, J POLYM SCI POL CHEM, V41, P2107, DOI 10.1002/pola.10759
NR 32
TC 12
Z9 12
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD SEP 15
PY 2005
VL 43
IS 18
BP 4233
EP 4247
DI 10.1002/pola.20766
PG 15
WC Polymer Science
SC Polymer Science
GA 959NG
UT WOS:000231524100021
DA 2018-10-20
ER

PT J
AU Rabiei, A
   O'Neill, AT
AF Rabiei, A
   O'Neill, AT
TI A study on processing of a composite metal foam via casting
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE closed cell foam; hollow spheres; casting; energy absorption; composite
   metal foam
AB The research sited in this paper involves the development of a new closed cell composite metal foam using gravity casting techniques. The foam is comprised of steel hollow spheres packed into a random dense arrangement, with the interstitial space between spheres infiltrated with a casting aluminum alloy. The measured density of the material is 2.4 g/cm(3), with a relative density of 41.5%. The composite foam developed in this study displayed superior compressive strength and energy absorption capacity. The compressive strength averaged 67 MPa over a region of 10-50% strain, densification began at approximately 50% strain, and the energy absorption at 50% strain is 30 MJ/m(3). Scanning electron microscopy (SEM)-energy dispersive X-ray spectroscopy (EDX) compositional analysis affirmed the presence of expected phases in the hollow spheres and aluminum matrix. This novel material has promising applications in the aerospace, automotive, and biomedical industries. (c) 2005 Elsevier B.V. All rights reserved.
C1 N Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA.
RP Rabiei, A (reprint author), N Carolina State Univ, Dept Mech & Aerosp Engn, 3211 Broughton Hall,2601 Stinson Dr,Campus Box 79, Raleigh, NC 27695 USA.
EM arabiei@eos.ncsu.edu
CR Andersen O, 2000, ADV ENG MATER, V2, P192, DOI 10.1002/(SICI)1527-2648(200004)2:4<192::AID-ADEM192>3.0.CO;2-#
   Ashby M.F., 2000, METAL FOAMS DESIGN G
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Degischer H-P, 2002, HDB CELLULAR METALS
   German R. M., 1989, PARTICLE PACKING CHA
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Grenestedt JL, 1998, MATER RES SOC SYMP P, V521, P3, DOI 10.1557/PROC-521-3
   LIM TJ, 2000, ACTA MAT, V50, P2867
   Sanders WS, 2003, MAT SCI ENG A-STRUCT, V347, P70, DOI 10.1016/S0921-5093(02)00583-X
   Smith W.F., 1993, STRUCTURE PROPERTIES
   Sugimura Y, 1999, MAT SCI ENG A-STRUCT, V269, P38, DOI 10.1016/S0921-5093(99)00147-1
   Villars P., 1995, HDB TERNARY ALLOY PH, V3
NR 12
TC 73
Z9 77
U1 3
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD SEP 15
PY 2005
VL 404
IS 1-2
BP 159
EP 164
DI 10.1016/j.msea.2005.05.089
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 969RQ
UT WOS:000232252800022
DA 2018-10-20
ER

PT J
AU Laroussi, M
   Lu, X
AF Laroussi, M
   Lu, X
TI Room-temperature atmospheric pressure plasma plume for biomedical
   applications
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID DISCHARGE
AB As low-temperature nonequilibrium plasmas come to play an increasing role in biomedical applications, reliable and user-friendly sources need to be developed. These plasma sources have to meet stringent requirements such as low temperature (at or near room temperature), no risk of arcing, operation at atmospheric pressure, preferably hand-held operation, low concentration of ozone generation, etc. In this letter, we present a device that meets exactly such requirements. This device is capable of generating a cold plasma plume several centimeters in length. It exhibits low power requirements as shown by its current-voltage characteristics. Using helium as a carrier gas, very little ozone is generated and the gas temperature, as measured by emission spectroscopy, remains at room temperature even after hours of operations. The plasma plume can be touched by bare hands and can be directed manually by a user to come in contact with delicate objects and materials including skin and dental gum without causing any heating or painful sensation.
C1 Old Dominion Univ, Dept Elect & Comp Engn, Ctr Bioelect, Norfolk, VA 23529 USA.
RP Laroussi, M (reprint author), Old Dominion Univ, Dept Elect & Comp Engn, Ctr Bioelect, Norfolk, VA 23529 USA.
EM mlarouss@odu.edu
RI Lu, XinPei/M-5570-2013
OI Lu, XinPei/0000-0003-0676-9585
CR Faure G, 1998, J PHYS D APPL PHYS, V31, P1212, DOI 10.1088/0022-3727/31/10/013
   KOINUMA H, 1992, APPL PHYS LETT, V60, P816, DOI 10.1063/1.106527
   Laroussi M, 2004, J APPL PHYS, V96, P3028, DOI 10.1063/1.1777392
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220
   Liu SH, 2001, J PHYS D APPL PHYS, V34, P1632, DOI 10.1088/0022-3727/34/11/312
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304
   Stoffels E, 2003, P GAS EL C SAN FRANC, P16
NR 7
TC 349
Z9 369
U1 4
U2 102
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0003-6951
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD SEP 12
PY 2005
VL 87
IS 11
AR 113902
DI 10.1063/1.2045549
PG 3
WC Physics, Applied
SC Physics
GA 963KC
UT WOS:000231802200068
DA 2018-10-20
ER

PT J
AU Bisht, HS
   Wan, L
   Mao, GZ
   Oupicky, D
AF Bisht, HS
   Wan, L
   Mao, GZ
   Oupicky, D
TI pH-controlled association of PEG-containing terpolymers of
   N-isopropylacrylamide and 1-vinylimidazole
SO POLYMER
LA English
DT Article
DE N-isopropylacrylamide; vinylimidazole; PEG
ID THERMALLY CONTROLLED ASSOCIATION; COIL-GLOBULE TRANSITION;
   AQUEOUS-SOLUTIONS; LIGHT-SCATTERING; PHASE-TRANSITION; POLY(ETHYLENE
   OXIDE); RESPONSIVE POLYMERS; POLY(N-ISOPROPYLACRYLAMIDE); COPOLYMERS;
   DELIVERY
AB Temperature- and pH-controlled association of terpolymers of N-isopropylacrylamide (NIPA) with I-vinylimidazole (VI) and polyethylene glycol (PEG) has been investigated by light scattering and atomic force microscopy (AFM) in situ. The polymers contained 0-15 mol% VI and 0-2 mol% PEG. The phase transition temperatures (T-p) have been in the range of 32-45 degrees C and exhibited significant dependence on the pH of solution in the pH range between 5 and 8. The T-p of the polymers increased with increasing VI content and with decreasing pH, confirming major effect of VI ionization status on T-p. The presence of PEG grafts in the polymer structure had augmenting effect on the magnitude of pH-responsiveness and on the pH-independent colloidal stability of the polymer particles formed above T-p. Incorporation of VI into the polymer structure had similar, but pH-dependent effect on colloidal stabilization of the polymer particles. The size of the particles formed after the phase transition is driven by the association of the collapsed NIPA segments in the globule conformation and it decreased with decreasing pH. The phase transition temperature of the polymers could be adjusted to increase from temperatures below, to temperatures above body temperature upon decreasing pH from 7 to 6, suggesting that such polymers could provide a material platform for a variety of biomedical applications. AFM analysis in situ showed a fully reversible formation of particles in the solutions of the polymers above their T-p. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA.
   Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA.
RP Oupicky, D (reprint author), Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA.
EM oupicky@wayne.edu
OI Oupicky, David/0000-0003-4710-861X
CR Anastase-Ravion S, 2001, J CHROMATOGR B, V761, P247, DOI 10.1016/S0378-4347(01)00336-X
   Asokan A, 2002, J PHARM SCI, V91, P903, DOI 10.1002/jps.10095
   Bulmus V, 2000, BIOCONJUGATE CHEM, V11, P78, DOI 10.1021/bc9901043
   Dautzenberg H, 2000, LANGMUIR, V16, P9070, DOI 10.1021/la000368+
   Ding ZL, 1999, BIOCONJUGATE CHEM, V10, P395, DOI 10.1021/bc980108s
   Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028
   Dube D, 2002, BIOCONJUGATE CHEM, V13, P685, DOI 10.1021/bc010084g
   Ebara M, 2000, MACROMOLECULES, V33, P8312, DOI 10.1021/ma000121j
   Franzin CM, 1998, BBA-BIOMEMBRANES, V1415, P219, DOI 10.1016/S0005-2736(98)00198-9
   GRAMM S, 2004, J POLYM SCI A, V43, P142
   Hahn M, 1998, MACROMOLECULES, V31, P5616, DOI 10.1021/ma9800010
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   INOMATA H, 1992, LANGMUIR, V8, P687, DOI 10.1021/la00038a064
   INOMATA H, 1992, LANGMUIR, V8, P1030, DOI 10.1021/la00039a048
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Jones CD, 2003, LANGMUIR, V19, P4544, DOI 10.1021/la034392+
   Kazakov S, 2003, LANGMUIR, V19, P8086, DOI 10.1021/la030066i
   Konak C, 2002, LANGMUIR, V18, P8217, DOI 10.1021/la020357b
   Konak C, 2000, MACROMOLECULES, V33, P5318, DOI 10.1021/ma000500c
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Leroux JC, 2001, J CONTROL RELEASE, V72, P71, DOI 10.1016/S0168-3659(01)00263-2
   Lin HH, 2001, MACROMOLECULES, V34, P3710, DOI 10.1021/ma001852m
   Maeda Y, 2001, LANGMUIR, V17, P6855, DOI 10.1021/la0106438
   Maeda Y, 2000, LANGMUIR, V16, P7503, DOI 10.1021/la0001575
   MEEWES M, 1991, MACROMOLECULES, V24, P5811, DOI 10.1021/ma00021a014
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Molina MJ, 2004, J POLYM SCI POL PHYS, V42, P2294, DOI 10.1002/polb.20104
   Oupicky D, 2003, CURR OPIN MOL THER, V5, P345
   OUPICKY D, 2003, MACROMOLECULES, V36, P6883
   Qiu XP, 1997, MACROMOLECULES, V30, P7921, DOI 10.1021/ma970894g
   Roux E, 2002, INT J PHARM, V242, P25, DOI 10.1016/S0378-5173(02)00183-7
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Virtanen J, 2000, MACROMOLECULES, V33, P336, DOI 10.1021/ma990978k
   Virtanen J, 2000, MACROMOLECULES, V33, P5970, DOI 10.1021/ma9918093
   Virtanen J, 2002, MACROMOLECULES, V35, P4763, DOI 10.1021/ma0122391
   Wohlrab S, 2001, J POLYM SCI POL CHEM, V39, P3797, DOI 10.1002/pola.10026
NR 36
TC 17
Z9 20
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD SEP 8
PY 2005
VL 46
IS 19
BP 7945
EP 7952
DI 10.1016/j.polymer.2005.06.080
PG 8
WC Polymer Science
SC Polymer Science
GA 960EN
UT WOS:000231573100014
DA 2018-10-20
ER

PT J
AU Huh, YM
   Jun, YW
   Song, HT
   Kim, S
   Choi, JS
   Lee, JH
   Yoon, S
   Kim, KS
   Shin, JS
   Suh, JS
   Cheon, J
AF Huh, YM
   Jun, YW
   Song, HT
   Kim, S
   Choi, JS
   Lee, JH
   Yoon, S
   Kim, KS
   Shin, JS
   Suh, JS
   Cheon, J
TI In vivo magnetic resonance detection of cancer by using multifunctional
   magnetic nanocrystals
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SEMICONDUCTOR QUANTUM DOTS; IRON-OXIDE NANOPARTICLES; CONTRAST AGENT;
   SIZE; MICELLES; RECEPTOR; CELLS
AB The unique properties of magnetic nanocrystals provide them with high potential as key probes and vectors in the next generation of biomedical applications. Although superparamagnetic iron oxide nanocrystals have been extensively studied as excellent magnetic resonance imaging (MRI) probes for various cell trafficking, gene expression, and cancer diagnosis, further development of in vivo MRI applications has been very limited. Here, we describe in vivo diagnosis of cancer, utilizing a well-defined magnetic nanocrystal probe system with multiple capabilities, such as small size, strong magnetism, high biocompatibility, and the possession of active functionality for desired receptors. Our magnetic nanocrystals are conjugated to a cancer-targeting antibody, Herceptin, and subsequent utilization of these conjugates as MRI probes has been successfully demonstrated for the monitoring of in vivo selective targeting events of human cancer cells implanted in live mice. Further conjugation of these nanocrystal probes with fluorescent dye-labeled antibodies enables both in vitro and ex vivo optical detection of cancer as well as in vivo MRI, which are potentially applicable for an advanced multimodal detection system. Our study finds that high performance in vivo MR diagnosis of cancer is achievable by utilizing improved and multifunctional material properties of iron oxide nanocrystal probes.
C1 Yonsei Univ, Nano Med Core Res Ctr, Dept Radiol, Dept Chem,Dept Biochem & Mol Biol, Seoul 120752, South Korea.
   Yonsei Univ, Dept Microbiol, Seoul 120752, South Korea.
RP Suh, JS (reprint author), Yonsei Univ, Nano Med Core Res Ctr, Dept Radiol, Dept Chem,Dept Biochem & Mol Biol, Seoul 120752, South Korea.
EM jss@yumc.yonsei.ac.kr; jcheon@yonsei.ac.kr
RI Jun, Young-wook/A-4141-2008
OI Jun, Young-wook/0000-0003-3182-5366; Suh, jin-suck/0000-0001-9455-9240
CR Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   Alivisatos AP, 2004, NAT BIOTECHNOL, V22, P47, DOI DOI 10.1038/NBT927
   Artemov D, 2003, MAGNET RESON MED, V49, P403, DOI 10.1002/mrm.10406
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   ELGAHANIAN R, 1997, SCIENCE, V277, P1078
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Hermanson G.T., 1996, BIOCONJUGATE TECHNIQ, P235
   HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155
   Kang HW, 2002, BIOCONJUGATE CHEM, V13, P122, DOI 10.1021/bc0155521
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929
   MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025
   POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F
   Sjogren CE, 1997, MAGN RESON IMAGING, V15, P55, DOI 10.1016/S0730-725X(96)00335-9
   Song HT, 2005, J AM CHEM SOC, V127, P9992, DOI 10.1021/ja051833y
   Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852
   WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101
   Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219
   Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764
   Yokoyama M, 1998, J CONTROL RELEASE, V55, P219, DOI 10.1016/S0168-3659(98)00054-6
   Zeng H, 2002, NATURE, V420, P395, DOI 10.1038/nature01208
   Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241
NR 26
TC 695
Z9 711
U1 16
U2 262
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD SEP 7
PY 2005
VL 127
IS 35
BP 12387
EP 12391
DI 10.1021/ja052337c
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 961BO
UT WOS:000231637100067
PM 16131220
DA 2018-10-20
ER

PT J
AU Abou Neel, EA
   Ahmed, I
   Blaker, JJ
   Bismarck, A
   Boccaccini, AR
   Lewis, MP
   Nazhat, SN
   Knowles, JC
AF Abou Neel, EA
   Ahmed, I
   Blaker, JJ
   Bismarck, A
   Boccaccini, AR
   Lewis, MP
   Nazhat, SN
   Knowles, JC
TI Effect of iron on the surface, degradation and ion release properties of
   phosphate-based glass fibres
SO ACTA BIOMATERIALIA
LA English
DT Article
DE phosphate glass fibres; iron oxide; degradation; tissue engineering;
   bioactive glasses
ID IN-VITRO; BIOMEDICAL MATERIALS; SODIUM-PHOSPHATE; BIOACTIVE GLASS;
   SOLUBLE GLASSES; DISSOLUTION; TIME
AB Phosphate-based glass fibres (PGF) have the unique characteristic of being completely soluble in an aqueous environment, releasing bioactive and biocompatible ions. They have been proposed as tissue engineering scaffolds for craniofacial skeletal muscle regeneration, where myoblasts are seeded directly onto the fibres. Studies have shown that these cells have a preference in their initial attachment to fibres of certain composition and size, which in turn control the rate of degradation. This study investigated the relationship between the surface properties, degradation properties and ion release (cationic and anionic species) by altering the chemical composition of the PGF. Iron oxide (Fe2O3) was incorporated into glasses containing P2O5 (50 mol%), CaO (30 mol%) and Na2O (20 mol%). Six glass compositions with Fe2O3 ranging from 0 to 5 mol% by replacing the equivalent Ni2O mol% were investigated. Contact angle measurements showed that polar interactions occurring on the glass surfaces diminished with increasing Fe2O3 content. This behaviour was reflected in the estimated surface energies of the glasses, where the overall surface energy decreased with increasing Fe2O3 content due to the decrease in polar or acid/base component. The incorporation of up to 5 mol% Fe2O3 into PGF resulted in a significant reduction in the degradation rate (by two orders of magnitude), which can be related to the formation of more hydration resistant P-O-Fe bonds. However, the degradation rate increased with decreasing fibre diameter (comparing average diameters of 31.6 +/- 6.5 mu m versus 13.1 +/- 1.3 mu m) for a given mass of fibre, and this is related to the surface area to volume ratio. Taken together the results suggest that fibres with the larger diameters and containing 3-5 mol% Fe2O3 could initially be a more durable scaffold than ones with 1 or 2 mol% Fe2O3 for initial cell attachment. (c) 2005 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
   Univ London Imperial Coll Sci & Technol, Dept Mat, London SW7 2AZ, England.
   Univ London Imperial Coll Sci & Technol, Ctr Tissue Engn & Regenerat Med, London SW7 2AZ, England.
   Univ London Imperial Coll Sci & Technol, PaCE Grp, Dept Chem Engn, London SW7 2AZ, England.
RP Knowles, JC (reprint author), UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, 256 Grays Inn Rd, London WC1X 8LD, England.
EM j.knowles@eastman.ucl.ac.uk
RI Knowles, Jonathan Campbell/B-9019-2008; Boccaccini, Aldo/C-7905-2013;
   Abou Neel, Ensanya/J-6908-2013
OI Knowles, Jonathan Campbell/0000-0003-3917-3446; Lewis,
   Mark/0000-0002-8430-4479; Ahmed, Ifty/0000-0001-7868-3698; Blaker,
   Jonny/0000-0003-1112-8619
CR Abou Neel EA, 2005, BIOMATERIALS, V26, P2247, DOI 10.1016/j.biomaterials.2004.07.024
   Ahmed I, 2005, J BIOMATER APPL, V20, P65, DOI 10.1177/088532805049396
   Ahmed I, 2004, BIOMATERIALS, V25, P3223, DOI 10.1016/j.biomaterials.2003.10.013
   Ahmed I, 2004, BIOMATERIALS, V25, P501, DOI 10.1016/S0142-9612(03)00547-7
   Bismarck A, 2004, J MATER SCI, V39, P401, DOI 10.1023/B:JMSC.0000011493.26161.a6
   Bitar M, 2004, BIOMATERIALS, V25, P2283, DOI 10.1016/j.biomaterials.2003.08.054
   BLAKER JJ, 2004, DPOLYMERS
   BUNKER BC, 1984, J NON-CRYST SOLIDS, V64, P291, DOI 10.1016/0022-3093(84)90184-4
   Clement J, 1999, J MATER SCI-MATER M, V10, P729, DOI 10.1023/A:1008927222081
   Clupper DC, 2004, J MATER SCI-MATER M, V15, P803, DOI 10.1023/B:JMSM.0000032821.32577.fc
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   Della Volpe C, 2004, J COLLOID INTERF SCI, V271, P434, DOI 10.1016/j.jcis.2003.09.049
   Della Volpe C, 1997, J COLLOID INTERF SCI, V195, P121
   Franks K, 2000, J MATER SCI-MATER M, V11, P609, DOI 10.1023/A:1008949527695
   GAO H, 2003, J CONTROL RELEASE, V96, P21
   Gough JE, 2003, J BIOMED MATER RES A, V66A, P233, DOI 10.1002/jbm.a.10574
   Gough JE, 2002, J BIOMED MATER RES, V59, P481, DOI 10.1002/jbm.10020
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holst KA, 1950, J AM CERAM SOC, V72, P639
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Knowles JC, 2003, J MATER CHEM, V13, P2395, DOI 10.1039/b307119g
   Laurencin C. T., 2000, BONE ENG, P462
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P335, DOI 10.1002/jbm.a.10587
   Marasinghe GK, 1997, J NON-CRYST SOLIDS, V222, P144, DOI 10.1016/S0022-3093(97)00393-1
   Parsons AJ, 2004, J BIOMED MATER RES A, V71A, P283, DOI 10.1002/jbm.a.30161
   Ray CS, 1999, J NON-CRYST SOLIDS, V249, P1, DOI 10.1016/S0022-3093(99)00304-X
   Rinehart JD, 1999, J BIOMED MATER RES, V48, P833, DOI 10.1002/(SICI)1097-4636(1999)48:6<833::AID-JBM11>3.0.CO;2-#
   Salih V, 2000, J MATER SCI-MATER M, V11, P615, DOI 10.1023/A:1008901612674
   Shah R, 2005, BIOMATERIALS, V26, P1497, DOI 10.1016/j.biomaterials.2004.04.049
   VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8
   Wu S, 1982, POLYM INTERFACE ADHE
   Yu XY, 1997, J NON-CRYST SOLIDS, V215, P21, DOI 10.1016/S0022-3093(97)00022-7
NR 32
TC 74
Z9 74
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2005
VL 1
IS 5
BP 553
EP 563
DI 10.1016/j.actbio.2005.05.001
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 008RB
UT WOS:000235057300007
PM 16701835
DA 2018-10-20
ER

PT J
AU Tirrell, M
AF Tirrell, M
TI Modular materials by self-assembly
SO AICHE JOURNAL
LA English
DT Editorial Material
ID AMPHIPHILES; DNA; MACROMOLECULES; ARCHITECTURE; MOLECULES; SHAPE; RNA
AB Self-assembly is a promising route to producing materials and other chemical products with unprecedented functionality for biomedical, electronic, catalytic and separation process technologies. However, self-assembly will not achieve its full potential unless it is taken seriously as a manufacturing process, as opposed to a laboratory technique, and the obstacles to large-scale implementation are tackled and surmounted. This article, which is an extension of an earlier AlChE Journal Perspectives article, defines and suggests important research directions for chemical engineers in an effort to develop self-assembly into a practical process technology. (c) 2005 American Institute of Chemical Engineers.
C1 Univ Calif Santa Barbara, California Nanosyst Inst, Inst Collaborat Biotechnol, Mat Res Lab,Dept Chem Engn, Santa Barbara, CA 93106 USA.
   Univ Calif Santa Barbara, California Nanosyst Inst, Inst Collaborat Biotechnol, Mat Res Lab,Dept Mat, Santa Barbara, CA 93106 USA.
RP Tirrell, M (reprint author), Univ Calif Santa Barbara, California Nanosyst Inst, Inst Collaborat Biotechnol, Mat Res Lab,Dept Chem Engn, Santa Barbara, CA 93106 USA.
EM tirrell@engineering.ucsb.edu
CR Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   Andre P, 2000, ADV MATER, V12, P119, DOI 10.1002/(SICI)1521-4095(200001)12:2<119::AID-ADMA119>3.0.CO;2-Y
   Barron AE, 1999, CURR OPIN CHEM BIOL, V3, P681, DOI 10.1016/S1367-5931(99)00026-5
   BATEY RT, 1999, ANGEW CHEM INT EDIT, V38, P2326
   Bockstaller MR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166106
   Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686
   Gore T, 2001, LANGMUIR, V17, P5352, DOI 10.1021/la010223i
   HARTWELL LH, 1999, NATURE, V402, P47
   Haynes CL, 2002, J PHYS CHEM B, V106, P1898, DOI 10.1021/jp013570+
   Jaeger L, 2001, NUCLEIC ACIDS RES, V29, P455, DOI 10.1093/nar/29.2.455
   JAEGER L, 2000, ANGEW CHEM INT EDIT, V14, P2521
   Jin RC, 2003, NATURE, V425, P487, DOI 10.1038/nature02020
   KLUG A, 1983, ANGEW CHEM INT EDIT, V22, P565, DOI 10.1002/anie.198305653
   LEHN JM, 1994, SUPRAMOLECULAR CHEM
   Manoharan VN, 2004, MRS BULL, V29, P91, DOI 10.1557/mrs2004.34
   Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   McKenna BJ, 2004, ANGEW CHEM INT EDIT, V43, P5652, DOI 10.1002/anie.200460510
   Mirkin CA, 2000, INORG CHEM, V39, P2258, DOI 10.1021/ic991123r
   Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137
   Ottino JM, 2003, AICHE J, V49, P292, DOI 10.1002/aic.690490202
   Peng XG, 2000, NATURE, V404, P59
   Pyun J, 2003, J MATER CHEM, V13, P2653, DOI 10.1039/b304682f
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simon PFW, 2001, CHEM MATER, V13, P3464, DOI 10.1021/cm0110674
   SMITH M, 1994, PRIX NOBELS 1993
   Texter J, 2001, AICHE J, V47, P1706, DOI 10.1002/aic.690470802
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Vernille JP, 2004, BIOTECHNOL PROGR, V20, P1776, DOI 10.1021/bp049971z
   Vernille JP, 2004, BIOCONJUGATE CHEM, V15, P1314, DOI 10.1021/bc049831a
   WESTHOF E, 1996, FOLD DES, V1, P78
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Wu YY, 2004, NAT MATER, V3, P816, DOI 10.1038/nmat1230
   YAN H, 2004, SCIENCE, V306
   Yu YC, 1999, BIOCHEMISTRY-US, V38, P1659, DOI 10.1021/bi982315l
NR 38
TC 25
Z9 27
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0001-1541
J9 AICHE J
JI AICHE J.
PD SEP
PY 2005
VL 51
IS 9
BP 2386
EP 2390
DI 10.1002/aic.10641
PG 5
WC Engineering, Chemical
SC Engineering
GA 955PB
UT WOS:000231237200005
DA 2018-10-20
ER

PT J
AU Papisov, MI
   Hiller, A
   Yurkovetskiy, A
   Yin, M
   Barzana, M
   Hillier, S
   Fischman, AJ
AF Papisov, MI
   Hiller, A
   Yurkovetskiy, A
   Yin, M
   Barzana, M
   Hillier, S
   Fischman, AJ
TI Semisynthetic hydrophilic polyals
SO BIOMACROMOLECULES
LA English
DT Article
ID CONTAINING LIPOTEICHOIC ACID; STREPTOCOCCUS-SANGUIS; OXIDATION;
   PERIODATE; BACTERIA; DEXTRANS; DELIVERY
AB Nonbioadhesive, fully biodegradable soluble polymers would be very instrumental in advanced biomedical applications, such as gene and drug delivery and tissue engineering. However, rational development of such materials is hindered by the complexity of macromolecule interactions with biological milieu. The prevalence of carbohydrates in naturally occurring interface structures suggests an alternative, biomimetic approach. Interface carbohydrates, regardless of their biological function, have common nonsignaling substructures (e.g., acetal and ketal groups, secondary and primary alcohols). We hypothesized that hydrophilic polymers (polyals) consisting of acyclic units built of nonsignaling carbohydrate substructures would be highly biocompatible and nonbioadhesive, while intrachain acetal or ketal groups would enable nonenzymatic biodegradation upon uptake by cells. Acyclic hydrophilic polyals can be prepared via either polymerization of suitable monomers or lateral cleavage of cyclic polyals (e.g., polysaccharides). In this study, model polyals were produced via lateral cleavage of polyaldoses and polyketoses. Best results were achieved using dextran B-512 as a precursor. The resultant poly[hydroxymethylethylene hydroxymethylformal], in agreement with the hypothesis, demonstrated excellent biological properties and technological flexibility. Materials of this type can potentially have several applications in pharmacology and bioengineering.
C1 Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Boston, MA 02114 USA.
RP Papisov, MI (reprint author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.
EM papisov@helix.mgh.harvard.edu
OI Papisov, Mikhail/0000-0003-4716-2122
FU NCRR NIH HHS [R21-RR14221, R21 RR014221-02, R21 RR014221-01A1, R21
   RR014221]
CR BERG EM, 1991, ANAESTHESIA, V46, P1033, DOI 10.1111/j.1365-2044.1991.tb09916.x
   BKHAKDI S, 1991, INFECT IMMUN, V59, P4614
   BOGDANOV AA, 1993, RADIOLOGY, V187, P701, DOI 10.1148/radiology.187.3.8497616
   BOWIE JU, 1984, CARBOHYD RES, V125, P301, DOI 10.1016/0008-6215(84)85165-4
   BRADE L, 1990, MICROB PATHOGENESIS, V9, P355, DOI 10.1016/0882-4010(90)90069-3
   Bubnis W., 1992, ANAL BIOCHEM, V297, P129
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   HARDIE JM, 1978, STREPTOCOCCI, P157
   ISHAK MF, 1978, CARBOHYD RES, V64, P189, DOI 10.1016/S0008-6215(00)83700-3
   JEANES A, 1986, MOL IMMUNOL, V23, P999, DOI 10.1016/0161-5890(86)90131-8
   JEANES A, 1979, CARBOHYD RES, V74, P31, DOI 10.1016/S0008-6215(00)84763-1
   KELLER R, 1992, INFECT IMMUN, V60, P3664
   KOCHANOWSKI B, 1993, EUR J BIOCHEM, V214, P757, DOI 10.1111/j.1432-1033.1993.tb17977.x
   KOCHANOWSKI B, 1993, EUR J BIOCHEM, V214, P747, DOI 10.1111/j.1432-1033.1993.tb17976.x
   LARSEN C, 1989, Advanced Drug Delivery Reviews, V3, P103, DOI 10.1016/0169-409X(89)90006-9
   OSMAN ME, 1993, CARBOHYD RES, V246, P303, DOI 10.1016/0008-6215(93)84042-5
   Papisov M, 1996, CRIT REV THER DRUG, V13, P57
   Papisov MI, 1998, J NUCL MED, V39, p223P
   PAPISOV MI, 1995, ADV DRUG DELIVER REV, V16, P127, DOI 10.1016/0169-409X(95)00021-X
   Papisov MI, 1998, ADV DRUG DELIVER REV, V32, P119, DOI 10.1016/S0169-409X(97)00135-X
   PAPISOV MI, 1998, 25 INT S CONTR REL B, P170
   PAPISOV MI, 1993, P SOC MAGN RES MED 1, P499
   PAPISOV MI, 1995, TARGETED DELIVERY IM, P385
   PAPISOV MI, 2001, ACS SYM SER, V786, P301
   PAPISOV MI, 1995, 22 INT S CONTR REL B, P442
   PAPISOV MI, 1992, P 6 INT C MAGN FLUID, P182
   PAPISOV MI, 1997, 8 INT S REC ADV DRUG, P184
NR 27
TC 12
Z9 12
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP-OCT
PY 2005
VL 6
IS 5
BP 2659
EP 2670
DI 10.1021/bm0502157
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 964RW
UT WOS:000231899200035
PM 16153104
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Tae, G
   Kornfield, JA
   Hubbell, JA
AF Tae, G
   Kornfield, JA
   Hubbell, JA
TI Sustained release of human growth hormone from in situ forming hydrogels
   using self-assembly of fluoroalkyl-ended poly(ethylene glycol)
SO BIOMATERIALS
LA English
DT Article
DE in situ forming; sustained release; human growth hormone; diffusion
ID PROTEIN; MICROENCAPSULATION; MICROSPHERES; FORMULATIONS; DELIVERY
AB Poly(ethylene glycol)s modified with fluorocarbon end groups are capable of in situ transition from an injectable liquid to a viscoelastic hydrogel by hydrophobic interaction of the end groups; this class of materials is useful for a variety of biomedical applications, including sustained protein release. The hydrogel state can be transformed into an injectable state by the addition of a toxicologically acceptable organic solvent, such as N-methyl pyrrolidone; after injection, this solution quickly returns to a gel state by diffusion of the water-miscible organic solvent into the surrounding environment. In vitro characterization of sustained release of human growth hormone (hGH) using this injectable depot shows that hGH remains stable inside the hydrogel formed, and demonstrates more than 2 weeks of prolonged release of hGH complexed with Zn2+ ions without protein aggregation or initial burst. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Gwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangju, South Korea.
   CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
   Ecole Polytech Fed Lausanne, Integrat Biosci Inst, CH-1115 Lausanne, Switzerland.
RP Kornfield, JA (reprint author), Gwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangju, South Korea.
EM jak@cheme.caltech.edu
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR Brodbeck KJ, 1999, PHARMACEUT RES, V16, P1825, DOI 10.1023/A:1018943107688
   Cleland JL, 1996, PHARMACEUT RES, V13, P1464, DOI 10.1023/A:1016063109373
   Dunn R. L., 1994, US Patent, Patent No. 5278202
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   Hubbell JA, 1996, MRS BULL, V21, P33
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Johnson OL, 1996, NAT MED, V2, P795, DOI 10.1038/nm0796-795
   Kim HK, 1999, BIOTECHNOL BIOENG, V65, P659, DOI 10.1002/(SICI)1097-0290(19991220)65:6<659::AID-BIT6>3.0.CO;2-9
   Lee HJ, 1997, J PHARMACOL EXP THER, V281, P1431
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MALMSTAN M, 1992, MACROMOLECULES, V25, P540
   Reiter EO, 2001, J CLIN ENDOCR METAB, V86, P4700, DOI 10.1210/jc.86.10.4700
   ROSENBLATT J, 1996, 5 WORLD BIOM C TOR C, P344
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   STEVENSON CL, 1995, PHARMACEUT RES, V12, P1671, DOI 10.1023/A:1016201319136
   Tae G, 2001, MACROMOLECULES, V34, P6409, DOI 10.1021/ma0107511
   VISSCHER GE, 1988, J BIOMED MATER RES, V22, P733, DOI 10.1002/jbm.820220806
   Zhao X, 1998, J PHARM SCI, V87, P1450, DOI 10.1021/js980065o
NR 22
TC 56
Z9 56
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2005
VL 26
IS 25
BP 5259
EP 5266
DI 10.1016/j.biomaterials.2005.01.042
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 920OK
UT WOS:000228699800019
PM 15792553
DA 2018-10-20
ER

PT J
AU Richardson, J
   Smith, JE
   McIntyre, M
   Thomas, R
   Pilkington, K
AF Richardson, J
   Smith, JE
   McIntyre, M
   Thomas, R
   Pilkington, K
TI Aloe vera for preventing radiation-induced skin reactions: A systematic
   literature review
SO CLINICAL ONCOLOGY
LA English
DT Article
DE aloe vera; cancer; complementary therapy; radiotherapy; skin reaction;
   systematic review
ID PHASE-III; PROPHYLACTIC AGENT; BREAST; GEL; RADIOTHERAPY; TOXICITY;
   CANCER
AB Aim: To systematically review and critically appraise the evidence for effectiveness of Aloe vera gel for radiation-induced skin reactions.
   Materials and methods: Major biomedical databases and specialist complementary and alternative medicine databases were searched. Additionally, efforts were made to identify unpublished and ongoing research. Relevant research was systematically categorised by study type and appraised according to study design. Clinical commentaries were obtained for each study included in the review.
   Results: One earlier systematic review on Aloe vera for a variety of conditions was located. Five-published randomised-controlled trials (RCTs) were found, along with two additional RCTs that are not published. No non-RCTs, uncontrolled studies or qualitative studies were found.
   Conclusions: There is no evidence from clinical trials to suggest that topical Aloe vera is effective in preventing or minimising radiation-induced skin reactions in cancer patients. Further methodologically rigorous, sufficiently powered research studies should be conducted to evaluate the effectiveness of currently used and novel therapies for the prevention, minimisation and management of radiation-induced skin reactions.
C1 Univ Plymouth, Fac Hlth & Social Work, Plymouth PL4 8AA, Devon, England.
   Res Council Complementary Med, London, England.
   Sch Integrated Hlth, NHSP, CAMEOL, Project Res Council Complementary Med, London, England.
   Midsummer Clin, Chipping Norton, Oxon, England.
   Univ Cambridge NHS Trust, Addenbrookes Hosp, Cambridge, England.
RP Richardson, J (reprint author), Univ Plymouth, Fac Hlth & Social Work, Drake Circus, Plymouth PL4 8AA, Devon, England.
EM janet.richardson@plymouth.ac.uk
CR ARCHAMBEAU JO, 1995, INT J RADIAT ONCOL, V31, P1171, DOI 10.1016/0360-3016(94)00423-I
   Arimoto T, 1989, Radiat Med, V7, P23
   Blackmar A, 1997, Medsurg Nurs, V6, P172
   Boot-Vickers M, 1999, Prof Nurse, V14, P706
   Bosley C., 2003, International Journal of Radiation Oncology Biology Physics, V57, pS438, DOI 10.1016/S0360-3016(03)01404-4
   BURK M, 1993, INT J RADIAT ONCOL, V27, P319, DOI 10.1016/0360-3016(93)90946-S
   Campbell I R, 1992, Clin Oncol (R Coll Radiol), V4, P78, DOI 10.1016/S0936-6555(05)80971-9
   CRD, 2001, UND SYST REV RES EFF
   Dische S, 1994, SEMIN RADIAT ONCOL, V4, P112, DOI [10.1053/SRAO00400112, DOI 10.1053/SRAO00400112]
   Fisher J, 2000, INT J RADIAT ONCOL, V48, P1307, DOI 10.1016/S0360-3016(00)00782-3
   Glean E, 2001, J RADIOTHER PRACT, V2, P75, DOI DOI 10.1017/S1460396900000133
   Heggie S, 2002, CANCER NURS, V25, P442, DOI 10.1097/00002820-200212000-00007
   JELLIN JM, 2003, NATURAL MED COMPREHE
   KLEIN AD, 1988, J AM ACAD DERMATOL, V18, P714, DOI 10.1016/S0190-9622(88)70095-X
   Lavery B A, 1995, Clin Oncol (R Coll Radiol), V7, P184, DOI 10.1016/S0936-6555(05)80513-8
   Lissoni P, 1998, NAT IMMUN, V16, P27, DOI 10.1159/000069427
   MUNRO AJ, 1989, BRIT J CANCER, V60, P370, DOI 10.1038/bjc.1989.287
   MURRAY MT, 1999, TXB NATURAL MED, P579
   *NHS QUAL IMPR SCO, 2004, BEST PRACT STAT SKIN
   Noble-Adams R, 1999, Br J Nurs, V8, P1208
   Oh WK, 2004, J CLIN ONCOL, V22, P3705, DOI 10.1200/JCO.2004.10.195
   Olsen D L, 2001, Oncol Nurs Forum, V28, P543
   PILKINGTON K, 2003, HEALTH INFORM INTERN, V34, P7
   Porock D, 1998, Oncol Nurs Forum, V25, P1019
   Porock D, 1999, EUR J CANCER CARE, V8, P143
   RATCLIFF C, 1990, J ENTEROSTOMAL THER, V17, P193
   Sitton E, 1992, Oncol Nurs Forum, V19, P801
   SU C, 2003, P AN M AM SOC CLIN, V22, P504
   Visuthikosol Vivat, 1995, Journal of the Medical Association of Thailand, V78, P403
   Vogler BK, 1999, BRIT J GEN PRACT, V49, P823
   Wells M., 2003, SUPPORTIVE CARE RADI, P135
   West DP, 2003, AM J INFECT CONTROL, V31, P40, DOI 10.1067/mic.2003.12
   Wickline MM, 2004, ONCOL NURS FORUM, V31, P237, DOI 10.1188/04.ONF.237-247
   Williams MS, 1996, INT J RADIAT ONCOL, V36, P345, DOI 10.1016/S0360-3016(96)00320-3
NR 34
TC 65
Z9 72
U1 0
U2 6
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0936-6555
EI 1433-2981
J9 CLIN ONCOL-UK
JI Clin. Oncol.
PD SEP
PY 2005
VL 17
IS 6
BP 478
EP 484
DI 10.1016/j.clon.2005.04.013
PG 7
WC Oncology
SC Oncology
GA 958QP
UT WOS:000231463100012
PM 16149293
DA 2018-10-20
ER

PT J
AU Oudadesse, H
   Derrien, AC
   Lucas-Girot, A
AF Oudadesse, H
   Derrien, AC
   Lucas-Girot, A
TI Statistical experimental design for studies of porosity and compressive
   strength in composite materials applied as biomaterials
SO EUROPEAN PHYSICAL JOURNAL-APPLIED PHYSICS
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; BONE INGROWTH; PARAMETERS; RESORPTION
AB Composites studied in this work are the associations of aluminosilicates and 13% of calcium phosphates. These composites present great interest. They are destined to be applied in biomedical field, particularly in orthopedic or jawbone surgery. Calcium phosphates are composed of HA ( hydroxyapatite) and TCP (tricalcic phosphate). The success of synthesised bony biomaterials depends on two determinant factors: the porosity ( which facilitate the cells deposition and the vascularisation) and the compressive strength ( which permits the support of body charge). In this way, a statistical experimental design was employed to quantify the influence of these two synthesis parameters. It concerns the effect of the K2O/SiO2 molecular ratio (X-1) and the effect of the calcium phosphate (HA/TCP) weight % (X-2). The K2O/SiO2 molecular ratio characterises the synthesis of the aluminosilicate. It varies between two limit levels: the stoichiometric ratio K2O/SiO2 = 0.54 corresponding to: X-1 = - 1 and the ratio K2O/ SiO2 = 0.80 corresponding to X-1 = 1. In bony biomaterials field, various calcium phosphates are commonly used as biomaterials. In our previous works, the influence of the commercial hydroxyapatite HA and tri-calcium phosphate TCP ( 13 wt%) addition was investigated. To study the effect of calcium phosphate composition, the weight percentage of mixing HA and TCP varied between two levels: the composite aluminosilicate with 13 wt% of HA ( X2 = - 1) and the composite aluminosilicate with 13 wt% of TCP (X-2 = 1). Eight samples were studied. The statistical experimental design predicted answer surfaces for compressive strength and percentage of porosity. After the validation of models, it was possible to determine composite which presents best compromise between percentage of porosity and compressive strength. This composite will be evaluated by "in-vitro" and "in-vivo" studies to investigate its potential for forthcoming applied as biomaterial.
C1 Univ Rennes 1, Inst Chim, CNRS, UMR 6511, F-35042 Rennes, France.
RP Oudadesse, H (reprint author), Univ Rennes 1, Inst Chim, CNRS, UMR 6511, Campus Beaulieu,263 Ave Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Davidovits 6 J., 1988, GEOPOLYMER 88, V88, P25
   DEGROOT K, 1991, CENTENNIAL MEMORIAL, V99, P943
   DERRIEN AC, 2003, J THERM ANAL, V75, P937
   DOEHLERT DH, 1970, APPL STATISTICS, V19, P231
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GOUPY J, 1988, PLANS EXPERIENCES SU
   Jallot E, 1999, EUR PHYS J-APPL PHYS, V6, P205, DOI 10.1051/epjap:1999172
   KOKUBO T, 1991, J CERAM SOC JPN, V99, P665
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   Lucas-Girot A, 2002, BIOMATERIALS, V23, P503, DOI 10.1016/S0142-9612(01)00132-6
   REGI MV, 2001, J CHEM SOC DA, P97
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Zoulgami M, 2002, EUR PHYS J-APPL PHYS, V19, P173, DOI 10.1051/epjap:2002063
NR 18
TC 9
Z9 9
U1 0
U2 5
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 1286-0042
J9 EUR PHYS J-APPL PHYS
JI Eur. Phys. J.-Appl. Phys
PD SEP
PY 2005
VL 31
IS 3
BP 217
EP 223
DI 10.1051/epjap:2005062
PG 7
WC Physics, Applied
SC Physics
GA 964IY
UT WOS:000231875500010
DA 2018-10-20
ER

PT J
AU Wilkinson, JD
   Bounds, C
   Brown, T
   Gerbi, BJ
   Peltier, J
AF Wilkinson, JD
   Bounds, C
   Brown, T
   Gerbi, BJ
   Peltier, J
TI Cancer-radiotherapy equipment as a cause of soft errors in electronic
   equipment
SO IEEE TRANSACTIONS ON DEVICE AND MATERIALS RELIABILITY
LA English
DT Article
DE biomedical applications of radiation; boron; BPSG; integrated circuit
   radiation effects; neutron radiation effects; radiotherapy; single event
   upset; soft errors
AB The undesirable production of secondary neutrons by cancer-radiotherapy linear accelerators (linac) has been demonstrated to cause soft errors in nearby electronics through the B-10 (n, a) Li-7 reaction. B-10 is a component in the BPSG used as a dielectric material in some integrated-circuit (IC) fabrication processes.
C1 Medtronic Inc, Minneapolis, MN 55432 USA.
   Univ Minnesota, Dept Therapeut Radiol, Minneapolis, MN 55455 USA.
RP Wilkinson, JD (reprint author), Medtronic Inc, Minneapolis, MN 55432 USA.
OI , Jeff/0000-0001-6454-0477
CR Baumann R., 1995, P 33 INT REL PHYS S, P297, DOI DOI 10.1109/RELPHY.1995.513695
   BAUMANN R, 1995, P IEEE S VLSI TECHN, P81
   Dirk JD, 2003, IEEE T NUCL SCI, V50, P2060, DOI 10.1109/TNS.2003.821587
   KHAN FM, 2003, PHYS RAD THERAPY, P412
   Kobayashi H., 2002, P INT EL DEV M, P337
   McGinnis Paul, 2002, STUART KINGDOMS 17 C, P70
   POWELL NL, 1987, PHYS MED BIOL, V32, P707, DOI 10.1088/0031-9155/32/6/004
   WILKINSON JD, 2005, P 43 INT REL PHYS S, P692
NR 8
TC 24
Z9 24
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1530-4388
J9 IEEE T DEVICE MAT RE
JI IEEE Trans. Device Mater. Reliab.
PD SEP
PY 2005
VL 5
IS 3
BP 449
EP 451
DI 10.1109/TDMR.2005.858342
PG 3
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 008WD
UT WOS:000235070500017
DA 2018-10-20
ER

PT J
AU Ioan, S
   Lungu, V
   Harabagiu, V
AF Ioan, S
   Lungu, V
   Harabagiu, V
TI Optical properties of poly(vinyl-g-dimethylsiloxane) copolymers
SO INTERNATIONAL JOURNAL OF POLYMER ANALYSIS AND CHARACTERIZATION
LA English
DT Article
DE poly(vinyl-g-dimethylsiloxane) copolymers; refractive index; specific
   refractive index increment
ID REFRACTIVE-INDEX; POLYMER
AB Refractive index is a key criterion in the evaluation of optical polymers. The continuous development of new materials for biomedical applications such as optical fibers or lenses raises questions on the fundamental physical limits of this class of materials. Using the Lorenz-Lorentz equations, we have investigated the theoretical refractive index and specific refractive index increments of some copolymers obtained by radical copolymerization of methyl methacrylate or styrene with allyl methacrylate, followed by the hydrosilation of the resulting copolymers with mono hydro-terminated polydimethylsiloxanes, starting from the refractive increments of the functional groups.
C1 Petru Poni Inst Macromol Chem, RO-6600 Iasi, Romania.
RP Ioan, S (reprint author), Petru Poni Inst Macromol Chem, Aleea Grigore Ghica Voda 41A, RO-6600 Iasi, Romania.
EM sioan@icmpp.tuiasi.ro
CR ARKLES B, 1983, CHEMTECH, V13, P542
   Bischoff R, 1999, PROG POLYM SCI, V24, P185, DOI 10.1016/S0079-6700(99)00006-4
   Dostal J, 1998, J APPL POLYM SCI, V68, P1917, DOI 10.1002/(SICI)1097-4628(19980620)68:12<1917::AID-APP4>3.0.CO;2-O
   GROH W, 1991, MACROMOLECULES, V24, P6660, DOI 10.1021/ma00025a016
   Ioan S, 2002, INT J POLYM ANAL CH, V7, P210, DOI 10.1080/10236660211184
   Lungu V, 1999, REV ROUM CHIM, V44, P811
   Menezo JL, 2001, J REFRACT SURG, V17, P32
   Noll W., 1968, CHEM TECHNOLOGY SILI
   RUTOSKI BN, 1951, PRIKLAD KHIM, V24, P851
   SCHADER D, 1999, POLYM HDB, P91
   Simionescu BC, 1996, POLYM MAT ENCY, V10, P7751
   SVEC F, 1992, ANAL CHEM, V64, P820, DOI 10.1021/ac00031a022
   Van Krevelen D. W., 1972, PROPERTIES POLYM
   Wunderlich W., 1999, POLYM HDB, P87
   YILGOR I, 1988, ADV POLYM SCI, V86, P3
NR 15
TC 2
Z9 2
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1023-666X
J9 INT J POLYM ANAL CH
JI Int. J. Polym. Anal. Charact.
PD SEP-DEC
PY 2005
VL 10
IS 5-6
BP 361
EP 372
DI 10.1080/10236660500479569
PG 12
WC Polymer Science
SC Polymer Science
GA 019XE
UT WOS:000235870700006
DA 2018-10-20
ER

PT J
AU MacEwan, MR
   Brodbeck, WG
   Matsuda, T
   Anderson, JM
AF MacEwan, MR
   Brodbeck, WG
   Matsuda, T
   Anderson, JM
TI Monocyte/lymphocyte interactions and the foreign body response: in vitro
   effects of biomaterial surface chemistry
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 30th Annual Meeting of the Society-for-Biomaterials
CY APR 27-30, 2005
CL Memphis, TN
SP Soc Biomat
DE coculture; biocompatibility; foreign body response; macrophage;
   lymphocyte
ID GIANT-CELL FORMATION; MONOCYTE/MACROPHAGE ADHESION; MACROPHAGE;
   BIOCOMPATIBILITY; MONOCYTES; APOPTOSIS; MIGRATION
AB To determine the effect of biomaterial surface chemistry on leukocyte interaction and activity at the material/tissue interface, human peripheral blood monocytes and lymphocytes were cultured on a series of poly(ethylene terephthalate) (PET)-based biomaterials. Both monocytes and lymphocytes were isolated from whole human blood and separated by a nonadherent density centrifugation method before being plated on PET disks, surface modified by photograft copolymerization to yield hydrophobic, hydrophilic, anionic, and cationic surface properties. Monocytes and lymphocytes were cultured separately, to elicit baseline levels of activity, in direct coculture, to promote direct cell surface interactions, or in an indirect coculture system with both cell types separated by a 0.02-mu m Transwell apparatus, to promote indirect paracrine interactions. Monocyte adhesion, macrophage fusion, and lymphocyte proliferation were measured on days 3, 7, 10, and, 14 of culture. Results demonstrated that the presence of monocytes increased the activity of cocultured lymphocytes at the biomaterial/tissue interface, while the corresponding presence of lymphocytes increased the activation and fusion of indirectly cocultured monocytes. Biomaterial surface chemistry was also found to have a significant effect on monocyte adhesion and activation, and lymphocyte activity. Hydrophilic surfaces significantly inhibited both initial and longterm monocyte adhesion, and inhibited lymphocyte proliferation at longer time points. Anionic and cationic surfaces both exhibited mild inhibition of monocyte adhesion at prolonged time,points, yet evoked different responses in lymphocyte populations. Anionic surfaces increased lymphocyte proliferation at longer time points and increased levels of macrophage fusion, while cationic surfaces decreased levels of lymphocyte proliferation and inhibited monocyte activity. These results elucidate the complex role of juxtacrine and paracrine interactions between monocytes and lymphocytes in the foreign body response, as well as promote the consideration of hydrophilic surfaces in future designs of implantable biomedical devices and prostheses. (c) 2005 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIBIB NIH HHS [EB 00282]
CR ABRAMSON SL, 1990, J IMMUNOL, V144, P625
   ADAMS DO, 1992, INFLAMMATION BASIC P, P637
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   COLDITZ IG, 1992, IMMUNOLOGY, V76, P272
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DEFIFE KM, 1997, J IMMUNOL, V158, P3395
   HENSON PM, 1980, AM J PATHOL, V101, P494
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MCNALLY AK, 1995, AM J PATHOL, V147, P1497
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   NAKAYAMA Y, UNPUB MICROPROCESS F
   Shankar Ravi, 1994, P67
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
NR 30
TC 45
Z9 46
U1 1
U2 18
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2005
VL 74A
IS 3
BP 285
EP 293
DI 10.1002/jbm.a.30316
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 954UG
UT WOS:000231179900001
PM 16124082
DA 2018-10-20
ER

PT J
AU Oliveira, NTC
   Biaggio, SR
   Rocha-Filho, RC
   Bocchi, N
AF Oliveira, NTC
   Biaggio, SR
   Rocha-Filho, RC
   Bocchi, N
TI Electrochemical studies on zirconium and its biocompatible alloys
   Ti-50Zr at.% and Zr-2.5Nb wt.% in simulated physiologic media
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE corrosion; pre-anodization; biocompatible alloys; titanium alloy;
   zirconium alloy
ID ANODIC-OXIDE-FILMS; BIOMEDICAL TITANIUM-ALLOYS; MECHANICAL-PROPERTIES;
   PASSIVE FILMS; IMPEDANCE SPECTROSCOPY; METALLIC BIOMATERIALS; NB
   ELECTRODES; VALVE METALS; ZR ALLOYS; CORROSION
AB Different electrochemical studies were carried out for Zr and its biocompatible alloys Ti-50Zr at.% and Zr-2.5Nb wt.% in solutions simulating physiologic media, Ringer and PBS (phosphate buffered saline) solutions. The results from rest-potential measurements showed that the three materials are spontaneously passivated in both solutions and that the Ti-50Zr alloy has the greatest tendency for spontaneous oxide formation. Some corrosion parameters (such as the pitting and repassivation potentials) were obtained via cyclic voltammetry in both solutions, revealing that the Ti-50Zr has the best corrosion protection while Zr has the worst. On the other hand, the pre-anodization (up to 8 V vs. SCE) of the alloys in a 0.15 mol/L Na2SO4 solution led to a significant improvement in their protection against pitting corrosion when exposed to the Ringer solution. Elemental analyses by EDX showed that during pitting corrosion, there is no preferential corrosion of any of the alloying elements (Zr, Ti, Nb). (c) 2005 Wiley Periodicals, Inc.
C1 Univ Fed Sao Carlos, Dept Quim, BR-13560970 Sao Carlos, SP, Brazil.
RP Biaggio, SR (reprint author), Univ Fed Sao Carlos, Dept Quim, CP 676, BR-13560970 Sao Carlos, SP, Brazil.
EM biaggio@power.ufscar.br
RI Rocha-Filho, Romeu/E-9681-2012; Bocchi, Nerilso/G-6839-2014; Oliveira,
   Nilson/G-4429-2015; Biaggio, Sonia/D-9810-2012
OI Rocha-Filho, Romeu/0000-0003-4699-2423; Bocchi,
   Nerilso/0000-0002-9170-9925; Biaggio, Sonia/0000-0003-2127-859X
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   [Anonymous], 1987, MET HDB, V13, P669
   ASAMI K, 1993, CORROS SCI, V34, P445, DOI 10.1016/0010-938X(93)90116-X
   BADAWY WA, 1989, ELECTROCHIM ACTA, V34, P1711, DOI 10.1016/0013-4686(89)85053-4
   Biaggio SR, 1997, ELECTROCHIM ACTA, V42, P1751, DOI 10.1016/S0013-4686(96)00375-1
   Biaggio SR, 1997, J BRAZIL CHEM SOC, V8, P615, DOI 10.1590/S0103-50531997000600008
   Biehl V, 2001, MATERIALWISS WERKST, V32, P137, DOI 10.1002/1521-4052(200102)32:2<137::AID-MAWE137>3.3.CO;2-Z
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   Crow D. R., 1994, PRINCIPLES APPL ELEC
   Frauchiger L, 1997, APPL SURF SCI, V115, P232, DOI 10.1016/S0169-4332(96)01019-7
   Giannetti B.F., 2003, Port. Electrochim. Acta, V21, P213
   Habazaki H, 2003, ELECTROCHIM ACTA, V48, P3257, DOI 10.1016/S0013-4686(03)00383-9
   HALLEYDEMOULIN I, 1994, MATER SCI FORUM, V157-, P521, DOI 10.4028/www.scientific.net/MSF.157-162.521
   HAMMAD AM, 1992, J NUCL MATER, V186, P166, DOI 10.1016/0022-3115(92)90331-E
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   ITO A, 1995, J BIOMED MATER RES, V29, P893, DOI 10.1002/jbm.820290715
   Kelly E. J., 1982, MOD ASPECT ELECTROC, P319
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Kuroda D., 1995, J BIOMED MATER RES, V29, P943
   LOHRENGEL MM, 1994, ELECTROCHIM ACTA, V39, P1265, DOI 10.1016/0013-4686(94)E0046-3
   MALIK F, 1991, THIN SOLID FILMS, V206, P345, DOI 10.1016/0040-6090(91)90448-7
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Oliveira NTC, 2002, J BRAZIL CHEM SOC, V13, P463, DOI 10.1590/S0103-50532002000400009
   PATRITO EM, 1994, J ELECTROANAL CHEM, V371, P59, DOI 10.1016/0022-0728(93)03226-F
   Piazza S, 1998, CORROS SCI, V40, P1087, DOI 10.1016/S0010-938X(98)00009-2
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Salot R, 1996, J ELECTROCHEM SOC, V143, P3902, DOI 10.1149/1.1837314
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   Yun YH, 1996, J BIOMED MATER RES, V32, P77, DOI 10.1002/(SICI)1097-4636(199609)32:1<77::AID-JBM9>3.0.CO;2-M
NR 37
TC 49
Z9 49
U1 0
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2005
VL 74A
IS 3
BP 397
EP 407
DI 10.1002/jbm.a.30352
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 954UG
UT WOS:000231179900013
PM 15983989
DA 2018-10-20
ER

PT J
AU Gobin, AS
   Froude, VE
   Mathur, AB
AF Gobin, AS
   Froude, VE
   Mathur, AB
TI Structural and mechanical characteristics of silk fibroin and chitosan
   blend scaffolds for tissue regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE silk fibroin; chitosan; tissue engineering scaffolds; tissue
   regeneration; mechanical properties
ID MEMBRANE; CONFORMATION; BIOMATERIALS; METHANOL; GROWTH; FILMS; MICE
AB The expanding field of tissue engineering has required the necessity of developing biomaterials that are tissue compatible, biodegradable, and comparable in mechanical properties to that of native tissue. We propose that the blending of two natural polymers, silk fibroin (SF) and chitosan (CS), into a 3D scaffold will provide unique chemical, structural, and mechanical properties that can be utilized for in vivo tissue regeneration. SF is an attractive material for biomedical applications because it is a fibrous protein that has high permeability to oxygen and water, relatively low thrombogenicity, low inflammatory response, protease susceptibility, supports cell adhesion and growth, and, foremost, high tensile strength with flexibility. CS is a crystalline polysaccharide, with structure similar to glycosaminoglycans, that has good wound healing properties, is nontoxic, and has minimal foreign body reactions. We hypothesized that increasing the SF-to-CS ratio would increase the ultimate tensile strength and elastic modulus and decrease the water capacity of the SFCS scaffolds. With increasing content of silk fibroin, it is observed that the ultimate tensile strength and elastic modulus increase significantly. The ultimate tensile strength and the elastic modulus were significantly higher in the short axis direction for 25:75 and 50:50 SFCS blends as compared to the long axis (p < 0.05), while they were similar for the 75:25 SFCS blend. However, no differences were observed in the strain at failure among blends or due to directionality of applied strain. Increasing the chitosan content resulted in an increased water capacity of SFCS blends. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Texas, MD Anderson Canc Ctr, Dept Plast Surg, Houston, TX 77230 USA.
   Univ Oklahoma, Chem Biol & Mat Engn Dept, Norman, OK 73019 USA.
RP Mathur, AB (reprint author), Univ Texas, MD Anderson Canc Ctr, Dept Plast Surg, Unit 602,POB 301402, Houston, TX 77230 USA.
EM amathur@mdanderson.org
OI Mathur, Anshu/0000-0002-6689-5906
CR Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Cooper GM, 2000, CELL MOL APPROACH
   DEMURA M, 1989, J BIOTECHNOL, V10, P113, DOI 10.1016/0168-1656(89)90033-3
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Kato Yoshinori, 2003, Current Pharmaceutical Biotechnology, V4, P303, DOI 10.2174/1389201033489748
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Kweon HY, 2001, POLYMER, V42, P6651, DOI 10.1016/S0032-3861(01)00104-5
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   TSUKADA M, 1995, J POLYM SCI POL PHYS, V33, P1995, DOI 10.1002/polb.1995.090331402
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 25
TC 96
Z9 109
U1 0
U2 45
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2005
VL 74A
IS 3
BP 465
EP 473
DI 10.1002/jbm.a.30382
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 954UG
UT WOS:000231179900021
PM 15983992
DA 2018-10-20
ER

PT J
AU Vitale-Brovarone, C
   Verne, E
AF Vitale-Brovarone, C
   Verne, E
TI SiO2-CaO-K2O coatings on alumina and Ti6Al4V substrates for biomedical
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PLASMA SPRAY DEPOSITION; BIOACTIVE GLASS-CERAMICS; SIMULATED BODY-FLUID;
   NA2O-CAO-SIO2 GLASSES; MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; SURFACE;
   BIOCERAMICS; CHEMISTRY
AB Alumina and Ti6Al4V alloys are widely used for orthopedics and dental applications due to their good mechanical properties and biocompatibility. Unfortunately they can not provide a satisfactory osteointegration when implanted. In fact, both alumina and Ti6Al4V are not bioactive and thus they can only guarantee a morphological fixation with the surrounding tissues without a suitable chemical anchorage. Aiming to impart bioactive properties to these materials a coating can be proposed. At this purpose, a bioactive glass belonging to the SiO2-CaO-K2O system was selected and prepared. This glass, named SCK, possess a thermal expansion coefficient matching with the alumina (8.5 x 10(-6)/degrees C) and T16Al4V (9 x 10(-6)/degrees C) ones and thus is a good candidate to produce coatings on both of them. Simple and low-cost enameling and glazing techniques were used to realize the coatings. Structural, morphological and compositional characterizations of the coatings were carried out by means of X-ray diffraction, optical and scanning microscopy and compositional analyses. The in vitro properties of the coatings were investigated by soaking them in a simulated body fluid (SBF) in order to study the precipitation, on their surfaces, of a biologically active layer of hydroxylapatite (HAp). (C) 2005 Springer Science + Business Media, Inc.
C1 Politecn Torino, Dept Mat Sci & Chem Engn, I-10129 Turin, Italy.
RP Vitale-Brovarone, C (reprint author), Politecn Torino, Dept Mat Sci & Chem Engn, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
EM chiara.vitale@polito.it
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Verne,
   Enrica/0000-0002-8649-4739
CR Branda F, 2002, BIOMATERIALS, V23, P711, DOI 10.1016/S0142-9612(01)00173-9
   Brovarone CV, 2001, J EUR CERAM SOC, V21, P2855
   BROVARONE CV, 2001, KEY ENG MATER, V192, P123
   BROVARONE CV, 2002, 7 M C CER CELLS TISS, P137
   DONALD IW, 1993, J MATER SCI, V28, P2841, DOI 10.1007/BF00354689
   Ferraris M, 1996, J AM CERAM SOC, V79, P1515, DOI 10.1111/j.1151-2916.1996.tb08759.x
   FERRARIS M, 1996, BIOCERAMIC COATINGS, P31
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   Gomez-Vega JM, 1999, J BIOMED MATER RES, V46, P549, DOI 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
   Hench L., 1993, ADV SERIES CERAMICS, P41
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1993, INTRO BIOCERAMICS, V1, P261
   Hulbert S. F., 1993, INTRO BIOCERAMICS, V1, P25
   Jana C., 1995, ADV SCI TECHNOLOGY, V12, P257
   Kim CY, 2003, J EUR CERAM SOC, V23, P1803, DOI 10.1016/S0955-2219(02)00444-2
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   Kweh SWK, 2000, BIOMATERIALS, V21, P1223, DOI 10.1016/S0142-9612(99)00275-6
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mardare CC, 2003, J EUR CERAM SOC, V23, P1027, DOI 10.1016/S0955-2219(02)00278-9
   MCMILLAN PW, 1979, PROPERTIES GLASS CER, P225
   Morey G., 1930, J SOC GLASS TECHNOL, V14, P158
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   OHTSUKI C, 1995, J CERAM SOC JPN, V103, P449, DOI 10.2109/jcersj.103.449
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   Pazo A, 1998, ACTA MATER, V46, P2551, DOI 10.1016/S1359-6454(98)80039-6
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   RAVAGLIOLI A, 1992, INTERCERAM, V41, P41
   SCHROEDER A, 1991, ORAL IMPLANTOLOGY, P37
   Sohmura T, 2001, J BIOMED MATER RES, V58, P478, DOI 10.1002/jbm.1044
   THAIN ES, 2001, BIOMAT, V22, P1225
   VEGA JMG, 2000, BIOMAT, V21, P105
   Verne E, 1998, J EUR CERAM SOC, V18, P363, DOI 10.1016/S0955-2219(97)00134-9
   Verne E, 2000, J EUR CERAM SOC, V20, P473, DOI 10.1016/S0955-2219(99)00181-8
   Verne E, 2002, BIOMATERIALS, V23, P3395, DOI 10.1016/S0142-9612(02)00040-6
   Verne E, 2000, ACTA MATER, V48, P4667, DOI 10.1016/S1359-6454(00)00255-X
   VERNE E, 1999, BIOCERAMICS, V12, P491
   Yamashita K, 1998, J BIOMED MATER RES, V43, P46, DOI 10.1002/(SICI)1097-4636(199821)43:1<46::AID-JBM5>3.0.CO;2-M
NR 42
TC 14
Z9 14
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2005
VL 16
IS 9
BP 863
EP 871
DI 10.1007/s10856-005-3583-4
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 961PB
UT WOS:000231673200011
PM 16167116
DA 2018-10-20
ER

PT J
AU Vargun, E
   Usanmaz, A
AF Vargun, E
   Usanmaz, A
TI Polymerization of 2-hydroxyethyl acrylate in bulk and solution by
   chemical initiator and by ATRP method
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE 2-hydroxyethyl acrylate; bulk polymerization; solution polymerization;
   ATRP; activation energy; polymer characterization
ID DENTAL BASE MATERIAL; MECHANICAL-PROPERTIES; CONTROLLED-RELEASE;
   HYDROGELS; MICROWAVE
AB In this study, 2-hydroxyethyl acrylate (HEA) was polymerized to obtain polymers that can be used as hydrogel and copolymerized for biomedical applications. Bulk, solution, and atom transfer radical polymerization (ATRP) techniques at different temperatures were applied. The polymerization in bulk form was carried out in vacuum and in open atmosphere. The polymerization curves showed autoacceleration mechanism and the limiting conversion was 100%. The polymers obtained were insoluable in most common solvents because of high molecular weights and strong intermolecular hydrogen bonding. They absorb more than 30% (w/w) water as hydrogel. To decrease the molecular weight and obtain soluble polymers, HEA was polymerized in solution by ATRP method, which also gave insoluble hydrogel type polymers. The activation energy for bulk polymerization was 155.8 kJ/mol, which is very high for a free radical polymerization. This is due to the high degree of intermolecular hydrogen bonding, which was also supported by FTIR and TGA analysis. The polymers were characterized by FT-IR, DSC, TGA, and H-1 NMR techniques. (c) 2005 Wiley Periodicals, Inc.
C1 Middle E Tech Univ, Dept Chem, TR-06531 Ankara, Turkey.
RP Usanmaz, A (reprint author), Middle E Tech Univ, Dept Chem, TR-06531 Ankara, Turkey.
EM usanmaz@metu.edu.tr
CR CALICETI P, 1992, FARMACO, V47, P275
   Coca S, 1998, J POLYM SCI POL CHEM, V36, P1417, DOI 10.1002/(SICI)1099-0518(19980715)36:9<1417::AID-POLA9>3.0.CO;2-P
   Degiorgi CF, 2002, RADIAT PHYS CHEM, V63, P109, DOI 10.1016/S0969-806X(01)00490-X
   FRIED JR, 2003, POLYM SCI TECHNOL, P179
   GOCHBERG DE, 1988, J MAGN RESON, V131, P191
   Guan JJ, 2000, J APPL POLYM SCI, V77, P2505, DOI 10.1002/1097-4628(20000912)77:11<2505::AID-APP20>3.3.CO;2-L
   Inukai M, 2000, CHEM PHARM BULL, V48, P850
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Muchlebach A., 1998, MACROMOLECULES, V31, P6046
   Muhtarogullari IY, 1999, J APPL POLYM SCI, V74, P2971, DOI 10.1002/1097-4628(19991213)74:12<2971::AID-APP24>3.0.CO;2-Q
   Pradas MM, 2001, COLLOID POLYM SCI, V279, P323, DOI 10.1007/s003960000426
   Rault J, 1997, MACROMOLECULES, V30, P7866, DOI 10.1021/ma970344i
   USANMAZ A, 1989, BRIT POLYM J, V21, P71, DOI 10.1002/pi.4980210112
   USANMAZ A, 1986, J POLYM SCI POL CHEM, V24, P3263, DOI 10.1002/pola.1986.080241210
   Usanmaz A, 2003, J APPL POLYM SCI, V90, P251, DOI [10.1002/app.12681, 10.1002/app/.12681]
   USANMAZ A, 1986, EUR POLYM J, V22, P657, DOI 10.1016/0014-3057(86)90165-5
NR 16
TC 40
Z9 42
U1 2
U2 30
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD SEP 1
PY 2005
VL 43
IS 17
BP 3957
EP 3965
DI 10.1002/pola.20867
PG 9
WC Polymer Science
SC Polymer Science
GA 957KW
UT WOS:000231369700024
DA 2018-10-20
ER

PT J
AU Huang, V
   Munarriz, R
   Goldstein, I
AF Huang, V
   Munarriz, R
   Goldstein, I
TI Bicycle riding and erectile dysfunction: An increase in interest (and
   concern)
SO JOURNAL OF SEXUAL MEDICINE
LA English
DT Article
DE bicycling; erectile dysfunction; impotence; penile numbness
ID PENILE OXYGEN-PRESSURE; PUDENDAL NERVE; BLOOD-FLOW; IMPOTENCE; INJURIES;
   PERINEAL; TRAUMA; NUMBNESS; CYCLISTS
AB Introduction. From 1999 to 2004, there had been 21 publications from multiple medical specialties (sexual medicine, urology, neurology, cardiology, biomedical engineering, sports medicine, emergency medicine, and officials from the National Institute for Safety and Occupational Health) investigating the relationship between bicycle riding and erectile dysfunction (ED). In the previous 18 years, there have been 14 such studies.
   Aim. The primary aim was to summarize accumulating data on the safety of bicycle riding based on medical evidence categorized by levels of evidence, including case reports, observational studies, case control studies, mechanistic studies, and population-based epidemiologic investigations. The secondary aim was to address the concerns of bicyclists and propose measures to minimize the risk of ED associated with bicycle riding.
   Methods. An English-language medical literature review was made of publications in peer review journals from 1981 to 2004, including published abstract presentations at major medical meetings.
   Main Outcome Measure. Ranked published epidemiologic data on bicycle riding and ED.
   Results. Bicycle riding more than 3 hours per week was an independent relative risk (RR = 1. 72) for moderate to severe ED. In case control studies, the prevalence of moderate to severe ED in bicyclists was 4.2% and 4% vs. age-matched runners 1.1% (P <= 0.018) and swimmers 2% (P= 0.05), respectively. Therefore, bicycle riders should take precautionary measures to minimize the risk of ED associated with bicycle riding: change the bicycle saddle with a protruding nose to a noseless seat, change the posture to a more upright/reclining position, change the material of the saddle (GEL), and tilt the saddle/seat downwards.
   Conclusions. The mechanism is hypothetically related to the rider interaction with the bicycle saddle at the perineum-saddle interface. Straddling bicycle saddles with a nose extension is associated with suprasystolic perineal compression pressures, temporarily occluding penile perfusion and potentially inducing endothelial injury and vasculogenic ED.
C1 Boston Univ, Sch Med, Inst Sexual Med, Dept Urol, Boston, MA 02118 USA.
RP Munarriz, R (reprint author), Boston Univ, Sch Med, Inst Sexual Med, Dept Urol, 720 Harrison Ave,Suite 600, Boston, MA 02118 USA.
EM munarriz@bu.edu
CR Andersen KV, 1997, ACTA NEUROL SCAND, V95, P233, DOI 10.1111/j.1600-0404.1997.tb00104.x
   BRODERICK GA, 1999, 94 ANN M AM UR ASS M
   DESAI KM, 1989, BRIT MED J, V298, P1072, DOI 10.1136/bmj.298.6680.1072
   Dettori JR, 2004, J UROLOGY, V172, P637, DOI 10.1097/01.ju.0000130749.37731.9f
   GODSON JD, 1981, NEW ENGL J MED, V304, P365
   GRUNBAUM A, 2002, IJIR, V14, pS50
   Jeong SJ, 2002, INT J IMPOT RES, V14, P513, DOI 10.1038/sj.ijir.3900929
   JONES WHS, 1923, HIPPOCRATES ENGLISH, V1, P125
   KERSTEIN MD, 1982, J UROLOGY, V127, P57, DOI 10.1016/S0022-5347(17)53601-0
   LASALLE MD, 1999, 94 ANN M AM UR ASS M
   LEVINE FJ, 1990, J UROLOGY, V144, P1147, DOI 10.1016/S0022-5347(17)39678-7
   Lowe BD, 2004, MED SCI SPORT EXER, V36, P1055, DOI 10.1249/01.MSS.0000128248.40501.73
   Marceau L, 2001, INT J IMPOT RES, V13, P298, DOI 10.1038/sj.ijir.3900733
   MELLION MB, 1991, SPORTS MED, V11, P52, DOI 10.2165/00007256-199111010-00004
   MORRIS JN, 1990, BRIT HEART J, V63, P325
   Munarriz R, 2005, J SEX MED, V2, P612, DOI 10.1111/j.1743-6109.2005.00089.x
   MUNARRIZ RM, 1995, J UROLOGY, V153, P1831, DOI 10.1016/S0022-5347(01)67324-5
   MYERS J, 2003, EXERCISE CARDIOVASCU
   Nayal W, 1999, BJU INT, V83, P623
   OBERPENNING F, 1994, J UROLOGY, V151, P423, DOI 10.1016/S0022-5347(17)34970-4
   OBRIEN KP, 1981, NEW ENGL J MED, V304, P1367
   RENZULLI JF, 1999, 94 ANN M AM UR ASS M
   Ricchiuti VS, 1999, J UROLOGY, V162, P2099, DOI 10.1016/S0022-5347(05)68116-5
   RONADO R, 2002, P 20 INT S BIOM SPOR, P606
   SALIMPOUR P, 1998, 93 ANN M AM UR ASS M
   Schrader SM, 2002, J ANDROL, V23, P927
   Schwarzer U, 2002, EUR UROL, V41, P139, DOI 10.1016/S0302-2838(01)00028-8
   SCHWARZER U, 1999, 94 ANN M AM UR ASS M
   Silbert P L, 1991, Clin Exp Neurol, V28, P191
   SOLOMON S, 1987, POSTGRAD MED, V81, P99, DOI 10.1080/00325481.1987.11699662
   Sommer F, 2001, INT J SPORTS MED, V22, P410, DOI 10.1055/s-2001-16248
   Sommer F, 2001, EUR UROL, V39, P720, DOI 10.1159/000052533
   Spears IR, 2003, MED SCI SPORT EXER, V35, P1620, DOI 10.1249/01.MSS.0000084559.35162.73
   *SPORT GOODS MAN A, SGMA REP SPORTS PART
   Taylor KS, 2002, PHYSICIAN SPORTSMED, V30, P27, DOI 10.3810/psm.2002.05.283
   TAYLOR KS, 2002, PHYSICIAN SPORTSMED, V30, P32
   TAYLOR KS, 2002, PHYSICIAN SPORTSMED, V30, P34
   Thompson MJ, 2001, AM FAM PHYSICIAN, V63, P2007
   WEISS BD, 1994, CLIN SPORT MED, V13, P175
   WEISS BD, 1985, AM J SPORT MED, V13, P187, DOI 10.1177/036354658501300308
   *WI PARTN CLEAN AR, AIR QUAL INF
   Xu QB, 2004, AM J PATHOL, V165, P1, DOI 10.1016/S0002-9440(10)63270-1
   YAN Q N R, 1992, Journal of Urology, V147, p368A
NR 43
TC 24
Z9 25
U1 1
U2 11
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1743-6095
J9 J SEX MED
JI J. Sex. Med.
PD SEP
PY 2005
VL 2
IS 5
BP 596
EP 604
DI 10.1111/j.1743-6109.2005.00099.x
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA 961UU
UT WOS:000231688100003
PM 16422816
DA 2018-10-20
ER

PT J
AU Di Landro, L
   Capone, C
   Inzoli, F
   Malacari, PE
AF Di Landro, L
   Capone, C
   Inzoli, F
   Malacari, PE
TI Coextruded PVC tubes for biomedical application
SO JOURNAL OF VINYL & ADDITIVE TECHNOLOGY
LA English
DT Article
ID DI-(2-ETHYLHEXYL) PHTHALATE; DI(2-ETHYLHEXYL)PHTHALATE
AB The use of PVC in biomedical applications is often questioned, owing to the possible adverse effects that this material may have on human health. Blood is transported in dialysis devices through flexible plastic tubes that are usually made of PVC. The most common plasticizer, even for such biomedical applications, is dioctyl phthalate (DOP). It improves the processability of the blend, thus reducing the viscosity, and improves the characteristics of the product by increasing its flexibility at low temperatures. However, the DOP migration to the tube surface may cause thrombogenic reactions, and for this reason, the medical use of PVC implies the addition of heparin to blood as an anticoagulant and is, however, limited to short-term applications. In this work the production of coextruded PVC tubes was explored. These two-layer tubes are characterized by an internal layer, in contact with the patient blood, which has a DOP content distinctly lower than that of the external layer. This difference can reduce the amount of released plasticizer harmful to the organism. On the other hand, the inner layer reduces the overall mechanical flexibility of the tube. A complete characterization, therefore, was carried out in order to evidence the advantages and drawbacks of such products. Extraction tests were conducted to evaluate the release rate of PVC in comparison to that of traditional tubes. Thermal and rheological analyses were performed to estimate material processability. Mechanical and dynamic-mechanical testing were done to determine performance. The results showed that the biocompatibility characteristics are significantly improved, while keeping acceptable levels of mechanical properties and of additional product cost.
C1 Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, I-20133 Milan, Italy.
   Politecn Milan, Dipartimento Energet, I-20133 Milan, Italy.
   Sis Ter SpA, Pignano, CR, Italy.
RP Di Landro, L (reprint author), Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
EM luca.dilandro@polimi.it
RI Di Landro, Luca/F-1021-2012
OI Di Landro, Luca/0000-0001-6649-2149; Inzoli, Fabio/0000-0003-0799-3458
CR *AG TOX SUBS DIS R, 1993, TOX PROF DI 2 ETH PH
   AHMED RS, 1980, FOOD CHEM TOXICOL, V28, P427
   BROOKMAN R, 1998, MED PLASTICS BIOMATE, V7, P24
   *CTR DEV RAD HLTH, 2001, SAF ASS DI 2 ETH DEH
   Davis AK, 2002, SOUTHEAST NAT, V1, P55, DOI 10.1656/1528-7092(2002)001[0055:AEOTMO]2.0.CO;2
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200
   *GOV ACC OFF, 2004, GAO04450
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302
   KARAGIANNIS A, 1988, POLYM ENG SCI, V28, P982, DOI 10.1002/pen.760281507
   KRAUSKOPF LG, 1993, HDB PVC FORMULATING
   Kurata Y, 1998, TOXICOL SCI, V42, P49
   Lakshmi S, 1998, ARTIF ORGANS, V22, P222, DOI 10.1046/j.1525-1594.1998.06124.x
   SEARS JK, 1992, ENCYCLOPEDIA
   THOMAS JA, 1984, CRC CR REV TOXICOL, V13, P283, DOI 10.3109/10408448409023761
   Yianni J P, 1995, Med Device Technol, V6, P20
NR 15
TC 8
Z9 8
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1083-5601
J9 J VINYL ADDIT TECHN
JI J. Vinyl Addit. Technol.
PD SEP
PY 2005
VL 11
IS 3
BP 111
EP 118
DI 10.1002/vnl.20046
PG 8
WC Chemistry, Applied; Materials Science, Textiles; Polymer Science
SC Chemistry; Materials Science; Polymer Science
GA 965NU
UT WOS:000231958200005
DA 2018-10-20
ER

PT J
AU Meglinski, IV
   Varejka, M
   Woodman, AC
   Turner, APF
   Piletsky, SA
AF Meglinski, IV
   Varejka, M
   Woodman, AC
   Turner, APF
   Piletsky, SA
TI Laser ice scaffolds modeling for tissue engineering
SO LASER PHYSICS LETTERS
LA English
DT Article
DE tissue engineering; ice scaffolds modeling; laser ice welding
ID SEA-ICE; KEYHOLE; DESIGN
AB Tissue engineering is one of the most exciting and rapidly growing areas in biomedical engineering that offers vast potential for changing traditional approaches to meeting many pharmaceutics and critical health care needs. Currently the bottle-neck area in this multidisciplmiary field appears to be materials and fabrication technology for the design of artificial extracellular matrices/scaffolds that support culturing and growth of new tissue. We have shown that stable relief structures can be created and maintained in the bulk of ice by continuous s canning with computer-guided IR CO2 laser. The optimal laser beam intensity and fluence rate distribution within the ice sample, as well as the rate of scanning were estimated based on the Monte Carlo model utilized physical/optical properties of ice. The results of numerical simulation are agreed well with the observed experimental results of thermo-coupling measurements and obtained microscopic images.
C1 Cranfield Univ, Sch Engn, Cranfield MK43 0AL, Beds, England.
   Cranfield Univ, Inst Biosci & Technol, Silsoe MK45 4DT, Beds, England.
RP Meglinski, IV (reprint author), Cranfield Univ, Sch Engn, Cranfield MK43 0AL, Beds, England.
EM i.meglinski@cranfield.ac.uk
RI Meglinski, Igor/J-2028-2012
OI Meglinski, Igor/0000-0002-7613-8191; Turner,
   Anthony/0000-0002-1815-9699; Piletsky, Sergey/0000-0003-2052-5763
CR Churmakov DY, 2002, PHYS MED BIOL, V47, P4271, DOI 10.1088/0031-9155/47/23/312
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jezek KC, 1998, IEEE T GEOSCI REMOTE, V36, P1633, DOI 10.1109/36.718635
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Matsunawa A, 1997, J PHYS D APPL PHYS, V30, P798, DOI 10.1088/0022-3727/30/5/013
   Meglinski IV, 2003, LASER PHYS, V13, P65
   Onstott RG, 1998, IEEE T GEOSCI REMOTE, V36, P1764, DOI 10.1109/36.718644
   Pham DT, 1998, INT J MACH TOOL MANU, V38, P1257, DOI 10.1016/S0890-6955(97)00137-5
   Rimell JT, 2000, J BIOMED MATER RES, V53, P414, DOI 10.1002/1097-4636(2000)53:4<414::AID-JBM16>3.0.CO;2-M
   Semak VV, 1999, J PHYS D APPL PHYS, V32, pL61, DOI 10.1088/0022-3727/32/15/103
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   2002, TRENDS TISSUE ENG
NR 13
TC 2
Z9 2
U1 0
U2 3
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1612-2011
EI 1612-202X
J9 LASER PHYS LETT
JI Laser Phys. Lett.
PD SEP
PY 2005
VL 2
IS 9
BP 465
EP 467
DI 10.1002/lapl.200510017
PG 3
WC Optics; Physics, Applied
SC Optics; Physics
GA 963FL
UT WOS:000231789100008
DA 2018-10-20
ER

PT J
AU Dalsin, JL
   Messersmith, PB
AF Dalsin, Jeffrey L.
   Messersmith, Phillip B.
TI Bioinspired antifouling polymers
SO MATERIALS TODAY
LA English
DT Review
AB Controlling biointerfacial phenomena is crucial to the success of many biomedical technologies. For applications in biosensing, diagnostics, and medical devices, precise control of interactions between material surfaces and the biological milieu is an important but elusive goal(1). Emerging strategies for manipulating the biological response to medical materials seek to take advantage of specific interactions between designed surfaces, biomolecules, and cells(2). Limiting nonspecific interaction of cells, proteins, and microorganisms with material surfaces is critical, since these interactions can prove highly problematic for device efficacy and safety. Thus, a central research focus continues to be the development of versatile, convenient, and cost-effective strategies for rendering surfaces resistant to fouling by proteins, cells, and bacteria.
C1 [Dalsin, Jeffrey L.; Messersmith, Phillip B.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Messersmith, PB (reprint author), Northwestern Univ, Dept Biomed Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA.
EM philm@northwestern.edu
RI Messersmith, Phillip/F-3433-2013
OI Messersmith, Phillip/0000-0002-1197-333X
FU US National Institutes of Health [DE 14193]; US National Aeronautics and
   Space Administration [NCC-1-02037]
FX The authors are grateful for support for this research from the US
   National Institutes of Health (DE 14193) and the US National Aeronautics
   and Space Administration (NCC-1-02037).
CR Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004
   BAIN CD, 1988, SCIENCE, V240, P62, DOI 10.1126/science.240.4848.62
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   Brunette D. M., 2001, TITANIUM MED, P1019
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Caldwell KD, 1997, ACS SYM SER, V680, P400
   Chen LX, 2002, J PHYS CHEM B, V106, P8539, DOI 10.1021/jp025544x
   Chirdon WM, 2003, J BIOMED MATER RES B, V66B, P532, DOI 10.1002/jbm.b.10041
   CONNOR PA, 1995, LANGMUIR, V11, P4193, DOI 10.1021/la00011a003
   CRISP DJ, 1985, J COLLOID INTERF SCI, V104, P40, DOI 10.1016/0021-9797(85)90007-4
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Falconnet D, 2004, ADV FUNCT MATER, V14, P749, DOI 10.1002/adfm.200305182
   Fan X., 2005, POLYM PREPR, V46, P442
   Fant C, 2000, BIOFOULING, V16, P119, DOI 10.1080/08927010009378437
   Floriolli RY, 2000, MAR BIOTECHNOL, V2, P352
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   Haemers S, 2003, BIOMACROMOLECULES, V4, P632, DOI 10.1021/bm025707n
   Han S, 1997, POLYMER, V38, P317, DOI 10.1016/S0032-3861(97)88175-X
   HARRIS JM, 1997, POLYETHYLENE GLYCOL, P489
   Holland NB, 1998, NATURE, V392, P799
   Holmberg K, 1997, COLLOID SURFACE A, V123, P297, DOI 10.1016/S0927-7757(96)03810-1
   Huang K, 2002, BIOMACROMOLECULES, V3, P397, DOI 10.1021/bm015650p
   Inoue K, 1996, EUR J BIOCHEM, V239, P172, DOI 10.1111/j.1432-1033.1996.0172u.x
   Inoue K, 1995, BIOL BULL, V189, P370, DOI 10.2307/1542155
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kirshenbaum K, 1998, P NATL ACAD SCI USA, V95, P4303, DOI 10.1073/pnas.95.8.4303
   LAIBINIS PE, 1989, SCIENCE, V245, P845, DOI 10.1126/science.245.4920.845
   Lee BP, 2004, J BIOMAT SCI-POLYM E, V15, P449, DOI 10.1163/156856204323005307
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   Maugh K. J., 1993, US patent, Patent No. [5,242,808,, 5242808]
   MERRILL EW, 1987, ANN NY ACAD SCI, V516, P196, DOI 10.1111/j.1749-6632.1987.tb33041.x
   Miki D, 1996, BIOL BULL, V190, P213, DOI 10.2307/1542541
   MILLER SM, 1995, DRUG DEVELOP RES, V35, P20, DOI 10.1002/ddr.430350105
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   Mrksich M, 1997, ACS SYM SER, V680, P361
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   OLIVIERI MP, 1990, J ADHES SCI TECHNOL, V4, P197, DOI 10.1163/156856190X00216
   Ooka AA, 2000, BIOPOLYMERS, V57, P92
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y
   Patch JA, 2002, CURR OPIN CHEM BIOL, V6, P872, DOI 10.1016/S1367-5931(02)00385-X
   Qin XX, 1998, P NATL ACAD SCI USA, V95, P10517, DOI 10.1073/pnas.95.18.10517
   Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623
   Rajh T, 2002, J PHYS CHEM B, V106, P10543, DOI 10.1021/jp021235v
   Rajh T, 2004, NANO LETT, V4, P1017, DOI 10.1021/nl049684p
   Ratner B. D, 2000, TITANIUM MED MAT SCI, P1
   Rice CR, 2000, NEW J CHEM, V24, P651, DOI 10.1039/b003823g
   Rodriguez R, 1996, J COLLOID INTERF SCI, V177, P122, DOI 10.1006/jcis.1996.0012
   Ruegsegger MA, 2001, J BIOMED MATER RES, V56, P159, DOI 10.1002/1097-4636(200108)56:2<159::AID-JBM1080>3.0.CO;2-R
   RZEPECKI LM, 1992, BIOL BULL, V183, P123, DOI 10.2307/1542413
   Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347
   Schoenfisch MH, 1998, J AM CHEM SOC, V120, P4502, DOI 10.1021/ja974301t
   Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759
   Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797
   SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tanaka M, 2002, COLLOID SURFACE A, V203, P195, DOI 10.1016/S0927-7757(01)01100-1
   Tanaka M, 2001, COLLOID SURFACE A, V193, P145, DOI 10.1016/S0927-7757(01)00682-3
   TARLOV MJ, 1992, LANGMUIR, V8, P1398, DOI 10.1021/la00041a026
   TAYLOR SW, 1994, INORG CHEM, V33, P5819, DOI 10.1021/ic00103a032
   TAYLOR SW, 1994, J AM CHEM SOC, V116, P10803, DOI 10.1021/ja00102a063
   Terada S, 1997, J RECONSTR MICROSURG, V13, P9, DOI 10.1055/s-2008-1063935
   WAITE JH, 1980, BIOCHEM BIOPH RES CO, V96, P1554, DOI 10.1016/0006-291X(80)91351-0
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
   WAITE JH, 1987, CHEMTECH, V17, P692
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   WAITE JH, 1992, BIOL BULL, V183, P178, DOI 10.2307/1542421
   WAITE JH, 1991, CHEM IND-LONDON, P607
   Warner SC, 1999, MAR BIOL, V134, P729, DOI 10.1007/s002270050589
   Weaver J. L., 1998, THESIS U DELAWARE
   Willis SL, 2001, BIOMATERIALS, V22, P3261, DOI 10.1016/S0142-9612(01)00164-8
   Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802
   Yamamoto H, 1996, BIOTECHNOL GENET ENG, V13, P133, DOI 10.1080/02648725.1996.10647926
   YAMAMOTO H, 1976, MACROMOLECULES, V9, P532, DOI 10.1021/ma60051a029
   Young G. A., 1982, ADHESION, V6, P279
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
   Zhang F, 2001, J BIOMED MATER RES, V56, P324, DOI 10.1002/1097-4636(20010905)56:3<324::AID-JBM1100>3.0.CO;2-P
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   ZHANG TH, 1994, MACROMOLECULES, V27, P7302, DOI 10.1021/ma00103a011
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
   ZUCKERMANN RN, 1992, J AM CHEM SOC, V114, P10646, DOI 10.1021/ja00052a076
NR 94
TC 128
Z9 133
U1 4
U2 77
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD SEP
PY 2005
VL 8
IS 9
BP 38
EP 46
DI 10.1016/S1369-7021(05)71079-8
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA V32DX
UT WOS:000208933000022
OA Other Gold
DA 2018-10-20
ER

PT J
AU Barnes, LL
AF Barnes, LL
TI American acupuncture and efficacy: Meanings and their points of
   insertion
SO MEDICAL ANTHROPOLOGY QUARTERLY
LA English
DT Article
DE acupuncture; efficacy; traditional medicine; religious healing;
   complementary and alternative medicine
ID ALTERNATIVE MEDICINE; UNITED-STATES; CONTROLLED-TRIAL; BREAST-CANCER;
   PLACEBO; COMPLEMENTARY; PERFORMANCE; BLIND
AB By its very definition, efficacy's meanings remain fluid, their particularities contingent on context. The change seen as significant may occur on a symbolic level or through the removal of physical symptoms. It may address conditions of a social body. Some discussions differentiate between "healing" and "curing." Many of these meanings surface when examining what efficacy means in the practice of acupuncture in the United States. This complex phenomenon is possible largely because acupuncture draws on the qi paradigm on the one hand, allowing for the most ephemeral dimensions of experience to be included in considerations of efficacy. On the other hand, in the most material sense, acupuncture is also susceptible to being conceptualized as a device, independent of that same paradigm, allowing for the insertion of biomedical models and criteria. Pluralism within acupuncture itself intersects with, and even embodies, the medical pluralism of U.S. culture.
C1 Boston Univ, Sch Med, Boston, MA 02215 USA.
RP Barnes, LL (reprint author), Boston Univ, Sch Med, Boston, MA 02215 USA.
CR Adler SR, 1999, MED ANTHROPOL Q, V13, P214, DOI 10.1525/maq.1999.13.2.214
   AHERN EM, 1979, MAN, V14, P1, DOI 10.2307/2801637
   Anderson R., 1992, ANTHR APPROACHES STU, P3
   Armstrong Terri S, 2003, Oncol Nurs Forum, V30, P601, DOI 10.1188/03.ONF.601-606
   Astin JA, 1998, ARCH INTERN MED, V158, P2303, DOI 10.1001/archinte.158.21.2303
   Baer H. A., 2001, BIOMEDICINE ALTERNAT
   Baer H. A., 2004, INTEGRATIVE MED MERG
   Baer HA, 2002, MED ANTHROPOL Q, V16, P403, DOI 10.1525/maq.2002.16.4.403
   Barnes L L, 2005, NEEDLES HERBS GODS G
   Barnes Linda L, 2003, Med Anthropol, V22, P261, DOI 10.1080/01459740306772
   Barnes Linda L., 2005, RELIG HEALING AM, P307
   Barnes LL, 1998, CULT MED PSYCHIAT, V22, P413, DOI 10.1023/A:1005403825213
   Bateson G., 1979, MIND NATURE NECESSAR
   Beinfield H, 2002, ALTERN THER HEALTH M, V8, P40
   BEINFIELD H, 1997, ACUPUNCTURE PRACTICE, P439
   Benson H., 1996, TIMELESS HEALING POW
   BOURGUIGNON E, 1970, OVERVIEWS, V13, P5
   Brewin TB, 1996, J ROY COLL PHYS LOND, V30, P406
   Bullinger M, 2004, HAEMOPHILIA, V10, P9, DOI 10.1111/j.1355-0691.2004.00874.x
   Cherkin Daniel C, 2002, J Am Board Fam Pract, V15, P378
   CROSS F, 1983, OXFORD ENGLISH DICT, P1291
   CSORDAS T J, 1988, Medical Anthropology Quarterly, V2, P121, DOI 10.1525/maq.1988.2.2.02a00030
   Csordas T. J., 1998, TRANSCULT PSYCHIATRY, V35, P435
   Csordas TJ, 2004, CULT MED PSYCHIAT, V28, P1, DOI 10.1023/B:MEDI.0000018095.54422.66
   Cunningham A., 1997, W MED CONTESTED KNOW, P1
   Ezzo J, 2001, CLIN ACUPUNCTURE SCI, P113
   FADIMAN A, 1997, SPIRIT CATCHES YOU Y
   FENNER W, 1648, SACRIFICE FAITHFULL
   Furin JJ, 1997, MED ANTHROPOL Q, V11, P498, DOI 10.1525/maq.1997.11.4.498
   Geertz C, 1973, INTERPRETATION CULTU
   GOOD BJ, 1994, MED RATIONALITY EXPE
   GRIFFITH RM, 2003, COMMUNICATION   0425
   Hammerschlag R, 2003, ALTERN THER HEALTH M, V9, P34
   HARE ML, 1993, MED ANTHROPOL Q, V7, P30, DOI 10.1525/maq.1993.7.1.02a00030
   HARRELL S, 1991, CULT MED PSYCHIAT, V15, P45, DOI 10.1007/BF00050827
   Heggenhoughen K., 1997, CURARE, V20, P5
   HELMS JM, 1995, ACUPUNCTURE ENERGETI
   Hughes Glenn, 2003, TRANSCENDENCE HIST S
   JIA HU, 1997, THESIS U N CAROLINA
   Jullien F., 1995, PROPENSITY THINGS HI
   Kaptchuk T, 2002, ANN INTERN MED, V137, P703, DOI 10.7326/0003-4819-137-8-200210150-00030
   Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7
   Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8
   Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159
   Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453
   Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011
   Kaptchuk TJ, 2001, J CLIN EPIDEMIOL, V54, P541, DOI 10.1016/S0895-4356(00)00347-4
   Kaptchuk TJ, 2002, ANN INTERN MED, V136, P374, DOI 10.7326/0003-4819-136-5-200203050-00010
   KAPTCHUK TJ, 2000, WEB THAT HAS NO WEAV
   KEMPER K, CLIN OUTCOMES RES CO
   Kleinman A, 1998, CONTRIB INDIAN SOC, V32, P237, DOI 10.1177/006996679803200205
   KLEINMAN A, 1994, WRITING MARGINS DISC
   KLEINMAN A, 1988, ILLNESS NARRATIVES S
   KLEINMAN A, 1981, SCI CULTURES, P161
   Korff Rudiger, 2003, DIALECT ANTHROPOL, V27, P1, DOI DOI 10.1023/A:1025466127833
   Langford JM, 1999, AM ETHNOL, V26, P24, DOI 10.1525/ae.1999.26.1.24
   Lao L, 2001, CLIN ACUPUNCTURE SCI, P187
   Leake R, 1999, ALTERN THER HEALTH M, V5, P94
   Macpherson H, 1997, ACUPUNCTURE PRACTICE
   Maynwaringe Everard, 1696, EFFICACY EXTENT TRUE
   McGuire MB, 2002, MED ANTHROPOL Q, V16, P409, DOI 10.1525/maq.2002.16.4.409
   Moerrnan DE, 2002, MEANING MED PLACEBO
   *NCCAM, 1997, AC NAT I HLTH CONS D
   *NCCAM, 2002, AC, P1
   *NCCAM, 2003, WAHT COMPL ALT MED C, P1
   Nichter Mark, 1992, ANTHR APPROACHES STU, pix
   Ots Thomas, 1991, ANTHROPOL MED, P43
   *OXF U PRESS, 1971, COMP ED OXF ENGL DIC, V1, P835
   Scheid V., 2002, CHINESE MED CONT CHI
   SCHEID V, 1997, ACUPUNCTURE PRACTICE, P47
   SCHEID V, 1999, LANCET, P354
   Schon D., 1994, FRAME REFLECTION RES
   *SCI AM FRONT, 2003, PROGR 1307 WOND PILL
   SEEM MD, 1992, TAS J, V11, P35
   Sered S, 1999, MED ANTHROPOL Q, V13, P223, DOI 10.1525/maq.1999.13.2.223
   So DW, 2002, AM J PUBLIC HEALTH, V92, P1662, DOI 10.2105/AJPH.92.10.1662
   Taussig M, 1993, MIMESIS ALTERITY PAR
   TILICH P, 1978, SYSTEMATIC THEOLOGY
   Tu Weiming, 1985, CONFUCIAN THOUGHT SE
   VENNER T, 1650, BATHS BATHE NECESSAR
   Waldram JB, 2000, MED ANTHROPOL Q, V14, P603, DOI 10.1525/maq.2000.14.4.603
   WALLACE W, 1827, PHYSL ENQUIRY RESPEC
NR 82
TC 18
Z9 18
U1 0
U2 2
PU AMER ANTHROPOLOGICAL ASSOC
PI ARLINGTON
PA 2200 WILSON BLVD, STE 600, ARLINGTON, VA 22201 USA
SN 0745-5194
J9 MED ANTHROPOL Q
JI Med. Anthropol. Q.
PD SEP
PY 2005
VL 19
IS 3
BP 239
EP 266
DI 10.1525/maq.2005.19.3.239
PG 28
WC Anthropology; Public, Environmental & Occupational Health; Social
   Sciences, Biomedical
SC Anthropology; Public, Environmental & Occupational Health; Biomedical
   Social Sciences
GA 963GF
UT WOS:000231791100001
PM 16222961
DA 2018-10-20
ER

PT J
AU Tabakov, S
   Roberts, VC
   Jonsson, BA
   Ljungberg, M
   Lewis, CA
   Wirestam, R
   Strand, SE
   Lamm, IL
   Milano, F
   Simmons, A
   Deane, C
   Goss, D
   Aitken, V
   Noel, A
   Giraud, JY
   Sherriff, S
   Smith, P
   Clarke, G
   Almqvist, M
   Jansson, T
AF Tabakov, S
   Roberts, VC
   Jonsson, BA
   Ljungberg, M
   Lewis, CA
   Wirestam, R
   Strand, SE
   Lamm, IL
   Milano, F
   Simmons, A
   Deane, C
   Goss, D
   Aitken, V
   Noel, A
   Giraud, JY
   Sherriff, S
   Smith, P
   Clarke, G
   Almqvist, M
   Jansson, T
CA EMERALD plus EMIT Int Consortia
TI Development of educational image databases and e-books for medical
   physics training
SO MEDICAL ENGINEERING & PHYSICS
LA English
DT Article
DE e-learning; medical physics training; medical physics education
ID BIOMEDICAL-ENGINEERING EDUCATION; COURSES; EUROPE
AB Medical physics education and training requires the use of extensive imaging material and specific explanations. These requirements provide an excellent background for application of e-Learning. The EU projects Consortia EMERALD and EMIT developed five volumes of such materials, now used in 65 countries. EMERALD developed e-Learning materials in three areas of medical physics (X-ray diagnostic radiology, nuclear medicine and radiotherapy). EMIT developed e-Learning materials in two further areas: ultrasound and magnetic resonance imaging. This paper describes the development of these e-Learning materials (consisting of e-books and educational image databases). The e-books include tasks helping studying of various equipment and methods. The text of these PDF e-books is hyperlinked with respective images. The e-books are used through the readers' own Internet browser. Each Image Database (IDB) includes a browser, which displays hundreds of images of equipment, block diagrams and graphs, image quality examples, artefacts, etc. Both the e-books and IDB are engraved on five separate CD-ROMs. Demo of these materials can be taken from www.emerald2.net. (c) 2005 IPEM. Published by Elsevier Ltd. All rights reserved.
C1 Kings Coll London, Dept Med Engn & Phys, London SE5 9RS, England.
   Kings Coll Hosp London, London SE5 9RS, England.
RP Tabakov, S (reprint author), Kings Coll London, Dept Med Engn & Phys, London SE5 9RS, England.
EM slavik.tabakov@kcl.ac.uk
RI Jonsson, Bo-Anders/B-6120-2013
CR [Anonymous], 1997, OFFICIAL J EUROPEAN
   Barnes GT, 1999, MED PHYS, V26, P2051, DOI 10.1118/1.598785
   *BES, 1981, ED TRAIN CAR BIOM EN
   *BES, 1974, ED TRAIN CAR BIOM EN
   *CALRAD, 1997, NEW APPR TEACH COR K
   CLIFTON JS, 1984, AUSTRALAS PHYS ENG S, V7, P42
   COTRUTZ C, 1995, MED PHYS ROMANIA AL, P147
   DEKHTYAR Y, 1999, MED BIOL ENG COMP S1, V37, P144
   Dendy PP, 1997, PHYS MEDICA, V13, P400
   *EVETSIN, 1999, EV VOC TRAIN SCI GRA
   FAUST U, 1988, BIOMED TECH, V33, P159, DOI 10.1515/bmte.1988.33.7-8.159
   Gander R E, 1996, J Clin Eng, V21, P317
   HINRIKUS H, 1999, MED BIOL ENG COMP S1, V37, P159
   *IAEA, 2003, IAEA TRAIN COURS RAD
   *IPEM, IPEM TRAIN SCHEM PRO
   Jessen KA, 1999, PHYS MEDICA, V15, P149
   Kolitsi Z., 2001, EUROPEAN FRAMEWORK E
   KREKULE I, 1996, LEKAR TECHNIKA, V27, P117
   LAMM IL, 2001, ED TRAINING CONTINUI, P14
   LESGOLD AM, 1984, BEHAV RES METH INSTR, pZ79
   Oliver L, 2001, Australas Phys Eng Sci Med, V24, P1
   PILKINGTON TC, 1989, IEEE ENG MED BIOL, V8, P9, DOI 10.1109/51.35573
   POTVIN AR, 1981, IEEE T BIO-MED ENG, V28, P22, DOI 10.1109/TBME.1981.324841
   PROIMOS B, 2001, EUROPEAN FRAMEWORK E, P25
   ROBERTS VC, 1982, MED PROG TECHNOL, V9, P171
   ROBERTS VC, 2001, E BOOKS IMAGE DATABA
   ROBERTS VC, 1995, MED RAD PHYS EUROPEA
   ROBERTS VC, 2004, E BOOKS IMAGE DATABA
   ROBERTS VC, 1984, SRHE NFER NELSON, P277
   SPELLER R, 2001, CDA RECOMMENDATIONS, P89
   TABAKOV S, 1999, MED BIOL ENG COMP S1, V37, P153
   TABAKOV S, 2001, EUROPEAN C MED PHYS, P31
NR 32
TC 12
Z9 12
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1350-4533
J9 MED ENG PHYS
JI Med. Eng. Phys.
PD SEP
PY 2005
VL 27
IS 7
BP 591
EP 598
DI 10.1016/j.medengphy.2004.11.012
PG 8
WC Engineering, Biomedical
SC Engineering
GA 963HV
UT WOS:000231795900007
PM 16076559
DA 2018-10-20
ER

PT J
AU Harris, TR
   Brophy, SP
AF Harris, TR
   Brophy, SP
TI Challenge-based instruction in biomedical engineering: A scalable method
   to increase the efficiency and effectiveness of teaching and learning in
   biomedical engineering
SO MEDICAL ENGINEERING & PHYSICS
LA English
DT Article
DE bioengineering education; learning technology; learning science
ID BIOENGINEERING EDUCATION; ADAPTIVE EXPERTISE; TECHNOLOGIES;
   BIOMECHANICS; FRAMEWORK; BIOTECHNOLOGY
AB Vanderbilt University, Northwestern University, the University of Texas and the Harvard/MIT Health Sciences Technology Program have collaborated since 1999 to develop means to improve bioengineering education. This effort, funded by the National Science Foundation as the VaNTH Engineering Research Center in Bioengineering Educational Technologies, has sought a synthesis of learning science, learning technology, assessment and the domains of bioengineering in order to improve learning by bioengineering students. Research has shown that bioengineering educational materials may be designed to emphasize challenges that engage the student and, when coupled with a learning cycle and appropriate technologies, can lead to improvements in instruction. (c) 2005 Published by Elsevier Ltd on behalf of IPEM.
C1 Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37205 USA.
RP Harris, TR (reprint author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37205 USA.
CR [Anonymous], 1982, Q NEWSLETTER LABORAT, V4, P15
   BENGHALIA M, 2003, P AM SOC ENG ED
   Besterfield-Sacre M, 2000, IEEE T EDUC, V43, P100, DOI 10.1109/13.848060
   Birol G, 2002, P ANN INT IEEE EMBS, P2640, DOI 10.1109/IEMBS.2002.1053468
   BIROL G, 2002, P AM SOC ENG ED IL I
   BRANSFORD JD, 2003, LEARNER CENTERED THE
   Bransford JD, 1999, PEOPLE LEARN BRAIN M
   Brophy SP, 2003, IEEE ENG MED BIOL, V22, P39, DOI 10.1109/MEMB.2003.1237490
   BROPHY SP, 2000, GUIDELINES MOL DESIG
   BROPHY SP, 2003, P AM SOC ENG ED
   Brown A. L., 1996, INNOVATIONS LEARNING, P289
   Clough G. W., 2004, ENG 2020 VISIONS ENG
   Cordray DS, 2003, IEEE ENG MED BIOL, V22, P47, DOI 10.1109/MEMB.2003.1237491
   DILLER KR, 2004, P 2004 AM SOC MECH E
   DUFRESNE RJ, 1996, J COMPUT HIGH ED, V7, P2
   Fries RC, 2003, IEEE ENG MED BIOL, V22, P111, DOI 10.1109/MEMB.2003.1237510
   GATCHELL DW, 2004, P AM SOC ENG ED
   Giorgio TD, 2002, P ANN INT IEEE EMBS, P2642, DOI 10.1109/IEMBS.2002.1053469
   GIORGIO TD, 2001, P AM SOC ENG ED
   Greenberg J. E., 2003, J ENG EDUC, V92, P155
   Greenberg JE, 2003, IEEE ENG MED BIOL, V22, P71, DOI 10.1109/MEMB.2003.1237505
   GUNTER HE, 2003, P AM SOC ENG ED
   Harris A., 2003, J ENG EDUC, V92, P329
   Harris TR, 2002, ANNU REV BIOMED ENG, V4, P29, DOI 10.1146/annurev.bioeng.4.091701.125502
   HARRIS TR, 2001, ASSESSMENT PRIMER
   HARRIS TR, 2004, VANTH BIOENGINEERING
   Howard L, 2003, IEEE ENG MED BIOL, V22, P58, DOI 10.1109/MEMB.2003.1237503
   JANSEN ED, 2003, P AM SOC ENG ED
   JANSEN ED, 2001, P AM SOC ENG ED
   KANTER DE, 2001, P AM SOC ENG ED
   KENNY R, 1968, REINVENTING UNDERGRA
   KING PH, 2002, P AM SOC ENG ED
   LAI I, 2003, P AM SOC ENG ED
   Lehrer R., 1998, DESIGNING LEARNING E
   Linn M. C., 2000, COMPUTERS TEACHERS P
   Martin T, 2005, SCI ENG ETHICS, V11, P257, DOI 10.1007/s11948-005-0045-9
   MCKENNA A, 2002, P AM SOC ENG ED
   Merrill MD, 2002, ETR&D-EDUC TECH RES, V50, P43, DOI 10.1007/BF02505024
   Nguyen J., 2002, J ENG EDUC, V91, P275
   Pandy MG, 2004, J ENG EDUC, V93, P211, DOI 10.1002/j.2168-9830.2004.tb00808.x
   PANDY MG, 2003, P AM SOC ENG ED
   Paschal CB, 2003, IEEE ENG MED BIOL, V22, P88, DOI 10.1109/MEMB.2003.1237507
   Paschal CB, 2002, ADV PHYSIOL EDUC, V26, P299, DOI 10.1152/advan.00030.2002
   PELLEGRINO JW, 2001, KNOWING WHAT STUDENT
   Riesbeck CK, 2003, IEEE ENG MED BIOL, V22, P55, DOI 10.1109/MEMB.2003.1237502
   Roselli R.J., 2003, P AM SOC ENG ED
   Roselli RJ, 2003, IEEE ENG MED BIOL, V22, P66, DOI 10.1109/MEMB.2003.1237504
   Roselli RJ, 2002, P ANN INT IEEE EMBS, P2617, DOI 10.1109/IEMBS.2002.1053455
   ROSELLI RJ, 2002, P AM SOC ENG ED
   ROSELLI RJ, 2004, P AM SOC ENG ED
   SAHAKIAN AV, 2002, P AM SOC ENG ED
   SCARDAMALIA M, 1989, J EDUC COMPUT RES, V5, P51, DOI 10.2190/CYXD-6XG4-UFN5-YFB0
   Schwartz Daniel L., 1999, INSTRUCTIONAL DESIGN, VII
   Schwartz DL, 1999, ETR&D-EDUC TECH RES, V47, P39, DOI 10.1007/BF02299464
   SHERWOOD RD, 2003, P AM SOC ENG ED
   SHEVIN R, 2003, P AM SOC ENG ED C
   Silverthorn DU, 2002, P ANN INT IEEE EMBS, P2646, DOI 10.1109/IEMBS.2002.1053471
   SMITH NT, P AM SOC ENG ED GREE
   Troy JB, 2003, IEEE ENG MED BIOL, V22, P80, DOI 10.1109/MEMB.2003.1237506
   WALKER J, 2002, P AM SOC ENG ED
   Walker J. M. T., 2003, J ENG EDUC, V19, P167, DOI DOI 10.1002/J.2168-9830.2003.TB00755.X
   WALKER JMT, 2003, P AM SOC ENG ED
   WATAI LL, 2004, P AM SOC ENG ED
   WEUSIJANA BK, 2002, P AM SOC ENG ED
   Wiggins G., 1998, UNDERSTANDING DESIGN
NR 65
TC 9
Z9 10
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1350-4533
J9 MED ENG PHYS
JI Med. Eng. Phys.
PD SEP
PY 2005
VL 27
IS 7
BP 617
EP 624
DI 10.1016/j.medengphy.2004.11.013
PG 8
WC Engineering, Biomedical
SC Engineering
GA 963HV
UT WOS:000231795900011
PM 16085445
DA 2018-10-20
ER

PT J
AU Leong, KW
AF Leong, KW
TI Polymeric controlled nucleic acid delivery
SO MRS BULLETIN
LA English
DT Review
DE biomedical materials; gene delivery; nanoparticles; nucleic acid
   delivery; polymeric
ID TARGETED GENE DELIVERY; CARBOHYDRATE-CONTAINING POLYCATIONS;
   CYCLODEXTRIN-CONTAINING POLYMERS; PLURONIC(R) BLOCK-COPOLYMERS;
   CHITOSAN-DNA NANOPARTICLES; IN-VIVO; PLASMID DNA; LINEAR
   POLYETHYLENIMINE; TRANSFECTION EFFICIENCY; CONTROLLED-RELEASE
AB Gene therapy harbors great promise for the treatment of a variety of inherited and acquired diseases, but its potential can be realized only with safe and effective carriers. Although viruses can efficiently transfer foreign genes to cells, their long-term safety remains a concern. Polymers can serve as a carrier to facilitate gene transfer, either by condensing DNA to the size of nanoparticles that can be internalized by cells, or by entrapping DNA in matrices or micro/nanoparticles for sustained release. However, polymeric controlled gene delivery remains highly inefficient. This review covers the major barriers for nonviral gene transfer and briefly describes the different types of polymers developed to overcome these barriers. With the tremendous promise of genetic medicine, nonviral gene delivery is a worthy goal for biomaterials and nanotechnology research.
OI Leong, Kam/0000-0002-8133-4955
CR Ahn CH, 2002, J CONTROL RELEASE, V80, P273, DOI 10.1016/S0168-3659(01)00547-8
   Ahn CH, 2004, J CONTROL RELEASE, V97, P567, DOI 10.1016/j.jconrel.2004.04.002
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Bellocq NC, 2003, BIOCONJUGATE CHEM, V14, P1122, DOI 10.1021/bc034125f
   Benns JM, 2001, J DRUG TARGET, V9, P123, DOI 10.3109/10611860108997923
   Blessing T, 2001, BIOCONJUGATE CHEM, V12, P529, DOI 10.1021/bc0001488
   Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bottcher C, 1998, J AM CHEM SOC, V120, P12, DOI 10.1021/ja971047w
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Branden LJ, 1999, NAT BIOTECHNOL, V17, P784, DOI 10.1038/11726
   Brissault B, 2003, BIOCONJUGATE CHEM, V14, P581, DOI 10.1021/bc0200529
   Brownlie A, 2004, INT J PHARM, V274, P41, DOI 10.1016/j.ijpharm.2003.12.029
   Cavazzana-Calvo M, 2004, NATURE, V427, P779, DOI 10.1038/427779a
   Cohen H, 2000, GENE THER, V7, P1896, DOI 10.1038/sj.gt.3301318
   Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179
   Dillon CP, 2005, ANNU REV PHYSIOL, V67, P147, DOI 10.1146/annurev.physiol.67.040403.130716
   Dunne M, 2003, J CONTROL RELEASE, V92, P209, DOI 10.1016/S0168-3659(03)00304-3
   ElOuahabi A, 1997, FEBS LETT, V414, P187, DOI 10.1016/S0014-5793(97)00973-3
   Fang N, 2001, BIOMACROMOLECULES, V2, P1161, DOI 10.1021/bm015548s
   Forrest ML, 2004, PHARM RES, V21, P365, DOI 10.1023/B:PHAM.0000016251.42392.1e
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Fratantoni JC, 2003, CYTOTHERAPY, V5, P208, DOI 10.1080/14653240310001479
   Funhoff AM, 2004, BIOMACROMOLECULES, V5, P32, DOI 10.1021/bm034041+
   Garrett SW, 2000, BIOORGAN MED CHEM, V8, P1779, DOI 10.1016/S0968-0896(00)00113-9
   Gautam Ajay, 2003, Methods Mol Med, V75, P561
   Golan R, 1999, BIOCHEMISTRY-US, V38, P14069, DOI 10.1021/bi990901o
   Gosselin MA, 2001, BIOCONJUGATE CHEM, V12, P989, DOI 10.1021/bc0100455
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Hong JW, 2004, J CONTROL RELEASE, V99, P167, DOI 10.1016/j.jconrel.2004.05.012
   Huang SW, 2004, BIOMACROMOLECULES, V5, P306, DOI 10.1021/bm034241l
   HUD HV, 1995, P NATL ACAD SCI USA, V92, P3581
   Hwang SJ, 2001, BIOCONJUGATE CHEM, V12, P280, DOI 10.1021/bc0001084
   Janat-Amsbury MM, 2004, MOL THER, V9, P829, DOI 10.1016/j.ymthe.2004.03.015
   Jeong JH, 2003, J BIOMAT SCI-POLYM E, V14, P1, DOI 10.1163/15685620360511100
   Jeong JH, 2003, BIOCONJUGATE CHEM, V14, P473, DOI 10.1021/bc025632k
   Jon S, 2003, BIOMACROMOLECULES, V4, P1759, DOI 10.1021/bm034176f
   Jones NA, 2000, BBA-GENE STRUCT EXPR, V1517, P1, DOI 10.1016/S0167-4781(00)00220-7
   Jones RA, 2003, BIOCHEM J, V372, P65, DOI 10.1042/BJ20021945
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kabanov AV, 2002, CRIT REV THER DRUG, V19, P1, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.10
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P223, DOI 10.1016/S0169-409X(02)00018-2
   Kaiser J, 2004, SCIENCE, V304, P1423
   Kiang T, 2004, J BIOMAT SCI-POLYM E, V15, P1405, DOI 10.1163/1568562042368112
   Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036
   Kim TG, 2004, BIOCONJUGATE CHEM, V15, P326, DOI 10.1021/bc0340262
   Kramer M, 2004, CHEMBIOCHEM, V5, P1081, DOI 10.1002/cbic.200300905
   Kunath K, 2003, J CONTROL RELEASE, V88, P159, DOI 10.1016/S0168-3659(02)00458-3
   Kyriakides TR, 2002, J CONTROL RELEASE, V78, P295, DOI 10.1016/S0168-3659(01)00504-1
   Lai E, 2001, BIOPHYS J, V80, P864, DOI 10.1016/S0006-3495(01)76065-1
   Lampela P, 2004, INT J PHARM, V270, P175, DOI 10.1016/j.ijpharm.2003.10.004
   Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867
   Lee JH, 2003, BIOCONJUGATE CHEM, V14, P1214, DOI 10.1021/bc034095g
   Lee JS, 2004, PHARM RES, V21, P1229, DOI 10.1023/B:PHAM.0000033010.96920.33
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   Lee M, 2003, J CONTROL RELEASE, V88, P333, DOI 10.1016/S0168-3659(03)00031-2
   Lemieux P, 2000, J DRUG TARGET, V8, P91, DOI 10.3109/10611860008996855
   Li AZ, 1999, BIOPHYS J, V77, P114, DOI 10.1016/S0006-3495(99)76876-1
   Li Y, 2004, GENE THER, V11, P109, DOI 10.1038/sj.gt.3302135
   Lim DW, 2000, BIOCONJUGATE CHEM, V11, P688, DOI 10.1021/bc000014u
   Lim YB, 2000, PHARMACEUT RES, V17, P811, DOI 10.1023/A:1007552007765
   Luten J, 2003, J CONTROL RELEASE, V89, P483, DOI 10.1016/S0168-3659(03)00127-5
   MacLaughlin FC, 1998, J CONTROL RELEASE, V56, P259, DOI 10.1016/S0168-3659(98)00097-2
   Maheshwari A, 2002, GENE THER, V9, P1075, DOI 10.1038/sj.gt.3301766
   McAllister K, 2002, J AM CHEM SOC, V124, P15198, DOI 10.1021/ja027759q
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Merdan T, 2003, BIOCONJUGATE CHEM, V14, P989, DOI 10.1021/bc0340767
   MIDOUX P, 1993, NUCLEIC ACIDS RES, V21, P871, DOI 10.1093/nar/21.4.871
   Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363
   Nishikawa M, 2001, HUM GENE THER, V12, P861, DOI 10.1089/104303401750195836
   Oster CG, 2004, PHARM RES, V21, P927, DOI 10.1023/B:PHAM.0000029279.50733.55
   Oupicky D, 2001, GENE THER, V8, P713, DOI 10.1038/sj.gt.3301446
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Popielarski SR, 2003, BIOCONJUGATE CHEM, V14, P672, DOI 10.1021/bc034010b
   Pun SH, 2004, BIOCONJUGATE CHEM, V15, P831, DOI 10.1021/bc049891g
   PUN SH, 2003, BIOCONJUGATE CHEM, V13, P630
   Putnam D, 2001, P NATL ACAD SCI USA, V98, P1200, DOI 10.1073/pnas.031577698
   Reineke TM, 2003, BIOCONJUGATE CHEM, V14, P247, DOI 10.1021/bc025592k
   Reineke TM, 2003, BIOCONJUGATE CHEM, V14, P255, DOI 10.1021/bc025593c
   Rhaese S, 2003, J CONTROL RELEASE, V92, P199, DOI 10.1016/S0168-3659(03)00302-X
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Rouzina I, 1998, BIOPHYS J, V74, P3152, DOI 10.1016/S0006-3495(98)78021-X
   ROUZINA IF, 1997, BIOPHYS J, V72, P437
   Roy K, 1999, NAT MED, V5, P387
   Schiavone N, 2004, CURR PHARM DESIGN, V10, P769, DOI 10.2174/1381612043452956
   Sosnowski BA, 1996, J BIOL CHEM, V271, P33647, DOI 10.1074/jbc.271.52.33647
   Thanou M, 2001, ADV DRUG DELIVER REV, V50, pS91, DOI 10.1016/S0169-409X(01)00180-6
   Thomas M, 2003, APPL MICROBIOL BIOT, V62, P27, DOI 10.1007/s00253-003-1321-8
   Truong-Le VL, 1999, ARCH BIOCHEM BIOPHYS, V361, P47, DOI 10.1006/abbi.1998.0975
   Truong-Le VL, 1998, HUM GENE THER, V9, P1709, DOI 10.1089/hum.1998.9.12-1709
   Vinogradov SV, 2002, ADV DRUG DELIVER REV, V54, P135, DOI 10.1016/S0169-409X(01)00245-9
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
   Wang J, 2001, J AM CHEM SOC, V123, P9480, DOI 10.1021/ja016062m
   Wang J, 2002, GENE THER, V9, P1254, DOI 10.1038/sj.gt.3301794
   Wang J, 2004, GENE THER, V11, P1001, DOI 10.1038/sj.gt.3302248
   Wang J, 2004, INT J PHARMACEUT, V279, P115, DOI 10.1016/j.ijpharm.2004.04.014
   Wang J, 2003, INT J PHARM, V265, P75, DOI 10.1016/j.ijpharm.2003.07.006
   Wang J, 2002, J CONTROL RELEASE, V83, P157, DOI 10.1016/S0168-3659(02)00180-3
   WANG X, 2002, 29 INT S CONTR REL B
   Wen J, 2004, J PHARM SCI-US, V93, P2142, DOI 10.1002/jps.20121
   Wightman L, 2001, J GENE MED, V3, P362, DOI 10.1002/jgm.187
   Williams DA, 2003, SCIENCE, V302, P400, DOI 10.1126/science.1091258
   Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019
   Zhang PC, 2005, BIOMACROMOLECULES, V6, P54, DOI 10.1021/bm040010l
   Zhang XQ, 2005, J CONTROL RELEASE, V102, P749, DOI 10.1016/j.jconrel.2004.10.024
   Zhang ZY, 2000, BIOCONJUGATE CHEM, V11, P805, DOI 10.1021/bc000018z
   Zhao Z, 2003, ADV DRUG DELIVER REV, V55, P483, DOI 10.1016/S0169-409X(03)00040-1
   Ziemienowicz A, 1999, P NATL ACAD SCI USA, V96, P3729, DOI 10.1073/pnas.96.7.3729
   Zou SM, 2000, J GENE MED, V2, P128, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<128::AID-JGM95>3.0.CO;2-W
   2005, UNPUB GENE THER
NR 111
TC 19
Z9 19
U1 0
U2 6
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD SEP
PY 2005
VL 30
IS 9
BP 640
EP 646
DI 10.1557/mrs2005.190
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 966CF
UT WOS:000231996500015
DA 2018-10-20
ER

PT J
AU Bergen, JM
   Pun, SH
AF Bergen, JM
   Pun, SH
TI Peptide-enhanced nucleic acid delivery
SO MRS BULLETIN
LA English
DT Article
DE biomedical materials; nucleic acid delivery; peptides
ID CELL-PENETRATING PEPTIDES; MEDIATED GENE-TRANSFER; HIV-1 TAT PROTEIN;
   LOCALIZATION SIGNAL PEPTIDE; ARGININE-RICH PEPTIDES; PHAGE DISPLAY
   LIBRARY; PLASMID DNA; IN-VIVO; MAMMALIAN-CELLS; TRANSFECTION EFFICIENCY
AB Numerous barriers, both extracellular and intracellular, hinder successful and efficient nonviral nucleic acid delivery. Due to their small size and ability to specifically recognize and interact with molecular targets, peptides can be incorporated as modular elements into synthetic nucleic acid delivery systems to overcome many of these barriers. Three classes of peptides that have frequently been integrated as components in nucleic acid delivery systems include cell-penetrating peptides (CPPs), endosomal release peptides, and nuclear localization sequences (NLSs). Various additional classes of peptides show promise for enhancing nucleic acid delivery by targeting cell surface receptors, inhibiting nuclease activity, and directing nucleic acids toward intracellular targets. In addition to a review of the various existing approaches to peptide-enhanced nucleic acid delivery, this article will discuss strategies for the development of new peptides and approaches for the incorporation of these peptides into nucleic acid delivery systems.
CR Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257
   ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919
   Astriab-Fisher A, 2000, BIOCHEM PHARMACOL, V60, P83, DOI 10.1016/S0006-2952(00)00310-5
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Branden LJ, 1999, NAT BIOTECHNOL, V17, P784, DOI 10.1038/11726
   Bremner KH, 2004, BIOCONJUGATE CHEM, V15, P152, DOI 10.1021/bc034140k
   Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001
   Brunner S, 2000, GENE THER, V7, P401, DOI 10.1038/sj.gt.3301102
   CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X
   Caron NJ, 2004, BIOCHEM BIOPH RES CO, V319, P12, DOI 10.1016/j.bbrc.2004.04.180
   Carriere M, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-14
   Cartier R, 2002, GENE THER, V9, P157, DOI 10.1038/sj.gt.3301635
   Chan CK, 2000, GENE THER, V7, P1690, DOI 10.1038/sj.gt.3301275
   Chan CK, 1999, HUM GENE THER, V10, P1695, DOI 10.1089/10430349950017699
   Chan CK, 2001, GENE THER, V8, P166, DOI 10.1038/sj.gt.3301366
   Ciolina C, 1999, BIOCONJUGATE CHEM, V10, P49, DOI 10.1021/bc980061a
   Colin M, 2000, GENE THER, V7, P139, DOI 10.1038/sj.gt.3301056
   Collas P, 1996, TRANSGENIC RES, V5, P451, DOI 10.1007/BF01980210
   Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200
   D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188
   Escriou V, 2003, ADV DRUG DELIVER REV, V55, P295, DOI 10.1016/S0169-409X(02)00184-9
   Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200
   Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l
   Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007
   Haas DH, 2004, J PEPT RES, V63, P9, DOI 10.1046/j.1399-3011.2004.00098.x
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   Harbottle RP, 1998, HUM GENE THER, V9, P1037, DOI 10.1089/hum.1998.9.7-1037
   Hebert E, 2003, BIOL CELL, V95, P59, DOI 10.1016/S0248-4900(03)00007-8
   Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200
   Isalan M, 2005, NAT METHODS, V2, P113, DOI 10.1038/NMETH732
   Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9
   Jenkins Y, 1998, J CELL BIOL, V143, P875, DOI 10.1083/jcb.143.4.875
   Kichler Antoine, 1997, Bioconjugate Chemistry, V8, P213, DOI 10.1021/bc970009z
   Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720
   Lee H, 2002, J CONTROL RELEASE, V79, P283, DOI 10.1016/S0168-3659(02)00002-0
   Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041
   Liu ZH, 2005, J CONTROL RELEASE, V102, P699, DOI 10.1016/j.jconrel.2004.10.013
   Ludtke JJ, 1999, J CELL SCI, V112, P2033
   Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Maruta F, 2003, J DRUG TARGET, V11, P53, DOI 10.1080/1061186031000086063
   Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349
   Moffatt S, 2005, HUM GENE THER, V16, P57, DOI 10.1089/hum.2005.16.57
   Mori T, 2004, CURR PHARM DESIGN, V10, P2335, DOI 10.2174/1381612043383944
   Morpurgo M, 2002, J BIOCHEM BIOPH METH, V52, P31, DOI 10.1016/S0165-022X(02)00033-7
   Morris MC, 1999, NUCLEIC ACIDS RES, V27, P3510, DOI 10.1093/nar/27.17.3510
   Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730
   Munkonge FM, 2003, ADV DRUG DELIVER REV, V55, P749, DOI 10.1016/S0169-409X(03)00050-4
   Muratovska A, 2004, FEBS LETT, V558, P63, DOI 10.1016/S0014-5793(03)01505-9
   Nagasaki T, 2003, BIOCONJUGATE CHEM, V14, P282, DOI 10.1021/bc025602h
   Nakanishi M, 2001, EUR J PHARM SCI, V13, P17, DOI 10.1016/S0928-0987(00)00203-7
   Neves C, 1999, FEBS LETT, V453, P41, DOI 10.1016/S0014-5793(99)00674-2
   Neves C, 1999, CELL BIOL TOXICOL, V15, P193, DOI 10.1023/A:1007693805849
   Nicklin SA, 2000, CIRCULATION, V102, P231, DOI 10.1161/01.CIR.102.2.231
   Ostensen CG, 2002, BIOCHEM BIOPH RES CO, V291, P945, DOI 10.1006/bbrc.2002.6536
   Pack DW, 2000, BIOTECHNOL BIOENG, V67, P217, DOI 10.1002/(SICI)1097-0290(20000120)67:2<217::AID-BIT11>3.3.CO;2-H
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc01-06-0308
   PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8713, DOI 10.1021/bi00489a030
   Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542
   Pichon C, 2000, NUCLEIC ACIDS RES, V28, P504, DOI 10.1093/nar/28.2.504
   Pinilla C, 2003, NAT MED, V9, P118, DOI 10.1038/nm0103-118
   Pooga M, 1998, FASEB J, V12, P67
   Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857
   Porkka K, 2002, P NATL ACAD SCI USA, V99, P7444, DOI 10.1073/pnas.062189599
   Potocky TB, 2003, J BIOL CHEM, V278, P50188, DOI 10.1074/jbc.M308719200
   Putnam D, 2001, P NATL ACAD SCI USA, V98, P1200, DOI 10.1073/pnas.031577698
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Ritter W, 2003, J MOL MED-JMM, V81, P708, DOI 10.1007/s00109-003-0483-2
   Ross MF, 2004, BIOCHEM J, V383, P457, DOI 10.1042/BJ20041095
   Rudolph C, 2003, J BIOL CHEM, V278, P11411, DOI 10.1074/M211891200
   Schwartz B, 1999, GENE THER, V6, P282, DOI 10.1038/sj.gt.3300795
   Sebestyen MG, 1998, NAT BIOTECHNOL, V16, P80, DOI 10.1038/nbt0198-80
   SEIBEL P, 1995, NUCLEIC ACIDS RES, V23, P10, DOI 10.1093/nar/23.1.10
   Siprashvili Z, 2003, HUM GENE THER, V14, P1225, DOI 10.1089/104303403767740768
   Smith PM, 2004, BBA-BIOENERGETICS, V1659, P232, DOI 10.1016/j.bbabio.2004.09.003
   Sperinde JJ, 2001, J GENE MED, V3, P101, DOI 10.1002/jgm.165
   Subramanian A, 1999, NAT BIOTECHNOL, V17, P873
   Subramanian A, 2002, J GENE MED, V4, P75, DOI 10.1002/jgm.235
   Tanimoto M, 2003, BIOCONJUGATE CHEM, V14, P1197, DOI 10.1021/bc034075e
   Temsamani J, 2004, DRUG DISCOV TODAY, V9, P1012, DOI 10.1016/S1359-6446(04)03279-9
   Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P1972, DOI 10.1073/pnas.0435906100
   Troy CM, 1996, J NEUROSCI, V16, P253
   Tung CH, 2002, BIOORGAN MED CHEM, V10, P3609, DOI 10.1016/S0968-0896(02)00248-1
   van der Aa MAEA, 2005, J GENE MED, V7, P208, DOI 10.1002/jgm.643
   van Rossenberg SMW, 2004, GENE THER, V11, P457, DOI 10.1038/sj.gt.3302183
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   WAGNER E, 1992, P NATL ACAD SCI USA, V89, P7934, DOI 10.1073/pnas.89.17.7934
   Writer MJ, 2004, J DRUG TARGET, V12, P185, DOI 10.1080/10611860410001724459
   ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997
   Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91
   Zelphati O, 2000, BIOTECHNIQUES, V28, P304, DOI 10.2144/00282rr01
   Zhang F, 1999, GENE THER, V6, P171, DOI 10.1038/sj.gt.3300801
   Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604
NR 94
TC 13
Z9 13
U1 1
U2 5
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD SEP
PY 2005
VL 30
IS 9
BP 663
EP 667
DI 10.1557/mrs2005.194
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 966CF
UT WOS:000231996500019
DA 2018-10-20
ER

PT J
AU Wang, X
   Zhuang, J
   Peng, Q
   Li, YD
AF Wang, X
   Zhuang, J
   Peng, Q
   Li, YD
TI A general strategy for nanocrystal synthesis
SO NATURE
LA English
DT Article
ID SINGLE-CRYSTAL NANOWIRES; QUANTUM DOTS; NANOPARTICLES; NANOTUBES;
   SUPERLATTICES; OXIDES
AB New strategies for materials fabrication are of fundamental importance in the advancement of science and technology(1-12). Organometallic(13,14) and other organic solution phase(15-17) synthetic routes have enabled the synthesis of functional inorganic quantum dots or nanocrystals. These nanomaterials form the building blocks for new bottom-up approaches to materials assembly for a range of uses; such materials also receive attention because of their intrinsic size-dependent properties and resulting applications(18-21). Here we report a unified approach to the synthesis of a large variety of nanocrystals with different chemistries and properties and with low dispersity; these include noble metal, magnetic/ dielectric, semiconducting, rare-earth fluorescent, biomedical, organic optoelectronic semiconducting and conducting polymer nanoparticles. This strategy is based on a general phase transfer and separation mechanism occurring at the interfaces of the liquid, solid and solution phases present during the synthesis. We believe our methodology provides a simple and convenient route to a variety of building blocks for assembling materials with novel structure and function in nanotechnology(13-29).
C1 Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.
   Natl Ctr Nanosci & Nanotechnol, Beijing 100084, Peoples R China.
RP Li, YD (reprint author), Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.
EM ydli@tsinghua.edu.cn
RI Wang, Xun/C-7638-2013
CR BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047
   Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367
   Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630
   HUO QS, 1994, NATURE, V368, P317, DOI 10.1038/368317a0
   Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jovin TM, 2003, NAT BIOTECHNOL, V21, P32, DOI 10.1038/nbt0103-32
   Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   Law M, 2004, SCIENCE, V305, P1269, DOI 10.1126/science.1100999
   Li YD, 2001, J AM CHEM SOC, V123, P9904, DOI 10.1021/ja016435j
   Li YDD, 2002, J AM CHEM SOC, V124, P1411, DOI 10.1021/ja012055m
   MOALES AM, 1998, SCIENCE, V279, P208
   MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025
   MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Peng Q, 2003, ANGEW CHEM INT EDIT, V42, P3027, DOI 10.1002/anie.200250695
   Peng XG, 2000, NATURE, V404, P59
   Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989
   Sun XM, 2004, ANGEW CHEM INT EDIT, V43, P3827, DOI 10.1002/anie.200353212
   Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229
   TENNE R, 1992, NATURE, V360, P444, DOI 10.1038/360444a0
   Tessler N, 2002, SCIENCE, V295, P1506, DOI 10.1126/science.1068153
   Wang X, 2004, ANGEW CHEM INT EDIT, V43, P2017, DOI 10.1002/anie.200353507
   Wang X, 2003, ANGEW CHEM INT EDIT, V42, P3497, DOI 10.1002/anie.200351006
   Wang X, 2002, ANGEW CHEM INT EDIT, V41, P4790, DOI 10.1002/anie.200290049
   Wang X, 2002, J AM CHEM SOC, V124, P2880, DOI 10.1021/ja0177105
   Yang PD, 1998, NATURE, V396, P152
NR 29
TC 1952
Z9 2037
U1 186
U2 2635
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD SEP 1
PY 2005
VL 437
IS 7055
BP 121
EP 124
DI 10.1038/nature03968
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 960AC
UT WOS:000231560400053
PM 16136139
DA 2018-10-20
ER

PT J
AU Kidd, KR
   Dal Ponte, D
   Stone, AL
   Hoying, JB
   Nagle, RB
   Williams, SK
AF Kidd, KR
   Dal Ponte, D
   Stone, AL
   Hoying, JB
   Nagle, RB
   Williams, SK
TI Stimulated endothelial cell adhesion and angiogenesis with laminin-5
   modification of expanded polytetrafluoroethylene
SO TISSUE ENGINEERING
LA English
DT Article
ID EXTRACELLULAR-MATRIX; VASCULAR PROSTHESES; SMOOTH-MUSCLE; SYNTHETIC
   MATERIALS; SOLUBLE LAMININ-5; EPITHELIAL-CELLS; TISSUE-RESPONSE; IVALON
   SPONGE; IN-VITRO; GRAFTS
AB Biomedical implants often exhibit poor clinical performance due to the formation of a periimplant avascular fibrous capsule. Surface modification of synthetic materials has been evaluated to accelerate the formation of functional microcirculation in association with implants. The current study used a flow-mediated protein deposition system to modify expanded polytetrafluoroethylene ( ePTFE) with a laminin-5-rich conditioned growth medium and with medium from which laminin-5 had been selectively removed. An in vitro model of endothelial cell adherence determined that laminin-5 modification resulted in significantly increased adhesion of human microvessel endothelial cells to ePTFE. In vivo studies evaluating the periimplant vascular response to laminin-5-treated samples indicated that absorption of laminin-5-rich conditioned medium supported accelerated neovascularization of ePTFE implants. A flow system designed to treat porous implant materials facilitates laminin-5 modification of commercially available ePTFE, resulting in increased endothelial cell adhesion in vitro and increased vascularization in vivo.
C1 Univ Arizona, Biomed Engn Program, Tucson, AZ 85724 USA.
   Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA.
RP Williams, SK (reprint author), Univ Arizona, Biomed Engn Program, 1501 N Campbell Ave, Tucson, AZ 85724 USA.
EM skwill@u.arizona.edu
FU NHLBI NIH HHS [HL63873]
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325
   Bellon JM, 1996, J BIOMED MATER RES, V31, P1, DOI 10.1002/(SICI)1097-4636(199605)31:1<1::AID-JBM1>3.0.CO;2-S
   Boswell CA, 1999, J BIOMAT SCI-POLYM E, V10, P319, DOI 10.1163/156856299X00388
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   BUDD JS, 1991, BRIT J SURG, V78, P878, DOI 10.1002/bjs.1800780733
   Champliaud MF, 1996, J CELL BIOL, V132, P1189, DOI 10.1083/jcb.132.6.1189
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   Didisheim P, 1994, ASAIO J, V40, P230, DOI 10.1097/00002480-199404000-00020
   El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R
   Fitchmun MI, 1998, ANAL BIOCHEM, V265, P1, DOI 10.1006/abio.1998.2877
   Greisler HP, 1998, J VASC SURG, V27, P106
   HABER RM, 1985, J AM ACAD DERMATOL, V13, P252, DOI 10.1016/S0190-9622(85)70168-5
   HARRISON JH, 1958, AM J SURG, V95, P3, DOI 10.1016/0002-9610(58)90735-9
   HARRISON JH, 1958, AM J SURG, V95, P16, DOI 10.1016/0002-9610(58)90736-0
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1984, SURGERY, V96, P745
   Homan SM, 1998, J CELL SCI, V111, P2717
   HORMIA M, 1995, J INVEST DERMATOL, V105, P557, DOI 10.1111/1523-1747.ep12323451
   Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.3.CO;2-9
   Kidd KR, 2004, J BIOMED MATER RES A, V69A, P294, DOI 10.1002/jbm.a.20133
   Kidd KR, 2002, J BIOMED MATER RES, V59, P366, DOI 10.1002/jbm.1253
   Kikkawa Y, 1996, IN VITRO CELL DEV-AN, V32, P46
   Kingsley K, 2002, BIOCHEM BIOPH RES CO, V294, P1017, DOI 10.1016/S0006-291X(02)00592-2
   Kingsley K, 2002, BIOCHEM BIOPH RES CO, V293, P1000, DOI 10.1016/S0006-291X(02)00331-5
   KOHLER TR, 1992, SURGERY, V112, P901
   Merzkirch C, 2001, ANAT REC, V263, P379, DOI 10.1002/ar.1118
   ORTENWALL P, 1990, J VASC SURG, V11, P403
   Polverini PJ, 1996, EUR J CANCER, V32A, P2430, DOI 10.1016/S0959-8049(96)00386-3
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   SALZMANN DL, 1997, THESIS U ARIZONA TUE
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   Sharkawy AA, 1998, J BIOMED MATER RES, V40, P598, DOI 10.1002/(SICI)1097-4636(19980615)40:4<598::AID-JBM11>3.0.CO;2-C
   Takeda A, 1999, J INVEST DERMATOL, V113, P38, DOI 10.1046/j.1523-1747.1999.00645.x
   Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x
   Thomson G J, 1989, Ann Vasc Surg, V3, P140, DOI 10.1016/S0890-5096(06)62007-4
   Updike SJ, 2000, DIABETES CARE, V23, P208, DOI 10.2337/diacare.23.2.208
   VOHRA R, 1991, BRIT J SURG, V78, P417, DOI 10.1002/bjs.1800780411
   VOLDER JGR, 1974, T AM SOC ART INT ORG, VB 20, P521
   Wagner S, 2000, NEUROSCI LETT, V284, P105, DOI 10.1016/S0304-3940(00)00987-3
   Wagner S, 1997, STROKE, V28, P858, DOI 10.1161/01.STR.28.4.858
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   WILLIAMS SK, 1994, J VASC SURG, V19, P916, DOI 10.1016/S0741-5214(94)70019-2
   WILLIAMS SK, 1991, J ELECTRON MICR TECH, V19, P439, DOI 10.1002/jemt.1060190406
   Wissink MJB, 2000, THROMB HAEMOSTASIS, V84, P325
   Yu H, 2001, J VASC SURG, V34, P337, DOI 10.1067/mva.2001.114817
   YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286
   YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636
NR 49
TC 24
Z9 24
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD SEP
PY 2005
VL 11
IS 9-10
BP 1379
EP 1391
DI 10.1089/ten.2005.11.1379
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 985AA
UT WOS:000233347300009
PM 16259593
DA 2018-10-20
ER

PT J
AU Kim, JI
   Kim, HY
   Inamura, T
   Hosoda, H
   Miyazaki, S
AF Kim, JI
   Kim, HY
   Inamura, T
   Hosoda, H
   Miyazaki, S
TI Shape memory characteristics of Ti-22Nb-(2-8)Zr(at.%) biomedical alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE shape memory effect; superelasticity; biomaterials; smart material;
   Ti-based alloy; Ti-Nb-Zr
ID MECHANICAL-PROPERTIES; INDUCED MARTENSITE; MO ALLOYS; BEHAVIOR
AB Shape memory characteristics of Ti-22Nb-(2-8)Zr(at.%) biomedical alloys were investigated by using tensile tests and X-ray diffraction (XRD) measurement. The alloy ingots were fabricated by an arc melting method. The ingots were cold-rolled by a reduction up to 95% in thickness at room temperature. All the alloys were solution-treated at 1173 K for 1.8 ks. The alloys subjected to the solution treatment exhibited large elongations ranging between 28 and 40%. The martensitic transformation temperature decreased by 38 K with I at.% increase of Zr content. The maximum recovered strain of 4.3% was obtained in the Ti-22Nb-4Zr(at.%) alloy. Ti-22Nb-(2-4)Zr(at.%) and Ti-22Nb-6Zr(at.%) alloys exhibited stable shape memory effect and superelastic behavior at room temperature, respectively. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
   Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011; Inamura,
   Tomonari/E-5712-2014
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678; 
CR Baker C., 1971, Metal Science Journal, V5, P92
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2001, T MRS J, V26, P243
   HOSODA H, 2003, MATER SCI FORUM, V425, P3121
   Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   KIM HY, 2004 FALL M JAP I ME, P330
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   KIM JI, 2003 FALL M JAP I ME, P149
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   Miyazaki S., 1990, ENG ASPECTS SHAPE ME, P394
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
NR 20
TC 223
Z9 237
U1 4
U2 59
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD AUG 25
PY 2005
VL 403
IS 1-2
BP 334
EP 339
DI 10.1016/j.msea.2005.05.050
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 961XK
UT WOS:000231694900042
DA 2018-10-20
ER

PT J
AU Andronova, N
   Srivastava, RK
   Albertsson, AC
AF Andronova, N
   Srivastava, RK
   Albertsson, AC
TI Potential tissue implants from the networks based on 1,5-dioxepan-2-one
   and epsilon-caprolactone
SO POLYMER
LA English
DT Article
DE 1,5-dioxepan-2-one; epsilon-caprolactone; 2,2
   '-bis-(epsilon-caprolactone-4-yl) propane
ID RING-OPENING POLYMERIZATION; BIODEGRADABLE POLYMERS; MOLECULAR-WEIGHT;
   COPOLYMERS; POLY(EPSILON-CAPROLACTONE); POLY(L-LACTIDE); ARCHITECTURE;
   POLYESTERS; CARBONATE; OLIGOMERS
AB The synthesis and characterization of degradable polymeric networks for biomedical applications was performed. Cross-linked films of poly(epsilon-caprolactone) (PCL) and poly(1,5-dioxepan-2-one) (PDXO) having various mole fractions of monomers and different cross-link densities were successfully prepared using 2,2'-bis-(epsilon-caprolactone-4-yl) propane (BCP) as cross-linking agent. Reaction parameters were carefully examined to optimise, the film-formin.,, conditions. Networks obtained were elastomeric materials. easy to cast and remove from the mould. Effect of CL content and cross-link density on the final properties of the polymer network was evaluated. High CL content or degree of cross-linking led to increase in Young's modulus and decrease in elongation at break. An increase in crystalline domains in films having a higher CL content was observed by optical microscopy. A greater thermal stability was observed in films having a high CL content. The hydrophilicity of the materials could be tailored by changing the CL content. The surface of the films became rougher with higher CL content. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Royal Inst Technol, Dept Polymer Technol, Sch Chem Sci & Engn, SE-10044 Stockholm, Sweden.
RP Albertsson, AC (reprint author), Royal Inst Technol, Dept Polymer Technol, Sch Chem Sci & Engn, Teknikringen 56-58, SE-10044 Stockholm, Sweden.
EM aila@polymer.kth.se
RI Albertsson, Ann-Christine/Q-6107-2016
OI Albertsson, Ann-Christine/0000-0001-8696-9143
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Albertsson A.-C., 2002, DEGRADABLE ALIPHATIC, P1, DOI 10.1007/3-540-45734-8_1
   Albertsson AC, 1996, J POLYM SCI POL CHEM, V34, P1395, DOI 10.1002/(SICI)1099-0518(199606)34:8<1395::AID-POLA2>3.0.CO;2-#
   Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   ALBERTSSON AC, 1995, POLYMER, V36, P1009, DOI 10.1016/0032-3861(95)93601-H
   ALBERTSSON AC, 1994, MACROMOL REPORT A S7, V31, P1185
   Andronova N, 2003, J POLYM SCI POL CHEM, V41, P2412, DOI 10.1002/pola.10781
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   Finne A, 2003, J POLYM SCI POL CHEM, V41, P1296, DOI 10.1002/pola.10682
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GRIJPMA DW, 1993, POLYMER, V34, P1496, DOI 10.1016/0032-3861(93)90868-B
   HAN YK, 1988, J MACROMOL SCI CHEM, VA25, P847, DOI 10.1080/00222338808053402
   Helminen AO, 2003, J POLYM SCI POL CHEM, V41, P3788, DOI 10.1002/pola.10951
   Helminen AO, 2002, MACROMOL CHEM PHYSIC, V203, P2630, DOI 10.1002/macp.200290039
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   LOFGREN A, 1995, J APPL POLYM SCI, V55, P1589
   MATHISEN T, 1989, MACROMOLECULES, V22, P3842, DOI 10.1021/ma00200a004
   Nijenhuis AJ, 1996, POLYMER, V37, P2783, DOI 10.1016/0032-3861(96)87642-7
   Ohrlander M, 2000, POLYMER, V41, P1277, DOI 10.1016/S0032-3861(99)00299-2
   Palmgren R, 1997, J POLYM SCI POL CHEM, V35, P1635, DOI 10.1002/(SICI)1099-0518(19970715)35:9<1635::AID-POLA5>3.0.CO;2-Q
   PITT CG, 1987, J POLYM SCI POL CHEM, V25, P955, DOI 10.1002/pola.1987.080250402
   Ryner M, 2002, J POLYM SCI POL CHEM, V40, P2049, DOI 10.1002/pola.10304
   Ryner M, 2001, MACROMOL SYMP, V175, P11, DOI 10.1002/1521-3900(200110)175:1<11::AID-MASY11>3.0.CO;2-F
   STOREY RF, 1994, POLYMER, V35, P830, DOI 10.1016/0032-3861(94)90882-6
   STOREY RF, 1993, J POLYM SCI POL CHEM, V31, P1825, DOI 10.1002/pola.1993.080310721
   STOREY RF, 1991, J POLYM SCI POL CHEM, V29, P1759, DOI 10.1002/pola.1991.080291209
   Stridsberg K, 1998, MACROMOL SYMP, V130, P367, DOI 10.1002/masy.19981300131
NR 27
TC 39
Z9 43
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD AUG 23
PY 2005
VL 46
IS 18
BP 6746
EP 6755
DI 10.1016/j.polymer.2005.06.038
PG 10
WC Polymer Science
SC Polymer Science
GA 957TW
UT WOS:000231397200003
DA 2018-10-20
ER

PT J
AU Crompton, KE
   Prankerd, RJ
   Paganin, DM
   Scott, TF
   Horne, MK
   Finkelstein, DI
   Gross, KA
   Forsythe, JS
AF Crompton, KE
   Prankerd, RJ
   Paganin, DM
   Scott, TF
   Horne, MK
   Finkelstein, DI
   Gross, KA
   Forsythe, JS
TI Morphology and gelation of thermosensitive chitosan hydrogels
SO BIOPHYSICAL CHEMISTRY
LA English
DT Article
DE chitosan; thermally responsive material; confocal microscopy;
   polysaccharide
ID POLY(VINYL ALCOHOL) HYDROGELS; POLYMER-SOLUTIONS; PHASE-SEPARATION;
   PHYSICAL GELS; TISSUE; TRANSPLANTATION; DYNAMICS; DELIVERY; SCAFFOLD;
   MATRIX
AB The morphology of physical hydrogels is often difficult to examine due to the delicate nature of the system and therefore has not been studied in detail. Chitosan/GP (glycerophosphate salt) is a significant hydrogel in the biomedical and cosmetic fields as it is thermosensitive and contains less than 5% polysaccharide. The morphology of this system was examined with laser scanning confocal microscopy (LSCM) to image the gel morphology. The images indicate that the gel is quite heterogeneous, and power spectra reveal a fractal-like morphology. A study of composition found that increasing chitosan concentration increased the amount of polymer-rich phase present in the gel, and that the smallest aggregates decreased in size. (c) 2005 Elsevier B.V. All rights reserved.
C1 Monash Univ, Sch Phys & Mat Engn, Clayton, Vic 3800, Australia.
   CRC Polymers, Notting Hill, Vic 3168, Australia.
   Monash Univ, Victorian Coll Pharm, Dept Pharmaceut, Parkville, Vic 3052, Australia.
   Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia.
RP Forsythe, JS (reprint author), Monash Univ, Sch Phys & Mat Engn, Wellington Rd, Clayton, Vic 3800, Australia.
EM John.Forsythe@spme.monash.edu.au
RI Gross, Karlis/G-2793-2010
OI Forsythe, John/0000-0003-2849-229X; Paganin, David/0000-0002-7758-7140;
   Finkelstein, David/0000-0002-8167-4917
CR AEBISCHER P, 1991, EXP NEUROL, V111, P269, DOI 10.1016/0014-4886(91)90093-R
   AEBISCHER P, 1991, BIOMATERIALS, V12, P50, DOI 10.1016/0142-9612(91)90132-T
   Andrianov AK, 1998, ADV DRUG DELIVER REV, V34, P155, DOI 10.1016/S0169-409X(98)00038-6
   AUBERT JH, 1990, MACROMOLECULES, V23, P1446, DOI 10.1021/ma00207a034
   BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481
   Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chou CM, 2004, MACROMOLECULES, V37, P5596, DOI 10.1021/ma049361f
   Chou CM, 2003, MACROMOLECULES, V36, P7331, DOI 10.1021/ma025831z
   Cohn D, 2003, BIOMATERIALS, V24, P3707, DOI 10.1016/S0142-9612(03)00245-X
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   EMERICH DF, 1992, NEUROSCI BIOBEHAV R, V16, P437, DOI 10.1016/S0149-7634(05)80185-X
   Fergg F, 2001, COLLOID POLYM SCI, V279, P61, DOI 10.1007/s003960000398
   Hirokawa Y, 1999, MACROMOLECULES, V32, P7093, DOI 10.1021/ma990437v
   Hoemann C., 2001, T ORTHOP RES SOC, V26, P626
   King S. M., 1999, MODERN TECHNIQUES PO, P171
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   LAMPRECHT A, 2000, AAPS PHARMSCITECH, V1
   Manno M, 1997, PHYS REV LETT, V79, P4286, DOI 10.1103/PhysRevLett.79.4286
   Matsuda T, 2002, BIOMACROMOLECULES, V3, P942, DOI 10.1021/bm0200229
   Miyazaki S, 1998, J CONTROL RELEASE, V56, P75, DOI 10.1016/S0168-3659(98)00079-0
   Nayak S, 2003, LANGMUIR, V19, P7374, DOI 10.1021/la034390p
   ONUKI A, 1999, PHYS REV E, V59, P1331
   Pitarresi G, 2000, MACROMOL CHEM PHYSIC, V201, P2542, DOI 10.1002/1521-3935(20001101)201:17<2542::AID-MACP2542>3.0.CO;2-A
   Ratner B.D., 1976, HYDROGELS MED RELATE, p[1, 1]
   Renard D, 1996, J CHIM PHYS PCB, V93, P998, DOI 10.1051/jcp/1996930998
   Ruel-Gariepy E, 2000, INT J PHARM, V203, P89, DOI 10.1016/S0378-5173(00)00428-2
   SONG SW, 1994, MACROMOLECULES, V27, P6389, DOI 10.1021/ma00100a024
   SRNIVASARAO M, 2003, COMPREENSIVE DESK RE, P408
   Takahashi A, 2003, COLLOID POLYM SCI, V281, P832, DOI 10.1007/s00396-002-0839-0
   TANIGAMI T, 1985, MACROMOLECULES, V18, P2595, DOI 10.1021/ma00154a040
   Taniguchi T, 1996, PHYS REV LETT, V77, P4910, DOI 10.1103/PhysRevLett.77.4910
   TRIEU H, 1995, POLYMER, V36, P2531, DOI 10.1016/0032-3861(95)91198-G
   WOERLY S, 1991, BIOMATERIALS, V12, P197, DOI 10.1016/0142-9612(91)90200-T
   Zhang XZ, 2002, BIOMATERIALS, V23, P1313, DOI 10.1016/S0142-9612(01)00249-6
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 39
TC 63
Z9 67
U1 2
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-4622
J9 BIOPHYS CHEM
JI Biophys. Chem.
PD AUG 22
PY 2005
VL 117
IS 1
BP 47
EP 53
DI 10.1016/j.bpc.2005.03.009
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA 957AG
UT WOS:000231341000006
PM 15905019
DA 2018-10-20
ER

PT J
AU Jewell, CM
   Zhang, JT
   Fredin, NJ
   Lynn, DM
AF Jewell, CM
   Zhang, JT
   Fredin, NJ
   Lynn, DM
TI Multilayered polyelectrolyte films promote the direct and localized
   delivery of DNA to cells
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE localized delivery; transfection; layer-by-layer; DNA; polyelectrolytes
ID BY-LAYER DEPOSITION; IN-VIVO REPAIR; GENE DELIVERY; THIN-FILMS;
   CORONARY-ARTERIES; BLOOD-VESSELS; SURFACE; RELEASE; MICROCAPSULES;
   TRANSFECTION
AB Multilayered polyelectrolyte films fabricated from plasmid DNA and a hydrolytically degradable synthetic polycation can be used to direct the localized transfection of cells without the aid of a secondary transfection agent. Multilayered assemblies 100 nm thick consisting of alternating layers of synthetic polymer I and plasmid DNA encoding for enhanced green fluorescent protein (EGFP) were deposited on quartz substrates using a layer-by-layer fabrication procedure. The placement of film-coated slides in contact with COS-7 cells growing in serum-containing culture medium resulted in gene expression in cells localized under the film-coated portion of the slides. The average percentage of cells expressing EGFP relative to the total number of cells ranged from 4.6% to 37.9%, with an average of 18.6% +/- 8.2%, as determined by fluorescence microscopy. In addition to providing a mechanism for the immobilization of DNA at the cell/surface interface, a preliminary analysis of film topography by atomic force microscopy (AFM) demonstrated that polymer 1/DNA films undergo significant structural rearrangements upon incubation to present surface bound condensed plasmid DNA nanoparticles. These data suggest that the presence of the cationic polymer in these materials may also contribute to the internalization and expression of plasmid. The materials and design principles reported here present an attractive framework for the local or non-invasive delivery of DNA from the surfaces of implantable materials or biomedical devices. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.
RP Lynn, DM (reprint author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.
EM dlynn@engr.wisc.edu
RI Xu, Qingguo/C-1962-2014; Fredin, Nathaniel/B-2890-2010; Zhang,
   Jingtao/D-2590-2011
OI Xu, Qingguo/0000-0003-3191-0771; 
FU NIBIB NIH HHS [EB02746]
CR Akinc A, 2003, BIOCONJUGATE CHEM, V14, P979, DOI 10.1021/bc034067y
   Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Fredin NJ, 2005, LANGMUIR, V21, P5803, DOI 10.1021/la050596+
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   HAMMONG PT, 1998, CURR OPIN COLLOID IN, V4, P32
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Lynn DM, 2001, J AM CHEM SOC, V123, P8155, DOI 10.1021/ja016288p
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Lynn DM, 2001, ANGEW CHEM INT EDIT, V40, P1707, DOI 10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.3.CO;2-6
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Peyratout CS, 2004, ANGEW CHEM INT EDIT, V43, P3762, DOI 10.1002/anie.200300568
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Saltzman WM, 1999, NAT BIOTECHNOL, V17, P534, DOI 10.1038/9835
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Schuler C, 2001, BIOMACROMOLECULES, V2, P921, DOI 10.1021/bm010052w
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Serizawa T, 2003, ANGEW CHEM INT EDIT, V42, P1115, DOI 10.1002/anie.200390293
   Serizawa T, 2002, MACROMOLECULES, V35, P8656, DOI 10.1021/ma012153s
   Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027
   Shchukin DG, 2004, J AM CHEM SOC, V126, P3374, DOI 10.1021/ja036952x
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   Trubetskoy VS, 1999, NUCLEIC ACIDS RES, V27, P3090, DOI 10.1093/nar/27.15.3090
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Wagner E, 1998, ADV DRUG DELIV REV, V30, P97
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
NR 36
TC 145
Z9 148
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 18
PY 2005
VL 106
IS 1-2
BP 214
EP 223
DI 10.1016/j.jconrel.2005.04.014
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 962NG
UT WOS:000231738900022
PM 15979188
DA 2018-10-20
ER

PT J
AU Marques, AP
   Reis, RL
   Hunt, JA
AF Marques, AP
   Reis, RL
   Hunt, JA
TI An in vivo study of the host response to starch-based polymers and
   composites subcutaneously implanted in rats
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biodegradable; biomaterials; in vivo; inflammation; starch
ID FOREIGN-BODY REACTIONS; FRACTURE FIXATION IMPLANTS; CELL-ADHESION
   MOLECULES; SOFT-TISSUE REACTION; MACROPHAGE POPULATIONS; ORTHOPEDIC
   IMPLANTS; ACID IMPLANTS; IFN-GAMMA; BIOMATERIALS; DEGRADATION
AB Implant failure is one of the major concerns in the biomaterials field. Several factors have been related to the fail but in general these biomaterials do not exhibit comparable physical, chemical or biological properties to natural tissues and ultimately, these devices can lead to chronic inflammation and foreign-body reactions. Starch-based biodegradable materials and composites have shown promising properties for a wide range of biomedical applications as well as a reduced capacity to elicit a strong reaction from immune system cells in vitro. In this work, blends of corn starch with ethylene vinyl alcohol (SEVA-C), cellulose acetate (SCA) and polycaprolactone (SPCL), as well as hydroxyapatite (HA) reinforced starch-based composites, were investigated in vivo. The aim of the work was to assess the host response evoked for starch-based biornaterials, identifying the presence of key cell types. The tissues surrounding the implant were harvested together with the material and processed histologically for evaluation using immunohistochemistry. At implant retrieval there was no cellular exudate around the implants and no macroscopic signs of an inflammatory reaction in any of the animals. The histological analysis of the sectioned interface tissue after immunohistochemical staining using ED 1, ED2, CD54, MHC class II and alpha/beta antibodies showed positively stained cells for all antibodies, except for alpha/beta for all the implantation periods, where it was different for the various polymers and for the period of implantation. SPCL and SCA composites were the materials that stimulated the greatest cellular tissue responses, but generally biodegradable starch-based materials did not induce a severe reaction for the studied implantation times, which contrasts with other types of degradable polymeric biomaterials.
C1 Univ Minho, Dept Polymer Engn, P-4810058 Guimaraes, Portugal.
   Univ Minho, 3Bs Res Grp Biomat Biodegradables, P-4710057 Braga, Portugal.
   Univ Liverpool, UKCTE, Liverpool L69 3GA, Merseyside, England.
RP Marques, AP (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4810058 Guimaraes, Portugal.
EM apmarques@dep.uminho.pt
RI Marques, Alexandra/B-1238-2012; Hunt, John/G-6366-2012; Group,
   3Bs/E-4374-2012; Reis, Rui L./A-8938-2008
OI Marques, Alexandra/0000-0002-3222-0310; Hunt, John/0000-0002-5168-4778;
   Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129
CR ALSAFFAR N, 1994, J MATER SCI-MATER M, V5, P813, DOI 10.1007/BF00213140
   ALSAFFAR N, 1995, ANN RHEUM DIS, V54, P201, DOI 10.1136/ard.54.3.201
   ALVES CM, 2005, IN VITRO IN VIVO PRO, P604
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ARNAOUT MA, 1990, BLOOD, V75, P1037
   ARTURSSON P, 1988, BIOMATERIALS, V9, P241, DOI 10.1016/0142-9612(88)90091-9
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   BASTIOLI C, 1994, RHEOL ACTA, V33, P307, DOI 10.1007/BF00366957
   BASTIOLI C, 1990, Patent No. 0400531
   Bastioli C, 1993, J ENVIRON POLYM DEGR, V1, P181
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   BOSTMAN OM, 1991, J BONE JOINT SURG BR, V73, P679
   Clarke SA, 2001, J BIOMED MATER RES, V57, P84, DOI 10.1002/1097-4636(200110)57:1<84::AID-JBM1145>3.0.CO;2-5
   Desevaux C, 2002, J BIOMED MATER RES, V63, P772, DOI 10.1002/jbm.10451
   Desevaux C, 2002, INT J PHARMACEUT, V232, P119, DOI 10.1016/S0378-5173(01)00912-7
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Hagerty RD, 2000, J BIOMED MATER RES, V49, P489, DOI 10.1002/(SICI)1097-4636(20000315)49:4<489::AID-JBM7>3.0.CO;2-2
   HEUFF G, 1993, SCAND J IMMUNOL, V38, P10, DOI 10.1111/j.1365-3083.1993.tb01688.x
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   Jackson JR, 1997, FASEB J, V11, P457
   Jansen K, 2004, BIOMATERIALS, V25, P483, DOI 10.1016/s0142-9612(03)00544-1
   JASTY M, 1992, Current Opinion in Rheumatology, V4, P204, DOI 10.1097/00002281-199204000-00012
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Kellar RS, 2002, J BIOMED MATER RES, V61, P226, DOI 10.1002/jbm.10021
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Khouw IMSL, 2000, J BIOMED MATER RES, V49, P297, DOI 10.1002/(SICI)1097-4636(20000305)49:3<297::AID-JBM1>3.0.CO;2-0
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Kohane DS, 2002, J BIOMED MATER RES, V59, P450, DOI 10.1002/jbm.1261
   Lickorish D, 2004, Eur Cell Mater, V8, P12
   LO SK, 1989, J IMMUNOL, V143, P3325
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Maloney WJ, 1996, AAOS INSTR COURS LEC, V45, P171
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   MARQUES AP, UNPUB J MAT SCI MAT
   MCLENNAN IS, 1993, CELL TISSUE RES, V272, P193, DOI 10.1007/BF00323586
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Ooms EM, 2003, BIOMATERIALS, V24, P749, DOI 10.1016/S0142-9612(02)00408-8
   Parker JATC, 2003, TISSUE ENG, V9, P117, DOI 10.1089/107632703762687591
   Parker JATC, 2002, BIOMATERIALS, V23, P3887, DOI 10.1016/S0142-9612(02)00134-5
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   Poshusta AK, 2003, J BIOMED MATER RES A, V64A, P62, DOI 10.1002/jbm.a.10274
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   ROSEN H, 1987, J EXP MED, V166, P1685, DOI 10.1084/jem.166.6.1685
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P597
   SANTAVIRTA S, 1998, CLIN ORTHOP RELAT R, V352, P16
   SMETANA K, 1987, EXP MOL PATHOL, V47, P271, DOI 10.1016/0014-4800(87)90080-3
   SOUILLAC V, 2001, BIOCERAMICS, V13, P433
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   SUNDERKOTTER C, 1991, PHARMACOL THERAPEUT, V51, P195, DOI 10.1016/0163-7258(91)90077-Y
   TABATA Y, 1990, ADV POLYM SCI, V94, P107
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Terada N, 1997, J MATER SCI-MATER M, V8, P391, DOI 10.1023/A:1018593219113
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   Vaz CM, 2002, BIOMATERIALS, V23, P629, DOI 10.1016/S0142-9612(01)00150-8
   WILLERT HG, 1989, ORTHOPADE, V18, P350
   WILLERT HG, 1980, ARCH ORTHOP TRAUM SU, V97, P197, DOI 10.1007/BF00389727
   Williams D. F., 1986, MATER RES SOC S P, V55, P117
NR 67
TC 38
Z9 38
U1 1
U2 21
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG 12
PY 2005
VL 5
IS 8
BP 775
EP 785
DI 10.1002/mabi.200500010
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 961HY
UT WOS:000231653900011
PM 16080170
DA 2018-10-20
ER

PT J
AU Takeda, T
AF Takeda, T
TI Phase-contrast and fluorescent X-ray imaging for biomedical researches
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 4th Workshop on Medical Applications of Synchrotron Radiation (MARS2004)
CY SEP 23-25, 2004
CL Trieste, ITALY
SP ICTP, Salam Int Ctr Theoret Phys, INFN, Sincrotrone Trieste SCpA, Univ Trieste
DE synchrotron radiation; phase-contrast X-ray imaging; fluorescent X-ray
   CT; tracer element; tumor; bio-imaging
ID BREAST-CANCER SPECIMENS; COMPUTED-TOMOGRAPHY; SYNCHROTRON-RADIATION;
   INTERFEROMETER; CT
AB Synchrotron X-ray imaging systems with phase-contrast and fluorescent techniques have been developed for biomedical researches. Since phase-contrast X-ray imaging with an X-ray interferometer is a highly sensitive imaging technique to differentiate the inner soft tissue in biological object, detailed morphological structures can be imaged without the use of contrast material. Fluorescent X-ray CT detects specific heavy atomic number elements such as iodine at the order of picogram in a volume of 10(-6) ml, so the functional information with labeling agents can be obtained. Here, I describe recent in vivo and ex vivo experimental results obtained by these imaging techniques. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan.
RP Takeda, T (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan.
EM ttakeda@md.tsukuba.ac.jp
CR Arfelli F, 2000, RADIOLOGY, V215, P286, DOI 10.1148/radiology.215.1.r00ap10286
   Beckmann F, 1997, J COMPUT ASSIST TOMO, V21, P539, DOI 10.1097/00004728-199707000-00006
   BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   Fitzgerald R, 2000, PHYS TODAY, V53, P23, DOI 10.1063/1.1292471
   HOGAN JP, 1991, IEEE T NUCL SCI, V38, P1721, DOI 10.1109/23.124168
   IIDA A, 1991, HDB SYNCHROTRON RAD, V4, pCH9
   Momose A, 2003, J PHYS IV, V104, P599, DOI 10.1051/jp4:20030153
   Momose A, 2001, NUCL INSTRUM METH A, V467, P917, DOI 10.1016/S0168-9002(01)00523-X
   Momose A, 1997, J SYNCHROTRON RADIAT, V4, P311, DOI 10.1107/S0909049597007097
   MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472
   Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473
   MOMOSE A, 1995, NUCL INSTRUM METH A, V352, P622, DOI 10.1016/0168-9002(95)90017-9
   MOMOSE A, 2004, P 8 INT C SYNCHR RAD, P1259
   Pisano ED, 2000, RADIOLOGY, V214, P895, DOI 10.1148/radiology.214.3.r00mr26895
   Rust GF, 1998, IEEE T NUCL SCI, V45, P75, DOI 10.1109/23.659557
   TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156
   Takeda T, 2000, J SYNCHROTRON RADIAT, V7, P280, DOI 10.1107/S0909049500004295
   Takeda T, 2004, JPN J APPL PHYS 1, V43, P5652, DOI 10.1143/JJAP.43.5652
   Takeda T, 2004, JPN J APPL PHYS 2, V43, pL1144, DOI 10.1143/JJAP.43.L1144
   Takeda T, 1996, P SOC PHOTO-OPT INS, V2708, P685, DOI 10.1117/12.237832
   Takeda T, 1999, P SOC PHOTO-OPT INS, V3772, P258, DOI 10.1117/12.363728
   Takeda T, 2001, NUCL INSTRUM METH A, V467, P1318, DOI 10.1016/S0168-9002(01)00654-4
   Takeda T, 2000, CELL MOL BIOL, V46, P1077
   TAKEDA T, 1995, ACAD RADIOL, V2, P799, DOI 10.1016/S1076-6332(05)80490-8
   Takeda T, 2000, RADIOLOGY, V214, P298, DOI 10.1148/radiology.214.1.r00ja08298
   TAKEDA T, 2001, PROGR PATHOLOGY, pCH6
   TAKEDA T, 2001, P JSBB, P112
   TAKEDA T, 2004, SPIE, V5535, P380
   TAKEDA T, 2004, P 8 INT C SYNCHR RAD, P1328
   TAKEDA T, 2004, P 8 INT C SYNCHR RAD, P1320
   THETTHETLWIN T, 2004, 8 S BIOL SYNCHR RAD, P514
   Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0
   Yoneyama A, 2004, NUCL INSTRUM METH A, V523, P217, DOI 10.1016/j.nima.2003.12.008
   Yoneyama A, 2002, J SYNCHROTRON RADIAT, V9, P277, DOI 10.1107/S090904950201350X
   YU Q, 2000, MED IMAG TECH, V18, P805
   Yu QW, 2001, J SYNCHROTRON RADIAT, V8, P1030, DOI 10.1107/S0909049500020483
   Yuasa T, 1997, IEEE T NUCL SCI, V44, P54, DOI 10.1109/23.554824
NR 38
TC 24
Z9 28
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
EI 1872-9576
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD AUG 11
PY 2005
VL 548
IS 1-2
BP 38
EP 46
DI 10.1016/j.nima.2005.03.063
PG 9
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 957ZA
UT WOS:000231410900006
DA 2018-10-20
ER

PT J
AU Freier, T
   Montenegro, R
   Koh, HS
   Shoichet, MS
AF Freier, T
   Montenegro, R
   Koh, HS
   Shoichet, MS
TI Chitin-based tubes for tissue engineering in the nervous system
SO BIOMATERIALS
LA English
DT Article
DE chitosan; nerve guidance channels; nerve regeneration; hollow fiber
   membranes
ID TENDON CHITOSAN TUBES; REGENERATION IN-VIVO; CELL AFFINITY; NEURITE
   EXTENSION; FILMS; DERIVATIVES; DEACETYLATION; SCAFFOLD; CHARGE; VITRO
AB The purpose of this study was to investigate chitin and chitosan as potential materials for biodegradable nerve guides. Transparent chitin hydrogel tubes were synthesized, for the first time. from chitosan solutions using acylation chemistry and mold casting techniques. Alkaline hydrolysis of chitin tubes resulted in chitosan tubes, with the extent of hydrolysis controlling the resulting amine content. This, in turn, impacted compressive strength and cell adhesion. Chitosan tubes were mechanically stronger than their chitin origins, as measured by the transverse compressive test, where tubes having degrees of acetylation of 1%, 3%, 18% (i.e. chitosan) and 94% (i.e. chitin) supported loads at a 30% displacement of 40.6 +/- 4.3, 25.3 +/- 4.5, 10.6 +/- 0.8, and 8.7 +/- 0.4g, respectively. However, the chitin processing methodology Could be optimized for compressive strength, by either incorporating reinforcing coils in the tube wall, or air-drying the hydrogel tubes. Chitin and chitosan supported adhesion and differentiation of primary chick dorsal root ganglion neurons in vitro. Chitosan films showed significantly enhanced neurite outgrowth relative to chitin films, reflecting the dependence of nerve cell affinity on the amine content in the polysaccharide: neurites extended 1794.7 +/- 392.0 mu m/mm(2) on chitosan films vs. 140.5 +/- 41.6 mu m/mm(2) on chitin films after 2 days of culture. This implies that cell adhesion and neurite extension can be adjusted by amine content, which is important for tissue engineering in the nervous system. The methods for easy processing and modification of chitin and chitosan described herein, allow the mechanical properties and cyto-compatibility to be controlled and provide a means for a broader investigation into their use in biomedical applications. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
   Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   matREGEN Corp, Toronto, ON M5S 1A1, Canada.
   Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.
RP Shoichet, MS (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.
EM molly@ecf.utoronto.ca
CR Balassa L. L., 1978, P 1 INT C CHIT CHIT, P296
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Cheng MY, 2003, J BIOMAT SCI-POLYM E, V14, P1155, DOI 10.1163/156856203769231628
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Dillon GP, 2000, J BIOMED MATER RES, V51, P510, DOI 10.1002/1097-4636(20000905)51:3<510::AID-JBM28>3.0.CO;2-G
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   GOROVOJ L, 2000, CHITOSAN PER OS DIET, P2001
   HIRANO S, 1980, J BIOMED MATER RES, V14, P477, DOI 10.1002/jbm.820140414
   HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1
   Hirata M, 1998, ZOOL SCI, V15, P903, DOI 10.2108/zsj.15.903
   HIROTA Y, 1996, ADV CHITIN SCI, V1, P407
   Ikeda T., 2000, CHITOSAN PER OS DIET, P275
   Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Khor E., 2001, CHITIN FULFILLING BI
   KIFUNE K, 1992, ADVANCES IN CHITIN AND CHITOSAN, P9
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Luo Y, 2001, CHEM MATER, V13, P4087, DOI 10.1021/cm010323+
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   MUZZARELLI RAA, 1977, CHITIN
   Nishi R, 1996, METHOD CELL BIOL, V51, P249, DOI 10.1016/S0091-679X(08)60632-9
   Nishikawa H., 2001, SILICON BASED MAT DE, V2, P93
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   SANTOS PM, 1991, OTOLARYNG HEAD NECK, V105, P12, DOI 10.1177/019459989110500103
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   Singh DK, 2000, J MACROMOL SCI R M C, VC40, P69, DOI 10.1081/MC-100100579
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Vachoud L, 1997, CARBOHYD RES, V302, P169, DOI 10.1016/S0008-6215(97)00126-2
   Vachoud L, 2001, BIOMACROMOLECULES, V2, P1294, DOI 10.1021/bm0155874
   Wu A. C. M., 1978, P 1 INT C CHIT CHIT, P88
   Yamaguchi I, 2003, BIOMATERIALS, V24, P3285, DOI 10.1016/S0142-9612(03)00163-7
   Yang F, 2002, J BIOMATER APPL, V16, P215, DOI 10.1106/088532802021176
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 40
TC 156
Z9 172
U1 0
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2005
VL 26
IS 22
BP 4624
EP 4632
DI 10.1016/j.biomaterials.2004.11.040
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 907UK
UT WOS:000227743300015
PM 15722132
DA 2018-10-20
ER

PT J
AU Tong, P
   Lam, DCC
   Yang, F
AF Tong, P
   Lam, DCC
   Yang, F
TI Mode I solution for micron-sized crack
SO ENGINEERING FRACTURE MECHANICS
LA English
DT Article; Proceedings Paper
CT International Conference on Heterogeneous Materials Mechanics (ICHMM)
CY JUN 21-26, 2004
CL Chongqing Univ, Chongqing, PEOPLES R CHINA
HO Chongqing Univ
DE crack-tip field; fracture; asymptotic analysis; strain gradient material
ID STRAIN GRADIENT PLASTICITY; ANTIPLANE SHEAR CRACKS; NEAR-TIP FIELDS;
   ELASTICITY THEORY; FRACTURE; DISPLACEMENTS; POLYMERS; HARDNESS; GROWTH;
   WORK
AB The feature size of micro-electronic, optoelectronic and biomedical devices is in the sub-micron scale and is pushing toward the nanometer scale. Defects in these small structures are correspondingly smaller such that small crack behavior is becoming an important design consideration for reliability and performance of such devices. Analyses of small cracks are complicated by the rapid variation in the deformation in the crack tip zone. Strain gradients in the near tip zone, which can be ignored in large cracks, will influence the small crack behavior when the crack tip zone is in the order of the crack size. In this paper, we consider two-dimensional crack deformations with strain gradient effect and establish the dual formulations in terms of potentials. The formulations reduce to the conventional linear elastic fracture theory, when the material length scale parameters for the higher order deformation measures are zero. One of the formulations is in terms of two complex stress functions and two pseudo potentials. The complex stress functions are harmonic and the governing equations for the pseudo-potentials are two uncoupled second order partial differential equations. The solutions for these equations are coupled through the boundary conditions.
   A perturbation method is used to construct the solution for mode I cracks under a K-field when only the effect of the rotational gradient is included. The perturbation solution has 1/root r induced singularity for the stresses. The induced deformation decays exponentially away from the crack tip. The induced stresses become insignificant beyond 38, the typical characteristics of a boundary layer type. To a first order approximation, the induced deformation energy normalized by that of the classical solution under constant applied crack opening load is linearly proportional to E. This implies that the induced energy release rate is linearly proportional to the length scale parameter. The induced energy release rate under a fixed crack opening load is negative indicating that the rotational gradient shields the crack and lowers the total deformation energy release rate for small crack. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Hong Kong Univ Sci & Technol, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.
   Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.
   SW Jiaotong Univ, Inst Computat Engn & Sci, Chengdu 610031, Peoples R China.
RP Lam, DCC (reprint author), Hong Kong Univ Sci & Technol, Dept Mech Engn, Clear Water Bay, Hong Kong, Hong Kong, Peoples R China.
EM medcclam@ust.hk
CR AIFANTIS EC, 1984, J ENG MATER-T ASME, V106, P326, DOI 10.1115/1.3225725
   Chen JY, 1999, ENG FRACT MECH, V64, P625, DOI 10.1016/S0013-7944(99)00073-9
   Chen JY, 1998, KEY ENG MAT, V145-9, P19, DOI 10.4028/www.scientific.net/KEM.145-149.19
   Chong ACM, 1999, J MATER RES, V14, P4103, DOI 10.1557/JMR.1999.0554
   FLECK NA, 1994, ACTA METALL MATER, V42, P475, DOI 10.1016/0956-7151(94)90502-9
   Fleck NA, 1997, ADV APPL MECH, V33, P295, DOI 10.1016/S0065-2156(08)70388-0
   Fung Y. C., 2001, CLASSICAL COMPUTATIO
   Ghani T, 2003, IEDM, P978
   Huang Y, 1999, INT J FRACTURE, V100, P1, DOI 10.1023/A:1018313421855
   Huang Y, 1997, J MECH PHYS SOLIDS, V45, P439, DOI 10.1016/S0022-5096(96)00089-0
   Jiang H, 2001, J MECH PHYS SOLIDS, V49, P979, DOI 10.1016/S0022-5096(00)00070-3
   Kailath T., 2000, LINEAR ESTIMATION
   KIM CH, 2003, IEEE S VLSI CIRC KY, P205
   Koiter W., 1964, P K NED AKAD B PHYS, V67, P17
   Lam DCC, 2003, J MECH PHYS SOLIDS, V51, P1477, DOI 10.1016/S0022-5096(03)00053-X
   Lam DCC, 1999, J MATER RES, V14, P3784, DOI 10.1557/JMR.1999.0512
   Mindlin R.D., 1965, INT J SOLIDS STRUCT, V1, P417, DOI DOI 10.1016/0020-7683(65)90006-5
   MINDLIN RD, 1964, ARCH RATION MECH AN, V16, P51
   NIX WD, 1989, METALL TRANS A, V20, P2217, DOI 10.1007/BF02666659
   Poole WJ, 1996, SCRIPTA MATER, V34, P559, DOI 10.1016/1359-6462(95)00524-2
   Radi E, 2003, J MECH PHYS SOLIDS, V51, P543, DOI 10.1016/S0022-5096(02)00057-1
   Shi MX, 2000, J MECH PHYS SOLIDS, V48, P2513, DOI 10.1016/S0022-5096(00)00020-X
   Sternberg E., 1967, International Journal of Solids and Structures, V3, P69, DOI 10.1016/0020-7683(67)90045-5
   Stolken JS, 1998, ACTA MATER, V46, P5109, DOI 10.1016/S1359-6454(98)00153-0
   Takao Y, 2003, FUJITSU SCI TECH J, V39, P32
   Tong P, 2004, KEY ENG MAT, V261-263, P11, DOI 10.4028/www.scientific.net/KEM.261-263.11
   TONG P, UNPUB SIZE EFFECT MO
   Toupin R. A, 1962, ARCH RATION MECH AN, V11, P385, DOI DOI 10.1007/BF00253945
   Unger DJ, 2000, THEOR APPL FRACT MEC, V34, P253, DOI 10.1016/S0167-8442(00)00042-2
   Unger DJ, 2000, THEOR APPL FRACT MEC, V34, P243, DOI 10.1016/S0167-8442(00)00041-0
   Wei YG, 1997, J MECH PHYS SOLIDS, V45, P1253, DOI 10.1016/S0022-5096(97)00018-5
   Xia ZC, 1996, J MECH PHYS SOLIDS, V44, P1621, DOI 10.1016/0022-5096(96)00035-X
   Zhang L, 1998, INT J FRACTURE, V92, P325, DOI 10.1023/A:1007552621307
NR 33
TC 3
Z9 3
U1 5
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-7944
J9 ENG FRACT MECH
JI Eng. Fract. Mech.
PD AUG
PY 2005
VL 72
IS 12
BP 1779
EP 1804
DI 10.1016/j.engfracmech.2004.10.013
PG 26
WC Mechanics
SC Mechanics
GA 931PH
UT WOS:000229496800002
DA 2018-10-20
ER

PT J
AU Platt, SR
   Farritor, S
   Garvin, K
   Haider, H
AF Platt, SR
   Farritor, S
   Garvin, K
   Haider, H
TI The use of piezoelectric ceramics for electric power generation within
   orthopedic implants
SO IEEE-ASME TRANSACTIONS ON MECHATRONICS
LA English
DT Article
DE orthopedics; piezoelectric (PZT) ceramics; piezoelectric (PZT)
   materials; power generation
ID LEAD-ZIRCONATE-TITANATE; TOTAL KNEE REPLACEMENTS; TOTAL HIP; FORCES;
   ARTHROPLASTY; POLYETHYLENE; TELEMETRY; FAILURE; WALKING; JOINT
AB This paper presents the results of tests that demonstrate the feasibility of using piezoelectric (PZT) ceramics to generate in vivo electrical energy for orthopedic implants. Sensors encapsulated within implants could provide in vivo diagnostic capabilities such as the monitoring of implant duty (i.e., walking) cycle, detecting abnormally asymmetric or high forces, sensing misalignment and early loosening, and early detection of wear. Early diagnosis of abnormalities or impending failure is critical to minimize patient harm. However, the routine use of sensors and microprocessors embedded within orthopedic implants for diagnostic and monitoring purposes has been limited by the lack of a long-term self-contained power source capable of lasting the expected 20-year implant lifetimes.
   By embedding PZT materials within orthopedic implants, a small amount of the mechanical energy generated during normal physica activity can be converted into useful electrical energy. This in vivo energy source can power embedded microprocessors and sensors for a broad range of biomedical uses. The current work investigates the application of this technology to total knee replacement (TKR) implants, but it is applicable to many other implanted biomedical devices.
C1 Univ Nebraska, Dept Mech Engn, Lincoln, NE 68588 USA.
   Univ Nebraska Med Ctr, Dept Orthoped Surg, Omaha, NE 68198 USA.
RP Platt, SR (reprint author), Univ Nebraska, Dept Mech Engn, Lincoln, NE 68588 USA.
EM srp@unlserve.unl.edu; sfarritor@unl.edu; kgarvin@unmc.edu;
   hhaider@unmc.edu
CR Bottom V. E., 1982, INTRO QUARTZ CRYSTAL
   BREINER DM, 1997, THESIS U NEBRASKA LI
   Burrows RT, 2000, DEV NEUROSCI-BASEL, V22, P7, DOI 10.1159/000017422
   CADY WG, 1964, PIEZOELECTRICITY INT, V2
   CADY WG, 1964, PIEZOELECTRICITY INT, V1
   CAIN MG, 1999, SMMTA148 NPL MAN LTD
   *CDC CDCP, ADV DAT 329
   COLLIER JP, 1991, CLIN ORTHOP RELAT R, P232
   DAVY DT, 1988, J BONE JOINT SURG AM, V70A, P45, DOI 10.2106/00004623-198870010-00008
   Engel TG, 2000, IEEE T PLASMA SCI, V28, P1338, DOI 10.1109/27.901194
   ENGER CC, 1964, T AM SOC ART INT ORG, V10, P373
   ENGER CC, 1963, 16 ANN C ENG MED BIO
   Espehaug B, 2002, J BONE JOINT SURG BR, V84B, P832, DOI 10.1302/0301-620X.84B6.12776
   Furnes O, 2002, ACTA ORTHOP SCAND, V73, P117, DOI 10.1080/000164702753671678
   GAUTSCHI G, 2001, PIEZOELECTRIC SENSOR
   Glynne-Jones P, 2001, IEE P-SCI MEAS TECH, V148, P68, DOI 10.1049/ip-smt:20010323
   Graichen F, 1999, J BIOMECH, V32, P1113, DOI 10.1016/S0021-9290(99)00110-4
   HAGGOD NW, 1999, 10 INT C AD STRUCT T
   Hill MD, 1996, J AM CERAM SOC, V79, P1915, DOI 10.1111/j.1151-2916.1996.tb08013.x
   *INT ORG STAND, 2002, 1424312002E ISO
   ISHIKAWA A, 2002, Patent No. 6447448
   Kaufman KR, 1996, J BIOMECH, V29, P667, DOI 10.1016/0021-9290(95)00124-7
   KO WH, 1966, 19 ANN C ENG MED BIO
   Kymissis J, 1998, SECOND INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS - DIGEST OF PAPERS, P132, DOI 10.1109/ISWC.1998.729539
   LOWRIE F, 1999, SMMTA151 NPL MAN LTD
   MCDOWELL CS, 2000, Patent No. 6143035
   MENDENHALL S, 2000, ORTHOPEDIC NETWORK N, V11, P7
   Mendes DG, 2002, ISRAEL MED ASSOC J, V4, P69
   MEYERS GH, 1963, IEEE T BIOMED ENG, V10, P83
   MEYERS GH, 1964, AM J MED ELECTRON, V3, P233
   Morris BA, 2001, J BONE JOINT SURG AM, V83A, P62, DOI 10.2106/00004623-200100021-00013
   MORRISON JB, 1970, J BIOMECH, V3, P51, DOI 10.1016/0021-9290(70)90050-3
   PLATT SR, 2003, THESIS U NEBRASKA LI
   Ritter MA, 2001, CLIN ORTHOP RELAT R, P94
   Rossi M., 1988, ACOUSTICS ELECTROACO
   ROUNDY S, 2002, LAB NOTES RES COLL E, V2
   Schneider E, 2001, J BIOMECH, V34, P849, DOI 10.1016/S0021-9290(01)00037-9
   Schneider W J, 1999, Curr Atheroscler Rep, V1, P115, DOI 10.1007/s11883-999-0007-9
   Shenck NS, 2001, IEEE MICRO, V21, P30, DOI 10.1109/40.928763
   Starner T, 1996, IBM SYST J, V35, P618, DOI 10.1147/sj.353.0618
   Taylor GW, 2001, IEEE J OCEANIC ENG, V26, P539, DOI 10.1109/48.972090
   Taylor SJG, 2001, J BIOMECH, V34, P839, DOI 10.1016/S0021-9290(01)00042-2
   Taylor SJG, 1998, J ARTHROPLASTY, V13, P428, DOI 10.1016/S0883-5403(98)90009-2
   Uchino K., 1996, PIEZOELECTRIC ACTUAT
   *US CENS BUR, 2000, TOT POP AG RAC HISP
   *US CENS BUR, 2000, PROJ TOT RES POP 5 Y
   Walker PS, 2000, CLIN ORTHOP RELAT R, P290
   WRIGHT TM, 2001, AM ACAD ORTHOPAED SU, P3
   Yang G, 2000, P SOC PHOTO-OPT INS, V3992, P103, DOI 10.1117/12.388193
   1961, EFFECTS HIGH STATIC, V33, P1339
   1959, DOMAIN PROCESSES LEA, V30, P1804
   2005, IEEE T MECH, V10, P240
NR 52
TC 119
Z9 119
U1 1
U2 18
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1083-4435
J9 IEEE-ASME T MECH
JI IEEE-ASME Trans. Mechatron.
PD AUG
PY 2005
VL 10
IS 4
BP 455
EP 461
DI 10.1109/TMECH.2005.852482
PG 7
WC Automation & Control Systems; Engineering, Manufacturing; Engineering,
   Electrical & Electronic; Engineering, Mechanical
SC Automation & Control Systems; Engineering
GA 969CM
UT WOS:000232211000014
DA 2018-10-20
ER

PT J
AU Parthasaradhi, STV
   Derakhshani, R
   Hornak, LA
   Schuckers, SAC
AF Parthasaradhi, STV
   Derakhshani, R
   Hornak, LA
   Schuckers, SAC
TI Time-series detection of perspiration as a liveness test in fingerprint
   devices
SO IEEE TRANSACTIONS ON SYSTEMS MAN AND CYBERNETICS PART C-APPLICATIONS AND
   REVIEWS
LA English
DT Article
DE biomedical image processing; biomedical measurements; biometrics;
   fingerprint recognition; liveness; pattern recognition; personal
   identification
AB Fingerprint scanners may be susceptible to spoofing using artificial materials, or in the worst case, dismembered fingers. An anti-spoofing method based on liveness detection has been developed for use in fingerprint scanners. This method quantifies a specific temporal perspiration pattern present in fingerprints acquired from live claimants. The enhanced perspiration detection algorithm presented here improves our previous work by including other fingerprint scanner technologies; using a larger, more diverse data set; and a shorter time window. Several classification methods were tested in order to separate live and spoof fingerprint images. The dataset included fingerprint images from 33 live subjects, 33 spoofs created with dental material and Play-Doh, and fourteen cadaver fingers. Each method had a different performance with respect to each scanner and time window. However, all the classifiers achieved approximately 90% classification rate for all scanners, using the reduced time window and the more comprehensive training and test sets.
C1 Bioscrypt Inc, Markham, ON L3R 8E3, Canada.
   Univ Missouri, Dept Comp Sci & Elect Engn, Kansas City, MO 64110 USA.
   W Virginia Univ, Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA.
RP Parthasaradhi, STV (reprint author), Bioscrypt Inc, Markham, ON L3R 8E3, Canada.
EM saradhi21@yahoo.com; reza@umkc.edu; lah@csee.wvu.edu;
   sschucke@clarkson.edu
RI Schuckers, Stephanie/F-6197-2017
OI Schuckers, Stephanie/0000-0002-9365-9642
CR DERAKHSHANI R, 2003, PATTERN RECOGNIT J, V36
   DHILLON WR, 1984, MULTIVARIATE ANAL ME
   Kallo P., 2001, US Patent, Patent No. 617564
   Lapsley P.D., 1998, U.S. Patent, Patent No. [5,737,439, 5737439]
   Matsumoto T, 2002, P SPIE, V4677
   Osten D., 1998, US Patent, Patent No. 5719950
   Ratha NK, 2001, IBM SYST J, V40, P614, DOI 10.1147/sj.403.0614
   SCHUCKERS SAC, 2002, SPOOFING ANTISPOOFIN, V7
   THALHEIM L, 2002, CT MAG           NOV
   VALENCIA V, BIOMETRICS
   VANDERPUTTE T, 2000, P IFIP TC8 WG8 8 4 W, P289
   WILLIS D, 1998, NETWORK COMPUTI 0601
   Witten I. H., 1999, DATA MINING PRACTICA
NR 13
TC 66
Z9 68
U1 1
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1094-6977
EI 1558-2442
J9 IEEE T SYST MAN CY C
JI IEEE Trans. Syst. Man Cybern. Part C-Appl. Rev.
PD AUG
PY 2005
VL 35
IS 3
BP 335
EP 343
DI 10.1109/TSMCC.2005.848192
PG 9
WC Computer Science, Artificial Intelligence; Computer Science,
   Cybernetics; Computer Science, Interdisciplinary Applications
SC Computer Science
GA 949OI
UT WOS:000230797600007
DA 2018-10-20
ER

PT J
AU Petrini, L
   Migliavacca, F
   Massarotti, P
   Schievano, S
   Dubini, G
   Auricchio, F
AF Petrini, L
   Migliavacca, F
   Massarotti, P
   Schievano, S
   Dubini, G
   Auricchio, F
TI Computational studies of shape memory alloy behavior in biomedical
   applications
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE shape memory alloy; finite element method; mathematical model; coronary
   stent; spinal vertebrae spacer
ID VENA-CAVA FILTER; PHASE-TRANSFORMATIONS; SUPERELASTIC BEHAVIOR;
   3-DIMENSIONAL MODEL; NITINOL; STENTS; PLACEMENT; SCOLIOSIS; WIRE
AB Background: Nowadays, shape memory alloys (SMAs) and in particular Ni-Ti alloys are commonly used in bioengineering applications as they join important qualities as resistance to corrosion, biocompatibility, fatigue resistance, MR compatibility, kink resistance with two unique thermo-mechanical behaviors: the shape memory effect and the pseudoelastic effect. They allow Ni-Ti devices to undergo large mechanically induced deformations and then to recover the original shape by thermal loading or simply by mechanical unloading. Method of approach: A numerical model is developed to catch the most significant SMA macroscopic thermo-mechanical properties and is implemented into a commercial finite element code to simulate the behavior of biomedical devices. Results: The comparison between experimental and numerical response of an intravascular coronary stent allows to verify the model suitability to describe pseudo-elasticity. The numerical study of a spinal vertebrae spacer, where the effects of different geometries and material characteristic temperatures are investigated, allows to verify the model suitability to describe shape memory effect. Conclusion: the results presented show the importance of computational studies in designing and optimizing new biomedical devices.
C1 Univ Pavia, Dipartimento Meccan Strutturale, I-27100 Pavia, Italy.
   Politecn Milan, Lab Biol Struct Mech, I-20133 Milan, Italy.
   CNR, Ist Matemat Applicata & Tecnol Informat, I-27100 Pavia, Italy.
RP Petrini, L (reprint author), Univ Pavia, Dipartimento Meccan Strutturale, Via Ferrata 1, I-27100 Pavia, Italy.
EM petrini@unipv.it
RI Dubini, Gabriele/F-6647-2013; Migliavacca, Francesco/F-6424-2013;
   Schievano, Silvia/B-6803-2009; Auricchio, Ferdinando/B-9405-2009;
   PETRINI, LORENZA/G-3989-2018
OI Dubini, Gabriele/0000-0002-0907-2903; Migliavacca,
   Francesco/0000-0003-4644-630X; Auricchio,
   Ferdinando/0000-0002-3735-2400; PETRINI, LORENZA/0000-0002-6349-1586;
   Schievano, Silvia/0000-0003-2037-5339
CR Auricchio F, 2004, INT J NUMER METH ENG, V61, P807, DOI 10.1002/nme.1086
   Auricchio F, 1997, COMPUT METHOD APPL M, V146, P281, DOI 10.1016/S0045-7825(96)01232-7
   Auricchio F, 2001, INT J SOLIDS STRUCT, V38, P6123, DOI 10.1016/S0020-7683(00)00282-1
   Barras CDJ, 2000, EUR J VASC ENDOVASC, V19, P564, DOI 10.1053/ejvs.2000.1111
   Bruckheimer E, 2003, J VASC INTERV RADIOL, V14, P469, DOI 10.1097/01.RVI.0000064863.65229.C3
   Carter AJ, 1998, CATHETER CARDIO DIAG, V44, P193, DOI 10.1002/(SICI)1097-0304(199806)44:2<193::AID-CCD13>3.0.CO;2-O
   DAI KR, 1993, INJURY, V24, P651, DOI 10.1016/0020-1383(93)90313-U
   Duerig T. W., 1990, ENG ASPECTS SHAPE ME
   DUERIG TW, 1997, MED PLASTICS BIOMATE, V2, P30
   FREMOND M, 1996, CISM, V351, P1
   Funakubo H., 1987, SHAPE MEMORY ALLOYS
   Govindjee S, 2001, COMPUT METHOD APPL M, V191, P215, DOI 10.1016/S0045-7825(01)00271-7
   Idesman AV, 1999, COMPUT METHOD APPL M, V173, P71, DOI 10.1016/S0045-7825(98)00258-8
   Kong H, 2002, CATHETER CARDIO INTE, V56, P267, DOI 10.1002/ccd.10152
   Kourambas J, 2000, UROLOGY, V56, P935, DOI 10.1016/S0090-4295(00)00821-9
   Leask RL, 2001, J VASC INTERV RADIOL, V12, P613, DOI 10.1016/S1051-0443(07)61486-9
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Liew KM, 2002, ENG STRUCT, V24, P51, DOI 10.1016/S0141-0296(01)00072-4
   Lubliner J., 1990, PLASTICITY THEORY
   Manach PY, 1997, MAT SCI ENG A-STRUCT, V222, P45, DOI 10.1016/S0921-5093(96)10510-4
   Migliavacca F, 2004, BIOMECH MODEL MECHAN, V2, P205, DOI [10.1007/s10237-004-0039-6, 10.1007/S10237-004-0039-6]
   NACHEMSON A., 1966, CLIN ORTHO RELAT RES, V45, P107
   Otsuka K., 1998, SHAPE MEMORY MAT
   Patoor E, 1996, J PHYS IV, V6, P277, DOI 10.1051/jp4:1996127
   PELTON AR, 1997, P 2 INT C SHAP MEM S
   PELTON AR, 1995, P 1 INT C SHAP MEM S
   Peng X, 2001, INT J SOLIDS STRUCT, V38, P6925, DOI 10.1016/S0020-7683(00)00402-9
   Peyroux R, 1998, INT J ENG SCI, V36, P489, DOI 10.1016/S0020-7225(97)00052-9
   Qidwai MA, 2000, INT J NUMER METH ENG, V47, P1123, DOI 10.1002/(SICI)1097-0207(20000228)47:6<1123::AID-NME817>3.0.CO;2-N
   Qidwai MA, 2000, INT J PLASTICITY, V16, P1309, DOI 10.1016/S0749-6419(00)00012-7
   RUSSEL SM, 2000, P 3 INT C SHAP MEM S
   Ryhanen J, 2003, J SHOULDER ELB SURG, V12, P442, DOI 10.1016/S1058-2746(03)00064-8
   RYHNEN J, 1995, THESIS OULU U
   SANDERS JO, 1993, SPINE, V18, P1640, DOI 10.1097/00007632-199309000-00012
   SIMON M, 1993, RADIOLOGY, V189, P769, DOI 10.1148/radiology.189.3.8234702
   SMITS M, 1995, ENDOSCOPY, V27, P505, DOI 10.1055/s-2007-1005756
   Song HY, 2004, J VASC INTERV RADIOL, V15, P369, DOI 10.1097/01.RVI.0000121406.46920.5C
   Souza AC, 1998, EUR J MECH A-SOLID, V17, P789, DOI 10.1016/S0997-7538(98)80005-3
   Sundaram CP, 2002, J UROLOGY, V167, P1376, DOI 10.1016/S0022-5347(05)65304-9
   Tamai H, 2000, CIRCULATION, V102, P399
   Thierry B, 2002, BIOMATERIALS, V23, P2997, DOI 10.1016/S0142-9612(02)00030-3
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   Tyagi S, 2003, AM HEART J, V146, P920, DOI 10.1067/S0002-8703(03)00434-4
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Walsh KP, 2000, CARDIOL YOUNG, V10, P493
   WAYMAN CM, 1992, PROG MATER SCI, V36, P203, DOI 10.1016/0079-6425(92)90009-V
   Wever DJ, 2002, EUR SPINE J, V11, P100, DOI 10.1007/s005860100347
   ZIOLKOWSKI A, 2001, WORKSH SHAP MEM ALL, P1
NR 48
TC 43
Z9 45
U1 1
U2 23
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD AUG
PY 2005
VL 127
IS 4
BP 716
EP 725
DI 10.1115/1.1934203
PG 10
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 952VS
UT WOS:000231034400020
PM 16121543
DA 2018-10-20
ER

PT J
AU Hedia, HS
AF Hedia, HS
TI Comparison of one-dimensional and two-dimensional functionally graded
   materials for the backing shell of the cemented acetabular cup
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE finite-element analysis; bone cement; stress shielding; titanium
ID SHAPE OPTIMIZATION; BIOMEDICAL APPLICATION; FEMORAL COMPONENT; IMPLANT;
   DESIGN
AB Among the factors that have been suggested as contributing to the failure of a total joint replacement are stress shielding and the subsequent bone resorption. Recent studies have shown that when a backing shell made from a Ti alloy is used, high stresses are generated in the cement at the edges of the cup, and low stresses are generated at the dome of the bone in the acetabulum; thus, the bone at the dome suffers stress shielding and the cement edge suffers high stresses. The aim of this study was to investigate the effect of using a functionally graded material (FGM), instead of Ti alloy, for the backing shell (BS) on the stress distribution in the BS-cement-bone system. Finite-element and optimization techniques were used to obtain the optimal distribution of materials in the tangential direction only of the backing (ID FGM) as well as in the tangential and radial directions of the backing (2D FGM). It was found that the stress distribution in the BS-cement-bone system was about the same, regardless of whether the BS was fabricated from a 1D or 2D FGM. The stress-shielding factor in the bone at the dome of the acetabulum and the maximum von Mises stress in cement at the cement interfaces for 1D and 2D FGM were reduced by about 51%, 69%, and 50%, respectively, compared to the case when the shell was fabricated from a Ti alloy. The optimal elastic modulus of the 1D FGM was obtained with the materials graded from HA at the dome of the acetabullum to a Ti alloy at the rim of the shell. The optimal elastic modulus of the 2D FGM was obtained with the materials graded from Ti alloy at the right edge of the rim, to Bioglass 45S5 at the left edge of the rim, and to HA at the dome of the shell. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Mansoura, Fac Engn, Prod & Mech Design Dept, Mansoura, Egypt.
RP Hedia, HS (reprint author), Univ Mansoura, Fac Engn, Prod & Mech Design Dept, Mansoura, Egypt.
EM hedia@mans.edu.eg
RI Hedia, Hassan/I-8289-2012
CR BIRKEN LMO, 2000, P 6 WORLD BIOM C, P420
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   DALSTRA M, 1994, P 2 WORLD C BIOM
   Hedia HS, 1996, BIO-MED MATER ENG, V6, P199
   Hedia HS, 2000, BIO-MED MATER ENG, V10, P73
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Hedia HS, 1997, BIO-MED MATER ENG, V7, P83
   HEDIA HS, 2000, J BIOMEDICAL MAT ENG, V10, P141
   HUISKES R, 1987, ACTA ORTHOP SCAND, V58, P620
   HUISKES R, 1989, J BIOMECH, V22, P793, DOI 10.1016/0021-9290(89)90063-8
   JIN ZM, 1994, MED ENG PHYS, V16, P398, DOI 10.1016/1350-4533(90)90006-T
   Katoozian H, 2001, MED ENG PHYS, V23, P503
   Katoozian H, 2000, MED ENG PHYS, V22, P243, DOI 10.1016/S1350-4533(00)00030-8
   KOLB ED, 1999, BIOENG C 16 20 JUN 1
   Kuiper JH, 1997, J BIOMECH ENG-T ASME, V119, P166, DOI 10.1115/1.2796076
   Manjubala I, 2000, BIOMATERIALS, V21, P1995, DOI 10.1016/S0142-9612(00)00092-2
   Nemat-Alla M, 2003, INT J SOLIDS STRUCT, V40, P7339, DOI 10.1016/j.ijsolstr.2003.08.017
   PEDERSEN DR, 1982, J BIOMECH, V15, P305, DOI 10.1016/0021-9290(82)90176-2
   RUSSOTTI GM, 1988, CLIN ORTHOP RELAT R, V235, P139
   SANTARE MH, 2002, J MECH BEHAV MAT, V12, P17
   THOMPSON I, 2000, COMPREHENSIVE COMPOS, V6, P727
   VASU R, 1983, J BIOMECH ENG-T ASME, V105, P332, DOI 10.1115/1.3138429
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Watari F, 2003, MATER SCI FORUM, V423-4, P321, DOI 10.4028/www.scientific.net/MSF.423-425.321
NR 25
TC 13
Z9 13
U1 2
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2005
VL 74B
IS 2
BP 732
EP 739
DI 10.1002/jbm.b.30258
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 951AK
UT WOS:000230900900010
PM 15934010
DA 2018-10-20
ER

PT J
AU Singh, J
   Wolfe, DE
AF Singh, J
   Wolfe, DE
TI Nanostructured component fabrication by electron beam-physical vapor
   deposition
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article; Proceedings Paper
CT International Symposium on Manufacturing, Properties and Applications
CY OCT 18-20, 2004
CL Columbus, OH
DE electron beam physical vapor depositon; function graded materials;
   nanostructure; Rhenium; TiBCN; yttria stabilized zirconia
ID THERMAL BARRIER COATINGS; EB-PVD; MULTILAYER COATINGS; FILMS;
   MICROSTRUCTURES; COEVAPORATION; CONDUCTIVITY; ORIENTATION; EVOLUTION;
   STRESSES
AB Fabrication of cost-effective, nano-grained net-shaped components has brought considerable interest to Department of Defense, National Aeronautics and Space Administration, and Department of Energy. The objective of this paper is to demonstrate the versatility of electron beam-physical vapor deposition (EB-PVD) technology in engineering new nanostructured materials with controlled microstructure and microchemistry in the form of coatings and net-shaped components for many applications including the space, turbine, optical, biomedical, and auto industries. Coatings are often applied on components to extend their performance and life under severe environmental conditions including thermal, corrosion, wear, and oxidation. Performance and properties of the coatings depend upon their composition, microstructure, and deposition condition. Simultaneous co-evaporation of multiple ingots of different compositions in the high energy EB-PVD chamber has brought considerable interest in the architecture of functional graded coatings, nano-laminated coatings, and design of new structural materials that could not be produced economically by conventional methods. In addition, high evaporation and condensate rates allowed fabricating precision net-shaped components with nanograined microstructure for various applications. Using EB-PVD, nano-grained rhenium (Re) coatings and net-shaped components with tailored microstructure and properties were fabricated in the form of tubes, plates, and Re-coated spherical graphite cores. This paper will also present the results of various metallic and ceramic coatings including chromium, titanium carbide (TIC), titanium diboride (TiB2), hafnium nitride (HfN), titanium-boron-carbonitride (TiBCN), and partially yttria stabilized zirconia (YSZ) TBC coatings deposited by EB-PVD for various applications.
C1 Penn State Univ, Appl Res Lab, State Coll, PA 16804 USA.
RP Singh, J (reprint author), Penn State Univ, Appl Res Lab, State Coll, PA 16804 USA.
EM dew125@psu.edu
CR ARNAULT JC, 1993, NUCL INSTRUM METH B, V80-1, P1384, DOI 10.1016/0168-583X(93)90804-F
   Beele W, 1999, SURF COAT TECH, V120, P61, DOI 10.1016/S0257-8972(99)00342-4
   Brogren M, 2000, THIN SOLID FILMS, V370, P268, DOI 10.1016/S0040-6090(00)00914-7
   Bunshah RF, 1994, HDB DEPOSITION TECHN
   Chin KC, 2004, CHEM PHYS LETT, V383, P72, DOI 10.1016/j.cplett.2003.11.007
   Choy KL, 2003, PROG MATER SCI, V48, P57, DOI 10.1016/S0079-6425(01)00009-3
   ENSINGER W, 1993, NUCL INSTRUM METH B, V80-1, P445, DOI 10.1016/0168-583X(93)96158-9
   Eskildsen SS, 1999, SURF COAT TECH, V116, P18, DOI 10.1016/S0257-8972(99)00142-5
   Fauchais P, 2000, INT J THERM SCI, V39, P852, DOI 10.1016/S1290-0729(00)01195-9
   GLASS DE, 2001, EFFECTIVENESS DIFFUS, P1264
   HILL RJ, 1986, PHYS VAPOR DEPOSITIO, P1
   HIRVONEN JK, 1991, MATER SCI REP, V6, P215, DOI 10.1016/0920-2307(91)90008-B
   Hocking M. G., 1989, METALLIC CERAMIC COA
   HOLLECK H, 1990, SURF COAT TECH, V41, P179, DOI 10.1016/0257-8972(90)90166-A
   HOLLECK H, 1999, TMS PUBLICATION, P207
   HULL R, 1992, MATER RES SOC SYMP P, V239, P379
   Je JH, 1997, J APPL PHYS, V81, P6126, DOI 10.1063/1.364394
   KAUFMAN H, 1987, CHARACTERISTICS CAPA, P1
   KNUYT G, 1995, THIN SOLID FILMS, V258, P159, DOI 10.1016/0040-6090(94)06353-2
   LEONHARDT T, 2000, C P 36 AM I AER AER, P1
   MCINTYRE R, 1996, MAT P, V8, P455
   Milewski JO, 1998, MATER MANUF PROCESS, V13, P719, DOI 10.1080/10426919808935294
   MILLER RA, 1987, SURF COAT TECH, V30, P1, DOI 10.1016/0257-8972(87)90003-X
   MILLER RA, 1987, SURF COAT TECH, V309, P1
   MILLER RA, 1995, 3312 NASA CP, P17
   NOYAN IC, 1995, CRIT REV SOLID STATE, V20, P125, DOI 10.1080/10408439508243733
   OBERLANDER BC, 1992, MATER SCI TECH SER, V8, P657, DOI 10.1179/mst.1992.8.8.657
   Oettel H, 1995, SURF COAT TECH, V76, P265
   PEITER A, 1987, STRAIN           AUG, P103
   QULI FA, 1999, THESIS PENN STATE U
   RAUSCHENBACH B, 1989, NUCL INSTRUM METH B, V42, P216, DOI 10.1016/0168-583X(89)90709-X
   Ravichandran KS, 1999, J AM CERAM SOC, V82, P673
   REED BD, 1997, 107453 NASA, P1
   Rigney DV, 1997, J THERM SPRAY TECHN, V6, P167, DOI 10.1007/s11666-997-0008-6
   ROTH T, 1987, THIN SOLID FILMS, V153, P123, DOI 10.1016/0040-6090(87)90176-3
   SCHULTZ U, 1997, P AGARD WORKSH THERM
   SHERMAN AJ, 1991, J METALS         JUL, P20
   SINGH J, 1994, J MATER SCI, V29, P5232, DOI 10.1007/BF01171533
   Singh J, 2002, J MATER SCI, V37, P3261, DOI 10.1023/A:1016187101616
   SINGH J, 2003, 2 INT MAT S U NOV LI
   SINGH J, 2002, J ADV MAT PROCESS, V160, P39
   SINGH J, 1996, SURF ENG B, V7, P8
   Sobota J, 2001, SURF COAT TECH, V142, P590, DOI 10.1016/S0257-8972(01)01173-2
   SOHN YH, 1993, THESIS WORCESTER POL
   SPROUL W, 1994, CUTTING TOOL ENG, V2, P52
   Tan YJ, 2003, SURF COAT TECH, V167, P255, DOI 10.1016/S0257-8972(02)00916-7
   UNAL O, 1994, J AM CERAM SOC, V77, P984, DOI 10.1111/j.1151-2916.1994.tb07256.x
   VOSSEN JL, 1978, THIN FILM PROCESSES, P11
   Wolfe D, 1998, J MATER SCI, V33, P3677, DOI 10.1023/A:1004675900887
   WOLFE D, 1996, THESIS PENN STATE U
   Wolfe DE, 2005, SURF COAT TECH, V190, P132, DOI 10.1016/j.surfcoat.2004.04.071
   Wolfe DE, 2000, SURF COAT TECH, V124, P142, DOI 10.1016/S0257-8972(99)00644-1
   Wolfe DE, 2003, SURF COAT TECH, V165, P8, DOI 10.1016/S0257-8972(02)00666-7
   Wolfe DE, 2002, J MATER SCI, V37, P3777, DOI 10.1023/A:1016533913894
   Wolfe DE, 2002, SURF COAT TECH, V160, P206, DOI 10.1016/S0257-8972(02)00404-8
   Wolfe DE, 1999, J MATER SCI, V34, P2997, DOI 10.1023/A:1004668325924
   WOLFE DE, 1997, P ADV COATING TECHNO, P93
   WOLFE DE, 2001, SYNTHESIS CHARACTERI
   WOLFE DE, 1996, METALLURGICAL EVALUA
   WOLFE DE, 1996, NATO ADV STUDY I SER, V21, P441
   Xiang Q, 2000, THIN SOLID FILMS, V370, P243, DOI 10.1016/S0040-6090(00)00915-9
NR 61
TC 10
Z9 10
U1 1
U2 13
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 1059-9495
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD AUG
PY 2005
VL 14
IS 4
BP 448
EP 459
DI 10.1361/105994905X56223
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 954VT
UT WOS:000231184000007
DA 2018-10-20
ER

PT J
AU Wei, QF
   Wang, XQ
AF Wei, QF
   Wang, XQ
TI Dynamic characterization of carboxymethyl cellulosic nonwoven material
   in the environmental scanning electron microscope
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE environmental scanning electron microscope; carboxymethyl cellulosic
   fibers; dynamic tensile testing
ID ESEM
AB Carboxymethyl cellulosic fibers have been increasingly used in health care, agriculture and biomedical areas. The fundamental understanding of the material under different conditions is of importance in these applications. The use of environmental scanning electron microscopy for dynamic characterization of these nonwoven materials under different conditions has been explored in this study. Dynamic tensile testing under different humidity conditions was performed in a Philips XL 30 FEG-ESEM. The relative humidity in the microscope chamber was adjusted from 10% up to 100% by controlling the specimen temperature and the chamber pressure. The tensile testing was carried out on a stage that was placed in the microscope chamber. The studies under dynamic conditions have given new insight into the kinetics of structure formation, rearrangement and breakdown that are important for the processing and product development of these fiber materials. (c) 2005 Elsevier Inc. All rights reserved.
C1 So Yangtze Univ, Wuxi 214122, Peoples R China.
   Anhui Univ Technol & Sci, Wuhu 241000, Peoples R China.
RP Wei, QF (reprint author), So Yangtze Univ, Wuxi 214122, Peoples R China.
EM qfwei@sytu.edu.cn
RI Wei, Qufu/B-2457-2013
OI Wei, Qufu/0000-0003-2143-9939
CR Bowler P G, 1999, J Wound Care, V8, P499
   KOOPMAN N, 1993, MICROSC RES TECHNIQ, V25, P493, DOI 10.1002/jemt.1070250521
   MESSIER P, 1993, MICROSC RES TECHNIQ, V25, P374, DOI 10.1002/jemt.1070250505
   Risnes OK, 2003, J MATER SCI, V38, P2161, DOI 10.1023/A:1023724013635
   Wei QF, 2002, J AEROSOL SCI, V33, P1589, DOI 10.1016/S0021-8502(02)00096-4
   WEI QF, 2002, TECH TEXT INT, V7, P19
   2002, MEX TEXT, V12, P12
NR 7
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
J9 MATER CHARACT
JI Mater. Charact.
PD AUG
PY 2005
VL 55
IS 2
BP 148
EP 152
DI 10.1016/j.matchar.2005.04.010
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 952CH
UT WOS:000230978900007
DA 2018-10-20
ER

PT J
AU El Fray, M
   Boccaccini, AR
AF El Fray, M
   Boccaccini, AR
TI Novel hybrid PET/DFA-TiO2 nanocomposites by in situ polycondensation
SO MATERIALS LETTERS
LA English
DT Article
DE polymers; nanomaterials; TiO2 nanoparticles
ID TISSUE ENGINEERING APPLICATIONS; COMPOSITE-MATERIALS; NANOPHASE
   CERAMICS; POLYESTER; TIO2; SOL; BIOCOMPATIBILITY; OSTEOBLAST;
   COPOLYMERS; ADHESION
AB Multiblock poly(aliphatic/aromatic-ester)s containing phthalic acid sequences (as in poly(ethylene terephthalate) (PET) or poly(butylene terephthalate) (PBT)) and a dimmer fatty acid (DFA) represent novel biocompatible materials offering the processability of thermoplastics combined with the good elasticity of rubber (thermoplastic elastomers, TPE). In the present investigation TiO2 nanoparticles were incorporated into PET/DFA copolymer with the aim of increasing mechanical properties and bioactivity, for use of the composites in tissue engineering and other biomedical applications. It was found that a relatively low concentration of TiO2 nanoparticles (0.13 vol.%) led to an impressive improvement of fracture strength (100%) and elongation at fracture (300%). As expected, the surface roughness increased with the addition of TiO2 nanoparticles. However upon immersion in simulated body fluid for up to 21 days, the composites did not exhibit formation of hydroxyapatite crystals on their surfaces, confirming the "bioinert" character of the composite constituents. This indicates that the possible bioactive behavior of the composites in in vitro or in vivo conditions may be related to the improved nanotopography imparted by TiO2 nanoparticle additions rather than due to chemistry related effects at the cell/biomaterial interface. (c) 2005 Elsevier B.V. All rights reserved.
C1 Szcsecin Univ Technol, Inst Polymer, PL-70322 Szczecin, Poland.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RP El Fray, M (reprint author), Szcsecin Univ Technol, Inst Polymer, Pulaskiego 10, PL-70322 Szczecin, Poland.
EM mirfray@ps.pl
RI El Fray, Miroslawa/J-4128-2016; Boccaccini, Aldo/C-7905-2013
OI El Fray, Miroslawa/0000-0002-2474-3517
CR Areva S, 2004, J BIOMED MATER RES A, V70A, P169, DOI 10.1002/jbm.a.20120
   BAKKER D, 1990, J BIOMED MATER RES, V24, P489, DOI 10.1002/jbm.820240407
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Chen XC, 2002, J MATER SCI LETT, V21, P1637, DOI 10.1023/A:1020871830587
   El Fray M, 2000, J MATER SCI-MATER M, V11, P757
   El Fray M, 1996, ANGEW MAKROMOL CHEM, V234, P103
   El Fray M, 2003, NANOSTRUCTURED ELAST, P1
   ELFRAY M, 2003, SCI PAPERS I ORGANIC, V52, P481
   ETTLINGER M, TECHNICAL B PIGMENTS, V80, P5
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Holden G., 1996, THERMOPLASTIC ELASTO
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jokinen M, 1998, J BIOMED MATER RES, V42, P295, DOI 10.1002/(SICI)1097-4636(199811)42:2<295::AID-JBM15>3.0.CO;2-I
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Moritz N, 2003, J BIOMED MATER RES A, V65A, P9, DOI 10.1002/jbm.a.10434
   Prowans P, 2002, BIOMATERIALS, V23, P2973, DOI 10.1016/S0142-9612(02)00026-1
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Renke-Gluszko M, 2004, BIOMATERIALS, V25, P5191, DOI 10.1016/j.biomaterials.2003.12.021
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   SZYCHER M, 1990, POLYURETHANE ELASTOM
   Wang SX, 1999, J MATER SCI LETT, V18, P2009, DOI 10.1023/A:1006646219253
   Webster TJ, 2003, AM CERAM SOC BULL, V82, P23
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wise DL, 2000, BIOMATERIALS BIOENGI
   Zheng MP, 2000, J MATER SCI LETT, V19, P433, DOI 10.1023/A:1006703224379
NR 27
TC 37
Z9 37
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2005
VL 59
IS 18
BP 2300
EP 2304
DI 10.1016/j.matlet.2005.03.008
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 935XQ
UT WOS:000229817100014
DA 2018-10-20
ER

PT J
AU Didenko, VV
   Moore, VC
   Baskin, DS
   Smalley, RE
AF Didenko, VV
   Moore, VC
   Baskin, DS
   Smalley, RE
TI Visualization of individual single-walled carbon nanotubes by
   fluorescent polymer wrapping
SO NANO LETTERS
LA English
DT Article
AB Manipulating optical properties Of single-walled nanotubes (SWNTs) is necessary for the development of nanoscale optical devices and probes for biomedical research. In life sciences it will make possible the direct observation of SWNTs inside living cells using optical microscopes. In the nanotechnology field it will enable the development of nanosensors with fluorescent reporting. However, the direct fluorescent labeling of SWNTs is obstructed by their strong light quenching qualities. Besides, chemical functionalization of SWNTs needed for the covalent attachment of fluorescent dyes could change favorable properties of nanotubes. Here we report that optical properties of SWNTs can be manipulated without their covalent modification by wrapping them with fluorescently labeled polymer poly(vinylpyrrolidone) (PVP-1300). Fluorescent PVP-1300 forms a monomolecular similar to 2.5 nm thick layer coiling around individual SWNTs and nanotube bundles. PVP casing is fluorescent although it is only several nanometers thick. This makes individual SWNTs observable by a fluorescent microscope. The spare polymer strands left over after wrapping around the relatively shorter nanotubes form junctions between SWNTs tying them together into new configurations, primarily Y- and Psi-type junctions. The ability to use a single fluorescent polymer strand to fasten nanotubes together can be useful in assembly of nanotube-made devices. In PVP-covered SWNTs multiple fluorophores are attached to each single nanotube making them unique composite fluorophores attractive as parts of biological fluorescent probes and in the development of the new materials in photonics and nanotechnology.
C1 Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA.
   Methodist Neurol Inst, Dept Neurosurg, Houston, TX 77030 USA.
   Rice Univ, Rice Quantum Inst, Dept Chem, Houston, TX 77005 USA.
   Rice Univ, Ctr Nanoscale Sci & Technol, Houston, TX 77005 USA.
RP Didenko, VV (reprint author), Baylor Coll Med, Dept Neurosurg, 2002 Holocombe Blvd,Bldg 109,Room 204, Houston, TX 77030 USA.
FU NIA NIH HHS [R03 AG022664]
CR Chiang IW, 2001, J PHYS CHEM B, V105, P8297, DOI 10.1021/jp0114891
   GROSS AJ, 1959, J BIOL CHEM, V234, P1611
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631
   Prakash R, 2003, APPL PHYS LETT, V83, P1219, DOI 10.1063/1.1599042
   Riggs JE, 2000, J AM CHEM SOC, V122, P5879, DOI 10.1021/ja9942282
   Zhu WH, 2003, J MATER CHEM, V13, P2196, DOI 10.1039/b303885h
NR 7
TC 74
Z9 76
U1 1
U2 38
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD AUG
PY 2005
VL 5
IS 8
BP 1563
EP 1567
DI 10.1021/nl050840h
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 955FQ
UT WOS:000231211300007
PM 16089489
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kalkan, AK
   Henry, MR
   Li, HD
   Cuiffi, JD
   Hayes, DJ
   Palmer, C
   Fonash, SJ
AF Kalkan, AK
   Henry, MR
   Li, HD
   Cuiffi, JD
   Hayes, DJ
   Palmer, C
   Fonash, SJ
TI Biomedical/analytical applications of deposited nanostructured Si films
SO NANOTECHNOLOGY
LA English
DT Article
ID CHEMICAL-VAPOR-DEPOSITION; IONIZATION MASS-SPECTROMETRY; LONG
   DNA-MOLECULES; POROUS SILICON; INFRARED-ABSORPTION; NANOCRYSTALLINE SI;
   RAMAN-SCATTERING; RAPID-RESPONSE; CELL BEHAVIOR; SURFACES
AB We report on various biomedical applications of our deposited nanostructured column-void Si films including respiratory monitoring, quick mass analysis for proteomics, and cell attachment. These applications exploit certain unique attributes of our nanostructured Si material that are not present for bulk Si, such as molecular immobilization, enhanced coupling with electromagnetic radiation, high surface area, and pronounced hydrophobicity. A brief review of morphology and film growth is also given according to our latest understanding. Our capability of controlling columnar separation and porosity by varying film growth conditions allows the tailoring of the properties of our films as well as the optimization of the performance in an application. The fact that these films can be deposited on low processing temperature substrates such as plastics further enhances their versatility.
C1 Penn State Ctr Nanotechnol Educ & Utilizat, University Pk, PA 16802 USA.
   NanoHorizons Inc, State Coll, PA 16803 USA.
   Penn State Univ Hosp, Milton S Hershey Med Ctr, Hershey, PA 17033 USA.
RP Kalkan, AK (reprint author), Penn State Ctr Nanotechnol Educ & Utilizat, University Pk, PA 16802 USA.
RI Kalkan, Ali/H-3413-2011
OI Hayes, Daniel/0000-0001-9499-4111
CR ANDERSON JH, 1968, J PHYS CHEM-US, V72, P3662, DOI 10.1021/j100856a051
   ANDERSON RC, 1990, SENSOR ACTUAT A-PHYS, V21, P835
   Arroyo-Hernandez M, 2003, MAT SCI ENG C-BIO S, V23, P697, DOI 10.1016/j.msec.2003.09.159
   Baba M, 2003, APPL PHYS LETT, V83, P1468, DOI 10.1063/1.1602555
   Bae SH, 1998, J VAC SCI TECHNOL A, V16, P1912, DOI 10.1116/1.581195
   Bayliss S, 1997, THIN SOLID FILMS, V297, P308, DOI 10.1016/S0040-6090(96)09416-3
   Bayliss SC, 1999, ADV MATER, V11, P318, DOI 10.1002/(SICI)1521-4095(199903)11:4<318::AID-ADMA318>3.0.CO;2-Z
   Bhatia SN, 1998, J BIOMAT SCI-POLYM E, V9, P1137, DOI 10.1163/156856298X00695
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Buttiglieri S, 2003, BIOMATERIALS, V24, P2731, DOI 10.1016/S0142-9612(03)00088-7
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   Canham LT, 1997, THIN SOLID FILMS, V297, P304, DOI 10.1016/S0040-6090(96)09534-X
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297
   Chun AL, 2004, NANOTECHNOLOGY, V15, pS234, DOI 10.1088/0957-4484/15/4/022
   COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204
   Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711
   Cuiffi JD, 2001, ANAL CHEM, V73, P1292, DOI 10.1021/ac001081k
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Falconnet D, 2004, NANO LETT, V4, P1909, DOI 10.1021/nl0489438
   Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550
   FLEMING WJ, 1981, P INT AUT M SAE DETR, P51
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fletcher BL, 2004, NANO LETT, V4, P1809, DOI 10.1021/nl0493702
   Fonash S. J., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4236, P280, DOI 10.1117/12.418778
   Gu LQ, 1999, NATURE, V398, P686
   Haes AJ, 2004, NANO LETT, V4, P1029, DOI 10.1021/nl049670j
   Han J, 1999, PHYS REV LETT, V83, P1688, DOI 10.1103/PhysRevLett.83.1688
   Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026
   HENRY MR, 2004, THESIS PENNSYLVANIA
   Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048
   JIA YQ, 1993, J APPL PHYS, V74, P7615, DOI 10.1063/1.354940
   Kalkan AK, 2000, APPL PHYS LETT, V77, P55, DOI 10.1063/1.126875
   Kalkan AK, 2004, IEEE ELECTR DEVICE L, V25, P526, DOI 10.1109/LED.2004.832657
   Kalkan AK, 2000, J APPL PHYS, V88, P555, DOI 10.1063/1.373695
   KALKAN AK, 2001, THESIS PENNSYLVANIA
   KANEKO T, 1994, APPL PHYS LETT, V64, P1865, DOI 10.1063/1.111781
   KIRK CT, 1988, PHYS REV B, V38, P1255, DOI 10.1103/PhysRevB.38.1255
   LANGE P, 1989, J APPL PHYS, V66, P201, DOI 10.1063/1.344472
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lau KKS, 2003, NANO LETT, V3, P1701, DOI 10.1021/nl034704t
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Laville C, 2002, IEEE SENS J, V2, P96, DOI 10.1109/JSEN.2002.1000249
   LI H, 2004, THESIS PENNSYLVANIA
   Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037
   Liu JQ, 2001, BIOMACROMOLECULES, V2, P362, DOI 10.1021/bm015515c
   Malac M, 2001, J VAC SCI TECHNOL A, V19, P158, DOI 10.1116/1.1326940
   PAI PG, 1986, J VAC SCI TECHNOL A, V4, P689, DOI 10.1116/1.573833
   Robertson J, 2003, J APPL PHYS, V93, P731, DOI 10.1063/1.1529090
   SASAKI Y, 1994, J APPL PHYS, V76, P4344, DOI 10.1063/1.357321
   Sgarbi N, 2004, BIOMATERIALS, V25, P1349, DOI 10.1016/j.biomaterials.2003.08.017
   Shah RR, 2001, SCIENCE, V293, P1296, DOI 10.1126/science.1062293
   Shi HQ, 1999, NATURE, V398, P593
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Stewart MP, 2000, ADV MATER, V12, P859, DOI 10.1002/1521-4095(200006)12:12<859::AID-ADMA859>3.0.CO;2-0
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Tatara T, 1997, J CLIN MONITOR, V13, P5, DOI 10.1023/A:1007380021895
   Teixeira AI, 2003, J VAC SCI TECHNOL B, V21, P683, DOI 10.1116/1.1545753
   THEIL JA, 1990, J VAC SCI TECHNOL A, V8, P1374, DOI 10.1116/1.576885
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wei J, 1999, NATURE, V399, P243, DOI 10.1038/20400
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Yonzon CR, 2004, ANAL CHEM, V76, P78, DOI 10.1021/ac035134k
NR 65
TC 21
Z9 21
U1 0
U2 1
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD AUG
PY 2005
VL 16
IS 8
BP 1383
EP 1391
DI 10.1088/0957-4484/16/8/068
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 957YX
UT WOS:000231410600068
DA 2018-10-20
ER

PT J
AU Skipper, LJ
   Sowrey, FE
   Rashid, R
   Newport, RJ
   Lin, Z
   Smith, ME
AF Skipper, LJ
   Sowrey, FE
   Rashid, R
   Newport, RJ
   Lin, Z
   Smith, ME
TI X-ray diffraction and solid state NMR studies of the growth of
   hydroxyapatite on bioactive calcia : silica sol-gel glasses
SO PHYSICS AND CHEMISTRY OF GLASSES
LA English
DT Article; Proceedings Paper
CT 9th International Conference on the Structure of Non-Crystalline
   Materials (NCM9)
CY JUL 11-15, 2004
CL Alfred Univ, Corning, NY
HO Alfred Univ
ID COMPOSITIONAL DEPENDENCE; SURFACE-CHEMISTRY; APATITE FORMATION; CAO-SIO2
   SYSTEM; BIOGLASSES
AB An advanced materials characterisation methodology has been used to examine systematically a range of sol-gel glass materials of contemporary biomedical interest. High energy x-ray total diffraction, x-ray fluorescence and Raman spectroscopy, and isotope-enriched O-17 and P-31 MAS NMR have been used to study the local calcium environment in four sol-gel derived bioactive calcium silicate glasses of the general formula (CaO)(x)(SiO2)(1-x), and to gain an atomic scale insight into the nature of the processes initiated when this bioactive glass is immersed in vitro in simulated body fluid (SBF). The results reveal a rapid dissolution of the labile surface calcium ions from the glass within 30 min of immersion in SBF and the later formation of a hydroxyapatite like layer, which MAS NMR suggests is partially ordered locally, but which x-ray diffraction confirms as amorphous overall Annealing the samples at 650 degrees C allows this layer to crystallise, revealing the anticipated hydroxyapatite layer more clearly. The results presented here are consistent with, but greatly extend our previous XRD, Ca-43 and Si-29 MAS-NMR, XANES and EXAFS studies of these materials.
C1 Univ Kent, Sch Phys Sci, Canterbury CT2 7NR, Kent, England.
   Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.
RP Skipper, LJ (reprint author), Univ Kent, Sch Phys Sci, Canterbury CT2 7NR, Kent, England.
EM ljs32@kent.ac.uk
RI Renold, Ria/K-7051-2018; Newport, Robert/C-9973-2012
OI Newport, Robert/0000-0002-2365-992X
CR Cerruti M, 2003, J MATER CHEM, V13, P1279, DOI 10.1039/b300961k
   DIRKEN PJ, 1995, J PHYS CHEM-US, V99, P395, DOI 10.1021/j100001a059
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Gunawidjaja PN, 2003, SOLID STATE NUCL MAG, V23, P88, DOI 10.1016/S0926-2040(02)00019-X
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1996, CLIN PERFORMANCE SKE
   KIM CY, 1992, J BIOMED MATER RES, V26, P1147, DOI 10.1002/jbm.820260905
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kontonasaki E, 2002, CRYST RES TECHNOL, V37, P1165, DOI 10.1002/1521-4079(200211)37:11<1165::AID-CRAT1165>3.0.CO;2-R
   LI R, 1992, CHEM PROCESSING ADV, pP627
   MacKenzie K. J. D., 2002, MULTINUCLEAR SOLID S
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   PEREIRA MM, 1994, J MATER SYNTH PROCES, V2, P189
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P1, DOI 10.1016/S0022-3093(02)01864-1
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   SARAVANAPAVAN P, 2004, BIOMED MAT ENG, P1
   Skipper LJ, 2004, J BIOMED MATER RES A, V70A, P354, DOI 10.1002/jbm.a.30093
NR 21
TC 22
Z9 22
U1 0
U2 5
PU SOC GLASS TECHNOLOGY
PI SHEFFIELD
PA THORNTON 20 HALLAM GATE ROAD, SHEFFIELD S10 5BT, S YORKSHIRE, ENGLAND
SN 0031-9090
J9 PHYS CHEM GLASSES
JI Phys. Chem. Glasses
PD AUG
PY 2005
VL 46
IS 4
BP 372
EP 376
PG 5
WC Chemistry, Physical; Materials Science, Ceramics
SC Chemistry; Materials Science
GA 002FQ
UT WOS:000234597300013
DA 2018-10-20
ER

PT J
AU Detrano, RC
   Anderson, M
   Nelson, J
   Wong, ND
   McNitt-Gray, M
   Bild, DE
AF Detrano, RC
   Anderson, M
   Nelson, J
   Wong, ND
   McNitt-Gray, M
   Bild, DE
TI Coronary calcium measurements: Effect of CT scanner type and calcium
   measure on rescan reproducibility - MESA study
SO RADIOLOGY
LA English
DT Article
ID ELECTRON-BEAM CT; ULTRAFAST COMPUTED-TOMOGRAPHY; ARTERY CALCIUM;
   QUANTIFICATION; CALCIFICATION; ATHEROSCLEROSIS; INDIVIDUALS; MOTION
AB PURPOSE: To evaluate the effect of scanner type and calcium measure on the reproducibility of calcium measurements.
   MATERIALS AND METHODS: This investigation was approved by the institutional review boards of each study site and by the Institutional Review Board of the Los Angeles Biomedical Research Institute. Informed consent for scanning and participation was obtained from all participants. The study was Health Insurance Portability and Accountability Act compliant. The Multi-Ethnic Study of Atherosclerosis (MESA) is a multicenter observational study of 6814 participants undergoing demographic, risk factor, and subdinical disease evaluations. Coronary artery calcium was measured by using duplicate CT scans. Three study centers used electron-beam computed tomography (CT), and three used multi-detector row CT. Coronary artery calcium was detected in 3355 participants. Three calcium measurement methods-Agatston score, calcium volume, and interpolated volume score-were evaluated. Mean absolute differences between calcium measures on scans 1 and 2, excluding cases for which both scans had a measure of zero, was modeled by using linear regression to compare reproducibility between scanner types. A repeated measures analysis of variance test was used to compare reproducibility across calcium measures, with mean percentage absolute difference as the outcome measure. Rescan reproducibility in relation to misregistrations, noise, and motion artifacts was also examined. Variables were log transformed to create a more normal distribution.
   RESULTS: Concordance for presence of calcium between duplicate scans was high and similar for both electron-beam and multi-detector row CT (96%, kappa = 0.92). Mean absolute difference between calcium scores for the two scans was 15.8 for electron-beam and 16.9 for multi-detector row CT scanners (P = .06). Mean relative differences were 20.1 for Agatston score, 18.3 for calcium volume, and 18.3 for interpolated volume score (P < .01). Reproducibility was lower for scans with versus those without image misregistrations or motion artifacts (P < .01 for both).
   CONCLUSION: Electron-beam and multi-detector row CT scanners have equivalent reproducibility for measuring coronary artery calcium. Calcium volumes and interpolated volume scores are slightly more reproducible than Agatston scores. Reproducibility is lower for scans with misregistrations or motion artifacts. (c) RSNA, 2005.
C1 Los Angeles Biomed Res Inst, Div Cardiol, Torrance, CA 90502 USA.
   Univ Washington, Ctr Hlth Studies, Grp Hlth Cooperat, Seattle, WA 98195 USA.
   Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA.
   Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA.
   NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA.
RP Detrano, RC (reprint author), Los Angeles Biomed Res Inst, Div Cardiol, 1124 W Carson St,Bldg E-5, Torrance, CA 90502 USA.
EM rdetrano@labiomed.org
OI McNItt-Gray, Michael/0000-0003-3004-4613
FU NHLBI NIH HHS [N01-HC-95159-95165]
CR Achenbach S, 2001, J COMPUT ASSIST TOMO, V25, P569, DOI 10.1097/00004728-200107000-00010
   Achenbach S, 2000, RADIOLOGY, V216, P457, DOI 10.1148/radiology.216.2.r00au19457
   AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Becker CR, 1999, EUR RADIOL, V9, P620, DOI 10.1007/s003300050720
   BIELAK LF, 1994, RADIOLOGY, V192, P631, DOI 10.1148/radiology.192.3.8058926
   Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272
   Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864
   Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439
   Carr JJ, 2000, AM J ROENTGENOL, V174, P915, DOI 10.2214/ajr.174.4.1740915
   DEVRIES S, 1995, AM J CARDIOL, V75, P973, DOI 10.1016/S0002-9149(99)80706-1
   Goldin JG, 2001, RADIOLOGY, V221, P213, DOI 10.1148/radiol.2211001038
   Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210
   International Commission on Radiological Protection, 1991, ICRP PUBL, V60, P21
   KAJINAMI K, 1993, CORONARY ARTERY DIS, V4, P1103, DOI 10.1097/00019501-199312000-00011
   Lu B, 2001, INVEST RADIOL, V36, P250, DOI 10.1097/00004424-200105000-00002
   Mao SS, 2001, RADIOLOGY, V220, P707, DOI 10.1148/radiol.2203001129
   McNitt-Gray MF, 2003, SEMIN ROENTGENOL, V38, P87, DOI 10.1053/sroe.2003.50004
   McNitt-Gray MF, 2002, RADIOGRAPHICS, V22, P1541, DOI 10.1148/rg.226025128
   Mohlenkamp S, 2001, INT J CARDIAC IMAG, V17, P133, DOI 10.1023/A:1010619216797
   Nelson JC, 2005, RADIOLOGY, V235, P403, DOI 10.1148/radiol.2352040515
   Ohnesorge B, 2002, EUR RADIOL, V12, P1532, DOI 10.1007/s00330-002-1394-2
   Park R, 2002, CIRCULATION, V106, P2073, DOI 10.1161/01.CIR.0000033819.29662.09
   Shields J P, 1995, Am J Card Imaging, V9, P62
   Wang SJ, 1996, AM HEART J, V132, P550, DOI 10.1016/S0002-8703(96)90237-9
   Yaghoubi S, 1995, Am J Card Imaging, V9, P231
NR 26
TC 184
Z9 185
U1 0
U2 1
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD AUG
PY 2005
VL 236
IS 2
BP 477
EP 484
DI 10.1148/radiol.23620405013
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 947TM
UT WOS:000230670200015
PM 15972340
DA 2018-10-20
ER

PT J
AU Izquierdo-Barba, I
   Ruiz-Gonzalez, L
   Doadrio, JC
   Gonzalez-Calbet, JM
   Vallet-Regi, M
AF Izquierdo-Barba, I
   Ruiz-Gonzalez, L
   Doadrio, JC
   Gonzalez-Calbet, JM
   Vallet-Regi, M
TI Tissue regeneration: A new property of mesoporous materials
SO SOLID STATE SCIENCES
LA English
DT Article
ID HYDROXYAPATITE FORMATION; MOLECULAR-SIEVES; GEL GLASSES; PORE SIZES;
   SILICA; MCM-41; ADSORPTION; SURFACE; RELEASE; GROWTH
AB A new application of mesoporous materials as bone regenerators is described. In vitro bioactivity studies by soaking three different mesoporous materials, SBA-15, MCM-48 and MCM-41, in simulated body fluid (SBF) have been carried out. After the in vitro test, the study by Fourier transform infrared spectroscopy, scanning electron microscopy, energy dispersive spectroscopy, electron diffraction and microscopy shows that an apatite-like layer is formed on the surface of SBA-15 and MCM-48 materials after 30 and 60 days, respectively, allowing their use in biomedical engineering for tissue regeneration. (c) 2005 Elsevier SAS. All rights reserved.
C1 UCM, Fac Farm, Dept Quim Inorgan & Bioinorgan, Madrid 28040, Spain.
   UCM, Fac Quim, Dept Quim Inorgan, Madrid 28040, Spain.
RP Vallet-Regi, M (reprint author), UCM, Fac Farm, Dept Quim Inorgan & Bioinorgan, Madrid 28040, Spain.
EM vallet@farm.ucm.es
RI IZQUIERDO-BARBA, ISABEL/M-9921-2014; Gonzalez-Calbet, Jose/K-8047-2014;
   Vallet-Regi, Maria/M-3378-2014; Doadrio, Juan Carlos/G-9445-2017
OI IZQUIERDO-BARBA, ISABEL/0000-0002-4139-4646; Gonzalez-Calbet,
   Jose/0000-0002-6481-6506; Vallet-Regi, Maria/0000-0002-6104-4889;
   Doadrio, Juan Carlos/0000-0001-7912-5663; RUIZ GONZALEZ, MARIA
   LUISA/0000-0003-3546-2347
CR BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   CASTNER DG, 2002, SURF SCI, V28, P500
   Charnay C, 2004, EUR J PHARM BIOPHARM, V57, P533, DOI 10.1016/j.ejph.2003.12.007
   Che S, 2004, NATURE, V429, P281, DOI 10.1038/nature02529
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   IZQUIERDOBARBA I, UNPUB MICROPOROUS MA
   Kaneda M, 2002, J PHYS CHEM B, V106, P1256, DOI 10.1021/jp0131875
   Kim JM, 1998, CHEM COMMUN, P259, DOI 10.1039/a707677k
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kruk M, 2000, CHEM MATER, V12, P1414, DOI 10.1021/cm990764h
   Kruk M, 1997, LANGMUIR, V13, P6267, DOI 10.1021/la970776m
   Kruk M, 1997, J PHYS CHEM B, V101, P583, DOI 10.1021/jp962000k
   LEGEROS RZ, 1991, MONOGRAPHS ORAL SCI, P114
   Li P., 1992, J AM CERAM SOC, V75, P2097
   Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q
   NAKANISHI K, 1991, J AM CERAM SOC, V74, P2518, DOI 10.1111/j.1151-2916.1991.tb06794.x
   NICOLOPOULOS S, 1995, J SOLID STATE CHEM, V116, P265, DOI 10.1006/jssc.1995.1212
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Vallet-Regi M, 1999, J BIOMED MATER RES, V44, P416, DOI 10.1002/(SICI)1097-4636(19990315)44:4<416::AID-JBM7>3.0.CO;2-S
   Vallet-Regi M, 2004, SOLID STATE IONICS, V172, P435, DOI 10.1016/j.ssi.2004.04.036
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vallet-Regi M, 2000, CHEM MATER, V12, P3770, DOI 10.1021/cm001068g
   XU J, 2000, CHEM MATER, V10, P360
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
NR 26
TC 136
Z9 140
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1293-2558
J9 SOLID STATE SCI
JI Solid State Sci.
PD AUG
PY 2005
VL 7
IS 8
BP 983
EP 989
DI 10.1016/j.solidstatesciences.2005.04.003
PG 7
WC Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed
   Matter
SC Chemistry; Physics
GA 956YG
UT WOS:000231335400011
DA 2018-10-20
ER

PT J
AU Oh, HJ
   Lee, JH
   Jeong, Y
   Kim, YJ
   Chi, CS
AF Oh, HJ
   Lee, JH
   Jeong, Y
   Kim, YJ
   Chi, CS
TI Microstructural characterization of biomedical titanium oxide film
   fabricated by electrochemical method
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Advances of Thin Films and Coating
   Technology
CY JUL 13-17, 2004
CL Singapore, SINGAPORE
DE anodizing; titanium oxide; X-ray diffraction; photoelectron spectroscopy
ID HEXAGONAL PORE ARRAYS; ANODIC ALUMINA; INTERPORE DISTANCE; APATITE
   FORMATION; SURFACE; IMPLANTS
AB For an application as biomedical materials of high performance with a good biocompatibility, the anodic TiO2 layer on Ti substrate has been fabricated by electrochemical method, and the characteristics of anodic titania film have been investigated. X-ray diffraction (XRD) results indicate that the titania film formed in acidic electrolyte with additives is mainly composed of anatase structure containing rutile. From the analysis of chemical states of the anodic film using X-ray photoelectron spectroscopy (XPS), phosphorus and sulfur were observed in the anodic film, which were penetrated from the electrolyte into the oxide layer during anodic process. From the result of biological evaluation in simulated body fluid (SBF), the anodic TiO2 film was effective for bioactive property. (c) 2004 Elsevier B.V. All rights reserved.
C1 Kookmin Univ, Sch Adv Mat Engn, Seoul 136702, South Korea.
   Hanseo Univ, Dept Mat Sci, Seosan 352820, South Korea.
   Hanseo Univ, Dept Chem, Seosan 352820, South Korea.
   Korea Inst Machinery & Mat, Chang Won 641010, South Korea.
   Sungkyunkwan Univ, Dept Met Engn, Suwon 440746, South Korea.
RP Chi, CS (reprint author), Kookmin Univ, Sch Adv Mat Engn, Seoul 136702, South Korea.
EM cschi@kookmin.ac.kr
CR Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Chen Q, 1999, BIOMATERIALS, V20, P1127, DOI 10.1016/S0142-9612(99)00015-0
   Clupper DC, 2001, J MATER SCI-MATER M, V12, P917, DOI 10.1023/A:1012836426866
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Jessensky O, 1998, APPL PHYS LETT, V72, P1173, DOI 10.1063/1.121004
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   Kontonasaki E, 2002, CRYST RES TECHNOL, V37, P1165, DOI 10.1002/1521-4079(200211)37:11<1165::AID-CRAT1165>3.0.CO;2-R
   Li AP, 1998, J APPL PHYS, V84, P6023, DOI 10.1063/1.368911
   Li AP, 2000, ELECTROCHEM SOLID ST, V3, P131
   Nakahira A, 2001, J CERAM PROCESS RES, V2, P108
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Weng WJ, 1998, BIOMATERIALS, V19, P125, DOI 10.1016/S0142-9612(97)00177-4
   Weng WJ, 2003, SURF COAT TECH, V167, P292, DOI 10.1016/S0257-8972(02)00922-2
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
NR 17
TC 80
Z9 80
U1 2
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 1
PY 2005
VL 198
IS 1-3
BP 247
EP 252
DI 10.1016/j.surfcoat.2004.10.029
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 944HZ
UT WOS:000230419400051
DA 2018-10-20
ER

PT J
AU Dearnley, PA
AF Dearnley, PA
TI A brief review of test methodologies for surface-engineered biomedical
   implant alloys
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Advances of Thin Films and Coating
   Technology
CY JUL 13-17, 2004
CL Singapore, SINGAPORE
DE total joint replacements; surface engineering; biomedical implant alloys
ID WEAR; 316L
AB Surface engineering opens up very many exciting opportunities for new designs of bio-medical implant devices like total joint replacements (TJRs). The development of new bearing surface materials for such devices, however, is a very slow process. This is due to the longevity of in vitro wear tests, biocompatibility studies, clinical trials and final adoption. Given the diversity of new bearing surface materials that modem surface engineering can make possible, there is a clear need to develop valid and rapid screening tests. A brief review of possible accelerated test methods, developed at Leeds, is presented. The tests are designed to evaluate tolerance to: (i) mechanical (third body abrasion) damage; (ii) corrosion and; (iii) corrosion-wear. By referring to specific investigations throughout, the scope of such tests is fully illustrated. It Is shown that both mechanical and chemical attributes for a given surface engineering design are important in the realisation of the overall goal of improved bearing surfaces for TJRs. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Leeds, Sch Mech Engn, Leeds LS2 9JT, W Yorkshire, England.
RP Dearnley, PA (reprint author), Univ Leeds, Sch Mech Engn, Leeds LS2 9JT, W Yorkshire, England.
EM p.a.dearnley@leeds.ac.uk
CR Dahm K.L., 2000, THINNING FILMS TRIBO, P155
   Dahm K. L., 1995, SURF ENG, V11, P138
   Dahm KL, 2000, P I MECH ENG L-J MAT, V214, P181, DOI 10.1243/1464420001544799
   Dearnley PA, 2004, WEAR, V256, P491, DOI 10.1016/S0043-1648(03)00559-3
   Dearnley PA, 2004, WEAR, V256, P469, DOI 10.1016/S0043-1648(03)00557-X
   Dearnley PA, 1999, P I MECH ENG H, V213, P107, DOI 10.1243/0954411991534843
   Harman MK, 1997, J ARTHROPLASTY, V12, P938, DOI 10.1016/S0883-5403(97)90164-9
   Komotori J, 2001, WEAR, V251, P1239, DOI 10.1016/S0043-1648(01)00753-0
   Minakawa H, 1998, J BONE JOINT SURG BR, V80B, P894, DOI 10.1302/0301-620X.80B5.8675
   NASSER S, 1990, CLIN ORTHOP RELAT R, P171
   Pappas M.J., 1992, European Patent Application, Patent No. [EP 0573694 A2, 0573694]
   Pina CF, 2004, TRIBOL INTER ENG, V43, P815
   Semlitsch M., 1996, P TIT 95 C SCI TECHN, V2, P1742
   WAUGH W, 1990, J CHARNLEY MAN HIP
NR 14
TC 38
Z9 42
U1 0
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 1
PY 2005
VL 198
IS 1-3
BP 483
EP 490
DI 10.1016/j.surfcoat.2004.10.067
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 944HZ
UT WOS:000230419400098
DA 2018-10-20
ER

PT J
AU Singh, R
   Martin, M
   Dahotre, NB
AF Singh, R
   Martin, M
   Dahotre, NB
TI Influence of laser surface modification on corrosion behavior of
   stainless steel 316L and Ti-6Al-4V in simulated biofluid
SO SURFACE ENGINEERING
LA English
DT Article
DE biomaterials; corrosion resistance; dendritic microstructure;
   electrochemical polarisation; E-pH diagram; laser surface melting; metal
   ion release; open circuit potential; passive current; pitting corrosion;
   Ringer's solution; SS316L; surface modification; Ti6Al4V; TiO2
ID METALLIC BIOMATERIALS; TITANIUM-ALLOY; RESISTANCE; MICROSTRUCTURE;
   IMPLANTATION
AB Laser surface engineering has been explored as a possible method for improving the functional surface properties of biomedical materials such as stainless steels and titanium alloys. This study emphasises the influence of laser surface processing, carried out at a range of laser powers from 500 to 1500 W in ambient atmosphere, on the surface microstructure and corrosion behaviour of stainless steel 316L (SS316L) and Ti-6Al-4V, and metal ions released during the corrosion process. A homogeneous surface microstructure includes columnar dendrites and fine grains in the resolidified region of SS316L. A gradual increase in grain size from the processed surface towards the substrate was revealed, The laser processing of Ti-6Al-4V produced a surface full of dendrites followed by acicular martensite in the interface region. The corrosion studies in Ringer's physiological solution showed an increase in the open circuit potential (OCP) as a result of laser surface treatment of both SS316L and Ti-6Al-4V (more noble than untreated). After laser processing, the corrosion properties of SS316L were seen to deteriorate, and those of Ti-6Al-4V to improve, as compared to their respective untreated counterparts. The variation of laser power influenced the corrosion resistance of SS316L, while that of Ti-6Al-4V did not vary significantly. Laser surface treatments at higher powers (> 1000 W) reduced the leaching of specific metallic ions from SS316L and Ti-6Al-4V during corrosion in Ringer's physiological solution.
C1 Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   Natl Met Lab, Jamshedpur 831007, Bihar, India.
   Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA.
   Oak Ridge Natl Lab, Mat Proc Grp, Div Met & Ceram, Oak Ridge, TN 37831 USA.
RP Dahotre, NB (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM ndahotre@utk.edu
RI Martin, Madhavi/A-5268-2011; Sahu, Anjani/E-7590-2015
CR BADEKAS H, 1994, J MATER PROCESS TECH, V44, P54, DOI 10.1016/0924-0136(94)90037-X
   Barbucci A, 2002, J ELECTROCHEM SOC, V149, pB534, DOI 10.1149/1.1516774
   Baszkiewicz J, 2000, J MATER SCI, V35, P767, DOI 10.1023/A:1004721721359
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Dayal RK, 1997, T INDIAN I METALS, V50, P1
   Garcia-Alonso MC, 2003, BIOMATERIALS, V24, P19, DOI 10.1016/S0142-9612(02)00237-5
   GRACIA I, 1998, CORROS SCI, V40, P1411
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   Hallab N, 2000, BIOMATERIALS, V21, P1301, DOI 10.1016/S0142-9612(99)00235-5
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   Harman MK, 2001, CLIN ORTHOP RELAT R, P383
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   KAZUHISA A, 2001, CORROS SCI, V43, P533
   KURZ W, 1992, FUNDAMENTALS SOLIDIF, P88
   Kwok CT, 2000, MAT SCI ENG A-STRUCT, V290, P55, DOI 10.1016/S0921-5093(00)00929-1
   Lei MK, 1997, J VAC SCI TECHNOL A, V15, P421, DOI 10.1116/1.580501
   Massoud SN, 1997, J BONE JOINT SURG BR, V79B, P603, DOI 10.1302/0301-620X.79B4.7131
   MUDALI UK, 1992, J MATER ENG PERFORM, V1, P341, DOI 10.1007/BF02652387
   MUDALI UK, 1991, MATER T JIM, V32, P845, DOI 10.2320/matertrans1989.32.845
   MUNITZ A, 1985, METALL TRANS B, V16, P149, DOI 10.1007/BF02657500
   SCHMETS J, 1963, ATLAS EQUILIBRES ELE, P213
   Schutz R.W., 1996, ASM HDB CORROSION, P669
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   SILVA RA, 1994, J MATER SCI-MATER M, V5, P353, DOI 10.1007/BF00058962
   SINGH R, 1995, TAPPI J, V12, P78
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Sun Z, 2003, MAT SCI ENG A-STRUCT, V345, P293, DOI 10.1016/S0921-5093(02)00477-X
   TOMASHOV ND, 1974, ELECTROCHIM ACTA, V19, P159, DOI 10.1016/0013-4686(74)85012-7
   TSYGANOV I, 2000, SURF COAT TECH, V158, P318
   Weerasinghe VM, 1996, J MATER PROCESS TECH, V58, P79, DOI 10.1016/0924-0136(95)02110-8
   Wilson AD, 1999, SURF COAT TECH, V114, P70, DOI 10.1016/S0257-8972(99)00024-9
   Yue TM, 2000, J MATER SCI LETT, V19, P205, DOI 10.1023/A:1006750422831
   YUE TM, 2002, MATER LETT, V5, P206
   ZIMMERMANN M, 1989, ACTA METALL MATER, V37, P3305, DOI 10.1016/0001-6160(89)90203-4
NR 34
TC 19
Z9 19
U1 0
U2 17
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0267-0844
J9 SURF ENG
JI Surf. Eng.
PD AUG
PY 2005
VL 21
IS 4
BP 297
EP 306
DI 10.1179/174329405X55320
PG 10
WC Materials Science, Coatings & Films
SC Materials Science
GA 968CG
UT WOS:000232138900005
DA 2018-10-20
ER

PT J
AU Zhao, YF
   Chen, CZ
   Wang, DG
AF Zhao, YF
   Chen, CZ
   Wang, DG
TI The current techniques for preparing bioglass coatings
SO SURFACE REVIEW AND LETTERS
LA English
DT Article
DE bioglass; coating; bioactivity; techniques
ID PULSED-LASER DEPOSITION; BIOACTIVE GLASS COATINGS; BIOCOMPOSITES;
   MICROSTRUCTURE; IMPLANTS; BEHAVIOR; FILMS
AB Bioglasses are promising alternatives as biomedical materials to repair or replace damaged parts of bones because of its good bioactivity and biocompatibility. It is possible to combine the bone-bonding ability of the bioglass surface with the high mechanical properties of the metallic substrate though the coating of metallic implants with bioglass. The principles and characteristics of some coating techniques, including sintering, plasma spray, sol-gel, electrophoresis deposition, ion beam assisted deposition and pulsed laser deposition, are introduced. Their current applications in preparing bioglass coatings are reviewed in detail. The future application trends are also reviewed.
C1 Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
   Shandong Architecture Engn Inst, Jinan 250014, Peoples R China.
RP Chen, CZ (reprint author), Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
EM czchen@sdu.edu.cn
OI Wang, Diangang/0000-0003-4980-116X; Chen, Chuanzhong/0000-0003-4044-6915
CR BARTH E, 1986, BIOMATERIALS, V4, P7
   Boyd IW, 1996, CERAM INT, V22, P429, DOI 10.1016/0272-8842(95)00086-0
   CHEN X, 2001, J CHIN CERAM SOC, V12, P565
   [陈晓明 Chen Xiaoming], 2002, [材料科学与工程, Materials Science and Engineering], V20, P545
   Cheung J T, 1994, PULSED LASER DEPOSIT, P1
   D'Alessio L, 2001, APPL SURF SCI, V183, P10, DOI 10.1016/S0169-4332(01)00466-4
   Fernandez-Pradas JM, 2002, BIOMATERIALS, V23, P2057, DOI 10.1016/S0142-9612(01)00335-0
   Ferraris M, 1996, J AM CERAM SOC, V79, P1515, DOI 10.1111/j.1151-2916.1996.tb08759.x
   FERRARIS M, 1995, MAT CLIN APPL ADV SC, P281
   FLAVIO LS, 1999, J NONCRYST SOLID, V247, P64
   GABBI C, 1995, BIOMATERIALS, V16, P515, DOI 10.1016/0142-9612(95)91123-G
   Gallardo J, 2000, J SOL-GEL SCI TECHN, V19, P107, DOI 10.1023/A:1008726608539
   GOLLER G, 2003, KEY ENG MATER, V15, P240
   HAMADOUCHE M, 2000, BIOACTIVITY SOL GEL, P35
   HAN Q, 2001, MATER ENG, V3, P45
   Hench LL., 1993, INTRO BIOCERAMICS, P239
   HENCH LL, 1991, BIOCERAMICS, V4, P231
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Kaczmarek SM, 1997, P SOC PHOTO-OPT INS, V11, P129
   Kitsugi T, 1996, J BIOMED MATER RES, V30, P261, DOI 10.1002/(SICI)1097-4636(199602)30:2<261::AID-JBM17>3.0.CO;2-P
   Li N, 2004, MATER LETT, V58, P2747, DOI 10.1016/j.matlet.2004.03.049
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   LI X, 2003, GLASS ENAMEL, V31, P37
   Liste S, 2004, THIN SOLID FILMS, V453, P224, DOI 10.1016/j.tsf.2003.11.258
   Liste S, 2004, THIN SOLID FILMS, V453, P219, DOI 10.1016/j.tsf.2003.11.123
   LIU Z, 2002, FUNCT MAT, V33, P200
   Lopez-Esteban S, 2003, J EUR CERAM SOC, V23, P2921, DOI 10.1016/S0955-2219(03)00303-0
   Lopez-Sastre A, 1998, INT ORTHOP, V22, P380, DOI 10.1007/s002640050282
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   NING C, 2002, MAT SCI TECHNICS, V8, P30
   Ning CQ, 2004, BIOMATERIALS, V25, P3379, DOI 10.1016/j.biomaterials.2003.10.017
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   PAJAMAKI KJJ, 1995, J MATER SCI-MATER M, V6, P14, DOI 10.1007/BF00121240
   TURUNEN T, 1995, J MATER SCI-MATER M, V6, P639, DOI 10.1007/BF00123444
   Verne E, 1999, J EUR CERAM SOC, V19, P2039, DOI 10.1016/S0955-2219(99)00036-9
   Verne E, 2002, J EUR CERAM SOC, V22, P2315, DOI 10.1016/S0955-2219(02)00030-4
   VERNE E, 1995, CERAM ORAL SURG, V12, P36
   VERNE E, 1997, BIOCERAMICS COATINGS, V11, P17
   Wang YH, 2003, CERAM RES, V1, P46
   [席仕伟 Xi Shiwei], 2002, [原子能科学技术, Atomic Energy Science and Technology], V36, P458
   YAN YH, 1997, J CHINESE CERAMIC SO, V25, P598
   Ylanen H, 2000, J NON-CRYST SOLIDS, V275, P107, DOI 10.1016/S0022-3093(00)00245-3
   Zhang F, 1998, SURF COAT TECH, V104, P146, DOI 10.1016/S0257-8972(98)00434-4
NR 43
TC 13
Z9 13
U1 2
U2 13
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-625X
EI 1793-6667
J9 SURF REV LETT
JI Surf. Rev. Lett.
PD AUG
PY 2005
VL 12
IS 4
BP 505
EP 513
DI 10.1142/S0218625X05007347
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 996BM
UT WOS:000234149400005
DA 2018-10-20
ER

PT J
AU Gray, JE
   Norton, PR
   Griffiths, K
AF Gray, JE
   Norton, PR
   Griffiths, K
TI Mechanism of adhesion of electroless-deposited silver on poly(ether
   urethane)
SO THIN SOLID FILMS
LA English
DT Article
DE adhesion; polymers; metallization; X-ray photoelectron spectroscopy
ID PLASMA; IDENTIFICATION; SPECTROSCOPY; ENVIRONMENT; CATHETERS
AB Bacterial growth on medical implants and devices is a common source of infection. There is a great deal of interest in the surface modification of polymeric materials to decrease infection rates without altering properties that affect their function. One possibility is to coat the material with an antibacterial agent such as silver. This paper explores the feasibility of depositing adherent silver films onto biomedical poly(ether urethanes) by an electroless plating process. The surface chemistry of the deposition process and the effect of a plasma treatment on the metal/polymer adhesion have been explored. The silver films produced on an unmodified poly(ether urethane) surface consist predominantly of micron-sized clusters that form in solution and are poorly adhered to the surface. However, some small adherent clusters are also deposited on the polymer surface and X-ray photoelectron spectroscopy of the metal/polymer interface shows evidence of chemical interaction between silver and surface carbonyl groups.
   An air plasma treatment of the polymer to increase the number of carbonyl containing groups at the surface has been shown to significantly improve the metal/polymer adhesion and to decrease the porosity of the silver films. This paper illustrates the importance of chemical bonding in the electroless metallization of polymers. (c) 2005 Published by Elsevier B.V.
C1 Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada.
   Univ Western Ontario, Dept Chem & Interface Sci Western, London, ON N6A 5B, Canada.
RP Gray, JE (reprint author), Laurentian Univ, Dept Chem & Biochem, 935 Ramsey Lake Rd, Sudbury, ON P3E 2C6, Canada.
EM jgray@laurentian.ca; pnorton@uwo.ca
CR BAHLS HJ, 1987, Patent No. 4737188
   Bambauer R, 1997, ARTIF ORGANS, V21, P1039
   Beamson G, 1992, HIGH RESOLUTION XPS, p[210, 212]
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   FESSENDEN RJ, 1982, ORGANIC CHEM, P555
   GERENSER LJ, 1990, J VAC SCI TECHNOL A, V8, P3682, DOI 10.1116/1.576480
   GERENSER LJ, 1988, J VAC SCI TECHNOL A, V6, P2897, DOI 10.1116/1.575448
   GERENSER LJ, 1990, METALLIZATION POLYM, pCH32
   Gray JE, 2003, APPL SURF SCI, V217, P210, DOI 10.1016/S0169-4332(03)00552-X
   KLEMBERGSAPIEHA JE, 1991, METALLIZED PLASTICS, V2, P315
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   Liston EM, 1994, PLASMA SURFACE MODIF
   LOWENHEIM FA, 1974, MODERN ELECTROPLATIN, pCH31
   MALLORY GO, 1990, ELECTROLESS PLATING, pCH19
   Nahrstedt B, 1996, APPL OPTICS, V35, P3680, DOI 10.1364/AO.35.003680
   Peeling J., 1978, CAN J CHEM, V56, P2407
   PIREAUX JJ, 1990, METALLIZATION POLYM, pCH4
   RUDZKI GJ, 1980, SURFACE FINISHING SY, pCH4
   SCHULTZ J, 1999, ADHESION PROMOTION T, pCH1
   Serghini-Monim S, 1998, J PHYS CHEM B, V102, P1450, DOI 10.1021/jp972899l
   SHARD AG, 1995, POLYMER, V36, P775, DOI 10.1016/0032-3861(95)93107-W
   SIOSHANSI P, 1994, ARTIF ORGANS, V18, P266, DOI 10.1111/j.1525-1594.1994.tb02193.x
   Strunskus T, 1996, LANGMUIR, V12, P2712, DOI 10.1021/la950125v
   TESMER JR, 1995, HDB MODERN ION BEAM, pCH1
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P535, DOI 10.1002/pola.1991.080290410
   WAGNER CD, 1980, ANAL CHEM, V52, P1445, DOI 10.1021/ac50059a017
   Xia YN, 1998, LANGMUIR, V14, P363, DOI 10.1021/la9707080
NR 28
TC 51
Z9 58
U1 3
U2 35
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD JUL 22
PY 2005
VL 484
IS 1-2
BP 196
EP 207
DI 10.1016/j.tsf.2005.01.090
PG 12
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 939BA
UT WOS:000230045900030
DA 2018-10-20
ER

PT J
AU Spirou, GM
   Oraevsky, AA
   Vitkin, IA
   Whelan, WM
AF Spirou, GM
   Oraevsky, AA
   Vitkin, IA
   Whelan, WM
TI Optical and acoustic properties at 1064 nm of polyvinyl
   chloride-plastisol for use as a tissue phantom in biomedical
   optoacoustics
SO PHYSICS IN MEDICINE AND BIOLOGY
LA English
DT Article
ID DIFFUSE REFLECTANCE MEASUREMENTS; SPATIALLY-RESOLVED FLUORESCENCE;
   FLUOROPHORE CONCENTRATIONS; THEORY MODEL; POLYACRYLAMIDE; HYPERTHERMIA;
   SCATTERING; GELS
AB A novel optoacoustic phantom made of polyvinyl chloride-plastisol (PVCP) for optoacoustic studies is described. The optical and acoustic properties of PVCP were measured. Titanium dioxide (TiO2) powder and black plastic colour (BPC) were used to introduce scattering and absorption, respectively, in the phantoms. The optical absorption coefficient (mu(a)) at 1064 nm was determined using an optoacoustic method, while diffuse reflectance measurements were used to obtain the optical reduced scattering coefficient These optical properties were calculated to be mu(a) = (12.818 +/- 0.001)A(BPC) cm(-1) and mu'(s) = (2.6 +/- 0.2) S-TiO2 + (1.4 +/- 0.1) cm(-1), where A(BPC) is the BPC per cent volume concentration, and S-TiO2 is the TiO2 volume concentration (mg mL(-1)). The speed of sound in PVCP was measured to be (1.40 +/- 0.02) x 10(3) m s(-1) using the pulse echo transmit receive method, with an acoustic attenuation of (0.56 +/- 1.01) f(Mhz)((1.51 +/- 0.06))(dB cm(-1)) in the frequency range of 0.61-1.25 MHz, and a density, calculated by measuring the displacement of water, of 1.00 +/- 0.04 g cm(-3). The speed of sound and density of PVCP are similar to tissue, and together with the user-adjustable optical properties, make this material well suited for developing tissue-equivalent phantoms for biomedical optoacoustics.
C1 Univ Toronto, Princess Margaret Hosp, Ontario Canc Inst, Hlth Network,Med Phys Div, Toronto, ON, Canada.
   Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.
   Fairway Med Technol Inc, Houston, TX USA.
   Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada.
   Ryerson Univ, Dept Phys, Toronto, ON, Canada.
RP Spirou, GM (reprint author), Univ Toronto, Princess Margaret Hosp, Ontario Canc Inst, Hlth Network,Med Phys Div, 100 Coll St, Toronto, ON, Canada.
RI Vitkin, Alex/I-8166-2012
OI Vitkin, Alex/0000-0001-5495-8888; Oraevsky,
   Alexander/0000-0002-9212-6211
FU NCI NIH HHS [R44 CA096153, R33 CA095883, R44 CA096153-03, R33
   CA095883-04]; FIC NIH HHS [R03 TW005776, R03 TW005776-03]
CR BINI MG, 1984, IEEE T BIO-MED ENG, V31, P317, DOI 10.1109/TBME.1984.325271
   CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354
   deKorte CL, 1997, ULTRASONIC IMAGING, V19, P112, DOI 10.1177/016173469701900202
   Diamond KR, 2003, PHYS MED BIOL, V48, P4135, DOI 10.1088/0031-9155/48/24/011
   FARRELL TJ, 1992, PHYS MED BIOL, V37, P2281, DOI 10.1088/0031-9155/37/12/009
   FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777
   Henrichs PM, 2004, PROC SPIE, V5320, P8, DOI 10.1117/12.536869
   Hyde DE, 2001, PHYS MED BIOL, V46, P369, DOI 10.1088/0031-9155/46/2/307
   Iizuka MN, 1999, LASER SURG MED, V25, P159, DOI 10.1002/(SICI)1096-9101(1999)25:2<159::AID-LSM10>3.3.CO;2-M
   Kharine A, 2003, PHYS MED BIOL, V48, P357, DOI 10.1088/0031-9155/48/3/306
   KIENLE A, 1996, PHYS MED BIOL, V41, P221
   Madsen EL, 1999, J ULTRAS MED, V18, P615
   MADSEN SJ, 1992, APPL OPTICS, V31, P3509, DOI 10.1364/AO.31.003509
   Oraevsky AA, 1997, APPL OPTICS, V36, P402, DOI 10.1364/AO.36.000402
   ORAEVSKY AA, 1993, P SOC PHOTO-OPT INS, V1882, P8
   Royston D D, 1996, J Biomed Opt, V1, P110, DOI 10.1117/12.227698
   Spirou GM, 2004, PROC SPIE, V5320, P44, DOI 10.1117/12.535360
   SUROWIEC A, 1992, INT J HYPERTHER, V8, P795, DOI 10.3109/02656739209005027
   TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124
   Taylor J., 1982, INTRO ERROR ANAL
   VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507
   Welch A. J., 1995, OPTICAL THERMAL RESP
   XU T, 1995, APPL OPTICS, V42, P5777
NR 23
TC 75
Z9 75
U1 0
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0031-9155
J9 PHYS MED BIOL
JI Phys. Med. Biol.
PD JUL 21
PY 2005
VL 50
IS 14
BP N141
EP N153
DI 10.1088/0031-9155/50/14/N01
PG 13
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 952ZA
UT WOS:000231043800018
PM 16177502
DA 2018-10-20
ER

PT J
AU Lu, XP
   Laroussi, M
AF Lu, XP
   Laroussi, M
TI Optimization of ultraviolet emission and chemical species generation
   from a pulsed dielectric barrier discharge at atmospheric pressure
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID PLASMA; EXCITATION; AIR; STERILIZATION
AB One of the attractive features of nonthermal atmospheric pressure plasmas is the ability to achieve enhanced gas phase chemistry without the need for elevated gas temperatures. This attractive characteristic recently led to their extensive use in applications that require low temperatures, such as material processing and biomedical applications. The agents responsible for the efficient plasma reactivity are the ultraviolet (UV) photons and the chemically reactive species. In this paper, in order to optimize the UV radiation and reactive species generation efficiency, the plasma was generated by a dielectric barrier discharge driven by unipolar submicrosecond square pulses. To keep the discharge diffuse and to maintain low operating temperatures, helium (He) was used as a carrier gas. Mixed with helium, varying amounts of nitrogen (N-2) with the presence of trace amounts of air were used. The gas temperature was determined to be about 350 K at a 1-kHz pulse frequency for all cases and only slightly increased with frequency. The UV emission power density, P-UV, reached its highest level when 5% to 10% of N-2 is mixed to a balance of He. A maximum P-UV of about 0.8 mW/cm(2) at 10-kHz pulse frequency for a He(90%)+N-2(10%) mixture was measured. This was more than four times higher than that when He or N-2 alone was used. Furthermore, the emission spectra showed that most of the UV was emitted by excited NO radicals, where the oxygen atoms came from residual trace amounts of air. In addition to NO, NO2, and excited N-2, N-2(+), OH, and He were also present in the plasma. (c) 2005 American Institute of Physics.
C1 Old Dominion Univ, Norfolk, VA 23529 USA.
RP Laroussi, M (reprint author), Old Dominion Univ, Norfolk, VA 23529 USA.
EM mlarouss@odu.edu
RI Lu, XinPei/M-5570-2013
OI Lu, XinPei/0000-0003-0676-9585
CR Carman RJ, 2003, J PHYS D APPL PHYS, V36, P19, DOI 10.1088/0022-3727/36/1/304
   Dorai R, 2003, J PHYS D APPL PHYS, V36, P666, DOI 10.1088/0022-3727/36/6/309
   Faure G, 1998, J PHYS D APPL PHYS, V31, P1212, DOI 10.1088/0022-3727/31/10/013
   Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01
   Herron JT, 1999, J PHYS CHEM REF DATA, V28, P1453, DOI 10.1063/1.556043
   Kogelschatz U, 2004, PLASMA PHYS CONTR F, V46, pB63, DOI 10.1088/0741-3335/46/12B/006
   Kossyi IA, 1992, PLASMA SOURCES SCI T, V1, P207, DOI 10.1088/0963-0252/1/3/011
   Kuo SP, 2001, PHYS PLASMAS, V8, P3258, DOI 10.1063/1.1376422
   Laroussi M, 2004, J APPL PHYS, V96, P3028, DOI 10.1063/1.1777392
   Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016
   Laroussi M, 1996, IEEE T PLASMA SCI, V24, P1188, DOI 10.1109/27.533129
   Lauer JL, 2004, J APPL PHYS, V96, P4539, DOI 10.1063/1.1786668
   Liu SH, 2003, J PHYS D APPL PHYS, V36, P3144, DOI 10.1088/0022-3727/36/24/009
   Liu SH, 2001, J PHYS D APPL PHYS, V34, P1632, DOI 10.1088/0022-3727/34/11/312
   Mildren RP, 2001, J PHYS D APPL PHYS, V34, pL1, DOI 10.1088/0022-3727/34/1/101
   Nersisyan G, 2004, PLASMA SOURCES SCI T, V13, P582, DOI 10.1088/0963-0252/13/4/005
   Pintassilgo CD, 2005, J PHYS D APPL PHYS, V38, P417, DOI 10.1088/0022-3727/38/3/011
   Zhang W, 2004, J APPL PHYS, V96, P6066, DOI 10.1063/1.1806264
NR 18
TC 44
Z9 44
U1 1
U2 25
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD JUL 15
PY 2005
VL 98
IS 2
AR 023301
DI 10.1063/1.1980530
PG 5
WC Physics, Applied
SC Physics
GA 951LJ
UT WOS:000230931500009
DA 2018-10-20
ER

PT J
AU Vaz, CM
   van Doeveren, PFNM
   Yilmaz, G
   de Graaf, LA
   Reis, RL
   Cunha, AM
AF Vaz, CM
   van Doeveren, PFNM
   Yilmaz, G
   de Graaf, LA
   Reis, RL
   Cunha, AM
TI Processing and characterization of biodegradable soy plastics: Effects
   of crosslinking with glyoxal and thermal treatment
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE extrusion; crosslinking; mechanical properties
ID MECHANICAL-PROPERTIES; PROTEIN PLASTICS; WATER-ABSORPTION; COLLAGEN;
   GLUTARALDEHYDE; FILMS; BIOPROSTHESES; CYTOTOXICITY; COMPOSITES;
   EXTRUSION
AB Processing and modification routes to produce and to improve properties of biodegradable plastics from soy isolate were studied. Soy isolate, acid-treated and crosslinked soy were subsequently compounded, extruded, and injection molded. Acetic acid and glyoxal were examined concerning their suitability for acid treating and crosslinking of soy, and their effect on the final properties of the obtained materials. Heat treatment was also used as a possible methodology to crosslink the protein structure. The molded specimens were tested in terms of their tensile properties and solubility at different pHs, and were also evaluated for the degree of crosslinking and molecular weight distributions. The obtained plastics were rigid and brittle with stiffness ranging from 1436 MPa for soy, to 1229 MPa for glyoxal crosslinked soy, up to 2698 MPa for heat-treated soy. The differences in stiffness were discussed in terms of the crosslinking efficiency and spatial distribution. The solubility profiles were studied as a function of the pH of the immersion solutions and the crosslinking degree of each material. A reduction in protein solubility with decreasing pH was observed, with a minimum between pH 4 and 5 and a resolubilization of the protein at pHs lower than pH 4 and greater than 8. Higher levels of crosslinking resulted in a decrease of the solubility and an aggregation of the protein molecules. The soy plastics proved to be very versatile materials with potential to be used in applications where quite demanding performances are expected, such as in the biomedical field. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4800058 Guimaraes, Portugal.
   ATO BV, Agrotechnol Res Inst, NL-6700 AA Wageningen, Netherlands.
RP Vaz, CM (reprint author), Univ Minho, Dept Polymer Engn, Campus Aruzem, P-4800058 Guimaraes, Portugal.
EM claudia.vaz@npl.co.uk
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Cunha
   M., Antonio/0000-0003-3860-7732
CR BERTRANDHARB C, 1993, SCI ALIMENT, V13, P577
   Cheftel J., 1985, AMINO ACIDS PEPTIDES, P245
   Cheftel J., 1985, FOOD CHEM, V2, P245
   Cuq B, 1997, POLYMER, V38, P2399, DOI 10.1016/S0032-3861(96)00781-1
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   DEGIOIA L, 1999, CERAM CHEM, V75, P514
   Ferreira SHP, 1993, J FOOD SCI, V58, P378
   FINLEY JW, 1989, PROTEIN QUALITY EFFE, P1
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GENNADIOS A, 1993, J AGR FOOD CHEM, V41, P1835, DOI 10.1021/jf00035a006
   Gogoi BK, 1996, FOOD RES INT, V29, P505, DOI 10.1016/S0963-9969(96)00051-8
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   *ISO, 1980, 62 ISO INT ORG STAND
   JOHNSON LA, 1992, US INFORM, V3, P282
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   LAI HM, 1997, CERAM CHEM, V74, P351
   MARQUIE C, 1995, J AGR FOOD CHEM, V43, P2762, DOI 10.1021/jf00058a040
   Otaigbe JU, 1997, J ENVIRON POLYM DEGR, V5, P199
   PAETAU I, 1994, IND ENG CHEM RES, V33, P1821, DOI 10.1021/ie00031a023
   Paetau I., 1994, Journal of Environmental Polymer Degradation, V2, P211, DOI 10.1007/BF02067447
   Rangavajhyala N, 1997, J AGR FOOD CHEM, V45, P4204, DOI 10.1021/jf9702048
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   SCHILLING CH, 1995, J MATER RES, V10, P2197, DOI 10.1557/JMR.1995.2197
   SHEARD PR, 1986, J FOOD TECHNOL, V21, P627
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   Wang S, 1996, J MACROMOL SCI PURE, VA33, P557, DOI 10.1080/10601329608010878
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Wong S.S., 1991, CHEM PROTEIN CONJUGA
NR 30
TC 35
Z9 36
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 15
PY 2005
VL 97
IS 2
BP 604
EP 610
DI 10.1002/app.20609
PG 7
WC Polymer Science
SC Polymer Science
GA 929ZZ
UT WOS:000229386800021
DA 2018-10-20
ER

PT J
AU Tsuji, H
AF Tsuji, H
TI Poly(lactide) stereocomplexes: Formation, structure, properties,
   degradation, and applications
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE association; biodegradable; biomaterials; blends; polyesters;
   stereospecific polymers
ID IN-VITRO HYDROLYSIS; LACTIC-ACID OLIGOMERS; RING-OPENING POLYMERIZATION;
   STEREOREGULAR POLY(METHYL METHACRYLATES); EXTENDED-CHAIN CRYSTALLITES;
   ENANTIOMERIC POLY(LACTIDE)S; POLY(L-LACTIC ACID); BLOCK-COPOLYMERS;
   POLY(L-LACTIDE)/POLY(D-LACTIDE) STEREOCOMPLEX; TRIBLOCK COPOLYMERS
AB Poly(lactides)s [i.e. poly(lactic acid) (PLA)] and lactide copolymers are biodegradable, compostable, producible from renewable resources, and nontoxic to the human body and the environment. They have been used as biomedical materials for tissue regeneration, matrices for drug delivery systems, and alternatives for commercial polymeric materials to reduce the impact on the environment. Since stereocomplexation or stereocomplex formation between enantiomeric PLA, poly(L-lactide) [i.e. poly(L-lactic acid) (PPLA)] and poly(D-lactide) [i.e. poly(D-lactic acid) (PDLA)] was reported in 1987, numerous studies have been carried out with respect to the formation, structure, properties, degradation, and applications of the PLA stereocomplexes. Stereocomplexation enhances the mechanical properties, the thermal-resistance, and the hydrolysis-resistance of PLA-based materials. These improvements arise from a peculiarly strong interaction between L-lactyl unit sequences and D-lactyl unit sequences, and stereocomplexation opens a new way for the preparation of biomaterials such as hydrogels and particles for drug delivery systems. It was revealed that the crucial parameters affecting stereocomplexation are the mixing ratio and the molecular weight of L-lactyl and D-lactyl unit sequences. On the other hand, PDLA was found to form a stereocomplex with L-configured polypeptides in 2001. This kind of stereocomplexation is called "hetero-stereocomplexation" and differentiated from "homo-stereocomplexation" between L-lactyl and D-lactyl unit sequences. This paper reviews the methods for tracing PLA stereocomplexation, the methods for inducing PLA stereocompelxation, the parameters affecting PLA stereocomplexation, and the structure, properties, degradation, and applications of a variety of stereocomplexed PLA materials.
C1 Toyohashi Univ Technol, Fac Engn, Dept Ecol Engn, Toyohashi, Aichi 4418580, Japan.
RP Tsuji, H (reprint author), Toyohashi Univ Technol, Fac Engn, Dept Ecol Engn, Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
EM tsuji@eco.tut.ac.jp
RI Tsuji, Hideto/M-3665-2014
OI Tsuji, Hideto/0000-0001-9986-5933
CR Abe H, 2001, BIOMACROMOLECULES, V2, P1007, DOI 10.1021/bm015543v
   ATKINSON J, 1972, EUR POLYM J, V8, P809, DOI 10.1016/0014-3057(72)90122-X
   Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   BOSSCHER F, 1981, POLYMER, V22, P124, DOI 10.1016/0032-3861(81)90086-0
   Bourque H, 2001, LANGMUIR, V17, P5842, DOI 10.1021/la0009792
   Brizzolara D, 1996, MACROMOLECULES, V29, P191, DOI 10.1021/ma951144e
   BRIZZOLARA D, 1996, J COMPUT-AIDED MATER, V3, P341
   BROCHU S, 1995, MACROMOLECULES, V28, P5230, DOI 10.1021/ma00119a010
   Cartier L, 1997, MACROMOLECULES, V30, P6313, DOI 10.1021/ma9707998
   CHALLA G, 1981, PURE APPL CHEM, V53, P627, DOI 10.1351/pac198153030627
   de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   de Jong SJ, 2002, J APPL POLYM SCI, V86, P289, DOI 10.1002/app.10954
   de Jong SJ, 2001, J CONTROL RELEASE, V72, P47, DOI 10.1016/S0168-3659(01)00261-9
   de Jong SJ, 2001, J CONTROL RELEASE, V71, P261, DOI 10.1016/S0168-3659(01)00228-0
   de Jong SJ, 1998, MACROMOLECULES, V31, P6397, DOI 10.1021/ma980553i
   DIJKSTRA PJ, 1991, 17TH ANN M SOC BIOM, P184
   Doyle CD., 1962, J APPL POLYM SCI, V6, P639, DOI [10.1002/app.1962.070062406, DOI 10.1002/APP.1962.070062406]
   DUMAS P, 1972, MAKROMOLEKUL CHEM, V156, P55
   DUPONT EI, 1988, Patent No. 4766182
   DUPONT EI, 1988, Patent No. 4719246
   DUPONT EI, 1994, Patent No. 5317064
   DUPONT EI, 1991, Patent No. 4981696
   DUPONT EI, 1990, Patent No. 48002515
   Fan YJ, 2004, POLYM DEGRAD STABIL, V86, P197, DOI 10.1016/j.polymdegradstab.2004.03.001
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   FOX TG, 1958, J AM CHEM SOC, V80, P1768, DOI 10.1021/ja01540a068
   Fujiwara T, 2001, MACROMOL BIOSCI, V1, P204, DOI 10.1002/1616-5195(20010701)1:5<204::AID-MABI204>3.3.CO;2-8
   Fukushima K, 2005, MACROMOL BIOSCI, V5, P21, DOI 10.1002/mabi.200400121
   Fukushima K, 2004, MACROMOL BIOSCI, V4, P1021, DOI 10.1002/mabi.200400080
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   GRENIER D, 1984, J POLYM SCI POL PHYS, V22, P577, DOI 10.1002/pol.1984.180220404
   Hartmann MH, 1998, BIOPOLYMERS RENEWABL, P367
   HATADA K, 1981, POLYM J, V13, P811, DOI 10.1295/polymj.13.811
   Hennink WE, 2004, INT J PHARM, V277, P99, DOI 10.1016/j.ijpharm.2003.02.002
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034
   Iribarren I, 1996, MACROMOLECULES, V29, P8413, DOI 10.1021/ma960473j
   JAMSHIDI K, 1988, POLYMER, V29, P2229, DOI 10.1016/0032-3861(88)90116-4
   JIANG ZZ, 1995, J AM CHEM SOC, V117, P7037, DOI 10.1021/ja00131a041
   KALB B, 1980, POLYMER, V21, P607, DOI 10.1016/0032-3861(80)90315-8
   Kharas GB, 1994, PLASTICS MICROBES, P93
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   LEENSLAG JW, 1987, POLYM COMMUN, V28, P92
   LI SM, 1994, POLYM INT, V33, P37, DOI 10.1002/pi.1994.210330105
   Li SM, 1996, J CONTROL RELEASE, V40, P41, DOI 10.1016/0168-3659(95)00138-7
   Li SM, 2003, MACROMOL BIOSCI, V3, P657, DOI 10.1002/rnabi.200350032
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   LI SM, 1994, MACROMOLECULES, V27, P3107, DOI 10.1021/ma00089a031
   Li SM, 1999, BIOMATERIALS, V20, P35, DOI 10.1016/S0142-9612(97)00226-3
   Lim DW, 2000, J APPL POLYM SCI, V75, P1615, DOI 10.1002/(SICI)1097-4628(20000328)75:13<1615::AID-APP7>3.0.CO;2-L
   Lim DW, 2000, MACROMOL RAPID COMM, V21, P464, DOI 10.1002/(SICI)1521-3927(20000501)21:8<464::AID-MARC464>3.0.CO;2-#
   LOHMEYER JHGM, 1978, POLYMER, V19, P1171, DOI 10.1016/0032-3861(78)90066-6
   Loomis G.L., 1990, POLYM PREPR AM CHEM, V31, P55
   MACCALLUM JR, 1970, EUR POLYM J, V6, P1033, DOI 10.1016/0014-3057(70)90035-2
   MACCALLUM JR, 1970, EUR POLYM J, V6, P907, DOI 10.1016/0014-3057(70)90014-5
   MacCallum JR, 1989, COMPREHENSIVE POLYM, V1, P903
   Miyata T, 1998, POLYMER, V39, P5515, DOI 10.1016/S0032-3861(97)10203-8
   Mohan R M., 2000, RES ADV MACROMOLECUL, V1, P25
   OKIHARA T, 1991, J MACROMOL SCI PHYS, VB30, P119, DOI 10.1080/00222349108245788
   Okihara T, 1988, B I CHEM RES KYOTO U, V66, P271
   Ovitt TM, 2002, J AM CHEM SOC, V124, P1316, DOI 10.1021/ja012052+
   Ovitt TM, 2000, J POLYM SCI POL CHEM, V38, P4686, DOI 10.1002/1099-0518(200012)38:1+<4686::AID-POLA80>3.0.CO;2-0
   OZAWA T, 1965, B CHEM SOC JPN, V38, P1881, DOI 10.1246/bcsj.38.1881
   PAULING L, 1953, P NATL ACAD SCI USA, V39, P253, DOI 10.1073/pnas.39.4.253
   Pelletier I, 2004, MACROMOLECULES, V37, P4967, DOI 10.1021/ma035949v
   Pensec S, 2000, POLYM BULL, V45, P373, DOI 10.1007/s002890070010
   Portinha D, 2004, MACROMOLECULES, V37, P3401, DOI 10.1021/ma035831e
   Portinha D, 2002, MACROMOLECULES, V35, P1484, DOI 10.1021/ma010887z
   Radano CP, 2000, J AM CHEM SOC, V122, P1552, DOI 10.1021/ja9930519
   REICH L, 1964, POLYM LETT, V2, P621
   SAKAKIHARA H, 1973, MACROMOLECULES, V6, P205, DOI 10.1021/ma60032a011
   Sanda F, 1996, MACROMOLECULES, V29, P8064, DOI 10.1021/ma960906i
   Sarasua JR, 1998, MACROMOLECULES, V31, P3895, DOI 10.1021/ma971545p
   Schmidt SC, 2001, J POLYM SCI POL PHYS, V39, P300, DOI 10.1002/1099-0488(20010201)39:3<300::AID-POLB1002>3.3.CO;2-D
   SCHOMAKER E, 1988, MACROMOLECULES, V21, P3506, DOI 10.1021/ma00190a028
   Schwach G, 2002, BIOMATERIALS, V23, P993, DOI 10.1016/S0142-9612(01)00209-5
   Serizawa T, 2003, MACROMOLECULES, V36, P1762, DOI 10.1021/ma021611+
   Serizawa T, 2001, MACROMOLECULES, V34, P1996, DOI 10.1021/ma001705o
   SINGFIELD KL, 1995, MACROMOLECULES, V28, P1290, DOI 10.1021/ma00108a068
   Slager J, 2004, EUR J PHARM BIOPHARM, V58, P461, DOI 10.1016/j.ejpb.2004.04.017
   Slager J, 2003, BIOMACROMOLECULES, V4, P1308, DOI 10.1021/bm030023g
   Slager J, 2003, BIOMACROMOLECULES, V4, P1316, DOI 10.1021/bm0300249
   Slager J, 2003, MACROMOLECULES, V36, P2999, DOI 10.1021/ma025753f
   Slager J, 2002, BIOMATERIALS, V23, P4389, DOI 10.1016/S0142-9612(02)00179-5
   Slager J, 2001, MACROMOL SYMP, V175, P105, DOI 10.1002/1521-3900(200110)175:1<105::AID-MASY105>3.0.CO;2-C
   Slager J, 2003, ADV DRUG DELIVER REV, V55, P549, DOI 10.1016/S0169-409X(03)00042-5
   Slivniak R, 2002, BIOMACROMOLECULES, V3, P754, DOI 10.1021/bm0200128
   SOLDERA A, 1993, POLYM MATER SCI ENG, V68, P304
   Spassky N, 1998, MACROMOL SYMP, V128, P39, DOI 10.1002/masy.19981280106
   Spassky N, 1996, MACROMOL CHEM PHYSIC, V197, P2627, DOI 10.1002/macp.1996.021970902
   Spinu M, 1996, J MACROMOL SCI PURE, VA33, P1497, DOI 10.1080/10601329608014922
   SPINU M, 1994, POLYM MAT SCI ENG, V74, P19
   STEVELS WM, 1995, MACROMOL CHEM PHYSIC, V196, P3687, DOI 10.1002/macp.1995.021961121
   Stevels WM, 1996, MACROMOL SYMP, V102, P107, DOI 10.1002/masy.19961020115
   Sweeney P J, 1993, Methods Mol Biol, V16, P305, DOI 10.1385/0-89603-234-5:305
   Takasaki M, 2003, J MACROMOL SCI PHYS, VB42, P403, DOI 10.1081/MB-120021570
   Tretinnikov ON, 2004, LANGMUIR, V20, P6748, DOI 10.1021/la049277t
   TSUBOI M, 1961, J MOL BIOL, V3, P705, DOI 10.1016/S0022-2836(61)80036-3
   Tsuji F, 2002, POLYMER, V43, P1789
   Tsuji H, 2005, MACROMOL BIOSCI, V5, P135, DOI 10.1002/mabi.200400154
   TSUJI H, 1992, MACROMOLECULES, V25, P4114, DOI 10.1021/ma00042a011
   TSUJI H, 1994, J APPL POLYM SCI, V53, P1061, DOI 10.1002/app.1994.070530808
   Tsuji H, 1996, POLYMER, V37, P595, DOI 10.1016/0032-3861(96)83146-6
   TSUJI H, 1995, J APPL POLYM SCI, V58, P1793, DOI 10.1002/app.1995.070581018
   TSUJI H, 1995, POLYMER, V36, P2709, DOI 10.1016/0032-3861(95)93647-5
   Tsuji H, 1996, MACROMOL CHEM PHYSIC, V197, P3483, DOI 10.1002/macp.1996.021971033
   TSUJI H, 1993, MACROMOLECULES, V26, P6918, DOI 10.1021/ma00077a032
   TSUJI H, 1991, MACROMOLECULES, V24, P5651, DOI 10.1021/ma00020a026
   TSUJI H, 1991, MACROMOLECULES, V24, P5657, DOI 10.1021/ma00020a027
   TSUJI H, 1992, MACROMOLECULES, V25, P5719, DOI 10.1021/ma00047a024
   TSUJI H, 1991, MACROMOLECULES, V24, P2719, DOI 10.1021/ma00010a013
   Tsuji H, 2004, BIOMACROMOLECULES, V5, P1181, DOI 10.1021/bm049835i
   TSUJI H, 1994, J APPL POLYM SCI, V51, P337, DOI 10.1002/app.1994.070510216
   Tsuji H, 2003, BIOMATERIALS, V24, P537, DOI 10.1016/S0142-9612(02)00365-4
   Tsuji H, 2003, BIOMACROMOLECULES, V4, P7, DOI 10.1021/bm020090v
   Tsuji H, 2000, POLYMER, V41, P3621, DOI 10.1016/S0032-3861(99)00545-5
   Tsuji H, 2003, POLYMER, V44, P2891, DOI 10.1016/S0032-3861(03)00175-7
   Tsuji H, 1999, POLYMER, V40, P6699, DOI 10.1016/S0032-3861(99)00004-X
   TSUJI H, 1992, MACROMOLECULES, V25, P2940, DOI 10.1021/ma00037a024
   Tsuji H, 1997, J APPL POLYM SCI, V63, P855
   Tsuji H, 2000, RRD POLYM SCI, V4, P13
   Tsuji H, 2001, SEN-I GAKKAISHI, V57, P198
   Tsuji H, 2001, POLYMER, V42, P4463, DOI 10.1016/S0032-3861(00)00792-8
   Tsuji H, 2001, BIOMACROMOLECULES, V2, P597, DOI 10.1021/bm010048k
   Tsuji H, 2004, POLYM DEGRAD STABIL, V84, P515, DOI 10.1016/j.polymdegradstab.2004.01.010
   Tsuji H, 2004, POLYM DEGRAD STABIL, V85, P647, DOI 10.1016/j.polymdegradstab.2004.03.004
   TSUJI H, 1999, CURRENT TRENDS POLYM, V4, P27
   Tsuji H., 2002, BIOPOLYMERS, VIII, P129
   Urayama H, 2003, POLYMER, V44, P5635, DOI 10.1016/S0032-3861(03)00583-4
   van Nostrum CF, 2004, MACROMOLECULES, V37, P2113, DOI 10.1021/ma035534+
   VASANTHAKUMARI R, 1983, POLYMER, V24, P175, DOI 10.1016/0032-3861(83)90129-5
   VORENKAMP EJ, 1981, POLYMER, V22, P1705, DOI 10.1016/0032-3861(81)90390-6
   VOYER R, 1989, EUR POLYM J, V25, P365, DOI 10.1016/0014-3057(89)90151-1
   Watanabe J, 2003, CHEM LETT, V32, P192, DOI 10.1246/cl.2003.192
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1375, DOI 10.1021/bm025652p
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1109, DOI 10.1021/bm025586r
   Wisniewski M, 1997, MACROMOL CHEM PHYSIC, V198, P1227, DOI 10.1002/macp.1997.021980424
   Yamane H, 2003, POLYMER, V44, P2569, DOI 10.1016/S0032-3861(03)00092-2
   YOSHIDA T, 1962, J AM CHEM SOC, V84, P3590, DOI 10.1021/ja00877a039
   YUI N, 1990, MAKROMOL CHEM, V191, P481
   Zhang JM, 2005, J MOL STRUCT, V735, P249, DOI 10.1016/j.molstruc.2004.11.033
   Zhang JM, 2005, MACROMOLECULES, V38, P1822, DOI 10.1021/ma047872w
NR 142
TC 690
Z9 708
U1 29
U2 507
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUL 14
PY 2005
VL 5
IS 7
BP 569
EP 597
DI 10.1002/mabi.200500062
PG 29
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 948SH
UT WOS:000230735500001
PM 15997437
DA 2018-10-20
ER

PT J
AU Ferruti, P
   Bianchi, S
   Ranucci, E
   Chiellini, F
   Caruso, V
AF Ferruti, P
   Bianchi, S
   Ranucci, E
   Chiellini, F
   Caruso, V
TI Novel poly(amido-amine)-based hydrogels as scaffolds for tissue
   engineering
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE bioactive and compatible polymers; hybrid albumine poly(amido-amine)
   networks; hydrogels; poly(amido-amine)s; tissue engineering
ID BIOMEDICAL APPLICATIONS; CELL-ADHESION; POLYMERS; COMPLEXES; AGMATINE;
   FORM
AB Biodegradable and biocompatible amphoteric poly(amido-amine) (PAA)-based hydrogels, containing carboxyl groups along with amino groups in their repeating unit, were considered as scaffolds for tissue engineering applications. These hydrogels were obtained by co-polymerising 2,2-bisacrylamidoacetic acid with 2-methylpiperazine with or without the addition of different mono-acrylamides as modifiers, and in the presence of primary bis-amines as cross-linking agents. Hybrid PAA/albumin hydrogels were also prepared. The polymerisation reaction was a Michael-type polyaddition carried out in aqueous media. The PAA hydrogels were soft and swellable materials. Cytotoxicity tests were carried out by the direct contact method with fibroblast cell lines on the hydrogels both in their native state (that is, as free bases) and as salts with acids of different strength, namely hydrochloric, sulfuric, acetic and lactic acid. This was done in order to ascertain whether counterion-specific differences in cytotoxicity existed. It was found that all the amphoteric PAA hydrogels considered were cytobiocompatible both as free bases and salts. Selected hydrogels samples underwent degradation tests under controlled conditions simulating biological environments, i.e. Dulbecco medium at pH 7.4 and 37 degrees C. All samples degraded completely and dissolved within 10 d, with the exception of hybrid PAA/albumin hydrogels that did not dissolve even after eight months. The degradation products of all samples turned to be non-cytotoxic. All these results led us to conclude that PAA-based hydrogels have a definite potential as degradable matrices for biomedical applications.
C1 Univ Milan, Dipartimento Chim Organ & Ind, I-20133 Milan, Italy.
   Univ Pisa, Dipartimento Chim & Chim Ind, I-56125 Pisa, Italy.
RP Ferruti, P (reprint author), Univ Milan, Dipartimento Chim Organ & Ind, Via Venezian 21, I-20133 Milan, Italy.
EM paolo.ferruti@unimi.it
RI Chiellini, Federica/F-3233-2010; Ranucci, Elisabetta/J-3899-2015
OI Chiellini, Federica/0000-0003-4680-9975; Ranucci,
   Elisabetta/0000-0002-6402-2650; Ferruti, Paolo/0000-0002-5404-440X
CR Ahluwalia A, 2001, J MATER SCI-MATER M, V12, P613, DOI 10.1023/A:1011241727138
   BARBUCCI R, 2002, BIOMATERIALS, V24, P915
   Bizzarri R, 2002, MACROMOLECULES, V35, P1215, DOI 10.1021/ma0111257
   Bizzarri R, 2002, MACROMOL CHEM PHYSIC, V203, P1684, DOI 10.1002/1521-3935(200207)203:10/11<1684::AID-MACP1684>3.0.CO;2-L
   CASALI M, 2002, J BIOACT COMPAT POLY, V16, P479
   Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO;2-P
   Chiellini F, 2001, MACROMOL RAPID COMM, V22, P1284, DOI 10.1002/1521-3927(20011001)22:15<1284::AID-MARC1284>3.0.CO;2-M
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Ferruti P, 2000, MACROMOLECULES, V33, P7793, DOI 10.1021/ma000378h
   Ferruti P, 2002, MACROMOL RAPID COMM, V23, P332, DOI 10.1002/1521-3927(20020401)23:5/6<332::AID-MARC332>3.0.CO;2-I
   Ferruti P, 1999, MACROMOL CHEM PHYS, V200, P1644
   FERRUTI P, 1994, BIOMATERIALS, V15, P1235, DOI 10.1016/0142-9612(94)90275-5
   Ferruti P., 1996, POLYM MAT ENCY, V5, P3334
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANZA RP, 2001, PRINCIPLES TISSUE EN
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   LUTOLF MP, 2003, ADV MATER, V11, P888
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Montanaro L, 2001, BIOMATERIALS, V22, P59, DOI 10.1016/S0142-9612(00)00163-0
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pattrick NG, 2001, J CONTROL RELEASE, V77, P225, DOI 10.1016/S0168-3659(01)00476-X
   Raasch W, 2001, BRIT J PHARMACOL, V133, P755, DOI 10.1038/sj.bjp.0704153
   RANUCCI E, 1995, POLYMER, V36, P2989, DOI 10.1016/0032-3861(95)94349-X
   RICHARDSON S, 1999, J DRUG TARGET, V6, P3
   Richardson SCW, 2001, BIOMACROMOLECULES, V2, P1023, DOI 10.1021/bm010079f
   Tanahashi K, 2002, BIOMACROMOLECULES, V3, P1030, DOI 10.1021/bm0200433
   Wan KW, 2004, BIOMACROMOLECULES, V5, P1102, DOI 10.1021/bm040007z
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
NR 30
TC 46
Z9 50
U1 1
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUL 14
PY 2005
VL 5
IS 7
BP 613
EP 622
DI 10.1002/mabi.200500020
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 948SH
UT WOS:000230735500004
PM 16010695
DA 2018-10-20
ER

PT J
AU Rossetti, FF
   Bally, M
   Michel, R
   Textor, M
   Reviakine, I
AF Rossetti, FF
   Bally, M
   Michel, R
   Textor, M
   Reviakine, I
TI Interactions between titanium dioxide and phosphatidyl serine-containing
   liposomes: Formation and patterning of supported phospholipid bilayers
   on the surface of a medically relevant material
SO LANGMUIR
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; ATOMIC-FORCE MICROSCOPY; LIPID VESICLE
   ADSORPTION; CALCIUM-ION BINDING; UNILAMELLAR VESICLES;
   ENERGY-DISSIPATION; PROTEIN ADSORPTION; COMPOSITION ARRAYS; PLASMON
   RESONANCE; DIVALENT-CATIONS
AB Titanium is widely used in biomedical applications. Its mechanical properties and biocompatibility, conferred by a layer of oxide present on its surface, make titanium the material of choice for various implants (artificial hip and knee joints, dental prosthetics, vascular stents, heart valves). Furthermore, the high refractive index of titanium oxide is advantageous in biosensor applications based on optical detection methods. In both of the above fields of application, novel surface modification strategies leading to biointeractive interfaces (that trigger specific responses in biological systems) are continuously sought. In this report, we investigate the interactions between TiO2 and phosphatidyl serine-containing liposomes, present a novel approach for preparing supported phospholipid bilayers (SPBs) of various compositions on TiO2, and use the unique ability of liposomes to distinguish between different surfaces to create SPB corrals on SiO2/TiO2 structured substrates. These results represent an important first step toward the design of biointeractive interfaces on titanium oxide surfaces that are based on a cell membrane-like environment.
C1 ETH, Swiss Fed Inst Technol, Dept Mat, BioInterfaceGrp,Lab Surface Sci & Technol, CH-8093 Zurich, Switzerland.
   Tech Univ Clausthal, Dept Phys Chem, D-38678 Clausthal Zellerfeld, Germany.
RP Reviakine, I (reprint author), ETH, Swiss Fed Inst Technol, Dept Mat, BioInterfaceGrp,Lab Surface Sci & Technol, CH-8093 Zurich, Switzerland.
EM ireviakine@uh.edu
RI Bally, Marta/G-8744-2011; Textor, Marcus/A-6200-2012; Wunder,
   Stephanie/B-5066-2012; Zdilla, Michael/B-4145-2011; Reviakine,
   Ilya/B-2631-2013
OI Textor, Marcus/0000-0002-0178-1801; Reviakine, Ilya/0000-0002-3448-5072;
   Bally, Marta/0000-0002-5865-8302
CR Ajo-Franklin CM, 2001, P NATL ACAD SCI USA, V98, P13643, DOI 10.1073/pnas.241208698
   AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4
   Berquand A, 2003, LANGMUIR, V19, P1700, DOI 10.1021/la0260180
   Boxer SG, 2000, CURR OPIN CHEM BIOL, V4, P704, DOI 10.1016/S1367-5931(00)00139-3
   Brunette D. M., 2001, TITANIUM MED
   CASAL HL, 1987, BIOCHEMISTRY-US, V26, P7395, DOI 10.1021/bi00397a030
   Chavez P, 1996, LANGMUIR, V12, P4111, DOI 10.1021/la950793g
   CHOI SH, 1991, BIOCHEMISTRY-US, V30, P8563, DOI 10.1021/bi00099a011
   Cremer PS, 1999, LANGMUIR, V15, P3893, DOI 10.1021/la981240j
   Dultsev FN, 2000, LANGMUIR, V16, P5036, DOI 10.1021/la990789v
   EISENBERG M, 1979, BIOCHEMISTRY-US, V18, P5213, DOI 10.1021/bi00590a028
   Ekeroth J, 2002, LANGMUIR, V18, P7923, DOI 10.1021/la026131q
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   FEIGENSON GW, 1989, BIOCHEMISTRY-US, V28, P1270, DOI 10.1021/bi00429a048
   FEIGENSON GW, 1986, BIOCHEMISTRY-US, V25, P5819, DOI 10.1021/bi00367a071
   Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060
   GREGORY DP, 1984, BIOCHIM BIOPHYS ACTA, V769, P238, DOI 10.1016/0005-2736(84)90028-2
   Groves JT, 1998, LANGMUIR, V14, P3347, DOI 10.1021/la9711701
   Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651
   HARRIS WE, 1977, CHEM PHYS LIPIDS, V19, P243, DOI 10.1016/0009-3084(77)90046-9
   Heyse S, 1998, BIOCHEMISTRY-US, V37, P507, DOI 10.1021/bi971564r
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   Hovis JS, 2001, LANGMUIR, V17, P3400, DOI 10.1021/la0017577
   Hovis JS, 2000, LANGMUIR, V16, P894, DOI 10.1021/la991175t
   Johnson JM, 2002, BIOPHYS J, V83, P3371, DOI 10.1016/S0006-3495(02)75337-X
   Kam L, 2000, J AM CHEM SOC, V122, P12901, DOI 10.1021/ja0034038
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Kurrat R, 1997, REV SCI INSTRUM, V68, P2172, DOI 10.1063/1.1148069
   Larsson C, 2003, ANAL CHEM, V75, P5080, DOI 10.1021/ac034269n
   Lenz P, 2004, LANGMUIR, V20, P11092, DOI 10.1021/la048450i
   LIS LJ, 1981, BIOCHEMISTRY-US, V20, P1771, DOI 10.1021/bi00510a010
   Lussi JW, 2004, PROG SURF SCI, V76, P55, DOI 10.1016/j.progsurf.2004.05.013
   MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J
   MATTAI J, 1989, BIOCHEMISTRY-US, V28, P2322, DOI 10.1021/bi00431a051
   MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X
   MCLAUGHLIN A, 1978, BIOCHIM BIOPHYS ACTA, V513, P338, DOI 10.1016/0005-2736(78)90203-1
   Michel R, 2002, LANGMUIR, V18, P8580, DOI 10.1021/la0258244
   MOU JX, 1995, J MOL BIOL, V248, P507, DOI 10.1006/jmbi.1995.0238
   NOLLERT P, 1995, BIOPHYS J, V69, P1447, DOI 10.1016/S0006-3495(95)80014-7
   OHKI S, 1982, BIOCHEMISTRY-US, V21, P2127, DOI 10.1021/bi00538a022
   Olson DJ, 2001, LANGMUIR, V17, P7396, DOI 10.1021/la010475j
   Otzen DE, 2003, COLLOID SURFACE B, V29, P67, DOI 10.1016/S0927-7765(02)00186-8
   PARSEGIAN VA, 1972, BIOPHYS J, V12, P1192, DOI 10.1016/S0006-3495(72)86155-1
   PARSEGIAN VA, 1983, J PROSTHET DENT, V49, P838, DOI 10.1016/0022-3913(83)90360-8
   PASHLEY RM, 1981, J COLLOID INTERF SCI, V83, P531, DOI 10.1016/0021-9797(81)90348-9
   PASHLEY RM, 1984, J COLLOID INTERF SCI, V97, P446, DOI 10.1016/0021-9797(84)90316-3
   Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100
   Pignataro B, 2000, BIOPHYS J, V78, P487, DOI 10.1016/S0006-3495(00)76611-2
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Reimhult E, 2003, LANGMUIR, V19, P1681, DOI 10.1021/la0263920
   Reimhult E, 2002, J CHEM PHYS, V117, P7401, DOI 10.1063/1.1515320
   Reviakine I, 2000, LANGMUIR, V16, P1806, DOI 10.1021/la9903043
   REVIAKINE I, 2005, IN PRESS J CHEM PHYS, V122
   REZWAN K, 2005, THESIS ETH ZURICH
   Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5
   Richter RP, 2005, LANGMUIR, V21, P299, DOI 10.1021/la0478402
   Richter RP, 2004, LANGMUIR, V20, P4609, DOI 10.1021/la049827n
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rossetti FF, 2004, BIOPHYS J, V87, P1711, DOI 10.1529/biophysj.104.041780
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   SCHMITT L, 1994, J AM CHEM SOC, V116, P8485, DOI 10.1021/ja00098a008
   Schonherr H, 2004, LANGMUIR, V20, P11600, DOI 10.1021/la049302v
   Seantier B, 2004, NANO LETT, V4, P5, DOI 10.1021/nl0345901
   SEIFERT U, 1990, PHYS REV A, V42, P4768, DOI 10.1103/PhysRevA.42.4768
   Seifert U, 1997, ADV PHYS, V46, P13, DOI 10.1080/00018739700101488
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5
   Starr TE, 2000, LANGMUIR, V16, P10301, DOI 10.1021/la000992m
   Svedhem S, 2003, LANGMUIR, V19, P6730, DOI 10.1021/la034172w
   Svedhem S, 2003, CHEMBIOCHEM, V4, P339, DOI 10.1002/cbic.200390055
   TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Ulman N, 1997, BIOPHYS J, V72, pMP444
   van Oudenaarden A, 1999, SCIENCE, V285, P1046, DOI 10.1126/science.285.5430.1046
   Vikholm I, 1999, BBA-BIOMEMBRANES, V1421, P39, DOI 10.1016/S0005-2736(99)00112-1
   Weng KC, 2004, LANGMUIR, V20, P7232, DOI 10.1021/la049940d
   Yee CK, 2004, J AM CHEM SOC, V126, P13962, DOI 10.1021/ja047714k
   Yoshina-Ishii C, 2003, J AM CHEM SOC, V125, P3696, DOI 10.1021/ja029783+
   Zhdanov VP, 2001, LANGMUIR, V17, P3518, DOI 10.1021/la001512u
   Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5
NR 84
TC 118
Z9 118
U1 2
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 5
PY 2005
VL 21
IS 14
BP 6443
EP 6450
DI 10.1021/la0509100
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 941XW
UT WOS:000230248500046
PM 15982052
DA 2018-10-20
ER

PT J
AU Haussy, B
   Ganghoffer, JF
AF Haussy, B
   Ganghoffer, JF
TI Instability analysis in pressurized transversely isotropic
   Saint-Venant-Kirchhoff and neo-Hookean cylindrical thick shells
SO ARCHIVE OF APPLIED MECHANICS
LA English
DT Article
DE thick shells; transverse isotropy; instability; bifurcation; aneurysm
ID NONLINEARLY ELASTIC SOLIDS; PLANE DEFORMATION; ARTERIAL-WALL; KINK
   SURFACES; BIFURCATION; CYLINDERS; STABILITY; BEHAVIOR; TORSION; MODEL
AB Under the effect of an inner pressure, a thick hyperelastic shell cylinder is susceptible to developing mechanical instabilities, leading to a bifurcated shape that no longer has the initial cylindrical symmetry. The considered problem has a strong resonance in a biomedical context, considering pathologies encountered for arteries, such as aneurysm. In this contribution, the mechanical behavior of thick elastic shells has been analyzed, considering a thick-walled cylindrical hyperelastic model material obeying a transversely isotropic behavior, first in a large-displacement situation and then in a large-deformation case. The response of the material is assumed to be instantaneous, so that time-dependent effects shall not be considered in this paper. The case of a Saint-Venant-Kirchhoff material is considered with special emphasis to exemplify a large-displacement small-strain situation; the neo-Hookean behavior is next considered to enlarge the constitutive law toward consideration of large strains. The stability conditions of the shell are studied and bifurcation conditions formulated in terms of the applied pressure and of the geometrical and mechanical parameters that characterize the shell. Analytical solutions of some bifurcation points are evidenced and calculated when the direction of the fibers coincide with the cylinder axis.
C1 LEMTA ENSEM, F-54054 Vandoeuvre Les Nancy, France.
   Ecole Super Elect Ouest, F-49009 Angers, France.
RP Ganghoffer, JF (reprint author), LEMTA ENSEM, 2 Ave Foret Haye,BP 160, F-54054 Vandoeuvre Les Nancy, France.
EM bernard.haussy@eseo.fr; jfgangho@ensem.inpl-nancy.fr
CR Bonet J, 1998, COMPUT METHOD APPL M, V162, P151, DOI 10.1016/S0045-7825(97)00339-3
   Brezis H., 1999, ANAL FONCTIONNELLE T
   Ciarlet P, 1986, ELASTICITE TRIDIMENS
   DANESCU A, 1991, MATH PROC CAMBRIDGE, V110, P385, DOI 10.1017/S0305004100070444
   Driessen NJB, 2004, J THEOR BIOL, V226, P53, DOI 10.1016/j.jtbi.2003.08.004
   DUKA ED, 1993, ACTA MECH, V98, P107, DOI 10.1007/BF01174297
   ETITUM P, 1995, INT J SOLIDS STRUCT, V32, P1231, DOI 10.1016/0020-7683(94)00145-M
   GENT AN, IN PRESS INT J NONLI
   Hanna K D, 1992, Refract Corneal Surg, V8, P152
   HAUGHTON DM, 1979, J MECH PHYS SOLIDS, V27, P179, DOI 10.1016/0022-5096(79)90001-2
   Holzapfel GA, 1998, COMPUT BIOL MED, V28, P377, DOI 10.1016/S0010-4825(98)00022-5
   Holzapfel GA, 2001, COMPUT METHOD APPL M, V190, P4379, DOI 10.1016/S0045-7825(00)00323-6
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Holzapfel GA, 2000, NONLINEAR SOLID MECH
   JOUVE F, 1993, MODELISATION OEIL EL
   Kocher M, 2004, EUR J RADIOL, V51, P181, DOI 10.1016/S0720-048X(03)00165-7
   KURASHIGE M, 1981, J APPL MECH-T ASME, V48, P351, DOI 10.1115/1.3157621
   Marsden J.E, 1994, MATH FDN ELASTICITY
   Merodio J., 2002, Archives of Mechanics, V54, P525
   Merodio J, 2001, J ELASTICITY, V62, P145, DOI 10.1023/A:1011693326593
   Merodio J, 2001, J ELASTICITY, V62, P119, DOI 10.1023/A:1011625509754
   Merodio J, 2003, INT J SOLIDS STRUCT, V40, P4707, DOI 10.1016/S0020-7683(03)00309-3
   OGDEN RW, 1984, NONLINEAR ELASTIC DE
   Oshima M, 2001, COMPUT METHOD APPL M, V191, P661, DOI 10.1016/S0045-7825(01)00307-3
   POLIGNONE DA, 1993, J ELASTICITY, V33, P27, DOI 10.1007/BF00042634
   Qiu GY, 1997, J ELASTICITY, V49, P1, DOI 10.1023/A:1007410321319
   SPENCER AJM, 1987, NLARGE DEFORMATION S
   TRIANTAFYLLIDIS N, 1983, J APPL MECH-T ASME, V50, P149, DOI 10.1115/1.3166983
   Truesdell C., 1965, ENCY PHYS, VIII/3
NR 29
TC 3
Z9 3
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0939-1533
J9 ARCH APPL MECH
JI Arch. Appl. Mech.
PD JUL
PY 2005
VL 74
IS 9
BP 600
EP 617
DI 10.1007/s00419-005-0376-7
PG 18
WC Mechanics
SC Mechanics
GA 944WZ
UT WOS:000230462900002
DA 2018-10-20
ER

PT J
AU Casper, CL
   Yamaguchi, N
   Kiick, KL
   Rabolt, JF
AF Casper, CL
   Yamaguchi, N
   Kiick, KL
   Rabolt, JF
TI Functionalizing electrospun fibers with biologically relevant
   macromolecules
SO BIOMACROMOLECULES
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; POLY(ETHYLENE OXIDE); CONTROLLED-RELEASE;
   DRUG-DELIVERY; POLYMERIC BIOMATERIALS; CROSS-LINKING; HEPARIN; TISSUE;
   SCAFFOLD; HYDROGELS
AB The development of functionalized polymers that can elicit specific biological responses is of great interest in the biomedical community, as well as the development of methods to fabricate these biologically functionalized polymers. For example, the generation of fibrous matrices with biological properties and fiber diameters commensurate with those of the natural extracellular matrix (ECM) may permit the development of novel materials for use in wound healing or tissue engineering. The goal of this work is, therefore, to create a biologically active functionalized electrospun matrix to permit immobilization and long-term delivery of growth factors. In this work, poly(ethylene glycol) functionalized with low molecular weight heparin (PEG-LMWH) was fabricated into fibers for possible use in drug delivery, tissue engineering, or wound repair applications. Electrospinning was chosen to process the LMWH into fiber form due to the small fiber diameters and high degree of porosity that can be obtained relatively quickly and using small amounts of starting material. Both free LMWH and PEG-LMWH were investigated for their ability to be incorporated into electrospun fibers. Each of the samples were mixed with a carrier polymer consisting of either a 10 wt % poly(ethylene oxide) (PEO) or 45 wt % poly(lactide-co-glycolide) (PLGA). Field emission scanning electron microscopy (FESEM), energy-dispersive X-ray analysis (EDX), UV-vis spectroscopy, and multiphoton microscopy were used to characterize the electrospun matrices. The incorporation of heparin into the electrospun PEO and PLGA fibers did not affect the surface morphology or fiber diameters. The fibers produced had diameters ranging from approximately 100 to 400 rim. Toluidine blue assays of heparin suggest that it can be incorporated into an electrospun matrix at concentrations ranging from 3.5 to 85 mu g per milligram of electrospun fibers. Multiphoton microscopy confirmed that incorporation of PEG-LMWH into the matrix permits retention of the heparin for at least 14 days. Improvements in the binding of basic fibroblast growth factor to the electrospun fibers were also observed for fibers functionalized with PEG-LMWH over those functionalized with LMWH alone. The combination of these results suggests the utility for producing electrospun fibers that are appropriately functionalized for use in biomaterials applications.
C1 Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   Delaware Biotechnol Inst, Newark, DE 19711 USA.
RP Rabolt, JF (reprint author), Univ Delaware, Dept Mat Sci & Engn, 201 Dupont Hall, Newark, DE 19716 USA.
EM rabolt@udel.edu
FU NIBIB NIH HHS [R01 EB003172, R01 EB003172-01, 1R01EB003172-01]
CR Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   BOLAND ED, 2001, ABSTR PAP AM CHEM S, V222
   CASPER CL, 2004, UNPUB POLYM NANOFIBR
   CASPER CL, 2004, FUNCTIONALIZED ELECT, V91, P1030
   CHINTALA SK, 1994, ARCH BIOCHEM BIOPHYS, V310, P180, DOI 10.1006/abbi.1994.1155
   CZYMMEK K, 2004, COMMUNICATION
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Guan R, 2004, BIOCONJUGATE CHEM, V15, P145, DOI 10.1021/bc034138t
   Hasirci V, 2001, J BIOTECHNOL, V86, P135, DOI 10.1016/S0168-1656(00)00409-0
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Irvine DJ, 1998, J BIOMED MATER RES, V40, P498, DOI 10.1002/(SICI)1097-4636(19980605)40:3<498::AID-JBM21>3.0.CO;2-E
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Ishihara M, 2001, J BIOMED MATER RES, V56, P536, DOI 10.1002/1097-4636(20010915)56:4<536::AID-JBM1125>3.3.CO;2-R
   Jiang HL, 2004, J BIOMAT SCI-POLYM E, V15, P279, DOI 10.1163/156856204322977184
   Jing Z, 2003, J CONTROL RELEASE, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Karakecili AG, 2002, J BIOMAT SCI-POLYM E, V13, P185, DOI 10.1163/156856202317414366
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kenawy ER, 2002, MACROMOL BIOSCI, V2, P261, DOI 10.1002/1616-5195(200208)2:6<261::AID-MABI261>3.0.CO;2-2
   Koski A, 2004, MATER LETT, V58, P493, DOI 10.1016/S0167-577X(03)00532-9
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   MACH H, 1993, BIOCHEMISTRY-US, V32, P5480, DOI 10.1021/bi00071a026
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Nagapudi K, 2002, MACROMOLECULES, V35, P1730, DOI 10.1021/ma011429t
   REYDERMAN L, 1995, INT J PHARM, V124, P75, DOI 10.1016/0378-5173(95)00078-W
   ROGHANI M, 1994, J BIOL CHEM, V269, P3976
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   SchroederTefft JA, 1997, J CONTROL RELEASE, V48, P29, DOI 10.1016/S0168-3659(97)00055-2
   Seal BL, 2003, BIOMACROMOLECULES, V4, P1572, DOI 10.1021/bm0342032
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   VOLDAVSKY I, 1991, J CELL BIOCHEM, V45, P167
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   YAMAGUCHI N, 2005, IN PRESS BIOMACROMOL
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhou D, 1999, REACT FUNCT POLYM, V39, P19, DOI 10.1016/S1381-5148(97)00149-1
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 46
TC 147
Z9 149
U1 0
U2 66
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL-AUG
PY 2005
VL 6
IS 4
BP 1998
EP 2007
DI 10.1021/bm050007e
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 945JI
UT WOS:000230498400026
PM 16004438
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dawlee, S
   Sugandhi, A
   Balakrishnan, B
   Labarre, D
   Jayakrishnan, A
AF Dawlee, S
   Sugandhi, A
   Balakrishnan, B
   Labarre, D
   Jayakrishnan, A
TI Oxidized chondroitin sulfate-cross-linked gelatin matrixes: A new class
   of hydrogels
SO BIOMACROMOLECULES
LA English
DT Article
ID BILAYER ARTIFICIAL SKIN; IN-VITRO; BIOMEDICAL APPLICATIONS; DEXTRAN
   DIALDEHYDE; WOUND DRESSINGS; LINKING; SPONGE; GLYCOSAMINOGLYCANS;
   ALGINATE; RELEASE
AB A naturally occurring glycosaminoglycan such as chondroitin-6-sulfate was first converted in to its aldehyde derivative by periodate oxidation and used as a cross-linking agent for gelatin giving rise to a new class of hydrogels. Cross-linking was predominantly due to Schiff's base formation between the c-amino groups of lysine or hydroxylysine side groups of gelatin and the aldehyde groups in oxidized chondroitin sulfate. The hydrogels were prepared from chondroitin sulfate with different degrees of oxidation and gelatin. They were characterized for degree of cross-linking, cross-linking density, equilibrium swelling, water vapor transmission rate, internal structure, and blood-compatibility. Degree of cross-linking of the gels determined by trinitrobenzene sulfonic acid assay showed that, the higher the degree of oxidation of the polysaccharide, the higher the degree of cross-linking. Examination of the internal structure by scanning electron microscopy showed that the hydrogels were highly porous in nature with interconnecting pores ranging from 50 to 200 mu m. Equilibrium swelling showed that the gels retained about 90% water and did not undergo dehydration rapidly. The hydrogels were nontoxic and blood-compatible. Since an important phase of early wound healing has been shown to involve secretion of glycosaminoglycans such as chondroitin sulfate by fibroblasts which form a hydrophilic matrix suitable for remodeling during healing, this new class of hydrogels prepared from chondroitin sulfate and gelatin without employing any extraneous cross-linking agents are expected to have potential as wound dressing materials.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Polymer Chem, Trivandrum 695012, Kerala, India.
   Univ Paris Sud, Ctr Etud Pharmaceut, CNRS, UMR 8612, F-92296 Chatenay Malabry, France.
RP Jayakrishnan, A (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Polymer Chem, Satelmond Palace, Trivandrum 695012, Kerala, India.
EM dr_jkrishnan@sify.com
RI Balakrishnan, Biji/A-2001-2011
OI Balakrishnan, Biji/0000-0003-2331-5032; Athipettah,
   Jayakrishnan/0000-0003-2738-6161
CR Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Barnett S. E., 1991, HIGH PERFORMANCE BIO, P583
   Bassett J., 1978, VOGELS TXB QUANTITAT, P370
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   Cenni E, 2000, J BIOMAT SCI-POLYM E, V11, P685, DOI 10.1163/156856200743959
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Choi YS, 2001, J MATER SCI-MATER M, V12, P67, DOI 10.1023/A:1026765321117
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6
   Gilbert ME, 2004, LARYNGOSCOPE, V114, P1406, DOI 10.1097/00005537-200408000-00017
   Gudemez E, 2002, J HAND SURG-AM, V27A, P293, DOI 10.1053/jhsu.2002.31161
   JONKMAN MF, 1988, MIOMATERIALS, V9, P263
   Keuren JFW, 2003, BIOMATERIALS, V24, P1917, DOI 10.1016/S0142-9612(02)00620-8
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Kosir MA, 2000, J SURG RES, V92, P45, DOI 10.1006/jsre.2000.5840
   Kuijpers AJ, 2000, BIOMATERIALS, V21, P1763, DOI 10.1016/S0142-9612(00)00064-8
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   LAMKE LO, 1977, BURNS, V3, P159, DOI 10.1016/0305-4179(77)90004-3
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   MARK HF, 1967, ENCY POLYM SCI TECHN, V7, P446
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   OLEARY RK, 1968, J PHARM SCI, V57, P12, DOI 10.1002/jps.2600570102
   PAINTER T, 1970, ACTA CHEM SCAND, V24, P813, DOI 10.3891/acta.chem.scand.24-0813
   Prathiba V, 2000, CURR SCI INDIA, V78, P697
   QUEEN D, 1987, BIOMATERIALS, V8, P367, DOI 10.1016/0142-9612(87)90007-X
   Schacht E, 1997, REACT FUNCT POLYM, V33, P109, DOI 10.1016/S1381-5148(97)00047-3
   SUZUKI S, 1990, BIOMATERIALS, V11, P356, DOI 10.1016/0142-9612(90)90114-6
   Wu P, 1996, BIOMATERIALS, V17, P1373, DOI 10.1016/0142-9612(96)87277-2
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   1992, BIOL EVALUATION MED
   2002, BIOL EVALUATION MED
NR 33
TC 73
Z9 76
U1 4
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL-AUG
PY 2005
VL 6
IS 4
BP 2040
EP 2048
DI 10.1021/bm050013a
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 945JI
UT WOS:000230498400031
PM 16004443
DA 2018-10-20
ER

PT J
AU Chen, P
AF Chen, P
TI Self-assembly of ionic-complementary peptides: a physicochemical
   viewpoint
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT International Workshop on Bubble and Drop Interfaces
CY APR 25-28, 2004
CL Genoa, ITALY
SP Italian Natl Res Council, Dept Inst energet & Interphase
DE self-assembly; peptides; ionic-complementarity; electrostatic
   interactions; amino acid sequence; secondary structure; nanostructure;
   nanofibers; nanotechnology; nanobiotechnology
ID AMYLOID BETA-PROTEIN; BLOCK-COPOLYMER MICELLES; NONVIRAL GENE DELIVERY;
   AMINO-ACID-SEQUENCE; DRUG-DELIVERY; ANTENNAPEDIA HOMEODOMAIN;
   TRANSDUCTION TECHNOLOGY; INTRACELLULAR DELIVERY; AMPHIPHILE NANOFIBERS;
   RECOGNITION SEQUENCES
AB A major focus in the current development in nanotechnology and biotechnology is to find suitable molecular materials that are amenable to engineering design. Self-assembling, ionic-complementary peptides have recently emerged as one of the most promising biomolecular materials. We provide a brief review of recent research on these newly discovered peptides from a physicochemical point of view. This new class of peptides has a unique molecular structure of alternating positive and negative charge distributions, leading to ionic-complementarity. In addition to hydrogen bonding and hydrophobic interaction, the ionic-complementarity contributes to peptide self-assembly. These peptides assume P-sheet secondary structure predominantly, and can further self-assemble into fibrils, membranes, and even hydrogels with an increase in peptide concentration or other physicochemical parameters. The self-assembly process is highly dependent on the peptide sequence, concentration, pH. presence of salts, and time (or kinetics). By varying these experimentally controllable factors, nanoscopic and/or macroscopic structures with great stability and functionality can be constructed. These nano/microstructures have various biomedical applications, including tissue engineering, drug/gene delivery and biological surface patterning. It is anticipated that molecular engineering of these ionic-complementary peptides will contribute in a significant way to the development of novel nanobiomaterials, and play air important role in the advance of rapidly emerging bionanotechnology fields. (c) 2005 Published by Elsevier B.V.
C1 Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
RP Chen, P (reprint author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
EM p4chen@cape.uwaterloo.ca
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Aggeli Amalia, 1999, Molecular Medicine Today, V5, P512, DOI 10.1016/S1357-4310(99)01610-X
   Akiyoshi K, 1998, J CONTROL RELEASE, V54, P313, DOI 10.1016/S0168-3659(98)00017-0
   Alakhov VY, 1996, BIOCONJUGATE CHEM, V7, P209, DOI 10.1021/bc950093n
   Allen C, 1998, BIOCONJUGATE CHEM, V9, P564, DOI 10.1021/bc9702157
   AMER YA, 2001, J BIOL CHEM, V276, P30499
   Applequist J., 1965, POLYAMINO ACID POLYP, P161
   ARAKAWA T, 1984, BIOCHEMISTRY-US, V23, P5912, DOI 10.1021/bi00320a004
   BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202
   Berriz GF, 1997, J CHEM PHYS, V106, P9276, DOI 10.1063/1.474039
   BIRKS JB, 1970, PHOTOPHYSICS AROMATI
   Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699
   BOGOYEVITCH MA, 2002, DNA CELL BIOL, V2, P879
   Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N
   Breen TL, 1999, SCIENCE, V284, P948, DOI 10.1126/science.284.5416.948
   Broglia RA, 1998, P NATL ACAD SCI USA, V95, P12930, DOI 10.1073/pnas.95.22.12930
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Buriak JM, 1997, MAT SCI ENG C-BIOMIM, V4, P207, DOI 10.1016/S0928-4931(97)00002-7
   CAO T, 1991, MACROMOLECULES, V24, P6300, DOI 10.1021/ma00023a036
   Caplan MR, 2002, IND ENG CHEM RES, V41, P403, DOI 10.1021/ie010149z
   Caplan MR, 2002, J BIOMAT SCI-POLYM E, V13, P225, DOI 10.1163/156856202320176493
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   CHOU PY, 1970, BIOCHEMISTRY-US, V15, P785
   Clint J. H., 1992, SURFACTANT AGGREGATI
   Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711
   de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199
   Denicourt C, 2003, TRENDS PHARMACOL SCI, V24, P216, DOI 10.1016/S0165-6147(03)00074-9
   DEROSSI D, 1994, J BIOL CHEM, V269, P10444
   Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188
   Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2
   Dobson CM, 2001, PHILOS T ROY SOC B, V356, P133, DOI 10.1098/rstb.2000.0758
   Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7
   Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514
   Favrin G, 2002, PROTEINS, V47, P99, DOI 10.1002/prot.10072
   Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601
   Fung SY, 2003, BIOPHYS J, V85, P537, DOI 10.1016/S0006-3495(03)74498-1
   FUNG SY, 2003, COMMUNICATION
   Gershanik T, 2000, EUR J PHARM BIOPHARM, V50, P179, DOI 10.1016/S0939-6411(00)00089-8
   GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0
   Goeden-Wood NL, 2003, MACROMOLECULES, V36, P2932, DOI 10.1021/ma025952z
   GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031
   Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385
   Harrison PM, 2001, PROTEIN SCI, V10, P819, DOI 10.1110/ps.38701
   Hart WE, 1997, J COMPUT BIOL, V4, P241, DOI 10.1089/cmb.1997.4.241
   Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hawiger J, 1999, CURR OPIN CHEM BIOL, V3, P89, DOI 10.1016/S1367-5931(99)80016-7
   Henry CM, 2003, CHEM ENG NEWS, V81, P35, DOI 10.1021/cen-v081n034.p035
   Ho A, 2001, CANCER RES, V61, P474
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong YS, 2004, J ADHESION, V80, P913, DOI 10.1080/00218460490508616
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Houseman BT, 2002, TRENDS BIOTECHNOL, V20, P279, DOI 10.1016/S0167-7799(02)01984-4
   Hubbell JA, 2003, SCIENCE, V300, P595, DOI 10.1126/science.1083625
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ikkala O, 2002, SCIENCE, V295, P2407, DOI 10.1126/science.1067794
   Istrail S, 1999, J COMPUT BIOL, V6, P143, DOI 10.1089/cmb.1999.6.143
   Jin W, 2001, J AM CHEM SOC, V123, P8121, DOI 10.1021/ja015807l
   Jun S, 2004, BIOPHYS J, V87, P1249, DOI 10.1529/biophysj.103.038166
   Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X
   Keyes-Baig C, 2004, J AM CHEM SOC, V126, P7522, DOI 10.1021/ja0381297
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KWON GS, 1994, COLLOID SURFACE B, V2, P429
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   Langer R, 2000, AICHE J, V46, P1286, DOI 10.1002/aic.690460702
   Langer R, 1998, NATURE, V392, P5
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   LEE SL, 1977, BIOCHEMISTRY-US, V16, P2971, DOI 10.1021/bi00632a026
   Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   Liaw J, 1998, PHARMACEUT RES, V15, P1721, DOI 10.1023/A:1011908728838
   Liu JQ, 2001, BIOMACROMOLECULES, V2, P362, DOI 10.1021/bm015515c
   Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942
   Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Lynn DG, 2000, J STRUCT BIOL, V130, P153, DOI 10.1006/jsbi.2000.4287
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Miura Y, 1998, LANGMUIR, V14, P6935, DOI 10.1021/la981296d
   Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   MUTTER M, 1990, ANGEW CHEM INT EDIT, V29, P185, DOI 10.1002/anie.199001851
   MUTTER M, 1991, ANGEW CHEM INT EDIT, V30, P1514, DOI 10.1002/anie.199115141
   Myers D., 1992, SURFACTANT SCI TECHN
   NANDI PK, 1972, J AM CHEM SOC, V94, P1299, DOI 10.1021/ja00759a042
   Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8
   OEHLKE J, 2002, CELL PENETRATING PEP, P71
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   PARDRIDGE WM, 1987, BIOCHEM BIOPH RES CO, V146, P307, DOI 10.1016/0006-291X(87)90726-1
   Park K., 2000, ACS SYM SER, V752, P2
   PENNISI E, 1993, SCI NEWS, V143, P316
   Persson CM, 2002, J COLLOID INTERF SCI, V251, P182, DOI 10.1006/jcis.2002.8386
   PETTITT BM, 1985, J AM CHEM SOC, V107, P1166, DOI 10.1021/ja00291a014
   Pooga M, 1998, FASEB J, V12, P67
   Powers ET, 2001, J AM CHEM SOC, V123, P775, DOI 10.1021/ja005528i
   Priester T, 1998, J COLLOID INTERF SCI, V208, P6, DOI 10.1006/jcis.1998.5773
   PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154
   QIU X, 2001, LANGMUIR, V17, P5380
   Qiu XP, 2001, MACROMOL MATER ENG, V286, P591, DOI 10.1002/1439-2054(20011001)286:10<591::AID-MAME591>3.0.CO;2-I
   Reif I, 2001, LANGMUIR, V17, P5801, DOI 10.1021/la0105578
   Reinhoudt DN, 2002, SCIENCE, V295, P2403, DOI 10.1126/science.1069197
   Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115
   Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Santoso S., 2003, ENCY NANOSCIENCE NAN
   Santoso SS, 2002, CURR OPIN COLLOID IN, V7, P262, DOI 10.1016/S1359-0294(02)00072-9
   Sapra P, 2003, PROG LIPID RES, V42, P439, DOI 10.1016/S0163-7827(03)00032-8
   Sawamura M, 2000, CHEM LETT, P1098, DOI 10.1246/cl.2000.1098
   SCHULZ GE, 1979, PRINCIPLES PROTEIN S
   Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2
   Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569
   Service RF, 2001, SCIENCE, V294, P1635
   Shea JE, 1998, J CHEM PHYS, V109, P2895, DOI 10.1063/1.476842
   Shi XY, 2001, LANGMUIR, V17, P2036, DOI 10.1021/la001550d
   Smith LC, 1998, ADV DRUG DELIVER REV, V30, P115, DOI 10.1016/S0169-409X(97)00111-7
   SOREGHAN B, 1994, J BIOL CHEM, V269, P28551
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   Sprossler C, 1999, PHYS REV E, V60, P2171, DOI 10.1103/PhysRevE.60.2171
   Strong AE, 1999, J MATER CHEM, V9, P1097, DOI 10.1039/a806860g
   Strong AE, 1998, CHEM COMMUN, P473, DOI 10.1039/a708663f
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Thirumalai D, 1999, CURR OPIN STRUC BIOL, V9, P197, DOI 10.1016/S0959-440X(99)80028-1
   Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Vendruscolo M, 2003, PHILOS T R SOC A, V361, P1205, DOI 10.1098/rsta.2003.1194
   Wadia J. S., 2002, CELL PENETRATING PEP, P365
   Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7
   Wagner E, 1999, ADV DRUG DELIVER REV, V38, P279, DOI 10.1016/S0169-409X(99)00033-2
   Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945
   WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349
   Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yeates TO, 2002, CURR OPIN STRUC BIOL, V12, P464, DOI 10.1016/S0959-440X(02)00350-0
   YEKTA A, 1995, MACROMOLECULES, V28, P956, DOI 10.1021/ma00108a025
   YOKOI H, 2003, COMMUNICATION
   YORK P, 1996, NEW MAT SYSTEMS DRUG, P1
   Zhang S., 2001, ENCY MAT SCI TECHNOL, P5822
   Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462
   Zhou SQ, 2001, SCIENCE, V291, P1944, DOI 10.1126/science.291.5510.1944
NR 157
TC 81
Z9 86
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD JUL 1
PY 2005
VL 261
IS 1-3
SI SI
BP 3
EP 24
DI 10.1016/j.colsurfa.2004.12.048
PG 22
WC Chemistry, Physical
SC Chemistry
GA 940RL
UT WOS:000230161600002
DA 2018-10-20
ER

PT J
AU Ferri, JK
   Miller, R
   Makievski, AV
AF Ferri, JK
   Miller, R
   Makievski, AV
TI Equilibrium and dynamics of PEO/PPO/PEO penetration into DPPC monolayers
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT International Workshop on Bubble and Drop Interfaces
CY APR 25-28, 2004
CL Genoa, ITALY
SP Italian Natl Res Council, Dept Inst energet & Interphase
DE lipid-polymer interactions; monolayer penetration; adsorption dynamics;
   novel subphase exchange; pendant drop technique
ID SYMMETRIC TRIBLOCK COPOLYMERS; AIR-WATER-INTERFACE; DROP SHAPE-ANALYSIS;
   LIPID MONOLAYERS; LIQUID INTERFACES; INSERTION; MEMBRANE; BALANCE;
   LAYERS
AB The interaction of synthetic polymers with living tissue is of interest in a wide range of biochemical and biomedical applications ranging from cell culture in large-scale bioreactors to pharmaceutic and cosmetic products. To gain insight into the physico-chemical interactions between polymeric material and cell membranes, we study the equilibrium and dynamic penetration of a symmetric triblock copolymer (PEO/PPO/PEO) into DPPC monolayers using a novel coaxial capillary pendant drop technique. A well-defined initial condition of the insoluble monolayer was established by first spreading the lipid onto a water drop formed at the tip of two (concentric) capillaries. The lipid was subsequently compressed to a specified surface state. Afterwards, the droplet subphase was exchanged by injecting a polymer solution from one of the capillaries and withdrawing liquid from the other under a constant total (drop) volume. The effects of polymer concentration and fractional coverage of the lipid monolayer on the surface pressure evolution were investigated. The data suggests that the adsorption of polymer into the lipid monolayer is reversible and that upon compression of the surface, the lipid can eject the macromolecule from the surface. A comparison of the equilibrium surface pressure of the penetrated monolayer with the surface pressure of the polymer alone shows that interactions in the adsorbed layer are non-ideal and consistent with polymer-lipid repulsion. Both desorption of the polymer from a suddenly compressed interface and response to oscillatory perturbation of the interface show that a characteristic timescale in the kinetics of monolayer relaxation is in the order of 100 s. Because of the elevated concentration of polymer in the bulk phase. this suggests a kinetic barrier to macromolecule adsorption/desorption. (c) 2004 Elsevier B.V. All rights reserved.
C1 Lafayette Coll, Dept Chem Engn, Easton, PA 18042 USA.
   Max Planck Inst Kolloid & Grenzflachenforsch, D-14476 Golm Potsdam, Germany.
RP Ferri, JK (reprint author), Lafayette Coll, Dept Chem Engn, Easton, PA 18042 USA.
EM ferrij@lafayette.edu
OI Miller, Reinhard/0000-0001-8943-7521
CR Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X
   Cabrerizo-Vilchez MA, 1999, REV SCI INSTRUM, V70, P2438, DOI 10.1063/1.1149773
   DEGENNES PG, 1990, NEW TRENDS PHYSICS C, P9
   FLEER GJ, 1993, POLYM INTERFACES, P121
   Ge LQ, 2003, COLLOID SURFACE A, V221, P49, DOI 10.1016/S0927-7757(03)00106-7
   Gennis R. B., 1989, BIOMEMBRANES MOL STR, P166
   Kretzschmar G, 1996, COLLOID SURFACE A, V114, P277, DOI 10.1016/0927-7757(96)03523-6
   Loglio G, 2001, STUD INTERF SCI, V11, P439, DOI 10.1016/S1383-7303(01)80038-7
   Maskarinec SA, 2003, LANGMUIR, V19, P1809, DOI 10.1021/la026175z
   Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4
   Mayer LD, 2000, J LIPOSOME RES, V10, P99, DOI 10.3109/08982100009029381
   Munoz MG, 2000, LANGMUIR, V16, P1094, DOI 10.1021/la9901433
   Munoz MG, 2000, LANGMUIR, V16, P1083, DOI 10.1021/la990142a
   MURHAMMER DW, 1989, THESIS U HOUSTON
   Rider KB, 2001, PHYS REV LETT, V86, P4330, DOI 10.1103/PhysRevLett.86.4330
   Sharma V, 1996, BIOPHYS J, V71, P3229, DOI 10.1016/S0006-3495(96)79516-4
   SUNDARAM S, 1998, THESIS J HOPKINS U
   Terry MA, 1999, ANN NY ACAD SCI, V888, P274, DOI 10.1111/j.1749-6632.1999.tb07962.x
   VANDEPAS JC, 1994, COLLOID SURFACE A, V85, P221, DOI 10.1016/0927-7757(94)02765-X
   VOGT TC, 2002, MOL THER, V5, P455
   VOURNAKIS JN, 1989, BIO-TECHNOL, V7, P143, DOI 10.1038/nbt0289-143
   Wege HA, 1999, COLLOID SURFACE A, V156, P509, DOI 10.1016/S0927-7757(99)00108-9
   XIR AF, 2002, NAT MATER, V1, P129
NR 23
TC 30
Z9 30
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD JUL 1
PY 2005
VL 261
IS 1-3
SI SI
BP 39
EP 48
DI 10.1016/j.colsurfa.2004.11.039
PG 10
WC Chemistry, Physical
SC Chemistry
GA 940RL
UT WOS:000230161600005
DA 2018-10-20
ER

PT J
AU Zhu, XM
   Lei, MK
AF Zhu, XM
   Lei, MK
TI Surface engineering of biomedical metallic materials by plasma-based
   low-energy ion implantation
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 2nd Korea-China Symposium on Biomaterials and Nano-Bio Technology
CY OCT 17-21, 2004
CL Yonsei Univ, Seoul, SOUTH KOREA
SP Nat Sci Fdn China, Korea Sci Engn Fdn, Korea Acad Sc Tech
HO Yonsei Univ
DE plasma-based low-energy ion implantation; austenitic stainless steel;
   Ti6Al4V alloy; surface modification
ID AUSTENITIC STAINLESS-STEEL; CORROSION-RESISTANCE; NITROGEN; TITANIUM;
   PHASE
AB Plasma-based low-energy ion implantation, including plasma source ion nitriding/carburizing and plasma source low-energy ion enhanced deposition of thin films, for surface engineering of metallic materials was emerged as low-temperature, low-pressure surface modification technique. Plasma source ion nitriding onto AISI 316L austenitic stainless steel produced a high nitrogen face-centered-cubic phase (gamma(N)) layer about 10 mu m thick at the temperature of 380 degrees C during 4 h with the high microhardness of HK0.1N 22.0 GPa. The microhardness of the nitrided surface from the titanium nitride phase [(Ti, Al, V)N] layer on Ti6Al4V alloy at 750 degrees C during 4 h achieved up to about HK0.5N 15.5 GPa. No pitting corrosion in the Ringer's solution at 37 degrees C was detected by electrochemical polarization measurement for the nitrided AISI 316L stainless steel and Ti6Al4V alloy, respectively. Plasma source ion nitriding of the metallic materials provided the engineering surfaces with combined improvement in hardness and corrosion resistance. (c) 2005 Elsevier B.V. All rights reserved.
C1 Dalian Jiaotong Univ, Sch Mat Sci & Engn, Dalian 116028, Peoples R China.
   Dalian Univ Technol, Dept Mat Engn, Surface Engn Lab, Dalian 116024, Peoples R China.
RP Zhu, XM (reprint author), Dalian Jiaotong Univ, Sch Mat Sci & Engn, Dalian 116028, Peoples R China.
EM xmzhu@djtu.edu.cn
CR CHANDRA L, 1995, J MATER SCI-MATER M, V6, P581, DOI 10.1007/BF00121282
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Lei MK, 2004, J VAC SCI TECHNOL A, V22, P2067, DOI 10.1116/1.1786305
   LEI MK, IN PRESS J ELECTROCH
   LEI MK, 1995, J VAC SCI TECHNOL A, V13, P2886
   Leitao E, 1997, J MATER SCI-MATER M, V8, P365, DOI 10.1023/A:1018532900458
   Maitz MF, 2002, SURF COAT TECH, V158, P151, DOI 10.1016/S0257-8972(02)00189-5
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Zhang Z.L., 1985, SURF ENG, V1, P131, DOI DOI 10.1179/SUR.1985.1.2.131
   Zhu XM, 2000, SURF COAT TECH, V131, P400, DOI 10.1016/S0257-8972(00)00856-2
NR 10
TC 14
Z9 15
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2005
VL 5
IS 5
BP 522
EP 525
DI 10.1016/j.cap.2005.01.018
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 944HX
UT WOS:000230419000029
DA 2018-10-20
ER

PT J
AU Franks, W
   Schenker, I
   Schmutz, P
   Hierlemann, A
AF Franks, W
   Schenker, I
   Schmutz, P
   Hierlemann, A
TI Impedance characterization and modeling of electrodes for biomedical
   applications
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE electrochemical impedance spectroscopy; Pt; Pt; black; and TiN
   bioelectrodes
ID POLARIZATION IMPEDANCE; ELECTRICAL-STIMULATION; BIOLOGICAL-MATERIALS;
   AUDITORY-NERVE; IN-VIVO; INTERFACE; ARRAY; OXIDE
AB A low electrode-electrolyte impedance interface is critical in the design of electrodes for biomedical applications. To design low-impedance interfaces a complete understanding of the physical processes contributing to the impedance is required. In this work a model describing these physical processes is validated and extended to quantify the effect of organic coatings and incubation time. Electrochemical impedance spectroscopy has been used to electrically characterize the interface for various electrode materials: platinum, platinum black, and titanium nitride; and varying electrode sizes: 1 cm(2), and 900 mu m(2). An equivalent circuit model comprising an interface capacitance, shunted by a charge transfer resistance, in series with the solution resistance has been fitted to the experimental results. Theoretical equations have been used to calculate the interface capacitance impedance and the solution resistance, yielding results that correspond well with the fitted parameter values, thereby confirming the validity of the equations. The effect of incubation time, and two organic cell-adhesion promoting coatings, poly-L-lysine and laminin, on the interface impedance has been quantified using the model. This demonstrates the benefits of using this model in developing a better understanding of the physical processes occurring at the interface in more complex, biomedically relevant situations.
C1 ETH, Phys Elect Lab, CH-8093 Zurich, Switzerland.
   Swiss Fed Inst Mat Testing & Res, EMPA, Lab Corros & Mat Integr, CH-8600 Dubendorf, Switzerland.
RP Franks, W (reprint author), ETH, Phys Elect Lab, CH-8093 Zurich, Switzerland.
EM franks@phys.ethz.ch; iwan.schenker@mat.ethz.ch; Patfik.Schmutz@empa.ch;
   hierlema@phys.ethz.ch
RI Schmutz, Patrik/D-6263-2014; Schenker, Iwan/B-5545-2013; Hierlemann,
   Andreas/A-7046-2008
OI Hierlemann, Andreas/0000-0002-3838-2468
CR Bard A. J, 2001, ELECTROCHEMICAL METH
   BATES JB, 1992, ANN BIOMED ENG, V20, P349, DOI 10.1007/BF02368536
   Bockris J.O.M., 1970, MODERN ELECTROCHEMIS, V2
   Borkholder D., 1998, THESIS STANFORD U ST
   Chou HA, 2003, BIOSENS BIOELECTRON, V18, P11, DOI 10.1016/S0956-5663(02)00116-1
   Davies PW, 1962, PHYS TECH, VIV, P137
   Fricke H., 1932, PHILOS MAG, V7, P310
   FRNKS W, 2003, TRANSDUCERS 03
   GRAHAME DC, 1952, J ELECTROCHEM SOC, V99, P370
   GROSS GW, 1993, J NEUROSCI METH, V50, P131, DOI 10.1016/0165-0270(93)90001-8
   Heer F, 2004, BIOSENS BIOELECTRON, V20, P358, DOI 10.1016/j.bios.2004.02.006
   Heuschkel M. O., 2001, SERIES MICROSYSTEMS, V13
   Huang CQ, 1999, IEEE T BIO-MED ENG, V46, P461, DOI 10.1109/10.752943
   JANDERS M, 1997, P IEEE ENG MED BIOL
   JARON D, 1968, MED BIOL ENG, V6, P579, DOI 10.1007/BF02474721
   Kovacs G. T. A., 1994, ENABLING TECHNOLOGIE, P121
   Macdonald J. R., 1987, IMPEDANCE SPECTROSCO
   Marquette CA, 2002, TALANTA, V56, P763, DOI 10.1016/S0039-9140(01)00633-6
   McAdams E.T., 1989, SURFACE TOPOGRAPHY, V2, P107
   MCADAMS ET, 1994, MED BIOL ENG COMPUT, V32, P126, DOI 10.1007/BF02518908
   MCADAMS ET, 1995, BIOSENS BIOELECTRON, V10, P67, DOI 10.1016/0956-5663(95)96795-Z
   Mirsky VM, 1997, BIOSENS BIOELECTRON, V12, P977, DOI 10.1016/S0956-5663(97)00053-5
   ONARAL B, 1982, MED BIOL ENG COMPUT, V20, P299, DOI 10.1007/BF02442796
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   RANDLES JEB, 1947, DISCUSS FARADAY SOC, V1, P11, DOI 10.1039/df9470100011
   SCHWAN HP, 1968, ANN NY ACAD SCI, V148, P191, DOI 10.1111/j.1749-6632.1968.tb20349.x
   SCHWAN HP, 1992, ANN BIOMED ENG, V20, P269, DOI 10.1007/BF02368531
   Thiebaud P, 1999, BIOSENS BIOELECTRON, V14, P61, DOI 10.1016/S0956-5663(98)00098-0
   Tykocinski M, 2001, HEARING RES, V159, P53, DOI 10.1016/S0378-5955(01)00320-3
   VALEON LO, 1997, J ALLOY COMPD, V253, P656
   Warburg E., 1899, Annalen der Physik und Chemie, V67, P493
   Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919
   Weiland JD, 2002, IEEE T BIO-MED ENG, V49, P1574, DOI 10.1109/TBME.2002.805487
   Yang YY, 2003, J MATER SCI TECHNOL, V19, P5
   YEAGER E, 1984, ELECTROCHIM ACTA, V29, P1527, DOI 10.1016/0013-4686(84)85006-9
NR 35
TC 292
Z9 298
U1 2
U2 87
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD JUL
PY 2005
VL 52
IS 7
BP 1295
EP 1302
DI 10.1109/TBME.2005.847523
PG 8
WC Engineering, Biomedical
SC Engineering
GA 938CW
UT WOS:000229978500015
PM 16041993
DA 2018-10-20
ER

PT J
AU Mattioli-Belmonte, M
   Lucarini, G
   Virgili, L
   Biagini, G
   Detomaso, L
   Favia, P
   D'Agostino, R
   Gristina, R
   Gigante, A
   Bevilacqua, C
AF Mattioli-Belmonte, M
   Lucarini, G
   Virgili, L
   Biagini, G
   Detomaso, L
   Favia, P
   D'Agostino, R
   Gristina, R
   Gigante, A
   Bevilacqua, C
TI Mesenchymal stem cells on plasma-deposited acrylic acid coatings: An in
   vitro investigation to improve biomaterial performance in bone
   reconstruction
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE plasma-deposited coatings; acrylic acid; polymer surface modification;
   mesenchymal stem cells; cell behavior; bone scaffolds
ID BIOMEDICAL POLYMERS
AB In this in vitro investigation of a heterogeneous range of biofunctional and modulatory performances of mesenchymal stem cells (MSCs) grown on two plasma-deposited acrylic acid (pdAA) coatings, which differed in chemical characteristics, a view of their potential utility as hybrid scaffolds for bone tissue engineering was obtained. The in vitro behavior of MKS was compared to that of MG-63 cells, an osteoblast-like cell line that is commonly used to test biocompatibility of materials intended for bone-tissue interface. The coatings exerted a greater stimulus on MSCs and on MG-63 cells in comparison with control cultures. Both studied coatings exhibited satisfactory compatibility and modulatory effects on MSCs, thus they may be suitable for use in 2D or 3D scaffolds for bone tissue reconstruction.
C1 Univ Politecn delle Marche, Ist Morfol Umana Normale, I-60020 Ancona, Italy.
   Univ Bari, Dipartimento Chim, I-70126 Bari, Italy.
   Univ Bari, CNR, IMIP, I-70126 Bari, Italy.
   Univ Politecn Marche, Dipartimento Patol Mol & Terapie Innovat, I-60020 Ancona, Italy.
RP Mattioli-Belmonte, M (reprint author), Univ Politecn delle Marche, Ist Morfol Umana Normale, Via Tronto 10-A, I-60020 Ancona, Italy.
EM belmonte@med.univpm.it
RI Mattioli-Belmonte, Monica/J-5861-2012
OI GIGANTE, ANTONIO/0000-0003-0772-563X
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BeauvaisJouneau A, 1997, EXP CELL RES, V233, P1, DOI 10.1006/excr.1997.3554
   DAGOSTINO R, 1990, PLASMA MAT INTERACTI, V496
   DAGOSTINO R, 1997, NATO ASI SERIES E, V346
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   ETIENNEMANNEVIL.S, 2002, NATURE, V429, P629
   Favia P, 2003, SURF COAT TECH, V169, P707, DOI 10.1016/S0257-8972(03)00174-9
   Favia P, 2002, J PHOTOPOLYM SCI TEC, V15, P341
   FAVIA P, 2002, VIDE, P1
   Fazzi R, 2002, LEUKEMIA RES, V26, P839, DOI 10.1016/S0145-2126(02)00008-5
   Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100
   Harris CT, 2004, J BIOMED MATER RES A, V68A, P747, DOI 10.1002/jbm.a.20107
   HERZOG EL, 2003, BLOOD, V102, P2483
   Hoffman A.S., 1996, BIOMATERIALS SCI INT, P124
   Huss R, 2002, BRIT J HAEMATOL, V118, P305, DOI 10.1046/j.1365-2141.2002.03587.x
   JAVAZON EH, 2004, EXPT HEMATOLOGY, V32, P4141
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   PALUMBO F, 1999, PLASMAS POLYM, V4, P133
   Pender SLF, 2000, AM J PATHOL, V157, P1955, DOI 10.1016/S0002-9440(10)64834-1
   RATNER BD, 1990, PLASMA DEPOSITION TR, P496
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   SHIMAZUI T, 2004, ONCOL REP, V118, P357
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Suh H, 2001, ARTIF ORGANS, V25, P459, DOI 10.1046/j.1525-1594.2001.025006459.x
   Torricelli P, 2003, BIOMED PHARMACOTHER, V57, P57, DOI 10.1016/S0753-3322(02)00329-3
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
NR 27
TC 18
Z9 20
U1 0
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2005
VL 20
IS 4
BP 343
EP 360
DI 10.1177/0883911505055159
PG 18
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 939RK
UT WOS:000230089900002
DA 2018-10-20
ER

PT J
AU Kurella, A
   Dahotre, NB
AF Kurella, A
   Dahotre, NB
TI Review paper: Surface modification for bioimplants: The role of laser
   surface engineering
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Review
DE biornaterials; interface; surface modification; bioimplants;
   osteointegration; lasers; coating; texturing
ID CALCIUM-PHOSPHATE COATINGS; THIN-FILMS; HYDROXYAPATITE COATINGS;
   MECHANICAL-PROPERTIES; CELL BEHAVIOR; IN-VITRO; BIOMEDICAL APPLICATIONS;
   PROCESSING PARAMETERS; TOPOGRAPHICAL CONTROL; STABILIZED ZIRCONIA
AB Often hard implants undergo detachment from the host tissue due to inadequate biocompatibility and poor osteointegration. Changing surface chemistry and physical topography of the surface influences biocompatibility. At present, the understanding of biocompatibility of both virgin and modified surfaces of bioimplant materials is limited and a great deal of research is being dedicated to this aspect. In view of this, the current review casts new light on research related to the surface modification of biomaterials, especially materials for prosthetic applications. A brief overview of the major surface modification techniques has been presented, followed by an in-depth discussion on laser surface modifications that have been explored so far along with those that hold tremendous potential for bioimplant applications.
C1 Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   Oak Ridge Natl Lab, Div Met & Ceram, Mat Proc Grp, Oak Ridge, TN 37831 USA.
RP Dahotre, NB (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM ndahotre@utk.edu
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR Agarwal A, 2000, METALL MATER TRANS A, V31, P461, DOI 10.1007/s11661-000-0282-0
   Agarwal A, 2000, METALL MATER TRANS A, V31, P401, DOI 10.1007/s11661-000-0277-x
   Antonov EN, 1997, BIOMATERIALS, V18, P1043, DOI 10.1016/S0142-9612(97)00030-6
   Antonov EN, 2003, J MATER SCI-MATER M, V14, P151, DOI 10.1023/A:1022071829917
   Bahnisch R, 1999, SENSOR ACTUAT A-PHYS, V74, P31, DOI 10.1016/S0924-4247(98)00333-1
   Bhushan B, 1991, HDB TRIBOLOGY MAT CO
   Booth HJ, 2004, THIN SOLID FILMS, V453, P450, DOI 10.1016/j.tsf.2003.11.130
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Callewaert K, 2003, APPL SURF SCI, V208, P218, DOI 10.1016/S0169-4332(02)01376-4
   Chevalier J, 2004, BIOMATERIALS, V25, P5539, DOI 10.1016/j.biomaterials.2004.01.002
   Chong TC, 2002, P SOC PHOTO-OPT INS, V4426, P17, DOI 10.1117/12.456805
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   COTELL CM, 1993, APPL SURF SCI, V69, P140, DOI 10.1016/0169-4332(93)90495-W
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   D'Alessio L, 1999, APPL SURF SCI, V138, P527, DOI 10.1016/S0169-4332(98)00610-2
   DAHOTRE NB, 1989, J APPL PHYS, V65, P5072, DOI 10.1063/1.343183
   Dahotre NB, 2001, JOM-J MIN MET MAT S, V53, P44, DOI 10.1007/s11837-001-0070-3
   Dan N, 2000, TRENDS BIOTECHNOL, V18, P370, DOI 10.1016/S0167-7799(00)01482-7
   DASARI A, 2002, MAT SCI TECHNOL, V18, P11
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   Duncan AC, 2002, BIOSENS BIOELECTRON, V17, P413, DOI 10.1016/S0956-5663(01)00281-0
   DUNSKY C, 2001, SPIE, V4443, P135
   Favret E, 2004, APPL SURF SCI, V230, P60, DOI 10.1016/j.apsusc.2003.12.036
   Fernandez-Pradas JM, 2002, BIOMATERIALS, V23, P1989, DOI 10.1016/S0142-9612(01)00327-1
   Fernandez-Pradas JM, 2001, BIOMATERIALS, V22, P2171, DOI 10.1016/S0142-9612(00)00408-7
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gaggl A, 2000, BIOMATERIALS, V21, P1067, DOI 10.1016/S0142-9612(00)00002-8
   Gerardino A, 2003, MICROELECTRON ENG, V67-8, P923, DOI 10.1016/S0167-9317(03)00155-2
   Godavarty A, 2000, APPL SURF SCI, V161, P131, DOI 10.1016/S0169-4332(00)00279-8
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Guillemot F, 2003, APPL PHYS A-MATER, V77, P899, DOI 10.1007/s00339-003-2162-0
   Gyorgy E, 2002, APPL SURF SCI, V197, P851, DOI 10.1016/S0169-4332(02)00461-0
   Gyorgy E, 2002, SURF COAT TECH, V154, P63, DOI 10.1016/S0257-8972(01)01699-1
   Hallgren C, 2003, BIOMATERIALS, V24, P701, DOI 10.1016/S0142-9612(02)00266-1
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   HARRIS JM, 1991, ACS SYM SER, V467, P418
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Hong MH, 2003, SENSOR ACTUAT A-PHYS, V108, P69, DOI 10.1016/S0924-4247(03)00364-9
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   JELINEK M, 1995, THIN SOLID FILMS, V257, P125, DOI 10.1016/0040-6090(94)06340-0
   Jersch J, 1996, APPL PHYS LETT, V68, P868, DOI 10.1063/1.116527
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Kadolkar P, 2003, MAT SCI ENG A-STRUCT, V342, P183, DOI 10.1016/S0921-5093(02)00286-1
   KANEKO Y, 1998, BIORELATED POLYM GEL, P29
   Karacs A, 2003, MAT SCI ENG C-BIO S, V23, P431, DOI 10.1016/S0928-4931(02)00316-8
   Karaiskou A, 2003, APPL SURF SCI, V208, P245, DOI 10.1016/S0169-4332(02)01396-X
   Kim HW, 2004, J BIOMED MATER RES A, V68A, P522, DOI 10.1002/jbm.a..20094
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Kuiry SC, 2004, SCRIPTA MATER, V50, P1237, DOI 10.1016/j.scriptamat.2004.02.005
   KURELLA A, 2004, UNPUB
   Kweh SWK, 2002, BIOMATERIALS, V23, P381, DOI 10.1016/S0142-9612(01)00116-8
   LeGeros J. P., 1991, P 17 ANN M SOC BIOM, P192
   Lemons JE, 1996, BONE, V19, pS121, DOI 10.1016/S8756-3282(96)00128-7
   Lossdorfer S, 2004, BIOMATERIALS, V25, P2547, DOI 10.1016/j.biomaterials.2003.09.094
   MANN S, 1995, J MATER CHEM, V5, P935, DOI 10.1039/jm9950500935
   Martin P, 1995, CELEST MECH DYN ASTR, V63, P29, DOI 10.1007/BF00691913
   Mele A, 1997, APPL SURF SCI, V109, P584, DOI 10.1016/S0169-4332(96)00742-8
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   Mondragon-Cortez P, 2004, MATER LETT, V58, P1336, DOI 10.1016/j.matlet.2003.09.024
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   Nayak S, 2003, J MATER RES, V18, P833, DOI 10.1557/JMR.2003.0114
   Nayak S, 2002, JOM-J MIN MET MAT S, V54, P39, DOI 10.1007/BF02709092
   Oliveira AL, 2003, CURR OPIN SOLID ST M, V7, P309, DOI 10.1016/j.cossms.2003.10.009
   OSHEA D, 1977, INTRO LASERS THEIR A, P107
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   PILLIAR RM, 1984, CRC CRIT R BIOCOMP, V1, P371
   Pique A, 2003, SURF COAT TECH, V163, P293, DOI 10.1016/S0257-8972(02)00606-0
   PREUSS S, 1995, APPL PHYS A-MATER, V61, P33, DOI 10.1007/BF01538207
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P1
   RATNER BD, 2004, BIOMATERIALS SCI INT, P201
   Reimers H, 2003, APPL PHYS A-MATER, V77, P491, DOI 10.1007/s00339-002-1477-6
   Rizvi NH, 2002, J MATER PROCESS TECH, V127, P206, DOI 10.1016/S0924-0136(02)00143-7
   Rizvi NH, 1999, P SOC PHOTO-OPT INS, V3680, P546, DOI 10.1117/12.341245
   SARDIN G, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P225
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Semak VV, 1998, LASER SURFACE TEXTUR, P35
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   Sioshansi P, 1996, SURF COAT TECH, V83, P175, DOI 10.1016/0257-8972(95)02838-2
   STEEN WM, 1991, LASER MAT PROCESSING, P7
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   Tan B, 2003, APPL SURF SCI, V207, P365, DOI 10.1016/S0169-4332(02)00006-0
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Tosto S, 1996, APPL PHYS A-MATER, V63, P385, DOI 10.1007/BF01567331
   Venkatakrishnan K, 2002, OPT LASER TECHNOL, V34, P575, DOI 10.1016/S0030-3992(02)00074-9
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wei M, 1999, J MATER SCI-MATER M, V10, P401, DOI 10.1023/A:1008923029945
   Wen J, 2000, BIOMATERIALS, V21, P1339, DOI 10.1016/S0142-9612(99)00273-2
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Wu PK, 2001, THIN SOLID FILMS, V398, P607, DOI 10.1016/S0040-6090(01)01347-5
   Yamada H, 2002, APPL SURF SCI, V197, P411, DOI 10.1016/S0169-4332(02)00351-3
   Yamashita K, 1998, J BIOMED MATER RES, V43, P46, DOI 10.1002/(SICI)1097-4636(199821)43:1<46::AID-JBM5>3.0.CO;2-M
   Yan LL, 2003, BIOMATERIALS, V24, P2585, DOI 10.1016/S0142-9612(03)00061-9
   Yang YZ, 2003, BIOMATERIALS, V24, P619, DOI 10.1016/S0142-9612(02)00376-9
   Zeng HT, 2000, BIOMATERIALS, V21, P23, DOI 10.1016/S0142-9612(99)00128-3
   Zhao JX, 2001, OPT LASER TECHNOL, V33, P487, DOI 10.1016/S0030-3992(01)00066-4
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 105
TC 192
Z9 197
U1 7
U2 90
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2005
VL 20
IS 1
BP 5
EP 50
DI 10.1177/0885328205052974
PG 46
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 939RI
UT WOS:000230089700001
PM 15972362
DA 2018-10-20
ER

PT J
AU Veleva, AN
   Khan, SA
   Cooper, SL
AF Veleva, AN
   Khan, SA
   Cooper, SL
TI Oxidative and hydrolytic stability of a novel acrylic terpolymer for
   biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE acrylic terpolymers; in vitro biostability; oxidative stress; hydrolytic
   stress; small-diameter vascular grafts
ID BIODEGRADATION; MECHANISMS; ELASTOMERS
AB Oxidative and hydrolytic biostability assessment was carried out on a novel acrylic material made of hexamethyl methacrylate (HMA), methyl methacrylate (MMA), and methacrylic acid (MAA). To simulate the in vivo micro-environment, solutions of H2O2/CoCl2 and buffered solutions of cholesterol esterase (CE) and phospholipase A2 (PLA) were used. As controls, film specimens were incubated in deionized water. Samples were incubated in these solutions at 37 degrees C for 10 weeks before physical and mechanical properties were evaluated by size exclusion chromatography (SEC), H-1- nuclear magnetic resonance (H-1-NMR), acid-base titration, and Instron tensile testing. The results from this study indicate excellent biostability of HMA-MMA-MAA terpolymers and thus their potential for use in biomedical devices for long-term implantation. (c) 2005 Wiley Periodicals, Inc. J Biomed Mater Res 74A: 117-123, 2005.
C1 N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
   Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
RP Veleva, AN (reprint author), N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
EM anveleva@unity.ncsu.edu
FU NHLBI NIH HHS [HL57917]
CR Anderson J. M., 1996, BIOMATERIALS SCI INT
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   COLEMAN MM, 1990, MACROMOLECULES, V23, P2339, DOI 10.1021/ma00210a033
   Finer Y, 2003, J BIOMAT SCI-POLYM E, V14, P837, DOI 10.1163/156856203768366558
   Fussell GW, 2004, BIOMATERIALS, V25, P2971, DOI 10.1016/j.biomaterials.2003.09.062
   Fussell GW, 2004, J BIOMED MATER RES A, V70A, P265, DOI 10.1002/jbm.a.30074
   Heiner J, 2003, POLYM TEST, V22, P253, DOI 10.1016/S0142-9418(02)00081-8
   Labow RS, 1997, J BIOMAT SCI-POLYM E, V8, P779, DOI 10.1163/156856297X00317
   Lamba NMK, 1998, FRONTIERS TISSUE ENG, P121
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   MATTESON LA, 2004, J CELL PHYSIOL, V199, P8
   RAWE A, 1995, PRINCIPLES POLYM CHE, P496
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   SALACINSKI HJ, 2002, BIOMATERIALS, V23, P3321
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Yourtee DM, 2001, J BIOMED MATER RES, V57, P522, DOI 10.1002/1097-4636(20011215)57:4<522::AID-JBM1198>3.0.CO;2-9
NR 19
TC 12
Z9 12
U1 2
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2005
VL 74A
IS 1
BP 117
EP 123
DI 10.1002/jbm.a.30349
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 944EA
UT WOS:000230407500012
PM 15924302
DA 2018-10-20
ER

PT J
AU Oh, KT
   Shim, HM
   Kim, KN
AF Oh, KT
   Shim, HM
   Kim, KN
TI Properties of titanium-silver alloys for dental application
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE titanium-silver alloy; cytotoxicity; corrosion resistance; dental
   material; mechanical properties
ID ION-IMPLANTED TI-6AL-4V; CORROSION; RELEASE; REFINEMENT; BEHAVIOR;
   INVITRO; TISSUE; INVIVO; NI; AL
AB The purpose of this study was to develop titanium-silver alloys with biocompatibility, high corrosion resistance, and low ion-release rate, and to evaluate the electrochemical properties of titanium-silver alloys in artificial saliva. Titanium-silver alloys with silver contents ranging from 0 to 4.5 at % in steps of 0.5 at % were designed. The alloys were arc melted, homogenized at 950 degrees C for 72 h, hot rolled to 2 mm in thickness, and finally solution heat treated at 950 degrees C for 1 h and quenched in water. Chemical compositions, phases, hardnesses, electrochemical properties, and the cytotoxicity of the alloys were investigated. The purity of titanium-silver alloys was maintained above 99.9%, because few impurities were introduced through their manufacture. In the case of alloys containing silver in the range 2.0-4.0 at %, the formation of an acicular a phase was observed inside the beta phase. The acicular phase got thinner with increasing amounts of silver. This means that silver is a beta-phase stabilizing element in titanium-silver alloys. The hardness value tended to rise with increasing silver content and increased largely over 3.5 at %, and the increase of the hardness value versus pure titanium was about 33%. It is believed that the substantial increases in hardness was due to the effects of solid solution strengthening and of alpha-beta phase transition. Moreover, titanium-silver alloys had higher corrosion resistances than pure titanium. These results mean that silver additions to titanium can improve alloy corrosion resistance. Passive current densities in the potentiodynamic polarization curves were dependent on the chemical compositions of the titanium-silver alloys. However, they did not show a linear relationship with respect to silver contents. Titanium-silver alloys did not show pitting corrosion in artificial saliva. It is believed that silver addition to titanium strengthened the passive film due to titanium dissolution induced by the different electromotive forces of titanium and silver. In the agar overlay test, the cytotoxicity of the titanium-silver alloys and of titanium were none or mild. In summary, titanium-silver alloys had higher mechanical properties and corrosion resistance than titanium, and toxicities that were similar to titanium. Therefore, it is recommended that titanium-silver alloys be adopted cautiously by the biomedical and dental fields. (c) 2005 Wiley Periodicals, Inc.
C1 Yonsei Univ, Coll Dent, Res Inst Dent Biomat & Bioengn, Seoul 120749, South Korea.
RP Kim, KN (reprint author), Yonsei Univ, Coll Dent, Res Inst Dent Biomat & Bioengn, Seoul 120749, South Korea.
EM kimkn@yumc.yonsei.ac.kr
CR Bomberger H. B., 1982, TITANIUM TITANIUM AL, P161
   Boyer R.R., 1984, BETA TITANIUM ALLOYS
   Brantley W.A., 2001, ORTHODONTIC MAT SCI, P78
   BREME HJ, 1998, METALS BIOMATERIALS, P37
   Breme HJ, 1998, METALS BIOMATERIALS, P1
   BROWN SA, 1988, J BIOMED MATER RES, V22, P321, DOI 10.1002/jbm.820220406
   Brunski JB, 1996, BIOMATERIALS SCI INT, P37
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P367, DOI 10.1002/jbm.820210309
   COLLINGS EW, 1984, TITANIUM ALLOYS, P111
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   ELLINGSEN JE, 2003, BIOIMPLANT INTERFACE, P1
   EWERS GJ, 1985, J ORAL REHABIL, V12, P469, DOI 10.1111/j.1365-2842.1985.tb01293.x
   GJERDET NR, 1987, ACTA ODONTOL SCAND, V45, P409, DOI 10.3109/00016358709096365
   HARN H, 1970, J BIOMED MATER RES, V4, P571
   Jin YG, 2004, SCRIPTA MATER, V51, P113, DOI 10.1016/j.scriptamat.2004.03.044
   JOHANSSON BI, 1989, DENT MATER, V5, P324, DOI 10.1016/0109-5641(89)90124-3
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KOHN DH, 1991, J MATER SCI, V26, P534, DOI 10.1007/BF00576555
   Lampman S., 1990, METALS HDB, V2, P592
   LUGOWSKI S, 1987, J BIOMED MATER RES, V21, P657, DOI 10.1002/jbm.820210510
   LUGOWSKI SJ, 1991, J BIOMED MATER RES, V25, P1443, DOI 10.1002/jbm.820251204
   MASSALSKI TB, 1986, BINARY ALLOY PHASE D, P74
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   Morais S, 1998, BIOMATERIALS, V19, P999, DOI 10.1016/S0142-9612(97)00234-2
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Pereira Maria L., 1994, Cytobios, V77, P73
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   PLICHTA MR, 1978, ACTA METALL MATER, V26, P1293, DOI 10.1016/0001-6160(78)90014-7
   PLICHTA MR, 1977, METALL T A, V8, P1977
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   ROBERT FM, 1982, TITANIUM TITANIUM AL, P33
   ROSTOKER W, 1979, J BIOMECH ENG-T ASME, V101, P2
   SCHARNWEBER D, 1998, METALS BIOMATERIALS, P101
   STERN M, 1959, J ELECTROCHEM SOC, V106, P759, DOI 10.1149/1.2427493
   Takada Y, 2001, Dent Mater J, V20, P34
   THERIN M, 1991, J MATER SCI-MATER M, V2, P1, DOI 10.1007/BF00701681
   WANHILL RJH, 1982, TITANIUM TITANIUM AL, P175
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI, P1
   YOLTON CF, 1979, METALL TRANS A, V10, P132, DOI 10.1007/BF02686421
NR 39
TC 27
Z9 28
U1 2
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2005
VL 74B
IS 1
BP 649
EP 658
DI 10.1002/jbm.b.30259
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 940PA
UT WOS:000230155200029
PM 15806569
DA 2018-10-20
ER

PT J
AU de Farias, PMA
   Santos, BS
   de Menezes, FD
   Ferreira, RD
   Barias-Castro, ML
   Castro, V
   Lima, PRM
   Fontes, A
   Cesar, CL
AF de Farias, PMA
   Santos, BS
   de Menezes, FD
   Ferreira, RD
   Barias-Castro, ML
   Castro, V
   Lima, PRM
   Fontes, A
   Cesar, CL
TI Investigation of red blood cell antigens with highly fluorescent and
   stable semiconductor quantum dots
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE biomedical optics; optical materials; quantum dots
ID NANOCRYSTALS; CLUSTERS; CDS
AB We report a new methodology for red blood cell antigen expression determination by a simple labeling procedure employing luminescent semiconductor quantum dots. Highly luminescent and stable core shell cadmium sulfide/cadmium hydroxide colloidal particles are obtained, with a predominant size of 9 nm. The core-shell quantum dots are functionalized with glutaraldehyde and conjugated to a monoclonal anti-A antibody to target antigen-A in red blood cell membranes. Erythrocyte samples of blood groups A(+), A(2)(+), and O+ are used for this purpose. Confocal microscopy images show that after 30 min of conjugation time, type A(+) and A(2)(+) erythrocytes present bright emission, whereas the O+ group cells show no emission. Fluorescence intensity maps show different antigen expressions for the distinct erythrocyte types. The results obtained strongly suggest that this simple labeling procedure may be employed as an efficient tool to investigate quantitatively the distribution and expression of antigens in red blood cell membranes. (C) 2005 Society of Photo-Optical Instrumentation Engineers.
C1 Univ Fed Pernambuco, BR-50670901 Recife, PE, Brazil.
   State Univ Campinas, Hematol & Transfus Hemotherapy Ctr, Sao Paulo, Brazil.
   State Univ Campinas, Phys Inst Gleb Wataghin, Sao Paulo, Brazil.
RP de Farias, PMA (reprint author), Univ Fed Pernambuco, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM pmaf@ufpe.br
RI Lenz Cesar, Carlos/F-2442-2018; Inst. of Physics, Gleb
   Wataghin/A-9780-2017; Cesar, Carlos/O-1470-2013; GFURCO, Grupo de
   Pesquisa/G-3042-2017; Castro, Vagner/F-9221-2013
OI Lenz Cesar, Carlos/0000-0001-5573-9636; Lima, Paulo/0000-0002-4323-3918;
   Santos, Beate/0000-0002-9909-5462
CR Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399
   Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   BORCHERT H, 2003, J CHEM PHYS, V271, P1800
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Daniels G, 2002, HUMAN BLOOD GROUPS
   de Farias PMA, 2005, MATER CHEM PHYS, V89, P21, DOI 10.1016/j.matchemphys.2004.08.017
   EYCHMULLER A, 1996, J PHYS CHEM B, V59, P13226
   Gao XH, 2003, TRENDS BIOTECHNOL, V21, P371, DOI 10.1016/S0167-7799(03)00209-9
   Hoshino A, 2004, BIOCHEM BIOPH RES CO, V314, P46, DOI 10.1016/j.bbrc.2003.11.185
   Mattheakis LC, 2004, ANAL BIOCHEM, V327, P200, DOI 10.1016/j.ab.2004.01.031
   Nowak C, 2001, J CHEM PHYS, V114, P489, DOI 10.1063/1.1328040
   Petrov DV, 2002, J PHYS CHEM B, V106, P5325, DOI 10.1021/jp010617i
   TAYLOR DL, 1986, APPL FLUORESCENT BIO
   Tokumasu F, 2003, J MICROSC-OXFORD, V211, P256, DOI 10.1046/j.1365-2818.2003.01219.x
   Watson A, 2003, BIOTECHNIQUES, V34, P296, DOI 10.2144/03342bi01
NR 17
TC 6
Z9 6
U1 0
U2 6
PU SPIE-INT SOCIETY OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD JUL-AUG
PY 2005
VL 10
IS 4
AR 044023
DI 10.1117/1.1993257
PG 4
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 977JJ
UT WOS:000232799200032
PM 16178656
DA 2018-10-20
ER

PT J
AU Soukka, T
   Kuningas, K
   Rantanen, T
   Haaslahti, V
   Lovgren, T
AF Soukka, T
   Kuningas, K
   Rantanen, T
   Haaslahti, V
   Lovgren, T
TI Photochemical characterization of up-converting inorganic lanthanide
   phosphors as potential labels
SO JOURNAL OF FLUORESCENCE
LA English
DT Article
DE up-conversion; rare earth; autofluorescence; infrared laser diode;
   immunoassay
ID TIME-RESOLVED FLUORESCENCE; LIQUID-MEMBRANE SYSTEM; CONVERSION EMISSION;
   FLUOROMETRIC-DETERMINATION; IMMUNOFLUOROMETRIC ASSAYS; ENERGY-TRANSFER;
   NUCLEIC-ACIDS; IMMUNOASSAY; EUROPIUM; NANOPARTICLES
AB We have characterized commercially available up-converting inorganic lanthanide phosphors for their rare earth composition and photoluminescence properties under infrared laser diode excitation. These up-converting phosphors, in contrast to proprietary materials reported earlier, are readily available to be utilized as particulate reporters in various ligand binding assays after grinding to submicron particle size. The laser power density required at 980 nm to generate anti-Stokes photoluminescence from these particulate reporters is significantly lower than required for two-photon excitation. The narrow photoluminescence emission bands at 520-550 nm and at 650-670 nm are at shorter wavelengths and thus totally discriminated from autofluorescence and scattered excitation light even without temporal resolution. Transparent solution of colloidal bead-milled up-converting phosphor nanoparticles provides intense green emission visible to the human eye under illumination by an infrared laser pointer. In this article, we show that the unique photoluminescence properties of the up-converting phosphors and the inexpensive measurement configuration, which is adequate for their sensitive detection, render the up-conversion an attractive alternative to the ultraviolet-excited time-resolved fluorescence of down-converting lanthanide compounds widely employed in biomedical research and diagnostics.
C1 Univ Turku, Dept Biotechnol, FIN-20520 Turku, Finland.
RP Soukka, T (reprint author), Univ Turku, Dept Biotechnol, Tykistokatu 6A, FIN-20520 Turku, Finland.
EM tero.soukka@utu.fi
CR ALPHA B, 1987, ANGEW CHEM INT EDIT, V26, P1266, DOI 10.1002/anie.198712661
   Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g
   Auzel F, 2002, P SOC PHOTO-OPT INS, V4766, P179, DOI 10.1117/12.475333
   Bazzi R, 2004, J COLLOID INTERF SCI, V273, P191, DOI 10.1016/j.jcis.2003.10.031
   BEVERLOO HB, 1992, ANAL BIOCHEM, V203, P326, DOI 10.1016/0003-2697(92)90320-7
   BEVERLOO HB, 1992, CYTOMETRY, V13, P561, DOI 10.1002/cyto.990130603
   BEVERLOO HB, 1990, CYTOMETRY, V11, P784, DOI 10.1002/cyto.990110704
   Blomberg K, 1999, CLIN CHEM, V45, P855
   BOGDANOV VK, 2003, J NONCRYST SOLIDS, V321, P1
   BOHMANN K, 2003, Patent No. 10153829
   Corstjens PLAM, 2003, ANAL BIOCHEM, V312, P191, DOI 10.1016/S0003-2697(02)00505-5
   DAKUBU S, 1985, ANAL BIOCHEM, V144, P20, DOI 10.1016/0003-2697(85)90078-8
   DAVID GS, 1984, Patent No. 4486530
   DIAMANDIS EP, 1991, CLIN CHEM, V37, P1486
   EKINS R, 1989, NATURE, V340, P256, DOI 10.1038/340256a0
   Ekins RP, 1998, CLIN CHEM, V44, P2015
   EKINS RP, 1978, RADIOIMMUNOASSAY REL, P39
   EKINS RP, 1987, CLIN BIOCHEM REV, V8, P12
   EKINS RP, 1985, PURE APPL CHEM, V57, P437
   Feng J, 2003, ANAL CHEM, V75, P5282, DOI 10.1021/ac034063m
   Hakala H, 2002, INORG CHEM COMMUN, V5, P1059, DOI 10.1016/S1387-7003(02)00646-9
   Hampl J, 2001, ANAL BIOCHEM, V288, P176, DOI 10.1006/abio.2000.4902
   Harma H, 2001, CLIN CHEM, V47, P561
   Heer S, 2003, ANGEW CHEM INT EDIT, V42, P3179, DOI 10.1002/anie.200351091
   Heer S, 2004, ADV MATER, V16, P2102, DOI 10.1002/adma.200400772
   HEMMILA I, 1993, J BIOCHEM BIOPH METH, V26, P283, DOI 10.1016/0165-022X(93)90029-N
   Hemmila I, 2001, CRIT REV CL LAB SCI, V38, P441, DOI 10.1080/20014091084254
   HEMMILA I, 1984, ANAL BIOCHEM, V137, P335, DOI 10.1016/0003-2697(84)90095-2
   HEMMILA I, 1985, CLIN CHEM, V31, P359
   Hirai T, 2004, J COLLOID INTERF SCI, V273, P470, DOI 10.1016/j.jcis.2003.12.013
   Hirai T, 2004, J COLLOID INTERF SCI, V269, P103, DOI 10.1016/j.jcis.2003.08.026
   Jackson TN, 1983, IMMUNOASSAYS CLIN CH, P557
   Karvinen J, 2004, ANAL BIOCHEM, V325, P317, DOI 10.1016/j.ab.2003.10.044
   Karvinen J, 2002, J BIOMOL SCREEN, V7, P223, DOI 10.1089/108705702760047727
   Kokko L, 2004, ANAL CHIM ACTA, V503, P155, DOI 10.1016/j.aca.2003.10.025
   Kompe K, 2003, ANGEW CHEM INT EDIT, V42, P5513, DOI 10.1002/anie.200351943
   KRICKA LJ, 1994, CLIN CHEM, V40, P347
   Kricka LJ, 1999, CLIN CHEM, V45, P453
   LAKOWICZ JR, 1997, TOPICS FLUORESCENCE, V5
   Low N. M. P., 1971, Journal of Luminescence, V4, P357, DOI 10.1016/0022-2313(71)90038-X
   MATHIS G, 1993, CLIN CHEM, V39, P1953
   Niedbala RS, 2001, ANAL BIOCHEM, V293, P22, DOI 10.1006/abio.2001.5105
   SEVIER ED, 1981, CLIN CHEM, V27, P1797
   SIITARI H, 1983, NATURE, V301, P258, DOI 10.1038/301258a0
   SOINI E, 1983, CLIN CHEM, V29, P65
   SOINI E, 1979, CLIN CHEM, V25, P353
   SOINI E, 1987, CRIT REV ANAL CHEM, V18, P105, DOI 10.1080/10408348708542802
   Song F, 1999, P SOC PHOTO-OPT INS, V3622, P182, DOI 10.1117/12.344493
   Soukka T, 2001, ANAL CHEM, V73, P2254, DOI 10.1021/ac001287i
   Steinkamp T, 2004, ANAL BIOANAL CHEM, V380, P24, DOI 10.1007/s00216-004-2682-2
   Stenroos K, 1998, CYTOKINE, V10, P495, DOI 10.1006/cyto.1997.0321
   STOUWDAM JW, 2004, CHEM MATER, V15, P4604
   TAKALO H, 1994, BIOCONJUGATE CHEM, V5, P278, DOI 10.1021/bc00027a015
   van de Rijke F, 2001, NAT BIOTECHNOL, V19, P273, DOI 10.1038/85734
   von Lode P, 2003, ANAL CHEM, V75, P3193, DOI 10.1021/ac0340051
   Wegh RT, 1999, SCIENCE, V283, P663, DOI 10.1126/science.283.5402.663
   Werts MHV, 1999, CHEM COMMUN, P799, DOI 10.1039/a902035g
   Wright WH, 1997, P SOC PHOTO-OPT INS, V2985, P248, DOI 10.1117/12.274357
   XU YY, 1992, CLIN CHEM, V38, P2038
   Yi GS, 2002, CHEM MATER, V14, P2910, DOI 10.1021/cm0115416
   Zijlmans HJMAA, 1999, ANAL BIOCHEM, V267, P30, DOI 10.1006/abio.1998.2965
NR 61
TC 86
Z9 89
U1 1
U2 32
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1053-0509
J9 J FLUORESC
JI J. Fluoresc.
PD JUL
PY 2005
VL 15
IS 4
BP 513
EP 528
DI 10.1007/s10895-005-2825-7
PG 16
WC Biochemical Research Methods; Chemistry, Analytical; Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA 965HH
UT WOS:000231940700008
PM 16167210
DA 2018-10-20
ER

PT J
AU Alhajraf, S
   Al-Awadhi, L
   Al-Fadala, S
   Al-Khubaizi, A
   Khan, AR
   Baby, S
AF Alhajraf, S
   Al-Awadhi, L
   Al-Fadala, S
   Al-Khubaizi, A
   Khan, AR
   Baby, S
TI Real-time response system for the prediction of the atmospheric
   transport of hazardous materials
SO JOURNAL OF LOSS PREVENTION IN THE PROCESS INDUSTRIES
LA English
DT Article; Proceedings Paper
CT International Conference on Bhopal Gas Tragedy and Its Effect on Process
   Safety
CY DEC 01-03, 2004
CL Indian Inst Technol, Kanpur, INDIA
HO Indian Inst Technol
DE emergency response system; decision support; gas diffusion; accidental
   release
AB Human urge of exploiting earth resources has resulted into unprecedented industrial development in the last century resulting into production of large quantities of hazardous chemicals. Chemical, petrochemical, nuclear, biomedical and pharmaceutical industrial accidents release large quantities of hazardous chemicals into the atmosphere. The accidental discharge during production or storage or transportation have subjected the population to be exposed to exceptionally high concentration levels of hazardous chemicals, taking them by surprise, unprepared with fatal consequences. An emergency planning organization has to be trained to combat this situation in the shortest possible time to minimize the number of causalities. The present paper focuses on computation of dispersion model, using emission source, accident location and online metrological data near to the sources, to provide necessary and accurate results swiftly. The predicted ground level concentrations with the hazardous nature of the chemical, speed and direction of plume, the emergency team will be supplied with all the information in graphical easy to grasp form, superimposed over a GIS map or the latest satellite image of the area.
   The emergency team has to be trained for all past scenarios and their preparedness, response and actions must be practiced regularly to be able to abate chemical releases accidentally or intentionally.
   Accidental releases of chlorine and ammonia gases in residential and industrial areas are simulated. The predicted ground level concentrations in the effected areas are shown after different time intervals. For low vapor pressure chemical, the dispersion time is large and concentration levels are low but persist for prolonged time while for volatile chemical, the concentrations are high in short time and recovering to safe environment is quick. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Kuwait Inst Sci Res, Coastal & Air Pollut Dept, Environm & Urban Dev Div, Safat 13109, Kuwait.
RP Alhajraf, S (reprint author), Kuwait Inst Sci Res, Coastal & Air Pollut Dept, Environm & Urban Dev Div, POB 24885, Safat 13109, Kuwait.
EM shajraf@kisr.edu.kw
CR ALHAJRAF S, 2003, EC012K KISR
   ALHARMI L, 1988, EES96 KISR
   ERMAK DL, 1990, USERS MANUAL SLAB AT
   ERMAK DL, 2002, UCRLJC148450 L LIV N
   Husain T., 1995, KUWAITI OIL FIRES RE
   LEE RL, 1995, UCRLJC120469 L LIV N
   Mazzola C., 1995, ATMOSPHERIC DISPERSI
   NAASSTROM JS, 2000, 11 JOINT C APPL AIR
   Quaranta N, 2002, ENVIRON MODELL SOFTW, V17, P497, DOI 10.1016/S1364-8152(02)00018-X
   *US EPA, 1999, ALOHA US MAN
NR 10
TC 18
Z9 22
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0950-4230
J9 J LOSS PREVENT PROC
JI J. Loss Prev. Process Ind.
PD JUL-NOV
PY 2005
VL 18
IS 4-6
SI SI
BP 520
EP 525
DI 10.1016/j.jlp.2005.07.013
PG 6
WC Engineering, Chemical
SC Engineering
GA 972IT
UT WOS:000232448200045
DA 2018-10-20
ER

PT J
AU Weil, KS
   Nyberg, EA
   Simmons, KL
AF Weil, KS
   Nyberg, EA
   Simmons, KL
TI Use of a naphthalene-based binder in injection molding net-shape
   titanium components of controlled porosity
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE powder injection molding; sintering; porous titanium
ID MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS; POROUS HYDROXYAPATITE;
   ALLOY; METAL; IMPLANTS; DENSITY
AB We have recently developed a naphthalene-based binder system for use in powder injection molding (PIM) of ceramic and metallic materials. The use of a binder that can be removed via sublimation offers several unique advantages relative to the typical thermoplastic and/or thermoset binders employed in PIM. One of these is that essentially no volume change takes place during debindering. This offers a relatively facile method of introducing porosity into a net-shape part of potentially complex geometry. In the study described in this paper, the effects of powder loading and subsequent isostatic compaction on the size and amount of porosity in the components produced by this technique were investigated. In general, it was found that the amount of porosity is inversely proportional to the initial concentration of metal powder in the PIM feedstock. Likewise, average pore size displays a similar relationship with powder loading.
C1 Battelle Mem Inst, NW Div, Richland, WA 99352 USA.
RP Weil, KS (reprint author), Battelle Mem Inst, NW Div, Richland, WA 99352 USA.
CR *AM SOC MET, 1980, MET HDB, P372
   Breme J, 2000, ADV ENG MATER, V2, P270, DOI 10.1002/(SICI)1527-2648(200005)2:5<270::AID-ADEM270>3.0.CO;2-9
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   CIOMEK A, 1991, Patent No. 5064463
   Clift S E, 1992, Proc Inst Mech Eng H, V206, P233, DOI 10.1243/PIME_PROC_1992_206_295_02
   Cornell CN, 1998, CLIN ORTHOP RELAT R, pS267
   EDIRISINGHE MJ, 1991, J MATER SCI LETT, V10, P1338, DOI 10.1007/BF00722654
   Fricke J, 1998, J SOL-GEL SCI TECHN, V13, P299, DOI 10.1023/A:1008663908431
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   GERMAN RM, 1992, METALL TRANS A, V23, P1455, DOI 10.1007/BF02647329
   GERMAN RM, 1993, REV PARTICUL MATER, V1, P109
   HALPIN J, 1967, C67423 AFML TR
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   KANEKO Y, 1990, J JPN SOC POWDER MET, V37, P591
   KARAGIANES MT, 1974, J BIOMED MATER RES, V8, P391, DOI 10.1002/jbm.820080419
   LEDBETTER H, 1995, REV PROGR QUANTITATI, P1663
   LEE YT, 1990, POWDER METALL INT, V22, P11
   Li HL, 2004, MATER TRANS, V45, P1124, DOI 10.2320/matertrans.45.1124
   Li YM, 2003, MAT SCI ENG A-STRUCT, V362, P292, DOI 10.1016/S0921-5093(03)00613-0
   Liu PS, 2000, MATER SCI TECH SER, V16, P575, DOI 10.1179/026708300101508108
   Maine E, 2000, ADV ENG MATER, V2, P205, DOI 10.1002/(SICI)1527-2648(200004)2:4<205::AID-ADEM205>3.0.CO;2-J
   Munir Z. A., 1988, CERAM B, V2, P342
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   SIMMONS KL, 2004, P ASM MAT PROC MED D
   Simone AE, 1996, ACTA MATER, V44, P1437, DOI 10.1016/1359-6454(95)00278-2
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   Sweeney SM, 2002, J MATER RES, V17, P89, DOI 10.1557/JMR.2002.0015
   TISDEL CL, 1994, J BONE JOINT SURG AM, V76A, P159, DOI 10.2106/00004623-199402000-00001
   VANEEDEN SP, 1994, PLAST RECONSTR SURG, V93, P959, DOI 10.1097/00006534-199404001-00010
   WANG SH, 1999, PM SCI TECH BRIEFS, V1, P16
   Wasz ML, 1996, INT MATER REV, V41, P1
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   WHITNEY JM, 1973, J STRUCTURAL DIV AM, V1, P113
   ZHANG LQ, 1996, J FUNCTIONAL MAT, V27, P88
NR 37
TC 6
Z9 8
U1 0
U2 6
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1525
EP 1531
DI 10.2320/matertrans.46.1525
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500017
OA Bronze
DA 2018-10-20
ER

PT J
AU Kasuga, J
   Yoneyama, T
   Kobayashi, E
   Hanawa, T
   Doi, H
AF Kasuga, J
   Yoneyama, T
   Kobayashi, E
   Hanawa, T
   Doi, H
TI Fatigue property of super-elastic Ti-Ni alloy dental castings
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; titanium-nickel alloy; dental casting; fatigue
   property; super-elasticity
ID SHAPE-MEMORY ALLOY; MECHANICAL-PROPERTIES; HEAT-TREATMENT; BIOMEDICAL
   APPLICATIONS; PHASE-TRANSFORMATION; CYCLIC DEFORMATION; TITANIUM-ALLOYS;
   THIN-FILMS; WIRE; BEHAVIOR
AB Ti-Ni alloy is a promising material in the medical and dental fields due to its special mechanical properties, especially super-elasticity. Since dental prostheses are generally used under repetitive stress condition, fatigue properties of Ti-Ni alloy castings were investigated in this study. Ti-50.85Ni (mol%) alloy ingots were used for casting, which exhibited super-elasticity at 3 10 K in tensile test. Specimens were prepared with a centrifugal casting machine and a magnesia-based mold material. Fatigue test was performed at 310 K under repetitive loading condition with sine-waved load. The minimum stress was set at 0 MPa to evaluate the fatigue properties and change in residual strain. The maximum stress was set in the appropriate range considering the tensile property. Ultimate tensile strength and elongation to fracture of Ti-Ni alloy castings were 732 MPa and 10.6 %, respectively, which were between those of CP-Ti and Ti-6AI-4V alloy castings. The fatigue limit of Ti-Ni alloy casting (206 MPa) was equivalent to or higher than that of CP-Ti or Ti-6AI-4V alloy. There was linear correlation between the fatigue ratios to ultimate tensile strength and the elongation to fracture for Ti-Ni alloy, CP-Ti and Ti-6AI-4V alloy castings, while Ti-Ni alloy showed high fatigue ratio to proof stress, which appears to relate to the twin deformation by stress-induced martensitic transformation. The stress-strain properties of Ti-Ni alloy castings were evaluated to be stable, and it is possible to utilize the super-elasticity in cast dental prostheses.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Div Biomat, Dept Met, Tokyo 1010062, Japan.
   Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Reconstruct & Funct, Sect Metall Biomat, Tokyo 1138510, Japan.
   Univ Tokyo, Sch Engn, Dept Mat Engn, Tokyo 1138656, Japan.
RP Yoneyama, T (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Div Biomat, Dept Met, Tokyo 1010062, Japan.
EM yoneyama.met@tmd.ac.jp
OI Doi, Hisashi/0000-0003-0833-4809
CR Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Akahori T, 2003, J JPN I MET, V67, P595, DOI 10.2320/jinstmet1952.67.10_595
   Akahori T, 2002, METALL MATER TRANS A, V33, P503, DOI 10.1007/s11661-002-0112-7
   ANDREASEN GF, 1971, J AM DENT ASSOC, V82, P1373, DOI 10.14219/jada.archive.1971.0209
   CALLISTER WD, 2003, MAT SCI ENG INTRO, P215
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   DOI H, 1997, J JPN SOC DENT MAT D, V16, P310
   DOI H, 1995, J JPN SOC DENT MAT D, V14, P101
   DOI H, 1999, J JPN SOC DENT MAT D, V18, P368
   Eggeler G, 2004, MAT SCI ENG A-STRUCT, V378, P24, DOI 10.1016/j.msea.2003.10.327
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   FURUYA Y, 1990, MATER T JIM, V31, P504, DOI 10.2320/matertrans1989.31.504
   FURUYA Y, 1988, J JPN I MET, V52, P139, DOI 10.2320/jinstmet1952.52.2_139
   HAMANAKA H, 1989, J DENT RES, V68, P1529, DOI 10.1177/00220345890680111201
   HAMANAKA H, 1987, J JPN SOC BIOMATER, V5, P29
   HELSEN JA, 1998, METALS BIOMATERIALS, P271
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Ishida A, 1995, MATER T JIM, V36, P1349, DOI 10.2320/matertrans1989.36.1349
   *JAP SOC MECH ENG, 1994, JSME S, P2
   Kang SB, 2002, MATER TRANS, V43, P1049, DOI 10.2320/matertrans.43.1049
   Khantachawana A, 2004, MATER TRANS, V45, P214, DOI 10.2320/matertrans.45.214
   KIM H, 2004, MAT T, V45, P1083
   Kim Y, 2002, MATER TRANS, V43, P1703, DOI 10.2320/matertrans.43.1703
   Kimura H, 1988, JPN J DENT MAT, V7, P106
   KOTAKE M, 1994, J DENT MAT, V13, P459
   Li SJ, 2002, MATER TRANS, V43, P2964, DOI 10.2320/matertrans.43.2964
   MATSUMOTO M, 1993, B J I METALS, V32, P505
   MELTON KN, 1979, ACTA METALL MATER, V27, P137, DOI 10.1016/0001-6160(79)90065-8
   MINAKAWA K, 1989, TETSU TO HAGANE, V75, P1104, DOI 10.2355/tetsutohagane1955.75.7_1104
   MIURA F, 1986, AM J ORTHOD DENTOFAC, V90, P1, DOI 10.1016/0889-5406(86)90021-1
   MIWA Y, 1985, B JPN I MET, V24, P61
   MIYAZAKI S, 1994, MATER T JIM, V35, P14, DOI 10.2320/matertrans1989.35.14
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   MIYAZAKI S, 1999, MAT JAPAN, V38, P279
   MIYAZAKI S, 1985, B JAPAN I METALS, V24, P33
   MIYAZAKI S, 1983, B JAPAN I METALS, V22, P33
   Mizumoto T, 2002, MATER TRANS, V43, P3160, DOI 10.2320/matertrans.43.3160
   NAKATA Y, 1991, MATER T JIM, V32, P580, DOI 10.2320/matertrans1989.32.580
   NAM TH, 1990, MATER T JIM, V31, P959, DOI 10.2320/matertrans1989.31.959
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Nishijima S., 1980, Journal of the Society of Materials Science, Japan, V29, P24
   Ohura Y, 1984, Nihon Kyosei Shika Gakkai Zasshi, V43, P71
   Okabe N, 2002, MATER TRANS, V43, P809, DOI 10.2320/matertrans.43.809
   Okazaki Y, 1997, MATER T JIM, V38, P163, DOI 10.2320/matertrans1989.38.163
   Okazaki Y, 2002, MATER TRANS, V43, P3134, DOI 10.2320/matertrans.43.3134
   OTSUKA K, 1985, B JAPAN I METALS, V24, P26
   Sawaguchi T, 2003, METALL MATER TRANS A, V34A, P2847, DOI 10.1007/s11661-003-0186-x
   SHIMIZU K, 1985, B JAPAN I METALS, V24, P13
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   SUGIMOTO K, 1985, B JPN I MET, V24, P45
   SUTOU Y, 2003, MAT JAPAN, V42, P813
   Suzuki K, 1996, J JPN I MET, V60, P853, DOI 10.2320/jinstmet1952.60.9_853
   SUZUKI Y, 1982, TITANIUM ZIRCONIUM, V30, P185
   Tobiume Y, 2000, J JPN DENT MAT DEVIC, V19, P170
   Tomus D, 2004, MATER TRANS, V45, P219, DOI 10.2320/matertrans.45.219
   WALIA H, 1988, J ENDODONT, V14, P346, DOI 10.1016/S0099-2399(88)80196-1
   Watanabe K, 2004, MATER TRANS, V45, P1653, DOI 10.2320/matertrans.45.1653
   Windler M. Klabunde, 2001, TITANIUM MED, P703
   YAMAUCHI K, 1993, B JAPAN I METALS, V32, P495
   Yoneyama T, 1992, Dent Mater J, V11, P157
   Yoneyama T, 2000, J MATER SCI-MATER M, V11, P333, DOI 10.1023/A:1008991405784
   Yoneyama T, 2002, J MATER SCI-MATER M, V13, P947, DOI 10.1023/A:1019804512137
   YONEYAMA T, 1990, J JPN SOC HEAT TREAT, V30, P207
   YOSHINO K, 1995, JPN J APPL PHYS, V34, P141
NR 65
TC 5
Z9 5
U1 0
U2 8
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1555
EP 1563
DI 10.2320/matertrans.46.1555
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500022
OA Bronze
DA 2018-10-20
ER

PT J
AU Akahori, T
   Niinomi, M
   Koyanagi, Y
   Kasuga, T
   Toda, H
   Fukui, H
   Ogawa, M
AF Akahori, T
   Niinomi, M
   Koyanagi, Y
   Kasuga, T
   Toda, H
   Fukui, H
   Ogawa, M
TI Mechanical properties of biocompatible beta-type titanium alloy coated
   with calcium phosphate invert glass-ceramic layer
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-29 mass%niobium-13mass%tantalum-4.6mass%zirconium; bioactive
   glass; microstructure; tensile properties; Young's modulus; fatigue
   properties
ID BIOMEDICAL APPLICATIONS; HYDROXYAPATITE COATINGS; HEAT-TREATMENT;
   FATIGUE; TI-29NB-13TA-4.6ZR; MICROSTRUCTURE; BIOCERAMICS; BEHAVIOR;
   ALKALI
AB The presence of calcium phosphate invert glass-ceramic (designated as CPIG) layer on the surface of artificial implant products can improve the bonding between these products and bones.
   In this study, the morphology of the CPIG layer on the surface of a beta-type titanium alloy, Ti-29Nb-13Ta-4.6Zr (TNTZ), was investigated for biomaterial applications by a dip-coating treatment. Furthermore, the mechanical properties of TNTZ coated with the CPIG layer were also investigated.
   In the CPIG layer, a compositionally gradient zone with a thickness of approximately 2.0 mu m exists on the surface of the TNTZ. The titanium concentration in the zone increases with the decreasing distance from the CPIG surface toward the base materials. On the other hand, calcium and phosphorus concentrations in the zone increase with the distance from the TNTZ surface. The tensile bonding strength between TNTZ and the CPIG layer is 25 MPa and that between aged TNTZ and the CPIG layer is 18.6 MPa.
   For easily understanding the change in mechanical properties by a dip-coating treatment, the values of those on TNTZ and TNTZ coated with CPIG layer were shown as follows. The tensile strength increases remarkably by a dip-coating treatment as compared with that of assolutionized TNTZ while the elongation is a reverse trend. Young's modulus of TNTZ and aged TNTZ coated with the CPIG increases by 15 to 27 GPa after the dip-coating treatment as compared with that of as-solutionized TNTZ (approximately 60 GPa). The fatigue limit of TNTZ coated with the CPIG layer is nearly equal to that (approximately 300 MPa) of as-solutionized TNTZ. On the other hand, the fatigue limit of aged TNTZ coated with the CPIG layer is a 100 MPa higher than that of as-solutionized TNTZ.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan.
   Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
   Daido Steel Co Ltd, R&D, Nagoya, Aichi 4578584, Japan.
RP Akahori, T (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2000, METALL MATER TRANS A, V31, P1949, DOI 10.1007/s11661-000-0222-z
   Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Ding SJ, 2003, SURF COAT TECH, V165, P248, DOI 10.1016/S0257-8972(02)00745-4
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   HAYASHI K, 1999, J JPN SCI MECH ENG A, V65, P2080
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Ikeda M, 2002, METALL MATER TRANS A, V33, P487, DOI 10.1007/s11661-002-0110-9
   KASAUGA T, 2001, BIOMATERIALS, V22, P577
   KASAUGA T, 2000, MAT JPN, V39, P250
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kuroda D, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P99
   LANCEFIELD WR, 1993, INTRO BIOCERAMICS, P223
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   MINAKAWA K, 1989, TETSU TO HAGANE, V75, P1104, DOI 10.2355/tetsutohagane1955.75.7_1104
   Nelea V, 2003, SURF COAT TECH, V173, P315, DOI 10.1016/S0257-8972(03)00729-1
   Niinomi M, 2003, J JPN I MET, V67, P604, DOI 10.2320/jinstmet1952.67.10_604
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   Nonami T., 1998, MAT JPN, V37, P856
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 26
TC 10
Z9 10
U1 1
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1564
EP 1569
DI 10.2320/matertrans.46.1564
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500023
OA Bronze
DA 2018-10-20
ER

PT J
AU Inamura, T
   Hosoda, H
   Wakashima, K
   Miyazaki, S
AF Inamura, T
   Hosoda, H
   Wakashima, K
   Miyazaki, S
TI Anisotropy and temperature dependence of Young's modulus in textured
   TiNbAl biomedical shape memory alloy
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE beta-titanium; texture; Young's modulus; anisotropy; superelasticity;
   low-modulus
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; TRANSFORMATION; MARTENSITE;
   OMEGA
AB Anisotropy and temperature dependence upon the Young's Modulus of Ti-24 mol %Nb-3 mol %Al (TiNbAl), a new biomedical shape memory alloy, were characterized in the temperature range from 133 to 413 K by dynamic mechanical analysis in the tensile mode. The material consisted of beta-phase (the parent phase, bee) at room temperature and a well developed {112} {110} type recrystallization texture was formed by a severe cold-rolling followed by a recrystallization heat-treatment. Test specimens were prepared from the textured material with the longitudinal direction of specimens being systematically varied within the ND-plane. Young's modulus was measured as a function of temperature along each loading direction. A large depression in Young's modulus was observed around beta-alpha" martensitic transformation temperature, below room temperature. The Young's moduli of the textured material exhibited anisotropy depending on the loading direction. Compliance anisotropy factor, J, and characteristic modulus S-11 of the beta-phase were calculated from the obtained results based upon the assumption that the texture was perfectly developed in the material. It was found that the Young's modulus of the beta-phase reaches a minimum value along {001} and a maximum value along {111} in the measured temperature range. A suitable texture to increase the total recovery strain in superelasticity and anisotropy of Young's modulus were discussed based on the obtained results.
C1 Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
   Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RP Inamura, T (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RI Miyazaki, Shuichi/A-3113-2012; Inamura, Tomonari/E-5712-2014
OI Miyazaki, Shuichi/0000-0003-3849-4176; 
CR Brooks C. R., 1982, HEAT TREATMENT STRUC, P329
   BROWN ARG, 1964, NATURE, V201, P914, DOI 10.1038/201914a0
   Collings E. W., 1984, PHYS METALLURGY TITA
   Duerig T. W., 1990, ENG ASPECTS SHAPE ME
   DUERIG TW, 1982, SCRIPTA METALL MATER, V16, P957, DOI 10.1016/0036-9748(82)90133-8
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   FUKUI Y, 2003, T MRS J, V28, P623
   Furubayashi T, 1996, J APPL PHYS, V79, P6258, DOI 10.1063/1.362025
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   Hattori T., 2002, J JPN CLIN BIOMECH, V23, P299
   HIRTH JP, 1968, THEORY DISLOCATIONS, P762
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   Humbeeck J V, 2003, J ALLOY COMPD, V355, P58
   Inamura T, 2005, MATER SCI FORUM, V475-479, P2323, DOI 10.4028/www.scientific.net/MSF.475-479.2323
   Inamura T, 2005, MATER SCI FORUM, V475-479, P1983, DOI 10.4028/www.scientific.net/MSF.475-479.1983
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   INAMURA T, IN PRESS MAT SCI E C
   KUAN TS, 1975, METALL TRANS A, V6, P1767, DOI 10.1007/BF02642306
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   KURODA D, 1996, IRON STEEL I JPN, V9, P421
   Kuroda K., 2003, T MRS J, V28, P631
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   MURA T, 1987, MICROMECHANICS DEFEC, P421
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   NYE NF, 1957, PHYS PROPERTIES CRYS, P32
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   Otsuka K., 1999, SHAPE MEMORY MAT
   SUEZAWA M, 1976, SCRIPTA METALL MATER, V10, P789, DOI 10.1016/0036-9748(76)90294-5
NR 30
TC 51
Z9 51
U1 1
U2 20
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1597
EP 1603
DI 10.2320/matertrans.46.1597
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500028
OA Bronze
DA 2018-10-20
ER

PT J
AU Boehlert, CJ
   Rider, KA
   Flick, LM
AF Boehlert, CJ
   Rider, KA
   Flick, LM
TI Biocompatibility evaluation of Ti-15Al-33Nb(at%) and Ti-21Al-29Nb(at%)
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-aluminum-niobium alloy; biocompatibility; stains; T-cells;
   osteoclasts; particles
ID NECROSIS-FACTOR-ALPHA; DEBRIS-INDUCED OSTEOLYSIS; TOTAL
   HIP-ARTHROPLASTY; PERIPHERAL-BLOOD MONOCYTES; SYNOVIAL-LIKE MEMBRANE;
   BONE-CEMENT INTERFACE; IN-VITRO; TITANIUM PARTICLES; BIOMEDICAL
   APPLICATIONS; ALLOYS
AB In this work the biocompatibility of two vanadium-free Ti-A1-Nb alloys, Ti-15A1-33Nb and Ti-21A1-29Nb, was evaluated and compared to that for commercially pure titanium (CP Ti) and alumina (Al2O3). Fine particles were milled from sheet-processed material and implanted onto mice calvaria using an established animal model. Various stains, including methylene blue/acid fuchsin, TRAcP, and immunohistochemistry, were used on the particle-treated calvaria to measure the extent of bone deterioration of the calvaria, quantify the amount of osteoclasts, and approximate the presence of T-cells. In addition, reaction with particle-stimulated macrophages was observed and the production of the cytokine TNF alpha was recorded and quantified. The results indicated that the Ti-Al-Nb alloys statistically outperformed both CP Ti and Al2O3 in terms of their overall biocompatibility with respect to the experiments performed.
C1 Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
   Alfred Univ, Dept Biol, Alfred, NY 14802 USA.
RP Boehlert, CJ (reprint author), Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
CR Akahori T, 2000, METALL MATER TRANS A, V31, P1949, DOI 10.1007/s11661-000-0222-z
   ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   *ASTM, R58350 UNS
   *ASTM, 2001, F206601 ASTM, P1605
   BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0
   Blaine TA, 1996, J BONE JOINT SURG AM, V78A, P1181, DOI 10.2106/00004623-199608000-00008
   Blaine TA, 1997, J BONE JOINT SURG AM, V79A, P1519, DOI 10.2106/00004623-199710000-00009
   Boehlert CJ, 2005, MAT SCI ENG C-BIO S, V25, P263, DOI 10.1016/j.msec.2004.12.011
   Cai Z, 2003, BIOMATERIALS, V24, P213, DOI 10.1016/S0142-9612(02)00293-4
   Callaghan JJ, 1998, J BONE JOINT SURG AM, V80A, P704, DOI 10.2106/00004623-199805000-00011
   Childs LM, 2001, J BONE MINER RES, V16, P338, DOI 10.1359/jbmr.2001.16.2.338
   Fender D, 1999, J BONE JOINT SURG BR, V81B, P577, DOI 10.1302/0301-620X.81B4.9859
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   Goater JJ, 2002, J ORTHOPAED RES, V20, P169, DOI 10.1016/S0736-0266(01)00083-3
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   HANSSEN AD, 1988, J BONE JOINT SURG AM, V70A, P491, DOI 10.2106/00004623-198870040-00003
   Harris WH, 2005, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000152603.58384.e9
   HOROWITZ SM, 1995, CALCIFIED TISSUE INT, V57, P301, DOI 10.1007/BF00298886
   Iijima D, 2003, BIOMATERIALS, V24, P1519, DOI 10.1016/S0142-9612(02)00533-1
   Kadoya Y, 1996, J ORTHOPAED RES, V14, P473, DOI 10.1002/jor.1100140318
   KERKER M, 1969, SCATTERING LIGHT OTH, P1
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kim YH, 1999, J ARTHROPLASTY, V14, P538, DOI 10.1016/S0883-5403(99)90074-8
   Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275
   KRATHOVIL JP, 1964, LIGHT SCATTERIN ANAL, V36, pR458
   Lader CS, 1998, ENDOCRINOLOGY, V139, P3157, DOI 10.1210/en.139.7.3157
   Lee SH, 1997, J ORTHOP RES, V15, P40, DOI 10.1002/jor.1100150107
   Lopez MF, 2003, ELECTROCHIM ACTA, V48, P1395, DOI 10.1016/S0013-4686(03)00006-9
   McKay GC, 1996, BIOMATERIALS, V17, P1339, DOI 10.1016/0142-9612(96)88681-9
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Papakyriacou M, 2000, INT J FATIGUE, V22, P873, DOI 10.1016/S0142-1123(00)00057-8
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Rider KA, 2004, ANAL QUANT CYTOL, V26, P246
   Schwarz EM, 2000, J ORTHOPAED RES, V18, P849, DOI 10.1002/jor.1100180602
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   SHANBHAG AS, 1995, J ARTHROPLASTY, V10, P498, DOI 10.1016/S0883-5403(05)80152-4
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   Watanabe I, 2004, J PROSTHET DENT, V92, P278, DOI 10.1016/j.prosdent.2004.05.019
NR 42
TC 1
Z9 1
U1 0
U2 8
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1618
EP 1626
DI 10.2320/matertrans.46.1618
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500031
OA Bronze
DA 2018-10-20
ER

PT J
AU Takenaka, K
   Wada, T
   Nishiyama, N
   Kimura, H
   Inoue, A
AF Takenaka, K
   Wada, T
   Nishiyama, N
   Kimura, H
   Inoue, A
TI New Pd-based bulk glassy alloys with high glass-forming ability and
   large supercooled liquid region
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomedical application; Ni-allergy; high strength; low Young's modulus
ID AMORPHOUS-ALLOYS; METALLIC-GLASS; STABILITY; DIAMETER; MM
AB With the aim of developing a new bulk glassy alloy which can be applied to biomedical applications, we examined glass-forming ability and mechanical properties of Ni-free glassy alloys in Pd50-xPtxCu30P20 system. As a result, the best glass-forming composition is located at Pd35Pt15Cu30P20, and the alloy can be formed into bulk glassy rods with diameters of up to at least 30 mm by fluxed water quenching. For the bulk glassy alloy, fracture strength, fracture elongation and Young's modulus were measured to be 1590 MPa, 1.8% and 99.8 GPa, respectively, under a compressive stress and 1410 MPa, 1.7% and 83.0 GPa, respectively, under a tensile stress. These features of high glass-forming ability and good mechanical properties are expected to be used as biomedical materials.
C1 Tohoku Univ, Grad Sch, Sendai, Miyagi 9808577, Japan.
   Tohoku Univ, RIMCOF, R&D Inst Met & Composites Future Ind, Sendai, Miyagi 9808577, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Takenaka, K (reprint author), Tohoku Univ, Grad Sch, Sendai, Miyagi 9808577, Japan.
RI Kimura, Hisamichi/D-5449-2012; Inoue, Akihisa/E-5271-2015; Nishiyama,
   Nobuyuki/C-8228-2015; Wada, Takeshi/B-2431-2015; BAI, JIE/D-7448-2016
CR CHEN HS, 1969, ACTA METALL MATER, V17, P1021, DOI 10.1016/0001-6160(69)90048-0
   Chu JP, 2002, INTERMETALLICS, V10, P1191, DOI 10.1016/S0966-9795(02)00132-2
   DREHMAN AJ, 1982, APPL PHYS LETT, V41, P716, DOI 10.1063/1.93645
   INOUE A, 1991, MATER T JIM, V32, P609, DOI 10.2320/matertrans1989.32.609
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   INOUE A, 1989, MATER T JIM, V30, P965, DOI 10.2320/matertrans1989.30.965
   Inoue A, 1997, MATER T JIM, V38, P179, DOI 10.2320/matertrans1989.38.179
   INOUE A, 1995, MATER T JIM, V36, P866, DOI 10.2320/matertrans1989.36.866
   Inoue A, 2001, MAT SCI ENG A-STRUCT, V304, P1, DOI 10.1016/S0921-5093(00)01551-3
   Inoue A, 1996, MATER T JIM, V37, P181, DOI 10.2320/matertrans1989.37.181
   INOUE A, 2001, SUPERCOOLED LIQUID B
   INOUE A, 1991, MAT T JIM, V32, P1005
   KUI HW, 1984, APPL PHYS LETT, V45, P615, DOI 10.1063/1.95330
   Nishiyama N, 2002, MATER TRANS, V43, P1913, DOI 10.2320/matertrans.43.1913
   NISHIYAMA N, 1997, THESIS TOHOKU U
   Ramamurty U, 2005, ACTA MATER, V53, P705, DOI 10.1016/j.actamat.2004.10.023
   ZHENG Y, 2005, UNPUB, V53, P705
NR 17
TC 22
Z9 22
U1 0
U2 26
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2005
VL 46
IS 7
BP 1720
EP 1724
DI 10.2320/matertrans.46.1720
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 950RI
UT WOS:000230874500048
OA Bronze
DA 2018-10-20
ER

PT J
AU Skirtach, AG
   Dejugnat, C
   Braun, D
   Susha, AS
   Rogach, AL
   Parak, WJ
   Mohwald, H
   Sukhorukov, GB
AF Skirtach, AG
   Dejugnat, C
   Braun, D
   Susha, AS
   Rogach, AL
   Parak, WJ
   Mohwald, H
   Sukhorukov, GB
TI The role of metal nanoparticles in remote release of encapsulated
   materials
SO NANO LETTERS
LA English
DT Article
ID GOLD NANOPARTICLES; MOLECULAR SENSORS; POLYELECTROLYTE MICROCAPSULES;
   NANOSHELLS; CAPSULES; FABRICATION; DELIVERY; LIGHT; DNA
AB Laser mediated remote release of encapsulated fluorescently labeled polymers from nanoengineered polyelectrolyte multilayer capsules containing gold sulfide core/gold shell nanoparticles in their walls is observed in real time on a single capsule level. We have developed a method for measuring the temperature increase and have quantitatively investigated the influence of absorption, size, and surface density of metal nanoparticles using an analytical model. Experimental measurements and numerical simulations agree with the model. The treatment presented in this work is of general nature, and it is applicable to any system where nanoparticles are used as absorbing centers. Potential biomedical applications are highlighted.
C1 Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany.
   Univ Munich, Dept Phys, Ctr Nanosci & Photon, D-80799 Munich, Germany.
   Univ Munich, Dept Phys, Optoelect Grp, D-80799 Munich, Germany.
   Queen Mary Univ London, IRC, Dept Mat, London E1 4NS, England.
RP Skirtach, AG (reprint author), Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany.
EM andre.skirtach@mpikg-golm.mpg.de
RI Parak, Wolfgang J./M-3998-2014; Rogach, Andrey/H-9192-2017; Dejugnat,
   Christophe/A-6875-2013; Mohwald, Helmuth/B-8265-2014; Skirtach,
   Andre/K-8152-2015
OI Parak, Wolfgang J./0000-0003-1672-6650; Rogach,
   Andrey/0000-0002-8263-8141; Dejugnat, Christophe/0000-0002-9795-8674;
   Mohwald, Helmuth/0000-0001-7833-3786; Skirtach,
   Andre/0000-0002-4468-7620
CR Ai H, 2003, J CONTROL RELEASE, V86, P59, DOI 10.1016/S0168-3659(02)00322-X
   Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   Antipov AA, 2002, LANGMUIR, V18, P6687, DOI 10.1021/la020052x
   Averitt RD, 1997, PHYS REV LETT, V78, P4217, DOI 10.1103/PhysRevLett.78.4217
   Braun D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.188103
   Caruso F, 2001, ADV MATER, V13, P1090, DOI 10.1002/1521-4095(200107)13:14<1090::AID-ADMA1090>3.0.CO;2-H
   Corbierre MK, 2001, J AM CHEM SOC, V123, P10411, DOI 10.1021/ja0166287
   Dahne L, 2001, J AM CHEM SOC, V123, P5431, DOI 10.1021/ja002911e
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Decher G, 2002, MULTILAYER THIN FILM
   Dejugnat C, 2005, MACROMOL RAPID COMM, V26, P961, DOI 10.1002/marc.200500121
   Dejugnat C, 2004, LANGMUIR, V20, P7265, DOI 10.1021/la049706n
   DEJUGNAT C, 2005, RESPONSIVE POLYM MAT
   Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E
   Duhr S, 2004, EUR PHYS J E, V15, P277, DOI 10.1140/epje/i2004-10073-5
   Gittins DI, 2002, ADV MATER, V14, P508, DOI 10.1002/1521-4095(20020404)14:7<508::AID-ADMA508>3.3.CO;2-K
   GOLDENBERG H, 1952, BRIT J APPL PHYS, V3, P296, DOI 10.1088/0508-3443/3/9/307
   Kreibig U., 1995, OPTICAL PROPERTIES M
   LAX M, 1977, J APPL PHYS, V48, P3919, DOI 10.1063/1.324265
   Lee D, 2005, CHEM MATER, V17, P1099, DOI 10.1021/cm048441v
   Malikova N, 2002, LANGMUIR, V18, P3694, DOI 10.1021/la025563y
   MOHWALD H, 2002, MULTILAYER THIN FILM
   Norman TJ, 2002, J PHYS CHEM B, V106, P7005, DOI 10.1021/jp0204197
   Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5
   Radt B, 2004, ADV MATER, V16, P2184, DOI 10.1002/adma.200400920
   Raschke G, 2005, NANO LETT, V5, P811, DOI 10.1021/nl050130b
   Raschke G, 2004, NANO LETT, V4, P1853, DOI 10.1021/nl049038q
   Rmaile HH, 2003, J PHYS CHEM B, V107, P14401, DOI 10.1021/jp035921l
   Schmitt J, 1999, LANGMUIR, V15, P3256, DOI 10.1021/la981078k
   Schroedter A, 2002, ANGEW CHEM INT EDIT, V41, P3218, DOI 10.1002/1521-3773(20020902)41:17<3218::AID-ANIE3218>3.0.CO;2-P
   Sershen SR, 2000, J BIOMED MATER RES, V51, P293, DOI 10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
   Sershen SR, 2001, APPL PHYS B-LASERS O, V73, P379, DOI 10.1007/s003400100689
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Skirtach AG, 2004, LANGMUIR, V20, P6988, DOI 10.1021/la048873k
   Sukhishvili SA, 1998, J CHEM PHYS, V109, P6861, DOI 10.1063/1.477253
   Sukhorukov GB, 1998, COLLOID SURFACE A, V137, P253, DOI 10.1016/S0927-7757(98)00213-1
   Sukhorukov GB, 2005, SMALL, V1, P194, DOI 10.1002/smll.200400075
   Zhang JZ, 2005, NANO LETT, V5, P809, DOI 10.1021/nl0479379
   ZHOU HS, 1994, PHYS REV B, V50, P12052, DOI 10.1103/PhysRevB.50.12052
NR 39
TC 381
Z9 388
U1 7
U2 124
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD JUL
PY 2005
VL 5
IS 7
BP 1371
EP 1377
DI 10.1021/nl050693n
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 946KP
UT WOS:000230571300033
PM 16178241
DA 2018-10-20
ER

PT J
AU Rogero, SO
   Sousa, JS
   Alario, D
   Lopergolo, L
   Lugao, AB
AF Rogero, SO
   Sousa, JS
   Alario, D
   Lopergolo, L
   Lugao, AB
TI Silicone crosslinked by ionizing radiation as potential polymeric matrix
   for drug delivery
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Ionizing Radiation and Polymers (IRaP
   2004)
CY SEP 25-30, 2004
CL Houffalize, BELGIUM
SP DSM DRECAM, CEA, Int Atom Energy Agcy, IBA, Fons Natl Rech Sci, IOM, Minist Communaute Francaise Belgique
DE silicone; DDS; radiation-crosslinked silicone; Charlesby-Rosiak
ID RUBBER
AB This work describes the use of a catalysis-free system for crosslinking of silicone. Biomedical Grade silicone was crosslinked by ionizing radiation and the physico-chemical and biocompatibility properties of the resulting material were evaluated. High gel content (> 90%) was obtained at the irradiation dose of 25 kGy, as indicated by gel fraction measurements. Swelling measurements showed a trend towards stabilization of crosslinking at 75 kGy. DMTA measurements showed that crystallization was impaired by the crosslinking reaction. The in vitro cytotoxicity data showed that radiation-induced crosslinking and degradation did not promote any toxicity in irradiated silicone. (c) 2005 Elsevier B.V. All rights reserved.
C1 IPEN CNEN SP, Inst Nucl Energy Res, Chem & Environm Ctr, BR-05508900 Sao Paulo, Brazil.
RP Rogero, SO (reprint author), IPEN CNEN SP, Inst Nucl Energy Res, Chem & Environm Ctr, Ave Prof Lineu Prestes,2242,Cidade Univ, BR-05508900 Sao Paulo, Brazil.
EM sorogero@ipen.br
RI Lugao, Ademar/B-6847-2013
CR Basfar AA, 1997, RADIAT PHYS CHEM, V50, P607, DOI 10.1016/S0969-806X(97)00123-0
   GIFFORD GH, 1918, J BIOMED MATER RES, V10, P857
   International Standardization Organization, 1992, 109935 ISO
   Li J, 1999, RADIAT PHYS CHEM, V55, P173, DOI 10.1016/S0969-806X(98)00323-5
   OLEJNICZAK J, 1991, RADIAT PHYS CHEM, V37, P499
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Rogero SO, 2003, ARTIF ORGANS, V27, P424, DOI 10.1046/j.1525-1594.2003.07249.x
   Stevenson I, 2001, POLYMER, V42, P9287, DOI 10.1016/S0032-3861(01)00470-0
NR 8
TC 11
Z9 12
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JUL
PY 2005
VL 236
BP 521
EP 525
DI 10.1016/j.nimb.2005.04.031
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 951RO
UT WOS:000230948600082
DA 2018-10-20
ER

PT J
AU Edwards, GS
   Allen, SJ
   Haglund, RF
   Nemanich, RJ
   Redlich, B
   Simon, JD
   Yang, WC
AF Edwards, GS
   Allen, SJ
   Haglund, RF
   Nemanich, RJ
   Redlich, B
   Simon, JD
   Yang, WC
TI Applications of free-electron lasers in the biological and material
   sciences
SO PHOTOCHEMISTRY AND PHOTOBIOLOGY
LA English
DT Review
ID AMPLIFIED SPONTANEOUS-EMISSION; VIBRATIONAL ECHO EXPERIMENTS;
   DESORPTION/IONIZATION MASS-SPECTROMETRY; ABSOLUTE NEGATIVE CONDUCTANCE;
   GAS-PHASE; PROTEIN DYNAMICS; PHOTOELECTRON MICROSCOPY; CARBON-MONOXIDE;
   PHOTON-ECHOES; MU-M
AB Free-Electron Lasers (FELs) collectively operate from the terahertz through the ultraviolet range and via intracavity Compton backscattering into the X-ray and gamma-ray regimes. FELs are continuously tunable and can provide optical powers, pulse structures and polarizations that are not matched by conventional lasers. Representative research in the biological and biomedical sciences and condensed matter and material research are described to illustrate the breadth and impact of FEL applications. These include terahertz dynamics in materials far from equilibrium, infrared non-linear vibrational spectroscopy to investigate dynamical processes in condensed-phase systems, infrared resonant-enhanced multiphoton ionization for gas-phase spectroscopy and spectrometry, infrared matrix-assisted laser-desorption-ionization and infrared matrix-assisted pulsed laser evaporation for analysis and processing of organic materials, human neurosurgery and ophthalmic surgery using a medical infrared FEL and ultraviolet photoemission electron microscopy for nanoscale characterization of materials and nanoscale phenomena. The ongoing development of ultraviolet and Xray FELs are discussed in terms of future opportunities for applications research.
C1 Duke Univ, Dept Phys, Durham, NC 27708 USA.
   Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.
   Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.
   N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA.
   N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   FOM, Inst Plasma Phys, FELIX, Nieuwegein, Netherlands.
   Duke Univ, Dept Chem, Durham, NC 27708 USA.
   Duke Univ, Dept Biochem, Durham, NC 27708 USA.
   Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.
RP Edwards, GS (reprint author), Duke Univ, Dept Phys, 221 FEL Bldg,Box 90319, Durham, NC 27708 USA.
EM edwards@fel.duke.edu
RI Redlich, Britta/F-9689-2015
OI Nemanich, Robert J./0000-0003-3576-8178
CR ABELLA ID, 1966, PHYS REV, V141, P391, DOI 10.1103/PhysRev.141.391
   Ade H, 1998, SURF REV LETT, V5, P1257, DOI 10.1142/S0218625X98001596
   Ambacher O, 1999, J APPL PHYS, V85, P3222, DOI 10.1063/1.369664
   Andruszkow J, 2000, PHYS REV LETT, V85, P3825, DOI 10.1103/PhysRevLett.85.3825
   Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634
   Babzien M, 1998, PHYS REV E, V57, P6093, DOI 10.1103/PhysRevE.57.6093
   Bakker JM, 2004, PHYS CHEM CHEM PHYS, V6, P2810, DOI 10.1039/b316158g
   Bakker JM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.203003
   Baltz-Knorr M, 2002, J MASS SPECTROM, V37, P254, DOI 10.1002/jms.295
   Baltz-Knorr ML, 2002, APPL SURF SCI, V197, P11, DOI 10.1016/S0169-4332(02)00295-7
   Berkenkamp S, 1997, RAPID COMMUN MASS SP, V11, P1399
   Berkenkamp S, 1998, SCIENCE, V281, P260, DOI 10.1126/science.281.5374.260
   BIRRELL GB, 1994, BIOPHYS J, V67, P2041, DOI 10.1016/S0006-3495(94)80687-3
   BIRRELL GB, 1991, ULTRAMICROSCOPY, V36, P235
   BONIFACIO R, 1984, OPT COMMUN, V50, P373, DOI 10.1016/0030-4018(84)90105-6
   Brau C A, 1990, FREE ELECT LASERS
   BRAU CA, 1988, SCIENCE, V239, P1115, DOI 10.1126/science.239.4844.1115
   BRINKMAN R, 1997, DESY97048
   Bubb DM, 2001, APPL PHYS LETT, V79, P2847, DOI 10.1063/1.1406556
   Budnik BA, 2000, RAPID COMMUN MASS SP, V14, P578, DOI 10.1002/(SICI)1097-0231(20000415)14:7<578::AID-RCM912>3.3.CO;2-9
   Carter SG, 2004, APPL PHYS LETT, V84, P840, DOI 10.1063/1.1645662
   Cole BE, 2001, NATURE, V410, P60, DOI 10.1038/35065032
   Colson WB, 2002, PHYS TODAY, V55, P35, DOI 10.1063/1.1457263
   COPELAND ML, 1998, NEUROSURGICAL TOPICS, P113
   CORNACCHIA M, 1998, SLACR521
   Cramer R, 1998, ANAL CHEM, V70, P4939, DOI 10.1021/ac9803939
   Cramer R, 2000, MASS SPECTROMETRY IN BIOLOGY & MEDICINE, P289
   DAM RJ, 1977, J MICROSC-OXFORD, V111, P211, DOI 10.1111/j.1365-2818.1977.tb00061.x
   Dlott DD, 1996, J AM CHEM SOC, V118, P7853, DOI 10.1021/ja961494w
   Dubois F, 1996, EUR MASS SPECTROM, V2, P167, DOI 10.1255/ejms.68
   EDWARDS G, 1994, NATURE, V371, P416, DOI 10.1038/371416a0
   Edwards GS, 2003, REV SCI INSTRUM, V74, P3207, DOI 10.1063/1.1584078
   Edwards GS, 1996, IEEE J SEL TOP QUANT, V2, P810, DOI 10.1109/2944.577303
   FARRAR TC, 1974, PULSE FOURIER TRANSF
   Fayer MD, 2001, ANNU REV PHYS CHEM, V52, P315, DOI 10.1146/annurev.physchem.52.1.315
   Feder T, 2002, PHYS TODAY, V55, P26, DOI 10.1063/1.1480773
   Fielicke A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023401
   Fielicke A, 2004, J PHYS CHEM B, V108, P14591, DOI 10.1021/jp049214j
   Fielicke A, 2003, J AM CHEM SOC, V125, P11184, DOI 10.1021/ja036897s
   FRANZ W, 1958, Z NATURFORSCH PT A, V13, P484
   Freund H. P., 1996, PRINCIPLES FREE ELEC
   Gamaly EG, 1999, J APPL PHYS, V85, P4213, DOI 10.1063/1.370333
   Ganichev SD, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.081302
   Goheen SC, 1997, J MASS SPECTROM, V32, P820, DOI 10.1002/(SICI)1096-9888(199708)32:8<820::AID-JMS538>3.0.CO;2-Q
   Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607
   Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b
   GRIFFITH OH, 1981, ULTRAMICROSCOPY, V6, P149, DOI 10.1016/0304-3991(81)90054-1
   GRIFFITH OH, 1985, ANNU REV BIOPHYS BIO, V14, P113, DOI 10.1146/annurev.biophys.14.1.113
   GRIFFITH OH, 1972, P NATL ACAD SCI USA, V69, P561, DOI 10.1073/pnas.69.3.561
   Grogan C, 2002, BIOSENS BIOELECTRON, V17, P201, DOI 10.1016/S0956-5663(01)00276-7
   Gross J, 1998, TRAC-TREND ANAL CHEM, V17, P470, DOI 10.1016/S0165-9936(98)00060-0
   GUO BC, 1989, J AM CHEM SOC, V111, P6506, DOI 10.1021/ja00199a005
   HABLISTON DL, 1995, BIOPHYS J, V69, P1615, DOI 10.1016/S0006-3495(95)80034-2
   Haglund RF, 2003, P SOC PHOTO-OPT INS, V5063, P13, DOI 10.1117/12.541054
   Haglund RF, 2003, SPECTROCHIM ACTA B, V58, P1125, DOI 10.1016/S0584-8547(03)00074-0
   HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580
   Harvey DJ, 1999, MASS SPECTROM REV, V18, P349, DOI 10.1002/(SICI)1098-2787(1999)18:6<349::AID-MAS1>3.3.CO;2-8
   Hegmann FA, 2000, APPL PHYS LETT, V76, P262, DOI 10.1063/1.125741
   Hess WP, 1998, APPL SURF SCI, V127, P235, DOI 10.1016/S0169-4332(97)00637-5
   Hill JR, 1996, J PHYS CHEM-US, V100, P12100, DOI 10.1021/jp9605414
   HILL JR, 1994, J PHYS CHEM-US, V98, P11213, DOI 10.1021/j100094a032
   HILL JR, 1995, CHEM PHYS LETT, V244, P218, DOI 10.1016/0009-2614(95)00927-V
   Hogan MJ, 1998, PHYS REV LETT, V81, P4867, DOI 10.1103/PhysRevLett.81.4867
   HOLTHAUS M, 1992, PHYS REV LETT, V69, P351, DOI 10.1103/PhysRevLett.69.351
   Hutson MS, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061906
   HUTSON MS, 2005, PHYS REV ST AB
   Jockusch RA, 2004, J AM CHEM SOC, V126, P5709, DOI 10.1021/ja031679k
   KARAS M, 1989, BIOMED ENVIRON MASS, V18, P841, DOI 10.1002/bms.1200180931
   Keay BJ, 1996, SEMICOND SCI TECH, V11, P1596, DOI 10.1088/0268-1242/11/11S/025
   KEAY BJ, 1995, PHYS REV LETT, V75, P4102, DOI 10.1103/PhysRevLett.75.4102
   Keldish L. V., 1958, SOV PHYS JETP, V34, P788
   Klassen JS, 1996, J PHYS CHEM-US, V100, P14218, DOI 10.1021/jp9608382
   Kondratenko A. M., 1979, Soviet Physics - Doklady, V24, P986
   KURNIT NA, 1964, PHYS REV LETT, V13, P567, DOI 10.1103/PhysRevLett.13.567
   Lippa T, 2002, EUR J MASS SPECTROM, V8, P263, DOI 10.1255/ejms.498
   Little MW, 2003, J MASS SPECTROM, V38, P772, DOI 10.1002/jms.494
   Litvinenko VN, 2001, NUCL INSTRUM METH A, V470, P66, DOI 10.1016/S0168-9002(01)01025-7
   Litvinenko VN, 1997, PHYS REV LETT, V78, P4569, DOI 10.1103/PhysRevLett.78.4569
   Liu Y, 2003, PIGM CELL RES, V16, P606, DOI 10.1046/j.1600-0749.2003.00098.x
   Luchini P, 1990, UNDULATORS FREE ELEC
   MADEY JMJ, 1971, J APPL PHYS, V42, P1906, DOI 10.1063/1.1660466
   MARSHALL TC, 1985, FREE RADICALS LASERS
   MEACHAM JE, 1996, SAFETY CRITERIA ORGA, P1
   Militsyn BL, 2003, NUCL INSTRUM METH A, V507, P494, DOI 10.1016/S0168-9002(03)00903-3
   Milton SV, 2000, PHYS REV LETT, V85, P988, DOI 10.1103/PhysRevLett.85.988
   Milton SV, 2001, SCIENCE, V292, P2037, DOI 10.1126/science.1059955
   Moore DT, 2004, CHEMPHYSCHEM, V5, P740, DOI 10.1002/cphc.200400062
   MOTZ H, 1953, J APPL PHYS, V24, P826, DOI 10.1063/1.1721389
   *NAT RES COUNC, 1994, REP COMM FREE EL LAS
   Nielen MWF, 1999, MASS SPECTROM REV, V18, P309, DOI 10.1002/(SICI)1098-2787(1999)18:5<309::AID-MAS2>3.3.CO;2-C
   Nofsinger JB, 1999, J PHYS CHEM B, V103, P11428, DOI 10.1021/jp992640y
   Nordstrom KB, 1998, PHYS REV LETT, V81, P457, DOI 10.1103/PhysRevLett.81.457
   O'Shea PG, 2001, SCIENCE, V292, P1853, DOI 10.1126/science.1055718
   OEPTS D, 1995, INFRARED PHYS TECHN, V36, P297, DOI 10.1016/1350-4495(94)00074-U
   Ohanessian G, 2002, INT J MASS SPECTROM, V219, P577, DOI 10.1016/S1387-3806(02)00744-3
   Oomens J, 2004, J AM CHEM SOC, V126, P724, DOI 10.1021/ja038867v
   Papantonakis MR, 2002, APPL SURF SCI, V197, P213, DOI 10.1016/S0169-4332(02)00366-5
   Park IS, 1998, BIOSENS BIOELECTRON, V13, P1091, DOI 10.1016/S0956-5663(98)00067-0
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   Rapp M, 1999, EARTH PLANETS SPACE, V51, P799, DOI 10.1186/BF03353238
   Rector KD, 1998, INT REV PHYS CHEM, V17, P261, DOI 10.1080/014423598230063
   Rector KD, 1997, J PHYS CHEM B, V101, P1468, DOI 10.1021/jp963226q
   Rector KD, 1999, J PHYS CHEM A, V103, P2381, DOI 10.1021/jp983923d
   Rector KD, 2001, J PHYS CHEM B, V105, P1081, DOI 10.1021/jp0023563
   RECTOR KD, 1996, J PHYS CHEM, V100, P18023
   Rella CW, 1996, PHYS REV LETT, V77, P1648, DOI 10.1103/PhysRevLett.77.1648
   RODE AV, 2004, APPL PHYS, V79, P1051
   Rosenfeld G, 1999, APPL PHYS A-MATER, V69, P489, DOI 10.1007/s003390051448
   Samokhvalov A, 2004, J PHYS CHEM B, V108, P16334, DOI 10.1021/jp046701q
   Savvidis PG, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.196802
   Serpentini CL, 2000, ELECTROCHIM ACTA, V45, P1663, DOI 10.1016/S0013-4686(99)00388-6
   Shchukin VA, 1999, REV MOD PHYS, V71, P1125, DOI 10.1103/RevModPhys.71.1125
   STRUPAT K, 1994, ANAL CHEM, V66, P464, DOI 10.1021/ac00076a008
   Stryer L., 1995, BIOCHEMISTRY
   Sun WS, 2000, J GLAUCOMA, V9, P325
   THEIS W, 1995, PHYS REV LETT, V75, P3328, DOI 10.1103/PhysRevLett.75.3328
   TOKMAKOFF A, 1995, CHEM PHYS LETT, V234, P289, DOI 10.1016/0009-2614(95)00068-F
   TOKMAKOFF A, 1995, J CHEM PHYS, V102, P3919, DOI 10.1063/1.468568
   TOKMAKOFF A, 1995, ACCOUNTS CHEM RES, V28, P437, DOI 10.1021/ar00059a001
   TOKMAKOFF A, 1994, J CHEM PHYS, V101, P1741, DOI 10.1063/1.467731
   van der Voort M, 2000, PHYS REV LETT, V84, P1236, DOI 10.1103/PhysRevLett.84.1236
   van Heijnsbergen D, 1999, PHYS REV LETT, V83, P4983, DOI 10.1103/PhysRevLett.83.4983
   von Helden G, 2000, SCIENCE, V288, P313
   von Helden G, 2003, J PHYS CHEM A, V107, P1671, DOI 10.1021/jp021982s
   von Helden G, 1997, PHYS REV LETT, V79, P5234, DOI 10.1103/PhysRevLett.79.5234
   Weller HR, 2003, MOD PHYS LETT A, V18, P1569, DOI 10.1142/S0217732303011216
   Wells JPR, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.115207
   Wells JPR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.125504
   Xie AH, 2000, PHYS REV LETT, V84, P5435, DOI 10.1103/PhysRevLett.84.5435
   Xie AH, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018102
   Xu J, 2003, PROC SPIE, V5268, P19, DOI 10.1117/12.518533
   Xu J, 2003, ASTROBIOLOGY, V3, P489, DOI 10.1089/153110703322610609
   Yang WC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.136102
   Yang WC, 2003, J APPL PHYS, V94, P5720, DOI 10.1063/1.1618355
   Zhang J, 2002, INT J MASS SPECTROM, V213, P237, DOI 10.1016/S1387-3806(01)00542-5
   Zhang J, 2002, J PHYS CHEM A, V106, P6610, DOI 10.1021/jp0203548
   Zhang WZ, 1998, J AM SOC MASS SPECTR, V9, P879, DOI 10.1016/S1044-0305(98)00060-9
   ZIMDARS D, 1993, PHYS REV LETT, V70, P2718, DOI 10.1103/PhysRevLett.70.2718
   Zinke-Allmang M, 1999, THIN SOLID FILMS, V346, P1, DOI 10.1016/S0040-6090(98)01479-5
   ZINKEALLMANG M, 1992, SURF SCI REP, V16, P377, DOI 10.1016/0167-5729(92)90006-W
   2003, J BIOL PHYS
NR 141
TC 34
Z9 34
U1 0
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0031-8655
EI 1751-1097
J9 PHOTOCHEM PHOTOBIOL
JI Photochem. Photobiol.
PD JUL-AUG
PY 2005
VL 81
IS 4
BP 711
EP 735
DI 10.1562/2004-11-08-IR-363R.1
PG 25
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 957KB
UT WOS:000231367600001
PM 15755193
DA 2018-10-20
ER

PT J
AU Rodriguez-Hernandez, J
   Checot, F
   Gnanou, Y
   Lecommandoux, S
AF Rodriguez-Hernandez, J
   Checot, F
   Gnanou, Y
   Lecommandoux, S
TI Toward 'smart' nano-objects by self-assembly of block copolymers in
   solution
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE self-assembly; micelle; nano-objects; block copolymers; cross-linking;
   stabilization; stimulus; smart
ID CROSS-LINKED MICELLES; POLYION COMPLEX FIBER; STIMULI-RESPONSIVE
   VESICLES; AQUEOUS-SOLUTION PROPERTIES; DYNAMIC LIGHT-SCATTERING; ABC
   TRIBLOCK COPOLYMERS; CORE-SHELL NANOSPHERES; DIBLOCK COPOLYMERS;
   SELECTIVE SOLVENT; DRUG-DELIVERY
AB In recent years, the synthesis and analysis of novel copolymer-based nanomaterials in solution have been extensively pursued. The interest in such structures lies in the fact that their dimensions, in the mesoscopic range (< 100 nm), and factors such as composition or structure lead to materials with singular properties and applications. In this article, we report the most significant developments in the preparation and characterization of nano-objects, presenting an organized and detailed overview of the state of the art. First, the basic principles of self-assembly and micellization of block copolymers in dilute solution will be discussed. A review of the methods for stabilization of the macromolecular aggregates will be then given, including selected recent examples. Finally, we will concentrate on stabilized nano-particles, so-called 'smart materials' that show responses to environmental changes (pH, temperature, ionic-strength, among others), focusing on their applications principally in the biomedical field. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Bordeaux 1, CNRS, UMR5629, ENSCPB,Lab Chim Polymeres Organ, F-33607 Pessac, France.
RP Lecommandoux, S (reprint author), Univ Bordeaux 1, CNRS, UMR5629, ENSCPB,Lab Chim Polymeres Organ, 16 Ave Pey Berland, F-33607 Pessac, France.
EM s.lecommandoux@enscpb.fr
RI Lecommandoux, Sebastien/B-9536-2011; Rodriguez-Hernandez,
   Juan/E-9975-2013
OI Lecommandoux, Sebastien/0000-0003-0465-8603; Rodriguez-Hernandez,
   Juan/0000-0003-2464-1040
CR Alexandridis P, 1996, CURR OPIN COLLOID IN, V1, P490, DOI 10.1016/S1359-0294(96)80118-X
   Alexandridis P., 2000, AMPHIPHILIC BLOCK CO
   Aranda-Espinoza H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208301
   Armes SP, 1998, J AM CHEM SOC, V20, P12135
   Arotcarena M, 2002, J AM CHEM SOC, V124, P3787, DOI 10.1021/ja012167d
   Baradie B, 2002, MACROMOLECULES, V35, P3569, DOI 10.1021/ma010461k
   Becker ML, 2001, J POLYM SCI POL CHEM, V39, P4152, DOI 10.1002/pola.10070
   BECKER ML, CHEM COMMUN, P180
   Bergbreiter DE, 1999, ANGEW CHEM INT EDIT, V38, P2870, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2870::AID-ANIE2870>3.0.CO;2-6
   Berne B. J., 2000, DYNAMIC LIGHT SCATTE
   BURCHARD W, 1983, ADV POLYM SCI, V48, P1
   Burke S, 2001, MACROMOL SYMP, V175, P273, DOI 10.1002/1521-3900(200110)175:1<273::AID-MASY273>3.0.CO;2-P
   Butun V, 1999, J AM CHEM SOC, V121, P4288, DOI 10.1021/ja9840596
   Butun V, 1998, J AM CHEM SOC, V120, P11818, DOI 10.1021/ja982295a
   Butun V, 1997, CHEM COMMUN, P671, DOI 10.1039/a700772h
   Butun V, 2001, MACROMOLECULES, V34, P1503, DOI 10.1021/ma0018392
   Cammas-Marion S, 1999, COLLOID SURFACE B, V16, P207, DOI 10.1016/S0927-7765(99)00071-5
   CANHAM PA, 1980, J CHEM SOC FARAD T 1, V76, P1857, DOI 10.1039/f19807601857
   Caruso F, 2000, CHEM-EUR J, V6, P413, DOI 10.1002/(SICI)1521-3765(20000204)6:3<413::AID-CHEM413>3.0.CO;2-9
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   Caruso RA, 2001, CHEM MATER, V13, P400, DOI 10.1021/cm001175a
   Checot F, 2005, LANGMUIR, V21, P4308, DOI 10.1021/la0468500
   Checot F, 2002, ANGEW CHEM INT EDIT, V41, P1339, DOI 10.1002/1521-3773(20020415)41:8<1339::AID-ANIE1339>3.0.CO;2-N
   Checot F, 2003, EUR PHYS J E, V10, P25, DOI 10.1140/epje/e2003-00006-1
   Chen DY, 2003, MACROMOLECULES, V36, P2576, DOI 10.1021/ma025640w
   Chen XL, 1999, LANGMUIR, V15, P8007, DOI 10.1021/la9810253
   Chen XL, 2000, MACROMOLECULES, V33, P4610, DOI 10.1021/ma000100p
   CHU B, 1995, LANGMUIR, V11, P414, DOI 10.1021/la00002a009
   Chu B., 1996, NONIONIC SURFACTANTS, V60
   Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427
   Dai ZF, 2001, ADV MATER, V13, P1339, DOI 10.1002/1521-4095(200109)13:17<1339::AID-ADMA1339>3.0.CO;2-Q
   DAOUD M, 1982, J PHYS-PARIS, V43, P531, DOI 10.1051/jphys:01982004303053100
   de Gennes P. G., 1978, SOLID STATE PHYS, V14
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   DEGENNES PG, 1976, J PHYS-PARIS, V37, P1445, DOI 10.1051/jphys:0197600370120144500
   Ding JF, 1998, MACROMOLECULES, V31, P6554, DOI 10.1021/ma980710d
   Ding JF, 1998, CHEM MATER, V10, P537, DOI 10.1021/cm970546t
   Discher BM, 2002, J PHYS CHEM B, V106, P2848, DOI 10.1021/jp011958z
   Dishcher D. E., 2002, SCIENCE, V297, P967
   DISHER BM, 2000, CURR OPIN COLLOID IN, V5, P125
   Dominguez A, 1997, J CHEM EDUC, V74, P1227, DOI 10.1021/ed074p1227
   Donath E., 1998, ANGEW CHEM INT EDIT, V37, P2201
   DONG DC, 1982, PHOTOCHEM PHOTOBIOL, V35, P17, DOI 10.1111/j.1751-1097.1982.tb03805.x
   Dou HJ, 2003, ANGEW CHEM INT EDIT, V42, P1516, DOI 10.1002/anie.200250254
   Du JZ, 2004, MACROMOLECULES, V37, P5710, DOI 10.1021/ma0497097
   Du JZ, 2003, J AM CHEM SOC, V125, P14710, DOI 10.1021/ja0368610
   Edrington AC, 2001, ADV MATER, V13, P421, DOI 10.1002/1521-4095(200103)13:6<421::AID-ADMA421>3.0.CO;2-#
   Emoto K, 1999, LANGMUIR, V15, P5212, DOI 10.1021/la980918s
   Erhardt R, 2003, J AM CHEM SOC, V125, P3260, DOI 10.1021/ja028982q
   Erhardt R, 2001, MACROMOLECULES, V34, P1069, DOI 10.1021/ma000670p
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   Forster S., 2002, ANGEW CHEM INT EDIT, V41, P688
   GAO ZS, 1993, MACROMOLECULES, V26, P7353, DOI 10.1021/ma00078a035
   Gillies ER, 2003, CHEM COMMUN, P1640, DOI 10.1039/b304251k
   Gohy JF, 2001, ANGEW CHEM INT EDIT, V40, P3214, DOI 10.1002/1521-3773(20010903)40:17<3214::AID-ANIE3214>3.0.CO;2-F
   Gohy JF, 2002, MACROMOLECULES, V35, P9748, DOI 10.1021/ma021175r
   Gohy JF, 2001, MACROMOLECULES, V34, P7435, DOI 10.1021/ma010535s
   Gravano SM, 2002, LANGMUIR, V18, P1938, DOI 10.1021/la011309e
   Guo A, 1996, MACROMOLECULES, V29, P2487, DOI 10.1021/ma951354r
   Hadjichristidis N., 2003, BLOCK COPOLYMERS SYN
   HALPERIN A, 1987, MACROMOLECULES, V20, P2943, DOI 10.1021/ma00177a051
   Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/ange.200200546
   Harada A, 1999, SCIENCE, V283, P65, DOI 10.1126/science.283.5398.65
   HARADA A, 1995, MACROMOLECULES, V28, P5294, DOI 10.1021/ma00119a019
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Henselwood F, 1997, MACROMOLECULES, V30, P488, DOI 10.1021/ma961401v
   Holden G., 1996, THERMOPLASTIC ELASTO
   Hoppenbrouwers E, 2003, MACROMOLECULES, V36, P876, DOI 10.1021/ma021535a
   Hsieh H. L., 1996, ANIONIC POLYMERIZATI
   Huang HY, 1999, J AM CHEM SOC, V121, P3805, DOI 10.1021/ja983610w
   Huang HY, 1997, J AM CHEM SOC, V119, P11653, DOI 10.1021/ja9717469
   Huang HY, 1998, CHEM COMMUN, P1415, DOI 10.1039/a708686e
   Huang HY, 2003, J POLYM SCI POL CHEM, V41, P1659, DOI 10.1002/pola.10712
   Iijima M, 1999, MACROMOLECULES, V32, P1140, DOI 10.1021/ma9815962
   ISHIZU K, 1993, J POLYM SCI POL CHEM, V31, P661, DOI 10.1002/pola.1993.080310309
   ISHIZU KJ, 1989, J POLYM SCI POL CHEM, V27, P3721, DOI 10.1002/pola.1989.080271113
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   IVIN KJ, 1984, RING OPENING POLYM, P1
   Jeong B, 1999, COLLOID SURFACE B, V16, P185, DOI 10.1016/S0927-7765(99)00069-7
   Jeong YI, 1998, J CONTROL RELEASE, V51, P169, DOI 10.1016/S0168-3659(97)00163-6
   Kakizawa Y, 2001, BIOMACROMOLECULES, V2, P491, DOI 10.1021/bm000142I
   KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004
   Kang YJ, 2003, J AM CHEM SOC, V125, P5650, DOI 10.1021/ja034082d
   Katayose S, 1998, J PHARM SCI, V87, P160, DOI 10.1021/js970304s
   Klok HA, 2001, ADV MATER, V13, P1217, DOI 10.1002/1521-4095(200108)13:16<1217::AID-ADMA1217>3.0.CO;2-D
   Kukula H, 2002, J AM CHEM SOC, V124, P1658, DOI 10.1021/ja012091l
   Kwon G, 1997, J CONTROL RELEASE, V48, P195, DOI 10.1016/S0168-3659(97)00039-4
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   Lazzari M, 2003, ADV MATER, V15, P1583, DOI 10.1002/adma.200300382
   Lecommandoux SB, 2005, ADV MATER, V17, P712, DOI 10.1002/adma.200400599
   Lee AS, 1999, MACROMOLECULES, V32, P4302, DOI 10.1021/ma981865o
   Lee JCM, 2001, BIOTECHNOL BIOENG, V73, P135, DOI 10.1002/bit.1045
   LEIBLER L, 1983, J CHEM PHYS, V79, P3550, DOI 10.1063/1.446209
   Lele BS, 2002, MACROMOLECULES, V35, P6714, DOI 10.1021/ma020433h
   LINSE P, 1993, MACROMOLECULES, V26, P4437, DOI 10.1021/ma00069a007
   LINSE P, 1994, MACROMOLECULES, V27, P6404, DOI 10.1021/ma00100a026
   LINSE P, 1992, MACROMOLECULES, V25, P5434, DOI 10.1021/ma00046a048
   Liu GJ, 1996, MACROMOLECULES, V29, P5508, DOI 10.1021/ma9604653
   Liu GJ, 1997, ADV MATER, V9, P437, DOI 10.1002/adma.19970090517
   Liu GJ, 1999, CHEM-EUR J, V5, P2740
   Liu GJ, 1999, CHEM MATER, V11, P2233, DOI 10.1021/cm990184k
   Liu JQ, 2001, BIOMACROMOLECULES, V2, P362, DOI 10.1021/bm015515c
   Liu SY, 2003, LANGMUIR, V19, P4432, DOI 10.1021/la020951l
   Liu SY, 2002, LANGMUIR, V18, P8350, DOI 10.1021/la020496t
   Liu SY, 2001, ANGEW CHEM INT EDIT, V40, P2328, DOI 10.1002/1521-3773(20010618)40:12<2328::AID-ANIE2328>3.0.CO;2-M
   Liu SY, 2002, MACROMOLECULES, V35, P6121, DOI 10.1021/ma020447n
   Liu XY, 2002, ANGEW CHEM INT EDIT, V41, P2950, DOI 10.1002/1521-3773(20020816)41:16<2950::AID-ANIE2950>3.0.CO;2-K
   Lodge TP, 2003, MACROMOL CHEM PHYSIC, V204, P265, DOI 10.1002/macp.200290073
   Luo LB, 2002, ANGEW CHEM INT EDIT, V41, P1001, DOI 10.1002/1521-3773(20020315)41:6<1001::AID-ANIE1001>3.0.CO;2-Q
   Ma QG, 2000, J POLYM SCI POL CHEM, V38, P4805, DOI 10.1002/1099-0518(200012)38:1+<4805::AID-POLA180>3.0.CO;2-O
   Matyjaszewski K., 2002, HDB RADICAL POLYMERI
   Moffitt M, 1996, ACCOUNTS CHEM RES, V29, P95, DOI 10.1021/ar940080+
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   Narain R, 2003, MACROMOLECULES, V36, P4675, DOI 10.1021/ma034321h
   Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u
   Nishikawa M, 1996, ADV DRUG DELIVER REV, V21, P135, DOI 10.1016/S0169-409X(96)00403-6
   NOOLANDI J, 1982, MACROMOLECULES, V15, P482, DOI 10.1021/ma00230a054
   NOOLANDI J, 1983, MACROMOLECULES, V16, P1443, DOI 10.1021/ma00243a007
   Ohkawa K, 2000, MACROMOL RAPID COMM, V21, P223, DOI 10.1002/(SICI)1521-3927(20000301)21:5<223::AID-MARC223>3.0.CO;2-#
   Ohkawa K, 2001, MACROMOL MATER ENG, V286, P168, DOI 10.1002/1439-2054(20010301)286:3<168::AID-MAME168>3.3.CO;2-Z
   Ohno K, 1998, MACROMOL CHEM PHYSIC, V199, P291, DOI 10.1002/(SICI)1521-3935(19980201)199:2<291::AID-MACP291>3.0.CO;2-D
   PAPISOV MI, 1995, ADV DRUG DELIVER REV, V16, P127, DOI 10.1016/0169-409X(95)00021-X
   Pastoriza-Santos I, 2001, ADV FUNCT MATER, V11, P122, DOI 10.1002/1616-3028(200104)11:2<122::AID-ADFM122>3.3.CO;2-E
   Penczek S., 1990, MODELS BIOPOLYMERS R
   PILON LN, 2003, POLYM MAT SCI ENG, V89, P166
   PRICE C, 1986, POLYM COMMUN, V27, P196
   PRICE C, 1987, EUR POLYM J, V23, P649, DOI 10.1016/0014-3057(87)90013-9
   PROCHAZKA A, 1979, Z MAKROMOL CHEM, V180, P2521
   Rheingans O, 2000, MACROMOLECULES, V33, P4780, DOI 10.1021/ma991985b
   Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Rodriguez-Hernandez J, 2005, J AM CHEM SOC, V127, P2026, DOI 10.1021/ja043920g
   Rosler A, 2001, ADV DRUG DELIVER REV, V53, P95, DOI 10.1016/S0169-409X(01)00222-8
   SAITO R, 1990, POLYMER, V31, P679, DOI 10.1016/0032-3861(90)90289-B
   Saito R, 1999, COLLOID SURFACE A, V153, P305, DOI 10.1016/S0927-7757(98)00624-4
   Sanji T, 2000, MACROMOLECULES, V33, P8524, DOI 10.1021/ma0011892
   Sauer M, 2001, CHEM COMMUN, P55, DOI 10.1039/b007118h
   Schrage S, 2003, MACROMOLECULES, V36, P1417, DOI 10.1021/ma0255940
   Schultz C, 1995, MACROMOLECULES, V28, P7295
   SELB J, 1985, DEV BLOCK COPOLYMERS, V2, P27
   Shchukin DG, 2003, ANGEW CHEM INT EDIT, V42, P4472, DOI 10.1002/anie.200352068
   Shusharina NP, 1996, MACROMOLECULES, V29, P3167, DOI 10.1021/ma9515745
   Shusharina NP, 2003, EUR PHYS J E, V10, P45, DOI 10.1140/epje/e2003-00001-6
   SKAFF H, 2003, POLYM MAT SCI ENG, V89, P145
   Soo PL, 2004, J POLYM SCI POL PHYS, V42, P923, DOI 10.1002/polb.10739
   Stewart S, 2000, ANGEW CHEM INT EDIT, V39, P340, DOI 10.1002/(SICI)1521-3773(20000117)39:2<340::AID-ANIE340>3.3.CO;2-8
   Stewart S, 1999, CHEM MATER, V11, P1048, DOI 10.1021/cm981009r
   Stoenescu R, 2002, CHEM COMMUN, P3016, DOI 10.1039/b209352a
   Sukhorukov GB, 2001, MACROMOL RAPID COMM, V22, P44, DOI 10.1002/1521-3927(20010101)22:1<44::AID-MARC44>3.0.CO;2-U
   Sukhorukov GB, 1998, POLYM ADVAN TECHNOL, V9, P759, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<759::AID-PAT846>3.0.CO;2-Q
   SUKHORUKOV GB, 2001, NOVEL METHODS STUDY
   Szczubialka K, 2003, POLYMER, V44, P5269, DOI 10.1016/S0032-3861(03)00479-8
   Tao J, 1997, MACROMOLECULES, V30, P4084, DOI 10.1021/ma9700237
   Thurmond KB, 1997, J AM CHEM SOC, V119, P6656, DOI 10.1021/ja9710520
   Thurmond KB, 1996, J AM CHEM SOC, V118, P7239, DOI 10.1021/ja961299h
   Thurmond KB, 1999, COLLOID SURFACE B, V16, P45, DOI 10.1016/S0927-7765(99)00060-0
   TORCHILIN VP, 1995, ADV DRUG DELIVER REV, V16, P141, DOI 10.1016/0169-409X(95)00022-Y
   TURNER JL, 2003, POLYM PREP-ACS, V44, P213
   TUZAR Z, 1996, NATO ASI SERIES E, V327
   TUZAR Z, 1993, SURFACE COLLOID SCI, V15
   Wang M, 2002, MACROMOLECULES, V35, P5980, DOI 10.1021/ma0201330
   WILSON DJ, 1988, EUR POLYM J, V24, P617, DOI 10.1016/0014-3057(88)90024-9
   Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960
   Wooley KL, 2000, J POLYM SCI POL CHEM, V38, P1397, DOI 10.1002/(SICI)1099-0518(20000501)38:9<1397::AID-POLA1>3.0.CO;2-N
   Wu C, 2000, MACROMOLECULES, V33, P645, DOI 10.1021/ma990288g
   Xu H, 2001, LANGMUIR, V17, P6787, DOI 10.1021/la010091t
   Yamamoto H, 2001, J APPL POLYM SCI, V79, P437, DOI 10.1002/1097-4628(20010118)79:3<437::AID-APP60>3.3.CO;2-H
   Yamamoto H, 2000, MACROMOL CHEM PHYSIC, V201, P84, DOI 10.1002/(SICI)1521-3935(20000101)201:1<84::AID-MACP84>3.0.CO;2-Y
   Yamamoto Y, 1999, COLLOID SURFACE B, V16, P135, DOI 10.1016/S0927-7765(99)00065-X
   Yang L, 2000, CURR OPIN COLLOID IN, V5, P132, DOI 10.1016/S1359-0294(00)00046-7
   Yokoyama M, 1998, J CONTROL RELEASE, V50, P79, DOI 10.1016/S0168-3659(97)00115-6
   Yokoyama M, 1996, ADV DRUG DELIVER REV, V21, P77, DOI 10.1016/S0169-409X(96)00439-5
   Yoshida E, 2002, J POLYM SCI POL CHEM, V40, P3063, DOI 10.1002/pola.10399
   Yu K, 1998, MACROMOLECULES, V31, P3509, DOI 10.1021/ma971419l
   YU KE, 1998, MACROMOLECULES, V31, P5546
   Zhang Q, 2000, J AM CHEM SOC, V122, P3642, DOI 10.1021/ja993941o
   Zhang YJ, 2003, ADV MATER, V15, P832, DOI 10.1002/adma.200304315
   Zhang ZG, 2000, MACROMOLECULES, V33, P7877, DOI 10.1021/ma000781o
   Zhou JY, 2002, MACROMOLECULES, V35, P3690, DOI 10.1021/ma0120005
   ZHULINA YB, 1985, VYSOKOMOL SOEDIN A+, V27, P511
   Zubarev ER, 1999, SCIENCE, V283, P523, DOI 10.1126/science.283.5401.523
NR 181
TC 576
Z9 585
U1 14
U2 437
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD JUL
PY 2005
VL 30
IS 7
BP 691
EP 724
DI 10.1016/j.progpolymsci.2005.04.002
PG 34
WC Polymer Science
SC Polymer Science
GA 960XG
UT WOS:000231625900002
DA 2018-10-20
ER

PT J
AU Clement, B
   Grimaud, JA
   Deleuze, JF
   Postaire, E
AF Clement, B
   Grimaud, JA
   Deleuze, JF
   Postaire, E
CA Participants Round Table Three Gi
TI The Human Biological Resource Centres network - A key infrastructure for
   biomedical research in Europe
SO THERAPIE
LA English
DT Article; Proceedings Paper
CT 20th National Clinical Pharmacology Workshop
CY OCT 03-05, 2004
CL Giens, FRANCE
SP French Inst Med Res, French Agcy Hlth Products, Paris Pubicl Hosp Network, Natl Public Hlth Insurance, French Soc Pharmacol, Marseille Public Hosp Network, Leem-Rech
DE biotechnology; biological resources; drugs; diagnosis
AB Continuing advances in life sciences and medical research are the result of the remarkable achievements of cell and molecular biology. In the post-sequencing era, the quality of the huge amount of data continuously generated by biotechnology, i.e. genomics, proteomics and high-throughput screening, depends on the quality assurance and the traceability of the original biological materials, including the annotations linked to these materials. Thus, biological resource centres are key infrastructures supporting biotechnology, bioprocessing and the development of new approaches in the prevention, diagnosis and treatment of diseases.
C1 INSERM Transfert, Paris, France.
   Univ Paris 06, CNRS, UMR 7623, Paris, France.
   Sanofi Aventis, Evry, France.
   INSERM, Direct Animat & Partenariats Sci, Paris, France.
RP Clement, B (reprint author), Univ Rennes 1, Fac Med & Pharm, INSERM, U620, 2 Ave Leon Bernard, Rennes, France.
EM bruno.clement@rennes.inserm.fr
RI Deplanque, Dominique/E-4901-2015; Clement, Bruno/E-5546-2016
OI Deplanque, Dominique/0000-0002-4995-584X; Clement,
   Bruno/0000-0001-8827-146X
CR *DECL INT DONN GEN, 2003, C GEN UNESCO 32 SESS
   *OECD, 2001, CTR RESS BIOL FOND D
   SCHWARTZENBERG MRG, 2001, INSTALLATION COMITE
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ADIS INTERNATIONAL LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW
   ZEALAND
SN 0040-5957
J9 THERAPIE
JI Therapie
PD JUL-AUG
PY 2005
VL 60
IS 4
BP 355
EP 357
DI 10.2515/therapie:2005050
PG 3
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 976MS
UT WOS:000232738300004
OA Green Published
DA 2018-10-20
ER

PT J
AU Geringer, J
   Forest, B
   Combrade, P
AF Geringer, J
   Forest, B
   Combrade, P
TI Fretting-corrosion of materials used as orthopaedic implants
SO WEAR
LA English
DT Article
DE fretting-corrosion; orthopaedic implants; PMMA; 316L
ID INTERFACE; SURFACES
AB In the biomedical field, about 6% of hip total joint prostheses have to be replaced after 9 years because of a loosening of the femoral stem. One of the main causes of a new surgical intervention is attributed to the phenomenon of fretting-corrosion, i.e. wear under small movements (lower than 100 mu m) in corrosive aqueous medium.
   To understand this degradation, the fretting between 316L steel and PMMA has been investigated to simulate the fretting between femoral stem and bone cement.
   First, fretting in air has been studied as a reference environment. No significant wear was observed on the stainless steel. PMMA suffers a wear that exhibits a linear evolution as a function of the cumulated dissipated energy. Third body evolution could explain the particular W shape of the active wear track in PMMA, in dry conditions.
   In aerated Ringer's solution, at free corrosion potential, stainless steel suffers significant wear damage, and the wear volume increases linearly with time but not with dissipated energy. Moreover the optical observations and three-dimensional (3-D) profilometry show a 'W' shape of the wear track of 316L. A corrosion mechanism involving a crevice effect enhanced by fretting allows to explain the location of the maximum damage zones.
   Finally, the effect of electrochemical potential on the behaviour of 316L/PMMA contacts has been studied by recording current intensity and cumulated dissipated energy under potentiodynamic conditions. Dissipated energy exhibited a reproducible variation with potential. Lubrication regimes and effect of potential on the surface charges could account for such a behaviour. (c) 2005 Elsevier B.V. All rights reserved.
C1 CNRS, Ecole Natl Super Mines St Etienne, UMR 5146, F-42023 St Etienne, France.
   ANP, Ctr Tech Framatome, F-71205 Le Creusot, France.
RP Geringer, J (reprint author), CNRS, Ecole Natl Super Mines St Etienne, UMR 5146, 158 Cours Fauriel, F-42023 St Etienne, France.
EM geringer@emse.fr
RI yang, lin/G-6662-2011
OI geringer, jean/0000-0002-4843-2844
CR BESSON J, 1984, PRECIS THERMODYNAMIQ, P102
   Exartier C, 2004, CORROS SCI, V46, P1777, DOI 10.1016/j.corsci.2003.10.012
   Fouvry S, 1997, WEAR, V203, P393, DOI 10.1016/S0043-1648(96)07436-4
   HERBERTS P, 1989, CLIN ORTHOP RELAT R, V249, P487
   Hertz H., 1881, ANGEW MATH, V92, P156
   HILLS DA, 1993, MECH ELASTIC CONTACT, P53
   Huq MZ, 1997, WEAR, V212, P151, DOI 10.1016/S0043-1648(97)00167-1
   Johnson K. L., 1985, CONTACT MECH, P84
   KOVACS P, 1992, AM SOC TEST MATER, V1144, P160, DOI 10.1520/STP14863S
   LANDOLT D, 1997, LAUSANNE, P386
   Le Bozec N, 2001, CORROS SCI, V43, P765, DOI 10.1016/S0010-938X(00)00113-X
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   RUBIN PJ, 1993, J BIOMECH, V26, P725, DOI 10.1016/0021-9290(93)90035-D
   Tritschler B, 1999, TRIBOL INT, V32, P587, DOI 10.1016/S0301-679X(99)00099-7
   Walker SL, 2002, LANGMUIR, V18, P2193, DOI 10.1021/la011284j
   WATERHOUSE RB, 1982, ASTM SPECIAL TECHNIC, V780, P3
NR 16
TC 78
Z9 81
U1 2
U2 26
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
EI 1873-2577
J9 WEAR
JI Wear
PD JUL-AUG
PY 2005
VL 259
SI SI
BP 943
EP 951
DI 10.1016/j.wear.2004.11.027
PN 2
PG 9
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 943QX
UT WOS:000230370300019
DA 2018-10-20
ER

PT J
AU Mandl, S
   Attenberger, W
   Stritzker, B
   Rauschenbach, B
AF Mandl, S
   Attenberger, W
   Stritzker, B
   Rauschenbach, B
TI Disorder formation in rutile during ion assisted deposition
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Surface Modification of Materials by
   Ion Beams
CY SEP 21-26, 2003
CL San Antonio, TX
SP SW Res Inst
DE ion implantation; rutile; TEM; XRD
ID OXIDE-FILMS; TITANIUM; IMPLANTATION; TIO2; BIOCOMPATIBILITY
AB Ion assisted deposition (IAD) is a well-known method for obtaining dense and well adhering surface layers. Conventional IAD operates with evaporated metal atoms and energetic gaseous ions whereas metal plasma immersion ion implantation and deposition (MePIIID) draws energetic metallic ions from a cathodic arc which may additionally ionise the background gas. TiO2 is a widely investigated material for biomedical, optical and catalysis applications. MePIIID is employed to deposit TiO2 films onto Si substrates at different pulse voltages up to 10 kV X-ray diffraction (XRD) and transmission electron microscopy (TEM) studies are performed to investigate the changing film properties as a function of pulse voltage and to estimate the barrier efficiency against diffusion through the layer. (c) 2004 Elsevier B.V. All rights reserved.
C1 Leibniz Inst Oberflachenmodifizierung, D-04303 Leipzig, Germany.
   Univ Augsburg, Inst Expt Phys 4, D-8900 Augsburg, Germany.
RP Mandl, S (reprint author), Leibniz Inst Oberflachenmodifizierung, Permoserstr 15, D-04303 Leipzig, Germany.
EM stephan.maendl@iom-leipzig.de
CR Alvarez-Herrero A, 1999, THIN SOLID FILMS, V349, P212, DOI 10.1016/S0040-6090(99)00145-5
   ANDERSSON S, 1959, ACTA CHEM SCAND, V13, P989, DOI 10.3891/acta.chem.scand.13-0989
   Attenberger W, 2001, SURF COAT TECH, V142, P412, DOI 10.1016/S0257-8972(01)01080-5
   Bilek MMM, 2003, IEEE T PLASMA SCI, V31, P939, DOI 10.1109/TPS.2003.818409
   Escobar-Alarcon L, 1999, APPL SURF SCI, V137, P38, DOI 10.1016/S0169-4332(98)00486-3
   HOFER F, 1995, ULTRAMICROSCOPY, V59, P15, DOI 10.1016/0304-3991(95)00015-S
   HOSTENPILLER PAM, 1996, J CRYST GROWTH, V106, P779
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Lee BH, 1999, APPL PHYS LETT, V74, P3143, DOI 10.1063/1.124089
   Leng YX, 2002, THIN SOLID FILMS, V420, P408, DOI 10.1016/S0040-6090(02)00814-3
   Mandl S, 2002, NUCL INSTRUM METH B, V190, P728, DOI 10.1016/S0168-583X(02)00448-2
   Mandl S, 2002, SURF COAT TECH, V156, P276, DOI 10.1016/S0257-8972(02)00085-3
   Mandl S, 2001, NUCL INSTRUM METH B, V178, P148, DOI 10.1016/S0168-583X(01)00513-4
   MANDL S, 2002, GENET ANAL-BIOMOL E, V19, P131
   MANDL S, 2003, P 26 INT C PHEN ION
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pham MT, 2000, SURF COAT TECH, V128, P313, DOI 10.1016/S0257-8972(00)00593-4
   THORNTON JA, 1974, SURF FILMS, V4, P666
NR 19
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 22
PY 2005
VL 196
IS 1-3
BP 76
EP 80
DI 10.1016/j.surfcoat.2004.08.100
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 929VV
UT WOS:000229375600015
DA 2018-10-20
ER

PT J
AU Fuchter, MJ
   Beall, LS
   Baum, SM
   Montalban, AG
   Sakellariou, EG
   Mani, NS
   Miller, T
   Vesper, BJ
   White, AJP
   Williams, DJ
   Barrett, AGM
   Hoffman, BM
AF Fuchter, MJ
   Beall, LS
   Baum, SM
   Montalban, AG
   Sakellariou, EG
   Mani, NS
   Miller, T
   Vesper, BJ
   White, AJP
   Williams, DJ
   Barrett, AGM
   Hoffman, BM
TI Synthesis of porphyrazine-octaamine, hexamine and diamine derivatives
SO TETRAHEDRON
LA English
DT Article
DE porphyrazine; aminoporphyrazine; nickel porphyrazines; Linstead
   macrocyclization; UV-vis spectroscopy; electrochemistry
ID METAL-ION BINDING; SPECTROSCOPIC INVESTIGATIONS;
   SOLITAIRE-PORPHYRAZINES; SECO-PORPHYRAZINES; HYDROGEN-CYANIDE;
   COMPLEXES; CORE; TETRAKIS(THIADIAZOLE)PORPHYRAZINES;
   BIS(DIMETHYLAMINO)PORPHYRAZINES; GENERATION
AB The syntheses of a variety of substituted diaminomaleonitriles, with variable nitrogen substituents, were undertaken. Linstead macrocyclization of the resulting diaminomaleonitriles gave access to a wide range of functionalized porphyrazine-octaamines and hexamines and norphthalocyaninediamines. Conversion of these macrocycles into metallic derivatives and studies of their electronic absorption, solubility and electrochemistry are described. These flexible tetraazaporphyrins show potential in a range of applications including biomedical agents, novel charge-transfer complexes, chemical sensors, novel electronic materials and non-linear optics. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.
   Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
RP Barrett, AGM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.
EM agmb@imperial.ac.uk; bmh@northwestern.edu
OI Fuchter, Matthew/0000-0002-1767-7072
CR Ahmed M, 2003, ORG LETT, V5, P669, DOI 10.1021/ol027406w
   ANANTANARAYAN A, 1986, J ORG CHEM, V51, P752, DOI 10.1021/jo00355a037
   Anderson ME, 1999, INORG CHEM, V38, P6143, DOI 10.1021/ic990410s
   Anderson ME, 2000, J INORG BIOCHEM, V80, P257, DOI 10.1016/S0162-0134(00)00084-2
   Angeloni S, 2001, J PORPHYR PHTHALOCYA, V5, P881, DOI 10.1002/jpp.558
   Bauer EM, 1999, INORG CHEM, V38, P6114, DOI 10.1021/ic990855g
   Bauer EM, 1999, J PORPHYR PHTHALOCYA, V3, P371, DOI 10.1002/(SICI)1099-1409(199906)3:5<371::AID-JPP140>3.0.CO;2-F
   Baum SM, 2003, J ORG CHEM, V68, P1665, DOI 10.1021/jo026484u
   BAUMANN TF, 1994, J AM CHEM SOC, V116, P2639, DOI 10.1021/ja00085a062
   Baumann TF, 1996, J AM CHEM SOC, V118, P10479, DOI 10.1021/ja9619115
   Baumann TF, 1997, INORG CHEM, V36, P5661, DOI 10.1021/ic9701367
   Beall LS, 1998, J ORG CHEM, V63, P5806, DOI 10.1021/jo9802574
   BEGLAND RW, 1974, J ORG CHEM, V39, P2341, DOI 10.1021/jo00930a004
   BOYER JH, 1976, J AM CHEM SOC, V98, P1099, DOI 10.1021/ja00421a008
   BOYER JH, 1970, CHEM COMMUN, P1204
   COOK AH, 1949, J CHEM SOC, P2337, DOI 10.1039/jr9490002337
   CUELLAR EA, 1981, INORG CHEM, V20, P3766, DOI 10.1021/ic50225a039
   Dolphin D., 1978, PORPHYRINS, VI
   Donzello MP, 2003, J AM CHEM SOC, V125, P14190, DOI 10.1021/ja0344361
   Ehrlich LA, 2000, INORG CHEM, V39, P3963, DOI 10.1021/ic991033m
   Eichhorn D. M., 1995, CHEM COMMUN, P1703
   FERRIS JP, 1972, J AM CHEM SOC, V94, P6968, DOI 10.1021/ja00775a018
   Forsyth TP, 1998, J ORG CHEM, V63, P331, DOI 10.1021/jo971683c
   Fuchter MJ, 2005, J ORG CHEM, V70, P2793, DOI 10.1021/jo047792q
   Goldberg DP, 1998, INORG CHEM, V37, P2873, DOI 10.1021/ic970624e
   Goldberg DP, 1998, INORG CHEM, V37, P2100, DOI 10.1021/ic971498h
   Gouterman M., 1978, PORPHYRINS, V3, P1
   GROVES JT, 1989, J AM CHEM SOC, V111, P4998, DOI 10.1021/ja00195a074
   HAMMER ND, 2005, UNPUB CHARGE DEPENDE
   Hochmuth DH, 2000, EUR J INORG CHEM, P593
   KATRITZKY AR, 1992, SYNTHESIS-STUTTGART, P911
   KHANA N, 1994, J ORG CHEM, V59, P4832
   Lange SJ, 1998, INORG CHEM, V37, P6435, DOI 10.1021/ic980791u
   Lee SW, 2003, PHOTOCHEM PHOTOBIOL, V77, P18, DOI 10.1562/0031-8655(2003)077<0018:TTSOQY>2.0.CO;2
   LEZNOFF CC, 1989, PHTHALOCYANINES PROP, V1
   LINSTEAD RP, 1952, J CHEM SOC, P4839, DOI 10.1039/jr9520004839
   Loiseau FA, 2004, J ORG CHEM, V69, P639, DOI 10.1021/jo035042v
   MAJNI NS, 1994, CHEM COMMUN, P2095
   MARQUIS D, 1995, J ORG CHEM, V60, P7984, DOI 10.1021/jo00129a045
   Michel SLJ, 2001, PROG INORG CHEM, V50, P473
   MOI MK, 1988, J AM CHEM SOC, V110, P6266, DOI 10.1021/ja00226a063
   Montalban AG, 1999, J PHYS CHEM A, V103, P4352, DOI 10.1021/jp9905068
   Montalban AG, 1997, J ORG CHEM, V62, P9284, DOI 10.1021/jo971599x
   Montalban AG, 2000, J ORG CHEM, V65, P2472, DOI 10.1021/jo991646g
   MONTALBAN AG, 2003, J CHEM SOC DA, P2093
   MOORE WJ, 1995, TETRAHEDRON LETT, V36, P6599, DOI 10.1016/00404-0399(50)1349M-
   Nie HL, 1999, J ORG CHEM, V64, P6791, DOI 10.1021/jo9907890
   Sakellariou EG, 2000, J PHOTOCH PHOTOBIO A, V136, P185, DOI 10.1016/S1010-6030(00)00343-9
   Sakellariou EG, 2003, TETRAHEDRON, V59, P9083, DOI 10.1016/j.tet.2003.09.060
   Sakellariou EG, 2002, INORG CHEM, V41, P2182, DOI 10.1021/ic0111583
   Savage SA, 1998, J ORG CHEM, V63, P10048, DOI 10.1021/jo981505z
   Stuzhin P.A., 2003, PORPHYRIN HDB, P263, DOI DOI 10.1016/B978-0-08-092389-5.50011-0
   Stuzhin PA, 1998, INORG CHEM, V37, P1533, DOI 10.1021/ic9609259
   Trabanco AA, 2000, SYNLETT, P1010
   VILLANUEVA A, 1994, J PHOTOCH PHOTOBIO B, V23, P49, DOI 10.1016/1011-1344(93)06982-9
   WIBERG KB, 1957, J AM CHEM SOC, V79, P3160, DOI 10.1021/ja01569a046
   Zhao M, 2003, ANGEW CHEM INT EDIT, V42, P462, DOI 10.1002/anie.200390140
   Zhao M, 2004, INORG CHEM, V43, P3377, DOI 10.1021/ic035402x
NR 58
TC 37
Z9 37
U1 2
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4020
J9 TETRAHEDRON
JI Tetrahedron
PD JUN 20
PY 2005
VL 61
IS 25
BP 6115
EP 6130
DI 10.1016/j.tet.2005.03.090
PG 16
WC Chemistry, Organic
SC Chemistry
GA 934PZ
UT WOS:000229722000013
DA 2018-10-20
ER

PT J
AU Sannino, A
   Nicolais, L
AF Sannino, A
   Nicolais, L
TI Concurrent effect of microporosity and chemical structure on the
   equilibrium sorption properties of cellulose-based hydrogels
SO POLYMER
LA English
DT Article
DE hydrogel; swelling; ionic strength
ID SWELLING EQUILIBRIA; CROSS-LINKING; POLYMER GELS; RELEASE; COMPOSITES;
   PHASES
AB Polyelectrolite hydrogels are crosslinked polymers which display high sorption capacity in water and water solutions. They are widely used in the marked of personal hygiene products, as well as in other biomedical and industrial applications. In the most industrial application they are not biodegradable and prepared starting from acrylamide.
   In this work, the chemical-physical analysis of a novel class of natural polymers-based microporous superabsorbent hydrogels has been presented. The main focus is the definition of the relationship between material's chemical-physical structure and its equilibrium sorption properties.
   The effect of the variation of the degree of crosslinking, the polyelectrolyte nature of the backbone and the hydrogel microporosity on its swelling properties has been analysed, and a good agreement with the theoretical statements has been displayed.
   The effect of the ionic strength and the pH of the external solution in contact with the hydrogel on its equilibrium sorption properties has also been assessed, and an high sensitivity to these variations was detected for all the tested chemical compositions and physical structures.
   This work have to be considered part of the efforts towards the reduction of the environmental impact of the large scale consumption industrial polymer based products. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Lecce, Dept Engn Innovat, I-73100 Lecce, Italy.
   Univ Naples Federico II, Dept Mat & Prod Engn, I-80125 Naples, Italy.
RP Sannino, A (reprint author), Univ Lecce, Dept Engn Innovat, Via Monteroni, I-73100 Lecce, Italy.
EM alessandro.sannino@unile.it
OI Sannino, Alessandro/0000-0001-8959-4412
CR ANBERGEN U, 1990, POLYMER, V31, P1854, DOI 10.1016/0032-3861(90)90006-K
   Antonietti M, 1998, LANGMUIR, V14, P2670, DOI 10.1021/la971054y
   Antonietti M, 1999, MACROMOLECULES, V32, P1383, DOI 10.1021/ma9812478
   BAKER JP, 1992, MACROMOLECULES, V25, P1955, DOI 10.1021/ma00033a019
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Bergbreiter DE, 1998, MACROMOLECULES, V31, P6053, DOI 10.1021/ma980836a
   BRANNONPEPPAS L, 1990, ABSORBENT POLYM TECH, P67
   Capitani D, 2000, MACROMOLECULES, V33, P430, DOI 10.1021/ma9914117
   Chen J, 2000, J CONTROL RELEASE, V64, P39, DOI 10.1016/S0168-3659(99)00139-X
   Chen J, 2000, CARBOHYD POLYM, V41, P259, DOI 10.1016/S0144-8617(99)00144-7
   Chen J, 2000, J CONTROL RELEASE, V65, P73, DOI 10.1016/S0168-3659(99)00238-2
   DELNOBILE MA, 2003, Patent No. 66304422
   Esposito F, 1996, J APPL POLYM SCI, V60, P2403
   Flory J., 1953, PRINCIPLES POLYM CHE
   GROSS JR, 1990, ABSORBENT POLYM TECH
   HARSH DC, 1990, ABSORBENT POLYM TECH, P103
   Holtz JH, 1997, NATURE, V389, P829
   HOOPER HH, 1990, MACROMOLECULES, V23, P1096, DOI 10.1021/ma00206a031
   Ichikawa H, 2000, J CONTROL RELEASE, V63, P107, DOI 10.1016/S0168-3659(99)00181-9
   IRIE Y, 1990, Patent No. 4920202
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Lenzi F, 2003, POLYMER, V44, P1577, DOI 10.1016/S0032-3861(02)00939-4
   Makino K, 2001, COLLOID SURFACE B, V20, P341, DOI 10.1016/S0927-7765(00)00201-0
   MASUDA F, 1987, SUPERABSORBENT POLYM
   MENSITIERI G, 2001, Patent No. 0168713
   OVERBEEK J T, 1956, Prog Biophys Biophys Chem, V6, P57
   Park TG, 1999, BIOMATERIALS, V20, P517, DOI 10.1016/S0142-9612(98)00197-5
   Pradas MM, 2001, POLYMER, V42, P4667
   Takeda H, 1985, US Patent, Patent No. [4,525,527, 4525527]
NR 29
TC 41
Z9 44
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD JUN 17
PY 2005
VL 46
IS 13
BP 4676
EP 4685
DI 10.1016/j.polymer.2005.03.072
PG 10
WC Polymer Science
SC Polymer Science
GA 933XW
UT WOS:000229667200019
DA 2018-10-20
ER

PT J
AU Lv, Q
   Cao, CB
   Zhang, Y
   Ma, XL
   Zhu, HS
AF Lv, Q
   Cao, CB
   Zhang, Y
   Ma, XL
   Zhu, HS
TI Preparation of insoluble fibroin films without methanol treatment
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE conformational analysis; mechanical properties; structure
ID MORI SILK FIBROIN; PHYSICAL-PROPERTIES; CASTING TEMPERATURE;
   HEAT-TREATMENT; CONFORMATION; MORPHOLOGY; MEMBRANE
AB Insoluble fibroin films were prepared without methanol treatment. A 15 wt % fibroin solution was obtained through concentration, and then, the insoluble film was achieved by the adjustment of the drying temperature and rate. These films were examined through Fourier transform infrared-attenuated total reflection, X-ray diffraction, and scanning electron microscopy to determine the structure of the silk fibroin. The physical and mechanical properties were investigated to discover the feasibility of using these films as biomedical materials. When fibroin films were dried above 60 degrees C, abundant beta-sheet crystals existed in the fibroin films, and many globule-containing micelles aggregated and interacted with each other, which resulted in excellent mechanical properties of the regenerated fibroin films in the wet state. Interestingly, the amide III band of the random coil structure in the fibroin films dried at 70 and 80 degrees C was shifted to a lower frequency, 1228 cm(-1), which meant that a partly orientated structure formed. This may have also affected the mechanical properties of the fibroin films. The tensile strength and breaking elongation of the films dried at 70 degrees C were 29.8 MPa and 59.6%,, which is distinctly superior to fibroin films treated with methanol. If the drying temperature was raised to 60 degrees C, the stability of the films in water was also excellent. (c) 2005 Wiley Periodicals, Inc.
C1 Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Cao, CB (reprint author), Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
EM cbcao@bit.edu.cn
RI Cao, Chuanbao/J-5396-2013
OI Cao, Chuanbao/0000-0003-2830-4383
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   Freddi G, 1997, J POLYM SCI POL PHYS, V35, P841, DOI 10.1002/(SICI)1099-0488(19970415)35:5<841::AID-POLB13>3.0.CO;2-A
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kweon H, 2001, J APPL POLYM SCI, V81, P2271, DOI 10.1002/app.1667
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   MAGOSHI J, 1985, J POLYM SCI POL PHYS, V23, P227, DOI 10.1002/pol.1985.180230120
   MAGOSHI J, 1977, POLYMER, V18, P643, DOI 10.1016/0032-3861(77)90229-4
   MASUHIRO T, 1994, J POLYM SCI POL LETT, V32, P961
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Noishiki Y, 2002, J APPL POLYM SCI, V86, P3425, DOI 10.1002/app.11370
   NORIHIKO M, 1990, POLYMER, V31, P265
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P1745, DOI 10.1002/app.1990.070400928
NR 21
TC 28
Z9 29
U1 0
U2 29
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 15
PY 2005
VL 96
IS 6
BP 2168
EP 2173
DI 10.1002/app.21682
PG 6
WC Polymer Science
SC Polymer Science
GA 921PF
UT WOS:000228776100022
DA 2018-10-20
ER

PT J
AU Laroussi, M
AF Laroussi, M
TI Low temperature plasma-based sterilization: Overview and
   state-of-the-art
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE atmospheric pressure glow discharges (APGD); bacteria spores; cold
   plasma; non-thermal plasma; ozone; radicals; sterilization; UV-photon
ID ATMOSPHERIC-PRESSURE PLASMAS; GLOW-DISCHARGE PLASMA; DECONTAMINATION;
   INACTIVATION; BACTERIA; SURFACES; VOLUME; ROLES
AB Low temperature, high pressure, non-equilibrium plasmas are now routinely used in several material processing applications, and in some cases are competing with low pressure plasmas in areas where these have historically been dominant. Etching and deposition are examples of such applications. Amongst the novel applications of non-equilibrium plasmas, biomedical applications such as electrosurgery, surface modification of biocompatible materials, and the sterilization of heat-sensitive medical tools are particularly interesting. In this paper, first a brief overview of recent research on reduced-pressure plasma-based sterilization/ decontamination methods is given. Then a detailed review and discussion on the effects of atmospheric pressure non-equilibrium plasmas on the cells of bacteria is presented. This includes the evaluation of the inactivation kinetics and the roles of the various plasma agents in the inactivation process. Measurements of the plasma temperature, the UV emission, and concentrations of various reactive species for the case of air plasma are presented. Plasma sub-lethal effects are also briefly discussed, and the prospects of the use of "cold" plasmas in the biomedical field are outlined.
C1 Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA.
   Old Dominion Univ, Ctr Bioelect, Norfolk, VA 23529 USA.
RP Laroussi, M (reprint author), Old Dominion Univ, Dept Elect & Comp Engn, 231 Kaufman Hall, Norfolk, VA 23529 USA.
EM mlarouss@odu.edu
CR BETTLEHIM FA, 1995, INTRO GEN ORGANIC BI, P525
   BIRMINGHAM J, 2003, P EL C VER ENG INC S, P16
   BLAKELY EA, 2002, P IEEE INT C PLASM S, P253
   BLOCK SS, 1992, ENCY MICROBIOLOGY, V4, P87
   Bol'shakov AA, 2004, AIAA J, V42, P823, DOI 10.2514/1.9562
   ELIASSON B, 1991, IEEE T PLASMA SCI, V19, P1063, DOI 10.1109/27.125031
   Herrmann HW, 1999, PHYS PLASMAS, V6, P2284, DOI 10.1063/1.873480
   KANAZAWA S, 1988, J PHYS D APPL PHYS, V21, P838, DOI 10.1088/0022-3727/21/5/028
   Kelly-Wintenberg K, 1998, J IND MICROBIOL BIOT, V20, P69, DOI 10.1038/sj.jim.2900482
   Kogelschatz U, 2002, IEEE T PLASMA SCI, V30, P1400, DOI 10.1109/TPS.2002.804201
   KOINUMA H, 1992, APPL PHYS LETT, V60, P816, DOI 10.1063/1.106527
   Kunhardt EE, 2000, IEEE T PLASMA SCI, V28, P189, DOI 10.1109/27.842901
   Laroussi M, 1999, IEEE T PLASMA SCI, V27, P34, DOI 10.1109/27.763016
   Laroussi M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/341
   Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016
   Laroussi M, 2002, APPL PHYS LETT, V81, P772, DOI 10.1063/1.1494863
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P158, DOI 10.1109/TPS.2002.1003972
   Laroussi M, 2000, IEEE T PLASMA SCI, V28, P184, DOI 10.1109/27.842899
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220
   Laroussi M, 2004, P IEEE INT C PLASM S, P122
   MASSINES E, 1992, P INT C GAS DISCH TH, P730
   Mendis DA, 2000, IEEE T PLASMA SCI, V28, P1304, DOI 10.1109/27.893321
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   MOISAN M, 1991, J PHYS D APPL PHYS, V24, P1025, DOI 10.1088/0022-3727/24/7/001
   MOISAN M, 2003, 5 INT WORKSH MICR DI, P210
   Montie TC, 2000, IEEE T PLASMA SCI, V28, P41, DOI 10.1109/27.842860
   Moreau S, 2000, J APPL PHYS, V88, P1166, DOI 10.1063/1.373792
   NORMAN A, 1954, J CELL COMPAR PHYSL, V44, P1, DOI 10.1002/jcp.1030440102
   Philip N, 2002, IEEE T PLASMA SCI, V30, P1429, DOI 10.1109/TPS.2002.804203
   SANCHEZESTRADA FS, 2002, P IEEE INT C PLASM S, P254
   Schoenbach KH, 1996, APPL PHYS LETT, V68, P13, DOI 10.1063/1.116739
   Scutze A, 1998, IEEE T PLASMA SCI, V26, P1685
   Smulders EHWM, 1998, IEEE T PLASMA SCI, V26, P1476, DOI 10.1109/27.736042
   Stalder K. R., 2003, P GAS EL C SAN FRANC, P16
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304
   Stoffels E, 2002, HIGH TEMP MATER P-US, V6, P191
   Stoffels E, 2003, P GAS EL C SAN FRANC, P16
   YAMAMOTO M, 2001, P 15 INT S PLASM CHE, V2, P743
NR 38
TC 616
Z9 639
U1 14
U2 222
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD JUN 14
PY 2005
VL 2
IS 5
BP 391
EP 400
DI 10.1002/ppap.200400078
PG 10
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 943WK
UT WOS:000230385400003
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Varian unveils expandable MRI
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
AB Varian have launched a new magnetic resonance imaging system for biomedical and materials science applications.This new system initially offers up to four transmitter and eight receiver channels. The scanner was designed to improve the rate of implementation of magnetic resonance imaging experiments.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD JUN 13
PY 2005
VL 83
IS 24
BP 29
EP 29
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 936JE
UT WOS:000229850500049
DA 2018-10-20
ER

PT J
AU Bayari, S
   Severcan, F
AF Bayari, S
   Severcan, F
TI FTIR study of biodegradable biopolymers: P(3HB), P(3HB-co-4HB) and
   P(3HB-co-3HV)
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article; Proceedings Paper
CT 27th European Congress on Molecular Spectroscopy
CY SEP 05-10, 2004
CL AGH Univ Sci & Technol, Cracow, POLAND
SP AGH Univ Sci & Technol, Fac Mat Sci Ceram
HO AGH Univ Sci & Technol
DE poly(3-hydroxybutyrate); poly(3-hydroxybutyrate-co-3-hydroxyvalerate);
   poly(3-hydroxybutyrate-co-4-hydroxybutyrate); FTIR; crystallinity
ID TRANSFORM INFRARED-SPECTROSCOPY; ENZYMATIC DEGRADATION;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); POLYHYDROXYALKANOATES;
   BACTERIAL; POLYESTERS; PLASMA; FILM
AB Biodegradable materials have various important applications in the biomedical field. Poly(hydroxyalkanoate)s are a family of microbially synthesized polymers and known to degrade in vitro and vivo, as well as in microorganism. The structure, crystallization and melting of three types of poly(hyroxyalkanoate)s namely poly(3-hydroxybutyrate) homopolymer, P(3HB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymer, P(3HB-co-3HV, and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) copolymer, P(3HB-co-4HB) were investigated using Fourier transform infrared (FTIR) spectroscopy. P(3HB-co-3HV) and P(3HB-co-4HB) were studied in the presence of different molar ratio of 3HV and 4HB, respectively. The FTIR spectra of samples in solution and as cast film were compared at room temperature, in the region of 4000-400 cm(-1) which showed significant differences between the two phases. Furthermore, the temperature dependent variations of these polymers were also studied between 25 and 200 degrees C. The heating and cooling FTIR experiments of the samples showed that P(3HB-co-3HV) and P(3HB-co-4HB) are reversible while P(3HB) is irreversible. The absorbance variances of the crystalline and the amorphous bands revealed that the structure, crystallinity and thermal behavior of, P(3HB), P(3HB-co-4HB) and P(3HB-co-3HV) are different from each other. This study also allowed us the identification of the bands which are sensitive to crystallinity. For example, the bands at 1185, 1278 and 1724 cm(-1) were found to be sensitive to crystallinity. In the present study, P(3HB) and P(3HB-co-3HV) samples which were modified by applying oxygen plasma to create hydrophilic surfaces were also analyzed. The shifting in the frequency of some infrared bands (i.e. C-O and C-O-C) and the appearance of some bands may indicate some modification on the structure of the polymers. (c) 2005 Elsevier B.V. All rights reserved.
C1 Hacettepe Univ, Fac Educ, Dept Phys, TR-06532 Ankara, Turkey.
   Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey.
RP Bayari, S (reprint author), Hacettepe Univ, Fac Educ, Dept Phys, TR-06532 Ankara, Turkey.
EM bayari@hacettepe.edu.tr
RI Bayari, Sevgi/N-9506-2018
OI Severcan, Feride/0000-0002-1717-2517
CR BARHAM PJ, 1986, J POLYM SCI POL PHYS, V24, P69, DOI 10.1002/polb.1986.180240108
   BLOEMBERGEN S, 1986, MACROMOLECULES, V19, P2865, DOI 10.1021/ma00165a034
   Fei B, 2003, EUR POLYM J, V39, P1939, DOI 10.1016/S0014-3057(03)00114-9
   KAMIYA N, 1991, MACROMOLECULES, V24, P2178, DOI 10.1021/ma00009a006
   KAMIYA N, 1990, MACROMOLECULES, V23, P1313, DOI 10.1021/ma00207a015
   KUNIOKA M, 1990, MACROMOLECULES, V23, P1933, DOI 10.1021/ma00209a009
   KUNIOKA M, 1989, MACROMOLECULES, V22, P694, DOI 10.1021/ma00192a031
   Lara L.M., 1991, MICROBIOL MOL BIOL R, V63, P21
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Mas A, 1996, MACROMOL CHEM PHYS, V197, P2331, DOI 10.1002/macp.1996.021970723
   NAKAMURA K, 1994, POLYMER, V35, P193, DOI 10.1016/0032-3861(94)90071-X
   Randriamahefa S, 2003, BIOMACROMOLECULES, V4, P1092, DOI 10.1021/bm034104o
   Ryou JH, 2003, MACROMOL BIOSCI, V3, P44, DOI 10.1002/mabi.200390004
   Spyros A, 1996, MACROMOLECULES, V29, P2479, DOI 10.1021/ma951549z
   Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Tian G, 2002, J POLYM SCI POL PHYS, V40, P649, DOI 10.1002/polb.10126
   Wu Q, 2001, J APPL POLYM SCI, V82, P934, DOI 10.1002/app.1925.abs
   Xu J, 2002, POLYMER, V43, P6893, DOI 10.1016/S0032-3861(02)00615-8
   Yoshie N, 2002, BIOMACROMOLECULES, V3, P1320, DOI 10.1021/bm020077a
   Yoshie N, 1999, MACROMOL CHEM PHYSIC, V200, P977, DOI 10.1002/(SICI)1521-3935(19990501)200:5<977::AID-MACP977>3.0.CO;2-Y
   1998, NATO SCI STABILITY P
NR 22
TC 34
Z9 34
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
EI 1872-8014
J9 J MOL STRUCT
JI J. Mol. Struct.
PD JUN 3
PY 2005
VL 744
SI SI
BP 529
EP 534
DI 10.1016/j.molstruc.2004.12.029
PG 6
WC Chemistry, Physical
SC Chemistry
GA 933UF
UT WOS:000229657700071
DA 2018-10-20
ER

PT J
AU Marvin, JS
   Zhu, ZP
AF Marvin, JS
   Zhu, ZP
TI Recombinant approaches to IgG-like bispecific antibodies
SO ACTA PHARMACOLOGICA SINICA
LA English
DT Review
DE bispecific antibodies; single chain Fv; diabody; immunoglobulin G;
   biomedical engineering
ID SINGLE-DOMAIN ANTIBODIES; METASTATIC BREAST-CANCER; GROWTH-FACTOR
   RECEPTOR; NON-HODGKINS-LYMPHOMA; MONOCLONAL-ANTIBODY; ANTIGEN-BINDING;
   IN-VITRO; EFFICIENT ROUTE; DIABODIES; FRAGMENTS
AB One of the major obstacles in the development of bispecific antibodies (BsAb) has been the difficulty of producing the materials in sufficient quality and quantity by traditional technologies, such as the hybrid hybridoma and chemical conjugation methods. In contrast to the rapid and significant progress in the development of recombinant BsAb fragments (such as diabody and tandem single chain Fv), the successful design and production of full length IgG-like BsAb has been limited. Compared to smaller fragments, IgG-like BsAb have long serum half-life and are capable of supporting secondary immune functions, such as antibody-dependent cellular cytotoxicity and complement-mediated cytotoxicity. The development of IgG-like BsAb as therapeutic agents will depend heavily on our research progress in the design of recombinant BsAb constructs (or formats) and production efficiency. This review will focus on recent advances in various recombinant approaches to the engineering and production of IgG-like BsAb.
C1 ImClone Syst Inc, Dept Antibody Technol, New York, NY 10014 USA.
RP Zhu, ZP (reprint author), ImClone Syst Inc, Dept Antibody Technol, New York, NY 10014 USA.
EM zhenping.zhu@imclone.com
OI Marvin, Jonathan/0000-0003-2294-4515
CR Alt M, 1999, FEBS LETT, V454, P90, DOI 10.1016/S0014-5793(99)00782-6
   Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116
   Baeuerle PA, 2003, CURR OPIN MOL THER, V5, P413
   BRENNAN M, 1985, SCIENCE, V229, P81, DOI 10.1126/science.3925553
   Cao Y, 2003, ADV DRUG DELIVER REV, V55, P171, DOI 10.1016/S0169-409X(02)00178-3
   Carter P, 1995, J Hematother, V4, P463, DOI 10.1089/scd.1.1995.4.463
   Chang CH, 2002, MOL CANCER THER, V1, P553
   Clynes RA, 2000, NAT MED, V6, P443
   Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639
   Colby DW, 2004, METHOD ENZYMOL, V388, P348
   COLCHER D, 1990, JNCI-J NATL CANCER I, V82, P1191, DOI 10.1093/jnci/82.14.1191
   Coloma MJ, 1997, J IMMUNOL, V158, P733
   Conrath KE, 2001, J BIOL CHEM, V276, P7346
   Corvalan J R, 1988, Int J Cancer Suppl, V2, P22
   DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001
   EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099
   Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381
   Ferrini S, 2001, METH MOL B, V166, P177
   FitzGerald K, 1997, PROTEIN ENG, V10, P1221, DOI 10.1093/protein/10.10.1221
   Ford CHJ, 2001, INT J CANCER, V92, P851, DOI 10.1002/ijc.1262
   Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2
   HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444
   Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000
   James ND, 2001, BRIT J CANCER, V85, P152, DOI 10.1054/bjoc.2001.1878
   JUNG SH, 1994, PROTEINS, V19, P35, DOI 10.1002/prot.340190106
   Kipriyanov Sergey M, 2002, Methods Mol Biol, V178, P317
   Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156
   Kipriyanov SM, 2002, J IMMUNOL, V169, P137, DOI 10.4049/jimmunol.169.1.137
   KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L
   Kontermann RE, 2005, ACTA PHARMACOL SIN, V26, P1, DOI 10.1111/j.1745-7254.2005.00008.x
   LI S, 2005, IN PRESS CANC CELL
   Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008
   Lu D, 2004, J BIOL CHEM, V279, P2856, DOI 10.1074/jbc.M310132200
   Lu D, 1999, J IMMUNOL METHODS, V230, P159, DOI 10.1016/S0022-1759(99)00135-0
   Lu D, 2003, J IMMUNOL METHODS, V279, P219, DOI 10.1016/S0022-1759(03)00251-5
   Lu D, 2002, J IMMUNOL METHODS, V267, P213, DOI 10.1016/S0022-1759(02)00148-5
   Lu D, 2001, CANCER RES, V61, P7002
   LU D, 2005, IN PRESS J BIOL 0309
   Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597
   McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825
   Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677
   Miller K, 2003, J IMMUNOL, V170, P4854, DOI 10.4049/jimmunol.170.9.4854
   MILSTEIN C, 1983, NATURE, V305, P537, DOI 10.1038/305537a0
   MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129
   Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899
   Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617
   Riechmann L, 1999, J IMMUNOL METHODS, V231, P25, DOI 10.1016/S0022-1759(99)00138-6
   SIDHUA SS, 2005, PHAGE DISPLAY BIOTEC
   Silverman DH, 2004, CANCER TREAT REV, V30, P165, DOI 10.1016/j.ctrv.2003.07.006
   Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101
   Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2
   Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265
   Xie ZG, 2005, J IMMUNOL METHODS, V296, P95, DOI 10.1016/j.jim.2004.11.005
   Xiong DS, 2002, CANCER LETT, V177, P29, DOI 10.1016/S0304-3835(01)00758-3
   Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x
   Zhu ZP, 1997, PROTEIN SCI, V6, P781
   Zhu ZP, 1996, BIO-TECHNOL, V14, P192, DOI 10.1038/nbt0296-192
   Zuo Z, 2000, PROTEIN ENG, V13, P361, DOI 10.1093/protein/13.5.361
NR 58
TC 68
Z9 69
U1 0
U2 17
PU ACTA PHARMACOLOGICA SINICA
PI SHANGHAI
PA 294 TAI-YUAN RD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1671-4083
EI 1745-7254
J9 ACTA PHARMACOL SIN
JI Acta Pharmacol. Sin.
PD JUN
PY 2005
VL 26
IS 6
BP 649
EP 658
DI 10.1111/j.1745-7254.2005.00119.x
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 937IL
UT WOS:000229917700002
PM 15916729
OA Bronze
DA 2018-10-20
ER

PT J
AU Delen, D
   Walker, G
   Kadam, A
AF Delen, D
   Walker, G
   Kadam, A
TI Predicting breast cancer survivability: a comparison of three data
   mining methods
SO ARTIFICIAL INTELLIGENCE IN MEDICINE
LA English
DT Article
DE breast cancer survivability; data mining; k-fold-cross-validation; SEER
ID ARTIFICIAL NEURAL-NETWORKS; PROGNOSIS; PROGRAM; TREES
AB Objective: The prediction of breast cancer survivability has been a challenging research problem for many researchers. Since the early dates of the related research, much advancement has been recorded in several related fields. For instance, thanks to innovative biomedical technologies, better explanatory prognostic factors are being measured and recorded; thanks to Low cost computer hardware and software technologies, high volume better quality data is being collected and stored automatically; and finally thanks to better analytical methods, those voluminous data is being processed effectively and efficiently. Therefore, the main objective of this manuscript is to report on a research project where we took advantage of those available technological advancements to develop prediction models for breast cancer survivability.
   Methods and material: We used two popular data mining algorithms (artificial neural networks and decision trees) along with a most commonly used statistical method (Logistic regression) to develop the prediction models using a Large dataset (more than 200,000 cases). We also used 10-fold cross-validation methods to measure the unbiased estimate of the three prediction models for performance comparison purposes.
   Results: The results indicated that the decision tree (C5) is the best predictor with 93.6% accuracy on the holdout sample (this prediction accuracy is better than any reported in the literature), artificial neural networks came out to be the second with 91.2% accuracy and the logistic regression models came out to be the worst of the three with 89.2% accuracy.
   Conclusion: The comparative study of multiple prediction models for breast cancer survivability using a large dataset along with a 10-fold cross-validation provided us with an insight into the relative prediction ability of different data mining methods. Using sensitivity analysis on neural network models provided us with the prioritized importance of the prognostic factors used in the study. &COPY; 2004 Elsevier B.V. All rights reserved.
C1 Oklahoma State Univ, Dept Management Sci & Informat Syst, Tulsa, OK 74106 USA.
RP Delen, D (reprint author), Oklahoma State Univ, Dept Management Sci & Informat Syst, 700 N Greenwood Venue, Tulsa, OK 74106 USA.
EM delen@okstate.edu
CR Abbass HA, 2002, ARTIF INTELL MED, V25, P265, DOI 10.1016/S0933-3657(02)00028-3
   Abu-Hanna A, 2003, ARTIF INTELL MED, V29, P5, DOI 10.1016/S0933-3657(03)00047-2
   Berman JJ, 2002, ARTIF INTELL MED, V26, P25, DOI 10.1016/S0933-3657(02)00050-7
   Bostwick DG, 2001, CANCER, V91, P1643, DOI 10.1002/1097-0142(20010415)91:8+<1643::AID-CNCR1177>3.0.CO;2-I
   BREIMAN L, 1984, CLASSIFICATION REGRE
   Brenner H, 2002, EUR J CANCER, V38, P690, DOI 10.1016/S0959-8049(02)00003-5
   Bundred NJ, 2001, CANCER TREAT REV, V27, P137, DOI 10.1053/ctrv.2001.0207
   Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO;2-Y
   Burke HB, 1995, ADV NEURAL INFORMATI, P1063
   Calle J., 2004, BREAST CANC FACTS FI, P1
   Cios KJ, 2002, ARTIF INTELL MED, V26, P1, DOI 10.1016/S0933-3657(02)00049-0
   COX DR, 1984, ANAL SURVIVAL DATA
   D'Eredita G, 2001, EUR J CANCER, V37, P591, DOI 10.1016/S0959-8049(00)00435-4
   Edwards BK, 2002, CANCER, V94, P2766, DOI 10.1002/cncr.10593
   Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117
   Hastie T., 2001, ELEMENTS STAT LEARNI
   Hornik K., 1990, NEURAL NETWORKS, V3, P359
   HYAKIN S, 1998, NEURAL NETWORKS COMP
   Jerez-Aragones JM, 2003, ARTIF INTELL MED, V27, P45, DOI 10.1016/S0933-3657(02)00086-6
   Jimenez-Lee R, 2003, AM J SURG, V186, P404, DOI 10.1016/S0002-9610(03)00283-6
   Kohavi R., 1995, 14 INT JOINT C ART I, P1137
   Lavrac N, 1999, ARTIF INTELL MED, V16, P3, DOI 10.1016/S0933-3657(98)00062-1
   Lundin M, 1999, ONCOLOGY-BASEL, V57, P281, DOI 10.1159/000012061
   *NCI SURV RES PROG, 1973, SEER CANC STAT REV S
   Ohno-Machado L, 2001, J BIOMED INFORM, V34, P428, DOI 10.1006/jbin.2002.1038
   OMALLEY CD, 2003, SOCIOECONOMIC STATUS, P1303
   Pendharkar PC, 1999, EXPERT SYST APPL, V17, P223, DOI 10.1016/S0957-4174(99)00036-6
   Principe J. C., 2000, NEURAL ADAPTIVE SYST
   Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1023/A:1022643204877
   Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN
   Rampaul RS, 2001, EUR J SURG ONCOL, V27, P229, DOI 10.1053/ejso.2001.1114
   Richards G, 2001, ARTIF INTELL MED, V22, P215, DOI 10.1016/S0933-3657(00)00110-X
   RITTER M, 2003, TULSA WORLD     0616, pD8
   ROSS E, 2003, ASS PRESS
   Santos-Garcia G, 2004, ARTIF INTELL MED, V30, P61, DOI 10.1016/S0933-3657(03)00059-9
   SHEARER C, 2000, J DATA WAREHOUSING, V5, P13
   Warren J, 2003, WEBMD MED NEWS
   BREAST CANC Q A FACT
NR 38
TC 363
Z9 372
U1 10
U2 90
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0933-3657
J9 ARTIF INTELL MED
JI Artif. Intell. Med.
PD JUN
PY 2005
VL 34
IS 2
BP 113
EP 127
DI 10.1016/j.artmed.2004.07.002
PG 15
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA 932NA
UT WOS:000229559200002
PM 15894176
DA 2018-10-20
ER

PT J
AU Yoo, HJ
   Kim, HD
AF Yoo, HJ
   Kim, HD
TI Characteristics of crosslinked blends of Pellethene((R)) and multiblock
   polyurethanes containing phospholipid
SO BIOMATERIALS
LA English
DT Article
DE polyurethane; phospholipid; biomaterials; platelet adhesion
ID PLATELET-ADHESION; SEGMENTED POLYURETHANE; GLYCOL) METHACRYLATE;
   POLY(ETHYLENE OXIDE); SURFACE MODIFICATION; BLOOD COMPATIBILITY; PROTEIN
   ADSORPTION; BACTERIAL ADHESION; POLYMER; PHOSPHORYLCHOLINE
AB A series of segmented multiblock polyurethanes (MPUs) were synthesized by polyaddition reaction using hexamethylene diisocyanate (HDI)/poly(ethylene oxide) (PEO, as a hydrophilic component)/ poly(tetramethylene oxide) (PTMO)/ poly(butadiene diol)(PBD)/1,4-butanediol(BD)/{2-[bis(2-hydroxyethyl) methyl ammonio]ethyl stearyl phosphate) [BESP, as a phospholipids component: 0-42mol% (0-9wt%)]. To improve the blood compatibility of biomedical grade polyurethane (Pelletheneg), the Pellethenee was blended with MPUs and then crosslinked using dicumyl peroxide as a crosslinking agent. Effects of BESP content [0-42mol% (0-9wt%)] in MPUs on the properties of MPUs and blend (Pellethene(g)/MPUs) films were investigated. The X-ray photoelectron spectra indicated that the BESP moieties were located at the surface of the crosslinked blend (Pellethene(R)/MPUS) films. As the BESP content in MPUs increased, the water contact angle on the surfaces of corsslinked blend film was decreased but the water absorption and mechanical properties were markedly increased. By the test of platelet adhesion on the surfaces of corsslinked blend film, it was found that the platelet adhesion on the surface was significantly decreased from 70% to 6% by increasing BESP content from 0 to 42 mol% (0-9 wt%) in MPUs. These results suggest that crosslinked blend films may have more potential as a new material for biomedical applications, which are directly in contact with blood. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Pusan Natl Univ, Dept Text Engn, Coll Engn, Pusan 609735, South Korea.
RP Kim, HD (reprint author), Pusan Natl Univ, Dept Text Engn, Coll Engn, 30 Changjeon Dong, Pusan 609735, South Korea.
EM kimhd@pusan.ac.kr
CR Abraham GA, 2002, BIOMATERIALS, V23, P1625, DOI 10.1016/S0142-9612(01)00289-7
   BAILEY FE, 1976, POLYETHYLENE OXIDE, P20
   BOATS JGF, 1987, BR POLYM J, V19, P527
   BOATS JGF, 1986, BIOMATERIALS, V7, P393
   BRINKMAN E, 1989, INT J ARTIF ORGANS, V12, P390
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   EDMUNDSON RS, 1962, CHEM IND-LONDON, V20, P828
   Flemming RG, 1999, J BIOMAT SCI-POLYM E, V10, P679, DOI 10.1163/156856299X00874
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   Ho SP, 2003, BIOMATERIALS, V24, P5121, DOI 10.1016/S0142-9612(03)00450-2
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   KOREMATSU A, 1999, J MATER RES, V14, P378
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee JH, 1997, POLYM-KOREA, V21, P332
   LELAH MD, 1986, POLYURETHANES MED, P57
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   LI YJ, 1995, MACROMOL CHEM PHYS, V196, P143
   LOGEARTAVRAMOGLOU, 1999, J BIOMED MATER RES, V48, P578
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Qiu YX, 1996, J APPL POLYM SCI, V61, P2373, DOI 10.1002/(SICI)1097-4628(19960926)61:13<2373::AID-APP17>3.0.CO;2-5
   Strel'tsov A. I., 1989, Izvestiya Vysshikh Uchebnykh Zavedenii, Energetika, P100
   Uyama Y, 1998, ADV POLYM SCI, V137, P3
   Yoo HJ, 2004, J APPL POLYM SCI, V91, P2348, DOI 10.1002/app.13377
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
NR 27
TC 15
Z9 17
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 2877
EP 2886
DI 10.1016/j.biomaterials.2004.09.001
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500010
PM 15603783
DA 2018-10-20
ER

PT J
AU Genove, E
   Shen, C
   Zhang, SG
   Semino, CE
AF Genove, E
   Shen, C
   Zhang, SG
   Semino, CE
TI The effect of functionalized self-assembling peptide scaffolds on human
   aortic endothelial cell function
SO BIOMATERIALS
LA English
DT Article
DE self-assembly; biomimetic material; cell proliferation; extracellular
   matrix; endotheliar monolayer
ID CAPILLARY-LIKE STRUCTURES; LAMININ GAMMA-1 CHAIN; BASEMENT-MEMBRANE; IV
   COLLAGEN; COMPLEMENTARY OLIGOPEPTIDE; ADHESION PEPTIDES; IDENTIFICATION;
   BINDING; DIFFERENTIATION; MATRICES
AB A class of designed self-assembling peptide nanofiber scaffolds with more than 99% water content has been shown to be a good biological material for cell culture. Here, we report the functionalization of one of these peptide scaffolds, RAD16-I (AcN-RADARADARADARADA-CONH2) by direct solid phase synthesis extension at the amino terminal with three short-sequence motifs. These motifs are present in two major protein components of the basement membrane, laminin I (YIGSR, RYVVLPR) and collagen IV (TAGSCLRKFSTM). These motifs have been previously shown to promote specific biological activities including endothelial cell adhesion, spreading, and tubular formation. Therefore, the generic functionalized peptide developed was AcN-X-GG-RADARADARADARADA-CONH2 with each motif represented by "X". We show in this work that these tailor-made peptide scaffolds enhance the formation of confluent cell monolayers of human aortic endothelial cells (HAEC) in culture. Moreover, additional assays designed to evaluate endothelial cell function showed that HAEC monolayers obtained on these scaffolds not only maintained LDL uptake activity but also enhanced nitric oxide release and elevated laminin 1 and collagen IV deposition. These results suggest that this new scaffold provide a better physiological substrate for endothelial cell culture and suggest its further application for biomedical research, cancer biology and regenerative biology. (C) 2004 Elsevier Ltd. All rights reserved.
C1 MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   Harvard Univ, Cambridge, MA 02138 USA.
   MIT, Ctr Biotechnol Proc Engn, Cambridge, MA 02139 USA.
RP Semino, CE (reprint author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM shuguang@mit.edu; semino@mit.edu
CR Ardini E, 2002, CANCER RES, V62, P1321
   BECK K, 1990, FASEB J, V4, P148
   Bell SE, 2001, J CELL SCI, V114, P2755
   Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   CHARONIS AS, 1985, J CELL BIOL, V100, P1848, DOI 10.1083/jcb.100.6.1848
   Davis GE, 2000, IN VITRO CELL DEV-AN, V36, P513
   Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159
   ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001
   FERENCZY A, 1979, AM J OBSTET GYNECOL, V133, P859, DOI 10.1016/0002-9378(79)90302-8
   Gloe T, 1999, J BIOL CHEM, V274, P15996, DOI 10.1074/jbc.274.23.15996
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   IWAMOTO Y, 1987, SCIENCE, V238, P1132, DOI 10.1126/science.2961059
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KLEINMAN HK, 1989, ARCH BIOCHEM BIOPHYS, V272, P39, DOI 10.1016/0003-9861(89)90192-6
   KOLIAKOS GG, 1989, J BIOL CHEM, V264, P2313
   KREIS T, 1999, GUIDEBOOK EXTRACELLU
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   Malinda KM, 1999, FASEB J, V13, P53
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x
   Ponce ML, 1999, CIRC RES, V84, P688, DOI 10.1161/01.RES.84.6.688
   Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x
   Reed MJ, 1996, CURR TOP MICROBIOL, V213, P81
   Sagnella SM, 2004, BIOMATERIALS, V25, P1249, DOI 10.1016/S0142-9612(03)00634-3
   SAKAMOTO N, 1991, CANCER RES, V51, P903
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   SILVA GA, 2004, SCI EXPRESS
   SKUBITZ APN, 1990, CANCER RES, V50, P7612
   TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583
   YURCHENCO PD, 1994, METHOD ENZYMOL, V245, P489
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 41
TC 211
Z9 225
U1 3
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 3341
EP 3351
DI 10.1016/j.biomaterials.2004.08.012
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500057
PM 15603830
DA 2018-10-20
ER

PT J
AU Kim, HK
   Kim, K
   Byun, Y
AF Kim, HK
   Kim, K
   Byun, Y
TI Preparation of a chemically anchored phospholipid monolayer on an
   acrylated polymer substrate
SO BIOMATERIALS
LA English
DT Article
DE phospholipid monolayer; in situ photopolymerization; acrylated polymer
   substrate; blood compatibility
ID LANGMUIR-BLODGETT MONOLAYER; IN-SITU PHOTOPOLYMERIZATION; CYTOMIMETIC
   BIOMATERIALS; TERMINATED SUBSTRATE; BLOOD COMPATIBILITY;
   PROTEIN-ADSORPTION; ALKYLATED SURFACE; MEMBRANES; BILAYER; BLEND
AB This paper describes a strategy for designing a chemically anchored phospholipid monolayer that could be used as coating materials for biomedical implants. To make a chemically anchored phospholipid monolayer on the polymer substrate, we prepared the mono-acrylated phospholipid (1-palmitoyl-2-[12-(acryloyloxy)-dodecanoyl]-sn-glycero-3-phosphocholine; acryloyl-PC) and the acrylated polymer (poly(octadecylacrylate-co-4-acryloyloxy butylacrylate)), which was synthesized by the acrylation of poly(octadecyl acrylate-co-hydroxybutyl acrylate, poly(OA-co-HA)) with acryloyl chloride. The chemically anchored phospholipid monolayer was prepared by using in situ photopolymerization of a pre-assembled phospholipid monolayer, produced by lipid vesicle fusion, onto the acrylated polymer coated silicon wafer. Optimal condition of vesicle fusion and irradiation time was determined from the degree of hydrophilicity rendered by the polymerized phospholipid surface. The physicochemical properties of polymerized phospholipid monolayer on the substrate were evaluated using water contact angle, field-emission scanning electron micrograph (FE-SEM), atomic force microscopy (AFM) and X-ray photoelectron spectroscopy (XPS). These results confirmed that the polymerized phospholipid monolayer was chemically anchored on the acrylated polymer substrate. The chemically anchored phospholipid monolayer was stable in aqueous condition for 2 weeks, but the physically adsorbed phospholipid monolayer got removed within I day. Moreover, the polymerized phospholipid monolayer also suppressed albumin absorption and platelet adhesion, in vitro. This polymerized phospholipid monolayer provides a new biomimetic system for coating medical devises. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Gwangju Inst Sci & Technol, Ctr Cell & Macromol Therapy, Dept Mat Sci & Engn, Kwangju 500712, South Korea.
RP Byun, Y (reprint author), Gwangju Inst Sci & Technol, Ctr Cell & Macromol Therapy, Dept Mat Sci & Engn, 1 Oryong Dong, Kwangju 500712, South Korea.
EM yrbyun@gist.ac.kr
RI BYUN, YOUNG RO/D-5735-2013
CR CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   Hasegawa T, 2001, BIOMATERIALS, V22, P243, DOI 10.1016/S0142-9612(00)00180-0
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HENCH LL, 1980, J BIOMED MATER RES, V14, P803, DOI 10.1002/jbm.820140611
   Iwasaki Y, 2002, BIOMATERIALS, V23, P3897, DOI 10.1016/S0142-9612(02)00135-7
   Kim K, 2003, J BIOMAT SCI-POLYM E, V14, P887, DOI 10.1163/156856203322381393
   Kim K, 2004, LANGMUIR, V20, P5396, DOI 10.1021/la049959g
   Kim K, 2001, LANGMUIR, V17, P5066, DOI 10.1021/la0102096
   Kim K, 2000, J BIOMED MATER RES, V52, P836, DOI 10.1002/1097-4636(20001215)52:4<836::AID-JBM30>3.3.CO;2-W
   KIM K, 2004, BIOMATERIALS, V25, P233
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lewis AL, 2001, BIOMATERIALS, V22, P99, DOI 10.1016/S0142-9612(00)00083-1
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   PLANT AL, 1994, BIOPHYS J, V67, P1126, DOI 10.1016/S0006-3495(94)80579-X
   Ross EE, 2001, LANGMUIR, V17, P2305, DOI 10.1021/la010752
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   SPINKE J, 1992, BIOPHYS J, V63, P1667, DOI 10.1016/S0006-3495(92)81742-3
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
NR 22
TC 21
Z9 21
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3435
EP 3444
DI 10.1016/j.biomaterials.2004.09.066
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200007
PM 15621232
DA 2018-10-20
ER

PT J
AU Gupta, AK
   Gupta, M
AF Gupta, AK
   Gupta, M
TI Synthesis and surface engineering of iron oxide nanoparticles for
   biomedical applications
SO BIOMATERIALS
LA English
DT Review
DE magnetic nanoparticles; MRI; drug delivery; surface modification;
   hyperthermia; cell labelling; iron oxide
ID MODIFIED SUPERPARAMAGNETIC NANOPARTICLES; PHYSIOLOGICAL PHARMACOKINETIC
   MODEL; MAGNETIC ALBUMIN MICROSPHERES; TRANSFERRIN RECEPTOR GENE;
   SELF-ASSEMBLED MONOLAYERS; TARGETED DRUG-DELIVERY;
   FINE-PARTICLE-SYSTEMS; IN-VIVO TRACKING; POLY(ETHYLENE GLYCOL); CONTRAST
   AGENTS
AB Superparamagnetic iron oxide nanoparticles (SPION) with appropriate surface chemistry have been widely used experimentally for numerous in vivo applications such as magnetic resonance imaging contrast enhancement, tissue repair, immunoassay, detoxification of biological fluids, hyperthermia, drug delivery and in cell separation, etc. All these biomedical and bioengineering applications require that these nanoparticles have high magnetization values and size smaller than 100 nm with overall narrow particle size distribution, so that the particles have uniform physical and chemical properties. In addition, these applications need special surface coating of the magnetic particles, which has to be not only non-toxic and biocompatible but also allow a targetable delivery with particle localization in a specific area. To this end, most work in this field has been done in improving the biocompatibility of the materials, but only a few scientific investigations and developments have been carried out in improving the quality of magnetic particles, their size distribution, their shape and surface in addition to characterizing them to get a protocol for the quality control of these particles. Nature of surface coatings and their subsequent geometric arrangement on the nanoparticles determine not only the overall size of the colloid but also play a significant role in biokinetics and biodistribution of nanoparticles in the body. The types of specific coating, or derivatization, for these nanoparticles depend on the end application and should be chosen by keeping a particular application in mind, whether it be aimed at inflammation response or anti-cancer agents. Magnetic nanoparticles can bind to drugs, proteins, enzymes, antibodies, or nucleotides and can be directed to an organ, tissue, or tumour using an external magnetic field or can be heated in alternating magnetic fields for use in hyperthermia. This review discusses the synthetic chemistry, fluid stabilization and surface modification of superpararnagnetic iron oxide nanoparticles, as well as their use for above biomedical applications. (C) 2004 Elsevier Ltd. All rights reserved.
C1 So Gen Hosp, Crusade Labs Ltd, Glasgow G51 4TF, Lanark, Scotland.
   Univ Glasgow, Div Biochem & Mol Biol, IBLS, Glasgow G12 8QQ, Lanark, Scotland.
RP Gupta, AK (reprint author), So Gen Hosp, Crusade Labs Ltd, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.
EM akgupta25@hotmail.com
RI sadeghi, meisam/K-2389-2018
OI sadeghi, meisam/0000-0002-8448-0149
CR Akiyoshi K., 1996, SUPRAMOL SCI, V3, P157
   Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215
   Babes L, 1999, J COLLOID INTERF SCI, V212, P474, DOI 10.1006/jcis.1998.6053
   Babincova M, 2001, Z NATURFORSCH C, V56, P909
   Bagwe RP, 2001, CRIT REV THER DRUG, V18, P77
   BAILEY RL, 1983, J MAGN MAGN MATER, V39, P178, DOI 10.1016/0304-8853(83)90428-6
   Baker ME, 1998, FEBS LETT, V439, P9, DOI 10.1016/S0014-5793(98)01346-5
   Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751
   BEAN CP, 1959, J APPL PHYS, V30, P1976, DOI 10.1063/1.1735100
   Berry CC, 2004, INT J PHARM, V269, P211, DOI 10.1016/j.ijpharm.2003.09.042
   Berry CC, 2003, BIOMATERIALS, V24, P4551, DOI 10.1016/S0142-9612(03)00237-0
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   Bhadriraju K, 2000, BIOMATERIALS, V21, P267, DOI 10.1016/S0142-9612(99)00175-1
   BHANDARKAR S, 1990, J COLLOID INTERF SCI, V139, P541, DOI 10.1016/0021-9797(90)90127-A
   Bhorade R, 2000, BIOCONJUGATE CHEM, V11, P301, DOI 10.1021/bc990168d
   BILBAO G, 1998, TARGETED ADENOVIRAL, P365
   Binh VT, 1998, APPL SURF SCI, V130, P803, DOI 10.1016/S0169-4332(98)00158-5
   BOISTELLE R, 1988, J CRYST GROWTH, V90, P14, DOI 10.1016/0022-0248(88)90294-1
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   BOYLE MDP, 1985, J IMMUNOL, V134, P564
   BRADBURY A, 1984, IEEE T MAGN, V20, P1846, DOI 10.1109/TMAG.1984.1063338
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256
   Burugapalli K, 2004, J BIOMED MATER RES A, V68A, P210, DOI 10.1002/jbm.a.10117
   Capek I, 2001, ADV COLLOID INTERFAC, V92, P195, DOI 10.1016/S0001-8686(00)00072-5
   Carpenter EE, 2001, J MAGN MAGN MATER, V225, P17, DOI 10.1016/S0304-8853(00)01222-1
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   CHARLES SW, 1980, IEEE T MAGN, V16, P172, DOI 10.1109/TMAG.1980.1060584
   CHARLES SW, 1992, N-HOLLAND D, P267
   Chatterjee J, 2003, J MAGN MAGN MATER, V257, P113, DOI 10.1016/S0304-8853(02)01066-1
   Chatterjee J, 2001, J MAGN MAGN MATER, V225, P21, DOI 10.1016/S0304-8853(00)01223-3
   Chemseddine A, 1999, EUR J INORG CHEM, P235, DOI 10.1002/(SICI)1099-0682(19990202)1999:2<235::AID-EJIC235>3.0.CO;2-N
   CHEN C, 1986, MAGNETISM METALLURGY
   CHEN GH, 1993, BIOCONJUGATE CHEM, V4, P509, DOI 10.1021/bc00024a013
   Chen M, 2003, J APPL PHYS, V93, P7551, DOI 10.1063/1.1555312
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   CHOI SW, 2003, J DISPERSION SCI TEC, V24, P2003
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   COEY JMD, 1971, PHYS REV LETT, V27, P1140, DOI 10.1103/PhysRevLett.27.1140
   Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245
   Cornelis K, 1977, MANUAL MINERALOGY
   Cornell R. M., 1991, IRON OXIDES LAB PREP
   COTTER TG, 1995, TRENDS BIOTECHNOL, V13, P150, DOI 10.1016/S0167-7799(00)88926-X
   Cotton F.A., 1988, ADV INORGANIC CHEM
   CREPON B, 1991, BIOMATERIALS, V12, P550, DOI 10.1016/0142-9612(91)90049-G
   CUATRECASAS P, 1983, RECEPTOR MEDIATED EN
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   D'Souza AJM, 2004, J CONTROL RELEASE, V94, P91, DOI 10.1016/j.jconrel.2003.09.014
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Deng Y, 2003, J MAGN MAGN MATER, V257, P69, DOI 10.1016/S0304-8853(02)00987-3
   Denizot B, 1999, J COLLOID INTERF SCI, V209, P66, DOI 10.1006/jcis.1998.5850
   Dormann JL, 1997, ADV CHEM PHYS, V98, P283, DOI 10.1002/9780470141571.ch4
   Dresco PA, 1999, LANGMUIR, V15, P1945, DOI 10.1021/la980971g
   ELLIOTT SR, 1998, PHYSICS CHEM SOLIDS
   Enochs WS, 1999, JMRI-J MAGN RESON IM, V9, P228, DOI 10.1002/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.3.CO;2-B
   FARQUHAR MG, 1978, J CELL BIOL, V77, pR35, DOI 10.1083/jcb.77.3.R35
   FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664
   FENDLER JH, 1987, CHEM REV, V87, P877, DOI 10.1021/cr00081a002
   Florence AT, 1997, PHARM RES-DORDR, V14, P259, DOI 10.1023/A:1012029517394
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   FRANCIS G, 1997, BLOOD, V89, P3778
   Frazier RA, 1997, LANGMUIR, V13, P7115, DOI 10.1021/la970382v
   FREEMAN JA, 1965, AM J DIG DIS, V10, P1004, DOI 10.1007/BF02233375
   Fried NM, 1999, LASER SURG MED, V25, P291, DOI 10.1002/(SICI)1096-9101(1999)25:4<291::AID-LSM4>3.0.CO;2-#
   FURUSAWA K, 1994, COLLOID POLYM SCI, V272, P1104, DOI 10.1007/BF00652379
   GALLO JM, 1989, J PHARMACOKINET BIOP, V17, P305, DOI 10.1007/BF01061899
   GALLO JM, 1989, J PHARM SCI, V78, P190, DOI 10.1002/jps.2600780303
   GALLO JM, 1993, J PHARMACOKINET BIOP, V21, P575, DOI 10.1007/BF01059115
   GHINEA N, 1985, J CELL BIOL, V100, P606, DOI 10.1083/jcb.100.2.606
   GILCHRIST RK, 1957, ANN SURG, V146, P596, DOI 10.1097/00000658-195710000-00007
   Gomez-Lopera SA, 2001, J COLLOID INTERF SCI, V240, P40, DOI 10.1006/jcis.2001.7579
   GORDON RT, 1979, MED HYPOTHESES, V5, P83, DOI 10.1016/0306-9877(79)90063-X
   Goya GF, 2003, J APPL PHYS, V94, P3520, DOI 10.1063/1.1599959
   Gruttner C, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P53
   Gupta AK, 2003, IEEE T NANOBIOSCI, V2, P255, DOI 10.1109/TNB.2003.820279
   Gupta AK, 2004, J MATER SCI-MATER M, V15, P493, DOI 10.1023/B:JMSM.0000021126.32934.20
   Gupta AK, 2004, IEEE T NANOBIOSCI, V3, P66, DOI 10.1109/TNB.2003.820277
   Gupta AK, 2004, BIOMATERIALS, V25, P3029, DOI 10.1016/j.biomaterials.2003.09.095
   GUPTA AK, 2003, P 30 ANN S CONTR REL, V30, P788
   GUPTA PK, 1989, LIFE SCI, V44, P175, DOI 10.1016/0024-3205(89)90593-6
   Gupta PK, 1993, MICROSPHERES REGIONA, P71
   HADJIPANAYIS GC, 1993, NATO ASI SERIES AP E, V260
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/ange.200200546
   Hampdenn-Smith M. J, 1999, AEROSOL PROCESSING M
   HAN DH, J MAGN MAGN MAT, V136, P176
   Handgretinger R, 1998, BONE MARROW TRANSPL, V21, P987, DOI 10.1038/sj.bmt.1701228
   HAYAT MA, 1991, COLLOIDAL GOLD PRINC, V1, P14
   Held GA, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.012408
   Hirao K, 2003, INT J ONCOL, V22, P1065
   Holland NB, 1998, NATURE, V392, P799
   Igartua M, 2002, INT J PHARM, V233, P149, DOI 10.1016/S0378-5173(01)00936-X
   ISABELLE B, 1997, CYTOTECHNOLOGY, V25, P231
   Ito A, 2001, CANCER GENE THER, V8, P649, DOI 10.1038/sj.cgt.7700357
   Janik J, 1997, LANGMUIR, V13, P4466, DOI 10.1021/la960452i
   Jeong YI, 1999, DRUG DEV IND PHARM, V25, P917, DOI 10.1081/DDC-100102252
   Jiles D., 1991, INTRO MAGNETISM MAGN
   JOHNSON GA, 1993, MAGN RESON QUART, V9, P1
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   JOSEPHSON L, 1990, MAGN RESON IMAGING, V8, P637, DOI 10.1016/0730-725X(90)90143-P
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Kaneo Y, 2001, J CONTROL RELEASE, V70, P365, DOI 10.1016/S0168-3659(00)00368-0
   Kataby G, 1998, LANGMUIR, V14, P1512, DOI 10.1021/la970978i
   Kawaguchi H, 1996, COLLOID SURFACE A, V109, P147, DOI 10.1016/0927-7757(95)03482-X
   KEMMNER W, 1992, J IMMUNOL METHODS, V147, P197, DOI 10.1016/S0022-1759(12)80008-1
   KHALAFALLA SE, 1980, IEEE T MAGN, V16, P178, DOI 10.1109/TMAG.1980.1060578
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kiessling AA, 2003, HUMAN EMBRYONIC STEM
   Kim DK, 2001, SCRIPTA MATER, V44, P1713, DOI 10.1016/S1359-6462(01)00870-3
   Kim DK, 2001, J MAGN MAGN MATER, V225, P30, DOI 10.1016/S0304-8853(00)01224-5
   KLEIN J, 1991, NATURE, V352, P143, DOI 10.1038/352143a0
   KRONICK P, 1986, J BIOCHEM BIOPH METH, V12, P73, DOI 10.1016/0165-022X(86)90052-7
   Krotz F, 2003, MOL THER, V7, P700, DOI 10.1016/S1525-0016(03)00065-0
   Krotz F, 2003, J VASC RES, V40, P425, DOI 10.1159/000073901
   Kubo T, 2000, INT J ONCOL, V17, P309
   Kubo T, 2001, INT J ONCOL, V18, P121
   KWEI GH, 1990, J MOL STRUCT, V223, P383, DOI 10.1016/0022-2860(90)80482-Y
   Lauffenburger DA, 1993, RECEPTORS MODELS BIN
   LAWRENCE MJ, 1994, EUR J DRUG METAB PH, V19, P257, DOI 10.1007/BF03188929
   LAWRENCE MJ, ADV DRUG DELIV REV, V45, P89
   Lee CS, 2001, APPL PHYS LETT, V79, P3308, DOI 10.1063/1.1419049
   Lee J, 1996, J COLLOID INTERF SCI, V177, P490, DOI 10.1006/jcis.1996.0062
   Lefebure S, 1998, J MATER RES, V13, P2975, DOI 10.1557/JMR.1998.0407
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Li JK, 1997, J PHARM SCI-US, V86, P891, DOI 10.1021/js970084i
   Li SC, 2000, COLLOID SURFACE A, V174, P275, DOI 10.1016/S0927-7757(00)00538-0
   Li YQ, 2002, APPL PHYS LETT, V80, P4644, DOI 10.1063/1.1487921
   Lin J, 2001, J SOLID STATE CHEM, V159, P26, DOI 10.1006/jssc.2001.9117
   Liz-Marzan L. M., 2003, NANOSCALE MAT
   Lobel B, 2000, LASER SURG MED, V26, P4, DOI 10.1002/(SICI)1096-9101(2000)26:1<4::AID-LSM3>3.0.CO;2-J
   LUDERER AA, 1983, RADIAT RES, V94, P190, DOI 10.2307/3575874
   Luisi P. L., 1983, BIOL TECHNOLOGICAL R, P73
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Mendenhall GD, 1996, J COLLOID INTERF SCI, V184, P519, DOI 10.1006/jcis.1996.0647
   Messersmith P, 2001, ENCY MAT SCI TECHNOL, P602
   MEYERS PH, 1966, AMER J ROENTGENOL RA, V96, P913, DOI 10.2214/ajr.96.4.913
   MILLER CR, 1988, BIOCHEMISTR, V37, P12875
   MILLER ES, 1983, J MEMBRANE SCI, V14, P79, DOI 10.1016/S0376-7388(00)81375-7
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Moore A, 1998, BBA-MOL CELL RES, V1402, P239, DOI 10.1016/S0167-4889(98)00002-0
   Moore A, 2001, RADIOLOGY, V221, P244, DOI 10.1148/radiol.2211001784
   Morawski AM, 2004, MAGN RESON MED, V51, P480, DOI 10.1002/mrm.20010
   MULLER BW, 1984, J PHARM SCI, V73, P919, DOI 10.1002/jps.2600730714
   Mulvaney P, 2000, J MATER CHEM, V10, P1259, DOI 10.1039/b000136h
   Munshi N, 1997, J COLLOID INTERF SCI, V190, P387, DOI 10.1006/jcis.1997.4889
   MUTSAERS SE, 1988, J LEUKOCYTE BIOL, V44, P17
   Najafi F, 2003, BIOMATERIALS, V24, P1175, DOI 10.1016/S0142-9612(02)00487-8
   NAKAJIMA K, 1990, POLYM J, V22, P985, DOI 10.1295/polymj.22.985
   Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755
   Nam JM, 2002, J AM CHEM SOC, V124, P3820, DOI 10.1021/ja0178766
   Ng V, 2002, NANOTECHNOLOGY, V13, P554, DOI 10.1088/0957-4484/13/5/302
   Nielsen OS, 2001, EUR J CANCER, V37, P1587, DOI 10.1016/S0959-8049(01)00193-9
   Nunn AVW, 1996, FEBS LETT, V392, P295, DOI 10.1016/0014-5793(96)00839-3
   Okamura Y, 2001, J BIOL CHEM, V276, P48183, DOI 10.1074/jbc.M106408200
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   OLSVIK O, 1994, CLIN MICROBIOL REV, V7, P43
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Pauser S, 1997, ANTI-CANCER DRUG DES, V12, P125
   Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969
   Penn RL, 1999, GEOCHIM COSMOCHIM AC, V63, P1549, DOI 10.1016/S0016-7037(99)00037-X
   Pierres A, 1996, J IMMUNOL METHODS, V196, P105, DOI 10.1016/0022-1759(96)00103-2
   Poptani H, 1998, CANCER GENE THER, V5, P101
   Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500
   Pratsinis SE, 1996, POWDER TECHNOL, V88, P267, DOI 10.1016/S0032-5910(96)03130-0
   Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561
   Reimer P, 1996, RADIOLOGE, V36, P153, DOI 10.1007/s001170050053
   REIMERS GW, 1972, PREPARING MAGNETIC F, P59
   Rishton SA, 1997, MICROELECTRON ENG, V35, P249, DOI 10.1016/S0167-9317(96)00107-4
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   ROSENSWE.RE, 1969, J COLLOID INTERF SCI, V29, P680, DOI 10.1016/0021-9797(69)90220-3
   Rosensweig R. E., 1985, FERROHYDRODYNAMICS
   RUIZ JM, 1991, J CONTROL RELEASE, V16, P177, DOI 10.1016/0168-3659(91)90041-B
   Sahoo Y, 2001, LANGMUIR, V17, P7907, DOI 10.1021/la010703+
   SALZMAN EW, 1983, AM J SOC ARTIF INTER, V6, P60
   Santra S, 2001, LANGMUIR, V17, P2900, DOI 10.1021/la0008636
   SATO T, 1987, J MAGN MAGN MATER, V65, P252, DOI 10.1016/0304-8853(87)90044-8
   Sauzedde F, 1999, COLLOID POLYM SCI, V277, P1041, DOI 10.1007/s003960050488
   Sauzedde F, 1999, COLLOID POLYM SCI, V277, P846, DOI 10.1007/s003960050461
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   Schoepf U, 1998, BIOTECHNIQUES, V24, P642, DOI 10.2144/98244rr01
   SCHOLTEN PC, 1978, THERMODYNAMICS MAGNE
   Schwertmann U, 1991, IRON OXIDES LAB PREP
   SCHWICK HG, 1969, BIBL HAEMATOL, P111
   Shan GB, 2003, BIOTECHNOL LETT, V25, P1977, DOI 10.1023/B:BILE.0000004388.15751.8c
   Shepherd P. G., 1970, Journal of Physics D (Applied Physics), V3, P1985, DOI 10.1088/0022-3727/3/12/430
   Shibli SM, 2001, BRAZ J PHYS, V31, P418, DOI 10.1590/S0103-97332001000300012
   Siegel R. W., 1999, NANOSTRUCTURE SCI TE
   Sinha A, 2000, CURR SCI INDIA, V79, P646
   SJOGREN CE, 1994, MAGNET RESON MED, V31, P268, DOI 10.1002/mrm.1910310305
   SNEED PK, 1996, THERMORADIOTHERAPY T, V2
   Sokolov K, 2003, CANCER RES, V63, P1999
   Sorensen CM, 2001, NANOSCALE MATERIALS IN CHEMISTRY, P169, DOI 10.1002/0471220620.ch6
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   Storhoff JJ, 1999, CHEM REV, V99, P1849, DOI 10.1021/cr970071p
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   SUGIMOTO T, 1987, ADV COLLOID INTERFAC, V28, P65, DOI 10.1016/0001-8686(87)80009-X
   Tadmor R, 2000, LANGMUIR, V16, P9117, DOI 10.1021/la0009137
   Tang J, 2003, J PHYS CHEM B, V107, P7501, DOI 10.1021/jp027048e
   Tanji N, 2001, ARCH ANDROLOGY, V47, P1
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   Tartaj P, 2002, LANGMUIR, V18, P4556, DOI 10.1021/la025566a
   Tartaj P, 2001, ADV MATER, V13, P1620, DOI 10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z
   Taylor AP, 2001, J MICROSC-OXFORD, V201, P84, DOI 10.1046/j.1365-2818.2001.00760.x
   Tchikov V, 2001, J MAGN MAGN MATER, V225, P285, DOI 10.1016/S0304-8853(00)01252-X
   Tepper T, 2003, J APPL PHYS, V93, P6948, DOI 10.1063/1.1540033
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   Tillotson TM, 2001, J NON-CRYST SOLIDS, V285, P338, DOI 10.1016/S0022-3093(01)00477-X
   TORCHILIN VP, 1995, ADV DRUG DELIVER REV, V16, P141, DOI 10.1016/0169-409X(95)00022-Y
   TOURINHO F, 1989, PROG COLL POL SCI S, V79, P128
   Uchegbu IF, 1996, DRUG SAFETY, V14, P39, DOI 10.2165/00002018-199614010-00005
   UGELSTAD J, 1993, BLOOD PURIFICAT, V11, P349, DOI 10.1159/000170129
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Varanda LC, 2002, J APPL PHYS, V92, P2079, DOI 10.1063/1.1496124
   VERGES MA, 1990, J CHEM SOC FARADAY T, V86, P959, DOI 10.1039/ft9908600959
   Vladimir S., 1999, J COLLOID INTERF SCI, V212, P49
   Voit W., 2001, MATER RES SOC S P, V676
   Wada S, 2003, ORAL DIS, V9, P218, DOI 10.1034/j.1601-0825.2003.02839.x
   Wang XX, 2000, CHAOS SOLITON FRACT, V11, P2319, DOI 10.1016/S0960-0779(99)00151-4
   Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140
   WEISSLEDER R, 1995, ADV DRUG DELIVER REV, V16, P321, DOI 10.1016/0169-409X(95)00033-4
   WEISSLEDER R, 1997, MAGN RESON IMAGING, V7, P258
   Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219
   WIDDER KJ, 1980, CANCER RES, V40, P3512
   WILBANKS GA, 1990, IMMUNOLOGY, V71, P566
   Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4
   Wilkinson J M, 2003, Med Device Technol, V14, P29
   WINOTOMORBACH S, 1994, J CLIN LAB ANAL, V8, P400, DOI 10.1002/jcla.1860080610
   Xu HHK, 2004, BIOMATERIALS, V25, P4615, DOI 10.1016/j.biomaterials.2003.12.058
   XU HK, 1992, J MATER RES, V7, P712, DOI 10.1557/JMR.1992.0712
   YAACOB II, 1994, J COLLOID INTERF SCI, V168, P289, DOI 10.1006/jcis.1994.1423
   YAACOB II, 1995, J COLLOID INTERF SCI, V171, P73, DOI 10.1006/jcis.1995.1152
   YAMAZAKI M, 1990, BIOCHEMISTRY-US, V29, P1309, DOI 10.1021/bi00457a029
   Yee C, 1999, LANGMUIR, V15, P7111, DOI 10.1021/la990663y
   YEH TC, 1993, MAGN RESON MED, V30, P617, DOI 10.1002/mrm.1910300513
   Yu J., 2003, REV ADV MATER SCI, V4, P55
   YUEN S, 1974, PROCESS BIOCHEM, V9, P7
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
   Zhao M, 2002, BIOCONJUGATE CHEM, V13, P840, DOI 10.1021/bc0255236
   Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241
   Zhao X, 1998, J PHARM SCI, V87, P1450, DOI 10.1021/js980065o
   Zhou WL, 2001, EUR PHYS J D, V16, P289, DOI 10.1007/s100530170112
   Zhou WL, 2001, J APPL PHYS, V89, P7398, DOI 10.1063/1.1358831
   ZIMMERMANN U, 1980, BIOELECTROCH BIOENER, V7, P553, DOI 10.1016/0302-4598(80)80014-6
   ZIOLO RF, 1992, SCIENCE, V257, P219, DOI 10.1126/science.257.5067.219
   ZOLA H, 1994, IMMUNOLOGIST, V2, P47
NR 251
TC 4115
Z9 4243
U1 229
U2 3917
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 18
BP 3995
EP 4021
DI 10.1016/j.biomaterials.2004.10.012
PG 27
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 899KR
UT WOS:000227143800024
PM 15626447
DA 2018-10-20
ER

PT J
AU Fortman, JL
   Sherman, DH
AF Fortman, JL
   Sherman, DH
TI Utilizing the power of microbial genetics to bridge the gap between the
   promise and the application of marine natural products
SO CHEMBIOCHEM
LA English
DT Review
DE biosynthesis; genomics; heterologous expression; marine natural
   products; secondary metabolites
ID CYANOBACTERIUM LYNGBYA-MAJUSCULA; LARGE-SCALE SYNTHESIS; PSEUDOPTEROSIN
   DITERPENE CYCLASE; ASCIDIAN LISSOCLINUM-PATELLA; SPONGE
   DISCODERMIA-DISSOLUTA; POLYKETIDE SYNTHASE; ANTITUMOR-ACTIVITY;
   IN-VITRO; HETEROLOGOUS EXPRESSION; ANTINEOPLASTIC AGENTS
AB Marine organisms are a rich source of secondary metabolites. They have yielded thousands of compounds with a broad range of biomedical applications. Thus for, samples required for preclinical and clinical studies have been obtained by collection from the wild, by moriculture, and by total chemical synthesis. However, for a number of complex marine metabolites, none of these options is feasible for either economic or environmental reasons. In order to proceed with the development of many of these promising therapeutic compounds, a reliable and renewable source must be found. Over the last twenty years, the study of microbial secondary metabolites has greatly advanced our understanding of how nature utilizes simple starting materials to yield complex small molecules. Much of this work has focused on polyketides and nonribosomol peptides, two classes of molecules that are prevalent in marine micro- and mocroorganisms. The lessons learned from the study of terrestrial metabolite biosynthesis are now being applied to the marine world. As techniques for cloning and heterologous expression of biosynthetic pathways continue to improve, they may provide our greatest hope for bridging the gap between the promise and application of many marine natural products.
C1 Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.
   Univ Michigan, Dept Med Chem, Inst Life Sci, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Chem, Inst Life Sci, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Microbiol & Immunol, Inst Life Sci, Ann Arbor, MI 48109 USA.
RP Sherman, DH (reprint author), Univ Minnesota, Dept Microbiol, 1460 Mayo Bldg,420 Delaware St SE, Minneapolis, MN 55455 USA.
EM davidhs@umich.edu
FU NCI NIH HHS [CA 83155]
CR Ahaidar A, 2003, J ORG CHEM, V68, P10020, DOI 10.1021/jo035332b
   AICHER TD, 1992, J AM CHEM SOC, V114, P3162, DOI 10.1021/ja00034a086
   ARAI T, 1977, J ANTIBIOT, V30, P1015
   Bangera MG, 1999, J BACTERIOL, V181, P3155
   Baz JP, 1997, J ANTIBIOT, V50, P738, DOI 10.7164/antibiotics.50.738
   Belarbi E, 2003, BIOMOL ENG, V20, P333, DOI 10.1016/S1389-0344(03)00043-1
   BERGMANN W, 1950, J AM CHEM SOC, V72, P2809, DOI 10.1021/ja01162a543
   BERGMANN W, 1951, J ORG CHEM, V16, P981, DOI 10.1021/jo01146a023
   BERGMANN W, 1955, J ORG CHEM, V20, P1501, DOI 10.1021/jo01128a007
   Bewley CA, 1996, EXPERIENTIA, V52, P716, DOI 10.1007/BF01925581
   Blunt JW, 2003, NAT PROD REP, V20, P1, DOI 10.1039/b207130b
   Blunt JW, 2004, NAT PROD REP, V21, P1, DOI 10.1039/b305250h
   Brady SF, 2001, ORG LETT, V3, P1981, DOI 10.1021/ol015949k
   Brakmann S, 2001, CHEMBIOCHEM, V2, P865, DOI 10.1002/1439-7633(20011203)2:12<865::AID-CBIC865>3.0.CO;2-6
   Burgett AWG, 2003, ANGEW CHEM INT EDIT, V42, P4961, DOI 10.1002/anie.200352577
   Burja AM, 2002, J MICROBIOL METH, V48, P207, DOI 10.1016/S0167-7012(01)00324-4
   CARDANI C, 1965, TETRAHEDRON LETT, P2537
   Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261
   Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0
   Coleman AC, 1999, ORG LETT, V1, P2173, DOI 10.1021/ol991120i
   Coleman AC, 2000, TETRAHEDRON, V56, P9569, DOI 10.1016/S0040-4020(00)00930-3
   Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002
   CORLEY DG, 1988, J ORG CHEM, V53, P3644, DOI 10.1021/jo00250a053
   Courtois S, 2003, APPL ENVIRON MICROB, V69, P49, DOI 10.1128/AEM.69.1.49-55.2003
   CREWS P, 1986, TETRAHEDRON LETT, V27, P2797, DOI 10.1016/S0040-4039(00)84645-6
   CREWS P, 1994, J ORG CHEM, V59, P2932, DOI 10.1021/jo00090a008
   Cropp TA, 2000, NAT BIOTECHNOL, V18, P980
   Cuevas C, 2000, ORG LETT, V2, P2545, DOI 10.1021/ol0062502
   Cundliffe E, 2001, ANTON LEEUW INT J G, V79, P229, DOI 10.1023/A:1012065300116
   DAMBROSIO M, 1987, HELV CHIM ACTA, V70, P2019, DOI 10.1002/hlca.19870700807
   DAURIA MV, 1993, TETRAHEDRON, V49, P8657, DOI 10.1016/S0040-4020(01)96271-4
   DAURIA MV, 1993, CHEM REV, V93, P1839, DOI 10.1021/cr00021a010
   Davidson SK, 2001, APPL ENVIRON MICROB, V67, P4531, DOI 10.1128/AEM.67.10.4531-4537.2001
   de Caralt S, 2003, BIOMOL ENG, V20, P339, DOI 10.1016/S1389-0344(03)00045-5
   DEARRUDA M, 1995, CANCER RES, V55, P3085
   DEGNAN BM, 1989, J MED CHEM, V32, P1354, DOI 10.1021/jm00126a035
   DEGNAN BM, 1989, J MED CHEM, V32, P1349, DOI 10.1021/jm00126a034
   DELL A, 1975, J AM CHEM SOC, V97, P2497, DOI 10.1021/ja00842a029
   DESILVA ED, 1992, TETRAHEDRON LETT, V33, P1561, DOI 10.1016/S0040-4039(00)91674-5
   Dewick PM, 2002, NAT PROD REP, V19, P181, DOI 10.1039/b002685i
   Dittmann E, 2001, APPL MICROBIOL BIOT, V57, P467
   DONADIO S, 1993, P NATL ACAD SCI USA, V90, P7119, DOI 10.1073/pnas.90.15.7119
   DORDICK JS, 1992, TRENDS BIOTECHNOL, V10, P287, DOI 10.1016/0167-7799(92)90246-R
   Duckworth AR, 2003, MAR BIOTECHNOL, V5, P519, DOI 10.1007/s10126-002-0111-0
   Duckworth AR, 2003, AQUACULTURE, V217, P139, DOI 10.1016/S0044-8486(02)00038-8
   Dupont E, 2002, CLIN EXP METASTAS, V19, P145, DOI 10.1023/A:1014546909573
   Edler MC, 2002, BIOCHEM PHARMACOL, V63, P707, DOI 10.1016/S0006-2952(01)00898-X
   Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g
   Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030
   El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7
   Eppelmann K, 2001, J BIOL CHEM, V276, P34824, DOI 10.1074/jbc.M104456200
   Erickson KL, 1997, J ORG CHEM, V62, P8188, DOI 10.1021/jo971556g
   Faulkner DJ, 2000, ANTON LEEUW INT J G, V77, P135, DOI 10.1023/A:1002405815493
   Faulkner DJ, 2000, NAT PROD REP, V17, P1, DOI 10.1039/a909113k
   Faulkner DJ, 2002, NAT PROD REP, V19, P1, DOI 10.1039/b009029h
   Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115
   FELING RH, 2003, ANGEW CHEM, V115, P369
   FERNANDEZ AM, 1999, PURE APPL CHEM, V70, P2130
   Flowers AE, 1998, CELL TISSUE RES, V292, P597, DOI 10.1007/s004410051089
   Freemantle M, 2004, CHEM ENG NEWS, V82, P33, DOI 10.1021/cen-v082n009.p033
   FRINCKE JM, 1982, J AM CHEM SOC, V104, P265, DOI 10.1021/ja00365a048
   Fu X, 2003, NAT BIOTECHNOL, V21, P1467, DOI 10.1038/nbt909
   FURUSAKI A, 1968, TETRAHEDRON LETT, P6301
   FURUSAKI A, 1978, J CHEM SOC CHEM COMM, P800, DOI 10.1039/c39780000800
   FUSETANI N, 1992, J ORG CHEM, V57, P3828, DOI 10.1021/jo00040a021
   GARSON MJ, 1992, LIPIDS, V27, P378, DOI 10.1007/BF02536153
   Garson MJ, 1998, CELL TISSUE RES, V293, P365, DOI 10.1007/s004410051128
   Gerwick WH, 2001, ALKALOIDS, V57, P75, DOI 10.1016/S0099-9598(01)57003-0
   GERWICK WH, 1994, J ORG CHEM, V59, P1243, DOI 10.1021/jo00085a006
   Gillespie DE, 2002, APPL ENVIRON MICROB, V68, P4301, DOI 10.1128/AEM.68.9.4301-4306.2002
   Gillor O, 2000, MAR BIOTECHNOL, V2, P213, DOI 10.1007/s101260000026
   GINER JL, 1993, CHEM REV, V93, P1735, DOI 10.1021/cr00021a004
   Goldspiel BR, 1997, PHARMACOTHERAPY, V17, pS110
   GOUIFFES D, 1988, TETRAHEDRON, V44, P451, DOI 10.1016/S0040-4020(01)85836-1
   GUELLA G, 1989, HELV CHIM ACTA, V72, P237, DOI 10.1002/hlca.19890720207
   GULAVITA NK, 1992, J NAT PROD, V55, P506, DOI 10.1021/np50082a019
   GUNASEKERA SP, 1991, J ORG CHEM, V56, P4830, DOI 10.1021/jo00016a006
   GUNASEKERA SP, 1990, J ORG CHEM, V55, P4912, DOI 10.1021/jo00303a029
   HAMANN MT, 1993, J AM CHEM SOC, V115, P5825, DOI 10.1021/ja00066a061
   Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9
   Hanson JR, 2003, NAT PROD REP, V20, P70, DOI 10.1039/b108963n
   Harrigan GG, 1998, J NAT PROD, V61, P1075, DOI 10.1021/np980321c
   Henne A, 1999, APPL ENVIRON MICROB, V65, P3901
   Hirama M, 2001, SCIENCE, V294, P1904, DOI 10.1126/science.1065757
   Hoffmeister D, 2003, P NATL ACAD SCI USA, V100, P13184, DOI 10.1073/pnas.2235011100
   Holloway GA, 2003, J ORG CHEM, V68, P2200, DOI 10.1021/jo026798h
   Hooper GJ, 1998, J NAT PROD, V61, P529, DOI 10.1021/np970443p
   Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i
   IKEDA Y, 1983, J ANTIBIOT, V36, P1284, DOI 10.7164/antibiotics.36.1284
   IRSCHIK H, 1988, J ANTIBIOT, V41, P993, DOI 10.7164/antibiotics.41.993
   ISHIBASHI M, 1986, J ORG CHEM, V51, P5300, DOI 10.1021/jo00376a047
   ITO S, 1972, TETRAHEDRON LETT, P1185
   Jansen R, 1996, LIEBIGS ANN, P285
   Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022
   Jennewein S, 2001, APPL MICROBIOL BIOT, V57, P13
   Jou G, 1997, J ORG CHEM, V62, P354, DOI 10.1021/jo961932h
   Julien B, 2002, ANTIMICROB AGENTS CH, V46, P2772, DOI 10.1128/AAC.46.9.2772-2778.2002
   Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633
   KASHMAN Y, 1980, TETRAHEDRON LETT, V21, P3629, DOI 10.1016/0040-4039(80)80255-3
   Kato Y, 2002, J AM CHEM SOC, V124, P5268, DOI 10.1021/ja0127483
   Kelecom A, 2002, AN ACAD BRAS CIENC, V74, P151, DOI 10.1590/S0001-37652002000100012
   Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219
   KINNEL RB, 1992, J ORG CHEM, V57, P6327, DOI 10.1021/jo00049a049
   KOBAYASHI J, 1988, TETRAHEDRON LETT, V29, P1177, DOI 10.1016/S0040-4039(00)86681-2
   KOBAYASHI M, 1994, TETRAHEDRON LETT, V35, P7969, DOI 10.1016/0040-4039(94)80024-3
   Kohl AC, 2004, ARCH BIOCHEM BIOPHYS, V424, P97, DOI 10.1016/j.abb.2004.01.019
   Kohl AC, 2003, J IND MICROBIOL BIOT, V30, P495, DOI 10.1007/s10295-003-0076-7
   KONISHI K, 1968, AGR BIOL CHEM TOKYO, V32, P678, DOI 10.1080/00021369.1968.10859118
   Kunze B, 1998, J ANTIBIOT, V51, P1075, DOI 10.7164/antibiotics.51.1075
   Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h
   LEE MD, 1987, J AM CHEM SOC, V109, P3466, DOI 10.1021/ja00245a051
   Li AY, 2002, CHEM BIOL, V9, P1017, DOI 10.1016/S1074-5521(02)00223-5
   Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879
   Li J, 2001, ANGEW CHEM INT EDIT, V40, P4770, DOI 10.1002/1521-3773(20011217)40:24<4770::AID-ANIE4770>3.0.CO;2-T
   LI J, 2001, ANGEW CHEM, V113, P4901
   Liao XB, 2003, ANGEW CHEM INT EDIT, V42, P1648, DOI 10.1002/anie.200351145
   Lindel T, 1997, J AM CHEM SOC, V119, P8744, DOI 10.1021/ja9717828
   LINDQUIST N, 1991, EXPERIENTIA, V47, P504, DOI 10.1007/BF01959957
   LINDQUIST N, 1991, J AM CHEM SOC, V113, P2303, DOI 10.1021/ja00006a060
   LOOK SA, 1986, J ORG CHEM, V51, P5140, DOI 10.1021/jo00376a016
   Lopanik N, 2004, OECOLOGIA, V139, P131, DOI 10.1007/s00442-004-1487-5
   Lopez JV, 2004, MOL GENET GENOMICS, V270, P420, DOI 10.1007/s00438-003-0937-9
   Lopez-Macia A, 2001, J AM CHEM SOC, V123, P11398, DOI 10.1021/ja0116728
   Luesch H, 2001, J NAT PROD, V64, P907, DOI 10.1021/np010049y
   Magarvey NA, 2004, APPL ENVIRON MICROB, V70, P7520, DOI 10.1128/AEM.70.12.7520-7529.2004
   Mao YQ, 1999, CHEM BIOL, V6, P251, DOI 10.1016/S1074-5521(99)80040-4
   Martinez A, 2004, APPL ENVIRON MICROB, V70, P2452, DOI 10.1128/AEM.70.4.2452-2463.2004
   MATSUMOTO T, 1968, TETRAHEDRON LETT, P6297
   Mayer AMS, 1998, LIFE SCI, V62, pPL401, DOI 10.1016/S0024-3205(98)00229-X
   McDonald LA, 1996, J AM CHEM SOC, V118, P10898, DOI 10.1021/ja961122n
   MEEKS JC, 2001, PHOTOSYN RES, V70
   Mendola D, 2003, BIOMOL ENG, V20, P441, DOI 10.1016/S1389-0344(03)00075-3
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P92, DOI 10.1021/op034130e
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P122, DOI 10.1021/op034134j
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P113, DOI 10.1021/op034133r
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P101, DOI 10.1021/op0341317
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P107, DOI 10.1021/op034132z
   Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002
   MIYAZAKI K, 1995, CHEM PHARM BULL, V43, P1706
   Mochizuki S, 2003, MOL MICROBIOL, V48, P1501, DOI 10.1046/j.1365-2958.2003.03523.x
   MOODY CJ, 1992, TETRAHEDRON, V48, P3589, DOI 10.1016/S0040-4020(01)88497-0
   Moore BS, 1999, NAT PROD REP, V16, P653, DOI 10.1039/a805873c
   MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354
   Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N
   Morita M, 1996, BIOSCI BIOTECH BIOCH, V60, P288, DOI 10.1271/bbb.60.288
   Muller WEG, 2000, J NAT PROD, V63, P1077, DOI 10.1021/np000003p
   MULLER WEG, 1986, J HISTOCHEM CYTOCHEM, V34, P1687, DOI 10.1177/34.12.3782777
   Muller WEG, 2004, MAR BIOTECHNOL, V6, P105, DOI 10.1007/s10126-002-0098-6
   Mydlarz LD, 2003, CHEM BIOL, V10, P1051, DOI 10.1016/j.chembiol.2003.10.012
   NATORI T, 1993, TETRAHEDRON LETT, V34, P5591, DOI 10.1016/S0040-4039(00)73889-5
   Natsume T, 2003, CANCER SCI, V94, P826, DOI 10.1111/j.1349-7006.2003.tb01526.x
   Nazi I, 2004, ANAL BIOCHEM, V324, P100, DOI 10.1016/j.ab.2003.09.005
   Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c
   Newman DJ, 2004, CURR MED CHEM, V11, P1693, DOI 10.2174/0929867043364982
   Nicolaou KC, 1999, CHEM PHARM BULL, V47, P1199
   Nieman JA, 2003, J NAT PROD, V66, P183, DOI 10.1021/np020375t
   OKAICHI T, 1962, AGR BIOL CHEM TOKYO, V26, P224, DOI 10.1080/00021369.1962.10857963
   Oku N, 2003, J AM CHEM SOC, V125, P2044, DOI 10.1021/ja0296780
   ORJALA J, 1995, J AM CHEM SOC, V117, P8281, DOI 10.1021/ja00136a031
   Osinga R, 2003, J BIOTECHNOL, V100, P141, DOI 10.1016/S0168-1656(02)00257-2
   Osinga R, 1999, MAR BIOTECHNOL, V1, P509, DOI 10.1007/PL00011807
   OTSUKA H, 1965, TETRAHEDRON, V21, P2931, DOI 10.1016/S0040-4020(01)98379-6
   Peng JN, 2003, J AGR FOOD CHEM, V51, P2246, DOI 10.1021/jf0207880
   PERRY NB, 1994, TETRAHEDRON, V50, P3987, DOI 10.1016/S0040-4020(01)89673-3
   PERRY NB, 1988, J AM CHEM SOC, V110, P4850, DOI 10.1021/ja00222a067
   Pettit GR, 1998, ANTI-CANCER DRUG DES, V13, P47
   PETTIT GR, 1987, J AM CHEM SOC, V109, P6883, DOI 10.1021/ja00256a070
   PETTIT GR, 1981, J NAT PROD, V44, P482, DOI 10.1021/np50016a016
   PETTIT GR, 1982, J AM CHEM SOC, V104, P6846, DOI 10.1021/ja00388a092
   Pettit GR, 1996, J NAT PROD, V59, P812, DOI 10.1021/np9604386
   PETTIT GR, 1989, J ORG CHEM, V54, P6005, DOI 10.1021/jo00287a003
   PETTIT GR, 1997, PROG CH ORG NAT PROD, V70, P1
   Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092
   Piel J, 2004, CHEMBIOCHEM, V5, P93, DOI 10.1002/cbic.200300782
   Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399
   Pomponi SA, 1999, J BIOTECHNOL, V70, P5, DOI 10.1016/S0168-1656(99)00053-X
   QUINOA E, 1988, J ORG CHEM, V53, P3642, DOI 10.1021/jo00250a052
   Reetz Manfred T., 2000, Science Progress, V83, P157
   Regentin R, 2002, J IND MICROBIOL BIOT, V28, P12, DOI 10.1038/sj/jim/7000208
   Remiszewski SW, 2003, CURR MED CHEM, V10, P2393, DOI 10.2174/0929867033456675
   Remiszewski SW, 2003, J MED CHEM, V46, P4609, DOI 10.1021/jm030235w
   RINEHART KL, 1988, J AM CHEM SOC, V110, P8557, DOI 10.1021/ja00233a049
   RINEHART KL, 1990, J ORG CHEM, V55, P4512, DOI 10.1021/jo00302a007
   RINEHART KL, 1981, J AM CHEM SOC, V103, P1857, DOI 10.1021/ja00397a055
   Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m
   Romero F, 1997, J ANTIBIOT, V50, P734, DOI 10.7164/antibiotics.50.734
   Rottmayr EM, 2001, ZOOMORPHOLOGY, V120, P159, DOI 10.1007/s004350000032
   SAKAI M, 1969, Review of Plant Protection Research, V2, P17
   SAKEMI S, 1988, J AM CHEM SOC, V110, P4851, DOI 10.1021/ja00222a068
   Salomon CE, 2002, J NAT PROD, V65, P689, DOI 10.1021/np010556f
   Salomon CE, 2001, MAR BIOL, V139, P313
   Sandmann G, 2001, ARCH BIOCHEM BIOPHYS, V385, P4, DOI 10.1006/abbi.2000.2170
   SASSE F, 1993, J ANTIBIOT, V46, P741, DOI 10.7164/antibiotics.46.741
   Sauder DN, 2002, J AM ACAD DERMATOL, V47, P535, DOI 10.1067/mjd.2002.124702
   Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273
   Schmidt-Dannert C, 2000, CURR OPIN BIOTECH, V11, P255, DOI 10.1016/S0958-1669(00)00093-8
   Schroeder H. C., 2003, P163
   Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k
   Sears P, 1996, P NATL ACAD SCI USA, V93, P12086, DOI 10.1073/pnas.93.22.12086
   SHIGEMORI H, 1992, J ORG CHEM, V57, P4317, DOI 10.1021/jo00041a053
   Snyder RV, 2003, MAR BIOTECHNOL, V5, P1, DOI 10.1007/s10126-002-0077-y
   Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63
   Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g
   Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101
   Tabata H, 2004, ADV BIOCHEM ENG BIOT, V87, P1
   Taglialatela-Scafati O, 2002, ORG LETT, V4, P4085, DOI 10.1021/ol026831m
   TALPIR R, 1994, TETRAHEDRON LETT, V35, P4453, DOI 10.1016/S0040-4039(00)73382-X
   Tanaka J, 1996, CHEM LETT, P255, DOI 10.1246/cl.1996.255
   Tang L, 2000, SCIENCE, V287, P640, DOI 10.1126/science.287.5453.640
   terHaar E, 1996, BIOCHEMISTRY-US, V35, P243, DOI 10.1021/bi9515127
   Tincu JA, 2000, BIOCHEM BIOPH RES CO, V270, P421, DOI 10.1006/bbrc.2000.2449
   TRIMURTULU G, 1994, J AM CHEM SOC, V116, P4729, DOI 10.1021/ja00090a020
   UEMURA D, 1985, J AM CHEM SOC, V107, P4796, DOI 10.1021/ja00302a042
   UNSON MD, 1993, EXPERIENTIA, V49, P349, DOI 10.1007/BF01923420
   Uriz MJ, 1996, MAR BIOL, V124, P583, DOI 10.1007/BF00351039
   Uriz MJ, 1996, CELL TISSUE RES, V285, P519, DOI 10.1007/s004410050668
   Vera MD, 2002, MED RES REV, V22, P102, DOI 10.1002/med.10003
   Walsh CT, 2002, CHEMBIOCHEM, V3, P125
   Wang GYS, 2000, ORG LETT, V2, P2401, DOI 10.1021/ol005860z
   WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045
   Warabi K, 2003, J ORG CHEM, V68, P2765, DOI 10.1021/jo0167910
   Wender PA, 1999, MED RES REV, V19, P388
   Wender PA, 2002, J AM CHEM SOC, V124, P4956, DOI 10.1021/ja0258428
   Wender PA, 1998, P NATL ACAD SCI USA, V95, P6624, DOI 10.1073/pnas.95.12.6624
   Wender PA, 1998, J AM CHEM SOC, V120, P4534, DOI 10.1021/ja9727631
   Wender PA, 1998, TETRAHEDRON LETT, V39, P8625, DOI 10.1016/S0040-4039(98)01955-8
   WENDER PA, 2001, GASSMAN MEMORIAL LEC
   West LM, 2000, J ORG CHEM, V65, P445, DOI 10.1021/jo991296y
   Willetts A, 1997, TRENDS BIOTECHNOL, V15, P55, DOI 10.1016/S0167-7799(97)84204-7
   WILLOUGHBY R, 2000, IN VITRO CELL DEV-AN, V36, P194
   Wipf P, 1996, J ORG CHEM, V61, P6556, DOI 10.1021/jo960845m
   WOOLLACOTT RM, 1981, MAR BIOL, V65, P155, DOI 10.1007/BF00397080
   WRIGHT AE, 1990, J ORG CHEM, V55, P4508, DOI 10.1021/jo00302a006
   Yun JM, 2003, J ORG CHEM, V68, P7675, DOI 10.1021/jo034755a
   ZABRISKIE TM, 1986, J AM CHEM SOC, V108, P3123, DOI 10.1021/ja00271a062
   Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784
   Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999
   Zhang DH, 2003, ORG LETT, V5, P3257, DOI 10.1021/o1035062j
   Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a
   Zhu G, 2002, GENE, V298, P79, DOI 10.1016/S0378-1119(02)00931-9
NR 240
TC 47
Z9 50
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1439-4227
EI 1439-7633
J9 CHEMBIOCHEM
JI ChemBioChem
PD JUN
PY 2005
VL 6
IS 6
BP 960
EP 978
DI 10.1002/cbic.200400428
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 934SZ
UT WOS:000229730000002
PM 15880675
DA 2018-10-20
ER

PT J
AU Worth, A
   Mucalo, M
   Horne, G
   Bruce, W
   Burbidge, H
AF Worth, A
   Mucalo, M
   Horne, G
   Bruce, W
   Burbidge, H
TI The evaluation of processed cancellous bovine bone as a bone graft
   substitute
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterials; bovine hydroxyapatite; composite bone grafting;
   histomorphometry; ovine condylar defect; xenografting; xenoimplant
ID ANIMAL-DERIVED BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS;
   BIO-OSS(R); IMPLANTS; DEFECTS; AUGMENTATION; HUMANS
AB Objective: To determine the ability of a novel bovine cancellous bone xenoimplant to act as an osteoconductive graft in an ovine femoral defect model. An autograft harvested from the xenoimplant site was placed in a contralateral limb defect for comparison.
   Material and methods: The xenoimplant used had been rendered immunologically inert by a novel defatting and deproteinating process. Following surgical implantation of cores into condylar cancellous bone defects, fluorochrome labels were administered to 12 sheep at 2 1/2, 4 1/2 and 8 weeks. Incorporation of the xenoimplants and autografts into the host bone was compared radiographically and histomorphometrically at 10 weeks.
   Results: Radiographically, the degree of osteointegration was comparable. Histomorphometric data, consisting of labelled surface (LS) estimates, confirmed osteoconductive properties of both the xenoimplants and autografts. Remodelling activity was greatest in the xenoimplants at 2 1/2, weeks. At 4 1/2 weeks, there was more activity in the autograft, but by 8 weeks they were performing similarly. Xenoimplant-LS estimates were comparable or greater than those of the autograft at all times.
   Conclusions: Processed bovine cancellous bone xenoimplants were osteoconductive in this model and show promise for development as a biomaterial in human and veterinary orthopaedic surgery.
C1 Massey Univ, Vet Teaching Hosp, Ctr Compan Anim Hlth, Palmerston North, New Zealand.
   Univ Waikato, Dept Chem, Hamilton, New Zealand.
   Univ Otago, Wellington Sch Med, Wellington, New Zealand.
   Adelaide Vet Specialist & Referral Ctr, Vet Specialist Orthopaed Serv, Adelaide, SA, Australia.
RP Worth, A (reprint author), Massey Univ, Vet Teaching Hosp, Ctr Compan Anim Hlth, Private Bag 11-222, Palmerston North, New Zealand.
EM A.J.Worth@massey.ac.nz
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR Anderson JC, 2001, AM J ARCHAEOL, V105, P371, DOI 10.2307/507312
   Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Eriksen E, 1994, BONE HISTOMORPHOMETR, P33
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P427, DOI 10.1023/A:1008987908917
   KERWIN SC, 1991, COMP CONT EDUC PRACT, V13, P1558
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   OHASHI H, 1994, J MATER SCI-MATER M, V5, P225, DOI 10.1007/BF00121093
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
   Salama R, 1973, J Bone Joint Surg Br, V55, P402
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Wolff J., 1986, LAW BONE REMODELLING
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 18
TC 19
Z9 23
U1 0
U2 4
PU BLACKWELL MUNKSGAARD
PI FREDERIKSBERG C
PA 1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2005
VL 16
IS 3
BP 379
EP 386
DI 10.1111/j.1600-0501.2005.01113.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 924FR
UT WOS:000228964900015
PM 15877759
DA 2018-10-20
ER

PT J
AU Chang, K
   Chiu, JJ
AF Chang, K
   Chiu, JJ
TI Clinical applications of nanotechnology in atherosclerotic diseases
SO CURRENT NANOSCIENCE
LA English
DT Article
DE atherosclerosis; diagnosis; nanotechnology; prevention; treatment
ID LOW-DENSITY-LIPOPROTEIN; ARTERIAL GENE-TRANSFER; LIPID-BASED SYSTEMS;
   IN-VIVO; DELIVERY-SYSTEMS; HEART-DISEASE; CARDIOVASCULAR-DISEASE;
   BIOLOGICAL DETECTION; ENDOTHELIAL-CELLS; QUANTUM DOTS
AB Nanotechnology can be defined as the science and engineering involved in the design, synthesis, characterization, and application of materials and devices whose smallest functional organization in at least one dimension is on the nanometer scale or one billionth of a meter. One of the great promises of nanotechnology is the application to biology and medicine. In medicine, the cardiovascular field is one of the most technically advanced disciplines. Engineering achievements have helped us develop novel diagnostic and therapeutic technologies that provide safe and efficient solutions for cardiovascular patients. In spite of such progress, cardiovascular disease remains a major cause of death, morbidity, and disability in Occidental and Oriental societies. To address this formidable public health issue, substantial advances will be needed, and in particular, some important technological hurdles need to be overcome. The burgeoning new field of nanotechnology might open up a brand new approach in addressing some of these technical challenges. In fact, recent rapid advances in nanotechnology and nanoscience offer a wealth of new opportunities for diagnosis, prevention, and therapy of cardiovascular diseases, especially atherosclerosis. The aim of this article is to provide a brief survey at promising, important targets for nanotechnology in atherosclerosis. We review some of the main advances in the field of nanotechnology over the past few years, explore the prospects of clinical application in atherosclerosis, and discuss the concepts, issues, approaches, and challenges, with the goal of triggering the interest of biomedical scientists in the field of extremely tiny world.
C1 Natl Hlth Res Inst, Div Med Engn Res, Zhunan Town 350, Miaoli, Taiwan.
RP Chiu, JJ (reprint author), Natl Hlth Res Inst, Div Med Engn Res, 35 Keyan Rd, Zhunan Town 350, Miaoli, Taiwan.
EM jjchiu@nhri.org.tw
RI Chiu, Jeng-Jiann/E-3980-2010
CR AMBROSE JA, 1996, SYNDROMES ATHEROSCLE, P105
   BARR E, 1994, GENE THER, V1, P51
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J
   BULTE JW, 2001, MOL IMAGING, V1, P225
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   CHANG MY, 1992, ARTERIOSCLER THROMB, V12, P1088, DOI 10.1161/01.ATV.12.9.1088
   Chesebro James H, 2004, Am Heart Hosp J, V2, P21
   Chilton Robert J, 2004, J Am Osteopath Assoc, V104, pS5
   Couvreur P, 1986, POLYM NANOPARTICLES
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1
   De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495
   Demos SM, 1999, J AM COLL CARDIOL, V33, P867, DOI 10.1016/S0735-1097(98)00607-X
   Deshpande D, 1998, PHARMACEUT RES, V15, P1340, DOI 10.1023/A:1011933117509
   DINSMORE R, 1996, SYNDROMES ATHEROSCLE, P277
   EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0
   Farmer JA, 1997, HEART DIS TXB CARDIO, P1126
   FELDMAN LJ, 1995, J CLIN INVEST, V95, P2662, DOI 10.1172/JCI117968
   French BA, 1998, CURR OPIN CARDIOL, V13, P205
   Fruchart JC, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000131513.33892.5b
   Garas SM, 2001, PHARMACOL THERAPEUT, V92, P165, DOI 10.1016/S0163-7258(01)00168-1
   Garnett MC, 1999, CRIT REV THER DRUG, V16, P147
   Gnatenko D, 1997, J INVEST MED, V45, P87
   GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333
   GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8
   GUZMAN PJ, 1993, CIRCULATION, V88, P2838
   Haes AJ, 2004, EXPERT REV MOL DIAGN, V4, P527, DOI 10.1586/14737159.4.4.527
   HANAFUSA S, 1995, CLIN ORTHOP RELAT R, V315, P262
   Herreros R, 1999, PALLIATIVE MED, V13, P83, DOI 10.1177/026921639901300114
   Hirko A, 2003, CURR MED CHEM, V10, P1185, DOI 10.2174/0929867033457412
   Iwata A, 2001, CIRCULATION, V103, P2753
   Jneid Hani, 2003, Expert Opin Emerg Drugs, V8, P349, DOI 10.1517/eoed.8.2.349.21131
   KOHLER T, 1996, SYNDROMES ATHEROSCLE, P205
   Kooi ME, 2003, CIRCULATION, V107, P2453, DOI 10.1161/01.CIR.0000068315.98705.CC
   KOPFLER WP, 1994, CIRCULATION, V90, P1319, DOI 10.1161/01.CIR.90.3.1319
   KOTTKE BA, 1986, MAYO CLIN PROC, V61, P313, DOI 10.1016/S0025-6196(12)61947-8
   KREUTER J, 1994, DRUGS PHARM SCI, V66, P219
   KUBOTA R, 1994, J NUCL MED, V35, P104
   Labarrere CA, 2004, AM J MED, V117, P499, DOI 10.1016/j.amjmed.2004.03.039
   Laitinen M, 2000, HUM GENE THER, V11, P263, DOI 10.1089/10430340050016003
   Lanza GM, 1996, CIRCULATION, V94, P3334, DOI 10.1161/01.CIR.94.12.3334
   LEES AM, 1988, ARTERIOSCLEROSIS, V8, P461, DOI 10.1161/01.ATV.8.5.461
   LEMARCHAND P, 1993, CIRC RES, V72, P1132, DOI 10.1161/01.RES.72.5.1132
   Lenter MC, 2004, PHARM RES, V21, P683, DOI 10.1023/B:PHAM.0000022416.33048.81
   Lynch CM, 1997, CIRC RES, V80, P497
   Lyon LA, 1998, ANAL CHEM, V70, P5177, DOI 10.1021/ac9809940
   Ma QG, 2001, J AM CHEM SOC, V123, P4627, DOI 10.1021/ja0156542
   MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641
   MATSUSUE Y, 1995, CLIN ORTHOP RELAT R, P246
   Maurer N, 1999, MOL MEMBR BIOL, V16, P129, DOI 10.1080/096876899294869
   MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Monfardini C, 1998, BIOCONJUGATE CHEM, V9, P418, DOI 10.1021/bc970184f
   Noon WH, 2002, P NATL ACAD SCI USA, V99, P6466, DOI 10.1073/pnas.022532599
   OLIGINO TJ, 2000, CLIN ORTHOP S, V379, pS17
   Paoletti R, 2004, CIRCULATION, V109, P20, DOI 10.1161/01.CIR.0000131514.71167.2e
   PARKER SE, 1995, HUM GENE THER, V6, P575, DOI 10.1089/hum.1995.6.5-575
   Peppas LB, 1995, INT J PHARMACEUT, V116, P1
   PIRICH C, 1995, ANN NY ACAD SCI, V748, P613
   Qian HS, 1999, CIRCULATION, V99, P2979, DOI 10.1161/01.CIR.99.23.2979
   Rader DJ, 1997, INT J CLIN LAB RES, V27, P35, DOI 10.1007/BF02827240
   Ranney DF, 2000, BIOCHEM PHARMACOL, V59, P105, DOI 10.1016/S0006-2952(99)00316-0
   Rasmussen Henrik Sandvad, 2002, Cardiovasc Radiat Med, V3, P114, DOI 10.1016/S1522-1865(02)00158-0
   Roessler BJ, 2001, BIOCHEM BIOPH RES CO, V283, P124, DOI 10.1006/bbrc.2001.4690
   ROSEN JM, 1990, J NUCL MED, V31, P343
   ROSS R, 1997, HEART DIS TXB CARDIO, P1105
   Schultz DA, 2003, CURR OPIN BIOTECH, V14, P13, DOI 10.1016/S0958-1669(02)000150
   Shah Svati H, 2003, Cardiol Rev, V11, P169, DOI 10.1097/01.CRD.0000077906.74217.6E
   Sipkins DA, 1998, NAT MED, V4, P623, DOI 10.1038/nm0598-623
   Smith AM, 2004, ANALYST, V129, P672, DOI 10.1039/b404498n
   SMITH LC, 1995, ADV EXP MED BIOL, V369, P79
   STEG PG, 1994, CIRCULATION, V90, P1648, DOI 10.1161/01.CIR.90.4.1648
   STEINBERG D, 1989, NEW ENGL J MED, V320, P915
   STEINBRECHER UP, 1989, J BIOL CHEM, V264, P15216
   Stephan DJ, 1996, HUM GENE THER, V7, P1803, DOI 10.1089/hum.1996.7.15-1803
   Torchilin VP, 1998, J MICROENCAPSUL, V15, P1, DOI 10.3109/02652049809006831
   Toussaint JF, 1996, CIRCULATION, V94, P932, DOI 10.1161/01.CIR.94.5.932
   TOUSSAINT JF, 1995, ARTERIOSCL THROM VAS, V15, P1533
   Tsimikas S, 1999, J NUCL CARDIOL, V6, P41, DOI 10.1016/S1071-3581(99)90064-8
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   VALLABHAJOSULA S, 1990, SEMIN NUCL MED, V20, P68, DOI 10.1016/S0001-2998(05)80177-1
   Vallabhajosula S., 1996, Journal of Nuclear Medicine, V37, p38P
   VALLABHAJOSULA S, 1988, J NUCL MED, V29, P1237
   VANDER A, 1998, HUMAN PHYSL MECH BOD
   VIRGOLINI I, 1991, EUR J NUCL MED, V18, P948
   WIENER EC, 1994, MAGNET RESON MED, V31, P1, DOI 10.1002/mrm.1910310102
   WILSON JM, 1989, SCIENCE, V244, P1344, DOI 10.1126/science.2734614
   Zaric V, 2004, J GENE MED, V6, P176, DOI 10.1002/jgm.484
   ZIMMER A, 1995, ADV DRUG DELIVER REV, V16, P61, DOI 10.1016/0169-409X(95)00017-2
NR 91
TC 0
Z9 0
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4137
EI 1875-6786
J9 CURR NANOSCI
JI Curr. Nanosci.
PD JUN
PY 2005
VL 1
IS 2
BP 107
EP 115
DI 10.2174/1573413054065349
PG 9
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA 992OY
UT WOS:000233894700002
DA 2018-10-20
ER

PT J
AU Herodin, F
   Thullier, P
   Garin, D
   Drouet, M
AF Herodin, F
   Thullier, P
   Garin, D
   Drouet, M
TI Nonhuman primates are relevant models for research in hematology,
   immunology and virology
SO EUROPEAN CYTOKINE NETWORK
LA English
DT Review
DE nonhuman primate model; hematopoiesis; stem cell; immunology; virology;
   cytokines; AIDS; vaccine
ID COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; LETHALLY IRRADIATED
   BABOONS; EX-VIVO EXPANSION; HUMAN MEGAKARYOCYTE GROWTH; AUTOLOGOUS
   BONE-MARROW; TOTAL-BODY IRRADIATION; GLYCOSYLATED HUMAN INTERLEUKIN-6;
   CD34(+) PROGENITOR CELLS; PERIPHERAL-BLOOD STEM
AB Nonhuman primates have been used for biomedical research for several decades. They have proved to be models that are relevant to humans because of the high level of gene homology which underlies physiological and biochemical similarities. The similarity of monkeys to humans has been used to investigate pathophysiological mechanisms in hematology, immunology and virology. New therapeutic procedures can be assessed in primates by using materials, in particular pharmacological reagents, and methods designed for humans. The relevance of these models also relies on the use of species-specific pathogens and the availability of recombinant, homologous cytokines. The introduction of more and more sophisticated cell and gene therapy protocols in hematopoietic cell transplantation and immunotherapy requires the development of preclinical trials similar to clinical settings. For several decades now, baboons and cynomolgus/rhesus monkeys have been the most useful primate models in experimental hematology, and this has contributed to numerous therapeutic advances. Primate models of AIDS have been developed to study the pathogenesis, transmission and immune responses to infection, and to test vaccines and drugs. Primate research should be restricted in quantity, and mainly designed with the aim of removing uncertainty as to the safety and clinical benefit to the patient, of new biomedical protocols.
C1 Ctr Rech, Serv Sante Armees, F-38702 La Tronche, France.
RP Herodin, F (reprint author), Ctr Rech, Serv Sante Armees, 24 Ave Maquis Gresivaudan,BP 87, F-38702 La Tronche, France.
EM fherodin@crssa.net
CR ADAMSON RH, 1975, BIBL HAEMATOL, V40, P723
   Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953
   ANDREWS RG, 1995, BLOOD, V85, P15
   ANDREWS RG, 1992, BLOOD, V80, P1693
   Andrews RG, 2000, EXP HEMATOL, V28, P508, DOI 10.1016/S0301-472X(00)00137-5
   Andrews RG, 1999, STEM CELLS, V17, P210, DOI 10.1002/stem.170210
   ANDRISWIHOPF J, 2001, PHAGE DISPLAY LAB MA
   Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409
   Berg SL, 1999, J PEDIAT HEMATOL ONC, V21, P26, DOI 10.1097/00043426-199901000-00006
   Bertho JM, 2001, INT J RADIAT BIOL, V77, P703, DOI 10.1080/09553000110043711
   Brandt JE, 1999, BLOOD, V94, P106
   Brown JM, 2004, EXP HEMATOL, V32, P693, DOI 10.1016/j.exphem.2004.07.001
   Bugelski PJ, 2000, HUM EXP TOXICOL, V19, P230, DOI 10.1191/096032700678815783
   Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054
   Chassagne S, 2004, MOL IMMUNOL, V41, P539, DOI 10.1016/j.molimm.2004.03.040
   Chenuaud P, 2004, BLOOD, V103, P3303, DOI 10.1182/blood-2003-11-3848
   CIVIN CI, 1984, J IMMUNOL, V133, P157
   Coates PTH, 2003, BLOOD, V102, P2513, DOI 10.1182/blood-2002-09-2929
   Cosimi AB, 2004, TRANSPLANTATION, V77, P943, DOI 10.1097/01.TP.0000117779.23431.3F
   DeJong MO, 1997, STEM CELLS, V15, P275, DOI 10.1002/stem.150275
   DEREVEL T, 2000, C SFGM MARS
   Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4
   Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830
   DONAHUE RE, 1986, NATURE, V321, P872, DOI 10.1038/321872a0
   Donahue RE, 2000, BLOOD, V95, P445
   DORSSERS LCJ, 1994, GROWTH FACTORS, V11, P93, DOI 10.3109/08977199409001051
   Drouet M, 1999, STEM CELLS, V17, P273, DOI 10.1002/stem.170273
   Drouet M, 2004, BLOOD, V103, P878, DOI 10.1182/blood-2003-05-1400
   Drouet M, 2003, EXP HEMATOL, V31, P180
   Drouet M, 2001, STEM CELLS, V19, P436, DOI 10.1634/stemcells.19-5-436
   Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331
   EVES EM, 1989, EXP HEMATOL, V17, P73
   Farese AM, 1996, J CLIN INVEST, V97, P2145, DOI 10.1172/JCI118652
   FARESE AM, 1995, BLOOD, V86, P54
   Fisher JW, 1996, BRIT J HAEMATOL, V95, P27, DOI 10.1046/j.1365-2141.1996.d01-1864.x
   Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297
   Gao CJ, 2003, MOL THER, V8, P974, DOI 10.1016/j.ymthe.2003.08.017
   GILLIO AP, 1990, J CLIN INVEST, V85, P1560, DOI 10.1172/JCI114605
   Glamann J, 1998, J VIROL, V72, P585
   Gomes APM, 2001, INT ENDOD J, V34, P93, DOI 10.1046/j.1365-2591.2001.00353.x
   Gorman S D, 1990, Semin Immunol, V2, P457
   Gottlieb AB, 2004, CLIN IMMUNOL, V111, P28, DOI 10.1016/j.clim.2004.01.006
   Gruber A, 2003, BLOOD, V102, P953, DOI 10.1182/blood-2003-01-0324
   Haig D, 1999, AM J PRIMATOL, V49, P285, DOI 10.1002/(SICI)1098-2345(199912)49:4<285::AID-AJP1>3.3.CO;2-O
   Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045
   Hanazono Y, 2001, STEM CELLS, V19, P12, DOI 10.1634/stemcells.19-1-12
   Harker LA, 1998, BLOOD, V91, P4427
   Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489
   HARRISON MR, 1989, LANCET, V2, P1425
   Hartong SCC, 2000, EXP HEMATOL, V28, P753, DOI 10.1016/S0301-472X(00)00171-5
   HERODIN F, 1992, BLOOD, V80, P688
   HILLYER CD, 1993, EXP HEMATOL, V21, P1455
   Hirsch V M, 2000, Adv Pharmacol, V49, P437
   Honig GR, 2004, BLOOD CELL MOL DIS, V32, P5, DOI 10.1016/j.bcmd.2003.09.008
   Horn PA, 2003, BLOOD, V102, P4329, DOI 10.1182/blood-2003-01-0082
   Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000
   JAHRLING PB, 2000, EMERG INFECT DIS, V4, P187
   Kaufman DS, 2004, BLOOD, V103, P1325, DOI 10.1182/blood-2003-03-0799
   Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101
   Kennedy AD, 2003, BLOOD, V101, P1071, DOI 10.1182/blood-2002-03-0876
   King AG, 2001, BLOOD, V97, P1534, DOI 10.1182/blood.V97.6.1534
   Kitchener S, 2004, VACCINE, V22, P2103, DOI 10.1016/j.vaccine.2004.01.026
   KOTZE HF, 1985, THROMB HAEMOSTASIS, V53, P408
   Kuramoto K, 2004, BLOOD, V103, P4070, DOI 10.1182/blood-2003-08-2934
   Laterveer L, 1996, BLOOD, V87, P781
   Laukkanen MO, 2005, BLOOD, V105, P1010, DOI 10.1182/blood-2004-04-1498
   Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006
   LEWIS AP, 1993, DEV COMP IMMUNOL, V17, P549, DOI 10.1016/S0145-305X(05)80010-2
   Lifson JD, 2004, AIDS RES HUM RETROV, V20, P772, DOI 10.1089/0889222041524661
   LUCCIANI P, 1998, PRIMATOLOGIE, V1, P285
   MacVittie TJ, 2000, BLOOD, V95, P837
   MacVittie TJ, 1996, BLOOD, V87, P4129
   MacVittie TJ, 1999, EXP HEMATOL, V27, P1557, DOI 10.1016/S0301-472X(99)00092-2
   Mahmud N, 2001, BLOOD, V97, P3061, DOI 10.1182/blood.V97.10.3061
   Marchevsky RS, 2003, VIROLOGY, V316, P55, DOI 10.1016/S0042-6822(03)00583-X
   MESTRIES JC, 1994, EUR CYTOKINE NETW, V5, P275
   Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877
   MONROY RL, 1987, BLOOD, V70, P1696
   MONROY RL, 1988, EXP HEMATOL, V16, P344
   Morris JC, 2004, BLOOD, V103, P492, DOI 10.1182/blood-2003-07-2324
   Muller MC, 2003, FRONT BIOSCI, V8, pD1170, DOI 10.2741/1130
   Mychaliska GB, 1997, J PEDIATR SURG, V32, P976, DOI 10.1016/S0022-3468(97)90381-X
   Nakatsuji Norio, 2002, ScientificWorldJournal, V2, P1762
   Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263
   Neelis KJ, 1997, BLOOD, V90, P2565
   NEWMAN R, 1992, BIO-TECHNOL, V10, P1455, DOI 10.1038/nbt1192-1455
   NIBLACK GD, 1976, CLIN EXP IMMUNOL, V23, P536
   Norol F, 2003, BLOOD, V102, P4361, DOI 10.1182/blood-2003-03-0685
   Norol F, 2002, BRIT J HAEMATOL, V117, P924, DOI 10.1046/j.1365-2141.2002.03531.x
   Norol F, 2000, BRIT J HAEMATOL, V109, P162, DOI 10.1046/j.1365-2141.2000.01995.x
   Ozwara H, 1997, J MED PRIMATOL, V26, P164, DOI 10.1111/j.1600-0684.1997.tb00048.x
   Papayannopoulou T, 1997, BLOOD, V90, P620
   PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374
   Prilliman K, 1996, TRANSPLANTATION, V61, P989, DOI 10.1097/00007890-199604150-00001
   Ramsburg E, 2004, J VIROL, V78, P3930, DOI 10.1128/JVI.78.8.3930-3940.2004
   Rey M, 1966, B SOC MED AFR NOIRE, V11, P560
   Rosenzweig M, 1999, BLOOD, V94, P2271
   Rubenstein JL, 2003, BLOOD, V101, P466, DOI 10.1182/blood-2002-06-1636
   Sablinski T, 1999, TRANSPLANTATION, V67, P972, DOI 10.1097/00007890-199904150-00007
   Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102
   SCHERMAN FJ, 1996, STEM CELLS, V14, P517
   Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407
   Shields LE, 2003, STEM CELLS, V21, P304, DOI 10.1634/stemcells.21-3-304
   Slungaard A, 2003, BLOOD, V102, P146, DOI 10.1182/blood-2002-11-3529
   Sopper S, 1997, CYTOMETRY, V29, P351
   Staprans Silvija I, 2004, Expert Rev Vaccines, V3, pS5, DOI 10.1586/14760584.3.4.S5
   Stittelaar KJ, 2002, VACCINE, V21, P155, DOI 10.1016/S0264-410X(02)00453-X
   STORB R, 1977, BLOOD, V50, P537
   STORB R, 1994, BLOOD, V83, P3384
   Storek J, 2003, BLOOD, V101, P4209, DOI 10.1182/blood-2002-08-2671
   Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343
   Thiebot H, 2005, BLOOD, V105, P2403, DOI 10.1182/blood-2004-01-0025
   Tisdale JF, 1998, BLOOD, V92, P1131
   Umeda K, 2004, DEVELOPMENT, V131, P1869, DOI 10.1242/dev.01065
   VANGILS FCJM, 1994, EXP HEMATOL, V22, P248
   Vetillard J, 1999, J HEMATOTH STEM CELL, V8, P365, DOI 10.1089/152581699320126
   VILLINGER F, 1995, J IMMUNOL, V155, P3946
   Vrana KE, 2003, P NATL ACAD SCI USA, V100, P11911, DOI 10.1073/pnas.2034195100
   WELTE K, 1987, J EXP MED, V165, P941, DOI 10.1084/jem.165.4.941
   WEN D, 1993, BLOOD, V82, P1507
   *WHO, 1998, WHO TECH REP SER, V872, P30
   WIENER A S, 1974, Haematologia, V8, P195
   Wild MA, 2003, NAT BIOTECHNOL, V21, P1305, DOI 10.1038/nbt891
   Williams Douglas E., 1993, Biotechnology Therapeutics, V4, P17
   Winkler A, 1999, HUM GENE THER, V10, P667, DOI 10.1089/10430349950018742
   WOLD DP, 2004, BIOL REPROD, V71, P1766
   Wu T, 2000, MOL THER, V1, P285, DOI 10.1006/mthe.2000.0034
   Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042
   2002, EUROPEAN PHARM
NR 130
TC 35
Z9 38
U1 0
U2 3
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1148-5493
J9 EUR CYTOKINE NETW
JI Eur. Cytokine Netw.
PD JUN
PY 2005
VL 16
IS 2
BP 104
EP 116
PG 13
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 937CG
UT WOS:000229901600002
PM 15941681
DA 2018-10-20
ER

PT J
AU Balasubramanian, A
   Bhuva, B
   Mernaugh, R
   Haselton, FR
AF Balasubramanian, A
   Bhuva, B
   Mernaugh, R
   Haselton, FR
TI Si-based sensor for virus detection
SO IEEE SENSORS JOURNAL
LA English
DT Article
DE Analog integrated circuits; biomedical transducers; capacitance
   measurement; dielectric material; differential amplifiers
ID BIOSENSOR; DNA; SIGNAL
AB This paper describes the development of a sensor for the detection of viruses. The detection scheme uses sense and dummy capacitors and a sense amplifier circuit to compare capacitance values. The presence of sufficient biological material within the sense capacitor alters the sense amplifier output. This promising approach has the potential to more rapidly test for the presence of virus using an IC platform.
C1 Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA.
   Vanderbilt Univ, Dept Biochem, Nashville, TN 37235 USA.
   Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.
RP Balasubramanian, A (reprint author), Vanderbilt Univ, Dept Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM bhuva@vuse.vanderbilt.edu
CR ANDERSON GP, 1994, IEEE ENG MED BIOL, V13, P358, DOI 10.1109/51.294007
   ANDLE JCV, 1990, IEEE 4 TECH DIG SOL
   Baselt DR, 1997, P IEEE, V85, P672, DOI 10.1109/5.573755
   BERGAUD CC, 2001, IEEE 8 INT C TECHN F
   Berggren C, 1998, BIOSENS BIOELECTRON, V13, P1061, DOI 10.1016/S0956-5663(98)00058-X
   BONE S, 1995, BBA-GENE STRUCT EXPR, V1260, P85, DOI 10.1016/0167-4781(94)00181-2
   BONINCONTRO A, 1993, BIOCHIM BIOPHYS ACTA, V1171, P288, DOI 10.1016/0167-4781(93)90067-N
   DHANG SHL, 1988, IEEE J, V23, P34
   Dumitrascu G, 2001, IEEE T MAGN, V37, P2932, DOI 10.1109/20.951351
   GEIB H, 1992, IEEE J SOLID-ST CIRC, V27, P1028, DOI 10.1109/4.142598
   HAFEMAN DG, 1992, Patent No. 5164319
   HELLER MJ, 1994, Patent No. 5632957
   JUNG CM, 2002, 15 TECH DIG OPT FIB
   KARLSSON N, 1994, IEEE 10 INT C INSTR
   KARLSSON NJ, 1993, IEEE 9 INT C INSTR M
   Kawabata T, 2001, IEEE T IND APPL, V37, P1625, DOI 10.1109/28.968170
   KOSSLINGER CR, 1981, INT C SOL STAT SENS
   KOTHARI MW, 1988, IEEE INT C ENG MED B
   KOUFAS DF, 1998, IEEE 24 ANN NE BIOEN
   Laurent DG, 2002, IEEE T CIRCUITS-I, V49, P269, DOI 10.1109/81.989159
   Machida K, 2001, IEEE T ELECTRON DEV, V48, P2273, DOI 10.1109/16.954466
   Moore SK, 2001, IEEE SPECTRUM, V38, P54, DOI 10.1109/6.908856
   PACE SJ, 1990, Patent No. 4908112
   SAKAI GO, 1997, INT C SOL STAT SENS
   SARPESHKAR RW, 1991, IEEE INT S CIRC SYST
   Souteyrand E, 1997, J PHYS CHEM B, V101, P2980, DOI 10.1021/jp963056h
   SUEHIRO JN, 2001, IEEE 36 IAS ANN M IN
   1989, Patent No. 4822566
NR 28
TC 19
Z9 19
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1530-437X
J9 IEEE SENS J
JI IEEE Sens. J.
PD JUN
PY 2005
VL 5
IS 3
BP 340
EP 344
DI 10.1109/JSEN.2005.844543
PG 5
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Physics, Applied
SC Engineering; Instruments & Instrumentation; Physics
GA 925WQ
UT WOS:000229084500002
DA 2018-10-20
ER

PT J
AU Fridman, G
   Li, MY
   Lelkes, PI
   Friedman, G
   Fridman, A
   Gutsol, AF
AF Fridman, G
   Li, MY
   Lelkes, PI
   Friedman, G
   Fridman, A
   Gutsol, AF
TI Nonthermal plasma bio-active liquid micro and nano-xerography
SO IEEE TRANSACTIONS ON PLASMA SCIENCE
LA English
DT Article
DE biomedical equipment; plasma applications; plasma materials-processing
   applications
AB Method of biochemical patterning which allows for micro- and nano-scale resolution on nonplanar substrates is presented. Utilizing this method, bio-molecules (including DNA, proteins, and enzymes) can be delivered to charged locations on surfaces by charged water buffer droplets. Charging of water droplets is accomplished using dielectric barrier discharge (DBD) plasma. DBD was effectively stabilized in the presence of high concentration of micron-size water droplets. The concepts of the proposed method, as well as first experimental results supporting the idea are discussed in this paper.
C1 Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, Philadelphia, PA 19104 USA.
   Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA.
RP Fridman, G (reprint author), Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, Philadelphia, PA 19104 USA.
EM gf33@drexel.edu; mengyan.li@drexel.edu; pilelkes@drexel.edu;
   gary@ece.drexel.edu; fridman@drexel.edu; gutsol@drexel.edu
OI Fridman, Gregory/0000-0003-4006-4722
CR Babaeva NY, 1996, J PHYS D APPL PHYS, V29, P2423, DOI 10.1088/0022-3727/29/9/029
   DJERMOUNE D, 1995, 11 INT C GAS DISCH T, V2, P484
   FORTOV VE, 2000, CHARGE COUPLING ORDE
   FRIDMAN A, 2003, FUNDAMENTALS PLASMS
   Kogelschatz U., 1988, PROCESS TECHNOLOGIES, P87
   Kogelschatz U., 2003, PLASMA CHEM PLASMA P
   KOZYREV AV, 2001, USPEKHI FIZICHESKIKH
   KULIKOVSKY AA, 1994, J PHYS D APPL PHYS, V27, P2556, DOI 10.1088/0022-3727/27/12/017
   Kunchardt E. E., 1988, PHYS REV A, VA38, P1410
   MORAVEJ M, 2004, J APPL PHYS
   RAIZER PR, 1991, GAS DISCHARE PHYS
   SIRIGNANO WA, 1999, FLUID DYNAMICS TRANS
NR 12
TC 3
Z9 4
U1 0
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0093-3813
J9 IEEE T PLASMA SCI
JI IEEE Trans. Plasma Sci.
PD JUN
PY 2005
VL 33
IS 3
BP 1061
EP 1065
DI 10.1109/TPS.2005.848602
PG 5
WC Physics, Fluids & Plasmas
SC Physics
GA 935TR
UT WOS:000229806800010
DA 2018-10-20
ER

PT J
AU Pound, MW
   May, DB
AF Pound, MW
   May, DB
TI Proposed mechanisms and preventative options of Jarisch-Herxheimer
   reactions
SO JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
LA English
DT Article
DE antibiotics; cytokines; endotoxin; Jarisch-Herxheimer reactions;
   spirochete
ID BORNE RELAPSING FEVER; TUMOR-NECROSIS-FACTOR; BORRELIA-RECURRENTIS
   INFECTION; TREPONEMA-PALLIDUM; ENDOTOXEMIA; PENICILLIN; TETRACYCLINE;
   MODEL
AB Objective: To review the aetiologies and preventative methods associated with Jarisch-Herxheimer reactions (JHR).
   Data sources: Ovid Medline((R)) (1966-June Week 1 2004) was utilized to assess biomedical literature; a review of the bibliographies of articles was also performed.
   Data synthesis: JHR often occurs with the treatment of spirochete infections. However, the mechanism by which the reaction takes place is not clearly defined.
   Conclusion: Studies suggest with conflicting evidence that the JHR is caused by release of endotoxin-like material from the spirochete as well as cytokine elevation in the body. It appears the type of drug and the rate of spirochete clearance from the body have little effect on the incidence of the reaction. Many pretreatment options have been explored with limited efficacy with the exception of anti-tumour necrosis factor antibodies.
C1 Campbell Univ, Sch Pharm, Dept Pharm Practice, Buies Creek, NC 27506 USA.
   Cape Fear Valley Hlth Syst, Dept Pharm, Fayetteville, NC USA.
   Duke Univ, Med Ctr, Dept Pharm, Durham, NC USA.
RP Pound, MW (reprint author), Campbell Univ, Sch Pharm, Dept Pharm Practice, POB 1090, Buies Creek, NC 27506 USA.
EM mpound@capefearvalley.com
CR BRYCESON AD, 1972, CLIN SCI, V43, P343, DOI 10.1042/cs0430343
   BUTLER T, 1978, J INFECT DIS, V137, P573, DOI 10.1093/infdis/137.5.573
   Cooper PJ, 2000, J INFECT DIS, V181, P203, DOI 10.1086/315183
   Dworkin MS, 1998, CLIN INFECT DIS, V26, P122, DOI 10.1086/516273
   ELIN RJ, 1975, NEW ENGL J MED, V293, P521, DOI 10.1056/NEJM197509112931102
   ELIN RJ, 1973, J INFECT DIS, V128, P349, DOI 10.1093/infdis/128.3.349
   Fekade D, 1996, NEW ENGL J MED, V335, P311, DOI 10.1056/NEJM199608013350503
   GALLOWAY RE, 1977, AM J MED, V63, P933, DOI 10.1016/0002-9343(77)90548-4
   GEBREHIWOT T, 1992, ETHIOPIAN MED J, V30, P175
   GELFAND JA, 1976, NEW ENGL J MED, V295, P211, DOI 10.1056/NEJM197607222950409
   Griffin GE, 1998, J ANTIMICROB CHEMOTH, V41, P25, DOI 10.1093/jac/41.suppl_1.25
   GUDJONSSON H, 1968, ACTA DERM-VENEREOL, V48, P15
   HARDY PH, 1983, P SOC EXP BIOL MED, V174, P47
   Herxheimer K, 1902, DEUT MED WOCHENSCHR, V28, P895, DOI 10.1055/s-0028-1139096
   Jarisch A., 1895, WIEN MED WOCHENSCHR, V45, P721
   Maloy A L, 1998, J Emerg Med, V16, P437, DOI 10.1016/S0736-4679(98)00011-0
   Meislin H W, 1976, JACEP, V5, P779, DOI 10.1016/S0361-1124(76)80309-7
   NADELMAN RB, 1992, ANN INTERN MED, V117, P273, DOI 10.7326/0003-4819-117-4-273
   NEGUSSIE Y, 1992, J EXP MED, V175, P1207, DOI 10.1084/jem.175.5.1207
   RADOLF JD, 1991, J IMMUNOL, V147, P1968
   REMICK DG, 1986, J INFECT DIS, V174, P627
   ROSEN T, 1989, ARCH DERMATOL, V125, P77, DOI 10.1001/archderm.125.1.77
   SHENEP JL, 1986, JAMA-J AM MED ASSOC, V256, P388, DOI 10.1001/jama.256.3.388
   TEKLU B, 1983, LANCET, V1, P835
   VAUGHAN C, 1994, POSTGRAD MED J, V70, P118, DOI 10.1136/pgmj.70.820.118
   WARRELL DA, 1983, J INFECT DIS, V147, P898, DOI 10.1093/infdis/147.5.898
   YOUNG EJ, 1982, J INFECT DIS, V146, P606, DOI 10.1093/infdis/146.5.606
   1967, BRIT MED J, V1, P384
NR 28
TC 52
Z9 53
U1 0
U2 6
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0269-4727
J9 J CLIN PHARM THER
JI J. Clin. Pharm. Ther.
PD JUN
PY 2005
VL 30
IS 3
BP 291
EP 295
DI 10.1111/j.1365-2710.2005.00631.x
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 927DX
UT WOS:000229173700014
PM 15896248
DA 2018-10-20
ER

PT J
AU Zhang, M
   James, SP
AF Zhang, M
   James, SP
TI Synthesis and properties of melt-processable hyaluronan esters
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID DERIVATIVES; ACID
AB A series of melt-processable hyaluronan ( HA) esters were synthesized for potential biomedical applications ( e. g., hot molding with thermoplastic ultra high molecular weight polyethylene for total joint replacements or molding tissue engineering scaffold). A silylated complex of HA with cetyltrimethylammonium cations ( silyl HA-CTA) was used as the starting material. The reactions were performed with acid chlorides as the acylation agents in xylenes or no solvent other than the acid chloride. The disappearance of all characteristic FT-IR vibration bands associated with the - OSi(CH3)(3) groups and the appearance of the strong ester carbonyl peak at 1753 cm(-1) demonstrated the success of esterification. Thermoplasticity was achieved when the length of aliphatic chains in the HA esters was equal to or greater than 10 carbon atoms. It was found that the longer the ester chain, the lower the melting point; thus, to meet various needs different melting temperatures can be obtained by adjusting the acid chloride chain length. (C) 2005 Springer Science + Business Media, Inc.
C1 Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
RP James, SP (reprint author), Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
EM sjames@lamar.colostate.edu
CR Balazs E. A., 1970, CHEMISTRY MOLECULAR, P1241
   BALAZS EA, 1989, CIBA F SYMP, V143, P265
   BALAZS EA, 1984, COSMET TOILETRIES, V99, P65
   BALAZS EA, 2000, SCARLESS WOUND HEALI, P143
   BARBUCCI R, 1993, J BIOMAT SCI-POLYM E, V4, P245, DOI 10.1163/156856293X00555
   Brun P, 2000, INT CONGR SER, V1196, P269
   Della Valle F, 1989, U.S. Patent, Patent No. [4,851,521, 4851521, 4851521A]
   FAVIA P, 1998, PLASMAS POLYM, V3, P77, DOI DOI 10.1023/B:PAPO.0000005940.30092.58
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Heinegard D, 1998, WENN GR INT, V72, P113
   Hoekstra D., 1999, MED DEVICES DIAGNOST, P51
   KENNEDY JF, 2002, HYALURONAN 2000, V2, P3461
   Klemm D, 1998, COMPREHENSIVE CELLUL, V2, P164
   KLEMM D, 1998, COMPREHENSIVE CELLUL, V1, P235
   LAURENT TC, 2003, GLYCOFORUM SCI HYALU
   LAURENT TC, 1970, CHEM MOL BIOL INTERC, P703
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Ogston AG, 1970, CHEMISTRY MOLECULAR, P1231
   SCOTT J. E., 1960, METHODS BIOCHEM ANAL, V8, P145
   SHIRAISHI N, 1979, J APPL POLYM SCI, V24, P2361, DOI 10.1002/app.1979.070241204
   SMITH B, 1998, INFRARED SPECTRAL IN, P158
   STEIN A, 1988, MAKROMOL CHEM-RAPID, V9, P569
   Weiss C, 1998, WENN GR INT, V72, P255
   YUI N, 2002, Patent No. 20020143171
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   ZHANG M, 2004, INSTRU SOC AM, V40, P13
   ZHANG M, UNPUB POLYMER
   ZHANG M, 2004, THESIS COLORADO STAT
NR 28
TC 4
Z9 4
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD JUN
PY 2005
VL 40
IS 11
BP 2937
EP 2943
DI 10.1007/s10853-005-2432-7
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 936TN
UT WOS:000229878400026
DA 2018-10-20
ER

PT J
AU Barralet, JE
   Wang, L
   Lawson, M
   Triffitt, JT
   Cooper, PR
   Shelton, RM
AF Barralet, JE
   Wang, L
   Lawson, M
   Triffitt, JT
   Cooper, PR
   Shelton, RM
TI Comparison of bone marrow cell growth on 2D and 3D alginate hydrogels
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID STROMAL CELLS
AB Calcium cross-linked sodium alginate hydrogels have several advantageous features making them potentially suitable as tissue engineering scaffolds and this material has been previously used in many biomedical applications. 3D cell culture systems are often very different from 2D petri dish type cultures. in this study the effect of alginate hydrogel architecture was investigated by comparing rat bone marrow cell proliferation and differentiation on calcium cross linked sodium alginate discs and 1mm internal diameter tubes. It was found that bone marrow cell proliferation was diminished as the concentration of alginate in the 2D hydrogel substrates increased, yet proliferation was extensive on tubular alginate constructs with high alginate contents. Alginate gel thickness was found to be an important parameter in determining cell behaviour and the different geometries did not generate significant alterations in BMC differentiation profiles. (C) 2005 Springer Science + Business Media, Inc.
C1 McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   Univ Birmingham, Sch Dent, Biomat Unit, Birmingham B4 6NN, W Midlands, England.
   Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford OX3 7LD, England.
RP Barralet, JE (reprint author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.
RI barralet, jake/A-5820-2008
OI barralet, jake/0000-0003-3543-6042; Cooper, Paul/0000-0003-1305-7287
CR Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   HAUSELMANN HJ, 1994, J CELL SCI, V17, P107
   Hishikawa K, 2004, BIOCHEM BIOPH RES CO, V317, P1103, DOI 10.1016/j.bbrc.2004.03.165
   Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1
   Lawson MA, 2004, TISSUE ENG, V10, P1480, DOI 10.1089/ten.2004.10.1480
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   MATTHEW IR, 1995, BIOMATERIALS, V16, P275, DOI 10.1016/0142-9612(95)93254-B
   TAYLOR KA, 1992, ANAL BIOCHEM, V201, P190, DOI 10.1016/0003-2697(92)90194-C
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
NR 15
TC 53
Z9 53
U1 3
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 515
EP 519
DI 10.1007/s10856-005-0526-z
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100005
PM 15928866
DA 2018-10-20
ER

PT J
AU Kuo, SM
   Wang, YJ
   Weng, CL
   Lu, HE
   Chang, SJ
AF Kuo, SM
   Wang, YJ
   Weng, CL
   Lu, HE
   Chang, SJ
TI Influence of alginate on type II collagen fibrillogenesis
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID IN-VITRO; FIBRIL FORMATION; CHONDROCYTES; INVITRO; TISSUE; CELLS
AB Collagen II is the majority of extracellular matrix components in articular cartilage, which with the major functions of preventing expansion of the tissue and distributing the load of body weight. To obtain man-made ECM, the reconstitution of collagen could be conducted in the presence of negatively charged polysaccharide, such as alginate. Alginate is an anionic polysaccharide capable of eversible gelated in calcium ion solution to prepare different shapes of biomaterials. Its well-known biocompatibility makes it an ideal material in biomedical applications. Thus, the aim of this study was to evaluate the effects of alginate on the fibrillogenesis of type II collagen. The preliminary results revealed that inclusion of alginate into soluble type II collagen solution could inhibit the development of turbidity of collagen solution, and the apparent rate constants in lag and growth phases decreased during collagen formation period, both rate constants decreased to about one-third of the original constants, respectively. From TEM observations, the collagen fibrils were significantly thicker in 0.05% and 0.1% alginate as compared with pure collagen solution. Furthermore, the D-periods of collagen fibers kept unchanged significantly under all reconstituted conditions, which meant the packing of collagen monomer was probably not affected by adding these amounts of alginate. (C) 2005 Springer Science + Business Media, Inc.
C1 I SHOU Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
   Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
RP Chang, SJ (reprint author), I SHOU Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
EM sjchang@isu.edu.tw
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Beekman B, 1997, EXP CELL RES, V237, P135, DOI 10.1006/excr.1997.3771
   BIRK DE, 1984, ARCH BIOCHEM BIOPHYS, V235, P178, DOI 10.1016/0003-9861(84)90266-2
   BROKAW JL, 1985, INT J BIOL MACROMOL, V7, P135, DOI 10.1016/0141-8130(85)90015-7
   de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8
   Delorenzi NJ, 1996, INT J BIOL MACROMOL, V19, P15, DOI 10.1016/0141-8130(96)01094-X
   Fried A, 1996, J CELL BIOCHEM, V61, P246
   GELMAN RA, 1980, J BIOL CHEM, V255, P8098
   Goh MC, 1997, PHYSICA A, V239, P95, DOI 10.1016/S0378-4371(96)00472-4
   Gregory KE, 1999, EXP CELL RES, V246, P98, DOI 10.1006/excr.1998.4291
   Kobayashi S, 2000, SURG NEUROL, V54, P66
   Lee CH, 2004, ARTIF ORGANS, V28, P537, DOI 10.1111/j.1525-1594.2004.00051.x
   Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Ohno T, 2004, MAT SCI ENG C-BIO S, V24, P407, DOI 10.1016/j.msec.2003.11.011
   Okada N, 1997, BIOCHEM BIOPH RES CO, V230, P524, DOI 10.1006/bbrc.1996.5996
   Peirone M, 1998, J BIOMED MATER RES, V42, P587, DOI 10.1002/(SICI)1097-4636(19981215)42:4<587::AID-JBM15>3.0.CO;2-X
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   PROCKOP DJ, 1994, EXTRACELLULAR MATRIX, P90
   RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081
   ROMANIC AM, 1992, J BIOL CHEM, V267, P22265
   SCOTT PG, 1995, BBA-GEN SUBJECTS, V1244, P121, DOI 10.1016/0304-4165(94)00209-G
   SILVER FH, 1979, BIOPOLYMERS, V18, P2523, DOI 10.1002/bip.1979.360181011
   SILVER FH, 1983, COLLAGEN REL RES, V3, P393
   SILVER FH, 1981, J BIOL CHEM, V256, P4973
   TRELSTAD RL, 1976, P NATL ACAD SCI USA, V73, P4027, DOI 10.1073/pnas.73.11.4027
   TSUHIYA K, 2001, MAT SCI ENG C-BIO S, V17, P79
   Veis A., 1994, EXTRACELLULAR MATRIX, P15
   WI WN, 2003, J ORTHOP RES, V21, P282
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
NR 29
TC 9
Z9 10
U1 1
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 525
EP 531
DI 10.1007/s10856-005-0528-x
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100007
PM 15928868
DA 2018-10-20
ER

PT J
AU Silva, SS
   Santos, MI
   Coutinho, OP
   Mano, JF
   Reis, RL
AF Silva, SS
   Santos, MI
   Coutinho, OP
   Mano, JF
   Reis, RL
TI Physical properties and biocompatibility of chitosan/soy blended
   membranes
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID SOYBEAN PROTEIN; FILMS; TENSILE
AB Blends of polysaccharides and proteins are a source for the development of novel materials with interesting and tailorable properties, with potential to be used in a range of biomedical applications. in this work a series of blended membranes composed by chitosan and soy protein isolate was prepared by solvent casting methodology. in addition, cross-linking was performed in situ with glutaraldehyde solutions in the range 5 x 10(-3) -0.1 M. Furthermore, the influence of the composition and cross-linking on the degradation behaviour, water uptake and cell adhesion was investigated. The obtained results showed that the incorporation of chitosan, associated to network formation by cross linking, promoted a slight decrease of water absorption and a slower degradability of the membranes. Moreover, direct contact biocompatibility studies, with L929 cells, indicate that the cross-linking enhances the capability of the material to support cell growth. (C) 2005 Springer Science + Business Media, Inc.
C1 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, Dept Biol, P-4710057 Braga, Portugal.
RP Silva, SS (reprint author), 3Bs Res Grp Biomat Biodegradables & Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM simonesilva@dep.uminho.pt
RI Coutinho, Olga/K-7155-2013; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Silva, Simone/F-9757-2011
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Mano,
   Joao/0000-0002-2342-3765; Silva, Simone/0000-0003-4268-9419; Coutinho,
   Olga/0000-0002-0647-080X
CR [Anonymous], 1992, 10993 ISO 5
   BAKOS D, 2001, NATO SCI SERIES, P55
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hua YF, 2003, FOOD HYDROCOLLOID, V17, P889, DOI 10.1016/S0268-005X(03)00110-3
   Khan TA, 2003, J PHARM PHARM SCI, V6, P20
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   Mo XQ, 2001, IND CROP PROD, V14, P1, DOI 10.1016/S0926-6690(00)00083-2
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   Rhim JW, 2000, J AGR FOOD CHEM, V48, P4937, DOI 10.1021/jf0005418
   Rhim JW, 1998, IND CROP PROD, V8, P195, DOI 10.1016/S0926-6690(98)00003-X
   Silva RM, 2004, J MATER SCI-MATER M, V15, P523, DOI 10.1023/B:JMSM.0000021132.60475.79
   SILVA RM, 2003, UNPUB J MAT SCI MAT
   Subirade M, 1998, INT J BIOL MACROMOL, V23, P241, DOI 10.1016/S0141-8130(98)00052-X
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   Were L, 1999, J FOOD SCI, V64, P514, DOI 10.1111/j.1365-2621.1999.tb15074.x
NR 18
TC 77
Z9 83
U1 1
U2 28
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 575
EP 579
DI 10.1007/s10856-005-0534-z
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100013
PM 15928874
DA 2018-10-20
ER

PT J
AU Zhang, M
   James, SP
AF Zhang, M
   James, SP
TI Synthesis and properties of melt-processable hyaluronan esters
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID DERIVATIVES; ACID
AB A series of melt-processable hyaluronan (HA) esters were synthesized for potential biomedical applications (e.g., hot molding with thermoplastic ultra high molecular weight polyethylene for total joint replacements or molding tissue engineering scaffold). A silylated complex of HA with cetyltrimethylammonium cations (silyl HA-CTA) was used as the starting material. The reactions were performed with acid chlorides as the acylation agents in xylenes or no solvent other than the acid chloride. The disappearance of all characteristic FT-IR vibration bands associated with the -OSi(CH3)(3) groups and the appearance of the strong ester carbonyl peak at 1753 cm(-1) demonstrated the success of esterification. Thermoplasticity was achieved when the length of aliphatic chains in the HA esters was equal to or greater than 10 carbon atoms. It was found that the longer the ester chain, the lower the melting point; thus, to meet various needs different melting temperatures can be obtained by adjusting the acid chloride chain length. (C) 2005 Springer Science + Business Media, Inc.
C1 Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
RP James, SP (reprint author), Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
EM sjames@lamar.colostate.edu
CR Balazs E. A., 1970, CHEMISTRY MOLECULAR, P1241
   BALAZS EA, 1989, CIBA F SYMP, V143, P265
   BALAZS EA, 1984, COSMET TOILETRIES, V99, P65
   BALAZS EA, 2000, SCARLESS WOUND HEALI, P143
   BARBUCCI R, 1993, J BIOMAT SCI-POLYM E, V4, P245, DOI 10.1163/156856293X00555
   Brun P, 2000, INT CONGR SER, V1196, P269
   Della Valle F, 1989, U.S. Patent, Patent No. [4,851,521, 4851521, 4851521A]
   FAVIA P, 1998, PLASMAS POLYM, V3, P77, DOI DOI 10.1023/B:PAPO.0000005940.30092.58
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Heinegard D, 1998, WENN GR INT, V72, P113
   Hoekstra D., 1999, MED DEVICES DIAGNOST, P51
   KENNEDY JF, 2002, HYALURONAN 2000, V2, P3461
   Klemm D, 1998, COMPREHENSIVE CELLUL, V2, P164
   KLEMM D, 1998, COMPREHENSIVE CELLUL, V1, P235
   LAURENT TC, 2003, GLYCOFORUM SCI HYALU
   LAURENT TC, 1970, CHEM MOL BIOL INTERC, P703
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Ogston AG, 1970, CHEMISTRY MOLECULAR, P1231
   SCOTT J. E., 1960, METHODS BIOCHEM ANAL, V8, P145
   SHIRAISHI N, 1979, J APPL POLYM SCI, V24, P2361, DOI 10.1002/app.1979.070241204
   SMITH B, 1998, INFRARED SPECTRAL IN, P158
   STEIN A, 1988, MAKROMOL CHEM-RAPID, V9, P569
   Weiss C, 1998, WENN GR INT, V72, P255
   YUI N, 2002, Patent No. 20020143171
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   ZHANG M, 2004, INSTRU SOC AM, V40, P13
   ZHANG M, UNPUB POLYMER
   ZHANG M, 2004, THESIS COLORADO STAT
NR 28
TC 6
Z9 6
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 587
EP 593
DI 10.1007/s10856-005-0536-x
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100015
PM 15928876
DA 2018-10-20
ER

PT J
AU Autiero, M
   Liuzzi, R
   Riccio, P
   Roberti, G
AF Autiero, M
   Liuzzi, R
   Riccio, P
   Roberti, G
TI Determination of the concentration scaling law of the scattering
   coefficient of water solutions of Intralipid at 832 nm by comparison
   between collimated detection measurements and Monte Carlo Simulations
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE photon transport; scattering media; Intralipid; Monte Carlo simulations;
   parallel computing; transmittance measurements; optical
   transillumination; optical parameters; absorption coefficient;
   scattering coefficient
ID INFRARED OPTICAL-PROPERTIES; TURBID MEDIA; BIOLOGICAL TISSUES; INVERSION
   TECHNIQUE; LIGHT DOSIMETRY; PHANTOM; INVIVO; STATE
AB Background and Objectives: Intralipid (IP) is a scatterer extensively used in the building of phantoms for Biomedical Optics measurements. Recently, deviations from the linearity have been shown for the concentration scaling law of the scattering coefficient of IP water solutions at visible wavelengths. In this work this scaling law was determined at 832 nm.
   Study Design/Materials and Methods: Space resolved transmittance measurements of a laser beam at 832 nm through water solutions of IP and ink were performed and compared with the corresponding results of Monte Carlo simulations.
   Results: The comparison provides a quadratic dependence of mu'(S) on the volume-to-volume scatterer concentration, C-IP, in the range of C-IP values (0.0024 < C-IP < 0.0075). These deviations from the linear behavior are related to the failure of the independent scatterer approximation.
   Conclusion: The quadratic dependence of mu'(S) on C-IP is in agreement with recent results obtained by other groups with different experimental techniques and is validated by a recent theoretical work. (c) 2005 Wiley-Liss, Inc.
C1 Univ Naples Federico II, Dipartimento Sci Fis, I-80126 Naples, Italy.
   Ist Nazl Fis Mat, I-80126 Naples, Italy.
   Consiglio Nazl Ist Ric Biostrutture & Bioimmagini, I-80131 Naples, Italy.
   Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy.
RP Roberti, G (reprint author), Univ Naples Federico II, Dipartimento Sci Fis, Complesso Univ Mt S Angelo,Via Cintia, I-80126 Naples, Italy.
EM Roberti@unina.it
OI liuzzi, raffaele/0000-0002-2350-6691
CR Barajas O, 1997, PHYS MED BIOL, V42, P1675, DOI 10.1088/0031-9155/42/9/001
   Beek JF, 1997, PHYS MED BIOL, V42, P2255, DOI 10.1088/0031-9155/42/11/017
   Bondani M, 2003, J OPT SOC AM B, V20, P2383, DOI 10.1364/JOSAB.20.002383
   CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354
   Choukeife JE, 1999, LASER MED SCI, V14, P286, DOI 10.1007/s101030050096
   Colasanti A, 2000, COMPUT PHYS COMMUN, V132, P84, DOI 10.1016/S0010-4655(00)00138-7
   COLASANTI A, 1998, SPIE, V3255, P118
   COLASANTI A, 1998, SPIE, V3566, P73
   COLASANTI A, 1997, SPIE, V3194, P471
   Cubeddu R, 1997, PHYS MED BIOL, V42, P1971, DOI 10.1088/0031-9155/42/10/011
   de Jode ML, 1999, PHYS MED BIOL, V44, P3027, DOI 10.1088/0031-9155/44/12/312
   FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777
   FLOCK ST, 1992, LASER SURG MED, V12, P510, DOI 10.1002/lsm.1900120510
   FURUTSU K, 1994, PHYS REV E, V50, P3634, DOI 10.1103/PhysRevE.50.3634
   Giusto A, 2003, APPL OPTICS, V42, P4375, DOI 10.1364/AO.42.004375
   GRAAFF R, 1993, APPL OPTICS, V32, P435, DOI 10.1364/AO.32.000435
   HASEGAWA Y, 1991, APPL OPTICS, V30, P4515, DOI 10.1364/AO.30.004515
   Hebden JC, 2003, J BIOMED OPT, V8, P87, DOI 10.1117/1.1528206
   Iizuka MN, 1999, LASER SURG MED, V25, P159, DOI 10.1002/(SICI)1096-9101(1999)25:2<159::AID-LSM10>3.3.CO;2-M
   Jacques SL, 1995, OPTICAL THERMAL RESP, P73
   JENTINK HW, 1991, APPL OPTICS, V29, P2371
   KEIZJER M, 1989, LASER SURG MED, V9, P148
   Kumar D, 2003, MED BIOL ENG COMPUT, V41, P310, DOI 10.1007/BF02348436
   MADSEN SJ, 1992, PHYS MED BIOL, V37, P985, DOI 10.1088/0031-9155/37/4/012
   Nakai T, 1997, PHYS MED BIOL, V42, P2541, DOI 10.1088/0031-9155/42/12/017
   Nomura Y, 1997, PHYS MED BIOL, V42, P1009, DOI 10.1088/0031-9155/42/6/002
   Nomura Y, 1989, Adv Exp Med Biol, V248, P77
   NOMURA Y, 1991, J BIOCHEM-TOKYO, V109, P455, DOI 10.1093/oxfordjournals.jbchem.a123403
   Ripley PM, 1999, PHYS MED BIOL, V44, P2451, DOI 10.1088/0031-9155/44/10/307
   Simpson CR, 1998, PHYS MED BIOL, V43, P2465, DOI 10.1088/0031-9155/43/9/003
   VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507
   WILSON B C, 1986, Lasers in Medical Science, V1, P235, DOI 10.1007/BF02032418
   Zaccanti G, 2003, APPL OPTICS, V42, P4023, DOI 10.1364/AO.42.004023
NR 33
TC 3
Z9 3
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PD JUN
PY 2005
VL 36
IS 5
BP 414
EP 422
DI 10.1002/lsm.20157
PG 9
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 941CE
UT WOS:000230191500012
PM 15900560
DA 2018-10-20
ER

PT J
AU Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
AF Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
TI Biomaterials functionalization using a novel peptide that selectively
   binds to a conducting polymer
SO NATURE MATERIALS
LA English
DT Article
ID DYNAMIC FORCE SPECTROSCOPY; ENERGY LANDSCAPES; POLYPYRROLE; SURFACE;
   ADHESION; FILMS; SPECIFICITY; MICROSCOPE; ATTACHMENT; TITANIUM
AB The goal in biomaterial surface modification is to retain a material's bulk properties while modifying only its surface to possess desired recognition and specificity. Here we develop a unique strategy for surface functionalization of an electrically conductive polymer, chlorine-doped polypyrrole (PPyCl), which has been widely researched for various electronic and biomedical applications. An M13 bacteriophage library was used to screen 109 different 12-mer peptide inserts against PPyCl. A binding phage (phi T59) was isolated, and its binding stability and specificity to PPyCl was assessed using fluorescence microscopy and titer count analysis. The relative binding strength and mechanism of the corresponding 12-mer peptide and its variants was studied using atomic force microscopy and fluorescamine assays. Further, the T59 peptide was joined to a cell adhesive sequence and used to promote cell attachment on PPyCl. This strategy can be extended to immobilize a variety of molecules to PPyCl for numerous applications. In addition, phage display can be applied to other polymers to develop bioactive materials without altering their bulk properties.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   MIT, Dept Bioengn, Cambridge, MA 02139 USA.
RP Sanghvi, AB (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
CR ADEY NB, 1995, GENE, V156, P27, DOI 10.1016/0378-1119(95)00058-E
   Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Barrett GC, 1998, AMINO ACIDS PEPTIDES
   Berglund J, 1998, ANAL COMMUN, V35, P3, DOI 10.1039/a708046h
   Blackburn S., 1978, AMINO ACID DETERMINA, P121
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cook AD, 1997, BIOMATERIALS, V18, P1417, DOI 10.1016/S0142-9612(97)00075-6
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   DIAZ AF, 1981, J ELECTROANAL CHEM, V129, P115, DOI 10.1016/0368-1874(81)87387-X
   Evans E, 1998, FARADAY DISCUSS, V111, P1
   Flynn CE, 2003, J MATER CHEM, V13, P2414, DOI 10.1039/b307593a
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HRKACH J, 1999, J MAT SCI RES, V78, P92
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   Kontturi K, 1998, J ELECTROANAL CHEM, V453, P231, DOI 10.1016/S0022-0728(98)00246-0
   Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7
   Labrou NE, 2003, J CHROMATOGR B, V790, P67, DOI 10.1016/S1570-0232(03)00098-9
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   MORI T, 2004, CURR PHARM DESIGN, V19, P2335
   MOY VT, 1994, COLLOID SURFACE A, V93, P343, DOI 10.1016/0927-7757(94)02933-4
   Nakamura C, 2004, BIOPOLYMERS, V76, P48, DOI 10.1002/bip.10572
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8120, P1
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8100
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8110, P1
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Sarikaya M, 2004, ANNU REV MATER RES, V34, P373, DOI 10.1146/annurev.matsci.34.040203.121025
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Silk T, 1998, SYNTHETIC MET, V93, P59, DOI 10.1016/S0379-6779(98)80131-8
   Sutar D, 2002, THIN SOLID FILMS, V417, P40, DOI 10.1016/S0040-6090(02)00649-1
   Tamm J, 1997, ELECTROCHIM ACTA, V42, P2929, DOI 10.1016/S0013-4686(97)00114-X
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Undenfriend S, 1972, SCIENCE, V178, P871
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Valuev IL, 1998, BIOMATERIALS, V19, P41, DOI 10.1016/S0142-9612(97)00147-6
   Vidal JC, 1999, ANAL CHIM ACTA, V385, P213, DOI 10.1016/S0003-2670(98)00838-1
   Wang LX, 2001, REACT FUNCT POLYM, V47, P125, DOI 10.1016/S1381-5148(00)00079-1
   Whaley SR, 2000, NATURE, V405, P665
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0
NR 49
TC 263
Z9 269
U1 7
U2 148
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD JUN
PY 2005
VL 4
IS 6
BP 496
EP 502
DI 10.1038/nmat1397
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 931RL
UT WOS:000229502700019
PM 15895095
DA 2018-10-20
ER

PT J
AU Coffer, JL
   Whitehead, MA
   Nagesha, DK
   Mukherjee, P
   Akkaraju, G
   Totolici, M
   Saffie, RS
   Canham, LT
AF Coffer, JL
   Whitehead, MA
   Nagesha, DK
   Mukherjee, P
   Akkaraju, G
   Totolici, M
   Saffie, RS
   Canham, LT
TI Porous silicon-based scaffolds for tissue engineering and other
   biomedical applications
SO PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Porous Semiconductors - Science and
   Technology (PSST-2004)
CY MAR 14-19, 2004
CL Cullera, SPAIN
ID BONE
AB This work describes the formation of porous composite materials based on a combination of bioactive mesoporous silicon and bioerodible polymers such as poly-caprolactone (PCL). The fabrication of a range of composites prepared by both salt leaching and microemulsion techniques are discussed. Particular attention to the influence of Si content in the composite on in vitro calcification assays are assessed. For each system, cytotoxicity and cellular proliferation are explicitly evaluated through fibroblast cell culture assays. (c) 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
C1 Texas Christian Univ, Dept Chem, Ft Worth, TX 76129 USA.
   Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA.
   PSi Medica Ltd, Malvern, Worcs, England.
RP Coffer, JL (reprint author), Texas Christian Univ, Dept Chem, Ft Worth, TX 76129 USA.
EM j.coffer@tcu.edu
RI Nagesha, Dattatri/O-3111-2013; Coffer, Jeffery/G-5686-2011
OI Nagesha, Dattatri/0000-0001-7277-4513; Coffer,
   Jeffery/0000-0003-0267-9646
CR Anderson SHC, 2003, PHYS STATUS SOLIDI A, V197, P331, DOI [10.1002/pssa.200306519, 10.1002/7pssa.200306519]
   Bellet D, 1996, J APPL PHYS, V80, P3772, DOI 10.1063/1.363305
   Bowditch AP, 1999, MATER RES SOC SYMP P, V536, P149
   CANHAM LT, Patent No. 9706101
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Wagner R. S., 1970, WHISKER TECHNOLOGY, P47
NR 10
TC 92
Z9 92
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0031-8965
J9 PHYS STATUS SOLIDI A
JI Phys. Status Solidi A-Appl. Mat.
PD JUN
PY 2005
VL 202
IS 8
BP 1451
EP 1455
DI 10.1002/pssa.200461134
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 941HW
UT WOS:000230206900024
DA 2018-10-20
ER

PT J
AU Ahlqvist, T
AF Ahlqvist, T
TI From information society to biosociety? On societal waves, developing
   key technologies, and new professions
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE information society; biosociety; transition; technology; profession
AB The article discusses the possible societal transition from information society toward biosociety. Furthermore, the impacts of this possible transition on professional and educational branches (PEBs) are examined. It is based on the study completed in Lahti Center at the Helsinki University of Technology between years 2001-2003. In the study, the most important developing key technologies were defined and their impacts on professions analysed through the application of Delphi technique. The developing key technology groups were information and communication technology, biotechnology, and material and nanotechnology. In addition, combinations of these technologies, that is, so-called fusion technologies, were also subjects for analysis. The first empirical aim was to analyse the plausibility and the timing of the so-called technological theses. The following technologies (technological theses) were deemed to be the most important ones: highly selective drugs, sensors, integrated technology, biomedical materials, photonic materials, 3G technology, intelligent materials, diagnostics, and virtual reality. The second empirical objective of the study was to analyze the professional and educational impacts of these technologies. Moreover, the article takes an experimental glance into the future through the creation and evaluation of "future professions". (c) 2004 Elsevier Inc. All rights reserved.
C1 Turku Univ, Dept Geog, FIN-20014 Turku, Finland.
RP Ahlqvist, T (reprint author), Turku Univ, Dept Geog, FIN-20014 Turku, Finland.
EM toni.ahlqvist@utu.fi
CR AHLQVIST T, 2003, KEYS FUTURES SOC REF
   BELL D, 1973, COMING POST IND SOC
   Castells Manuel, 1996, RISE NETWORK SOC
   Drucker P, 1993, POST CAPITALIST SOC
   FUKUYAMA F., 2002, OUR POSTHUMAN FUTURE
   Gershuny J., 1978, EMERGING SELF SERVIC
   KODAMA F, 1992, HARVARD BUSINESS JUL, P70
   Kuusi O., 1999, EXPERTISE FUTURE USE
   Latour Bruno, 1993, WE HAVE NEVER BEEN M
   MANNERMAA M, 2003, BIOSOCIETY HUMAN BEN
   MANNERMAA M, 1996, FUTURA, V15, P17
   MASUDA Y, 1983, INFORMATION SOC POST
   NEGROPONTE N, 2003, MITS TECHNOL REV
   Paterson J, 2002, FUTURIST, V36, P9
   Rifkin J., 1998, BIOTECH CENTURY HARN
   SCHIENSTOCK D, 2001, SITRA REPORTS SERIES, V7
   SCHWARTZ P, 1999, LONG BOOM VISION COM, P191
   Stock G, 2002, REDESIGNING HUMANS O
   STONIER T, 1983, WEALTH INFORMATION P
   2003, EXPERT MED BIOTECHNO
   2003, MITS TECHNOL REV
NR 21
TC 7
Z9 7
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD JUN
PY 2005
VL 72
IS 5
BP 501
EP 519
DI 10.1016/j.techfore.2004.06.001
PG 19
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 927DI
UT WOS:000229172200001
DA 2018-10-20
ER

PT J
AU Yang, Q
   Xu, ZK
   Dai, ZW
   Wang, JL
   Ulbricht, M
AF Yang, Q
   Xu, ZK
   Dai, ZW
   Wang, JL
   Ulbricht, M
TI Surface modification of polypropylene microporous membranes with a novel
   glycopolymer
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID MICROFILTRATION MEMBRANES; GRAFT-POLYMERIZATION; ULTRAFILTRATION
   MEMBRANES; CHEMOENZYMATIC SYNTHESIS; SYNTHETIC GLYCOPOLYMERS;
   POLY(ETHYLENE GLYCOL); CONCANAVALIN-A; SUGAR; POLYMERS; BEHAVIOR
AB Membrane-based biomedical processes have increased considerably in recent years. However, the natural disadvantages of common membrane materials, such as hydrophobic surface and poor biocompatibility, cause many side effects in use and cumber further applications. In this work, to meet the requirements of biomedical applications, a novel sugar-containing monomer (D-gluconamidoethyl methacrylate (GAMA)) was grafted on polypropylene microporous membrane (PPMM) with an UV-induced polymerization to improve both the surface hydrophilicity and hemocompatibility. Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy, and scanning electron microscopy were employed to confirm the surface modification on the membranes. Water contact angle, protein adsorption, and platelet adhesion measurements were used to evaluate the anti-fouling property and the hemocompatibility of the membranes. It was found that the GAMA grafting degree increases reasonably with the increase of GAMA monomer concentration, and then the increase slows down when the GAMA concentration exceeds 40 g/L. At the same time, a 20-25-min UV irradiation is enough for the grafting polymerization. The water contact angle of the modified membrane decreases from 149 to 64 degrees with the increase of GAMA grafting degree from 0 to 6.18 wt %, which indicates a hydrophilic variation of the membrane surface by the grafting of GAMA. Furthermore, the modified membranes show higher water and protein solution fluxes, lower BSA adsorption, and better flux recovery after cleaning than those of the original PPMM. Platelet adhesion experiment also reveals that a more hemocompatible interface can be obtained between the membrane and the biomolecules.
C1 Zhejiang Univ, Inst Polymer Sci, Hangzhou 310027, Peoples R China.
   Zhejiang Univ Technol, Coll Chem Engn & Mat, Hangzhou 310014, Peoples R China.
   Univ Duisberg, Inst Tech Chem, D-45117 Essen, Germany.
RP Xu, ZK (reprint author), Zhejiang Univ, Inst Polymer Sci, Hangzhou 310027, Peoples R China.
EM xuzk@ipsm.zju.edu.cn
RI Yang, Qian/F-6704-2011; Ulbricht, Mathias/L-5844-2015; Xu,
   Zhi-Kang/B-1462-2009
OI Yang, Qian/0000-0002-7925-6775; Ulbricht, Mathias/0000-0002-2094-0708; 
CR Albertin L, 2004, BIOMACROMOLECULES, V5, P255, DOI 10.1021/bm034199u
   ARTURSSON P, 1990, J POLYM SCI POL CHEM, V28, P2651, DOI 10.1002/pola.1990.080281006
   Bahulekar R, 1998, CARBOHYD POLYM, V37, P71, DOI 10.1016/S0144-8617(98)00027-7
   BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7
   CHEN XM, 1995, MACROMOLECULES, V28, P6014, DOI 10.1021/ma00122a005
   Deng HT, 2004, J MOL CATAL B-ENZYM, V28, P95, DOI 10.1016/j.molcatb.2004.01.004
   Deppisch R, 1998, SEP PURIF TECHNOL, V14, P241, DOI 10.1016/S1383-5866(98)00079-3
   GarciaOteiza MC, 1997, MACROMOL CHEM PHYSIC, V198, P2237, DOI 10.1002/macp.1997.021980718
   GOLDSTEIN IJ, 1965, BIOCHEMISTRY-US, V4, P876, DOI 10.1021/bi00881a013
   Gupta B, 2003, ADV POLYM SCI, V162, P35
   Karamuk E, 1999, ARTIF ORGANS, V23, P881, DOI 10.1046/j.1525-1594.1999.06308.x
   KELLY ST, 1993, J MEMBRANE SCI, V80, P175, DOI 10.1016/0376-7388(93)85142-J
   KIM KJ, 1992, J MEMBRANE SCI, V68, P79
   KITA H, 1994, J MEMBRANE SCI, V87, P139, DOI 10.1016/0376-7388(93)E0098-X
   Kobayashi K, 1997, MACROMOLECULES, V30, P2016, DOI 10.1021/ma961681e
   Kou RQ, 2003, LANGMUIR, V19, P6869, DOI 10.1021/la0345486
   Ladmiral V, 2004, EUR POLYM J, V40, P431, DOI 10.1016/j.eurpolymj.2003.10.019
   LIU FP, 1995, LANGMUIR, V11, P2674, DOI 10.1021/la00007a056
   Liu ZM, 2005, J MEMBRANE SCI, V249, P21, DOI 10.1016/j.memsci.2004.10.001
   Liu ZM, 2004, EUR POLYM J, V40, P2077, DOI 10.1016/j.eurpolymj.2004.05.020
   Ma HM, 2000, J MEMBRANE SCI, V173, P191, DOI 10.1016/S0376-7388(00)00360-4
   Narain R, 2003, BIOMACROMOLECULES, V4, P1746, DOI 10.1021/bm034166e
   Nie FQ, 2003, LANGMUIR, V19, P9889, DOI 10.1021/la035315h
   Okada M, 2001, PROG POLYM SCI, V26, P67, DOI 10.1016/S0079-6700(00)00038-1
   OKAHATA Y, 1987, J CHEM SOC PERK T 2, P1317, DOI 10.1039/p29870001317
   Patankar NA, 2003, LANGMUIR, V19, P1249, DOI 10.1021/la026612+
   Richey T, 2000, BIOMATERIALS, V21, P1057, DOI 10.1016/S0142-9612(99)00281-1
   SMITH DA, 1970, J POLYM SCI A1, V8, P783, DOI 10.1002/pol.1970.150080321
   Steen ML, 2002, J MEMBRANE SCI, V204, P341, DOI 10.1016/S0376-7388(02)00061-3
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Taniguchi M, 2003, CHEM MATER, V15, P3805, DOI 10.1021/cm020283p
   Thom VH, 2000, LANGMUIR, V16, P2756, DOI 10.1021/la990303a
   TRACEY EM, 1994, J COLLOID INTERF SCI, V167, P104, DOI 10.1006/jcis.1994.1338
   Ulbricht M, 1998, COLLOID SURFACE A, V138, P353, DOI 10.1016/S0927-7757(98)00236-2
   Wang Q, 2002, CHEM MATER, V14, P3232, DOI 10.1021/cm0200137
   Wavhal DS, 2003, LANGMUIR, V19, P79, DOI 10.1021/la020653o
   Xu ZK, 2004, LANGMUIR, V20, P1481, DOI 10.1021/la035930l
   Xu ZK, 2003, J MEMBRANE SCI, V214, P71, DOI 10.1016/S0376-7388(02)00536-7
   Xu ZK, 2002, J MEMBRANE SCI, V196, P221, DOI 10.1016/S0376-7388(01)00600-7
   YASUDA T, 1992, LANGMUIR, V8, P1425, DOI 10.1021/la00041a030
   ZEMAN LJ, 1983, J MEMBRANE SCI, V15, P213, DOI 10.1016/S0376-7388(00)82300-5
   Zhou WJ, 1999, J POLYM SCI POL CHEM, V37, P1393, DOI 10.1002/(SICI)1099-0518(19990515)37:10<1393::AID-POLA1>3.3.CO;2-Z
NR 42
TC 184
Z9 199
U1 6
U2 142
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD MAY 31
PY 2005
VL 17
IS 11
BP 3050
EP 3058
DI 10.1021/cm048012x
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 933TO
UT WOS:000229656000037
DA 2018-10-20
ER

PT J
AU Nuti, F
   Hildenbrand, S
   Chelli, M
   Wodarz, R
   Papini, AM
AF Nuti, F
   Hildenbrand, S
   Chelli, M
   Wodarz, R
   Papini, AM
TI Synthesis of DEHP metabolites as biomarkers for GC-MS evaluation of
   phthalates as endocrine disrupters
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Article
DE DEHP metabolites; phthalates; GC-MS analytes; endocrine disrupters;
   plasticizers
ID DI(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL
   PHTHALATE; EXCHANGE-TRANSFUSION; NEWBORN-INFANTS; HUMAN URINE; EXPOSURE;
   RATS; CHROMATOGRAPHY; OXIDATION
AB Phthalates are used primarily as plasticizers to make polyvinyl chloride (PVC) soft and flexible. In recent years the phthalate esters have attracted increasing attention as environmental and biomedical pollutants and, because of their toxicological characteristics. In particular, they are more and more recognized as endocrine disrupters. In this context, we describe herein an efficient synthetic pathway leading to a series of metabolites of di(2-ethylhexyl) phthalate (DEHP). Mono(2-ethylhexenyl) phthalate was used as starting material to obtain these products in good yield, large scale and GC-MS purity. The metabolites of DEHP were synthesized, for the first time, as biomarkers to verify their quantitative determination in human urine and serum by GC-MS analysis for studying the exposure to phthalates and establishing reference values. &COPY; 2005 Elsevier Ltd. All rights reserved.
C1 Univ Tubingen, Dept Occupat & Social Med, D-72074 Tubingen, Germany.
   Univ Florence, Dept Organ Chem, Lab Peptide & Prot Chem & Biol, I-50019 Florence, Italy.
   CNR, ICCOM, I-50019 Florence, Italy.
RP Hildenbrand, S (reprint author), Univ Tubingen, Dept Occupat & Social Med, Wilhelmstr 27, D-72074 Tubingen, Germany.
EM sibylle.hildenbrand@med.uni-tuebingen.de; annamaria.papini@unifi.it
RI Nuti, Francesca/L-6282-2015; Chelli, Mario/L-7389-2015
OI Nuti, Francesca/0000-0001-9908-5996; Chelli, Mario/0000-0003-2939-6961;
   Papini, Anna Maria/0000-0002-2947-7107
CR Albro P. W., 1987, REV BIOCHEM TOXICOL, V8, P73
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8
   ARBIN A, 1980, J CHROMATOGR, V193, P405, DOI 10.1016/S0021-9673(00)87740-7
   Baczko K, 2000, J CHEM SOC PERK T 2, P521, DOI 10.1039/a907987d
   deBoer T. J., 1956, ORG SYNTH, V36, P16
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700
   EISENBRAUN EJ, 1973, ORG SYNTH, V5, P310
   EMA M, 1995, TOXICOL LETT, V78, P101, DOI 10.1016/0378-4274(94)03241-X
   Gilsing HD, 2003, MONATSH CHEM, V134, P1207, DOI 10.1007/s00706-003-0044-y
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664
   HILDENBRAND S, 2002, PERSPEKTIVEN KLIN AR, P535
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381, DOI 10.5271/sjweh.2209
   MEINWALD J, 1973, ORG SYNTH, V5, P866
   Mettang T, 1996, PERITON DIALYSIS INT, V16, P58
   Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439, DOI 10.1093/oxfordjournals.ndt.a027211
   MORIARTY RM, 1989, ORG SYNTH, V68, P175
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x
   SCHMID P, 1985, XENOBIOTICA, V15, P251, DOI 10.3109/00498258509045356
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375, DOI 10.1080/02652039409374236
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x
   SUZUKI T, 2001, ENVIRON SCI TECHNOL, V35, P3563
   TSUJI J, 1984, SYNTHESIS-STUTTGART, P369
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6
   WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195
NR 30
TC 13
Z9 13
U1 1
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD MAY 16
PY 2005
VL 13
IS 10
BP 3461
EP 3465
DI 10.1016/j.bmc.2005.03.005
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA 926PW
UT WOS:000229136100016
PM 15848759
DA 2018-10-20
ER

PT J
AU Ellman, PI
   Reece, TB
   Maxey, TS
   Tache-Leon, C
   Taylor, JL
   Spinosa, DJ
   Pineros-Fernandez, AC
   Rodeheaver, GT
   Kern, JA
AF Ellman, PI
   Reece, TB
   Maxey, TS
   Tache-Leon, C
   Taylor, JL
   Spinosa, DJ
   Pineros-Fernandez, AC
   Rodeheaver, GT
   Kern, JA
TI Evaluation of an absorbable cyanoacrylate adhesive as a suture line
   sealant
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE vascular surgery; anastomosis; PTFE; cyanoacrylate; biomedical
   engineering; tissue adhesives; glue; oxidized cellulose; hemostasis;
   vascular research
ID DISSECTION; TRIAL; GLUE
AB Background. Previous formulations of cyanoacrylate, though very effective, proved to have too high a tissue reactivity to be used internally. A novel cyanoacrylate compound with less tissue reactivity was recently developed. The objective of this study was to assess this novel cyanoacrylate compound for the use as vascular suture line sealant.
   Materials and methods. Twelve adult female sheep received a 6 mm PTFE interposition graft in each iliac artery, for a total of 24 grafts. Using oxidized cellulose (Surgicel) as a control, two formulations of a new cyanoacrylate compound (named "compound A" and "compound B") were assessed during this trial. Hemostatic efficiency was measured at the time of operation by the assessment of bleeding time and amount of blood loss. Long-term graft patency was assessed angiographically at 4, 6, and 18 months. Tissue reaction at 2 weeks, 1, 6, and 18 months was assessed grossly by vascular surgeons and microscopically by a blinded pathologist.
   Results. Average time to hemostasis was 37.6, 50.6, and 219 s in g-roup A, group B, and oxidized cellulose control groups, respectively (P <= 0.001 for both compounds versus control). There were no significant differences between groups with regards to graft patency. Histopathology analysis demonstrated mild to moderate tissue reaction at 2 weeks and 1 month in the cyanoacrylate groups compared with controls at 1 month (ANOVA P = 0.004). Mild tissue reaction was seen at 6 months and 18 months, with no significant differences between groups (ANOVA P = 0.08, 0.62, respectively).
   Conclusions. The novel cyanoacrylate compound examined in this study is a highly effective suture line sealant with only mild tissue reactivity and no significant effects on graft patency when studied over an 18 month period. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Virginia, Dept Surg, Charlottesville, VA USA.
   Univ Virginia, Dept Radiol, Charlottesville, VA USA.
   Univ Virginia, Dept Plast Surg, Charlottesville, VA USA.
   Univ Utah, Anim Resources Ctr, Salt Lake City, UT USA.
RP Ellman, PI (reprint author), Bldg MR4,POB 801359, Charlottesville, VA 22908 USA.
EM pie8y@virginia.edu
CR Barbalinardo R J, 1986, J Vasc Surg, V4, P220
   Bavaria JE, 2002, ANN THORAC SURG, V74, pS1848, DOI 10.1016/S0003-4975(02)04128-0
   CITRIN P, 1985, J VASC SURG, V2, P488, DOI 10.1067/mva.1985.avs0020488
   Coover H, 1959, J SOC PLAST SURG ENG, V15, P5
   GIUNTA J, 1972, ARCH ORAL BIOL, V17, P617, DOI 10.1016/0003-9969(72)90188-4
   Glickman M, 2002, ARCH SURG-CHICAGO, V137, P326, DOI 10.1001/archsurg.137.3.326
   Hile J. P, 1978, FED REGISTER, V43, P1131
   Hino M, 2000, BRIT J HAEMATOL, V108, P194, DOI 10.1046/j.1365-2141.2000.01818.x
   *I LAB AN RES COLS, 1996, GUID CAR US LAB AN
   KUNG H, 1986, EVALUATION UNDESIRAB
   MCCREADY RA, 1992, J VASC SURG, V15, P661, DOI 10.1016/0741-5214(92)90012-W
   Miller DC, 2002, ANN THORAC SURG, V74, pS1857, DOI 10.1016/S0003-4975(02)04263-7
   REITER A, 1987, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V20, P55
   Spotnitz WD, 1999, TRANSFUSION THERAPY, P199
   Switzer EF, 2003, AM SURGEON, V69, P434
   VINTERS HV, 1985, NEURORADIOLOGY, V27, P279, DOI 10.1007/BF00339559
NR 16
TC 24
Z9 31
U1 1
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD MAY 15
PY 2005
VL 125
IS 2
BP 161
EP 167
DI 10.1016/j.jss.2004.12.014
PG 7
WC Surgery
SC Surgery
GA 922AR
UT WOS:000228808500007
PM 15854669
DA 2018-10-20
ER

PT J
AU Niewold, TA
   Kerstens, HHD
   van der Meulen, J
   Smits, MA
   Hulst, MM
AF Niewold, TA
   Kerstens, HHD
   van der Meulen, J
   Smits, MA
   Hulst, MM
TI Development of a porcine small intestinal cDNA micro-array:
   characterization and functional analysis of the response to
   enterotoxigenic E-coli
SO VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
LA English
DT Article
DE genomics; micro-array; pig; mucosa; small intestine; enterotoxigenic
   Escherichia coli
ID ACID-BINDING PROTEIN; GENE DISCOVERY; PIGS; GENERATION; GENOMICS;
   ADHESION; LIBRARY; PLASMA; HEALTH; EST
AB The intestine is a complex and dynamic ecosystem, in which nutrients, exogenous compounds and micro-flora interact, and its condition is influenced by the complex interaction between these factors and host genetic elements. Furthermore, interactions of immune cells with the other components of the intestinal mucosa are essential in the defense against pathogens. The outcomes of these complex interactions determine resistance to infectious diseases. The development of genomic tools and techniques allows for analysis of multiple and complex host responses.
   We have constructed a porcine small intestinal micro-array, based on cDNA from jejunal mucosal scrapings. Material from two developmental distinct stages (4- and 12-week-old pigs) was used in order to assure a reasonably broad representation of mucosal transcripts. The micro-array consists of 3468 cDNAs spotted in quadruplicate. Comparison of the 4-week-old versus 12-week-old pigs revealed a differential expression in at least 300 spots. Furthermore, we report the early gene expression response of pig small intestine jejunal mucosa to infection with enterotoxigenic E. coli (ETEC) using the small intestinal segment perfusion (SISP) technique. A response pattern was found in which a marker for innate defense dominated, demonstrating the strength of this applied technology. Further analysis of these response patterns will contribute to a better understanding of enteric health and disease in pigs. The great similarity between pig and human suggest results from these continuing studies should be applicable for both agricultural and human biomedical purposes. (c) 2005 Elsevier B.V. All rights reserved.
C1 Wageningen UR, Anim Sci Grp, Res Cluster Anim Physiol & Hlth, NL-8200 AB Lelystad, Netherlands.
   Anim Genom, NL-8200 AB Lelystad, Netherlands.
RP Niewold, TA (reprint author), Wageningen UR, Anim Sci Grp, Res Cluster Anim Physiol & Hlth, POB 65, NL-8200 AB Lelystad, Netherlands.
EM theo.niewold@wur.nl
RI smits, mari/J-4892-2013
OI smits, mari/0000-0002-3493-291X; Niewold, Theo/0000-0001-8838-750X
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BOERSMA WJA, IN PRESS WELFARE PIG
   Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034
   Desjeux A, 2002, GASTROEN CLIN BIOL, V26, P23
   DIEKGRAEFE BK, 2000, PHYSIOL GENOMICS, V4, P1
   Dudoit S, 2002, STAT SINICA, V12, P111
   Fahrenkrug SC, 2002, MAMM GENOME, V13, P475, DOI 10.1007/s00335-001-2072-4
   Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   KARSTEN SL, 2002, NUCLEIC ACIDS RES, V30, P4
   Kiers J. L., 2001, P261, DOI 10.1079/9780851995175.0261
   MONTROSE MH, 2003, AM J PHYSIOL-GASTR L, V284, P547
   NABUURS MJA, 1993, RES VET SCI, V55, P108, DOI 10.1016/0034-5288(93)90043-F
   NABUURS MJA, 1993, RES VET SCI, V55, P78, DOI 10.1016/0034-5288(93)90038-H
   Niewold TA, 2004, RES VET SCI, V77, P89, DOI 10.1016/j.rvsc.2004.02.006
   Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1
   REID G, 2003, J CLIN GASTROENTEROL, V7, P105
   Roberts MA, 2001, CURR OPIN BIOTECH, V12, P516, DOI 10.1016/S0958-1669(00)00256-1
   Rothschild MF, 2003, COMP FUNCT GENOM, V4, P266, DOI 10.1002/cfg.261
   Sambrook J, 1989, MOL CLONING LAB MANU
   SELLWOOD R, 1975, J MED MICROBIOL, V8, P405, DOI 10.1099/00222615-8-3-405
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Van Dijk AJ, 2002, J VET MED A, V49, P81, DOI 10.1046/j.1439-0442.2002.jv415.x
   van Hemert S, 2003, ANIM BIOTECHNOL, V14, P133, DOI 10.1081/ABIO-120026483
   van Ommen B, 2002, CURR OPIN BIOTECH, V13, P517, DOI 10.1016/S0958-1669(02)00349-X
   van Zijderveld FG, 1998, VET QUART, V20, pS73
   Verburg M, 2002, J HISTOCHEM CYTOCHEM, V50, P1525, DOI 10.1177/002215540205001113
   Wintero AK, 1996, MAMM GENOME, V7, P509, DOI 10.1007/s003359900153
   Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100
   Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15
NR 30
TC 45
Z9 50
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2427
J9 VET IMMUNOL IMMUNOP
JI Vet. Immunol. Immunopathol.
PD MAY 15
PY 2005
VL 105
IS 3-4
BP 317
EP 329
DI 10.1016/j.vetimm.2005.02.010
PG 13
WC Immunology; Veterinary Sciences
SC Immunology; Veterinary Sciences
GA 918ZZ
UT WOS:000228589400012
PM 15808309
DA 2018-10-20
ER

PT J
AU Cibula, E
   Donlagic, D
AF Cibula, E
   Donlagic, D
TI Miniature fiber-optic pressure sensor with a polymer diaphragm
SO APPLIED OPTICS
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; MEDICAL PRESSURE; OPTICAL-FIBER;
   INTERFEROMETER; STRAIN
AB The fabrication and experimental investigation of a miniature optical fiber pressure sensor for biomedical and industrial applications are described. The sensor measures only 125 mu m in diameter. The essential element is a thin polymer diaphragm that is positioned inside the hollow end of an optical fiber. The cavity at the fiber end is made by a simple and effective micromachining process based on wet etching in diluted HF acid. Thus a Fabry-Perot interferometer is formed between the inner fiber-cavity interface and the diaphragm. The fabrication technique is described in detail. Different sensor prototypes were fabricated upon 125 mu m-diameter optical fiber that demonstrated pressure ranges from 0 to 40 and from 0 to 1200 kPa. A resolution of less than 10 Pa was demonstrated in practice. The fabrication technique presented facilitates production of simple and low-cost disposable pressure sensors by use of materials with that ensure the required biocompatibility. (c) 2005 Optical Society of America.
C1 Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia.
RP Donlagic, D (reprint author), Univ Maribor, Fac Elect Engn & Comp Sci, Smetanova 17, SLO-2000 Maribor, Slovenia.
EM ddonlagic@uni-mb.si
RI Donlagic, Denis/E-4621-2011
OI Donlagic, Denis/0000-0002-0247-503X
CR Abeysinghe DC, 2001, IEEE PHOTONIC TECH L, V13, P993, DOI 10.1109/68.942671
   BEHEIM G, 1987, REV SCI INSTRUM, V89, P1655
   BELLEVILLE C, 1995, Patent No. 5392117
   BELOVOLOV MI, 1999, Patent No. 9966299
   CHAN MA, 1994, SENSOR ACTUAT A-PHYS, V43, P196, DOI 10.1016/0924-4247(93)00694-Y
   Chatzandroulis S, 1997, SENSOR ACTUAT A-PHYS, V62, P551, DOI 10.1016/S0924-4247(97)01567-7
   De Brabander GN, 1998, APPL OPTICS, V37, P3264, DOI 10.1364/AO.37.003264
   Druzhinin A, 1999, SENSOR ACTUAT B-CHEM, V58, P415, DOI 10.1016/S0925-4005(99)00121-5
   Ezbiri A, 1997, OPT COMMUN, V133, P62, DOI 10.1016/S0030-4018(96)00445-2
   HE G, 1993, P 9 OPT FIB SENS C F, P463
   JI J, 1992, IEEE T ELECTRON DEV, V39, P2260, DOI 10.1109/16.158797
   JOHANNESEN K, 1999, Patent No. 9945352
   Katsumata T., 2000, Transactions of the Institute of Electrical Engineers of Japan, Part E, V120-E, P58
   KAYOUN P, 1981, ELECTRON LETT, V17, P400, DOI 10.1049/el:19810278
   Koysal O, 2002, OPT COMMUN, V205, P1, DOI 10.1016/S0030-4018(02)01203-8
   LEE CE, 1991, J LIGHTWAVE TECHNOL, V9, P129, DOI 10.1109/50.64932
   LEE CE, 1989, OPT LETT, V14, P1225, DOI 10.1364/OL.14.001225
   LEE YS, 1982, IEEE T ELECTRON DEV, V29, P42, DOI 10.1109/T-ED.1982.20656
   LI TC, 1995, OPT LETT, V20, P785, DOI 10.1364/OL.20.000785
   Liu T, 2000, REV SCI INSTRUM, V71, P1275, DOI 10.1063/1.1150453
   Narendran N, 1996, ASAIO J, V42, pM500, DOI 10.1097/00002480-199609000-00037
   Potter J, 1997, OPT COMMUN, V140, P11, DOI 10.1016/S0030-4018(97)00133-8
   RAO YJ, 1993, OPT LETT, V18, P2153, DOI 10.1364/OL.18.002153
   SADKOWSKI R, 1995, APPL OPTICS, V34, P5861, DOI 10.1364/AO.34.005861
   SANTOS JL, 1992, APPL OPTICS, V31, P7361, DOI 10.1364/AO.31.007361
   Schmidt M, 1999, OPT LETT, V24, P599, DOI 10.1364/OL.24.000599
   SIRKIS J, 1995, J LIGHTWAVE TECHNOL, V13, P1256, DOI 10.1109/50.400690
   Stropnik C, 1996, J APPL POLYM SCI, V61, P1821, DOI 10.1002/(SICI)1097-4628(19960906)61:10<1821::AID-APP24>3.0.CO;2-3
   Tohyama O, 1998, SENSOR ACTUAT A-PHYS, V66, P150, DOI 10.1016/S0924-4247(97)01764-0
   WOLTHUIS RA, 1991, IEEE T BIO-MED ENG, V38, P974, DOI 10.1109/10.88443
   WU N, 1993, SENSOR ACTUAT A-PHYS, V35, P197
   Yoshino T., 1982, IEEE Transactions on Microwave Theory and Techniques, VMTT-30, P1612
   Zaatar Y, 2000, MAT SCI ENG B-SOLID, V74, P296, DOI 10.1016/S0921-5107(99)00579-6
NR 33
TC 74
Z9 79
U1 1
U2 29
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1559-128X
EI 2155-3165
J9 APPL OPTICS
JI Appl. Optics
PD MAY 10
PY 2005
VL 44
IS 14
BP 2736
EP 2744
DI 10.1364/AO.44.002736
PG 9
WC Optics
SC Optics
GA 925IN
UT WOS:000229046900006
PM 15943325
DA 2018-10-20
ER

PT J
AU Nguyen, B
   Bowers, RM
   Wahlund, TM
   Read, BA
AF Nguyen, B
   Bowers, RM
   Wahlund, TM
   Read, BA
TI Suppressive subtractive hybridization of and differences in gene
   expression content of calcifying and noncalcifying cultures of Emiliania
   huxleyi strain 1516
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID INORGANIC CARBON; COCCOLITH FORMATION; CALCIFICATION; PHOTOSYNTHESIS;
   IDENTIFICATION; PROTEIN; BIOMINERALIZATION; PRYMNESIOPHYCEAE;
   PHOSPHORUS; SHELL
AB The marine coccolithophorid Emiliania huxleyi is a cosmopolitan alga intensely studied in relation to global carbon cycling, biogeochemistry, marine ecology, and biomineralization processes. The biomineralization capabilities of coccolithophorids have attracted the attention of scientists interested in exploiting this ability for the development of materials science and biomedical and biotechnological applications. Although it has been well documented that biomineralization in E. huxleyi is promoted by growth under phosphate-limited conditions, the genes and proteins that govern the processes of calcification and coccolithogenesis remain unknown. Suppressive subtractive hybridization (SSH) libraries were constructed from cultures grown in phosphate-limited and phosphate-replete media as tester and driver populations for reciprocal SSH procedures. Positive clones from each of the two libraries were randomly selected, and dot blotting was performed for the analysis of expression patterns. A total of 513 clones from the phosphate-replete library and 423 clones from the phosphate-limited library were sequenced, assembled, and compared to sequences in GenBank using BIASTX. Of the 103 differentially expressed gene fragments from the phosphate-replete library, 34% showed significant homology to other known proteins, while only 23% of the 65 differentially expressed gene fragments from the phosphate-limited library showed homology to other proteins. To further assess mRNA expression, real-time RT-PCR analysis was employed and expression profiles were generated over a 14-day time course for three clones from the phosphate-replete library and five clones from the phosphate-limited library. The fragments isolated provide the basis for future cloning of full-length genes and functional analysis.
C1 Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA.
RP Read, BA (reprint author), Calif State Univ San Marcos, Dept Biol Sci, 333 S Twin Oaks Valley Rd, San Marcos, CA 92096 USA.
EM bread@csusm.edu
FU NIGMS NIH HHS [GM 059833, S06 GM059833]
CR ANDERSEN OK, 1981, THESIS U OSLO OSLO
   BALCH WM, 1992, CONT SHELF RES, V12, P1353, DOI 10.1016/0278-4343(92)90059-S
   BROWN CW, 1994, J GEOPHYS RES-OCEANS, V99, P7467, DOI 10.1029/93JC02156
   Buitenhuis ET, 1999, J PHYCOL, V35, P949, DOI 10.1046/j.1529-8817.1999.3550949.x
   Corstjens PLAM, 1998, J PHYCOL, V34, P622, DOI 10.1046/j.1529-8817.1998.340622.x
   Cramer RA, 2004, FUNGAL GENET BIOL, V41, P115, DOI 10.1016/j.fgb.2003.10.009
   DEVRINDDEJONG EW, 1997, GEOMICROBIOLOGY INTE, P267
   Diatchenko L, 1999, METHOD ENZYMOL, V303, P349
   Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025
   Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548
   Guillard R. R. L, 1975, CULTURE MARINE INVER, P29, DOI DOI 10.1007/978-1-4615-8714-9_3
   Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x
   Henriksen K, 2003, AM MINERAL, V88, P2040, DOI 10.2138/am-2003-11-1248
   HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731
   Illies MR, 2002, DEV GENES EVOL, V212, P419, DOI 10.1007/s00427-002-0261-0
   Kim M, 2001, MOL CELLS, V11, P213
   Laguna R, 2001, APPL ENVIRON MICROB, V67, P3824, DOI 10.1128/AEM.67.9.3824-3831.2001
   Liao H, 2003, GENE, V318, P103, DOI 10.1016/S0378-1119(03)00764-9
   Mahalingam R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r20
   Marsh ME, 2003, COMP BIOCHEM PHYS B, V136, P743, DOI 10.1016/S1096-4959(03)00180-5
   Moyano E, 1998, PLANT PHYSIOL, V117, P711, DOI 10.1104/pp.117.2.711
   Ozaki N, 2001, BIOSCI BIOTECH BIOCH, V65, P2330, DOI 10.1271/bbb.65.2330
   Paasche E, 1998, EUR J PHYCOL, V33, P33, DOI 10.1017/S0967026297001480
   PAASCHE E, 1994, PHYCOLOGIA, V33, P324, DOI 10.2216/i0031-8884-33-5-324.1
   Palenik B, 1997, LIMNOL OCEANOGR, V42, P1544, DOI 10.4319/lo.1997.42.7.1544
   SEKINO K, 1994, PLANT CELL PHYSIOL, V35, P353
   Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472
   Shiraiwa Y, 2003, COMP BIOCHEM PHYS B, V136, P775, DOI 10.1016/S1096-4959(03)00221-5
   SIKES CS, 1980, LIMNOL OCEANOGR, V25, P248, DOI 10.4319/lo.1980.25.2.0248
   Stoll HM, 2002, PHILOS T R SOC A, V360, P719, DOI 10.1098/rsta.2001.0966
   Strommer Judith, 1993, P49
   Tyrrell T, 1996, J MARINE SYST, V9, P83, DOI 10.1016/0924-7963(96)00019-X
   VANBLEIJSWIJK JDL, 1995, MAR ECOL PROG SER, V121, P271, DOI 10.3354/meps121271
   VANDERWAL P, 1983, PROTOPLASMA, V118, P157, DOI 10.1007/BF01293073
   VANEMBURG PR, 1989, THESIS LEIDEN U LEID
   Wahlund TM, 2004, MAR BIOTECHNOL, V6, P278, DOI 10.1007/s10126-003-0035-3
   WAHLUND TM, 2004, J MICROPALEONTOL, V51, P145
   Wang XB, 2002, GENE, V297, P93, DOI 10.1016/S0378-1119(02)00870-3
   Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907
   Wustman BA, 2002, BIOPOLYMERS, V65, P362, DOI 10.1002/bip.10274
   Young JR, 1999, J STRUCT BIOL, V126, P195, DOI 10.1006/jsbi.1999.4132
   Zhang B, 2000, BIOPOLYMERS, V54, P464, DOI 10.1002/1097-0282(200011)54:6<464::AID-BIP90>3.0.CO;2-N
   Zhang XN, 2002, DNA SEQUENCE, V13, P195, DOI 10.1080/1042517021000003905
NR 43
TC 23
Z9 23
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD MAY
PY 2005
VL 71
IS 5
BP 2564
EP 2575
DI 10.1128/AEM.71.5.2564-2575.2005
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 926EH
UT WOS:000229105300047
PM 15870347
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Morra, M
AF Morra, M
TI Engineering of biomaterials surfaces by hyaluronan
SO BIOMACROMOLECULES
LA English
DT Review
ID MOLECULAR-DYNAMICS SIMULATIONS; ATOMIC-FORCE MICROSCOPY; SOLID-PHASE
   ASSAY; ANGIOGENIC OLIGOSACCHARIDES; CARTILAGE PROTEOGLYCANS;
   AQUEOUS-SOLUTION; IN-VIVO; POLYELECTROLYTE MULTILAYERS;
   EXTRACELLULAR-MATRIX; TERTIARY STRUCTURES
AB This review addresses the area of study that defines the field of surface modification of biomedical materials and devices by hyaluronan (HA), as related to the exploitation of HA biological properties. To provide a comprehensive view of the subject matter, initial sections give a quick introduction to basic information on HA-protein and HA-cell interactions, together with some discussion on the bioactive role of HA in wound healing and related phenomena. This is followed by a description of current theories that correlate HA properties to its molecular structure in aqueous media, underlying how HA molecular details are crucial for its biological interaction and role. Finally, existing approaches to surface modification by HA are reviewed, stressing the need for HA-surface engineering founded on the knowledge and control of the surface-linked HA molecular conformation at the solid/aqueous interface.
C1 Nobil Bio Ricerche Srl, I-14018 Villafranca Asti, Italy.
RP Morra, M (reprint author), Nobil Bio Ricerche Srl, Str S Rocco 36, I-14018 Villafranca Asti, Italy.
CR ABATANGELO G, 2000, REDEFINING HYALURONA
   Almond A, 1998, GLYCOBIOLOGY, V8, P973, DOI 10.1093/glycob/8.10.973
   Almond A, 1997, GLYCOBIOLOGY, V7, P597, DOI 10.1093/glycob/7.5.597
   Almond A, 2000, J PHYS CHEM B, V104, P5634, DOI 10.1021/jp000402t
   Bajorath J, 1998, J BIOL CHEM, V273, P338, DOI 10.1074/jbc.273.1.338
   BALAZS EA, 1970, CHEM MOL BIOL INTERC, V2
   BALAZS EA, 1970, CHEM MOL BIOL INTERC, V3
   BALL V, 2003, SURFACTANT SCI SER, V110, P295
   Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971
   Barbucci R, 2003, BIOMATERIALS, V24, P915, DOI 10.1016/S0142-9612(02)00425-8
   Beavers E. M., 1987, US America Patent, Patent No. 4663233
   Benz M, 2004, J BIOMED MATER RES A, V71A, P6, DOI 10.1002/jbm.a.30123
   BOSKEY AL, 1991, CALCIFIED TISSUE INT, V49, P389, DOI 10.1007/BF02555848
   Burke SE, 2003, BIOMACROMOLECULES, V4, P1773, DOI 10.1021/bm034184w
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   Cassinelli C, 2000, J BIOMAT SCI-POLYM E, V11, P961, DOI 10.1163/156856200744138
   Catterall JB, 1997, GLYCOCONJUGATE J, V14, P867, DOI 10.1023/A:1018598223579
   Cen L, 2002, LANGMUIR, V18, P8633, DOI 10.1021/la025979b
   Chajara A, 1998, PATHOL BIOL, V46, P561
   Chen L, 2004, BIOMACROMOLECULES, V5, P238, DOI 10.1021/bm0344102
   CHEN WYJ, 1999, WOUND REPAIR REGEN, P79
   CHEN WYJ, 2002, HYALURONAN, P147
   COMPER WD, 1978, PHYSIOL REV, V58, P255
   DAGOSTINO R, 1995, PLASMA DEPOSITION TR
   Day AJ, 1999, BIOCHEM SOC T, V27, P115, DOI 10.1042/bst0270115
   Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   DELPECH B, 1985, ANAL BIOCHEM, V149, P555, DOI 10.1016/0003-2697(85)90613-X
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004
   EVERED D, 1989, BIOL HYALURONAN
   Fagerholm P, 1987, Acta Ophthalmol Suppl, V182, P110
   Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831
   Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200
   GOETINCK PF, 1987, J CELL BIOL, V105, P2403, DOI 10.1083/jcb.105.5.2403
   Gribbon P, 1999, BIOPHYS J, V77, P2210, DOI 10.1016/S0006-3495(99)77061-X
   Gribbon P, 2000, BIOCHEM J, V350, P329, DOI 10.1042/0264-6021:3500329
   Grigoreas GHA, 2003, ANAL BIOCHEM, V320, P179, DOI 10.1016/S0003-2697(03)00386-5
   GROVER J, 1994, BIOCHEM J, V300, P317, DOI 10.1042/bj3000317
   Guo MML, 1996, ANAL BIOCHEM, V233, P216, DOI 10.1006/abio.1996.0031
   HALPERN G, 1991, Patent No. 5037677
   Halpern G., 1989, US Patent, Patent No. 4801475
   HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2
   HARDINGHAM TE, 1973, BIOCHEM J, V135, P905, DOI 10.1042/bj1350905
   HASCALL VC, 1974, J BIOL CHEM, V249, P4242
   HASCALL VC, 1974, J BIOL CHEM, V249, P4232
   HEINEGARD D, 1974, J BIOL CHEM, V249, P4250
   HERSH LS, 1972, J BIOMED MATER RES, V6, P85, DOI 10.1002/jbm.820060408
   Heublein B, 2002, INT J ARTIF ORGANS, V25, P1166
   HOEKSTRA D, 1999, MED DEVICE DIAGN FEB, P23
   Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535
   Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   JACKSON DG, 2002, HYALURONAN, V1, P335
   Jacoboni I, 1999, J STRUCT BIOL, V126, P52, DOI 10.1006/jsbi.1999.4090
   Jha BK, 2003, J BIOL CHEM, V278, P27464, DOI 10.1074/jbc.M206696200
   JOHNSTON JB, MALE INFERTILITY
   KENNEDY JF, 2002, HYALURONAN
   Kito H, 1996, J BIOMED MATER RES, V30, P321
   Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8
   KUJAWA MJ, 1986, DEV BIOL, V114, P504, DOI 10.1016/0012-1606(86)90214-9
   Larsen NE, 1998, WENN GR INT, V72, P267
   LARSSON R, 1987, ACTA OTO-LARYNGOL, P44
   LAURENT TC, 1957, ARK KEMI, V11, P487
   LAURENT TC, 1964, BIOCHEM J, V93, P106, DOI 10.1042/bj0930106
   Laurent TC, 1998, CHEM BIOL MED APPL H
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   LEES VC, 1995, LAB INVEST, V73, P259
   Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200
   Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200
   LESLEY J, 2002, HYALURONAN, V1, P341
   LISE M, 2000, REDEFINING HYALURONA, P339
   Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641
   Lovekamp J, 2001, J BIOMED MATER RES, V56, P478, DOI 10.1002/1097-4636(20010915)56:4<478::AID-JBM1119>3.0.CO;2-C
   LOWRY KM, 1994, J BIOMED MATER RES, V28, P861, DOI 10.1002/jbm.820280804
   Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6
   Mason M, 2000, BIOMATERIALS, V21, P31, DOI 10.1016/S0142-9612(99)00129-5
   Meyer K, 1934, J BIOL CHEM, V107, P629
   Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604
   Montesano R, 1996, LAB INVEST, V75, P249
   Morra M, 1998, SURF INTERFACE ANAL, V26, P742, DOI 10.1002/(SICI)1096-9918(199809)26:10<742::AID-SIA417>3.0.CO;2-P
   Morra M, 2003, J COLLOID INTERF SCI, V259, P236, DOI 10.1016/S0021-9797(02)00204-7
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Morra M, 2001, WATER BIOMATERIALS S
   MORRA M, 2000, Patent No. 6129956
   Nasreen N, 2001, ONCOL RES, V13, P71
   NICHOL LW, 1967, BIOCHEM J, V102, P407, DOI 10.1042/bj1020407
   OGSTON AG, 1966, J BIOL CHEM, V241, P17
   Ohri R, 2004, J BIOMED MATER RES A, V70A, P328, DOI 10.1002/jbm.a.30088
   PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257
   PESSAC B, 1972, SCIENCE, V175, P898, DOI 10.1126/science.175.4024.898
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Pitt WG, 2004, J BIOMED MATER RES A, V68A, P95, DOI 10.1002/jbm.a.10170
   Plant AL, 2003, LANGMUIR, V19, P1449, DOI 10.1021/la024035z
   Ponnuraj K, 2000, J MOL BIOL, V299, P885, DOI 10.1006/jmbi.2000.3817
   POUYANI T, 1992, J AM CHEM SOC, V114, P5972, DOI 10.1021/ja00041a010
   POUYANI T, 1994, J AM CHEM SOC, V116, P7515, DOI 10.1021/ja00096a007
   PRESTI D, 1994, CELL BIOCHEM FUNCT, V12, P281, DOI 10.1002/cbf.290120409
   PRESTON BN, 1965, BIOCHEM J, V96, P449, DOI 10.1042/bj0960449
   Ranganathan S, 1995, CELL MOL BIOL RES, V41, P467
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   ROWEN JW, 1956, BIOCHIM BIOPHYS ACTA, V19, P480, DOI 10.1016/0006-3002(56)90471-1
   SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880
   Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200
   Savani RC, 1995, INT J TISSUE REACT, V17, P141
   Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850
   Scott JE, 2002, BIOMACROMOLECULES, V3, P547, DOI 10.1021/bm010170j
   Scott JE, 1998, WENN GR INT, V72, P7
   Sengupta K, 2003, BIOPHYS J, V84, p381A
   Sengupta K, 2003, LANGMUIR, V19, P1775, DOI 10.1021/la026146o
   Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200
   Slevin M, 1998, LAB INVEST, V78, P987
   Stile RA, 2002, J BIOMED MATER RES, V61, P391, DOI 10.1002/jbm.10154
   SUH KP, IN PRESS J BIOMED B
   Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180
   Sweeney DF, 2003, INVEST OPHTH VIS SCI, V44, P3301, DOI 10.1167/iovs.02-0561
   Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200
   TENGBLAD A, 1979, Biochimica et Biophysica Acta, V578, P281
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2004, BIOMATERIALS, V25, P3895, DOI 10.1016/j.biomaterials.2003.10.068
   TOOLE BP, 1971, DEV BIOL, V25, P57, DOI 10.1016/0012-1606(71)90019-4
   Toole BP, 2000, J CLIN INVEST, V106, P335, DOI 10.1172/JCI10706
   TOOLE BP, 1972, P NATL ACAD SCI USA, V69, P1384, DOI 10.1073/pnas.69.6.1384
   TURLEY EA, 1989, J BIOL CHEM, V264, P8951
   TURLEY EA, 1982, BIOCHEM BIOPH RES CO, V108, P1016, DOI 10.1016/0006-291X(82)92101-5
   UNDERHILL C, 1978, EXP CELL RES, V117, P155, DOI 10.1016/0014-4827(78)90438-X
   UNDERHILL C, 1992, J CELL SCI, V103, P293
   UNDERHILL CB, 1980, J BIOL CHEM, V255, P4544
   UNDERHILL CB, 1979, J CELL BIOL, V82, P475, DOI 10.1083/jcb.82.2.475
   Verheye S, 2000, ARTERIOSCL THROM VAS, V20, P1168, DOI 10.1161/01.ATV.20.4.1168
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   Vyavahare N, 1999, J BIOMED MATER RES, V46, P44
   WAN B, 1999, SOC BIOMATERIALS T, V22, P228
   Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057
   Weber E, 2004, LYMPHOLOGY, V37, P15
   WEIGEL PH, 1988, INT J TISSUE REACT, V10, P355
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   WEST DC, 2002, HYALURONAN, V2, P165
   WEST RH, 1995, J MATER SCI-MATER M, V6, P63, DOI 10.1007/BF00120408
   WIGHT TN, 2002, HYALURONAN, V2, P173
   Wisniewski HG, 1996, J IMMUNOL, V156, P1609
   Xu HP, 2002, J BIOL CHEM, V277, P17308, DOI 10.1074/jbc.M112371200
   Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342
NR 150
TC 130
Z9 135
U1 0
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1205
EP 1223
DI 10.1021/bm049346i
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900008
PM 15877335
DA 2018-10-20
ER

PT J
AU Stevens, MM
   Allen, S
   Davies, MC
   Roberts, CJ
   Sakata, JK
   Tendler, SJB
   Tirrell, DA
   Williams, PM
AF Stevens, MM
   Allen, S
   Davies, MC
   Roberts, CJ
   Sakata, JK
   Tendler, SJB
   Tirrell, DA
   Williams, PM
TI Molecular level investigations of the inter- and intramolecular
   interactions of pH-responsive artificial triblock proteins
SO BIOMACROMOLECULES
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPE; LEUCINE-ZIPPER; SENSITIVE HYDROGELS;
   SPECTROSCOPY; PEPTIDE; ELASTICITY; ADHESION; DOMAINS; DESIGN; HELIX
AB Intelligent materials that can undergo physical gelation in response to environmental stimuli have potential impacts in the bioengineering and biomedical fields where the entrapment of cellular or molecular species is desired. Here, we utilize atomic force microscopy (AFM) to perform molecular level investigations of designer artificial proteins that undergo physical gelation. These are engineered as triblock copolymers with independent interchain binding and solvent retention functions, namely, two terminal leucine zipper-like peptide sequences and a central alanylglycine rich sequence, respectively. AFM force measurements between probes and surfaces functionalized with molecules of this triblock protein revealed adhesive interactions that increased in average force and frequency as the pH was lowered from pH 11.2 to 7.4 to 4.5, reflecting an increase in the numbers of interacting molecular strands. In bulk solution, lowering the pH results in a viscous liquid to gel transition. The modular design of the triblock protein was also exploited for single molecule force spectroscopy investigations, which revealed altered intramolecular interactions in response to changes in pH. An increased understanding of the inter- and intramolecular forces involved in biomolecule driven gelation processes is not only of great fundamental interest in the study of the biomolecular systems involved but may also prove key in enabling the rational design of new generations of intelligent hydrogel systems.
C1 Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
   CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
RP Allen, S (reprint author), Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
EM stephanie.allen@nottingham.ac.uk
RI Williams, Philip/C-6947-2009; Roberts, Clive/C-6970-2009
OI Williams, Philip/0000-0002-1822-2133; Roberts,
   Clive/0000-0001-9443-3445; Allen, Stephanie/0000-0001-5384-2998; Davies,
   Martyn/0000-0001-7695-0596
CR Adamson J. Gordon, 1993, Current Opinion in Biotechnology, V4, P428, DOI 10.1016/0958-1669(93)90008-K
   Alber T, 1992, Curr Opin Genet Dev, V2, P205, DOI 10.1016/S0959-437X(05)80275-8
   Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   DeSilva TM, 1997, BIOCHEMISTRY-US, V36, P3991, DOI 10.1021/bi962412j
   Durr E, 1999, BIOCHEMISTRY-US, V38, P870, DOI 10.1021/bi981891e
   Evans E, 1999, FARADAY DISCUSS, V111, P1
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hodges RS, 1996, BIOCHEM CELL BIOL, V74, P133, DOI 10.1139/o96-015
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   KOHN WD, 1995, PROTEIN SCI, V4, P237
   KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   Oberhauser AF, 1998, NATURE, V393, P181
   Oesterhelt F., 1999, NEW J PHYS, P1
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pope LH, 2001, EUR BIOPHYS J BIOPHY, V30, P53, DOI 10.1007/s002490000107
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764
   Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stevens MM, 2004, LANGMUIR, V20, P7747, DOI 10.1021/la030440e
   Stevens MM, 2004, J ORTHOPAED RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021
   Stevens MM, 2004, ADV MATER, V16, P915, DOI 10.1002/adma.200306430
   Stevens MM, 2002, LANGMUIR, V18, P6659, DOI 10.1021/la0202024
   Stevens MM, 2000, ANALYST, V125, P245, DOI 10.1039/a907741c
   STEVENS MM, 2004, UNPUB LANGMUIR
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Willemsen OH, 1999, BIOPHYS J, V76, P716, DOI 10.1016/S0006-3495(99)77238-3
   WILLIAMS PM, 2002, HOUCHES ECOLE ETE PH
NR 39
TC 28
Z9 29
U1 2
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1266
EP 1271
DI 10.1021/bm049369x
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900014
PM 15877341
DA 2018-10-20
ER

PT J
AU Shingel, KI
   Faure, MP
AF Shingel, KI
   Faure, MP
TI Structure-property relationships in poly(ethylene glycol)-protein
   hydrogel systems made from various proteins
SO BIOMACROMOLECULES
LA English
DT Article
ID BIOARTIFICIAL POLYMERIC MATERIAL; PEG HYDROGEL; ALBUMIN; GLYCOL);
   FRACTIONS; PEPTIDE; WATER; GELS
AB A series of poly(ethylene glycol)-protein hydrogels were synthesized with different proteins, and the resultant structures were characterized in terms of swelling behavior and mechanical, optical, and drug release properties. Irrespectively of the protein involved in polymerization with poly(ethylene glycol), all studied systems were found to be loosely cross-linked networks, where both polymer and protein are completely solvated, enabling as high as 96% water content. Changes in the apparent transparency of the hydrogels synthesized with different proteins were attributed to the ability of the protein component to self-associate via hydrophobic interactions. The polyelectrolyte nature of the protein component governs the pH responsiveness of the network, which manifested itself in a pH-dependent mechanism of swelling and drug release. It was demonstrated that there is great opportunity to modulate the final characteristics of the hydrogel system to fit the need of specific biomedical application.
C1 Bioartificial Gel Technol Inc, Montreal, PQ H3A 1L4, Canada.
RP Shingel, KI (reprint author), Bioartificial Gel Technol Inc, 400 Maisonneuve W,Suite 1156, Montreal, PQ H3A 1L4, Canada.
EM kirill.shingel@bagtech.com
CR DAIS M, 1999, INT J PHARM, V182, P41
   DURSO EM, 1994, BIOTECHNOL TECH, V8, P71, DOI 10.1007/BF00152843
   DURSO EM, 1994, J BIOACT COMPAT POL, V9, P367, DOI 10.1177/088391159400900402
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   FORTIER G, 1993, BIOTECHNOL APPL BIOC, V17, P115
   FORTIER G, 1998, METHODS BIOTECHNOLOG, V1
   Fortier G., 1998, U.S. Patent, Patent No. [5733563, 5,733,563]
   Gayet JC, 1998, J BIOACT COMPAT POL, V13, P179, DOI 10.1177/088391159801300302
   Gayet JC, 1996, J CONTROL RELEASE, V38, P177, DOI 10.1016/0168-3659(95)00118-2
   HETTIARACHCHY NS, 1998, FUNCTIONAL PROPERTIE, V708, P80
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   HORKAY F, 1982, MACROMOLECULES, V15, P1306, DOI 10.1021/ma00233a018
   JAKUBEK M, 1979, J GENET POL, V20, P369
   Lu BY, 2000, J SCI FOOD AGR, V80, P1964, DOI 10.1002/1097-0010(200010)80:13<1964::AID-JSFA737>3.0.CO;2-J
   Malin EL, 2001, J PROTEIN CHEM, V20, P391, DOI 10.1023/A:1012232804665
   NAKAI S, 1996, FOOD PROTEINS PROPER, P122
   NOZAWA I, 1991, J BIOMED MATER RES, V25, P243, DOI 10.1002/jbm.820250210
   PERRIER E, 1994, Patent No. 9418944
   REFOJO MF, 1965, J APPL POLYM SCI, V9, P3417, DOI 10.1002/app.1965.070091019
   Renkema JMS, 2002, J AGR FOOD CHEM, V50, P6064, DOI 10.1021/jf020061b
   Riblett AL, 2001, J AGR FOOD CHEM, V49, P4983, DOI 10.1021/jf0105081
   ROBERT M, 2003, APGI S
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   Stubbe BG, 2002, MACROMOLECULES, V35, P2501, DOI 10.1021/ma011408z
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
NR 26
TC 15
Z9 15
U1 2
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1635
EP 1641
DI 10.1021/bm0492475
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900061
PM 15877388
DA 2018-10-20
ER

PT J
AU Liu, ZF
   Wu, X
   Yang, XY
   Liu, DP
   Jun, C
   Sun, RM
   Liu, XP
   Li, FX
AF Liu, ZF
   Wu, X
   Yang, XY
   Liu, DP
   Jun, C
   Sun, RM
   Liu, XP
   Li, FX
TI Synthesis and characterization of novel blood-compatible soluble
   chemically cross-linked polyurethanes with excellent mechanical
   performance for biomedical applications
SO BIOMACROMOLECULES
LA English
DT Article
ID CHAIN ALKYL-GROUPS; PHOSPHATIDYLCHOLINE POLAR HEADGROUPS; SIDE-CHAINS;
   SEGMENTED POLYURETHANES; MAIN CHAINS; POLY(URETHANE UREA); ALBUMIN
   ADSORPTION; SIZE DETERMINATION; ANALOGS; SURFACE
AB A controlled cross-linking polymerization system was designed, and soluble chemically cross-linked polyurethane was synthesized using laurylamine, n-octylamine, n-pentylamine, and ethylenediamine chain extenders. The mechanical analysis showed that the polyurethane materials synthesized in this paper have very excellent mechanical properties with a breaking elongation of 1914% and a tensile strength of 4303 N/cm(2). Such good mechanical properties must enable it to have good longevity when used as biomaterials. The polyurethane materials with n-pentylamine and n-octylamine chain extenders show reduced platelet adhesion than that with an ethylenediamine chain extender after sustaining 200 000 times of load cycles, indicating that polyurethanes introduced with an alkyl side chain onto the hard segments keep good antithrombogenic properties after sustaining load cycles. This might be because the hard segments are shielded by the alkyl side chain when the micro- phase- separation structure is destroyed in the repeated deformation of the polyurethane materials. The present investigation reveals that the influence of introducing long alkyl side chains into the backbone of the polyurethane macromolecule has been shown to reduce platelet deposition and to enhance in vitro albumin adsorption. However, in this paper, it has been observed that the polyurethane material introduced with a proper-length alkyl side chain onto the hard segment has the best antithrombogenic properties after the fatigue test.
C1 State Key Lab Funct Polymer Mat Adsorpt & Separat, Tianjin 300071, Peoples R China.
   Nankai Univ, Dept Chem, Tianjin 300071, Peoples R China.
   Tianjin Med Univ, Pharmaceut Coll, Tianjin 300070, Peoples R China.
RP Li, FX (reprint author), State Key Lab Funct Polymer Mat Adsorpt & Separat, Tianjin 300071, Peoples R China.
EM lifangxing@nankai.edu.cn
CR COURY AJ, 1984, ADV URETHANE SCI TEC, V9, P130
   Dai XH, 2004, MACROMOLECULES, V37, P5615, DOI 10.1021/ma049900g
   EBERHART RC, 1987, ARTIF ORGANS, V11, P375
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   Jayabalan M, 2000, POLYM INT, V49, P88, DOI 10.1002/(SICI)1097-0126(200001)49:1<88::AID-PI298>3.0.CO;2-7
   JAYABALAN M, 1998, VINOY THOMAS MACOMOL, P617
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   Lelah M. D., 1986, POLYURETHANES MED
   Li F, 1999, CHIN J INORG CHEM, V15, P55
   Li FX, 1998, EUR POLYM J, V34, P59, DOI 10.1016/S0014-3057(97)00077-3
   Li FX, 2001, EUR POLYM J, V37, P193, DOI 10.1016/S0014-3057(00)00082-3
   Li FX, 2005, MACROMOLECULES, V38, P69, DOI 10.1021/ma0491558
   Li FX, 2004, MACROMOLECULES, V37, P764, DOI 10.1021/ma034593k
   LI FX, 1994, J POLYM SCI A, V52, P1939
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1999, CHEM MATER, V11, P763, DOI 10.1021/cm9806432
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   Li YJ, 1996, MACROMOL CHEM PHYSIC, V197, P2827, DOI 10.1002/macp.1996.021970920
   Marand E, 1996, MACROMOLECULES, V29, P2555, DOI 10.1021/ma950569y
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   MARCONI W, 1994, MACROMOL CHEM PHYS, V195, P875, DOI 10.1002/macp.1994.021950306
   MUNRO MS, 1983, ASAIO J, V6, P65
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   Planck H, 1987, PROGR BIOMEDICAL ENG
   POLLACK SK, 1992, MACROMOLECULES, V25, P2381, DOI 10.1021/ma00035a014
   RAHMAN R, 1989, J POLYM SCI POL CHEM, V27, P2673, DOI 10.1002/pola.1989.080270815
   SOLOMON DH, 1972, STEP GROWTH POLYM, pCH3
   STRIZINAR I, 1992, J BIOMED MATER RES, V26, P577
   TAKAHARA A, 1985, POLYMER, V26, P978, DOI 10.1016/0032-3861(85)90217-4
   Teo LS, 1997, MACROMOLECULES, V30, P1793, DOI 10.1021/ma961035f
   Thomas V, 2001, BIOMACROMOLECULES, V2, P588, DOI 10.1021/bm010044f
   Tomita T, 1999, CHEM MATER, V11, P2155, DOI 10.1021/cm9901257
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
   ZUO J, 1994, PRINCIPLES APPL LASE, P65
NR 40
TC 15
Z9 18
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1713
EP 1721
DI 10.1021/bm049173x
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900071
PM 15877398
DA 2018-10-20
ER

PT J
AU Watanabe, J
   Ishihara, K
AF Watanabe, J
   Ishihara, K
TI Cell engineering biointerface focusing on cytocompatibility using
   phospholipid polymer with an isomeric oligo(lactic acid) segment
SO BIOMACROMOLECULES
LA English
DT Article
ID PHOSPHORYLCHOLINE; WATER; STEREOCOMPLEX; COPOLYMERS; SUBSTRATE;
   ADHESION; ASSAY
AB Initial contact between a biological environment and a biomaterial ultimately decides the in vivo performance. Therefore, the fabrication of a delicate biointerface is important because it can be utilized as a platform for novel biomaterials. For the preparation of advanced biomedical devices such as biochips, nanoparticles, and cell engineering devices, the surface properties may be modified by the design of polymeric biomaterials. Anomalous phospholipid polymers with an isomeric oligo(lactic acid) segment were designed and evaluated as a biointerface. The phospholipid polymer containing 2-methacryloyloxyethyl phosphorylcholine was easily copolymerized with isomeric oligo(lactic acid) macromonomers, and the obtained polymer could easily form thin coating membranes as biointerfaces. The oligo(lactic acid) involves three kinds of isomers: DL-, D-, and L-forms. The favorable characteristic on the surface provides regulation of cell-material interactions on the biointerface. The oligo(lactic acid) segment could form hydrophobic domains, which were considered to be located on the interface, to enhance protein adsorption and cell adhesion. The most favorable characteristics on the biointerface were dual functions of cytocompatibility by the phospholipid polymer and cell adhesion property by the oligo(lactic acid) segment. In this study, we focused on the biological responses such as protein adsorption and cell adhesion by change in the oligo(lactic acid) component. The cell viability on the confluent stage was evaluated in terms of metabolic activity.
C1 Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ishihara@bmw.t.u-tokyo.ac.jp
CR Baskin A, 1980, J BIOMED MATER RES, V14, P393
   Biran I, 2002, ANAL CHEM, V74, P3046, DOI 10.1021/ac020009e
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kitano H, 2000, J PHYS CHEM B, V104, P11425, DOI 10.1021/jp000429c
   Konno T, 2004, BIOMACROMOLECULES, V5, P342, DOI 10.1021/bm034356p
   MATSUDA T, 1994, J JAPANESE SOC BIOMA, V12, P187
   Miyamoto D, 2004, BIOMATERIALS, V25, P71, DOI 10.1016/S0142-9612(03)00474-5
   Miyazawa K, 2002, MACROMOLECULES, V35, P2440, DOI 10.1021/ma011898v
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Oki A, 2001, ELECTROPHORESIS, V22, P341, DOI 10.1002/1522-2683(200101)22:2<341::AID-ELPS341>3.0.CO;2-W
   Park J, 2004, ANAL CHEM, V76, P2649, DOI 10.1021/ac035321i
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Takei K, 2004, BIOMACROMOLECULES, V5, P858, DOI 10.1021/bm0344250
   Watanabe J, 2003, ARTIF ORGANS, V27, P242, DOI 10.1046/j.1525-1594.2003.07015.x
   Watanabe J, 2003, CHEM LETT, V32, P192, DOI 10.1246/cl.2003.192
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1109, DOI 10.1021/bm025586r
   Whelan DM, 2000, HEART, V83, P338, DOI 10.1136/heart.83.3.338
   YONEYAMA T, 2002, BIOMATERIALS, V23, P1445
NR 22
TC 21
Z9 23
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1797
EP 1802
DI 10.1021/bm050138f
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900080
PM 15877407
DA 2018-10-20
ER

PT J
AU Frost, MC
   Reynolds, MM
   Meyerhoff, ME
AF Frost, MC
   Reynolds, MM
   Meyerhoff, ME
TI Polymers incorporating nitric oxide releasing/generating substances for
   improved biocompatibility of blood-contactincy medical devices
SO BIOMATERIALS
LA English
DT Review
DE nitric oxide; blood compatible polymers; anti-platelet activity
ID MUSCLE-CELL-PROLIFERATION; IN-STENT RESTENOSIS; VASCULAR ACCESS
   DYSFUNCTION; SIROLIMUS-ELUTING STENT; S-NITROSOTHIOLS;
   PLATELET-ADHESION; NEOINTIMAL HYPERPLASIA; NITROGEN(II) OXIDE; CHEMICAL
   SENSORS; RELEASE POLYMERS
AB The current state-of-the-art with respect to the preparation, characterization and biomedical applications of novel nitric oxide (NO) releasing or generating polymeric materials is reviewed. Such materials show exceptional promise as coatings to prepare a new generation of medical devices with superior biocompatiblity. Nitric oxide is a well-known inhibitor of platelet adhesion and activation, as well as a potent inhibitor of smooth muscle cell proliferation. Hence, polymers that release OF generate NO locally at their surface exhibit greatly enhanced thromboresistivity and have the potential to reduce neointimal hyperplasia caused by device damage to blood vessel walls. In this review, the use of diazeniumdiolates and nitrosothiols as NO donors within a variety polymeric matrixes are summarized. Such species can either be doped as discrete NO donors within polymeric films, or covalently baked to polymer backbones and/or inorganic polymeric filler particles that are often employed to enhance the strength of biomedical polymers (e.g., fumed silica or titanium dioxide). In addition, very recent efforts to create catalytic polymers posssessing immobilized Cu(II) sites capable of generating NO from endogenous oxidized forms of NNO already present in blood and other physiological fluids (nitrite and nitrosothiols) are discussed. Preliminary literature data illustrating the efficacy of the various NO release/ generating polymers as coatings for intravascular sensors, extracorporeal blood loop circuits. and arteriovenous grafts/shunts are reviewed. circle * 2004 Elsevier Ltd. All rights reserved.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
EM mmeyerho@umich.edu
CR Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   BAMFORD CH, 1992, INT J ARTIF ORGANS, V15, P71
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   BATCHELOR MM, 2004, THESIS U MICHIGAN, P157
   Bohl KS, 2000, BIOMATERIALS, V21, P2273, DOI 10.1016/S0142-9612(00)00153-8
   Braybrook J.H., 1997, BIOCOMPATIBILITY ASS
   Bruemmer D, 2003, BIOCHEM BIOPH RES CO, V303, P251, DOI 10.1016/S0006-291X(03)00343-7
   Chandrasekar B, 2000, J AM COLL CARDIOL, V35, P555, DOI 10.1016/S0735-1097(99)00596-3
   Chaux A, 1998, J THORAC CARDIOV SUR, V115, P604, DOI 10.1016/S0022-5223(98)70325-3
   Chen CY, 1997, J SURG RES, V67, P26, DOI 10.1006/jsre.1996.4915
   COLMAN RW, 1993, CARDIOVASC PATHOL, V2, pS23
   Degertekin M, 2003, J AM COLL CARDIOL, V41, P184, DOI 10.1016/S0735-1097(02)02704-3
   Dicks AP, 1996, CHEM SOC P2, V4, P481
   DRAGO RS, 1960, J AM CHEM SOC, V82, P96, DOI 10.1021/ja01486a021
   DRAGO RS, 1961, J AM CHEM SOC, V83, P1819, DOI 10.1021/ja01469a012
   Duan XB, 2002, BIOMATERIALS, V23, P1197, DOI 10.1016/S0142-9612(01)00234-4
   EspadasTorre C, 1997, J AM CHEM SOC, V119, P2321, DOI 10.1021/ja963054a
   Etchenique R, 2000, J AM CHEM SOC, V122, P3967, DOI 10.1021/ja9939845
   Feng J., 2000, POLYM PREPR, V41, P16
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Frost MC, 2003, MICROCHEM J, V74, P277, DOI 10.1016/S0026-265X(03)00033-X
   Frost MC, 2002, ANAL CHEM, V74, P5942, DOI 10.1021/ac025944g
   Gabikian P, 2002, STROKE, V33, P2681, DOI 10.1161/01.STR.0000033931.62992.B1
   GOLDSTEIN S, 1995, J AM CHEM SOC, V117, P12078, DOI 10.1021/ja00154a007
   GROVES PH, 1995, CARDIOVASC RES, V30, P87, DOI 10.1016/0008-6363(95)00009-7
   Groves PH, 2000, BIOMATERIALS, V21, P2273
   Gruberg L, 2000, EXPERT OPIN INV DRUG, V9, P2555, DOI 10.1517/13543784.9.11.2555
   Hoffmann R, 2000, EUR HEART J, V21, P1739, DOI 10.1053/euhj.2000.2153
   HOLMES AJ, 2000, CHEM SOC P2, V8, P1639
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   Jourd'heuil D, 2000, FREE RADICAL BIO MED, V28, P409, DOI 10.1016/S0891-5849(99)00257-9
   KELLY BS, 2002, KIDNEY INT, V262, P2272
   Makrides SC, 1998, THROMBOSIS HEMORRHAG, P295
   Marxer SM, 2003, CHEM MATER, V15, P4193, DOI 10.1021/cm034347n
   Masters KSB, 2002, WOUND REPAIR REGEN, V10, P286, DOI 10.1046/j.1524-475X.2002.10503.x
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Mowery KA, 1999, ELECTROANAL, V11, P681, DOI 10.1002/(SICI)1521-4109(199907)11:10/11<681::AID-ELAN681>3.3.CO;2-R
   Oh BK, 2003, J AM CHEM SOC, V125, P9552, DOI 10.1021/ja035775x
   OH BK, 2004, BIOMATERIALS, V23, P283
   Parzuchowski PG, 2002, J AM CHEM SOC, V124, P12182, DOI 10.1021/ja020268l
   Pulfer SK, 1997, J BIOMED MATER RES, V37, P182, DOI 10.1002/(SICI)1097-4636(199711)37:2<182::AID-JBM6>3.0.CO;2-N
   RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Regar E, 2001, BRIT MED BULL, V59, P227, DOI 10.1093/bmb/59.1.227
   Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.0590062325.x
   Roy-Chaudhury P, 2003, BLOOD PURIFICAT, V21, P99, DOI 10.1159/000067863
   Roy-Chaudhury P, 2002, ADV RENAL REPLACE TH, V9, P74, DOI 10.1053/jarr.2002.33519
   ROYCHAUDHURY P, 2002, J INVASIVE CARDIOL, V14, pE25
   Saavedra JE, 1999, J ORG CHEM, V64, P5124, DOI 10.1021/jo9901539
   Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s
   SARKAR R, 1995, THESIS U MICHIGAN
   Schoenfisch MH, 2002, ANAL CHEM, V74, P5937, DOI 10.1021/ac026075y
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   Shishido SM, 2003, BIOMATERIALS, V24, P3543, DOI 10.1016/S0142-9612(03)00153-4
   Shishido SM, 2000, PHOTOCHEM PHOTOBIOL, V71, P273, DOI 10.1562/0031-8655(2000)071<0273:PGMRTR>2.0.CO;2
   SINEY L, 1992, EUR J PHARMACOL, V229, P223, DOI 10.1016/0014-2999(92)90559-M
   Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Smith DJ, 1998, J CONTROL RELEASE, V51, P153, DOI 10.1016/S0168-3659(97)00161-2
   SNEDDON JM, 1988, P NATL ACAD SCI USA, V85, P2800, DOI 10.1073/pnas.85.8.2800
   Sousa JE, 2003, CIRCULATION, V107, P24, DOI 10.1161/01.CIR.0000047063.22006.41
   Tierney TS, 2001, NEUROSURGERY, V49, P945, DOI 10.1097/00006123-200110000-00028
   Tyurin VA, 2002, METHOD ENZYMOL, V352, P347
   VAUGHN M, 1998, AM J PHYSIOL, V274, P2163
   Williams DLH, 1999, ACCOUNTS CHEM RES, V32, P869, DOI 10.1021/ar9800439
   WISE DL, 2000, BIOMATERIALS ENV DEV, V1
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 70
TC 206
Z9 214
U1 5
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1685
EP 1693
DI 10.1016/j.biomaterials.2004.06.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800009
PM 15576142
DA 2018-10-20
ER

PT J
AU Rimmer, S
   German, MJ
   Maughan, J
   Sun, Y
   Fullwood, N
   Ebdon, J
   MacNeil, S
AF Rimmer, S
   German, MJ
   Maughan, J
   Sun, Y
   Fullwood, N
   Ebdon, J
   MacNeil, S
TI Synthesis and properties of amphiphilic networks 3: preparation and
   characterization of block conetworks of poly(butyl
   methacrylate-block-(2,3 propandiol-1-methacrylate-stat-ethandiol
   dimethacrylate))
SO BIOMATERIALS
LA English
DT Article
DE ampiphilic network; hydrogel; fibroblast; cell proliferation;
   methacrylate
ID BIOMEDICAL APPLICATIONS; TELECHELIC OLIGOMERS; POLYMER COMPOSITION;
   MAIN-CHAIN; HYDROGELS; RELEASE; DEGRADATION; COPOLYMERS; SCAFFOLDS;
   ADHESION
AB Amphiphilic conetwork polymers were prepared and studied as substrates in the culture of dermal fibroblasts. Both block and random conetworks polymers were produced by radical polymerization of either low-molecular weight monomers or oligomeric macromonomers. The oligomeric macromonomers were prepared by methacrylation of biscarboxy oligo(butyl methacrylates) (OBMA). The latter were synthesized by ozononolysis of poly(butyl methacrylate-co-butadiene) materials. The hydrophilic component was derived from copolymerization with 2,3 propandiol-l-methacrylate and cross-linking was provided by inclusion of ethandiol dimethacrylate (EDMA). None of the synthesized materials showed indications of cytotoxicity to human dermal fibroblasts. All of the block conetworks were highly phase separated and possessed pores on the micron length scale. The equilibrium water contents of the latter could be controlled by addition of EDMA. Block conetworks that did not contain EDMA were highly swollen and had smoother surfaces than those that contained EDMA. The former were poor substrates for cell proliferation (as measured by monitoring DNA content) whilst the latter class gave increasing levels of DNA during culture; an indicator proliferation. The performance of these materials in cell culture was also dependent on the fraction of OBMA in the formulation. Increasing the fractions of BMA, either in the random terpolymer or block networks, system had the effect of increasing both cell proliferation and viability (as measured by the Alamar Blue assay). (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Sheffield, Dept Chem, Ctr Polymer, Polymer & Biomat Chem Labs, Sheffield S3 7HF, S Yorkshire, England.
   Univ Sheffield, Dept Chem, Polymer & Biomat Chem Labs, CTEB, Sheffield S3 7HF, S Yorkshire, England.
   Univ Lancaster, Dept Phys, Lancaster LA1 4YB, Lancs, England.
   Univ Lancaster, Dept Sci Biol, Lancaster LA1 4YQ, England.
   Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England.
   No Gen Hosp, Div Clin Sci, Sheffield S5 7AU, S Yorkshire, England.
RP Rimmer, S (reprint author), Univ Sheffield, Dept Chem, Ctr Polymer, Polymer & Biomat Chem Labs, Sheffield S3 7HF, S Yorkshire, England.
EM s.rimmer@sheffield.ac.uk
RI German, Matthew/R-5269-2018
OI German, Matthew/0000-0002-3910-6377; Ebdon, John/0000-0003-4176-3912;
   Fullwood, Nigel James/0000-0002-9405-8515
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Bae YH, 2000, J CONTROL RELEASE, V64, P3, DOI 10.1016/S0168-3659(99)00126-1
   Barakat I, 1999, J POLYM SCI POL CHEM, V37, P2401, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2401::AID-POLA14>3.0.CO;2-9
   Bellesia F, 1998, TETRAHEDRON, V54, P7849, DOI 10.1016/S0040-4020(98)00419-0
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   BLEZER R, 1995, POLYM BULL, V34, P101, DOI 10.1007/BF00294894
   CHEN D, 1989, J BIOMED MATER RES, V23, P1327, DOI 10.1002/jbm.820231109
   Cunliffe D, 2002, DES MONOMERS POLYM, V5, P233, DOI 10.1163/156855502760157953
   Cunliffe D, 2001, MACROMOLECULES, V34, P3882, DOI 10.1021/ma001313h
   DAVID G, 2002, EUR POLYM J, V39, P77
   EBDON J, 1991, NEW METHODS POLYM SY, pCH7
   Ebdon JR, 1997, J POLYM SCI POL CHEM, V35, P3255, DOI 10.1002/(SICI)1099-0518(19971115)35:15<3255::AID-POLA19>3.3.CO;2-K
   EBDON JR, 1995, MACROMOL REP A, V32, P603
   GOEGAN P, 1995, TOXICOL IN VITRO, V9, P257, DOI 10.1016/0887-2333(95)00004-R
   Guan Y, 2002, MACROMOL CHEM PHYSIC, V203, P900, DOI 10.1002/1521-3935(20020401)203:5/6<900::AID-MACP900>3.0.CO;2-E
   GUAN Y, 1999, HUAXUE JINZHAN, V11, P86
   Haigh R, 2002, BIOMATERIALS, V23, P3509, DOI 10.1016/S0142-9612(02)00081-9
   Haigh R, 2000, BIOMATERIALS, V21, P735, DOI 10.1016/S0142-9612(99)00245-8
   Higham MC, 2003, TISSUE ENG, V9, P919, DOI 10.1089/107632703322495565
   Isayeva IS, 2002, POLYM BULL, V48, P475, DOI 10.1007/s00289-002-0062-7
   Ivan B, 2001, MACROMOLECULES, V34, P1579, DOI 10.1021/ma000062+
   Ivan B, 1996, MACROMOL SYMP, V102, P81, DOI 10.1002/masy.19961020112
   IVAN B, 1990, POLYM PREPR, V31, P217
   Kennedy J. P., 2001, MACROMOL S, V172, P56
   KENNEDY JP, 1994, J MACROMOL SCI PURE, VA31, P1771, DOI 10.1080/10601329408545881
   KENNEDY JP, 1993, TRENDS POLYM SCI, V1, P381
   KENNEDY JP, 2000, POLYM PREPR AM CHEM, V41, P710
   KESZLER B, 1993, J CONTROL RELEASE, V25, P115, DOI 10.1016/0168-3659(93)90100-J
   LIMA V, 2003, POLYM PREPR, V44, P812
   Lovell P. A., 1997, EMULSION POLYM EMULS
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Nakayama Y, 2000, J BIOMED MATER RES, V51, P520, DOI 10.1002/1097-4636(20000905)51:3<520::AID-JBM29>3.0.CO;2-A
   Patrickios CS, 2003, CURR OPIN COLLOID IN, V8, P76, DOI 10.1016/S1359-0294(03)00005-0
   Rimmer S, 1996, J POLYM SCI POL CHEM, V34, P3573, DOI 10.1002/(SICI)1099-0518(199612)34:17<3573::AID-POLA12>3.0.CO;2-B
   Rimmer S, 1995, REACT FUNCT POLYM, V26, P145, DOI 10.1016/1381-5148(95)00014-7
   Simmons MR, 2000, MACROMOLECULES, V33, P3176, DOI 10.1021/ma991720x
   TOLNAI M, 1998, POLYM MAT SCI ENG, V79, P250
   Triftaridou AI, 2002, MACROMOLECULES, V35, P2506, DOI 10.1021/ma0114077
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   YU H, 1995, J CONTROL RELEASE, V34, P117, DOI 10.1016/0168-3659(94)00127-G
   Zhang ZR, 1999, THERMOCHIM ACTA, V336, P133, DOI 10.1016/S0040-6031(99)00127-6
NR 41
TC 51
Z9 51
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2219
EP 2230
DI 10.1016/j.biomaterials.2004.07.013
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400003
PM 15585223
DA 2018-10-20
ER

PT J
AU De Aza, PN
   De Aza, AH
   De Aza, S
AF De Aza, PN
   De Aza, AH
   De Aza, S
TI Crystalline bioceramic materials
SO BOLETIN DE LA SOCIEDAD ESPANOLA DE CERAMICA Y VIDRIO
LA English
DT Review
DE alumina; zirconia; zirconia-toughened alumina; graphite; hydroxyapatite;
   bioactive silicates; bioeutectic; tricalcium phosphate
ID TOUGHENED ALUMINA CERAMICS; TRICALCIUM PHOSPHATE BIOEUTECTIC(R);
   TRANSMISSION ELECTRON-MICROSCOPY; CRACK-GROWTH RESISTANCE; PULSED-LASER
   DEPOSITION; CALCIUM-PHOSPHATE; PROSTHETIC APPLICATIONS; BIOMEDICAL
   APPLICATION; JOINT REPLACEMENT; HIGH-RESOLUTION
AB A strong interest in the use of ceramics for biomedical engineering applications developed in the late 1960's. Used initially as alternatives to metallic materials in order to increase the biocoinpatibility of implants, bioceramics have become a diverse class of biomaterials, presently including three basic types: relatively bioinert ceramics; bioactive or surface reactive bioceramics and bioresorbable ceramics.
   This review will only refer to bioceramics "sensus stricto", it is to say, those ceramic materials constituted for nonmetallic inorganic compounds, crystallines and consolidated by thermal treatments of powders to high temperatures. Leaving bioglasses, glass-ceramics and biocements apart, since, although all of them are obtained by thermal treatments to high temperatures, the first are amorphous, the second are obtained by desvitrification of a glass and in them vitreous phase normally prevails on the crystalline phases and the third are consolidated by means of a hydraulic or chemical reaction to room temperature.
   A review of the composition, physiochemical properties and biological behaviour of the principal types of crystalline bioceramics is given, based on the literature data and on the own experience of the authors.
C1 Univ Miguel Hernandez, Inst Bioingn, Alicante, Spain.
   CSIC, Inst Ceram & Vidrio, Madrid, Spain.
RP De Aza, PN (reprint author), Univ Miguel Hernandez, Inst Bioingn, Alicante, Spain.
RI de Aza, Antonio/G-4626-2015; De Aza, Piedad/A-7621-2015
OI de Aza, Antonio/0000-0002-1655-3932; De Aza, Piedad/0000-0001-9316-4407
CR Abe Y, 1975, Shika Rikogaku Zasshi, V16, P196
   AKAO M, 1982, J MATER SCI, V17, P343, DOI 10.1007/BF00591468
   ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   ASHBROOK RL, 1977, J AM CERAM SOC, V60, P428, DOI 10.1111/j.1151-2916.1977.tb15527.x
   BAILEY A, 1971, AM J SCI, V27, P464
   BAKO Z, 1992, CERAM INT, V18, P373, DOI 10.1016/0272-8842(92)90068-O
   BERGER G, 1989, P 15 INT C GLASS A, V3, P120
   BLENKE BA, 1973, LANGENBECHS ARCH CHI, V107
   Bragdon CR, 1997, J ARTHROPLASTY, V12, P119, DOI 10.1016/S0883-5403(97)90057-7
   BROWN L, 2004, 7 WORLD BIOM C SIDN
   BUTLER EP, 1985, MATER SCI TECH SER, V1, P417, DOI 10.1179/mst.1985.1.6.417
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   Chevalier J, 2000, ADV MATER, V12, P1619, DOI 10.1002/1521-4095(200011)12:21<1619::AID-ADMA1619>3.0.CO;2-O
   Christel P., 1988, BIOCERAMICS MAT CHAR, V523, P237
   CLARK A, 1991, ENG MAT HDB, V4, P1091
   Cleries L, 2000, J BIOMED MATER RES, V49, P43, DOI 10.1002/(SICI)1097-4636(200001)49:1<43::AID-JBM6>3.0.CO;2-G
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   DAUSKARDT RH, 1993, INTRO BIOCERAMICS, P261
   De Aza AH, 2003, J AM CERAM SOC, V86, P115
   De Aza AH, 2002, KEY ENG MAT, V206-2, P1535, DOI 10.4028/www.scientific.net/KEM.206-213.1535
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   De Aza P. N., 1995, ADV SCI TECHNOLOGY, P19
   De Aza PN, 2004, BIOMATERIALS, V25, P1983, DOI 10.1016/j.biomaterials.2003.08.036
   De Aza PN, 1998, ANALYST, V123, P681, DOI 10.1039/a708445e
   De Aza PN, 1999, J DENT, V27, P107, DOI 10.1016/S0300-5712(98)00029-3
   De Aza PN, 2001, J MICROSC-OXFORD, V201, P33, DOI 10.1046/j.1365-2818.2001.00779.x
   De Aza PN, 1998, ACTA MATER, V46, P2541, DOI 10.1016/S1359-6454(98)80038-4
   de Aza PN, 1998, J MICROSC-OXFORD, V189, P145
   De Aza PN, 2000, BIOMATERIALS, V21, P1735, DOI 10.1016/S0142-9612(00)00058-2
   de Aza PN, 2000, J MICROSC-OXFORD, V197, P60
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   De Santis E, 2000, KEY ENG MAT, V192-1, P995
   DeAza PN, 1997, BIOMATERIALS, V18, P1285, DOI 10.1016/S0142-9612(97)00063-X
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   DeAza PN, 1996, J MICROSC-OXFORD, V182, P24, DOI 10.1111/j.1365-2818.1996.tb04794.x
   DeAza PN, 1996, J MATER SCI-MATER M, V7, P399, DOI 10.1007/BF00122007
   DEAZA PN, 1995, J AM CERAM SOC, V78, P1653
   DEAZA PN, 1998, CERAMIC MICROSTRUCTU, P761
   DEAZA PN, 1999, ADV SCI TECHN 28 MAT, P25
   DEER WA, 1972, INTRO ROCK FORMING B, V5
   DEGROOT K, 1988, BIOCERAMICS MAT CHAR, P227
   DEGROOT K, 1991, CENTENNIAL MEMORIAL, V99, P943
   DEGROOT K, 1988, BIOCERAMICS MAT CHAR, P268
   Dubok VA, 2000, POWDER METALL MET C+, V39, P381, DOI 10.1023/A:1026617607548
   Dufrane D, 2003, J MATER SCI-MATER M, V14, P33, DOI 10.1023/A:1021545302732
   ELLIOTT R, 1977, INT METALS REV, P161
   Fernandez-Pradas JM, 2002, BIOMATERIALS, V23, P2057, DOI 10.1016/S0142-9612(01)00335-0
   Fernandez-Pradas JM, 2002, BIOMATERIALS, V23, P1989, DOI 10.1016/S0142-9612(01)00327-1
   Frondel C, 1941, AM MINERAL, V26, P145
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Glasmacher B, 1999, MATERIALWISS WERKST, V30, P806, DOI 10.1002/(SICI)1521-4052(199912)30:12<806::AID-MAWE806>3.3.CO;2-6
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   GROSS UM, 1982, CLIN APPLICATIONS BI, P237
   GROSS UM, 1993, INTRO BIOCERAMICS, P105
   HAYASHI K, 1992, BIOMATERIALS, V13, P195, DOI 10.1016/0142-9612(92)90184-P
   HAYEK E, 1963, INORG SYN, V7, P63, DOI 10.1002/9780470132388.ch17
   Hench L.L., 1981, FUNDAMENTAL ASPECTS
   HENCH LL, 1975, ANNU REV MATER SCI, V5, P279, DOI 10.1146/annurev.ms.05.080175.001431
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1978, J NON-CRYST SOLIDS, V28, P83, DOI 10.1016/0022-3093(78)90077-7
   HENCH LL, 1988, BIOCERAMICS MAT CHAR, V523, P54
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOLMES R, 1984, CLIN ORTHOP RELAT R, P252
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hulbert S. F., 1987, HIGH TECH CERAMICS, P189
   Hulbert S.F., 1983, CERAMICS SURGERY, P3
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   JACKSON SA, 1978, CALC TISS RES, V25, P217, DOI 10.1007/BF02010772
   Josset Y, 2000, KEY ENG MAT, V192-1, P329
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   KAWAHARA H, 1980, J BIOMED MATER RES, V14, P597, DOI 10.1002/jbm.820140506
   KEREBEL B, 1976, J ULTRA MOL STRUCT R, V57, P266, DOI 10.1016/S0022-5320(76)80116-5
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1993, 3 EUROCERAMICS, V3, P1
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   Kurz W., 1984, FUNDAMENTAL SOLIDIFI
   Lancaster JG, 1997, P I MECH ENG H, V211, P17, DOI 10.1243/0954411971534647
   Lee SY, 2000, BIOMATERIALS, V21, P1315, DOI 10.1016/S0142-9612(99)00217-3
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   LEWANDOWSKASZUMIEL, 1997, J MATER SCI-MATER M, V8, P485
   Miake Y, 1995, J DENT RES, V74, P1756, DOI 10.1177/00220345950740110701
   *MIN SANTE FAM PER, 2002, J OFFICIEL NOR  0722
   Mitura S, 1996, DIAM RELAT MATER, V5, P1185, DOI 10.1016/0925-9635(95)00525-0
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Nkamgueu EM, 2000, J BIOMED MATER RES, V52, P587, DOI 10.1002/1097-4636(20001215)52:4<587::AID-JBM2>3.3.CO;2-T
   NONAMI T, 1995, J SOC MAT ENG RESOUR, V8, P12
   NURSE RW, 1969, J CHEM SOC, P1077
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   PASCUAL C, 1983, J AM CERAM SOC, V66, P23, DOI 10.1111/j.1151-2916.1983.tb09961.x
   PERNOT F, 1979, J MATER SCI, V14, P1694, DOI 10.1007/BF00569292
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   ROY DM, 1974, NATURE, P274
   SANTOS C, 1994, THESIS U SANTIAGO SP
   Sarmento C, 2004, J BIOMED MATER RES A, V69A, P351, DOI 10.1002/jbm.a.30012
   Schulte W, 1984, QUINTESSENCE INT, V15, P1
   Sedel L, 2000, KEY ENG MAT, V192-1, P969
   Serra E, 2002, BIOMATERIALS, V23, P1131, DOI 10.1016/S0142-9612(01)00227-7
   Shackelford JF, 1999, MATER SCI FORUM, V293, P99, DOI 10.4028/www.scientific.net/MSF.293.99
   Sivakumar M, 1996, BIOMATERIALS, V17, P1709, DOI 10.1016/0142-9612(96)87651-4
   Stevens R., 1986, INTRO ZIRCONIA
   TAEISHI T, 1987, B MECH ENG LAB, V45, P1
   TENCER AF, 1990, HDB BIOACTIVE CERAMI, V2, P209
   Vallet-Regis M., 2001, J CHEM SOC DA, V2, P97
   Van der Woude A., 1980, P INT C IMPLANTOLOGY, P157
   Villora JM, 2002, BOL SOC ESP CERAM V, V41, P443, DOI 10.3989/cyv.2002.v41.i5.663
   WELCH JH, 1961, J CHEM SOC, P4442, DOI 10.1039/jr9610004442
   Williams D. F., 1987, DEFINITIONS BIOMATER
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Williams DF., 1985, BIOCOMPATIBILITY TIS, VII, P43
   YAMAGAMI A, 1988, P 1 INT S CER MED, P332
   Young RA, 1975, C INT CNRS, V230, P21
   YUBAO L, 1994, J MAT SCI MAT ME, P26
   2000, ENCY BRITANICA MICRO, V12, P324
NR 116
TC 61
Z9 63
U1 1
U2 44
PU SOCIEDAD ESPANOLA CERAMICA VIDRIO
PI MADRID
PA ANTIGUA CTRA MADRID-VALENCIA, KM 24,300, ARGANDA DEL REY, 28500 MADRID,
   SPAIN
SN 0366-3175
J9 BOL SOC ESP CERAM V
JI Bol. Soc. Esp. Ceram. Vidr.
PD MAY-JUN
PY 2005
VL 44
IS 3
BP 135
EP 145
DI 10.3989/cyv.2005.v44.i3.382
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA 936ZW
UT WOS:000229895300002
DA 2018-10-20
ER

PT J
AU Ho, C
   Soolaman, DM
   Yu, HZ
AF Ho, C
   Soolaman, DM
   Yu, HZ
TI 2004 Fred Beamish Award Lecture - Analytical - materials chemistry on
   old CDs - Beyond self-assembly
SO CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE
LA English
DT Article
DE compact disc-recordable (CD-R); self-assembled monolayers (SAMs);
   electrochemical analysis; material micro- and (or) nanostructures;
   biomedical diagnosis
ID ELECTRON-TRANSFER KINETICS; ZIRCONIA THIN-FILMS; GOLD ELECTRODES;
   RECORDABLE CDS; AMPEROMETRIC DETERMINATION; COMPACT DISCS; FLOW CELL;
   MONOLAYERS; FABRICATION; MICROARRAYS
AB This review describes a variety of new chemistry that has been established in our research laboratory and by other scientists worldwide related to optical compact disc (CD) technology. In particular, we have discovered that gold substrates from CD-Rs can be used to prepare high-quality, self-assembled monolayers (SAMs) after removing the protective polymer films with concentrated nitric acid. It was proven that these substrates are feasible for electrochemical, spectroscopic, and surface wetting studies. We have also demonstrated that CD-R gold films are ideal micropatterned conductive substrates for the "customized" fabrication of material microstructures. In addition, we have been working on the micropatterning of DNA probes on CD-R substrates, and exploring the possibility of using the CD-R writing/reading system for biochip fabrication and gene analysis.
C1 Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.
RP Yu, HZ (reprint author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.
EM hzyu@sfu.ca
CR Alexandre I, 2002, BIOTECHNIQUES, V33, P435, DOI 10.2144/02332pf01
   Alexandre I, 2001, ANAL BIOCHEM, V295, P1, DOI 10.1006/abio.2001.5176
   Angnes L, 2000, ANAL CHEM, V72, P5503, DOI 10.1021/ac000437p
   Banks JT, 2002, J PHYS CHEM B, V106, P3538, DOI 10.1021/jp013970x
   Birkett D, 2002, J CHEM EDUC, V79, P1081, DOI 10.1021/ed079p1081
   CHAIM R, 1991, J ELECTROCHEM SOC, V138, P1942, DOI 10.1149/1.2085905
   Daniel D, 2003, ELECTROCHEM COMMUN, V5, P782, DOI 10.1016/j.elecom.2003.07.004
   Daniel D, 2001, ELECTROANAL, V13, P681, DOI 10.1002/1521-4109(200105)13:8/9<681::AID-ELAN681>3.0.CO;2-F
   Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873
   FINKLEA HO, 1992, J AM CHEM SOC, V114, P3173, DOI 10.1021/ja00035a001
   FOJTA M, 2002, ELECTROANAL, V14, P1149
   Hamels S, 2001, BIOTECHNIQUES, V31, P1364, DOI 10.2144/01316md04
   Hazarika P, 2003, LAB CHIP, V3, P128, DOI 10.1039/b302563m
   Helt JM, 2004, J AM CHEM SOC, V126, P628, DOI 10.1021/ja035142i
   Khoshtariya DE, 2003, J AM CHEM SOC, V125, P7704, DOI 10.1021/ja034719t
   Kido H, 2000, ANAL CHIM ACTA, V411, P1, DOI 10.1016/S0003-2670(00)00776-5
   KUHN KJ, 2003, AUDIO COMPACT DISK I
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   La Clair JJ, 2003, ORG BIOMOL CHEM, V1, P3244, DOI 10.1039/b306391g
   Lai S, 2004, ANAL CHEM, V76, P1832, DOI 10.1021/ac0348322
   Madou MJ, 2001, BIOMED MICRODEVICES, V3, P245, DOI 10.1023/A:1011419515576
   Munoz RAA, 2001, J PHARM SCI, V90, P1972, DOI 10.1002/jps.1148
   PICKNETT RG, 1977, J COLLOID INTERF SCI, V61, P336, DOI 10.1016/0021-9797(77)90396-4
   Pohlman Kenneth, 1992, COMPACT DISC HDB
   Richter EM, 2000, FRESEN J ANAL CHEM, V366, P444, DOI 10.1007/s002160050090
   Richter EM, 2003, QUIM NOVA, V26, P839, DOI 10.1590/S0100-40422003000600011
   Richter EM, 2001, ELECTROANAL, V13, P760, DOI 10.1002/1521-4109(200105)13:8/9<760::AID-ELAN760>3.0.CO;2-N
   SAKAI H, 1998, LANGMUIR, V14, P2008
   Shacham R, 2004, CHEM-EUR J, V10, P1936, DOI 10.1002/chem.200305469
   Su L, 2004, ANAL CHEM, V76, P5953, DOI 10.1021/ac0494331
   Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664
   Therese GHA, 2000, CHEM MATER, V12, P1195, DOI 10.1021/cm990447a
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Vercoutere W, 2002, CURR OPIN CHEM BIOL, V6, P816, DOI 10.1016/S1367-5931(02)00395-2
   Westbroek P, 2002, ANAL CHEM, V74, P915, DOI 10.1021/ac0104072
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yu HZ, 2004, CHEM COMMUN, P2633, DOI 10.1039/b412784f
   Yu HZ, 2004, CHEMPHYSCHEM, V5, P1035, DOI 10.1002/cphc.200301042
   Yu HZ, 2003, ANAL CHEM, V75, P3902, DOI 10.1021/ac034318w
   Yu HZ, 2002, ANAL CHEM, V74, P5742, DOI 10.1021/ac025686n
   Yu HZ, 2001, ANAL CHEM, V73, P4743, DOI 10.1021/ac015521z
   Yu HZ, 1996, LANGMUIR, V12, P2843, DOI 10.1021/la950632c
NR 42
TC 5
Z9 7
U1 0
U2 8
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA
SN 0008-4042
J9 CAN J CHEM
JI Can. J. Chem.-Rev. Can. Chim.
PD MAY
PY 2005
VL 83
IS 5
BP 403
EP 412
DI 10.1139/V05-006
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 930KO
UT WOS:000229414900001
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Engineering biomedical materials from corn and wool
SO CHEMICAL ENGINEERING PROGRESS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER INST CHEMICAL ENGINEERS
PI NEW YORK
PA 3 PARK AVE, NEW YORK, NY 10016-5901 USA
SN 0360-7275
EI 1945-0710
J9 CHEM ENG PROG
JI Chem. Eng. Prog.
PD MAY
PY 2005
VL 101
IS 5
BP 10
EP 11
PG 2
WC Engineering, Chemical
SC Engineering
GA 926XA
UT WOS:000229155800009
DA 2018-10-20
ER

PT J
AU Hollaus, K
   Biro, O
   Gerstenberger, C
   Preis, K
   Stollberger, R
   Wagner, B
AF Hollaus, K
   Biro, O
   Gerstenberger, C
   Preis, K
   Stollberger, R
   Wagner, B
TI Effect of stray capacitances on bio-impedances in quasi-static electric
   field
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article; Proceedings Paper
CT 11th IEEE Biennial Conference on Electromagnetic Field Computation
CY JUN 06-09, 2004
CL Seoul, SOUTH KOREA
SP IEEE Magnet Soc, Seoul Natl Univ
DE biomedical computing; capacitance; dielectric materials; electric
   fields; finite-element method
ID HZ
AB Evaluating bio-impedances, inevitable stray capacitances have considerable impact on the measurement data. If the stray capacitances are not considered when simulating the electric impedance tomography problem, incorrect conductivities are reconstructed. To study the effect of the stray capacitances, a finite-element model of a test person in surroundings exposed to a quasi-static electric field is used to simulate the measuring setup. Results clearly demonstrate that the displacement currents at high frequencies in air have to be modeled appropriately.
C1 IGTE, Inst Fundamentals & Theory Elect Engn, A-8010 Graz, Austria.
RP Hollaus, K (reprint author), IGTE, Inst Fundamentals & Theory Elect Engn, A-8010 Graz, Austria.
RI Biro, Oszkar/F-9812-2015
OI Biro, Oszkar/0000-0003-0792-8955
CR Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002
   HOLLAUS K, 2003, P 72 ICB SEM REC ACH
   KANAI H, 1987, MED PROG TECHNOL, V12, P159
   Morucci JP, 1996, CRIT REV BIOMED ENG, V24, P599, DOI 10.1615/CritRevBiomedEng.v24.i4-6.50
   ROSELL J, 1988, IEEE T BIO-MED ENG, V35, P649, DOI 10.1109/10.4599
   Scharfetter H, 1998, PHYSIOL MEAS, V19, P247, DOI 10.1088/0967-3334/19/2/012
   Webster JG, 1990, ELECT IMPEDANCE TOMO
   ZIENKIEWICZ OC, 1994, FINITE ELEMENT METHO
NR 8
TC 1
Z9 2
U1 1
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD MAY
PY 2005
VL 41
IS 5
BP 1940
EP 1943
DI 10.1109/TMAG-2005.846218
PG 4
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 925WN
UT WOS:000229084200147
DA 2018-10-20
ER

PT J
AU Kim, SY
   Park, J
   Kwon, DS
AF Kim, SY
   Park, J
   Kwon, DS
TI The real-time haptic simulation of a biomedical volumetric object with
   shape-retaining chain linked model
SO IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS
LA English
DT Article
DE medical simulation; modeling; haptic; biomedical volumetric object;
   virtual reality
ID SURGERY SIMULATION; FORCE
AB This paper presents a new model which computes the deformation and the feedback force of high-resolution biomedical volumetric objects consisting of hundreds of thousands of volume elements. The main difficulty in the simulation of these high-resolution volumetric objects is to compute and generate stable feedback force from the objects within a haptic update time (1 msec). In our model, springs are used in order to represent material properties of volume elements and cylinders are used to activate corresponding springs according to the amount of deformation. Unlike in a mass-spring model, springs in our model have constraint conditions. In our model, the deformation is calculated locally and then is propagated outward through object's volume as if a chain is pulled or pushed. The deformed configuration is then used to compute the object's internal potential energy that is reflected to the user. The simple nature of our model allows the much faster calculation of the deformation and the feedback force from the volumetric deformable object than the conventional model (an FEM or a mass-spring model). Experiments are conducted with homogenous and non-homogenous volumetric cubic objects and a volumetric human liver model obtained from CT data at a haptic update rate of 1000 Hz and a graphic update rate of 100 Hz to show that our model can be utilized in the real-time volume haptic rendering. We verify that our model provides a realistic haptic feeling for the user in real time through comparative study.
C1 Informat & Commun Univ, Sch Engn, Taejon, South Korea.
   Korea Adv Inst Sci & Technol, Dept ME, Taejon 305701, South Korea.
EM sangyoun7.kim@samsung.com; jinah@icu.ac.kr; kwonds@kaist.ac.kr
RI Park, Jinah/I-6949-2016; Kwon, Dong-Soo/C-1540-2011
OI Park, Jinah/0000-0003-4676-9862; 
CR Astley OR, 1998, IEEE INT CONF ROBOT, P989, DOI 10.1109/ROBOT.1998.677216
   BALANIUK R, 2003, INT S SURG SIMULATIO, P48
   BASDOGAN C, 2002, HDB VIRTUAL ENV, pCH6
   Bro-Nielsen M, 1998, P IEEE, V86, P490, DOI 10.1109/5.662874
   CAVUSOGLU MC, 2000, IEEE INT C ROB AUT, P2458
   Costa IF, 2001, IEEE INT CONF ROBOT, P2337, DOI 10.1109/ROBOT.2001.932971
   Cotin S, 1999, IEEE T VIS COMPUT GR, V5, P62, DOI 10.1109/2945.764872
   CUGINI U, 1999, EUROGRAPHICS99 STAT
   DAULIGNAC R, 2000, IEEE INT C ROB AUT, P2452
   Frisken-Gibson SF, 1999, IEEE T VIS COMPUT GR, V5, P333, DOI 10.1109/2945.817350
   HANNAFORD B, 2001, P USC WORKSH HAPT IN
   Ho CH, 2000, INT J ROBOT RES, V19, P668
   Jones L.A., 2000, KINESTHETIC SENSING
   JONES LA, 1986, PSYCHOL BULL, V100, P29, DOI 10.1037/0033-2909.100.1.29
   KIM SY, 2003, INT S SURG SIM SOFT, P108
   Kruse SA, 2000, PHYS MED BIOL, V45, P1579, DOI 10.1088/0031-9155/45/6/313
   MASS H, 1999, 13 INT C COMP ASS RA, P865
   Mendoza CA, 2001, P IEEE VIRT REAL ANN, P264, DOI 10.1109/VR.2001.913795
   Nedel LP, 1998, COMPUTER GRAPHICS INTERNATIONAL, PROCEEDINGS, P156, DOI 10.1109/CGI.1998.694263
   Park J, 2002, IEEE/ACM SIGGRAPH SYMPOSIUM ON VOLUME VISUALIZATION AND GRAPHICS 2002, PROCEEDINGS, P65, DOI 10.1109/SWG.2002.1226511
   PARK J, 2004, INT S MED SIM CAMBR, P144
   Picinbono G, 2001, IEEE INT CONF ROBOT, P1370, DOI 10.1109/ROBOT.2001.932801
   Tokumoto S, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P767, DOI 10.1109/ROBOT.1999.770067
   Wu XL, 2001, COMPUT GRAPH FORUM, V20, pC349
   Zilles C., 1995, IEEE INT C INT ROB S, V3, P146, DOI DOI 10.1109/IROS.1995.525876
NR 25
TC 11
Z9 12
U1 0
U2 1
PU IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG
PI TOKYO
PA KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011,
   JAPAN
SN 1745-1361
J9 IEICE T INF SYST
JI IEICE Trans. Inf. Syst.
PD MAY
PY 2005
VL E88D
IS 5
BP 1012
EP 1020
DI 10.1093/ietisy/e88-d.5.1012
PG 9
WC Computer Science, Information Systems; Computer Science, Software
   Engineering
SC Computer Science
GA 928EF
UT WOS:000229253200030
DA 2018-10-20
ER

PT J
AU Gou, ZG
   Chang, J
   Zhai, WY
   Wang, JY
AF Gou, ZG
   Chang, J
   Zhai, WY
   Wang, JY
TI Study on the self-setting property and the in vitro bioactivity of
   beta-Ca2SiO4
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE beta-dicalcium silicate; self-setting; bioactivity; injectability; cell
   proliferation; bone cement
ID BETA-DICALCIUM SILICATE; LOADED BONE-CEMENT; HUMAN OSTEOBLASTS; CALCIUM
   PHOSPHATES; IONIC PRODUCTS; EXPRESSION; HYDRATION; BEHAVIOR; RELEASE;
   REPAIR
AB This study sought to investigate the physical and chemical properties of &beta;-dicalcium silicate (&beta;-Ca2SiO4) in order to evaluate its use as an injectable bioactive cement filler. Workable &beta;-Ca2SiO4 pastes with a liquid-to-powder (LIP) ratio of 1.0-1.2 could be injected for 10-30 min (nozzle diameter 2.0 mm) and enabled initial setting times of 60-180 min. The setting process yielded cellular structures with compressive strengths of 4.8-28.8 MPa after 2-28 days. The paste was soaked in simulated body fluid (SBF), and the results demonstrated that it exhibited a moderate degradation and could induce carbonated hydroxyapatite formation. The ionic products of the paste dissolution enhanced a proliferative response of fibroblasts compared with the cells cultured alone, and this cement could also support adhesion and spreading of the mesenchymal stem cells. Finally, with the use of gentamicin as a model drug, it was found that a high dose of drug release from the paste was maintained for 14 days, and there was a sustained release over 4 weeks. This combination of properties indicates that the novel &beta;-Ca2SiO4 cement might be suitable for potential applications in the biomedical field, preferentially as materials for bone/dental repair and controlled drug-delivery systems. &COPY; 2005 Wiley Periodicals, Inc.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
   Chinese Acad Sci, Grad Sch, Shanghai 200050, Peoples R China.
   E China Normal Univ, Sch Biol Sci, Shanghai 200062, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Dingxi Rd 1295, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
CR Blom EJ, 2000, J BIOMED MATER RES, V50, P67, DOI 10.1002/(SICI)1097-4636(200004)50:1<67::AID-JBM10>3.0.CO;2-E
   BOHNER M, 2002, P 17 EUR C BIOM BARC, P124
   BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821
   BRUNAUER S, 1958, J AM CHEM SOC, V80, P761, DOI 10.1021/ja01537a001
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   FUJII K, 1979, J AM CERAM SOC, V62, P16
   FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806
   GHOSH SN, 1979, J MATER SCI, V14, P1554, DOI 10.1007/BF00569274
   GIBSON IR, 1999, P 12 INT S CER MED N, P191
   Gou ZG, 2004, J EUR CERAM SOC, V24, P93, DOI 10.1016/S0955-2219(03)00320-0
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Hong SH, 1999, J AM CERAM SOC, V82, P1681, DOI 10.1111/j.1151-2916.1999.tb01986.x
   Ijima T., 1992, GYPSUM LIME, V238, P159
   ISHIDA H, 1992, J AM CERAM SOC, V75, P359, DOI 10.1111/j.1151-2916.1992.tb08187.x
   Ishida H., 1992, J AM CERAM SOC, V72, P2779
   JAWED I, 1983, STRUCTURE PERFORMANC, P237
   Kamegai Akihide, 1994, Bio-Medical Materials and Engineering, V4, P291
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   Knabe C, 2004, J BIOMED MATER RES A, V69A, P145, DOI 10.1002/jbm.a.20131
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1992, BONE BONDING BIOMATE, P31
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.3.CO;2-I
   LIDGREN L, 2002, Patent No. 2002005861
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Lu J. X., 1999, BONE S, V25, P41
   Malafaya PB, 2002, CURR OPIN SOLID ST M, V6, P283, DOI 10.1016/S1359-0286(02)00075-X
   MASRI BA, 1995, J ARTHROPLASTY, V10, P453, DOI 10.1016/S0883-5403(05)80145-7
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Phan PV, 2003, J BIOMED MATER RES A, V67A, P1001, DOI 10.1002/jbm.a.10162
   Pittet C, 2000, J BIOMED MATER RES, V53, P769, DOI 10.1002/1097-4636(2000)53:6<769::AID-JBM19>3.0.CO;2-P
   Ringe J, 2002, CELL TISSUE RES, V307, P321, DOI 10.1007/s00441-002-0525-z
   Sarda S, 2001, J MATER SCI-MATER M, V12, P905, DOI 10.1023/A:1012832325957
   Schildhauer TA, 1999, J ORTHOPAED RES, V17, P67, DOI 10.1002/jor.1100170111
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Silver IA, 2003, MATERIALWISS WERKST, V34, P1069, DOI 10.1002/mawe.200300710
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   TAYLOR HFW, 1950, J CHEM SOC, P3682, DOI 10.1039/jr9500003682
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yoshikawa T, 2001, MAT SCI ENG C-BIO S, V17, P19, DOI 10.1016/S0928-4931(01)00330-7
   ZHANG XC, 1994, J PHARM PHARMACOL, V46, P718, DOI 10.1111/j.2042-7158.1994.tb03890.x
   CHUNG HUA KOU CHIANG, V25, P216
NR 51
TC 64
Z9 65
U1 4
U2 24
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2005
VL 73B
IS 2
BP 244
EP 251
DI 10.1002/jbm.b.30203
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 923UR
UT WOS:000228935300006
PM 15793821
DA 2018-10-20
ER

PT J
AU Neuberger, T
   Schopf, B
   Hofmann, H
   Hofmann, M
   von Rechenberg, B
AF Neuberger, T
   Schopf, B
   Hofmann, H
   Hofmann, M
   von Rechenberg, B
TI Superparamagnetic nanoparticles for biomedical applications:
   Possibilities and limitations of a new drug delivery system
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Scientific and Clinical Applications of
   Magnetic Carriers
CY MAY 20-22, 2004
CL Lyon, FRANCE
DE superparamagnetic iron oxide nanoparticles (SPION); nanoparticles;
   magnetic drug targeting (MDT); immunomagnetic cell sorting (IMS);
   magnetic hyperthermia; toxicity; hyperthermia; review; contrast agent;
   nanoparticle functionalization; nanoparticle application
ID IRON-OXIDE NANOPARTICLES; MAGNETIC FLUID HYPERTHERMIA; IN-VIVO; PROTEIN
   ADSORPTION; CONTRAST AGENTS; TRIAMCINOLONE ACETONIDE; HYPERLIPIDEMIC
   RABBITS; ACID) NANOPARTICLES; POLYMER PARTICLES; CANCER-TREATMENT
AB Nanoparticles can be used in biomedical applications, where they facilitate laboratory diagnostics, or in medical drug targeting. They are used for in vivo applications such as contrast agent for magnetic resonance imaging (MRI), for tumor therapy or cardiovascular disease. Very promising nanoparticles for these applications are superparamagnetic nanoparticles based on a core consisting of iron oxides (SPION) that can be targeted through external magnets. SPION are coated with biocompatible materials and can be functionalized with drugs, proteins or plasmids. In this review, the characteristics and applications of SPION in the biomedical sector are introduced and discussed. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Zurich, Fac Vet, Musculoskeletal Res Unit, CH-8057 Zurich, Switzerland.
   Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Inst Mat, Lab Powder Technol, CH-1015 Lausanne, Switzerland.
   MatSearch Pully, CH-1009 Pully, Switzerland.
RP von Rechenberg, B (reprint author), Univ Zurich, Fac Vet, Musculoskeletal Res Unit, Winterthurerstr 260, CH-8057 Zurich, Switzerland.
EM bvonrechenberg@vetclinics.unizh.ch
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR Abe Y, 2000, Radiat Med, V18, P97
   Alexiou C, 2000, CANCER RES, V60, P6641
   Allen LM, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P481
   Altman RD, 1998, OSTEOARTHR CARTILAGE, V6, P22, DOI 10.1016/S1063-4584(98)80007-1
   Armstrong TI, 1997, J DRUG TARGET, V4, P389, DOI 10.3109/10611869709017896
   Artemov D, 2003, MAGNET RESON MED, V49, P403, DOI 10.1002/mrm.10406
   Babes L, 1999, J COLLOID INTERF SCI, V212, P474, DOI 10.1006/jcis.1998.6053
   Bacri JC, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P597
   Barratt G, 2003, CELL MOL LIFE SCI, V60, P21, DOI 10.1007/s000180300002
   Barratt G., 2002, POLYM BIOMATERIALS, P753
   BAZILE DV, 1992, BIOMATERIALS, V13, P1093, DOI 10.1016/0142-9612(92)90142-B
   BECK PH, 1993, THESIS J W GOETHE U
   Beckmann N, 2003, MAGNET RESON MED, V49, P459, DOI 10.1002/mrm.10387
   Blankenstein G, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P233
   BLUNK T, 1993, ELECTROPHORESIS, V14, P1382, DOI 10.1002/elps.11501401214
   BLUNK T, 1994, THESIS U KIEL
   Bonnemann H, 2001, EUR J INORG CHEM, P2455
   Borchard G, 1993, J DRUG TARGET, V1, P15, DOI 10.3109/10611869308998760
   Borchard G, 1996, PHARMACEUT RES, V13, P1055, DOI 10.1023/A:1016010808522
   BORCHARD G, 1993, THESIS J W GOETHE U
   Bordat C, 2000, J MAGN RESON IMAGING, V12, P505, DOI 10.1002/1522-2586(200009)12:3<505::AID-JMRI18>3.0.CO;2-A
   Bosnes M, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P269
   Brauer M, 2003, PROG NEURO-PSYCHOPH, V27, P323, DOI 10.1016/S0278-5846(03)00026-5
   Bulte JWM, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P527
   CANET E, 1995, AM HEART J, V130, P949, DOI 10.1016/0002-8703(95)90193-0
   Chalmers JJ, 1998, BIOTECHNOL PROGR, V14, P141, DOI 10.1021/bp970140l
   CHAMBON C, 1993, MAGN RESON IMAGING, V11, P509, DOI 10.1016/0730-725X(93)90470-X
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Chan DCF, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P607
   Chastellain M, 2004, ADV ENG MATER, V6, P235, DOI 10.1002/adem.200300574
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   Dardzinski BJ, 2001, MAGN RESON IMAGING, V19, P1209, DOI 10.1016/S0730-725X(01)00448-9
   DAVIS S S, 1986, Acta Pharmaceutica Technologica, V32, P4
   Davis SS, 1997, TRENDS BIOTECHNOL, V15, P217, DOI 10.1016/S0167-7799(97)01036-6
   Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1
   Dousset V, 1999, MAGNET RESON MED, V41, P329, DOI 10.1002/(SICI)1522-2594(199902)41:2<329::AID-MRM17>3.0.CO;2-Z
   Ehrlich P, 1906, COLLECTED STUDIES IM
   EVERETT ED, 1991, PERITON DIALYSIS INT, V11, P206
   Fattal E., 1993, STP PHARMA SCI, V3, P11
   Fleige G, 2001, NEOPLASIA, V3, P489, DOI 10.1038/sj.neo.7900176
   Frisbie DD, 1997, EQUINE VET J, V29, P349, DOI 10.1111/j.2042-3306.1997.tb03138.x
   FUSSEL F, 1997, THESIS TECHNISCHE HO
   Gruttner C, 1999, J MAGN MAGN MATER, V194, P8, DOI 10.1016/S0304-8853(98)00561-7
   GUIMARAES R, 1994, AM J ROENTGENOL, V162, P201, DOI 10.2214/ajr.162.1.8273666
   Hilger I, 2001, RADIOLOGY, V218, P570, DOI 10.1148/radiology.218.2.r01fe19570
   HSU MJ, 1982, BIOCHIM BIOPHYS ACTA, V720, P411, DOI 10.1016/0167-4889(82)90120-3
   Johansson LO, 2001, J MAGN RESON IMAGING, V13, P615, DOI 10.1002/jmri.1086
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Jordan A, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P569
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   KARINO A, 1987, J PHARM SCI, V76, pS273
   Kawcak CE, 1998, EQUINE VET J, V30, P66, DOI 10.1111/j.2042-3306.1998.tb04090.x
   Kim DK, 2003, CHEM MATER, V15, P1617, DOI 10.1021/cm021349j
   Kissel T, 1991, P INT S CONTR REL BI, V18, P275
   Krause M, 2002, OPHTHALMIC RES, V34, P241, DOI 10.1159/000063883
   Kresse M, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P545
   KREUTER J, 1983, PHARM ACTA HELV, V58, P196
   KREUTER J, 1981, THESIS FEDERAL I TEC
   KREUTER J, 1985, DRUG TARGETING
   Kroft LJM, 1998, MAGN RESON IMAGING, V16, P755, DOI 10.1016/S0730-725X(98)00091-5
   Kuznetsov AA, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P379
   Lacava ZGM, 1999, J MAGN MAGN MATER, V194, P90, DOI 10.1016/S0304-8853(98)00583-6
   Lacava ZGM, 1999, J MAGN MAGN MATER, V201, P431, DOI 10.1016/S0304-8853(99)00002-5
   Laissy J P, 2000, J Magn Reson Imaging, V12, P278, DOI 10.1002/1522-2586(200008)12:2<278::AID-JMRI10>3.0.CO;2-V
   LEROUX JC, 1995, LIFE SCI, V57, P695, DOI 10.1016/0024-3205(95)00321-V
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Liberti PA, 2001, J MAGN MAGN MATER, V225, P301, DOI 10.1016/S0304-8853(00)01254-3
   Lind K, 2002, J DRUG TARGET, V10, P221, DOI 10.1080/10611860290022651
   Litovsky S, 2003, CIRCULATION, V107, P1545, DOI 10.1161/01.CIR.0000055323.57885.88
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Lubbe AS, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P457
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   Lubbe AS, 1999, J MAGN MAGN MATER, V194, P149, DOI 10.1016/S0304-8853(98)00574-5
   LUCK M, 1997, THESIS FU BERLIN
   MAHMUDOV SY, 1997, SCI CLIN APPL MAGNET, P495
   McCloskey KE, 2001, BIOTECHNOL BIOENG, V75, P642, DOI 10.1002/bit.10040
   MENIK K, 2001, BIOTECHNOL PROGR, V17, P907
   Meza M, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P303
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Moore A, 2000, RADIOLOGY, V214, P568, DOI 10.1148/radiology.214.2.r00fe19568
   Muller RH, 1996, J DRUG TARGET, V4, P161, DOI 10.3109/10611869609015973
   Muller RH, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P135
   MULLER RH, 1990, DAZ, V130, P1509
   Muller RH, 1996, ZETAPOTENTIAL PARTIK, V37
   MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222
   Nanz D, 2000, MAGNET RESON MED, V43, P645, DOI 10.1002/(SICI)1522-2594(200005)43:5<645::AID-MRM5>3.0.CO;2-E
   NEUBERGER T, 2002, THESIS U ZURICH
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   NORMAN ME, 1993, BIOMATERIALS, V14, P193, DOI 10.1016/0142-9612(93)90023-U
   OLSVIK O, 1994, CLIN MICROBIOL REV, V7, P43
   OPPENHEIM RC, 1981, INT J PHARM, V8, P217, DOI 10.1016/0378-5173(81)90100-9
   Oswald P, 1997, MAGN RESON IMAGING, V15, P1025, DOI 10.1016/S0730-725X(97)00004-0
   PAPATHEOFANIS FJ, 1991, J BIOMED MATER RES, V25, P761, DOI 10.1002/jbm.820250606
   PATEL HM, 1992, CRIT REV THER DRUG, V9, P39
   POLIQUEN D, 1991, J MAGN RESON IMAGING, V9, P275
   Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500
   POSTE G, 1984, LIPOSOME TECHNOLOGY, P1
   Prestvik WS, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P11
   REIMER P, 1990, RADIOLOGY, V177, P729, DOI 10.1148/radiology.177.3.2243978
   RINCK PA, 1992, ROFO FORTSCHR RONTG, V157, P533, DOI 10.1055/s-2008-1033058
   RINCK PA, 1991, RADIOLOGY, V178, P775, DOI 10.1148/radiology.178.3.1994417
   ROGERS JM, 1994, MAGN RESON IMAGING, V12, P1161, DOI 10.1016/0730-725X(94)90081-2
   Rousseau V, 1997, MAGN RESON MATER PHY, V5, P213, DOI 10.1007/BF02594584
   Rudge S, 2001, J CONTROL RELEASE, V74, P335, DOI 10.1016/S0168-3659(01)00344-3
   RUDT S, 1992, THESIS U KIEL
   Ruehm SG, 2001, CIRCULATION, V103, P415
   Sbarbati A, 2000, NEUROIMAGE, V12, P418, DOI 10.1006/nimg.2000.0618
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   Schmidt RF, 1995, PHYSL MENSCHEN, P515
   Schmitz SA, 2000, INVEST RADIOL, V35, P460, DOI 10.1097/00004424-200008000-00002
   Schutt W, 1999, ARTIF ORGANS, V23, P98, DOI 10.1046/j.1525-1594.1999.06278.x
   Schutt W, 1997, HYBRIDOMA, V16, P109, DOI 10.1089/hyb.1997.16.109
   SCOTT G, 1999, J MAGN MAGN MATER, V194, P132
   SENETERRE E, 1991, RADIOLOGY, V179, P529, DOI 10.1148/radiology.179.2.2014305
   Sezaki H, 1984, Crit Rev Ther Drug Carrier Syst, V1, P1
   SHINKAI M, 1995, BIOTECHNOL APPL BIOC, V21, P125, DOI 10.1111/j.1470-8744.1995.tb00329.x
   Sinclair B, 1998, SCIENTIST, V12, P16
   STROM G, 1995, ADV DRUG DELIV REV, V17, P31
   Strom V, 2004, NANOTECHNOLOGY, V15, P457, DOI 10.1088/0957-4484/15/5/009
   SUZUKI M, 1995, BIOTECHNOL APPL BIOC, V21, P335
   TANIMOTO A, 1994, JMRI-J MAGN RESON IM, V4, P653, DOI 10.1002/jmri.1880040506
   Tobin T., 1981, DRUGS PERFORMANCE HO, P132
   Torchilin VP, 2000, EUR J PHARM SCI, V11, pS81, DOI 10.1016/S0928-0987(00)00166-4
   TORCHILIN VP, 1988, HAEMOSTASIS, V18, P113
   TRELEAVEN JG, 1984, LANCET, V1, P70
   TROSTER S, 1990, THESIS J W GOETHE U
   UGELSTAD J, 1993, BLOOD PURIFICAT, V11, P349, DOI 10.1159/000170129
   UGELSTAD J, 1992, PROG POLYM SCI, V17, P87, DOI 10.1016/0079-6700(92)90017-S
   van Ewijk GA, 1999, J MAGN MAGN MATER, V201, P31, DOI 10.1016/S0304-8853(99)00080-3
   VANBEERS B, 1995, J RADIOL, V76, P991
   WEISE K, 1993, MEAS SCI TECHNOL, V4, P1, DOI 10.1088/0957-0233/4/1/001
   WEISSLEDER R, 1990, AM J ROENTGENOL, V155, P1161, DOI 10.2214/ajr.155.6.2122660
   WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167
   WEISSLEDER R, 1995, ADV DRUG DELIVER REV, V16, P321, DOI 10.1016/0169-409X(95)00033-4
   Wen Ge, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P451
   Widder K J, 1979, Adv Pharmacol Chemother, V16, P213, DOI 10.1016/S1054-3589(08)60246-X
   Ye Q, 2002, KIDNEY INT, V61, P1124, DOI 10.1046/j.1523-1755.2002.00195.x
   Zhang YQ, 2000, KIDNEY INT, V58, P1300, DOI 10.1046/j.1523-1755.2000.00286.x
NR 139
TC 1104
Z9 1131
U1 25
U2 547
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
EI 1873-4766
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD MAY 1
PY 2005
VL 293
IS 1
SI SI
BP 483
EP 496
DI 10.1016/j.jmmm.2005.01.064
PG 14
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 933VQ
UT WOS:000229661400074
DA 2018-10-20
ER

PT J
AU Cazalbou, S
   Eichert, D
   Ranz, X
   Drouet, C
   Combes, C
   Harmand, MF
   Rey, C
AF Cazalbou, S
   Eichert, D
   Ranz, X
   Drouet, C
   Combes, C
   Harmand, MF
   Rey, C
TI Ion exchanges in apatites for biomedical application
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID CALCIUM-PHOSPHATE; BONE; HYDROXYAPATITE; CARBONATE; ADHESION
AB The modification of the composition of apatite materials can be made by several processes corresponding to ion exchange reactions which can conveniently be adapted to current coatings and ceramics and are an alternative to setting up of new synthesis methods. In addition to high temperature thermal treatments, which can partly or almost totally replace the monovalent OH- anion of stoichiometric hydroxyapatite by any halogen ion or carbonate, aqueous processes corresponding to dissolution-reprecipitation reactions have also been proposed and used. However, the most interesting possibilities are provided by aqueous ion exchange reactions involving nanocrystalline apatites. These apatites are characterised by the existence on the crystal surface of a hydrated layer of loosely bound mineral ions which can be easily exchanged in solution. This layer offers a possibility to trap mineral ions and possibly active molecules which can modify the apatite properties. Such processes are involved in mineralised tissues and could be used in biomaterials for the release of active mineral species. (C) 2005 Springer Science + Business Media, Inc.
C1 Inst Natl Polytech Toulouse, ENSIACET, CIRIMAT, CNRS,UMR 5085, F-31077 Toulouse, France.
RP Cazalbou, S (reprint author), Inst Natl Polytech Toulouse, ENSIACET, CIRIMAT, CNRS,UMR 5085, 118 Route Narbonne, F-31077 Toulouse, France.
EM Christian.Rey@ensiacet.fr
RI Drouet, Christophe/A-8023-2008; CAZALBOU, sophie/G-5683-2012; Drouet,
   Christophe/S-1680-2018
OI Drouet, Christophe/0000-0002-8471-8719; Drouet,
   Christophe/0000-0002-8471-8719
CR BESHAH K, 1990, J SOLID STATE CHEM, V84, P71, DOI 10.1016/0022-4596(90)90185-Z
   BONEL G, 1972, ANN CHIM FRANCE, V7, P127
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   CAZALBOU S, 2000, THESIS INPT TOULOUSE
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Denissen HW, 1996, INT J PROSTHODONT, V9, P142
   EICHERT D, 2003, P CIMTEC 2002 6, P23
   EICHERT D, 2001, THESIS INPT TOULOUSE
   ELLIOTT JC, 1967, NATURE, V214, P904, DOI 10.1038/214904b0
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Feng B, 2002, BIOMATERIALS, V23, P173, DOI 10.1016/S0142-9612(01)00093-X
   Glimcher M.J., 1992, DISORDERS BONE MINER, P265
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.3.CO;2-I
   NEUMAN WF, 1968, CALC TISS RES, V2, P262, DOI 10.1007/BF02279214
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Ranz X., 1996, THESIS INPT TOULOUSE
   REDEY S, 2000, J BONE MINER RES, V353
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Rey C, 1995, CELL MATER, V5, P345
   REY C, 1994, B I OCEANOGRAPHIQUE, V14, P55
   SAMEC F, 1966, CR ACAD SCI C CHIM, V262, P837
   Sfihi H., 2002, NATO ASI SER, VII, P409
   TROMBE JC, 1974, CR ACAD SCI C CHIM, V278, P1227
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
NR 24
TC 97
Z9 100
U1 4
U2 45
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2005
VL 16
IS 5
BP 405
EP 409
DI 10.1007/s10856-005-6979-2
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 924IY
UT WOS:000228973700006
PM 15875249
DA 2018-10-20
ER

PT J
AU Boehlert, C
   Niinomi, M
   Ikeda, M
AF Boehlert, C
   Niinomi, M
   Ikeda, M
TI Selected papers presented at the Materials Science and Technology 2004
   Meeting: Titanium for Biomedical, Dental and Healthcare Applications -
   Introduction
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Editorial Material
C1 Michigan State Univ, Coll Engn, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Kansai Univ, Dept Mat Sci & Engn, Suita, Osaka 5648680, Japan.
RP Boehlert, C (reprint author), Michigan State Univ, Coll Engn, Dept Chem Engn & Mat Sci, 2527 Engn Bldg, E Lansing, MI 48824 USA.
EM boehlert@egr.msu.edu; niinomi@sp-Mac4.tutpse.tut.ac.jp;
   hikoik@ipcku.kansai-u.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
NR 0
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 247
EP 247
DI 10.1016/j.msec.2004.12.008
PG 1
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000001
DA 2018-10-20
ER

PT J
AU Atwood, RC
   Lee, PD
   Curtis, RV
   Di Silvio, L
AF Atwood, RC
   Lee, PD
   Curtis, RV
   Di Silvio, L
TI Multiscale modeling of titanium investment cast dental prostheses
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE dental prostheses; titanium; investment casting; multiscale modeling;
   mold-metal interfacial reactions
ID SOLIDIFICATION; ALLOY; CONTAMINATION; PREDICTION; SIMULATION; POROSITY;
   SURFACE
AB Titanium alloys are attractive materials for biomedical applications due to their superior biocompatibility. However, the use of titanium alloys for dental and maxillofacial prostheses is particularly challenging because each prosthesis has a unique, complex shape. A multiscale model for the processing of Ti prostheses was developed that combines a commercial macrocode for process simulation with an in-house code to explicitly track the development of the microstructure including surface reactions. The model was applied to simulate the dental titanium investment casting process. The macroscopic heat transfer model is coupled with a microscale simulation incorporating the release and diffusion of impurity elements at the mold-metal interface. The penetration depth of impurity species was simulated to determine the amount of alpha-case formed. The microstructural modeling results indicate that the critical factor is the time for which liquid Ti is in contact with the mold and that the incorporation of silicon from the mold increases this time by depressing the solidus temperature. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ London Imperial Coll Sci & Technol, Dept Mat, London SW7 2BP, England.
   Kings Coll London, Guys Kings & St Thomas Dent Inst, Dept Dent Biomat, London, England.
RP Lee, PD (reprint author), Univ London Imperial Coll Sci & Technol, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
EM p.d.lee@imperial.ac.uk
RI Lee, Peter/R-2323-2016
OI Lee, Peter/0000-0002-3898-8881; Di Silvio, Lucy/0000-0003-2554-2052
CR Anderson D.A., 1984, COMPUTATIONAL FLUID
   Atwood RC, 2005, DENT MATER, V21, P178, DOI 10.1016/j.dental.2004.02.010
   Atwood RC, 2003, ACTA MATER, V51, P5447, DOI 10.1016/S1359-6454(03)00411-7
   Atwood RC, 2002, METALL MATER TRANS B, V33, P209, DOI 10.1007/s11663-002-0006-5
   Beckermann C, 2002, INT MATER REV, V47, P243, DOI 10.1179/095066002225006557
   BIRD RB, 1960, TRANSPORT PHENOMENA
   Boettinger WJ, 2000, METALL MATER TRANS B, V31, P1419, DOI 10.1007/s11663-000-0026-y
   BRIDGES PJ, 1997, TITANIUM, V2, P1
   Brunette D. M., 2001, TITANIUM MED, P145
   CAMPBELL J, 1991, CATINGS
   DURHAM DR, 1974, AFS T, V74, P101
   KUMAR TSP, 1991, METALL T B, V22
   KURZ W, 1986, ACTA METALL MATER, V34, P823, DOI 10.1016/0001-6160(86)90056-8
   Lee P.D., 2001, J LIGHT METALS, V1, P15, DOI DOI 10.1016/S1471-5317(00)00003-1
   Lee PD, 2004, MAT SCI ENG A-STRUCT, V365, P57, DOI 10.1016/j.msea.2003.09.007
   LEE PD, 1999, ISIJ INT, P97
   MAIJER DM, 2004, UNPUB METALL T A
   MAJOR JF, 1994, VEHICLE SUSPENSION S, P117
   Mills K. C., 2001, RECOMMENDED VALUES T
   Nishido S, 2002, INT J CAST METAL RES, V15, P325
   Okabe T, 1998, JOM-J MIN MET MAT S, V50, P24, DOI 10.1007/s11837-998-0410-7
   Papadopoulos T, 1999, J MATER SCI, V34, P3639, DOI 10.1023/A:1004639002688
   Pollock TM, 1996, METALL MATER TRANS A, V27, P1081, DOI 10.1007/BF02649777
   Rafii-Tabar H, 2002, PHYS REP, V365, P145, DOI 10.1016/S0370-1573(02)00028-5
   Veeck S, 2002, ADV MATER PROCESS, V160, P59
   Wu M, 2001, JOM-J MIN MET MAT S, V53, P36, DOI 10.1007/s11837-001-0146-0
   Wu MH, 1998, DENT MATER, V14, P321, DOI 10.1016/S0109-5641(98)00045-1
NR 27
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 255
EP 262
DI 10.1016/j.msec.2005.01.019
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000003
DA 2018-10-20
ER

PT J
AU He, G
   Hagiwara, M
AF He, G
   Hagiwara, M
TI Bimodal structured Ti-base alloy with large elasticity and low Young's
   modulus
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE biomaterials; Young's modulus; Martensite transformation; Ti alloys;
   superelasticity
ID NANOSTRUCTURE-DENDRITE COMPOSITE; MECHANICAL-PROPERTIES;
   TITANIUM-ALLOYS; BIOMEDICAL APPLICATIONS; ENHANCED PLASTICITY;
   MICROSTRUCTURE; TRANSFORMATION
AB A bimodal structured Ti60Cu14Ni12Sn4Nb10 alloy has been fabricated by different methods. The as-prepared microstructure is composed of a dendritic bcc-beta-Ti(Nb,Sn) phase and a nano/ultrafine structured matrix. Except for beta-Ti, gamma-TiCu and a few intermetallics the matrix also contains the B2 structure, which acts as a parent phase for a reversible phase transformation around room temperature. Annealing induces precipitation of intermetallics, which significantly increases the yield strength and the Young's modulus, but does not change the reversible phase transformation. The alloy exhibits very high yield strength, large elasticity and low Young's modulus, providing an advantage for biomedical application. The reversible phase transformation provides potential applications as a smart material. (c) 2005 Elsevier B.V. All rights reserved.
C1 Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RP He, G (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
EM he.guo@nims.go.jp
CR Breme HJ, 1998, METALS BIOMATERIALS, P1
   Dai QL, 2004, J MATER RES, V19, P2557, DOI 10.1557/JMR.2004.0332
   FUKUDA T, 1995, MATER T JIM, V36, P1244, DOI 10.2320/matertrans1989.36.1244
   FURUYA Y, 1990, MATER T JIM, V31, P504, DOI 10.2320/matertrans1989.31.504
   He G, 2004, ACTA MATER, V52, P3035, DOI 10.1016/j.actamat.2004.03.006
   He G, 2004, MATER TRANS, V45, P1120, DOI 10.2320/matertrans.45.1120
   He G, 2003, ACTA MATER, V51, P5223, DOI [10.1016/S1359-6454(03)00386-0, 10.1016/s1359-6454(03000386-0]
   He G, 2002, J MATER RES, V17, P3015, DOI 10.1557/JMR.2002.0439
   He G, 2003, NAT MATER, V2, P33, DOI 10.1038/nmat792
   HE G, 2003, BIOMATERIALS, V24, P2115
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Ratner B. D., 2001, TITANIUM MED, P1
   SUN BB, UNPUB ACTA MAT
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   ZHANG ZF, 2003, PHYS REV LETT, V91, DOI UNSP 045501-045505
NR 19
TC 26
Z9 27
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 290
EP 295
DI 10.1016/j.msec.2005.03.001
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000007
DA 2018-10-20
ER

PT J
AU Gunawarman, B
   Niinomi, M
   Akahori, T
   Souma, T
   Ikeda, M
   Toda, H
AF Gunawarman, B
   Niinomi, M
   Akahori, T
   Souma, T
   Ikeda, M
   Toda, H
TI Mechanical properties and microstructures of low cost beta titanium
   alloys for healthcare applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE mechanical properties; microstructure; healthcare; wheelchair; titanium
   alloys; Ti-4.3Fe-7.1Cr; Ti-4.3Fe-7.1Cr-3.0Al
AB Titanium alloys are the best choice of metallic materials for biomedical and healthcare applications due to the combination of their excellent mechanical properties and biocompatibility. However, the usage of titanium alloys is limited due to its high cost. In order to reduce their cost, two new titanium alloys, Ti-4.3Fe-7.1Cr (TFC alloy) and Ti-4.3Fc-7.1Cr-3.0Al (TFCA alloy), for healthcare goods such as wheelchairs have been recently developed using low cost ferro-chrom elements. The microstructure and mechanical properties of both alloys subjected to solution treatment in the beta field or thermomechanical treatment were investigated, and then evaluated for their potential to be used as wheelchair materials.
   The specific strength and fatigue ratio of TFC and TFCA alloys are much greater than those of the existing wheelchair materials. Unrecrystallized grains obtained in the alloys at low solution treatment temperature can be eliminated by increasing solution treatment temperature or by conducting thermomechanical treatment. The latter method is recommended because it also gives a better strength and ductility balance as a result, mainly, of grain refinement. However, TFCA alloy seems to have more potential to be used as wheelchair materials compared to TFC alloy because of its better workability and post thermomechanical treatment ductility. (c) 2005 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
   Andalas Univ, W Sumatera, Indonesia.
   Kansai Univ, Suita, Osaka 5648680, Japan.
RP Gunawarman, B (reprint author), Toyohashi Univ Technol, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM gunawarman@ft.unand.ac.id
RI Niinomi, Mitsuo/B-5965-2011
OI Gunawarman, Gunawarman/0000-0002-2291-5514
CR Boyer R., 1994, MAT PROPERTIES HDB T, P685
   Ikeda M, 2004, MATER TRANS, V45, P1566, DOI 10.2320/matertrans.45.1566
   IKEDA M, 2001, PRICM, V4, P213
   IKEDA M, 2001, LIMAT 2001, P73
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   SOUMA T, 2004, THESIS TOYOHASHI U T
   Weiss I, 1998, MAT SCI ENG A-STRUCT, V243, P46, DOI 10.1016/S0921-5093(97)00783-1
NR 7
TC 31
Z9 36
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 304
EP 311
DI 10.1016/j.msec.2004.12.015
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000009
DA 2018-10-20
ER

PT J
AU Nyberg, E
   Miller, M
   Simmons, K
   Weil, KS
AF Nyberg, E
   Miller, M
   Simmons, K
   Weil, KS
TI Microstructure and mechanical properties of titanium components
   fabricated by a new powder injection molding technique
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
ID BIOMEDICAL APPLICATIONS; ALLOY
AB A powder injection molding (PIM) binder system has been developed for reactive metals such as titanium that employs an aromatic compound as the primary component to facilitate easy binder removal and mitigate problems with carbon contamination. In the study presented here, we examined the densification behavior, microstructure, and mechanical properties of titanium specimens formed by this process using naphthalene as the principle binder constituent. In general, it was found that tensile strengths could be achieved comparable to wrought titanium in the PIM-formed specimens, but that maximum elongation was less than expected. Chemical and microstructural analyses indicate that this process does not add oxygen to the material, suggesting that the use of higher purity powder and further process optimization should lead to significant improvements in ductility. (c) 2005 Published by Elsevier B.V.
C1 Battelle Mem Inst, Richland, WA 99352 USA.
RP Nyberg, E (reprint author), Battelle Mem Inst, Richland, WA 99352 USA.
EM Eric.Nyberg@pnl.gov
CR *AM SOC MET, 1980, MET HDB, P372
   ANDERMANN HH, 1995, MATER MANUF PROCESS, V10, P439
   Breme J, 2000, ADV ENG MATER, V2, P270, DOI 10.1002/(SICI)1527-2648(200005)2:5<270::AID-ADEM270>3.0.CO;2-9
   CIOMEK A, 1991, Patent No. 5064463
   CONACHIE MJ, 2000, TITANIUM TECHNICAL G
   Fricke J, 1998, J SOL-GEL SCI TECHN, V13, P299, DOI 10.1023/A:1008663908431
   German R.M., 1997, INJECTION MOLDING ME
   GERMAN RM, 1992, METALL TRANS A, V23, P1455, DOI 10.1007/BF02647329
   GERMAN RM, 1993, REV PARTICUL MATER, V1, P109
   Guillemot F, 2004, MED BIOL ENG COMPUT, V42, P137, DOI 10.1007/BF02351023
   Huang CT, 1996, POWDER METALL, V39, P119, DOI 10.1179/pom.1996.39.2.119
   KANEKO Y, 1990, J JAPAN SOC POWDER P, V37, P13
   Kato K., 1999, J JAPAN SOC POWDER P, V46, P865
   Kyogoku H, 1993, J JPN SOC POWDER POW, V40, P439
   LEDBETTER H, 1995, REV PROGR QUANTITATI, P1663
   LEE YT, 1990, POWDER METALL INT, V22, P11
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   NYBERG E, 2005, TRENDS MAT MANUFACTU
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Ouchi C, 1998, MAT SCI ENG A-STRUCT, V243, P186, DOI 10.1016/S0921-5093(97)00799-5
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Wang H., 1999, P M SCI TECH BRIEFS, V1, P16
   Wasz ML, 1996, INT MATER REV, V41, P1
   Zu YS, 1996, J MATER ENG PERFORM, V5, P609, DOI 10.1007/BF02646090
NR 26
TC 39
Z9 43
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 336
EP 342
DI 10.1016/j.msec.2005.04.006
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000013
DA 2018-10-20
ER

PT J
AU Koike, M
   Ohkubo, C
   Sato, H
   Fujii, H
   Okabe, T
AF Koike, M
   Ohkubo, C
   Sato, H
   Fujii, H
   Okabe, T
TI Evaluation of cast Ti-Fe-O-N alloys for dental applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE titanium alloys; dental alloys; tensile testing; corrosion studies;
   grindability; mold filling
ID TITANIUM
AB Good mechanical properties, biocompatibility and corrosion resistance make titanium an excellent material for biomedical applications. However, when better mechanical properties than those offered by commercially pure titanium (CPTi) are needed, Ti-6Al-4V is sometimes a good alternative. Some new titanium alloys, developed as industrial structural materials, aim at an intermediate range of strength between that of CP Ti and Ti-6Al-4V Two of these alloys are Super-TIX800 (TM) (Ti-1% Fe-0.35% O-0.01% N) and Super-TIX800N (TM) (Ti-1% Fe-0.3% O-0.04% N) (both produced by Nippon Steel Corp., Japan). Besides being stronger than CP Ti, the cost of manufacturing these alloys is reportedly lower than for Ti-6Al-4V since they do not contain any expensive elements. In addition, they are not composed of elements such as aluminum or vanadium, which have caused biocompatibility concerns in medical and dental appliances. To evaluate these alloys as candidates for dental use, it is helpful to compare them to CP Ti (ASTM Grade 2) and Ti-6Al-4V (ASTM Grade 5), which have already been employed in dentistry. We evaluated the tensile properties, mold filling capacity, corrosion characteristics and grindability of these industrial alloys prepared by investment casting. Compared to the strengths of cast CPTi, the yield strength and tensile strength of these cast alloys were more than 20% and approximately 30% higher, respectively. On the other hand, both of these properties were 30% lower than for Ti-6Al-4V. Better grindability and wear resistance were additional benefits of these new alloys for dental applications. (c) 2005 Elsevier B.V All rights reserved.
C1 Texas A&M Univ, Syst Hlth Sci Ctr, Baylor Coll Dent, Dallas, TX 75246 USA.
   Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528588, Japan.
   Tsurumi Univ, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan.
   Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 9808575, Japan.
   Nippon Steel Corp Ltd, Futtsu, Chiba 2938511, Japan.
RP Okabe, T (reprint author), Texas A&M Univ, Syst Hlth Sci Ctr, Baylor Coll Dent, 3302 Gaston Ave, Dallas, TX 75246 USA.
EM tokabe@bcd.tamhsc.edu
CR BOYER R, 1994, MAT PROPERTIES HDB, P1065
   Donachie MJ, 2000, TITANIUM TECHNICAL G, P126
   EWERS GJ, 1985, J ORAL REHABIL, V12, P469, DOI 10.1111/j.1365-2842.1985.tb01293.x
   FUJII H, 1996, TITANIUM 95, P2309
   FUJII H, 2001, TITANIUM, V49, P171
   *ICDD, 1998, POWD DIFFR FIL SET 1
   Kikuchi M, 2003, DENT MATER J, V22, P191, DOI 10.4012/dmj.22.191
   Koike M, 2003, BIOMATERIALS, V24, P4541, DOI 10.1016/S0142-9612(03)00063-2
   MAREK M, 1990, J DENT RES, V69, P1167, DOI 10.1177/00220345900690050901
   MILLER I, 1985, PROBABILITY STAT ENG, P188
   MURRAY JL, 1984, PHASE DIAGRAMS BINAR
   OBrien WJ, 2002, DENT MAT THEIR SELEC
   OHKUBO C, 2004, J DENT RES, V83
   Okabe T, 1998, JOM-J MIN MET MAT S, V50, P24, DOI 10.1007/s11837-998-0410-7
   Okabe T, 2004, COST-AFFORDABLE TITANIUM, P177
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Shimizu H, 2002, BIOMATERIALS, V23, P2275, DOI 10.1016/S0142-9612(01)00357-X
   SIEGEL S, 1988, NONPARAMETRIC STAT B
   Stem M., 1957, J ELECTROCHEM SOC, V104, P56
   Watanabe I, 1997, J DENT RES, V76, P773, DOI 10.1177/00220345970760031001
NR 20
TC 21
Z9 26
U1 3
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 349
EP 356
DI 10.1016/j.msec.2005.04.002
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000015
DA 2018-10-20
ER

PT J
AU Sakaguchi, N
   Niinomi, M
   Akahori, T
   Takeda, J
   Toda, H
AF Sakaguchi, N
   Niinomi, M
   Akahori, T
   Takeda, J
   Toda, H
TI Relationships between tensile deformation behavior and microstructure in
   Ti-Nb-Ta-Zr system alloys
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE Ti-Nb-Ta-Zr system titanium alloy; biomedical applications; Mechanical
   properties; elastic modulus; stress-induced martensite; super elastic
   behavior; shape memory effect
ID TITANIUM-ALLOY; MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS;
   SHAPE-MEMORY; MO ALLOYS; TI-29NB-13TA-4.6ZR; FATIGUE
AB Ti-Nb-Ta-Zr system alloys are receiving more attention for biomedical material component applications. However, the deformation behavior of the Ti-Nb-Ta-Zr system has not been evaluated to date. Therefore, the deformation behavior of Ti-Nb-Ta-Zr alloys with different Nb contents was investigated in this study.
   The behaviors of loading-unloading stress-strain curves of Ti-20Nb-10Ta-5Zr and Ti-25Nb-10Ta-5Zr air-cooled after final heating of the manufacturing process are similar to that obtained in metastable beta type titanium alloys that have the shape memory effect. Therefore, the shape memory effect was expected in Ti-20Nb-10Ta-5Zr and Ti-25Nb-10Ta-5Zr alloys. The elastic deformation of Ti-30Nb-10Ta-5Zr disobeyed Hooke's law. However, stress or strain-induced martensite (SIM) is not observed on the loading-unloading stress-strain curve. The deformation mechanism of Ti-25Nb-10Ta-5Zr changes with varying its microstructure. In Ti-25Nb-10Ta-5Zr air-cooled after final heating, the microstructure consisted of an omega phase in a beta phase. The stress for inducing martensite in a phase, am, was nearly equal to the yielding stress, sigma(y). Therefore, stress-induced martensitic transformation and movement of dislocations occurred together. In Ti-25Nb-10Ta-5Zr water-quenched after final heating of the manufacturing process, the microstructure consisted of a single phase, where am is lower than ay, Therefore, stress-induced martensitic transformation occurred before yielding. (c) 2005 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM Niinomi@sp-Mac4.tutpse.tut.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Grosdidier T, 2000, METALL MATER TRANS A, V31, P1095, DOI 10.1007/s11661-000-0105-3
   HANADA S, 1985, METALL TRANS A, V16, P789, DOI 10.1007/BF02814829
   HIDA M, 1980, J JPN I MET, V44, P436, DOI 10.2320/jinstmet1952.44.4_436
   Karasevskaya OP, 2003, MAT SCI ENG A-STRUCT, V354, P121, DOI 10.1016/S0921-5093(02)00935-8
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Kasuga T, 2001, BIOMATERIALS, V22, P577, DOI 10.1016/S0142-9612(00)00216-7
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Li SJ, 2002, MATER TRANS, V43, P2964, DOI 10.2320/matertrans.43.2964
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Meng XL, 2002, MATER LETT, V55, P111, DOI 10.1016/S0167-577X(01)00631-0
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   OHMORI Y, 2001, MAT SCI ENG A-STRUCT, V321, P182
   OKA M, 1978, J JPN I MET, V42, P814, DOI 10.2320/jinstmet1952.42.8_814
   Sakaguch N, 2004, MATER TRANS, V45, P1113, DOI 10.2320/matertrans.45.1113
   SAKAGUCHI N, 2003, P ATEM 03 JAP SOC ME
   YOSHITANI S, 2000, P 2000 POWD MET WORL, V2, P1085
NR 18
TC 79
Z9 88
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 363
EP 369
DI 10.1016/j.msec.2004.12.014
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000017
DA 2018-10-20
ER

PT J
AU Niinomi, M
   Akahori, T
   Takeuchi, T
   Katsura, S
   Fukui, H
   Toda, H
AF Niinomi, M
   Akahori, T
   Takeuchi, T
   Katsura, S
   Fukui, H
   Toda, H
TI Mechanical properties and cyto-toxicity of new beta type titanium alloy
   with low melting points for dental applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE beta titanium alloy; casting; melting point; surface reaction layer;
   tensile properties; biocompatibility
ID BIOMEDICAL APPLICATIONS; FATIGUE PROPERTIES; TI-29NB-13TA-4.6ZR
AB Beta stabilized new alloys such as Ti-29Nb-13Zr-2Cr, Ti-29Nb-15Zr-1.5Fe, Ti-29Nb-10Zr-0.5Si, Ti-29Nb-10Zr-0.5Cr-0.5Fe and Ti-29Nb-18Zr-2Cr-0.5Si have been developed for dental applications. These alloys were designed based on master alloy Ti-29Nb-13Ta-4.6Zr (TNTZ) for biomedical applications. In this research, high melting temperature element Ta was replaced with beta stabilizing elements such as Cr, Fe and Si to lower the melting temperature of the alloy.
   Their melting points, mechanical properties, surface reaction layers and cyto-toxicity were investigated in this study.
   Melting points of designed alloys fall by about 50 K to 370 K as compared with that of TNTZ, and Ti-29Nb-13Zr-2Cr has the lowest melting point of around 2050 K. Vickers hardness of the surface of each designed alloy cast into modified magnesia based investment material is in the range of 400 Hv to 500 Hv, which is lower than that of TNTZ (around 560 Hv).
   Balances of strength and ductility of cast Ti-29Nb-13Zr-2Cr, Ti-29Nb-15Zr-1.5Fe and Ti-29Nb-10Zr-0.5Cr-0.5Fe are nearly equal to that of cast TNTZ.
   Cell viability of each cast designed alloy is excellent. (c) 2005 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Takauchikatan Ltd, Toyohashi, Aichi 4418132, Japan.
   Yamahachi Dent Co, Aichi 4430105, Japan.
   Aichi Gakuin Univ, Dept Dent Mat Sci, Sch Dent, Nagoya, Aichi 4648650, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM Niinomi@sp-Mac4.tutpse.tut.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Akahori T, 2002, J JPN I MET, V66, P715, DOI 10.2320/jinstmet1952.66.7_715
   DOI H, 1999, J J SOC DENT MAT DEV, V18, P122
   KATO A, 1993, CURRENT ADV MAT PROC, V6, P1584
   Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   MORINAGA M, 1992, J JPN I LIGHT MET, V42, P416
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2004, TETSU TO HAGANE, V90, P154, DOI 10.2355/tetsutohagane1955.90.3_154
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   NIINOMI M, 2002, MAT T, V43, P2877
   NIINOMI M, 2001, J J FOUNDRY ENG SOC, V73, P798
   Okazaki Y., 1997, MAT JAPAN, V36, P1092
   OUCHI C, 1998, MAT JAPAN, V37, P22
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   TAKAHASHI J, 1995, J J SOC BIOMATERIALS, V13, P131
NR 18
TC 32
Z9 32
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 417
EP 425
DI 10.1016/j.msec.2005.01.024
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000024
DA 2018-10-20
ER

PT J
AU Steller, S
   Angenendt, P
   Cahill, DJ
   Heuberger, S
   Lehrach, H
   Kreutzberger, J
AF Steller, S
   Angenendt, P
   Cahill, DJ
   Heuberger, S
   Lehrach, H
   Kreutzberger, J
TI Bacterial protein microarrays for identification of new potential
   diagnostic markers for Neisseria meningitidis infections
SO PROTEOMICS
LA English
DT Article
DE opacity proteins; pathogen; phase variation; protein chip; vaccine
ID COMPLETE GENOME SEQUENCE; OUTER-MEMBRANE PROTEIN; PHASE-VARIABLE GENES;
   STRAIN MC58; SEROGROUP-B; MENINGOCOCCAL MENINGITIS; MOLECULAR
   MECHANISMS; ENDOTHELIAL-CELLS; SUPPORT MATERIALS; EXPRESSION
AB Neisseria meningitidis is the most common cause of meningitis and causes epidemic outbreaks. One trait of N. meningitidis, which is associated with most of the currently recognized virulence determinants, is the presence of phase-variable genes that are suspected to enhance its ability to cause an invasive disease. To detect the immune responses to phase-variable expressed proteins, we applied protein microarray technology for the screening of meningitis patient sera. We amplified all 102 known phase-variable genes from N. meningitidis serogroup B strain MC58 by polymerase chain reaction and subcloned them for expression in Escherichia coli. With this approach, we were able to express and purify 67 recombinant proteins representing 66 % of the annotated genes. These were spotted robotically onto coated glass slides to generate protein microarrays, which were screened using 20 sera of patients suffering from meningitis, as wen as healthy controls. From these screening experiments, 47 proteins emerged as immunogenic, exhibiting a variable degree of seroreactivity with some of the patient sera. Nine proteins elicited an immune response in more than three patients, with one of them, the phase-variable opacity protein OpaV (NMB0442), showing responses in 11 patient sera. This is the first time that protein microarray technology has been applied for the investigation of genetic phase variation in pathogens. The identification of disease-specific proteins is a significant target in biomedical research, as such proteins may have medical, diagnostic, and commercial potential as disease markers.
C1 Max Planck Inst Mol Genet, D-14195 Berlin, Germany.
   Ruhr Univ Bochum, Med Proteome Ctr, D-4630 Bochum, Germany.
   PROTAGEN AG, Dortmund, Germany.
   Royal Coll Surgeons Ireland, Ctr Human Proteom, Dublin 2, Ireland.
   AGES BSU Graz, Natl Referenzzentrale Meningokokken, Graz, Austria.
RP Kreutzberger, J (reprint author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.
EM kreutzbg@molgen.mpg.de
CR Angenendt P, 2005, PROTEOMICS, V5, P420, DOI 10.1002/pmic.200400955
   Angenendt P, 2004, ANAL CHEM, V76, P2916, DOI 10.1021/ac035357a
   Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6
   Angenendt P, 2002, ANAL BIOCHEM, V309, P253, DOI 10.1016/S0003-2697(02)00257-9
   Bacarese-Hamilton T, 2002, BIOTECHNIQUES, P24
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007
   Courtney HS, 2003, INFECT IMMUN, V71, P5097, DOI 10.1128/IAI.71.9.5097-5103.2003
   Freissler E, 2000, CELL MICROBIOL, V2, P69, DOI 10.1046/j.1462-5822.2000.00036.x
   Glokler J, 2003, J CHROMATOGR B, V797, P229, DOI 10.1016/j.jchromb.2003.08.034
   Haab BB, 2001, GENOME BIOL, V2
   Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x
   Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje
   Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013
   Jennings MP, 1998, MOL MICROBIOL, V29, P975, DOI 10.1046/j.1365-2958.1998.00962.x
   Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x
   Kotilainen P, 1998, J CLIN MICROBIOL, V36, P2205
   KRISTIANSEN BE, 1991, LANCET, V337, P1568, DOI 10.1016/0140-6736(91)93262-8
   Lewis LA, 1999, MOL MICROBIOL, V32, P977, DOI 10.1046/j.1365-2958.1999.01409.x
   Lueking A, 2003, MOL CELL PROTEOMICS, V2, P1342, DOI 10.1074/mcp.T3000010-MCP200
   MacBeath G, 2000, SCIENCE, V289, P1760
   Mahler E, 2004, CLIN EXP IMMUNOL, V136, P527, DOI 10.1111/j.1365-2249.2004.02480.x
   Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x
   Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910
   MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1
   MURALIDHARAN K, 1987, A VAN LEEUW J MICROB, V53, P435, DOI 10.1007/BF00415499
   Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295
   Rowe CA, 1999, ANAL CHEM, V71, P433, DOI 10.1021/ac980798t
   SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x
   Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x
   Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321
   Sun YH, 2000, NAT MED, V6, P1269
   Templin MF, 2003, PROTEOMICS, V3, P2155, DOI 10.1002/pmic.200300600
   Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2
   Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809
   Tikhomirov Eugene, 1997, World Health Statistics Quarterly, V50, P170
   TRAMONT EC, 1977, J IMMUNOL, V118, P1843
   VANDERENDE A, 1995, J BACTERIOL, V177, P2475, DOI 10.1128/jb.177.9.2475-2480.1995
   VANPUTTEN JPM, 1995, MOL MICROBIOL, V16, P847
   Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x
   VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x
   Wren BW, 2000, NAT REV GENET, V1, P30, DOI 10.1038/35049551
   Zhu H, 2000, NAT GENET, V26, P283
NR 45
TC 49
Z9 55
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD MAY
PY 2005
VL 5
IS 8
BP 2048
EP 2055
DI 10.1002/pmic.200401097
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 932LJ
UT WOS:000229554900006
PM 15852346
DA 2018-10-20
ER

PT J
AU Fisher, JK
   Cummings, JR
   Desai, KV
   Vicci, L
   Wilde, B
   Keller, K
   Weigle, C
   Bishop, G
   Taylor, RM
   Davis, CW
   Boucher, RC
   O'Brien, ET
   Superfine, R
AF Fisher, JK
   Cummings, JR
   Desai, KV
   Vicci, L
   Wilde, B
   Keller, K
   Weigle, C
   Bishop, G
   Taylor, RM
   Davis, CW
   Boucher, RC
   O'Brien, ET
   Superfine, R
TI Three-dimensional force microscope: A nanometric optical tracking and
   magnetic manipulation system for the biomedical sciences
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID MITOTIC SPINDLE; BEAT PATTERN; CILIARY BEAT; TWEEZERS; MOVEMENT;
   MICROMANIPULATION; MOTILITY; CELLS; RESOLUTION; FLAGELLA
AB We report here the development of a three-dimensional (3D) magnetic force microscope for applying forces to and measuring responses of biological systems and materials. This instrument combines a conventional optical microscope with a free-floating or specifically bound magnetic bead used as a mechanical probe. Forces can be applied by the bead to microscopic structures of interest (specimens), while the reaction displacement of the bead is measured. This enables 3D mechanical manipulations and measurements to be performed on specimens in fluids. Force is generated by the magnetically permeable bead in reaction to fields produced by external electromagnets. The displacement is measured by interferometry using forward light scattered by the bead from a focused laser beam. The far-field interference pattern is imaged on a quadrant photodetector from which the 3D displacement can be computed over a limited range about the focal point. The bead and specimen are mounted on a 3D translation stage and feedback techniques are used to keep the bead within this limited range. We demonstrate the system with application to beads attached to cilia in human lung cell cultures. &COPY; 2005 American Institute of Physics.
C1 Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Med Cyst Fibrosis Ctr, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA.
RP Fisher, JK (reprint author), Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA.
RI Superfine, Richard/A-1968-2012
OI Superfine, Richard/0000-0002-2569-071X
CR Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7
   Amblard F, 1996, REV SCI INSTRUM, V67, P818, DOI 10.1063/1.1146816
   ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288
   Assi F, 2002, J APPL PHYS, V92, P5584, DOI 10.1063/1.1509086
   Baker AA, 2000, BIOPHYS J, V79, P1139, DOI 10.1016/S0006-3495(00)76367-3
   Barbic M, 2001, APPL PHYS LETT, V79, P1897, DOI 10.1063/1.1402963
   BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0
   BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0
   Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003
   Braga P. C., 2003, METHODS MOL BIOL, V242
   Chilvers MA, 2000, THORAX, V55, P314, DOI 10.1136/thorax.55.4.314
   CRAMER LP, 1994, CURR OPIN CELL BIOL, V6, P82, DOI 10.1016/0955-0674(94)90120-1
   CRICK FHC, 1950, EXP CELL RES, V1, P37, DOI 10.1016/0014-4827(50)90048-6
   DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2
   Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949
   DENK W, 1990, APPL OPTICS, V29, P2382, DOI 10.1364/AO.29.002382
   Ellison V, 2001, CELL, V106, P655, DOI 10.1016/S0092-8674(01)00498-6
   Endow SA, 2003, BIOESSAYS, V25, P1212, DOI 10.1002/bies.10358
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   Florin EL, 1998, APPL PHYS A-MATER, V66, pS75, DOI 10.1007/s003390051103
   Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007
   Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5
   Haber C, 2000, REV SCI INSTRUM, V71, P4561, DOI 10.1063/1.1326056
   HARADA Y, 1998, LASER TWEEZERS CELL, V55, P99
   Hirakawa E, 2000, P NATL ACAD SCI USA, V97, P2533, DOI 10.1073/pnas.050585297
   Hosu BG, 2003, REV SCI INSTRUM, V74, P4158, DOI 10.1063/1.1599066
   Huang H, 2002, BIOPHYS J, V82, P2211, DOI 10.1016/S0006-3495(02)75567-7
   HUANG HD, 2002, BIOPHYS J, V82, P2008
   HUITOREL P, 1988, BIOL CELL, V63, P249, DOI 10.1016/0248-4900(88)90062-7
   Kachynski AV, 2003, OPT LETT, V28, P2288, DOI 10.1364/OL.28.002288
   KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0
   KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975
   Lang MJ, 2003, AM J PHYS, V71, P201, DOI 10.1119/1.1532323
   Mark W. R., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P447
   Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687
   Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527
   Morio D, 2000, J DENT RES, V79, P468
   NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542
   Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7
   Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z
   Pralle A, 1998, APPL PHYS A-MATER, V66, pS71, DOI 10.1007/s003390051102
   RAUTIAINEN M, 1992, ACTA OTO-LARYNGOL, V112, P845, DOI 10.3109/00016489209137483
   RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223
   Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482
   RUBIN BK, 2002, RESP CARE, V23, P761
   SANDERSON MJ, 1981, J CELL SCI, V47, P331
   Schmitz KA, 2000, BIOPHYS J, V79, P468, DOI 10.1016/S0006-3495(00)76308-9
   Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599
   Signor D, 2000, Essays Biochem, V35, P89
   Skibbens RV, 1997, EXP CELL RES, V235, P314, DOI 10.1006/excr.1997.3691
   STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552
   Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835
   TEUNIS PFM, 1994, BIOPHYS J, V67, P381, DOI 10.1016/S0006-3495(94)80493-X
   VALBERG PA, 1985, J CELL BIOL, V101, P130, DOI 10.1083/jcb.101.1.130
   VICCI L, 2001, DEPT COMPUTER SCI U, pTR1
   Visscher K, 1999, NATURE, V400, P184
   Wallace RA, 1981, BIOL SCI LIFE
   Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7
   Wintermeyer W, 2000, Essays Biochem, V35, P117
   YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653
   ZIEMANN F, 1994, BIOPHYS J, V66, P2210, DOI 10.1016/S0006-3495(94)81017-3
   1996, ANN BOOK STANDARDS
NR 62
TC 26
Z9 26
U1 0
U2 19
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD MAY
PY 2005
VL 76
IS 5
AR 053711
DI 10.1063/1.1914777
PG 11
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 925PF
UT WOS:000229064300037
DA 2018-10-20
ER

PT J
AU Feili, D
   Schuettler, M
   Doerge, T
   Kammer, S
   Stieglitz, T
AF Feili, D
   Schuettler, M
   Doerge, T
   Kammer, S
   Stieglitz, T
TI Encapsulation of organic field effect transistors for flexible
   biomedical microimplants
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article
DE organic field effect transistor; polyimide; microimplants; parylene;
   encapsulation; neural prostheses
ID THIN-FILM TRANSISTORS; MICROELECTRODE ARRAY; PENTACENE; MOBILITY
AB Biomedical microimplants are used as neural prostheses to restore body functions after paraplegia by means of functional electrical stimulation (FES). This paper describes an approach of the integration of organic transistors into flexible biomedical microimplant for FES use. Encapsulation is used to ensure the electrical functionality of implants (insulation) and to protect them from the harsh environments in the human body. So far, biomedical microdevices have been fabricated using silicon or polyimide substrate, respectively. Highly flexible polyimide based microdevices that have been interfaced with nerves as neural prostheses showed excellent properties as implant material [1-3]. Therefore, we have developed transistors on polyimide, which is used as flexible substrate. Gold was sputtered as gate, drain and source. Silicon oxide formed the gate insulator and pentacene (C14H22) was evaporated at ultra high vacuum (UHV) and 75 degrees C substrate temperature as active layer in an organic field effect transistor (OFET). Parylene is used as encapsulation material. First transistors have been fabricated and characterized. So far, they are still in low scale integration. The first investigation on the electrical properties of the OFETs before and after encapsulation with Parylene at room temperature led to promising results. (c) 2004 Elsevier B.V. All rights reserved.
C1 Fraunhofer Inst Biomed Engn, Neural Prosthet Grp, D-66386 St Ingbert, Germany.
   UCL, Dept Med Phys, London WC1E 6JA, England.
   UCL, Bioengn Implanted Devices Grp, London WC1E 6JA, England.
RP Feili, D (reprint author), Fraunhofer Inst Biomed Engn, Neural Prosthet Grp, Ensheimer Str 48, D-66386 St Ingbert, Germany.
EM dara.feili@ibmt.fraunhofer.de
RI Stieglitz, Thomas/C-7916-2013
OI Stieglitz, Thomas/0000-0002-7349-4254
CR Dimitrakopoulos CD, 2001, IBM J RES DEV, V45, P11, DOI 10.1147/rd.451.0011
   Dimitrakopoulos CD, 1996, J APPL PHYS, V80, P2501, DOI 10.1063/1.363032
   Dimitrakopoulos CD, 1999, SCIENCE, V283, P822, DOI 10.1126/science.283.5403.822
   GORHAM WF, 1966, J POLYM SCI A1, V4, P3027, DOI 10.1002/pol.1966.150041209
   Gundlach DJ, 1997, IEEE ELECTR DEVICE L, V18, P87, DOI 10.1109/55.556089
   Horowitz G, 1998, ADV MATER, V10, P365, DOI 10.1002/(SICI)1521-4095(199803)10:5<365::AID-ADMA365>3.0.CO;2-U
   IHANTOLA HKJ, 1964, SOLID STATE ELECTRON, V7, P423, DOI 10.1016/0038-1101(64)90039-5
   Jackson TN, 1998, IEEE J SEL TOP QUANT, V4, P100, DOI 10.1109/2944.669475
   KENNEDY DP, 1973, IBM J RES DEV, V17, P1, DOI 10.1147/rd.171.0002
   Lin YY, 1997, IEEE T ELECTRON DEV, V44, P1325, DOI 10.1109/16.605476
   Lin YY, 1997, IEEE ELECTR DEVICE L, V18, P606, DOI 10.1109/55.644085
   MATSUO Y, 2000, SYNTHETIC MET, V121, P408
   MINAKATA T, 1993, J APPL PHYS, V74, P1079, DOI 10.1063/1.354955
   Nelson SF, 1998, APPL PHYS LETT, V72, P1854, DOI 10.1063/1.121205
   PHILIPPOW E, 1987, TASCHENBUCH ELEKTROT, V2, P920
   Sandison M, 2002, J NEUROSCI METH, V114, P63, DOI 10.1016/S0165-0270(01)00509-X
   Schwarz M, 2000, SENSOR ACTUAT A-PHYS, V83, P40, DOI 10.1016/S0924-4247(00)00290-9
   Steiger J, 2001, SYNTHETIC MET, V122, P49, DOI 10.1016/S0379-6779(00)01359-X
   Stieglitz T, 1997, SENSOR ACTUAT A-PHYS, V60, P240, DOI 10.1016/S0924-4247(97)01494-5
   Suaning GJ, 2003, SENSOR ACTUAT A-PHYS, V108, P155, DOI 10.1016/j.sna.2003.07.002
   Swiggers ML, 2001, APPL PHYS LETT, V79, P1300, DOI 10.1063/1.1394952
   Takahashi H, 2003, IEEE T BIO-MED ENG, V50, P510, DOI 10.1109/TBME.2003.809483
   Thompson RW, 2003, INVEST OPHTH VIS SCI, V44, P5035, DOI 10.1167/iovs.03-0341
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   WANG J, 1999, 41 EL MAT C SANT BAR, P16
NR 25
TC 47
Z9 48
U1 0
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD APR 29
PY 2005
VL 120
IS 1
BP 101
EP 109
DI 10.1016/j.sna.2004.11.021
PG 9
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 921NG
UT WOS:000228770700014
DA 2018-10-20
ER

PT J
AU Mano, JF
AF Mano, JF
TI Viscoelastic properties of bone: Mechanical spectroscopy studies on a
   chicken model
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Learning from Nature
   How to Design New Implantable Biomaterials
CY OCT 13-24, 2003
CL Alvor, PORTUGAL
DE biocomposites; bone viscoelasticity; complex modulus; DMA
ID HUMAN CORTICAL BONE; DEMINERALIZED BONE; COMPACT-BONE; COLLAGEN; BOVINE;
   ATTENUATION; TEMPERATURE; BEHAVIOR
AB The mechanical behaviour of bone exhibits a time-dependent response, as a consequence of its viscoelastic character. New materials for biomedical applications should have similar time-dependent mechanical behaviour as bone (viscoelastic biocompatibility). Hence, it is important to evaluate the properties of bone and to understand the underlying mechanism responsible for its damping features. In this work the solid-state theological properties were studied in chicken bone. Fresh ulna specimens were tested using dynamic mechanical analysis in the temperature range -50 to 80 &DEG; C, at a constant frequency of 1 Hz. A broad tan 6 peak was found between -50 and 30 &DEG; C, that was attributed to melting of water and molecular mobility involving collagen molecules. A minimum in the loss factor was detected at physiological temperature, which is consistent with isothermal results previously reported. It was hypothesised that this behaviour would have a physiological significance and could be associated to some damage process occurring within the organic phase caused by energy absorption during cyclic loading. This minimum is not detected in the demineralised bone or in collagen, indicating that the specific interactions between the collagen molecules and the apatite crystals, as well as the complex hierarchical organisation of the bone structure, are designed to reduce damping at functional time scales. A broad loss process was observed at low temperature in collagen. Local molecular motions at low temperatures occurring in collagen molecules could enhance bone toughness. Creep tests also revealed bone viscoelasticity features, and are useful to monitor irrecoverable strain upon static loads, which could be mainly a consequence of structural damage, rather than pure-viscous flow. &COPY; 2005 Elsevier B.V All rights reserved.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, 3Bs Res Grp Biomat Biodegradable & Biomimet, P-4710057 Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765
CR BONAR LC, 1970, J ULTRA MOL STRUCT R, V32, P545, DOI 10.1016/S0022-5320(70)80027-2
   Bowman SM, 1999, J BIOMECH ENG-T ASME, V121, P253, DOI 10.1115/1.2835112
   Buechner PM, 2001, ANN BIOMED ENG, V29, P719, DOI 10.1114/1.1385813
   CHIEN JCW, 1972, BIOPOLYMERS, V11, P2015, DOI 10.1002/bip.1972.360111003
   CURREY J, 1984, MECH ADAPTATION BONE
   EVANS FG, 1973, MECH PROPERTIES BONE
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Fois M, 2001, J APPL POLYM SCI, V79, P2527, DOI 10.1002/1097-4628(20010401)79:14<2527::AID-APP1061>3.0.CO;2-J
   FONDRK M, 1988, J BIOMECH, V21, P623, DOI 10.1016/0021-9290(88)90200-X
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Garner E, 2000, J BIOMECH ENG-T ASME, V122, P166, DOI 10.1115/1.429638
   Johari GP, 1996, SCIENCE, V273, P90, DOI 10.1126/science.273.5271.90
   LAKES R, 1986, J BIOMED ENG, V8, P143, DOI 10.1016/0141-5425(86)90049-X
   LAKES R, 1979, SCIENCE, V204, P503
   LAKES RS, 1979, J BIOMECH, V12, P657, DOI 10.1016/0021-9290(79)90016-2
   LAKES RS, 1979, J BIOMECH, V12, P679, DOI 10.1016/0021-9290(79)90017-4
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   LEE S, 1981, CALCIFIED TISSUE INT, V33, P591
   Mano J. F., 2002, POLYM BASED SYSTEMS
   Mano JF, 2004, POLYM TEST, V23, P423, DOI 10.1016/j.polymertesting.2003.09.011
   Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832
   NGUYEN AL, 1974, BIOPOLYMERS, V13, P1023, DOI 10.1002/bip.1974.360130516
   Oliveira AL, 2003, CURR OPIN SOLID ST M, V7, P309, DOI 10.1016/j.cossms.2003.10.009
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Schaller R, 2004, MAT SCI ENG A-STRUCT, V370, P569, DOI 10.1016/j.msea.2003.08.107
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Toyras J, 2002, BONE, V31, P503, DOI 10.1016/S8756-3282(02)00843-8
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   WOLFF J, 1892, GESETZ TRANFORMATION
   Woo L, 1996, THERMOCHIM ACTA, V284, P57, DOI 10.1016/0040-6031(96)02890-0
   WOO L, 1994, POLYM ENG SCI, V34, P420, DOI 10.1002/pen.760340507
   Yamashita J, 2002, J BIOMED MATER RES, V63, P31, DOI 10.1002/jbm.10086
   Yamashita J, 2001, J BIOMED MATER RES, V58, P47, DOI 10.1002/1097-4636(2001)58:1<47::AID-JBM70>3.0.CO;2-U
NR 35
TC 35
Z9 36
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR 28
PY 2005
VL 25
IS 2
BP 145
EP 152
DI 10.1016/j.msec.2005.01.017
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 932EA
UT WOS:000229535800007
DA 2018-10-20
ER

PT J
AU Silva, GA
   Pedro, A
   Costa, FJ
   Neves, NM
   Coutinho, OP
   Reis, RL
AF Silva, GA
   Pedro, A
   Costa, FJ
   Neves, NM
   Coutinho, OP
   Reis, RL
TI Soluble starch and composite starch Bioactive Glass 45S5 particles:
   Synthesis, bioactivity, and interaction with rat bone marrow cells
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Learning from Nature
   How to Design New Implantable Biomaterials
CY OCT 13-24, 2003
CL Alvor, PORTUGAL
DE starch-based; bioactive glass; rat bone marrow cells; bioactivity; Ca-P
   layer; cytotoxicity
ID IN-VITRO SYNTHESIS; BIOMATERIALS; PROLIFERATION; TISSUE;
   DIFFERENTIATION; HYDROXYAPATITE; DEGRADATION; OSTEOBLASTS; SCAFFOLDS;
   POLYMERS
AB For many biomedical applications, biodegradable and simultaneously bioactive materials are desired. These materials should at the same time be able to support cell function and co-exist with the organism without triggering a relevant immune response.
   In this work, the synthesis as well as the bioactivity evaluation of newly developed polymer soluble potato starch and composite (with Bioactive Glass 45S5) micron-size particles are reported. An extremely interesting result is that although with different properties, both polymer and composite particles were able to form a calcium phosphate layer at their surface, which is a clear indication of their bioactivity.
   The cytotoxicity and the ability to support cell attachment and growth of the developed materials were also studied, and both polymer and composite materials were shown to be non-cytotoxic. Preliminary results show that both types of materials were found to allow rat bone marrow cells to attach and to proliferate on their surface and to express osteogenic markers, such as alkaline phosphatase and osteopontin.
   The obtained results indicate that the developed carriers might be used as substrates for cell culture in vitro, in order to form constructs that might be used as a part of a tissue engineering strategy. &COPY; 2005 Elsevier B.V. All rights reserved.
C1 Univ Minho, 3Bs Res Grp Biomat Biodegradables Biomimet, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, Dept Biol, P-4710057 Braga, Portugal.
RP Silva, GA (reprint author), Univ Minho, 3Bs Res Grp Biomat Biodegradables Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM gsilva@dep.uminho.pt
RI Pedro, Adriano/B-5519-2012; Group, 3Bs/E-4374-2012; Coutinho,
   Olga/K-7155-2013; silva, gabriela/F-4409-2012; Neves, Nuno/B-4685-2008;
   Reis, Rui L./A-8938-2008
OI Pedro, Adriano/0000-0002-1653-1725; Group, 3Bs/0000-0002-5195-3456;
   silva, gabriela/0000-0001-5946-1918; Neves, Nuno/0000-0003-3041-0687;
   Reis, Rui L./0000-0002-4295-6129; Coutinho, Olga/0000-0002-0647-080X
CR Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Cenni E, 1999, TOXICOL IN VITRO, V13, P801, DOI 10.1016/S0887-2333(99)00058-2
   DUCHEYNE P, 1994, J CELL BIOCHEM, V56, P162, DOI 10.1002/jcb.240560207
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Leonor IB, 2003, J MATER SCI-MATER M, V14, P435, DOI 10.1023/A:1023214918592
   Leonor IB, 2003, BIOMATERIALS, V24, P579, DOI 10.1016/S0142-9612(02)00371-X
   LI PJ, 1993, BIOMATERIALS, V14, P963, DOI 10.1016/0142-9612(93)90186-6
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OHGUSHI H, 1994, MAT SCI ENG C-BIOMIM, V1, P139, DOI 10.1016/0928-4931(94)90045-0
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.3.CO;2-9
   Reis RL, 1999, MOD PLAST, V76, P73
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   Silva GA, 2004, J BIOMED MATER RES A, V70A, P442, DOI 10.1002/jbm.a.30099
   Silva GA, 2003, J MATER SCI-MATER M, V14, P1055, DOI 10.1023/B:JMSM.0000004002.11278.30
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 29
TC 20
Z9 20
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR 28
PY 2005
VL 25
IS 2
BP 237
EP 246
DI 10.1016/j.msec.2005.01.012
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 932EA
UT WOS:000229535800018
DA 2018-10-20
ER

PT J
AU Matousek, P
   Clark, IP
   Draper, ERC
   Morris, MD
   Goodship, AE
   Everall, N
   Towrie, M
   Finney, WF
   Parker, AW
AF Matousek, P
   Clark, IP
   Draper, ERC
   Morris, MD
   Goodship, AE
   Everall, N
   Towrie, M
   Finney, WF
   Parker, AW
TI Subsurface probing in diffusely scattering media using spatially offset
   Raman spectroscopy
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE Raman spectroscopy; Confocal microscopy; diffuse scattering; turbid
   media; photon migration; optical tomography
ID TARGET ENTROPY MINIMIZATION; PHOTON MIGRATION; FLUORESCENCE; BTEM;
   SPECTRA; REJECTION; MIXTURES
AB We describe a simple methodology for the effective retrieval of Raman spectra of subsurface layers in diffusely scattering media. The technique is based on the collection of Raman scattered light from surface regions that are laterally offset away from the excitation laser spot on the sample. The Raman spectra obtained in this way exhibit a variation in relative spectral intensities of the surface and subsurface layers of the sample being investigated. The data set is processed using a multivariate data analysis to yield pure Raman spectra of the individual sample layers, providing a method for the effective elimination of surface Raman scatter. The methodology is applicable to the retrieval of pure Raman spectra from depths well in excess of those accessible with conventional confocal microscopy. In this first feasibility study we have differentiated between surface and subsurface Raman signals within a diffusely scattering sample composed of two layers: trans-stilbene powder beneath a I rum thick over-layer of PMMA (poly(methyl methacrylate)) powder. The improvement in contrast of the subsurface trans-stilbene layer without numerical processing was 19 times. The potential applications include biomedical subsurface probing of specific tissues through different overlying tissues such as assessment of bone quality through skin, providing an effective noninvasive means of screening for bone degeneration, other skeletal disease diagnosis, and dermatology studies, as well as materials and catalyst research.
C1 Rutherford Appleton Lab, CCLRC, Cent Laser Facil, Didcot OX11 0QX, Oxon, England.
   Univ London Royal Vet Coll, Hatfield AL9 7TA, Herts, England.
   Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   Wilton Res Ctr, ICI PLC, Redcar TS10 4RF, Cleveland, England.
RP Matousek, P (reprint author), Rutherford Appleton Lab, CCLRC, Cent Laser Facil, Didcot OX11 0QX, Oxon, England.
RI Parker, Anthony/G-5445-2011; Morris, Michael/A-9327-2009; Matousek,
   Pavel/D-5750-2011
OI Parker, Anthony/0000-0003-3094-9762; Matousek, Pavel/0000-0003-0912-5339
FU NIAMS NIH HHS [P30 AR46024]
CR Brenan CJH, 1996, J RAMAN SPECTROSC, V27, P561, DOI 10.1002/(SICI)1097-4555(199608)27:8<561::AID-JRS7>3.3.CO;2-0
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Chew W, 2002, ORGANOMETALLICS, V21, P1982, DOI 10.1021/om0108752
   Das BB, 1997, REP PROG PHYS, V60, P227, DOI 10.1088/0034-4885/60/2/002
   Everall N, 2004, APPL SPECTROSC, V58, P591, DOI 10.1366/000370204774103426
   Everall N, 2001, APPL SPECTROSC, V55, P1701, DOI 10.1366/0003702011954053
   Koizumi H, 1999, J BIOMED OPT, V4, P403, DOI 10.1117/1.429959
   Li CZ, 2003, J CATAL, V213, P126, DOI 10.1016/S0021-9517(02)00009-X
   Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518
   Matousek P, 2001, J RAMAN SPECTROSC, V32, P983, DOI 10.1002/jrs.784
   Matousek P, 1999, APPL SPECTROSC, V53, P1485, DOI 10.1366/0003702991945993
   MATOUSEK P, 2005, APPL SPECTROSC, V59, P300
   TUCHIN V, 2000, TISSUE OPTICS LIGHT, P3
   Widjaja E, 2003, APPL SPECTROSC, V57, P1353, DOI 10.1366/000370203322554509
   Widjaja E, 2002, ORGANOMETALLICS, V21, P1991, DOI 10.1021/om010933j
   Widjaja E, 2003, ANAL CHEM, V75, P4499, DOI 10.1021/ac0263622
   WU J, 1995, APPL OPTICS, V34, P3425, DOI 10.1364/AO.34.003425
NR 17
TC 268
Z9 270
U1 9
U2 91
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-7028
EI 1943-3530
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD APR
PY 2005
VL 59
IS 4
BP 393
EP 400
DI 10.1366/0003702053641450
PG 8
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA 914NP
UT WOS:000228234900001
PM 15901323
DA 2018-10-20
ER

PT J
AU Niinomi, M
   Hanawa, T
   Narushima, T
AF Niinomi, M
   Hanawa, T
   Narushima, T
TI Japanese research and development on metallic biomedical, dental, and
   healthcare materials
SO JOM
LA English
DT Article
ID SURFACE OXIDE-FILM; QUASI-BIOLOGICAL ENVIRONMENTS; AUSTENITIC
   STAINLESS-STEEL; NB-TA-ZR; SHAPE-MEMORY; MECHANICAL-PROPERTIES; FATIGUE
   PROPERTIES; TITANIUM-ALLOY; CYTOTOXICITY EVALUATION; CRYSTAL ORIENTATION
AB There is considerable demand for metallic materials for use in medical and dental devices. Metals and alloys are widely used as biomedical materials and are indispensable in the medical field. In dentistry, metal is used for restorations, orthodontic wires, and dental implants. This article describes R&D on metallic biomaterials primarily conducted by the members of the Japan Institute of Metals.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Tokyo Med & Dent Univ, Tokyo, Japan.
   Tohoku Univ, Sendai, Miyagi 980, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
EM niinomi@sp-Mac4.tutpse.tut.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Akahori T, 2002, J JPN I MET, V66, P715, DOI 10.2320/jinstmet1952.66.7_715
   Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   CLEMOW AJT, 1980, WEAR, V61, P219, DOI 10.1016/0043-1648(80)90287-2
   COOPER CV, 1989, J TRIBOL-T ASME, V111, P668, DOI 10.1115/1.3261993
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   Hanawa T, 2004, MATER TRANS, V45, P1635, DOI 10.2320/matertrans.45.1635
   Hanawa T, 2002, MATER TRANS, V43, P3088, DOI 10.2320/matertrans.43.3088
   Hanawa T, 2002, MATER TRANS, V43, P3000, DOI 10.2320/matertrans.43.3000
   HANAWA T, 1992, J JPN I MET, V56, P1168, DOI 10.2320/jinstmet1952.56.10_1168
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   HANAWA T, P 4 AS INT S BIOM AI, P67
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   Hiromoto S, 2002, ELECTROCHIM ACTA, V48, P387, DOI 10.1016/S0013-4686(02)00684-9
   Hiromoto S, 2002, MATER TRANS, V43, P261, DOI 10.2320/matertrans.43.261
   Hiromoto S, 2002, CORROS SCI, V44, P955, DOI 10.1016/S0010-938X(01)00110-X
   Hiromoto S, 2001, MATER TRANS, V42, P656, DOI 10.2320/matertrans.42.656
   Hiromoto S, 2001, CORROS SCI, V43, P1767, DOI 10.1016/S0010-938X(00)00168-2
   HOSODA H, 2004, J JPN SOC MECH ENG, V107, P509
   Hosoda H, 2001, T MRS J, V26, P243
   Ikeda M, 2004, MATER TRANS, V45, P1566, DOI 10.2320/matertrans.45.1566
   Ikeda M, 2004, MATER TRANS, V45, P1106, DOI 10.2320/matertrans.45.1106
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Inoue K, 2003, KEY ENG MATER, V240-2, P513, DOI 10.4028/www.scientific.net/KEM.240-242.513
   Kasuga T, 2001, BIOMATERIALS, V22, P577, DOI 10.1016/S0142-9612(00)00216-7
   KAWASAKI H, 2003, P FALL M JPN I MET, P130
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kuroda D, 2002, MATER TRANS, V43, P3100, DOI 10.2320/matertrans.43.3100
   Kuroda D, 2002, MATER TRANS, V43, P3093, DOI 10.2320/matertrans.43.3093
   Li SJ, 2004, WEAR, V257, P869, DOI 10.1016/j.wear.2004.04.001
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Mano T, 2004, MATER TRANS, V45, P1601, DOI 10.2320/matertrans.45.1601
   MARUYAMA N, 1999, J JPN SOC BIOMATER, V17, P172
   Mizumoto T, 2002, MATER TRANS, V43, P3160, DOI 10.2320/matertrans.43.3160
   MRUYAMA N, 2000, J JPN I BIOMATERIALS, V18, P17
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   Nakano T, 2004, MATER SCI FORUM, V449-4, P1289, DOI 10.4028/www.scientific.net/MSF.449-452.1289
   Nakazawa K, 1999, J JPN I MET, V63, P1600, DOI 10.2320/jinstmet1952.63.12_1600
   Niinomi M, 2005, MATER SCI FORUM, V475-479, P2303, DOI 10.4028/www.scientific.net/MSF.475-479.2303
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   NIINOMI M, 2002, MAT T, V43
   NIINOMI M, 2002, J IRON STEEL I JPN, V88, P553
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   NIINOMI M, IN PRESS MAT SCI ENG
   NIINOMI M, 2002, J IRON STEEL I JPN, V88, P567
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   NINOMI M, 2002, P FAT 2002, V3, P2073
   Nishio K, 2004, MATER TRANS, V45, P1613, DOI 10.2320/matertrans.45.1613
   NITTA K, 2001, STRUCTURAL BIOMATERI
   Ogata Y, 2004, MATER TRANS, V45, P1070, DOI 10.2320/matertrans.45.1070
   Ohtsu N, 2004, MATER TRANS, V45, P1778, DOI 10.2320/matertrans.45.1778
   OKAZAKI M, 2004, MAT JAPAN, V43, P182
   Okazaki Y, 2000, MATER T JIM, V41, P1247, DOI 10.2320/matertrans1989.41.1247
   Okazaki Y, 2004, BIOMATERIALS, V25, P5913, DOI 10.1016/j.biomaterials.2004.01.064
   Okazaki Y, 2002, MATER TRANS, V43, P3134, DOI 10.2320/matertrans.43.3134
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   OKAZAKI Y, 2002, MAT T, V43, P2936
   Okido M, 2002, SOLID STATE IONICS, V151, P47, DOI 10.1016/S0167-2738(02)00603-3
   Okuyama M, 2004, MATER TRANS, V45, P1045, DOI 10.2320/matertrans.45.1045
   OU A, 2003, P ANN M JPN I MET SE, P326
   OZAWA A, 2001, J JPN SOC DENT MAT D, V38, P20
   Sakaguch N, 2004, MATER TRANS, V45, P1113, DOI 10.2320/matertrans.45.1113
   SRRIMANEEPONG V, P 4 AS INT S BIOM AI, P237
   Takahashi S., 2000, J JAPANESE SOC DENT, V19, P162
   Takamura R, 1997, J DENT RES, V76, P1177
   Tamura Y, 2002, MATER TRANS, V43, P3043, DOI 10.2320/matertrans.43.3043
   TOYOSHIMA K, 2003, P ANN M JPN I MET SE, P130
   Ueda K, 2005, MATER SCI FORUM, V475-479, P2333, DOI 10.4028/www.scientific.net/MSF.475-479.2333
   UENISHI K, 2002, MAT T, V43, P3065
   UGGOWITZER PJ, 1997, P ADV POWDER METAL P, V3
   van Dijk K, 1998, J BIOMED MATER RES, V41, P624, DOI 10.1002/(SICI)1097-4636(19980915)41:4<624::AID-JBM15>3.0.CO;2-E
   Yamamoto A, 2004, MAT SCI ENG C-BIO S, V24, P737, DOI 10.1016/j.msec.2004.08.017
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yamamoto A, 2004, J BIOMED MATER RES A, V68A, P244, DOI 10.1002/jbm.a.20020
   Yamamoto A, 2002, J BIOMED MATER RES, V59, P176, DOI 10.1002/jbm.1231
   YAMAMOTO A, 1995, P 4 JPN INT SAMPE S, P638
   YONEYAMA T, P 4 AS INT S BIOM AI, P241
   Yoshinari M, 2002, METALL MATER TRANS A, V33, P511, DOI 10.1007/s11661-002-0113-6
   Zhou YL, 2004, MATER TRANS, V45, P1549, DOI 10.2320/matertrans.45.1549
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
   ZHOU YL, 2003, P ATEM 03
NR 87
TC 39
Z9 41
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
EI 1543-1851
J9 JOM-US
JI JOM
PD APR
PY 2005
VL 57
IS 4
BP 18
EP 24
DI 10.1007/s11837-005-0076-3
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 914WU
UT WOS:000228259600002
DA 2018-10-20
ER

PT J
AU Fare, S
   Valtulina, V
   Petrini, P
   Alessandrini, E
   Pietrocola, G
   Tanzi, MC
   Speziale, P
   Visai, L
AF Fare, S
   Valtulina, V
   Petrini, P
   Alessandrini, E
   Pietrocola, G
   Tanzi, MC
   Speziale, P
   Visai, L
TI In vitro interaction of human fibroblasts and platelets with a
   shape-memory polyurethane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyurethane; shape memory; cytocompatibility; fibroblasts; platelets;
   extracellular matrix (ECM) proteins
ID OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; POLYCARBONATE URETHANES;
   BIOMEDICAL APPLICATIONS; SOFT-SEGMENT; POLYETHER; PROLIFERATION;
   FIBRONECTIN; STABILITY; INTEGRINS; POLYMERS
AB Physicochernical and mechanical properties, in vitro cytotoxicity, cytocompatibility, and platelet adhesion were investigated on a shape-memory polyether-based polyurethane (MM-5520 SMPu) using the polyether-based Pellethane 2363-80AE (Pell-2363 SPU) as reference. MM5520 SMPu and Pell-2363 SPU showed similar average molecular weights and different surface properties, with a higher hydrophilicity and roughness for the SMPu. By tensile tests and dynamic mechanical analysis, the peculiar characteristics of the MM-5520 SMPu were evidenced: strong temperature-dependent behavior for SMPu compared with SPU, and a high shape recovery. MM-5520 SMPu did not show any cytotoxic effect on the adhesion and proliferation of human skin fibroblasts and gingival fibroblasts, and a good cytocompatibility was observed with both cell types, as demonstrated by cell counting and scanning electron microscopy observations. SMPu compared with SPU showed higher adsorption of extracellular matrix proteins such as fibronectin, fibrinogen, and collagens. Proteins adsorbed onto SMPu significantly enhanced the adhesion and proliferation of human fibroblasts. The interaction of SMPu with platelets was studied with platelet rich plasma. Fewer platelets adhered to the SMPu, with minor morphological variations than onto the SPU. The cytocompatibility and hemocompatibility of MM-5520 SMPu combined with its unique properties such as change in shape or in stiffness, depending on practical requirements, make this shape-memory material potentially advantageous for biomedical applications. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Pavia, Dept Biochem, I-27100 Pavia, Italy.
   Politecn Milan, Dept Bioengn, Biomat Lab, I-20133 Milan, Italy.
RP Visai, L (reprint author), Univ Pavia, Dept Biochem, Via Taramelli 3-B, I-27100 Pavia, Italy.
EM lvisai@unipv.it
RI Fare', Silvia/F-6484-2013; Tanzi, Maria Cristina/I-4620-2013; Petrini,
   Paola/A-3150-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633; Petrini,
   Paola/0000-0002-5081-5254; Fare', Silvia/0000-0002-0303-1131;
   PIETROCOLA, GIAMPIERO/0000-0002-7069-8155
CR Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   AYAD S, 1994, EXTRACELLULAR MATRIX, P104
   FARE S, 2002, ADV MAT BIOMEDICAL A, P133
   FLATAU AB, 2000, ENG STRUCT, V224, P261
   GABEL K, 1991, BIOMATERIALS, V12, P597
   GOODMAN SL, 1984, SEM 1984, V1, P279
   GRAY AJ, 1993, J CELL SCI, V104, P409
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hayashi S, 1992, Patent No. [5145935, US 5,145,935 A]
   Hayashi S., 1993, INT PROGR URETHANES, V6, P90
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   Jahangir AR, 2002, J BIOMED MATER RES, V60, P135, DOI 10.1002/jbm.10033
   JAHANGIR AR, 1986, BIOMED MAT RES, V20, P589
   Jeong HM, 2000, POLYMER, V41, P1849, DOI 10.1016/S0032-3861(99)00334-1
   Kim BK, 1998, POLYMER, V39, P2803, DOI 10.1016/S0032-3861(97)00616-2
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   LI F, 1996, J APPL POLYM SCI, V64, P1511
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   Li FK, 1998, POLYMER, V39, P6929, DOI 10.1016/S0032-3861(98)00099-8
   Li Y, 1997, J APPL POLYM SCI, V63, P1173, DOI 10.1002/(SICI)1097-4628(19970228)63:9<1173::AID-APP9>3.0.CO;2-E
   LIPSCOMB P, 1996, APPL SHAPE MEMORY AL
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Monkman GJ, 2000, MECHATRONICS, V10, P489, DOI 10.1016/S0957-4158(99)00068-9
   NA GC, 1986, BIOCHEMISTRY-US, V25, P958, DOI 10.1021/bi00353a003
   OTSUDA K, 1998, SHAPE MEMORY MAT
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   Planck H, 1987, PROGR BIOMEDICAL ENG
   REESE CA, 1981, BIOCHEMISTRY-US, V20, P5443, DOI 10.1021/bi00522a014
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   Tanzi MC, 2000, J BIOMATER APPL, V14, P325, DOI 10.1106/7TJU-H1YA-4NYT-XL84
   TOBUSHI H, 1997, J INTELL MAT SYS AUG, P24
   TUCCI V, 1995, ANTEC 95 - THE PLASTICS CHALLENGER: A REVOLUTION IN EDUCATION, CONFERENCE PROCEEDINGS, VOLS I-III, P2102
   TUSZYNSKI GP, 1990, ANAL BIOCHEM, V184, P184
   van Wachem PB, 2002, BIOMATERIALS, V23, P1401, DOI 10.1016/S0142-9612(01)00174-0
   Visai L, 2002, J BIOMATER APPL, V16, P191, DOI 10.1106/088532802021175
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wang MT, 1998, EUR POLYM J, V34, P1, DOI 10.1016/S0014-3057(97)00082-7
   WARD RS, 1985, MD DI            AUG, P24
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 49
TC 28
Z9 28
U1 2
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2005
VL 73A
IS 1
BP 1
EP 11
DI 10.1002/jbm.a.30193
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 906ZR
UT WOS:000227684500001
PM 15704114
DA 2018-10-20
ER

PT J
AU Day, RM
   Boccaccini, AR
AF Day, RM
   Boccaccini, AR
TI Effect of particulate bioactive glasses on human macrophages and
   monocytes in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bioactive glass; cytokines; inflammation; macrophage
ID TISSUE ENGINEERING APPLICATIONS; OSTEOBLAST-LIKE CELLS;
   TUMOR-NECROSIS-FACTOR; MECHANICAL-PROPERTIES; MOLECULAR-MECHANISMS;
   BIOMEDICAL MATERIALS; COMPOSITES; BIOLOGY; SYSTEM; ZINC
AB Bioactive glasses, originally developed to promote tissue adhesion, are finding an increasing array of biomedical applications. The aim of the current study was to assess the ability of silicate- and zinc phosphate-based bioactive glasses to modulate the secretion of cytokines from activated human macrophages and monocytes. Human macrophages and monocytes were isolated and cultured on surfaces coated with a range of quantities of the bioactive glasses. Nontoxic concentrations of the glasses were selected and assessed further for their ability to modulate the secretion of tumor necrosis factor (TNF)-alpha, interleukin (IL)-10 and -6, in the presence or absence of the stimulant lipopolysaccharide. 45S5 glass produced a significant reduction to the amount of TNF-alpha (p < 0.05) and IL-6 (p < 0.01) secreted by stimulated cells compared with cells stimulated in the absence of bioactive glass. A significant reduction in IL-6 secretion was also observed with the other silicate- and zinc phosphate-based glasses tested. IL-10 secretion was increased (but not significantly) in presence of all glasses tested. TNF-alpha and IL-6 secretion from stimulated cells was lower in presence of the silicate glasses compared with the zinc phosphate glasses, indicating that this system of bioactive glass might be of clinical use in conditions associated with inflammation. (c) 2005 Wiley Periodicals, Inc.
C1 Univ London Kings Coll, Burdett Inst Gastrointestinal Nursing, Biomat & Tissue Engn Grp, Harrow HA1 3UJ, Middx, England.
   St Marks Hosp, Harrow HA1 3UJ, Middx, England.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   Univ London Imperial Coll Sci Technol & Med, Ctr Tissue Engn & Regenerat Med, London SW7 2BP, England.
RP Day, RM (reprint author), Univ London Kings Coll, Burdett Inst Gastrointestinal Nursing, Biomat & Tissue Engn Grp, Watford Rd, Harrow HA1 3UJ, Middx, England.
EM richard.day@kcl.ac.uk
RI Day, Richard/C-5725-2009; Boccaccini, Aldo/C-7905-2013
CR Ahmed I, 2004, BIOMATERIALS, V25, P491, DOI 10.1016/S0142-9612(03)00546-5
   Bendall SP, 1998, J BIOMED MATER RES, V41, P392, DOI 10.1002/(SICI)1097-4636(19980905)41:3<392::AID-JBM8>3.0.CO;2-7
   BENNETT S, 1992, J IMMUNOL METHODS, V153, P201, DOI 10.1016/0022-1759(92)90323-L
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Bosetti M, 2002, J BIOMED MATER RES, V60, P79, DOI 10.1002/jbm.1282
   Braat H, 2003, EXPERT OPIN BIOL TH, V3, P725, DOI 10.1517/14712598.3.5.725
   DALLMAN M, 2000, HAEMATOPOIETIC LYMPH, P123
   DAY R, 2004, IN PRESS ASSESSMENT
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Falchuk KH, 1998, MOL CELL BIOCHEM, V188, P41, DOI 10.1023/A:1006808119862
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003
   Hashimoto SI, 2003, SCAND J INFECT DIS, V35, P619, DOI 10.1080/00365540310015926
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8
   Ito Hiroaki, 2003, Current Drug Targets - Inflammation and Allergy, V2, P125, DOI 10.2174/1568010033484296
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Kamimura D, 2003, Rev Physiol Biochem Pharmacol, V149, P1
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Rectenwald JE, 2002, SHOCK, V17, P135, DOI 10.1097/00024382-200202000-00009
   Riches DWH, 1996, IMMUNOBIOLOGY, V195, P477, DOI 10.1016/S0171-2985(96)80017-9
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Schrooten J, 2000, BIOMATERIALS, V21, P1461, DOI 10.1016/S0142-9612(00)00027-2
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   VILCEK J, 1991, J BIOL CHEM, V266, P7313
   Wellinghausen N, 1998, J LEUKOCYTE BIOL, V64, P571
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yokota S, 2003, CURR OPIN RHEUMATOL, V15, P581, DOI 10.1097/00002281-200309000-00010
   Zanotti S, 2002, EXPERT OPIN INV DRUG, V11, P1061, DOI 10.1517/13543784.11.8.1061
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zoli A, 1998, CLIN RHEUMATOL, V17, P378, DOI 10.1007/BF01450895
NR 37
TC 51
Z9 52
U1 5
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2005
VL 73A
IS 1
BP 73
EP 79
DI 10.1002/jbm.a.30262
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 906ZR
UT WOS:000227684500009
PM 15714504
DA 2018-10-20
ER

PT J
AU Bomati-Miguel, O
   Leconte, Y
   Morales, MP
   Herlin-Boime, N
   Veintemillas-Verdaguer, S
AF Bomati-Miguel, O
   Leconte, Y
   Morales, MP
   Herlin-Boime, N
   Veintemillas-Verdaguer, S
TI Laser pyrolysis preparation of SiO2-coated magnetic nanoparticles for
   biomedical applications
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT Joint European Magnetic Symposia (JEMS 04)
CY SEP 05-10, 2004
CL Dresden, GERMANY
DE composites materials; laser; magnetisation curves; nanoparticles;
   surface; exchange enhancement
AB The encapsulation of magnetic particles into silica has been achieved efficiently in a single and continuous process by laser-induced pyrolysis of ferrocene and TEOS aerosols. This process results in rather homogeneous iron/magnetite particles smaller than 10 nm in diameter surrounded by a SiO2 coating of about 20 nm. Interactions between the metal core and the passivation layer dominates the coercivity at low temperature in these systems. (c) 2004 Elsevier B.V. All rights reserved.
C1 Inst Ciencia Mat Madrid, Madrid 28049, Spain.
   CEA Saclay, CNRS, CEA, URA 2453,SPAM, F-91191 Gif Sur Yvette, France.
RP Veintemillas-Verdaguer, S (reprint author), Inst Ciencia Mat Madrid, Sor Juana Ines Cruz S-N, Madrid 28049, Spain.
EM sabino@icmm.csic.es
RI Bomati Miguel, Oscar/B-5206-2012; Morales Herrero, Maria del
   Puerto/A-4558-2011; Veintemillas, Sabino/A-7276-2012
OI Bomati Miguel, Oscar/0000-0003-4787-6061; Morales Herrero, Maria del
   Puerto/0000-0002-7290-7029; Veintemillas, Sabino/0000-0002-3015-1470
CR Bate G., 1980, FERROMAGNETIC MAT
   BOMATIMIGUEL O, 2002, IEEE T MAGN, V38, P2616
   Carpenter EE, 2001, J MAGN MAGN MATER, V225, P17, DOI 10.1016/S0304-8853(00)01222-1
   GANGOPADHYAY S, 1992, PHYS REV B, V45, P9778, DOI 10.1103/PhysRevB.45.9778
   Kuhn LT, 2002, J PHYS-CONDENS MAT, V14, P13551, DOI 10.1088/0953-8984/14/49/311
   LesliePelecky DL, 1996, CHEM MATER, V8, P1770, DOI 10.1021/cm960077f
   Tartaj P, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.094401
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
NR 8
TC 15
Z9 15
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD APR
PY 2005
VL 290
SI SI
BP 272
EP 275
DI 10.1016/j.jmmm.2004.11.207
PN 1
PG 4
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 922KU
UT WOS:000228837600066
DA 2018-10-20
ER

PT J
AU Kim, JI
   Kim, HY
   Hosoda, H
   Miyazaki, S
AF Kim, JI
   Kim, HY
   Hosoda, H
   Miyazaki, S
TI Shape memory behavior of Ti-22Nb-(0.5-2.0)O(at%) biomedical alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterials; smart material;
   titanium based alloy; titanium-niobium-oxygen; interstitial element
ID MECHANICAL-PROPERTIES; MO ALLOYS
AB In order to develop new biomedical shape memory alloys, mechanical properties and shape memory behavior of Ti-22Nb-(0.5-2.0)O(at%) alloys were investigated by tensile tests at various temperatures and X-ray diffraction measurement. The Ti-Nb-O alloys were fabricated by an arc melting method and then homogenized at 1273 K for 7.2 ks. The ingots were cold-rolled with a reduction up to 98.5% in thickness and solution treated at 1173 K for 1.8 ks. The fracture stress of both as-rolled specimen and Solution treated specimen increased with increasing oxygen content. A fracture stress of 1.37GPa was obtained in the as-rolled Ti-22Nb-2O alloy. The martensitic transformation temperature decreased by 160 K per I at% increase of oxygen content. Superior shape memory effect and superelastic behavior were observed at room temperature in the Ti-22Nb-(0.5-1.5)O alloys. The addition of oxygen stabilized superelastic behavior of Ti-Nb alloys by increasing the critical stress for permanent deformation. The maximum shape recovery strain of 4.0% and the critical stress of 900 MPa for permanent deformation were obtained in the Ti-22Nb-0.5O and Ti-22Nb-1.5O alloys, respectively.
C1 Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
   Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678
CR ANNAKA S, 2004 FALL M JAP I ME, P333
   Baker C., 1971, Metal Science Journal, V5, P92
   DEURIG TW, 1982, ACTA METALL, V30, P2161
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2001, T MRS J, V26, P243
   HOSODA H, 2003, MATER SCI FORUM, V425, P3121
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   KIM HY, 2004 SPR M JAP I MET, P327
   KIM JI, 2003 FALL M JAP I ME, P149
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   MIYAZAKI T, 2004 FALL M JAP I ME, P466
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   OHMATSU Y, 2003 SPR M JAP I MET, P144
   OSHIKA N, 2004 FALL M JAP I ME, P330
   OSHIKA N, 2003 FALL M JAP I ME, P149
   OSHIKA N, UNPUB
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
   YONEZAWA M, UNPUB
NR 22
TC 133
Z9 139
U1 1
U2 34
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2005
VL 46
IS 4
BP 852
EP 857
DI 10.2320/matertrans.46.852
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 933CP
UT WOS:000229601900017
OA Bronze
DA 2018-10-20
ER

PT J
AU Mills, CA
   Escarre, J
   Engel, E
   Martinez, E
   Errachid, A
   Bertomeu, J
   Andreu, J
   Planell, JA
   Samitier, J
AF Mills, CA
   Escarre, J
   Engel, E
   Martinez, E
   Errachid, A
   Bertomeu, J
   Andreu, J
   Planell, JA
   Samitier, J
TI Micro- and nanostructuring of poly(ethylene-2,6-naphthalate) surfaces,
   for biomedical applications, using polymer replication techniques
SO NANOTECHNOLOGY
LA English
DT Article
ID NANOIMPRINT LITHOGRAPHY; ADHESION
AB Here we investigate the formation of superficial micro- and nanostructures in poly(ethylene-2,6-naphthalate) (PEN), with a view to their use in biomedical device applications, and compare its performance with a polymer commonly used for the fabrication of these devices, poly(methyl methacrylate) (PMMA). The PEN is found to replicate both micro- and nanostructures in its surface, albeit requiring more forceful replication conditions than PMMA, producing a slight increase in surface hydrophilicity. This ability to form micro/nanostructures, allied to biocompatibility and good optical transparency, suggests that PEN could be a useful material for production of, or for incorporation into, transparent devices for biomedical applications. Such devices will be able to be autoclaved, due to the polymer's high temperature stability, and will be useful for applications where forceful experimental conditions are required, due to a superior chemical resistance over PMMA.
C1 CREBEC, Lab Nanobioengn, Ctr Reference Bioengn Catalonia, Barcelona 08028, Spain.
   Univ Barcelona, Fac Fis, E-08028 Barcelona, Spain.
   Tech Univ Catalonia, Div Biomat & Biomech, Dept Mat Sci & Met, Ctr Reference Bioengn Catalonia, Barcelona 08028, Spain.
RP Mills, CA (reprint author), CREBEC, Lab Nanobioengn, Ctr Reference Bioengn Catalonia, Parc Cientific Barcelona,C-Josep Samitier 1-5, Barcelona 08028, Spain.
EM cmills@pcb.ub.es
RI Bertomeu, Joan/N-1846-2013; Martinez, Elena/C-6008-2009; Andreu,
   Jordi/I-3543-2014; Engel, Elisabeth/D-4365-2014; MARTINEZ,
   ELENA/F-7572-2014; Mills, Christopher/C-5535-2009
OI Bertomeu, Joan/0000-0003-0903-6192; Andreu, Jordi/0000-0001-9446-8242;
   Engel, Elisabeth/0000-0003-4855-8874; Mills,
   Christopher/0000-0002-2906-4978
CR Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   BESSUEILLE F, 2005, UNPUB BIOSENS BIOELE
   CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851
   Chou SY, 1996, J VAC SCI TECHNOL B, V14, P4129, DOI 10.1116/1.588605
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   de Mello A, 2002, LAB CHIP, V2, p31N, DOI 10.1039/b203828p
   Eaton PJ, 2000, LANGMUIR, V16, P7887, DOI 10.1021/la000159p
   Heidari B, 2000, J VAC SCI TECHNOL B, V18, P3557, DOI 10.1116/1.1326923
   HEKELE M, 2004, J MICROMECH MICROENG, V14, pR1
   Higashioji T, 2003, TRIBOL INT, V36, P437, DOI 10.1016/S0301-679X(02)00232-3
   Jakeways R, 1996, POLYMER, V37, P3761, DOI 10.1016/0032-3861(96)00113-9
   Jaszewski RW, 1998, MICROELECTRON ENG, V42, P575, DOI 10.1016/S0167-9317(98)00135-X
   Jokinen E, 2002, MICROELECTRON RELIAB, V42, P1913, DOI 10.1016/S0026-2714(02)00100-2
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Ouchi I, 2003, NUCL INSTRUM METH B, V199, P270, DOI 10.1016/S0168-583X(02)01586-0
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   Tonelli AE, 2002, POLYMER, V43, P637, DOI 10.1016/S1089-3156(00)00028-3
   Torres CMS, 2003, MAT SCI ENG C-BIO S, V23, P23, DOI 10.1016/S0928-4931(02)00221-7
   Zhu YB, 2004, J BIOMED MATER RES A, V69A, P436, DOI 10.1002/jbm.a.30007
NR 19
TC 22
Z9 23
U1 0
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD APR
PY 2005
VL 16
IS 4
BP 369
EP 375
DI 10.1088/0957-4484/16/4/007
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 923ZX
UT WOS:000228949300016
DA 2018-10-20
ER

PT J
AU Kuzuya, M
   Kondo, S
   Sasai, Y
AF Kuzuya, M
   Kondo, S
   Sasai, Y
TI Recent advances in plasma techniques for biomedical and drug engineering
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Plasma Chemistry
CY JUN, 2003
CL Taormina, ITALY
ID IRRADIATED PHARMACEUTICAL AIDS; ELECTRON-SPIN-RESONANCE; INDUCED SURFACE
   RADICALS; DELIVERY SYSTEM; CONTROLLED-RELEASE; WALL MATERIAL; CELLULOSE
   DERIVATIVES; THEOPHYLLINE; SPECTROCHEMISTRY; IMMOBILIZATION
AB Plasma-induced surface radicals formed on a variety of organic polymers have been studied by electron spin resonance (ESR), making it possible to provide a sound basis for future experimental design of polymer surface processing (i.e., plasma treatment). On the basis of the findings from such studies on the nature of radical formation and radical reactivity, several novel bioapplications in the field of biomedical and drug engineering have been developed. Applications derived from the nature of plasma-induced surface radical formation include the preparation of a reservoir-type drug delivery system (DDS) of sustained and delayed release, and a floating drug delivery system (FDDS) possessing gastric retention capabilities, the combined findings leading to preparation of a novel "patient-tailored DDS" administered under consideration of the fact that the environment (pH and transit time, etc.) in the gastrointestinal (GI) tract varies with each patient. Applications derived from the reactivity of plasma-induced surface radicals include the preparation of composite powders applicable to a matrix-type DDS by making a mechanical application to the surface radical-containing polymer powders with drug powders, plasma-assisted immobilization of oligo-nucleotides (DNA) onto polymer surfaces applicable to constructing a DNA diagnosis system, and basic study of plasma-assisted preparation of a novel functionalized chemo-embolic agent of non-crosslinked hydrogel, vinyl alcohol-sodium acrylate copolymer (PVA-PAANa).
C1 Gifu Pharmaceut Univ, Lab Pharmaceut Phys Chem, Gifu 5025858, Japan.
RP Kuzuya, M (reprint author), Gifu Pharmaceut Univ, Lab Pharmaceut Phys Chem, 5-6-1 Mitahora Higashi, Gifu 5025858, Japan.
CR Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   HORI S, 1996, JPN J INTERVENT RADI, V11, P375
   INABA F, 1996, INTERVENTIONAL RADIO, V11, P108
   ISHIKAWA M, 1993, CHEM PHARM BULL, V41, P1626
   Ishikawa M, 1995, CHEM PHARM BULL, V43, P2215
   Ishikawa M, 1996, CHEM PHARM BULL, V44, P1232
   Ito K, 2001, CHEM PHARM BULL, V49, P1615, DOI 10.1248/cpb.49.1615
   Jiaqi Y, 1996, Nihon Igaku Hoshasen Gakkai Zasshi, V56, P19
   Kondo S, 2003, J PHOTOPOLYM SCI TEC, V16, P71, DOI 10.2494/photopolymer.16.71
   KONDO S, 2000, DDS, V17, P127
   Kuzuya M, 1999, J PHYS CHEM B, V103, P8051, DOI 10.1021/jp984278d
   Kuzuya M., 1997, Plasmas and Polymers, V2, P133, DOI 10.1007/BF02766028
   Kuzuya M, 2002, THIN SOLID FILMS, V407, P144, DOI 10.1016/S0040-6090(02)00029-9
   Kuzuya M, 2002, J PHOTOPOLYM SCI TEC, V15, P331, DOI 10.2494/photopolymer.15.331
   KUZUYA M, 1991, MACROMOLECULES, V24, P6612, DOI 10.1021/ma00025a010
   Kuzuya M., 1997, Plasmas and Polymers, V2, P79, DOI 10.1007/BF02766025
   Kuzuya M, 1995, CHEM PHARM BULL, V43, P2037
   KUZUYA M, 1994, J PHYS CHEM-US, V98, P11301, DOI 10.1021/j100095a011
   KUZUYA M, 1991, J PHYS CHEM-US, V95, P2398, DOI 10.1021/j100159a052
   Kuzuya M, 1996, CHEM PHARM BULL, V44, P192
   Kuzuya M, 2001, CHEM PHARM BULL, V49, P1586, DOI 10.1248/cpb.49.1586
   Kuzuya M, 1998, MACROMOLECULES, V31, P3230, DOI 10.1021/ma970937t
   KUZUYA M, 1993, MACROMOLECULES, V26, P1990, DOI 10.1021/ma00060a030
   KUZUYA M, 1991, DDS, V6, P119
   Kuzuya M., 2001, PLASMAS POLYM, V6, P145
   Kuzuya M., 1999, J PHOTOPOLYM SCI TEC, V12, P75
   Kuzuya M., 2001, J PHOTOPOLYM SCI TEC, V14, P87
   KUZUYA M, 1993, DDS, V8, P149
   KUZUYA M, 1991, DDS, V6, P437
   KUZUYA M, 1996, MOL CRYST LIQ CRYST, V277, P343
   Phimister B, 1999, NAT GENET, V21, P1, DOI 10.1038/4423
   Ramsay G, 1998, NAT BIOTECHNOL, V16, P40, DOI 10.1038/nbt0198-40
   Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7
   YAMAKAWA I, 1993, BIOL PHARM BULL, V16, P182
   Yamauchi Y, 1999, CHEM PHARM BULL, V47, P273
NR 35
TC 7
Z9 7
U1 0
U2 3
PU INT UNION PURE APPLIED CHEMISTRY
PI RES TRIANGLE PK
PA 104 TW ALEXANDER DR, PO BOX 13757, RES TRIANGLE PK, NC 27709-3757 USA
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PD APR
PY 2005
VL 77
IS 4
BP 667
EP 682
DI 10.1351/pac200577040667
PG 16
WC Chemistry, Multidisciplinary
SC Chemistry
GA 925JW
UT WOS:000229050400001
DA 2018-10-20
ER

PT J
AU Martin, T
   Rayne, K
   Kemp, NJ
   Hart, J
   Diller, KR
AF Martin, T
   Rayne, K
   Kemp, NJ
   Hart, J
   Diller, KR
TI Teaching for adaptive expertise in biomedical engineering ethics
SO SCIENCE AND ENGINEERING ETHICS
LA English
DT Article
DE engineering ethics; stem cell research; adaptive expertise;
   instructional methods; ethical decision making; undergraduate
   engineering education
ID STAKEHOLDERS; LESSONS
AB This paper considers an approach to teaching ethics in bioengineering based on the How People Learn (HPL) framework. Curricula based on this framework have been effective in mathematics and science instruction from the kindergarten to the college levels. This framework is well suited to teaching bioengineering ethics because it helps learners develop "adaptive expertise". Adaptive expertise refers to the ability to use knowledge and experience in a domain to learn in unanticipated situations. It differs from routine expertise, which requires using knowledge appropriately to solve routine problems. Adaptive expertise is an important educational objective for bioengineers because the regulations and knowledge base in the discipline are likely to change significantly over the course of their careers. This study compares the performance of undergraduate bioengineering students who learned about ethics for stem cell research using the HPL method of instruction to the performance of students who learned following a standard lecture sequence. Both groups learned the factual material equally well, but the HPL group was more prepared to act adaptively when presented with a novel situation.
C1 Univ Texas, Dept Curriculum & Instruct, Austin, TX 78712 USA.
   Univ Texas, Dept Educ Psychol, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX USA.
RP Martin, T (reprint author), Univ Texas, Dept Curriculum & Instruct, 1 Univ Stn,D5700, Austin, TX 78712 USA.
EM taylormartin@mail.utexas.edu
CR *ADV COMM NAT SCI, 1998, SHAP FUT, V2
   ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369
   Barron BJS, 1998, J LEARN SCI, V7, P271, DOI 10.1207/s15327809jls0703&4_2
   BELL J, 2003, BALTIMORE SUN   1111
   Bransford J. D., 2000, PEOPLE LEARN MIND BR
   BRANSFORD JD, 1989, SIMILARITY AND ANALOGICAL REASONING, P470, DOI 10.1017/CBO9780511529863.022
   BROPHYS S, 2002, P AM SOC ENG ED CD R, V2273
   Chase W. G., 1973, COGNITIVE PSYCHOL, V1, P33
   Cognition and Technology Group at Vanderbilt, 1997, JASP PROJ LESS CURR
   Cognition and Technology Group at Vanderbilt University, 1990, ED RES, V19, P2, DOI DOI 10.3102/0013189X019006002
   COLLINS J, 2002, P AM SOC ENG ED CD R, V2164
   DAVIS M, 2003, TEACHING ETHICS ENG
   Fisher F. T., 2001, P 2001 AM SOC ENG ED
   Freeman R. E, 1984, STRATEGIC MANAGEMENT
   GICK ML, 1983, COGNITIVE PSYCHOL, V1, P1
   Harris TR, 2002, ANNU REV BIOMED ENG, V4, P29, DOI 10.1146/annurev.bioeng.4.091701.125502
   Harrison JS, 1999, ACAD MANAGE J, V42, P479, DOI 10.2307/256971
   Hatano G., 1986, CHILD DEV ED JAPAN, P262, DOI DOI 10.1002/CCD.10470
   Hatano G., 2003, ED RES, V32, P26, DOI DOI 10.3102/0013189X032008026
   Hatano Giyoo, 1999, INT J EDUC RES, V31, P645, DOI DOI 10.1016/S0883-0355(99)00029-4
   HAYS WL, 1994, STATISTICS
   Herkert J. R., 2000, European Journal of Engineering Education, V25, P303, DOI 10.1080/03043790050200340
   LAVE J, 1991, SITUATED LEARNING
   Mongoven AM, 2003, BIOETHICS, V17, P319, DOI 10.1111/1467-8519.00348
   PALIWODA J, 2002, BEHAV HLTH MANAGEMEN, V22, P44
   PANDY MG, 2005, UNPUB J ENG ED
   Pintrich PR, 1996, MOTIVATION ED THEORY
   SADLER DR, 1989, INSTR SCI, V18, P119, DOI 10.1007/BF00117714
   Scaife M, 1996, INT J HUM-COMPUT ST, V45, P185, DOI 10.1006/ijhc.1996.0048
   Schwartz DL, 2004, COGNITION INSTRUCT, V22, P129, DOI 10.1207/s1532690xci2202_1
   Schwartz DL, 1999, ETR&D-EDUC TECH RES, V47, P39, DOI 10.1007/BF02299464
   Schwartz DL, 1998, COGNITION INSTRUCT, V16, P475, DOI 10.1207/s1532690xci1604_4
   SCHWARTZ DL, 2005, UNPUB TRANSFER
   *U TEX AUST ETH GR, 2005, ETH LEARN MOD
   VYE N, 1998, METACOGNITION ED THE
   Weiss J., 2003, BUSINESS ETHICS STAK
   Williams S. M., 1992, J LEARN SCI, V2, P367, DOI DOI 10.1207/S15327809JLS0204_2
NR 37
TC 35
Z9 35
U1 0
U2 16
PU OPRAGEN PUBLICATIONS
PI GUILDFORD
PA PO BOX 54, GUILDFORD GU1 2YF, SURREY, ENGLAND
SN 1353-3452
J9 SCI ENG ETHICS
JI Sci. Eng. Ethics
PD APR
PY 2005
VL 11
IS 2
BP 257
EP 276
DI 10.1007/s11948-005-0045-9
PG 20
WC Ethics; Engineering, Multidisciplinary; History & Philosophy Of Science;
   Multidisciplinary Sciences; Philosophy
SC Social Sciences - Other Topics; Engineering; History & Philosophy of
   Science; Science & Technology - Other Topics; Philosophy
GA 927PL
UT WOS:000229205900010
PM 15915863
DA 2018-10-20
ER

PT J
AU Amer, MS
   El-Ashry, MA
   Dosser, LR
   Hix, KE
   Maguire, JF
   Irwin, B
AF Amer, MS
   El-Ashry, MA
   Dosser, LR
   Hix, KE
   Maguire, JF
   Irwin, B
TI Femtosecond versus nanosecond laser machining: comparison of induced
   stresses and structural changes in silicon wafers
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Raman spectroscopy; laser machining; micromachining; silicon
   amorphization; induced stress; femtosecond laser machining
ID MICRO-RAMAN SPECTROSCOPY; PHASE-TRANSFORMATIONS; MECHANICAL-STRESS;
   SEMICONDUCTORS; DEVICES; MATTER
AB Laser micromachining has proven to be a very successful tool for precision machining and microfabrication with applications in microelectronics, MEMS, medical device, aerospace, biomedical, and defense applications. Femtosecond (FS) laser micromachining is usually thought to be of minimal heat-affected zone (HAZ) local to the micromachined feature. The assumption of reduced HAZ is attributed to the absence of direct coupling of the laser energy into the thermal modes of the material during irradiation. However, a substantial HAZ is thought to exist when machining with lasers having pulse durations in the nanosecond (NS) regime. In this paper, we compare the results of micromachining a single crystal silicon wafer using a 150-femtosecond and a 30-nanosecond lasers.
   Induced stress and amorphization of the silicon single crystal were monitored using micro-Raman spectroscopy as a function of the fluence and pulse duration of the incident laser. The onset of average induced stress occurs at lower fluence when machining with the femtosecond pulse laser. Induced stresses were found to maximize at fluence of 44 J cm(-2) and 8 J cm(-2) for nanosecond and femtosecond pulsed lasers, respectively. In both laser pulse regimes, a maximum induced stress is observed at which point the induced stress begins to decrease as the fluence is increased. The maximum induced stress was comparable at 2.0 GPa and 1.5 GPa for the two lasers. For the nanosecond pulse laser, the induced amorphization reached a plateau of approximately 20% for fluence exceeding 22 J cm(-2). For the femtosecond pulse laser, however, induced amorphization was approximately 17% independent of the laser fluence within the experimental range. These two values can be considered nominally the same within experimental error. For femtosecond laser machining, some effect of the laser polarization on the amount of induced stress and amorphization was also observed. (C) 2004 Elsevier B.V. All rights reserved.
C1 Wright State Univ, Dept Mech & Mat Engn, Dayton, OH 45435 USA.
   Mound Laser & Photon Ctr Inc, Miamisburg, OH 45342 USA.
   Sciperio Inc, Stillwater, OK 74075 USA.
RP Amer, MS (reprint author), Wright State Univ, Dept Mech & Mat Engn, 3640 Colonel Glenn HWY, Dayton, OH 45435 USA.
EM maher.amer@wright.edu
RI Amer, Maher/A-1802-2009
CR AHN SJ, 1999, APPL PHYS A, V69, P527
   Amer MS, 2002, APPL SURF SCI, V187, P291, DOI 10.1016/S0169-4332(01)01043-1
   AMIMOTO ST, SPIE, V3512, P123
   Bergmann HW, 1996, APPL SURF SCI, V96-8, P287, DOI 10.1016/0169-4332(95)00432-7
   Dauer S, 1999, SENSOR ACTUAT A-PHYS, V76, P381, DOI 10.1016/S0924-4247(99)00029-1
   DeWolf I, 1996, MICROELECTRON RELIAB, V36, P1751, DOI 10.1016/0026-2714(96)00190-4
   DEWOLF I, 1993, J APPL PHYS, V74, P4490, DOI 10.1063/1.354365
   Domnich V, 2000, APPL PHYS LETT, V76, P2214, DOI 10.1063/1.126300
   Gogotsi Y, 1999, SEMICOND SCI TECH, V14, P936, DOI 10.1088/0268-1242/14/10/310
   *ICALEO, 2000, LAS MICR SESS OCT 2
   Jandeleit J, 1998, APPL SURF SCI, V127, P885, DOI 10.1016/S0169-4332(97)00762-9
   Kimura Y, 1997, APPL SURF SCI, V117, P790, DOI 10.1016/S0169-4332(97)80184-5
   Li J, 2001, J MICROMECH MICROENG, V11, P38, DOI 10.1088/0960-1317/11/1/307
   MARINOV M, 1997, PHYS REV B, V55, P2939
   Marowsky G, 1998, APPL PHYS B-LASERS O, V66, P475, DOI 10.1007/s003400050422
   READY JF, 1997, IND APPL LASERS, P394
   Simon P, 1996, APPL PHYS A-MATER, V63, P505, DOI 10.1007/BF01571681
   Xu W, 1998, J PHYS-CONDENS MAT, V10, P6105, DOI 10.1088/0953-8984/10/27/011
NR 18
TC 91
Z9 95
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 31
PY 2005
VL 242
IS 1-2
BP 162
EP 167
DI 10.1016/j.apsusc.2004.08.029
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 904OU
UT WOS:000227508400020
DA 2018-10-20
ER

PT J
AU Sinani, VA
   Gheith, MK
   Yaroslavov, AA
   Rakhnyanskaya, AA
   Sun, K
   Mamedov, AA
   Wicksted, JP
   Kotov, NA
AF Sinani, VA
   Gheith, MK
   Yaroslavov, AA
   Rakhnyanskaya, AA
   Sun, K
   Mamedov, AA
   Wicksted, JP
   Kotov, NA
TI Aqueous dispersions of single-wall and multiwall carbon nanotubes with
   designed amphiphilic polycations
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID FIELD-EFFECT TRANSISTORS; NONCOVALENT FUNCTIONALIZATION;
   ELECTRONIC-STRUCTURE; OPTICAL-ABSORPTION; ORGANIC POLYMER; PURIFICATION;
   WATER; SOLUBILIZATION; COMPOSITES; FILMS
AB Poor solubility of single-walled and multiwalled carbon nanotubes (NTs) in water and organic solvents presents a considerable challenge for their purification and applications. Macromolecules can be convenient solubilizing agents for NTs and a structural element of composite materials for them. Several block copolymers with different chemical functionalities of the side groups were tested for the preparation of aqueous NT dispersions. Poly(N-cetyl-4-vinylpyridinium bromide-co-N-ethyl-4-vinylpyridinium bromideco-4-vinylpyridine) was found to form exceptionally stable NT dispersions. It is suggested that the efficiency of macromolecular dispersion agents for NT solubilization correlates with the topological and electronic similarity of polymer-NT and NT-NT interactions in the nanotube bundles. Raman spectroscopy and atomic force and transmission electron microcopies data indicate that the polycations are wrapped around NTs forming a uniform coating 1.0-1.5 nm thick. The ability to wind around the NT originates in the hydrophobic attraction of the polymer backbone to the graphene surface and topological matching. Tetraalkylammonium functional groups in the side chains of the macromolecule create a cloud of positive charge around NTs, which makes them hydrophilic. The prepared dispersions could facilitate the processing of the nanotubes into composites with high nanotube loading for electronic materials and sensing. Positive charge on their surface is particularly important for biological and biomedical applications because it strengthens interactions with negatively charged cell membranes. A high degree of spontaneous bundle separation afforded by the polymer coating can also be beneficial for NT sorting.
C1 Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119899, Russia.
   Oklahoma State Univ, Dept Phys, Stillwater, OK 74078 USA.
   Univ Michigan, Electron Microbeam Anal Lab, Ann Arbor, MI 48109 USA.
   Nomad Inc, Stillwater, OK 74074 USA.
RP Kotov, NA (reprint author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
EM kotov@umich.edu
RI 李, 府中/H-4357-2011
OI Kotov, Nicholas/0000-0002-6864-5804
CR Abatemarco T, 1999, J PHYS CHEM B, V103, P3534, DOI 10.1021/jp984020n
   Ago H, 1999, SYNTHETIC MET, V103, P2494, DOI 10.1016/S0379-6779(98)01062-5
   Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Alvarez L, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.153401
   Alvaro M, 2002, CHEM COMMUN, P3004, DOI 10.1039/b209225p
   Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s
   Bahr JL, 2001, CHEM MATER, V13, P3823, DOI 10.1021/cm0109903
   Bandow S, 1997, J PHYS CHEM B, V101, P8839, DOI 10.1021/jp972026r
   Banerjee S, 2002, J PHYS CHEM B, V106, P12144, DOI 10.1021/jp026304k
   Banerjee S, 2002, J AM CHEM SOC, V124, P8940, DOI 10.1021/ja026487o
   Brown SDM, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.073403
   Carrillo A, 2003, NANO LETT, V3, P1437, DOI 10.1021/nl034376x
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   CARUSO F, 2001, MRS BULL, V26, P992
   Chen J, 2001, J PHYS CHEM B, V105, P2525, DOI 10.1021/jp002596i
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Dalton AB, 2000, J PHYS CHEM B, V104, P10012, DOI 10.1021/jp002857o
   Dalton AB, 2001, SYNTHETIC MET, V121, P1217, DOI 10.1016/S0379-6779(00)00861-4
   Dalton AB, 1999, SYNTHETIC MET, V102, P1176, DOI 10.1016/S0379-6779(98)01067-4
   Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x
   Dresselhaus M.S., 1996, SCI FULLERENES CARBO, P965
   Dresselhaus MS, 2002, CARBON, V40, P2043, DOI 10.1016/S0008-6223(02)00066-0
   Dyke CA, 2003, J AM CHEM SOC, V125, P1156, DOI 10.1021/ja0289806
   Dyke CA, 2003, NANO LETT, V3, P1215, DOI 10.1021/nl034537x
   FUOSS RM, 1948, J POLYM SCI, V3, P246, DOI 10.1002/pol.1948.120030211
   Gartstein YN, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.045503
   Georgakilas V, 2002, CHEM COMMUN, P3050, DOI 10.1039/b209843a
   GUAN W, 2002, HUAZHONG KEJI DAXUE, V30, P114
   Guo YZ, 2002, PHYSICA B, V323, P235, DOI 10.1016/S0921-4526(02)00975-4
   Hamon MA, 1999, ADV MATER, V11, P834, DOI 10.1002/(SICI)1521-4095(199907)11:10<834::AID-ADMA834>3.0.CO;2-R
   HIURA H, 1995, ADV MATER, V7, P275, DOI 10.1002/adma.19950070304
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u
   Jacquemin R, 2000, SYNTHETIC MET, V115, P283, DOI 10.1016/S0379-6779(00)00318-0
   Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797
   Jin ZX, 2003, SYNTHETIC MET, V135, P735, DOI 10.1016/S0379-6779(02)00824-X
   JISHI RA, 1993, CHEM PHYS LETT, V209, P77, DOI 10.1016/0009-2614(93)87205-H
   Kim OK, 2003, J AM CHEM SOC, V125, P4426, DOI 10.1021/ja029233b
   KIRSH YE, 1970, VYSOKOMOL SOEDIN A, V12, P186
   Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622
   Krstic V, 1998, CHEM MATER, V10, P2338, DOI 10.1021/cm980207f
   Kukovecz A, 2002, EUR PHYS J B, V28, P223, DOI 10.1140/epjb/e2002-00224-8
   Kuzmany H, 2001, EUR PHYS J B, V22, P307, DOI 10.1007/s100510170108
   Li B, 2001, CHEM LETT, P598, DOI 10.1246/cl.2001.598
   Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253
   Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747
   Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477
   Maser WK, 2003, MAT SCI ENG C-BIO S, V23, P87, DOI 10.1016/S0928-4931(02)00235-7
   Matthews MJ, 1999, PHYS REV B, V59, pR6585, DOI 10.1103/PhysRevB.59.R6585
   Mickelson ET, 1999, J PHYS CHEM B, V103, P4318, DOI 10.1021/jp9845524
   Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j
   Nativ-Roth E, 2002, J POLYM ENG, V22, P353
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   Pimenta MA, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.041401
   Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187
   Rouse JH, 2003, NANO LETT, V3, P59, DOI 10.1021/nl025780j
   Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94
   Saito R, 1998, PHYS REV B, V57, P4145, DOI 10.1103/PhysRevB.57.4145
   SAITO R, 1998, PHYS CARBON NANOTUBE, P200
   Sancho MPL, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.165419
   Sauvajol JL, 2002, CARBON, V40, P1697, DOI 10.1016/S0008-6223(02)00010-6
   SCHREUDERGIBSON H, 2000, P ELECT SOC, V2000, P210
   Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A
   Star A, 2001, ANGEW CHEM INT EDIT, V40, P1721, DOI 10.1002/1521-3773(20010504)40:9<1721::AID-ANIE17210>3.0.CO;2-F
   Stephan C, 2000, SYNTHETIC MET, V108, P139, DOI 10.1016/S0379-6779(99)00259-3
   Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691
   Strano MS, 2003, J NANOSCI NANOTECHNO, V3, P81, DOI 10.1166/jnn.2003.194
   Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0
   Tans SJ, 1998, NATURE, V393, P49
   VANHOVE L, 1953, PHYS REV, V89, P1189, DOI 10.1103/PhysRev.89.1189
   Venema LC, 1999, SCIENCE, V283, P52, DOI 10.1126/science.283.5398.52
   Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139
   Yaroslavov AA, 1999, COLLOID SURFACE B, V16, P29, DOI 10.1016/S0927-7765(99)00059-4
   Yudasaka M, 2000, APPL PHYS A-MATER, V71, P449, DOI 10.1007/s003390000688
   Zengin H, 2002, ADV MATER, V14, P1480, DOI 10.1002/1521-4095(20021016)14:20<1480::AID-ADMA1480>3.0.CO;2-O
   Zhang J, 2003, NANO LETT, V3, P403, DOI 10.1021/nl025952c
   Zhang NY, 2003, SMART MATER STRUCT, V12, P260, DOI 10.1088/0964-1726/12/2/314
   Zhang XF, 2003, NANO LETT, V3, P1285, DOI 10.1021/nl034336t
   Zhao B, 2001, J AM CHEM SOC, V123, P11673, DOI 10.1021/ja010488j
   Zhao W, 2002, J AM CHEM SOC, V124, P12418, DOI 10.1021/ja027861n
NR 80
TC 298
Z9 303
U1 4
U2 143
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAR 16
PY 2005
VL 127
IS 10
BP 3463
EP 3472
DI 10.1021/ja045670+
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 906GD
UT WOS:000227627800053
PM 15755166
DA 2018-10-20
ER

PT J
AU Kang, YL
   Zyryanov, GV
   Rudkevich, DM
AF Kang, YL
   Zyryanov, GV
   Rudkevich, DM
TI Towards supramolecular fixation of NOx gases: Encapsulated reagents for
   nitrosation
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE calixarenes; molecular recognition; nitrogen oxides; structure-activity
   relationships; supramolecular chemistry
ID ALKYL-N-NITROSOAMIDES; NITRIC-OXIDE; NITROGEN-DIOXIDE; MOLECULAR
   ENCAPSULATION; RECOVERABLE CATALYSTS; DINITROGEN TETROXIDE; SOLUBLE
   POLYMERS; AMIDES; CHEMISTRY; CONVERSION
AB the use of simple calix[4]arenes for chemical conversion of NO2/ N2O4 gases is demonstrated in solution and in the solid state. Upon reacting with these gases, calixarenes 1 encapsulate nitrosonium (NO+) cations within their cavities with the formation of stable calixarene-NO+ complexes 2. These complexes act as encapsulated nitrosating reagents; cavity effects control their reactivity and selectivity. Complexes 2 were effectively used for nitrosation of secondary amides 5, including chiral derivatives. Unique size-shape selectivity was observed, allowing for exclusive nitrosation of less crowded N-Me amides 5a-e (up to 95% yields). Bulkier N-Alk (Alk > Me) substrates 5 did not react due to the hindered approach to the encapsulated NO+ reagents. Robust, silica gel based calixarene material 3 was prepared, which reversibly traps NO2/ N2O4 with the formation of NO'-storing silica gel 4. With material 4, similar size-shape selectivity was observed for nitrosation. The N-Me-N-nitroso derivatives 6d,e were obtained with similar to 30% yields, while bulkier amides were nitrosated with much lower yields (< 8%). Enantiomerically pure encapsulating reagent 2d was tested for nitrosation of racemic amide 5t, showing modest but reproducible stereoselectivity and similar to 15% ee. Given high affinity to NO+ species, which can be generated by a number of NOx gases, these supramolecular reagents and materials may be useful for NOx entrapment and separation in the environment and biomedical areas.
C1 Univ Texas, Dept Chem & Biochem, Arlington, TX 76019 USA.
RP Rudkevich, DM (reprint author), Univ Texas, Dept Chem & Biochem, Arlington, TX 76019 USA.
EM rudkevich@uta.edu
CR ADDISON CC, 1980, CHEM REV, V80, P21, DOI 10.1021/cr60323a002
   ANDERSON JE, 1991, J ORG CHEM, V56, P1731, DOI 10.1021/jo00005a016
   Antonovic DG, 1997, J MOL STRUCT, V408, P421, DOI 10.1016/S0022-2860(96)09743-8
   Aronica LA, 2001, EUR J ORG CHEM, P4321
   AUERBACH J, 1976, J ORG CHEM, V41, P725, DOI 10.1021/jo00866a038
   BEDENBAUGH AO, 1979, J ORG CHEM, V44, P4703, DOI 10.1021/jo00393a051
   BERENGUER R, 1989, SYNTHESIS-STUTTGART, P305
   Bergbreiter DE, 2002, CHEM REV, V102, P3345, DOI 10.1021/cr010343v
   BIANCHI F, 2003, NEW J CHEM, P502
   Birney DM, 2004, ORG LETT, V6, P851, DOI 10.1021/ol049867i
   Borodkin GI, 2001, RUSS CHEM REV, V70, P211
   BOSCH E, 1994, J ORG CHEM, V59, P3314, DOI 10.1021/jo00091a018
   BUTLER AR, 1993, CHEM SOC REV, V22, P233, DOI 10.1039/cs9932200233
   CASNATI A, 1995, J AM CHEM SOC, V117, P2767, DOI 10.1021/ja00115a012
   CHALLIS BC, 1984, J CHEM SOC CHEM COMM, P1050, DOI 10.1039/c39840001050
   Chen J, 2002, NATURE, V415, P385, DOI 10.1038/415385b
   Cram D. J., 1994, CONTAINER MOL THEIR
   D'Alelio GF, 1937, J AM CHEM SOC, V59, P109, DOI 10.1021/ja01280a025
   Darbeau RW, 2002, J ORG CHEM, V67, P2942, DOI 10.1021/jo011002k
   Darbeau RW, 2001, J ORG CHEM, V66, P5027, DOI 10.1021/jo001741l
   Darbeau RW, 2000, J ORG CHEM, V65, P1121, DOI 10.1021/jo9916378
   Dickerson TJ, 2002, CHEM REV, V102, P3325, DOI 10.1021/cr010335e
   Espey MG, 2001, J BIOL CHEM, V276, P30085, DOI 10.1074/jbc.M101723200
   EVANS DA, 1997, TETRAHEDRON LETT, V38, P54353
   Fujita M, 2001, CHEM COMMUN, P509, DOI 10.1039/b008684n
   GARCIA J, 1984, TETRAHEDRON, V40, P3121, DOI 10.1016/S0040-4020(01)82437-6
   GARCIA J, 1984, J ORG CHEM, V49, P3322, DOI 10.1021/jo00192a014
   GARCIA J, 1982, TETRAHEDRON LETT, V23, P1127, DOI 10.1016/S0040-4039(00)87040-9
   Glatzhofer DT, 2002, ORG LETT, V4, P2349, DOI 10.1021/ol026051d
   Granik VG, 2002, RUSS CHEM B+, V51, P1375, DOI 10.1023/A:1020994402835
   GUTSCHE CD, 1990, ORG SYNTH, V68, P234
   Hof F, 2002, ANGEW CHEM INT EDIT, V41, P1488, DOI 10.1002/1521-3773(20020503)41:9<1488::AID-ANIE1488>3.0.CO;2-G
   Hof F., 2002, ANGEW CHEM, V114, P1556
   Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u
   HOOD DB, 1993, ARCH BIOCHEM BIOPHYS, V304, P17, DOI 10.1006/abbi.1993.1316
   HUISGEN R, 1956, LIEBIGS ANN CHEM, V599, P161
   IKEDA A, 1994, J CHEM SOC CHEM COMM, P2375, DOI 10.1039/c39940002375
   IKEDA A, 1994, TETRAHEDRON LETT, V35, P8417, DOI 10.1016/S0040-4039(00)74422-4
   Ikeda A, 1997, J ORG CHEM, V62, P3568, DOI 10.1021/jo962040k
   IKEDA A, 1994, J AM CHEM SOC, V116, P3102, DOI 10.1021/ja00086a045
   Ito H, 2000, CHEM LETT, P598, DOI 10.1246/cl.2000.598
   Itoh T, 1997, TETRAHEDRON LETT, V38, P5017, DOI 10.1016/S0040-4039(97)01074-5
   Jasat A, 1999, CHEM REV, V99, P931, DOI 10.1021/cr960048o
   JOHNSTONE RAW, 1979, TETRAHEDRON, V35, P2169, DOI 10.1016/0040-4020(79)87035-0
   KAKUDA Y, 1980, J AGR FOOD CHEM, V28, P584, DOI 10.1021/jf60229a036
   Kang JM, 1998, J AM CHEM SOC, V120, P7389, DOI 10.1021/ja980927n
   Kang YL, 2004, TETRAHEDRON, V60, P11219, DOI 10.1016/j.tet.2004.08.063
   KARANEWSKY DS, 1991, J ORG CHEM, V56, P3744, DOI 10.1021/jo00011a064
   Kavallieratos K, 2000, ANAL CHEM, V72, P5258, DOI 10.1021/ac0005971
   KELLY TR, 1989, J AM CHEM SOC, V111, P4522, DOI 10.1021/ja00194a071
   KELLY TR, 1993, J AM CHEM SOC, V115, P5843, DOI 10.1021/ja00066a070
   KIM YH, 1990, TETRAHEDRON LETT, V31, P3893
   Kirsch M, 2002, BIOL CHEM, V383, P389, DOI 10.1515/BC.2002.043
   Korner SK, 2000, CHEM-EUR J, V6, P187, DOI 10.1002/(SICI)1521-3765(20000103)6:1<187::AID-CHEM187>3.0.CO;2-I
   KRAWCZYK W, 1989, J CHROMATOGR, V463, P297, DOI 10.1016/S0021-9673(01)84484-8
   KUHN LP, 1967, J AM CHEM SOC, V89, P3858, DOI 10.1021/ja00991a030
   LINKE S, 1978, SYNTHESIS-STUTTGART, P303
   Liu CQ, 2004, MACROMOL RAPID COMM, V25, P804, DOI 10.1002/marc.200300277
   McNamara CA, 2002, CHEM REV, V102, P3275, DOI 10.1021/cr0103571
   Megson IL, 2002, EXPERT OPIN INV DRUG, V11, P587
   MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V
   Mogck O, 1996, J CHEM SOC PERK T 1, P1711, DOI 10.1039/p19960001711
   NAUMOV YA, 1974, ZH PRIKL KHIM, V47, P1888
   Nicolaou K. C., 1996, CLASSICS TOTAL SYNTH, P130
   NIKOLAIDES N, 1990, TETRAHEDRON LETT, V31, P1113, DOI 10.1016/S0040-4039(00)88739-0
   NIKOLAIDES N, 1990, TETRAHEDRON LETT, V31, P6009, DOI 10.1016/S0040-4039(00)98015-8
   OLAH GA, 1965, J ORG CHEM, V30, P2386, DOI 10.1021/jo01018a066
   Pariiskii G. B., 2000, RUSS CHEM REV, V69, P985
   POUR PM, 1984, IARC SCI PUBL, V57, P683
   Rathore R, 2000, ANGEW CHEM INT EDIT, V39, P2123, DOI 10.1002/1521-3773(20000616)39:12<2123::AID-ANIE2123>3.0.CO;2-4
   Rathore R., 2000, ANGEW CHEM, V112, P2207
   ROMEA P, 1991, J ORG CHEM, V56, P7038, DOI 10.1021/jo00025a017
   Rudkevich DA, 2002, B CHEM SOC JPN, V75, P393, DOI 10.1246/bcsj.75.393
   Rudkevich DM, 2004, AUST J CHEM, V57, P713, DOI 10.1071/CH04102
   Rudkevich DM, 2004, ANGEW CHEM INT EDIT, V43, P558, DOI 10.1002/anie.200300606
   RUDKEVICH DM, 2004, ANGEW CHEM, V116, P568
   SAAVEDRA JE, 1979, J ORG CHEM, V44, P860, DOI 10.1021/jo01319a046
   SCHWAIER R, 1966, Z VEREBUNGSL, V98, P309, DOI 10.1007/BF00895261
   Sergeeva MV, 2000, BIOTECHNOL LETT, V22, P1419, DOI 10.1023/A:1005621117392
   Stepanov AV, 2003, USP KHIM+, V72, P363
   TEMPE J, 1968, CR ACAD SCI C CHIM, V266, P834
   THATCHER GRJ, 1908, CHEM SOC REV, V27, P331
   TORRA N, 1989, TETRAHEDRON, V45, P863, DOI 10.1016/0040-4020(89)80118-8
   USKOKOVI M, 1970, J AM CHEM SOC, V92, P203, DOI 10.1021/ja00704a036
   Vysotsky M, 2000, ADV SUPR CH, V7, P139
   Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l
   Warmuth R, 2001, EUR J ORG CHEM, P423
   Warmuth R, 2003, J ORG CHEM, V68, P2077, DOI 10.1021/jo026649z
   WEBSTER FX, 1986, TETRAHEDRON LETT, V27, P4941, DOI 10.1016/S0040-4039(00)85102-3
   WHITE EH, 1955, J AM CHEM SOC, V77, P6008, DOI 10.1021/ja01627a063
   WHITE EH, 1955, J AM CHEM SOC, V77, P6014, DOI 10.1021/ja01627a065
   WUDL F, 1971, J AM CHEM SOC, V93, P271, DOI 10.1021/ja00730a058
   YOSHIZAWA M, 2000, ANGEW CHEM INT EDIT, V39, P4119
   YOSHIZAWA M, 2000, ANGEW CHEM, V112, P4285
   YUREV YK, 1959, ZH OBSHCH KHIM+, V29, P2594
   Zyryanov GV, 2004, J AM CHEM SOC, V126, P4264, DOI 10.1021/ja0392869
   Zyryanov GV, 2003, ORG LETT, V5, P1253, DOI 10.1021/ol0342195
   Zyryanov GV, 2003, J AM CHEM SOC, V125, P2997, DOI 10.1021/ja029166l
NR 98
TC 23
Z9 23
U1 0
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD MAR 4
PY 2005
VL 11
IS 6
BP 1924
EP 1932
DI 10.1002/chem.200400939
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 906SK
UT WOS:000227662900024
PM 15674979
DA 2018-10-20
ER

PT J
AU Lynn, AK
   Bonfield, W
AF Lynn, AK
   Bonfield, W
TI A novel method for the simultaneous, titrant-free control of pH and
   calcium phosphate mass yield
SO ACCOUNTS OF CHEMICAL RESEARCH
LA English
DT Review
ID SELF-ORGANIZATION MECHANISM; BONE TISSUE; SUBSTITUTED HYDROXYAPATITE;
   BIOMEDICAL APPLICATIONS; CHITOSAN HYDROGELS; IN-VIVO; COLLAGEN;
   MINERALIZATION; NANOCOMPOSITES; REGENERATION
AB Calcium phosphate (Cap) bioceramics have long been of interest for the unique properties that they exhibit as bone substitute materials. By harnessing the unique bone-bonding capacity of CaP's, biomaterials scientists have made great strides over the past 2 decades to produce novel materials to assist in the treatments of defects caused by trauma, disease, or both. In recent years, however, it has become apparent that the traditional set of techniques used to produce calcium phosphates does not satisfy all of the requirements necessary to meet the challenges of emerging applications. In particular, recent interest in (i) the synthesis of coprecipitated CaP/bioorganic composites and (ii) the investigation of the mechanisms of biomineralization has highlighted the need for new methods to control pH and Cap mass yield.
C1 Univ Cambridge, Cambridge Ctr Med Mat, Dept Mat Sci & Met, Cambridge CB2 1TP, England.
RP Lynn, AK (reprint author), Univ Cambridge, Cambridge Ctr Med Mat, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 1TP, England.
EM akl28@cam.ac.uk
CR BENEBASSATH H, 1994, CELLS MAT, V4, P37
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   BIANCHI E, 1967, J BIOL CHEM, V242, P1361
   BODEN SD, 1995, SPINE S, V20, P113
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   CARTER DR, 1978, CLIN ORTHOP RELAT R, P192
   CHRISTIANSEN DL, 1993, CELL MATER, V3, P177
   Doll B, 2001, CRIT REV EUKAR GENE, V11, P173
   DRIESSENS FCM, 1994, J MATER SCI-MATER M, V5, P164, DOI 10.1007/BF00053338
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Ferreira A, 2003, J CRYST GROWTH, V252, P599, DOI 10.1016/S0022-0248(03)00899-6
   GERHART TN, 1989, J BIOMED MATER RES, V23, P1, DOI 10.1002/jbm.820230102
   Geyer G, 1999, HNO, V47, P77, DOI 10.1007/s001060050363
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hasegawa K, 1998, ARCH ORTHOP TRAUM SU, V117, P175, DOI 10.1007/s004020050223
   Hing KA, 2000, KEY ENG MATER, V192-1, P373
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kikuchi M, 2004, KEY ENG MAT, V254-2, P561, DOI 10.4028/www.scientific.net/KEM.254-256.561
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Kumar RR, 2000, KEY ENG MAT, V192-1, P19
   Lawson AC, 1998, P I MECH ENG H, V212, P413, DOI 10.1243/0954411981534187
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lynn AK, 2004, KEY ENG MATER, V254-2, P593, DOI 10.4028/www.scientific.net/KEM.254-256.593
   Moreira-Gonzalez A, 2003, PLAST RECONSTR SURG, V111, P1808, DOI 10.1097/01.PRS.0000055432.20074.93
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   OVERGAARD S, 2000, ACTA ORTHOP SCAND, V71, pU1
   Rhee SH, 2001, BIOMATERIALS, V22, P2843, DOI 10.1016/S0142-9612(01)00028-X
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   SYLVESTER MF, 1989, THROMB RES, V55, P135, DOI 10.1016/0049-3848(89)90463-5
   YANNAS IV, 1972, J MACROMOL SCI R M C, VC  7, P49, DOI 10.1080/15321797208068160
   Zeng HT, 2000, J BIOMED MATER RES, V50, P248, DOI 10.1002/(SICI)1097-4636(200005)50:2<248::AID-JBM20>3.3.CO;2-9
NR 36
TC 34
Z9 35
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0001-4842
J9 ACCOUNTS CHEM RES
JI Accounts Chem. Res.
PD MAR
PY 2005
VL 38
IS 3
BP 202
EP 207
DI 10.1021/ar040234d
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 907XL
UT WOS:000227751400006
PM 15766239
DA 2018-10-20
ER

PT J
AU Chen, AS
   Taguchi, T
   Okamoto, H
   Danjo, K
   Sakai, K
   Matahira, Y
   Wang, MW
   Miwa, I
AF Chen, AS
   Taguchi, T
   Okamoto, H
   Danjo, K
   Sakai, K
   Matahira, Y
   Wang, MW
   Miwa, I
TI Pharmacokinetics of chitobiose and chitotriose administered
   intravenously or orally to rats
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE chitobiose; chitotriose; pharmacokinetic; chitooligosaccharide
ID CHITOSAN OLIGOSACCHARIDE; OLIGOMER
AB Chitooligosaccharides have attracted much attention as new biomedical materials. The biologic availability of each of these chitooligosaccharides, however, has not yet been studied. In the present study, we found that chitobiose and chitotriose appeared in the blood of rats with maximum plasma concentrations at around 1 h after administration when given orally at a dose of 30 mg/kg. However, chitotetraose and chitopentaose did not appear in the blood when given at a dose of 300 mg/kg. Pharmacokinetic analysis of chitobiose and chitotriose after intravenous administration at 100 mg/kg revealed that both sugars were eliminated from the body following a one-compartment model and that the former relative to the latter was higher for both the total body clearance (224 +/- 43 vs. 155 +/- 26 ml/h/kg) and the distribution volume (107 +/- 15 vs. 65 +/- 9 ml/kg). The absolute oral bioavailability of chitobiose was higher than that of chitotriose at all doses (30, 100, and 300 mg/kg) examined. The first-order absorption rate constants for chitobiose and chitotriose at all doses were less than 1.0 h(-1) and smaller than the elimination rate constants (2.2 +/- 0.3, 2.7 +/- 0.1 h(-1), respectively). The absorption was slow, resulting in flip-flop kinetics. This study indicates that among various chitooligosaccharides, only chitobiose and chitotriose can be appreciably absorbed from the gastrointestinal tract.
C1 Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, Nagoya, Aichi 4688503, Japan.
   Meijo Univ, Fac Pharm, Dept Ind Pharm, Nagoya, Aichi 4688503, Japan.
   Yaizu Suisan Kagaku Ind Co, Yaizu 4258750, Peoples R China.
   Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmacol, Shenyang 110016, Peoples R China.
RP Miwa, I (reprint author), Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, Nagoya, Aichi 4688503, Japan.
EM miwaichi@ccmfs.meijo-u.ac.jp
CR Chen AS, 2003, BIOL PHARM BULL, V26, P1326, DOI 10.1248/bpb.26.1326
   Choi BK, 2001, INT J ANTIMICROB AG, V18, P553, DOI 10.1016/S0924-8579(01)00434-4
   HIRANO S, 1989, AGR BIOL CHEM TOKYO, V53, P3065, DOI 10.1080/00021369.1989.10869777
   Je JY, 2004, FOOD CHEM TOXICOL, V42, P381, DOI 10.1016/j.fct.2003.10.001
   KENDRA DF, 1984, EXP MYCOL, V8, P276, DOI 10.1016/0147-5975(84)90013-6
   Nam KS, 2001, BIOTECHNOL LETT, V23, P971, DOI 10.1023/A:1010519224254
   Pae HO, 2001, LEUKEMIA RES, V25, P339, DOI 10.1016/S0145-2126(00)00138-7
   Shon YH, 2002, BIOL PHARM BULL, V25, P1161, DOI 10.1248/bpb.25.1161
   Xue CH, 1998, BIOSCI BIOTECH BIOCH, V62, P206, DOI 10.1271/bbb.62.206
   Yasuno S, 1999, BIOSCI BIOTECH BIOCH, V63, P1353, DOI 10.1271/bbb.63.1353
NR 10
TC 10
Z9 12
U1 0
U2 9
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD MAR
PY 2005
VL 28
IS 3
BP 545
EP 548
DI 10.1248/bpb.28.545
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 907GW
UT WOS:000227705300030
PM 15744088
OA Bronze
DA 2018-10-20
ER

PT J
AU Arimura, H
   Ohya, Y
   Ouchi, T
AF Arimura, H
   Ohya, Y
   Ouchi, T
TI Formation of core-shell type biodegradable polymeric micelles from
   amphiphilic poly(aspartic acid)-block-polylactide diblock copolymer
SO BIOMACROMOLECULES
LA English
DT Article
ID BLOCK-COPOLYMERS; POLY(ETHYLENE GLYCOL); DEGRADATION
AB Poly(aspartic acid)-block-polylactide diblock copolymers (PA.sp-b-PLAs) having both hydrophilic and hydrophobic segments of various lengths were synthesized. These PAsp-b-PLA diblock copolymers formed polymeric micelles consisting of a hydrophobic PLA core and a hydrophilic, pH-sensitive PAsp shell in aqueous solution. The effects of the segment length of both the PLA and the PAsp portions and the pH of the solution on the shapes and sizes of the PAsp-b-PLA polymeric micelles were investigated. The results indicated a balance between the effects of electrostatic repulsion, hydrogen bonding in the PAsp shell layer, and hydrophobic interactions in the PLA core determine the sizes of the PAsp-b-PLA polymeric micelles. Moreover, the PAsp-b-PLA polymeric micelles did not possess any cytotoxic activity against L929 fibroblast cells. The obtained polymeric micelle should be useful for biodegradable biomedical materials such as drug delivery vehicle.
C1 Kansai Univ, Fac Engn & High Technol Res Ctr, Dept Appl Chem, Suita, Osaka 5648680, Japan.
RP Ohya, Y (reprint author), Kansai Univ, Fac Engn & High Technol Res Ctr, Dept Appl Chem, Suita, Osaka 5648680, Japan.
EM yohya@ipcku.kansai-u.ac.jp; touchi@ipcku.kansai-u.ac.jp
CR Arimura H, 2004, MACROMOL RAPID COMM, V25, P743, DOI 10.1002/marc.200300259
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   HAMLEY IW, 1998, PHYS BLOCK COPOLYMER, P332
   Iijima M, 1999, MACROMOLECULES, V32, P1140, DOI 10.1021/ma9815962
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   KWON G, 1996, ADV DRUG DEL REV, V16, P107
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   Li SM, 2002, BIOMACROMOLECULES, V3, P525, DOI 10.1021/bm010168s
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   Ouchi T, 2003, BIOMACROMOLECULES, V4, P477, DOI 10.1021/bm020118t
   Ouchi T, 2002, J POLYM SCI POL CHEM, V40, P1426, DOI 10.1002/pola.10226
   WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010
   Xiong XY, 2004, MACROMOLECULES, V37, P3425, DOI 10.1021/ma049662p
   Yoo HS, 2002, J CONTROL RELEASE, V82, P17, DOI 10.1016/S0168-3659(02)00088-3
NR 14
TC 117
Z9 121
U1 1
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR-APR
PY 2005
VL 6
IS 2
BP 720
EP 725
DI 10.1021/bm0494491
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 907AT
UT WOS:000227687800028
PM 15762635
DA 2018-10-20
ER

PT J
AU Masuko, T
   Minami, A
   Iwasaki, N
   Majima, T
   Nishimura, SI
   Lee, YC
AF Masuko, T
   Minami, A
   Iwasaki, N
   Majima, T
   Nishimura, SI
   Lee, YC
TI Thiolation of chitosan. Attachment of proteins via thioether formation
SO BIOMACROMOLECULES
LA English
DT Article
ID N-CARBOXYBUTYL CHITOSAN; WATER-SOLUBLE CHITOSAN; IN-VITRO EVALUATION;
   CONTROLLED-RELEASE; SUCCINYL-CHITOSAN; GENE DELIVERY; TISSUE;
   NANOPARTICLES; SCAFFOLDS; CHITIN
AB Chitosan has a variety of biological functions through conjugating of other compounds to their amino and hydroxyl groups. To further expand applicability of chitosan, we have modified the amino group of chitosan with 2-iminothiolane to bestow thiol groups and obtained about 20% yield, which is equivalent to 913 mu equiv SH/g chitosan or 457 nequiv SH/nmol chitosan. Bovine serum albumin (BSA) was reacted with N-(c-maleimidocaproyloxy)sulfosuccinimide ester (sulfo-EMCS), and maleimide-modified BSA (MaINBSA) was obtained. The yield of sulfo-EMCS addition was 12.8-36.8 mol MaIN/mol BSA. When the chitosan-SH was reacted with MalN-BSA via thioether, 97.8% of the maleimide group was reacted, and 37.2% of the SH group was consumed. The remaining SH group was quenched by bromoacetamide. This is the first report of covalent conjugation of a protein to chitosan. Our method should find many applications in developing new chitosan-based biomedical materials containing other components such as growth factors and cell adhesion molecules, known to be crucial to cells. Our thiolated chitosan will facilitate conjugation of such biomedical components to provide new types of materials for tissue engineering.
C1 Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.
   Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Sci, Div Biol Sci,Lab Biomacromol Chem,Kita Ku, Sapporo, Hokkaido 0010021, Japan.
RP Lee, YC (reprint author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.
EM yclee@jhu.edu
RI Nishimura, Shinichiro/F-5277-2011; Iwasaki, Norimasa/D-6448-2012;
   Majima, Tokifumi/E-2412-2012
CR Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   Bernkop-Schnurch A, 2003, INT J PHARM, V260, P229, DOI 10.1016/S0378-5173(03)00271-0
   BIAGINI G, 1991, BIOMATERIALS, V12, P287, DOI 10.1016/0142-9612(91)90036-A
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   Brown CD, 2001, J CONTROL RELEASE, V72, P35, DOI 10.1016/S0168-3659(01)00260-7
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Degim Z, 2002, AMINO ACIDS, V22, P187, DOI 10.1007/s007260200007
   Elcin AE, 1998, NEUROL RES, V20, P648
   Elcin YM, 1998, ARTIF ORGANS, V22, P837
   Elcin YM, 1999, ARTIF ORGANS, V23, P146, DOI 10.1046/j.1525-1594.1999.06222.x
   ELKAMEL A, 2002, PHARMSCI, V4, pE44
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Huang M, 2002, PHARM RES-DORDR, V19, P1488, DOI 10.1023/A:1020404615898
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   JENNINGS CD, 1988, P SOC EXP BIOL MED, V189, P13
   Kato Y, 2000, BIOMATERIALS, V21, P1579, DOI 10.1016/S0142-9612(00)00044-2
   Kato Y, 2004, BIOMATERIALS, V25, P907, DOI 10.1016/S0142-9612(03)00598-2
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Kumar G, 1999, BIOTECHNOL BIOENG, V63, P154, DOI 10.1002/(SICI)1097-0290(19990420)63:2<154::AID-BIT4>3.3.CO;2-I
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Liu WG, 2003, BIOCONJUGATE CHEM, V14, P782, DOI 10.1021/bc020051g
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MACLAUGHLIN FC, 1998, CONTROLLED RELEASE, V56, P259
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Nishikawa H., 2001, SILICON BASED MAT DE, V2, P93
   NISHIOKA Y, 1992, CHEM PHARM BULL, V40, P267, DOI 10.1248/cpb.40.267
   NISHIOKA Y, 1990, CHEM PHARM BULL, V38, P2871, DOI 10.1248/cpb.38.2871
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Park YJ, 2000, BIOMATERIALS, V21, P153
   PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358
   Qin CQ, 2002, INT J BIOL MACROMOL, V31, P111, DOI 10.1016/S0141-8130(02)00064-8
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Roy K, 1999, NAT MED, V5, P387
   SANZGIRI YD, 1990, PHARMACEUT RES, V7, P418, DOI 10.1023/A:1015887910184
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   SOSA MAG, 1991, BIOCHEM BIOPH RES CO, V174, P489, DOI 10.1016/0006-291X(91)91443-G
   SUGANO M, 1980, AM J CLIN NUTR, V33, P787
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tommeraas K, 2001, CARBOHYD RES, V336, P291, DOI 10.1016/S0008-6215(01)00275-0
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Vongchan P, 2002, CARBOHYD RES, V337, P1239, DOI 10.1016/S0008-6215(02)00098-8
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Xu YM, 2003, INT J PHARM, V250, P215, DOI 10.1016/S0378-5173(02)00548-3
   Xu YM, 2003, BIOMATERIALS, V24, P5015, DOI 10.1016/S0142-9612(03)00408-3
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
NR 62
TC 42
Z9 42
U1 1
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR-APR
PY 2005
VL 6
IS 2
BP 880
EP 884
DI 10.1021/bm049352e
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 907AT
UT WOS:000227687800047
PM 15762654
DA 2018-10-20
ER

PT J
AU Cheng, FY
   Su, CH
   Yang, YS
   Yeh, CS
   Tsai, CY
   Wu, CL
   Wu, MT
   Shieh, DB
AF Cheng, FY
   Su, CH
   Yang, YS
   Yeh, CS
   Tsai, CY
   Wu, CL
   Wu, MT
   Shieh, DB
TI Characterization of aqueous dispersions of Fe3O4 nanoparticles and their
   biomedical applications
SO BIOMATERIALS
LA English
DT Article
DE MRI; nanoparticle; cytotoxicity
ID SUPERPARAMAGNETIC IRON-OXIDE; POOL CONTRAST-MEDIUM; MAGNETITE
   NANOPARTICLES; MR-ANGIOGRAPHY; CLINICAL-APPLICATION; PARTICLES VSOP;
   MAST-CELLS; PHASE-I; AGENTS; LIVER
AB A newly developed non-polymer coated Fe3O4 nanoparticles showing well-dispersion were synthesized using Fe(II) and Fe(III) salt chemical coprecipitation with tetramethylammonium hydroxide (N(CH3)(4)OH) in an aqueous solution. Transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier transform infrared spectrometer (FT-IR), X-ray photoelectron spectrometer (XPS) and superconducting quantum interference measurement device (SQUID) measurements were employed to investigate the iron oxide properties. The resulting iron oxide particles were manipulated to be as small as 9 nm diameter in size. Based on FT-IR and X-ray photoelectron spectrometer results, it is suggested that the surfaces of the magnetite (Fe3O4) particles are covered with hydroxide (-OH) groups incorporated with (CH3)(4)N+ through electrostatic interaction. The in vitro cytotoxicity test revealed that the magnetite particles exhibited excellent biocompatibility, suggesting that they may be further explored for biomedical applications. NMR measurements revealed significantly reduced water proton relaxation times T1 and T2. The MR images of the nanoparticles in water, serum, and whole blood were investigated using a 1.5T clinical MR imager. Significant reduction of the background medium signal was achieved in the T2-weighted and the T2*-weighted sequence especially in the serum and whole blood. Combining the advantage of MRI signal contrast, the non-polymer-coated surface chemistry for distinct bioconjugation and the homogenous nanometer size for better controlled biodistribution, these preliminary experiments demonstrated the potential of the as-synthesized magnetite material in functional molecular imaging for biomedical research and clinical diagnosis. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Dept Biochem, Tainan 701, Taiwan.
   Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung 813, Taiwan.
   Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.
   Natl Cheng Kung Univ, Dept Dent, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 701, Taiwan.
RP Yeh, CS (reprint author), Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
EM csyeh@mail.ncku.edu.tw; wumolbio@mail.ncku.edu.tw;
   dshieh@mail.ncku.edu.tw
RI Wu, Chao-Liang/K-5272-2013; Yeh, Chen-Sheng/H-4347-2011
OI Wu, Chao-Liang/0000-0001-7821-9406; 
CR ATKINSON TP, 1988, J IMMUNOL, V141, P1302
   Bean C., 1959, J APPL PHYS, V30, P120
   Bellin MF, 2000, EUR J RADIOL, V34, P257, DOI 10.1016/S0720-048X(00)00204-7
   Bergemann C, 1999, J MAGN MAGN MATER, V194, P45, DOI 10.1016/S0304-8853(98)00554-X
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   Closmann C, 1996, AM MINERAL, V81, P1321
   Cornell R.M., 1996, IRON OXIDE STRUCTURE
   Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n
   ENNIS M, 1986, AGENTS ACTIONS, V18, P235, DOI 10.1007/BF01988029
   FINN P, 1972, INORG CHEM, V11, P893, DOI 10.1021/ic50110a051
   Fu L, 2001, APPL SURF SCI, V181, P173, DOI 10.1016/S0169-4332(01)00388-9
   HAHN PF, 1990, RADIOLOGY, V174, P361, DOI 10.1148/radiology.174.2.2296646
   Harris LA, 2003, CHEM MATER, V15, P1367, DOI 10.1021/cm020994n
   HARVEY DT, 1981, ANAL CHEM, V53, P1684, DOI 10.1021/ac00234a030
   INCORVIA MJ, 1989, J ELECTROCHEM SOC, V136, P2493, DOI 10.1149/1.2097443
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   JUNG CW, 1995, MAGN RESON IMAGING, V13, P675, DOI 10.1016/0730-725X(95)00023-A
   Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5
   Kim DK, 2001, J MAGN MAGN MATER, V225, P30, DOI 10.1016/S0304-8853(00)01224-5
   Knag YS, 1996, CHEM MATER, V8, P2209
   Koenig S H, 1987, Magn Reson Annu, P263
   Lind K, 2002, J DRUG TARGET, V10, P221, DOI 10.1080/10611860290022651
   Lubbe AS, 1996, CANCER RES, V56, P4686
   MANN S, 1988, J COLLOID INTERF SCI, V122, P326, DOI 10.1016/0021-9797(88)90368-2
   MCLACHLAN SJ, 1994, JMRI-J MAGN RESON IM, V4, P301, DOI 10.1002/jmri.1880040313
   MULLER N, 1990, METEORITICS, V25, P1
   NOLTE H, 1988, AM J PEDIAT HEMATOL, V10, P308
   Qu SC, 1999, J COLLOID INTERF SCI, V215, P190, DOI 10.1006/jcis.1999.6185
   Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7
   REIMER P, 1992, JMRI-J MAGN RESON IM, V2, P177, DOI 10.1002/jmri.1880020210
   Reynolds CH, 2000, J AM CHEM SOC, V122, P8940, DOI 10.1021/ja001426g
   SAINI S, 1988, RADIOLOGY, V169, P656, DOI 10.1148/radiology.169.3.3186987
   Schnorr J, 2002, ACAD RADIOL, V9, pS307, DOI 10.1016/S1076-6332(03)80211-8
   Shen LF, 1999, LANGMUIR, V15, P447, DOI 10.1021/la9807661
   STARK DD, 1988, RADIOLOGY, V168, P297, DOI 10.1148/radiology.168.2.3393649
   Sun SH, 2002, J AM CHEM SOC, V124, P8204, DOI 10.1021/ja026501x
   Taupitz M, 2002, RADIOLOGY, V222, P120, DOI 10.1148/radiol.2221001452
   Taupitz M, 2000, J MAGN RESON IMAGING, V12, P905, DOI 10.1002/1522-2586(200012)12:6<905::AID-JMRI14>3.0.CO;2-5
   Thode K, 1997, J DRUG TARGET, V5, P35, DOI 10.3109/10611869708995856
   Vijayakumar R, 2000, MAT SCI ENG A-STRUCT, V286, P101, DOI 10.1016/S0921-5093(00)00647-X
   Wagner S, 2002, INVEST RADIOL, V37, P167, DOI 10.1097/00004424-200204000-00002
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
NR 45
TC 459
Z9 486
U1 52
U2 630
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2005
VL 26
IS 7
BP 729
EP 738
DI 10.1016/j.biomaterials.2004.03.016
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 860DK
UT WOS:000224319300005
PM 15350777
DA 2018-10-20
ER

PT J
AU Alarcon, CDH
   Pennadam, S
   Alexander, C
AF Alarcon, CDH
   Pennadam, S
   Alexander, C
TI Stimuli responsive polymers for biomedical applications
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID SCHIZOPHRENIC DIBLOCK COPOLYMER; CROSS-LINKED MICELLES; CONTACT-ANGLE
   MEASUREMENTS; SELF-ASSEMBLED MONOLAYERS; CELL-CULTURE MEMBRANES;
   TARGETED DRUG-DELIVERY; PROTEINS IN-VIVO; THERMORESPONSIVE POLYMER;
   BLOCK-COPOLYMERS; AQUEOUS-SOLUTION
AB Polymers that can respond to external stimuli are of great interest in medicine, especially as controlled drug release vehicles. In this critical review, we consider the types of stimulus response used in therapeutic applications and the main classes of responsive materials developed to date. Particular emphasis is placed on the wide-ranging possibilities for the biomedical use of these polymers, ranging from drug delivery systems and cell adhesion mediators to controllers of enzyme function and gene expression (134 references).
C1 Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
RP Alexander, C (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.
EM cameron.alexander@port.ac.uk
RI Alexander, Cameron/N-7729-2014
OI Alexander, Cameron/0000-0001-8337-1875
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   ALEXANDRIDIS P, 1995, LANGMUIR, V11, P1468, DOI 10.1021/la00005a011
   Arotcarena M, 2002, J AM CHEM SOC, V124, P3787, DOI 10.1021/ja012167d
   Arvidsson P, 2001, J CHROMATOGR B, V753, P279, DOI 10.1016/S0378-4347(00)00558-2
   BAE YH, 1991, PHARMACEUT RES, V8, P624, DOI 10.1023/A:1015860824953
   BAE YH, 1989, J CONTROL RELEASE, V9, P271, DOI 10.1016/0168-3659(89)90096-5
   Barker SLR, 2000, ANAL CHEM, V72, P5925, DOI 10.1021/ac0008690
   BRONDSTED H, 1992, ACS SYM SER, V480, P285
   Cadee JA, 2002, J CONTROL RELEASE, V78, P1, DOI 10.1016/S0168-3659(01)00483-7
   Caliceti P, 2003, ADV DRUG DELIVER REV, V55, P1261, DOI 10.1016/S0169-409X(03)00108-X
   Callow ME, 2000, APPL ENVIRON MICROB, V66, P3249, DOI 10.1128/AEM.66.8.3249-3254.2000
   Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO;2-P
   Chao HM, 1998, J CHROMATOGR B, V715, P307, DOI 10.1016/S0378-4347(98)00172-8
   Chen GP, 1998, J BIOMED MATER RES, V42, P38, DOI 10.1002/(SICI)1097-4636(199810)42:1<38::AID-JBM6>3.0.CO;2-P
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Crommelin DJA, 2003, J CONTROL RELEASE, V87, P81, DOI 10.1016/S0168-3659(03)00014-2
   Cunliffe D, 2003, LANGMUIR, V19, P2888, DOI 10.1021/la026358l
   Cunliffe D, 2000, BIOTECHNOL LETT, V22, P141, DOI 10.1023/A:1005622424821
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Ding ZL, 1998, J BIOMED MATER RES, V39, P498, DOI 10.1002/(SICI)1097-4636(19980305)39:3<498::AID-JBM22>3.0.CO;2-5
   Donini C, 2002, INT J PHARM, V245, P83, DOI 10.1016/S0378-5173(02)00335-6
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   DUNCAN R, 1994, CLIN PHARMACOKINET, V27, P290, DOI 10.2165/00003088-199427040-00004
   ELSAYED M, 2001, PHARM RES, V18, P223
   Fu Q, 2003, ADV MATER, V15, P1262, DOI 10.1002/adma.200305165
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gan DJ, 2001, J AM CHEM SOC, V123, P7511, DOI 10.1021/ja010609f
   Gao J, 2003, LANGMUIR, V19, P5212, DOI 10.1021/la0269762
   Garrigues A, 2002, MOL PHARMACOL, V62, P1288, DOI 10.1124/mol.62.6.1288
   Goldmints I, 1997, LANGMUIR, V13, P6130, DOI 10.1021/la970534m
   Grabstain V, 2003, BIOTECHNOL PROGR, V19, P1728, DOI 10.1021/bp034161t
   Graham NB, 1998, PURE APPL CHEM, V70, P1271, DOI 10.1351/pac199870061271
   Greish K, 2003, CLIN PHARMACOKINET, V42, P1089, DOI 10.2165/00003088-200342130-00002
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Harimoto M, 2003, MACROMOL SYMP, V195, P231, DOI 10.1002/masy.200390127
   HELLER J, 1993, ADV DRUG DELIVER REV, V10, P163, DOI 10.1016/0169-409X(93)90047-8
   Hinrichs WLJ, 1999, J CONTROL RELEASE, V60, P249, DOI 10.1016/S0168-3659(99)00075-9
   Hoffmann J, 1999, SENSOR ACTUAT A-PHYS, V77, P139, DOI 10.1016/S0924-4247(99)00080-1
   Ista LK, 1999, APPL ENVIRON MICROB, V65, P1603
   Ista LK, 2001, LANGMUIR, V17, P2552, DOI 10.1021/la001257d
   Ista LK, 1998, J IND MICROBIOL BIOT, V20, P121, DOI 10.1038/sj.jim.2900490
   Kaneko Y, 1996, MACROMOL SYMP, V109, P41, DOI 10.1002/masy.19961090105
   Kaneko Y, 1999, J BIOMAT SCI-POLYM E, V10, P1079, DOI 10.1163/156856299X00757
   KANEKO Y, 1995, J MEMBRANE SCI, V101, P13, DOI 10.1016/0376-7388(94)00268-4
   Kato N, 2003, B CHEM SOC JPN, V76, P543, DOI 10.1246/bcsj.76.543
   Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kim B, 2003, J APPL POLYM SCI, V89, P1606, DOI 10.1002/app.12337
   Kim SJ, 2003, J APPL POLYM SCI, V89, P890, DOI 10.1002/app.12331
   Kirshenbaum K, 2002, CHEMBIOCHEM, V3, P235, DOI 10.1002/1439-7633(20020301)3:2/3<235::AID-CBIC235>3.0.CO;2-7
   Kishi R, 2003, J APPL POLYM SCI, V89, P75, DOI 10.1002/app.11996
   Koh AYC, 2002, PHYS CHEM CHEM PHYS, V4, P96, DOI 10.1039/b105990b
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   Kuckling D, 2003, MACROMOL MATER ENG, V288, P144, DOI 10.1002/mame.200390007
   Kuckling D, 2002, LANGMUIR, V18, P4263, DOI 10.1021/la015758q
   Kurisawa M, 2000, J CONTROL RELEASE, V68, P1, DOI 10.1016/S0168-3659(00)00246-7
   Kurisawa M, 2000, J CONTROL RELEASE, V69, P127, DOI 10.1016/S0168-3659(00)00297-2
   Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200
   Kwon I, 2003, J AM CHEM SOC, V125, P7512, DOI 10.1021/ja0350076
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Kwon OH, 2003, BIOMATERIALS, V24, P1223, DOI 10.1016/S0142-9612(02)00469-6
   Kyriakides TR, 2002, J CONTROL RELEASE, V78, P295, DOI 10.1016/S0168-3659(01)00504-1
   Lee J, 2001, J BIOMAT SCI-POLYM E, V12, P229, DOI 10.1163/156856201750180942
   LEHR CM, 1992, PHARMACEUT RES, V9, P70, DOI 10.1023/A:1018931811189
   Li SK, 2001, J CONTROL RELEASE, V75, P55, DOI 10.1016/S0168-3659(01)00365-0
   Liu SY, 2002, ANGEW CHEM INT EDIT, V41, P1413, DOI 10.1002/1521-3773(20020415)41:8<1413::AID-ANIE1413>3.0.CO;2-K
   Liu SY, 2003, LANGMUIR, V19, P4432, DOI 10.1021/la020951l
   Liu SY, 2002, LANGMUIR, V18, P8350, DOI 10.1021/la020496t
   Liu SY, 2001, J AM CHEM SOC, V123, P9910, DOI 10.1021/ja011206i
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lustig SR, 2001, MACROMOLECULES, V34, P2364, DOI 10.1021/ma001393p
   Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1
   Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0
   Maeda H, 2001, ADV DRUG DELIVER REV, V46, P169, DOI 10.1016/S0169-409X(00)00134-4
   MAKINO K, 1990, J CONTROL RELEASE, V12, P235, DOI 10.1016/0168-3659(90)90104-2
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Murata M, 2003, CHEM LETT, V32, P986, DOI 10.1246/cl.2003.986
   Murata M, 2003, BIOORG MED CHEM LETT, V13, P3967, DOI 10.1016/j.bmcl.2003.08.062
   Murthy KS, 2003, J MATER CHEM, V13, P2785, DOI 10.1039/b304166b
   Nagarsekar A, 2002, J BIOMED MATER RES, V62, P195, DOI 10.1002/jbm.10272
   Nakamura K, 1999, J CONTROL RELEASE, V61, P329, DOI 10.1016/S0168-3659(99)00150-9
   Nishida K, 2003, INVEST OPHTH VIS SCI, V44, pU127
   Noguchi Y, 1998, JPN J CANCER RES, V89, P307, DOI 10.1111/j.1349-7006.1998.tb00563.x
   OKANO T, 1995, J CONTROL RELEASE, V36, P125, DOI 10.1016/0168-3659(95)00054-C
   PARK TG, 1993, ENZYME MICROB TECH, V15, P476, DOI 10.1016/0141-0229(93)90079-H
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Pinkrah VT, 2003, LANGMUIR, V19, P585, DOI 10.1021/la0262831
   Poortinga AT, 2001, LANGMUIR, V17, P2851, DOI 10.1021/la001673y
   RAMKISSOONGANORKAR, 1999, J CONTROL RELEASE, V59, P287
   Raucher D, 2001, CANCER RES, V61, P7163
   Raula J, 2003, LANGMUIR, V19, P3499, DOI 10.1021/la026872r
   Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmitt FJ, 1998, LANGMUIR, V14, P2838, DOI 10.1021/la9709195
   Sharma N, 2000, FEBS LETT, V467, P37, DOI 10.1016/S0014-5793(00)01120-0
   SHIINO D, 1994, BIOMATERIALS, V15, P121, DOI 10.1016/0142-9612(94)90261-5
   Shiino D, 1995, J CONTROL RELEASE, V37, P269, DOI 10.1016/0168-3659(95)00084-4
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimoboji T, 2002, P NATL ACAD SCI USA, V99, P16592, DOI 10.1073/pnas.262427799
   Shiroyanagi Y, 2003, TISSUE ENG, V9, P1005, DOI 10.1089/107632703322495646
   Sosnik A, 2004, BIOMATERIALS, V25, P2851, DOI 10.1016/j.biomaterials.2003.09.057
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Stile RA, 2003, LANGMUIR, V19, P1853, DOI 10.1021/la026256v
   Sun YM, 1999, J BIOMED MATER RES, V45, P125, DOI 10.1002/(SICI)1097-4636(199905)45:2<125::AID-JBM7>3.0.CO;2-B
   Thurmond KB, 1996, J AM CHEM SOC, V118, P7239, DOI 10.1021/ja961299h
   Thurmond KB, 1999, NUCLEIC ACIDS RES, V27, P2966, DOI 10.1093/nar/27.14.2966
   Twaites BR, 2004, J CONTROL RELEASE, V97, P551, DOI 10.1016/j.jconrel.2004.03.032
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Ulbrich K, 1996, MACROMOL SYMP, V103, P177
   Urry DW, 1999, TRENDS BIOTECHNOL, V17, P249, DOI 10.1016/S0167-7799(99)01306-2
   Urry DW, 1998, BIOPOLYMERS, V47, P167, DOI 10.1002/(SICI)1097-0282(1998)47:2<167::AID-BIP6>3.0.CO;2-S
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   van der Weert M, 2000, J CONTROL RELEASE, V68, P31, DOI 10.1016/S0168-3659(00)00227-3
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Von Recum HA, 1999, EXP EYE RES, V69, P97, DOI 10.1006/exer.1999.0682
   Wang P, 2003, J AM CHEM SOC, V125, P6900, DOI 10.1021/ja0298287
   Weaver JVM, 2002, CHEM COMMUN, P2122, DOI 10.1039/b207251n
   Weaver JVM, 2004, ANGEW CHEM INT EDIT, V43, P1389, DOI 10.1002/anie.200352428
   Wu JZ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.048304
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, J BIOMED MATER RES, V55, P137, DOI 10.1002/1097-4636(200104)55:1<137::AID-JBM180>3.0.CO;2-L
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   Youngster S, 2002, CURR PHARM DESIGN, V8, P2139, DOI 10.2174/1381612023393242
NR 132
TC 1026
Z9 1037
U1 60
U2 878
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PD MAR
PY 2005
VL 34
IS 3
BP 276
EP 285
DI 10.1039/b406727d
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 908HV
UT WOS:000227779000019
PM 15726163
DA 2018-10-20
ER

PT J
AU Schroeder, C
   Regli, WC
   Shokoufandeh, A
   Sun, W
AF Schroeder, C
   Regli, WC
   Shokoufandeh, A
   Sun, W
TI Computer-aided design of porous artifacts
SO COMPUTER-AIDED DESIGN
LA English
DT Article
DE computer-aided design; representation; heterogeneous models; solid
   modeling; porous models; biomedical applications
ID SYNTHETIC MICROSTRUCTURES; SEDIMENTARY-ROCK; 2-PHASE FLOW; RANDOM-MEDIA;
   RECONSTRUCTION
AB Heterogeneous structures represent an important new frontier for 21st century engineering. Human tissues, composites, 'smart' and multimaterial objects are all physically manifest in the world as three-dimensional (31)) objects with varying surface, internal and volumetric properties and geometries. For instance, a tissue engineered structure, such as bone scaffold for guided tissue regeneration, can be described as a heterogeneous structure consisting of 3D extra-cellular matrices (made from biodegradable material) and seeded donor cells and/or growth factors.
   The design and fabrication of such heterogeneous structures requires new techniques for solid models to represent 3D heterogeneous objects with complex material properties. This paper presents a representation of model density and porosity based on stochastic geometry. While density has been previously studied in the solid modeling literature, porosity is a relatively new problem. Modeling porosity of bio-materials is critical for developing replacement bone tissues. The paper uses this representation to develop an approach to modeling of porous, heterogeneous materials and provides experimental data to validate the approach. The authors believe that their approach introduces ideas from the stochastic geometry literature to a new set of engineering problems. It is hoped that this paper stimulates researchers to find new opportunities that extend these ideas to be more broadly applicable for other computational geometry, graphics and computer-aided design problems. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Drexel Univ, Dept Comp Sci, Coll Engn, Philadelphia, PA 19104 USA.
   Drexel Univ, Coll Engn, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Regli, WC (reprint author), Drexel Univ, Dept Comp Sci, Coll Engn, Philadelphia, PA 19104 USA.
EM regli@drexel.edu
CR ADZHIEV V, 2002, P 7 ACM S SOL MOD AP
   BARNDORFFNIELSE.O, 1999, STOCKHASTIC GEOMETRY
   Biswal B, 1998, PHYSICA A, V255, P221, DOI 10.1016/S0378-4371(98)00111-3
   Biswal B, 1999, PHYSICA A, V273, P452, DOI 10.1016/S0378-4371(99)00248-4
   Biswal B, 1999, PHYSICA A, V266, P307, DOI 10.1016/S0378-4371(98)00607-4
   BOWYER A, 1999, SVLIS INTRO USER MAN
   CHO W, 2000, P NSF DES MAN GRANT
   CHO W, 2002, P NSF DES  SERV MAN
   Corney J., 2001, 3D MODELING ACIS
   DAVIS D, 1999, GITGVU9913, P99
   Flake G. W., 1998, COMPUTATIONAL BEAUTY
   HILFER R, 1991, PHYS REV B, V44, P60, DOI 10.1103/PhysRevB.44.60
   Hilfer R, 2000, GRANUL MATTER, V2, P137
   HILFER R, 1992, PHYS REV B, V45, P7115, DOI 10.1103/PhysRevB.45.7115
   Hilfer R, 2002, J PHYS-CONDENS MAT, V14, P2297, DOI 10.1088/0953-8984/14/9/318
   Hilfer R, 1997, PHYSICA A, V241, P105, DOI 10.1016/S0378-4371(97)00067-8
   Hilfer R, 2000, PHYSICA B, V279, P125, DOI 10.1016/S0921-4526(99)00694-8
   Hilfer R, 1998, PHYS REV E, V58, P2090, DOI 10.1103/PhysRevE.58.2090
   Hilfer R., 1996, ADV CHEM PHYS, P299
   HILFER R, 2000, LECTURE NOTES PHYS, V31, P203
   HILFER R, 2001, PHYS REV E, P64
   Jackson T. R., 2000, THESIS MIT
   Jackson TR, 1999, MATER DESIGN, V20, P63, DOI 10.1016/S0261-3069(99)00011-4
   JACKSON TR, 2002, J COMPUT INFORM SCI, V2
   Johnsen T, 1997, PHYS REV E, V55, P5433, DOI 10.1103/PhysRevE.55.5433
   Kumar V, 1999, COMPUT AIDED DESIGN, V31, P541, DOI 10.1016/S0010-4485(99)00051-2
   KUMAR V, 1997, 4 ACM S SOL MOD
   KUMAR V, 1998, GEOM MOD WORKSH
   LIU H, 2000, P ASME IDETC CIE
   Liu H, 2000, THESIS MIT
   Manwart C, 1999, PHYS REV E, V59, P5596, DOI 10.1103/PhysRevE.59.5596
   Manwart C, 2000, PHYS REV E, V62, P893, DOI 10.1103/PhysRevE.62.893
   PARK SM, 2001, S SOL MOD APPL
   PATIL O, 2000, P ASME C
   Pratt MJ, 2002, COMPUT AIDED DESIGN, V34, P1111, DOI 10.1016/S0010-4485(01)00189-0
   QIAN X, 2003, ASME T, V125, P416
   Qian XP, 2003, COMPUT GRAPH-UK, V27, P943, DOI 10.1016/j.cag.2003/08.001
   Russell SJ, 1995, ARTIFICIAL INTELLIGE
   *SPAT TECHN INC, 1997, ACIS 3 D TOOLK GETT
   Stoyan D, 1987, STOCHASTIC GEOMETRY
   *STRUCT DYN RES CO, EXPL I DEAS GEN MACH
   Sun W, 2002, COMPUT AIDED DESIGN, V34, P481, DOI 10.1016/S0010-4485(01)00131-2
   Tscheschel A, 2000, PHYSICA A, V284, P46, DOI 10.1016/S0378-4371(00)00116-3
   VOELCKER H, 1978, P 5 ANN C COMP GRAPH
   Yeong CLY, 1998, PHYS REV E, V58, P224, DOI 10.1103/PhysRevE.58.224
NR 45
TC 49
Z9 52
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0010-4485
J9 COMPUT AIDED DESIGN
JI Comput.-Aided Des.
PD MAR
PY 2005
VL 37
IS 3
BP 339
EP 353
DI 10.1016/j.cad.2004.03.008
PG 15
WC Computer Science, Software Engineering
SC Computer Science
GA 878XA
UT WOS:000225679500005
DA 2018-10-20
ER

PT J
AU Huang, C
AF Huang, C
TI Designing high-quality interactive multimedia learning modules
SO COMPUTERIZED MEDICAL IMAGING AND GRAPHICS
LA English
DT Article
DE educational media; interactive teaching for biology and medicine;
   instructional web design; physiology modules; multimedia module design
AB Modem research has broadened scientific knowledge and revealed the interdisciplinary nature of the sciences. For today's students, this advance translates to teaming a more diverse range of concepts, usually in less time, and without supporting resources. Students can benefit from technology-enhanced learning supplements that unify concepts and are delivered on-demand over the Internet. Such supplements, like imaging informatics databases, serve as innovative references for biomedical information, but could improve their interaction interfaces to support teaming. With information from these digital datasets, multimedia teaming tools can be designed to transform teaming into an active process where students can visualize relationships over time, interact with dynamic content, and immediately test their knowledge. This approach bridges knowledge gaps, fosters conceptual understanding, and builds problem-solving and critical thinking skills-all essential components to informatics training for science and medicine. Additional benefits include cost-free access and ease of dissemination over the Intemet or CD-ROM. However, current methods for the design of multimedia learning modules are not standardized and lack strong instructional design.
   Pressure from administrators at the top and students from the bottom are pushing faculty to use modern technology to address the teaming needs and expectations of contemporary students. Yet, faculty lack adequate support and training to adopt this new approach. So how can faculty learn to create educational multimedia materials for their students? This paper provides guidelines on best practices in educational multimedia design, derived from the Virtual Labs Project at Stanford University. The development of a multimedia module consists of five phases: (1) understand the teaming problem and the users needs; (2) design the content to harness the enabling technologies; (3) build multimedia materials with web style standards and human factors principles; (4) user testing; (5) Evaluate and improve design. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Stanford Univ, Sch Med, SUMMIT, Stanford, CA 94305 USA.
RP Huang, C (reprint author), Stanford Univ, Sch Med, SUMMIT, Wallenberg Hall,450 Serra Mall,Bldg 160, Stanford, CA 94305 USA.
CR Alessi S.M., 2001, MULTIMEDIA LEARNING
   *AM ASS HIGH ED TE, FLASHLIGHT TOOL KIT
   [Anonymous], RES BASED WEB DESIGN
   Bransford J. D., 2000, PEOPLE LEARN BRAIN M, P39
   Clark R. C., 2003, E LEARNING SCI INSTR, P322
   COOPER A, 1995, FACE ESSENTIALS USER, P580
   Creswell J. W, 2003, RES DESIGN QUALITATI, P246
   DICK W, 1996, SYSTEMATIC DESIGN IN
   Fogg BJ, 2002, PERSUASIVE TECHNOLOG
   HARVEY J, 1998, LEARNING TECHNOLOGY
   HUANG C, 2003, JCMIG, V27, P157
   HUANG C, 2003, CELL MOL BIOL, V49, P9
   HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837
   KELLOGG WK, 1998, KELLOGG FDN EV HDB 1
   KOZMA RB, 1991, REV EDUC RES, V61, P179, DOI 10.2307/1170534
   LEPPER M, 1987, APTITUDE LEARNING IN, V3, P256
   LYNCH PJ, 2001, WEB STYLE GUIDE, P223
   NIELSEN J., 1999, DESIGNING WEB USABIL
   Nielsen J., 1999, USABILITY ENG
   RETTIG M, 1994, COMMUN ACM, V37, P21, DOI 10.1145/175276.175288
   ROGERS G, 2001, MAT DEV ATE PROGRAM
   SHNEIDERMAN B, 1997, DESIGNING USER INTER
   STRUNK W, 1992, ELEMENTS STYLE
   Tufte E. R., 1990, ENVISIONING INFORMAT, P126
   WICKENS C, 2000, ENG PSYCHOL HUMAN PE, P350
   RES BASED WEB DESIGN, V2004
NR 27
TC 33
Z9 33
U1 1
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-6111
J9 COMPUT MED IMAG GRAP
JI Comput. Med. Imaging Graph.
PD MAR-APR
PY 2005
VL 29
IS 2-3
BP 223
EP 233
DI 10.1016/j.compmedimag.2004.09.017
PG 11
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 910VZ
UT WOS:000227961600012
PM 15755539
DA 2018-10-20
ER

PT J
AU Fernandes, AJS
   Salgueiredo, E
   Oliveira, FJ
   Silva, R
   Costa, FM
AF Fernandes, AJS
   Salgueiredo, E
   Oliveira, FJ
   Silva, R
   Costa, FM
TI Directly MPCVD diamond-coated Si3N4 disks for dental applications
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th European Conference on Diamond, Diamond-Like Materials, Carbon
   Nanotubes, Nitrides, and Silicon Carbide
CY SEP 12-17, 2004
CL Riva del Garda, ITALY
SP Aixtron AG, Diamond Business-Magazine, Elsevier Ltd, Iplas Innovat Plasma Syst GmbH, Roth & Rau AG, Seki Technotron Corp
DE abrasion; diamond film; plasma CVD; biomedical applications
ID DEPOSITION; TOOLS
AB Embedded diamond grains in a metal matrix, generally Ni, constitutes a very common material for abrasive machining, namely, in dentistry. Its replacement with CVD diamond in high added-value technological areas is desirable, since metal contamination from the binder matrix can thus be eliminated, and the tool life can be extended. This was already reported in dental burs but has never been attempted in abrasive disks.
   In this work, silicon nitride (Si3N4) substrates were sintered, disk shaped (circle divide 16 mm x 0.35 mm), laser patterned and diamond coated by microwave plasma CVD (MPCVD). For a performance comparison with an electroplated diamond commercial disk in the grinding of two materials used in dentistry (Opaque Dentine 900 ceramic and Luna metal alloy), CVD, diamond-coated disks having distinct surface roughness were prepared.
   Laser patterning was successful for increasing the Si3N4 surface roughness, but this feature was less important for the grinding efficiency than the CVD diamond grain size and shape. A CVD diamond disk removed 1.7 times more material in the ceramic grinding than the commercial one, which evidenced wear by extensive grain pullout in the grinding of the metal alloy. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Aveiro, Dept Fis, P-3810193 Aveiro, Portugal.
   Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
RP Fernandes, AJS (reprint author), Univ Aveiro, Dept Fis, Campus Santiago, P-3810193 Aveiro, Portugal.
EM toze2@fis.ua.pt
RI Universidade Aveiro, Departamento Fisica/E-4128-2013; Costa,
   Florinda/J-4345-2013; Oliveira, Filipe/H-2618-2013
OI Costa, Florinda/0000-0001-8729-714X; Oliveira,
   Filipe/0000-0001-7956-6565; Silva, Rui/0000-0002-2584-1792
CR Amaral M, 2003, SURF ENG, V19, P410, DOI [10.1179/026708403225010136, 10.1179/02670840322510136]
   Belmonte M, 2003, J AM CERAM SOC, V86, P749, DOI 10.1111/j.1151-2916.2003.tb03369.x
   FLOTER A, 1995, DIAM RELAT MATER, V4, P930, DOI 10.1016/0925-9635(94)00253-3
   Sein H, 2004, THIN SOLID FILMS, V447, P455, DOI 10.1016/j.tsf.2003.08.044
   Sein H, 2002, DIAM RELAT MATER, V11, P731, DOI 10.1016/S0925-9635(01)00579-9
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   TravaAiroldi VJ, 1996, DIAM RELAT MATER, V5, P857, DOI 10.1016/0925-9635(95)00516-1
NR 7
TC 1
Z9 1
U1 0
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD MAR-JUL
PY 2005
VL 14
IS 3-7
SI SI
BP 626
EP 630
DI 10.1016/j.diamond.2004.11.017
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 935AP
UT WOS:000229751400074
DA 2018-10-20
ER

PT J
AU Hirakuri, KK
   Kuwashima, K
   Tatsuta, K
   Sato, K
AF Hirakuri, KK
   Kuwashima, K
   Tatsuta, K
   Sato, K
TI Etching of diamond-like carbon films deposited on polyethylene
   terephthalate
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th European Conference on Diamond, Diamond-Like Materials, Carbon
   Nanotubes, Nitrides, and Silicon Carbide
CY SEP 12-17, 2004
CL Riva del Garda, ITALY
SP Aixtron AG, Diamond Business-Magazine, Elsevier Ltd, Iplas Innovat Plasma Syst GmbH, Roth & Rau AG, Seki Technotron Corp
DE diamond-like carbon; etching; chemical vapor deposition; microscopy
ID INTEGRATED-CIRCUIT FABRICATION; BIOMEDICAL APPLICATIONS; POLYMERIC
   MATERIALS
AB Recently, the diamond-like carbon (DLC) films are deposited in the wall of the polyethylene terephthalate (PET) bottles because of the protection for carbon dioxide gas penetration and deterioration against ultraviolet irradiation. However the DLC films fall into the contamination through the recycling process of PET bottle. In order to recycle the PET bottles deposited in DLC films, it is quite necessary to remove the DLC films at the early stage of recycling process. The DLC films were chemically etched by the glow discharge plasma of oxygen gas because carbon films were greatly reacted by the oxygen radicals and ions in the plasma. The etching of the DLC films deposited on the PET materials has been investigated using Raman spectroscopy. The complete removal of the DLC films was confirmed by Raman spectra. The etching depth increases with the etching time and the etching rate at optimum condition is approximately 50 nm/min. Atomic force microscopy observation was relieved surface condition of the PET after the etching treatment at different etching time. The surface roughness of the PET completely removed DLC films is almost same as the pure PET substrate without the exposure of oxygen plasma. (c) 2005 Elsevier B.V All rights reserved.
C1 Tokyo Denki Univ, Fac Sci & Engn, Dept Elect & Comp Engn, Hatoyama, Saitama 3500394, Japan.
RP Kuwashima, K (reprint author), Tokyo Denki Univ, Fac Sci & Engn, Dept Elect & Comp Engn, Hatoyama, Saitama 3500394, Japan.
EM hirakuri@f.dendai.ac.jp; kuwaman@agate.plala.or.jp
CR Alanazi A, 2000, ARTIF ORGANS, V24, P624, DOI 10.1046/j.1525-1594.2000.06576.x
   HATTA A, 2004, NEW DIAMOND, V20, P20
   HIRAKURI KK, 1995, VACUUM, V46, P57, DOI 10.1016/0042-207X(93)E0008-9
   Hirakuri KK, 2003, DIAM RELAT MATER, V12, P1013, DOI 10.1016/S0925-9635(02)00379-5
   Hirakuri KK, 1997, THIN SOLID FILMS, V302, P5, DOI 10.1016/S0040-6090(97)00022-9
   KOBAYASHI K, 1988, THIN SOLID FILMS, V158, P233, DOI 10.1016/0040-6090(88)90025-9
   Komatsu Y, 1999, DIAM RELAT MATER, V8, P2018, DOI 10.1016/S0925-9635(99)00138-7
   Ohgoe Y, 2004, SURF COAT TECH, V184, P263, DOI 10.1016/j.surfcoat.2003.10.009
   Ohgoe Y, 2003, ASAIO J, V49, P701, DOI 10.1097/01.MAT.0000093970.59796.40
   Pelletier MJ., 1999, ANAL APPL RAMAN SPEC
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   SHIRAKURA A, 2000, NEW DIAMOND, V57, P32
   TANAKA K, 2003, SEN-I GAKKAISHI, V59, P202
   Vasquez S, 1997, DIAM RELAT MATER, V6, P551, DOI 10.1016/S0925-9635(96)00659-0
   von Keudell A, 2002, DIAM RELAT MATER, V11, P969, DOI 10.1016/S0925-9635(01)00553-2
NR 15
TC 5
Z9 5
U1 2
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD MAR-JUL
PY 2005
VL 14
IS 3-7
SI SI
BP 1067
EP 1072
DI 10.1016/j.diamond.2004.12.032
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 935AP
UT WOS:000229751400156
DA 2018-10-20
ER

PT J
AU Park, GE
   Webster, TJ
AF Park, Grace E.
   Webster, Thomas J.
TI A Review of Nanotechnology for the Development of Better Orthopedic
   Implants
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Review
DE Nanophase; Ceramics; Metals; Polymers; Composites; Orthopedic Implants;
   Tissue Engineering
AB Over the past 9 decades of administering bioimplants to humans, most synthetic prostheses consist of material particles and/or grain sizes with conventional dimensions (on the order of 1 to 10(4) mu m). But the lack of sufficient bonding of synthetic implants to surrounding body tissues have, in recent years, led to the investigations of novel material formulations. One such classification of materials, nanomaterials (or materials with constituent components less than 100 nm in at least one direction), can be used to synthesize implants with similar surface roughness to that of natural tissues. Natural tissues have numerous nanometer features available for cellular interactions, since they are composed of many nanostructures (specifically, proteins). Several nanophase biomedical implants are currently being investigated, and are likely to gain approval for clinical use in the near future. The critical factor for this drive is the increasingly documented special, biologically improved material properties of nanophase implants compared to conventional grain-size formulations of the same material chemistry. In this manner, this review paper highlights a novel property of nanophase materials that makes them attractive for use as implants: enhanced cytocompatibility leading to increased tissue regeneration. Active works are focused in the domains of orthopedic, dental, bladder, neurologic, vascular, cartilage, and cardiovascular applications. However, only orthopedic applications, which are the closest to clinical applications, will be emphasized herein. This entry will briefly articulate the seeming revolutionary changes and the potential gains nanostructured materials can make for bone implant technology.
C1 [Park, Grace E.; Webster, Thomas J.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Webster, Thomas J.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.
RP Webster, TJ (reprint author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
CR AYAD S, 1994, EXTRACELLULAR MATRIX, P29
   Baraton MI, 1997, NANOSTRUCT MATER, V8, P435, DOI 10.1016/S0965-9773(97)00189-X
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Brunette DM, 2001, TITANIUM MED, P486
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Chun AL, 2004, NANOTECHNOLOGY, V15, pS234, DOI 10.1088/0957-4484/15/4/022
   COWIN R, 1987, HDB BIOENGINEERING
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   DANILOV YN, 1989, EXP CELL RES, V182, P186, DOI 10.1016/0014-4827(89)90290-5
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dowson D, 2001, P I MECH ENG H, V215, P335, DOI 10.1243/0954411011535939
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Guidi V., 1999, P 12 EUR C SOL STAT, V1, P501
   Gutwein LG, 2002, J NANOPART RES, V4, P231, DOI 10.1023/A:1019920105207
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   Horbett Thomas A., 1996, P133
   HUGHES RC, 1979, EXP CELL RES, V121, P307, DOI 10.1016/0014-4827(79)90009-0
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Klabunde KJ, 1996, J PHYS CHEM-US, V100, P12141
   LARSSON C, 1994, BIOMATERIALS, V15, P1325
   Lerouge S, 1996, J BIOMED MATER RES, V32, P627, DOI 10.1002/(SICI)1097-4636(199612)32:4<627::AID-JBM16>3.0.CO;2-A
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   LITSY AS, 1994, ORTHOPEDIC BASIC SCI, P482
   MALSCH I, 2001, LECT COST NANOSTAG C
   MALSCH I, 2002, IND PHYS
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   MININO AM, 2001, NATL VITAL STAT REP, V49, P12
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Oparaugo PC, 2001, ACTA ORTHOP SCAND, V72, P22, DOI 10.1080/000164701753606644
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   PATTISON M, 2004, BIOMATERIALS, V26, P2491
   Price RL, 2003, J BIOMED MATER RES A, V67A, P1284, DOI 10.1002/jbm.a.20011
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Price RL, 2004, NANOTECHNOLOGY, V15, P892, DOI 10.1088/0957-4484/15/8/004
   Roco M. C., 1999, NANOTECHNOLOGY RES D
   SATO M, 2005, 29 INT C ADV CER COM
   Schakenraad J.M., 1996, BIOMATERIALS SCI INT, P141
   Siegel R. W., 1999, NANOSTRUCTURE SCI TE
   Siegel RW, 1995, NANOSTRUCT MATER, V6, P205, DOI 10.1016/0965-9773(95)00044-5
   SIEGEL RW, 1994, NATO ADV SCI INST SE, V260, P233
   Siegel RW, 1996, SCI AM, V275, P42
   Simon SP, 1994, ORTHOPAEDIC BASIC SC, P127
   SINGER II, 1987, J CELL BIOL, V104, P573, DOI 10.1083/jcb.104.3.573
   SMITH TA, 2005, J BIOMED MA IN PRESS
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thull R, 2001, TITANIUM MED, P284
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   Webster T. J., 2000, BIOCERAMICS, V13, P321
   Webster T.J., 1998, BIOCERAMICS, P273
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, SCRIPTA MATER, V44, P1639, DOI 10.1016/S1359-6462(01)00873-9
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Webster TJ, 2001, ADV CHEM ENG, V27, P125
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
   Wu SJ, 1996, J AM CERAM SOC, V79, P2207, DOI 10.1111/j.1151-2916.1996.tb08962.x
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 67
TC 30
Z9 32
U1 0
U2 24
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD MAR
PY 2005
VL 1
IS 1
BP 18
EP 29
DI 10.1166/jbn.2005.003
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA V85AQ
UT WOS:000205747600003
DA 2018-10-20
ER

PT J
AU Kino-Oka, M
   Maeda, Y
   Yamamoto, T
   Sugawara, K
   Taya, M
AF Kino-Oka, M
   Maeda, Y
   Yamamoto, T
   Sugawara, K
   Taya, M
TI A kinetic modeling of chondrocyte culture for manufacture of
   tissue-engineered cartilage
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Review
DE biomedical engineering; tissue-engineered cartilage; collagen-embedded
   culture; chondrocytes; kinetic model
ID HUMAN ARTICULAR CHONDROCYTES; COLLAGEN-GEL; IN-VITRO; BOVINE
   CHONDROCYTES; MATRIX SYNTHESIS; QUALITY-ASSURANCE; OXYGEN-TENSION;
   TACTILE SENSOR; CELL YIELD; TRANSPLANTATION
AB For repairing articular cartilage defects, innovative techniques based on tissue engineering have been developed and are now entering into the practical stage of clinical application by means of grafting in vitro cultured products. A variety of natural and artificial materials available for scaffolds, which permit chondrocyte cells to aggregate, have been designed for their ability to promote e cell growth and differentiation. From the viewpoint of the manufacturing process for tissue-engineered cartilage, the diverse nature of raw materials (seeding cells) and end products (cultured cartilage) oblige us to design a tailor-made process with less reproducibility, which is an obstacle to establishing a production doctrine based on bioengineering knowledge concerning growth kinetics and modeling as well as designs of bioreactors and culture operations for certification of high product quality. In this article, we review the recent advances in the manufacturing of tissue-engineered cartilage. After outlining the manufacturing processes for tissue-engineered cardlage in the first section, the second and third sections, respectively, describe the three-dimensioual culture of chondrocytes with Aterocollagen gel and kinetic model consideration as a tool for evaluating this culture process. In the final section, culture strategy is discussed in terms of the combined processes of monolayer growth (ex vivo chondrocyte cell expansion) and three-dimensioinal growth (construction of cultured cartilage in the gel).
C1 Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan.
   Japan Tissue Engn Co Ltd, Gamagori, Aichi 4430022, Japan.
   Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 5608531, Japan.
RP Taya, M (reprint author), Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.
EM taya@cheng.es.osaka-u.ac.jp
OI Kino-oka, Masahiro/0000-0002-4912-5811
CR Barbero A, 2003, ARTHRITIS RHEUM, V48, P1315, DOI 10.1002/art.10950
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Boyce ST, 2004, BIOCHEM ENG J, V20, P107, DOI 10.1016/j.bej.2003.09.017
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2001, CLIN ORTHOP RELAT R, pS337
   Chen G, 2003, FEBS LETT, V542, P95, DOI 10.1016/S0014-5793(03)00354-5
   Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492
   du Moulin GC, 2000, MAT SCI ENG C-BIO S, V13, P15, DOI 10.1016/S0928-4931(00)00171-5
   Enmon RM, 2002, BIOTECHNOL BIOENG, V80, P580, DOI 10.1002/bit.10394
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X
   Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606
   Galban CJ, 1999, BIOTECHNOL BIOENG, V64, P633, DOI 10.1002/(SICI)1097-0290(19990920)64:6<633::AID-BIT1>3.0.CO;2-6
   GALBAN CJ, 1999, BIOTECHNOL BIOENG, V65, P122
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Haisch A, 2002, EUR ARCH OTO-RHINO-L, V259, P316, DOI 10.1007/s00405-002-0446-1
   Hesse F, 2000, TRENDS BIOTECHNOL, V18, P173, DOI 10.1016/S0167-7799(99)01420-1
   Heywood HK, 2004, TISSUE ENG, V10, P1467, DOI 10.1089/ten.2004.10.1467
   Homicz MR, 2002, OTOLARYNG HEAD NECK, V127, P398, DOI 10.1067/mhn.2002.129730
   Hunzinker E. B., 2001, OSTEOARTHR CARTILAGE, V10, P432
   Iwasa J, 2003, ARTIF ORGANS, V27, P249, DOI 10.1046/j.1525-1594.2003.07073.x
   Kang KA, 2002, ANN NY ACAD SCI, V961, P216, DOI 10.1111/j.1749-6632.2002.tb03088.x
   KAVALKOVICH KW, 2002, IN VITRO CELL DEV, V38, P1071
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   Kino-Oka M, 2005, TISSUE ENG, V11, P597, DOI 10.1089/ten.2005.11.597
   Kino-Oka M, 2000, J BIOSCI BIOENG, V89, P285, DOI 10.1016/S1389-1723(00)88836-2
   Kinoshita N, 2004, GENES CELLS, V9, P1, DOI 10.1111/j.1365-2443.2004.00696.x
   Kremer M, 2000, BRIT J PLAST SURG, V53, P459, DOI 10.1054/bjps.2000.3368
   Lindahl A, 2001, KNEE SURG SPORT TR A, V9, P358, DOI 10.1007/s001670100209
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   MacArthur BD, 2004, BIOCHEM BIOPH RES CO, V313, P825, DOI 10.1016/j.bbrc.2003.11.171
   Malda J, 2004, OSTEOARTHR CARTILAGE, V12, P306, DOI 10.1016/j/joca.2003.12.001
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Mandl EW, 2004, TISSUE ENG, V10, P109, DOI 10.1089/107632704322791754
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Miyaji K, 1997, CANCER, V80, P1920, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1920::AID-CNCR8>3.0.CO;2-R
   Mizuno S, 2002, J CELL PHYSIOL, V193, P319, DOI 10.1002/jcp.10180
   Mizuno S, 1998, MAT SCI ENG C-BIO S, V6, P301, DOI 10.1016/S0928-4931(98)00068-X
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   NEWMANGAGE H, 1995, CELL TRANSPLANT, V4, P447, DOI 10.1016/0963-6897(95)00033-T
   NOLL T, 2002, ADV BIOCH ENG BIOTEC, V74, P112
   Obradovic B, 1999, J ORTHOP RES, V17, P130
   Ochi M, 2004, ARTIF ORGANS, V28, P28, DOI 10.1111/j.1525-1594.2004.07317.x
   Omata S, 2004, SENSOR ACTUAT A-PHYS, V112, P278, DOI 10.1016/j.sna.2004.01.038
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Ratcliffe A, 2002, ANN NY ACAD SCI, V961, P210, DOI 10.1111/j.1749-6632.2002.tb03087.x
   Robinson D, 2001, CELL TRANSPLANT, V10, P203
   Ronziere MC, 2003, BIOMATERIALS, V24, P851, DOI 10.1016/S0142-9612(02)00418-0
   Saha AK, 2003, IEEE T NANOBIOSCI, V2, P89, DOI 10.1109/TNB.2003.813921
   Saha AK, 2003, IEEE T NANOBIOSCI, V2, P158, DOI 10.1109/TNB.2003.816226
   SCHUMAN L, 1995, BIOMATERIALS, V16, P809, DOI 10.1016/0142-9612(95)99644-2
   Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Yamamoto T, 2002, TISSUE ENG, V8, P119, DOI 10.1089/107632702753503117
   Yashiki S, 2004, KAGAKU KOGAKU RONBUN, V30, P515, DOI 10.1252/kakoronbunshu.30.515
   YASUI N, 1982, EXP CELL BIOL, V50, P92
   Yoshida T, 2004, BIOCHEM ENG J, V20, P99, DOI 10.1016/j.bej.2003.10.004
NR 66
TC 41
Z9 47
U1 3
U2 16
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD MAR
PY 2005
VL 99
IS 3
BP 197
EP 207
DI 10.1263/jbb.99.197
PG 11
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 925KP
UT WOS:000229052300002
PM 16233778
DA 2018-10-20
ER

PT J
AU Neuse, EW
AF Neuse, EW
TI Macromolecular ferrocene compounds as cancer drug models
SO JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS
LA English
DT Review
DE aerospace materials; antiproliferative activity; cancer research;
   carrier-drug conjugation; cell culture test; ferrocene; metallocene;
   water solubility
ID WATER-SOLUBLE POLYAMIDOAMINES; ELECTRON-TRANSFER REACTIONS; METALLOCENE
   POLYMERS; BIOMEDICAL APPLICATIONS; ANTITUMOR-ACTIVITY;
   SUPEROXIDE-DISMUTASE; DIFERRICENIUM MU-OXO-BIS<TRICHLOROFERRATE(III)>;
   ANTINEOPLASTIC ACTIVITY; MOLECULAR STRUCTURE; ION DERIVATIVES
C1 Univ Witwatersrand, Sch Chem, Johannesburg, South Africa.
RP Neuse, EW (reprint author), Univ Witwatersrand, Sch Chem, Johannesburg, South Africa.
EM neuse@aurum.wits.ac.za
CR ANDERSON JD, 1969, AIAA J, V7, P1665, DOI 10.2514/3.5373
   ARMSTRON.AT, 1967, J CHEM PHYS, V46, P4321, DOI 10.1063/1.1840547
   Babin V. N., 1995, MENDELEEV CHEM J, V17, P39
   BEDNARIK L, 1980, J ORG CHEM, V45, P2032, DOI 10.1021/jo01298a067
   BLAIR AH, 1983, J IMMUNOL METHODS, V59, P129
   BLOM NF, 1987, TRANSIT METAL CHEM, V12, P301, DOI 10.1007/BF01024018
   BOEYENS JC, 1984, S AFR J CHEM, V37, P32
   BOEYENS JCA, 1984, S AFR J CHEM, V37, P187
   BOHN RK, 1966, J ORGANOMET CHEM, V5, P470, DOI 10.1016/S0022-328X(00)82382-7
   BUBLITZ DE, 1969, ORG REACTIONS, V17, P1
   Cais M., 1966, ORGANOMET CHEM REV, V1, P435
   CALDWELL G, 1993, J APPL POLYM SCI, V50, P393, DOI 10.1002/app.1993.070500303
   Caldwell G, 1998, APPL ORGANOMET CHEM, V12, P793
   Caldwell G, 2000, J INORG ORGANOMET P, V10, P93, DOI 10.1023/A:1009475909111
   CALDWELL G, 1992, S AFR J CHEM-S-AFR T, V45, P93
   CARLSON BW, 1984, J AM CHEM SOC, V106, P7233, DOI 10.1021/ja00335a062
   CARLSON BW, 1983, J AM CHEM SOC, V105, P7453, DOI 10.1021/ja00363a047
   CARNEY MJ, 1984, J AM CHEM SOC, V106, P2565, DOI 10.1021/ja00321a013
   Casas JS, 2004, J INORG BIOCHEM, V98, P1009, DOI 10.1016/j.jinorgbio.2004.02.019
   CHEN SC, 1980, J ORGANOMET CHEM, V202, P183, DOI 10.1016/S0022-328X(00)90515-1
   CHU BCF, 1977, MOL PHARMACOL, V13, P80
   DANUSSO F, 1970, POLYMER, V11, P88, DOI 10.1016/0032-3861(70)90029-7
   DIACONIS NS, 1965, 16 INT ASTR C ATH SE, V16, P397
   DOMBROWSKI KE, 1986, J ORGANOMET CHEM, V302, P281, DOI 10.1016/0022-328X(86)80097-3
   Drobnik J., 1979, J POLYM SCI PS, V66, P65
   EPTON R, 1977, J ORGANOMET CHEM, V134, pC23, DOI 10.1016/S0022-328X(00)81426-6
   Ferruti P., 1996, POLYM MAT ENCY, V5, P3334
   FIORINA VJ, 1978, J MED CHEM, V21, P393, DOI 10.1021/jm00202a016
   FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051
   Gopal YNV, 2000, ARCH BIOCHEM BIOPHYS, V376, P229
   Greenwald RB, 2000, CRIT REV THER DRUG, V17, P101
   GRUNDFEST IJ, 1964, ENCY POLYM SCI TECH, V1, P1
   HALLIWELL B, 1985, FREE RADICALS BIOL M
   HANZLIK RP, 1979, J MED CHEM, V22, P424, DOI 10.1021/jm00190a013
   Hartinger CG, 2002, NEW J CHEM, V26, P671, DOI 10.1039/b200701k
   HENDRY SP, 1993, ANAL CHIM ACTA, V281, P453, DOI 10.1016/0003-2670(93)85002-2
   HILL DT, 1989, INORG CHEM, V28, P3529, DOI 10.1021/ic00317a027
   HOES CJT, 1989, DRUG CARRIER SYSTEMS, P57
   HOULTON A, 1991, J ORGANOMET CHEM, V418, P107, DOI 10.1016/0022-328X(91)86350-Y
   HURWITZ E, 1983, BIOPOLYMERS, V22, P557, DOI 10.1002/bip.360220168
   *ISR AC SCI HUM, 1971, JER S QUANT CHEM BIO, V3, P96
   Johnson D, 2002, ENTERTAIN DES, V36, P1
   Johnson MT, 2003, J INORG ORGANOMET P, V13, P255, DOI 10.1023/A:1026148211721
   Johnson MT, 2003, J INORG ORGANOMET P, V13, P55, DOI 10.1023/A:1024103629830
   JOY AM, 1989, INT J RADIAT ONCOL, V16, P1053, DOI 10.1016/0360-3016(89)90914-0
   KEALY TJ, 1951, NATURE, V168, P1039, DOI 10.1038/1681039b0
   KENSLER TW, 1983, SCIENCE, V221, P75, DOI 10.1126/science.6857269
   KENSLER TW, 1983, BIOCHEM PHARMACOL, V32, P3485, DOI 10.1016/0006-2952(83)90382-9
   KOOPF H, 1979, ANGEW CHEM INT EDIT, V18, P477
   KOOPFMAIER P, 1988, STRUCT BOND, V70, P103
   KOOPFMAIER P, 1984, J CANCER RES CLIN, V108, P336
   KOOPFMAIER P, 1984, ANGEW CHEM, V96, P446
   KORNICKER WA, 1968, ANN NY ACAD SCI, V153, P689
   KOVACIC P, 1988, ANTI-CANCER DRUG DES, V3, P205
   Kovjazin R, 2003, FASEB J, V17, P467, DOI 10.1096/fj.02-0558fje
   LOGAN SR, 1983, J CHEM SOC PERK T 2, P1781, DOI 10.1039/p29830001781
   LOGAN SR, 1990, Z PHYS CHEM NEUE FOL, V167, P41, DOI 10.1524/zpch.1990.167.Part_1.041
   MADDOX ML, 1965, ADV ORGANOMETALLIC C, V3, P1
   MAEDA H, 1991, ADV DRUG DELIVER REV, V6, P181, DOI 10.1016/0169-409X(91)90040-J
   Mason RW, 1999, APPL ORGANOMET CHEM, V13, P163, DOI 10.1002/(SICI)1099-0739(199903)13:3<163::AID-AOC821>3.0.CO;2-K
   Matson PA, 1987, GLOBAL BIOGEOCHEM CY, V1, P163, DOI 10.1029/GB001i002p00163
   Matthews SE, 1996, ADV DRUG DELIVER REV, V18, P219, DOI 10.1016/0169-409X(95)00098-R
   MCDOWELL MS, 1984, INORG CHEM, V23, P2232, DOI 10.1021/ic00183a007
   Meirim MG, 1997, J INORG ORGANOMET P, V7, P71, DOI 10.1023/A:1021488110997
   Meirim MG, 1998, J INORG ORGANOMET P, V8, P225, DOI 10.1023/A:1021436126927
   Minges M. L., 1969, High Temperatures - High Pressures, V1, P607
   MULVANEY JE, 1962, J POLYM SCI, V62, P59, DOI 10.1002/pol.1962.1206217305
   NERI P, 1973, J MED CHEM, V16, P893, DOI 10.1021/jm00266a006
   NERI P, 1982, MACROMOL SYNTHESES, V8, P25
   Neuse E. W., 1970, METALLOCENE POLYM
   Neuse E. W., 1988, APPL ORGANOMET CHEM, V2, P53
   Neuse E. W., 1990, INORGANIC METAL CONT, P139
   NEUSE EW, 1981, J MACROMOL SCI CHEM, VA16, P3, DOI 10.1080/00222338108082042
   NEUSE EW, 1977, POLYM ENG SCI, V17, P821, DOI 10.1002/pen.760171202
   NEUSE EW, 1972, J MATER SCI, V7, P708, DOI 10.1007/BF00549384
   NEUSE EW, 1966, B CHEM SOC JPN, V39, P1508, DOI 10.1246/bcsj.39.1508
   NEUSE EW, 1985, J ORGANOMET CHEM, V286, P329, DOI 10.1016/0022-328X(85)80049-8
   NEUSE EW, 1979, MACROMOLECULES, V12, P187, DOI 10.1021/ma60068a005
   NEUSE EW, 1985, TRANSIT METAL CHEM, V10, P135, DOI 10.1007/BF00641583
   NEUSE EW, 1990, APPL ORGANOMET CHEM, V4, P19, DOI 10.1002/aoc.590040105
   NEUSE EW, 1963, J AM CHEM SOC, V85, P1952, DOI 10.1021/ja00896a013
   NEUSE EW, 1982, ADV POLYM SCI, V47, P1
   NEUSE EW, 1965, J POLYM SCI PART A, V3, P1499, DOI 10.1002/pol.1965.100030418
   Neuse EW, 1999, J INORG ORGANOMET P, V9, P221, DOI 10.1023/A:1021706123621
   NEUSE EW, 1986, MACROMOLECULES, V19, P269, DOI 10.1021/ma00156a004
   NEUSE EW, 1984, TRANSIT METAL CHEM, V9, P12, DOI 10.1007/BF00620720
   NEUSE EW, 1968, ENCYCL POLYM SCI TEC, V8, P667
   NEUSE EW, 1985, METAL CONTAINING POL, P99
   NEUSE EW, 1989, POLYM MAT SCI ENG, V61, P94
   NEUSE EW, 1967, Patent No. 3341495
   NEUSE EW, 1966, Patent No. 3238185
   NEUSE EW, 1987, APPL ORGANOMET CHEM, V1, P499
   NEUSE EW, 1977, SYNTHESIS-STUTTGART, P479
   NEUSE EW, 1968, MACROMOLECULES, V1, P751
   NEUSE EW, 1968, ADV MACROMOL CHEM, V1, P1
   NEUSE EW, 1990, INORGANIC METAL CONT, P394
   OBERLEY LW, 1979, CANCER RES, V39, P1141
   OBRIEN PJ, 1985, ENVIRON HEALTH PERSP, V64, P219, DOI 10.2307/3430012
   Osella D, 2000, INORG CHIM ACTA, V306, P42, DOI 10.1016/S0020-1693(00)00147-X
   PALENIK GJ, 1970, INORG CHEM, V9, P2424, DOI 10.1021/ic50093a008
   PLADZIEWICZ JR, 1985, INORG CHEM, V24, P1450, DOI 10.1021/ic00204a009
   PLADZIEWICZ JR, 1982, J AM CHEM SOC, V104, P3544, DOI 10.1021/ja00376a068
   POPOVA LV, 1993, APPL ORGANOMET CHEM, V7, P85, DOI 10.1002/aoc.590070203
   POPOVA LV, 1994, Patent No. 2025125
   POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7
   Putnam D, 1995, ADV POLYM SCI, V122, P55
   Pytela J, 1998, J BIOACT COMPAT POL, V13, P198, DOI 10.1177/088391159801300303
   Ringsdorf H., 1975, J POLYM SCI POLYM S, V51, P135
   ROSATO DV, 1968, ENV EFFECTS POLYM MA, V1, P487
   ROSENBLUM M, 1967, ADV CHEM SER, V62, P532
   Sachdeva M S, 1998, Expert Opin Investig Drugs, V7, P1849, DOI 10.1517/13543784.7.11.1849
   SCHLOGL K, 1966, FORTSCHR CHEM FORSCH, V6, P479
   SCHMIDT DL, 1960, MOD PLAST, V37, P147
   SCHMIDT DL, 1960, MOD PLAST, V37, P131
   SEVILLA MD, 1983, BIOCHEM BIOPH RES CO, V115, P800, DOI 10.1016/S0006-291X(83)80005-9
   Shen W., UNPUB
   Swarts JC, 2001, ANTICANCER RES, V21, P2033
   SWARTS JC, 1994, J INORG ORGANOMET P, V4, P143
   Takakura Y, 1996, ADV DRUG DELIVER REV, V19, P377, DOI 10.1016/0169-409X(96)00010-5
   Togni A., 1994, FERROCENES
   Togni A., 1998, METALLOCENES
   Top S, 2001, J ORGANOMET CHEM, V637, P500, DOI 10.1016/S0022-328X(01)00953-6
   TRIFAN DS, 1960, TETRAHEDRON LETT, V13, P1
   Troll W, 1982, Carcinog Compr Surv, V7, P593
   TROUET A, 1982, P NATL ACAD SCI-BIOL, V79, P626, DOI 10.1073/pnas.79.2.626
   WATTS WE, 1967, ORGANOMET CHEM REV, V2, P231
   Waud W.R., 1995, CANC CHEMOTHERAPEUTI, P121
   WENZEL M, 1988, Z NATURFORSCH C, V43, P963
   YASHCHENKO GN, 1978, KHIM FARM ZH+, V12, P68
NR 129
TC 126
Z9 127
U1 0
U2 51
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1574-1443
J9 J INORG ORGANOMET P
JI J. Inorg. Organomet. Polym. Mater.
PD MAR
PY 2005
VL 15
IS 1
BP 3
EP 32
DI 10.1007/s10904-004-2371-9
PG 30
WC Polymer Science
SC Polymer Science
GA 935JV
UT WOS:000229778500002
DA 2018-10-20
ER

PT J
AU Jenkins, GL
   Sugarman, J
AF Jenkins, GL
   Sugarman, J
TI The importance of cultural considerations in the promotion of ethical
   research with human biologic material
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Review
ID UMBILICAL-CORD-BLOOD; HEMATOPOIETIC STEM; PLACENTAL-BLOOD; UNRELATED
   DONORS; ORGAN DONATION; BODY PARTS; TRANSPLANTATION; BANKING; ATTITUDES;
   CELLS
AB Although ethical consideration has been given to a wide variety of issues that arise in the collection and storage of human biologic material for research, little attention has been focused on the ethical implications of the diverse cultural meanings often associated with these materials. We explore the rich social meanings of the placenta across cultures and contrast these meanings with the assumption that the placenta is typically considered waste tissue that may find value in biomedical research. We suggest that the incorporation of sensitivity to the cultural meanings people give human biologic material and the use of empirical research, where necessary, to delineate these meanings should enhance the ability to craft and conduct ethically appropriate research.
C1 Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD 21205 USA.
   Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA.
   Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA.
   Univ Kansas, Womens Studies Program, Lawrence, KS 66045 USA.
RP Sugarman, J (reprint author), Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Hampton House 351,624 N Broadway, Baltimore, MD 21205 USA.
EM jsugarm1@jhmi.edu
CR AGINKSY BW, 1939, AM SOCIOL REV, V8, P4
   ALPERT S, 1999, RES INVOLVING HUMAN, V2, pA1
   Annas GJ, 1999, NEW ENGL J MED, V340, P1521, DOI 10.1056/NEJM199905133401923
   Ballen KK, 2002, TRANSFUSION, V42, P1279, DOI 10.1046/j.1537-2995.2002.00191.x
   BELLERHANN I, 1999, CONCEIVING PERSONS E, P113
   BROXMEYER HE, 1992, BONE MARROW TRANSPL, V9, P7
   Campbell C.S., 1999, RES INVOLVING HUMAN, V2, pC1
   CANESSA A, 1999, CONCEIVING PERSONS, P69
   CARSTEN J, 1995, AM ETHNOL, V22, P223, DOI 10.1525/ae.1995.22.2.02a00010
   CEDERCREUTZ S, 1999, CONCEIVING PERSONS E, P89
   CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786
   Conklin BA, 1996, ETHOS, V24, P657, DOI 10.1525/eth.1996.24.4.02a00040
   *CTR HLTH POL STUD, 1999, RES INV HUM BIOL MAT, V2, pG4
   Dame L, 2001, J PEDIAT HEMATOL ONC, V23, P409, DOI 10.1097/00043426-200110000-00003
   Danzer E, 2003, TRANSFUSION, V43, P604, DOI 10.1046/j.1537-2995.2003.00375.x
   DAVIDSON JR, 1985, CULT MED PSYCHIAT, V9, P75
   Doran C, 1997, WOMEN HIST REV, V6, P29
   Downey GL, 1997, SCH AM RES, P5
   Eiseman E., 1999, RES INVOLVING HUMAN, V2, pD1
   EISENBRUCH M, 1997, PSYCHOL ASPECTS GEOG, P109
   Fox M, 2000, HEALTH CARE ANAL, V8, P83, DOI 10.1023/A:1009498810174
   Fruzzetti Lina M., 1984, KINSHIP RITUAL BENGA
   Furness PN, 2001, J PATHOL, V195, P277
   Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602
   GRANQUIST H, 1947, BIRTH CHILDHOOD AMON
   Hilger M. I., 1951, CHIPPEWA CHILD LIFE
   Hogle LF, 1996, MED ANTHROPOL Q, V10, P675, DOI 10.1525/maq.1996.10.4.02a00150
   KEELER C, 1957, B GEORGIA ACAD SCI, V15, P97
   KEYER GG, 1986, MEXICAN AM ANGLO MID
   KOHLIKUMAR M, 1993, BRIT J HAEMATOL, V85, P419, DOI 10.1111/j.1365-2141.1993.tb03192.x
   Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303
   Laderman Carol, 1983, WIVES MIDWIVES CHILD
   Lam WA, 2000, CLIN TRANSPLANT, V14, P449, DOI 10.1034/j.1399-0012.2000.140502.x
   Leith-Ross Sylvia, 1965, AFRICAN WOMEN STUDY
   LIAMPUTTONG RP, 1999, AUSMED PUBLICATIONS, P117
   MARSHALL PA, 1992, MED ANTHROPOL Q, V6, P49, DOI 10.1525/maq.1992.6.1.02a00040
   MARSHALL PA, 1996, MED ANTHR CONT THEOR, P349
   MARTIN E, 1992, AM ETHNOL, V19, P121, DOI 10.1525/ae.1992.19.1.02a00070
   MARTIN E, 1987, WOMAN BODY CULTURAL
   Maschke KJ, 2004, THEOR MED BIOETH, V25, P143, DOI 10.1023/B:META.0000033773.44765.7c
   MERZ J, 1997, RISK HLTH SAFETY ENV, V8, P235
   Morgan Lynn M, 2002, Med Anthropol, V21, P247, DOI 10.1080/01459740214079
   Munzer SR, 2001, J PEDIAT HEMATOL ONC, V23, P203, DOI 10.1097/00043426-200105000-00004
   OBER WB, 1979, B NEW YORK ACAD MED, V55, P591
   OUDSHOORN N, 1990, SOC STUD SCI, V20, P5, DOI 10.1177/030631290020001001
   SARGENT C, 1984, MED ANTHROPOL Q, V16, P7
   Saura B, 2002, J POLYNESIAN SOC, V111, P127
   Seligman CG, 1938, MAN, V38, P20, DOI 10.2307/2790004
   Siminoff LA, 2000, KENNEDY INST ETHIC J, V10, P59
   SPENCER RF, 1977, CULTURE DIS HEALING, P289
   Sugarman J, 1997, JAMA-J AM MED ASSOC, V278, P938, DOI 10.1001/jama.278.11.938
   SUGARMAN J, 1995, JAMA-J AM MED ASSOC, V274, P1783, DOI 10.1001/jama.274.22.1783
   Sugarman J, 1998, J WOMENS HEALTH, V7, P747, DOI 10.1089/jwh.1998.7.747
   Surbek DV, 1998, SCHWEIZ MED WSCHR, V128, P689
   Vawter DE, 2002, TRANSFUSION, V42, P1268, DOI 10.1046/j.1537-2995.2002.00227.x
   WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1
   Wagner JE, 1996, BLOOD, V88, P795
   Yuen CC, 1998, J NATL MED ASSOC, V90, P13
   1999, RES INVOLVING HUMAN, V1
NR 59
TC 13
Z9 13
U1 1
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD MAR
PY 2005
VL 145
IS 3
BP 118
EP 124
DI 10.1016/j.lab.2005.01.001
PG 7
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 913TC
UT WOS:000228175100001
PM 15871302
DA 2018-10-20
ER

PT J
AU Brunke, O
   Odenbach, S
   Fritsche, C
   Hilger, I
   Kaiser, WA
AF Brunke, O
   Odenbach, S
   Fritsche, C
   Hilger, I
   Kaiser, WA
TI Determination of magnetic particle distribution in biomedical
   applications by X-ray microtomography
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Magnetic Fluids
CY AUG 02-06, 2004
CL Guaruja, BRAZIL
SP FINEP, FAPESP, CNPq, CAPES, ICTP
DE X-ray microtomography; biodistribution of magnetic particles; biomedical
   application
AB In biomedical application of ferrofluids the resulting biodistribution of the magnetic nanoparticles is a crucial parameter for the effect of the therapeutic approach. Usually the biodistribution is determined by histological cuts of the investigated specimen, a technique which provides only a very local information about the overall distribution of the magnetic material, e.g. in a tumor. Here we will introduce X-ray microtomography as a tool for a three-dimensional analysis of the distribution of magnetic nanoparticles in biological applications. Within the experiments presented here a spatial resolution of 80 mu m could be achieved which can be enhanced to approximately 2 pm by the use of a synchrotron as X-ray radiation source. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Bremen, ZARM, D-28359 Bremen, Germany.
   FSU Jena, Inst Diagnost & Interventionelle Radiol, D-07740 Jena, Germany.
RP Odenbach, S (reprint author), Univ Bremen, ZARM, Am Fallturm, D-28359 Bremen, Germany.
EM odenbach@zarm.uni-bremen.de
RI Odenbach, Stefan/D-4542-2009
CR Alexiou C, 2003, J DRUG TARGET, V11, P139, DOI 10.1080/1061186031000150791
   BRUNKE O, UNPUB EUR PHYS J APP
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   Hilger I, 2002, INVEST RADIOL, V37, P580, DOI 10.1097/00004424-200210000-00008
   Winter PM, 2003, CANCER RES, V63, P5838
NR 5
TC 16
Z9 16
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD MAR
PY 2005
VL 289
BP 428
EP 430
DI 10.1016/j.jmmm.2004.11.120
PG 3
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 912YU
UT WOS:000228117100121
DA 2018-10-20
ER

PT J
AU Verne, E
   Brovarone, C
   Moisescu, C
AF Verne, E
   Brovarone, C
   Moisescu, C
TI Glazing of alumina by a fluoroapatite-containing glass-ceramic
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID BIOACTIVE GLASSES; COATINGS; HYDROXYAPATITE; BIOCERAMICS
AB Glazing of alumina substrates was performed in order to prepare bioactive glass-ceramic coatings for biomedical applications. The coating material was a fluoroapatite-containing glass-ceramic (SAF) with a good degree of bioactivity. A careful optimisation of the coating conditions was carried out. The obtained coatings were characterized by means of scanning electron microscopy (SEM), compositional analysis (EDS), X-Ray diffraction (XRD), and in vitro tests (soaking into a simulated body fluid). Direct firing of SAF powders on the ceramic substrates gave unsatisfactory results in terms of crack propagation and bioactivity, due to the nucleation of a non-bioactive Al-rich phase (leucite) with high linear expansion coefficient. The use of an intermediate layer based on a SiO(2)-CaO glass (SC) was necessary in order to avoid Al ions diffusion through the coating and thus the formation of undesired additional phases. The coatings obtained with the optimised processing parameters resulted to be adherent, defect-free, and characterized by unchanged composition and structure as well as unmodified bioactivity if compared with the bulk SAF glass-ceramic. (C) 2005 Springer Science + Business Media, Inc.
C1 Politecn Torino, Dept Mat Sci & Chem Engn, Turin, Italy.
   Johnson Matthey BV, NL-6222 NZ Maastricht, Netherlands.
RP Verne, E (reprint author), Politecn Torino, Dept Mat Sci & Chem Engn, Turin, Italy.
EM enrica.verne@polito.it
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Verne,
   Enrica/0000-0002-8649-4739
CR Bosetti M, 2003, J BIOMED MATER RES A, V66A, P615, DOI 10.1002/jbm.a.10030
   Brovarone CV, 2001, J EUR CERAM SOC, V21, P2855
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Ferraris M, 1996, J EUR CERAM SOC, V16, P421, DOI 10.1016/0955-2219(95)00114-X
   Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1999, MATER SCI FORUM, V293, P37, DOI 10.4028/www.scientific.net/MSF.293.37
   Holand W, 1997, J NON-CRYST SOLIDS, V219, P192, DOI 10.1016/S0022-3093(97)00329-3
   Hulbert S. F., 1993, INTRO BIOCERAMICS, V1, P25
   Kim CY, 2003, J EUR CERAM SOC, V23, P1803, DOI 10.1016/S0955-2219(02)00444-2
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LEVIN EM, 1964, PHASE DIAGRAMS CERAM, P1969
   Moisescu C, 1999, J NON-CRYST SOLIDS, V248, P169, DOI 10.1016/S0022-3093(99)00239-2
   Moisescu C, 1999, J NON-CRYST SOLIDS, V248, P176, DOI 10.1016/S0022-3093(99)00240-9
   MOISESCU C, 2000, THESIS FSU JENA
   RAVAGLIOLI A, 1992, INTERCERAM, V41, P69
   Rawlings Rees D., 1993, Clinical Materials, V14, P155, DOI 10.1016/0267-6605(93)90038-9
   TOSHITAKA O, 1993, J AM CERAM SOC, V76, P2379
   Verne E, 2000, J EUR CERAM SOC, V20, P473, DOI 10.1016/S0955-2219(99)00181-8
   Verne E, 2002, BIOMATERIALS, V23, P3395, DOI 10.1016/S0142-9612(02)00040-6
   VERNE E, 1999, BIOCERAMICS, V12, P491
   VERNE E, 1997, BIOCERAMICS, V12, P491
NR 24
TC 6
Z9 7
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD MAR
PY 2005
VL 40
IS 5
BP 1209
EP 1215
DI 10.1007/s10853-005-6939-8
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 910TT
UT WOS:000227955800022
DA 2018-10-20
ER

PT J
AU Pritsos, C
   Kontonasaki, E
   Chatzistavrou, X
   Papadopoulou, L
   Pappas, F
   Koidis, P
   Paraskevopoulos, KM
AF Pritsos, C
   Kontonasaki, E
   Chatzistavrou, X
   Papadopoulou, L
   Pappas, F
   Koidis, P
   Paraskevopoulos, KM
TI Studying morphological characteristics of thermally treated bioactive
   glass ceramic using image analysis
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE electron microscopy; optical microscopy; glass ceramics; biomedical
   applications image analysis
ID SIMULATED BODY-FLUID; HYDROXYAPATITE; TEMPERATURE; BIOGLASS(R);
   PARTICLES; BEHAVIOR; SIZE
AB Bioactive glass ceramics are materials which develop a strong bond with living tissues through a carbonate-containing hydroxyapatatite layer, similar to that of bone. Recently, the use of thermally treated bioactive glass in dental restorations has been proposed, as it could provide a bioactive surface, which in combination with a tissue regenerative technique could lead to periodontal tissues attachment. The purpose of this study was the investigation of the qualitative and quantitative alterations of thermally treated bioactive glasses after incubation in simulated body fluid (SBF) for different time intervals, through the use of Image Analysis methods. There is a remarkable decrease in the dimensions of bioactive glass particles-their shape being more elongated-with the immersion time in SBF and the depth from the surface. The influence on particles morphology in deeper layers is recognizable and the species in the coating, present bioactivity on the surface and in the volume. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Aristotle Univ Thessaloniki, Dept Fixed Prosthesis & Implant Proshtodont, Sch Dent, Thessaloniki 54124, Greece.
   Aristotle Univ Thessaloniki, Dept Phys, Thessaloniki 54124, Greece.
   Aristotle Univ Thessaloniki, Dept Geol, Thessaloniki 54124, Greece.
RP Paraskevopoulos, KM (reprint author), Aristotle Univ Thessaloniki, Dept Fixed Prosthesis & Implant Proshtodont, Sch Dent, Thessaloniki 54124, Greece.
EM kpar@auth.gr
RI Papadopoulou, Lambrini/R-3341-2017; Paraskeuopoulos,
   Konstantinos/F-9926-2011
CR ANDERSON OH, 1990, J NONCRYST SOLIDS, V112, P290
   Arcos D, 2002, CHEM MATER, V14, P1515, DOI [10.1021/cm011119p, 10.1021/cmO11119p]
   Chatzistavrou X, 2004, PHYS STATUS SOLIDI A, V201, P944, DOI 10.1002/pssa.200306776
   Clupper DC, 2002, BIOMATERIALS, V23, P2599, DOI 10.1016/S0142-9612(01)00398-2
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   FUJIU T, 1983, J NON-CRYST SOLIDS, V56, P417, DOI 10.1016/0022-3093(83)90505-7
   Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3
   Greenspan D. C., 1994, BIOCERAMICS, V7, P55
   GUMMEL J, 1988, Z KLIN MED, V43, P1971
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HYAKUNA K, 1990, J BIOMED MATER RES, V24, P471, DOI 10.1002/jbm.820240406
   KELLERHALS R, 1975, J GEOL, V83, P79, DOI 10.1086/628046
   Khajotia SS, 1999, DENT MATER, V15, P390, DOI 10.1016/S0109-5641(99)00062-7
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kontonasaki E, 2003, J ORAL REHABIL, V30, P893, DOI 10.1046/j.1365-2842.2003.01072.x
   KRAJEWSKI A, 1985, AM CERAM SOC BULL, V64, P679
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O, P4
   Legeros Z. R., 1991, CALCIUM PHOSPHATES O, P82
   MacNeill SR, 1999, J CLIN PERIODONTOL, V26, P239, DOI 10.1034/j.1600-051X.1999.260407.x
   Merwin GE, 1990, HDB BIOACTIVE CERAMI, V1, P323
   NAKAMURA T, 1994, BIOCERAMICS, V7, P145
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Papadopoulou L, 2003, PHYS STATUS SOLIDI A, V198, P65, DOI 10.1002/pssa.200306588
   Peterson TD, 1996, CONTRIB MINERAL PETR, V124, P395, DOI 10.1007/s004100050199
   Pryce RS, 2003, KEY ENG MAT, V240-2, P201, DOI 10.4028/www.scientific.net/KEM.240-242.201
   Shi DL, 2002, J BIOMED MATER RES, V63, P71, DOI 10.1002/jbm.10087
   TUOMINEN U, 1993, BIOCERAMICS, V6, P151
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   WANG SA, 1989, J ORAL REHABIL, V16, P229
   WILSON J, 1994, BIOCERAMICS, V7, P415
   Zamet JS, 1997, J CLIN PERIODONTOL, V24, P410, DOI 10.1111/j.1600-051X.1997.tb00205.x
   Zhong J. P., 1998, BIOCERAMICS, V11, P415
NR 34
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. European Ceram. Soc.
PD MAR
PY 2005
VL 25
IS 6
BP 891
EP 897
DI 10.1016/j.jeurceramsoc.2004.04.004
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA 908XB
UT WOS:000227822400014
DA 2018-10-20
ER

PT J
AU Herr, HW
AF Herr, HW
TI A history of partial nephrectomy for renal tumors
SO JOURNAL OF UROLOGY
LA English
DT Article
DE kidney; kidney neoplasms; nephrectomy; history of medicine
ID NEPHRON SPARING SURGERY; 10-YEAR FOLLOW-UP; CELL CARCINOMA;
   ADENOCARCINOMA; KIDNEY
AB Purpose: This article records the history of nephron sparing surgery for renal tumors.
   Materials and Methods: Multiple biomedical databases were queried. Original sources were reviewed to document the history of partial nephrectomy.
   Results: For more than a century partial nephrectomy evolved as treatment for renal tumors, first by accident, then rejected as a planned procedure in favor of radical nephrectomy, later in mandatory cases of solitary kidney, poor renal function or bilateral renal tumors and then to an accepted elective procedure in cases with a healthy opposite kidney. Partial nephrectomy became widely accepted only recently for many renal tumors due to parallel advances in tumor biology, radiological imaging and surgical technology.
   Conclusions: The history of partial nephrectomy is a timely story setting important precedents for understanding current and future strategies to treat changing patterns of renal neoplasms.
C1 Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY USA.
RP Herr, HW (reprint author), Mem Hosp, 1275 York Ave, New York, NY 10021 USA.
EM herrh@mskcc.org
CR Bell ET, 1938, J UROLOGY, V39, P238, DOI 10.1016/S0022-5347(17)71856-3
   ENGEN DE, 1981, BR J UROL, V53, P378
   Fergany AF, 2000, J UROLOGY, V163, P442, DOI 10.1016/S0022-5347(05)67896-2
   FLEMING JOSEPH P., 1964, BRIT J UROL, V36, P313, DOI 10.1111/j.1464-410X.1964.tb09515.x
   Goldstein AE, 1937, J UROLOGY, V38, P15, DOI 10.1016/S0022-5347(17)71922-2
   Gregoire W, 1903, B MED SOC ANAT PARIS, V78, P764
   GROSS R, 1985, AM J MED SCI, V90, P79
   Herczel E., 1890, BRUNS BEITR KLIN CHI, V6, P485
   Herr HW, 1999, J UROLOGY, V161, P33, DOI 10.1016/S0022-5347(01)62052-4
   HESS E, 1950, J UROLOGY, V64, P175, DOI 10.1016/S0022-5347(17)68617-8
   LICHT MR, 1993, J UROLOGY, V149, P1
   MARBERGER M, 1981, BRIT J UROL, V53, P528, DOI 10.1111/j.1464-410X.1981.tb03254.x
   Newman D., 1901, LANCET, V23, P149
   NOVICK AC, 1977, J UROLOGY, V118, P932, DOI 10.1016/S0022-5347(17)58254-3
   PUIGVERT A, 1976, European Urology, V2, P70
   ROBSON CJ, 1963, J UROLOGY, V89, P37, DOI 10.1016/S0022-5347(17)64494-X
   Simon G., 1876, CHIRURG NIEREN, V2, P314
   VERMOOTEN V, 1950, J UROLOGY, V64, P200, DOI 10.1016/S0022-5347(17)68620-8
   Wells S, 1884, Br Med J, V1, P758
   Wharton LR, 1939, J UROLOGY, V42, P713, DOI 10.1016/S0022-5347(17)71567-4
   WICKHAM JEA, 1975, BRIT J UROL, V47, P25, DOI 10.1111/j.1464-410X.1975.tb03914.x
NR 21
TC 39
Z9 45
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAR
PY 2005
VL 173
IS 3
BP 705
EP 708
DI 10.1097/01.ju.0000146270.65101.1d
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 898KK
UT WOS:000227075500009
PM 15711247
DA 2018-10-20
ER

PT J
AU Mills, CA
   Martinez, E
   Bessueille, F
   Villanueva, G
   Bausells, J
   Samitier, J
   Errachid, A
AF Mills, CA
   Martinez, E
   Bessueille, F
   Villanueva, G
   Bausells, J
   Samitier, J
   Errachid, A
TI Production of structures for microfluidics using polymer imprint
   techniques
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT 30th International Conference on Micro and Nano Engineering
CY SEP 19-22, 2004
CL Rotterdam, NETHERLANDS
DE hot embossing; nanoimprint lithography; micromoldin; micromechanisation;
   polymers
ID MASS-SPECTROMETRY; DEVICES
AB We present a technology for the fabrication of three dimensional microfluidic channels in optically transparent substrates consisting of polymers with different properties. The microstructures are fabricated using polymer replication techniques with a view to the production of microfluidic devices with characteristics suitable for biomedical applications. The replication processes can be used to fabricate large numbers of highly precise, complex microchannels via replication from a single similarly precise master, containing microstructures fabricated from silicon-based materials using lithographic micromachining techniques. Silicon oxide and silicon nitride-based masters have been used, due to their anti-adhesion properties, to produce microchannels, in the transparent polymers, that are suitable for channel profiling measurements and optical studies of fluid flow. (c) 2005 Elsevier B.V. All rights reserved.
C1 CREBEC, Nanobioengn Lab, E-08028 Barcelona, Spain.
   CSIC, IBM, Ctr Nacl Microelect, E-08193 Barcelona, Spain.
RP Mills, CA (reprint author), CREBEC, Nanobioengn Lab, Barcelona Sci Pk,Josep Samitier 1-5, E-08028 Barcelona, Spain.
EM cmills@pcb.ub.es
RI Mills, Christopher/C-5535-2009; Bausells, Joan/K-1808-2014; MARTINEZ,
   ELENA/F-7572-2014; Villanueva, Luis Guillermo/C-4904-2009; Martinez,
   Elena/C-6008-2009
OI Mills, Christopher/0000-0002-2906-4978; Bausells,
   Joan/0000-0003-3706-4975; Villanueva, Luis
   Guillermo/0000-0003-3340-2930; 
CR Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   Bendix D, 1998, POLYM DEGRAD STABIL, V59, P129, DOI 10.1016/S0141-3910(97)00149-3
   BESSUEILLE F, UNPUB BIOSENS BIOELE
   BRYUNG HJ, 2000, J MICROELECTROMECH S, V9, P76
   FREEMANTLE M, 1999, CHEM ENG NEWS, V22, P27
   HEKELE M, 2004, J MICROMECH MICROENG, V14, pR1
   Higashioji T, 2003, TRIBOL INT, V36, P437, DOI 10.1016/S0301-679X(02)00232-3
   Liu HH, 2000, ANAL CHEM, V72, P3303, DOI 10.1021/ac000115l
   Meng ZJ, 2001, ANAL CHEM, V73, P1286, DOI 10.1021/ac000984a
   MILLS CA, UNPUB J BIOMED MAT R
   MILLS CA, IN PRESS NANOTECHNOL
   Ouchi I, 2003, NUCL INSTRUM METH B, V199, P270, DOI 10.1016/S0168-583X(02)01586-0
   RENAUD P, 1998, MICRO TOTAL ANAL SYS, P17
   Torres CMS, 2003, MAT SCI ENG C-BIO S, V23, P23, DOI 10.1016/S0928-4931(02)00221-7
   Wen J, 2000, ELECTROPHORESIS, V21, P191, DOI 10.1002/(SICI)1522-2683(20000101)21:1<191::AID-ELPS191>3.0.CO;2-M
   Xue QF, 1997, ANAL CHEM, V69, P426, DOI 10.1021/ac9607119
   Yuan CH, 2001, ANAL CHEM, V73, P1080, DOI 10.1021/ac001305z
NR 17
TC 52
Z9 54
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
EI 1873-5568
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD MAR
PY 2005
VL 78-79
SI SI
BP 695
EP 700
DI 10.1016/j.mee.2004.12.087
PG 6
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 919AC
UT WOS:000228589700113
DA 2018-10-20
ER

PT J
AU Georg, C
   Welker, V
   Eidam, H
   Alfkel, H
AF Georg, C
   Welker, V
   Eidam, H
   Alfkel, H
TI Aortic stentgraft movement detection using digital roentgen
   stereophotogrammetric analysis on plane film radiographs - Initial
   results of a phantom study
SO ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER
   BILDGEBENDEN VERFAHREN
LA English
DT Article
DE stentgraft movement; roentgen stereophotogrammetric analysis; RSA
ID RADIOSTEREOMETRIC ANALYSIS RSA; TOTAL KNEE ARTHROPLASTY; RECONSTRUCTION;
   MIGRATION; ACCURACY; ENDOGRAFTS; FIXATION; ANEURYSM; LIGAMENT; HIP
AB Purpose: To evaluate the feasibility of aortic stentgraft micromovement detection using digital roentgen stereophotogrammetric analysis on plane film radiographs. Material and Methods: An aortic stentgraft used for demonstration purposes was marked with 10 tantalum markers of 0.8 mm in diameter. The stentgraft was placed on a Plexiglas phantom with 5 tantalum markers of 1 mm in diameter simulating a fixed segment needed for mathematical analysis. In a subsequent step, the stentgraft was placed onto an orthopaedic spine model to simulate in vivo conditions in a next step. Two radiographs taken simultaneously from different angles were used for simulating different stentgraft movement, e.g. translation, angulation, aortic pulsation and migration in the spine model. Movement of the stentgraft markers was analysed using a commercially available digital RSA setup (UmRSA(R) 4.1, RSA Biomedical, Umea, Sweden). Results: Our study shows the feasibility of measuring aortic stentgraft movement and changes in stentgraft shape in the submillimeter range using digital roentgen stereophotogrammetric analysis. Translation along the 3 cardinal axes, change in stentgraft shape, simulation of aortic pulsation and simulation of in vivo conditions could be described precisely. Conclusion: Aortic stentgraft movement detection using digital roentgen stereophotogrammetric analysis on plane film radiographs is a very promising, precise method.
C1 Hosp Luedenscheid, Dept Diagnost & Intervent Radiol, D-58515 Luedenscheid, Germany.
   Univ Marburg, Dept Diagnost Radiol, Marburg, Germany.
   Univ Marburg, Dept Math, Marburg, Germany.
   Univ Marburg, Dept Tech Serv, Marburg, Germany.
RP Alfkel, H (reprint author), Hosp Luedenscheid, Dept Diagnost & Intervent Radiol, Paulmannshoher Str 14, D-58515 Luedenscheid, Germany.
EM alfke@klinikum-luedenscheid.de
CR Chuter TAM, 2002, CARDIOVASC SURG, V10, P7, DOI 10.1016/S0967-2109(01)00120-X
   Flora HS, 2001, J ENDOVASC THER, V8, P511, DOI 10.1583/1545-1550(2001)008<0511:MATAAN>2.0.CO;2
   Fukuoka S, 2000, J BONE JOINT SURG BR, V82B, P222, DOI 10.1302/0301-620X.82B2.9461
   GALLAND RB, 1991, BRIT J SURG, V78, P1259, DOI 10.1002/bjs.1800781036
   Jorn LP, 1997, ACTA ORTHOP SCAND, V68, P427, DOI 10.3109/17453679708996256
   Kramer SC, 2001, J ENDOVASC THER, V8, P34, DOI 10.1583/1545-1550(2001)008<0034:GCIAEO>2.0.CO;2
   LOFVENBERG R, 1994, ACTA ORTHOP SCAND, V65, P401, DOI 10.3109/17453679408995479
   MALCHAU H, 1995, ACTA ORTHOP SCAND, V66, P418, DOI 10.3109/17453679508995578
   Nilsson KG, 1996, J BONE JOINT SURG BR, V78B, P1
   Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271
   Regner L, 2000, J ARTHROPLASTY, V15, P681, DOI 10.1054/arth.2000.8103
   RYD L, 1995, J BONE JOINT SURG BR, V77B, P377
   RYD L, 1992, CLIN ORTHOP RELAT R, P56
   Ryd L, 2000, ACTA ORTHOP SCAND, V71, P403, DOI 10.1080/000164700317393420
   SELVIK G, 1990, ACTA RADIOL, V31, P113
   Valstar ER, 2000, J BIOMECH, V33, P1593, DOI 10.1016/S0021-9290(00)00138-X
   Vrooman HA, 1998, J BIOMECH, V31, P491, DOI 10.1016/S0021-9290(98)00025-6
   Yuan XH, 2000, J BIOMECH, V33, P493, DOI 10.1016/S0021-9290(99)00182-7
NR 18
TC 2
Z9 2
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 1438-9029
J9 ROFO-FORTSCHR RONTG
JI Rofo-Fortschr. Gebiet Rontgenstrahlen Bildgeb. Verfahr.
PD MAR
PY 2005
VL 177
IS 3
BP 321
EP 325
DI 10.1055/s-2005-857964
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 903BV
UT WOS:000227401300003
PM 15719292
DA 2018-10-20
ER

PT J
AU Ludlage, E
   Murphy, CL
   Davern, SM
   Solomon, A
   Weiss, DT
   Glenn-Smith, D
   Dworkin, S
   Mansfield, KG
AF Ludlage, E
   Murphy, CL
   Davern, SM
   Solomon, A
   Weiss, DT
   Glenn-Smith, D
   Dworkin, S
   Mansfield, KG
TI Systemic AA amyloidosis in the common marmoset
SO VETERINARY PATHOLOGY
LA English
DT Article
DE AA amyloid; amyloidosis; common marmoset
ID PROTEIN AA; PATHOGENESIS; PATHOLOGY; CATS; SAA
AB The common marmoset (Callithrix jacchus) is a small New World primate native to Brazil that has been used extensively in biomedical research. A retrospective analysis of archived hematoxylin and eosin-stained tissue sections and clinical records was conducted at the New England primate Research Center on 86 marmosets more than I year of age that were euthanized during the past decade because of morbidity and failure to thrive. Approximately 17% (15 of 86) were found to have amyloid deposits in one or more organs, including the liver, adrenal glands, kidneys, and intestine. This material was shown by amino acid sequence analysis to be composed of serum amyloid A (SAA)-related protein. This type of amyloidosis, designated AA or "secondary," is associated typically with an inflammatory process that induces elevated levels of the SAA amyloidogenic precursor molecule. Notably, there were no significant pathologic differences or other distinguishing features in animals with amyloid versus those without; furthermore, on the basis of the limited number of serum specimens available for analysis, the SAA concentrations in the two groups were comparable, thus Suggesting the possible inheritable nature of the disorder. In this respect, the common marmoset provides a unique experimental model for Study of the pathogenesis and treatment of AA and other forms of systemic amyloidosis.
C1 Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Southborough, MA 01772 USA.
   Univ Tennessee, Grad Sch Med, Dept Med, Human Immunol & Canc Program, Knoxville, TN 37996 USA.
   Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.
RP Ludlage, E (reprint author), Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Southborough, MA 01772 USA.
EM elisabeth_ludlage@hms.harvard.edu
FU NCRR NIH HHS [P51RR000168-41]; NCI NIH HHS [CA10056]
CR ABE M, 1993, HYBRIDOMA, V12, P475, DOI 10.1089/hyb.1993.12.475
   BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9
   Benson M. D., 2001, METABOLIC MOL BASES, P5345
   Benson MD, 1996, CIBA F SYMP, V199, P104
   BLANCHARD JL, 1986, VET PATHOL, V23, P425, DOI 10.1177/030098588602300412
   Booth DR, 1998, AMYLOID, V5, P262, DOI 10.3109/13506129809007299
   BOYCE JT, 1984, VET PATHOL, V21, P33, DOI 10.1177/030098588402100106
   CHALIFOUX LV, 1982, VET PATHOL, V19, P141, DOI 10.1177/030098588201907s11
   DIBARTOLA SP, 1989, J VET INTERN MED, V3, P31, DOI 10.1111/j.1939-1676.1989.tb00326.x
   Hubbard GB, 2001, J MED PRIMATOL, V30, P260, DOI 10.1034/j.1600-0684.2001.d01-58.x
   HUSBY G, 1994, AMYLOID, V1, P119, DOI 10.3109/13506129409148635
   Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558
   Johnson KH, 1997, AMYLOID, V4, P171, DOI 10.3109/13506129709014381
   Johnson KH, 1996, AMYLOID, V3, P270, DOI 10.3109/13506129609014375
   Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999
   Mansfield KG, 2001, AM J PATHOL, V159, P693, DOI 10.1016/S0002-9440(10)61740-3
   Mensua C, 2003, VET PATHOL, V40, P71, DOI 10.1354/vp.40-1-71
   Murphy CL, 2001, AM J CLIN PATHOL, V116, P135
   PRAS M, 1968, J CLIN INVEST, V47, P924
   Rocken C, 2002, VIRCHOWS ARCH, V440, P111, DOI 10.1007/s00428-001-0582-9
   SKINNER M, 1977, LAB INVEST, V36, P420
   SLATTUM MM, 1989, LAB ANIM SCI, V39, P567
   Solomon A, 1999, AM J PATHOL, V154, P1267, DOI 10.1016/S0002-9440(10)65378-3
   Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x
   WESTERMARK GT, 1990, AM J PATHOL, V137, P377
   YAMAMOTO M, 1998, REV TOXICOL, V2, P5
NR 26
TC 19
Z9 19
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0300-9858
EI 1544-2217
J9 VET PATHOL
JI Vet. Pathol.
PD MAR
PY 2005
VL 42
IS 2
BP 117
EP 124
DI 10.1354/vp.42-2-117
PG 8
WC Pathology; Veterinary Sciences
SC Pathology; Veterinary Sciences
GA 901RU
UT WOS:000227300400001
PM 15753464
DA 2018-10-20
ER

PT J
AU Ghoroghchian, PP
   Frail, PR
   Susumu, K
   Blessington, D
   Brannan, AK
   Bates, FS
   Chance, B
   Hammer, DA
   Therien, MJ
AF Ghoroghchian, PP
   Frail, PR
   Susumu, K
   Blessington, D
   Brannan, AK
   Bates, FS
   Chance, B
   Hammer, DA
   Therien, MJ
TI Near-infrared-emissive polymersomes: Self-assembled soft matter for in
   vivo optical imaging
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE porphyrin; vesicles; nanoscale; diblock copolymer
ID FLUORESCENT CONTRAST AGENTS; BLOCK-COPOLYMERS; MOLECULAR-WEIGHT;
   DRUG-DELIVERY; VESICLES; SURFACTANTS; MICROSCOPY; SYSTEMS; TUMORS; LIGHT
AB We demonstrate that synthetic soft materials can extend the utility of natural vesicles, from predominantly hydrophilic reservoirs to functional colloidal carriers that facilitate the biomedical application of large aqueous-insoluble compounds. Near-infrared (NIR)emissive polymersomes (50-nm- to 50-mum-diameter polymer vesicles) were generated through cooperative self assembly of amphiphilic diblock copolymers and conjugated multi(porphyrin)based NIR fluorophores (NIRFs). When compared with natural vesicles comprised of phospholipids, polymersomes were uniquely capable of incorporating and uniformly distributing numerous large hydrophobic NIRFs exclusively in their lamellar membranes. Within these sequestered compartments, long polymer chains regulate the mean fluorophore-fluorophore interspatial separation as well as the fluorophore-localized electronic environment. Porphyrin-based NIRFs manifest photophysical properties within the polymersomal matrix akin to those established for these high-emission dipole strength fluorophores in organic solvents, thereby yielding uniquely emissive vesicles. Furthermore, the total fluorescence emanating from the assemblies gives rise to a localized optical signal of sufficient intensity to penetrate through the dense tumor tissue of a live animal. Robust NIR-emissive polymersomes thus define a soft matter platform with exceptional potential to facilitate deep-tissue fluorescence-based imaging for in vivo diagnostic and drug-delivery applications.
C1 Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Engn & Appl Sci, Inst Med & Engn, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Med, Johnson Res Fdn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.
   Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.
RP Therien, MJ (reprint author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.
EM hammer@seas.upenn.edu; therien@sas.upenn.edu
OI Bates, Frank/0000-0003-3977-1278
FU NCI NIH HHS [R33-NO1-CO-29008]; NIBIB NIH HHS [EB003457-01, R01
   EB003457]
CR Achilefu S, 2000, INVEST RADIOL, V35, P479, DOI 10.1097/00004424-200008000-00004
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   Becker A, 2001, NAT BIOTECHNOL, V19, P327, DOI 10.1038/86707
   Bellomo EG, 2004, NAT MATER, V3, P244, DOI 10.1038/nmat1093
   Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l
   Chance B, 1998, ANN NY ACAD SCI, V838, P29, DOI 10.1111/j.1749-6632.1998.tb08185.x
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Franceschini MA, 1997, P NATL ACAD SCI USA, V94, P6468, DOI 10.1073/pnas.94.12.6468
   Gu YQ, 2002, REV SCI INSTRUM, V73, P172, DOI 10.1063/1.1424907
   Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/ange.200200546
   Hawrysz DJ, 2000, NEOPLASIA, V2, P388, DOI 10.1038/sj.neo.7900118
   Intes X, 2003, MED PHYS, V30, P1039, DOI 10.1118/1.1573791
   Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778
   Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kimizuka N, 2003, CURR OPIN CHEM BIOL, V7, P702, DOI 10.1016/j.cbpa.2003.10.010
   Langer R, 1998, NATURE, V392, P5
   Lin JJ, 2004, LANGMUIR, V20, P5493, DOI 10.1021/la036417a
   Lin VSY, 1995, CHEM-EUR J, V1, P645, DOI 10.1002/chem.19950010913
   LIN VSY, 1994, SCIENCE, V264, P1105, DOI 10.1126/science.8178169
   Meng FH, 2003, MACROMOLECULES, V36, P3004, DOI 10.1021/ma034040+
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Najafi F, 2003, BIOMATERIALS, V24, P1175, DOI 10.1016/S0142-9612(02)00487-8
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   Photos PJ, 2003, J CONTROL RELEASE, V90, P323, DOI 10.1016/S0168-3659(03)00201-3
   Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7
   Rubtsov IV, 2003, J AM CHEM SOC, V125, P2687, DOI 10.1021/ja021157p
   Sevick-Muraca EM, 2002, CURR OPIN CHEM BIOL, V6, P642, DOI 10.1016/S1367-5931(02)00356-3
   Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384
   Susumu K, 2002, J AM CHEM SOC, V124, P8550, DOI 10.1021/ja0203925
   Torchilin V. P., 2003, PRACTICAL APPROACH S, V264, P1
   Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   Won YY, 2002, J PHYS CHEM B, V106, P3354, DOI 10.1021/jp013639d
   Zaheer A, 2001, NAT BIOTECHNOL, V19, P1148, DOI 10.1038/nbt1201-1148
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
NR 42
TC 272
Z9 276
U1 5
U2 95
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 22
PY 2005
VL 102
IS 8
BP 2922
EP 2927
DI 10.1073/pnas.0409394102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 900RQ
UT WOS:000227232400046
PM 15708979
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Deville, S
   Gremillard, L
   Chevalier, J
   Fantozzi, G
AF Deville, S
   Gremillard, L
   Chevalier, J
   Fantozzi, G
TI A critical comparison of methods for the determination of the aging
   sensitivity in biomedical grade yttria-stabilized zirconia
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE aging; hip replacement prosthesis; yttria-stabilized zirconia
ID ATOMIC-FORCE MICROSCOPY; Y-TZP CERAMICS; DEGRADATION; ALUMINA
AB Since the recent failure events of two particular series of zirconia femoral heads for total hip replacement prosthesis, a large decrease in the use of zirconia ceramics for orthopaedic implants has been observed. In spite of the biomedical success of this material during the last 10 years, this decrease in use was required for safety reasons, until the cause of the failures is known. It has been shown that these failures were related to the low temperature hydrothermal degradation (also known as aging). Thus, it is crucial to better understand the aging behavior, in order to be able to assess its importance and then control it if required. In this study, various techniques relevant to assess the hydrothermal degradation sensitivity of biomedical grade yttria-stabilized zirconia are discussed and compared. The expected outputs of conventional methods, that is, X-ray diffraction and scanning electron microscopy are examined. More recent methods like optical interferometry and atomic force microscopy are presented, with their respective benefits and drawbacks. An up-to-date comparison of these different techniques is provided, and their use for ensuring the long-term reliability of a particular batch of zirconia in terms of aging degradation is demonstrated. (C) 2004 Wiley Periodicals, Inc.
C1 Inst Natl Sci Appl, Etud Met Phys & Phys Mat Grp, Dept Mat Sci, Associate Res Unit 5510, F-69621 Villeurbanne, France.
   LBNL, Div Sci Mat, Berkeley, CA 94720 USA.
RP Chevalier, J (reprint author), Inst Natl Sci Appl, Etud Met Phys & Phys Mat Grp, Dept Mat Sci, Associate Res Unit 5510, 20 Av A Einstein, F-69621 Villeurbanne, France.
EM jerome.chevalier@insa-lyon.fr
OI Gremillard, Laurent/0000-0001-7258-6483; Deville,
   Sylvain/0000-0002-3363-3184
CR Affatato S, 1999, BIOMATERIALS, V20, P1925, DOI 10.1016/S0142-9612(99)00093-9
   Burlington D. B., 1997, STEAM RESTERILIZATIO
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Christian J. W., 1965, THEORY TRANSFORMATIO, P1
   Deville S, 2003, J AM CERAM SOC, V86, P2225, DOI 10.1111/j.1151-2916.2003.tb03639.x
   Fullman R.L., 1953, J MET, V5, P447
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Gremillard L, 2004, J EUR CERAM SOC, V24, P3483, DOI 10.1016/j.jeurceramsoc.2003.11.025
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   HIRANO M, 1991, J MATER SCI, V26, P5047, DOI 10.1007/BF00549890
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   MCKELLOP H, 1992, P 38 ANN M ORTH RES, P402
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Tsubakino H, 1999, J AM CERAM SOC, V82, P2921
   *UK MED DEV AG SAF, 2001, REC SPEC BATCH ZIRC
   Willmann G, 1996, J MATER PROCESS TECH, V56, P168, DOI 10.1016/0924-0136(96)85101-6
   WURST JC, 1972, J AM CERAM SOC, V55, P109, DOI 10.1111/j.1151-2916.1972.tb11224.x
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 21
TC 95
Z9 95
U1 0
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2005
VL 72B
IS 2
BP 239
EP 245
DI 10.1002/jbm.b.30123
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892GS
UT WOS:000226638700003
PM 15654702
OA Green Published
DA 2018-10-20
ER

PT J
AU Jiang, GQ
   Mishler, D
   Davis, R
   Mobley, JP
   Schulman, JH
AF Jiang, GQ
   Mishler, D
   Davis, R
   Mobley, JP
   Schulman, JH
TI Zirconia to Ti-6Al-4V braze joint for implantable biomedical device
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE zirconia; titanium alloys; mechanical properties; biocompatibility/soft
   tissue
ID MICROSTRUCTURE
AB A strong, hermetic, reliable, and biocompatible ceramic-to-metal seal is essential for many implantable medical devices. Yttria-stabilized tetragonal zirconia polycrystals (Y-TZPs) and a titanium alloy Ti-6AI-4V were selected as the ceramic and metal components of the seal because both materials have excellent mechanical properties and favorable biocompatibility. A brazing method using titanium nickel (TiNi)-clad braze filler material is presented to bond the components together forming a seal. Laboratory tests show that the ceramic-to-metal seal is hermetic, strong, and resistant to electrochemical corrosion. Twenty-eight microstimulators utilizing the ceramic-to-metal seals were implanted in seven sheep to stimulate the hypoglossal nerve. When the tissue was evaluated by gross inspection at necropsy and examined histologically by a pathologist, there were no signs of local hemorrhage, infection, or hypoglossal nerve tissue damage. (C) 2004 Wiley Periodicals, Inc.
C1 Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.
   Alfred E Mann Fdn Sci Res, Santa Clarita, CA 91355 USA.
RP Jiang, GQ (reprint author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.
EM jiang@aemf.org
CR Agathopoulos S, 2002, KEY ENG MAT, V206-2, P487, DOI 10.4028/www.scientific.net/KEM.206-213.487
   AGATHOPOULOS S, 1997, CERAMIC T, V77, P75
   AGATHOPOULOS S, 2002, ADV JOINING CERAMICS, P135
   ARCOS I, 2001, ARTIF ORGANS, V26, P228
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Correia RN, 1998, J MATER SCI, V33, P215, DOI 10.1023/A:1004378520526
   KUBASCHEWSKI O, 1955, J I MET, V84, P440
   PARK E, 1991, METAL CERAMIC JOININ, P1676
   PEYTOUR C, 1990, J MATER SCI LETT, V9, P1129, DOI 10.1007/BF00721864
   SANTELLA ML, 1993, WELDING RES S, P165
   Uo M, 1999, BIOMATERIALS, V20, P747, DOI 10.1016/S0142-9612(98)00224-5
NR 11
TC 15
Z9 17
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2005
VL 72B
IS 2
BP 316
EP 321
DI 10.1002/jbm.b.30161
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892GS
UT WOS:000226638700014
PM 15497165
DA 2018-10-20
ER

PT J
AU Li, XD
   Wang, XN
   Bondokov, R
   Morris, J
   An, YHH
   Sudarshan, TS
AF Li, XD
   Wang, XN
   Bondokov, R
   Morris, J
   An, YHH
   Sudarshan, TS
TI Micro/nanoscale mechanical and tribological characterization of SiC for
   orthopedic applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE SiC; biomaterials; orthopedic; nanoindentation; mechanical properties;
   tribology
ID SILICON-CARBIDE; IN-VITRO; RETRIEVAL; PARTICLES; DIAMOND; FILMS
AB Micro/nanomechanical and tribological characterization of SiC has been carried out. For comparison, measurements on SiC, CoCrMo, Ti-6Al-4V, and stainless steel have also been made. Hardness and elastic modulus of these materials were measured by nanoindentation using a nanoindenter. The nanoindentation impressions were imaged using an atomic force microscope (AFM). Scratch, friction, and wear properties were measured using an accelerated microtribometer. Scratch and wear damages were studied using a scanning electron microscope (SEM). It is found that SiC exhibits higher hardness, elastic modulus, scratch resistance as well as lower friction with fewer and smaller debris particles compared to other materials. These results show that SiC possesses superior mechanical and tribological properties that make it an ideal material for use in orthopedic and other biomedical applications. (C) 2004 Wiley Periodicals, Inc.
C1 Univ S Carolina, Dept Mech Engn, Columbia, SC 29208 USA.
   Univ S Carolina, Dept Elect Engn, Columbia, SC 29208 USA.
   Med Univ S Carolina, Orthopaed Res Lab, Charleston, SC 29425 USA.
RP Li, XD (reprint author), Univ S Carolina, Dept Mech Engn, 300 Main St, Columbia, SC 29208 USA.
EM lixiao@engr.sc.edu
RI Li, Xiaodong/B-6530-2008
CR ALLEN M, 1995, BIO-MED MATER ENG, V5, P151
   Aspenberg P, 1996, BIOMATERIALS, V17, P807, DOI 10.1016/0142-9612(96)81418-9
   Bessette BIJ, 2003, CAN J SURG, V46, P257
   Bhushan B, 2003, INT MATER REV, V48, P125, DOI 10.1179/095066003225010227
   Bhushan B., 1999, PRINCIPLES APPL TRIB
   BHUSHAN B, 1998, TRIBOLOGY ISSUES OPP, P407
   BHUSHAN B, 2003, HIGH PRESSURE SURFAC, P321
   Cherednichenko DI, 2004, J CRYST GROWTH, V262, P175, DOI 10.1016/j.jcrysgro.2003.09.048
   Friedman RJ, 1996, J ORTHOPAED RES, V14, P455, DOI 10.1002/jor.1100140316
   Goodman SB, 1998, CLIN ORTHOP RELAT R, P25
   Kadoya Y, 1998, Acta Orthop Scand Suppl, V278, P1
   Kalnins Uldis, 2002, Med Sci Monit, V8, pPI16
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   LEMONS J, 2002, BONEZONE         FAL
   Li XD, 2003, ULTRAMICROSCOPY, V97, P481, DOI 10.1016/S0304-3991(03)00077-9
   Li XD, 2002, MATER CHARACT, V48, P11
   Li XD, 1999, THIN SOLID FILMS, V340, P210, DOI 10.1016/S0040-6090(98)01153-5
   McGee MA, 2000, WEAR, V241, P158, DOI 10.1016/S0043-1648(00)00370-7
   MCLAUGHLIN J, 2000, SIC SUBRETINAL APPL, P34
   Monnink SHJ, 1999, J INVEST MED, V47, P304
   Nordsletten L, 1996, BIOMATERIALS, V17, P1521, DOI 10.1016/0142-9612(96)89777-8
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Santavirta S, 1998, ARCH ORTHOP TRAUM SU, V118, P89, DOI 10.1007/s004020050319
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
NR 24
TC 50
Z9 51
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2005
VL 72B
IS 2
BP 353
EP 361
DI 10.1002/jbm.b.30168
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892GS
UT WOS:000226638700020
PM 15538716
DA 2018-10-20
ER

PT J
AU Kitano, H
   Kawasaki, A
   Kawasaki, H
   Morokoshi, S
AF Kitano, H
   Kawasaki, A
   Kawasaki, H
   Morokoshi, S
TI Resistance of zwitterionic telomers accumulated on metal surfaces
   against nonspecific adsorption of proteins
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 53rd Symposium of the Society-of-Polymer-Science on Macromolecules
CY SEP, 2004
CL Sapporo, JAPAN
SP Soc Polymer Sci
DE cyclic voltammetry Iniferter; nonspecific adsorption; protein
   adsorption; self-assembled monolayer; surface plasmon resonance;
   Telomerization; Zwitterionic telomer
ID SELF-ASSEMBLED MONOLAYERS; LIVING-RADICAL POLYMERIZATION; ORGANIZED
   MOLECULAR ASSEMBLIES; RESONANCE RAMAN-SPECTROSCOPY; GOLD COLLOID
   MONOLAYERS; ATOMIC-FORCE MICROSCOPY; AG ISLAND FILMS; INTERFACIAL
   RECOGNITION; THIOLATED CYCLODEXTRIN; BENZYL N,N-DIETHYLDITHIOCARBAMATE
AB Telomers of N,N-dimethyl-N-(3-sulfopropyl)(-3')-methacryloylaminopropanaminium inner salt (SPB), 2-methacryloyloxyethyl phosphorylcholine (MPC), and N,N-dimethyl-N-(1-carboxymethyl)-2-methacryloyloxylethanaminium inner salt (CMB) were prepared by UV irradiation in the presence of N,N,N',N'-tetraethylthiuram disulfide and a disulfide-group-carrying iniferter (a compound which pursues initiation, chain transfer, and termination). Cys-BDC, which had been prepared by coupling N.N-diethyldithiocarbamoylmethylbenzoic acid succinimidyl ester with cystamine dihydrochloride. The telomers formed a self-assembled rnonolayer (SAM) on a gold electrode and a monolayer of colloidal gold deposited on a glass plate, as confirmed by the increase in potential difference (DeltaE(p)) of the voltammogram for hydroquinone as a probe using cyclic voltammetry (CV) and the increase in absorbance using localized surface plasmon resonance (LSPR) absorption spectroscopy, respectively. Nonspecific adsorption of various proteins onto the surfaces of various telomer SAMs was examined from the decrease in peak current (DeltaI) using CV and the absorption increase at 550 nm using LSPR absorption spectroscopy. The zwitterionic telomer SAM in general did not adsorb proteins significantly, suggesting the usability of zwitterionic polymer SAMs and brushes to coat various materials used in biomedical fields. The correlation between the structure of water in the vicinity of zwitterionic telomers and the resistance of the zwitterionic telomer SAMs against the nonspecific adsorption of proteins was discussed. (C) 2004 Elsevier Inc. All rights reserved.
C1 Toyama Univ, Dept Chem & Biochem Engn, Toyama 9308555, Japan.
RP Kitano, H (reprint author), Toyama Univ, Dept Chem & Biochem Engn, Toyama 9308555, Japan.
EM kitano@eng.toyama-u.ac.jp
CR ANUFRIEVA EV, 1968, J POLYM SCI POL SYM, P3519
   Baethge H, 1997, MACROMOL RAPID COMM, V18, P911, DOI 10.1002/marc.1997.030181003
   Bain C. D., 1989, ADV MATER, V1, P506
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Beulen MWJ, 1998, LANGMUIR, V14, P7463, DOI 10.1021/la981031z
   Cheng SF, 2003, ANAL CHEM, V75, P16, DOI 10.1021/ac020310v
   Chi QJ, 2000, J AM CHEM SOC, V122, P4047, DOI 10.1021/ja993174t
   CHIDSEY CED, 1990, LANGMUIR, V6, P682, DOI 10.1021/la00093a026
   DALY WH, 1988, TETRAHEDRON LETT, V29, P5859, DOI 10.1016/S0040-4039(00)82209-1
   Dirix Y, 1999, ADV MATER, V11, P223, DOI 10.1002/(SICI)1521-4095(199903)11:3<223::AID-ADMA223>3.0.CO;2-J
   DOI T, 1994, J POLYM SCI POL CHEM, V32, P2911, DOI 10.1002/pola.1994.080321512
   DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253
   Emory SR, 1998, J PHYS CHEM B, V102, P493, DOI 10.1021/jp9734033
   Flink S, 1998, J AM CHEM SOC, V120, P4652, DOI 10.1021/ja9734713
   FREEMAN RG, 1995, SCIENCE, V267, P1629, DOI 10.1126/science.267.5204.1629
   Fukuda T, 1999, LANGMUIR, V15, P1887, DOI 10.1021/la981269n
   Fukuda T, 1996, MACROMOLECULES, V29, P3050, DOI 10.1021/ma951792y
   GARRETT RH, 1995, BIOCHEMISTRY
   GENNIS RB, 1989, BIOMEMBRANES MOL STR
   Gorman CB, 1998, LANGMUIR, V14, P3312, DOI 10.1021/la9803023
   Grabar KC, 1997, ANAL CHEM, V69, P471, DOI 10.1021/ac9605962
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   Guo SR, 2001, POLYMER, V42, P1017, DOI 10.1016/S0032-3861(00)00472-9
   Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hawker CJ, 1996, MACROMOLECULES, V29, P2686, DOI 10.1021/ma9515137
   HILL W, 1993, J PHYS CHEM-US, V97, P9451, DOI 10.1021/j100139a032
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Horton H. R., 2002, PRINCIPLES BIOCH
   Huisman BH, 1996, ADV MATER, V8, P561, DOI 10.1002/adma.19960080704
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1077
   Jensen TR, 2000, APPL SPECTROSC, V54, P371, DOI 10.1366/0003702001949654
   Jeon NL, 1997, LANGMUIR, V13, P3382, DOI 10.1021/la970166m
   Ji J, 2000, POLYMER, V41, P3713, DOI 10.1016/S0032-3861(99)00556-X
   Jonsson B., 1998, SURFACTANTS POLYM AQ
   Jun Z., 2003, COLLOID SURFACE B, V28, P1
   Kaifer A. E., 1996, COMPREHENSIVE SUPRAM, V8, P499
   Kanayama N, 2000, J PHYS CHEM B, V104, P271, DOI 10.1021/jp990884c
   Kanayama N, 2000, LANGMUIR, V16, P577, DOI 10.1021/la990182e
   Kitamura T, 2002, J TEMPORAL DESIGN AR, V2, P13
   KITANO H, 1989, J AM CHEM SOC, V111, P6809, DOI 10.1021/ja00199a048
   Kitano H, 2004, J COLLOID INTERF SCI, V273, P106, DOI 10.1016/j.jcis.2004.01.027
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kitano H, 2002, J PHYS CHEM B, V106, P11391, DOI 10.1021/jp020185r
   Kitano H, 2001, LANGMUIR, V17, P1878, DOI 10.1021/la000869v
   KITANO H, 1994, LANGMUIR, V10, P4131, DOI 10.1021/la00023a036
   Kitano H, 1999, LANGMUIR, V15, P2709, DOI 10.1021/la981250k
   Kitano H, 2000, J PHYS CHEM B, V104, P11425, DOI 10.1021/jp000429c
   Kitano H, 1998, LANGMUIR, V14, P165, DOI 10.1021/la9704260
   Kitano H, 2000, ANAL CHEM, V72, P2976, DOI 10.1021/ac000074t
   KITANO H, UNPUB
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Kroeze E, 1996, MACROMOLECULES, V29, P8599, DOI 10.1021/ma961131g
   KROSCHWITZ JI, 1994, GLASS, V12, P569
   LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011
   LASCHEWSKY A, 1995, POLYMER, V36, P3045, DOI 10.1016/0032-3861(95)94357-Y
   Lee HJ, 1999, MACROMOLECULES, V32, P6989, DOI 10.1021/ma990566b
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   MAEDA Y, 1995, J PHYS CHEM-US, V99, P487, DOI 10.1021/j100002a004
   Maeda Y, 1997, LANGMUIR, V13, P4187, DOI 10.1021/la9701384
   MAEDA Y, 1995, J PHYS CHEM-US, V99, P4837, DOI 10.1021/j100013a063
   Matyjaszewski K, 1997, MACROMOL RAPID COMM, V18, P1057, DOI 10.1002/marc.1997.030181209
   Meriaudeau F, 1998, APPL OPTICS, V37, P8030, DOI 10.1364/AO.37.008030
   Morokoshi S, 2004, LANGMUIR, V20, P8897, DOI 10.1021/la049201x
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   Nakayama Y, 1999, LANGMUIR, V15, P1667, DOI 10.1021/la981169h
   Nath N, 2002, ANAL CHEM, V74, P504, DOI 10.1021/ac015657x
   NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012
   NUZZO RG, 1987, J AM CHEM SOC, V109, P2358, DOI 10.1021/ja00242a020
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   Okamoto T, 2000, OPT LETT, V25, P372, DOI 10.1364/OL.25.000372
   OKAWARA M, 1964, KOGYO KAGAKU ZASSHI, V67, P2108
   OTSU T, 1989, EUR POLYM J, V25, P643, DOI 10.1016/0014-3057(89)90023-2
   OTSU T, 1986, MACROMOLECULES, V19, P287, DOI 10.1021/ma00156a007
   OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P127
   Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866
   Pipino ACR, 1996, PHYS REV B, V53, P4162, DOI 10.1103/PhysRevB.53.4162
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Sawamato M, 1999, CHEMTECH, V29, P30
   SAWAMOTO M, 1999, MAT SCI TECHNOLOGY S, pCH6
   SCHIERBAUM KD, 1994, SCIENCE, V265, P1413, DOI 10.1126/science.265.5177.1413
   Schonherr H, 1997, LANGMUIR, V13, P1567, DOI 10.1021/la961084l
   Senoo M, 1999, MACROMOLECULES, V32, P8005, DOI 10.1021/ma9909814
   SPINKE J, 1993, LANGMUIR, V9, P1821, DOI 10.1021/la00031a033
   Takei H, 2002, OPT LETT, V27, P342, DOI 10.1364/OL.27.000342
   Tarcha PJ, 1999, APPL SPECTROSC, V53, P43, DOI 10.1366/0003702991945443
   TSUJI S, 2004, LANGMUIR, V20, P2499
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   VANDUYNE RP, 1993, J CHEM PHYS, V99, P2101, DOI 10.1063/1.465276
   VEREGIN RPN, 1993, MACROMOLECULES, V26, P5316, DOI 10.1021/ma00072a007
   Voet D., 1995, BIOCHEMISTRY
   Wadayama T, 1999, APPL PHYS A-MATER, V69, P77, DOI 10.1007/s003390050974
   WANG JS, 1995, MACROMOLECULES, V28, P7901, DOI 10.1021/ma00127a042
   WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035
   West SL, 2004, BIOMATERIALS, V25, P1195, DOI 10.1016/j.biomaterials.2003.08.010
   Yamamoto H, 1997, J PHYS CHEM B, V101, P6855, DOI 10.1021/jp963916u
   Yang WH, 1996, J CHEM PHYS, V104, P4313, DOI 10.1063/1.471241
   Yoshizumi A, 1999, LANGMUIR, V15, P482, DOI 10.1021/la980374u
   Yuan J, 2003, POLYM INT, V52, P1869, DOI 10.1002/pi.1277
   Yuan YL, 2004, POLYM INT, V53, P121, DOI 10.1002/pi.1122
   YUAN YL, 2003, J BIOMAT SCI-POLYM E, V13, P1081
   YUKI H, 1956, NIPPON KAGAKU ZASSHI, V77, P44
NR 104
TC 74
Z9 76
U1 5
U2 56
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD FEB 15
PY 2005
VL 282
IS 2
BP 340
EP 348
DI 10.1016/j.jcis.2004.08.157
PG 9
WC Chemistry, Physical
SC Chemistry
GA 885TB
UT WOS:000226178700011
PM 15589539
DA 2018-10-20
ER

PT J
AU Benabderrahmane, S
   Bousalem, S
   Mangeney, C
   Azioune, A
   Vaulay, MJ
   Chehimi, MM
AF Benabderrahmane, S
   Bousalem, S
   Mangeney, C
   Azioune, A
   Vaulay, MJ
   Chehimi, MM
TI Interfacial physicochemical properties of functionalized conducting
   polypyrrole particles
SO POLYMER
LA English
DT Article; Proceedings Paper
CT 5th Conference on Polymers in Dispersed Media
CY 2004
CL Lyon, FRANCE
DE polypyrrole dispersions; reactivity; protein
ID COATED POLYSTYRENE LATEX; RAY PHOTOELECTRON-SPECTROSCOPY; BIOMEDICAL
   APPLICATIONS; COMPOSITES; IMMOBILIZATION; PROTEINS
AB Polypyrrole-coated polystyrene latex particles bearing reactive N-succinimidyl ester functional groups (PS-PPyNSE75) were prepared by the in situ copolymerization of pyrrole 1 and the active N-succinimidyl ester-functionalized pyrrole 2 (pyrroleNSE), with initial 1:2 fractions of 25:75 (%) in the presence of sterically stabilized polystyrene (PS) latex particles. PS particles were prepared by dispersion polymerization leading to particles having a diameter of 600 +/- 10 nm. The PS-PPyNSE75 particles were characterized in terms of surface morphology and chemical composition. Surface analysis of the colloidal materials by X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM) indicated a substantial coating of PS by the reactive conducting copolymer. Infrared spectroscopy permitted to detect pyrroleNSE repeat units at the surface of the particles indicating that 1 and 2 did indeed copolymerise.
   Reactivity of the PS-PPyNSE75 particles has been investigated using 2-aminoethanol and 2-mercaptoethanol, two model molecules bearing functional groups borne by proteins. Incubation of the particles with these model molecules clearly showed that the particles are highly reactive towards amine and thiol groups. The functionalized particles were then tested as bioadsorbents. PS-PPyNSE75 particles were found to be effective in attaching an aminated biotin. The Biotin-decorated PS-PPyNSE75 latex particles were incubated with avidin with a result of a significant change in the surface composition that is in line with the attachment of the protein by specific binding to biotin. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Paris 07, CNRS, UMR 7086, Itodys, F-75005 Paris, France.
RP Chehimi, MM (reprint author), Univ Paris 07, CNRS, UMR 7086, Itodys, 1 Rue Guy Brosse, F-75005 Paris, France.
EM chehimi@paris7.jussieu.fr
CR Azioune A, 2004, LANGMUIR, V20, P3350, DOI 10.1021/la030407s
   Beamson G., 1992, HIGH RESOLUTION XPS
   Bousalem S, 2004, COLLOID SURFACE A, V249, P91, DOI 10.1016/j.colsurfa.2004.08.056
   Bousalem S, 2004, COLLOID POLYM SCI, V282, P1301, DOI 10.1007/s00396-004-1065-8
   Bousalem S, 2003, POLYM ADVAN TECHNOL, V14, P820, DOI 10.1002/pat.401
   Cairns DB, 1999, LANGMUIR, V15, P8059, DOI 10.1021/la990443k
   CAIRNS DB, 2003, CHEM MATER, V15, P223
   CHEHIMI MM, 2003, SURFACTANT SCI SER, V115, P245
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   GUBITZ G, 1988, J CHROMATOGRAPHY L A, V39, pCH3
   HUIJIS FM, 2000, THESIS NETHERLANDS
   Lascelles SF, 1997, J MATER CHEM, V7, P1339, DOI 10.1039/a700237h
   Omastova M, 1998, POLYMER, V39, P6559, DOI 10.1016/S0032-3861(97)10178-1
   Omastova M, 1996, EUR POLYM J, V32, P681, DOI 10.1016/0014-3057(95)00206-5
   Perruchot C, 1996, LANGMUIR, V12, P3245, DOI 10.1021/la960057s
   Skotheim T.A, 1998, HDB CONDUCTING POLYM
   WANG C, SURFACTANT SCI SER, V115, P93
   WIERSMA AE, 1995, SYNTHETIC MET, V71, P2269, DOI 10.1016/0379-6779(94)03254-4
   YASSAR A, 1987, POLYM COMMUN, V28, P103
NR 19
TC 35
Z9 35
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD FEB 7
PY 2005
VL 46
IS 4
BP 1339
EP 1346
DI 10.1016/j.polymer.2004.11.066
PG 8
WC Polymer Science
SC Polymer Science
GA 893BS
UT WOS:000226694900036
DA 2018-10-20
ER

PT J
AU Es-Souni, M
   Es-Souni, M
   Fischer-Brandies, H
AF Es-Souni, M
   Es-Souni, M
   Fischer-Brandies, H
TI Assessing the biocompatibility of NiTi shape memory alloys used for
   medical applications
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Review
DE NiTi shape memory alloys; corrosion; biocompatibility; genotoxicity; Ni
   release
ID IN-VITRO BIOCOMPATIBILITY; FIXED ORTHODONTIC APPLIANCES; NICKEL-TITANIUM
   ALLOY; CORROSION BEHAVIOR; CALCIUM-PHOSPHATE; STAINLESS-STEEL; TI ALLOY;
   CYTOTOXICITY; RESISTANCE; TOXICITY
AB The present paper reviews aspects related to the biocompatibility of NiTi shape memory alloys used for medical applications. These smart metallic materials which are characterised by outstanding mechanical properties, have been gaining increasing importance over the last two decades in many minimal invasive surgery and diagnostic applications, as well as for other uses, such as in orthodontic appliances. Due to the presence of high amounts of Ni, the cytotoxicity of such alloys is under scrutiny. In this review paper we analyse work published on the biocompatibility of NiTi alloys, considering aspects related to: (1) corrosion properties and the different methods used to test them, as well as specimen surface states; (2) biocompatibility tests in vitro and in vivo; (3) the release of Ni ions. It is shown that NiTi shape memory alloys are generally characterised by good corrosion properties, in most cases superior to those of conventional stainless steel or Co-Cr-Mo-based biomedical materials. The majority of biocompatibility studies suggest that these alloys have low cytotoxicity (both in vitro and in vivo) as well as low genotoxicity. The release of Ni ions depends on the surface state and the surface chemistry. Smooth surfaces with well-controlled structures and chemistries of the outermost protective TiO2 layer lead to negligible release of Ni ions, with concentrations below the normal human daily intake.
C1 Univ Appl Sci Kiel, Inst Mat & Surface Technol, D-24149 Kiel, Germany.
   Univ Kiel, Fac Med, Dept Orthodont, D-24149 Kiel, Germany.
RP Es-Souni, M (reprint author), Univ Appl Sci Kiel, Inst Mat & Surface Technol, D-24149 Kiel, Germany.
EM me@fh-kiel.de
RI Fischer-Brandies, Prof. Dr., Helge/E-9480-2010
CR Agaoglu G, 2001, ANGLE ORTHOD, V71, P375
   ASSAD M, 1994, ANN CHIR, V48, P731
   Assad M, 2002, BIO-MED MATER ENG, V12, P339
   Assad M, 2002, BIO-MED MATER ENG, V12, P225
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P239, DOI 10.1081/CLT-100102423
   BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   Bogdanski D, 2004, BIOMATERIALS, V25, P4627, DOI 10.1016/j.biomaterials.2003.12.001
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Choi J, 2003, BIOMATERIALS, V24, P3689, DOI 10.1016/S0142-9612(03)00241-2
   COUNTS AL, 2001, J OROFACIAL ORTHOP, V63, P509
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   DUERIG TW, 1995, MATER RES SOC SYMP P, V360, P497
   DUNLAP CL, 1989, J AM DENT ASSOC, V118, P449, DOI 10.14219/jada.archive.1989.0174
   El Medawar L, 2002, BIOMOL ENG, V19, P153, DOI 10.1016/S1389-0344(02)00041-2
   Es-Souni M, 2002, BIOMATERIALS, V23, P2887, DOI 10.1016/S0142-9612(01)00416-1
   Es-Souni M, 2001, BIOMATERIALS, V22, P2153, DOI 10.1016/S0142-9612(00)00406-3
   Es-Souni Martha, 2003, J Orofac Orthop, V64, P16, DOI 10.1007/s00056-003-0235-5
   Faccioni F, 2003, AM J ORTHOD DENTOFAC, V124, P687, DOI 10.1016/j.ajodo.2003.09.010
   Filip P, 2001, BIOMATERIALS, V22, P2131, DOI 10.1016/S0142-9612(00)00404-X
   Gil FJ, 1999, J BIOMED MATER RES, V48, P682, DOI 10.1002/(SICI)1097-4636(1999)48:5<682::AID-JBM12>3.0.CO;2-M
   Kerosuo H, 1996, AM J ORTHOD DENTOFAC, V109, P148, DOI 10.1016/S0889-5406(96)70175-0
   Kim H, 1999, ANGLE ORTHOD, V69, P39
   Kujala S, 2004, BIOMATERIALS, V25, P353, DOI 10.1016/S0142-9612(03)00488-5
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Kuphasuk C, 2001, J PROSTHET DENT, V85, P195, DOI 10.1067/mpr.2001.113029
   Lamberti M, 2004, TOXICOL APPL PHARM, V195, P321, DOI 10.1016/j.taap.2003.09.022
   Melton KN, 1998, SHAPE MEMORY MAT, P220
   Menne T, 1996, ANN CLIN LAB SCI, V26, P133
   Mockers O, 2002, DENT MATER, V18, P311, DOI 10.1016/S0109-5641(01)00055-0
   MonteroOcampo C, 1996, J BIOMED MATER RES, V32, P583, DOI 10.1002/(SICI)1097-4636(199612)32:4<583::AID-JBM11>3.0.CO;2-F
   NIELSEN NH, 1992, ACTA DERM-VENEREOL, V72, P456
   PELTONEN L, 1979, CONTACT DERMATITIS, V5, P27, DOI 10.1111/j.1600-0536.1979.tb05531.x
   Prymak O, 2004, MATERIALWISS WERKST, V35, P346, DOI 10.1002/mawe.200400753
   Rahilly G, 2003, J Orthod, V30, P171, DOI 10.1093/ortho/30.2.171
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   Rondelli G, 2000, J BIOMED MATER RES, V51, P47, DOI 10.1002/(SICI)1097-4636(200007)51:1<47::AID-JBM7>3.3.CO;2-G
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   Rose E C, 1998, J Orofac Orthop, V59, P253, DOI 10.1007/BF01321792
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Saburi T, 1998, SHAPE MEMORY MAT, P49
   Schuster Gabriele, 2004, J Orofac Orthop, V65, P48, DOI 10.1007/s00056-004-0312-4
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   SHI ZC, 1994, SCI TOTAL ENVIRON, V148, P293, DOI 10.1016/0048-9697(94)90406-5
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   SUZUKI Y, 1992, MAT SMART SYSTEMS, P403
   Tan L, 2003, BIOMATERIALS, V24, P3931, DOI 10.1016/S0142-9612(03)00271-0
   TEMPLETON DM, 1994, SCI TOTAL ENVIRON, V148, P243, DOI 10.1016/0048-9697(94)90400-6
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Uthus EO, 1996, BIOL TRACE ELEM RES, V52, P23, DOI 10.1007/BF02784087
   Veien N., 1989, NICKEL SKIN IMMUNOLO, P165
   Venugopalan R, 2000, MINIM INVASIV THER, V9, P67, DOI 10.3109/13645700009063052
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   WILLIAMS DF, 1998, ADV BIOMATER, P11
   WINTERMANTEL E, 1998, BIOKOMPATIBLE WERKST, P7
   Zhou DJ, 1998, CANCER RES, V58, P2182
NR 61
TC 146
Z9 160
U1 3
U2 57
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD FEB
PY 2005
VL 381
IS 3
BP 557
EP 567
DI 10.1007/s00216-004-2888-3
PG 11
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 907EE
UT WOS:000227697400006
PM 15660223
DA 2018-10-20
ER

PT J
AU Bunescu, R
   Ge, RF
   Kate, RJ
   Marcotte, EM
   Mooney, RJ
   Ramani, AK
   Wong, YW
AF Bunescu, R
   Ge, RF
   Kate, RJ
   Marcotte, EM
   Mooney, RJ
   Ramani, AK
   Wong, YW
TI Comparative experiments on learning information extractors for proteins
   and their interactions
SO ARTIFICIAL INTELLIGENCE IN MEDICINE
LA English
DT Article
DE information extraction; text mining; machine learning; protein
   interactions; Medline
ID GENES; MODELS
AB Objective: Automatically extracting information from biomedical text holds the promise of easily consolidating large amounts of biological knowledge in computer-accessible form. This strategy is particularly attractive for extracting data relevant to genes of the human genome from the 11 million abstracts in Medline. However, extraction efforts have been frustrated by the lack of conventions for describing human genes and proteins. We have developed and evaluated a variety of learned information extraction systems for identifying human protein names in Medtine abstracts and subsequently extracting information on interactions between the proteins.
   Methods and Material: We used a variety of machine learning methods to automaticatly develop information extraction systems for extracting information on gene/ protein name, function and interactions from Medline abstracts. We present crossvalidated results on identifying human proteins and their interactions by training and testing on a set of approximately 1000 manuatly-annotated Medline abstracts that discuss human genes/proteins. Results: We demonstrate that machine learning approaches using support vector machines and maximum entropy are able to identify human proteins with higher accuracy than several previous approaches. We also demonstrate that various rule induction methods are able to identify protein interactions with higher precision than manually-developed rules.
   Conclusion: Our results show that it is promising to use machine learning to automatically build systems for extracting information from biomedical text. The results also give a broad picture of the relative strengths of a wide variety of methods when tested on a reasonably large human-annotated corpus. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Texas, Dept Comp Sci, Austin, TX 78712 USA.
   Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA.
   Univ Texas, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.
RP Mooney, RJ (reprint author), Univ Texas, Dept Comp Sci, Austin, TX 78712 USA.
EM razvan@cs.utexas.edu; grf@cs.utexas.edu; rjkate@cs.utexas.edu;
   marcotte@icmb.utexas.edu; mooney@cs.utexas.edu; arun@icmb.utexas.edu;
   ywwong@cs.utexas.edu
CR Berger AL, 1996, COMPUT LINGUIST, V22, P39
   Bikel DM, 1999, MACH LEARN, V34, P211, DOI 10.1023/A:1007558221122
   Blaschke C, 2002, IEEE INTELL SYST, V17, P14, DOI 10.1109/MIS.2002.999215
   Blaschke C, 2001, COMPAR FUNCT GENOM, V2, P196, DOI 10.1002/cfg.91
   Brill E, 1995, COMPUT LINGUIST, V21, P543
   Califf ME, 1999, SIXTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-99)/ELEVENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE (IAAI-99), P328
   CALIFF ME, 1999, AAAI1999 WORKSH MACH
   Cardie C, 1997, AI MAG, V18, P65
   CESTNIK B, 1990, P 9 EUR C ART INT, P147
   CHARRAS C, 1998, SEQUENCE COMPAR LAB
   COLLIER N, 2000, P 18 INT C COMP LING, P201
   Collins M., 2002, P ANN M ASS COMP LIN
   COLLINS M, 1999, P C EMP METH NAT LAN
   Cowie J, 1996, COMMUN ACM, V39, P80, DOI 10.1145/234173.234209
   Craven M, 1999, Proc Int Conf Intell Syst Mol Biol, P77
   DARROCH JN, 1972, ANN MATH STAT, V43, P1470, DOI 10.1214/aoms/1177692379
   Duda R. O., 1973, PATTERN CLASSIFICATI
   ELIASSIRAD T, 2001, P 18 INT C MACH LEAR
   Freitag D, 2000, SEVENTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-2001) / TWELFTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-2000), P577
   Freund Y, 1996, P 13 INT C MACH LEAR
   Friedman C, 2001, Bioinformatics, V17 Suppl 1, pS74
   Fukuda K, 1998, Pac Symp Biocomput, P707
   GUSFIELD D, 1997, AGLORITHMS STRINGS
   Hahn Udo, 2002, Pac Symp Biocomput, P338
   HUMPHREYS K, 2000, PAC S BIOC, P502
   JOACHIMS T, 1998, P 10 EUR C MACH LEAR, P137
   Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027
   Kudoh Taku, 2000, P CONLL 2000 LLL 200, P142
   KUSHMERICK N, 1997, P 15 INT JOINT C ART, P729
   LAFFERTY J, 2001, PROBABLISTIC MODELS
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Leonard JE, 2002, BIOINFORMATICS, V18, P1515, DOI 10.1093/bioinformatics/18.11.1515
   Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707
   MACCALLUM A, P 1N INT C MACH LEAR
   Marcotte EM, 2001, BIOINFORMATICS, V17, P359, DOI 10.1093/bioinformatics/17.4.359
   Marcus M.P., 1993, COMPUTATIONAL LINGUI, V19, P313, DOI DOI 10.1080/07494460903404410
   *NAT I STAND TECH, ACE AUT CONT EXTR
   Park J C, 2001, Pac Symp Biocomput, P396
   Pearl J, 1988, PROBABILISTIC REASON
   Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895
   Proux D., 2000, Proceedings. Eighth International Conference on Intelligent Systems for Molecular Biology, P279
   PROUX D, 1998, GENOME INFORM SER WO, V9, P72
   Pustejovsky J, 2002, Pac Symp Biocomput, P362
   RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626
   Ramshaw L. A., 1995, P 3 WORKSH VER LARG
   RAY S, 2001, P 17 INT JOINT C ART, P1273
   Raychaudhuri S, 2002, GENOME RES, V12, P203, DOI 10.1101/gr.199701
   RINDFLESCH TC, 2000, PAC S BIOC 2000, P515
   ROTH D, 2002, P 6 C NAT LANG LEARN
   Tanabe L, 2002, BIOINFORMATICS, V18, P1124, DOI 10.1093/bioinformatics/18.8.1124
   Thomas J, 2000, Pac Symp Biocomput, P541
   THOMPSON CA, 1999, P 16 INT C MACH LEAR, P406
   Vapnik V., 1998, STAT LEARNING THEORY
   Vapnik VN, 1995, NATURE STAT LEARNING
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239
NR 56
TC 128
Z9 137
U1 2
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0933-3657
EI 1873-2860
J9 ARTIF INTELL MED
JI Artif. Intell. Med.
PD FEB
PY 2005
VL 33
IS 2
BP 139
EP 155
DI 10.1016/j.artmed.2004.07.016
PG 17
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA 920FC
UT WOS:000228673800004
PM 15811782
DA 2018-10-20
ER

PT J
AU Tettamanti, M
   Tralamazza, S
   Berati, M
   Molteni, M
   Gamba, N
AF Tettamanti, M
   Tralamazza, S
   Berati, M
   Molteni, M
   Gamba, N
TI Human research tissue banks: The ATRA Project for establishing a human
   research tissue bank in Switzerland
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE cadaveric donor; donor card; human cell culture; legislation; surplus
   surgical tissue; tissue bank; tissue and organ donation
ID RECOMMENDATIONS; HEPATOCYTES; WORKSHOP; CELLS; MODEL
AB A large number of experiments in biomedical research are carried out on tissues, but, even though the results should be applicable to humans, these tissues are mainly of animal origin. The difficulty encountered in obtaining human organs and tissues is an acknowledged problem: not enough human tissues are available to meet research needs. We are introducing the ATRA Project, with the purpose of supporting progress in biomedical research in Switzerland through the establishment of one or more human tissue banks, which will be able to find, treat, preserve and supply human material. Where similar projects have already been launched, concerns have been expressed that donation for research purposes might compete with donation for transplantation, but most organs and tissues are in any case non-transplantable. Surplus surgical tissue is considered "sanitary waste", and must be treated according to specific regulations for collection, packaging, transport, treatment and disposal. A human tissue bank would not only abate the costs of treating sanitary waste, but would actually turn what is now considered waste into a resource which could be used to save human and animal lives.
C1 ATRA, Schweizer Vereinigung Abschaffung Tierversuche, CH-6900 Lugano, Switzerland.
   NoVivisez Working Grp, Turin, Italy.
RP Tettamanti, M (reprint author), ATRA, Schweizer Vereinigung Abschaffung Tierversuche, Via Capelli 28, CH-6900 Lugano, Switzerland.
EM massimo.tettamanti@gmail.com
CR *AAVV, 1993, HUM CELLS VITR PHARM
   Anderson R, 1998, ATLA-ALTERN LAB ANIM, V26, P763
   Anderson R, 2001, ATLA-ALTERN LAB ANIM, V29, P125
   Bach PH, 1996, ATLA-ALTERN LAB ANIM, V24, P893
   Bader A, 1996, EXP CELL RES, V226, P223, DOI 10.1006/excr.1996.0222
   CHESNE C, 1993, HEPATOLOGY, V18, P406, DOI 10.1016/0270-9139(93)90026-J
   DON M, 1992, CRYOBIOLOGY, V29, P454
   *EUR COMM, 2003, 3 COMM COUNC EUR PAR
   FENTEM JH, 1994, HUM EXP TOXICOL, V13, P445, DOI 10.1177/096032719401300614
   GUILLOUZO A, 1992, IN VITRO METHODS TOX, P133
   GURNEY J, 1993, HUMAN CELLS IN IN VITRO PHARMACO-TOXICOLOGY, P315
   HAWKSWORTH GM, 1994, HUM EXP TOXICOL, V13, P568, DOI 10.1177/096032719401300811
   HIREL B, 1994, IN VITRO CELL DEV-AN, V30A, P372
   Lloyd TDR, 2003, ATLA-ALTERN LAB ANIM, V31, P483
   MORGAN R, 1997, MANAGING BIOL CHEM R
   *NHS EX, 1996, GUID MICR SAF HUM TI
   Nuffield Council on Bioethics, 1995, HUM TISS ETH LEG ISS
   Orr Samantha, 2002, Cell and Tissue Banking, V3, P133, DOI 10.1023/A:1022811232250
   SKETT P, 1995, BIOCHEM PHARMACOL, V50, P280, DOI 10.1016/0006-2952(95)90011-X
   Start RD, 1996, BRIT MED J, V313, P1366, DOI 10.1136/bmj.313.7069.1366
   Ward RK, 1998, TOXICOL IN VITRO, V12, P163, DOI 10.1016/S0887-2333(97)00098-2
   Ward SL, 1997, TOXICOL IN VITRO, V11, P121, DOI 10.1016/S0887-2333(96)00068-9
   2003, TIERVERSUCHE SCHWEIZ
NR 23
TC 4
Z9 4
U1 0
U2 1
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD FEB
PY 2005
VL 33
IS 1
BP 29
EP 36
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 907WP
UT WOS:000227749100008
PM 15804215
DA 2018-10-20
ER

PT J
AU Keselowsky, BG
   Garcia, AJ
AF Keselowsky, BG
   Garcia, AJ
TI Quantitative methods for analysis of integrin binding and focal adhesion
   formation on biomaterial surfaces
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; integrin; focal adhesion; vinculin; talin
ID CELL-ADHESION; FIBRONECTIN; ACTIVATION; POLYSTYRENE
AB Integrin binding and focal adhesion assembly are critical to cellular responses to biomaterial surfaces in biomedical and biotechnological applications. While immunostaining techniques to study focal adhesion assembly are well established, a crucial need remains for quantitative methods for analyzing adhesive structures. We present simple yet robust approaches to quantify integrin binding and focal adhesion assembly on biomaterial surfaces. Integrin binding to fibronectin and a RGD-containing synthetic peptide was quantified by sequentially cross-linking integrin ligand complexes via a water-soluble homo-bifunctional cross-linker, extracting bulk cellular components in detergent, and detecting bound integrins by ELISA. Focal adhesion components (vinculin, talin, alpha-actinin) localized to adhesion plaques were isolated from bulk cytoskeletal and cytoplasmic components by mechanical rupture at a plane close to the basal cell surface and quantified by Western blotting. These approaches represent simple and efficient methodologies to analyze structure-function relationships in cell-material interactions. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Andersson H, 2001, J APPL ELECTROCHEM, V31, P1, DOI 10.1023/A:1004105622558
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   BRANDS R, 1988, EXP CELL RES, V176, P309, DOI 10.1016/0014-4827(88)90333-3
   BRODBECK WG, 2003, P NATL ACAD SCI USA, V99, P10287
   Clark RA, 1990, J INVEST DERMATOL, V94, p128S
   ENOMOTOIWAMOTO M, 1993, CELL ADHES COMMUN, V1, P191, DOI 10.3109/15419069309097253
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1998, J BIOL CHEM, V273, P34710, DOI 10.1074/jbc.273.52.34710
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   HAIMOVICH B, 1991, CELL REGUL, V2, P271
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   KESCLOWSKY BG, 2003, J BIOMED MATER RES, V66, P247
   KESELOWSKY BG, IN PRESS BIOMATERIAL
   PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
NR 26
TC 60
Z9 62
U1 3
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 4
BP 413
EP 418
DI 10.1016/j.biomaterials.2004.02.050
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RG
UT WOS:000224135400007
PM 15275815
DA 2018-10-20
ER

PT J
AU LaVan, DA
   Padera, RF
   Friedmann, TA
   Sullivan, JP
   Langer, R
   Kohane, DS
AF LaVan, DA
   Padera, RF
   Friedmann, TA
   Sullivan, JP
   Langer, R
   Kohane, DS
TI In vivo evaluation of tetrahedral amorphous carbon
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; amorphous diamond; amorphous carbon; thin film; in
   vivo testing
ID BIOMEDICAL APPLICATIONS; DIAMOND; FILMS; BIOCOMPATIBILITY; COATINGS;
   MACROPHAGES; ACTIVATION; ADHESION; VITRO
AB The in vivo behavior and tissue reaction to tetrahedral amorphous carbon (ta-C) has been evaluated for periods of up to 6 months in SV129 mice. Two sample types were tested-silicon die coated with ta-C (n=53) and micromachined particles (n=40). The coated samples were compared to uncoated silicon die (n=22). Die samples were implanted subcutaneously, and tissue reaction and capsule formation were evaluated at various time points. Micromachined particles of 1, 3 10, and 30 mum were injected adjacent to the sciatic nerve, and tissue samples were examined histologically at various time points (4 days-6 months).
   Tissue reaction to ta-C was mild and was localized to the area of the injection or implantation. Samples with a higher ratio of 3-fold bonding appeared to shed material during the experiments; this was not observed on samples with a higher level of 4-fold bonding. nor on uncoated silicon die. The results strongly suggest that films with greater 4-fold bonding character (more diamondlike) are more resistant to in vivo fragmentation than films with higher 3-fold character (more graphitic) (C) 2004 Elsevier Ltd. All rights reserved.
C1 Massachusetts Gen Hosp, Pediat Intens Care Unit, Dept Pediat, Boston, MA 02114 USA.
   Yale Univ, Dept Mech Engn, New Haven, CT 06520 USA.
   MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
   Sandia Natl Labs, Albuquerque, NM 87185 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Kohane, DS (reprint author), Massachusetts Gen Hosp, Pediat Intens Care Unit, Dept Pediat, Ellison 317,55 Fruit St, Boston, MA 02114 USA.
EM dkohane@partners.org
RI LaVan, David/C-3943-2012
OI LaVan, David/0000-0002-1952-0028
FU NIGMS NIH HHS [GM00684]
CR Alanazi A, 2000, ARTIF ORGANS, V24, P624, DOI 10.1046/j.1525-1594.2000.06576.x
   ALEKSOV A, 2003, P EL SOC, P2003
   ALEKSOV A, STATE OF THE ART PRO, V3, P146
   Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   ALLEN M, 1995, BIO-MED MATER ENG, V5, P151
   Carlisle J. A., 2003, Electrochemical Society Interface, V12, P28
   DAVIDSON JL, 1997, P 5 INT S DIAM MAT, P635
   DAVIDSON JL, 1998, P EL SOC, P97
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Friedmann TA, 1997, APPL PHYS LETT, V71, P3820, DOI 10.1063/1.120515
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211
   Kohane DS, 2003, PHARM RES-DORDR, V20, P1533, DOI 10.1023/A:1026162628965
   Kohane DS, 2003, PAIN, V104, P415, DOI 10.1016/S0304-3959(03)00049-6
   Kohane DS, 2002, J BIOMED MATER RES, V59, P450, DOI 10.1002/jbm.1261
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   KOSKINEN J, 1993, SURF COAT TECH, V62, P356, DOI 10.1016/0257-8972(93)90267-R
   LAVAN DA, 2000, MATER RES SOC S P, P295
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   PACCAGNELLA A, 1986, INT J ARTIF ORGANS, V9, P127
   Sullivan JP, 2001, MRS BULL, V26, P309, DOI 10.1557/mrs2001.68
   SULLIVAN JP, 2001, MAT RES SOC S P
   TABATA Y, 1990, ADV POLYM SCI, V94, P107
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Veerasamy VS, 2003, THIN SOLID FILMS, V442, P1, DOI 10.1016/S0040-6090(03)00929-5
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779
NR 29
TC 25
Z9 26
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 5
BP 465
EP 473
DI 10.1016/j.biomaterials.2004.02.071
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RJ
UT WOS:000224135700001
PM 15276354
DA 2018-10-20
ER

PT J
AU Khan, M
   Smith, N
   Jones, E
   Finch, DS
   Cameron, RE
AF Khan, M
   Smith, N
   Jones, E
   Finch, DS
   Cameron, RE
TI Analysis and evaluation of a biomedical polycarbonate urethane tested in
   an in vitro study and an ovine arthroplasty model. Part I: materials
   selection and evaluation
SO BIOMATERIALS
LA English
DT Article
DE hip replacement prosthesis; polyurethane elastomer; compliance;
   biocompatibihty; animal model
ID SEGMENTED POLYURETHANES; ARTIFICIAL-HEART; STRESS CRACKING;
   BIOSTABILITY; CALCIFICATION; POLYETHER; INVIVO; BIODEGRADATION;
   STABILITY; ELASTOMERS
AB The polyurethane elastomer (PU) Corethane 80A (Corvita) is being considered as the acetabular bearing material in a novel total replacement hip joint. The biostability of Corethane 80A was investigated in vitro (this work) and in vivo (reported separately) in a fully functioning ovine total hip arthroplasty (THA) model, with the PU as the bearing layer in a prototype compliant layer acetabular cup. The in vitro studies assessed the resistance of Corethane 80A to the main degradation mechanisms observed in PUs: hydrolysis, environmental stress cracking (ESC), metal ion oxidation (MIO) and calcification. The performance of the polycarbonate PU Corethane 80A was assessed alongside three other commercially available biomedical PUs: polyether PUs Pellethane 2363-80A (DOW Chemical) and PHMO-PU (CSIRO, not supplied as a commercial material) as well as polycarbonate PU ChronoFlex AL-80A (CardioTech). Chemical and structural variables that affect the properties of the materials were analysed with particular attention to the nature of the material's hard and soft segments. PU degradation was probed using a range of analytical tools and physical-testing methods, including mechanical testing, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and environmental scanning microscopy (ESEM). Corethane 80A displayed the best overall resistance to hydrolysis, ESC, MIO and calcification, followed by ChronoFlex 80A and PHMO-PU. Pellethane 80A was the least stable. This study provides compelling evidence for the biostability and effectiveness of Corethane 80A and points to its suitability for use as a compliant bearing layer in hip arthroplasty, and possibly also other joints. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Stryker Howmedica Osteon, Staines, England.
   Stryker Europe, CASA Grp, Limerick, Ireland.
   Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
RP Cameron, RE (reprint author), Univ Cambridge, Dept Mat Sci & Met, New Museums Site,Pembroke St, Cambridge CB2 3QZ, England.
EM rec11@cam.ac.uk
OI Cameron, Ruth/0000-0003-1573-4923
CR Bernacca GM, 1997, J BIOMED MATER RES, V34, P371
   Boretos J W, 1971, J Biomed Mater Res, V5, P373, DOI 10.1002/jbm.820050408
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   COURY AJ, 1984, ADV URETHANE SCI TEC, V9, P130
   COURY AJ, 1996, BIOMATERIALS SCI INT
   COVALOS GC, 1977, SPE NAT TECHN C DENV, P5558
   DREYER B, 1959, J APPL PHYSIOL, V14, P475
   Gunatillake PA, 2003, AUST J CHEM, V56, P545, DOI 10.1071/CH02168
   GUNATILLAKE PA, 1998, Patent No. 9800546
   HARASAKI H, 1979, T AM SOC ART INT ORG, V25, P305
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HOFFMAN D, 1993, CLIN MATER, V13, P95
   KHAN I, 2002, THESIS U CAMBRIDGE
   KHAN I, IN PRESS BIOAMTERIAL
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KWEI TK, 1982, J APPL POLYM SCI, V27, P2891, DOI 10.1002/app.1982.070270815
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LEMM W, 1984, POLYURETHANES BIOMED, P103
   MANDARINO MP, 1960, ARCH SURG-CHICAGO, V80, P623, DOI 10.1001/archsurg.1960.01290210091019
   MANDARINO MP, 1958, ORTHOP SURG, V9, P762
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   McLean RS, 1997, MACROMOLECULES, V30, P8314, DOI 10.1021/ma970350e
   MIRKOVITCH V, 1962, T AM SOC ART INT ORG, V8, P79
   PANGMAN WJ, 1965, Patent No. 921
   PANGMAN WJ, 1958, Patent No. 775
   PARINS DJ, 1985, ASTM STP, V859, P322
   Phillips R E, 1988, J Biomater Appl, V3, P207, DOI 10.1177/088532828800300204
   PHILLIPS RE, 1987, POLYURETHANES BIOMED, V2, P91
   PINCHUK L, 1993, Patent No. 9431
   PINCHUK L, 1992, Patent No. 742
   PINCHUK L, 1996, T SOC BIOM 19 M BIRM, P22
   Rabek J. F, 1995, POLYM PHOTODEGRADATI
   RAPOPORT NY, 1985, DEV POLYM DEGRADATIO, V6, P207
   REVENKO I, 1999, SOC BIOM 25 ANN M T, P354
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SINGH PI, 1985, MECH ETIOLOGY CALCIF, P104
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STOKES K, 1984, POLYURETHANES BIOMED, P243
   Stokes KB, 1987, ADV BIOMEDICAL POLYM, P147
   SZYCHER M, 1991, BLOOD COMPATIBLE MAT, P3385
   Szycher Michael, 1994, P233
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   Tanzi MC, 2000, J BIOMATER APPL, V14, P325, DOI 10.1106/7TJU-H1YA-4NYT-XL84
   Thoma R J, 1987, J Biomater Appl, V1, P449
   THOMA RJ, 1986, T SOC BIOMATER, V9, P47
   Ward R. S., 2000, MED DEVICE DIAGN IND, V22, P68
   WARD RS, 1994, T 20 ANN M SOC BIOM
   WARD RS, 1996, Patent No. 5589563
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WILLIAMS DF, 1984, POLYURETHANES BIOMED, P98
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
   Yang MJ, 1999, J BIOMED MATER RES, V48, P648, DOI 10.1002/(SICI)1097-4636(1999)48:5<648::AID-JBM8>3.0.CO;2-6
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 64
TC 100
Z9 107
U1 1
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 6
BP 621
EP 631
DI 10.1016/j.biomaterials.2004.02.065
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RK
UT WOS:000224135800005
PM 15282140
DA 2018-10-20
ER

PT J
AU Khan, M
   Smith, N
   Jones, E
   Finch, DS
   Cameron, RE
AF Khan, M
   Smith, N
   Jones, E
   Finch, DS
   Cameron, RE
TI Analysis and evaluation of a biomedical polycarbonate urethane tested in
   an in vitro study and an ovine arthroplasty model. Part II: in vivo
   investigation
SO BIOMATERIALS
LA English
DT Article
DE hip replacement prostheses; polyurethane; elstomer; compliance;
   biocompatibility; animal model
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL HIP-REPLACEMENT; ENZYME-INDUCED
   BIODEGRADATION; JOINT FORCES; WEAR DEBRIS; POLYURETHANES; DEGRADATION;
   MORPHOLOGY; SHEEP; CHOLESTEROL
AB The polyurethane (PU) elastomer Corethane 80A (Corvita) is being considered as the acetabular bearing material in a novel total replacement hip joint. Its biostability was investigated in vitro (Analysis and evaluation of a biomedical polycarbonate urethane tested in an in vitro study and an ovine arthroplasty model. Part 1: material selection and evaluation, Biomaterials, in press) together with three other commercially available biomedical PUs: Pellethane 2363-80A (DOW Chemical), a polyhexamethylene oxide based PU, PHMO-PU (CSIRO, not supplied as a commercial product) and ChronoFlex AL-80A (CardioTech). From the in vitro studies, Corethane 80A displayed the best overall resistance to hydrolysis, ESC, MIO and calcification, followed by ChronoFlex 80A and PHMO-PU, with Pellethane 80A being the least stable. Building on the in vitro investigation, the follow-up ill vivo study (reported here) assessed Corethane 80A as the bearing layer in a prototype compliant layer acetabular cup, in a fully functioning ovine total hip arthoplasty (THA) model. PU degradation in the retrieved cups was analysed using a range of analytical and physical-testing methods including mechanical testing, differential scanning calorimetry, Fourier transform infrared spectroscopy and environmental scanning electron microscopy. The Corethane 80A functioned well in the THA model, with the bearing surfaces of the retrieved hip cups showing no significant evidence of biodegradation or wear damage after 3 years in vivo. The findings in this study provide compelling evidence for the biostability and effectiveness of acetabular cups incorporating a Corethane 80A compliant bearing layer. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Stryker Howmedica Osteon, Staines, England.
   Stryker Europe, CASA Grp, Limerick, Ireland.
   Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
RP Cameron, RE (reprint author), Univ Cambridge, Dept Mat Sci & Met, New Museums Site,Pembroke St, Cambridge CB2 3QZ, England.
EM recll@cam.ac.uk
OI Cameron, Ruth/0000-0003-1573-4923
CR ALEXANDER JW, 1999, T 45 ANN M ORTH RES, P906
   Bergmann G, 1999, J BIOMECH, V32, P769, DOI 10.1016/S0021-9290(99)00068-8
   BERGMANN G, 1984, J BIOMECH, V17, P907, DOI 10.1016/0021-9290(84)90004-6
   Brumby SA, 1998, CLIN ORTHOP RELAT R, P229
   Bruns DP, 1996, VET COMP ORTHOPAED, V9, P158
   CARAVIA L, 1993, WEAR, V160, P191, DOI 10.1016/0043-1648(93)90420-Q
   CARBONE A, VET J BIOMATER DRAFT
   Cooper R A, 1992, J Arthroplasty, V7, P285, DOI 10.1016/0883-5403(92)90050-Z
   Dillon J., 1989, INFRARED SPECTROSCOP
   DOWSON D, 1986, FLUID FILM LUBRICATI
   DOWSON D, 1991, P I MECH ENG H, V205, P52
   DOWSON D, 1983, P 9 CAN C APPL MECH, P15
   Eisenbach C., 1986, ADV ELASTOMERS RUBBE
   Field JR, 2001, VET COMP ORTHOPAED, V14, P32
   HU WC, 1994, J POLYM SCI POL PHYS, V32, P437, DOI 10.1002/polb.1994.090320304
   James SP, 1999, J BIOMED MATER RES, V48, P374, DOI 10.1002/(SICI)1097-4636(1999)48:3<374::AID-JBM23>3.0.CO;2-O
   KELLOP HA, 1999, T 45 ANN M ORTH RES, P76
   KHAN I, IN PRESS BIOMATERIAL
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1999, BIOMATERIALS, V32, P769
   LAURENT MP, 2000, T 26 ANN M SOC BIOM, P851
   LAURENT MP, 2000, T 25 ANN M SOC BIOM, P874
   LI S, 1994, J BONE JOINT SURG AM, V76A, P1080, DOI 10.2106/00004623-199407000-00020
   Mai MT, 1996, J BONE JOINT SURG AM, V78A, P505, DOI 10.2106/00004623-199604000-00004
   MALCHAU H, 1998, REVISION REREVISION
   MANLEY MT, 1994, CLIN ORTHOP RELAT R, P137
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   McKellop H, 1999, CLIN ORTHOP RELAT R, P73
   McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203
   MOODY J, 1999, T 45 ANN M ORTH RES, P278
   Muratoglu OK, 2001, J ORTHOPAED RES, V19, P1210, DOI 10.1016/S0736-0266(01)00059-6
   MURATOGLU OK, 1999, T 4 ANN M ORTH RES S, P77
   Naidu SH, 1997, ORTHOPEDICS, V20, P137
   OKUMURA Y, 1999, T 45 ANN M ORTH RES, P928
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   Shaw JH, 1997, EFFECT GAMMA IRRADIA
   SHINDE A, 1985, J POLYM SCI POL PHYS, V23, P1681, DOI 10.1002/pol.1985.180230819
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SMITN N, 1996, Patent No. 698382
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   THANNER J, 1999, ACTA ORTHOP SCAND S, V286, P141
   Unsworth A, 1995, TRIBOL INT, V28, P485, DOI 10.1016/0301-679X(95)00027-2
   VERONROBERTS B, 1997, I ETHICS COMMITTEE G
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
NR 51
TC 62
Z9 63
U1 3
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 6
BP 633
EP 643
DI 10.1016/j.biomaterials.2004.02.064
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RK
UT WOS:000224135800006
DA 2018-10-20
ER

PT J
AU Fenderson, BA
AF Fenderson, BA
TI Strategies for teaching pathology to graduate students and allied health
   professionals
SO HUMAN PATHOLOGY
LA English
DT Article
DE pathology education; graduate students; allied health professionals
ID BASIC SCIENCE
AB Pathology is an essential course for many students in the biomedical sciences and allied health professions. These students learn the language of pathology and medicine, develop an appreciation for mechanisms of disease, and understand the close relationship between basic research and clinical medicine. We have developed 3 pathology courses to meet the needs of our undergraduates, graduate students, and allied health professionals. Through experience, we have settled on an approach to teaching pathology that takes into account the diverse educational backgrounds of these students. Educational resources such as assigned reading, online homework, lectures, and review sessions are carefully balanced to adjust course difficulty. Common features of our pathology curricula include a web-based computer laboratory and review sessions on the basis of selected pathology images and open-ended study questions. Lectures, computer-guided homework, and review sessions provide the core educational content for undergraduates. Graduate students, using the same computer program and review material, rely more heavily on assigned reading for core educational content. Our experience adapting a pathology curriculum to the needs of divergent groups of students suggests a general strategy for monitoring course difficulty. We hypothesize that course difficulty is proportional to the information density of specific learning resources (eg, lecture or textbook) multiplied by the weight of those learning resources placed on examinations. This formula allows educators to match the difficulty of a course with the educational needs of students, and provides a useful tool for longitudinal studies of curriculum reform. (c) 2005 Elsevier Inc. All rights reserved.
C1 Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
RP Fenderson, BA (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
EM bruce.fenderson@jefferson.edu
CR ARIAS IM, 1989, NEW ENGL J MED, V321, P972, DOI 10.1056/NEJM198910053211412
   Damjanov I, 2000, PATHOLOGY HLTH RELAT
   E Rubin, 2001, ESSENTIAL PATHOLOGY
   FENDERSON BA, 1999, PATHOL ED, V24, P17
   FENDERSON BA, 2001, PATHOL ED, V25, P25
   FENDERSON BA, 1999, PATHOL ED, V23, P21
   GRAY ML, 2003, NAT MED, V8, P433
   Kemp JD, 2004, HUM PATHOL, V35, P785, DOI 10.1016/j.humpath.2004.03.014
   Mallon WT, 2003, ACAD MED, V78, P302, DOI 10.1097/00001888-200303000-00014
NR 9
TC 9
Z9 9
U1 0
U2 4
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0046-8177
J9 HUM PATHOL
JI Hum. Pathol.
PD FEB
PY 2005
VL 36
IS 2
BP 146
EP 153
DI 10.1016/j.humpath.2004.09.022
PG 8
WC Pathology
SC Pathology
GA 905UL
UT WOS:000227595800003
PM 15754291
DA 2018-10-20
ER

PT J
AU Robertson, SW
   Imbeni, V
   Wenk, HR
   Ritchie, RO
AF Robertson, SW
   Imbeni, V
   Wenk, HR
   Ritchie, RO
TI Crystallographic texture for tube and plate of the
   superelastic/shape-memory alloy nitinol used for endovascular stents
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nitinol; texture; stents
ID POLYCRYSTALLINE NITI; STRAIN; TENSION
AB The superelastic/shape-memory material, Nitinol, an approximately equiatomic alloy of Ni and Ti, is rapidly becoming one of the most important metallic implant materials in the biomedical industry, in particular for the manufacture of endovascular stents. As such stents are invariably laser-machined from Nitinol tubes or sheets rolled into tubes, it is important to fully understand the physical phenomena that may affect the mechanical behavior of this material. With tubing and plate, one major issue is crystallographic texture, which can play a key role in influencing the mechanical properties of Nitinol. In this article, we present a study on how geometry and heat treatment can affect the texture of Nitinol, with specific quantification of the texture of Nitinol tube used for the production of endovascular stents. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
   SRI Int, Menlo Pk, CA 94025 USA.
   Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.
RP Ritchie, RO (reprint author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
EM roritchie@lbl.gov
RI Ritchie, Robert/A-8066-2008
OI Ritchie, Robert/0000-0002-0501-6998
CR Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Gall K, 1999, INT J PLASTICITY, V15, P69, DOI 10.1016/S0749-6419(98)00060-6
   Gao S, 2003, MAT SCI ENG A-STRUCT, V362, P107, DOI 10.1016/S0921-5093(03)00585-9
   Hornbogen E, 2002, Z METALLKD, V93, P3, DOI 10.3139/146.020003
   Inoue H, 1996, ACTA MATER, V44, P4825, DOI 10.1016/S1359-6454(96)00120-6
   KITAMURA K, 1997, P INT C SHAP MEM SUP, P47
   Kocks U. F., 1998, TEXTURE ANISOTROPY, P195
   LI DY, 1990, ACTA METALL MATER, V38, P19, DOI 10.1016/0956-7151(90)90130-9
   MATTHIES S, 1982, PHYS STATUS SOLIDI B, V112, pK111, DOI 10.1002/pssb.2221120254
   McNaney JM, 2003, MECH MATER, V35, P969, DOI 10.1016/S0167-6636(02)00310-1
   MIYAZAKI S, 1989, ACTA METALL, V37, P1837
   MONASEVICH LA, 1979, MET SCI HEAT TREAT+, V21, P735, DOI 10.1007/BF00708647
   MULDER JH, 1993, Z METALLKD, V84, P501
   PELTON AR, 2000, MIN INVAS THER APPL, V200, P107
   Shu YC, 1998, ACTA MATER, V46, P5457, DOI 10.1016/S1359-6454(98)00184-0
   Sitepu H, 2002, APPL PHYS A-MATER, V74, pS1676, DOI 10.1007/s003390201934
   Vaidyanathan R, 2001, METALL MATER TRANS A, V32, P777
   WENK HR, 1987, METALL TRANS A, V18, P1083, DOI 10.1007/BF02668557
   Wenk HR, 1998, J APPL CRYSTALLOGR, V31, P262, DOI 10.1107/S002188989700811X
   Yuan WQ, 1999, MAT SCI ENG A-STRUCT, V271, P439, DOI 10.1016/S0921-5093(99)00311-1
NR 20
TC 29
Z9 30
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2005
VL 72A
IS 2
BP 190
EP 199
DI 10.1002/jbm.a.30214
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 887TF
UT WOS:000226327700008
PM 15625682
DA 2018-10-20
ER

PT J
AU Weldon, LM
   McHugh, PE
   Carroll, W
   Costello, E
   O'Bradaigh, C
AF Weldon, LM
   McHugh, PE
   Carroll, W
   Costello, E
   O'Bradaigh, C
TI The influence of passivation and electropolishing on the performance of
   medical grade stainless steels in static and fatigue loading
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CORROSION-FATIGUE; MECHANICAL-PROPERTIES; SURFACE-ROUGHNESS; IMPLANT
   MATERIALS; BIOMATERIALS; TECHNOLOGY; BEHAVIOR; METALS; COPPER; BODY
AB The effects of surface passivation and electropolishing on the mechanical performance of a group of biomedical grade stainless steels have been investigated. Surface roughness measurements showed that the treatments had a significant effect on the final surface finish. However, static mechanical testing demonstrated no difference in static mechanical properties, regardless of surface treatment. High cycle fatigue testing was carried out at a frequency of 120 Hz with a load ratio of R = 0.1, in both air and a simulated in vivo wet corrosive environment. 316LVM (cold worked) proved superior to 316L (annealed) in fatigue performance, in both dry and wet environments. The fatigue performance of both materials did depend on the surface treatment, with electropolishing resulting in better performance than passivation. The fatigue performance of both materials was significantly better in the dry environment in comparison to the wet environment. The dry-to-wet deterioration in fatigue performance was. somewhat dependent on the surface treatment for the 316L material but almost independent of surface treatment for the 316LVM material. Significant surface pitting and damage was evident for 316L during fatigue in the wet environment, whereas almost no pitting and damage was observed for 316LVM. (C) 2005 Springer Science + Business Media, Inc.
C1 Natl Univ Ireland Univ Coll Galway, Dept Mech & Biomed Engn, Galway, Ireland.
   Natl Univ Ireland Univ Coll Galway, Dept Chem, Galway, Ireland.
   Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
RP McHugh, PE (reprint author), Natl Univ Ireland Univ Coll Galway, Dept Mech & Biomed Engn, Galway, Ireland.
EM peter.mchugh@nuigalway.ie
RI O Bradaigh, Conchur/G-5347-2013
OI O Bradaigh, Conchur/0000-0002-8048-4222
CR ASKELAND D, 1985, SCI ENG MAT, P507
   BASINSKI SJ, 1969, PHILOS MAG, V19, P899, DOI 10.1080/14786436908225856
   Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Collins J. A, 1993, FAILURE MAT MECH DES, P374
   COSTELLO E, 2003, THESIS NUI GALWAY IR
   FIELD M, 1971, STC S, V20, P107
   FORREST FG, 1962, FATIGUE METALS
   FROST NE, 1974, METAL FATIGUE, P121
   Gough HJ, 1932, J I MET, V49, P17
   HAYASHI K, 1987, JSME INT J, V30, P1517, DOI 10.1299/jsme1987.30.1517
   HAYASHI K, 1994, J SOC MAT SCI JPN, V43, P1502
   HIGO Y, 1994, AM SOC TEST MATER, V1173, P148, DOI 10.1520/STP18101S
   HIGO Y, 1993, CORROS SCI, V35, P587
   HULTQUIST G, 1980, CORROSION-US, V36, P126, DOI 10.5006/0010-9312-36.3.126
   KAKAJIMA M, 1998, FAT FRACT ENG MAT ST, V21, P35
   KHANI MK, 1996, METAL T A, V27, P133
   Landgraf RW, 1988, ASTM STP, P1
   LANDGRAF RW, 1975, ASTM STP, V569, P130
   LUKAS P, 1996, ASM HDB, V19, P97
   MAIYA PS, 1975, METALL TRANS A, V6, P1761, DOI 10.1007/BF02642305
   MANSON SS, 1971, ASTM STP, V495, P254
   Marsland LC, 2000, ELECTROCHEM COMMUN, V2, P591, DOI 10.1016/S1388-2481(00)00084-9
   *MAT INF SOC ASM I, 1985, MET HDB, P1214
   MAYER H, 1994, INT MATER REV, V44, P1
   MCADAM DJ, 1941, P ASTM, V41, P696
   MEULLER MP, 1982, MET TECHNOL, V9, P587
   MORITA M, 1992, ANN BIOMED ENG, V20, P505, DOI 10.1007/BF02368170
   MORITA M, 1988, J BIOMED MATER RES, V22, P529, DOI 10.1002/jbm.820220608
   Murphy BP, 2003, ANN BIOMED ENG, V31, P686, DOI 10.1114/1.1569268
   Murtaza G, 2000, ENG FRACT MECH, V67, P461, DOI 10.1016/S0013-7944(00)00057-6
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Palmaz JC, 1997, TEX HEART I J, V24, P156
   Papakyriacou M, 2000, INT J FATIGUE, V22, P873, DOI 10.1016/S0142-1123(00)00057-8
   QIAN YR, 1977, CORROS SCI, V53, P129
   RYU JH, 1989, INT J FATIGUE, V11, P433, DOI 10.1016/0142-1123(89)90183-7
   SALVAGO G, 1994, CORROS SCI, V36, P733, DOI 10.1016/0010-938X(94)90077-9
   SCHULZE V, 1996, P ICSP, V6, P403
   Shih CC, 2000, J BIOMED MATER RES, V52, P323
   Suresh S., 1988, FATIGUE MAT
   SZKLARSKASMIALO.Z, 1986, PITTING CORROSION ME
   TAIRA M, 1992, J BIOMED MATER RES, V26, P1131, DOI 10.1002/jbm.820260903
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   THOMPSON N, 1956, PHILOS MAG, V1, P113, DOI 10.1080/14786435608238086
   Wareing J., 1979, Metal Science, V13, P1
   WELDON LM, 2001, THESIS NUI GALWAY IR
   Wescott B.B., 1938, Mechanical Engineering, V60, P813
   WILSON AD, 1996, ASM HDB, V19, P591
   WOOD DS, 1980, FATIGUE ENG MATER, V3, P39, DOI 10.1111/j.1460-2695.1980.tb01103.x
NR 48
TC 15
Z9 15
U1 1
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2005
VL 16
IS 2
BP 107
EP 117
DI 10.1007/s10856-005-5922-x
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901KW
UT WOS:000227282400003
PM 15744598
DA 2018-10-20
ER

PT J
AU Sivakumar, K
   Panchapakesan, B
AF Sivakumar, K
   Panchapakesan, B
TI Electric field-assisted deposition of nanowires on carbon nanotubes for
   nanoelectronics and sensor applications
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE carbon nanotubes; single-walled carbon nanotubes; nanowires;
   electrostatic double layer; supercapacitor; nanoelectrochemical cell;
   electrophoresis
ID QUANTUM CONFINEMENT; SILVER NANOWIRES; ROOM-TEMPERATURE; SILICON;
   NANOMATERIALS; CONDUCTIVITY; WIRES
AB Manipulation and control of matter at the nanoscale and atomic scale levels are crucial for the success of nanoscale sensors and actuators. The ability to control and synthesize multilayer structures using carbon nanotubes that will enable the building of electronic devices within a nanotube is still in its infancy. In this paper, we present results on selective electric field-assisted deposition of metals on carbon nanotubes realizing metallic nanowire structures. Silver and platinum nanowires have been fabricated using this approach for their applications in chemical sensing as catalytic materials to sniff toxic agents and in the area of biomedical nanotechnology for construction of artificial muscles. Electric field-assisted deposition allows the deposition of metals with a high degree of selectivity on carbon nanotubes by manipulating the charges on the surface of the nanotubes and forming electrostatic double-layer supercapacitors. Deposition of metals primarily occurred due to electrochemical reduction, electrophoresis, and electro-osmosis inside the walls of the nanotube. SEM and TEM investigations revealed silver and platinum nanowires between 10 nm and 100 nm in diameter. The present technique is versatile and enables the fabrication of a host of different types of metallic and semiconducting nanowires using carbon nanotube templates for nanoelectronics and a myriad of sensor applications.
C1 Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.
RP Panchapakesan, B (reprint author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.
CR Avouris P, 2002, CHEM PHYS, V281, P429, DOI 10.1016/S0301-0104(02)00376-2
   Barbic M, 2002, J APPL PHYS, V91, P9341, DOI 10.1063/1.1476071
   Cheng YH, 2004, NANOTECHNOLOGY, V15, P171, DOI 10.1088/0957-4484/15/1/033
   Constantin C, 2000, J APPL PHYS, V88, P141, DOI 10.1063/1.373634
   Cui Y, 2003, NANO LETT, V3, P149, DOI 10.1021/nl025875l
   Dai HJ, 1996, SCIENCE, V272, P523, DOI 10.1126/science.272.5261.523
   DRESSELHAUS G, 1998, NANOTECHNOLOGY CARBO
   DRESSELHAUS MS, 1998, NANOTECHNOLOGY
   Ebbesen TW, 1996, NATURE, V382, P54, DOI 10.1038/382054a0
   Emmenegger C, 2000, APPL SURF SCI, V162, P452, DOI 10.1016/S0169-4332(00)00232-4
   Feng SQ, 2000, J CRYST GROWTH, V209, P513, DOI 10.1016/S0022-0248(99)00608-9
   Fujiwara A, 2002, APPL PHYS LETT, V80, P4567, DOI 10.1063/1.1487451
   Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367
   Huber TE, 2004, APPL PHYS LETT, V84, P1326, DOI 10.1063/1.1650038
   Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h
   Ijima S., 1991, NATURE, V354, P56
   Johnson JC, 2002, NAT MATER, V1, P106, DOI 10.1038/nmat728
   Karpus V, 1997, SEMICOND SCI TECH, V12, P781, DOI 10.1088/0268-1242/12/7/005
   Klemic JF, 2001, NAT BIOTECHNOL, V19, P924, DOI 10.1038/nbt1001-924
   Krapf D, 2003, PHYS STATUS SOLIDI A, V197, P566, DOI 10.1002/pssa.200306564
   Li C, 2003, APPL PHYS LETT, V82, P1613, DOI 10.1063/1.1559438
   Liu CY, 1999, ELECTROCHEM SOLID ST, V2, P577, DOI 10.1149/1.1390910
   MADOU MJ, 2001, FUNDAMENTALS MICROFA
   MEYAYAPPAN M, 2003, HDB NANOSCIENCE TECH
   Mulligan RF, 2003, J APPL POLYM SCI, V89, P1058, DOI 10.1002/app.12250
   Shtyrkov EI, 2003, RADIAT EFF DEFECT S, V158, P125, DOI 10.1080/1042015021000052412
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   XIA Y, 2003, ADV MATER, P15
   Zhang DB, 2001, CHEM MATER, V13, P2753, DOI 10.1021/cm0105007
NR 29
TC 4
Z9 4
U1 2
U2 27
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD FEB
PY 2005
VL 5
IS 2
BP 313
EP 318
DI 10.1166/jnn.2005.050
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 908KO
UT WOS:000227786100022
PM 15853154
DA 2018-10-20
ER

PT J
AU Bova, GS
   Eltoum, IA
   Kiernan, JA
   Siegal, GP
   Frost, AR
   Best, CJM
   Gillespie, JW
   Su, GH
   Emmert-Buck, MR
AF Bova, GS
   Eltoum, IA
   Kiernan, JA
   Siegal, GP
   Frost, AR
   Best, CJM
   Gillespie, JW
   Su, GH
   Emmert-Buck, MR
TI Optimal molecular profiling of tissue and tissue components - Defining
   the best processing and microdissection methods for biomedical
   applications
SO MOLECULAR BIOTECHNOLOGY
LA English
DT Article
DE tissue processing; tissue fixation; tissue staining; molecular
   profiling; microdissection; laser capture microdissection; proteomics;
   DNA analysis; RNA analysis; cytology; phenotype-genotype correlation
ID LASER-CAPTURE MICRODISSECTION; GENE-EXPRESSION; PROTEOMIC ANALYSIS;
   ARCHIVAL TISSUE; ASSISTED MICRODISSECTION; ARRAY HYBRIDIZATION; GENOMIC
   DNA; SECTIONS; RNA; CELLS
AB Isolation of well-preserved pure cell populations is a prerequisite for sound studies of the molecular basis of any tissue-based biological phenomenon. This article reviews current methods for obtaining anatomically specific signals from molecules isolated from tissues, a basic requirement for productive linking of phenotype and genotype. The quality of samples isolated from tissue and used for molecular analysis is often glossed over or omitted from publications, making interpretation and replication of data difficult or impossible. Fortunately, recently developed techniques allow life scientists to better document and control the quality of samples used for a given assay, creating a foundation for improvement in this area. Tissue processing for molecular studies usually involves some or all of the following steps: tissue collection, gross dissection/identification, fixation, processing/embedding, storage/archiving, sectioning, staining, microdissection/annotation, and pure analyte labeling/identification and quantification. We provide a detailed comparison of some current tissue microdissection technologies, and provide detailed example protocols for tissue component handling upstream and downstream from microdissection. We also discuss some of the physical and chemical issues related to optimal tissue processing, and include methods specific to cytology specimens. We encourage each laboratory to use these as a starting point for optimization of their overall process of moving from collected tissue to high quality, appropriately anatomically tagged scientific results. In optimized protocols is a source of inefficiency in current life science research. Improvement in this area will significantly increase life science quality and productivity. The article is divided into introduction, materials, protocols, and notes sections. Because many protocols are covered in each of these sections, information relating to a single protocol is not contiguous. To get the greatest benefit from this article, readers are advised to read through the entire article first, identify protocols appropriate to their laboratory for each step in their workflow, and then reread entries in each section pertaining to each of these single protocols.
C1 Johns Hopkins Univ Hosp, PELICAN Lab, Dept Pathol, Baltimore, MD 21287 USA.
   Johns Hopkins Univ Hosp, PELICAN Lab, Dept Oncol, Baltimore, MD 21287 USA.
   Johns Hopkins Univ Hosp, PELICAN Lab, Inst Med Genet, Baltimore, MD 21287 USA.
   Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Surg, Birmingham, AL 35294 USA.
   Univ Alabama, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA.
   Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.
   NCI, Pathogenet Unit, NIH, Bethesda, MD 20892 USA.
   NCI, Sci Applicat Int Corp, Bethesda, MD 20892 USA.
   Columbia Univ, Coll Phys & Surg, Dept Otolaryngol, New York, NY USA.
   Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA.
RP Bova, GS (reprint author), Johns Hopkins Univ Hosp, PELICAN Lab, Dept Pathol, Carnegie 628, Baltimore, MD 21287 USA.
EM gbov@jhmi.edu
OI Kiernan, John/0000-0002-3324-1092
CR Ahram M, 2003, PROTEOMICS, V3, P413, DOI 10.1002/pmic.200390056
   Bancroft J.D., 2002, THEORY PRACTICE HIST
   Beltinger C. P., 1998, Molecular Pathology, V51, P233
   Best C J, 2001, Expert Rev Mol Diagn, V1, P53, DOI 10.1586/14737159.1.1.53
   Brockhoff G, 1999, CYTOMETRY, V38, P184, DOI 10.1002/(SICI)1097-0320(19990815)38:4<184::AID-CYTO5>3.0.CO;2-W
   Burgemeister R, 2003, PATHOL RES PRACT, V199, P431, DOI 10.1078/0344-0338-00442
   Carson FL, 2003, HISTOTECHNOLOGY SELF
   Cohen CD, 2002, KIDNEY INT, V61, P125, DOI 10.1046/j.1523-1755.2002.00112.x
   Craven RA, 2002, METHOD ENZYMOL, V356, P33
   Curran S, 2000, J CLIN PATHOL-MOL PA, V53, P64
   Eltoum IA, 2002, ADV ANAT PATHOL, V9, P316, DOI 10.1097/00125480-200209000-00006
   Emmert-Buck MR, 2000, MOL CARCINOGEN, V27, P158, DOI 10.1002/(SICI)1098-2744(200003)27:3<158::AID-MC2>3.0.CO;2-2
   EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998
   Englert CR, 2000, CANCER RES, V60, P1526
   Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0
   Fink L, 2002, AM J PATHOL, V160, P81, DOI 10.1016/S0002-9440(10)64352-0
   GASSMANN M, 2003, QUALITY ASSURANCE RN
   Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X
   Gillespie JW, 2001, CANCER J, V7, P32
   GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0
   Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W
   Guerrero RB, 1997, DIAGN MOL PATHOL, V6, P277, DOI 10.1097/00019606-199710000-00005
   Gupta SK, 1997, J CLIN PATHOL-MOL PA, V50, P218
   Harsch M, 2001, AM J PATHOL, V158, P1985, DOI 10.1016/S0002-9440(10)64669-X
   Horobin RW, 2002, CONNS BIOL STAINS HD
   Ikeda K, 1998, J HISTOCHEM CYTOCHEM, V46, P397, DOI 10.1177/002215549804600314
   Inoue K, 2003, VIRCHOWS ARCH, V442, P159, DOI 10.1007/s00428-002-0719-5
   KIERNAN JA, 2002, MICROSCOPY HISTOLOGY
   Kiernan JA, 2001, HISTOLOGICAL HISTOCH
   Kleeberger W, 2000, PATHOBIOLOGY, V68, P196, DOI 10.1159/000055923
   Lawrie L. C., 2001, Molecular Pathology, V54, P253, DOI 10.1136/mp.54.4.253
   Lee JY, 1998, VIRCHOWS ARCH, V433, P305, DOI 10.1007/s004280050253
   Luzzi V, 2003, J MOL DIAGN, V5, P9, DOI 10.1016/S1525-1578(10)60445-X
   Maitra A, 1999, NAT MED, V5, P459
   Mori M, 2002, SURGERY, V131, pS39, DOI 10.1067/msy.2002.119292
   Moskaluk CA, 1997, AM J PATHOL, V150, P1547
   Nakazono M, 2003, PLANT CELL, V15, P583, DOI 10.1105/tpc.008102
   Novelli M, 2000, CLIN EXP DERMATOL, V25, P423, DOI 10.1046/j.1365-2230.2000.00680.x
   Ohyama H, 2000, BIOTECHNIQUES, V29, P530, DOI 10.2144/00293st05
   Ornstein DK, 2000, ELECTROPHORESIS, V21, P2235, DOI 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.3.CO;2-1
   Pertoft H, 2000, J BIOCHEM BIOPH METH, V44, P1, DOI 10.1016/S0165-022X(00)00066-X
   Simone NL, 2000, AM J PATHOL, V156, P445, DOI 10.1016/S0002-9440(10)64749-9
   Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0
   Tai YT, 2000, J IMMUNOL METHODS, V235, P11, DOI 10.1016/S0022-1759(99)00199-4
   Zhang ZQ, 1997, ANAL QUANT CYTOL, V19, P514
   ZHUANG ZP, 1995, AM J PATHOL, V146, P620
NR 46
TC 13
Z9 14
U1 0
U2 6
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1073-6085
J9 MOL BIOTECHNOL
JI Mol. Biotechnol.
PD FEB
PY 2005
VL 29
IS 2
BP 119
EP 152
DI 10.1385/MB:29:2:119
PG 34
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 905UK
UT WOS:000227595700004
PM 15699569
DA 2018-10-20
ER

PT J
AU Vavere, AL
   Laforest, R
   Welch, MJ
AF Vavere, AL
   Laforest, R
   Welch, MJ
TI Production, processing and small animal PET imaging of titanium-45
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
DE titanium-45; microPET; ion chromatography
ID TITANOCENE DICHLORIDE; RADIOPHARMACEUTICALS; CYCLOTRON; ISOTOPES; CANCER
AB Introduction: Titanium-45 was prepared as a tool for elucidation of the mechanism of action of titanium anticancer drugs in vivo using microPET imaging.
   Methods: Titanium-45 was produced by the Sc-45(p,n)Ti-45 nuclear reaction using 14.5 MeV protons. Sufficient yields of 45Ti were produced and separated from the target material with 99.8% radionuclidic purity using a simple, efficient separation procedure.
   Results: A typical bombardment of 5 mu A for 1 h produced an average of 2105 +/- 150 MBq (56.9 +/- 4.0 mCi) at the end of bombardment (EOB), well within acceptable range of the calculated theoretical yields of 2165 MBq and 433 MBq mu A(-1) h(-1) (58.5 mCi and 11.7 mCi mu A(-1) h(-1)). This amount of activity is sufficient for the radiosynthesis of target compounds as well as imaging studies. MicroPET images of a miniature Derenzo phantom show excellent resolution where rods of 1.25 mm were separated by four times their diameter.
   Conclusions: Titanium-45 can be easily produced on a biomedical cyclotron with excellent yields as compared to calculated theoretical values with imaging studies demonstrating that the decay properties of titanium-45 are well suited for microPET. (c) 2005 Elsevier Inc. All rights reserved.
C1 Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA.
   Washington Univ, Dept Chem, St Louis, MO 63104 USA.
RP Welch, MJ (reprint author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
EM welchm@mir.wustl.edu
CR Christodoulou CV, 1998, J CLIN ONCOL, V16, P2761, DOI 10.1200/JCO.1998.16.8.2761
   Clark R.J.H., 1968, CHEM TITANIUM VANADI
   DEAN JA, 1992, LANGES HDB CHEM
   DELL GF, 1965, NUCL PHYS, V64, P513, DOI 10.1016/0029-5582(65)90576-6
   DERENZO SE, 1981, IEEE T NUCL SCI, V28, P81, DOI 10.1109/TNS.1981.4331144
   Guo ML, 2000, BIOCHEMISTRY-US, V39, P10023, DOI 10.1021/bi000798z
   Harding MM, 2000, CURR MED CHEM, V7, P1289, DOI 10.2174/0929867003374066
   ISHIWATA K, 1991, APPL RADIAT ISOTOPES, V42, P707
   ISHIWATA K, 1982, J LABELLED COMPD RAD, V19, P11
   KAWAMURA M, 1986, J LABELLED COMPD RAD, V23, P1360
   Knoess C, 2003, EUR J NUCL MED MOL I, V30, P737, DOI 10.1007/s00259-002-1052-6
   Koepf-Maier P., 1994, European Journal of Clinical Pharmacology, V47, P1
   KOEPF-MAIER P, 1989, Cancer Chemotherapy and Pharmacology, V23, P225
   KOEPF-MAIER P, 1986, Anticancer Research, V6, P33
   KOEPFMAIER P, 1981, CANCER CHEMOTHER PHA, V5, P237
   Laforest R, 2002, IEEE T NUCL SCI, V49, P2119, DOI 10.1109/TNS.2002.803685
   LEDERER CM, 1978, TABLE ISOTOPES
   Levkovskij V. N., 1991, ACTIVATION CROSS SEC
   Lewis MR, 2002, NUCL MED BIOL, V29, P701, DOI 10.1016/S0969-8051(02)00330-X
   McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6
   MERRILL JC, 1978, INT J APPL RADIAT IS, V29, P115, DOI 10.1016/0020-708X(78)90033-9
   TONEY JH, 1985, J AM CHEM SOC, V107, P947, DOI 10.1021/ja00290a033
NR 22
TC 18
Z9 18
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0969-8051
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PD FEB
PY 2005
VL 32
IS 2
BP 117
EP 122
DI 10.1016/j.nucmedbio.2004.10.003
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 907BF
UT WOS:000227689100002
PM 15721756
DA 2018-10-20
ER

PT J
AU Moreau, C
   Bisson, JF
   Lima, RS
   Marple, BR
AF Moreau, C
   Bisson, JF
   Lima, RS
   Marple, BR
TI Diagnostics for advanced materials processing by plasma spraying
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Plasma Chemistry
CY JUN, 2003
CL Taormina, ITALY
DE particle diagnostics; plasma spraying; optical sensors; particle
   flattening; nanostructured coatings
ID PARTIALLY-STABILIZED ZIRCONIA; FLIGHT PARTICLE PARAMETERS; THERMAL
   SPRAY; SUBSTRATE SURFACE; SPLAT FORMATION; DROPLETS; TEMPERATURE;
   IMPACT; FLUCTUATIONS; COLD
AB Advanced coatings deposited by plasma spraying are used in a large variety of industrial applications. The sprayed coatings are employed typically in industry to protect parts from severe operating conditions or to produce surfaces with specific functions. Applications are found in many industrial sectors such as aerospace, automobile, energy generation, and biomedical implants.
   Coatings are built by the successive deposition of molten or partially molten particles that flatten and solidify upon contact on the substrate, forming lamellae. The coating properties are intimately linked to the properties of these lamellae, which in turn depend on in-flight particle properties as well as substrate temperature during spraying. Consequently, the development of diagnostic tools for monitoring and controlling these spray parameters will help provide the necessary information to study the coating formation process, optimize the coating properties, and, eventually, control the spray process in production.
   In this paper, a review of some recent developments of optical diagnostic techniques applied to monitor plasma-sprayed particles is presented. In the first part of the paper, two different sensing techniques for in-flight particle measurement are described. First, time-resolved diagnostics on individual particles is described. This technique is used to study the instabilities of the particle characteristics associated with the plasma fluctuations. Secondly, a technique adapted for use in an industrial production environment for measuring the particle jet characteristics as an ensemble is presented. In the second part of the paper, the use of an optical system to study the influence of the substrate temperature on the flattening and solidification of sprayed particles impacting on a flat substrate is described. The last part of this paper describes the optimization of nanostructured coatings based on a tight control of the temperature and velocity of the plasma-sprayed particles.
C1 Natl Res Council Canada, Inst Ind Mat, Boucherville, PQ J4B 6Y4, Canada.
RP Moreau, C (reprint author), Natl Res Council Canada, Inst Ind Mat, 75 Mortagne, Boucherville, PQ J4B 6Y4, Canada.
EM christian.moreau@cnrc-nrc.gc.ca
CR Beck M.S., 1987, CROSS CORRELATION FL
   Bianchi L, 1997, THIN SOLID FILMS, V305, P35, DOI 10.1016/S0040-6090(97)80005-3
   Bisson JF, 2003, J THERM SPRAY TECHN, V12, P38, DOI 10.1361/105996303770348483
   Bisson JF, 2003, J THERM SPRAY TECHN, V12, P258, DOI 10.1361/105996303770348375
   Bisson JF, 2001, THERMAL SPRAY 2001: NEW SURFACES FOR A NEW MILLENNIUM, P705
   Blain J., 1997, Surface Engineering, V13, P420
   BLAIN J, 2003, THERMAL SPRAY 2003 A, P1131
   BOURQUE G, 2000, SURFACE ENG VIA APPL, P45
   COULOMBE S, 1995, PLASMA CHEM PLASMA P, V15, P653, DOI 10.1007/BF01447065
   CRAIG JE, 2003, THERMAL SPRAY 2003 A, P1107
   DUAN Z, 2000, THERMAL SPRAY SURFAC, P1
   Escure C, 2003, PLASMA CHEM PLASMA P, V23, P185, DOI 10.1023/A:1022976914185
   Fauchais P, 2001, J THERM SPRAY TECHN, V10, P44, DOI 10.1361/105996301770349510
   FINCKE J, 1993, MEAS SCI TECHNOL, V4, P449
   FINCKE JR, 1988, J PHYS E SCI INSTRUM, V21, P367, DOI 10.1088/0022-3735/21/4/005
   Fincke JR, 2001, SURF COAT TECH, V146, P537, DOI 10.1016/S0257-8972(01)01432-3
   FINCKE JR, 2003, THERMAL SPRAY 2003 A, P1093
   Friis M, 2003, J THERM SPRAY TECHN, V12, P44, DOI 10.1361/105996303770348492
   Fukumoto M, 2002, SURF COAT TECH, V161, P103, DOI 10.1016/S0257-8972(02)00471-1
   Fukumoto M, 1999, SURF COAT TECH, V120, P131, DOI 10.1016/S0257-8972(99)00349-7
   Gougeon P, 2001, J THERM SPRAY TECHN, V10, P76, DOI 10.1361/105996301770349538
   Gougeon P, 1995, ADVANCES IN THERMAL SPRAY SCIENCE AND TECHNOLOGY, P149
   Jiang XY, 2001, THIN SOLID FILMS, V385, P132, DOI 10.1016/S0040-6090(01)00769-6
   Leblanc L, 2002, J THERM SPRAY TECHN, V11, P380, DOI 10.1361/105996302770348772
   LEBLANC L, 1997, THERMAL SPRAY UNITED, P567
   Lima RS, 2002, MAT SCI ENG A-STRUCT, V327, P224, DOI 10.1016/S0921-5093(01)01530-1
   Lima RS, 2001, MAT SCI ENG A-STRUCT, V313, P75, DOI 10.1016/S0921-5093(01)01146-7
   LYAGUSHKIN VP, S P INT S PLASM CHEM
   MADEJSKI J, 1976, INT J HEAT MASS TRAN, V19, P1009, DOI 10.1016/0017-9310(76)90183-6
   MADEJSKI J, 1983, INT J HEAT MASS TRAN, V26, P1095, DOI 10.1016/S0017-9310(83)80137-9
   MISHIN J, 1987, J PHYS E SCI INSTRUM, V20, P620, DOI 10.1088/0022-3735/20/6/008
   Miyayama M., 1991, ENG MAT HDB, V4, P748
   MOREAU C, 1994, THERMAL SPRAY IND AP, P431
   MOREAU C, 1998, THERMAL SPRAY M CHAL
   Mostaghimi J, 2002, PLASMA CHEM PLASMA P, V22, P59, DOI 10.1023/A:1012940515065
   Pawlowski L., 1995, SCI ENG THERMAL SPRA
   PFENDER E, 1988, SURF COAT TECH, V34, P1, DOI 10.1016/0257-8972(88)90083-7
   VARDELLE M, 1983, AICHE J, V29, P236, DOI 10.1002/aic.690290210
   Vardelle M, 2001, J THERM SPRAY TECHN, V10, P267, DOI 10.1361/105996301770349367
   Vattulainen J, 2001, J THERM SPRAY TECHN, V10, P94, DOI 10.1361/105996301770349556
   WUTZKE S, 1967, AIAA, V5, P1216
NR 41
TC 33
Z9 33
U1 0
U2 8
PU INT UNION PURE APPLIED CHEMISTRY
PI RES TRIANGLE PK
PA 104 TW ALEXANDER DR, PO BOX 13757, RES TRIANGLE PK, NC 27709-3757 USA
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PD FEB
PY 2005
VL 77
IS 2
BP 443
EP 462
DI 10.1351/pac200577020443
PG 20
WC Chemistry, Multidisciplinary
SC Chemistry
GA 908CP
UT WOS:000227765200010
DA 2018-10-20
ER

PT J
AU Karabanova, LV
   Mikhalovsky, SV
   Lloyd, AW
   Boiteux, G
   Sergeeva, LM
   Novikova, TI
   Lutsyk, ED
   Meikle, S
AF Karabanova, LV
   Mikhalovsky, SV
   Lloyd, AW
   Boiteux, G
   Sergeeva, LM
   Novikova, TI
   Lutsyk, ED
   Meikle, S
TI Gradient semi-interpenetrating polymer networks based on polyurethane
   and poly(vinyl pyrrolidone)
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TEMPERATURE TRANSITIONS; FABRICATION; BEHAVIOR
AB Gradient semi-interpenetrating polymer networks (gradient semi-IPNs) were synthesized using polyurethane (PU) and poly(vinyl pyrrolidone) (PVP). The materials were characterized with respect to thermodynamic miscibility, IR-spectroscopy, mechanical properties and morphological structure. The positive values of Gibbs free energy indicated that the polymeric systems were thermodynamically immiscible. The gradient semi-IPNs were shown to have unique mechanical properties dependent on the composition and the subsequent degree of microphase separation. Given the ability to control both the mechanical properties and surface chemistry, these materials offer the potential for further development as biocompatible biomedical materials for the fabrication of medical implants.
C1 Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
   Natl Acad Sci Ukraine, Inst Macromol Chem, UA-253660 Kiev, Ukraine.
   Univ Lyon 1, CNRS, UMR 5627, Lab Mat Polymers & Biomat, F-69622 Villeurbanne, France.
RP Lloyd, AW (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
EM a.w.lloyd@brighton.ac.uk
RI Lloyd, Andrew/D-1369-2011; Meikle, Steven/A-8268-2012
OI Lloyd, Andrew/0000-0003-2778-8195; Meikle, Steven/0000-0002-3846-5001
CR Akovali G, 1999, J APPL POLYM SCI, V73, P1721, DOI 10.1002/(SICI)1097-4628(19990829)73:9<1721::AID-APP12>3.0.CO;2-U
   Bershtein VA, 1999, J POLYM SCI POL PHYS, V37, P429, DOI 10.1002/(SICI)1099-0488(19990301)37:5<429::AID-POLB3>3.0.CO;2-E
   DROR M, 1981, J APPL POLYM SCI, V26, P1741, DOI 10.1002/app.1981.070260601
   HARRIC HJ, 1967, INTERNAL REFLECTION, P287
   HEDVIG P, 1977, DIELECTRIC SPECTROSC, P245
   Huang JH, 1998, J MATER SCI LETT, V17, P2033
   Ilshner B., 1993, J PHYS IV, V3, P763
   Jang J, 1998, J MATER SCI, V33, P5445, DOI 10.1023/A:1004466804733
   Karabanova L, 1998, J APPL POLYM SCI, V68, P161, DOI 10.1002/(SICI)1097-4628(19980404)68:1<161::AID-APP18>3.0.CO;2-3
   KARABANOVA L, 2000, P 9 INT C POL MED SU, P13
   Karabanova LV, 2004, POLYM ENG SCI, V44, P940, DOI 10.1002/pen.20085
   Karabanova LV, 2002, RUSS J APPL CHEM+, V75, P800, DOI 10.1023/A:1020322931890
   Kryszewski M, 1998, POLYM ADVAN TECHNOL, V9, P244, DOI 10.1002/(SICI)1099-1581(199804)9:4<244::AID-PAT748>3.0.CO;2-J
   LIPATOV YS, 1992, POLYM INT, V28, P99, DOI 10.1002/pi.4990280202
   LIPATOV YS, 1994, ADV INTERPENETRATING, P456
   MARTIN GC, 1981, J APPL POLYM SCI, V26, P1465, DOI 10.1002/app.1981.070260503
   Tager A. A., 1978, PHYSICAL CHEM POLYM, P544
   Tager A. A., 1977, VYSOKOMOL SOEDIN, V19, P1654
   WANG JS, 1995, MACROMOLECULES, V28, P7527
   YU S, 1990, J MACROMOL SCI REV M, V30, P209
NR 20
TC 18
Z9 24
U1 0
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD JAN 28
PY 2005
VL 15
IS 4
BP 499
EP 507
DI 10.1039/b410178b
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 890ZK
UT WOS:000226550300009
DA 2018-10-20
ER

PT J
AU Liao, CS
   Lee, GB
   Wu, JJ
   Chang, CC
   Hsieh, TM
   Huang, FC
   Luo, CH
AF Liao, CS
   Lee, GB
   Wu, JJ
   Chang, CC
   Hsieh, TM
   Huang, FC
   Luo, CH
TI Micromachined polymerase chain reaction system for multiple DNA
   amplification of upper respiratory tract infectious diseases
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE polymerase chain reaction; DNA diagnosis; multiplex PCR; MEMS
ID STREPTOCOCCUS-PNEUMONIAE; CAPILLARY-ELECTROPHORESIS;
   HAEMOPHILUS-INFLUENZAE; RAPID IDENTIFICATION; BLOOD CULTURES; PCR; GENES
AB This paper presents a micro polymerase chain reaction (PCR) chip for the DNA-based diagnosis of microorganism genes and the detection of their corresponding antibiotic-resistant genes. The micro PCR chip comprises cheap biocompatible soda-lime glass substrates with integrated thin-film platinum resistors as heating/sensing elements, and is fabricated using micro-electro-mechanical-system (MEMS) techniques in a reliable batch-fabrication process. The heating and temperature sensing elements are made of the same material and are located inside the reaction chamber in order to ensure a uniform temperature distribution. This study performs the detection of several genes associated with upper respiratory tract infection microorganisms, i.e. Streptococcus pneumoniae, Haemopilus influenze, Staphylococcu aureus, Streptococcus pyogenes, and Neisseria meningitides, together with their corresponding antibiotic-resistant genes. The lower thermal inertia of the proposed micro PCR chip relative to conventional bench-top PCR systems enables a more rapid detection operation with reduced sample and reagent consumption. The experimental data reveal that the high heating and cooling rates of the system (20 and 10 degreesC/s, respectively) pen-nit successful DNA amplification within 15 min. The micro PCR chip is also capable of performing multiple DNA amplification, i.e. the simultaneous duplication of multiple genes under different conditions in separate reaction wells. Compared with the large-scale PCR system, it is greatly advantageous for fast diagnosis of multiple infectious diseases. Multiplex PCR amplification of two DNA segments in the same well is also feasible using the proposed micro device. The developed micro PCR chip provides a crucial tool for genetic analysis, molecular biology, infectious disease detection, and many other biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Inst Microelect Mech Syst Engn, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Dept Med Technol, Tainan 701, Taiwan.
   Kaohsiung Med Univ, Grad Inst Publ Hlth, Kaohsiung 807, Taiwan.
   Natl Cheng Kung Univ, Dept Elect Engn, Tainan 701, Taiwan.
RP Lee, GB (reprint author), Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
EM gwobin@mail.ncku.edu.tw
RI Lee, Gwo-Bin/D-3032-2012
OI Lee, Gwo-Bin/0000-0001-6910-9133
CR Baron EJ, 2001, CLIN INFECT DIS, V33, P220, DOI 10.1086/321816
   Chang CC, 2000, INFECT IMMUN, V68, P2630, DOI 10.1128/IAI.68.5.2630-2637.2000
   Chang HC, 2001, J CLIN MICROBIOL, V39, P3466, DOI 10.1128/JCM.39.10.3466-3471.2001
   DAVID H, 1993, DIAGNOSTIC MOL MICRO, P539
   Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235
   Fuh DT, 2001, J MED ENG TECHNOL, V25, P118, DOI 10.1080/03091900110052441
   GILLESPIE SH, 1994, J CLIN MICROBIOL, V32, P1308
   Hakenbeck R, 1999, MICROB DRUG RESIST, V5, P91, DOI 10.1089/mdr.1999.5.91
   HASSANKING M, 1994, J CLIN MICROBIOL, V32, P1721
   Hendolin PH, 2000, J CLIN MICROBIOL, V38, P125
   Hsueh PR, 1998, CLIN INFECT DIS, V26, P584, DOI 10.1086/514567
   Huang AH, 2000, J HOSP INFECT, V44, P309, DOI 10.1053/jhin.1999.0692
   Kataja J, 1999, ANTIMICROB AGENTS CH, V43, P48, DOI 10.1128/AAC.43.1.48
   Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046
   Lagally ET, 2000, SENSOR ACTUAT B-CHEM, V63, P138, DOI 10.1016/S0925-4005(00)00350-6
   LAGALLY ET, 2001, MICRO TOTAL ANAL SYS, P117
   LEAVES N, 2000, J ANTIMICROB CHEMOTH, V445, P599
   Monstein HJ, 2001, FEMS MICROBIOL LETT, V199, P103, DOI 10.1016/S0378-1097(01)00171-9
   Northrup M. A., 1993, P 7 INT C SOL STAT S, V93, P924
   NORTHRUP MA, 1995, MEMS MINIATURE DNA A, V9, P764
   PERSING DH, 1994, DIAGNOSTIC MOL MICRO
   RADSTROM P, 1994, J CLIN MICROBIOL, V32, P2738
   Tay F.E.H, 2002, MICROFLUIDICS BIOMEM
   Woolley AT, 1996, ANAL CHEM, V68, P4081, DOI 10.1021/ac960718q
   Zhang QT, 2002, SENSOR ACTUAT B-CHEM, V82, P75, DOI 10.1016/S0925-4005(01)00993-5
NR 25
TC 69
Z9 69
U1 1
U2 9
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JAN 15
PY 2005
VL 20
IS 7
BP 1341
EP 1348
DI 10.1016/j.bios.2004.05.006
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 887ZN
UT WOS:000226344100012
PM 15590288
DA 2018-10-20
ER

PT J
AU Case, ED
   Smith, IO
   Baumann, MJ
AF Case, ED
   Smith, IO
   Baumann, MJ
TI Microcracking and porosity in calcium phosphates and the implications
   for bone tissue engineering
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE hydroxyapatite; bone tissue engineering; microcracking; thermal
   expansion anisotropy; bone remodeling
ID THERMAL-EXPANSION ANISOTROPY; GRAIN-SIZE; MECHANICAL-PROPERTIES;
   RESIDUAL-STRESS; THOROUGHBRED RACEHORSES; BRITTLE MATERIALS; 3RD
   METACARPAL; CERAMICS; FRACTURE; ALUMINA
AB Calcium phosphates including hydroxyapatite (HA) have been widely studied as bone scaffold materials. However their mechanical properties are highly variable and may be a function of thermal expansion anisotropy (TEA) induced stresses and microcracking. There is confusion concerning the mechanisms and microscopic identification of microcracks in HA. This study presents clear evidence of microcracking from micrographs of as-sintered HA surfaces which avoids the complications of identifying TEA-induced microcracks on fracture surfaces. Additionally, the existing literature of TEA-induced microcracking is briefly reviewed and pertinent papers involving likely microcracking in HA are analyzed. The recent realization in the biomedical literature notes that microcracks are of critical importance in remodeling and repair of damaged bone tissue. Hence, the similarities between microcracking in HA used for scaffolds in bone tissue engineering and that in the normal bone repair process is of importance in designing HA scaffolds with improved mechanical properties and biocompatibility. (C) 2004 Elsevier B.V. All rights reserved.
C1 Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
RP Baumann, MJ (reprint author), Michigan State Univ, Dept Chem Engn & Mat Sci, 2527 Engn Bldg, E Lansing, MI 48824 USA.
EM casee@egr.msu.edu; smithian@egr.msu.edu; mbaumann@egr.msu.edu
CR Bae IJ, 1997, J AM CERAM SOC, V80, P1149
   BARSOUM M, 1997, FUNDAMENTAL CERAMICS, P411
   Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5
   BERRY KA, 1986, J AM CERAM SOC, V69, P143, DOI 10.1111/j.1151-2916.1986.tb04719.x
   Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6
   Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6
   Case E.D., 2002, SATURATION THEMOMECH, P137
   CASE ED, 1981, J NUCL MATER, V102, P135, DOI 10.1016/0022-3115(81)90553-5
   CASE ED, 1981, MATER SCI ENG, V51, P175, DOI 10.1016/0025-5416(81)90193-2
   CASE ED, 1980, J MATER SCI, V15, P149, DOI 10.1007/BF00552439
   CASE ED, 1983, MICROCRACK HEALING D, P507
   CLEVELAND JJ, 1978, J AM CERAM SOC, V61, P478, DOI 10.1111/j.1151-2916.1978.tb16121.x
   CORBRIDGE DEC, 1995, PHOSPHORUS OUTLINE C, P455
   Davidge RW, 1968, J MATER SCI, V3, P629, DOI 10.1007/BF00757910
   ELLIOTT JC, 1994, STRUCTURE CHEM APATI, P29
   EVANS AG, 1984, J AM CERAM SOC, V67, P255
   FU Y, 1984, J AM CERAM SOC, V67, P626, DOI 10.1111/j.1151-2916.1984.tb19607.x
   GERMAN RM, 1994, POWDER METALLURGY SC, P244
   GERMAN RM, 1996, SINTERING THEORY PRA, P99
   GUPTA TK, 1972, J AM CERAM SOC, V55, P276, DOI 10.1111/j.1151-2916.1972.tb11281.x
   HALQUANI R, 1994, J MATER SCI-MATER M, V5, P563
   HASSELMAN DPH, 1993, J AM CERAM SOC, V76, P2180, DOI 10.1111/j.1151-2916.1993.tb07752.x
   HIRAI M, 1990, J NUCL MATER, V173, P247, DOI 10.1016/0022-3115(90)90392-Z
   Hoepfner TP, 2004, MATER LETT, V58, P489, DOI 10.1016/S0167-577X(03)00531-7
   Johnson KA, 2001, AM J VET RES, V62, P787, DOI 10.2460/ajvr.2001.62.787
   KINGREY WD, 1976, INTRO CERAMICS, P504
   Kon M, 2001, J DENT RES, V80, P1758, DOI 10.1177/00220345010800081501
   KUSZYK JA, 1973, J AM CERAM SOC, V56, P420, DOI 10.1111/j.1151-2916.1973.tb12714.x
   LEE WJ, 1989, MAT SCI ENG A-STRUCT, V119, P113, DOI 10.1016/0921-5093(89)90530-3
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Luo J, 1997, J EUR CERAM SOC, V17, P1565, DOI 10.1016/S0955-2219(97)00014-9
   Mackert JR, 2001, J DENT RES, V80, P1574, DOI 10.1177/00220345010800061901
   MANNING WR, 1972, J AM CERAM SOC, V55, P342, DOI 10.1111/j.1151-2916.1972.tb11306.x
   MECHOLSKY JJ, 1981, TOUGHENING GLASS CER, P15
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   MORI S, 1993, BONE, V14, P103, DOI 10.1016/8756-3282(93)90235-3
   Muir P, 1999, BONE, V25, P571, DOI 10.1016/S8756-3282(99)00205-7
   Nye J. F., 1985, PHYS PROPERTIES CRYS, P22
   Paulik SW, 1996, J MATER RES, V11, P2795, DOI 10.1557/JMR.1996.0354
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Radtke CL, 2003, AM J VET RES, V64, P1110, DOI 10.2460/ajvr.2003.64.1110
   RAHAMAN MN, 2003, CERAMIC PROCESSING S, P416
   Raynaud S, 2002, BIOMATERIALS, V23, P1081, DOI 10.1016/S0142-9612(01)00220-4
   Reilly GC, 1997, J ORTHOP RES, V15, P862, DOI 10.1002/jor.1100150611
   Rice RW, 1996, J MATER SCI, V31, P1969, DOI 10.1007/BF00356616
   RICHERSON DW, 1992, MODERN CERAMIC ENG, P549
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   SARNO RD, 1995, J MATER SCI, V30, P4380, DOI 10.1007/BF00361521
   Stepnik MW, 2004, VET SURG, V33, P2, DOI 10.1111/j.1532-950x.2004.04007.x
   SUETSUGU Y, 2001, KEY ENG MATER, V192, P287
   TOTH JM, 1991, J APPL BIOMATER, V2, P37, DOI 10.1002/jab.770020106
   Wheeler DL, 1997, J BIOMED MATER RES, V35, P249, DOI 10.1002/(SICI)1097-4636(199705)35:2<249::AID-JBM12>3.0.CO;2-C
   YAN MF, 1981, MATER SCI ENG, V48, P55
   Zimmermann A, 2000, MATER SCI FORUM, V347-3, P211, DOI 10.4028/www.scientific.net/MSF.347-349.211
NR 54
TC 32
Z9 33
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JAN 15
PY 2005
VL 390
IS 1-2
BP 246
EP 254
DI 10.1016/j.msea.2004.08.021
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 888KI
UT WOS:000226372400030
DA 2018-10-20
ER

PT J
AU Kikuchi, A
   Okano, T
AF Kikuchi, A
   Okano, T
TI Nanostructured designs of biomedical materials: Applications of cell
   sheet engineering to functional regenerative tissues and organs
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 8th European Symposium on Controlled Drug Delivery
CY APR 07-09, 2004
CL Noordwijk, NETHERLANDS
DE cell-adhesive surfaces; cell non-adhesive surfaces; cell detachment;
   hydrophilic surfaces; nanophase separated surfaces; thermoresponsive
   polymer; cell sheet engineering
ID RESPONSIVE CULTURE DISHES; MICRODOMAIN-STRUCTURED SURFACES; TOTAL
   ARTIFICIAL-HEART; PLATELET-ADHESION; 2-DIMENSIONAL MANIPULATION; BLOOD
   COMPATIBILITY; PROTEIN ADSORPTION; GRAFTED SURFACES;
   POLY(N-ISOPROPYLACRYLAMIDE)-GRAFTED SURFACES; CYTOSKELETAL
   REORGANIZATION
AB Biomaterials surface design is critical for control of cell-materials interactions. Materials surface characteristics important to cell-materials interactions are the following: (a) nonfouling surfaces where cells cannot interact; (b) surfaces that interact with cells but do not alter cell morphology or metabolism (passive adhesion processes); and (c) surfaces that strongly interact with cells and cell-surface receptors to alter cell shape after metabolic interactions (active adhesion). In this paper, we briefly discuss the relationship between materials surface characteristics and cells for biomaterials designs in these categories. We have extensively investigated the thermoresponsive polymer, poly(N-isopropylacrylamide) (PIPAAm), as grafted surfaces allowing recovery of confluent cell monolayers as contiguous living cell sheets for tissue engineering applications. Cellular interactions with PIPAAm-grafted surfaces can be regulated vertically using the thickness of the PIPAAm-grafted layers in nanometer-scale levels, as well as laterally (spatially) using nano-patterned PIPAAm chemistry on various other surface chemistries. PIPAAm-grafted surfaces with 15-20-nm thick layers exhibit temperature-dependent cell adhesion/detachment control, while surfaces with PIPAAm layer thicknesses of more than 30 nm do not support cell adhesion. These changes in cell adhesion are explained by the limited mobility of the surface grafted polymer chains as a function of grafting, hydration, and temperature. (c) 2004 Elsevier B.V. All rights reserved.
C1 Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, COE Program Century 21, Tokyo 1628666, Japan.
RP Kikuchi, A (reprint author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, COE Program Century 21, 8-1 Kawadacho, Tokyo 1628666, Japan.
EM kik-uchia@abmes.twm.ac.jp; tokano@abmes.twmu.ac.jp
RI Okano, Teruo/J-4028-2012
CR Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Aoyagi T, 2000, J BIOMAT SCI-POLYM E, V11, P101, DOI 10.1163/156856200743526
   BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   Bamford CH, 1996, POLYMER, V37, P4885, DOI 10.1016/0032-3861(96)00538-1
   DEVRIES WC, 1984, NEW ENGL J MED, V310, P273, DOI 10.1056/NEJM198402023100501
   Ebara M, 2000, MACROMOLECULES, V33, P8312, DOI 10.1021/ma000121j
   Ebara M, 2004, BIOMACROMOLECULES, V5, P505, DOI 10.1021/bm0343601
   Ebara M, 2003, BIOMACROMOLECULES, V4, P344, DOI 10.1021/bm025692t
   EBARA M, 2004, IN PRESS TISSUE ENG
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961
   IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507
   Ito E, 1998, J BIOMED MATER RES, V42, P148
   IWANAGA S, 2004, UNPUB
   Joyce L D, 1986, J Heart Transplant, V5, P203
   JOYCE LD, 1983, T AM SOC ART INT ORG, V29, P81
   Kanazawa H, 1997, J PHARMACEUT BIOMED, V15, P1545, DOI 10.1016/S0731-7085(96)02004-3
   Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j
   Kanazawa H, 1997, ANAL CHEM, V69, P823, DOI 10.1021/ac961024k
   Kikuchi A, 2002, PROG POLYM SCI, V27, P1165, DOI 10.1016/S0079-6700(02)00013-8
   Kikuchi A, 1998, J BIOMAT SCI-POLYM E, V9, P1331, DOI 10.1163/156856298X00424
   KIKUCHI A, UNPUB
   KINUGASA E, 1989, J JPN ARTIF ORGANS, V18, P1346
   Kobayashi J, 2001, ANAL CHEM, V73, P2027, DOI 10.1021/ac0013507
   Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K
   Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7
   Kushida A, 2001, J BIOMED MATER RES, V54, P37, DOI 10.1002/1097-4636(200101)54:1<37::AID-JBM5>3.0.CO;2-7
   MARUYAMA A, 1988, BIOMATERIALS, V9, P471, DOI 10.1016/0142-9612(88)90041-5
   MARUYAMA A, 1989, BIOMATERIALS, V10, P291, DOI 10.1016/0142-9612(89)90068-9
   MATSUDA T, 1995, J BIOMED MATER RES, V29, P749, DOI 10.1002/jbm.820290611
   Nakajima K, 2001, BIOMATERIALS, V22, P1213, DOI 10.1016/S0142-9612(00)00270-2
   Nandkumar MA, 2002, BIOMATERIALS, V23, P1121, DOI 10.1016/S0142-9612(01)00225-3
   Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NOJIRI C, 1992, J BIOMAT SCI-POLYM E, V4, P75
   NOJIRI C, 1989, T ASAIO, V35, P357
   OKANO T, 1978, J APPL POLYM SCI, V22, P369, DOI 10.1002/app.1978.070220206
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1979, JPN J ARTIF ORGANS, V8, P292
   OKANO T, 1979, J JPN ARTIF ORGANS, V8, P800
   OKANO T, 1979, SYNTHESES AMPHIPHILI
   OKUYAMA Y, 1993, J BIOMAT SCI-POLYM E, V4, P545, DOI 10.1163/156856293X00195
   Park KD, 1996, ASAIO J, V42, pM876, DOI 10.1097/00002480-199609000-00117
   PIAO AZ, 1992, ASAIO J, V38, P638
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   Sakai H, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P229
   SAKAMAOTO C, 2004, J CHROMATOGR A, V103, P247
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimizu T, 2002, J BIOMED MATER RES, V60, P110, DOI 10.1002/jbm.1284
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   SHIMIZU T, 2002, CIRC RES, V90, P40
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P341, DOI 10.1021/bc00023a006
   Tsuda Y, 2004, J BIOMED MATER RES A, V69A, P70, DOI 10.1002/jbm.a.20114
   TSUDA Y, 2004, IN PRESS BIOMATERIAL
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Winblade ND, 2000, BIOMACROMOLECULES, V1, P523, DOI 10.1021/bm000040v
   Yakushiji T, 1998, LANGMUIR, V14, P4657, DOI 10.1021/la980090+
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   Yamanaka H, 2003, ANAL CHEM, V75, P1658, DOI 10.1021/ac0263768
   Yamato M, 2000, BIOMATERIALS, V21, P981, DOI 10.1016/S0142-9612(99)00239-2
   Yamato M, 1999, J BIOMED MATER RES, V44, P44, DOI 10.1002/(SICI)1097-4636(199901)44:1<44::AID-JBM5>3.3.CO;2-O
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, J BIOMED MATER RES, V55, P137, DOI 10.1002/1097-4636(200104)55:1<137::AID-JBM180>3.0.CO;2-L
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   Yoshizako K, 2002, ANAL CHEM, V74, P4160, DOI 10.1021/ac025523z
   YUI N, 1984, MAKROMOL CHEM-RAPID, V5, P805
   YUI N, 1984, MAKROMOL CHEM, V185, P2259
   YUI N, 1986, J BIOMED MATER RES, V20, P929, DOI 10.1002/jbm.820200708
NR 78
TC 180
Z9 192
U1 2
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JAN 3
PY 2005
VL 101
IS 1-3
SI SI
BP 69
EP 84
DI 10.1016/j.jconrel.2004.08.026
PG 16
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 884LP
UT WOS:000226086800008
PM 15588895
DA 2018-10-20
ER

PT B
AU Lee, CC
   Kim, J
AF Lee, CC
   Kim, J
GP IEEE
TI Fundamentals of fluxless soldering technology
SO 2005 10th International Symposium on Advanced Packaging Materials:
   Processes, Properties and Interfaces
LA English
DT Proceedings Paper
CT 10th International Symposium on Advanced Packaging Materials
CY MAR 16-18, 2005
CL Irvine, CA
SP IEEE
DE fluxless bonding; fluxless soldering; tin-gold alloys; tin-gold solders
ID TRANSMISSION ELECTRON-MICROSCOPY; TIN MULTILAYER COMPOSITE;
   ROOM-TEMPERATURE; GOLD; JOINTS; COUPLES; AG
AB Fluxless (flux-free) soldering technology deals with investigating and developing techniques and methods that can eliminate the use of fluxes in the soldering process. The fluxless feature in soldering processes has become increasing more important and received more attention from industries because there are more and more devices and products that cannot take fluxes in the soldering process. Examples are MEMS devices, sensor devices, biomedical devices, and photonic devices. In addition, in flip-chip soldering processes with very small gap between chips and substrates, flux residues are hard to clean out or are embedded in the underfills. The residues may reduce the reliability of the resulting flip-chip devices.
   There are two basic fluxless approaches that have been reported. The first is to use chemicals or RF plasma to convert or to remove the oxide layer that already exists. The existence of oxide layer is the reason why the flux is needed in nearly all soldering operations. The second approach is to remove the root cause, which is solder oxidation. This is accomplished by producing the solder materials in a non-oxidizing environment, followed immediately by capping the solder with a barrier layer that would prevent oxygen from penetrating into the solder layer.
   In this paper, we first present the root cause of needing fluxes in the soldering process. The fluxless processes dealing with oxides are summarized. The four fundamental steps of the oxidation prevention approach are reported. A fluxless process based on Sn-rich Sn-Au alloys is described as an example to illustrate the fluxless fundamentals. Results show that strong and nearly void-free joints can indeed be produced using this new technology.
C1 Univ Calif Irvine, Irvine, CA 92697 USA.
RP Lee, CC (reprint author), Univ Calif Irvine, Irvine, CA 92697 USA.
CR BERANEK, 1997, P IEEE EL COMP TECHN, P755
   BERNIER, 1998, NATURE WHITE RESIDUE
   BUENE L, 1980, THIN SOLID FILMS, V65, P247, DOI 10.1016/0040-6090(80)90258-8
   BUENE L, 1980, THIN SOLID FILMS, V67, P95, DOI 10.1016/0040-6090(80)90292-8
   Chen YC, 1997, IEEE T COMPON PACK A, V20, P46, DOI 10.1109/95.558543
   Chuang RW, 2004, IEEE T COMPON PACK T, V27, P177, DOI 10.1109/TCAPT.2004.825757
   Chuang RW, 2002, IEEE T COMPON PACK T, V25, P453, DOI 10.1109/TCAPT.2002.801113
   Hong SM, 2004, IEEE T ADV PACKAGING, V27, P90, DOI 10.1109/TADVP.2003.821079
   KALLMAYER C, 1996, P 1996 IEEE CPMT INT, P18
   KIM DW, 2004, P IEEE EL COMP TECHN, P1642
   KOOPMAN N, 1993, P ELECTR C, P595, DOI 10.1109/ECTC.1993.346788
   LEE CC, 1995, MATER RES SOC SYMP P, V390, P225, DOI 10.1557/PROC-390-225
   LEE CC, 1993, IEEE T COMPON HYBR, V16, P311, DOI 10.1109/33.232058
   Lee CC, 2003, IEEE T COMPON PACK T, V26, P416, DOI 10.1109/TCAPT.2003.815109
   LEE CC, 1991, IEEE T COMPON HYBR, V14, P407, DOI 10.1109/33.87322
   Lin W, 1999, IEEE TRANS ADV PACK, V22, P592, DOI 10.1109/6040.803451
   MARINKOVIC Z, 1988, THIN SOLID FILMS, V156, P105, DOI 10.1016/0040-6090(88)90286-6
   Matijasevic G., 1994, International Journal of Microcircuits and Electronic Packaging, V17, P108
   MATIJASEVIC GS, 1993, THIN SOLID FILMS, V223, P276, DOI 10.1016/0040-6090(93)90533-U
   Matsuki H, 2001, INTERNATIONAL SYMPOSIUM ON ADVANCED PACKAGING MATERIALS: PROCESSES, PROPERTIES AND INTERFACES, PROCEEDINGS, P135, DOI 10.1109/ISAOM.2001.916563
   NAKAHARA S, 1981, THIN SOLID FILMS, V84, P185, DOI 10.1016/0040-6090(81)90468-5
   Okamoto H., 1987, PHASE DIAGRAM BINARY, P278
   Park CB, 2001, MATER TRANS, V42, P820, DOI 10.2320/matertrans.42.820
   So WW, 2000, IEEE T COMPON PACK T, V23, P377, DOI 10.1109/6144.846777
   *US DEP DEF, 1977, MILSTD883 US DEP DEF
   ZAKEL E, 1994, P 1994 IEMT S, P177
NR 26
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-9085-7
PY 2005
BP 33
EP 38
PG 6
WC Engineering, Manufacturing; Engineering, Electrical & Electronic;
   Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA BCO74
UT WOS:000230430400008
DA 2018-10-20
ER

PT S
AU Tzavaras, A
   Kontodimopoulos, N
   Monoyiou, E
   Kalatzis, I
   Piliouras, N
   Trapezanidis, I
   Cavouras, D
   Ventouras, E
AF Tzavaras, A.
   Kontodimopoulos, N.
   Monoyiou, E.
   Kalatzis, I.
   Piliouras, N.
   Trapezanidis, I.
   Cavouras, D.
   Ventouras, E.
GP IEEE
TI Upgrading undergraduate biomedical engineering laboratory training
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
DE biomedical engineering; laboratory training; student-centered learning
ID EDUCATION
AB This paper presents the upgrading of biomedical engineering laboratory training at the Department of Medical Instrumentation Technology of the Technological Educational Institution of Athens (TEI-A), taking place in the framework of the "Upgrading of Undergraduate Curricula of TEI-A" project. The educational material of selected specialized laboratory sectors is totally renewed, and new sectors are introduced, so that student-centered learning is promoted utilizing advanced computer-enhanced educational environments. The current implementation status is presented for the laboratories dealing with biosignal acquisition, medical data digital processing and, more extensively, computer networks applications in medicine, where a training application simulating a Radiology Department computer network was developed. Benefits of the use of a balanced training approach, combining hands-on experience with computer simulations, are discussed.
C1 Inst Educ Technol, Dept Med Instrumentat Technol, Athens 12210, Greece.
RP Tzavaras, A (reprint author), Inst Educ Technol, Dept Med Instrumentat Technol, Agiou Spyridonas Str, Athens 12210, Greece.
CR Cook JL, 1998, BRAIN RES PROTOC, V3, P1, DOI 10.1016/S1385-299X(98)00012-9
   DREYER KJ, 2001, PACS GUIDE DIGITAL R
   Gunderman RB, 2003, RADIOLOGY, V227, P15, DOI 10.1148/radiol.2271021124
   Harris TR, 2002, ANNU REV BIOMED ENG, V4, P29, DOI 10.1146/annurev.bioeng.4.091701.125502
   Kontodimopoulos N., 2004, WSEAS Transactions on Advances in Engineering Education, V1, P42
   Kontodimopoulos N, 2004, P ANN INT IEEE EMBS, V26, P5184
   *NAT EL MAN ASS AM, 2003, DIG IM COMM MED DI 1
   Spencer JA, 1999, BRIT MED J, V318, P1280
NR 8
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 353
EP 356
DI 10.1109/IEMBS.2005.1616417
PG 4
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998400091
PM 17282186
DA 2018-10-20
ER

PT S
AU Blagosklonov, O
   Cardot, JC
   Roux, C
   Gharbi, T
   Picart, P
AF Blagosklonov, O.
   Cardot, J. C.
   Roux, C.
   Gharbi, T.
   Picart, P.
GP IEEE
TI The first experience of a dedicated biomedical education unit at the
   University of Franche-Comte
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
AB Biomedical activity is rapidly expanding. Actually, the demand for hi-tech technologies in health is in constant increase. At the Franche-Comte High Institute of Engineers (ISIFC) an engineer can acquire the knowledge and skills to carry out various tasks in biomedical engineering field including academic research, in-hospital devices maintenance or industrial development.
   The main advantage of the ISIFC is that it offers an exceptional multidisciplinary programme thank to close cooperation between Besancon University Hospital professionals and Engineering Sciences professors and researchers. As a result, the graduates obtain real experience in the both fields.
   The majority of the ISIFC engineers are employed by firms producing and/or commercializing health-oriented materials and equipments such as Alcis, Arthesis, Aventis Pasteur, Biomerieux, Imasonic, Medos, Statice Santk, Sophysa, Symbios, Praxim, Protheos, Tornier, Zimmer etc.
C1 Inst Super Ingn Franche Comte, Besancon, France.
RP Blagosklonov, O (reprint author), Inst Super Ingn Franche Comte, Besancon, France.
OI GHARBI, Tijani/0000-0002-3620-2806
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 361
EP 362
DI 10.1109/IEMBS.2005.1616419
PG 2
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998400093
PM 17282188
DA 2018-10-20
ER

PT S
AU Lu, XY
   He, J
   Qin, T
   Jiang, DX
   Chen, W
AF Lu Xiaoying
   He Jian
   Qin Tian
   Jiang Dongxu
   Chen Wei
GP IEEE
TI Construction of multimedia courseware and web-based e-learning courses
   of "Biomedical Materials"
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
DE multimedia courseware; web courses; Biomedical Materials
AB In order to reform the traditional teaching methodology and to improve the teaching effect, we developed new teaching system for course "Biomedical Materials" in our university by the support of the computer technique and Internet. The new teaching system includes the construction of the multimedia courseware and web-based e-learning courses. More than 2000 PowerPoint slides have been designed and optimized and flash movies for several capitals are included. On the basis of this multimedia courseware, a web-based educational environment has been established further, which includes course contents, introduction of the teacher, courseware. download, study forum, sitemap of the web, and relative link. The multimedia courseware has been introduced in the class teaching for "Biomedical Materials" for 6 years and a good teaching effect has been obtained. The web-based e-learning courses have been constructed for two years and proved that they are helpful for the students by their preparing and reviewing the teaching contents before and after the class teaching.
C1 SE Univ, Biomed & Engn Dept, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
RP Lu, XY (reprint author), SE Univ, Biomed & Engn Dept, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
CR BUYENS J, 2002, MICROSOFT FRONTPAGE
   Gu H. Q., 1993, BIOMEDICAL MAT
   HU B, 2004, ASP NETWORK PROGRAMM
   LI BL, 2002, MASTER ELECT DEMO
   LIU K, 2002, 80 WONDERFUL EXAMPLE
   SONG TY, 2001, MULTIMEDIA DEMO METH
   WANG J, 2002, CONTACT PHOTOSHOP 6
   YU MS, 1993, TODAY TOMORROW BIOME
   YU YT, 2000, BIOMEDICAL MAT
   ZHU ZS, 2002, MASTER FLASH MX SHOR
NR 10
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 2886
EP 2889
DI 10.1109/IEMBS.2005.1617077
PG 4
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998402179
PM 17282846
DA 2018-10-20
ER

PT S
AU Lymberis, A
AF Lymberis, A.
GP IEEE
TI Wearable Health Systems and Applications: The contribution of
   Information & Communication Technologies
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
DE smart wearable; health systems; biomedical sensors; Information &
   Communication Technologies
ID DISEASE MANAGEMENT; INTELLIGENT
AB The interest for wearable health systems originates mainly from the need to extend health services out of the hospital and monitor patients over extensive periods of time. Smart Wearable Health Systems (SWHS) are integrated systems in contact with or near to the body able to sense, (and/or act), process and communicate biomedical and physical parameters. Significant advances in biomedical technology, materials engineering, micro/nanotechnologies and Information and Communication Technologies (ICT) lead to new possibilities for increasing miniaturisation, communication capabilities and system "intelligence". The new possibilities for wearable monitoring are mainly provided at the level of microsensors, wrist and other body worn devices, and smart biomedical clothing. Research and development in these areas has been strongly supported through public funding and private investments worldwide. In Europe the major R&D activities were promoted and supported by the European Commission, Information Society Technologies (IST) programme, mainly through health telematics (telemedicine, e-Health) and micro-nano technologies activities. The aim of these projects was the development and testing of innovative integrated user-friendly systems, environments and scenarios of use that could lead to market exploitation in a short to mid term future (3-5 years). This paper presents the rationale and the results of research on wearable health systems in Europe and comments on the current challenges and futures perspectives in the field.
C1 Commiss European Communities, Informat Soc Directorate Gen, B-1049 Brussels, Belgium.
RP Lymberis, A (reprint author), Commiss European Communities, Informat Soc Directorate Gen, B-1049 Brussels, Belgium.
CR BONATO P, 2003, IEEE ENG MED BIO JUN, P18
   DITTMAR A, 2003, P 25 ANN INT C IEEE, V4, P3744
   Doughty K, 1996, J Telemed Telecare, V2, P71, DOI 10.1258/1357633961929826
   Hovorka Roman, 2004, Diabetes Technol Ther, V6, P307, DOI 10.1089/152091504774197990
   Lauter J., 2004, STUDIES HLTH TECHNOL, P34
   Lymberis A, 2003, TELEMED J E-HEALTH, V9, P379, DOI 10.1089/153056203772744716
   LYMBERIS A, 2004, STUDIES HLTH TECHNOL, V104, P155
   Marculescu D., 2003, P IEEE, V91, P1991
   PARADISO R, 2003, P 25 ANN INT C IEEE, V4, P3720
   Rubel P, 2001, COMPUT CARDIOL, V28, P193, DOI 10.1109/CIC.2001.977624
   van Halteren Aart, 2004, Stud Health Technol Inform, V108, P181
   WEBER L, 2004, STUDIES HLTH TECHNOL, V108, P260
   Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925
   Wilkinson J.M, 2002, INT NEWSLETTER M SEP, V4, P37
NR 14
TC 3
Z9 3
U1 1
U2 14
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 4149
EP 4152
DI 10.1109/IEMBS.2005.1615377
PG 4
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998403208
PM 17281147
DA 2018-10-20
ER

PT B
AU Lymberis, A
AF Lymberis, A
GP IEEE
TI Progress in R&D on wearable and implantable biomedical sensors for
   better healthcare and medicine
SO 2005 3rd IEEE/EMBS Special Topic Conference on Microtechnology in
   Medicine and Biology
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Medicine
   and Biology
CY MAY 12-15, 2005
CL Oahu, HI
SP IEEE, EMBS
DE wearable biomedical sensors; implantable biomedical sensors;
   microtechnologies
AB The management and coordination of healthcare and medicine throughout the entire range of services. from primary to tertiary care. undergo fundamental changes such as, more emphasis on prevention and education or users. new ways or delivering care and empowerment or individuals to manage their own health. This is being possible mainly thanks to extraordinary progress in sciences and technologies e.g. micro and nano technologies, mobile communications, human computer interface and genomics. Integrated smart micro and nano systems provide large spectrum of solutions spanning from health monitoring and diagnosis at the point of care, to chronic diseases management. healthy lifestyle support and human performance monitoring and assessment.
   Communicative biomedical sensors/biosensors and wearable integrated systems are becoming major driving forces for cutting edge developments. Further research in the intersection or disciplines like micro-nano technologies, materials, physiology/biology/medicine and Information & Communication Technologies (ICT) is necessary in order to achieve highly performing. user-friendly, and cost-effective wearable and implantable medical/healthcare systems.
C1 European Commiss, Informat Soc Directorate Gen, Brussels, Belgium.
RP Lymberis, A (reprint author), European Commiss, Informat Soc Directorate Gen, Brussels, Belgium.
CR Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423
   DEROSSI D, 2000, 1 ANN INT IEEE EMBS
   DITTMAR A, 1997, BIOMEDICAL MICROSENS, P13
   KIMBERLEY TJ, 2002, NEUROMUSCULAR ELECT, V85
   Lymberis A, 2003, TELEMED J E-HEALTH, V9, P379, DOI 10.1089/153056203772744716
   Wilkinson J.M, 2002, INT NEWSLETTER M SEP, V4, P37
   1999, TEL 21 CENT OPP CIT
NR 7
TC 1
Z9 1
U1 1
U2 8
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8711-2
J9 ENG MED BIOL SOC ANN
PY 2005
BP 296
EP 298
DI 10.1109/MMB.2005.1548453
PG 3
WC Engineering, Biomedical
SC Engineering
GA BDL92
UT WOS:000234204800090
DA 2018-10-20
ER

PT B
AU Perale, G
   Maccagnan, S
   Contro, R
AF Perale, G
   Maccagnan, S
   Contro, R
GP IEEE
TI Novel technological process to manufacture ceramic microelectrodes for
   biomedical applications implying microextrusion of preceramic precursors
SO 2005 3rd IEEE/EMBS Special Topic Conference on Microtechnology in
   Medicine and Biology
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Medicine
   and Biology
CY MAY 12-15, 2005
CL Oahu, HI
SP IEEE, EMBS
DE ceramic-based microelectrodes; preceramic polymers; electrically
   conductive ceramics; extrusion
ID MULTISITE MICROELECTRODES
AB A novel technological process is under development to obtain ceramic microelectrodes from preceramic precursors, basically for biomedical applications. A microextrusion approach is applied. Commercially available silicone resins are used as preceramic polymers. Drugging with carbon black results in electrically conductive ceramics. A coextrusion approach is used to obtain the filament with inner conductive lines. Chemical reticulation and pyrolysis are applied to convert polymeric resins into ceramics. Some different geometries of profiles and cross sections can be considered and obtained. Circular microelectrodes can be provided with diameters in the range between 100 mu m and 5mm and wide coextrusion dimension ratios are obtainable. Preliminary results on filaments with diameter between 100 mu m and 500 mu m showed bending strength ranging from 30MPa to 1100MPa and average conductivity of 0.375 1/Omega cm for a 50% weight carbon black load. Selecting such characteristics and related materials mainly depends on specific applications. Biomedical electrodes can be devised as stimulators or sensors in neurosurgery, beep brain stimulation and cell biology. It's important to achieve strict control of the above characteristics demanded by desired performances and obtained by suitably adjusting the technological process. Such control is hard to attain for great sensitiveness of some features of microgeometry and micro-structure to process parameters.
C1 Politecn Milan, Dept Bioengn, I-20133 Milan, Italy.
RP Perale, G (reprint author), Politecn Milan, Dept Bioengn, Via Golgi 39, I-20133 Milan, Italy.
CR Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429
   Burmeister JJ, 2000, ANAL CHEM, V72, P187, DOI 10.1021/ac9907991
   Colombo P, 2003, J AM CERAM SOC, V86, P1025, DOI 10.1111/j.1151-2916.2003.tb03413.x
   Interrante L. V., 1998, CHEM ADV MAT
   MACCAGNAN G, Patent No. 03011791
   MOXON K, 2005, IN PRESS CERAMIC BAS
   Pantano CG, 1999, J SOL-GEL SCI TECHN, V14, P7, DOI 10.1023/A:1008765829012
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8711-2
J9 ENG MED BIOL SOC ANN
PY 2005
BP 323
EP 325
DI 10.1109/MMB.2005.1548461
PG 3
WC Engineering, Biomedical
SC Engineering
GA BDL92
UT WOS:000234204800098
DA 2018-10-20
ER

PT B
AU Zhu, XY
   Mills, KL
   Peters, PR
   Naruse, K
   Csete, ME
   Thouless, MD
   Takayama, S
AF Zhu, XY
   Mills, KL
   Peters, PR
   Naruse, K
   Csete, ME
   Thouless, MD
   Takayama, S
GP IEEE
TI Reconfigurable protein matrices for prolonged neuroblasts patterning and
   retraction
SO 2005 3rd IEEE/EMBS Special Topic Conference on Microtechnology in
   Medicine and Biology
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Medicine
   and Biology
CY MAY 12-15, 2005
CL Oahu, HI
SP IEEE, EMBS
DE micro/nano fabrication; patterning; ECM
ID SURFACES; CELLS; MODEL
AB Here we present long-term patterning and response studies of neuroblasts on arrays of extracellular matrix (ECM) protein lines fabricated by cracking a polymer-supported thin film and selectively depositing proteins inside the cracks. Neuroblasts cultured for five days on the protein matrix switched between spreading and retraction upon changing the protein line width. This technique provides a novel tool to pursue further understanding of the basic mechanisms of neuroblast pathfinding on adhesion and morphology. Biomedical device design will also benefit from materials engineered with the reconfigurable protein patterns.
C1 Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Zhu, XY (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
CR Clarkson ED, 1999, P SOC EXP BIOL MED, V222, P157, DOI 10.1046/j.1525-1373.1999.d01-126.x
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Hutchinson JW, 1992, ADV APPL MECH, V29, P64
   Jiang XY, 2003, J AM CHEM SOC, V125, P2366, DOI 10.1021/ja029485c
   Nelson CM, 2003, LANGMUIR, V19, P1493, DOI 10.1021/la026178b
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   SANES DH, 2000, DEV NERVOUS SYSTEM
   Schutt M, 2003, CHEM BIOL, V10, P487, DOI 10.1016/S1074-5521(03)00128-5
   THOULESS MD, 1990, J AM CERAM SOC, V73, P2144, DOI 10.1111/j.1151-2916.1990.tb05290.x
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
   ZHU X, 2005, IN PRESS NATURE MAT
NR 12
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8711-2
J9 ENG MED BIOL SOC ANN
PY 2005
BP 393
EP 395
DI 10.1109/MMB.2005.1548485
PG 3
WC Engineering, Biomedical
SC Engineering
GA BDL92
UT WOS:000234204800122
DA 2018-10-20
ER

PT B
AU Nishizawa, M
   Kaji, H
AF Nishizawa, M
   Kaji, H
GP IEEE
TI Electrochemical bio-lithography for in situ control of cellular adhesion
   and growth on a chip
SO 2005 3rd IEEE/EMBS Special Topic Conference on Microtechnology in
   Medicine and Biology
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Medicine
   and Biology
CY MAY 12-15, 2005
CL Oahu, HI
SP IEEE, EMBS
DE patterning; cells; microelectrode
ID CELLS
AB Controlling the interfaces between cells and materials is important subject for a wide range of research fields such as cell biology, tissue engineering, and biomedical devices. Here we report a novel electrochemical method to direct the adhesion and growth of mammalian cells on a substrate during cultivation in situ, named "Electrochemical Bio-Lithography". We found that the cell-repellent nature of the albumin- or heparin-coated substrates can be locally switched to cell-adhesive, by treatment with hypobromous acid electrochemically generated at the tip of the scanning microelectrode. Since this technique can be conducted under typical physiological conditions, we were able to direct cellular proliferation and migration by drawing adhesive micropatterns over the preexisting cellular pattern. The integration of this electrochemical system into a microfluiclic device will provide a novel type of cell-chip which enables on-demand immobilization of cells just prior to the use of devices.
C1 Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan.
RP Nishizawa, M (reprint author), Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan.
CR Kaji H, 2004, LANGMUIR, V20, P16, DOI 10.1021/la035537f
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Li Nianzhen, 2003, Crit Rev Biomed Eng, V31, P423, DOI 10.1615/CritRevBiomedEng.v31.i56.20
   NAJI H, 2004, J AM CHEM SOC, V126, P15026
   Nishizawa M, 2002, LANGMUIR, V18, P3645, DOI 10.1021/la011576k
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8711-2
J9 ENG MED BIOL SOC ANN
PY 2005
BP 396
EP 397
DI 10.1109/MMB.2005.1548486
PG 2
WC Engineering, Biomedical
SC Engineering
GA BDL92
UT WOS:000234204800123
DA 2018-10-20
ER

PT B
AU Chen, CJ
   Haik, Y
   Chatterjee, J
AF Chen, CJ
   Haik, Y
   Chatterjee, J
GP IEEE
TI Development of nanotechnology for biomedical applications
SO 2005 Emerging Information Technology Conference (EITC)
LA English
DT Proceedings Paper
CT Emerging Information Technology Conference (EITC)
CY AUG 15-16, 2005
CL Taipei, TAIWAN
AB This presentation discusses the technological advancement in nanotechnology and some aspects of applications in engineering devices and biotechnologies. The lecture outlines the logical development of technology and engineering following (1) initiation of idea and visualization, (2) ability to control and measurements and (3) intense effort in engineering developments. The talk includes a brief review of the historical development in biology, nano and potential applications of electro-magnetic phenomena. The talk also describes the activities in the Center for Nanomagnetics and Biotechnology for clinical applications using nanomagnetic particles. Several magnetic phenomena in life sciences are illustrated. Brief discussions of nano materials are introduced. The lecture then concludes with possible near term applications and long term developments of nanotechnology in biomedical and bioengineering.
C1 Florida State Univ, Ctr Nanomagnet & Biotechnol, Coll Engn, Florida A&M Univ, Tallahassee, FL 32310 USA.
RP Chen, CJ (reprint author), Florida State Univ, Ctr Nanomagnet & Biotechnol, Coll Engn, Florida A&M Univ, Tallahassee, FL 32310 USA.
CR CHEN CJ, 2003, RECENT RES DEV MAGNE
   CHEN CJ, 2004, HDB THEORETICAL COMP
NR 2
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-9328-7
PY 2005
BP 9
EP 12
PG 4
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Engineering, Biomedical; Engineering,
   Electrical & Electronic
SC Computer Science; Engineering
GA BDZ91
UT WOS:000236376100003
DA 2018-10-20
ER

PT S
AU Lin, HY
   Lin, CP
   Lee, GB
   Chou, TC
AF Lin, HY
   Lin, CP
   Lee, GB
   Chou, TC
GP IEEE
TI The recognition of lysozyme by patterned molecularly imprinted polymers
SO 2005 IEEE 31ST ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 31st Annual Northeast Bioengineering Conference
CY APR 02-03, 2005
CL Stevens Inst Technol, Hoboken, NJ
SP IEEE, EMB
HO Stevens Inst Technol
AB Micro-Electro-Mechanical-System (MEMS) micro-sensing devices have recently been extensively researched for their application in biomedical diagnostics. Molecularly imprinted polymers with highly specific binding to targets and their low cost have potential for use in devices as sensing materials. Both techniques were combined to synthesize localized molecularly imprinted polymers (MIPS) by microcontact printing for integration in a micro-total analysis system (mu TAS).
C1 Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
RP Lin, HY (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
RI Lee, Gwo-Bin/D-3032-2012
OI Lee, Gwo-Bin/0000-0001-6910-9133
CR BERNARD A, 1998, LANGMUIR, V14, P2226
   Dickert FL, 1999, TRAC-TREND ANAL CHEM, V18, P192, DOI 10.1016/S0165-9936(98)00123-X
   Katz A, 2000, NATURE, V403, P286, DOI 10.1038/35002032
   Shi HQ, 1999, NATURE, V398, P593
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
NR 5
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 0-7803-9105-5
J9 NORTHEAST BIOENGIN C
PY 2005
BP 40
EP 41
PG 2
WC Engineering, Biomedical
SC Engineering
GA BCO98
UT WOS:000230459300019
DA 2018-10-20
ER

PT S
AU Nishizawa, Y
   Takeda, S
   Obara, M
   Hongo, A
AF Nishizawa, Y
   Takeda, S
   Obara, M
   Hongo, A
GP IEEE
TI Biomedical material ablation by femtosecond laser double pulses through
   small-core hollow fibers
SO 2005 IEEE LEOS Annual Meeting Conference Proceedings (LEOS)
SE IEEE Lasers and Electro-Optics Society (LEOS) Annual Meeting
LA English
DT Proceedings Paper
CT 18th Annual Meeting of the IEEE-Lasers-and-Electro-Optical-Society
CY OCT 22-28, 2005
CL Sydney, AUSTRALIA
SP IEEE Lasers & Elect Opt Soc
C1 Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2138522, Japan.
RP Nishizawa, Y (reprint author), Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2138522, Japan.
CR Matsuura Y, 2002, J APPL PHYS, V91, P887, DOI 10.1063/1.1425070
   Ozono K, 2003, APPL PHYS A-MATER, V77, P303, DOI 10.1007/s00339-003-2119-3
NR 2
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1092-8081
BN 0-7803-9217-5
J9 IEEE LEOS ANN MTG
PY 2005
BP 93
EP 94
DI 10.1109/LEOS.2005.1547894
PG 2
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BDR62
UT WOS:000235109700049
DA 2018-10-20
ER

PT S
AU Herraiz, JL
   Espana, S
   Udias, JM
   Vaquero, JJ
   Desco, M
AF Herraiz, J. L.
   Espana, S.
   Udias, J. M.
   Vaquero, J. J.
   Desco, M.
BE Yu, B
TI Statistical reconstruction methods in PET: Resolution limit, noise, edge
   artifacts and considerations for the design of better scanners
SO 2005 IEEE Nuclear Science Symposium Conference Record, Vols 1-5
SE IEEE NUCLEAR SCIENCE SYMPOSIUM - CONFERENCE RECORD
LA English
DT Proceedings Paper
CT Nuclear Science Symposium/Medical Imaging Conference
CY OCT 23-29, 2005
CL Fajardo, PR
SP IEEE Nucl & Plasma Sci Soc, Brookhaven Natl Lab, CEA Saclay, DOE, CERN, Lawrence Berkeley Natl Lab, Lawrence Livermore Natl Lab, Stanford Linear Accelerator Ctr, Univ Calif Davis, Univ Washington
DE image reconstruction; positron emission tomography; resolution limit;
   noise; iterative methods; MLEM; OSEM
ID EMISSION-TOMOGRAPHY
AB Small animal positron emission tomography (PET) scanners are being increasingly used as a basic measurement tool in modern biomedical research. The new designs and technologies of these scanners and the modern reconstruction methods have allowed to reach high spatial resolution and sensitivity. Despite their successes, some important issues remain to be addressed in high resolution PET imaging. First, iterative reconstruction methods like maximum likelihood-expectation maximization (MLEM) are known to recover resolution, but also to create noisy images and edge artifacts if some kind of regularization is not imposed. Second, the limit of resolution achievable by iterative methods on high resolution scanners is not quantitatively understood. Third, the use of regularization methods like Sieves or maximum a posteriori (MAP) requires the determination of the optimal values of several adjustable parameter that may be object-dependent.
   In this work we review these problems in high resolution PET and establish that the origin of them is more related with the physical effects involved in the emission and detection of the radiation during the acquisition than with the kind of iterative reconstruction method chosen. These physical effects (positron range, non-collinearity, scatter inside the object and inside the detector materials) cause that the tube of response (TOR) that connects the voxels with a line of response (LOR) is rather thick. This implies that the higher frequencies of the patient organ structures are not recorded by the scanner and therefore cannot be recovered during the reconstruction. As iterations grow, MLEM algorithms try to recover higher frequencies in the image. Once that a certain critic frequency is reached, this only maximizes high frequency noise.
   Using frequency response analyses techniques, we determine the maximum achievable resolution, before edge artifacts spoil the quality of the image, for a particular scanner as a function of the thickness of the TOR, and independently of the reconstruction method employed. With the same techniques, we can deduce well defined stopping criteria for reconstructions methods. Also, criteria for the highest number of subsets which should be used and how the design of the scanners can be optimized when statistical reconstruction methods are employed, is established.
C1 Univ Complutense Madrid, Dpto Fis Atom Mol & Nucl, Madrid, Spain.
RP Herraiz, JL (reprint author), Univ Complutense Madrid, Dpto Fis Atom Mol & Nucl, Madrid, Spain.
RI Vaquero, Juan Jose/D-3033-2009; Desco, Manuel/D-2822-2009; Udias,
   Jose/A-7523-2010; Espana, Samuel/E-9240-2010; LOPEZ HERRAIZ,
   JOAQUIN/E-9234-2010
OI Vaquero, Juan Jose/0000-0001-9200-361X; Desco,
   Manuel/0000-0003-0989-3231; Udias, Jose/0000-0003-3714-764X; Espana,
   Samuel/0000-0001-9092-4597; LOPEZ HERRAIZ, JOAQUIN/0000-0001-7208-8863
CR Bettinardi V, 2002, EUR J NUCL MED, V29, P7, DOI 10.1007/s002590100651
   Boreman GD, 2001, MODULATION TRANSFER
   BROWNE J, 1996, IEEE T MED IMAG, V15
   HERRAIZ JL, 2004, IEEE NUC SCI S MED I, P106, DOI UNSP M05-106
   POLITTE DG, 1988, IEEE T NUCL SCI, V35, P608, DOI 10.1109/23.12796
   SABBA N, 2002, IEEE NUC SCI S MED I, DOI UNSP M11-170-
   Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558
   Slijpen ETP, 1999, IEEE T NUCL SCI, V46, P2233, DOI 10.1109/23.819309
   SNYDER DL, 1987, IEEE T MED IMAGING, V6, P228, DOI 10.1109/TMI.1987.4307831
NR 9
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1082-3654
BN 0-7803-9221-3
J9 IEEE NUCL SCI CONF R
PY 2005
BP 1846
EP 1850
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Instruments & Instrumentation; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BFH22
UT WOS:000241851903003
DA 2018-10-20
ER

PT S
AU Sboros, V
   Glynos, E
   Butler, M
   Moran, CM
   Ross, J
   Pye, SD
   McDicken, WN
   Koutsos, V
AF Sboros, V
   Glynos, E
   Butler, M
   Moran, CM
   Ross, J
   Pye, SD
   McDicken, WN
   Koutsos, V
GP IEEE
TI Microbubble nano-interrogation using the Atomic Force Microscope
SO 2005 IEEE Ultrasonics Symposium, Vols 1-4
SE ULTRASONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT IEEE International Ultrasonics Symposium
CY SEP 18-21, 2005
CL Rotterdam, NETHERLANDS
SP IEEE
ID CONTRAST AGENT MICROBUBBLES; BEHAVIOR; CAMERA
AB The Atomic Force Microscope (AFM) is a versatile tool that provides spatial and force resolution of the order of Angstroms and subnationewtons, respectively; therefore, it is ideally suited to study morphology and mechanical properties of materials at the nanometer scale. This paper introduces the use of the AFM to study the topography and the mechanical properties of individual biSphere (R) microbubbles (Point Biomedical Corp, San Carlos, CA, USA) microbubbles. The Bioscope AFM (Veeco, Santa Barbara, CA, USA) was used for the measurements: a) Tapping mode AFM was used for imaging, with cantilevers resonating at 5-8 kHz (NP-20, Veeco). b) Contact mode AFM was used for mechanical measurements using tipless cantilevers (NSC-20, MikroMash, Spain) with spring constants ranging from 0.03-15 N/m.
   The resolution of the topography of the microbubble was as small as 20 nm. Such figures are comparable with data from electron microscopy, but AFM provides superior flexibility as it can interrogate microbubbles in various chemical and physical environments (in liquid at a range of different temperatures, pressures and viscosities). Optimal measurements of the stiffness of microbubbles ranging in size from 1-10 mu m was provided by cantilevers between 0.3-0.6 N/m as cantilevers with lower spring constant were too soft for the measurements, and higher spring constant would destroy the microbubbles. The stiffness (effective spring constant) of the microbubbles ranged between 1 and 5 N/m. These measurements can be translated to shell properties by using an appropriate model for the shape and structure of the microbubbles.
C1 Univ Edinburgh, Sch Clin Sci & Community Hlth, Edinburgh EH8 9YL, Midlothian, Scotland.
RP Sboros, V (reprint author), Univ Edinburgh, Sch Clin Sci & Community Hlth, Edinburgh EH8 9YL, Midlothian, Scotland.
RI Glynos, Emmanouil/M-2571-2015
OI Sboros, Vassilis/0000-0002-9133-7252; Koutsos,
   Vasileios/0000-0002-2203-8179
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Chin CT, 2003, REV SCI INSTRUM, V74, P5026, DOI 10.1063/1.1626013
   de Jong N, 2000, ULTRASOUND MED BIOL, V26, P487, DOI 10.1016/S0301-5629(99)00159-3
   Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156
   Morgan KE, 2000, IEEE T ULTRASON FERR, V47, P1494, DOI 10.1109/58.883539
   Postema M, 2004, ULTRASOUND MED BIOL, V30, P1337, DOI 10.1016/j.ultrasmedbio.2004.08.008
   Sboros V, 2003, ULTRASOUND MED BIOL, V29, P687, DOI 10.1016/S0301-5629(03)00027-9
   SBOROS V, 2002, IEEE ULTR S, P1897
   Vinogradova OI, 2004, J PHYS-CONDENS MAT, V16, pR1105, DOI 10.1088/0953-8984/16/32/R01
NR 9
TC 0
Z9 0
U1 0
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 0-7803-9382-1
J9 ULTRASON
PY 2005
BP 985
EP 987
PG 3
WC Acoustics; Engineering, Biomedical; Physics, Applied
SC Acoustics; Engineering; Physics
GA BDY24
UT WOS:000236090701065
DA 2018-10-20
ER

PT B
AU Pau, JL
   Rivera, C
   Pereiro, J
   Navarro, A
   Munoz, E
AF Pau, JL
   Rivera, C
   Pereiro, J
   Navarro, A
   Munoz, E
GP IEEE
TI Ultraviolet and visible nitride photodetectors: Applications
SO 2005 SPANISH CONFERENCE ON ELECTRON DEVICES, PROCEEDINGS
LA English
DT Proceedings Paper
CT 5th Spanish Conference on Electron Devices
CY FEB 02-04, 2005
CL Tarragona, SPAIN
SP Minist Educ & Ciencia, gencat, Diputacio Tarragona, Red IberNAM, LEAR Corp, La Caixa, Univ Rovira Virgili, IEEE Electron Devices Soc
ID III NITRIDES; GAN; SKIN
AB One of the main interests of wide-bandgap materials such as diamond, Ill-nitrides or SiC is their intrinsic ability to perform selective ultraviolet detection. Over the rest, Ill-nitrides present the undoubted advantage of tuning the absorption edge in a wide spectral range by varying the At and In mole fractions in AlGaN and InGaN ternary alloys. This property makes them suited for many applications in the ultraviolet and visible ranges. This work presents a short view of fabrication and spectral responses of AlGaN- and InGaN-based photodetectors and their potential use in industrial, environment, military and biomedical research. For visible detection, as an alternative to InGaN bulk-based devices, InGaN/GaN multiple-quantum-well (MQW) photodiodes are also described.
C1 ETSI Telecomunicac, ISOM, E-28040 Madrid, Spain.
RP Pau, JL (reprint author), ETSI Telecomunicac, ISOM, Ciudad Univ, E-28040 Madrid, Spain.
EM jlpau@die.upm.es
RI Navarro-Tobar, Alvaro/K-7864-2014; Pau, Jose Luis/L-1193-2014
OI Navarro-Tobar, Alvaro/0000-0003-3606-1780; Pereiro Viterbo,
   Juan/0000-0002-2582-3498
CR Ambacher O, 1998, J PHYS D APPL PHYS, V31, P2653, DOI 10.1088/0022-3727/31/20/001
   Carrano JC, 1997, ELECTRON LETT, V33, P1980, DOI 10.1049/el:19971322
   Look DC, 2001, PHYS STATUS SOLIDI B, V228, P293, DOI 10.1002/1521-3951(200111)228:1<293::AID-PSSB293>3.0.CO;2-F
   MACLAUGHLIN JA, 1982, SCIENCE, V216, P1001, DOI 10.1126/science.6281884
   Munoz E, 2004, NATO SCI SER II MATH, V144, P161
   Munoz E, 2001, J PHYS-CONDENS MAT, V13, P7115, DOI 10.1088/0953-8984/13/32/316
   Pau JL, 2004, J APPL PHYS, V95, P8275, DOI 10.1063/1.1748855
   Pau JL, 2002, P SOC PHOTO-OPT INS, V4650, P104, DOI 10.1117/12.467653
   Pearton SJ, 2000, MAT SCI ENG R, V30, P55, DOI 10.1016/S0927-796X(00)00028-0
   Rivera C, 2004, SUPERLATTICE MICROST, V36, P849, DOI 10.1016/j.spmi.2004.09.040
   Rivera C, 2004, PHYS STATUS SOLIDI A, V201, P2658, DOI 10.1002/pssa.200405019
   SETLOW RB, 1974, P NATL ACAD SCI USA, V71, P3363, DOI 10.1073/pnas.71.9.3363
NR 12
TC 0
Z9 0
U1 1
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8810-0
PY 2005
BP 7
EP 10
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BCM87
UT WOS:000230064900002
DA 2018-10-20
ER

PT B
AU Blagosklonov, O
   Cardot, JC
   Roux, C
   Gharbi, T
   Picart, P
AF Blagosklonov, Oleg
   Cardot, Jean-Claude
   Roux, Cristophe
   Gharbi, Tijani
   Picart, Philippe
BE Malpica, F
   Welsch, F
   Tremante, A
   Lawler, J
TI Institut Superieur d'Ingenieurs de Franche-Comte: Dual skills for high
   level bio-medical engineers
SO 3rd International Conference on Education and Information Systems:
   Technologies and Applications, Vol 1, Proceedings
LA English
DT Proceedings Paper
CT 3rd International Conference on Education and Information Systems
CY JUL 14-17, 2005
CL Orlando, FL
SP Int Inst Informat & Syst, Int Federat Syst Res
DE biomedical education; multidisciplinary; cooperation academic education
AB Biomedical activity is rapidly expanding. Actually, the demand for hi-tech technologies in health is in constant increase. At the High Institute of Engineers of Franche Comte (ISIFC) an engineer can acquire the knowledge and skins to carry out various tasks in biomedical engineering field including academic research, in-hospital devices maintenance or industrial development.
   The main advantage of the ISICF is that it offers an exceptional multidisciplinary programme thank to close cooperation between Besancon University Hospital professionals and Engineering Sciences professors and researchers. As a result, the graduates obtain real experience in the both fields.
   The majority of the ISIFC engineers are employed by firms producing and/or commercializing health-oriented materials and equipments such as Alcis, Arthesis, Aventis Pasteur, Biomdrieux, Imasonic, Medos, Statice Sante, Sophysa, Symbios, Praxim, Protheos, Tornier, Zimmer etc.
C1 Inst Super Ingn Franche Comte, Besancon, France.
OI GHARBI, Tijani/0000-0002-3620-2806
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT INST INFORMATICS & SYSTEMICS
PI ORLANDO
PA 14269 LORD BARCLAY DR, ORLANDO, FL 32837 USA
BN 978-980-6560-33-8
PY 2005
BP 206
EP 207
PG 2
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Education & Educational Research
SC Computer Science; Education & Educational Research
GA BFQ04
UT WOS:000243711100043
DA 2018-10-20
ER

PT S
AU Doraiswami, R
   Tummala, R
AF Doraiswami, R
   Tummala, R
GP IEEE
TI Nano-composite lead-free interconnect and reliability
SO 55th Electronic Components & Technology Conference, Vols 1 and 2, 2005
   Proceedings
SE ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE
LA English
DT Proceedings Paper
CT 55th Electronic Components and Technology Conference
CY MAY 31-JUN 04, 2005
CL Lake Buena Vista, FL
SP Elect Components, Assemblies & Mat Assoc, Elect Ind Alliance, IEEE, CPMT
AB Lead free solder bumping requirements have challenged researchers to develop new technologies to achieve fine pitch interconnects. ITRS has predicts that by 2017 the industry will require 70 micron pitch area array lead free interconnects for flip chips. This paper describes bumping, assembly and reliability evaluation of a new nano composite 20 micron pitch interconnect technology.
   Nanoparticles are the most common building blocks in several applications of Nanotechnology-Beside, the enormous increase of their surface area, the high surface to volume ratio of the nano particles results in extraordinary high reactivity, and unusual physical properties (optical, magnetic, etc.). Several types of nanostructures (nano particles, nano-wires and nano-rods) can be fabricated. Dispersed nano particles are used in several important applications, e.g., catalysis, biomedical applications, nano coatings and nanocomposites. Nanostructured materials, prepared by consolidating nanoparticles with a very high density of grain boundary, have been shown to lead to dramatically improved mechanical and physical properties. Lead free interconnect reliability has been a concern due tin pest (whiskers), intermetalics and high temperature reflow problems. This problem becomes even more pronounced when the pitch of the flip chip reduces to 100 microns or lesser. This paper proposes a novel nano metal composite for fine pitch lead free interconnect as an alternative to solder for fine pitch flip chip interconnect [1-2].
   This paper describes design, process, fabrication and reliability test for composite interconnects fabricated using Ni nano particles distributed in a tin core. A wafer level process is developed for flip chip having 20 micron pitch composite nano structured interconnect. The composition and intermetallics formed at the chip-to- interconnect-interface are evaluated when sent through 4 reflow cycles. Composition of the intemetalics is evaluated to study the distribution Ni3Sn4, Cu6Sn5 and Cu3Sn. Shear test on the interconnects provide bump adhesion strength and fatigue resistance information. The failure mode associated with shear test is also presented. The chip is thermally cycled in a oven from -55 degrees C to 125 degrees C and after every 100 cycles is evaluated for defects using X-Ray and Sonoscan techniques. A crossection is made and the composition at interface is also evaluated for intermetalic diffusion. The paper provides optimized data for next generation nano composite interconnect for fine pitch flip chip to achieve high reliability.
   This paper describes design, process, fabrication and reliability test for composite interconnects fabricated using Ni nano particles distributed in a tin core. A wafer level process is developed for flip chip having 20 micron pitch composite nano structured interconnect. The composition and intermetallics formed at the chip-to- interconnect-interface are evaluated when sent through 4 reflow cycles. Composition of the intermetalics is evaluated to study the distribution Ni3Sn4, Cu6Sn5 and Cu3Sn. Shear test on the interconnects provide bump adhesion strength and fatigue resistance information. The failure mode associated with shear test is also presented. The chip is thermally cycled in a oven from -55 degrees C to 125 degrees C and after every 100 cycles is evaluated for defects using X-Ray and Sonoscan techniques. A crossection is made and the composition at interface is also evaluated for intermetalic diffusion. The paper provides optimized data for next generation nano composite interconnect for fine pitch flip chip to achieve high reliability.
   Introduction: The European commission has required that all electronics be converted to lead free process by 2006. Fine pitch techniques for flip chip drives I/O density and chip size. Screen printing, solder jetting,ball placement and electroplating techniques are the leading techniques used for bumping wafers. Identifying new techniques to develop finepitch bumping becomes very important since the existing techniques have limitation to migrating towards nano interconnects.
   Several types of interconnects have been proposed by researcher to address mechanical issues of lead free flip chip assembly. Georgia Tech. has introduced sea of leads, helical interconnects and metal coated polymer posts as novel interconnects to solve compliant, reliability, electrical and high density fabrications issues for interconnects [3-6]. Nano interconnects have inherent problem of mechanical strength at the interface and very high interface resistance. It becomes very important to develop a new technique which has the best of properties of nano materials and high interfacial strength.
   Interconnect materials choice is based on the mechanical and electrical property of materials. Tin has emerged as the predominant material used in interconnects. NEMI has identified Sn3.5Ag and Sn3.5Ag0.7Cu as the lead free solders with the best of electrical and mechanical properties. Both these solders have tin as a predominant metal ranging up to 96% of the composition.
   Nickel is a high strength material used as barrier metallurgy in UBM on chips and surface finishes on substrates. Its inherent magnetic properties are detrimental to high speed signal transmission.. It has very good adhesion to metals and organics. The modulus and shear strength of nickel is several times greater than tin and tin based alloys (solder).
   In this paper nickel nano particles, having 50mn size as a statistical average, have been used develop a novel wafer level nickel-tin composite interconnect process using electroplating. The interconnects formed vary in dimensions depending on the particle distribution in the interconnect. A shear test is conducted to compare shear strengths of the nano composite interconnect with conventional lead free solder interconnects. By understanding the results from the shear test the reliability effects due to the presence of Sn3.5Ag or Sn3.5Ag0.7 is evaluated. Effects of L,C &R introduced my nano composite interconnect, which interterm affect high speed signal propagation, is also evaluated.
C1 Georgia Inst Technol, Packaging Res Ctr, Atlanta, GA 30332 USA.
RP Doraiswami, R (reprint author), Georgia Inst Technol, Packaging Res Ctr, Atlanta, GA 30332 USA.
CR Aggarwal AO, 2004, 9TH INTERNATIONAL SYMPOSIUM ON ADVANCED PACKAGING MATERIALS: PROCESSES, PROPERTIES AND INTERFACES, 2004 PROCEEDINGS, P69, DOI 10.1109/ISAPM.2004.1287991
   BAKIR MS, 2002, P 52 EL COMP TECHN C, P1087
   BROWN WD, 1999, ADV ELECT PACKAGING
   DORAISWAMI R, 2003, ADV FINE PITCH LEAD, P834
   MA L, 2002, P EL COMP TECHN C, P1359
   Tummala RR, 2001, FUNDAMENTALS MICROSY
   ZHU Q, 2002, P C THERM PHEN EL SY, P833
NR 7
TC 1
Z9 1
U1 0
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0569-5503
BN 0-7803-8906-9
J9 ELEC COMP C
PY 2005
BP 871
EP 873
PG 3
WC Engineering, Electrical & Electronic
SC Engineering
GA BCP57
UT WOS:000230581600140
DA 2018-10-20
ER

PT S
AU Giffoni, YA
   Ramos, ECT
   Ramos, AS
   Sandim, HRZ
   Pacheco, MTT
AF Giffoni, YA
   Ramos, ECT
   Ramos, AS
   Sandim, HRZ
   Pacheco, MTT
BE Salgado, L
   Filho, FA
TI Preparation of Nb-40Ti powders by high-energy milling
SO ADVANCED POWDER TECHNOLOGY IV
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Latin-American Conference on Power Technology
CY NOV 19-21, 2003
CL Guaruja, BRAZIL
SP Abbott, Basf, Brassinter, Bruker, Dorst, Eckagranules, Engefor, GM, Hoganas, Magneti Marelli, Mahle Miba, Metaldyne, Metalpo, Mextra, Osterwalder, Qmp, Qualisinter, Shimadzu, Uniwidia, Zoz, CNPz, FINEP, CAPES, FAPESP
DE titanium alloys; biomaterials; mechanical alloying
ID TITANIUM-ALLOYS; CORROSION; IMPLANTS; BONE
AB Porous Ti-Nb alloys are promising candidates for biomedical applications. In the present study, alloy powders containing 60 wt-% Nb were prepared by high-energy milling of Nb, Ti, and/or TiH2 powders. The high-energy milling process was carried out in a planetary ball mill. The starting and as-milled materials were characterized by X-ray diffraction (XRD), and scanning electron microscopy (SEM). Elemental (Nb, and Ti) and TiH2 powder mixtures with composition Nb-40wt%Ti were mechanically alloyed for 2 to 30 h. The formation of a BCC Nb(Ti) solid solution by high-energy milling using elemental Ti powder to produce Nb-40Ti was observed after milling for 30 h. A HCP-Ti solid solution was formed after milling for 30 h due to the partial decomposition of titanium hydride powder mixture during high-energy milling.
C1 UNIVAP, Inst Pesquisa & Desenvolvimento, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
   FAENQUIL, Dept Mat Engn, BR-12600000 Lorena, SP, Brazil.
RP Giffoni, YA (reprint author), UNIVAP, Inst Pesquisa & Desenvolvimento, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
RI Pacheco, Marcos/B-7991-2012; Sandim, Hugo/F-2778-2013
OI Pacheco, Marcos/0000-0002-1725-4803; Sandim, Hugo/0000-0003-4522-6639
CR FROES FH, 1995, MAT SCI ENG A-STRUCT, V192, P612
   Grosgogeat B, 1999, BIOMATERIALS, V20, P933, DOI 10.1016/S0142-9612(98)00248-8
   Hwang Y, 2002, MATER LETT, V54, P1, DOI 10.1016/S0167-577X(01)00526-2
   Kaczmar JW, 2000, J MATER PROCESS TECH, V106, P58, DOI 10.1016/S0924-0136(00)00639-7
   Kanagaraja S, 2001, BIOMATERIALS, V22, P1809, DOI 10.1016/S0142-9612(00)00362-8
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   KOCK CC, 1988, INT MATER REV, V33, P201
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lee KM, 1996, J ALLOY COMPD, V241, P153, DOI 10.1016/0925-8388(96)02306-7
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mante F, 1999, BIOMATERIALS, V20, P1051, DOI 10.1016/S0142-9612(98)00257-9
   Nishiguchi S, 2001, BIOMATERIALS, V22, P2525, DOI 10.1016/S0142-9612(00)00443-9
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Senkov ON, 2000, J ALLOY COMPD, V297, P246, DOI 10.1016/S0925-8388(99)00558-7
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Yang JY, 2000, PHYSICA B, V279, P241, DOI 10.1016/S0921-4526(99)01228-4
   Ye LL, 1998, MAT SCI ENG A-STRUCT, V241, P290, DOI 10.1016/S0921-5093(97)00505-4
   ZHOVNIR YNT, 1998, MET SCI HEAT TREAT, V40, P210
NR 18
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-984-9
J9 MATER SCI FORUM
PY 2005
VL 498-499
BP 146
EP 151
DI 10.4028/www.scientific.net/MSF.498-499.146
PG 6
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BDK21
UT WOS:000233984500024
DA 2018-10-20
ER

PT S
AU Georgiadis, A
   Sergeev, E
AF Georgiadis, Anthimos
   Sergeev, Elena
BE Mizuno, M
   Zhu, D
   Kriven, WM
TI DRY HIGH SPEED MILLING AS A NEW MACHINING TECHNOLOGY OF CERAMICS FOR
   BIOMEDICAL AND OTHER APPLICATIONS
SO ADVANCES IN BIOCERAMICS AND BIOCOMPOSITES
SE Ceramic Engineering and Science Proceedings
LA English
DT Proceedings Paper
CT 29th International Conference on Advanced Ceramics and Composites
CY JAN 23-28, 2005
CL Cocoa Beach, FL
SP Amer Ceram Soc
AB Ceramics are the first choice for orthopaedic, dental and other biomedical applications. Because of the processes used, the conventional production of ceramic parts is moreover limited to materials that are not optimal from a medical point of view. Further critical issues for biomedical applications are cooling lubricants and polishing materials used for machining the ceramics. Absorption into the surface of the machined ceramic parts makes them not neutral for the human body so they can cause allergic reactions or diseases. The developed thy, high speed milling of ceramics (Ceramill) presented in this work solves this problem. The method and a prototype machine tool for 3D treatment with the implementation of advanced controls, CAD-CAM coupling, high speed spindle, the dry process and the dedicated new tools have been developed and approved in field tests. Work pieces with dimensions till 200x400x400 mm has been constructed. Suitable geometries and coatings for new milling tools have been determined. The machining tests were performed with various parameters such as diamond coating thickness and composition. The trials have been performed with aluminium oxide, zirconium oxide and silicon nitride. Ceratnill leads to accurately finished products with tolerances of the order of magnitude of 1 micron and surface roughness of 0.2 microns. First measurements of the Weibull factor for silicon nitride show an encouraging value of 57 by a load of 628 MPa. A first model for the process based on the mechanistic approach has been established on the MatLab platform.
C1 [Georgiadis, Anthimos; Sergeev, Elena] Univ Luneburg, D-21339 Luneburg, Germany.
RP Georgiadis, A (reprint author), Univ Luneburg, Volgershall 1, D-21339 Luneburg, Germany.
CR ALTINTAS U, 2000, MANUFACTURING AUTOMA
   ALTINTAS U, 1991, ANN CIRP, P31
   Armarego E.A.J., 1969, MACHINING METALS
   BINNER JGP, 1990, ADV CERAMIC PROCESSI
   HUANG PT, 1999, J IND TECHNOLOGY, V15
   *IBAG GMBH, IBAG SPINDL HF 100 A
   Jayaram S, 2001, INT J MACH TOOL MANU, V41, P265, DOI 10.1016/S0890-6955(00)00076-6
   KLINE WA, 1982, INT J MACH TOOL MANU, P7
   Konig W, 1973, SPEZIFISCHE SCHNITTK
   Moufki A, 2000, INT J MECH SCI, V42, P1205, DOI 10.1016/S0020-7403(99)00036-3
   PAUCKSCH E, 1992, ZERSPANTECHNIK
NR 11
TC 2
Z9 2
U1 0
U2 3
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 0196-6219
BN 978-1-57498-236-7
J9 CERAM ENG SCI PROC
PY 2005
VL 26
IS 6
BP 41
EP 51
PG 11
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BOE32
UT WOS:000276374000006
DA 2018-10-20
ER

PT S
AU Flack, WW
   Nguyen, HA
   Neisser, M
   Sison, E
   Lu, PH
   Plass, B
   Makii, T
   Murakami, Y
AF Flack, WW
   Nguyen, HA
   Neisser, M
   Sison, E
   Lu, PH
   Plass, B
   Makii, T
   Murakami, Y
BE Sturtevant, JL
TI A comparison of new thick photoresists for solder bumping
SO Advances in Resist Technology and Processing XXII, Pt 1 and 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Advances in Resist Technology and Processing XXII
CY FEB 28-MAR 02, 2005
CL San Jose, CA
SP SPIE, AZ Elect Mat, Rohm & Haas Elect Mat
DE advanced packaging; thick photoresist; solder bumping; plating; process
   optimization
ID SOLVENT
AB The performance requirements for ultra-thick photoresists are rapidly increasing with the dramatic growth in lithographic applications that require electroplating processes. Two of the main applications for ultra-thick photoresists are advanced packaging and nanotechnology (MEMS). Flipchip packaging has become widely adopted to address electrical device performance and chip form factor considerations. The growth in the nanotechnology market is driven by a wide range of products, which include accelerometers, inkjet print heads, biomedical sensors and optical switches.
   The requirements of thick photoresists for solder electroplating are significantly different from typical thin photoresists used in front end of line applications. As the photoresist becomes thicker, processing times increase for many process steps. Photospeed gets slower due to the requirements for more chemical reactions per area of coating. Coating uniformity and edge bead control also become more difficult as photoresist films get thicker and time delay issues between process steps can arise. This result has led to the requirement for special photoresist formulations for thick photoresist films. These are traditionally positive tone DNQ-Novolak materials such as AZ 50XT. Such materials can be designed to work for a particular range of thicknesses, but as the desired thicknesses increases the processing times can become very long for high volume manufacturing.
   Many new bumping schemes require photoresists in a 60 to 70 mu m thickness range. While DNQ-Novolak chemistry can work, there is a desire for faster alternatives to improve total cost of ownership (COO) of the lithography cell. In order to have fast photospeeds and reasonable processing times a chemistry that is very photo efficient is needed. Negative tone cross linking chemistries, which can give tens of thousands of chemical events for one photochemical event, provide excellent photospeed and process times. Positive tone chemically amplified photoresist provide hundreds or thousands of chemical events per photochemical event. They are somewhat slower in photospeed than free radical materials, but still provide reasonable photospeeds.
   This paper compares the lithography and processing performance of these two newer types of thick film chemistries with the performance of a state of the art DNQ-Novolak thick film photoresist. The lithographic performance of these three ultra-thick positive photoresists were optimized to control critical dimensions (CD), sidewall angles and aspect ratios. The experimental results includes process latitude studies, electroplating performance and stripping performance. The general result is that negative free radical chemistry has the edge in photo-speed and processing times, but positive photoresist is better for stripping and perhaps for process integration.
C1 Ultratech Inc, San Jose, CA 95134 USA.
RP Flack, WW (reprint author), Ultratech Inc, San Jose, CA 95134 USA.
CR BEAUCHEMIN BT, 1994, P SOC PHOTO-OPT INS, V2195, P610
   DERBYSHIRE K, 1995, SOLID STATE TECH SEP, P57
   Ficner S, 1996, P SOC PHOTO-OPT INS, V2724, P654, DOI 10.1117/12.241864
   FLACK W, 2001, SPIE, V4326
   Gardiner AB, 1997, P SOC PHOTO-OPT INS, V3049, P850, DOI 10.1117/12.275886
   MACK CA, 1996, DATA STORAGE     MAY, P55
   RANJAN M, 2002, ADV PACKAGING    AUG
   SCHURZ D, 1997, SPIE, V3236
   TODD B, 1999, SPIE, V3874
NR 9
TC 1
Z9 1
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5733-7
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5753
BP 899
EP 911
DI 10.1117/12.598469
PN 1&2
PG 13
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Optics
SC Materials Science; Optics
GA BCI43
UT WOS:000229580700096
DA 2018-10-20
ER

PT J
AU Alteheld, A
   Feng, YK
   Kelch, S
   Lendlein, A
AF Alteheld, A
   Feng, YK
   Kelch, S
   Lendlein, A
TI Biodegradable, amorphous copolyester-urethane networks having
   shape-memory properties
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE amorphous materials; materials science; polymers; shape-memory polymers
ID IN-VITRO DEGRADATION; BIOMEDICAL APPLICATIONS;
   OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; BIOMATERIALS; POLYMERS; IMPLANTS;
   SURGERY; ACID)
C1 GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@gkss.de
RI feng, yakai/F-3854-2015; Lendlein, Andreas/K-9553-2013
OI feng, yakai/0000-0002-4511-0874; Lendlein, Andreas/0000-0003-4126-4670
CR Bruining MJ, 2002, BIOMATERIALS, V23, P1213, DOI 10.1016/S0142-9612(01)00237-X
   Edelman ER, 2000, BIOMATERIALS, V21, P2279, DOI 10.1016/S0142-9612(00)00154-X
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Jabbal-Gill I, 2001, ADV DRUG DELIVER REV, V51, P97, DOI 10.1016/S0169-409X(01)00173-9
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Liu L, 2005, BIOMATERIALS, V26, P233, DOI 10.1016/j.biomaterials.2004.02.025
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   Ramchandani M, 1998, J CONTROL RELEASE, V54, P167, DOI 10.1016/S0168-3659(97)00113-2
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   STOY VA, 1990, Patent No. 0439892
   TAKEDA K, 1988, ANGEW MAKROMOL CHEM, V157, P123, DOI 10.1002/apmc.1988.051570110
   VERT M, 1984, MACROMOLECULAR BIOMA, P119
   WARD IM, 1975, STRUCTURE PROPERTIES, P256
   Williams DF, 2003, SADHANA-ACAD P ENG S, V28, P563, DOI 10.1007/BF02706447
   Witschi C, 1998, J CONTROL RELEASE, V51, P327, DOI 10.1016/S0168-3659(97)00188-0
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   YAMAGUCHI K, 1993, J CONTROL RELEASE, V24, P81, DOI 10.1016/0168-3659(93)90169-6
NR 25
TC 166
Z9 171
U1 8
U2 75
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2005
VL 44
IS 8
BP 1188
EP 1192
DI 10.1002/anie.200461360
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 898WM
UT WOS:000227106900006
PM 15654685
OA Bronze
DA 2018-10-20
ER

PT J
AU Giri, S
   Trewyn, BG
   Stellmaker, MP
   Lin, VSY
AF Giri, S
   Trewyn, BG
   Stellmaker, MP
   Lin, VSY
TI Stimuli-responsive controlled-release delivery system based on
   mesoporous silica nanorods capped with magnetic nanoparticles
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE drug delivery; fluorescence; magnetic properties; mesoporous materials;
   nanostructures
ID DRUG-DELIVERY; IN-VITRO; SUPERPARAMAGNETIC NANOPARTICLES; ORGANIC
   FUNCTIONALIZATION; BIOMEDICAL APPLICATIONS; GENE DELIVERY; IRON-OXIDES;
   MCM-41; MOLECULES; CELLS
C1 Iowa State Univ, Dept Chem, Ames, IA 50011 USA.
   Iowa State Univ, US DOE Ames Lab, Ames, IA 50011 USA.
RP Lin, VSY (reprint author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.
EM vsylin@iastate.edu
OI Giri, Supratim/0000-0002-1658-1968
CR Biaglow JE, 2000, ANAL BIOCHEM, V281, P77, DOI 10.1006/abio.2000.4533
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Chattopadhyay P, 2002, IND ENG CHEM RES, V41, P6049, DOI 10.1021/ie020205b
   Diaz JF, 1996, J MOL CATAL B-ENZYM, V2, P115, DOI 10.1016/S1381-1177(96)00017-3
   Doyle PS, 2002, SCIENCE, V295, P2237, DOI 10.1126/science.1068420
   Gellissen J, 1999, MAGN RESON IMAGING, V17, P557, DOI 10.1016/S0730-725X(98)00206-9
   GREUNHAGEN JA, 2005, APPL SPECTROSC, V59, P424
   Gu HW, 2003, J AM CHEM SOC, V125, P15702, DOI 10.1021/ja0359310
   Gupta AK, 2004, J MATER SCI-MATER M, V15, P493, DOI 10.1023/B:JMSM.0000021126.32934.20
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Han YJ, 1999, J AM CHEM SOC, V121, P9897, DOI 10.1021/ja992138r
   Hernandez R, 2004, J AM CHEM SOC, V126, P3370, DOI 10.1021/ja039424u
   Hilger I, 2001, RADIOLOGY, V218, P570, DOI 10.1148/radiology.218.2.r01fe19570
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Huh S, 2003, CHEM MATER, V15, P4247, DOI 10.1021/cm0210041
   Huh S, 2003, CHEM COMMUN, P2364, DOI 10.1039/b306255d
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Josephson L, 2002, BIOCONJUGATE CHEM, V13, P554, DOI 10.1021/bc015555d
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Lee J., 2005, ANGEW CHEM, V117, P1092
   Lin VSY, 2001, J AM CHEM SOC, V123, P11510, DOI 10.1021/ja016223m
   Lubbe AS, 1999, J MAGN MAGN MATER, V194, P149, DOI 10.1016/S0304-8853(98)00574-5
   Ma M, 2003, COLLOID SURFACE A, V212, P219, DOI 10.1016/S0927-7757(02)00305-9
   Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362
   Marler B, 1996, MICROPOROUS MATER, V6, P375, DOI 10.1016/0927-6513(96)00016-8
   Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q
   Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064
   Perez JM, 2002, J AM CHEM SOC, V124, P2856, DOI 10.1021/ja017773n
   Perez JM, 2002, NAT BIOTECHNOL, V20, P816, DOI 10.1038/nbt720
   Radu DR, 2005, CHEM COMMUN, P1264, DOI 10.1039/b412618a
   Radu DR, 2004, J AM CHEM SOC, V126, P13216, DOI 10.1021/ja046275m
   Radu DR, 2004, J AM CHEM SOC, V126, P1640, DOI 10.1021/ja038222v
   Ramila A, 2003, J SOL-GEL SCI TECHN, V26, P1199, DOI 10.1023/A:1020764319963
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   Schillinger U, 2005, J MAGN MAGN MATER, V293, P501, DOI 10.1016/j.jmmm.2005.01.032
   Takahashi H, 2001, MICROPOR MESOPOR MAT, V44, P755, DOI 10.1016/S1387-1811(01)00257-8
   Tourne-Peteilh C, 2003, NEW J CHEM, V27, P1415, DOI 10.1039/b307046h
   Trewyn BG, 2004, NANO LETT, V4, P2139, DOI 10.1021/nl048774r
   Vallet-Regi M, 2004, SOLID STATE IONICS, V172, P435, DOI 10.1016/j.ssi.2004.04.036
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Wang DS, 2004, NANO LETT, V4, P409, DOI 10.1021/nl035010n
   Winkler H, 1999, ADV MATER, V11, P1444, DOI 10.1002/(SICI)1521-4095(199912)11:17<1444::AID-ADMA1444>3.0.CO;2-H
   Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802
   Yoon TJ, 2005, ANGEW CHEM INT EDIT, V44, P1068, DOI 10.1002/anie.200461910
   Zhang WH, 2000, CHEM MATER, V12, P1408, DOI 10.1021/cm990740a
   Zhang WH, 2001, CHEM MATER, V13, P648, DOI 10.1021/cm000621r
NR 49
TC 723
Z9 735
U1 25
U2 402
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2005
VL 44
IS 32
BP 5038
EP 5044
DI 10.1002/anie.200501819
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 957JY
UT WOS:000231367300007
PM 16038000
DA 2018-10-20
ER

PT J
AU Knudson, AG
AF Knudson, AG
TI A personal sixty-year tour of genetics and medicine
SO ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS
SE Annual Review of Genomics and Human Genetics
LA English
DT Review; Book Chapter
DE cancer; two hits; genetic chaos
ID TAY-SACHS-DISEASE; DOMINANTLY INHERITED CANCER; DEPENDENT DNA
   POLYMERASE; EKER RAT MODEL; TSC2 GENE; RETINOBLASTOMA; MUTATION;
   CHROMOSOME; DELETION; SARCOMA
AB The past 60 years surely constitute a Golden Age for biomedical science, and for medical genetics in particular. A personal experience began with an encounter with inborn errors of metabolism, selection, and the incidences of hereditary diseases, and peaked with molecular biology, virology, and cytogenetics, finally focusing all three on the problem of cancer. If the past dominates my contribution to this volume it is probably because octogenarians have much more past than future. There is also a strong temptation to contemplate a past that spans a Golden Age in genetics from the discovery by Avery and his colleagues that the genetic material of our cells is DNA, to the revelations of the human genome. Here I wish to tell how I first came upon the subject of genetics, how I became diverted to medicine just as medicine was making its first enduring relationship with genetics, and how this merger has led to a preoccupation with medical genetics and the genetic Gotterdammerung that is cancer.
C1 Fox Chase Canc Ctr, Philadelphia, PA 19111 USA.
RP Knudson, AG (reprint author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.
EM Alfred.Knudson@fccc.edu
CR BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0
   BENEDICT WF, 1983, SCIENCE, V219, P973, DOI 10.1126/science.6336308
   Borsook H, 1935, PROC R SOC SER B-BIO, V118, P488, DOI 10.1098/rspb.1935.0069
   BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0
   CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0
   Childs B., 1999, GENETIC MED LOGIC DI
   EKER R, 1961, NATURE, V189, P858, DOI 10.1038/189858b0
   ELLERMAN V, 1908, PARASITENKD ORIG ABT, V46, P595
   FRANCKE U, 1976, MED PEDIATR ONCOL, V2, P379, DOI 10.1002/mpo.2950020404
   FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0
   GAUCHER PCE, 1882, THESIS FACULTE MED P
   GODBOUT R, 1983, NATURE, V304, P451, DOI 10.1038/304451a0
   GROS F, 1961, NATURE, V190, P581, DOI 10.1038/190581a0
   HALLETT WY, 1965, AM REV RESPIR DIS, V92, P714
   HINO O, 1993, P NATL ACAD SCI USA, V90, P327, DOI 10.1073/pnas.90.1.327
   HUNT JA, 1958, NATURE, V181, P1062, DOI 10.1038/1811062a0
   JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7
   Kaback MM, 2001, ADV GENET, V44, P253
   KNUDSON A. G., 1967, J VIROL, V1, P1150
   KNUDSON AG, 1973, PROG MED GENET, V9, P113
   KNUDSON AG, 1972, AM J HUM GENET, V24, P514
   KNUDSON AG, 1951, J PEDIATR-US, V39, P408, DOI 10.1016/S0022-3476(51)80199-9
   KNUDSON AG, 1961, AM J CLIN NUTR, V9, P55, DOI 10.1093/ajcn/9.1.55
   KNUDSON AG, 1973, AM J HUM GENET, V25, P108
   KNUDSON AG, 1979, AM J HUM GENET, V31, P401
   KNUDSON AG, 1967, AM J HUM GENET, V19, P388
   KNUDSON AG, 1978, SEMIN ONCOL, V5, P57
   KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820
   KNUDSON AG, 1972, J NATL CANCER I, V48, P313
   KNUDSON AG, 1966, AM NAT, V100, P162, DOI 10.1086/282410
   KNUDSON AG, 1965, CANCER, V18, P815, DOI 10.1002/1097-0142(196507)18:7<815::AID-CNCR2820180707>3.0.CO;2-M
   KNUDSON AG, 1953, AMA AM J DIS CHILD, V85, P316, DOI 10.1001/archpedi.1953.02050070328007
   KNUDSON AG, 1976, NEW ENGL J MED, V295, P1120, DOI 10.1056/NEJM197611112952007
   KNUDSON AG, 1965, GENETICS DIS
   KNUDSON AG, 1968, STRUCTURAL CHEM MOL, P281
   KNUDSON AG, 1962, CEREBRAL SPHINGOLIPI, P395
   KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70
   KRUH J, 1956, J BIOL CHEM, V220, P905
   LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721
   NOWELL PC, 1960, SCIENCE, V132, P1497
   OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698
   OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400
   PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543
   Rennebeck G, 1998, P NATL ACAD SCI USA, V95, P15629, DOI 10.1073/pnas.95.26.15629
   Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397
   Schoenheimer R, 1942, DYNAMIC STATE BODY C
   SCHWEET R, 1958, P NATL ACAD SCI USA, V44, P1029, DOI 10.1073/pnas.44.10.1029
   SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916
   STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0
   TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0
   Tucker M, 2000, J NATL CANCER I, V92, P530, DOI 10.1093/jnci/92.7.530
   Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100
   YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413
NR 53
TC 10
Z9 11
U1 0
U2 2
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1527-8204
EI 1545-293X
J9 ANNU REV GENOM HUM G
JI Annu. Rev. Genomics Hum. Genet.
PY 2005
VL 6
BP 1
EP 14
DI 10.1146/annurev.genom.6.080604.162320
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA 972GE
UT WOS:000232441500002
PM 16124851
OA Bronze
DA 2018-10-20
ER

PT S
AU Levin, IW
   Bhargava, R
AF Levin, IW
   Bhargava, R
TI Fourier transform infrared vibrational spectroscopic imaging:
   Integrating microscopy and molecular recognition
SO ANNUAL REVIEW OF PHYSICAL CHEMISTRY
SE Annual Review of Physical Chemistry
LA English
DT Review; Book Chapter
DE Fourier transform infrared spectroscopy; interferometry; histopathology;
   brain tissue; bone tissue; breast tissue; esophageal tissue; skin
   tissue; prostate tissue; pharmaceuticals; single cells; drug delivery
ID PLANE ARRAY DETECTION; RESOLVED FT-IR; GRAM-SCHMIDT ORTHOGONALIZATION;
   INDUCED REORIENTATION DYNAMICS; DISPERSED LIQUID-CRYSTAL;
   BARRETTS-ESOPHAGUS; POLYMERIC SYSTEMS; RAMAN-SPECTROSCOPY; DELIVERY
   SYSTEMS; SINGLE CELLS
AB The recent development of Fourier transform infrared (FTIR) spectroscopic imaging has enhanced our capability to examine, on a microscopic scale, the spatial distribution of vibrational spectroscopic signatures of materials spanning the physical and biomedical disciplines. Recent activity in this emerging area has concentrated on instrumentation development, theoretical analyses to provide guidelines for imaging practice, novel data processing algorithms, and the introduction of the technique to new fields. To illustrate the impact and promise of this spectroscopic imaging methodology, we present fundamental principles of the technique in the context of FTIR spectroscopy and review new applications in various venues ranging from the physical chemistry of macromolecular systems to the detection of human disease.
C1 NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA.
RP Levin, IW (reprint author), NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA.
EM iwl@helix.nih.gov; rb3l9b@nih.gov
RI Coe, James/D-2578-2013
OI Bhargava, Rohit/0000-0001-7360-994X
CR Arfken G. B., 2000, MATH METHODS PHYS
   Bhargava R, 2004, APPL SPECTROSC, V58, P995, DOI 10.1366/0003702041655412
   Bhargava R, 1999, APPL SPECTROSC, V53, P1313, DOI 10.1366/0003702991945812
   Bhargava R, 2000, APPL SPECTROSC, V54, P486, DOI 10.1366/0003702001949898
   Bhargava R, 2001, APPL SPECTROSC, V55, P1580, DOI 10.1366/0003702011954143
   Bhargava R, 2000, APPL SPECTROSC, V54, P1743, DOI 10.1366/0003702001949069
   Bhargava R, 2001, ANAL CHEM, V73, P5157, DOI 10.1021/ac010380m
   Bhargava R, 2003, ADV POLYM SCI, V163, P137, DOI 10.1007/b11052
   Bhargava R, 2003, APPL SPECTROSC, V57, P357, DOI 10.1366/00037020360625880
   Bhargava R, 2003, MACROMOLECULES, V36, P92, DOI 10.1021/ma021336r
   Bhargava R, 1998, APPL SPECTROSC, V52, P323, DOI 10.1366/0003702981943653
   Bhargava R, 2002, ANAL CHEM, V74, P1429, DOI 10.1021/ac011153n
   Bhargava R, 2001, APPL SPECTROSC, V55, P1079, DOI 10.1366/0003702011952983
   Bhargava R, 2000, APPL SPECTROSC, V54, P470, DOI 10.1366/0003702001949870
   Bhargava R, 2004, J PHYS CHEM A, V108, P3896, DOI 10.1021/jp037847c
   Bhargava R, 2000, APPL SPECTROSC, V54, P1690, DOI 10.1366/0003702001948745
   BHARGAVA R, 2000, E ANAL S
   BHARGAVA R, 2002, PITTCON 2002
   BRISSEY GM, 1984, ANAL CHEM, V56, P2002, DOI 10.1021/ac00276a005
   BUDEVSKA BO, 1993, APPL SPECTROSC, V47, P1843, DOI 10.1366/0003702934065920
   Budevska BO, 2003, APPL SPECTROSC, V57, P124, DOI 10.1366/000370203321535015
   Cadet F, 1996, SPECTROSC LETT, V29, P901, DOI 10.1080/00387019608001620
   Carr GL, 2001, REV SCI INSTRUM, V72, P1613, DOI 10.1063/1.1347965
   Chalmers J.M., 2002, HDB VIBRATIONAL SPEC, V5
   Chan KLA, 2003, ANAL CHEM, V75, P2140, DOI 10.1021/ac026456b
   Chan KLA, 2003, APPL SPECTROSC, V57, P381, DOI 10.1366/00037020360625907
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Colarusso P, 1998, APPL SPECTROSC, V52, p106A, DOI 10.1366/0003702981943545
   Coutts-Lendon CA, 2003, J CONTROL RELEASE, V93, P223, DOI 10.1016/j.jconrel.2003.06.003
   CROCOMBE RA, 1991, P SPIE INT SOC OPT E, V1575, P189
   CROCOMBE RA, 1999, P 12 INT C FOUR TRAN, P277
   DEHASETH JA, 1977, ANAL CHEM, V49, P1977
   DIEM M, 1999, APPL SPECTROSC, V53, P148, DOI DOI 10.1366/0003702991946712
   DOANE JW, 1986, APPL PHYS LETT, V48, P269, DOI 10.1063/1.96577
   Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212
   Ekgasit S, 2001, APPL SPECTROSC, V55, P1352, DOI 10.1366/0003702011953478
   Fabian H, 2002, BIOPOLYMERS, V67, P354, DOI 10.1002/bip.10088
   FERNANDEZ DC, 2004, UNPUB NAT BIOTECH
   Garidel P, 2003, PHYS CHEM CHEM PHYS, V5, P2673, DOI 10.1039/b302749j
   Gazi E, 2003, J PATHOL, V201, P99, DOI 10.1002/path.1421
   GRAHAM JR, 1999, OSA FTS M SANT BARB
   GREGORIOU VG, 1991, CHEM PHYS LETT, V179, P491, DOI 10.1016/0009-2614(91)87092-P
   Gremlich H U, 2000, INFRARED RAMAN SPECT
   Griffiths PR, 1986, FOURIER TRANSFORM IN
   Haaland DM, 1997, APPL SPECTROSC, V51, P340, DOI 10.1366/0003702971940468
   Haka AS, 2000, APPL SPECTROSC, V54, P753, DOI 10.1366/0003702001950049
   HASEGAWA R, 1993, APPL SPECTROSC, V47, P1386, DOI 10.1366/0003702934067441
   HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69
   HIRSCHFELD T, 1979, APPL SPECTROSC, V33, P525, DOI 10.1366/0003702794925390
   Huang ZW, 2003, INT J ONCOL, V23, P649
   Huffman SW, 2004, CHEM PHYS LIPIDS, V130, P167, DOI 10.1016/j.chemphyslip.2004.03.004
   Huffman SW, 2002, APPL SPECTROSC, V56, P965, DOI 10.1366/000370202760249684
   Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837
   Kazarian SG, 2003, MACROMOLECULES, V36, P9866, DOI 10.1021/ma035210l
   Kendall C, 2003, J PATHOL, V200, P602, DOI 10.1002/path.1376
   Kidder LH, 1997, OPT LETT, V22, P742, DOI 10.1364/OL.22.000742
   Kidder LH, 1997, NAT MED, V3, P235, DOI 10.1038/nm0297-235
   Kidder LH, 1999, J BIOMED OPT, V4, P7, DOI 10.1117/1.429915
   Knoll B, 1999, NATURE, V399, P134, DOI 10.1038/20154
   Koenig J, 2002, ADV MATER, V14, P457, DOI 10.1002/1521-4095(20020318)14:6<457::AID-ADMA457>3.0.CO;2-8
   Koenig J. L., 1999, SPECTROSCOPY POLYM
   Koenig JL, 1998, SPECTROSCOPY, V13, P22
   Koenig JL, 2001, ANAL CHEM, V73, p360A, DOI 10.1021/ac012471p
   KOENIG JL, 1998, MICROSPECTROSCOPIC I
   KOHRI S, 1993, APPL SPECTROSC, V47, P1367, DOI 10.1366/0003702934067342
   Lasch P, 2002, VIB SPECTROSC, V28, P147, DOI 10.1016/S0924-2031(01)00153-9
   Lasch P, 2002, BIOPOLYMERS, V67, P335, DOI 10.1002/bip.10095
   Lasch P, 1998, CELL MOL BIOL, V44, P189
   Laubereau A., 1985, TIME RESOLVED VIBRAT, V4
   Lester DS, 1998, CELL MOL BIOL, V44, P29
   Lewis EN, 1997, ANN NY ACAD SCI, V820, P234, DOI 10.1111/j.1749-6632.1997.tb46199.x
   Lewis EN, 1997, APPL SPECTROSC, V51, P563, DOI 10.1366/0003702971940602
   LEWIS EN, 1995, ANAL CHEM, V67, P3377, DOI 10.1021/ac00115a003
   Lewis EN, 1996, APPL SPECTROSC, V50, P263, DOI 10.1366/0003702963906618
   LEWIS EN, 1995, J MICROSC SOC AM, V1, P35
   Marcott C, 1998, CELL MOL BIOL, V44, P109
   MARCOTT C, 1994, ANAL CHEM, V66, pA1065, DOI 10.1021/ac00093a001
   MARCOTT C, 1999, PHOSPHORUS SULFUR, V146, P417
   Mariey L, 2001, VIB SPECTROSC, V26, P151, DOI 10.1016/S0924-2031(01)00113-8
   Massart D.L., 1990, CHEMOMETRICS TXB
   MASUTANI K, 1992, APPL SPECTROSC, V46, P560, DOI 10.1366/0003702924124871
   Mendelsohn R, 1999, J BIOMED OPT, V4, P14, DOI 10.1117/1.429916
   Mendelsohn R, 2000, APPL SPECTROSC, V54, P1183, DOI 10.1366/0003702001950751
   Mendelsohn R, 2003, J BIOMED OPT, V8, P185, DOI 10.1117/1.1560645
   MESSERSCHMIDT RG, 1995, PRACTICAL GUIDE INFR, P3
   MESSERSCHMIDT RG, 1988, PRACTICAL SPECTROSCO, V6
   Michaels CA, 2004, APPL SPECTROSC, V58, P257, DOI 10.1366/000370204322886582
   NAKANO T, 1993, APPL SPECTROSC, V47, P1354, DOI 10.1366/0003702934067702
   National Cancer Institute (NCI), 1973, SEER CANC STAT REV
   Oh SJ, 1998, ANAL CHEM, V70, P1768, DOI 10.1021/ac971290d
   PALMER RA, 1993, APPL SPECTROSC, V47, P1297, DOI 10.1366/0003702934067568
   PALMER RA, 1989, APPL SPECTROSC, V43, P193, DOI 10.1366/0003702894203101
   Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/s002239900161
   PETERS JH, 1994, J THORAC CARDIOV SUR, V108, P813
   PIZZI N, 1995, ARTIF INTELL MED, V7, P67, DOI 10.1016/0933-3657(94)00027-P
   POLAVARAPU PL, 1995, APPL SPECTROSC, V49, P229, DOI 10.1366/0003702953963797
   Rafferty DW, 2002, APPL SPECTROSC, V56, P1549, DOI 10.1366/000370202321116002
   Reffner JA, 1998, CELL MOL BIOL, V44, P1
   REFFNER JA, 1997, MIKROCHIM ACTA S, V14, P333
   ROUSCH PB, 1985, ASTM SPEC TECH PUBL, V949
   SAKAI H, 1978, APPL OPTICS, V17, P1342, DOI 10.1364/AO.17.001342
   SASAKI H, 1993, APPL SPECTROSC, V47, P1390, DOI 10.1366/0003702934067522
   Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302
   SHILOV SV, 1995, VIB SPECTROSC, V9, P57, DOI 10.1016/0924-2031(94)00043-G
   Shim MG, 1996, PHOTOCHEM PHOTOBIOL, V63, P662, DOI 10.1111/j.1751-1097.1996.tb05671.x
   Shin EM, 2002, J ADHESION, V78, P877, DOI 10.1080/00218460290010485
   SLOAN JJ, 1989, ADV SPECTROSC, V18, P219
   Snively C, 1996, MOL CRYST LIQ CRYS A, V289, P11, DOI 10.1080/10587259608042309
   Snively CM, 1999, APPL SPECTROSC, V53, P170, DOI 10.1366/0003702991946497
   Snively CM, 1999, OPT LETT, V24, P1841, DOI 10.1364/OL.24.001841
   Snively CM, 1998, MACROMOLECULES, V31, P3753, DOI 10.1021/ma971511h
   SOLTANIANZADEH H, 1993, IEEE T NUCL SCI, V40, P1204, DOI 10.1109/23.256737
   Sommer A. J., 1991, APPL SPECTROSC, V45, P1663
   Sommer AJ, 2001, APPL SPECTROSC, V55, P252, DOI 10.1366/0003702011951803
   SPARKS DT, 1982, ANAL CHEM, V54, P1922, DOI 10.1021/ac00249a003
   SUGISAWA H, 1992, MOL CRYST LIQ CRYST, V214, P11, DOI 10.1080/10587259208037278
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Takahata H, 1998, J CONTROL RELEASE, V50, P237, DOI 10.1016/S0168-3659(97)00145-4
   THOMAS EV, 1990, ANAL CHEM, V62, P1091, DOI 10.1021/ac00209a024
   Turrell G., 1996, RAMAN MICROSCOPY DEV
   UHMANN W, 1991, APPL SPECTROSC, V45, P390, DOI 10.1366/0003702914337128
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   van der Weert M, 2000, J CONTROL RELEASE, V68, P31, DOI 10.1016/S0168-3659(00)00227-3
   Webb AR, 2002, STAT PATTERN RECOGNI
   WEST JL, 1988, MOL CRYST LIQ CRYST, V157, P427, DOI 10.1080/00268948808080247
   Wetzel DL, 1999, SCIENCE, V285, P1224, DOI 10.1126/science.285.5431.1224
   WHITE RL, 1981, ANAL CHEM, V53, P1778, DOI 10.1021/ac00235a014
   Wong PTT, 2002, BIOPOLYMERS, V67, P376, DOI 10.1002/bip.10166
   Zhang L, 2003, APPL SPECTROSC, V57, P14, DOI 10.1366/000370203321165151
NR 129
TC 192
Z9 194
U1 2
U2 86
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0066-426X
BN 978-0-8243-1056-1
J9 ANNU REV PHYS CHEM
JI Annu. Rev. Phys. Chem.
PY 2005
VL 56
BP 429
EP 474
DI 10.1146/annurev.physchem.56.092503.141205
PG 52
WC Chemistry, Physical
SC Chemistry
GA 954VX
UT WOS:000231184400016
PM 15796707
DA 2018-10-20
ER

PT B
AU Mao, S
   Misra, D
   Seamans, J
   Thoma, GR
AF Mao, S
   Misra, D
   Seamans, J
   Thoma, GR
GP SOC IMAGING SCI & TECHNOL
TI Design strategies for a prototype electronic preservation system for
   biomedical documents
SO Archiving 2005, Final Program and Proceedings
LA English
DT Proceedings Paper
CT 2nd IS&T Archiving Conference
CY APR 26-29, 2005
CL Washington, DC
SP IS&T, Amer Inst Conservat, Assoc Lib Collect & Tech Serv, Coalit Networked Informat, Digital Lib Federat, Digital Preservat Coalit, ECPA, Inter Soc Color Council, Museum Comp Network, Online Comp Lib Ctr, Res Lib Grp, SPIE
AB Among the digital material considered for preservation at the National Library of Medicine (NLM) are TIFF, PDF and HTML files of biomedical journals, laboratory notebooks, correspondence of major figures in biomedical research, and similar documents. Although most of these materials are already in digital form (either as born-digital information, or converted to digital form through scanning), preservation of these materials involve complex administrative and technical issues, such as obtaining and storing adequate levels of metadata for a preserved resource, assuring intellectual integrity of the contents, and avoiding technical obsolescence of encoded information. (1,2) An R&D project has been initiated at NLM to develop a prototype system that would help investigate the key technical functions required to effectively preserve NLM's digital resources over the long term. This system, named the System for Preservation of Electronic Resources (SPER) has had its initial design and implementation phase completed. Here we describe the main functions of SPER, and the strategies adopted in designing the system to meet these functionalities in a modular and cost-effective manner. In particular, an automated metadata extraction subsystem is designed to minimize manual entry, using string matching and machine learning techniques. Also given are preliminary performance assessments of the subsystems in this prototype. We discuss the overall system architecture, automated metadata extraction techniques, and file migration in the SPER system.
CR HASTIE T, 2000, ESTIMATING NUMBER DA
   HASUER SE, 2001, P SPIE DOCUMENT RECO, V7, P248
   KIM J, 2001, SPIE C DOC REC RETR, V8, P111
   KRISHNAMOORTHY M, 1993, IEEE T PATTERN ANAL, V15, P737, DOI 10.1109/34.221173
   LE DX, 2001, P 14 IEEE S COMP BAS
   Mao S, 2004, Proceedings of the Fourth IASTED International Conference on Visualization, Imaging, and Image Processing, P329
   Mao S, 2004, FIRST INTERNATIONAL WORKSHOP ON DOCUMENT IMAGE ANALYSIS FOR LIBRARIES, PROCEEDINGS, P225
   Mao S, 2003, IEEE IMAGE PROC, P533
   *NISO, Z39872002 DATA DICT
   *TASI, INTR DIG PRES TECHN
   The Consultative Committee for Space Data Systems, REF MOD OP ARCH INF
   WALKER FL, 2003, P INF 2003 MEDF NJ I, P313
NR 12
TC 0
Z9 0
U1 0
U2 0
PU SOC IMAGING SCIENCE & TECHNOLOGY
PI SPRINGFIELD
PA 7003 KILWORTH LANE, SPRINGFIELD, VA 22151 USA
BN 0-89208-255-0
PY 2005
BP 48
EP 53
PG 6
WC Computer Science, Information Systems; Information Science & Library
   Science
SC Computer Science; Information Science & Library Science
GA BCZ85
UT WOS:000232157800011
DA 2018-10-20
ER

PT S
AU Leng, YX
   Yang, P
   Chen, JY
   Xu, LX
   Zhao, AS
   Sun, H
   Wang, J
   Huang, N
AF Leng, YX
   Yang, P
   Chen, JY
   Xu, LX
   Zhao, AS
   Sun, H
   Wang, J
   Huang, N
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI The role of surface physical properties on blood compatibility of
   titanium oxide films synthesized by unbalanced magnetron sputtering
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE titanium oxide; unbalanced magnetron sputtering; blood compatibility;
   semiconducting properties
ID IMMERSION ION-IMPLANTATION; THIN-FILMS; HEMOCOMPATIBILITY; DEPOSITION;
   OXIDATION; TI
AB Surface modification has shown great potential for improving the hemocompatibility of biomedical materials and devices. In this paper we describe our work on improving blood compatibility with Ti-O thin films prepared by unbalanced DC magnetron sputtering. The structure and surface chemical and physical properties of the films were characterized by X-ray diffraction, X-ray photoelectron spectroscopy (XPS), SEM, sheet resistance tests, and Hall effect measurements. The sheet resistance of the titanium oxide samples increased with oxygen pressure and shows a sharp increase when only TiO2 exists in the films. The band gap, carrier density and sheet resistance of the titanium oxide films synthesized at different oxygen pressure are different. These properties affect blood compatibility significantly. We suggest that the semiconducting nature of n-type Ti-O films with bandgap 3.0-3.2 eV, sheet resistance greater than 1 ohm.cm and carrier density of about 1.17 x 10(16) cm(-2) leads to their excellent blood compatibility.
C1 SW Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Lab Surface Engn Artificial Organs Sichuan, Chengdu 610031, Peoples R China.
RP Leng, YX (reprint author), SW Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Lab Surface Engn Artificial Organs Sichuan, Chengdu 610031, Peoples R China.
EM yxleng@26.net; nhyang@262.net
RI Leng, Yongxiang/G-5488-2010
OI Leng, Y.X./0000-0001-6823-1233
CR Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Leng YX, 2002, THIN SOLID FILMS, V420, P408, DOI 10.1016/S0040-6090(02)00814-3
   Leng YX, 2003, SURF COAT TECH, V166, P176, DOI 10.1016/S0257-8972(02)00780-6
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   Mardare D, 2000, APPL SURF SCI, V156, P200, DOI 10.1016/S0169-4332(99)00508-5
   Mardare D, 2002, MATER LETT, V56, P210, DOI 10.1016/S0167-577X(02)00441-X
   Paxton AT, 1998, PHYS REV B, V57, P1579, DOI 10.1103/PhysRevB.57.1579
   Sawase T, 2001, Clin Implant Dent Relat Res, V3, P221, DOI 10.1111/j.1708-8208.2001.tb00144.x
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
NR 12
TC 5
Z9 5
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 311
EP 314
DI 10.4028/www.scientific.net/KEM.288-289.311
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600076
DA 2018-10-20
ER

PT S
AU Mayer, G
   Blanchemain, N
   Dupas-Bruzek, C
   Traisnel, M
   Derozier, D
   Laude, LD
   Hildebrand, HF
AF Mayer, G
   Blanchemain, N
   Dupas-Bruzek, C
   Traisnel, M
   Derozier, D
   Laude, LD
   Hildebrand, HF
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Physico-chemical modifications and biological improvements of biomedical
   PET as a consequence of excimer LASER irradiation
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE polyethylene terephthalate; LASER excimer irradiation; surface profile;
   surface energy; cristallinity; scanning electron microscopy; cell
   viability; vitality; proliferation; adhesion
ID ROUGHNESS; BEHAVIOR; ADHESION
AB LASER Excimer irradiation can modify surface properties for biocompatibility improvement of a medical device. The PETs from 3 different origins were used in this study. The samples have been irradiated by excimer LASER with 10 different energies. The surface profile, the surface energy and the materials crystallinity have been assessed. Biological characterizations were made with human embryonic epithelial cells L132: proliferation, vitality, viability, adhesion with the p-NPP, and morphology. - The profile measurements allowed to establish the ablation threshold, which was 36 mJ/cm(2). The surface hydrophilic state increased reciprocally with the irradiation intensity. The gain is 13 %. The irradiated and non-irradiated product has identical cristallinity. PET was shown not to be toxic for L132 cells. Cell proliferation and cell vitality showed dose-dependant increases reciprocal to the irradiation energy (from 88 to 138% with respect to control). The correlation was highly significant (RI = 0,8). SEM micrographs show that the cells are better spread on the surface of irradiated PET than on untreated PET.
C1 Fac Med Lille, UPRES EA 1049, Grp Rech Biomat, F-59045 Lille, France.
   Univ Mons, LPES, B-7000 Mons, Belgium.
   ENSCL, F-59652 Villeneuve Dascq, France.
   CERLA, F-59655 Villeneuve Dascq, France.
RP Mayer, G (reprint author), Fac Med Lille, UPRES EA 1049, Grp Rech Biomat, F-59045 Lille, France.
EM nblanchemain@univ-lille2.fr; hildebrand@univ-lille2.fr
CR Buth J, 2000, J VASC SURG, V31, P134, DOI 10.1016/S0741-5214(00)70075-9
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   Hornez JC, 2002, BIOMOL ENG, V19, P103, DOI 10.1016/S1389-0344(02)00017-5
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Laude LD, 2001, NUCL INSTRUM METH B, V185, P147, DOI 10.1016/S0168-583X(01)00750-9
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   WATANABE H, 1993, POLYM INT, V31, P247, DOI 10.1002/pi.4990310306
NR 9
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 347
EP 350
DI 10.4028/www.scientific.net/KEM.288-289.347
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600085
DA 2018-10-20
ER

PT S
AU Jee, KS
   Bae, JW
   Park, KD
   Kim, YH
   Shin, JW
   Lee, JW
AF Jee, KS
   Bae, JW
   Park, KD
   Kim, YH
   Shin, JW
   Lee, JW
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Heparinized tissue matrices as novel biomaterials
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE heparin; biological tissue; chemical modification
AB Novel approaches using bioactive molecules in the purpose for overcoming the limitation of established materials have been studied. Their ultimate goal is focused on improved blood/cell compatible biomaterials for various biomedical applications. Heparin-bound bioactive materials using bovine pericardium have been developed. From results of heparinized cellular or acellular tissue matrices, the effect of heparin on the tissue in cell-related biological responses as well as improved blood compatibility was confirmed. These heparinized matrices can be useful for tissue regeneration through the control of growth factor in tissue engineering as well as cardiovascular application.
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
   KIST, Biomat Res Ctr, Seoul, South Korea.
   Inje Univ, Dept Biomed Engn, Kimhae, Kyongnam, South Korea.
   Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea.
RP Jee, KS (reprint author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
EM kdp@ajou.ac.kr
CR CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Jee KS, 2003, BIOMATERIALS, V24, P3409, DOI 10.1016/S0142-9612(03)00204-7
   Park KD, 1997, BIOMATERIALS, V18, P47, DOI 10.1016/S0142-9612(96)00096-8
   PARK KD, 1994, ASAIO J, V40, P377
NR 5
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 453
EP 456
DI 10.4028/www.scientific.net/KEM.288-289.453
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600111
DA 2018-10-20
ER

PT S
AU Xu, YX
   Wang, WJ
   Zhang, Y
   Song, XH
   Li, L
   Wang, JJ
   Cui, FZ
   Feng, QL
AF Xu, YX
   Wang, WJ
   Zhang, Y
   Song, XH
   Li, L
   Wang, JJ
   Cui, FZ
   Feng, QL
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI A novel method for evaluating compatibility of hepatocytes with some
   kinds of biomaterials
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE biomaterial; biocompatibility; hepatocyte; automatic biochemical
   analyzer
ID LIVER
AB To evaluate the biocompatibility of biomedical materials for hepatic tissue engineering, another new method was introduced to observe hepatocytes functions. In this experiment, hepatocytes were seeded onto four kinds of membranes of PLLA, PLGA (90:10), PLGA (75:25), and Chitosan cross-linked with collagen. The culture mediums were collected at 21 day after seeding, and then albumin (Alb), Urea (UN), glucose (Glu), total protein (TP), and triglyceride (TG) in the supernatant were detected by automatic biochemical analyzer. Results showed that hepatocytes on film of Chitosan cross-linked with collagen exhibited the highest level of TP and TG. These results were highly corresponding with the results of morphological observation. This data indicated that analyzing TP and TG in culture medium by automatic biochemical analyzer might be applied to evaluate hepatocytes biocompatibility on materials as a convenient and feasible method.
C1 Chinese Peoples Liberat Army Gen Hosp, Inst Gen Surg, Beijing 1000853, Peoples R China.
   Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Xu, YX (reprint author), Chinese Peoples Liberat Army Gen Hosp, Inst Gen Surg, Beijing 1000853, Peoples R China.
EM xu_yingxin@hotmail.com; wwj01@mails.tsinghua.edu.cn
CR [Anonymous], 1992, 10993 ISO
   Catapano G, 1996, INT J ARTIF ORGANS, V19, P61
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   Elcin YM, 1998, ARTIF ORGANS, V22, P837
   FRIEND JR, 1999, TISSUE ENG METHODS P, P245
   Kang S, 2000, BBA-MOL CELL BIOL L, V1529, P223, DOI 10.1016/S1388-1981(00)00151-7
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   STRAIN AJ, SCIENCE, V295, P5557
NR 8
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 511
EP 514
DI 10.4028/www.scientific.net/KEM.288-289.511
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600125
DA 2018-10-20
ER

PT S
AU Yu, ZT
   Zhou, L
   Lu, LJ
   Fan, MH
   Fu, YY
AF Yu, ZT
   Zhou, L
   Lu, LJ
   Fan, MH
   Fu, YY
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Investigation on mechanical compatibility matching for biomedical
   titanium alloys
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE titanium; near-beta type titanium alloys; mechanical properties;
   matching of mechanical compatibility; surgical implants
AB The effects of alloying elements such as Mo, Sn, Zr, Nb, deforming-rate, solid solution and aging treatment on mechanical property and microstructure of near beta type biomedical Ti alloys based on Ti-Nb-Zr system were studied. The Influential factors and their solution were discussed to keep matching of strength, elastic modulus, plasticity and toughness. Ti-Zr-Mo-Nb and Ti-Zr-Sn-Mo-Nb alloy systems possess excellent biocompatibility, lower elastic modulus, higher strength, finer plasticity and fracture toughness matching by means of solid solution and ageing treatment which are much more suitable for surgical implant and orthopedic materials.
C1 NW Inst Nonferrous Met Res, Xian 710016, Shaanxi, Peoples R China.
   Iowa State Univ Sci & Technol, Ctr Sustainable Environm Technol, Ames, IA 50011 USA.
RP Yu, ZT (reprint author), NW Inst Nonferrous Met Res, Xian 710016, Shaanxi, Peoples R China.
EM yzt@c-nin.com; Zhoul@c-nin.com; fan@ameslab.gov
OI Fan, Maohong/0000-0003-1334-7292
CR FROS FH, 1985, J MET, V37, P28
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   STEINEMANN S, 1993, TIT 92 SCI TECHN TMS
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Wang XT, 1999, ISSUES STUD, V35, P167
   YU ZT, 2004, RARE METALS LETT, V23, P5
NR 7
TC 7
Z9 11
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 595
EP 598
DI 10.4028/www.scientific.net/KEM.288-289.595
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600145
DA 2018-10-20
ER

PT J
AU Eglin, D
   Coradin, T
   Giraud Guille, MM
   Helary, C
   Livage, J
AF Eglin, D
   Coradin, T
   Giraud Guille, MM
   Helary, C
   Livage, J
TI Collagen-silica hybrid materials: Sodium silicate and sodium chloride
   effects on type I collagen fibrillogenesis
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE sodium silicate; type I collagen; fibrils
ID FIBRIL FORMATION; WATER
AB Collagen-silica hybrid materials have been considered for potential biomedical applications. Understanding of the collagen-silica interactions is the key to control hybrids structure and properties. For this purpose, the effect of sodium silicate and sodium chloride addition at two concentrations, 0.83 and 10 mM, on the kinetic of the type I collagen fibrillogenesis at 20degreesC, and pH 7.4 were studied. Absorbance profiles of fibrillogenesis experiments were collected together with measures of silicic acid concentration and transmission electron microscopy analysis. The specific effect of silica addition on the collagen fibrils self-assembly mechanisms was demonstrated by comparison with the sodium chloride. Sodium silicate at 10 mM inhibited the collagen fibrillogenesis. At the same concentration, the sodium chloride decreased the rate of the collagen fibril assembly. Collagen fibrillogenesis kinetic was not significantly disturbed by the presence of 0.83 mM of sodium chloride. However, the same concentration of sodium silicate modified the collagen fibrillogenesis kinetic. Transmission electron microscopy indicated for experiment with 0.83 mM of sodium silicate, the formation of longer and wider fibrils than for the equivalent collagen fibrillogenesis experiment with sodium chloride. The effect of sodium chloride is explained in terms of osmotic exclusion and influence on electrostatic interactions between collagen fibrils. The specific involvement of silicic acid in collagen helices hydrogen-bond interactions is suggested. Finally, the results of this study are discussed regarding the preparation of composites by co-gelation of type I collagen and sodium silicate, for potential application as bone repair device.
C1 Univ Paris 06, CNRS, EPHE, Lab Chim Mat Condensee, F-75252 Paris 05, France.
RP Eglin, D (reprint author), Univ Paris 06, CNRS, EPHE, Lab Chim Mat Condensee, 4 Pl Jussieu, F-75252 Paris 05, France.
EM eglin@ccr.jussieu.fr
RI Coradin, Thibaud/L-8932-2013
OI Eglin, David/0000-0002-8500-6887
CR Besseau L, 2002, BIOMATERIALS, V23, P27, DOI 10.1016/S0142-9612(01)00075-8
   Brasack I, 2000, J SOL-GEL SCI TECHN, V19, P479, DOI 10.1023/A:1008763900729
   COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369
   Coradin T, 2002, MATER RES SOC SYMP P, V726, P79
   Delorenzi NJ, 1996, INT J BIOL MACROMOL, V19, P15, DOI 10.1016/0141-8130(96)01094-X
   ESTEVEROMERO JS, 1994, ANAL LETT, V27, P1557, DOI 10.1080/00032719408006389
   GELMAN RA, 1979, J BIOL CHEM, V254, P180
   GIRAUDGUILLE MM, 1994, J STRUCT BIOL, V113, P99, DOI 10.1006/jsbi.1994.1035
   GROSS J, 1958, J BIOL CHEM, V233, P355
   Iler R.K., 1979, CHEM SILICA SOLUBILI
   Kuznetsova N, 1998, BIOCHEMISTRY-US, V37, P11888, DOI 10.1021/bi980089+
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588
   WOODHEADGALLOWA.JW, 1968, COLLAGEN ANATOMY PRO, P32
NR 14
TC 23
Z9 23
U1 1
U2 14
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2005
VL 15
IS 1-2
BP 43
EP 50
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HY
UT WOS:000226003400005
PM 15623929
DA 2018-10-20
ER

PT J
AU Tan, KH
   Chua, CK
   Leong, KF
   Cheah, CM
   Gui, WS
   Tan, WS
   Wiria, FE
AF Tan, KH
   Chua, CK
   Leong, KF
   Cheah, CM
   Gui, WS
   Tan, WS
   Wiria, FE
TI Selective laser sintering of biocompatible polymers for applications in
   tissue engineering
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE biomaterials; tissue engineering; selective laser sintering
ID SCAFFOLDS; FABRICATION; DESIGN
AB The ability to use biological substitutes to repair or replace damaged tissues lead to the development of Tissue Engineering (TE), a field that is growing in scope and importance within biomedical engineering. Anchorage dependent cell types often rely on the use of temporary three-dimensional scaffolds to guide cell proliferation. Computer-controlled fabrication techniques such as Rapid Prototyping (RP) processes have been recognised to have an edge over conventional manual-based scaffold fabrication techniques due to their ability to create structures with complex macro- and micro-architectures. Despite the immense capabilities of RP fabrication for scaffold production, commercial available RP modelling materials are not biocompatible and are not suitable for direct use in the fabrication of scaffolds. Work is carried out with several biocompatible polymers such as Polyetheretherketone (PEEK), Poly(vinyl alcohol) (PVA), Polycaprolactone (PCL) and Poly(L-lactic acid) (PLLA) and a bioceramic namely, Hydroxyapatite (HA). The parameters of the selective laser sintering (SLS) process are optimised to cater to the processing of these materials. SLS-fabricated scaffold specimens are examined using a Scanning Electron Microscope (SEM). Results observed from the micrographs indicate the viability of them being used for building TE scaffolds and ascertain the capabilities of the SLS process for creating highly porous scaffolds for Tissue Engineering applications.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mckchua@ntu.edu.sg
RI Leong, Kah-Fai/B-6183-2009; Chua, Chee Kai/B-6171-2009
CR Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Chu C.C., 2000, BIOMEDICAL ENG HDB
   CHUA CK, RAPID PROTOTYPING J
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   Gibson I, 1997, RAPID PROTOTYPING J, V3, P129, DOI 10.1108/13552549710191836
   KU JCW, 2002, THESIS U HONG KONG
   LEE G, 1996, P SOL FREEF FABR S A, P15
   Lee G., 1993, P SOL FREEF FABR S A, P376
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Li S, 1995, DEGRADABLE POLYM PRI
   Low KH, 2001, RAPID PROTOTYPING J, V7, P262, DOI 10.1108/13552540110410468
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 17
TC 142
Z9 155
U1 4
U2 58
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2005
VL 15
IS 1-2
BP 113
EP 124
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HY
UT WOS:000226003400011
PM 15623935
DA 2018-10-20
ER

PT S
AU Garcia, C
   Paucar, C
   Gaviria, J
   Duran, A
AF Garcia, C
   Paucar, C
   Gaviria, J
   Duran, A
BE Li, P
   Zhang, K
   Colwell, CW
TI Effect of some physical-chemical variables in the synthesis of
   hydroxyapatite by the precipitation route
SO BIOCERAMICS 17
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE biomedical applications; chemical properties; hydroxyapatite;
   precipitation route; synthesis
ID PHOSPHATE
AB The synthetic hydroxyapatite is a very useful material for numerous applications in medicine as a biomaterial. One of the most economic manufacturing process is the precipitation route. In the present work, synthetic hydroxyapatite was prepared using the precipitation route, starting with aqueous solutions of calcium nitrate (Ca(NO3).4H(2)O) and ammonium phosphate (H-2(PO4)NH4). The effects of physical-chemical variables such as pH, temperature, time of agitation, ageing time and heat treatment of the mixture were evaluated. The characterization of the samples obtained in different conditions made possible to conclude about the optimal values of the studied variables for the synthesis of this material in laboratory conditions.
C1 Univ Nacl Colombia Medellin, Fac Ciencias, Escuelas Fis & Quim, Medellin 3840, Colombia.
   CSIC, Inst Ceram & Vidrio, E-28049 Madrid, Spain.
RP Garcia, C (reprint author), Univ Nacl Colombia Medellin, Fac Ciencias, Escuelas Fis & Quim, Medellin 3840, Colombia.
EM cpgarcia@unalmed.edu.co; cgpaucar@unalmed.edu.co;
   jgarango@unalmed.edu.co; aduran@icv.csic.es
RI Garcia, Claudia/P-7860-2017; Paucar, Carlos/P-4755-2017
OI Garcia, Claudia/0000-0002-8241-9969; Paucar, Carlos/0000-0003-1457-0445
CR Elliott J. C., 1994, STRUCTURE CHEM APATI, P111
   Hsieh MF, 2001, J AM CERAM SOC, V84, P2123
   Lin FH, 1998, BIOMATERIALS, V19, P1101, DOI 10.1016/S0142-9612(98)00040-4
   Lin FH, 2000, MAT SCI ENG C-BIO S, V13, P97, DOI 10.1016/S0928-4931(00)00182-X
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   SANTOS C, 1994, THESIS U SANTIAGO SA
   SECKLER MM, 1999, MAT RES, V2, P59
   Velayudhan S, 2000, MATER LETT, V46, P142, DOI 10.1016/S0167-577X(00)00157-9
   Weng W, 1997, J EUR CERAM SOC, V17, P1151, DOI 10.1016/S0955-2219(96)00215-4
NR 11
TC 9
Z9 9
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MATER
PY 2005
VL 284-286
BP 47
EP 50
DI 10.4028/www.scientific.net/KEM.284-286.47
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500012
OA Green Published
DA 2018-10-20
ER

PT S
AU Navarro, M
   Sanzana, ES
   Planell, JA
   Ginebra, MP
   Torres, PA
AF Navarro, M
   Sanzana, ES
   Planell, JA
   Ginebra, MP
   Torres, PA
BE Li, P
   Zhang, K
   Colwell, CW
TI In vivo behavior of calcium phosphate glasses with controlled solubility
SO BIOCERAMICS 17
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE calcium phosphate glasses; in vivo
ID BONE
AB Resorbable calcium phosphate glasses offer interesting solutions in the biomedical field, as bone cavity fillers, drug delivery systems, biodegradable reinforcing phase in the case of composites for bone fixation devices and tissue engineering scaffolds. In this work, two different glass formulations in the systems 44.5CaO-44.5P(2)O(5)-(11-X)Na(2)O-XTiO(2) (X=0or 5) have been elaborated. It is known that the incorporation or TiO(2) into the vitreous system reduces considerably the solubility of the glasses. To study the material solubility effect on the in vivo response, glass particles of the two formulations were implanted in rabbits. Results showed that both glasses elicited a similar biological response and good biocompatibility. The percentage of new bone formation in the glasses was comparable to that obtained for the autologous bone (control) after 12 weeks of implantation. The materials showed to have an osteoconductive potential. Finally, this study showed that in spite of the solubility difference of the studied glasses, there were no significant differences in the in vivo response
C1 Tech Univ Catalonia, Ctr Reference Bioengn Catalonia, Dept Mat Sci & Met, Biomat & Biomech Div, ES-08028 Barcelona, Spain.
   Univ Concepcion, Fac Med, Dept Surg, Concepcion, Chile.
RP Navarro, M (reprint author), Tech Univ Catalonia, Ctr Reference Bioengn Catalonia, Dept Mat Sci & Met, Biomat & Biomech Div, Avda Diagonal 647, ES-08028 Barcelona, Spain.
EM melba.navarro@upc.es; esanzana@udec.cl; maria.pau.ginebra@upc.es
RI Ginebra, Maria-Pau/J-8149-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621
CR BURNIE J, 1981, BIOMATERIALS, V2, P244, DOI 10.1016/0142-9612(81)90065-X
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Navarro M, 2004, J MATER SCI-MATER M, V15, P419, DOI 10.1023/B:JMSM.0000021113.88702.9d
   Navarro M, 2003, J BIOMED MATER RES A, V67A, P1009, DOI 10.1002/jbm.a.20014
   Navarro M, 2003, J AM CERAM SOC, V86, P1345, DOI 10.1111/j.1151-2916.2003.tb03474.x
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
NR 6
TC 3
Z9 4
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MATER
PY 2005
VL 284-286
BP 893
EP 896
DI 10.4028/www.scientific.net/KEM.284-286.893
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500218
DA 2018-10-20
ER

PT S
AU Mansur, HS
   Mansur, AAP
   Pereira, MM
AF Mansur, HS
   Mansur, AAP
   Pereira, MM
BE Li, P
   Zhang, K
   Colwell, CW
TI XRD, SEM/EDX and FTIR characterization of Brazilian natural coral
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioceramics; biomaterial; characterization; coral; scaffolds
AB In the present work, natural coral from Brazilian reefs were studied according to their crystallography by X-ray diffraction and microstructure by Scanning Electron Microscopy (SEM/EDX). FTIR spectroscopy was also used to evaluate the chemical functionalities and major components present in the material. The SEM morphology results have shown a tri-dimensional coral structure with porous ranging from 50 to 200 mu m. Aragonite was identified as the major crystalline phase through XRD analysis and FTIR spectroscopy. Strontium calcium carbonate, (Sr,Ca)CO3, was also identified by XRD analysis. After sintering at 900 degrees/1h, the conversion from aragonite to CaO and calcite was observed. These results have endorsed the high potential application of natural coral materials as 3D scaffolds for biomedical application, because of calcium carbonate compounds can be converted to RA by hydrothermal and biomimetic coating processes.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
EM ahmansur@demet.ufmg.br; aapiscitelli@uol.com.br; mpereira@demet.ufmg.br
OI Mansur, Herman/0000-0002-3032-495X; Mansur,
   Alexandra/0000-0003-1526-2508
CR Farmer V. C., 1974, INFRARED SPECTRA MIN
   FERNANDES GF, 2000, QUIM NOVA, V23, P441
   FERRARI K. R., 2000, CERAMICA IND, V5, P53
   VUOLA J, 2001, NATURAL CORAL HYDROX
   White WB, 1997, ENVIRON GEOL, V30, P46, DOI 10.1007/s002540050131
   Xu Y, 2001, MATER CHARACT, V47, P83, DOI 10.1016/S1044-5803(01)00154-1
NR 6
TC 2
Z9 2
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 43
EP 46
DI 10.4028/www.scientific.net/KEM.284-286.43
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500011
DA 2018-10-20
ER

PT S
AU Nowak, D
   Florek, M
   Nowak, J
   Kwiatek, W
   Lekki, J
   Zieba, E
   Romero, PG
   Ben-Nissan, B
   Kuczumow, A
AF Nowak, D
   Florek, M
   Nowak, J
   Kwiatek, W
   Lekki, J
   Zieba, E
   Romero, PG
   Ben-Nissan, B
   Kuczumow, A
BE Li, P
   Zhang, K
   Colwell, CW
TI Micro-spectrometric investigations of inorganic components of the black
   corals for biomedical applications
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
ID SKELETON COELENTERATA; CHITIN; ANTIPATHARIA; CUTICLE
AB The distribution of about twenty inorganic elements was traced in the skeletons of black corals of the Antipathes salix species. Electron microprobe and PIXE mappings revealed the peculiar structure of this material, composed of the large cells (arranged in annual rings), surrounded by thin layers with an elevated level of iodine (up to 5%). Our current knowledge of the chemical composition of these corals' skeleton is not complete. Essentially the organic skeleton is saturated with inorganic elements and several of these could be commercially important. In fact, they have never been investigated for biomedical applications. In this preliminary current work, black corals from the Antipathes salix species were studied with the aim of detecting the inorganic components of their matrix and their suitability as biomedical materials.
C1 Catholic Univ Lublin, Dept Chem, Lublin, Poland.
   Inst Nucl Phys, Dept Nucl Spect, PL-31342 Krakow, Poland.
   ICMAB, ES-08193 Bellaterra, Spain.
   Univ Technol, Dept Chem Mat & Forens Sci, Broadway, NSW 2007, Australia.
RP Nowak, D (reprint author), Catholic Univ Lublin, Dept Chem, Lublin, Poland.
EM b.ben-nissan@uts.edu.au; kuczon@kul.lublin.pl
RI Lekki, Janusz/B-5720-2013; Gomez-Romero, Pedro/B-7855-2008
OI Gomez-Romero, Pedro/0000-0002-6208-5340; Lekki,
   Janusz/0000-0001-9848-6448; Kwiatek, Wojciech/0000-0002-2197-8572
CR Brown C. H., 1975, STRUCTURAL MAT ANIMA
   Chevallier P, 1996, J TRACE MICROPROBE T, V14, P517
   Dillmann P, 1997, J TRACE MICROPROBE T, V15, P251
   ELLIS LC, 1980, COMP BIOCHEM PHYS B, V66, P163, DOI 10.1016/0305-0491(80)90102-9
   Goldberg W.M., 1978, MAR BIOL, V49, P669
   GOLDBERG WM, 1994, COMP BIOCHEM PHYS B, V107, P633, DOI 10.1016/0305-0491(94)90197-X
   Grigg R. W., 1977, REEF SHORE FAUNA HAW, P242
   Hammersley AP, 1997, J SYNCHROTRON RADIAT, V4, P67, DOI 10.1107/S0909049596015087
   HOLL SM, 1992, ARCH BIOCHEM BIOPHYS, V292, P107, DOI 10.1016/0003-9861(92)90057-4
   KIM K, 1992, BIOL BULL-US, V182, P195, DOI 10.2307/1542113
   Lebed S, 1999, NUCL INSTRUM METH B, V158, P44, DOI 10.1016/S0168-583X(99)00387-0
   Manoli F, 1997, J CRYST GROWTH, V182, P116, DOI 10.1016/S0022-0248(97)00318-7
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
NR 14
TC 7
Z9 7
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 297
EP 300
DI 10.4028/www.scientific.net/KEM.284-286.297
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500073
DA 2018-10-20
ER

PT S
AU de Carlos, A
   Borrajo, JP
   Serra, J
   Gonzalez, P
   Liste, S
   Leon, B
AF de Carlos, A
   Borrajo, JP
   Serra, J
   Gonzalez, P
   Liste, S
   Leon, B
BE Li, P
   Zhang, K
   Colwell, CW
TI In vitro cytotoxicity testing of wood-based biomorphic SiC ceramics
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioactive glass; bioceramic; MG-63 cells; MTT assay; silicon carbide;
   Ti6Al4V
AB The aim of this study was to test the in vitro cytotoxicity of wood-based biomorphic Silicon Carbide (SiC) ceramics, using MG-63 human osteoblast-like cells. This innovative material has been recently developed and it exhibits unique mechanical properties towards their application in biomedical technology. In the solvent extraction test the SiC ceramic extracts had almost no effect on cellular activity even at 100% concentration. A similar behaviour was found for Ti6Al4V and bioactive glass, used as reference materials. The results of the cell morphology and the cellular attachment response have also demonstrated that the in vitro performance of these biomorphic SiC ceramics is qualitatively comparable to that produced by titanium alloy and bioactive glass, which seems very promising.
C1 Fac Biol, Dpto Bioquim Genet & Immunol, E-36200 Vigo, Spain.
   ETSI Ind, Dept Fis Aplicada, Vigo, Spain.
RP de Carlos, A (reprint author), Fac Biol, Dpto Bioquim Genet & Immunol, E-36200 Vigo, Spain.
EM adcarlos@uvigo.es; jpb@uvigo.es; jserra@uvigo.es; pglez@uvigo.es;
   liste@uvigo.es; bleon@uvigo.es
RI de Carlos, Alejandro/L-5819-2014; New Materials Group, FA3/D-6799-2014
OI de Carlos, Alejandro/0000-0003-0138-4918; New Materials Group,
   FA3/0000-0003-4286-2015; Serra, Julia/0000-0001-6187-4025; GONZALEZ,
   PIO/0000-0002-7353-712X
CR Gonzalez P, 2003, BIOMATERIALS, V24, P4827, DOI 10.1016/S0142-9612(03)00405-8
   MARTINEZFERNANDEZ, 2000, SCRIPTA MATER, V43, P813
   Singh M., 2000, CERAM SCI ENG P, V21, P39
   Varela-Feria F. M., 2002, Ceramic Engineering and Science Proceedings, V23, P681
NR 4
TC 3
Z9 3
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 581
EP 584
DI 10.4028/www.scientific.net/KEM.284-286.581
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500142
DA 2018-10-20
ER

PT S
AU Pelaez, A
   Pareja, A
   Garcia, CP
   Marquez, ME
   Toro, A
   Castaneda, R
   Abad, P
AF Pelaez, A
   Pareja, A
   Garcia, CP
   Marquez, ME
   Toro, A
   Castaneda, R
   Abad, P
BE Li, P
   Zhang, K
   Colwell, CW
TI Genotoxicity effects of ceramic coatings applied on metallic substrates
   using single cell gel electrophoresis assay in vitro
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE coatings; genotoxicity; PVD; SCGE; sol-gel
ID BIOMEDICAL APPLICATIONS; VITREOUS COATINGS; DEVICES
AB Sol-Gel coatings are a good choice for protection and bioactivation of metals used as dentistry and standard surgical implant materials. These films should both prevent degradation of the substrates by wear or corrosion, and bioactivate the material for inducing the formation of a hydroxyapatite (HA) rich layer onto the material surface, thereby permitting a natural bonding to living tissues.
   The aim of this work was to estimate the clastogenicity in vitro by Single Cell Gel Electrophoresis Assay (SCGE) or "comet" assay of coatings of TiN applied by magnetron sputtering and of hybrid layers obtained by Sol-Gel containing glass, glass-ceramic and HA particles on stainless steel AISI 304.
   Six test specimens were prepared: AISI 304 Stainless Steel coated with an hybrid silica single film (SF), applied by sol-gel process, AISI 304 SS coated with double film with bioactive glass (DFG), glass-ceramics (DFGC) and HA (DFHA) particles, AISI 304 SS coated with TiN multi films (MFTiN) applied by PVD and bare AISI 304 SS (304SS). Significantly lower DNA migration (p > 0.005) was observed in the cells of the cultures corresponding to the samples coated with SF, DFG, DFGC, DFHA and MFTiN respect to the bare 304 SS. ne comparison between negative control and the same coated samples did not reveal any statistically significant difference (p > 0.005) in clastogenicity in vitro evaluated by SCGE.
C1 Univ Nacl Colombia, Biosci Sch, Medellin, Colombia.
   Univ Nacl Colombia, Sch Phys, Medellin, Colombia.
   Univ Nacl Colombia, Sch Mat, Medellin, Colombia.
   Inst Ciencias Salud, Fac Dent, Medellin, Colombia.
RP Pelaez, A (reprint author), Univ Nacl Colombia, Biosci Sch, Medellin, Colombia.
EM continuo@unalmed.edu.co; apareja@unalmed.edu.co;
   cpgarcia@unalmed.edu.co; memarquez@unalmed.edu.co;
   aotoro@unalmed.edu.co; rcastane@unalmed.edu.co; pdjabad@unalmed.edu.co
RI Castaneda Sepulveda, Roman Eduardo/S-5361-2017; Garcia,
   Claudia/P-7860-2017
OI Castaneda Sepulveda, Roman Eduardo/0000-0002-1805-3958; Garcia,
   Claudia/0000-0002-8241-9969; Toro, Alejandro/0000-0002-5589-5820;
   Pelaez-Vargas, Alejandro/0000-0001-7582-2760
CR Ballarre J, 2002, J NON-CRYST SOLIDS, V304, P278, DOI 10.1016/S0022-3093(02)01035-9
   CHRISTOFFERSEN MR, 1987, CALCIFIED TISSUE INT, V41, P27, DOI 10.1007/BF02555127
   Duran A, 2004, J MATER CHEM, V14, P2282, DOI 10.1039/b401370k
   Gallardo J, 2000, J SOL-GEL SCI TECHN, V19, P107, DOI 10.1023/A:1008726608539
   Gallardo J, 2001, J SOL-GEL SCI TECHN, V21, P65, DOI 10.1023/A:1011257516468
   Galliano P, 1998, J SOL-GEL SCI TECHN, V13, P723, DOI 10.1023/A:1008653208083
   Garcia C, 2003, MATER LETT, V57, P1810, DOI 10.1016/S0167-577X(02)01073-X
   Gurappa I, 2002, SURF COAT TECH, V161, P70, DOI 10.1016/S0257-8972(02)00380-8
   Harris GK, 2003, MUTAT RES-FUND MOL M, V533, P183, DOI 10.1016/j.mrfmmm.2003.08.025
   Innocenzi P. C., 1992, Journal of the European Ceramic Society, V10, P431, DOI 10.1016/0955-2219(92)90018-9
   Kannan S, 2003, MATER LETT, V57, P2382, DOI 10.1016/S0167-577X(02)01239-9
   Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6
   SANCTIS O, 1990, J NONCRYST SOLIDS, V121, P338
   Singh NP, 2000, MUTAT RES-FUND MOL M, V455, P111, DOI 10.1016/S0027-5107(00)00075-0
NR 14
TC 5
Z9 7
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 593
EP 596
DI 10.4028/www.scientific.net/KEM.284-286.593
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500145
DA 2018-10-20
ER

PT S
AU Osaka, A
   Yoshioka, T
   Yabuta, T
   Tsuru, K
   Hayakawa, S
AF Osaka, A
   Yoshioka, T
   Yabuta, T
   Tsuru, K
   Hayakawa, S
BE Li, P
   Zhang, K
   Colwell, CW
TI Blood compatibility of organic-inorganic biomedical materials
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE blood compatibility; organic-inorganic hybrids; titanium oxide
AB Organic-inorganic hybrids involving Ti-O bonds were coated on stainless-steel (SUS316L) substrates. Tetraisopropoxide and titanium methacrylate triisopropoxide were employed as the major starting chemicals to provide TiO2-polydimethylsiloxane (PDMS) layers or organotitanium molecular thin layers, respectively. Fourier transform infrared spectra indicated that each layer contained Ti-O bonds in their structure. The obtained hybrid layers had little effects on the blood-clotting times such as active partial thromboplastin time and prothrombin time. In addition, the number of adhered platelet on the TiO2-PDMS layers depended on the composition, while the organotitanium molecular thin layers suppressed fibrinogen adsorption compared with coating-free SUS 316L substrate.
C1 Okayama Univ, Biomat Lab, Fac Engn, Okayama 7008530, Japan.
   Okayama Univ, Biomed Engn Res Ctr, Okayama 7008530, Japan.
RP Osaka, A (reprint author), Okayama Univ, Biomat Lab, Fac Engn, Okayama 7008530, Japan.
EM osaka@cc.okayama-u.ac.jp; kanji@cc.okayama-u.ac.jp;
   satoshi@cc.okayama-u.ac.jp
RI HAYAKAWA, Satoshi/B-2104-2011
OI HAYAKAWA, Satoshi/0000-0002-1097-8614
CR Asano T, 2003, J CERAM SOC JPN, V111, P645, DOI 10.2109/jcersj.111.645
   IWAMOTO T, 1995, J MATER SCI, V30, P2566, DOI 10.1007/BF00362135
   Kitazaki Y., 1972, J ADHES SOC JPN, V8, P131
   LIU ZF, 1994, J PHYS CHEM-US, V98, P1253, DOI 10.1021/j100055a035
   MACKENZIE JD, 1992, J NON-CRYST SOLIDS, V147, P271, DOI 10.1016/S0022-3093(05)80629-5
   Marth M. S., 1992, J NONCRYST SOLIDS, V143, P93
   TAKASHIMA S, 2001, KEY ENG MATER, V192, P889
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Yamada N, 1997, J MATER CHEM, V7, P1491, DOI 10.1039/a700793k
   Yoshioka T, 2003, BIOMATERIALS, V24, P2889, DOI 10.1016/S0142-9612(03)00127-3
   YOSHIOKA T, UNPUB T MAT RES SOC
NR 11
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 713
EP 716
DI 10.4028/www.scientific.net/KEM.284-286.713
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500174
DA 2018-10-20
ER

PT S
AU Mansur, HS
   Mansur, AAP
   Bicallho, SMCM
AF Mansur, HS
   Mansur, AAP
   Bicallho, SMCM
BE Li, P
   Zhang, K
   Colwell, CW
TI Lignin-hydroxyapatite/tricalcium phosphate biocomposites: SEM/EDX and
   FTIR characterization
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioceramics; biomaterial; characterization; lignin; scaffolds
AB In the present work, a novel biocomposite has been developed based on lignin (Lig) and HA/beta-TCP bioceramic materials. The Lig/HA and Lig/beta-TCP systems were investigated by Scanning Electron Microscopy coupled to EDX microprobe (SEM/EDX). Lignin is a lignosulfonate natural polymer with complex random coupling and the exact chemical structure is yet unknown. FTIR spectroscopy is an important tool for lignin characterization based on several major vibration bands associated with generally found chemical groups. Consequently, FTIR spectroscopy was used to evaluate the chemical functionalities and major components present in the material. SEM photomicrographs of biocomposites Lig/HA and Lig/beta-TCP have shown uniform dispersion of the natural polymer binder in the bioceramic matrix. Also, chemical composition obtained by EDX spectra have indicated lignin evenly distributed in the HA and beta-TCP compounds. Novel biocomposites based on lignin/RA and lignin/beta-TCP were developed with porosity ranging from 50 to 100 mu m. These results have confirmed the high potential application of lignin as a non-toxic natural polymer binder to be used as 3D scaffold template for biomedical applications.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br; aapiscitelli@uol.com.br; jhs@jhs.med.br
OI Mansur, Herman/0000-0002-3032-495X; Mansur,
   Alexandra/0000-0003-1526-2508
CR HUTMACHER DW, 2000, BIOMATERIALS, V21, P25
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Nada AAMA, 1998, POLYM DEGRAD STABIL, V60, P247, DOI 10.1016/S0141-3910(97)00072-4
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
NR 4
TC 11
Z9 12
U1 3
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 745
EP 748
DI 10.4028/www.scientific.net/KEM.284-286.745
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500182
DA 2018-10-20
ER

PT S
AU Piconi, C
   Maccauro, G
   Muratori, F
AF Piconi, C
   Maccauro, G
   Muratori, F
BE Li, P
   Zhang, K
   Colwell, CW
TI Alumina matrix composites in arthroplasty
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE alumina; ceramic; composite; zirconia
ID ZIRCONIA-TOUGHENED ALUMINA; CERAMIC BALL HEADS; ZRO2 FRACTION; WEAR;
   PROSTHESES; JOINTS
AB It is well known that the introduction of zirconia into the alumina matrix has a positive effect on bending strength of the material, and especially on toughness which is the main limit of alumina ceramics. While the many attempts made in the past to develop alumina matrix composites suitable for biomedical applications containing zirconia as a toughening phase (Zirconia Toughened Alumina - ZTA) did not leave the developmental stage, recently ball heads and inlays for THR bearings made out a three phase alumina matrix composite were introduced into the market. In the alumina matrix of this material both zirconia and exagonal aluminate platelets are distributed, and then it belongs to the class of Zirconia and Platelets Toughened Alumina - ZPTA. Besides ball heads and inlays, also several other innovative orthopedic devices made out this new ceramic biomaterial are in different development stage. This paper reviews the present status of alumina matrix composites in orthopedic application, with special attention to ZPTA.
C1 Catholic Univ Rome, Rome, Italy.
   Catholic Univ Rome, Dip Orthoped & Traumatol, I-00167 Rome, Italy.
RP Piconi, C (reprint author), Catholic Univ Rome, Polo Didatt Format,Lgo O Respighi 1, Rome, Italy.
EM corpico@libero.it; giuliomac@tiscali.it; fmuratori@inwind.it
OI MACCAURO, Giulio/0000-0002-7359-268X
CR Affatato S, 1999, BIOMATERIALS, V20, P971, DOI 10.1016/S0142-9612(98)00253-1
   Affatato S, 1999, BIOMATERIALS, V20, P1925, DOI 10.1016/S0142-9612(99)00093-9
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   Burger W., 2001, KEY ENG MATER, p[192, 545], DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.545
   BURGER W, Patent No. 5830816
   Burger W., 1997, KERAM Z, V49, P1067
   CIAPETTI G, 2000, P 9 SIMCER CENTR CER, P39
   CLAUSSEN N, 1984, SCI TECHNOLOGY ZIRCO, V2, P325
   Deville S, 2003, J EUR CERAM SOC, V23, P2975, DOI 10.1016/S0955-2219(03)00313-3
   GARINO J, 2002, BIOCERAMICS JOINT AR, P131
   Heimke G, 2002, BIOMATERIALS, V23, P1539, DOI 10.1016/S0142-9612(01)00262-9
   Insley GM, 2004, KEY ENG MAT, V254-2, P675, DOI 10.4028/www.scientific.net/KEM.254-256.675
   Kaddick C, 2002, BIOCERAMICS JOINT AR, P16
   KADDICK C, 2000, BIOCERAMICS HIP JOIN, P146
   Lazennec JY, 2004, BIOCERAMICS IN JOINT ARTHROPLASTY, P51
   Maccauro G, 2004, BIOCERAMICS IN JOINT ARTHROPLASTY, P47
   MANDRINO A, 1992, J MATER SCI-MATER M, V3, P457, DOI 10.1007/BF00701243
   Merkert P, 2004, BIOCERAMICS IN JOINT ARTHROPLASTY, P129
   Merkert P., 2003, BIOCERAMICS JOINT AR, P123
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Rack R, 2000, BIOCERAMICS HIP JOIN, P141
   Rack R., 2001, BIOCERAMICS JOINT AR, P103
   Rieu J., 1993, Clinical Materials, V12, P211, DOI 10.1016/0267-6605(93)90075-I
   SALOMONI A, 1994, J MATER SCI-MATER M, V5, P651, DOI 10.1007/BF00120349
   Stewart TD, 2003, J BIOMED MATER RES B, V66B, P567, DOI 10.1002/jbm.b.10035
   WILLMANN G, 2001, KEY ENG MATER, V192, P545
   ZABRA L, 2004, BIOCERAMICS JOINT AR, P163
NR 28
TC 11
Z9 11
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 979
EP 982
DI 10.4028/www.scientific.net/KEM.284-286.979
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500239
DA 2018-10-20
ER

PT S
AU Lawson, TR
   Catledge, SA
   Vohra, YK
AF Lawson, TR
   Catledge, SA
   Vohra, YK
BE Li, P
   Zhang, K
   Colwell, CW
TI Nanostructured diamond coated CoCrMo alloys for use in biomedical
   implants
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE chromium nitride (CrN, Cr2N); cobalt-chromium-molybdenum (CoCrMo);
   diamond; total hip replacement
ID CHROMIUM NITRIDE INTERLAYERS; STEEL; DEPOSITION
AB A wide variety of materials are currently under consideration for use in biomedical implants. Within the scope of certain implants is the need to withstand extensive wear created by repeated use and pressure on high stress joints. Substantial research is directed toward metal-on-metal technology and cobalt chrome molybdenum (CoCrMo) is a prime candidate given its longevity [I]. Wear-resistant surface coatings for the standard CoCrMo biomedical alloy may be a simple and effective way to extend implant lifetime. In this study, we show that an initial plasma nitriding step for CoCrMo alloy is beneficial for attaining adhesion of a nanostructured diamond coating subsequently grown by microwave plasma chemical vapor deposition (CVD). The initial plasma nitriding step is quickly and easily performed in the CVD reactor and results in the formation of chromium nitride phases (CrN, Cr2N) as well as a phase transformation of cobalt from hexagonal to face centered cubic. We suggest that the success in terms of achieving adhesion of the diamond coating to the CoCrMo alloy involves chromium nitride phases acting as a diffusion barrier to carbon, thus preventing direct reaction of carbon with cobalt and the extensive graphitization that would follow.
C1 Univ Alabama, Birmingham, AL 35294 USA.
RP Lawson, TR (reprint author), Univ Alabama, 310 Campbell Hall,1300 Univ Blvd, Birmingham, AL 35294 USA.
EM vithar@uab.edu; catledge@uab.edu; ykvohra@uab.edu
CR Buijnsters JG, 2002, DIAM RELAT MATER, V11, P536, DOI 10.1016/S0925-9635(01)00628-8
   Cawley J, 2003, WEAR, V255, P999, DOI 10.1016/S0043-1648(03)00046-2
   Chekour L, 2003, WEAR, V255, P1438, DOI 10.1016/S0043-1648(03)00229-1
   Glozman O, 1997, DIAM RELAT MATER, V6, P1847, DOI 10.1016/S0925-9635(97)00151-9
   Glozman O, 1997, DIAM RELAT MATER, V6, P796, DOI 10.1016/S0925-9635(96)00671-1
   *NAT CTR HLTH STAT, 1994 REP
NR 6
TC 4
Z9 4
U1 1
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 1015
EP 1018
DI 10.4028/www.scientific.net/KEM.284-286.1015
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500248
DA 2018-10-20
ER

PT S
AU Cole, M
   Voelcker, NH
   Thissen, H
AF Cole, M
   Voelcker, NH
   Thissen, H
BE Nicolau, DV
TI Switchable coatings for biomedical applications
SO Biomedical Applications of Micro- and Nanoengineering II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Applications of Micro- and Nanoengineering II
CY DEC 13-15, 2004
CL Sydney, AUSTRALIA
SP SPIE, Univ New S Wales, Australian Govt Dept Def, Def Sci & Technol Org, Cochlear, NSW Minist Sci & Med Res
DE surface modification; protein adsorption; plasma polymerisation
ID POLY(ETHYLENE GLYCOL); PLASMA POLYMERIZATION; SURFACES; PROTEINS;
   ALLYLAMINE; ADSORPTION; ADHESION; RELEASE; DENSITY; LAYERS
AB The control over protein adsorption is of major importance for a variety of biomedical applications from diagnostic assays to tissue engineered medical devices. Most research has focused on the prevention of non-specific protein adsorption on solid substrates. Examples for surface modifications that significantly reduce protein adsorption include the grafting of polyacrylamide, poly (ethylene oxide) and polysaccharides.
   Here, we describe a method for creating surfaces that prevent non-specific protein adsorption, which in addition can be transformed into surfaces showing high protein adsorption on demand.
   Doped silicon wafers were used as substrate materials. Coatings were constructed by deposition of allylamine plasma polymer. The subsequent grafting of poly (ethylene oxide) aldehyde resulted in a surface with low protein fouling character. When the conductive silicon wafer was used as an electrode, the resulting field induced the adsorption of selected proteins.
   Surface modifications were analysed by X-ray photoelectron spectroscopy and atomic force microscopy. The controlled adsorption of proteins was investigated using a colorimetric assay to test enzymatic activity. The method described here represents an effective tool for the control over protein adsorption and is expected to find use in a variety of biomedical applications particularly in the area of biochips.
C1 Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Bedford Pk, SA 5042, Australia.
RP Cole, M (reprint author), Flinders Univ S Australia, Sch Chem Phys & Earth Sci, GPO Box 2100, Bedford Pk, SA 5042, Australia.
RI Cole, Martin/A-4927-2008; Voelcker, Nicolas/D-6199-2012; Thissen,
   Helmut/D-3835-2011
OI Cole, Martin/0000-0001-8539-1466; Voelcker, Nicolas/0000-0002-1536-7804;
   
CR BAGHDOYAN S, 2004, NUCLEIC ACIDS RES, V32, P1
   Beck AJ, 2001, J PHYS CHEM B, V105, P5730, DOI 10.1021/jp0043468
   Chen Q, 2004, CHEM MATER, V16, P614, DOI 10.1021/cm034529h
   DESAI T, 2002, BUSINESS BRIEFING ME, P80
   Fuentes M, 2004, BIOTECHNOL PROGR, V20, P1134, DOI 10.1021/bp0499449
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hyun J, 2004, J AM CHEM SOC, V126, P7330, DOI 10.1021/ja049721e
   Jon SY, 2003, LANGMUIR, V19, P9989, DOI 10.1021/la034839e
   Kingshott P, 2002, BIOMATERIALS, V23, P4775, DOI 10.1016/S0142-9612(02)00228-4
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   MINGHONG W, 1999, RADIAT PHYS CHEM, V56, P341
   RodriguezLopez JN, 1997, J BIOL CHEM, V272, P5469, DOI 10.1074/jbc.272.9.5469
   SHARMA S, 2003, LANGMUIR, V20, P348
   Szili E, 2004, BIOSENS BIOELECTRON, V19, P1395, DOI 10.1016/j.bios.2003.12.019
   Thissen H, 2002, SMART MATER STRUCT, V11, P792, DOI 10.1088/0964-1726/11/5/326
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Wang J, 2000, BIOELECTROCHEMISTRY, V52, P111, DOI 10.1016/S0302-4598(00)00081-7
   WANG Y, 2003, P 12 INT C SOL STAT, P979
   Wei J, 2003, COLLOID SURFACE B, V32, P275, DOI 10.1016/S0927-7765(03)00180-2
   Zdyrko B, 2003, LANGMUIR, V19, P10179, DOI 10.1021/la034974r
   Zhang K, 2002, J CONTROL RELEASE, V80, P169, DOI 10.1016/S0168-3659(02)00024-X
NR 23
TC 5
Z9 5
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5611-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5651
BP 19
EP 27
DI 10.1117/12.582306
PG 9
WC Engineering, Biomedical; Instruments & Instrumentation; Imaging Science
   & Photographic Technology
SC Engineering; Instruments & Instrumentation; Imaging Science &
   Photographic Technology
GA BCC90
UT WOS:000228665300006
OA Green Published
DA 2018-10-20
ER

PT S
AU Williams, CM
   Nash, MA
   Poole-Warren, LA
AF Williams, CM
   Nash, MA
   Poole-Warren, LA
BE Nicolau, DV
TI Electrically conductive polyurethanes for biomedical applications
SO Biomedical Applications of Micro- and Nanoengineering II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Applications of Micro- and Nanoengineering II
CY DEC 13-15, 2004
CL Sydney, AUSTRALIA
SP SPIE, Univ New S Wales, Australian Govt Dept Def, Def Sci & Technol Org, Cochlear, NSW Minist Sci & Med Res
DE carbon nanotubes; cytotoxicity; cell inhibition; polyurethane; polymer
   nanocomposite; electrical conductivity
ID CARBON NANOTUBES; NEURITE GROWTH; NERVE GROWTH; FIELD; STIMULATION;
   POLYSTYRENE; ORIENTATION; DIRECTION; NEURONS; POLYMER
AB Electrical interfacing with neural tissue poses significant problems due to host response to the material. This response Generally leads to fibrous encapsulation and increased impedance across the electrode. In neural electrodes such as cochlear implants, an elastomeric material like silicone is used as an insulator for the metal electrode. This project ultimately aims to produce a polymer electrode with elastomeric mechanical properties, metal like conductivity and capability. The approach taken was to produce a nanocomposite elastomeric material based on polyurethane (PU) and carbon nanotubes. Carbon nanotubes are ideal due to their high aspect ratio as well as being a ballistic conductor. The choice of PU is based on its elastomeric properties, processability and biocompatibility. Multi-walled nanotubes (MWNTs) were dispersed ultrasonically in various dispersive solutions before being added at up to 20wt% to a 5wt% PU (Pellethane80A) in Dimethylacetamide (DMAc). Films were then solvent cast in a vacuum oven overnight. The resulting films were tested for conductivity using a two-probe technique and mechanically tested using an Instron tensiometer. The percolation threshold (p) of the PU/MWNT films occurred at loadings of between 7 and 10 wt% in this polymer system. Conductivity of the films (above p) was comparable to those for similar systems reported in the literature at up to approximately 7 x 10(-2) Scm(-1). Although PU stiffness increased with increased %loading of nanotubes, all composites were highly flexible and maintained elastomeric properties. From these preliminary results we have demonstrated electrical conductivity. So far it is evident that a superior percolation threshold is dependent on the degree of dispersion of the nanotubes. This has prompted work into investigating other preparations of the films, including melt-processing and electrospinning.
C1 Univ New S Wales, Kensington, NSW 2033, Australia.
RP Williams, CM (reprint author), Univ New S Wales, Kensington, NSW 2033, Australia.
OI Poole-Warren, Laura/0000-0002-4414-022X; Nash,
   Michael/0000-0003-3842-1567
CR ERSKINE L, 1995, DEV BIOL, V171, P330, DOI 10.1006/dbio.1995.1285
   HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695
   Huczko A, 2001, FULLERENE SCI TECHN, V9, P247, DOI 10.1081/FST-100102972
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   MCCAIG CD, 1991, EXP PHYSIOL, V76, P473, DOI 10.1113/expphysiol.1991.sp003514
   McCaig CD, 2000, DEV DYNAM, V217, P299, DOI 10.1002/(SICI)1097-0177(200003)217:3<299::AID-DVDY8>3.0.CO;2-G
   Mitchell CA, 2002, MACROMOLECULES, V35, P8825, DOI 10.1021/ma020890y
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   PATEL N, 1982, J NEUROSCI, V2, P483
   Qian D, 2000, APPL PHYS LETT, V76, P2868, DOI 10.1063/1.126500
   Rajnicek AM, 1998, DEV BIOL, V203, P412, DOI 10.1006/dbio.1998.9039
   RAJNICEK AM, 1992, EXP PHYSIOL, V77, P229, DOI 10.1113/expphysiol.1992.sp003580
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
NR 17
TC 6
Z9 6
U1 1
U2 14
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5611-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5651
BP 329
EP 335
DI 10.1117/12.282321
PG 7
WC Engineering, Biomedical; Instruments & Instrumentation; Imaging Science
   & Photographic Technology
SC Engineering; Instruments & Instrumentation; Imaging Science &
   Photographic Technology
GA BCC90
UT WOS:000228665300038
DA 2018-10-20
ER

PT J
AU Ryan, MT
   Mulholland, CW
AF Ryan, MT
   Mulholland, CW
TI Evaluation of a distance-learning immunology and pathology module in a
   postgraduate biomedical science course
SO BRITISH JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
DE computer-aided learning; biomedical science; distance learning
AB An electronic presentation of materials for a distance-learning immunology and pathology module from a postgraduate biomedical science course is evaluated. Two different electronic presentation formats for the delivery of the educational material to distance learners are assessed. Responses from users of this material highlighted a preference for a format that has a design tailored to distance learning. There was no significant difference in learning outcome between those taking the module on campus and by distance learning. This suggests that the prerequisites for entry, learning materials and direction given to the students studying by distance learning are adequate for these students to achieve the learning objectives outlined in the course. The evaluation also gave direction for areas within the (CAL) application that can be improved for future students.
C1 Univ Coll Dublin, Fac Med Vet, Dept Vet Physiol & Biochem, Dublin 4, Ireland.
   Univ Ulster, Inst Lifelong Learning, Newtownabbey BT37 0QB, Antrim, North Ireland.
RP Ryan, MT (reprint author), Univ Coll Dublin, Fac Med Vet, Dept Vet Physiol & Biochem, Dublin 4, Ireland.
EM marion.ryan@ucd.ie
OI Ryan, Marion/0000-0001-7359-6085
CR Bloom B, 1956, HDB, P201
   Coleman JN, 1998, IEEE T EDUC, V41, P177, DOI 10.1109/13.704542
   COX K, 1997, COMP EDUC, V30, P157
   Davis MJ, 1997, ADV PHYSIOL EDUC, V17, P1
   Dewhurst DG, 2000, COMPUT EDUC, V35, P223, DOI 10.1016/S0360-1315(00)00033-6
   Draper SW, 1996, COMPUT EDUC, V26, P17, DOI 10.1016/0360-1315(95)00068-2
   GLASTONBURY B, 1994, CTISS FILE, V17, P33
   Gunn C, 1996, J COMPUT ASSIST LEAR, V12, P205, DOI 10.1111/j.1365-2729.1996.tb00052.x
   Harrold MW, 1998, AM J PHARM EDUC, V62, P24
   KING T, 1994, CTISS FILE, V17, P30
   Matthew IR, 1998, MED EDUC, V32, P89, DOI 10.1046/j.1365-2923.1998.00156.x
   PARLETT M, 1997, INTRO ILLUMINATIVE E
   PREECE J, 1994, HUMAN COMPUTER INTER
   Reid WA, EVALUATION COMPUTER
   Ryan M, 2000, BRIT J BIOMED SCI, V57, P28
   Sweeters W., 1994, Educational Technology, V34, P47
   Ward M, 1998, COMPUT EDUC, V31, P171, DOI 10.1016/S0360-1315(98)00024-4
   LEARNING TECHNOLOGY
   GUIDE I BIOMEDICAL S
NR 19
TC 2
Z9 2
U1 0
U2 0
PU STEP PUBLISHING LTD
PI TUNBRIDGE WELLS
PA SUBSCRIPTION DEPT, NORTH FARM RD, TUNBRIDGE WELLS TN2 3DR, KENT, ENGLAND
SN 0967-4845
J9 BRIT J BIOMED SCI
JI Br. J. Biomed. Sci.
PY 2005
VL 62
IS 1
BP 9
EP 14
DI 10.1080/09674845.2005.11732680
PG 6
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 910BH
UT WOS:000227903900003
PM 15816205
DA 2018-10-20
ER

PT B
AU Laroussi, M
AF Laroussi, Mounir
BE Leys, C
TI LOW TEMPERATURE PLASMA-BASED STERILIZATION/DECONTAMINATION OF BIOLOGICAL
   MATTER
SO CAPPSA 2005, PROCEEDINGS
LA English
DT Proceedings Paper
CT 2nd International Workshop on Cold Atmospheric Pressure Plasmas: Sources
   and Applications
CY AUG 30-SEP 02, 2005
CL Bruges, BELGIUM
SP Minist Flemish Commun, Ghent Univ, Dept Appl Phys, Czech Techn Univ, Inst Chem Technol, Inst Plasma Phys
DE cold plasma; sterilization; ultraviolet; reactive species; bacteria
ID ATMOSPHERIC-PRESSURE; STERILIZATION; INACTIVATION; DISCHARGES; ROLES
AB In the last two decades, non-equilibrium atmospheric pressure plasmas have been used in several applications such as UV sources, surface treatment, and the cleaning of flue gases. Amongst the more recent novel applications, the use of atmospheric pressure "cold" plasmas in the biomedical field is presently experiencing a heightened interest from the plasma science research community. This is due to promising applications of these plasmas in medical research such as wound healing, tissue engineering, surface modification of biocompatible materials, and the sterilization of reusable heat sensitive medical instruments.
   In this paper, the focus will be on the effects of low temperature plasmas on the cells of bacteria. First an overview of research efforts carried out at both low and high pressures will be presented. Then a detailed review and discussion on the effects of atmospheric pressure non-equilibrium plasmas on the cells of bacteria will be given. This includes the evaluation of the inactivation kinetics and the roles of the various plasma agents in the inactivation process. In particular, measurements of the plasma temperature, the UV emission, and concentrations of various reactive species (O(3), NO(2), OH ...) for the special case of an air plasma are presented.
C1 Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23510 USA.
RP Laroussi, M (reprint author), Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23510 USA.
EM mlarouss@odu.edu
CR Bettleheim F. A., 1995, INTRO GEN ORGANIC BI
   BIRMINGHAM J, 2003, P EL C VER ENG INC S, P16
   BLAKELY EA, 2002, P IEEE INT C PLASM S, P253
   BLOCK SS, 1992, ENCY MICROBIOLOGY, V4, P87
   Bol'shakov AA, 2004, AIAA J, V42, P823, DOI 10.2514/1.9562
   KANAZAWA S, 1988, J PHYS D APPL PHYS, V21, P838, DOI 10.1088/0022-3727/21/5/028
   Kogelschatz U, 2002, IEEE T PLASMA SCI, V30, P1400, DOI 10.1109/TPS.2002.804201
   KOINUMA H, 1992, APPL PHYS LETT, V60, P816, DOI 10.1063/1.106527
   Kunhardt EE, 2000, IEEE T PLASMA SCI, V28, P189, DOI 10.1109/27.842901
   Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P158, DOI 10.1109/TPS.2002.1003972
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220
   Laroussi M, 2004, P IEEE INT C PLASM S, P122
   LAROUSSI M, 2003, NEW J PHYS, V5
   Mendis DA, 2000, IEEE T PLASMA SCI, V28, P1304, DOI 10.1109/27.893321
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   MOISAN M, 1991, J PHYS D APPL PHYS, V24, P1025, DOI 10.1088/0022-3727/24/7/001
   MOISAN M, 2003, 5 INT WORKSH MICR DI, P210
   Moreau S, 2000, J APPL PHYS, V88, P1166, DOI 10.1063/1.373792
   Philip N, 2002, IEEE T PLASMA SCI, V30, P1429, DOI 10.1109/TPS.2002.804203
   SANCHEZESTRADA FS, 2002, P IEEE INT C PLASM S, P254
   Schoenbach KH, 1996, APPL PHYS LETT, V68, P13, DOI 10.1063/1.116739
   Scutze A, 1998, IEEE T PLASMA SCI, V26, P1685
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304
NR 24
TC 0
Z9 0
U1 0
U2 11
PU UNIVERSITEIT GENT
PI GHENT
PA COUPURE LINKS 653, B-9000 GHENT, BELGIUM
BN 978-90-808669-2-8
PY 2005
BP 18
EP 27
PG 10
WC Engineering, Electrical & Electronic; Physics, Applied; Physics, Fluids
   & Plasmas
SC Engineering; Physics
GA BST18
UT WOS:000285739300003
DA 2018-10-20
ER

PT J
AU Li, N
   Jie, Q
   Zhu, SM
   Wang, RD
AF Li, N
   Jie, Q
   Zhu, SM
   Wang, RD
TI Preparation and characterization of macroporous sol-gel bioglass
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE sol-gel processes; porosity; glass; biomedical applications
ID BIOMEDICAL MATERIALS; GLASSES; BIOACTIVITY; SYSTEM
AB Sol-gel bioglasses have many advantages comparing to melt-derived bioglasses. 3-D scaffold prepared by sol-gel method is a promising substrate material for bone tissue engineering. But, it is difficult to produce macroporous sol-gel bioglasses with pores larger than 100 mu m. In this work. a series of macroporous bioglasses was produced by adding PEG particles into the sol as pore former. The mesoporous texture features of the samples were assessed through a nitrogen sorption technique. The macropore structure was collected by intrusion mercury porosimetry. In vitro tests showed that the samples had good bioactivity. Combining the sol-gel routine with the pore former might be a useful approach for preparation scaffolds with applications to the repair and reconstruction of damaged tissue. (c) 2004 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Zhu, SM (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, 1295 Ding Xi Rd, Shanghai 200050, Peoples R China.
EM smzhu@mail.sic.ac.cn
RI Zhu, Sumin/D-3686-2009; Jie, Qing/N-8673-2013; Jie, Qing/H-3780-2011
CR Coleman NJ, 2000, CERAM INT, V26, P171, DOI 10.1016/S0272-8842(99)00037-1
   GREENSPAN DC, 1997, BIOCERAMICS, V10, P391
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lenza RFS, 2002, J MATER SCI-MATER M, V13, P837, DOI 10.1023/A:1016592127407
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   Olmo N, 2003, BIOMATERIALS, V24, P3383, DOI 10.1016/S0142-9612(03)00200-X
   Perez-Pariente J., 2002, J BIOMED MATER RES, V61, P524
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Yan HW, 2001, CHEM MATER, V13, P1374, DOI 10.1021/cm000895e
   Zhong J., 1997, BIOCERAMICS, V10, P265
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 15
TC 51
Z9 52
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 2005
VL 31
IS 5
BP 641
EP 646
DI 10.1016/j.ceramint.2004.05.011
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 929PR
UT WOS:000229358700002
DA 2018-10-20
ER

PT J
AU Ding, SJ
   Wang, CW
   Chen, DCH
   Chang, HC
AF Ding, SJ
   Wang, CW
   Chen, DCH
   Chang, HC
TI In vitro degradation behavior of porous calcium phosphates under
   diametral compression loading
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE mechanical properties; biomedical application; calcium phosphate;
   degradation
ID HYDROXYAPATITE CERAMICS; BONE SUBSTITUTE; IMPLANTS; POROSITY;
   FABRICATION; SCAFFOLDS; FATIGUE; STRESS
AB Four different types of porous calcium phosphates were made on addition of a pore-forming compound (PVA) by sinter processing. Mechanical properties, morphology, and weight change with immersion time in Hanks' physiological solution were evaluated. The in vitro fatigue test was also performed. Experimental results showed the pore microstructure of the as-sintered bodies to be made up of the macropores and micropores. The initial strength of the porous bodies was dependent on the contents of the PVA additive. Porous bodies subjected to Cycling fatigue in Hanks' solution remarkably decreased in the strength. With increasing immersion time in solution, the tensile strength and elastic modulus of various porous bodies decreased. The weight loss data confirmed the degradation behavior of the porous bodies in Hank's solution. The biomedical uses of the present porous materials are limited to non-load bearing applications such as bone defect repair. (c) 2004 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 Chung Shan Med Univ, Inst Dent Mat, Taichung 402, Taiwan.
   Chung Shan Med Univ, Inst Vet Microbiol, Taichung 402, Taiwan.
   Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 701, Taiwan.
RP Ding, SJ (reprint author), Chung Shan Med Univ, Inst Dent Mat, 110 Sec 1,Chien Kuo N Rd, Taichung 402, Taiwan.
EM sjding@csmu.edu.tw
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   *ASTM, 1982, C37372 ASTM, P182
   Baksh D, 1998, J MATER SCI-MATER M, V9, P743, DOI 10.1023/A:1008959103864
   Catanese J, 1999, J BIOMED MATER RES, V45, P327, DOI 10.1002/(SICI)1097-4636(19990615)45:4<327::AID-JBM7>3.0.CO;2-L
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   da Silva MHP, 2002, J NON-CRYST SOLIDS, V304, P286, DOI 10.1016/S0022-3093(02)01036-0
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Flautre B, 2001, J MATER SCI-MATER M, V12, P679, DOI 10.1023/A:1011256107282
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Goldstein S. A., 2001, CURR OPIN ORTHOP, V12, P424
   KIKUCHI M, 2002, J BIOMED MATER RES, V62, P256
   KLEIN CPA, 1990, HDB BIOACTIVE CERAMI, V2, P53
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   LIN CL, 2003, P ANN C CHIN SOC MAT
   Lin JHC, 2001, J MATER SCI-MATER M, V12, P731, DOI 10.1023/A:1011280828663
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   Liu DM, 1996, BIOMATERIALS, V17, P1955, DOI 10.1016/0142-9612(95)00301-0
   Lu L, 2000, CURR OPIN ORTHOP, V11, P383
   Ogiso M, 1998, J BIOMED MATER RES, V39, P23, DOI 10.1002/(SICI)1097-4636(199801)39:1<23::AID-JBM4>3.3.CO;2-X
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Porter NL, 2001, J BIOMED MATER RES, V56, P504, DOI 10.1002/1097-4636(20010915)56:4<504::AID-JBM1122>3.0.CO;2-J
   Qiao GJ, 2002, INT J FATIGUE, V24, P499, DOI 10.1016/S0142-1123(01)00175-X
   Raynaud S, 1998, J MATER SCI-MATER M, V9, P221, DOI 10.1023/A:1008840308094
   REED JS, 1989, INTRO PRINCIPLES CER, P152
   RICHERSON DW, 1992, MODERN CERAMIC ENG, P520
   SHIMA T, 1979, J NEUROSURG, V51, P533, DOI 10.3171/jns.1979.51.4.0533
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   WANG CW, 2003, J MED BIOL ENG, V23, P159
NR 28
TC 17
Z9 17
U1 4
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 2005
VL 31
IS 5
BP 691
EP 696
DI 10.1016/j.ceramint.2004.08.007
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 929PR
UT WOS:000229358700010
DA 2018-10-20
ER

PT J
AU Bunzli, JCG
   Piguet, C
AF Bunzli, JCG
   Piguet, C
TI Taking advantage of luminescent lanthanide ions
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID CIRCULARLY-POLARIZED LUMINESCENCE; NEAR-INFRARED PHOTOLUMINESCENCE;
   TRIPLE-HELICAL COMPLEXES; ELECTRONIC ENERGY LEVELS;
   TRANSITION-METAL-COMPLEXES; TIME-RESOLVED FLUOROIMMUNOASSAY; CONTAINING
   LIQUID-CRYSTALS; D-F COMPLEXES; AQUO IONS; EXCITED-STATES
AB Lanthanide ions possess fascinating optical properties and their discovery, first industrial uses and present high technological applications are largely governed by their interaction with light. Lighting devices (economical luminescent lamps, light emitting diodes), television and computer displays, optical fibres, optical amplifiers, lasers, as well as responsive luminescent stains for biomedical analysis, medical diagnosis, and cell imaging rely heavily on lanthanide ions. This critical review has been tailored for a broad audience of chemists, biochemists and materials scientists; the basics of lanthanide photophysics are highlighted together with the synthetic strategies used to insert these ions into mono- and polymetallic molecular edifices. Recent advances in NIR-emitting materials, including liquid crystals, and in the control of luminescent properties in polymetallic assemblies are also presented.
C1 Ecole Polytech Fed Lausanne, LCSL, CH-1015 Lausanne, Switzerland.
   Univ Geneva, Dept Inorgan Analyt & Appl Chem, CH-1211 Geneva, Switzerland.
RP Bunzli, JCG (reprint author), Ecole Polytech Fed Lausanne, LCSL, CH-1015 Lausanne, Switzerland.
EM jean-claude.bunzli@epfl.ch; claude.piguet@chiam.unige.ch
RI Bunzli, Jean-Claude/C-7303-2008
OI Bunzli, Jean-Claude/0000-0003-0140-3402
CR Aime S, 1998, J CHEM SOC DALTON, P881, DOI 10.1039/a708667i
   Ananias D, 2004, J AM CHEM SOC, V126, P10410, DOI 10.1021/ja047905n
   Andre N, 2004, INORG CHEM, V43, P515, DOI 10.1021/ic0351996
   Archer RD, 1998, INORG CHEM, V37, P2089, DOI 10.1021/ic960244d
   Arenz S, 2005, CHEM PHYS LETT, V402, P75, DOI 10.1016/j.cplett.2004.12.008
   Artizzu F, 2005, INORG CHEM, V44, P840, DOI 10.1021/ic0483895
   Asfari Z., 2001, CALIXARENES 2001
   Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g
   Bazzicalupi C, 2000, CHEM COMMUN, P561, DOI 10.1039/a909581k
   Beeby A, 2000, J PHOTOCH PHOTOBIO B, V57, P83, DOI 10.1016/S1011-1344(00)00070-1
   Beeby A, 2000, CHEM COMMUN, P1183, DOI 10.1039/b002452j
   Beeby A, 1999, J CHEM SOC PERK T 2, P493, DOI 10.1039/a808692c
   Beer PD, 2004, INORG CHEM, V43, P3965, DOI 10.1021/ic0499401
   Billard I, 2003, INORG CHEM, V42, P1726, DOI 10.1021/ic0260318
   Billard I, 2004, EUR J INORG CHEM, P1190, DOI 10.1002/ejic.200300588
   Binnemans K, 2002, CHEM REV, V102, P2303, DOI 10.1021/cr010287y
   Binnemans K, 2002, J MATER CHEM, V12, P3374, DOI 10.1039/b206810a
   Binnemans K, 1998, J MATER CHEM, V8, P1551, DOI 10.1039/a803227k
   Binnemans K, 2000, J AM CHEM SOC, V122, P4335, DOI 10.1021/ja993351q
   Binnemans K, 2001, CHEMPHYSCHEM, V2, P680, DOI 10.1002/1439-7641(20011119)2:11<680::AID-CPHC680>3.0.CO;2-#
   BINNEMANS K, 2005, HDB PHYS CHEM RARE E, V35, pS225
   BLASSE G, 1979, HDB PHYSICS CHEM RAR, V4, pCH34
   Bobba G, 2002, CHEM COMMUN, P890, DOI 10.1039/b201451n
   Bornhop DJ, 2003, APPL SPECTROSC, V57, P1216, DOI 10.1366/000370203769699063
   Bornhop DJ, 1999, ANAL CHEM, V71, P2607, DOI 10.1021/ac981208u
   Boyaval J, 2001, MOL CRYST LIQ CRYST, V359, P337
   Bunzli J.-C. G., 2005, SPECTROSCOPIC PROPER, V83
   Bunzli J.-C.G., 1998, RARE EARTHS, P223
   Bunzli JCG, 2004, MET IONS BIOL SYST, V42, P39
   Bunzli JCG, 2002, CHEM REV, V102, P1897, DOI 10.1021/cr010299j
   BUNZLI JCG, 2000, CALIXARENES SEPARATI, V757, P179
   BUNZLI JCG, 2001, ENCY MAT SCI TECHNOL, V10, P4465
   Burton-Pye BP, 2005, DALTON T, P146, DOI 10.1039/b413005g
   Cantuel M, 2004, INORG CHEM, V43, P1840, DOI 10.1021/ic035292u
   Cantuel M, 2002, J CHEM SOC DALTON, P1929, DOI 10.1039/b200011c
   Carnall W.T., 1979, HDB PHYSICS CHEM RAR, V3
   CARNALL WT, 1968, J CHEM PHYS, V49, P4424, DOI 10.1063/1.1669893
   CARNALL WT, 1968, J CHEM PHYS, V49, P4443, DOI 10.1063/1.1669894
   CARNALL WT, 1968, J CHEM PHYS, V49, P4450, DOI 10.1063/1.1669896
   CARNALL WT, 1968, J CHEM PHYS, V49, P4447, DOI 10.1063/1.1669895
   Casnati A, 2003, EUR J ORG CHEM, P1475, DOI 10.1002/ejoc.200390206
   Charbonniere LJ, 2002, J AM CHEM SOC, V124, P7779, DOI 10.1021/ja0200847
   Chaumont A, 2004, INORG CHEM, V43, P5891, DOI 10.1021/ic049386v
   Choppin G. R., 1989, LANTHANIDE PROBES LI, P1
   Chudinov AV, 2004, RUSS J BIOORG CHEM+, V30, P89, DOI 10.1023/B:RUBI.0000015779.37503.8d
   COMBY S, 2005, UNPUB
   Coppo P, 2005, ANGEW CHEM INT EDIT, V44, P1806, DOI 10.1002/anie.200461953
   Cotton S., 1991, MCMILLAN PHYS SCI SE
   Crookes W., 1885, PHILOS T R SOC LON A, V176, P691
   de Sa GF, 2000, COORDIN CHEM REV, V196, P165, DOI 10.1016/S0010-8545(99)00054-5
   de Silva AP, 2000, COORDIN CHEM REV, V205, P41, DOI 10.1016/S0010-8545(00)00238-1
   de Silva AP, 1997, CHEM COMMUN, P1891
   Deng H, 1998, J AM CHEM SOC, V120, P3522, DOI 10.1021/ja9743654
   Dickins RS, 1998, NEW J CHEM, V22, P891, DOI 10.1039/a801004h
   Dickins RS, 2002, J AM CHEM SOC, V124, P12697, DOI 10.1021/ja020836x
   Donnio B., 2003, COMPREHENSIVE COORDI, P357, DOI DOI 10.1016/B0-08-043748-6/06150-8
   Driesen K, 2004, CHEM PHYS LETT, V395, P306, DOI 10.1016/j.cplett.2004.08.001
   Driesen K, 2004, CHEM MATER, V16, P1531, DOI 10.1021/cm031166c
   Driesen K, 2004, LIQ CRYST, V31, P601, DOI 10.1080/02678290410001667399
   Edder C, 2001, CHEM-EUR J, V7, P3014, DOI 10.1002/1521-3765(20010716)7:14<3014::AID-CHEM3014>3.0.CO;2-D
   Faulkner S, 2005, APPL SPECTROSC REV, V40, P1, DOI 10.1081/ASR-200038308
   Faulkner S, 2004, DALTON T, P1405, DOI 10.1039/b401302f
   Faulkner S, 2003, J AM CHEM SOC, V125, P10526, DOI 10.1021/ja035634v
   Faulkner S., 2004, COMPREHENSIVE COORDI, V9, P913
   Floquet S, 2004, CHEM-EUR J, V10, P1091, DOI 10.1002/chem.200305498
   Frias JC, 2003, ORG BIOMOL CHEM, V1, P905, DOI 10.1039/b301385p
   Fu LM, 2005, ANGEW CHEM INT EDIT, V44, P747, DOI 10.1002/anie.200462382
   Galyametdinov YG, 2002, LIQ CRYST, V29, P1581, DOI 10.1080/0267829021000034826
   GALYAMETDINOV YG, 1994, RUSS CHEM B+, V43, P938, DOI 10.1007/BF01558051
   GALYAMETDINOV YG, 1991, B ACAD SCI USSR CH+, V40, P1109, DOI 10.1007/BF00961392
   Galyametdinov YG, 2001, CHEM-EUR J, V7, P99, DOI 10.1002/1521-3765(20010105)7:1<99::AID-CHEM99>3.3.CO;2-K
   Gamelin DR, 2000, ACCOUNTS CHEM RES, V33, P235, DOI 10.1021/ar990102y
   Gau WJ, 1996, J ELECTROCHEM SOC, V143, P914, DOI 10.1149/1.1836558
   Gerner P, 2001, INORG CHEM, V40, P4534, DOI 10.1021/ic010081f
   Glover PB, 2003, J AM CHEM SOC, V125, P9918, DOI 10.1021/ja029886s
   Gorller-Walrand C., 1998, HDB PHYS CHEM RARE E, V25
   Guillet E, 2004, CHEM MATER, V16, P4063, DOI 10.1021/cm049296o
   GUILLOU O, 2004, HDB PHYS CHEM RARE E, V34, pCH221
   Gunnlaugsson T, 2004, CHEM COMMUN, P782, DOI 10.1039/b316176e
   Gunnlaugsson T, 2003, J AM CHEM SOC, V125, P12062, DOI 10.1021/ja035425a
   Guo D, 2004, CHEM COMMUN, P1486, DOI 10.1039/b403519d
   Gutierrez F, 2004, DALTON T, P1334, DOI 10.1039/b316246j
   Hai XD, 2004, ANAL SCI, V20, P245, DOI 10.2116/analsci.20.245
   Hanaoka K, 2003, ANGEW CHEM INT EDIT, V42, P2996, DOI 10.1002/anie.200351122
   Harrison BS, 2004, CHEM MATER, V16, P2938, DOI 10.1021/cm049937f
   Harvey E. N., 1957, HIST LUMINESCENCE EA
   Hasegawa Y, 2004, J PHOTOCH PHOTOBIO C, V5, P183, DOI 10.1016/j.jphotochemrev.2004.10.003
   Hasegawa Y, 2003, J LUMIN, V101, P235, DOI 10.1016/S0022-2313(02)00440-4
   He HS, 2004, EUR J INORG CHEM, P837, DOI 10.1002/ejic.200300511
   Hebbink GA, 2003, J PHYS CHEM A, V107, P2483, DOI 10.1021/jp0260090
   Heer S, 2003, J LUMIN, V102, P144, DOI 10.1016/S0022-2313(02)00490-8
   Hemmila I, 2001, CRIT REV CL LAB SCI, V38, P441, DOI 10.1080/20014091084254
   HEMMILA I, 1995, BIOANALYTICAL APPL
   Hufner S., 1978, OPTICAL SPECTRA TRAN
   HURSKAINEN P, 1995, J ALLOY COMPD, V225, P489, DOI 10.1016/0925-8388(94)07055-5
   Imbert D, 2005, CHEM COMMUN, P1432, DOI 10.1039/b416575f
   Imbert D, 2003, J AM CHEM SOC, V125, P15698, DOI 10.1021/ja0386501
   IZATT RM, 1985, CHEM REV, V85, P271, DOI 10.1021/cr00068a003
   IZATT RM, 1991, CHEM REV, V91, P1721, DOI 10.1021/cr00008a003
   Jensen MP, 2003, J AM CHEM SOC, V125, P15466, DOI 10.1021/ja037577b
   Justel T, 1998, ANGEW CHEM INT EDIT, V37, P3085, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3084::AID-ANIE3084>3.0.CO;2-W
   Kaltsoyannis N., 1999, F ELEMENTS
   Kang TS, 2003, ADV FUNCT MATER, V13, P205, DOI 10.1002/adfm.200390031
   Kido J, 2002, CHEM REV, V102, P2357, DOI 10.1021/cr010448y
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   KLEINERMAN M, 1968, J CHEM PHYS, V49, P3901, DOI 10.1063/1.1670698
   Klink SI, 2000, ANGEW CHEM INT EDIT, V39, P4319, DOI 10.1002/1521-3773(20001201)39:23<4319::AID-ANIE4319>3.0.CO;2-X
   Klink SI, 2002, SYNTHETIC MET, V127, P213, DOI 10.1016/S0379-6779(01)00625-7
   Kojima T., 1999, PHOSPHOR HDB, P623
   Korovin Y, 2001, REV INORG CHEM, V21, P299
   Lakowicz JR, 2001, CHEMPHYSCHEM, V2, P247, DOI 10.1002/1439-7641(20010417)2:4<247::AID-CPHC247>3.0.CO;2-G
   Latva M, 1997, J LUMIN, V75, P149, DOI 10.1016/S0022-2313(97)00113-0
   Lehn J.-M, 1995, SUPRAMOLECULAR CHEM
   Li C, 2002, CHEM COMMUN, P2034, DOI 10.1039/b206561b
   Lincoln SF, 2005, HELV CHIM ACTA, V88, P523, DOI 10.1002/hlca.200590036
   Liu S, 2004, CHEM SOC REV, V33, P445, DOI 10.1039/b309961j
   Lowe MP, 2000, CHEM COMMUN, P707, DOI 10.1039/b001629m
   Lukes I, 2001, COORDIN CHEM REV, V216, P287, DOI 10.1016/S0010-8545(01)00336-8
   Manning HC, 2004, BIOCONJUGATE CHEM, V15, P1488, DOI 10.1021/bc049904q
   MATHIS G, 1995, CLIN CHEM, V41, P1391
   Matsumoto K., 2003, MET IONS BIOL SYST, V40
   Maupin CL, 1998, J AM CHEM SOC, V120, P10563, DOI 10.1021/ja982147k
   MELHUISH WH, 1984, PURE APPL CHEM, V56, P231, DOI 10.1351/pac198456020231
   MENZEL ER, 1989, ANAL CHEM, V61, pA557, DOI 10.1021/ac00183a003
   Merbach A, 2001, CHEM CONTRAST AGENT
   Meskers SCJ, 2001, J PHYS CHEM A, V105, P4589, DOI 10.1021/jp004428w
   Mortellaro MA, 1996, J AM CHEM SOC, V118, P7414, DOI 10.1021/ja961323r
   Motson GR, 2001, J CHEM SOC DALTON, P1389, DOI 10.1039/b102295b
   MOUTIERS G, 2004, 6712 AF
   Muller G, 2002, CHEM COMMUN, P1522, DOI 10.1039/b203691f
   Muller G, 2002, EUR J INORG CHEM, P3101
   Muller G, 2001, J CHEM SOC DALTON, P2655, DOI 10.1039/b102728j
   NG DKP, 2001, HDB PHYS CHEM RARE E, V32, pCH210
   Nozary H, 1998, J AM CHEM SOC, V120, P12274, DOI 10.1021/ja982545n
   Ozawa L, 2003, CHEM REV, V103, P3835, DOI 10.1021/cr0203490
   Parac-Vogt TN, 2002, J CHEM SOC DALTON, P1602, DOI 10.1039/b109334g
   Parker D, 2000, COORDIN CHEM REV, V205, P109, DOI 10.1016/S0010-8545(00)00241-1
   Parker D, 2004, CHEM SOC REV, V33, P156, DOI 10.1039/b311001j
   Parker David, 2003, Met Ions Biol Syst, V40, P233
   Petoud S, 1999, J LUMIN, V82, P69, DOI 10.1016/S0022-2313(99)00015-0
   Petoud S, 2003, J AM CHEM SOC, V125, P13324, DOI 10.1021/ja0379363
   PIECHOCKI C, 1985, CHEM PHYS LETT, V122, P124, DOI 10.1016/0009-2614(85)85490-7
   Piguet C, 2005, COORDIN CHEM REV, V249, P705, DOI 10.1016/j.ccr.2004.08.023
   Piguet C, 1999, CHEM SOC REV, V28, P347, DOI 10.1039/a804240c
   Piguet C, 1997, J CHEM SOC DALTON, P421, DOI 10.1039/a605986d
   Piguet C, 2000, J CHEM SOC DALTON, P3999, DOI 10.1039/b003521l
   Piszczek G, 2001, J FLUORESC, V11, P101, DOI 10.1023/A:1016673300913
   Poole RA, 2005, ORG BIOMOL CHEM, V3, P1013, DOI 10.1039/b418964g
   Pope SJA, 2004, J AM CHEM SOC, V126, P9490, DOI 10.1021/ja047523h
   Pope SJA, 2004, CHEM COMMUN, P1550, DOI 10.1039/b402270j
   Pope SJA, 2003, DALTON T, P3780, DOI 10.1039/b309115e
   Pope SJA, 2003, CHEM COMMUN, P1550, DOI 10.1039/b303012a
   Reany O, 2000, J CHEM SOC PERK T 2, P1819, DOI 10.1039/b003963m
   Renaud F, 1999, J AM CHEM SOC, V121, P9326, DOI 10.1021/ja990898w
   RICHARDSON FS, 1991, J PHYS CHEM-US, V95, P6249, DOI 10.1021/j100169a036
   RICHARDSON FS, 1982, CHEM REV, V82, P541, DOI 10.1021/cr00051a004
   Riehl JP, 2005, HANDB PHYSI, V34, P289
   RIEHL JP, 1986, CHEM REV, V86, P1, DOI 10.1021/cr00071a001
   RIEHL JP, 2000, ENCY SPECTROSCOPY SP, P243
   Rodriguez-Cortinas R, 2002, INORG CHEM, V41, P5336, DOI 10.1021/ic025587s
   ROUNDHILL DM, 1995, PROG INORG CHEM, V43, P533, DOI 10.1002/9780470166444.ch6
   Sakamoto M, 2001, COORDIN CHEM REV, V219, P379, DOI 10.1016/S0010-8545(01)00341-1
   Sanada T, 1998, INORG CHEM, V37, P4712, DOI 10.1021/ic971568k
   Sastri V. R, 2003, MODERN ASPECTS RARE
   SELTZER MD, 1995, J CHEM EDUC, V72, P886, DOI 10.1021/ed072p886
   Shavaleev NM, 2003, CHEM COMMUN, P1134, DOI 10.1039/b301878d
   Shavaleev NM, 2005, INORG CHEM, V44, P61, DOI 10.1021/ic048875s
   Shavaleev NM, 2003, CHEM-EUR J, V9, P5283, DOI 10.1002/chem.200305132
   Shavaleev NM, 2002, J CHEM SOC DALTON, P3925, DOI 10.1039/b207832e
   Shen YR, 2000, PHYS REV B, V61, P11460, DOI 10.1103/PhysRevB.61.11460
   Shionoya S., 1999, PHOSPHOR HDB
   Silva FRGE, 2002, J PHYS CHEM A, V106, P1670, DOI 10.1021/jp012884u
   Silva FRGE, 2000, PHYS CHEM CHEM PHYS, V2, P5400
   Stang PJ, 1997, ACCOUNTS CHEM RES, V30, P502, DOI 10.1021/ar9602011
   Stouwdam JW, 2003, CHEM MATER, V15, P4604, DOI 10.1021/cm034495d
   Strohhofer C, 2003, OPT MATER, V21, P705, DOI 10.1016/S0925-3467(02)00056-3
   Suarez S, 2005, NEW J CHEM, V29, P1323, DOI 10.1039/b503591k
   Suarez S, 2004, CHEM MATER, V16, P3257, DOI [10.1021/cm049754t, 10.1021/cm.049754t]
   Suarez S, 2003, CHEM COMMUN, P1226, DOI 10.1039/b302438e
   Subhan MA, 2003, J LUMIN, V101, P307, DOI 10.1016/S0022-2313(02)00573-2
   Subhan MA, 2002, J CHEM SOC DALTON, P1416, DOI 10.1039/b108770c
   Subhan MA, 2001, J CHEM SOC DALTON, P492, DOI 10.1039/b007369p
   Supkowski RM, 2002, INORG CHIM ACTA, V340, P44, DOI 10.1016/S0020-1693(02)01022-8
   Telfer SG, 2004, INORG CHEM, V43, P5302, DOI 10.1021/ic049540d
   Terazzi E, 2005, J AM CHEM SOC, V127, P888, DOI 10.1021/ja0446101
   TORELLI S, 2005, CHEM-EUR J, V11, P3238
   Tsukube H, 2002, CHEM REV, V102, P2389, DOI 10.1021/cr010450p
   Tsukube H, 2002, COORDIN CHEM REV, V226, P227, DOI 10.1016/S0010-8545(01)00450-7
   Urbain G, 1909, ANN CHIM PHYS, V18, P222
   Van Deun R, 2004, INORG CHEM, V43, P8461, DOI 10.1021/ic048736a
   Van Deun R, 2003, PHYS CHEM CHEM PHYS, V5, P2754, DOI 10.1039/b304491b
   Van Deun R, 2003, J MATER CHEM, V13, P1520, DOI 10.1039/b305158g
   Vereb G, 1998, BIOPHYS J, V74, P2210, DOI 10.1016/S0006-3495(98)77930-5
   Vigato PA, 2004, COORDIN CHEM REV, V248, P1717, DOI 10.1016/j.cct.2003.09.003
   Visser AE, 2003, J SOLID STATE CHEM, V171, P109, DOI 10.1016/S0022-4596(02)00193-7
   Voloshin AI, 2001, J LUMIN, V93, P199, DOI 10.1016/S0022-2313(01)00194-6
   Wang HS, 2004, J PHYS CHEM B, V108, P8084, DOI 10.1021/jp049886
   Wasserscheid P., 2005, IONIC LIQUIDS SYNTHE
   Wegh RT, 1999, SCIENCE, V283, P663, DOI 10.1126/science.283.5402.663
   Weibel N, 2004, J AM CHEM SOC, V126, P4888, DOI 10.1021/ja031886k
   Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684
   Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t
   Werts MHV, 2002, PHYS CHEM CHEM PHYS, V4, P1542, DOI 10.1039/b107770h
   Williams DB, 2005, CHEM COMMUN, P1438, DOI 10.1039/b416830e
   XU YY, 1992, TALANTA, V39, P759, DOI 10.1016/0039-9140(92)80091-Q
   Yam VWW, 1999, COORDIN CHEM REV, V184, P157, DOI 10.1016/S0010-8545(98)00262-8
   Yamada T, 2003, INORG CHEM, V42, P7932, DOI 10.1021/ic020726r
   YU LJ, 1977, APPL PHYS LETT, V31, P719, DOI 10.1063/1.89528
   Yuan JL, 1997, ANAL BIOCHEM, V254, P283, DOI 10.1006/abio.1997.2444
   Zijlmans HJMAA, 1999, ANAL BIOCHEM, V267, P30, DOI 10.1006/abio.1998.2965
NR 210
TC 2191
Z9 2211
U1 56
U2 848
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2005
VL 34
IS 12
BP 1048
EP 1077
DI 10.1039/b406082m
PG 30
WC Chemistry, Multidisciplinary
SC Chemistry
GA 983SP
UT WOS:000233252700006
PM 16284671
DA 2018-10-20
ER

PT J
AU Mitsuishi, M
   Warisawa, S
   Sugita, N
   Suzuki, M
   Moriya, H
   Hashizume, H
   Fujiwara, K
   Abe, N
   Inoue, H
   Kuramoto, K
   Inoue, T
   Nakashima, Y
   Tanimoto, K
AF Mitsuishi, M
   Warisawa, S
   Sugita, N
   Suzuki, M
   Moriya, H
   Hashizume, H
   Fujiwara, K
   Abe, N
   Inoue, H
   Kuramoto, K
   Inoue, T
   Nakashima, Y
   Tanimoto, K
TI A study of bone micro-cutting characteristics using a newly developed
   advanced bone cutting machine tool for total knee arthroplasty
SO CIRP ANNALS-MANUFACTURING TECHNOLOGY
LA English
DT Article
DE biomedical material cutting; machine tool; cutting force analysis
AB Bone cutting experiments were conducted on a cadaver using a newly developed machine tool. The effectiveness of the system was evaluated by comparing the planned shape for the mating surface between the femur and an artificial joint with the cutting result. It is desirable to know the machining phenomena and characteristics at the microscale because the material and the tissue structure are anisotropic in both cortical and cancellous bones. In the paper, the influence of the material characteristics on machining is discussed for cortical bone. Pig cortical bone was used in the experiment for visualizing 2-dimensional micro-cutting.
C1 Univ Tokyo, Sch Engn, Dept Engn Synthesis, Tokyo, Japan.
   Chiba Univ, Grad Sch Med, Chiba, Japan.
   Okayama Univ, Grad Sch Med & Dent, Okayama, Japan.
   Okayama Univ, Grad Sch Med & Dent, Okayama, Japan.
   Nakashima Propeller Co Ltd, Okayama, Japan.
   CORETEC Inc, Okayama, Japan.
RP Mitsuishi, M (reprint author), Univ Tokyo, Sch Engn, Dept Engn Synthesis, Tokyo, Japan.
CR BERNARD A, 2002, ANN CIRP, V51, P635
   BURGER T, 2001, ANN CIRP, V50, P295
   Cowin SC., 2000, BONE MECH HDB
   ITOH S, 1983, B JSME, V26, P2295
   Mak TW, 2004, CIRP ANN-MANUF TECHN, V53, P117, DOI 10.1016/S0007-8506(07)60658-1
   Mitsuishi M, 2004, CIRP ANN-MANUF TECHN, V53, P107, DOI 10.1016/S0007-8506(07)60656-8
   MITSUISHI M, 2003, ANN CIRP, V52, P323
   NAODA Y, 2004, CIRP ICME 04, P461
   SHU LH, 2003, ANN CIRP, V52, P101
   Ueda K, 2000, ANN CIRP, V49, P343
   Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8
NR 11
TC 18
Z9 18
U1 0
U2 6
PU TECHNISCHE RUNDSCHAU EDITION COLIBRI LTD
PI BERN
PA NORDRING 4, CH-3001 BERN, SWITZERLAND
J9 CIRP ANN-MANUF TECHN
JI CIRP Ann-Manuf. Technol.
PY 2005
VL 54
IS 1
BP 41
EP 46
DI 10.1016/S0007-8506(07)60045-6
PG 6
WC Engineering, Industrial; Engineering, Manufacturing
SC Engineering
GA 942ZS
UT WOS:000230322000010
DA 2018-10-20
ER

PT J
AU Lendlein, A
   Kelch, S
AF Lendlein, A
   Kelch, S
TI Shape-memory polymers as stimuli-sensitive implant materials
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE biodegradable shape-memory polymers; polymer systems; stimuli-sensitive
   implant materials; smart suture
ID OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; BIOMEDICAL APPLICATIONS; IN-VITRO;
   ANGIOGENESIS; NETWORKS; STERILIZATION
AB Shape-memory polymers are stimuli-responsive materials. Upon exposure to an external stimulus, e.g. an increase in temperature, they have the capability of changing their shape. The shape-memory effect results from the polymer's structure and morphology in combination with a certain processing and programming technology. Stimuli-sensitive implant materials have a high potential for applications in minimally invasive surgery. A group of biodegradable implant materials with shape-memory has been developed for applications in biomedicine. These implant materials are not a single polymer but polymer systems that allow the variation of different macroscopic properties over a wide range by only small changes in the chemical structure. In this way, it is possible to implement a variety of different applications with tailor-made polymers of the same family. Two different types of degradable shape-memory polymer systems, covalently cross-linked polymer networks and thermoplastic elastomers, are presented and examples are given for each case.
C1 GKSS Res Ctr Geesthacht GmbH, Inst Chem, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Res Ctr Geesthacht GmbH, Inst Chem, Kantstr 55, D-14513 Teltow, Germany.
EM lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   BRONZINO J, 1995, BIOMEDICAL ENG HDB
   Hall H, 2001, MICROVASC RES, V62, P315, DOI 10.1006/mvre.2001.2348
   LAURENCIN CT, 1995, BIOMEDICAL APPL SYNT
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   LENDLEIN A, 2002, ENCY POLYM SCI TECHN
   LIPSCOMB P, 1996, APPL SHAPE MEMORY AL
   MAK AFT, 1998, HDB BIOMATERIAL PROP
   Mikos A.G, 2000, ELECT J BIOTECHNOLOG, V3
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Rickert D, 2002, BIOMED TECH, V47, P285, DOI 10.1515/bmte.2002.47.11.285
   SHALABY SW, 1994, BIOMEDICAL POLYM
   Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970
   Suzuki Y, 1998, SHAPE MEMORY MAT
   THOMSON RC, 1997, PRINCIPLES TISSUE EN
   Tobushi H, 1996, J PHYS IV, V6, P377, DOI 10.1051/jp4:1996136
NR 20
TC 106
Z9 108
U1 1
U2 40
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2005
VL 32
IS 2
BP 105
EP 116
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 912UH
UT WOS:000228104900004
PM 15764819
DA 2018-10-20
ER

PT J
AU Groth, T
   Seifert, B
   Albrecht, W
   Malsch, G
   Gross, U
   Fey-Lamprecht, F
   Michanetzis, G
   Missirlis, Y
   Engbers, G
AF Groth, T
   Seifert, B
   Albrecht, W
   Malsch, G
   Gross, U
   Fey-Lamprecht, F
   Michanetzis, G
   Missirlis, Y
   Engbers, G
TI Development of polymer membranes with improved haemocompatibility for
   biohybrid organ technology
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE bioartificial organs; haemocompatibility; kidney epithelial cells;
   polymer membranes
ID ARTIFICIAL LIVER SUPPORT; BIOARTIFICIAL LIVER; DIALYSIS; SYSTEM; KIDNEY;
   BLOOD; IMMOBILIZATION; BIOMATERIALS; POLYLACTIDE; ACTIVATION
AB Biomedical technology has opened up possibilities of treating the failure of internal organs like kidney and liver by artificial organ therapy. Most of these techniques are based on polymer membranes, which allow the removal of excess of water, salts and toxins from the circulation. However, haemodialysis for the replacement of kidney function results in an increased morbidity and mortality of patients after long-term application. Conventional therapy, such as haemofiltration for the treatment of acute liver failure does not improve significantly the survival rate of patients. Biohybrid organ support as a combination of the artificial organ therapy with the functional activity of immobilised cells seems to be a solution of the problem. Membranes applied in these devices have to face both tissue cells and blood. Organ cells in biohybrid organs have to make intimate contact with the surface of membrane but must also develop close cell-cell-connections as a prerequisite for their survival and high functional activity. Blood to be detoxified will contact the other side of membrane and may not become activated by the synthetic material. New polymer membranes based on acrylonitrile were developed to address these requirements by tailoring the composition of copolymers and to be applied in a specific hollow fibre bioreactor with an outer fibre for blood contact, and an inner fibre for tissue contact or vice versa.
C1 GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Teltow, Germany.
   Free Univ Berlin, Inst Pathol, D-1000 Berlin, Germany.
   Univ Patras, Biomed Engn Lab, GR-26110 Patras, Greece.
   Holland Biomat Grp BV, Enschede, Netherlands.
RP Groth, T (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Teltow, Germany.
RI Seifert, Barbara/K-7569-2012
OI Groth, Thomas/0000-0001-6647-9657
CR ARNAOUT WS, 1990, J SURG RES, V48, P379, DOI 10.1016/0022-4804(90)90079-H
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   DESCAMPSLATSCHA B, 1993, KIDNEY INT, V43, pS135
   DIXIT V, 1994, ARTIF ORGANS, V18, P371, DOI 10.1111/j.1525-1594.1994.tb02219.x
   Fey-Lamprecht F, 2003, J BIOMED MATER RES A, V65A, P144, DOI 10.1002/jbm.a.10328
   FLENDRIG LM, 1997, ARTIF ORGANS, V16, P209
   Franke RP, 2001, CLIN HEMORHEOL MICRO, V24, P101
   FROMM M, 1997, PHYSL MENSCHEN, P719
   GEJYO F, 1993, KIDNEY INT S, V41, P78
   GERLACH J, 1994, INT J ARTIF ORGANS, V17, P549
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   HUBBELL JA, 1995, CHEM ENG NEWS, V13, P42
   Humes HD, 1999, NAT BIOTECHNOL, V17, P451, DOI 10.1038/8626
   IMAI Y, 1983, J BIOMED MATER RES, V17, P905, DOI 10.1002/jbm.820170602
   IP TK, 1989, ARTIF ORGANS, V13, P58, DOI 10.1111/j.1525-1594.1989.tb02833.x
   Jauregui HO, 1996, CELL TRANSPLANT, V5, P353, DOI 10.1016/0963-6897(95)02020-9
   Jung F, 2003, CLIN HEMORHEOL MICRO, V28, P189
   KAZATCHKINE MD, 1982, PROG ALLERGY, V30, P193
   KHAN IH, 1993, KIDNEY INT, V43, pS143
   KLINKMANN H, 1995, NEPHROL DIAL TRANSPL, V10, P39, DOI 10.1093/ndt/10.supp3.39
   KOLFF WJ, 1943, NED TIJDSCHR GENEES, V87, P1684
   Legallais C, 2001, J MEMBRANE SCI, V181, P81, DOI 10.1016/S0376-7388(00)00539-1
   Lins RL, 2000, CLIN NEPHROL, V53, P10
   LODISH H, 1995, MOL CELL BIOL, P623
   Mege JL, 1996, AM J KIDNEY DIS, V28, P395, DOI 10.1016/S0272-6386(96)90497-7
   Nikolovski J, 1999, CELL TRANSPLANT, V8, P351, DOI 10.1177/096368979900800403
   Qiang S, 1997, INT J ARTIF ORGANS, V20, P119
   RHODES NP, 1994, BIOMATERIALS, V15, P35, DOI 10.1016/0142-9612(94)90194-5
   RHODES NP, 1997, CELLULAR ENG, V2, P1
   Sanaka T, 1989, ASAIO Trans, V35, P527, DOI 10.1097/00002480-198907000-00114
   SCHMIDT B, 1995, CONTRIB NEPHROL, V113, P32
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   SEIFERT B, 1995, J BIOMAT SCI-POLYM E, V7, P277, DOI 10.1163/156856295X00319
   STUART J, 1986, CLIN HEMORHEOL, V6, P439
   SUSSMAN NL, 1993, BLOOD PURIFICAT, V11, P170, DOI 10.1159/000170114
   USSING HH, 1951, ACTA PHYSIOL SCAND, V23, P110, DOI 10.1111/j.1748-1716.1951.tb00800.x
   VONSENGBUSCH G, 1993, ARTIF ORGANS, V17, P244
   Ward R. A., 1988, T AM SOC ART INT ORG, V34, P334
   Yasutomi M, 2001, LIVER TRANSPLANT, V7, P38, DOI 10.1053/jlts.2001.18482
NR 39
TC 8
Z9 8
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2005
VL 32
IS 2
BP 129
EP 143
PG 15
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 912UH
UT WOS:000228104900006
PM 15764821
DA 2018-10-20
ER

PT J
AU MacLeod, AM
   Campbell, M
   Cody, JD
   Daly, C
   Donaldson, C
   Grant, A
   Khan, I
   Rabindranath, KS
   Vale, L
   Wallace, S
AF MacLeod, AM
   Campbell, M
   Cody, JD
   Daly, C
   Donaldson, C
   Grant, A
   Khan, I
   Rabindranath, KS
   Vale, L
   Wallace, S
TI Cellulose, modified cellulose and synthetic membranes in the
   haemodialysis of patients with end-stage renal disease
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID HIGH-FLUX DIALYSIS; BLOOD MONONUCLEAR-CELLS; C-REACTIVE PROTEIN;
   OXIDATIVE STRESS; DIALYZER MEMBRANE; BICARBONATE HEMODIALYSIS;
   BIOCOMPATIBLE MEMBRANE; NUTRITIONAL PARAMETERS; COMPLEMENT ACTIVATION;
   PLATELET ACTIVATION
AB Background When the kidney fails the blood-borne metabolites of protein breakdown and water cannot be excreted. The principle of haemodialysis is that such substances can be removed when blood is passed over a semipermeable membrane. Natural membrane materials include cellulose or modified cellulose, more recently various synthetic membranes have been developed. Synthetic membranes are regarded as being more "biocompatible" in that they incite less of an immune response than cellulose-based membranes.
   Objectives To assess the effects of different haemodialysis membrane material in patients with end-stage renal disease (ESRD).
   Search strategy We searched MEDLINE, EMBASE, PreMEDLINE, HealthStar CINAHL, the Cochrane Central Register of Controlled Trials (CENTRAL), Biosis, SIGLE, CRIB, UK National Research Register and reference lists of relevant articles. We contacted biomedical companies, known investigators and handsearched selected journals and conference proceedings. Date of most recent search: June 2004.
   Selection criteria All randomised controlled trials (RCTs) or quasi-RCTs comparing different haemodialysis membrane material in patients with ESRD.
   Data collection and analysis Two reviewers independently assessed the methodological quality of studies. Data was abstracted onto a standard form by one reviewer and checked by another. Relative Risk (RR) and weighted mean difference (WMD) with 95% confidence intervals (CI))
   Main results Thirty two studies were identified. Pre-dialysis beta(2) microglobulin concentrations were not significantly lower in patients treated with synthetic membranes (WMD-14.67, 95% CI-33.10 to 4.05). When analysed for change in beta(2) microglobulin, a fall was only noted with high-flux membranes. The incidence of amyloid was less in patients who were dialysed for six years with high-flux synthetic membranes (one study, RR 0.03, 95% CI 0.00 to 0.54). There was a significant difference in favour of the synthetic (high-flux) membrane in comparison to cellulose membranes for triglycerides (WMD- 0.66;95% CI-1.18 to -0.14) but not for modified cellulose membranes. Dialysis adequacy measured by Kt/V was marginally higher when cellulose membranes were used (WMD- 0.10;95% CI-0.16 to 0.04), whereas synthetic membranes achieved significantly higher Kt/V values when compared with modified cellulose membranes (WMD 0.20, 95% 0.11 to 0.29). There were no data on quality of life measures.
   Authors' conclusions We found no evidence of benefit when synthetic membranes were compared with cellulose/modified cellulose membranes in terms of reduced mortality no reduction in dialysis-related adverse symptoms. Despite the relatively large number of RCTs undertaken in this area none of the included studies reported any measures of quality of life.
C1 Univ Aberdeen, Aberdeen AB25 2ZD, Scotland.
RP MacLeod, AM (reprint author), Univ Aberdeen, Polwarth Bldg, Aberdeen AB25 2ZD, Scotland.
EM mmd175@abdn.ac.uk
RI Wallace, Sheila/A-6921-2018
OI Wallace, Sheila/0000-0003-2853-3653
CR AAKHUS S, 1995, BLOOD PURIFICAT, V13, P229, DOI 10.1159/000170206
   AKIZAWA T, 1986, T AM SOC ART INT ORG, V32, P76
   ALMADANI HA, 2000, MED SCI RES, V28, P23
   BAURMEISTER U, 1989, ARTIF ORGANS, V13, P52, DOI 10.1111/j.1525-1594.1989.tb02832.x
   BERGAMO, 1991, KIDNEY INT, V40, P714
   Biasioli S, 2000, ASAIO J, V46, P625, DOI 10.1097/00002480-200009000-00023
   BLANKESTIJN PJ, 1995, J AM SOC NEPHROL, V5, P1703
   Bonomini M, 1996, INT J ARTIF ORGANS, V19, P232
   CARAMELO C, 1994, NEPHROL DIAL TRANSPL, V9, P675, DOI 10.1093/ndt/9.6.675
   CHEUNG AK, 1990, J AM SOC NEPHROL, V1, P150
   CHURCHILL DN, 1993, NEPHRON, V65, P573, DOI 10.1159/000187566
   CHURCHILL DN, 1995, NEPHROLOGY DIALYSI S, V9, P52
   Clermont G, 2001, FREE RADICAL BIO MED, V31, P233, DOI 10.1016/S0891-5849(01)00577-9
   COLLINS DM, 1993, J AM SOC NEPHROL, V4, P148
   COMBE C, 1994, AM J KIDNEY DIS, V24, P437, DOI 10.1016/S0272-6386(12)80900-0
   Coyne DW, 1998, AM J KIDNEY DIS, V32, P1031, DOI 10.1016/S0272-6386(98)70079-4
   DANIELSON B G, 1986, Blood Purification, V4, P147, DOI 10.1159/000169438
   DAUGIRDAS JT, 1994, NEPHROL DIAL TRANSPL, V9, P145
   DAUGIRDAS JT, 2001, HDB DIALYSIS, P46
   De Broe M E, 1986, Blood Purif, V4, P168, DOI 10.1159/000169441
   De Vriese AS, 2003, NEPHROL DIAL TRANSPL, V18, P2596, DOI 10.1093/ndt/gfg437
   Depner T, 1999, AM J KIDNEY DIS, V33, P142, DOI 10.1016/S0272-6386(99)70272-6
   Dungen HD, 2001, INT J ARTIF ORGANS, V24, P357
   Eiselt J, 2001, ARTIF ORGANS, V25, P430, DOI 10.1046/j.1525-1594.2001.025006430.x
   Ferreira A, 2001, NEPHROL DIAL TRANSPL, V16, P1230, DOI 10.1093/ndt/16.6.1230
   Fourtounas C, 2001, NEPHROL DIAL TRANSPL, V16, P1077, DOI 10.1093/ndt/16.5.1077
   GARDINALI M, 1994, INT J ARTIF ORGANS, V17, P337
   Girndt M, 2000, AM J KIDNEY DIS, V35, P95, DOI 10.1016/S0272-6386(00)70307-6
   Goldberg IJ, 1996, NEPHROL DIAL TRANSPL, V11, P104
   Grooteman M P, 1995, ASAIO J, V41, P215
   Gutzwiller JP, 2002, NEPHROL DIAL TRANSPL, V17, P1037, DOI 10.1093/ndt/17.6.1037
   Hakim RM, 1996, J AM SOC NEPHROL, V7, P472
   Hartmann J, 1997, AM J KIDNEY DIS, V30, P366, DOI 10.1016/S0272-6386(97)90281-X
   HAUFE CC, 2001, KIDNEY INT S, V78, P177
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HIMMELFARB J, 1993, J AM SOC NEPHROL, V4, P178
   Hoenich NA, 1997, CLIN NEPHROL, V48, P253
   Hoenich NA, 2000, AM J KIDNEY DIS, V36, P345, DOI 10.1053/ajkd.2000.8985
   HOSOKAWA S, 1991, International Urology and Nephrology, V23, P281, DOI 10.1007/BF02550425
   IVANOVICH P, 1993, NEPHROL DIAL TRANSPL, V8, P15, DOI 10.1093/ndt/8.supp2.15
   Kato A, 2001, ARTIF ORGANS, V25, P441, DOI 10.1046/j.1525-1594.2001.025006441.x
   KISHIMOTO T, 1993, NEPHROL DIAL TRANSPL, V8, P25, DOI 10.1093/ndt/8.supp2.25
   Kobayashi S, 2003, KIDNEY INT, V63, P1881, DOI 10.1046/j.1523-1755.2003.00920.x
   KRAMER BK, 1992, INT J ARTIF ORGANS, V15, P408
   Kuragano T, 2003, BLOOD PURIFICAT, V21, P176, DOI 10.1159/000069157
   Lang SM, 2001, PERITON DIALYSIS INT, V21, P52
   Lesaffer G, 2000, NEPHROL DIAL TRANSPL, V15, P50, DOI 10.1093/ndt/15.1.50
   LEVIN N, 1993, NEPHROL DIAL TRANSPL, V8, P2, DOI 10.1093/ndt/8.supp2.2
   LEVIN NW, 1993, NEPHROL DIAL TRANSPL, V8, P30, DOI 10.1093/ndt/8.supp2.30
   LINENWEBER S, 2001, KIDNEY INT S, V78, P282
   Locatelli F, 1996, KIDNEY INT, V50, P1293, DOI 10.1038/ki.1996.441
   Locatelli F., 1996, Journal of the American Society of Nephrology, V7, P1454
   Locatelli F, 2000, NEPHROL DIAL TRANSPL, V15, P1399, DOI 10.1093/ndt/15.9.1399
   MacLeod A, 1998, Health Technol Assess, V2, P1
   Matos JPS, 2000, AM J KIDNEY DIS, V35, P839, DOI 10.1016/S0272-6386(00)70253-8
   Memoli B, 2002, AM J KIDNEY DIS, V39, P266, DOI 10.1053/ajkd.2002.30545
   Memoli B, 2000, KIDNEY INT, V58, P417, DOI 10.1046/j.1523-1755.2000.00181.x
   MOLL S, 1990, INT J ARTIF ORGANS, V13, P273
   Munger MA, 2000, AM J KIDNEY DIS, V36, P130, DOI 10.1053/ajkd.2000.8285
   Navarro J, 1992, ASAIO J, V38, P811, DOI 10.1097/00002480-199210000-00013
   Ohi H, 2001, AM J KIDNEY DIS, V38, P384, DOI 10.1053/ajkd.2001.26106
   OPATRNY K, 1993, ARTIF ORGANS, V17, P971, DOI 10.1111/j.1525-1594.1993.tb03178.x
   Opatrny K, 1998, ARTIF ORGANS, V22, P816, DOI 10.1046/j.1525-1594.1998.06107.x
   Ottosson P, 2001, ASAIO J, V47, P229, DOI 10.1097/00002480-200105000-00014
   Parker TF, 1996, KIDNEY INT, V49, P551, DOI 10.1038/ki.1996.78
   Pertosa G, 2002, KIDNEY INT, V62, P602, DOI 10.1046/j.1523-1755.2002.00458.x
   QUEREDA C, 1988, INT J ARTIF ORGANS, V11, P259
   RABINDRANATH KS, 2004, COCHRANE DATABASE SY, V4
   RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311
   Rao M, 2004, KIDNEY INT, V65, P682, DOI 10.1111/j.1523-1755.2004.00429.x
   Richardson D, 2003, AM J KIDNEY DIS, V42, P551, DOI 10.1016/S0272-6386(03)00788-1
   SANAKA T, 1995, NEPHROL DIAL TRANSPL, V10, P34, DOI 10.1093/ndt/10.supp3.34
   SCHAEFER RM, 1993, AM J NEPHROL, V13, P473, DOI 10.1159/000168666
   SCHAEFER RM, 1994, CLIN NEPHROL S1, V42, P21
   SCHIFFL H, 1995, CONTRIB NEPHROL, V112, P156
   SCHMITT GW, 1987, AM J MED, V83, P411, DOI 10.1016/0002-9343(87)90749-2
   Schouten WEM, 2000, NEPHROL DIAL TRANSPL, V15, P379, DOI 10.1093/ndt/15.3.379
   Sklar AH, 1998, AM J KIDNEY DIS, V31, P1007, DOI 10.1053/ajkd.1998.v31.pm9631846
   SKROEDER NR, 1994, INT J ARTIF ORGANS, V17, P521
   SKROEDER NR, 1995, AM J KIDNEY DIS, V25, P896, DOI 10.1016/0272-6386(95)90572-3
   SKROEDER NR, 1993, AM J KIDNEY DIS, V21, P519, DOI 10.1016/S0272-6386(12)80398-2
   SKTOEDER NR, 1994, ARTIF ORGANS, V18, P880
   STRASSER T, 1991, KLIN WOCHENSCHR, V69, P808, DOI 10.1007/BF01744274
   STUARD S, 1995, KIDNEY INT, V48, P93, DOI 10.1038/ki.1995.272
   Tayeb JS, 2000, AM J KIDNEY DIS, V35, P606, DOI 10.1016/S0272-6386(00)70005-9
   THYLEN P, 1992, AM J NEPHROL, V12, P393, DOI 10.1159/000168488
   Todeschini M, 2002, AM J KIDNEY DIS, V40, P783, DOI 10.1053/ajkd.2002.35690
   TRIDON A, 1987, NEPHROLOGIE, V8, P217
   Tsuruoka S, 2002, AM J KIDNEY DIS, V39, P127, DOI 10.1053/ajkd.2002.29901
   Usberti M, 2002, AM J KIDNEY DIS, V40, P590, DOI 10.1053/ajkd.2002.34919
   van Tellingen A, 2002, KIDNEY INT, V62, P632, DOI 10.1046/j.1523-1755.2002.00470.x
   van Tellingen A, 2004, NEPHROL DIAL TRANSPL, V19, P1198, DOI 10.1093/ndt.gfh122
   VANHOLDER R, 1991, KIDNEY INT, V39, P320, DOI 10.1038/ki.1991.40
   VANHOLDER R, 1992, INT J ARTIF ORGANS, V15, P89
   Varela MP, 2001, BLOOD PURIFICAT, V19, P370, DOI 10.1159/000046967
   VERBEELEN D, 1991, NEPHRON, V59, P567, DOI 10.1159/000186645
   Ward RA, 1997, NEPHROL DIAL TRANSPL, V12, P965, DOI 10.1093/ndt/12.5.965
   WARD RA, 1993, NEPHROL DIAL TRANSPL, V8, P47, DOI 10.1093/oxfordjournals.ndt.a092271
   WEHLE B, 1993, NEPHROL DIAL TRANSPL, V8, P20, DOI 10.1093/ndt/8.supp2.20
NR 99
TC 2
Z9 2
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2005
IS 3
AR CD003234.pub2
DI 10.1002/14651858.CD003234.pub2
PG 65
WC Medicine, General & Internal
SC General & Internal Medicine
GA 968ZI
UT WOS:000232202500121
DA 2018-10-20
ER

PT S
AU Wiesauer, K
   Pircher, M
   Gotzinger, E
   Engelke, R
   Ahrens, G
   Grutzner, G
   Hitzenberger, CK
   Stifter, D
AF Wiesauer, K
   Pircher, M
   Gotzinger, E
   Engelke, R
   Ahrens, G
   Grutzner, G
   Hitzenberger, CK
   Stifter, D
BE Neev, J
   Schaffer, CB
   Ostendorf, A
   Nolte, S
TI Ultra-high resolution optical coherence tomography for material
   characterization and quality control
SO Commercial and Biomedical Applications of Ultrafast Lasers V
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
   V
CY JAN 24-27, 2005
CL San Jose, CA
SP SPIE, Spectra Psys, IMRA Amer Inc
DE transversal optical coherence tomography; non-destructive testing;
   material characterization; ultra-high resolution; acousto-optic
   modulators
ID HIGH-SPEED
AB Optical coherence tomography (OCT), so far mainly used in the biomedical field. has a high potential as non-destructive and contactless technique for material characterization and analysis. For these applications, OCT systems with ultrahigh resolution in the micrometer range and capable of high imaging speeds are required. In this work, we combine ultra-high resolution imaging using a femtosecond Ti:sapphire laser as light source with the concepts of transversal OCT. Based on acquisition by heterodyne detection via acousto-optic modulators (AOMs), and by using an xy-galvano scanner unit we are able to obtain en-face scans with sizes as large as 3 x 3 mm 2 within a few seconds. The ultra-high resolution of our OCT system of 2.95 mu m axially and 4 tm laterally, both in air, is shown to be essential for imaging of different compounds and fibre materials. We demonstrate the benefits of en-face scanning OCT for various applications in material investigation where in-plane information is of interest which can hardly be obtained by cross-sectional OCT.
C1 Upper Austrian Res GmbH, A-4020 Linz, Austria.
RP Wiesauer, K (reprint author), Upper Austrian Res GmbH, Hafenstr 47-51, A-4020 Linz, Austria.
RI Wiesauer, Karin/D-3751-2013; Stifter, David/B-5767-2016
OI Michael, Pircher/0000-0001-9285-7527
CR Bashkansky M, 1997, OPT LETT, V22, P61, DOI 10.1364/OL.22.000061
   Bouma BE, 2002, HDB OPTICAL COHERENC
   De Martino A, 2001, PROC SPIE, V4431, P38, DOI 10.1117/12.447398
   DREXLER W, 1999, OPT LETT, V24, P2112
   DUBOIS A, 2004, APPL OPTICS, V43, P2847
   Dunkers JP, 2001, OPT LASER ENG, V35, P135, DOI 10.1016/S0143-8166(01)00010-0
   FERCHER AF, 1993, AM J OPHTHALMOL, V116, P113, DOI 10.1016/S0002-9394(14)71762-3
   Hitzenberger CK, 2003, OPT EXPRESS, V11, P2753, DOI 10.1364/OE.11.002753
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   JIAN L, 2003, SPIE, V4797, P394
   Kowalevicz AM, 2002, OPT EXPRESS, V10, P349, DOI 10.1364/OE.10.000349
   PIRCHER M, 2004, J PHYS MED BIOL, V49, P1257
   Saxer CE, 2000, OPT LETT, V25, P1355, DOI 10.1364/OL.25.001355
   Stifter D, 2003, APPL PHYS A-MATER, V76, P947, DOI 10.1007/s00339-002-2065-5
   SWANSON EA, 1992, OPT LETT, V17, P152
   Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037
   UNTERHUBER A, 2003, OPT LETT, V28, P995
   Wang HW, 1999, PROC SPIE, V3598, P204, DOI 10.1117/12.347491
   WOJTKOWSKI M, 2004, OPT EXPRESS, V11, P2404
   Xie TQ, 2003, OPT EXPRESS, V11, P3210, DOI 10.1364/OE.11.003210
   YUN SH, 2003, OPT EXPRESS, V11, P3589
NR 21
TC 2
Z9 2
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5688-8
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5714
BP 108
EP 115
DI 10.1117/12.593612
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA BCH75
UT WOS:000229338100012
DA 2018-10-20
ER

PT S
AU Hagiwara, Y
   Hongo, A
   Obara, M
AF Hagiwara, Y
   Hongo, A
   Obara, M
BE Neev, J
   Schaffer, CB
   Ostendorf, A
   Nolte, S
TI Ablation processing of biomedical materials with femtosecond double
   pulse lasers through hollow fiber
SO Commercial and Biomedical Applications of Ultrafast Lasers V
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
   V
CY JAN 24-27, 2005
CL San Jose, CA
SP SPIE, Spectra Psys, IMRA Amer Inc
DE femtosecond; laser; ablation; collagen; hollow fiber; double pulses
ID TI-SAPPHIRE LASER; DELIVERY
AB We have demonstrated the ablation processing of dry-collagen with double pulsed femtosecond lasers through a bent hollow fiber. Using a 320 mu m core-diameter hollow fiber, we have delivered an ultrashort pulse with a pulse width of 200 fs (straight condition), 320 fs (bent condition), and a near Gaussian beam profile. Furthermore, a precise biomedical material processing is obtainable with a transmitted femtosecond laser beam through a bent hollow fiber. The material processing speed is increased using femtosecond double pulses and by optimizing the delay time. The optimal delay time between the double pulses is from 1 ps to 3 ps, because the ablation rate decreased due to a plasma shielding effect beyond a 5ps delay time. Our results will open up new medical endoscopic applications.
C1 Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
RP Hagiwara, Y (reprint author), Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
CR Choi TY, 2002, APPL SURF SCI, V197, P720, DOI 10.1016/S0169-4332(02)00400-2
   Clark SW, 2001, OPT LETT, V26, P1320, DOI 10.1364/OL.26.001320
   Gobel W, 2004, OPT LETT, V29, P1285, DOI 10.1364/OL.29.001285
   Juhasz T, 1999, IEEE J SEL TOP QUANT, V5, P902, DOI 10.1109/2944.796309
   KAMINO L, 2003, LEOS 2003 ANN M
   KRUEGER J, 1999, APPL PHYS A, V69, pS403
   Matsuura Y, 2002, J APPL PHYS, V91, P887, DOI 10.1063/1.1425070
   Neev J, 1996, IEEE J SEL TOP QUANT, V2, P790, DOI 10.1109/2944.577301
   Ozono K, 2003, APPL PHYS A-MATER, V77, P303, DOI 10.1007/s00339-003-2119-3
   Perry MD, 1999, J APPL PHYS, V85, P6803, DOI 10.1063/1.370197
   PREUSS S, 1993, APPL PHYS LETT, V62, P3049, DOI 10.1063/1.109135
   Semerok A, 2004, THIN SOLID FILMS, V453, P501, DOI 10.1016/j.tsf.2003.11.115
NR 12
TC 2
Z9 2
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5688-8
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5714
BP 283
EP 289
DI 10.1117/12.589972
PG 7
WC Optics; Physics, Applied
SC Optics; Physics
GA BCH75
UT WOS:000229338100031
DA 2018-10-20
ER

PT J
AU Charitidis, C
   Logothetidis, S
AF Charitidis, C
   Logothetidis, S
TI Nanoscale effects on the nanomechanical properties of multifunctional
   materials
SO COMPUTATIONAL MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT Spring Meeting of the European-Materials-Research-Society
CY MAY 24-28, 2004
CL Strasbourg, FRANCE
SP European Mat Res Soc
ID DIAMOND-LIKE CARBON; THIN-FILMS; INDENTATION EXPERIMENTS; COATINGS;
   ADHESION; BEHAVIOR; DEPOSITION; HARDNESS; LOAD
AB Nanoscale measurements of mechanical and tribological properties play an important role in many emerging fields, such as surface engineering, magnetic storage disks, biomedical coatings and microelectromechanical systems. The understanding of scale effects is of great importance, since surface to volume ratio increases with miniaturization and surface phenomena dominate. Nanoindentation and nanoscratching tests are now commonly used for the evaluation of the functionality of the film-substrate compound and it can be satisfactorily used for the multifunctional materials characterization.
   In the present study nanoscale effects on the nanomechanical properties of flexible polymeric components and multilayered amorphous carbon (a-C) films using the nanoindentation and nanoscratching techniques, are considered. In specific, (i) Creep effects in nanoscale and the dependence of the dominant friction mechanisms and surface damage mechanisms on the applied load for flexible polymeric components. Load dependent transitions in the load range 1-15 mN, in both the scratch and the friction responses are considered and discussed as well as resultant deformation in nanoscale. The friction mechanism in the low-load range was adhesion. In the intermediate and high load ranges, adhesion, elastic and plastic deformations and ploughing mechanisms contributed to the friction behavior. (ii) The hardness behavior of multilayered a-C films and the role of the intrinsic material length, namely the total (100 nm) and bilayers thickness (10-45 nm), where it was found that the reduction of the bilayer thickness results in film's strengthening. (c) 2004 Elsevier B.V. All rights reserved.
C1 Aristotle Univ Thessaloniki, Dept Phys, Solid State Phys Sect, Lab Thin Films Nanosyst & Nanometrol, Thessaloniki 54124, Greece.
RP Charitidis, C (reprint author), Aristotle Univ Thessaloniki, Dept Phys, Solid State Phys Sect, Lab Thin Films Nanosyst & Nanometrol, Thessaloniki 54124, Greece.
EM cchar@skiathos.physics.auth.gr
OI Charitidis, Costas/0000-0003-1367-7603
CR ANGUS JC, 1986, PLASMA DEPOSITION TH, V4, P89
   BHUSHAN B, 1999, HDB MICRO NANO TRIBO
   Bichler C, 1997, SURF COAT TECH, V97, P299, DOI 10.1016/S0257-8972(97)00206-5
   CASEY F, 1999, P 42 ANN TECHN C, P415
   Charitidis C, 2003, DIAM RELAT MATER, V12, P1088, DOI 10.1016/S0925-9635(02)00268-6
   Charitidis C, 2000, SURF COAT TECH, V125, P201, DOI 10.1016/S0257-8972(99)00546-0
   CHARITIDIS C, UNPUB
   Chudoba T, 2001, SURF COAT TECH, V148, P191, DOI 10.1016/S0257-8972(01)01340-8
   Deng H, 1997, J APPL PHYS, V81, P5396, DOI 10.1063/1.364551
   Gioti M, 1998, APPL PHYS LETT, V73, P184, DOI 10.1063/1.121749
   Grill A, 1997, SURF COAT TECH, V94-5, P507, DOI 10.1016/S0257-8972(97)00458-1
   Gupta BK, 1995, WEAR, V190, P110, DOI 10.1016/0043-1648(95)06746-9
   Johnson K. L., 1985, CONTACT MECH
   KOELER JS, 1970, PHYS REV B, V2, P547
   KOSKINEN J, 1993, SURF COAT TECH, V62, P356, DOI 10.1016/0257-8972(93)90267-R
   LEHOCZKY SL, 1978, PHYS REV LETT, V41, P1814, DOI 10.1103/PhysRevLett.41.1814
   Leterrier Y, 1997, J POLYM SCI POL PHYS, V35, P1449, DOI 10.1002/(SICI)1099-0488(19970715)35:9<1449::AID-POLB15>3.0.CO;2-6
   Lettington AH, 1998, CARBON, V36, P555, DOI 10.1016/S0008-6223(98)00062-1
   Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4
   Logothetidis S, 1999, THIN SOLID FILMS, V353, P208, DOI 10.1016/S0040-6090(99)00425-3
   Logothetidis S, 2004, CARBON, V42, P1133, DOI 10.1016/j.carbon.2003.12.054
   Mathioudakis C, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205203
   MCCOLL IR, 1993, DIAM RELAT MATER, V3, P83
   MIYOSHI K, 1988, SURF COAT TECH, V36, P487, DOI 10.1016/0257-8972(88)90177-6
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   OUYANG M, 2000, POLYM DEGRAD STABIL, V70, P217, DOI DOI 10.1016/S0141-3910(00)00116-6
   PATSALAS P, 2000, J APPL PHYS, V88, P6349
   Sobrinho ASD, 1998, J VAC SCI TECHNOL A, V16, P3190, DOI 10.1116/1.581519
   Tadanaga K, 1996, J SOL-GEL SCI TECHN, V6, P107, DOI 10.1007/BF00402593
   Thome J, 2003, SURF COAT TECH, V174, P584, DOI 10.1016/S0257-8972(03)00703-5
   Tonelli AE, 2002, POLYMER, V43, P637, DOI 10.1016/S1089-3156(00)00028-3
   Voevodin AA, 1998, DIAM RELAT MATER, V7, P463, DOI 10.1016/S0925-9635(97)00214-8
   YOKOYAMA S, 1999, P 42 ANN TECHN C, P420
NR 33
TC 9
Z9 10
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0256
J9 COMP MATER SCI
JI Comput. Mater. Sci.
PY 2005
VL 33
IS 1-3
BP 296
EP 302
DI 10.1016/j.commatsci.2004.12.014
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 911QV
UT WOS:000228020500046
DA 2018-10-20
ER

PT S
AU Kimura, Y
AF Kimura, Y
BE DeHosson, JTM
   Brebbia, CA
   Nishida, SI
TI Improvement of corrosion resistance and bio compatibility of Ni-Ti shape
   memory alloy by various surface modifications
SO Computer Methods and Experimental Measurements for Surface Effects and
   Contact Mechanics VII
SE WIT TRANSACTIONS ON ENGINEERING SCIENCES
LA English
DT Proceedings Paper
CT 7th International Conference on Computer Methods and Experimental
   Measurements for Surface Effects and Contact Mechanics
CY SEP, 2005
CL Bologna, ITALY
SP Wessex Inst Technol, Univ Groningen, WIT Transact Engn Sci
DE nickel-titanium shape memory alloy; cytocompatibility;
   bio-compatibility; biomaterial
AB Nickel-titanium shape memory alloy (Ni-Ti alloy) has unique mechanical properties such as shape memory effect and super elasticity along with good wear and corrosion resistances. For this reason Ni-Ti alloy is expected to be used as implant material in the biomedical field. However, the biocompatibility of the Ni-Ti alloy is not fully examined. The purpose of this research is to evaluate in vitro cytocompatibility and to try to improve corrosion resistance for Ni-Ti alloy by various surface modifications. Ni-Ti alloy showed good cytocompatibility compared with that of a Ti-6Al-4V alloy, judging from the small amount of hIL-1 beta and LDH generations. Biocompatibility of the Ni-Ti alloy is superior compared with pure nickel. Also, it was made clear that the biocompatibility of the Ni-Ti alloy showed almost the same level as that of stainless steel, which gave a lot of actual results as a biomaterial until now. Therefore, it was understood that there is no problem in the biocompatibility of the Ni-Ti alloy for application as a biomaterial. Moreover, corrosion resistance of in air oxidized Ni-Ti alloy was recognized to be greatly improved.
C1 Kogakuin Univ, Dept Mat Sci & Technol, Tokyo 160, Japan.
RP Kimura, Y (reprint author), Kogakuin Univ, Dept Mat Sci & Technol, Tokyo 160, Japan.
CR Eliades T, 2000, EUR J ORTHODONT, V22, P317, DOI 10.1093/ejo/22.3.317
   Gil FJ, 1998, P I MECH ENG H, V212, P473, DOI 10.1243/0954411981534231
   KAKIUCHI T, 1996, KNOWLEDGE IMMUNOLOGY, P41
   MIYAZAKI S, 1993, MECH PROPERTIES SHAP, pCH1
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   TANAKA K, 1999, J SOC MATER SCI JPN, V48, P1341
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   TORRISI L, 1998, BIOMED MAT ENG, V9, P39
   Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5
NR 9
TC 0
Z9 0
U1 0
U2 1
PU WIT PRESS
PI SOUTHAMPTON
PA ASHURST LODGE, SOUTHAMPTON SO40 7AA, ASHURST, ENGLAND
SN 1746-4471
BN 1-84564-022-5
J9 WIT TRANS ENG SCI
PY 2005
VL 49
BP 3
EP 11
PG 9
WC Engineering, Mechanical; Mechanics; Materials Science, Characterization
   & Testing
SC Engineering; Mechanics; Materials Science
GA BDU51
UT WOS:000235463100001
DA 2018-10-20
ER

PT J
AU Buszewski, B
   Kowalska, S
   Krupczynska, K
AF Buszewski, B
   Kowalska, S
   Krupczynska, K
TI New generation of chromatographic packings and columns for determination
   of biologically active compounds
SO CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE vitamins; steroids; nucleosides; peptides and proteins; separation
   techniques; stationary phase; sample preparation
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; SUPERCRITICAL-FLUID EXTRACTION;
   WATER-SOLUBLE VITAMINS; ELECTROSPRAY-MASS-SPECTROMETRY; REVERSED-PHASE
   HPLC; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; UNDERIVATIZED SMALL
   PEPTIDES; CHEMICALLY BONDED PHASES; ION-PAIR CHROMATOGRAPHY; CHIRAL
   STATIONARY-PHASE
AB Analysis of biologically active substances is particularly important in the pharmaceutical and biomedical area. For separation of polar compounds or complex mixtures by normal (NP) or reversed phase liquid chromatography (RP-HPLC) and/or electromigration techniques, it is necessary to apply a new generation of packings and columns with strictly defined properties. It is connected to the definition of chromatographic behavior and determination of compounds that are described by its structure, as well as chemical and physical properties. One of the factors playing a predominant role in the separation process is the interaction between analyte and stationary phases. During recent years a large variety of stationary phases have become available and have been also applied in routine and research chromatographic separations. Bonded phases are in widespread use and popular because of the great number of available packing materials, allowing the solution of a scale of different separation problems. At the present time analytical methods cannot be restricted only to the so-called "black box:' To meet the requirements of modern analytical techniques, strong demands are put on further, deeper understanding of the essence of the separation process, among other things, on the basis of conclusions about interactions between solute and stationary phase surfaces. For surface characterization different physicochemical methods such as CP/MAS, NMR, FT IR, DCS, chromatography, etc., have been described. The resolution, as reflected by efficiency, selectivity, and retention patterns on these materials, has been demonstrated. The effect of structure of stationary phases on retention of a model series of test analytes has been proved and numerically expressed by means of the Quantitative Structure-Retention Relationship (QSSR). The main aim of this paper is to present possibilities of determining different biologically active compounds (e.g., vitamins, steroids, nucleosides, peptides) in complex chromatographic methods (sample preparation, final analysis, validation) using new generation of stationary phases, columns, and chips divides. Special attention is dedicated to the advantage of packing materials imitating natural membranes because of the possible examination of the interaction between drug double left right arrow membrane. They can permit to the design of new pharmaceuticals and observation of processes taking place on the border of phases without interfering in natural systems.
C1 Nicholas Copernicus Univ, Fac Chem, Dept Environm Chem & Ecoanalyt, PL-87100 Torun, Poland.
RP Buszewski, B (reprint author), Nicholas Copernicus Univ, Fac Chem, Dept Environm Chem & Ecoanalyt, 7 Gagarin Str, PL-87100 Torun, Poland.
EM bbusz@chem.uni.torun.pl
RI Buszewski, Boguslaw/A-3187-2009; Studzinska, Sylwia/E-6689-2011
OI Studzinska, Sylwia/0000-0002-4658-7092
CR ABRAHAM MH, 1987, CHROMATOGRAPHIA, V23, P243, DOI 10.1007/BF02311772
   ABUBAKER MA, 1995, J CHROMATOGR B, V674, P31, DOI 10.1016/0378-4347(95)00284-2
   Adoubel AA, 2000, J LIQ CHROMATOGR R T, V23, P2433, DOI 10.1081/JLC-100100499
   Ake M, 1998, J CHROMATOGR A, V826, P183, DOI 10.1016/S0021-9673(98)00747-X
   AKIYAMA S, 1990, B CHEM SOC JPN, V63, P2809, DOI 10.1246/bcsj.63.2809
   Al-Haj MA, 2001, J CHROMATOGR SCI, V39, P29, DOI 10.1093/chromsci/39.1.29
   Albert K, 2003, J SEP SCI, V26, P215, DOI 10.1002/jssc.200390028
   *AM BIOSC, 2002, GEL FILTR PRINC METH
   AMIN M, 1993, ANAL CHEM, V65, P2346, DOI 10.1021/ac00065a030
   ARMSTRONG DW, 1994, CHIRALITY, V6, P496, DOI 10.1002/chir.530060609
   ARMSTRONG DW, 1987, CHIRALITY, V59, pA87
   BACZYK S, 1983, MIKROCHIM ACTA, V1, P437
   Bean KA, 1997, J CHROMATOGR B, V690, P65, DOI 10.1016/S0378-4347(96)00403-3
   BENJAMIN E, 2003, J CHROMATOGR A, V984, P97
   Berek D, 2002, J CHROMATOGR A, V976, P27, DOI 10.1016/S0021-9673(02)01150-0
   BERENDSEN GE, 1978, J LIQ CHROMATOGR, V1, P561, DOI 10.1080/01483917808060019
   BERENDSEN GE, 1980, J CHROMATOGR, V196, P21, DOI 10.1016/S0021-9673(00)80356-8
   BERTELLONI S, 1993, CLIN CHEM, V39, P1086
   BERTHOD A, 1992, ANAL CHEM, V64, P395, DOI 10.1021/ac00028a014
   Berthod A, 1996, J CHROMATOGR A, V731, P123, DOI 10.1016/0021-9673(95)01198-6
   Blanco D, 2000, ANALYST, V125, P427, DOI 10.1039/a909027d
   BOGAR RG, 1984, ANAL CHEM, V56, P1080, DOI 10.1021/ac00271a008
   Boonkerd S, 1996, J CHROMATOGR A, V756, P279, DOI 10.1016/S0021-9673(96)00636-X
   Borek E, 1972, Adv Cancer Res, V15, P163, DOI 10.1016/S0065-230X(08)60374-7
   Bowers LD, 1996, J CHROMATOGR B, V687, P61, DOI 10.1016/S0378-4347(96)00232-0
   BRAMHALL J, 1976, CLIN CHIM ACTA, V68, P203, DOI 10.1016/0009-8981(76)90383-1
   BRETER HJ, 1977, J CHROMATOGR, V140, P251, DOI 10.1016/S0021-9673(00)93584-2
   BRISTOW PA, 1977, CHROMATOGRAPHIA, V10, P279, DOI 10.1007/BF02263001
   Burri BJ, 1997, J CHROMATOGR A, V762, P201, DOI 10.1016/S0021-9673(96)00705-4
   BUSZEWSKA T, 1998, GIT SPEZIAL, V4, P65
   Buszewski B, 1999, J CHROMATOGR A, V845, P433, DOI 10.1016/S0021-9673(99)00141-7
   Buszewski B, 1998, CHROMATOGRAPHIA, V48, P615, DOI 10.1007/BF02467590
   Buszewski B, 2004, COMB CHEM HIGH T SCR, V7, P383
   Buszewski B, 2003, CHEM ANAL-WARSAW, V48, P347
   Buszewski B, 2003, J CHROMATOGR B, V792, P279, DOI 10.1016/S1570-0232(03)00283-6
   Buszewski B, 2002, LC GC EUR, V15, P792
   Buszewski B, 1997, ANAL CHEM, V69, P3277, DOI 10.1021/ac9612032
   Buszewski B, 2002, J LIQ CHROMATOGR R T, V25, P1229, DOI 10.1081/JLC-120004021
   BUSZEWSKI B, 1990, J CHROMATOGR, V499, P305, DOI 10.1016/S0021-9673(00)96981-4
   Buszewski B, 2001, CHROMATOGRAPHIA, V53, pS204, DOI 10.1007/BF02490329
   Buszewski B, 2001, MATER CHEM PHYS, V72, P30, DOI 10.1016/S0254-0584(01)00320-0
   BUSZEWSKI B, 1996, 21 INT S CHROM STUTT
   BUSZEWSKI B, 1998, J HIGH RES CHROMATOG, V21, P267
   BUSZEWSKI B, 1992, THESIS BRAITSLAVA ST
   Careri A, 2003, J CHROMATOGR A, V1000, P609, DOI 10.1016/S0021-9673(03)00237-1
   Careri M, 2002, J CHROMATOGR A, V970, P3, DOI 10.1016/S0021-9673(02)00903-2
   CAREY FA, 2001, ORGANIC CHEM
   CARR D, 2002, HDB ANAL PURIFICATIO
   CARR JW, 1986, ANAL CHEM, V58, P626, DOI 10.1021/ac00294a031
   CARTAS ST, 1995, ANAL CHIM ACTA, V302, P163, DOI 10.1016/0003-2670(94)00460-4
   Cavina G, 1983, Boll Chim Farm, V122, P531
   Chaimbault P, 1999, J CHROMATOGR A, V855, P191, DOI 10.1016/S0021-9673(99)00685-8
   CHANG JP, 2000, J CHROMATOGR A, V891, P235
   Chase GW, 1999, J AOAC INT, V82, P663
   CHIBA R, 1991, CHROMATOGRAPHIA, V588, P344
   Choudhary G, 1997, J CHROMATOGR A, V781, P161, DOI 10.1016/S0021-9673(97)00626-2
   CHRISTIANSON T, 1994, ANAL BIOCHEM, V223, P119, DOI 10.1006/abio.1994.1556
   Chu KO, 1998, ANAL LETT, V31, P2707
   Claessens HA, 1998, J CHROMATOGR A, V826, P135, DOI 10.1016/S0021-9673(98)00749-3
   Claessens HA, 1996, J CHROMATOGR A, V728, P259, DOI 10.1016/0021-9673(95)00904-3
   CLAUDY P, 1985, J CHROMATOGR, V329, P331, DOI 10.1016/S0021-9673(01)81940-3
   COHEN MB, 1980, J CHROMATOGR, V198, P435, DOI 10.1016/S0021-9673(00)80512-9
   COLE RB, 1997, ELECTROSPRAY IONIZAT
   DALDRUP T, 1984, CHROMATOGRAPHIA, V18, P81, DOI 10.1007/BF02268461
   DAVIS GE, 1979, J CHROMATOGR, V173, P281, DOI 10.1016/S0021-9673(00)92297-0
   DEAN B, 1988, CLIN CHIM ACTA, V176, P169, DOI 10.1016/0009-8981(88)90204-5
   Delaurent C, 1997, CHROMATOGRAPHIA, V45, P355, DOI 10.1007/BF02505584
   DELGADOZAMARRENO MM, 1995, J CHROMATOGR A, V694, P399, DOI 10.1016/0021-9673(94)01142-2
   DePhillips P, 2001, J CHROMATOGR A, V933, P57, DOI 10.1016/S0021-9673(01)01275-4
   DESIDERIO DM, 1996, PROTEIN PEPTIDE ANAL, V61
   Desportes C, 2000, J CHROMATOGR A, V893, P281, DOI 10.1016/S0021-9673(00)00698-1
   Di Pietro MC, 2001, J CHROMATOGR B, V751, P87, DOI 10.1016/S0378-4347(00)00471-0
   DINELLI G, 1994, ELECTROPHORESIS, V15, P1147, DOI 10.1002/elps.11501501173
   EDELSON EH, 1979, J CHROMATOGR, V174, P409, DOI 10.1016/S0021-9673(00)86015-X
   EHRLICH M, 1979, J CHROMATOGR SCI, V17, P531, DOI 10.1093/chromsci/17.9.531
   EKSTEEN R, 1978, J CHROMATOGR, V148, P413
   ELICONE C, 1994, J CHROMATOGR A, V676, P121, DOI 10.1016/0021-9673(94)00089-1
   ENGELHARDT H, 1997, LC GC EUR, V10, P803
   FALICK AM, 1989, TECHNIQUES PROTEIN C
   Fotsing L, 1997, J PHARMACEUT BIOMED, V15, P1113, DOI 10.1016/S0731-7085(96)02010-9
   Gadzala-Kopciuch R, 2003, J LIQ CHROMATOGR R T, V26, P195, DOI 10.1081/JLC-120017163
   GALUSHKO SV, 1993, CHROMATOGRAPHIA, V36, P39, DOI 10.1007/BF02263833
   Gamiz-Gracia L, 2000, CHROMATOGRAPHIA, V51, P428, DOI 10.1007/BF02490479
   GARNICK RL, 1988, ANAL CHEM, V60, P2546, DOI 10.1021/ac00174a004
   Gatti R, 1998, J PHARMACEUT BIOMED, V17, P337, DOI 10.1016/S0731-7085(97)00207-0
   GAZIANO JM, 1995, AM J CLIN NUTR, V61, P1248
   GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9
   GEHRKE CW, 1980, J CHROMATOGR, V188, P129, DOI 10.1016/S0021-9673(00)88424-1
   GEHRKE CW, 1978, J CHROMATOGR, V150, P455, DOI 10.1016/S0021-9673(00)88205-9
   GEHRKE CW, 1976, J CHROMATOGR, V123, P335, DOI 10.1016/S0021-9673(00)82202-5
   GILPIN RK, 1993, J CHROMATOGR A, V656, P217, DOI 10.1016/0021-9673(93)80803-G
   GOLDBERG ME, 1981, PHARM BIOCH PROPERTI
   GORAMASLAK G, 1997, SUPELCO REP, V16, P5
   GUO D, 1987, J CHROMATOGR, V386, P205
   HAGAR AF, 1994, J AOAC INT, V77, P1047
   HANSCH C, 1979, SUBSTITUENT CONSTANT
   HANSEN P, 1992, J CHROMATOGR, V627, P125, DOI 10.1016/0021-9673(92)87192-B
   HANSEN SJ, 1983, J CHROMATOGR SCI, V21, P560, DOI 10.1093/chromsci/21.12.560
   HARTWICK RA, 1975, J CHROMATOGR, V112, P651, DOI 10.1016/S0021-9673(00)99994-1
   HARTWICK RA, 1979, J LIQ CHROMATOGR, V2, P725, DOI 10.1080/01483917908060099
   HARTWICK RA, 1979, J CHROMATOGR, V186, P647, DOI 10.1016/S0021-9673(00)95285-3
   HATCH RG, 1990, J CHROMATOGR SCI, V28, P210, DOI 10.1093/chromsci/28.4.210
   HELOBE T, 1999, J CHROMATOGR A, V836, P315
   HEMRESY TP, 2003, J CHROMATOGR A, V1009, P15
   Higashi T, 2004, ANAL BIOANAL CHEM, V378, P875, DOI 10.1007/s00216-003-2252-z
   HONDO T, 1986, BUNSEKI KAGAKU, V35, P316
   Hu WC, 1996, J AM OIL CHEM SOC, V73, P1653, DOI 10.1007/BF02517967
   Hua-Bin L., 2000, J CHROMATOGR A, V891, P243
   Huang XA, 2002, ANAL CHEM, V74, P2336, DOI 10.1021/ac011202w
   HUNNICUTT ML, 1986, ANAL CHEM, V58, P748, DOI 10.1021/ac00295a021
   Igarashi Y, 1982, Rinsho Byori, VSuppl 52, P143
   INDYK H, 1985, J DAIRY SCI TECHNOL, V20, P19
   ITOH K, 1993, CLIN CHIM ACTA, V217, P221
   Ivanovic D, 1999, J PHARMACEUT BIOMED, V18, P999, DOI 10.1016/S0731-7085(98)00109-5
   IVANOVIC D, 1995, CHROMATOGRAPHIA, V40, P652, DOI 10.1007/BF02315132
   Iwase H, 2000, J CHROMATOGR A, V881, P189, DOI 10.1016/S0021-9673(00)00198-9
   JARONIEC M, 1981, J CHROMATOGR, V210, P130, DOI 10.1016/S0021-9673(00)91188-9
   JINNO K, 1997, CHROMATOGRAPHIC SEPA
   Jiskra J, 2002, J SEP SCI, V25, P1337, DOI 10.1002/jssc.200290005
   Juricskay S, 2000, CLIN BIOCHEM, V33, P97, DOI 10.1016/S0009-9120(99)00091-0
   JUSTOVA V, 1984, J CHROMATOGR, V290, P107, DOI 10.1016/S0021-9673(01)93565-4
   Kaliszan R., 1987, QUANTITATIVE STRUCTU
   KALISZAN R, 1995, HDB ADV MAT TESTING
   Kalman A, 1996, J CHROMATOGR A, V729, P155, DOI 10.1016/0021-9673(95)01059-9
   KERR SJ, 1970, BIOCHEMISTRY-US, V9, P690, DOI 10.1021/bi00805a032
   KHACHIK F, 1995, J CELL BIOCHEM, P236
   KIMATA K, 1989, J CHROMATOGR SCI, V27, P721, DOI 10.1093/chromsci/27.12.721
   Kintz P, 1999, J ANAL TOXICOL, V23, P424, DOI 10.1093/jat/23.6.424
   KITO M, 1990, J CHROMATOGR-BIOMED, V528, P91, DOI 10.1016/S0378-4347(00)82365-8
   KOBAYASHI S, 1989, J CHROMATOGR, V480, P179, DOI 10.1016/S0021-9673(01)84287-4
   KOHLER J, 1987, J CHROMATOGR, V385, P125, DOI 10.1016/S0021-9673(01)94628-X
   Koutny LB, 1996, ANAL CHEM, V68, P18, DOI 10.1021/ac9508311
   KOWALSKA S, IN PRESS J SEPARATIO
   Krupczynska K, 2005, ANAL CHIM ACTA, V540, P127, DOI 10.1016/j.aca.2004.11.039
   Krupczynska K, 2004, ANAL CHEM, V76, p226A, DOI 10.1021/ac041583o
   KUNITANI M, 1986, J CHROMATOGR, V371, P313, DOI 10.1016/S0021-9673(01)94716-8
   Kvasnicka F, 2005, J SEP SCI, V28, P813, DOI 10.1002/jssc.200500054
   LAMBERT D, 1992, J CHROMATOGR, V608, P311, DOI 10.1016/0021-9673(92)87137-W
   Lee J, 1999, J FOOD SCI, V64, P968, DOI 10.1111/j.1365-2621.1999.tb12261.x
   LENEHAN A, 2003, ANABOLIC STEROIDS
   LEROY B, 1998, CHEM NUCL NUCL
   Liebich HM, 1997, J CHROMATOGR A, V763, P193, DOI 10.1016/S0021-9673(96)00757-1
   LINDON JC, 1995, MAGN RESON CHEM, V33, P857, DOI 10.1002/mrc.1260331103
   Link AJ, 2002, TRENDS BIOTECHNOL, V20, pS8, DOI 10.1016/S1471-1931(02)00202-1
   LOCHMULLER CH, 1980, ANAL CHIM ACTA, V19, P116
   Lord GA, 1997, J CHROMATOGR A, V768, P9, DOI 10.1016/S0021-9673(96)01081-3
   LUNDELL N, 1992, CHROMATOGRAPHIA, V34, P369, DOI 10.1007/BF02268370
   Luque-Garcia JL, 2001, J CHROMATOGR A, V935, P3, DOI 10.1016/S0021-9673(01)01118-9
   Ma YC, 1997, J AM SOC MASS SPECTR, V8, P1010, DOI 10.1016/S1044-0305(97)00122-0
   MACIEL GE, 1980, J AM CHEM SOC, V102, P7606, DOI 10.1021/ja00545a056
   MAKIN HLJ, 1995, STEROID ANALY
   MANT CT, 1991, HIGH PERFORMANCE LI
   Manzi P, 1996, CHROMATOGRAPHIA, V43, P89, DOI 10.1007/BF02272829
   MASON SR, 1992, J CHROMATOGR-BIOMED, V581, P267, DOI 10.1016/0378-4347(92)80280-4
   MASUDA M, 1993, ANAL SCI, V9, P29, DOI 10.2116/analsci.9.29
   MATSUURA K, 1990, RAPID COMMUN MASS SP, V4, P381, DOI 10.1002/rcm.1290041007
   Matyska MT, 2001, J CHROMATOGR A, V924, P211, DOI 10.1016/S0021-9673(01)00830-5
   McCalley DV, 2003, J SEP SCI, V26, P187, DOI 10.1002/jssc.200390026
   MCCROSKEY MC, 1987, ANAL BIOCHEM, V163, P427, DOI 10.1016/0003-2697(87)90244-2
   MCGRAW CA, 1990, MED LAB SCI, V47, P17
   MILLER V, 1976, J CHROMATOGR, V119, P355, DOI 10.1016/S0021-9673(00)86799-0
   MOREL D, 1981, J CHROMATOGR, V214, P202, DOI 10.1016/S0021-9673(00)98525-X
   Moreno P, 2000, J CHROMATOGR A, V870, P207, DOI 10.1016/S0021-9673(99)01021-3
   NARAYANAN SR, 1994, J CHROMATOGR A, V658, P237, DOI 10.1016/0021-9673(94)80018-9
   Neue UD, 2003, J SEP SCI, V26, P174, DOI 10.1002/jssc.200390025
   NIERENBERG DW, 1987, J CHROMATOGR-BIOMED, V413, P79, DOI 10.1016/0378-4347(87)80215-3
   NONDEK L, 1986, J CHROMATOGR, V360, P241, DOI 10.1016/S0021-9673(00)91669-8
   NOZAKI O, 1995, J BIOLUM CHEMILUM, V10, P339, DOI 10.1002/bio.1170100606
   Nozaki O, 2001, J CHROMATOGR A, V935, P267, DOI 10.1016/S0021-9673(01)01104-9
   Ogawa H, 1983, Nihon Naibunpi Gakkai Zasshi, V59, P801
   ONeil M. J., 2001, MERCK INDEX ENCY CHE
   Ortiz Boyer F., 1999, Chromatographia, V50, P399, DOI 10.1007/BF02490733
   ORTIZBOYER F, 1998, CHROMATOGRAPHIA, V47, P367
   PASSWATER RA, 1999, BEGINNERS INTRO VITA
   PATEL AB, 1977, J CHROMATOGR, V130, P115, DOI 10.1016/S0021-9673(00)89787-3
   PEARSON JD, 1982, ANAL BIOCHEM, V124, P217, DOI 10.1016/0003-2697(82)90240-8
   Perez-Ruiz T, 2003, CHROMATOGRAPHIA, V58, P757, DOI 10.1365/s10337-003-0088-5
   PESEK JJ, 1994, J CHROMATOGR A, V687, P33, DOI 10.1016/0021-9673(94)00815-9
   Peter A, 1996, J CHROMATOGR A, V728, P455, DOI 10.1016/0021-9673(95)01022-X
   Petritis K, 2002, J CHROMATOGR A, V957, P173, DOI 10.1016/S0021-9673(02)00372-2
   Petritis K, 2001, J CHROMATOGR A, V913, P331, DOI 10.1016/S0021-9673(00)01268-1
   PLUSCEC J, 1987, J ASSOC OFF ANA CHEM, V70, P599
   Podda M, 1996, J LIPID RES, V37, P893
   Pursch M, 1996, ANAL CHEM, V68, P386, DOI 10.1021/ac950761y
   Que AH, 2000, J CHROMATOGR A, V887, P379, DOI 10.1016/S0021-9673(00)00427-1
   RANDERATH K, 1973, J CHROMATOGR, V82, P59, DOI 10.1016/S0021-9673(01)80075-3
   Rentel C, 1998, ANAL CHEM, V70, P4394, DOI 10.1021/ac971329e
   Righetti PG, 2005, CLIN CHIM ACTA, V357, P123, DOI 10.1016/j.cccn.2005.03.018
   RIVIER J, 1984, J CHROMATOGR, V288, P303, DOI 10.1016/S0021-9673(01)93709-4
   Rohrschneider L, 2001, J SEP SCI, V24, P3, DOI 10.1002/1615-9314(20010101)24:1<3::AID-JSSC3>3.0.CO;2-O
   SADLEJSOSNOWSKA N, 1986, J CHROMATOGR, V357, P227, DOI 10.1016/S0021-9673(01)95825-X
   SANDER LC, 1995, ANAL CHEM, V67, P3284, DOI 10.1021/ac00114a027
   SANDER LC, 1987, CRIT REV ANAL CHEM, V18, P299, DOI 10.1080/10408348708545263
   SCALIA S, 1995, J PHARMACEUT BIOMED, V13, P273, DOI 10.1016/0731-7085(95)01275-P
   SCARBOROUGH RM, 1984, P NATL ACAD SCI-BIOL, V81, P5575, DOI 10.1073/pnas.81.17.5575
   SCHAUMANN C, 1993, J CHROMATOGR, V646, P227, DOI 10.1016/S0021-9673(99)87024-1
   SCHIEWE J, 1995, J CHROMATOGR A, V717, P255, DOI 10.1016/0021-9673(95)00510-3
   SCHLITTLER MR, 1989, 9 ISPPP
   Schneiderman MA, 1997, J CHROMATOGR A, V765, P215, DOI 10.1016/S0021-9673(96)00923-5
   SCHNEIDERMAN MA, 1988, J ASSOC OFF ANA CHEM, V71, P815
   SCHONESHOFER M, 1983, J STEROID BIOCHEM, V18, P65, DOI 10.1016/0022-4731(83)90332-1
   Seifar R. M., 1998, Biomedical Chromatography, V12, P140
   SERPINET J, 1972, J CHROMATOGR, V68, P9, DOI 10.1016/S0021-9673(00)88758-0
   SHACKLETON CHL, 1993, J STEROID BIOCHEM, V45, P127, DOI 10.1016/0960-0760(93)90132-G
   Shediac R, 2001, J CHROMATOGR A, V925, P251, DOI 10.1016/S0021-9673(01)01036-6
   Shibata N, 1998, J CHROMATOGR B, V706, P191, DOI 10.1016/S0378-4347(97)00557-4
   Shimada K, 2001, J CHROMATOGR A, V935, P141, DOI 10.1016/S0021-9673(01)00943-8
   SHIMIZU M, 1995, J CHROMATOGR B, V672, P63, DOI 10.1016/0378-4347(95)00187-N
   SMITH RM, 1993, J CHROMATOGR A, V656, P381, DOI 10.1016/0021-9673(93)80811-L
   SOBER HA, 1970, HDB BIOCH SELECTED D
   Soczewinski E, 2002, J CHROMATOGR A, V965, P109, DOI 10.1016/S0021-9673(01)01278-X
   Somenath M, 2003, SAMPLE PREPARATION T
   SRIEWOELAN S, 1984, ACTA PHARM INDONES, V9, P143
   STANEVA L, 1989, IZV DURZH I KONTROL, V22, P12
   STASZCZUK P, 1988, CHROMATOGRAPHIA, V25, P881, DOI 10.1007/BF02311422
   Stead DA, 1998, J CHROMATOGR A, V798, P259, DOI 10.1016/S0021-9673(97)00840-6
   STEIMER T, 1985, J STEROID BIOCHEM, V23, P955, DOI 10.1016/0022-4731(85)90053-6
   STONE K, 1988, 2 S PROT SOC
   Stryer L., 1999, BIOCHEMISTRY
   Stulik K, 1997, ANAL CHIM ACTA, V352, P1, DOI 10.1016/S0003-2670(97)00262-6
   SZEPESY L, 1994, J CHROMATOGR A, V668, P337, DOI 10.1016/0021-9673(94)80123-1
   Szumski M, 2002, CRIT REV ANAL CHEM, V32, P1, DOI 10.1080/10408340290765434
   TAKEDA M, 1990, BIOMED CHROMATOGR, V4, P119, DOI 10.1002/bmc.1130040309
   TEMPST P, 1986, J CHROMATOGR, V359, P403, DOI 10.1016/0021-9673(86)80094-2
   Thiam S, 2000, ANAL CHEM, V72, P2541, DOI 10.1021/ac991306v
   TOMLINSON E, 1976, J PHARM PHARMACOL, V28, pP43
   Turner C, 2000, J CHROMATOGR A, V874, P275, DOI 10.1016/S0021-9673(00)00096-0
   Turner C, 2001, J CHROMATOGR A, V936, P215, DOI 10.1016/S0021-9673(01)01082-2
   Turpeinen U, 1997, CLIN CHEM, V43, P1386
   Uesugi T, 1997, J CHROMATOGR B, V703, P63, DOI 10.1016/S0378-4347(97)00430-1
   Unger K.K., 1979, POROUS SILICA
   Unger K. K., 1990, PACKINGS STATIONARY
   VANDERGREEF J, 1986, LC GC, V4, P636
   VANHOOF HJC, 1993, J CHROMATOGR-BIOMED, V621, P33, DOI 10.1016/0378-4347(93)80073-D
   VANMILTENBURG JC, 1983, J CHROMATOGR, V268, P147, DOI 10.1016/S0021-9673(01)95401-9
   Vinas P, 2003, J CHROMATOGR A, V1007, P77, DOI 10.1016/S0021-9673(03)00977-4
   VOELTER W, 1980, J CHROMATOGR, V199, P345, DOI 10.1016/S0021-9673(01)91386-X
   WALTERS MJ, 1987, J ASSOC OFF ANA CHEM, V70, P465
   WALTERS MJ, 1990, J ASSOC OFF ANA CHEM, V73, P904
   WARD TJ, 1996, LC GC, V9, P429
   WEISSMANN B, 1957, J BIOL CHEM, V224, P407
   WELLS J, 2002, PHARM REFORMULATION
   WILLCOX DL, 1983, ANAL BIOCHEM, V135, P304, DOI 10.1016/0003-2697(83)90687-5
   Williams TM, 2000, J VET PHARMACOL THER, V23, P57
   Wolthers BG, 1999, J CHROMATOGR A, V843, P247, DOI 10.1016/S0021-9673(99)00153-3
   Wu JC, 2000, ANALYST, V125, P391, DOI 10.1039/b000287i
   Xiong L, 2004, J CHROMATOGR A, V1030, P187, DOI 10.1016/j.chroma.2003.11.009
   Ye ML, 2000, J CHROMATOGR A, V869, P385, DOI 10.1016/S0021-9673(99)01192-9
   ZAKARIA M, 1981, J CHROMATOGR, V226, P267, DOI 10.1016/S0378-4347(00)86062-4
   Zbanyszek W, 2002, J LIQ CHROMATOGR R T, V25, P1243, DOI 10.1081/JLC-120004022
   ZHOU NE, 1991, J CHROMATOGR, V548, P179, DOI 10.1016/S0021-9673(01)88600-3
   1998, PRINCIPLES APPL HIGH
NR 252
TC 17
Z9 17
U1 0
U2 24
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8347
EI 1547-6510
J9 CRIT REV ANAL CHEM
JI Crit. Rev. Anal. Chem.
PY 2005
VL 35
IS 2
BP 89
EP 116
DI 10.1080/10408340500207367
PG 28
WC Chemistry, Analytical
SC Chemistry
GA 964VK
UT WOS:000231908900001
DA 2018-10-20
ER

PT J
AU Kashyap, N
   Kumar, N
   Kumar, MNVR
AF Kashyap, N
   Kumar, N
   Kumar, MNVR
TI Hydrogels for pharmaceutical and biomedical applications
SO CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
LA English
DT Review
DE hydrogels; environment-sensitive hydrogels; bioadhesive gels; tissue
   engineering; molecular imprinting; wound dressings; immunoisolation;
   drug delivery
ID DRUG-DELIVERY SYSTEM; CATIONIC COPOLYMER HYDROGELS; LINKED CHITOSAN
   HYDROGELS; CONTROLLED-RELEASE; PHASE-TRANSITION; IN-VITRO; INSULIN
   DELIVERY; BIOARTIFICIAL PANCREAS; STATISTICAL-MECHANICS; BIOADHESIVE
   POLYMER
AB Hydrogels are crosslinked hydrophilic polymer structures that can imbibe large amounts of water or biological fluids. Hydrogels are one of the upcoming classes of polymer-based systems that embrace numerous biomedical and pharmaceutical applications. This review discusses various parameters of hydrogels such as surface properties, water content and swelling behavior, effect of nature of polymer, ionic content, and thermodynamics, all of which can influence the biomedical usage of hydrogels. Meanwhile, intelligent or environment-sensitive hydrogels and bioadhesive hydrogels continue to be important materials for medical applications; therefore, a part of this review is devoted to some of their important classes. Hydrogels are extensively used for various biomedical applications-tissue engineering, molecular imprinting, wound dressings materials, immunoisolation, drug delivery, etc. Thus, this review aims to throw light on the numerous applications that hydrogels have in the biomedical arena.
C1 Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, Punjab, Punjab, India.
RP Kumar, MNVR (reprint author), Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, Punjab, Punjab, India.
EM mnvrkumar@niper.ac.in
RI Kumar, M N V R/D-6286-2011; Xu, Qingguo/C-1962-2014
OI Kumar, M N V R/0000-0001-5606-401X; Xu, Qingguo/0000-0003-3191-0771
CR ABOBAKR AM, 1994, INT J ARTIF ORGANS, V17, P171
   Allender CJ, 2000, INT J PHARM, V195, P39, DOI 10.1016/S0378-5173(99)00355-5
   BABA Y, 1992, ANAL CHEM, V64, P1920, DOI 10.1021/ac00041a029
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bernkop-Schnurch A, 1998, J CONTROL RELEASE, V50, P215, DOI 10.1016/S0168-3659(97)00136-3
   BERNKOPSCHNURCH KA, 2004, IN PRESS EUR J PHARM
   BOS GW, 2002, BUSINESS BRIEF PHARM, P184
   Brauker J, 1996, TRANSPLANTATION, V61, P1671, DOI 10.1097/00007890-199606270-00002
   BRAUN K, 1988, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V21, P58
   BROWN AS, 1981, PLAST RECONSTR SURG, V67, P810
   Bulmus V, 2000, BIOCONJUGATE CHEM, V11, P78, DOI 10.1021/bc9901043
   Bures P, 2001, J CONTROL RELEASE, V72, P25, DOI 10.1016/S0168-3659(01)00259-0
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   CALAFIORE R, 2002, POLYM BIOMATERIALS
   Cerchiara T, 2002, J PHARM PHARMACOL, V54, P1453, DOI 10.1211/00223570281
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   Chen G X, 1991, ASAIO Trans, V37, pM439
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHICK WL, 1975, T AM SOC ART INT ORG, V21, P8
   CHO YW, 1999, BIOMATERIALS, V20
   CHUNG DJ, 1992, J CONTROL RELEASE, V18, P45
   DERJAGUIN BV, 1969, ADHESION FUNDAMENTAL
   DEURLOO MJM, 1991, CANCER CHEMOTH PHARM, V27, P347, DOI 10.1007/BF00688856
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   EDELMAN ER, 1985, J BIOMED MATER RES, V19, P67, DOI 10.1002/jbm.820190107
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Eouani C, 2001, EUR J PHARM BIOPHARM, V52, P45, DOI 10.1016/S0939-6411(01)00146-1
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   Flory PJ, 1943, J CHEM PHYS, V11, P512, DOI 10.1063/1.1723791
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Gariepy E. R., 2000, INT J PHARMACEUT, V203, P89, DOI DOI 10.1016/S0378-5173(00)00428-2
   Ghandehari H, 1997, BIOMATERIALS, V18, P861, DOI 10.1016/S0142-9612(97)00007-0
   GUO K, 1987, BIOCHIM BIOPHYS ACTA, V897, P377
   Haas J, 2002, EXPERT OPIN BIOL TH, V2, P287, DOI 10.1517/14712598.2.3.287
   Haginaka J, 1999, J CHROMATOGR A, V849, P331, DOI 10.1016/S0021-9673(99)00570-1
   Hashimoto T, 2004, BIOMATERIALS, V25, P1407, DOI 10.1016/j.biomaterials.2003.07.004
   HASSE C, 1983, TRANSPLANTATION, V36, P599
   HEJAZI R, 1993, POLYM BIOMATERIALS
   HELFMAN T, 1994, CLIN DERMATOL, V12, P121, DOI 10.1016/0738-081X(94)90262-3
   Hennink WE, 2004, INT J PHARM, V277, P99, DOI 10.1016/j.ijpharm.2003.02.002
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hilt JZ, 2004, ADV DRUG DELIVER REV, V56, P1599, DOI 10.1016/j.addr.2004.04.002
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hornof M, 2003, J CONTROL RELEASE, V89, P419, DOI 10.1016/S0168-3659(03)00135-4
   Huang G, 2004, J CONTROL RELEASE, V94, P303, DOI 10.1016/j.jconrel.2003.10.007
   Huang YB, 2002, MACROMOLECULES, V35, P1373, DOI 10.1021/ma011294r
   HUI HW, 1985, INT J PHARM, V26, P203, DOI 10.1016/0378-5173(85)90230-3
   HUNTSBERGER JR, 1967, J PAINT TECHNOL, V39, P199
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   JEYANTHI R, 1990, J CONTROL RELEASE, V13, P91, DOI 10.1016/0168-3659(90)90078-8
   JONG SJ, 2001, J CONTROL RELEASE, V72, P47
   Jong SJD, 2001, J CONTROL RELEASE, V1, P261
   JUNGINGER HE, 1990, ACTA PHARM TECHNOL, V36, P110
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   KASHYAP N, 2004, DRUG DELIV TECH, V4, P31
   Kast CE, 2003, INT J PHARM, V256, P183, DOI 10.1016/S0378-5173(03)00076-0
   KATONO H, 1991, J CONTROL RELEASE, V16, P215, DOI 10.1016/0168-3659(91)90045-F
   Kaufmann PM, 1997, CELL TRANSPLANT, V6, P463, DOI 10.1016/S0963-6897(97)00052-3
   KHARE AR, 1995, BIOMATERIALS, V16, P559, DOI 10.1016/0142-9612(95)91130-Q
   KHOR E, 2003, BIOMATERIALS, V23, P2339
   Kim B, 2003, POLYMER, V44, P3701, DOI 10.1016/S0032-3861(03)00307-0
   Kim B, 2003, J APPL POLYM SCI, V89, P1606, DOI 10.1002/app.12337
   Kim HJ, 2000, BIOMATERIALS, V21, P131, DOI 10.1016/S0142-9612(99)00140-4
   Kim JJ, 2001, J CONTROL RELEASE, V77, P39, DOI 10.1016/S0168-3659(01)00447-3
   KINLOCH AJ, 1980, J MATER SCI, V15, P2141, DOI 10.1007/BF00552302
   Kirker KR, 2004, J BURN CARE REHABIL, V25, P276, DOI 10.1097/01.BCR.0000124790.69026.3D
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   KISHIDA A, 2002, POLYM BIOMATERIALS
   KITANO S, 1992, J CONTROL RELEASE, V19, P162
   KOKUFATA E, 1991, NATURE, V351, P302, DOI 10.1038/351302a0
   KOST J, 1987, J BIOMED MATER RES, V21, P1367, DOI 10.1002/jbm.820211202
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kwok CS, 2001, J BIOMED MATER RES, V57, P151, DOI 10.1002/1097-4636(200111)57:2<151::AID-JBM1154>3.0.CO;2-5
   KWON IC, 1991, J CONTROL RELEASE, V17, P149, DOI 10.1016/0168-3659(91)90054-H
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LANZA RP, 1992, DIABETES, V41, P886, DOI 10.2337/diabetes.41.7.886
   LANZA RP, 1993, TRANSPLANTATION, V56, P1067, DOI 10.1097/00007890-199311000-00003
   Lanza RP, 1997, IMMUNOL TODAY, V18, P135, DOI 10.1016/S0167-5699(97)01008-6
   Lee CH, 1996, J CONTROL RELEASE, V39, P93, DOI 10.1016/0168-3659(95)00142-5
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee MK, 2000, ADV DRUG DELIVER REV, V42, P103, DOI 10.1016/S0169-409X(00)00056-9
   LEHR CM, 1994, CRIT REV THER DRUG, V11, P119
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lorenzo C. A., 2004, J CHROMATOGR B, VB 804, P231
   Lu ZR, 1999, NAT BIOTECHNOL, V17, P1101
   Lugao AB, 2002, RADIAT PHYS CHEM, V63, P543, DOI 10.1016/S0969-806X(01)00551-5
   Lugao AB, 2001, NUCL INSTRUM METH B, V185, P37, DOI 10.1016/S0168-583X(01)00807-2
   MAMADA A, 1990, MACROMOLECULES, V23, P1517, DOI 10.1021/ma00207a046
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   MATTEW HWT, 2002, POLYM BIOMATERIALS
   McBain JW, 1925, J PHYS CHEM-US, V29, P188, DOI 10.1021/j150248a008
   Mi FL, 1999, J POLYM SCI POL PHYS, V37, P1551, DOI 10.1002/(SICI)1099-0488(19990715)37:14<1551::AID-POLB1>3.3.CO;2-8
   Morishita M, 2004, J CONTROL RELEASE, V97, P115, DOI 10.1016/j.jconrel.2004.03.008
   MYERS JA, 1983, PHARM J, V230, P263
   NAGAI T, 1985, PHARM INT, V6, P196
   Nakamura K, 2004, J CONTROL RELEASE, V95, P589, DOI 10.1016/j.jconrel.2003.12.022
   Needleman IG, 1998, J CLIN PERIODONTOL, V25, P74, DOI 10.1111/j.1600-051X.1998.tb02366.x
   Neill MAA, 2003, INT J PHARMACEUT, V263, P61
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Obaidat AA, 1996, PHARM RES-DORDR, V13, P989, DOI 10.1023/A:1016090103979
   OKUYAMA Y, 1993, J BIOMAT SCI-POLYM E, V4, P545, DOI 10.1163/156856293X00195
   Orive G, 2002, TRENDS BIOTECHNOL, V20, P382, DOI 10.1016/S0167-7799(02)02037-1
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   PACKNAEUSER CB, 2004, IN PRESS EUR J PHARM
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   PHILIPP B, 1989, PROG POLYM SCI, V14, P91, DOI 10.1016/0079-6700(89)90018-X
   Podual K, 2000, J CONTROL RELEASE, V67, P9, DOI 10.1016/S0168-3659(00)00195-4
   Podual K, 2000, POLYMER, V41, P3975, DOI 10.1016/S0032-3861(99)00620-5
   REACH G, 1981, DIABETES, V30, P296, DOI 10.2337/diab.30.4.296
   REINHART CT, 1984, J MEMBRANE SCI, V18, P227, DOI 10.1016/S0376-7388(00)85036-X
   RICHARDSON JL, 1992, ADV DRUG DELIVER REV, V8, P341, DOI 10.1016/0169-409X(92)90008-E
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   ROBINSON JR, 1995, ADV DRUG DELIVER REV, V16, P45, DOI 10.1016/0169-409X(95)00013-W
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sahoo SK, 1998, J COLLOID INTERF SCI, V206, P361, DOI 10.1006/jcis.1998.5692
   SAWAHATA K, 1990, J CONTROL RELEASE, V14, P253, DOI 10.1016/0168-3659(90)90165-P
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shiino D, 1995, J CONTROL RELEASE, V37, P269, DOI 10.1016/0168-3659(95)00084-4
   Shu XZ, 2001, INT J PHARM, V212, P19, DOI 10.1016/S0378-5173(00)00582-2
   SIEGEL RA, 1988, J CONTROL RELEASE, V8, P179, DOI 10.1016/0168-3659(88)90044-2
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Southern LJ, 2000, J HEART VALVE DIS, V9, P241
   SUDEE R, 2002, DRUG DELIV, V9, P19
   SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0
   Tamburic S, 1995, PHARM SCI, V1, P107, DOI DOI 10.1111/J.2042-7158.1995.TB00403.X
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   TEDER H, 1993, ANTICANCER RES, V13, P2161
   ULUDAG H, 1995, J CONTROL RELEASE, V33, P273, DOI 10.1016/0168-3659(94)00094-B
   Valenta C, 2001, J CONTROL RELEASE, V77, P323, DOI 10.1016/S0168-3659(01)00520-X
   Vinogradov SV, 2002, ADV DRUG DELIVER REV, V54, P135, DOI 10.1016/S0169-409X(01)00245-9
   VOS PD, 1993, INT J ARTIF ORGANS, V16, P205
   Wang TG, 1998, ARTIF ORGANS, V22, P68
   Ward R.S., 1993, ASAIO J, V39, P261
   Weidener J, 2003, DRUG DISCOV TODAY, V8, P906
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Woolfson A., 2002, POLYM BIOMATERIALS
   WOOLFSON AD, 1995, J CONTROL RELEASE, V35, P49, DOI 10.1016/0168-3659(95)00018-4
   Wozniewicz B, 1996, TRANSPLANT P, V28, P3542
   Yang J, 2001, BIOTECHNOL LETT, V23, P1385, DOI 10.1023/A:1011600414225
   YATES DW, 1984, INJURY, V16, P23, DOI 10.1016/0020-1383(84)90109-8
   Yusof NLBM, 2001, J BIOMED MATER RES, V54, P59, DOI 10.1002/1097-4636(200101)54:1<59::AID-JBM7>3.0.CO;2-U
   ZEMAN SPO, 2001, NAT BIOTECHNOL, V19, P201
   Zhong X, 1996, CHEM ENG SCI, V51, P3235, DOI 10.1016/0009-2509(95)00344-4
   ZHU H, 2002, J BIOMED MATER RES, V64, P532
   ZONG N, 2001, TETRAHEDRON LETT, V42, P1839
NR 157
TC 148
Z9 155
U1 6
U2 96
PU BEGELL HOUSE INC
PI NEW YORK
PA 145 MADISON AVE, NEW YORK, NY 10016 USA
SN 0743-4863
J9 CRIT REV THER DRUG
JI Crit. Rev. Ther. Drug Carr. Syst.
PY 2005
VL 22
IS 2
BP 107
EP 149
DI 10.1615/CritRevTherDrugCarrierSyst.v22.i2.10
PG 43
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 921AT
UT WOS:000228737300001
PM 15862110
DA 2018-10-20
ER

PT S
AU Suaste-Gomez, E
   Gonzalez-Ballesteros, R
   Castillo-Rivas, V
AF Suaste-Gomez, E
   Gonzalez-Ballesteros, R
   Castillo-Rivas, V
BE MendezVilas, A
TI Pyroelectric and photoacustic properties of
   Pb-0.88(Ln)(0.08)Ti0.98Mn0.02O3 (Ln = La, Sm, Eu) piezoceramics for
   biomedical use
SO CROSS-DISCIPLINARY APPLIED RESEARCH IN MATERIALS SCIENCE AND TECHNOLOGY
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 1st International Meeting on Applied Physics
CY OCT 13-18, 2003
CL Badajoz, SPAIN
SP Dept Phys Univ Extremadura, Junta Extremadura & Consejer Educ, Cienc Tecnol, INNOVA
DE ferroelectric ceramic; pyroelectricity; rare-earth elements;
   pyroelectric ceramic; photoacustic
ID TITANATE
AB In this work are studied the pyroelectric and photoacustic properties of Pb-0.88(Ln)(0.08)Ti0.98Mn0.02O3 (Ln = La, Sm, Eu) ferroelectric ceramic system. These type of ferroelectric ceramics presents high values in the following characteristics: dielectric constant, Curie temperature, electromechanical anisotropy, and frequencies of operation. These properties make them useful for applications such as: the detection of infrared radiation, ultrasonic transducers for biomedical applications. The relationship between dielectric constant and temperature measurements as well as pyroelectric measurements using the technique of Byer-Roundy were performed. Values of the pyroelectric coefficient and figure of merit for infrared detector materials were obtained. Also the photoacustic spectra of the samples was obtained.
C1 CINVESTAV IPN, Dept Ing Elect, Secc Bioelectron, Mexico City 07000, DF, Mexico.
RP Suaste-Gomez, E (reprint author), CINVESTAV IPN, Dept Ing Elect, Secc Bioelectron, Apdo Postal 14-740, Mexico City 07000, DF, Mexico.
EM esuaste@mail.cinvestav.mx; moyocoyani@hotmail.com; vcastil9@hotmail.com
CR BYER RL, 1972, IEEE T SON ULTRASON, VSU19, P333, DOI 10.1109/T-SU.1972.29679
   CHYNOWETH AG, 1956, J APPL PHYS, V27, P78, DOI 10.1063/1.1722201
   GLASS AM, 1968, PHYS REV, V172, P564, DOI 10.1103/PhysRev.172.564
   GLASS AM, 1969, J APPL PHYS, V40, P4699, DOI 10.1063/1.1657277
   JAFFE B, 1955, J RES NAT BUR STAND, V55, P239, DOI 10.6028/jres.055.028
   Perez Martinez O., 1995, Revista Mexicana de Fisica, V41, P85
   Ramirez-Rosales D, 2001, SOLID STATE COMMUN, V118, P371, DOI 10.1016/S0038-1098(01)00072-2
   ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296
   Suaste-Gomez E., 2002, Ferroelectrics, V273, P273, DOI 10.1080/00150190211757
NR 9
TC 2
Z9 2
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-962-8
J9 MATER SCI FORUM
PY 2005
VL 480
BP 645
EP 649
PG 5
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA BBW59
UT WOS:000228157300105
DA 2018-10-20
ER

PT J
AU Muller, AJ
   Albuerne, J
   Marquez, L
   Raquez, JM
   Degee, P
   Dubois, P
   Hobbs, J
   Hamley, IW
AF Muller, AJ
   Albuerne, J
   Marquez, L
   Raquez, JM
   Degee, P
   Dubois, P
   Hobbs, J
   Hamley, IW
TI Self-nucleation and crystallization kinetics of double crystalline
   poly(p-dioxanone)-b-poly(epsilon-caprolactone) diblock copolymers
SO FARADAY DISCUSSIONS
LA English
DT Article; Proceedings Paper
CT Meeting on Self-Organising Polymers
CY JUL 19-21, 2004
CL Univ Leeds, Leeds, ENGLAND
HO Univ Leeds
ID DIFFERENTIAL SCANNING CALORIMETRY; HEXAGONALLY PERFORATED LAYERS;
   BLOCK-COPOLYMERS; POLYMER CRYSTALLIZATION; TRIBLOCK COPOLYMERS;
   ISOTHERMAL CRYSTALLIZATION; CONFINED CRYSTALLIZATION; POLY(ETHYLENE
   OXIDE); EPSILON-CAPROLACTONE; MOLECULAR-WEIGHT
AB The crystallization kinetics of each constituent of poly(p-dioxanone)-b-poly(epsilon-caprolactone) diblock copolymers (PPDX-b-PCL) has been determined in a wide composition range by differential scanning calorimetry and compared to that of the equivalent homopolymers. Spherulitic growth rates were also measured by polarized optical microscopy while atomic force microscopy was employed to reveal the morphology of one selected diblock copolymer. It was found that crystallization drives structure formation and both components form lamellae within mixed spherulitic superstructures. The overall isothermal crystallization kinetics of the PPDX block at high temperatures, where the PCL is molten, was determined by accelerating the kinetics through a previous self-nucleation procedure. The application of the Lauritzen and Ho. man theory to overall growth rate data yielded successful results for PPDX and the diblock copolymers. The theory was applied to isothermal overall crystallization of previously self-nucleated PPDX ( where growth should be the dominant factor if self-nucleation was effective) and the energetic parameters obtained were perfectly matched with those obtained from spherulitic growth rate data of neat PPDX. A quantitative estimate of the increase in the energy barrier for crystallization of the PPDX block, caused by the covalently bonded molten PCL as compared to homo-PPDX, was thus determined. This energy increase can dramatically reduce the crystallization rate of the PPDX block as compared to homo-PPDX. In the case of the PCL block, both the crystallization kinetics and the self-nucleation results indicate that the PPDX is able to nucleate the PCL within the copolymers and heterogeneous nucleation is always present regardless of composition. Finally, preliminary results on hydrolytic degradation showed that the presence of relatively small amounts of PCL within PPDX-bPCL copolymers substantially retards hydrolytic degradation of the material in comparison to homo-PPDX. This increased resistance to hydrolysis is a complex function of composition and its knowledge may allow future prediction of the lifetime of the material for biomedical applications.
C1 Univ Simon Bolivar, Dept Ciencia Mat, Grp Polimeros, Caracas 1080A, Venezuela.
   Univ Mons, Lab Polymer & Composite Mat, B-7000 Mons, Belgium.
   Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.
   Univ Leeds, Dept Chem, Leeds LS2 9JT, W Yorkshire, England.
RP Muller, AJ (reprint author), Univ Simon Bolivar, Dept Ciencia Mat, Grp Polimeros, Apartado 89000, Caracas 1080A, Venezuela.
EM amuller@usb.ve
RI Muller, Alejandro/A-1415-2008; Hamley, Ian/D-1643-2009; DUBOIS,
   Philippe/B-9983-2008
OI Muller, Alejandro/0000-0001-7009-7715; Hamley, Ian/0000-0002-4549-0926;
   Dubois, Philippe/0000-0003-1534-1564
CR Albuerne J, 2003, MACROMOLECULES, V36, P1633, DOI 10.1021/ma025766t
   Andjelic S, 2001, J APPL POLYM SCI, V79, P742, DOI 10.1002/1097-4628(20010124)79:4<742::AID-APP190>3.3.CO;2-A
   Arnal ML, 2001, MACROMOLECULES, V34, P7973, DOI 10.1021/ma011058g
   Arnal ML, 2004, EUR POLYM J, V40, P1461, DOI 10.1016/j.eurpolymj.2004.02.023
   Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872
   Avrami M., 1940, Journal of Chemical Physics, V8, P212, DOI 10.1063/1.1750631
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   Balsamo V, 2000, MACROMOL CHEM PHYSIC, V201, P2711, DOI 10.1002/1521-3935(20001201)201:18<2711::AID-MACP2711>3.3.CO;2-Y
   Bezwada RS, 1997, HDB BIODEGRADABLE PO, P29
   Bhattarai N, 2003, EUR POLYM J, V39, P1365, DOI 10.1016/S0014-3057(02)00389-0
   Bogdanov B, 1999, MACROMOLECULES, V32, P726, DOI 10.1021/ma980226a
   Brandrup J., 1999, POLYM HDB
   CASTILLO V, 2004, UNPUB
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   DOUZINAS KC, 1991, MACROMOLECULES, V24, P4457, DOI 10.1021/ma00015a033
   FILLON B, 1993, J POLYM SCI POL PHYS, V31, P1383, DOI 10.1002/polb.1993.090311013
   Floudas G, 1997, MACROMOLECULES, V30, P4381, DOI 10.1021/ma9616118
   GERVAIS M, 1981, POLYMER, V22, P1129, DOI 10.1016/0032-3861(81)90304-9
   Hamley IW, 1996, MACROMOLECULES, V29, P8835, DOI 10.1021/ma960343a
   Hillmyer MA, 1997, MACROMOL SYMP, V117, P121, DOI 10.1002/masy.19971170116
   Ho RM, 2003, MACROMOLECULES, V36, P9085, DOI 10.1021/ma0347868
   Hobbs JK, 2001, MACROMOLECULES, V34, P5508, DOI 10.1021/ma0104478
   LAMBERT WS, 1994, MACROMOLECULES, V27, P3537, DOI 10.1021/ma00091a014
   LAURITZEN JI, 1973, J APPL PHYS, V44, P4340, DOI 10.1063/1.1661962
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Loo YL, 2002, MACROMOLECULES, V35, P2365, DOI 10.1021/ma011824j
   Loo YL, 2001, MACROMOLECULES, V34, P8968, DOI 10.1021/ma011521p
   Lotz B., 1969, POLYMER, V10, P820
   MANDELKERN L, 1993, PHYS PROPERTIES POLY
   Mark JE, 1996, PHYS PROPERTIES POLY
   Muller AJ, 2002, MACROMOLECULES, V35, P3048, DOI 10.1021/ma012026w
   MULLER AJ, 2004, IN PRESS MACR S
   Nojima S, 2002, POLYMER, V43, P4087, DOI 10.1016/S0032-3861(02)00217-3
   NOJIMA S, 1992, MACROMOLECULES, V25, P2237, DOI 10.1021/ma00034a027
   OMALLEY JJ, 1977, J POLYM SCI PS, V60, P151
   Quiram DJ, 1998, MACROMOLECULES, V31, P4891, DOI 10.1021/ma971218h
   Quiram DJ, 1997, MACROMOLECULES, V30, P8338, DOI 10.1021/ma9708050
   Quiram DJ, 1997, MACROMOLECULES, V30, P4551, DOI 10.1021/ma961524f
   RANGARAJAN P, 1995, MACROMOLECULES, V28, P4932, DOI 10.1021/ma00118a022
   RANGARAJAN P, 1995, MACROMOLECULES, V28, P1422, DOI 10.1021/ma00109a013
   RANGARAJAN P, 1993, MACROMOLECULES, V26, P4640, DOI 10.1021/ma00069a034
   Raquez JM, 2000, MACROMOL RAPID COMM, V21, P1063, DOI 10.1002/1521-3927(20001001)21:15<1063::AID-MARC1063>3.0.CO;2-B
   Reiter G, 2003, J POLYM SCI POL PHYS, V41, P1869, DOI 10.1002/polp.10518
   Reiter G, 2001, PHYS REV LETT, V87, DOI [10.1103/PhysRevLett.87.226101, 10.1103/PhysRevLett.87.186101, 10.1103/PhysRevLett.87.166103]
   RICHARDSON PH, 1995, POLYMER, V36, P3059, DOI 10.1016/0032-3861(95)97866-E
   ROBITAILLE C, 1983, MACROMOLECULES, V16, P665, DOI 10.1021/ma00238a033
   Rohadi A, 2000, POLYM J, V32, P602, DOI 10.1295/polymj.32.602
   Rohadi A, 2000, POLYM J, V32, P859, DOI 10.1295/polymj.32.859
   Ryan AJ, 1997, MACROMOLECULES, V30, P1723, DOI 10.1021/ma960943+
   RYAN AJ, 1995, MACROMOLECULES, V28, P3860, DOI 10.1021/ma00115a016
   Sabino MA, 2004, BIOMACROMOLECULES, V5, P358, DOI 10.1021/bm034367i
   Sabino MA, 2000, MACROMOL CHEM PHYSIC, V201, P2687, DOI 10.1002/1521-3935(20001201)201:18<2687::AID-MACP2687>3.0.CO;2-#
   Schmalz H, 2003, MACROMOL CHEM PHYSIC, V204, P111, DOI 10.1002/macp.200290063
   Schultz JM., 2001, POLYM CRYSTALLIZATIO
   Shiomi T, 2002, MACROMOLECULES, V35, P8056, DOI 10.1021/ma0200118
   Sommer J-U, 2003, POLYM CRYSTALLIZATIO
   Ueda M, 2003, POLYMER, V44, P6995, DOI 10.1016/S0032-3861(03)00697-9
   Wang YB, 2001, J POLYM SCI POL CHEM, V39, P2755, DOI 10.1002/pola.1254
   Weimann PA, 1999, J POLYM SCI POL PHYS, V37, P2053, DOI 10.1002/(SICI)1099-0488(19990815)37:16<2053::AID-POLB9>3.3.CO;2-C
   WUNDERLICH B, 1976, MACROMOLECULAR PHYSI, V2, P52
   Xu JT, 2003, EUR POLYM J, V39, P2091, DOI 10.1016/S0014-3057(03)00155-1
   Zhu L, 2002, MACROMOLECULES, V35, P3553, DOI 10.1021/ma012184n
   Zhu L, 1999, PHYS REV B, V60, P10022, DOI 10.1103/PhysRevB.60.10022
   Zhu L, 2001, POLYMER, V42, P9121, DOI 10.1016/S0032-3861(01)00394-9
   Zhu L, 2002, ADV MATER, V14, P31, DOI 10.1002/1521-4095(20020104)14:1<31::AID-ADMA31>3.0.CO;2-3
   Zhu L, 2001, POLYMER, V42, P5829, DOI 10.1016/S0032-3861(00)00902-2
NR 66
TC 103
Z9 103
U1 2
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-6640
EI 1364-5498
J9 FARADAY DISCUSS
JI Faraday Discuss.
PY 2005
VL 128
BP 231
EP 252
DI 10.1039/b403085k
PG 22
WC Chemistry, Physical
SC Chemistry
GA 872PX
UT WOS:000225220800016
PM 15658776
DA 2018-10-20
ER

PT S
AU Lendlein, A
   Kelch, S
AF Lendlein, A
   Kelch, S
BE VanderBiest, O
   Gasik, M
   Vleugels, J
TI Degradable, multifunctional polymeric biomaterials with shape-memory
SO FUNCTIONALLY GRADED MATERIALS VIII
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 8th International Symposium on Multifunctional and Functionally Graded
   Materials (FMG2004)
CY JUL 11-14, 2004
CL Leuven, BELGIUM
SP Royal Soc Flemish Engineers, Technol Inst, Katholieke Univ Leuven, Dept Met & Mat Engn
DE elastomers; polymer networks; shape-memory polymers; stimuli-sensitive
   polymers; functionalized material; multifunctionality
ID POLYETHER-BASED POLYURETHANES; HEAT SHRINKABLE PRODUCTS;
   HYBRID-COMPOSITES; OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; BIOMEDICAL
   APPLICATIONS; SMART SYSTEMS; POLYNORBORNENE; BEHAVIOR
C1 GKSS Forschungszentrum Geesthacht GmbH, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Kantstr 55, D-14513 Teltow, Germany.
EM lendlein@gkss.de; kelch@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Charlesby A, 1960, ATOMIC RAD POLYM, P198
   CHEN W, 1983, RADIAT PHYS CHEM, V22, P593, DOI 10.1016/0146-5724(83)90068-7
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Jeong HM, 2000, J MATER SCI, V35, P279, DOI 10.1023/A:1004728814128
   Jeong HM, 2000, POLYMER, V41, P1849, DOI 10.1016/S0032-3861(99)00334-1
   Kim BK, 1998, POLYMER, V39, P2803, DOI 10.1016/S0032-3861(97)00616-2
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   KLEINHEINS G, 1984, KUNSTST-GER PLAST+, V74, P445
   KLEINHEINS G, 1986, KUNSTST-GER PLAST+, V76, P1069
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Li FK, 1997, J APPL POLYM SCI, V64, P1511, DOI 10.1002/(SICI)1097-4628(19970523)64:8<1511::AID-APP8>3.0.CO;2-K
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   Lin JR, 1998, J APPL POLYM SCI, V69, P1563, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1563::AID-APP11>3.0.CO;2-W
   Lin JR, 1998, J APPL POLYM SCI, V69, P1575, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1575::AID-APP12>3.0.CO;2-U
   LIPSCOMB P, 1996, APPL SHAPE MEMORY AL
   Machi S, 1996, RADIAT PHYS CHEM, V47, P333, DOI 10.1016/0969-806X(95)00125-H
   Maitland DJ, 2002, P SOC PHOTO-OPT INS, V4626, P394, DOI 10.1117/12.472105
   MANTOVANI D, 2000, JOM, V10, P36
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   NAKASIMA A, 1991, EUR J ORTHODONT, V13, P179, DOI 10.1093/ejo/13.3.179
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   Otsuka K., 1998, SHAPE MEMORY MAT, P1
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   SAKURAI K, 1993, J APPL POLYM SCI, V47, P937, DOI 10.1002/app.1993.070470521
   SAKURAI K, 1989, J APPL POLYM SCI, V38, P1191, DOI 10.1002/app.1989.070380616
   Uchino K., 1998, SHAPE MEMORY MAT, P184
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247
   Wei ZG, 1998, J MATER SCI, V33, P3763, DOI 10.1023/A:1004674630156
   WILKES KE, 2000, JOM, V10, P45
   Yang DZ, 2000, MATER DESIGN, V21, P503, DOI 10.1016/S0261-3069(00)00008-X
NR 36
TC 53
Z9 53
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-970-9
J9 MATER SCI FORUM
PY 2005
VL 492-493
BP 219
EP 223
DI 10.4028/www.scientific.net/MSF.492-493.219
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Characterization & Testing; Materials Science,
   Coatings & Films
SC Materials Science
GA BCR97
UT WOS:000230986100036
DA 2018-10-20
ER

PT S
AU Kaufman, JD
   Klapperich, CM
AF Kaufman, JD
   Klapperich, CM
BE Wahl, KJ
   Huber, N
   Mann, AB
   Bahr, DF
   Cheng, YT
TI Nanomechanical testing of hydrated biomaterials: Sample preparation,
   data validation and analysis
SO Fundamentals of Nanoindentation and Nanotribology III
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Fundamentals of Nanoindentation and Nanotribology III held
   at the 2004 MRS Fall Meeting
CY NOV 29-DEC 03, 2004
CL Boston, MA
SP MRS
AB Implants, tissue engineering scaffold materials, drug delivery and bio-micro electromechanical systems (BioMEMs) all use polymer or hydrogel materials. These applications require both mechanical performance and successful integration of the material into a biological environment. Mechanical strength, storage and loss moduli, wear resistance and surface adhesion proper-ties are all critical in biomedical device design and can be determined using nanoindentation. The difficulty of obtaining large samples of specialized materials, and the complexity of testing soft materials in traditional materials testing apparatus, make nanoindentation an attractive alternative. Our previous research using nanoindentation to measure the surface mechanical properties of non-hydrated polymers led to improvement in nanoindentation testing protocols. One of the major challenges in using this technique for hydrogels and tissues is maintaining and controlling hydration of the materials during the test. Here we describe the design of a microfluidic platform for nanoindentation that facilitates continuous hydration of hydrogel samples and high throughput nanomechanical testing. Data from creep experiments on synthetic, hydrated poly-2-hydroxyethyl methaerylate (poly-HEMA) are presented. In addition, we show data to validate the materials properties determined from nanomechanical testing by complementary testing. Finally, the data is fitted to a phenomenological model for viscoelastic materials, specifically the three-element standard linear solid model used by Cheng et al. [1].
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Kaufman, JD (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
OI Klapperich, Catherine/0000-0001-6103-849X
CR Cheng L, 2000, J POLYM SCI POL PHYS, V38, P10, DOI 10.1002/(SICI)1099-0488(20000101)38:1<10::AID-POLB2>3.0.CO;2-6
   EBENSTEIN DM, 1996, THESIS U CALIFORNIA
   KLAPPERICH CM, 2004, WORLD BIOM C SYDN AU
   KLAPPERICH CM, 2004, MAT RES SOC P, V823
   OLIVER WC, 1992, J MATER RES, V7, P6
   Tsui TY, 1997, MATER RES SOC SYMP P, V473, P57
   XIA X, 2000, THESIS U MINNESOTA
NR 7
TC 1
Z9 1
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-789-X
J9 MATER RES SOC SYMP P
PY 2005
VL 841
BP 69
EP 74
PG 6
WC Materials Science, Multidisciplinary; Mechanics; Materials Science,
   Characterization & Testing
SC Materials Science; Mechanics
GA BCI82
UT WOS:000229609400010
DA 2018-10-20
ER

PT S
AU Salzer, R
   Steiner, G
   Tunc, S
AF Salzer, R
   Steiner, G
   Tunc, S
BE Kundu, T
TI In-vivo investigation of protein adsorption on implant surfaces
SO Health Monitoring and Smart Nondestructive Evaluation of Structural and
   Biological Systems IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Health Monitoring and Smart Nondestructive Evaluation of
   Structural and Biological Systems IV
CY MAR 07-09, 2005
CL San Diego, CA
SP SPIE
DE infrared; Raman; spectroscopic imaging; biomolecules; biomimetic
   material
ID ATOMIC-FORCE MICROSCOPY; DEPENDENT CONFORMATIONS; FIBRINOGEN
AB A decisive problem in biomedical or biomaterial research of the post-genomic era is the determination of protein structure and function. Common techniques that can give full structural information do not permit in-vivo measurements. Vibrational Proteomics - an innovative combination of biochemical techniques and infrared or Raman spectroscopy - can provide information which will hell) substantially to fill this gap. Infrared and Raman spectroscopy are well established as methods for qualitative and quantitative analysis of protein secondary structure, in solution and even when adsorbed to implant surfaces. Their singular advantage over other techniques is that spectra can be obtained for proteins in a wide range of environments, in solutions and on surfaces including polymers, metals and bioceramics. Here we report on structural changes in fibrinogen from the dissolved to the adsorbed state on implant material of different hydrophobicity. FTIR imaging permits the identification of coagulation spots on the implant.
C1 Dresden Univ Technol, Inst Analyt Chem, D-01062 Dresden, Germany.
RP Salzer, R (reprint author), Dresden Univ Technol, Inst Analyt Chem, D-01062 Dresden, Germany.
RI Tunc, Sibel/C-1651-2016
CR Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Jones DB, 2004, PROTEOMICS, V4, P1007, DOI 10.1002/pmic.200300662
   JORGENSEN L, 2003, INT J PHARM, V18, P7
   JUN HW, 2005, BIOMACROMOLECULES
   Kawamoto N, 1998, J BIOMAT SCI-POLYM E, V9, P543, DOI 10.1163/156856298X00037
   Kopecky V, 2003, BIOCHEM BIOPH RES CO, V300, P41, DOI 10.1016/S0006-291X(02)02765-1
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu XY, 2003, J BIOMED MATER RES A, V66A, P722, DOI 10.1002/jbm.a.10014
   MATHEWS CK, 1999, BIOCHEMISTRY-US, P161
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Salzer R, 2003, P SOC PHOTO-OPT INS, V5047, P362, DOI 10.1117/12.484153
   SARVER RW, 1991, ANAL BIOCHEM, V199, P61, DOI 10.1016/0003-2697(91)90269-Y
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   TUNC S, UNPUB COLLOIDS SUR B
NR 18
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5749-3
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5768
BP 19
EP 26
DI 10.1117/12.598386
PG 8
WC Engineering, Civil; Instruments & Instrumentation; Materials Science,
   Characterization & Testing; Optics
SC Engineering; Instruments & Instrumentation; Materials Science; Optics
GA BCO19
UT WOS:000230386200003
DA 2018-10-20
ER

PT B
AU Zarkadas, DM
   Li, B
   Sirkar, KK
AF Zarkadas, Dimitrios M.
   Li, Baoan
   Sirkar, Kamalesh K.
GP ASME
TI Polymeric Hollow Fiber Heat Exchangers (PHFHEs): A new type of compact
   heat exchanger for lower temperature applications
SO HT2005: PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE 2005,
   VOL 4
LA English
DT Proceedings Paper
CT ASME Heat Transfer Summer Conference
CY JUL 15-22, 2005
CL San Francisco, CA
SP ASME
ID FILM; CONDENSATION; PERFORMANCE; SYSTEMS
AB Plastic heat exchangers are characterized by an inferior thermal performance compared to their metal counterparts. Therefore, their usage is mainly limited to handling corrosive media or when ultra high purity is required, e.g., pharmaceutical industry. Polymeric Hollow Fiber Heat Exchangers (PHFHEs) have recently been proposed [1] as a new type of heat exchanger that can overcome these constraints and offer the same or better thermal performance than metallic shell and tube or plate heat exchangers while occupying a much smaller volume. In this paper we report our results for heat transfer in PHFHEs with both parallel and cross flow in the shell side of the device. Fibers made of polypropylene (PP) and polyetheretherketone (PEEK) were tested. In addition, steam condensation studies in PHFHEs are reported for the first time. The overall heat transfer coefficients achieved for water-water and water-brine systems are as high as 1400 Wm(-2) K-1. These values are higher than any value reported for plastic heat exchangers and comparable with commonly acceptable design values for metal shell and tube heat exchangers. Similar coefficients were obtained for steam condensation. Polymeric hollow fiber heat exchangers can also achieve high thermal effectiveness, large number of transfer units (NTU) and very small height of a transfer unit (HTU), if properly rated. If designed like commercial membrane contactors, they can achieve up to 12 transfer units in a single device, not longer than 60-70 cm! In addition, the conductance per unit volume PHFHEs achieved was up to one order of magnitude higher compared to metal heat transfer equipment. This superior thermal performance is also accompanied by considerably lower pressure drops. Therefore, the operation of PHFHEs will be characterized by a low operating cost. Combined with the much lower cost, lower weight and elimination of metal contamination polymer materials offer, it is obvious that PHFHEs constitute a potential substitute for metal heat exchangers on both thermal performance and economical grounds. Possible application fields include the food, pharmaceutical and biomedical industries as well as applications where corrosion resistant, light and very efficient devices are required, i.e., desalination, solar and offshore heat transfer applications.
C1 New Jersey Inst Technol, Ctr Membrane Technol, York Dept Chem Engn, Newark, NJ 07102 USA.
RP Zarkadas, DM (reprint author), New Jersey Inst Technol, Ctr Membrane Technol, York Dept Chem Engn, Newark, NJ 07102 USA.
CR BANDELIER P, 1992, MAT TECH PARIS, V9, P67
   BIGG DM, 1989, POLYM ENG SCI, V29, P1111, DOI 10.1002/pen.760291607
   Bourouni K, 1997, DESALINATION, V114, P111, DOI 10.1016/S0011-9164(98)00003-4
   Brouwers HJH, 1996, INT J HEAT MASS TRAN, V39, P391, DOI 10.1016/0017-9310(95)00113-N
   Burns JR, 2001, APPL THERM ENG, V21, P495, DOI 10.1016/S1359-4311(00)00063-6
   DAVIDSON J, 1999, P REN ADV EN SYST 21
   Deronzier JC, 1997, APPL THERM ENG, V17, P799, DOI 10.1016/S1359-4311(96)00086-5
   Drummond M, 2003, ARTIF ORGANS, V27, P465, DOI 10.1046/j.1525-1594.2003.07240.x
   DUERI JP, 2002, Patent No. 6428747
   El-Dessouky HT, 1999, DESALINATION, V122, P271, DOI 10.1016/S0011-9164(99)00048-X
   ELGAS RJ, 1997, Patent No. 9725080
   GITHENS RE, 1965, CHEM ENG PROG, V61, P55
   HETSRONI G, 1994, CHEM ENG PROCESS, V33, P91, DOI 10.1016/0255-2701(94)85007-0
   JACHUCK RJJ, 1994, CHEM ENG RES DES, V72, P255
   JOHANNSEN K, 1983, LOW REYNOLDS NUMBER, P229
   Kays W. M., 1984, COMPACT HEAT EXCHANG
   Kern DQ, 1965, PROCESS HEAT TRANSFE
   LAURO F, 1979, DESALINATION, V31, P221, DOI 10.1016/S0011-9164(00)88523-9
   LIU W, 2000, T ASME, V122, P84
   LONDON AL, 1983, LOW REYNOLDS NUMBER, P815
   MCFALL FB, 1999, Patent No. 6001306
   MORCOS VH, 1995, J ELASTOM PLAST, V27, P200, DOI 10.1177/009524439502700208
   Perry R. H, 1999, PERRYS CHEM ENG HDB
   Raju KS, 1983, LOW REYNOLDS NUMBER, P899
   Raman R, 2000, J SOL ENERG-T ASME, V122, P92, DOI 10.1115/1.1288214
   SCHLUNDLER EU, 1983, HEAT EXCHANGER DESIG
   SHAH RK, 1983, LOW REYNOLDS NUMBER, P21
   WANG KL, 1993, J MEMBRANE SCI, V85, P265, DOI 10.1016/0376-7388(93)85280-A
   WEAVER JM, 1960, CHEM ENG PROG, V56, P49
   WHARRY JR, 1995, MET FINISH, V93, P693
   Whitley D. M., 1957, CHEM ENG, V64, P308
   Zaheed L, 2005, J POWER SOURCES, V140, P304, DOI 10.1016/j.jpowsour.2004.08.024
   Zaheed L, 2004, APPL THERM ENG, V24, P2323, DOI 10.1016/j.applthermaleng.2004.03.018
   Zarkadas DM, 2004, IND ENG CHEM RES, V43, P8093, DOI 10.1021/ie040143k
NR 34
TC 3
Z9 3
U1 0
U2 11
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-4734-9
PY 2005
BP 429
EP 438
DI 10.1115/HT2005-72590
PG 10
WC Thermodynamics
SC Thermodynamics
GA BFN98
UT WOS:000243380100051
DA 2018-10-20
ER

PT S
AU Ban, YH
   Choi, SJ
   Jiang, ZW
   Park, C
AF Ban, YH
   Choi, SJ
   Jiang, ZW
   Park, C
BE Wei, YL
   Chong, KT
   Takahashi, T
   Liu, SP
   Li, Z
   Jiang, ZW
   Choi, JY
TI Development of a belt-type wearable sensor system with multi-function
   for home health care - art. no. 60401Y
SO ICMIT 2005: Mechatronics, MEMS, and Smart Materials
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Conference on Mechatronics and Information Technology
   (ICMIT 05)
CY SEP 20-23, 2005
CL Chongqing, PEOPLES R CHINA
SP Chongqing Inst Technol, Korea/Japan Joint Adv Mech Res Assoc, Mech Engn Soc, Chongqing Inst Technol, Mechatron Res Ctr, Biomed & Welfare Div, CRC, Inst B W E, Yamaguchi Univ, Fac Symbiot Syst Sci, Fukushima Univ, Natl Sci Fdn China, China Assoc Artificial Intelligence, China Assoc Automatizat, Special Comm Intelligent Automatizat, Inst Control Automat & Syst Engineers, Soc Instruments & Control Engn, Korea Soc Precis Engn, Japan Soc Mech Engineers, Robot Soc Japan, Korea Inst Informat & Telecommun Fac Engn, Chongqing Sci & Technol Comm, Mech Engn Soc Chongqing, Chongqing Educ Comm, Biomed Engn Soc Chongqing
DE belt-type wearable sensor; body impedance; ECG; primary health care;
   respiration; %BF
AB Some reports show that the physiological information measured in hospital is not enough without the one measured in home. The physiological information monitored in home, therefore, is strongly required recently. The goal of this research is to develop a wearable and tractable sensor system for detecting biomedical signals such as cardiac rhythm, respiration, body movement, and percentage of body fat (%BF) and for home health care. A belt type sensor for this purpose is developed, which consists of sensing materials of PVDF film and conductive fabrics. Also several data processing techniques, such as the discrete wavelet transform, cross correlation and adaptive filtering method, were introduced to eliminate noises and base wandering and to extract the specified components. The ECG and respiration signals obtained by the proposed belt type sensor system gave good agreements with commercial medical system. Furthermore, the body fat (%BF) measurement based on the four-electrode BIA was also built in the belt sensor. The body fat was calculated by measuring the body impedance from the belt type sensor and compared with the predicted %BF measured by the commercial adipometer (TBF-607). The results validated also the efficiency of the belt type sensor system.
C1 Yamaguchi Univ, Dept Mech Engn, Ube, Yamaguchi 7558611, Japan.
RP Ban, YH (reprint author), Yamaguchi Univ, Dept Mech Engn, Ube, Yamaguchi 7558611, Japan.
CR Edwards T., 1991, DISCRETE WAVELET TRA
   EISENBERG A, 1992, GUIDE TECHNICAL EDIT
   Kyle UG, 2005, NUTRITION, V21, P161, DOI 10.1016/j.nut.2004.04.023
   Liedtke R.J., 1998, FUNDAMENTALS BIOELEC
   LUKASHI HC, 1998, AVIAT SPACE ENV MED, V59, P1163
   Piccoli A, 2005, KIDNEY INT, V67, P301, DOI 10.1111/j.1523-1755.2005.00083.x
   Quiroga RQ, 2001, BRAIN RES PROTOC, V8, P16
NR 7
TC 0
Z9 0
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6072-9
J9 P SOC PHOTO-OPT INS
PY 2005
VL 6040
BP Y401
EP Y401
AR 60401Y
DI 10.1117/12.664240
PG 6
WC Engineering, Electrical & Electronic; Engineering, Mechanical;
   Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Engineering; Instruments & Instrumentation; Materials Science
GA BDU16
UT WOS:000235358400070
DA 2018-10-20
ER

PT J
AU Byoungjoong, K
   Park, JH
   Cho, J
   Kwon, K
   Lim, S
   Yoon, J
   Cheon, C
   Kim, YK
   Kwon, Y
AF Byoungjoong, K
   Park, JH
   Cho, J
   Kwon, K
   Lim, S
   Yoon, J
   Cheon, C
   Kim, YK
   Kwon, Y
TI Novel low-cost planar probes with broadside apertures for nondestructive
   dielectric measurement of biological materials at microwave frequencies
SO IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES
LA English
DT Article
DE biomedical application; microelectromechanical systems (MEMS);
   nondestructive measurement; planar-type probe
ID ENDED COAXIAL LINE; LYMPH-NODE; SENSORS; PERMITTIVITY; CALIBRATION;
   RADIATION; LIQUIDS; TISSUES
AB Novel planar-type probes were developed to demonstrate the possibility of replacing the existing high-cost open-ended coaxial probes. The planar probes of this study define an aperture on the broadside of the probe body. In this way, the contact area can be maximized and/or customized according to specific medical needs. The probes with various aperture sizes and shapes can also be fabricated simultaneously in a single batch process. Three probes are developed in this paper: a probe combining two laminates, a microelectromechanical systems (MEMS)-based probe with a single benzocyclobutene (BCB) layer on a quartz substrate, and another MEMS probe with two BCB layers defined on a silicon substrate. The third probe was specifically designed for monolithic integration with driving circuits on a single substrate. Limitations in the high-frequency performance of the planar probes were carefully studied, and higher order modes and incomplete shielding were found to be the main causes. The measurement results of each probe showed excellent compatibility with those of the open-ended coaxial probe up to almost 40 GHz. The proposed planar-type probes have great potentials for practical medical applications in view of low cost, disposability, and monolithic integration capability with the driving circuits.
C1 Seoul Natl Univ, Ctr Three Dimens Millimeter Wave Integrated, Sch Elect Engn, Seoul 151742, South Korea.
   Seoul Natl Univ, Dept Elect Engn, Seoul 130743, South Korea.
RP Byoungjoong, K (reprint author), Samsung Elect Co, Syst Large Scale Integrat Div, RF Grp, Yongin 449711, South Korea.
EM ykwon@snu.ac.kr
CR BAKHTIARI S, 1994, IEEE T MICROW THEORY, V42, P1261, DOI 10.1109/22.299765
   Choi JW, 2004, BREAST CANCER RES TR, V86, P107, DOI 10.1023/B:BREA.0000032979.52773.fb
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   ESSELLE KPAP, 1988, IEEE T INSTRUM MEAS, V37, P101, DOI 10.1109/19.2675
   FRATTICCIOLI E, 2002, IEEE MTT S INT MICR, V2, P647
   Hagl DA, 2003, IEEE T MICROW THEORY, V51, P1194, DOI 10.1109/TMTT.2003.809626
   Hagness SC, 1998, IEEE T BIO-MED ENG, V45, P1470, DOI 10.1109/10.730440
   Harrington R. F., 1961, TIME HARMONIC ELECTR
   JOINES WT, 1994, MED PHYS, V21, P547, DOI 10.1118/1.597312
   KANG B, 2004, IEEE MTT S INT MICR, P1441
   KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6
   LARSON LE, 1991, MICR MILL WAV MON CI, P27
   MISRA D, 1990, IEEE T MICROW THEORY, V38, P8, DOI 10.1109/22.44150
   NYSHADHAM A, 1992, IEEE T MICROW THEORY, V40, P305, DOI 10.1109/22.120103
   POURNAROPOULOS CL, 1994, IEEE T INSTRUM MEAS, V43, P111, DOI 10.1109/19.293405
   Raj A, 2001, IEEE T INSTRUM MEAS, V50, P905, DOI 10.1109/19.948297
   STUCHLY MA, 1980, IEEE T INSTRUM MEAS, V29, P176, DOI 10.1109/TIM.1980.4314902
   STUCHLY SS, 1998, 12 INT MICR RAD C, V3, P755
   SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374
   WEI YZ, 1991, IEEE T MICROW THEORY, V39, P526, DOI 10.1109/22.75296
   WELLER TM, 1995, IEEE T MICROW THEORY, V43, P534, DOI 10.1109/22.372098
NR 21
TC 3
Z9 3
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9480
J9 IEEE T MICROW THEORY
JI IEEE Trans. Microw. Theory Tech.
PD JAN
PY 2005
VL 53
IS 1
BP 134
EP 143
DI 10.1109/TMTT.2004.839904
PG 10
WC Engineering, Electrical & Electronic
SC Engineering
GA 887ZI
UT WOS:000226343600015
DA 2018-10-20
ER

PT J
AU Bloomsmith, MA
   Else, JG
AF Bloomsmith, MA
   Else, JG
TI Behavioral management of chimpanzees in biomedical research facilities:
   The state of the science
SO ILAR JOURNAL
LA English
DT Article
DE animal care; animal husbandry; animal training; behavioral management;
   breeding; chimpanzee; distress; environmental enrichment
ID CAPTIVE CHIMPANZEES; PAN-TROGLODYTES; ABNORMAL BEHAVIORS; YOUNG
   CHIMPANZEES; PEER GROUPS; FEEDING ENRICHMENT; FORAGE MATERIAL;
   LARGE-SAMPLE; AGGRESSION; ROCKING
AB The current status of the behavioral management of chimpanzees housed in US research facilities is examined, and recent advances are described. Behavioral management includes the application of environmental enrichment, animal training, and environmental design for improving animal welfare. Authors surveyed the six major chimpanzee holding facilities and found that the vast majority of chimpanzees are housed socially, with access to the outdoors. The institutions currently invest in behavioral scientists, enrichment specialists, and, most recently, chimpanzee trainers to implement and study chimpanzee behavioral management. This review is based on the substantial scientific literature related to managing social behavior, identifying the behavioral effects of restricted socialization, evaluating various forms of enrichment, and describing positive reinforcement animal training. Authors outline recent accomplishments in behavioral management, summarize behavioral issues that have been evaluated, and identify issues for future consideration. It is proposed that the enhanced application of behavioral management techniques, including training., could significantly reduce chimpanzee stress that is generally associated with experimental manipulations, and could improve animal welfare and the quality of biomedical research. The next challenge is to implement effectively and thoroughly the approaches that have been shown to be beneficial.
C1 Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.
RP Bloomsmith, MA (reprint author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.
FU NCRR NIH HHS [RR-00165]
CR ALFORD PL, 1995, ZOO BIOL, V14, P347, DOI 10.1002/zoo.1430140406
   Aureli F, 1997, AM J PRIMATOL, V41, P213, DOI 10.1002/(SICI)1098-2345(1997)41:3<213::AID-AJP4>3.0.CO;2-#
   Baker KC, 1997, ZOO BIOL, V16, P225, DOI 10.1002/(SICI)1098-2361(1997)16:3<225::AID-ZOO3>3.3.CO;2-H
   Baker KC, 2000, AM J PRIMATOL, V51, P161, DOI 10.1002/1098-2345(200007)51:3<161::AID-AJP1>3.0.CO;2-5
   Baker KC, 1996, AM J PRIMATOL, V40, P283, DOI 10.1002/(SICI)1098-2345(1996)40:3<283::AID-AJP5>3.0.CO;2-U
   Baker KC, 1996, APPL ANIM BEHAV SCI, V49, P403, DOI 10.1016/0168-1591(96)01061-1
   Baker KC, 2000, ETHOLOGY, V106, P527, DOI 10.1046/j.1439-0310.2000.00553.x
   BAKER KC, 1996, CONTEMP TOP LAB ANIM, V35, P71
   BAKER KC, 2004, ANIM WELFARE, V12, P239
   BARD KA, 1994, EARLY DEV PARENTING, V3, P19
   BETTINGER T, 1994, ZOO BIOL, V13, P167, DOI 10.1002/zoo.1430130208
   Bloomsmit MA, 1990, LAB ANIM, V19, P42
   BLOOMSMITH M, 1992, AM ASS ZOOL PARKS AQ, P403
   Bloomsmith M. A., 2000, American Journal of Primatology, V51, P44
   Bloomsmith M. A., 2000, American Journal of Primatology, V51, P45
   Bloomsmith M.A., 1989, P336
   BLOOMSMITH MA, 1990, LAB ANIM SCI, V40, P319
   Bloomsmith MA, 1998, ZOO BIOL, V17, P333, DOI 10.1002/(SICI)1098-2361(1998)17:4<333::AID-ZOO6>3.3.CO;2-3
   BLOOMSMITH MA, 1995, APPL ANIM BEHAV SCI, V44, P65, DOI 10.1016/0168-1591(95)00570-I
   BLOOMSMITH MA, 1988, AM J PRIMATOL, V16, P155, DOI 10.1002/ajp.1350160206
   BLOOMSMITH MA, 1994, ZOO BIOL, V13, P557, DOI 10.1002/zoo.1430130605
   BLOOMSMITH MA, 1992, ZOO BIOL, V11, P53, DOI 10.1002/zoo.1430110107
   Bloomsmith MA, 2003, APPL ANIM BEHAV SCI, V84, P235, DOI 10.1016/j.applanim.2003.08.005
   BLOOMSMITH MA, 1994, APPL ANIM BEHAV SCI, V39, P73, DOI 10.1016/0168-1591(94)90017-5
   Bloomsmith MA, 2000, ZOO BIOL, V19, P541, DOI 10.1002/1098-2361(2000)19:6<541::AID-ZOO6>3.0.CO;2-3
   BLOOMSMITH MA, 2001, APES CHALLENGES 21 C, P88
   BLOOMSMITH MA, 2005, IN PRESS NURSERY REA
   BLOOMSMITH MA, 1989, AM J PRIMATOL S, V1, P93
   Bloomsmith MA, 1991, INT J COMP PSYCHOL, V4, P171
   BLOOMSTRAND M, 1986, ZOO BIOL, V5, P293, DOI 10.1002/zoo.1430050307
   BRENT L, 1991, ZOO BIOL, V10, P353, DOI 10.1002/zoo.1430100409
   Brent L, 1997, ZOO BIOL, V16, P335
   BRENT L, 1995, PRIMATES, V36, P265, DOI 10.1007/BF02381352
   BRENT L, 1989, LAB ANIM SCI, V39, P345
   Brent L, 2004, LAB ANIMAL, V33, P37, DOI 10.1038/laban0104-37
   BRENT L, 1995, J MED PRIMATOL, V24, P12, DOI 10.1111/j.1600-0684.1995.tb00139.x
   BRENT L, 1991, J MED PRIMATOL, V20, P29
   Brent L, 1996, AM J PRIMATOL, V39, P139, DOI 10.1002/(SICI)1098-2345(1996)39:2<139::AID-AJP5>3.0.CO;2-#
   Brent L, 1998, J Appl Anim Welf Sci, V1, P5, DOI 10.1207/s15327604jaws0101_2
   Brent L, 1996, LAB ANIM SCI, V46, P405
   Brent L., 2001, CARE MANAGEMENT CAPT
   BRENT L, 1989, AM J PRIMATOL S, V1, P65
   Caws C, 2003, INT J PRIMATOL, V24, P1077, DOI 10.1023/A:1026280329544
   Davenport R. K., 1970, CHIMPANZEE, V3, P337
   DEWAAL FBM, 1986, ETHOL SOCIOBIOL, V7, P237, DOI 10.1016/0162-3095(86)90051-8
   DEWAAL FBM, 1989, ZOO BIOL S, V1, P89
   EDER G, 1994, ROLE CHIMPANZEE RES
   Erwin J., 1979, CAPTIVITY BEHAV PRIM
   Erwin J., 1992, CHIMPANZEE CONSERVAT, P65
   FITCH AL, 1989, AM J PRIMATOL S, V1, P71
   FRITZ J, 1992, AM J PRIMATOL, V27, P161, DOI 10.1002/ajp.1350270302
   FRITZ J, 1992, ZOO BIOL, V11, P313, DOI 10.1002/zoo.1430110503
   FRITZ J, 1989, AM J PRIMATOL S, V1, P79
   FULK R, 1992, CAPTIVE ENV HUSBANDR, pR12
   GOFF C, 1994, ZOO BIOL, V3, P61
   HANNAH AC, 1990, ZOO BIOL, V9, P233, DOI 10.1002/zoo.1430090306
   Howell S, 2003, LAB ANIMAL, V32, P31, DOI 10.1038/laban1103-31
   HOWELL SM, 1993, ANIM WELFARE, V2, P153
   Keeling ME, 1991, LOOKING GLASS, P57
   Kessel A, 1996, ANIMAL TECHNOLOGY, V47, P1
   KING NE, 1994, ZOO BIOL, V13, P51, DOI 10.1002/zoo.1430130107
   Lambeth SP, 2004, AM J PRIMATOL, V62, P37
   LAMBETH SP, 1994, ANIM WELFARE, V3, P13
   LAMBETH SP, 1992, LAB ANIM SCI, V42, P261
   Lambeth SP, 1997, ZOO BIOL, V16, P327, DOI 10.1002/(SICI)1098-2361(1997)16:4<327::AID-ZOO4>3.0.CO;2-C
   Laule GE, 1996, ZOO BIOL, V15, P587, DOI 10.1002/(SICI)1098-2361(1996)15:6<587::AID-ZOO4>3.0.CO;2-7
   MAKI K, 1989, NTT REVIEW, V1, P71
   MAKI S, 1989, ZOO BIOL, V8, P79, DOI 10.1002/zoo.1430080110
   MAKI S, 1993, INFANT BEHAV DEV, V16, P373, DOI 10.1016/0163-6383(93)80042-7
   Maple T., 1979, CAPTIVITY BEHAV PRIM, P239
   Morgan Kathleen N., 1998, P153
   Nash LT, 1999, AM J PRIMATOL, V48, P15, DOI 10.1002/(SICI)1098-2345(1999)48:1<15::AID-AJP2>3.0.CO;2-R
   NOVAK MA, 1988, AM J PRIMATOL, V14, P435
   *NRC, 1996, GUID CAR US LAB AN
   NRC (National Research Council), 1997, CHIMP RES STRAT THEI
   ORKIN JL, 1993, LAB ANIM SCI, V43, P260
   PAQUETTE D, 1988, ZOO BIOL, V7, P15, DOI 10.1002/zoo.1430070103
   Pazol KA, 1997, ANIM WELFARE, V6, P133
   PAZOL KA, 1993, ANIM WELFARE, V2, P113
   PRINCE AM, 1989, J MED PRIMATOL, V18, P27
   Pruetz JD, 1992, ANIM WELFARE, V1, P127
   Pruetz JD, 1995, FOLIA PRIMATOL, V65, P174, DOI 10.1159/000156886
   PRUETZ JDE, 2001, CARE MANAGEMENT CAPT, P17
   ROGERS CM, 1970, CHIMPANZEE, V3, P361
   Russell W. M. S., 1959, PRINCIPLES HUMANE EX
   Sanz Crickette, 1999, Journal of Applied Animal Welfare Science, V2, P1, DOI 10.1207/s15327604jaws0201_1
   Seres M, 2001, ZOO BIOL, V20, P501, DOI 10.1002/zoo.10003
   SHEFFERLY N, 1992, AM J PRIMATOL, V26, P119, DOI 10.1002/ajp.1350260206
   Shepherdson David J., 1998, P1
   Spijkerman RP, 1995, NETH J ZOOL, V45, P402
   Spijkerman RP, 1997, INT J PRIMATOL, V18, P439, DOI 10.1023/A:1026342602018
   SPIJKERMAN RP, 1990, FOLIA PRIMATOL, V55, P41, DOI 10.1159/000156496
   Spijkerman RP, 1996, BEHAVIOUR, V133, P717, DOI 10.1163/156853996X00440
   Visalberghi E, 2002, ZOO BIOL, V21, P539, DOI 10.1002/zoo.10057
   Whittaker Margaret, 2001, P131
   WRANGHAM RW, 1992, CHIMPANZEE CONSERVAT, P71
   Wrangham RW, 1994, CHIMPANZEE CULTURES
NR 97
TC 18
Z9 18
U1 0
U2 13
PU INST LABORATORY ANIMAL RESEARCH, NATL RES COUNCIL
PI WASHINGTON
PA 500 FIFTH ST, N W, WASHINGTON, DC 20001 USA
SN 1084-2020
J9 ILAR J
JI ILAR J.
PY 2005
VL 46
IS 2
BP 192
EP 201
DI 10.1093/ilar.46.2.192
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA 901BW
UT WOS:000227259000012
PM 15775028
OA Bronze
DA 2018-10-20
ER

PT J
AU Singh, VR
AF Singh, VR
TI Smart sensors: Physics, technology and applications
SO INDIAN JOURNAL OF PURE & APPLIED PHYSICS
LA English
DT Review
DE smart sensors; biochips; biosensors; silicon strain sensor;
   physiological sensor
ID BIOCHIPS
AB The semiconductor technology has advanced a rapid progress in the sensors which are heart of instrumentation systems. These days, most of the sensors are 'smart' in nature. In such sensors, the sensing elements and associated electronics are integrated on the same chip. Generally, silicon is preferred as sensor material because it can give a suitable physical conversion effect and can give suitable signal processing circuit, with integration of the sensing element and electronic circuits on the chip, by using standard planar technology. The smart sensors have main advantages of fast signal conditioning, higher signal-to-noise ratio, self testing, auto calibration, small physical size, high reliability, failure prevention and detection. In the present paper, recent advances in smart sensors along with their design and fabrication aspects, are discussed. The smart sensors developed in this Laboratory, mainly smart pressure sensors and smart lithotripsy sensor, are presented, besides smart sensors used in industrial controls, automotive and biomedical fields. Biochips and biosensors are also cited for some of the specific applications.
C1 Natl Phys Lab, Instrumentat & Sensors Grp, New Delhi 110012, India.
RP Singh, VR (reprint author), Natl Phys Lab, Instrumentat & Sensors Grp, Dr Krishnan Rd, New Delhi 110012, India.
EM vrsingh@mail.nplindia.ernet.in
CR AGARWAL R, 2000, P NAT C BIOM ENG ROO, P224
   Bhatia KG, 2002, INDIAN J PURE AP PHY, V40, P515
   GIACHINO JM, 1986, SENSOR ACTUATOR, V10, P239, DOI 10.1016/0250-6874(86)80048-8
   Gomez R, 2001, BIOMED MICRODEVICES, V3, P201, DOI 10.1023/A:1011403112850
   Gomez R, 2002, SENSOR ACTUAT B-CHEM, V86, P198, DOI 10.1016/S0925-4005(02)00175-2
   HEINTZ F, 1989, SENSOR ACTUATOR, V13, P39
   HUIJSING JH, 1992, SENSOR ACTUAT A-PHYS, V30, P167, DOI 10.1016/0924-4247(92)80212-L
   Lee MY, 2003, BIOTECHNOL BIOENG, V83, P20, DOI 10.1002/bit.10642
   Lochab J, 2004, INDIAN J PURE AP PHY, V42, P595
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   SINGH K, 2000, 24 NAT S INSTR GOA I
   SINGH K, 2000, P AS PAC IEEE C BIOM, P863
   Singh R., 1993, IETE Technical Review, V10, P557
   Singh VR, 2004, INDIAN J PURE AP PHY, V42, P189
   SINGH VR, 1974, BIOTELEMETRY, V2, P28
   SINGH VR, 1997, P C METR REL ENV NEW
   SINGH VR, 1997, PHYS SEMICONDUCTOR D, P195
   SINGH VR, 1996, P IND S MOD AUT IND, P10
   SINGH VR, 1996, MAIN GROUP ELEMENTS, P204
   SINGH VR, 1996, ADV METROLOGY ITS RO, P242
   SMITH G, 1995, SENSOR ACTUAT A-PHYS, V46, P521
   Vo-Dinh T, 1999, ANAL CHEM, V71, P358, DOI 10.1021/ac980043m
   Vo-Dinh T, 2001, SENSOR ACTUAT B-CHEM, V74, P2, DOI 10.1016/S0925-4005(00)00705-X
NR 23
TC 6
Z9 6
U1 2
U2 14
PU NATL INST SCIENCE COMMUNICATION
PI NEW DELHI
PA DR K S KRISHNAN MARG, NEW DELHI 110 012, INDIA
SN 0019-5596
J9 INDIAN J PURE AP PHY
JI Indian J. Pure Appl. Phys.
PD JAN
PY 2005
VL 43
IS 1
BP 7
EP 16
PG 10
WC Physics, Multidisciplinary
SC Physics
GA 893DE
UT WOS:000226698700001
DA 2018-10-20
ER

PT B
AU Nowak, MD
AF Nowak, Michael D.
GP ASME
TI Combined mechanical engineering materials lecture and mechanics of
   materials laboratory: Cross-disciplinary teaching
SO Innovations in Engineering Education - 2005: Mechanical Engineering
   Education; Mechanical Engineering Technology Department Heads
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 05-11, 2005
CL Orlando, FL
SP ASME, Proc Ind Div, ASME, Rail Transportat Div, ASME, Noise Control & Acoust Div, ASME, Triol Div, ASME, Pressure Vessels & Piping Div, ASME, Bioengn Div, ASME, Mat Div, ASME, Appl Mech Div, ASME, Fluids Engn Div, ASME, Micro Elect Mech Syst Div, ASME, Heat Transfer Div, ASME, Nucl Engn Div, ASME, Power Div, ASME, Solar Energy Div, ASME, Safety Engn & Risk Anal Div, ASME, Technol & Soc Div, ASME, Adv Energy Syst Div, ASME, Aerosp Div, ASME, Comp & Informat Engn Div
AB We have developed a course combining a Mechanical Engineering Materials Laboratory with a Materials Science lecture for a small combined population of undergraduate Mechanical and Biomedical Engineering students. By judicious selection of topic order, we have been able to utilize one lecture and one laboratory for both Mechanical and Biomedical Engineering students (with limited splitting of groups).
   The primary reasons for combining the Mechanical and Biomedical students are to reduce faculty load and required resources in a small university. For schools with medium or small Mechanical and Biomedical Engineering programs, class sizes could be improved if they could include other populations. The heterogeneous populations also aid in teaching students that the same engineering techniques are useful in more than a single engineering realm.
   The laboratory sections begin with the issues common to designing and evaluating mechanical testing, followed by tensile, shear, and torsion evaluation of metals. To introduce composite materials, wood and cement are evaluated. While the Mechanical Engineering students are evaluating impact and strain gauges, the Biomedical Engineering students are performing tensile studies of soft tissues, and compression of long bones.
   The basic materials lectures (beginning at the atomic level) are in common with both Mechanical and Biomedical student populations, until specific topics such as human body materials are discussed. Three quarters of the term is thus taught on a joint basis, and three or four lectures are split. Basic metal, plastic and wood behavior is common to both groups.
C1 Univ Hartford, Coll Engn Technol & Architecture, Dept Civil Environ & Biomed Engn, Hartford, CT 06001 USA.
RP Nowak, MD (reprint author), Univ Hartford, Coll Engn Technol & Architecture, Dept Civil Environ & Biomed Engn, Hartford, CT 06001 USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-4232-0
PY 2005
BP 137
EP 142
PG 6
WC Education, Scientific Disciplines; Engineering, Multidisciplinary;
   Engineering, Mechanical
SC Education & Educational Research; Engineering
GA BFM36
UT WOS:000243055200018
DA 2018-10-20
ER

PT S
AU Postma, H
   Perego, RC
   Borella, A
   Siegler, P
   Wynants, R
   Schillebeeckx, P
AF Postma, H
   Perego, RC
   Borella, A
   Siegler, P
   Wynants, R
   Schillebeeckx, P
BE Haight, RC
   Chadwick, MB
   Kawano, T
   Talou, P
TI Some applications of neutron resonance capture analysis
SO International Conference on Nuclear Data for Science and Technology, Pts
   1 and 2
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Nuclear Data for Science and Technology
CY SEP 26-OCT 01, 2004
CL Santa Fe, NM
SP OECD Nucl Energy Agcy, Int Atom Energy Agcy, US DOE, Los Alamos Natl Lab, Acqiris Corp, Amer Inst Phys, Canberra Ind Inc, Eljen Technologies, Goodfellow Corp, Inst Phys, St Gobain, Bicron, Scionix USA, Struck, Techsource, Thermoelectron, Wiener, Natl Nucl Data Ctr
ID ACTIVATION ANALYSIS
AB The probability for nuclei to capture neutrons reveals sharp peaks, so-called "resonances," which occur at neutron energies specific for each element. These resonances are very suitable for identifying and quantifying elements in objects and materials. They are the basis of an analytical method called "Neutron-Resonance-Capture-Analysis" (NRCA). This is a fully non-destructive method applicable to almost all stable isotopes, which determines the bulk elemental composition, and does not require any sample preparation and results in negligible residual activity. Up to now NRCA has been mostly applied for archaeological applications. In this paper we review the technique and discuss the applicability of the technique in the biomedical field and in material science.
C1 Tech Univ Delft, IRI, NL-2629 JB Delft, Netherlands.
RP Postma, H (reprint author), Tech Univ Delft, IRI, Mekelweg 15, NL-2629 JB Delft, Netherlands.
RI Borella, Alessandro/K-3054-2012
CR Blaauw M, 2003, NUCL INSTRUM METH A, V505, P508, DOI 10.1016/S0168-9002(03)01134-3
   BOCKHOFF KH, 1990, NUCL SCI ENG, V106, P192
   BORELLA A, AIP CONF PROC
   de Jonge S., GEDER2487 IRMM
   Gonzalez J., GERINF0697 IRMM
   GUNSING F, 1994, THESIS DELFT U
   PEREGO RC, 2004, P MOD TRENDS ACT AN
   POSTMA H, IN PRESS J RADIOANAL
   POSTMA H, 2003, CZECH J PHYS, V33, pA233
   POSTMA H, 2004, P MOD TRENDS ACT AN
   POSTMA H, IN PRESSA ARCHAEOMET
   Tzaphlidou M, 2002, APPL RADIAT ISOTOPES, V57, P779, DOI 10.1016/S0969-8043(02)00171-9
   VOGEL AI, 1961, QUANTITATIVE INORGAN
   Winkler EM, 1994, STONE ARCHITECTURE
NR 14
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0254-X
J9 AIP CONF PROC
PY 2005
VL 769
BP 1393
EP 1396
PN 1-2
PG 4
WC Nuclear Science & Technology; Physics, Applied; Physics, Nuclear
SC Nuclear Science & Technology; Physics
GA BCP35
UT WOS:000230511801071
DA 2018-10-20
ER

PT J
AU Kawashita, M
AF Kawashita, M
TI Ceramic microspheres for biomedical applications
SO INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY
LA English
DT Article
ID Y-90 GLASS MICROSPHERES; PRIMARY LIVER-CANCER; HEPATIC
   RADIOEMBOLIZATION; SYSTEM FEO-FE2O3-CAO-SIO2; HEPATOCELLULAR-CARCINOMA;
   HYPERTHERMIC TREATMENT; MAMMARY-CARCINOMA; ARTERIAL Y-90; TUMOR-THERAPY;
   HEAT
AB Cera-mic microspheres are expected to be useful for cancer treatment and antibacterial treatment. In this article, several attempts to prepare ceramic microspheres for such biomedical applications are described. Ceramic microspheres containing large amounts of yttrium or phosphorus are useful for radiotherapy of cancers, since they can be activated to become P-emitters by neutron bombardment. Ferrimagnetic microspheres are useful as thermoseeds for hyperthermia of cancers because they can heat cancers locally by hysteresis loss of the ferrimagnetic materials under an alternating magnetic field. Silver-containing silica glass microspheres are useful as antibacterial materials when mixed with organic polymers, particularly fine-spun polymer fibers.
C1 Kyoto Univ, Grad Sch Engn, Ion Beam Engn Expt Lab, Kyoto 6158510, Japan.
RP Kawashita, M (reprint author), Kyoto Univ, Grad Sch Engn, Ion Beam Engn Expt Lab, Kyoto 6158510, Japan.
EM kawashita@kuee.kyoto-u.ac.jp
RI Kawashita, Masakazu/E-6632-2016
OI Kawashita, Masakazu/0000-0002-4329-9001
CR ANDERSON JH, 1992, RADIOTHER ONCOL, V25, P137, DOI 10.1016/0167-8140(92)90020-U
   ANDREWS JC, 1994, J NUCL MED, V35, P1637
   ARAKI N, 2004, T 7 WORLD BIOM C AUS, P1827
   BORRELLI NF, 1982, AM CERAM SOC BULL, V61, P819
   BORRELLI NF, 1984, PHYS MED BIOL, V29, P487, DOI 10.1088/0031-9155/29/5/001
   BURTON MA, 1989, NUCL MED BIOL, V16, P495
   Cao XC, 1999, CHINESE MED J-PEKING, V112, P430
   CAVALIER.R, 1967, CANCER, V20, P1351, DOI 10.1002/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO;2-#
   Chen SD, 2001, NUCL MED COMMUN, V22, P121, DOI 10.1097/00006231-200102000-00002
   Day DE, 1993, INTRO BIOCERAMICS, P305
   EBISAWA Y, 1991, NIPPON SERAM KYO GAK, V99, P7
   EBISAWA Y, 1993, J MATER SCI-MATER M, V4, P225, DOI 10.1007/BF00122273
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Ebisawa Y, 1997, J CERAM SOC JPN, V105, P947, DOI 10.2109/jcersj.105.947
   EHRHARDT GJ, 1987, NUCL MED BIOL, V14, P233
   ERBE EM, 1993, J BIOMED MATER RES, V27, P1301, DOI 10.1002/jbm.820271010
   HIRAOKA M, 1989, CANCER RES, V49, P3734
   HOULE S, 1989, RADIOLOGY, V172, P857, DOI 10.1148/radiology.172.3.2549567
   HYATT MJ, 1987, J AM CERAM SOC, V70, pC283, DOI 10.1111/j.1151-2916.1987.tb04901.x
   IKENAGA M, 1993, J ORTHOP RES, V11, P849, DOI 10.1002/jor.1100110611
   Kawashita M, 1999, J AM CERAM SOC, V82, P683
   Kawashita M, 2005, BIOMATERIALS, V26, P2231, DOI 10.1016/j.biomaterials.2004.07.014
   Kawashita M, 2004, J CERAM SOC JPN, V112, P373, DOI 10.2109/jcersj.112.373
   Kawashita M, 2003, J BIOMED MATER RES A, V66A, P266, DOI 10.1002/jbm.a.10547
   Kawashita M, 2003, BIOMATERIALS, V24, P2955, DOI 10.1016/S0142-9612(03)00094-2
   Kawashita M, 2001, J CERAM SOC JPN, V109, P39, DOI 10.2109/jcersj.109.39
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   KNOWLES JE, 1981, J MAGN MAGN MATER, V25, P105, DOI 10.1016/0304-8853(81)90153-0
   KOKUBO T, 1992, BIOCERAMICS, V3, P213
   Konaka H, 1997, J CERAM SOC JPN, V105, P833, DOI 10.2109/jcersj.105.833
   LUDERER AA, 1983, RADIAT RES, V94, P190, DOI 10.2307/3575874
   MANTRAVADI RVP, 1982, RADIOLOGY, V142, P783, DOI 10.1148/radiology.142.3.7063703
   OHURA K, 1991, J APPL BIOMATER, V2, P153, DOI 10.1002/jab.770020303
   OVERGAARD J, 1977, CANCER-AM CANCER SOC, V39, P2637, DOI 10.1002/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S
   OVERGAARD K, 1972, EUR J CANCER, V8, P573, DOI 10.1016/0014-2964(72)90111-9
   SHEPHERD FA, 1992, CANCER, V70, P2250, DOI 10.1002/1097-0142(19921101)70:9<2250::AID-CNCR2820700906>3.0.CO;2-4
   Tian JH, 1996, J NUCL MED, V37, P958
   WOLLNER I, 1988, CANCER, V61, P1336, DOI 10.1002/1097-0142(19880401)61:7<1336::AID-CNCR2820610711>3.0.CO;2-K
   YAN ZP, 1993, ACTA RADIOL, V34, P395
   YAN ZP, 1993, CANCER, V72, P3210, DOI 10.1002/1097-0142(19931201)72:11<3210::AID-CNCR2820721113>3.0.CO;2-6
NR 41
TC 24
Z9 24
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1546-542X
EI 1744-7402
J9 INT J APPL CERAM TEC
JI Int. J. Appl. Ceram. Technol.
PY 2005
VL 2
IS 3
BP 173
EP 183
DI 10.1111/j.1744-7402.2005.02023.x
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA 934MU
UT WOS:000229713700001
DA 2018-10-20
ER

PT B
AU Tjandra, W
   Ravi, P
   Tam, KC
   Yao, J
AF Tjandra, Wiliana
   Ravi, Palaniswamy
   Tam, Kam Chiu
   Yao, Jia
BE Zhou, W
   Ngoi, B
   Lim, GC
TI Precipitation of calcium phosphate in the presence of double hydrophilic
   block copolymer PEO-b-PMAA
SO INTERNATIONAL JOURNAL OF NANOSCIENCE, VOL 4, NO 4
SE International Journal of Nanoscience Series
LA English
DT Proceedings Paper
CT 1st International Conference on Nanotechnology (Nanotech 2004)
CY JUL 13-17, 2004
CL Singapore, SINGAPORE
DE calcium phosphate; PEO-b-PMAA
ID CRYSTAL-GROWTH MODIFIERS; DESIGN
AB Polyethylene oxide-block-polymethacrytic acid (PEO-b-PMAA) copolymer was employed as template for the controlled precipitation of calcium phosphate from aqueous solution at different pH values. Two interesting superstructures of an organized inorganic/organic hybrid material were characterized by electron microscopy. At pH of 4, a nested structure was obtained, which consists of hybrid nancifilaments. The fibers originate from a core of similar size to the primary polymer aggregates, suggesting that cooperative interactions at a local level between dissolving calcium phosphate clusters and disassembling polymer units could be responsible for the highly anisotropic nature of the secondary growth process. At pH of 9, a fractal induced growth morphology was obtained through the mineralization process. Such calcium phosphate/polymer nanohybrids with complex morphologies are interesting and may find application as novel ceramics precursors, reinforcing fillers, or biomedical implants.
C1 Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
RP Tjandra, W (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
RI Tam, Michael/G-4813-2010
OI Tam, Michael/0000-0002-7603-5635
CR Antonietti M, 1998, CHEM-EUR J, V4, P2493, DOI 10.1002/(SICI)1521-3765(19981204)4:12<2493::AID-CHEM2493>3.0.CO;2-V
   Colfen H, 2001, MACROMOL RAPID COMM, V22, P219, DOI 10.1002/1521-3927(20010201)22:4<219::AID-MARC219>3.0.CO;2-G
   Colfen H, 1998, LANGMUIR, V14, P582, DOI 10.1021/la970765t
   Mann S, 1995, BIOMIMETIC MAT CHEM
   Qi LM, 2000, ANGEW CHEM INT EDIT, V39, P604, DOI 10.1002/(SICI)1521-3773(20000204)39:3<604::AID-ANIE604>3.0.CO;2-B
   Qi LM, 2001, CHEM-EUR J, V7, P3526, DOI 10.1002/1521-3765(20010817)7:16<3526::AID-CHEM3526>3.0.CO;2-Z
   Ravi P, 2003, MACROMOLECULES, V36, P173, DOI 10.1021/ma021302j
   Sedlak M, 1998, MACROMOL CHEM PHYSIC, V199, P247, DOI 10.1002/(SICI)1521-3935(19980201)199:2<247::AID-MACP247>3.0.CO;2-9
   Yao J, 2003, J MATER CHEM, V13, P3053, DOI 10.1039/b308801d
   Yu SH, 2002, CHEM-EUR J, V8, P2937, DOI 10.1002/1521-3765(20020703)8:13<2937::AID-CHEM2937>3.0.CO;2-I
NR 10
TC 1
Z9 1
U1 0
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
J9 INT J NANOSCI SER
PY 2005
VL 4
IS 4
BP 731
EP 736
DI 10.1142/S0219581X05003437
PG 6
WC Nanoscience & Nanotechnology
SC Science & Technology - Other Topics
GA BGE42
UT WOS:000246301500042
DA 2018-10-20
ER

PT J
AU De Teresa, JM
   Marquina, C
   Serrate, D
   Fernandez-Pacheco, R
   Morellon, L
   Algarabel, PA
   Ibarra, MR
AF De Teresa, J. M.
   Marquina, C.
   Serrate, D.
   Fernandez-Pacheco, R.
   Morellon, L.
   Algarabel, P. A.
   Ibarra, M. R.
TI From magnetoelectronic to biomedical applications based on the nanoscale
   properties of advanced magnetic materials
SO INTERNATIONAL JOURNAL OF NANOTECHNOLOGY
LA English
DT Article
DE magnetoelectronic applications; biomedical applications; half-metals;
   magnetic tunnel junctions; inter-grain tunnel magnetoresistance;
   encapsulated nanoparticles
ID HALF-METALLIC FERROMAGNETS; ELECTRON-SPIN POLARIZATION;
   TUNNEL-JUNCTIONS; LARGE MAGNETORESISTANCE; INTERGRAIN MAGNETORESISTANCE;
   DOUBLE PEROVSKITES; CURIE-TEMPERATURE; ROOM-TEMPERATURE; FIELD;
   PARTICLES
AB In this paper, we review some results obtained in our group in the framework of research projects concerning magnetoelectronic and biomedical applications with advanced magnetic materials. First, we focus on the type of materials used, and then we describe specific magnetoelectronic devices based on spin-dependent tunnelling and magnetic nanoparticles for biomedical applications. Special attention is drawn to the phenomena occurring at the nanometric scale, which in most cases completely determine the observed macroscopic properties.
C1 Univ Zaragoza, CSIC, Inst Ciencia Mat Aragon, Fac Ciencias, Zaragoza, Spain.
   Inst Nanociencia Aragon, Zaragoza, Spain.
RP De Teresa, JM (reprint author), Univ Zaragoza, CSIC, Inst Ciencia Mat Aragon, Fac Ciencias, Zaragoza, Spain.
EM deteresa@unizar.es; clara@unizar.es; serrate@unizar.es;
   pacheco@unizar.es; morellon@unizar.es; algarabe@unizar.es;
   ibarra@unizar.es
RI DE TERESA, JOSE/E-2430-2011; Serrate, David/B-1433-2016; Marquina,
   Clara/N-4123-2014; Ibarra, Manuel Ricardo/K-1150-2014; Algarabel,
   Pedro/K-8583-2014
OI DE TERESA, JOSE/0000-0001-9566-0738; Serrate, David/0000-0002-3260-9641;
   Marquina, Clara/0000-0003-0602-492X; Ibarra, Manuel
   Ricardo/0000-0003-0681-8260; Algarabel, Pedro/0000-0002-4698-3378;
   /0000-0003-3724-508X
CR Alexiou C, 2002, J MAGN MAGN MATER, V252, P363, DOI 10.1016/S0304-8853(02)00605-4
   ALVARADO SF, 1975, PHYS REV LETT, V34, P319, DOI 10.1103/PhysRevLett.34.319
   Bowen M, 2001, APPL PHYS LETT, V79, P1655, DOI 10.1063/1.1404125
   Brown PJ, 2000, J PHYS-CONDENS MAT, V12, P1827, DOI 10.1088/0953-8984/12/8/325
   Bulte JWM, 1999, J MAGN MAGN MATER, V194, P204, DOI 10.1016/S0304-8853(98)00556-3
   Butler WH, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054416
   Cadek M, 2002, CARBON, V40, P923, DOI 10.1016/S0008-6223(01)00221-4
   Cullity B. D., 1974, INTRO MAGNETIC MAT
   Dagotto E, 2001, PHYS REP, V344, P1, DOI 10.1016/S0370-1573(00)00121-6
   De Teresa JM, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144401
   De Teresa JM, 1999, SCIENCE, V286, P507, DOI 10.1126/science.286.5439.507
   De Teresa JM, 1999, PHYS REV LETT, V82, P4288, DOI 10.1103/PhysRevLett.82.4288
   DEGROOT RA, 1983, PHYS REV LETT, V50, P2024, DOI 10.1103/PhysRevLett.50.2024
   DeTeresa JM, 1997, NATURE, V386, P256
   Diouf B, 2003, J MAGN MAGN MATER, V265, P204, DOI 10.1016/S0304-8853(03)00267-1
   Faure-Vincent J, 2003, APPL PHYS LETT, V82, P4507, DOI 10.1063/1.1586785
   Fontcuberta J, 2002, J MAGN MAGN MATER, V242, P98, DOI 10.1016/S0304-8853(01)01208-2
   Gabillet L, 2004, J MAGN MAGN MATER, V272, pE1525, DOI 10.1016/j.jmmm.2003.12.1056
   Gruttner C, 2001, J MAGN MAGN MATER, V225, P1, DOI 10.1016/S0304-8853(00)01220-8
   Hehn M, 2004, EUR PHYS J B, V40, P19, DOI 10.1140/epjb/e2004-00234-6
   Inoue J, 1996, PHYS REV B, V53, P11927, DOI 10.1103/PhysRevB.53.R11927
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   JULLIERE M, 1975, PHYS LETT A, V54, P225, DOI 10.1016/0375-9601(75)90174-7
   Kato H, 2002, APPL PHYS LETT, V81, P328, DOI 10.1063/1.1493646
   Kobayashi KL, 1998, NATURE, V395, P677, DOI 10.1038/27167
   Kozlova N, 2003, J MAGN MAGN MATER, V261, P48, DOI 10.1016/S0304-8853(02)01411-7
   KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0
   Kuznetsov AA, 2001, J MAGN MAGN MATER, V225, P95, DOI 10.1016/S0304-8853(00)01235-X
   LeClair P, 2002, APPL PHYS LETT, V80, P625, DOI 10.1063/1.1436284
   LeClair P, 2001, PHYS REV LETT, V86, P1066, DOI 10.1103/PhysRevLett.86,1066
   Lee S, 1999, PHYS REV LETT, V82, P4508, DOI 10.1103/PhysRevLett.82.4508
   Mariotto G, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.245426
   MARTINEZBOUBETA C, 2003, J APPL PHYS, V94, P4006
   MOODERA JS, 1988, PHYS REV LETT, V61, P637, DOI 10.1103/PhysRevLett.61.637
   MOODERA JS, 1993, PHYS REV LETT, V70, P853, DOI 10.1103/PhysRevLett.70.853
   MOODERA JS, 1995, PHYS REV LETT, V74, P3273, DOI 10.1103/PhysRevLett.74.3273
   Navarro J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.092411
   Oleinik II, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.020401
   OTTO MJ, 1989, J PHYS-CONDENS MAT, V1, P2341, DOI 10.1088/0953-8984/1/13/007
   PALSTROM F, 2003, MRS BULL, V28, P725
   Pannetier M, 2004, SCIENCE, V304, P1648, DOI 10.1126/science.1096841
   Pardoe H, 2003, MAGN RESON IMAGING, V21, P483, DOI 10.1016/S0730-725X(03)00072-9
   Pardoe H, 2001, J MAGN MAGN MATER, V225, P41, DOI 10.1016/S0304-8853(00)01226-9
   Park JH, 1998, NATURE, V392, P794, DOI 10.1038/33883
   Rechenberg HR, 2001, J MAGN MAGN MATER, V226, P1930, DOI 10.1016/S0304-8853(00)00667-3
   Rittmannsberger H, 2000, EUR ADDICT RES, V6, P2, DOI 10.1159/000019003
   Seneor P, 1999, APPL PHYS LETT, V74, P4017, DOI 10.1063/1.123246
   Serrate D, 2004, EUR PHYS J B, V39, P35, DOI 10.1140/epjb/e2004-001G7-0
   Serrate D, 2002, APPL PHYS LETT, V80, P4573, DOI 10.1063/1.1485119
   Soulen RJ, 1998, SCIENCE, V282, P85, DOI 10.1126/science.282.5386.85
   Ziolo R. F., 2002, EUR CELLS MATER, V3, P92
NR 51
TC 16
Z9 16
U1 0
U2 8
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA
PA WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 856, CH-1215
   GENEVA, SWITZERLAND
SN 1475-7435
EI 1741-8151
J9 INT J NANOTECHNOL
JI Int. J. Nanotechnol.
PY 2005
VL 2
IS 1-2
BP 3
EP 22
PG 20
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 074FF
UT WOS:000239797400002
DA 2018-10-20
ER

PT J
AU Shikanov, A
   Kumar, N
   Domb, AJ
AF Shikanov, A
   Kumar, N
   Domb, AJ
TI Biodegradable polymers: An update
SO ISRAEL JOURNAL OF CHEMISTRY
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; PLASMID DNA; GAMMA-IRRADIATION; MOLECULAR-WEIGHT;
   IN-VITRO; POLY(4-HYDROXY-L-PROLINE ESTER); ALIPHATIC POLYESTERS;
   RICINOLEIC ACID; GENE DELIVERY; BONE FIXATION
AB The use of polymeric materials for the administration of pharmaceuticals, and as biomedical devices has increased dramatically. This review focuses on synthetic biodegradable polymers of current interest for medical use, based on ester and anhydride bonds. Special attention is given to factors affecting biodegradation, including: polymer structure, morphology, molecular weight, radiation, and chemical treatment, as well as the effects of drugs and plasticizers added to the polymer mass. The toxicity and biocompatibility of the polymers and their current and future applications in medicine are also briefly reviewed.
C1 Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel.
   NIPER, Dept Pharmaceut, Mohali 160062, India.
RP Domb, AJ (reprint author), Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel.
EM adomb@md.huji.ac.il
OI Shikanov, Ariella/0000-0003-0159-6419
CR Alexis F, 2005, POLYM INT, V54, P36, DOI 10.1002/pi.1697
   Amsden B, 2004, BIOMACROMOLECULES, V5, P637, DOI 10.1021/bm034457n
   Arvanitoyannis IS, 1999, J MACROMOL SCI R M C, VC39, P205
   ATALA A, 2005, REGENERATIVE MED LI, V994, P181
   BENEDICT CV, 1983, J APPL POLYM SCI, V28, P327, DOI 10.1002/app.1983.070280128
   BENEDICT CV, 1983, J APPL POLYM SCI, V28, P335, DOI 10.1002/app.1983.070280129
   Bezwada R. S., 1990, T SOC BIOMATER, VXIII, P194
   BOGDANSKY S, 1990, DRUGS PHARM SCI, V45, P231
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   CHU CC, 1985, POLYMER, V26, P591, DOI 10.1016/0032-3861(85)90160-0
   Dang WB, 1996, J CONTROL RELEASE, V42, P83, DOI 10.1016/0168-3659(96)01371-5
   Dang WB, 1996, PHARMACEUT RES, V13, P683, DOI 10.1023/A:1016035229961
   DOMB AJ, 1995, BIOMATERIALS, V16, P1069, DOI 10.1016/0142-9612(95)98902-Q
   Domb AJ, 1997, DRUG TARG D, V7, P135
   Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067
   Durucan C, 2001, ADV ENG MATER, V3, P227, DOI 10.1002/1527-2648(200104)3:4<227::AID-ADEM227>3.3.CO;2-T
   Eberhart RC, 2003, J BIOMAT SCI-POLYM E, V14, P299, DOI 10.1163/156856203321478838
   Edwards RC, 2001, J ORAL MAXIL SURG, V59, P19, DOI 10.1053/joms.2001.19267
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   Freudenberg S, 2004, EUR SURG RES, V36, P376, DOI 10.1159/000081648
   Gomes ME, 2004, INT MATER REV, V49, P261, DOI 10.1179/095066004225021918
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   Hakkarainen M, 2002, ADV POLYM SCI, V157, P113
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Huang SJ, 1999, MACROMOL SYMP, V144, P7, DOI 10.1002/masy.19991440104
   Hyon SH, 2003, MACROMOL SYMP, V197, P355, DOI 10.1002/masy.200350731
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Joraku A, 2005, LARYNGOSCOPE, V115, P244, DOI 10.1097/01.mlg.0000154726.77915.cc
   KAWAGUCHI T, 1982, CHEM PHARM BULL, V30, P1517
   KEMNITZER J, 1997, HDB BIODEGRADABLE PO, V7, P251
   Koh JJ, 2000, GENE THER, V7, P2099, DOI 10.1038/sj.gt.3301334
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Korhonen H, 2004, MACROMOL CHEM PHYSIC, V205, P937, DOI 10.1002/macp.200300208
   Krasko MY, 2003, J POLYM SCI POL CHEM, V41, P1059, DOI 10.1002/pola.10651
   Lee M, 2001, PHARMACEUT RES, V18, P427, DOI 10.1023/A:1011037807261
   Leong K W, 1995, Connect Tissue Res, V31, pS69, DOI 10.3109/03008209509116838
   LEONG KW, 1991, POLYM CONTROLLED DRU, V127
   LEONG KW, 1997, CONTROLLED DRUG DELI, V469
   LEWIS DH, 1984, LONG ACTING CONTRACE, V1, P77
   Lim YB, 1999, J AM CHEM SOC, V121, P5633, DOI 10.1021/ja984012k
   Mader K, 1996, APPL RADIAT ISOTOPES, V47, P1669, DOI 10.1016/S0969-8043(96)00236-9
   Maheshwari A, 2000, MOL THER, V2, P121, DOI 10.1006/mthe.2000.0105
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   MCCORMICK CL, 1985, ENCY POLYM SCI ENG, V1, P611
   MENDAK SH, 1984, ANN THORAC SURG, V38, P488, DOI 10.1016/S0003-4975(10)64190-2
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Mumper RJ, 1999, DRUG TARGETING DELIV, V10, P143
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Nagarsekar A, 1999, J DRUG TARGET, V7, P11, DOI 10.3109/10611869909085489
   Nathan A., 1994, BIOMEDICAL POLYM DES, P117
   Orloff LA, 1997, ADV DRUG DELIVER REV, V24, P3, DOI 10.1016/S0169-409X(96)00478-4
   PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1
   Perrin D.E., 1997, HDB BIODEGRADABLE PO, V7, P63
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   POTTS JE, 1984, KIRK OTHMER ENCY C S
   Pruitt LA, 2003, ADV POLYM SCI, V162, P63
   Putnam D, 1999, MACROMOLECULES, V32, P3658, DOI 10.1021/ma982004i
   Schindler A, 1977, CONT TOPICS POLYM SC, V2, P251
   Shikanov A, 2004, J BIOMED MATER RES A, V69A, P47, DOI 10.1002/jbm.a.20101
   Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016
   SIEMANN U, 1985, P INT S CONTROLLED R, V12, P53
   Soppimath KS, 2001, J CONTROL RELEASE, V75, P331, DOI 10.1016/S0168-3659(01)00404-7
   Teomim D, 2001, BIOMACROMOLECULES, V2, P1015, DOI 10.1021/bm010078n
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Tomihata K, 2001, J BIOMED MATER RES, V58, P511, DOI 10.1002/jbm.1048
   VACANTI JP, 1999, LANCET S1, V354, P132
   VERT M, 2005, BIOMACROMOLECULES, V6, P358
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   WALTER KA, 1995, NEUROSURGERY, V37, P1129, DOI 10.1227/00006123-199512000-00013
   WILLIAMS DF, 1984, J APPL POLYM SCI, V29, P1865, DOI 10.1002/app.1984.070290537
   Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425
   Zhang XC, 1996, INT J PHARM, V137, P199, DOI 10.1016/0378-5173(96)04521-8
NR 74
TC 19
Z9 19
U1 0
U2 8
PU LASER PAGES PUBL LTD
PI JERUSALEM
PA MERKAZ SAPIR 6/36, GIVAT SHAUL, PO BOX 35409, JERUSALEM 91352, ISRAEL
SN 0021-2148
J9 ISRAEL J CHEM
JI Isr. J. Chem.
PY 2005
VL 45
IS 4
BP 393
EP 399
DI 10.1560/ATQM-MQ02-GLDU-EF6L
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 988CZ
UT WOS:000233570300002
DA 2018-10-20
ER

PT J
AU Kenawy, ER
   Abdel-Hay, FI
   Abou El-Magd, A
   Mahmoud, Y
AF Kenawy, ER
   Abdel-Hay, FI
   Abou El-Magd, A
   Mahmoud, Y
TI Biologically active polymers: Modification and anti-microbial activity
   of chitosan derivatives
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE anti-microbial polymers; chitosan; biomedical polymers; biocide;
   biological applications of polymers
ID QUATERNARY AMMONIUM; ANTIBACTERIAL ACTIVITY; PHOSPHONIUM GROUPS;
   ADSORPTION; SURFACE; BIOCIDES; RELEASE; FABRICS; CHITIN; FIBER
AB The principal derivative of chitin is chitosan, which is obtained by deacetylation of chitin. Chemical modification of synthetic and natural polymers is a convenient way to obtain materials with unique chemical and physical properties. Chitosan has an amino group at C-2 which is important because amino groups are nucleophilic and readily react with electrophilic reagents. Chitosan modified under mild conditions often results in regioselectivity for the C-2 amino group.
   In the present work, this reactivity was exploited to attach biologically active moieties into the amino groups of chitosan to yield anti-microbial chitosans. Specifically, vanillin, p-hydroxybenzaldehyde, p-chlorobenzaldehyde, anisaldehyde, methyl 4-hydroxybenzoate, methyl 2,4-dihydroxybenzoate, propyl 3,4,5-trihydroxybenzoate and 2-hydroxymethylbenzoate were attached. The anti-microbial activity of these modified chitosans was explored against fungi such as Candida albicans SC5314, Aspergillus flavus and Fusarium oxysporium. Also, they were tested against bacteria such as Bacillus subtilis, Escherichia coli and Staphylococcus aureus. These modified chitosans were found to be highly active toward fungi species more than bacterial species.
C1 Tanta Univ, Fac Sci, Dept Chem, Polymer Res Grp, Tanta, Egypt.
   Tanta Univ, Fac Sci, Dept Bot, Tanta, Egypt.
RP Kenawy, ER (reprint author), Tanta Univ, Fac Sci, Dept Chem, Polymer Res Grp, Tanta, Egypt.
EM ekenawy@yahoo.com
RI ABOUELMAGD, Ahmed/A-2952-2012
OI Mahmoud, Yehia/0000-0002-7009-0115; Kenawy,
   El-Refaie/0000-0002-0194-843X
CR Agullo E, 2003, MACROMOL BIOSCI, V3, P521, DOI 10.1002/mabi.200300010
   Benesch J, 2002, BIOMATERIALS, V23, P2561, DOI 10.1016/S0142-9612(01)00391-X
   Chen Y, 2004, J APPL POLYM SCI, V92, P368, DOI 10.1002/app.20038
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Choi HM, 2004, J APPL POLYM SCI, V92, P3343, DOI 10.1002/app.20332
   Debbaudt A, 2001, MACROMOL BIOSCI, V1, P249, DOI 10.1002/1616-5195(20010801)1:6<249::AID-MABI249>3.0.CO;2-G
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Hu SG, 2002, J APPL POLYM SCI, V86, P2977, DOI 10.1002/app.11261
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   Humeres E, 2002, J PHYS ORG CHEM, V15, P852, DOI 10.1002/poc.559
   Kenawy ER, 2002, J POLYM SCI POL CHEM, V40, P2384, DOI 10.1002/pola.10325
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kenawy ER, 2003, MACROMOL BIOSCI, V3, P107, DOI 10.1002/mabi.200390016
   Kenawy ER, 2002, MACROMOL BIOSCI, V2, P261, DOI 10.1002/1616-5195(200208)2:6<261::AID-MABI261>3.0.CO;2-2
   Kenawy ER, 2001, J APPL POLYM SCI, V82, P1364, DOI 10.1002/app.1973
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   Koseva N, 2001, J BIOACT COMPAT POL, V16, P3
   Lim SH, 2004, CARBOHYD RES, V339, P313, DOI 10.1016/j.carres.2003.10.024
   Mahmoud Y. A. G., 2001, ARAB J BIOTECH, V4, P15
   Morimoto M, 2001, BIOMACROMOLECULES, V2, P1133, DOI 10.1021/bm010063p
   PLASCENCIAJATOMEA, 2003, MACROMOL BIOSCI, V3, P582
   Shin Y, 2001, J APPL POLYM SCI, V80, P2495, DOI 10.1002/app.1357
   Sun YY, 2001, J APPL POLYM SCI, V80, P2460, DOI 10.1002/app.1353
   Sun YY, 2001, J POLYM SCI POL CHEM, V39, P3348, DOI 10.1002/pola.1317
   Tang XH, 2002, J APPL POLYM SCI, V83, P1886, DOI 10.1002/app.2316
   Tozaki H, 1997, J PHARM SCI, V86, P1016, DOI 10.1021/js970018g
   Tsubokawa N, 2000, REACT FUNCT POLYM, V43, P341, DOI 10.1016/S1381-5148(99)00065-6
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Zhu P, 2004, J APPL POLYM SCI, V93, P1037, DOI 10.1002/app.20563
NR 29
TC 50
Z9 50
U1 2
U2 32
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2005
VL 20
IS 1
BP 95
EP 111
DI 10.1177/0883911505049655
PG 17
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 886QA
UT WOS:000226242200006
DA 2018-10-20
ER

PT J
AU Ciardelli, G
   Silvestri, D
   Cristallini, C
   Barbani, N
   Giusti, P
AF Ciardelli, G
   Silvestri, D
   Cristallini, C
   Barbani, N
   Giusti, P
TI The relevance of the transfer of molecular information between natural
   and synthetic materials in the realisation of biomedical devices with
   enhanced properties
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE molecular information; molecular imprinting; biosensors; tissue
   engineering
ID BIOARTIFICIAL POLYMERIC MATERIALS; ACID COPOLYMER MEMBRANE; IMPRINTED
   POLYMERS; ACRYLIC-ACID; TEMPLATE POLYMERIZATION; PHARMACEUTICAL
   APPLICATIONS; RADICAL POLYMERIZATION; SELECTIVE RECOGNITION; ARTIFICIAL
   ANTIBODIES; REACTION-MECHANISM
AB Past and recent attempts to introduce in synthetic polymers molecular information from natural substances through simple blending, template polymerization and molecular imprinting are reviewed. The most promising approaches that can open the way to the realisation of new materials with improved biocompatibility, antibody- or enzyme-like performances are analysed more deeply. The realisation of bioartificial blends from natural and synthetic polymers, molecularly imprinted nanospheres or membranes that can act as recognition element in (bio)sensing devices, as synthetic enzymes or as key constituents of body fluids purification tools is presented in order to make the reader aware of the fascinating possibilities that these techniques make available to the biomedical science and engineering in the close future. The last part of the paper describes recent attempts to insert recognition elements for large molecules as proteins, DNA segments, viruses or whole cells in synthetic polymer systems, in order to develop new systems in the treatments of diseases and for tissue-engineering applications.
C1 Univ Pisa, Dept Chem Engn Ind Chem & Mat Sci, Pisa, Italy.
   CNR, Sect Pisa, Composite & Biomed Mat Inst, I-56100 Pisa, Italy.
RP Ciardelli, G (reprint author), Univ Pisa, Dept Chem Engn Ind Chem & Mat Sci, Pisa, Italy.
EM gianluca.ciardelli@ing.unipi.it
OI Ciardelli, Gianluca/0000-0003-0199-1427; Cristallini,
   Caterina/0000-0002-5924-8401
CR Aherne A, 1996, J AM CHEM SOC, V118, P8771, DOI 10.1021/ja960123c
   Allender CJ, 2000, INT J PHARM, V195, P39, DOI 10.1016/S0378-5173(99)00355-5
   ANDERSSON LI, 1995, P NATL ACAD SCI USA, V92, P4788, DOI 10.1073/pnas.92.11.4788
   ANDERSSON LI, 1996, ADV MOL CELL BIOL B, V15, P651
   BAMFORD CH, 1980, MAKROMOL CHEM, V1, P52
   BOLISAY LD, 2003, MRS FALL M 2003 BOST
   Bossi A, 2001, ANAL CHEM, V73, P5281, DOI 10.1021/ac0006526
   Bures P, 2001, J CONTROL RELEASE, V72, P25, DOI 10.1016/S0168-3659(01)00259-0
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   CERRAI P, 1996, MACROMOL CHEM PHYS, V197, P1
   CHALLA G, 1981, PURE APPL CHEM, V53, P627, DOI 10.1351/pac198153030627
   Cheong SH, 1997, MACROMOLECULES, V30, P1317, DOI 10.1021/ma961014l
   Cheong SH, 1998, J POLYM SCI POL CHEM, V36, P1725, DOI 10.1002/(SICI)1099-0518(199808)36:11<1725::AID-POLA5>3.0.CO;2-Q
   Ciardelli G, 2002, MACROMOL CHEM PHYSIC, V203, P1666, DOI 10.1002/1521-3935(200207)203:10/11<1666::AID-MACP1666>3.0.CO;2-D
   Ciardelli G, 2001, POLYM INT, V50, P588, DOI 10.1002/pi.670
   CIARDELLI G, 2004, MAT RES SOC S P, V787
   Cormack PAG, 1999, REACT FUNCT POLYM, V41, P115, DOI 10.1016/S1381-5148(99)00024-3
   Cristallini C, 2004, MACROMOL BIOSCI, V4, P31, DOI 10.1002/mabi.200300026
   Cristallini C, 2001, MACROMOL CHEM PHYSIC, V202, P2104, DOI 10.1002/1521-3935(20010601)202:10<2104::AID-MACP2104>3.0.CO;2-H
   Cristallini C, 1999, POLYM INT, V48, P1251, DOI 10.1002/(SICI)1097-0126(199912)48:12<1251::AID-PI297>3.0.CO;2-H
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   Giusti P., 1996, POLYM MAT ENCY, P538
   GLAD M, 1995, REACT POLYM, V25, P47, DOI 10.1016/0923-1137(95)00018-E
   Hilal N, 2003, J MEMBRANE SCI, V213, P97, DOI 10.1016/S0376-7388(02)00516-1
   Hirayama K, 1998, CHEM LETT, P731, DOI 10.1246/cl.1998.731
   Hjerten S, 1997, CHROMATOGRAPHIA, V44, P227, DOI 10.1007/BF02466386
   KABANOV VA, 1979, MAKROMOL CHEM S, V3, P41
   Kobayashi T, 2001, ANAL CHIM ACTA, V435, P141, DOI 10.1016/S0003-2670(00)01281-2
   Kobayashi T, 1998, ANAL CHIM ACTA, V365, P81, DOI 10.1016/S0003-2670(97)00667-3
   KOBAYASHI T, 1995, CHEM LETT, P927, DOI 10.1246/cl.1995.927
   KOST J, 1992, TRENDS BIOTECHNOL, V10, P127, DOI 10.1016/0167-7799(92)90194-Z
   Lai JP, 2001, ANAL CHIM ACTA, V442, P105, DOI 10.1016/S0003-2670(01)01115-1
   Lanza F, 1999, ANAL CHEM, V71, P2092, DOI 10.1021/ac981446p
   Levi R, 1997, ANAL CHEM, V69, P2017, DOI 10.1021/ac960983b
   Liao JL, 1996, CHROMATOGRAPHIA, V42, P259, DOI 10.1007/BF02290306
   MANESIOTIS P, 2003, SYNTHETIC RECEPTORS
   MathewKrotz J, 1996, J AM CHEM SOC, V118, P8154, DOI 10.1021/ja954066j
   MAYES AG, 1994, ANAL BIOCHEM, V222, P483, DOI 10.1006/abio.1994.1521
   Mosbach K, 2001, J AM CHEM SOC, V123, P12420, DOI 10.1021/ja017096x
   MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X
   Mosbach K, 1996, BIO-TECHNOL, V14, P163, DOI 10.1038/nbt0296-163
   Nicholls IA, 2001, ANAL CHIM ACTA, V435, P9, DOI 10.1016/S0003-2670(01)00932-1
   Ou SH, 2004, ANAL CHIM ACTA, V504, P163, DOI 10.1016/S0003-2670(03)00531-2
   PARMPI P, 2004, MAT RES SOC S, V787
   Perez-Moral N, 2004, ANAL CHIM ACTA, V504, P15, DOI 10.1016/S0003-2670(03)00533-6
   PILETSKII S A, 1990, Biopolimery i Kletka, V6, P55
   Piletsky SA, 1999, J MEMBRANE SCI, V157, P263, DOI 10.1016/S0376-7388(99)00007-1
   Rachkov A, 2004, ANAL CHIM ACTA, V504, P191, DOI 10.1016/S0003-2670(03)00764-5
   Rachkov A, 2001, BBA-PROTEIN STRUCT M, V1544, P255, DOI 10.1016/S0167-4838(00)00226-0
   Rachkov A, 2000, J CHROMATOGR A, V889, P111, DOI 10.1016/S0021-9673(00)00568-9
   Rainaldi I, 2000, MACROMOL CHEM PHYSIC, V201, P2424, DOI 10.1002/1521-3935(20001101)201:17<2424::AID-MACP2424>3.0.CO;2-8
   Ramstrom O, 1996, CHEM BIOL, V3, P471, DOI 10.1016/S1074-5521(96)90095-2
   Sellergren B, 2000, ANGEW CHEM INT EDIT, V39, P1031, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1031::AID-ANIE1031>3.0.CO;2-F
   Sellergren B, 1998, CHEM MATER, V10, P4037, DOI 10.1021/cm980730u
   SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166
   Silvestri D, 2004, J BIOMAT SCI-POLYM E, V15, P255, DOI 10.1163/156856204322977175
   SLINCHENKO O, SYNTHETIC RECEPTORS
   SRIVASTAVA AK, 1987, J MACROMOL SCI R M C, VC27, P171
   Steinke J, 1995, ADV POLYM SCI, V123, P81
   Subrahmanyam S, 2001, BIOSENS BIOELECTRON, V16, P631, DOI 10.1016/S0956-5663(01)00191-9
   Wang HY, 1997, J CHEM TECHNOL BIOT, V70, P355, DOI 10.1002/(SICI)1097-4660(199712)70:4<355::AID-JCTB793>3.0.CO;2-#
   Wang HY, 1996, LANGMUIR, V12, P4850, DOI 10.1021/la960243y
   Wizeman WJ, 2001, BIOMATERIALS, V22, P1485
   WULFF G, 1972, ANGEW CHEM INT EDIT, V11, P341
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   Ye L, 2000, MACROMOLECULES, V33, P8239, DOI 10.1021/ma000825t
   Ye L, 2001, REACT FUNCT POLYM, V48, P149, DOI 10.1016/S1381-5148(01)00050-5
   YOSHIKAWA M, 1995, J MEMBRANE SCI, V108, P171, DOI 10.1016/0376-7388(95)00160-8
   Yoshikawa M, 1996, CHEM LETT, P611, DOI 10.1246/cl.1996.611
   Yoshikawa M, 1997, MACROMOL RAPID COMM, V18, P761, DOI 10.1002/marc.1997.030180902
   Yu YH, 2002, ANGEW CHEM INT EDIT, V41, P4459, DOI 10.1002/1521-3773(20021202)41:23<4459::AID-ANIE4459>3.0.CO;2-2
   Zi-Hui Meng, 2001, Analytica Chimica Acta, V435, P121, DOI 10.1016/S0003-2670(01)00858-3
NR 72
TC 8
Z9 8
U1 0
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2005
VL 16
IS 2
BP 219
EP 236
DI 10.1163/1568562053115417
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 907QW
UT WOS:000227734000007
PM 15794487
DA 2018-10-20
ER

PT J
AU Ouchi, T
   Kontani, T
   Saito, T
   Ohya, Y
AF Ouchi, T
   Kontani, T
   Saito, T
   Ohya, Y
TI Suppression of cell attachment and protein adsorption onto amphiphilic
   polylactide-grafted dextran films
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biodegradable polymer; dextran; polylactide cell attachment; protein
   adsorption
ID TRIMETHYLSILYL PROTECTION METHOD; L-LACTIDE; BLOCK-COPOLYMERS; IN-VITRO;
   ACID; POLYMERIZATION; DEGRADATION; PULLULAN; SURFACE
AB To develop novel biodegradable biomedical materials, potylactide-grafted dextrans (Dex-g-PLA)s having various lengths, numbers of graft chains and sugar units were synthesized using the trimethylsilyl (TMS) protection method. To explore the possibility of using Dex-g-PLA as a biomedical soft-material, the contact angle, cell attachment and protein adsorption properties of the films prepared from these biodegradable and amphiphilic graft co-polymers were investigated. The poly-L-lactide (PLLA) film did not absorb water at all because of its high hydrophobicity, while the graft co-polymer films started immediately to swell after immersion in PBS. The percentage of water absorption at equilibrium increased with increasing sugar unit content. The receding contact angle of the Dex-g-PLA films against water was smaller than that of the PLLA film. The receding contact angle of Dex-g-PLA films against water decreased with increasing the sugar unit content. The top surface of the Dex-g-PLA film was suggested to be covered with hydrophilic Dex segments by means of annealing in water and to afford the wettable surface. Such a wettable surface led to the suppression of cell attachment and protein adsorption onto the film.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Suita, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
EM touchi@ipcku.karisai-u.ac.jp; yohya@ipcku.kansai-u.ac.jp
CR CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   Donabedian DH, 1998, MACROMOLECULES, V31, P1032, DOI 10.1021/ma961741g
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Harada A, 1998, MACROMOLECULES, V31, P288, DOI 10.1021/ma971277v
   Kissel T, 1996, J CONTROL RELEASE, V39, P315, DOI 10.1016/0168-3659(95)00163-8
   KRICHELDORF HR, 1993, MAKROMOL CHEM-M SYMP, V73, P47, DOI 10.1002/masy.19930730107
   Li YX, 1997, POLYMER, V38, P6197, DOI 10.1016/S0032-3861(97)00178-X
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095
   Ohya Y, 1998, MACROMOL CHEM PHYSIC, V199, P2017, DOI 10.1002/(SICI)1521-3935(19980901)199:9<2017::AID-MACP2017>3.0.CO;2-9
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Ouchi T, 2003, J POLYM SCI POL CHEM, V41, P2462, DOI 10.1002/pola.10783
   Ouchi T, 2003, POLYMER, V44, P3927, DOI 10.1016/S0032-3861(03)000308-2
   Ouchi T, 2001, MACROMOL BIOSCI, V1, P371, DOI 10.1002/1616-5195(20011201)1:9<371::AID-MABI371>3.3.CO;2-N
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TANADA Y, 1994, J BIOMED MATER RES, V28, P783
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   Yamaoka T, 2001, J BIOMED MATER RES, V54, P470, DOI 10.1002/1097-4636(20010315)54:4<470::AID-JBM20>3.3.CO;2-O
   Ydens I, 2000, MACROMOLECULES, V33, P6713, DOI 10.1021/ma0002803
NR 21
TC 12
Z9 12
U1 2
U2 14
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2005
VL 16
IS 8
BP 1035
EP 1045
DI 10.1163/1568562054414649
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 955LF
UT WOS:000231226700008
PM 16128236
DA 2018-10-20
ER

PT J
AU Mequanint, K
   Sheardown, H
AF Mequanint, K
   Sheardown, H
TI 2-methacryloyloxyethyl N-butylcarbamate: a new co-monomer for synthesis
   of polyurethane hydrogels with improved mechanical properties for
   biomedical applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE hydrogel; 2-methacryloyloxyethyl N-butylcarbamate (MBC); 2-hydroxyethyl
   methacrylate (HEMA); mechanical properties; protein adsorption
ID CORNEAL EPITHELIAL-CELLS; WATER-ABSORPTION; ADSORPTION; COMPOSITES;
   COPOLYMERS; PROTEINS; SURFACES; ADHESION; STATES; HEMA
AB Hydrogels with tunable hydrophilic and mechanical properties were synthesized by the free radical polymerization of 2-hydroxyethyl methacrylate (HEMA) and 2-methacryloyloxyethyl N-butylcarbamate. The resulting hydrogels were investigated for their equilibrium water content, sessile drop water contact angles, gel fraction, mechanical properties and protein adsorption. Results indicated that co-polymer hydrogels have good hydrophilicity and that, with the incorporation of the 2-methacryloyloxyethyl N-butylcarbamate, mechanical properties could be improved significantly without affecting other important properties. Lysozyme and albumin adsorption experiments demonstrated that, similar to most hydrogel materials, the co-polymer hydrogels adsorb more lysozyme than albumin and that the adsorption was dependent on hydrophilicity. The control poly(HEMA) hydrogels were found to adsorb more protein than the co-polymer hydrogels; this is thought to be primarily a consequence of protein absorption rather than protein adsorption.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
RP Sheardown, H (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM sheardow@mcmaster.ca
OI Mequanint, Kibret/0000-0002-7888-418X
CR BAE YH, 1993, ADV DRUG DELIVER REV, V11, P109, DOI 10.1016/0169-409X(93)90029-4
   BARNES A, 1988, POLYMER, V29, P2191, DOI 10.1016/0032-3861(88)90111-5
   BERCHTOLD K, 2001, P RADT EUR C BAS, pCH4
   Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   Bruining MJ, 2002, BIOMATERIALS, V23, P1213, DOI 10.1016/S0142-9612(01)00237-X
   CASTILLO EJ, 1985, BIOMATERIALS, V6, P338, DOI 10.1016/0142-9612(85)90089-4
   CHIRILA TV, 1995, J BIOMED MATER RES, V29, P1029, DOI 10.1002/jbm.820290815
   Crawford GJ, 2002, OPHTHALMOLOGY, V109, P883, DOI 10.1016/S0161-6420(02)00958-2
   DAVIS PA, 1991, HIGH PERFORMANCE BIO, P343
   DECKER C, 1991, EUR POLYM J, V27, P403, DOI 10.1016/0014-3057(91)90196-U
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Franco M, 2000, J BIOMED MATER RES, V52, P261, DOI 10.1002/1097-4636(200011)52:2<261::AID-JBM4>3.0.CO;2-2
   Garrett Q, 1996, INVEST OPHTH VIS SCI, V37, P2594
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Garrett Q, 2000, INVEST OPHTH VIS SCI, V41, P1687
   Hodge RM, 1996, POLYMER, V37, P1371, DOI 10.1016/0032-3861(96)81134-7
   Jarvie AWP, 1998, BIOMATERIALS, V19, P1957, DOI 10.1016/S0142-9612(98)00100-8
   Karlsson JO, 1997, POLYMER, V38, P4727, DOI 10.1016/S0032-3861(96)01075-0
   Kliment K, 1968, J Biomed Mater Res, V2, P237, DOI 10.1002/jbm.820020207
   KOBAYASHI H, 1991, BIOMATERIALS, V12, P747, DOI 10.1016/0142-9612(91)90024-5
   Liu Q, 2000, BIOMATERIALS, V21, P2163, DOI 10.1016/S0142-9612(00)00137-X
   MACK EJ, 1988, HYDROGELS MED PHARM, V2, P65
   Merrett K, 2001, J BIOMAT SCI-POLYM E, V12, P647, DOI 10.1163/156856201316883467
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   Moszner N, 2001, PROG POLYM SCI, V26, P535, DOI 10.1016/S0079-6700(01)00005-3
   MOUSSA K, 1993, J POLYM SCI POL CHEM, V31, P2197, DOI 10.1002/pola.1993.080310903
   Muh E, 2002, BIOMATERIALS, V23, P2849, DOI 10.1016/S0142-9612(01)00411-2
   Muller-Plathe F, 1998, MACROMOLECULES, V31, P6721, DOI 10.1021/ma980685b
   Nagura M, 1997, POLYM GELS NETW, V5, P455, DOI 10.1016/S0966-7822(97)00016-6
   NATHAN P, 1974, APPL MICROBIOL, V28, P465
   Okoroafor EU, 1999, J PHYS D APPL PHYS, V32, P2454, DOI 10.1088/0022-3727/32/18/319
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   REFOJO MF, 1965, J APPL POLYM SCI, V9, P3417, DOI 10.1002/app.1965.070091019
   REFOJO MF, 1979, J POLYM SCI POL SYM, P227
   ROORDA WE, 1988, BIOMATERIALS, V9, P494, DOI 10.1016/0142-9612(88)90044-0
   Sideridou I, 2002, BIOMATERIALS, V23, P1819, DOI 10.1016/S0142-9612(01)00308-8
   Stol M, 1993, J Biomater Appl, V7, P224, DOI 10.1177/088532829300700302
   Vermette P., 2001, BIOMEDICAL APPL POLY
   VOLDRICH Z, 1975, J BIOMED MATER RES, V9, P675, DOI 10.1002/jbm.820090612
   Young CD, 1998, J MEMBRANE SCI, V146, P83, DOI 10.1016/S0376-7388(98)00097-0
   Zhang JM, 2002, POLYM BULL, V48, P277, DOI 10.1007/s00289-002-0028-9
NR 41
TC 6
Z9 6
U1 1
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2005
VL 16
IS 10
BP 1303
EP 1318
DI 10.1163/156856205774269548
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 977YB
UT WOS:000232838300008
PM 16268255
DA 2018-10-20
ER

PT J
AU Verma, S
   Padmawar, PA
   Hauck, T
   Canteenwala, T
   Chiang, LY
   Pritzker, KPH
AF Verma, S
   Padmawar, PA
   Hauck, T
   Canteenwala, T
   Chiang, LY
   Pritzker, KPH
TI Synthesis of water-soluble highly two-photon responsive
   [60]fullerene-diphenylaminofluorene chromophore dyads
SO JOURNAL OF MACROMOLECULAR SCIENCE-PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE C60; diphenylaminofluorene; poly(ethylene-glycol); amphiphilic molecule;
   molecular self-assembly
ID POLY(ETHYLENE OXIDE); ELECTRON-TRANSFER; VESICLE
AB We have synthesized an amphiphilic donor-acceptor type [60] fullerene-diphenylaminofluorene (DPAF) containing oligo( ethylene glycol) moieties, denoted C-60-DPAF-EG(n). The hydrophobic C-60-DPAF moiety consisting of an electron-donating diphenylaminofluorene unit and an electron-accepting C-60 cage shows large cross-sections of two-photon absorptivity (2PA) in the nanosecond region. The attachment of two hydrophilic oligo( ethylene glycol) segments on DPAF mainly increases water-solubility of the corresponding chromophoric macromolecules that enhances their potential application in biomedical treatments. Here, we present the synthesis and self-assembly study of these amphiphilic materials in aqueous solution. New C-60-DPAF-EGn compounds were structurally characterized by various spectroscopic methods including, H-1-NMR, C-13-NMR, FT-IR, and UV spectroscopies. In the vesicle formation investigation, UV-visible absorption spectra, dynamic light scattering measurements, and transmission electron microscopy were used as primary methods for morphology characterization of molecular self-assembly behavior of these amphiphilic [60]fullerene-diphenylaminofluorene chromophore dyads.
C1 Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA.
   Mt Sinai Hosp, Pathol & Lab Med, Toronto, ON, Canada.
   Univ Toronto, Toronto, ON, Canada.
RP Chiang, LY (reprint author), Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA.
EM long_chiang@uml.edu
CR Burger C, 2004, J COLLOID INTERF SCI, V275, P632, DOI 10.1016/j.jcis.2004.02.048
   CHIANG LY, 2002, CHEM COMMUN, V17, P1854
   Effenberger F, 1998, SYNTHESIS-STUTTGART, P1372
   Georgakilas V, 2002, P NATL ACAD SCI USA, V99, P5075, DOI 10.1073/pnas.072006599
   Guldi DM, 2002, J ORG CHEM, V67, P1141, DOI 10.1021/jo0108313
   HAO J, 2004, CHEM COMMUN, V5, P602
   Huang XD, 2000, MACROMOL CHEM PHYSIC, V201, P2660
   Imahori H, 1997, ADV MATER, V9, P537, DOI 10.1002/adma.19970090704
   Jeng US, 1999, J PHYS CHEM B, V103, P1059, DOI 10.1021/jp9834659
   Kannan R, 2001, CHEM MATER, V13, P1896, DOI 10.1021/cm000747o
   Li Z, 2004, J APPL POLYM SCI, V92, P867, DOI 10.1002/app.13695
   Martin N, 1998, CHEM REV, V98, P2527, DOI 10.1021/cr9701039
   Padmawar PA, 2004, J MACROMOL SCI PURE, VA41, P1387, DOI 10.1081/MA-200035292
   Rispens MT, 2002, DEV FULL SC, V4, P387
   Tan CH, 2004, LANGMUIR, V20, P9882, DOI 10.1021/la049747j
   Zojer E, 2004, CHEM-EUR J, V10, P2668, DOI 10.1002/chem.200305650
NR 16
TC 5
Z9 5
U1 1
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1060-1325
J9 J MACROMOL SCI PURE
JI J. Macromol. Sci.-Pure Appl. Chem.
PY 2005
VL A42
IS 11
BP 1497
EP 1505
DI 10.1080/10601320500229038
PG 9
WC Polymer Science
SC Polymer Science
GA 990BD
UT WOS:000233717300006
DA 2018-10-20
ER

PT J
AU Berry, CC
AF Berry, CC
TI Possible exploitation of magnetic nanoparticle-cell interaction for
   biomedical applications
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID GENE-THERAPY; CLINICAL-APPLICATIONS; PENETRATING PEPTIDES; RESONANCE;
   ADHESION; DELIVERY; ENDOCYTOSIS; DOXORUBICIN; DEFORMATION; TENSEGRITY
AB Magnetic nanoparticles have been advocated for use in magnetic resonance (MR) image enhancement and as bio-carriers in biological systems for many years. However it is only in recent years that the fields of nanotechnology, materials science and cell biology have combined to enable us to fully comprehend the potential uses of such nanoparticles in biomedical applications. This short review aims to detail some of the more recent advances using magnetic nanoparticles in biological research, highlighting possible biomedical applications and relating how the advancement of such research relies on parallel interdisciplinary research in materials chemistry.
C1 Univ Glasgow, Ctr Cell Engn, IBLS, Glasgow G12 8QQ, Lanark, Scotland.
RP Berry, CC (reprint author), Univ Glasgow, Ctr Cell Engn, IBLS, Joseph Black Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.
EM Catherine.berry@bio.gla.ac.uk
CR Alexiou C, 2000, CANCER RES, V60, P6641
   ALLEMANN E, 1993, PHARMACEUT RES, V10, P1732, DOI 10.1023/A:1018970030327
   Allport JR, 2001, EXP HEMATOL, V29, P1237, DOI 10.1016/S0301-472X(01)00739-1
   Araujo L, 1999, J DRUG TARGET, V6, P373, DOI 10.3109/10611869908996844
   ARIAS JL, 2000, J CONTROL RELEASE, V77, P309
   Babincova M, 2000, MED HYPOTHESES, V54, P177, DOI 10.1054/mehy.1999.0011
   BAUCH AR, 2001, BIOPHYS J, V80, P2649
   Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5
   Bausch AR, 1998, BIOPHYS J, V75, P2038, DOI 10.1016/S0006-3495(98)77646-5
   Berry CC, 2004, INT J PHARM, V269, P211, DOI 10.1016/j.ijpharm.2003.09.042
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   BONADONNA G, 1993, ANN ONCOL, V4, P359, DOI 10.1093/oxfordjournals.annonc.a058514
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   BRIGHTMAN MW, 1965, AM J ANAT, V117, P193, DOI 10.1002/aja.1001170204
   Caplen NJ, 2001, TRENDS MOL MED, V7, P488, DOI 10.1016/S1471-4914(01)02168-2
   CARTMELL SH, 2003, EUR CELLS MAT, V6, P7
   Chen CS, 1999, OSTEOARTHR CARTILAGE, V7, P81, DOI 10.1053/joca.1998.0164
   CHEN J, 2001, AM J PHYSIOL-CELL PH, V280, pC1478
   Cho CS, 2001, J CONTROL RELEASE, V77, P7, DOI 10.1016/S0168-3659(01)00390-X
   Connolly J, 2002, EUR CELLS MATER, V3, P106
   Davis SS, 1997, TRENDS BIOTECHNOL, V15, P217, DOI 10.1016/S0167-7799(97)01036-6
   Dobson J, 2001, FEBS LETT, V496, P1, DOI 10.1016/S0014-5793(01)02386-9
   Eastwood M, 1998, P I MECH ENG H, V212, P85, DOI 10.1243/0954411981533854
   Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x
   FUSSELL GW, 2004, BIOMATERIALS, V15, P2971
   Gaur U, 2000, INT J PHARM, V202, P1, DOI 10.1016/S0378-5173(99)00447-0
   Goodwin SC, 2001, TOXICOL SCI, V60, P177, DOI 10.1093/toxsci/60.1.177
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hogemann D, 2002, BIOCONJUGATE CHEM, V13, P116, DOI 10.1021/bc015549h
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Kawashima Y, 2001, ADV DRUG DELIVER REV, V47, P1, DOI 10.1016/S0169-409X(00)00117-4
   KREUTER J, 1994, EUR J DRUG METAB PH, V19, P253, DOI 10.1007/BF03188928
   Lacava LM, 2001, BIOPHYS J, V80, P2483, DOI 10.1016/S0006-3495(01)76217-0
   LANZA GM, 2003, ACAD RADIOL, V9, pS330
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   Lubbe AS, 1999, J MAGN MAGN MATER, V194, P149, DOI 10.1016/S0304-8853(98)00574-5
   Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Nichol C, 2001, J NUCL MED, V42, P1368
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   OGRADY K, 2003, J PHYS D, V36, pR165
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Pap T, 2002, ARTHRITIS RES, V4, P10, DOI 10.1186/ar377
   Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500
   QUALMANN B, 2000, J CELL BIOL, V150, P111
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Rudge SR, 2000, BIOMATERIALS, V21, P1411, DOI 10.1016/S0142-9612(00)00006-5
   Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6
   Shen TT, 1996, BIOCONJUGATE CHEM, V7, P311, DOI 10.1021/bc960003u
   STPIERRE TG, 2000, EUR BIOPHYS J, V26, P455
   Svensson EC, 1996, MOL MED TODAY, V2, P166, DOI 10.1016/1357-4310(96)88792-2
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   WIDDER KJ, 1983, EUR J CANCER CLIN ON, V19, P135, DOI 10.1016/0277-5379(83)90408-X
   WILHELM C, 2002, BIOMATERIALS, V24, P1001
   WUNDERBALDINGER P, 2001, BIOCONJUGATE CHEM, V131, P264
   Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189
NR 64
TC 159
Z9 162
U1 0
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2005
VL 15
IS 5
BP 543
EP 547
DI 10.1039/b409715g
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 893EZ
UT WOS:000226703400001
DA 2018-10-20
ER

PT J
AU Singh, J
   Wolfe, DE
AF Singh, J
   Wolfe, DE
TI Nano and macro-structured component fabrication by electron
   beam-physical vapor deposition (EB-PVD)
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID TITANIUM NITRIDE FILMS; ACTIVATED REACTIVE EVAPORATION; THERMAL BARRIER
   COATINGS; ASSISTED DEPOSITION; THIN-FILMS; MULTILAYER COATINGS; HARD
   COATINGS; TIN FILMS; SUBSTRATE TEMPERATURE; GROWTH ORIENTATION
AB The objective of this paper is to demonstrate the versatility of electron beam-physical vapor deposition (EB-PVD) technology in engineering new materials with controlled microstructure and microchemistry in the form of coatings. EB-PVD technology is being explored in forming net-shaped components for many applications including space, turbine, optical, biomedical and auto industry. Coatings are often applied on components to extend their performance and life under severe environmental conditions including thermal, corrosion, wear, and oxidation. In addition, coatings have been used in designing and developing sensors. Performance and properties of the coatings depend upon its composition, microstructure and deposition condition. This paper presents recent results of various materials including ceramic, metallic, and functionally graded coatings produced by EB-PVD. Simultaneous co-evaporation of multiple ingots of different compositions in the high energy EB-PVD chamber has brought considerable interest in the architecture of functional graded coatings, nano-laminated coatings and designing of new structural materials that could not be produced economically by conventional methods. In addition, high evaporation and condensate rate allowed fabricating precision net-shaped components with nanograined microstructure for various applications. This paper will also present the results of various metallic and ceramic coatings including chromium, titanium carbide (TiC), hafnium carbide (HfC), tantalum carbide (TaC), hafnium nitride (HfN), titanium-boron-carbonitride (TiBCN), and partially yttria stabilized zirconia (YSZ), and HfO2-based TBC coatings deposited by EB-PVD for various applications. (C) 2005 Springer Science + Business Media, Inc.
C1 Penn State Univ, Appl Res Lab, State Coll, PA 16804 USA.
RP Singh, J (reprint author), Penn State Univ, Appl Res Lab, 115 MRI Bldg, State Coll, PA 16804 USA.
EM jxs46@psu.edu
CR AMATEAU MF, 2000, 2 I MAN SUST TECHN
   ANDOH Y, 1989, NUCL INSTRUM METH B, V39, P158, DOI 10.1016/0168-583X(89)90761-1
   ARAI T, 1988, THIN SOLID FILMS, V165, P139, DOI 10.1016/0040-6090(88)90685-2
   ARNAULT JC, 1993, NUCL INSTRUM METH B, V80-1, P1384, DOI 10.1016/0168-583X(93)90804-F
   AUCIELLO O, 1991, SURFACE MODIFICATION, P109
   Barna P. B., 1995, GROWTH MECH POLYCRYS, P1
   BARNA PB, 1993, SURF COAT TECH, V57, P7, DOI 10.1016/0257-8972(93)90330-Q
   Barna PB., 1991, DIAGNOSTICS APPL THI, P295
   BATTY SV, 1995, THIN SOLID FILMS, V266, P96, DOI 10.1016/0040-6090(95)06693-4
   Beele W, 1999, SURF COAT TECH, V120, P61, DOI 10.1016/S0257-8972(99)00342-4
   Brogren M, 2000, THIN SOLID FILMS, V370, P268, DOI 10.1016/S0040-6090(00)00914-7
   Bunshah RF, 1994, HDB DEPOSITION TECHN
   Chin KC, 2004, CHEM PHYS LETT, V383, P72, DOI 10.1016/j.cplett.2003.11.007
   Choy KL, 2003, PROG MATER SCI, V48, P57, DOI 10.1016/S0079-6425(01)00009-3
   CHU X, 1992, J VAC SCI TECHNOL A, V10, P1604, DOI 10.1116/1.578030
   CHU Z, 1995, J APPL PHYS, V77, P4403
   Dini JW, 1997, MATER MANUF PROCESS, V12, P437, DOI 10.1080/10426919708935157
   DIXIT GA, 1993, APPL PHYS LETT, V62, P357, DOI 10.1063/1.109644
   ENSINGER W, 1993, NUCL INSTRUM METH B, V80-1, P1409, DOI 10.1016/0168-583X(93)90810-S
   ENSINGER W, 1993, SURFACE MODIFICATION TECHNOLOGIES VI, P859
   ENSINGER W, 1993, NUCL INSTRUM METH B, V80-1, P445, DOI 10.1016/0168-583X(93)96158-9
   Ensinger W, 1995, NUCL INSTRUM METH B, V106, P142, DOI 10.1016/0168-583X(95)00693-1
   Eskildsen SS, 1999, SURF COAT TECH, V116, P18, DOI 10.1016/S0257-8972(99)00142-5
   Fauchais P, 2000, INT J THERM SCI, V39, P852, DOI 10.1016/S1290-0729(00)01195-9
   Gerlach JW, 1996, APPL PHYS LETT, V68, P2360, DOI 10.1063/1.115858
   Gilmore DL, 1999, J THERM SPRAY TECHN, V8, P576, DOI 10.1361/105996399770350278
   GILMORE DL, 1999, MRS FALL M BOST M A
   GLASS DE, 2001, EFFECTIVENESS DIFFUS, P1264
   GOI, 2003, COMMUNICATION
   Haberland H., 1995, 2 INT C BEAM PROC MA, P69
   HAYWOOD B, 1990, ADV MATER PROCESS, V12, P35
   HILL RJ, 1986, PHYSL VAPOR DEPOSITI
   HIRVONEN JK, 1989, ANNU REV MATER SCI, V19, P401
   HIRVONEN JK, 1991, MATER SCI REP, V6, P215, DOI 10.1016/0920-2307(91)90008-B
   Hocking M. G., 1989, METALLIC CERAMIC COA
   HOLLECK H, 1988, SURF COAT TECH, V36, P707, DOI 10.1016/0257-8972(88)90011-4
   Holleck H, 1999, SURFACE ENGINEERING: SCIENCE AND TECHNOLOGY I, P207
   HOLLECK H, 1991, MAT SCI ENG A-STRUCT, V140, P609, DOI 10.1016/0921-5093(91)90485-6
   HOLLECK H, 1990, SURF COAT TECH, V41, P179, DOI 10.1016/0257-8972(90)90166-A
   HOLLECK H, 1999, TMS PUBLICATION, P207
   HULL R, 1992, MATER RES SOC SYMP P, V239, P379
   JACOBSON BE, 1984, THIN SOLID FILMS, V118, P285, DOI 10.1016/0040-6090(84)90199-8
   Je JH, 1997, J APPL PHYS, V81, P6126, DOI 10.1063/1.364394
   JIANG H, 1995, THIN SOLID FILMS, V258, P51, DOI 10.1016/0040-6090(94)06367-2
   KAUFMAN H, 1987, CHARACTERISTICS CAPA, P1
   KIUCHI M, 1988, NUCL INSTRUM METH B, V33, P649
   KNUYT G, 1995, THIN SOLID FILMS, V258, P159, DOI 10.1016/0040-6090(94)06353-2
   KOLITSCH A, 1993, THIN FILM PROCESSES, V80, P258
   Kutner G., 1991, ADV MATER PROCESS, V4, P68
   KUWAHARA K, 1981, THIN SOLID FILMS, V78, P41, DOI 10.1016/0040-6090(81)90416-8
   LEONHARDT T, 2000, C P 36 AM I AER AER, P1
   LEVIT M, 1996, MAT SCI ENG A-STRUCT, V206, P3038
   Ma KJ, 1995, SURF COAT TECH, V76, P297
   MATTOX DM, 1988, ION IMPLANTATION PLA, P9
   MCINTYRE R, 1996, MAT P, V8, P455
   MESSIER R, 1984, J VAC SCI TECHNOL A, V2, P500, DOI 10.1116/1.572604
   Milewski JO, 1998, MATER MANUF PROCESS, V13, P719, DOI 10.1080/10426919808935294
   Miller R. A, 1995, THERM BARR COAT WORK, P17
   MILLER RA, 1987, SURF COAT TECH, V30, P1, DOI 10.1016/0257-8972(87)90003-X
   MILLER RA, 1987, SURF COAT TECH, V309, P1
   Movchan B. A., 1969, Fizika Metallov i Metallovedenie, V28, P653
   MOVCHAN M, 1996, P EB PVD WORKSH PENN
   Nakamura Y, 1995, SURF COAT TECH, V76, P337
   NICHOLLS JR, 1997, AGARD SMP M THERM BA
   NIMMAGADDA R, 1977, THIN SOLID FILMS, V45, P477
   NOYAN IC, 1995, CRIT REV SOLID STATE, V20, P125, DOI 10.1080/10408439508243733
   OBERLANDER BC, 1992, MATER SCI TECH SER, V8, P657, DOI 10.1179/mst.1992.8.8.657
   Oettel H, 1995, SURF COAT TECH, V76, P265
   PEITER A, 1987, STRAIN           AUG, P103
   PIERCE JR, 1954, THEORY DESIGN ELECTR
   Pochet LF, 1997, SURF COAT TECH, V94-5, P70, DOI 10.1016/S0257-8972(97)00478-7
   QUAEYHAEGENS C, 1995, THIN SOLID FILMS, V258, P1710
   QULI FA, 1999, THESIS PENN STATE U
   QULI FA, 1999, J MAT SCI ENG B, P139
   RAGHURAM AC, 1972, J VAC SCI TECHNOL, V9, P1389, DOI 10.1116/1.1317046
   RAUSCHENBACH B, 1989, NUCL INSTRUM METH B, V42, P216, DOI 10.1016/0168-583X(89)90709-X
   Ravichandran KS, 1999, J AM CERAM SOC, V82, P673
   REED BD, 1997, 107453 NASA, P1
   RICKERBY DS, 1988, THIN SOLID FILMS, V157, P195, DOI 10.1016/0040-6090(88)90004-1
   Rigney DV, 1997, J THERM SPRAY TECHN, V6, P167, DOI 10.1007/s11666-997-0008-6
   ROHDE SL, 1993, J ELECTRON MATER, V22, P1327, DOI 10.1007/BF02817695
   ROTH T, 1987, THIN SOLID FILMS, V153, P123, DOI 10.1016/0040-6090(87)90176-3
   SANDHU G, 1993, APPL PHYS LETT, V63, P240
   SCHROEDER M, 1997, ADV MATER PROCESS, V8, P19
   *SCI COAT INC, TECHN APPL GUID, P1
   SEQUEDA F, 1986, J MET, P55
   SHAH PL, 1979, IEEE T ELECTRON DEV, V26, P631, DOI 10.1109/T-ED.1979.19470
   SHCULTZ U, 1997, P AGARD WORKSH THERM
   SHERMAN AJ, 1991, J METALS         JUL, P20
   SINGH J, 1994, J MATER SCI, V29, P5232, DOI 10.1007/BF01171533
   Singh J, 2002, J MATER SCI, V37, P3261, DOI 10.1023/A:1016187101616
   SINGH J, 1993, 108419 NASA, P1
   SINGH J, 2003, FUNCTIONALLY GRADED
   SINGH J, 2003, TAILORED MICROSTRUCT
   SINGH J, 1997, J MATER SCI, P3891
   SINGH J, 2004, IN PRESS J ADV MAT M
   SINGH J, 2002, J ADV MAT PROCESS, V160, P39
   SINGH J, 1996, SURF ENG B, V7, P8
   SINGH J, 1996, ADV MATER PROCESS, V11, P32
   SMITH D, 1995, THIN FILM DEPOSITION, P431
   Sobota J, 2001, SURF COAT TECH, V142, P590, DOI 10.1016/S0257-8972(01)01173-2
   SOHN YH, 1993, THESIS WORCESTER POL
   SPROUL W, 1994, CUTTING TOOL ENG, V2, P52
   STELMACK LA, 1989, NUCL INSTRUM METH B, V37-8, P787, DOI 10.1016/0168-583X(89)90299-1
   STIMMELL J, 1986, J VAC SCI TECHNOL B, V4, P1377, DOI 10.1116/1.583461
   SUNDGREN JE, 1983, THIN SOLID FILMS, V105, P367, DOI 10.1016/0040-6090(83)90319-X
   SUNDGREN JE, 1985, THIN SOLID FILMS, V128, P21, DOI 10.1016/0040-6090(85)90333-5
   SUNDGREN JE, 1995, MAT PROCESSES SURFAC, P453
   Tan YJ, 2003, SURF COAT TECH, V167, P255, DOI 10.1016/S0257-8972(02)00916-7
   THORNTON JA, 1975, J VAC SCI TECHNOL, V12, P830, DOI 10.1116/1.568682
   THORNTON JA, 1974, J VAC SCI TECHNOL, V11, P666, DOI 10.1116/1.1312732
   UNAL O, 1994, J AM CERAM SOC, V77, P984, DOI 10.1111/j.1151-2916.1994.tb07256.x
   VANDERDRIFT A, 1967, PHILIPS RES REP, V22, P267
   VAUER VE, 1962, T 9 NAT VAC S, P35
   VOSSEN JL, 1978, THIN FILM PROCESSES, P11
   WOLF G, 1991, NUCL INSR METH PHY B, V29, P173
   WOLF GK, 1992, J VAC SCI TECHNOL A, V10, P1757, DOI 10.1116/1.577743
   Wolfe D, 1998, J MATER SCI, V33, P3677, DOI 10.1023/A:1004675900887
   Wolfe DE, 2000, SURF COAT TECH, V124, P142, DOI 10.1016/S0257-8972(99)00644-1
   Wolfe DE, 2003, SURF COAT TECH, V165, P8, DOI 10.1016/S0257-8972(02)00666-7
   Wolfe DE, 2002, J MATER SCI, V37, P3777, DOI 10.1023/A:1016533913894
   Wolfe DE, 2002, SURF COAT TECH, V160, P206, DOI 10.1016/S0257-8972(02)00404-8
   Wolfe DE, 1999, J MATER SCI, V34, P2997, DOI 10.1023/A:1004668325924
   WOLFE DE, 1997, TMS ANN M ORL, P93
   WOLFE DE, 2001, THESIS PENN STATE U
   WOLFE DE, 1996, EFFECT SUBSTRATE ROT
   WOLFE DE, 1997, P ADV COATING TECHNO, P93
   WOLFE DE, IN PRESS J SURF COAT
   WOLFE DE, 1997, 98109 EB PVD PENNS S
   WOLFE DE, 1996, NATO ADV STUDY I SER, V21, P441
   WOLFE JSD, 2003, 2 INT MAT S U NOV LI
   Xiang Q, 2000, THIN SOLID FILMS, V370, P243, DOI 10.1016/S0040-6090(00)00915-9
   ZONG D, 2001, THIN SOLID FILMS, V398, P320
NR 133
TC 83
Z9 89
U1 9
U2 135
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN 1
PY 2005
VL 40
IS 1
BP 1
EP 26
DI 10.1007/s10853-005-5682-5
PG 26
WC Materials Science, Multidisciplinary
SC Materials Science
GA 897BB
UT WOS:000226977900001
DA 2018-10-20
ER

PT J
AU Tuusa, SMR
   Puska, MA
   Lassila, LVJ
   Vallittu, PK
AF Tuusa, SMR
   Puska, MA
   Lassila, LVJ
   Vallittu, PK
TI Residual monomers released from glass-fibre-reinforced composite
   photopolymerised in contact with bone and blood
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; FLEXURAL PROPERTIES; RESIN COMPOSITES; BIOMEDICAL
   APPLICATIONS; OXYGEN INHIBITION; FISSURE SEALANTS; DENTAL RESINS; HPLC
   ANALYSIS; BIS-GMA; CARBON
AB Purpose: The aim of this study was to determine the quantity of residual monomers of glass fibre-reinforced composite released into water from the composite that had been photopolymerized in contact with bone and blood. Materials and methods: E-glass fibre reinforced composite (FRC) made of E-glass fibre veil and the bis-GMA-TEGDMA-PMMA resin system was used in the study. In the first group, pieces of non-polymerised FRC were photopolymerised (40 s) in air which influenced the oxygen inhibited resin layer (positive control). In the second group, the FRC was polymerized between two glass plates allowing both surfaces to be well polymerized (negative control). In the test groups, the FRC was polymerized in contact with bone or in contact with blood. FRC specimens from all four groups were incubated in three milliliters of deionised water at 37 degreesC for three days. At the end of the incubation period, the residual monomers were extracted from the water with dichloromethane, and the residual monomers of TEGDMA and bis-GMA quantitatively analysed by HPLC. The degree of monomer conversion was measured by FTIR from the surface of the test specimen. Differences between the groups were analysed using one-way ANOVA (p < 0.05). Results: The total quantity of residual monomers released from FRC polymerized in contact with bone was lower (0.55 wt%) than in the positive control group (0.97 wt%) (p = 0.021), and only slightly exceeded that of the negative control group (0.42 wt%) (p = 0.717). The total quantity of monomers released from FRC polymerized in contact with blood was at the level of the negative control group. The main residual monomer released was TEGDMA. The surfaces of the positive and negative controls showed a clear difference between the degree of monomer conversion, 34.0 and 62.8%, respectively, when analysed with FTIR (p < 0.001). Conclusion: The surface of the bone or contact with blood did not significantly inhibit the photoinitiated free radical polymerisation of the dimethacrylate monomer system of the FRC. (C) 2005 Springer Science + Business Media, Inc.
C1 Univ Turku, Inst Dent, Dept Prosthet Dent & Biomat Res, Turku, Finland.
RP Tuusa, SMR (reprint author), Univ Turku, Inst Dent, Dept Prosthet Dent & Biomat Res, Turku, Finland.
EM sari.tuusa@utu.fi
CR BRADLEY JS, 1980, BIOMATERIALS, V1, P38, DOI 10.1016/0142-9612(80)90057-5
   Ciapetti G, 2000, J BIOMED MATER RES, V52, P338, DOI 10.1002/1097-4636(200011)52:2<338::AID-JBM13>3.3.CO;2-C
   Drummond JL, 2003, DENT MATER, V19, P226, DOI 10.1016/S0109-5641(02)00034-9
   FEITH R, 1975, ACTA ORTHOP SCAND S, V161, P1
   GOLDBERG AJ, 1992, DENT MATER, V8, P197, DOI 10.1016/0109-5641(92)90083-O
   Hamid A, 1997, DENT MATER, V13, P98, DOI 10.1016/S0109-5641(97)80018-8
   HASTINGS GW, 1985, POLYMER, V26, P1331, DOI 10.1016/0032-3861(85)90308-8
   INOUE K, 1982, J ORAL REHABIL, V9, P493, DOI 10.1111/j.1365-2842.1982.tb01039.x
   JANG BZ, 1992, COMPOS SCI TECHNOL, V44, P333, DOI 10.1016/0266-3538(92)90070-J
   Lassila LVJ, 2002, BIOMATERIALS, V23, P2221, DOI 10.1016/S0142-9612(01)00355-6
   Lastumaki TM, 2003, J MATER SCI-MATER M, V14, P803, DOI 10.1023/A:1025044623421
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   LIN ST, 1994, BIOMATERIALS, V15, P1057, DOI 10.1016/0142-9612(94)90091-4
   Lovell LG, 1999, J DENT RES, V78, P1469, DOI 10.1177/00220345990780081301
   Mariotti A, 1998, EUR J ORAL SCI, V106, P1022, DOI 10.1046/j.0909-8836.1998.eos106607.x
   MAROM G, 1993, BIOMATERIALS, V14, P127, DOI 10.1016/0142-9612(93)90224-P
   MAYER J, 1994, COMPOSITES, V25, P763, DOI 10.1016/0010-4361(94)90213-5
   Miettinen VM, 1996, J PROSTHET DENT, V76, P531
   Nathanson D, 1997, J AM DENT ASSOC, V128, P1517, DOI 10.14219/jada.archive.1997.0091
   Noda M, 1999, J BIOMED MATER RES, V47, P374, DOI 10.1002/(SICI)1097-4636(19991205)47:3<374::AID-JBM12>3.0.CO;2-7
   Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888
   Ortengren U, 2001, J ORAL REHABIL, V28, P1106, DOI 10.1046/j.1365-2842.2001.00802.x
   Pelka M, 1999, Clin Oral Investig, V3, P194, DOI 10.1007/s007840050101
   Peutzfeldt A, 1997, EUR J ORAL SCI, V105, P97, DOI 10.1111/j.1600-0722.1997.tb00188.x
   Pulgar R, 2000, ENVIRON HEALTH PERSP, V108, P21, DOI 10.2307/3454291
   Puska MA, 2003, BIOMATERIALS, V24, P417, DOI 10.1016/S0142-9612(02)00354-X
   RUEGGEBERG FA, 1990, J DENT RES, V69, P1652, DOI 10.1177/00220345900690100501
   RUYTER IE, 1981, ACTA ODONTOL SCAND, V39, P27, DOI 10.3109/00016358109162255
   RUYTER IE, 1980, J PROSTHET DENT, V43, P95, DOI 10.1016/0022-3913(80)90362-5
   Scotchford CA, 2003, BIOMATERIALS, V24, P4871, DOI 10.1016/S0142-9612(03)00403-4
   Shajii L, 1999, BIOMATERIALS, V20, P1897, DOI 10.1016/S0142-9612(99)00087-3
   SHINTANI H, 1995, J LIQ CHROMATOGR, V18, P613, DOI 10.1080/10826079508009261
   Shinzato S, 2000, J BIOMED MATER RES, V53, P51
   Sideridou I, 2002, BIOMATERIALS, V23, P1819, DOI 10.1016/S0142-9612(01)00308-8
   Tarumi H, 2000, J DENT RES, V79, P1838, DOI 10.1177/00220345000790110401
   Vallittu PK, 1999, J PROSTHET DENT, V81, P318, DOI 10.1016/S0022-3913(99)70276-3
   Vallittu PK, 1997, J MATER SCI-MATER M, V8, P489, DOI 10.1023/A:1018578210453
   Wada H, 2004, J DENT RES, V83, P222, DOI 10.1177/154405910408300307
NR 38
TC 15
Z9 16
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2005
VL 16
IS 1
BP 15
EP 20
DI 10.1007/s10856-005-6441-5
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901KV
UT WOS:000227282300003
PM 15754139
DA 2018-10-20
ER

PT J
AU Yamashita, K
   Nakamura, S
AF Yamashita, K
   Nakamura, S
TI Concept and development of vector ceramics for bio-interface engineering
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Review
DE vector ceramics; electrovector ceramics; hydroxyapatite; electrical
   polarization; biointerface engineering; biomaterials; bioceramics
ID ELECTRICALLY POLARIZED HYDROXYAPATITE; CALCIUM-PHOSPHATE CERAMICS;
   BIOACTIVE GLASS-CERAMICS; TRANSMISSION ELECTRON-MICROSCOPY;
   DEXTRAN-MAGNETITE COMPLEX; SIMULATED BODY-FLUID; IN-VITRO;
   MAMMARY-CARCINOMA; APATITE FORMATION; SURFACE-CHARGES
AB A vector material is defined as the one to manipulate surrounding inorganic and organic compounds, microorganisms, and tissues using a force irradiated locally and continuously from the material itself. The effect given by a vector material is ca materials are of unparalleled importance under the circumstance of the limited use of external forces such as in vivo. We have recently experimentally demonstrated the effectiveness of electrically polarized hydroxyapatite (HA) electrets as vector ceramics, which can independently irradiate an electrostatic force to the surrounding constituents; crystal growth from a simulated body fluid was accelerated or decelerated and proliferation of a microorganism was controlled on the surfaces of polarized HA, depending upon the electric signs of surface charges. Prior to our study, certain types of vector effects have already been employed in biomedical applications; the so-called 45S5-type bioactive glass (Bioglass(R)), developed by Hench et al., has long been recognized to be bioactive because of its solubility in a aqueous medium. Radioactive ceramics irradiate, beta-ray to and work on surrounding cancer cells. These are also vector materials. In addition to these examples, various kinds of vector effects and ceramics are now under development. This advanced report presents the concept of vector effects and reviews the examples of vector ceramics.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Yamashita, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
CR ABE Y, 1984, J AM CERAM SOC, V67, P142
   BREEDIS C, 1954, AM J PATHOL, V30, P969
   Bromer H., 1973, German patent, Patent No. [2,326,100, 2326100]
   Conzone SD, 1998, J BIOMED MATER RES, V42, P617
   Day DE, 1993, INTRO BIOCERAMICS, P305
   Driskell T D, 1972, J Biomed Mater Res, V6, P345, DOI 10.1002/jbm.820060107
   EBISAWA Y, 1991, J CERAM SOC JPN, V99, P7
   EHRHARDT GJ, 1987, NUCL MED BIOL, V14, P233
   ERBE EM, 1993, J BIOMED MATER RES, V27, P1301, DOI 10.1002/jbm.820271010
   FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806
   Hafeli UO, 1999, INT J RADIAT ONCOL, V44, P189, DOI 10.1016/S0360-3016(98)00554-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HOLAND W, 1985, J BIOMED MATER RES, V19, P303, DOI 10.1002/jbm.820190311
   Hyatt MJ, 1987, J AM CERAM SOC, V70C, P283
   Ikeuchi M, 2003, J BIOMED MATER RES A, V67A, P1115, DOI 10.1002/jbm.a.10041
   Imayoshi N., 1997, MEM FAC ENG OKAYAMA, V31, P39
   INUZUKA M, IN PRESS SOLID STATE
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, J BIOMED MATER RES, V60, P224, DOI 10.1002/jbm.10068
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559
   Kasuga T, 2003, J CERAM SOC JPN, V111, P633, DOI 10.2109/jcersj.111.633
   KASUGA T, 2004, J CERAM SOC JAPAN S, V112, pS800
   Kawamura H, 2003, J BIOMED MATER RES A, V65A, P468, DOI 10.1002/jbm.a.10524
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Kawashita M, 1999, J AM CERAM SOC, V82, P683
   Kawashita M, 2003, BIOMATERIALS, V24, P2955, DOI 10.1016/S0142-9612(03)00094-2
   Kawashita M., 2002, BIOCERAMICS, P645
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P467, DOI 10.1002/jbm.820210407
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P234, DOI 10.1016/0142-9612(87)90071-8
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P362, DOI 10.1016/0142-9612(84)90036-X
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Konaka H, 1997, J CERAM SOC JPN, V105, P833, DOI 10.2109/jcersj.105.833
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   LUDERER AA, 1983, RADIAT RES, V94, P190, DOI 10.2307/3575874
   Maeda H, 2004, J EUR CERAM SOC, V24, P2125, DOI 10.1016/S0955-2219(03)00327-3
   MITSUMORI M, 1994, INT J HYPERTHER, V10, P785, DOI 10.3109/02656739409012371
   Mitsumori M, 1996, HEPATO-GASTROENTEROL, V43, P1431
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785
   NAKAHIRA A, 2004, J CERAM SOC JPN S, V112, pS845
   Nakamura S, 2004, J BIOMED MATER RES A, V68A, P90, DOI 10.1002/jbm.a.10124
   Nakamura S, 2002, J BIOMED MATER RES, V61, P593, DOI 10.1002/jbm.10224
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Obata A, 2004, BIOMATERIALS, V25, P5163, DOI 10.1016/j.biomaterials.2003.12.028
   Obata A, 2003, J BIOMED MATER RES A, V67A, P413, DOI 10.1002/jbm.a.10069
   OBATA A, 2004, J CERAM SOC JAPAN S, V112, pS822
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTSUKI C, 1992, J MATER SCI-MATER M, V3, P119, DOI 10.1007/BF00705279
   Ohtsuki C, 1991, PHOSPHORUS RES B, V1, P191
   Ohtsuki C., 1991, J CERAM SOC JPN, V99, P1
   ONO K, 1990, BIOMATERIALS, V11, P265
   Otsuki C., 1994, BIOCERAMICS, V7, P73
   OVERGAARD J, 1995, LANCET, V345, P540, DOI 10.1016/S0140-6736(95)90463-8
   OWADA H, 1989, SOLID STATE IONICS, V35, P401, DOI 10.1016/0167-2738(89)90327-5
   Owada H., 1986, J CERAM SOC JPN, V94, P837
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Ozawa M., 1995, SEITAIZAIRYOU, V13, P167
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RECK R, 1984, LARYNGOSCOPE, V94, P1, DOI 10.1288/00005537-198402001-00001
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Takeda H, 2002, J MATER CHEM, V12, P2490, DOI 10.1039/b202262c
   Toyama Y, 2002, SOLID STATE IONICS, V151, P159, DOI 10.1016/S0167-2738(02)00704-X
   Tsuru K, 1995, P 17 INT C GLASS, V5, P85
   Ueshima M, 2002, SOLID STATE IONICS, V151, P29, DOI 10.1016/S0167-2738(02)00600-8
   Ueshima M, 2002, ADV MATER, V14, P591, DOI 10.1002/1521-4095(20020418)14:8<591::AID-ADMA591>3.0.CO;2-7
   Ueshima M, 2002, J BIOMED MATER RES, V60, P578, DOI 10.1002/jbm.10113
   Wang P., 1990, SILICATES IND, V7-8, P231
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   YAMASHITA K, 1995, J AM CERAM SOC, V78, P1191, DOI 10.1111/j.1151-2916.1995.tb08468.x
   YAMASHITA K, 1988, SOLID STATE IONICS, V28, P660, DOI 10.1016/S0167-2738(88)80121-8
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Yamashita K, 2002, PHOSPHORUS SULFUR, V177, P1889, DOI 10.1080/10426500290093829
   YAMASHITA K, 1990, SOLID STATE IONICS, V40-1, P918, DOI 10.1016/0167-2738(90)90153-I
   YAMASHITA K, 1986, J AM CERAM SOC, V69, P590, DOI 10.1111/j.1151-2916.1986.tb04813.x
NR 90
TC 50
Z9 50
U1 0
U2 15
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JAN
PY 2005
VL 113
IS 1313
BP 1
EP 9
DI 10.2109/jcersj.113.1
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 897YC
UT WOS:000227041800001
OA Bronze
DA 2018-10-20
ER

PT J
AU Van Loo, PLR
   Blom, HJM
   Meijer, MK
   Baumans, V
AF Van Loo, PLR
   Blom, HJM
   Meijer, MK
   Baumans, V
TI Assessment of the use of two commercially available environmental
   enrichments by laboratory mice by preference testing
SO LABORATORY ANIMALS
LA English
DT Article
DE mice; preference; welfare; environmental enrichment; nest box; nesting
   material
ID NESTING MATERIAL; ANIMAL-WELFARE; STRESS
AB In the field of biomedical research, the demand for standardization of environmental enrichment for laboratory animals is growing. For laboratory mice, a wide variety of environmental enrichment items are commercially available. Most of these comply with the demands for standardization, hygiene and ergonomics. Whether these items also comply with their actual purpose, to enhance the well-being of the mice, is often not assessed scientifically. In this study, we tested the preference of mice for two commercially available nest boxes differing in shape and material: the Shepherd Shack/DesRes (SS/DR) and the Tecniplast Mouse House (TMH), in a simple preference test. To indicate strength of preference, both nest boxes were also tested against a highly preferred nesting material. Preference for the most preferred nest box was investigated further. Our results indicated a strong preference by mice for the SS/DR, but not for the TMH. Furthermore, nesting material was almost always combined with the SS/DR, but not with the TMH. More elaborate testing of the SS/DR in an automated preference test system confirmed that mice spent significantly more time in a cage in which an SS/DR is provided. Differences between both nest boxes are discussed with regard to their attractiveness to mice. It is also argued that enrichment should primarily be developed in concordance with the animals' needs prior to the marketing of enrichment tools.
C1 Univ Utrecht, Dept Lab Anim Sci, NL-3508 TD Utrecht, Netherlands.
   Karolinska Inst, S-17177 Stockholm, Sweden.
RP Van Loo, PLR (reprint author), Univ Utrecht, Dept Lab Anim Sci, POB 80166, NL-3508 TD Utrecht, Netherlands.
EM P.L.P.vanloo@vet.uu.nl
CR Baumans V, 2002, CONTEMP TOP LAB ANIM, V41, P13
   BLOM HJM, 1992, APPL ANIM BEHAV SCI, V35, P67, DOI 10.1016/0168-1591(92)90017-6
   *COUNC EUR, 1997, RES ACC CAR LAB AN
   Dean SW, 1999, LAB ANIM, V33, P309, DOI 10.1258/002367799780487823
   Eskola S, 1999, SCAND J LAB ANIM SCI, V26, P134
   HUGHES BO, 1989, ANIM BEHAV, V37, P210, DOI 10.1016/0003-3472(89)90111-5
   JENSEN P, 1993, APPL ANIM BEHAV SCI, V37, P161, DOI 10.1016/0168-1591(93)90108-2
   KORNERUPHANSEN A, 1999, ICLAS FELASA C PALM
   Mortell N., 2001, Animal Technology, V52, P1
   Olsson I. Anna S., 2002, Laboratory Animals (London), V36, P243, DOI 10.1258/002367702320162379
   POOLE TB, 1998, ANIMAL TECHNOLOGY, V49, P7
   Sambrook TD, 1997, ANIM WELFARE, V6, P207
   TRUSZKOWSKI J, 1974, Acta Theriologica, V19, P441
   TSAI PP, 1999, ICLAS FELASA JOINT C, P112
   Van de Weerd H, 1995, ENV ENRICHMENT INFOR, V2, P145
   Van de Weerd HA, 1998, ANIM WELFARE, V7, P11
   Van de Weerd HA, 1998, APPL ANIM BEHAV SCI, V55, P369, DOI 10.1016/S0168-1591(97)00043-9
   Van de Weerd Heleen A., 2002, Journal of Applied Animal Welfare Science, V5, P87, DOI 10.1207/S15327604JAWS0502_01
   Van Loo PLP, 2002, APPL ANIM BEHAV SCI, V76, P65, DOI 10.1016/S0168-1591(01)00200-3
   VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152
   Ward G. E., 1991, ANIMAL TECHNOLOGY, V42, P149
   WEISS JM, 1972, SCI AM, V226, P104, DOI 10.1038/scientificamerican0672-104
   Wemelsfelder F, 1997, APPL ANIM BEHAV SCI, V53, P75, DOI 10.1016/S0168-1591(96)01152-5
   WIEPKEMA PR, 1993, ANIM WELFARE, V2, P195
NR 24
TC 19
Z9 19
U1 1
U2 9
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0023-6772
J9 LAB ANIM-UK
JI Lab. Anim.
PD JAN
PY 2005
VL 39
IS 1
BP 58
EP 67
DI 10.1258/0023677052886501
PG 10
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 890CO
UT WOS:000226489500004
PM 15703125
OA Bronze
DA 2018-10-20
ER

PT S
AU Della Valle, G
   Galzerano, G
   Toncelli, A
   Tonelli, M
   Laporta, P
AF Della Valle, G.
   Galzerano, G.
   Toncelli, A.
   Tonelli, M.
   Laporta, P.
BE Abramski, KM
   Lapucci, A
   Plinski, EF
TI Novel solid-state lasers for Lidar applications at 2 mu m
SO LASERS AND APPLICATIONS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Lasers and Applications
CY AUG 30, 2005
CL Warsaw, POLAND
DE Solid state laser; diode-pumped laser; tunable laser; laser material
ID HO
AB A review on the results achieved by our group in the development of novel solid-state lasers for Lidar applications at 2 mu m is presented. These lasers, based on fluoride crystals (YLF(4), BaY(2)F(8), and KYF(4)) doped with Tm and Ho ions, are characterized by high-efficiency and wide wavelength tunability around 2 mu m. Single crystals of LiYF(4), BaY(2)F(8), and KYF(4) codoped with the same Tm(3+) and Ho(3+) concentrations were successfully grown by the Czochralski method. The full spectroscopic characterization of the different laser crystals and the comparison between the laser performance are presented. Continuous wave operation was efficiently demonstrated by means of a CW diode-pumping. These oscillators find interesting applications in the field of remote sensing (Lidar and Dial systems) as well as in high-resolution molecular spectroscopy, frequency metrology, and biomedical applications.
C1 [Della Valle, G.; Galzerano, G.; Laporta, P.] Ist Foton & Nanotecnol CNR, Dipartimento Fis, I-20133 Milan, Italy.
RP Della Valle, G (reprint author), Ist Foton & Nanotecnol CNR, Dipartimento Fis, Piazza L Da Vinci 32, I-20133 Milan, Italy.
EM gianluca.galzerano@fisi.polimi.it
OI GALZERANO, GIANLUCA/0000-0002-4388-1421; Della Valle,
   Giuseppe/0000-0003-0117-2683
CR Cornacchia F, 2002, APPL PHYS B-LASERS O, V75, P817, DOI 10.1007/s00340-002-1055-9
   HEMMATI H, 1987, APPL PHYS LETT, V51, P564, DOI 10.1063/1.98348
   Marano M, 2003, OPT MATER, V24, P327, DOI 10.1016/S0925-3467(03)00145-9
   McAleavey FJ, 1997, IEEE J SEL TOP QUANT, V3, P1103, DOI 10.1109/2944.649549
   Mobert PEA, 1998, LASER PHYS, V8, P210
   REMSKI RL, 1969, IEEE J QUANTUM ELECT, VQE 5, P214, DOI 10.1109/JQE.1969.1075760
   STORM ME, 1989, APPL OPTICS, V28, P408, DOI 10.1364/AO.28.000408
NR 7
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-5965-7
J9 PROC SPIE
PY 2005
VL 5958
AR 59581H
DI 10.1117/12.619930
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA BRU42
UT WOS:000283716700042
DA 2018-10-20
ER

PT S
AU Yang, Y
   Li, K
   Nam, SH
   Yin, SZ
   Wang, Q
AF Yang, Y
   Li, K
   Nam, SH
   Yin, SZ
   Wang, Q
BE Stockman, SA
   Yao, HW
   Schubert, EF
TI A unique point OLED source
SO Light-Emitting Diodes: Research, Manufacturing, and Applications IX
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 9th Conference on Light-Emitting Diodes
CY JAN 25-27, 2005
CL San Jose, CA
SP SPIE, Aixtron Inc, Lumileds Lighting, LLC, USA Res Off
DE organic light-emitting diodes (OLED's); polymer light-emitting diodes
   (PLED's); point source; fiber-based devices; poly(phenylene vinylene);
   PPV; conjugated polymers
ID ORGANIC ELECTROLUMINESCENT DEVICES; ELECTRO-LUMINESCENCE; POLYMERS;
   DIODES; FILMS
AB Highly luminous polymers have been successfully prepared by copolymerization of various arylene vinylene units. Among the copolymers synthesized, poly(phenylene vinylene) (PPV) and its derivatives have been studied most intensively because they show fairly strong fluorescence and have a wide structural variety. In this paper, light-emitting polymers and traditional organic LED technology are briefly reviewed at first. A novel and unique point source based on the organic LED fabricated on an optical fiber is then proposed. As proof of concept, some preliminary experimental results are shown. Two light-emitting materials needed for our experiments are synthesized. It is illustrated that the unique point OLED source is feasible, which can lead to many practical applications, such as biomedical imaging.
C1 Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
RP Yang, Y (reprint author), Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
CR ADACHI C, 1988, JPN J APPL PHYS, V27, P269
   Bernius M, 2000, THIN SOLID FILMS, V363, P55, DOI 10.1016/S0040-6090(99)00982-7
   BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0
   DOI S, 1993, SYNTHETIC MET, V57, P4174, DOI 10.1016/0379-6779(93)90577-J
   HAMADA Y, 1995, JPN J APPL PHYS, V34, P824
   HELFRICH W, 1965, PHYS REV LETT, V14, P229, DOI 10.1103/PhysRevLett.14.229
   Nakada H., 1996, Inorganic and Organic Electroluminescence, P385
   Ohnishi T, 1997, IEEE T ELECTRON DEV, V44, P1253, DOI 10.1109/16.605464
   OHNISHI T, 2000, Patent No. 5247460
   OHNISHI T, 1996, MAT MEASUREMENT MOL, V81, P545
   PARTRIDGE RH, 1983, POLYMER, V24, P733, DOI 10.1016/0032-3861(83)90012-5
   TANG CW, 1989, J APPL PHYS, V65, P3610, DOI 10.1063/1.343409
   TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799
   TANG CW, 1996, IEEE1996 SID INT S D, V17, P181
   VanSlyke SA, 1996, APPL PHYS LETT, V69, P2160, DOI 10.1063/1.117151
   VINCETT PS, 1982, THIN SOLID FILMS, V94, P171, DOI 10.1016/0040-6090(82)90509-0
NR 16
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5713-2
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5739
BP 42
EP 50
DI 10.1117/12.587220
PG 9
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BCE20
UT WOS:000228826900006
DA 2018-10-20
ER

PT J
AU Yang, R
   Xu, S
   Wang, Z
   Yang, W
AF Yang, R
   Xu, S
   Wang, Z
   Yang, W
TI Aqueous extraction of corncob xylan and production of
   xylooligosaccharides
SO LWT-FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article
DE corncob; xylooligosaccharides; steaming; crystalline structure of
   cellulose; xylan-lignin complex
ID ENZYMATIC HYDROLYSIS EXTRACTION; CONTAINING NATURAL MATERIALS; LIGNIN;
   STREPTOMYCES; PRETREATMENT; SYSTEM
AB Xylooligosaccharide, which is usually produced from xylan by enzymatic hydrolysis, is a newly developed functional oligosaccharide having many beneficial biomedical and health effects. In this study, a process for producing xylooligosaccharides from corncob was developed. The procedure consisted of soaking the corncob in 1.0 g/l H2SO4 at 60 &DEG; C for 12h, followed by filtrating and washing with tap water to pH 6 and steaming at 135-140 &DEG; C for 0.5 h. The steamed corncob was mashed and hydrolysed by xylanase. The cumulative yield of xylooligosaccharides after enzymatic hydrolysis was close to 67.7 g/100 g by steaming (based on xylan in raw material), and the purity of xylooligosaccharides was over 70 g/100 g (based on the total sugars in the hydrolysate). This study demonstrated that the xylan-lignin complex present in the corncob was affected during steaming at 135 &DEG; C for 30 min. Almost all of the xylan was removed from the lignin after steam application and subsequent enzymatic hydrolysis. &COPY; 2004 Swiss Society of Food Science and Technology. Published by Elsevier Ltd. All rights reserved.
C1 SoYangtze Univ, Sch Food Sci & Technol, Wuxi 214036, Jiangsu, Peoples R China.
   Alabama A&M Univ, Dept Food & Anim Sci, Normal, AL 35762 USA.
RP Yang, R (reprint author), SoYangtze Univ, Sch Food Sci & Technol, Wuxi 214036, Jiangsu, Peoples R China.
EM yrj@sytu.edu.cn; wyang@aamu.edu
CR DAS NN, 1984, CARBOHYD RES, V129, P197
   Dekker R.F.H., 1985, BIOSYNTHESIS BIODEGR, P505
   ERIKSSON O, 1980, WOOD SCI TECHNOL, V14, P267, DOI 10.1007/BF00383454
   FENGEL D, 1976, SVEN PAPPERSTIDN, V79, P24
   FENGEL D, 1976, HOLZFORSCHUNG, V30, P1, DOI 10.1515/hfsg.1976.30.1.1
   KARR WE, 1991, J WOOD CHEM TECHNOL, V11, P447
   KARR WE, 1991, J WOOD CHEM TECHNOL, V11, P465
   KOGA K, 1985, OLIGOSACCARIDES, V3, P130
   KOSIKOVA B, 1978, HOLZFORSCHUNG, V32, P15, DOI 10.1515/hfsg.1978.32.1.15
   KUSAKABE I, 1976, J AGR CHEM SOC JPN, V50, P209, DOI 10.1271/nogeikagaku1924.50.5_209
   KUSAKABE I, 1976, J AGR CHEM SOC JPN, V50, P199, DOI 10.1271/nogeikagaku1924.50.5_199
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3
   PELLERIN P, 1991, ENZYME MICROB TECH, V13, P617, DOI 10.1016/0141-0229(91)90074-K
   Sasaka M., 1995, BIOTECHNOL BIOENG, V45, P517
   SELVENDRAN RR, 1985, J CELL SCI S, V2, P51
   WILLIAM S, 1984, AOAC OFFICIAL METHOD
NR 17
TC 71
Z9 80
U1 4
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0023-6438
J9 LWT-FOOD SCI TECHNOL
JI LWT-Food Sci. Technol.
PY 2005
VL 38
IS 6
BP 677
EP 682
DI 10.1016/j.lwt.2004.07.023
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA 924AE
UT WOS:000228950000014
DA 2018-10-20
ER

PT J
AU Hedia, HSM
   Shabara, MAN
   Fattah, AA
   Helal, MMK
AF Hedia, HSM
   Shabara, MAN
   Fattah, AA
   Helal, MMK
TI Effect of crack configuration and pre-crack length on stress intensity
   factors - Study of the tearing mode using a three-dimensional finite
   element model
SO MATERIALPRUFUNG
LA English
DT Article
ID NOTCH TIP SHARPNESS
AB In this paper, the results for the stress intensity factor of a mode III (tearing mode) have been investigated using the method of finite element analysis. A compact tension specimen containing a pre-crack and subjected to out-of-plane tearing loads has been used. A three-dimensional finite element analysis (FEA) model using the ANSYS program has been built for specimens made of different biomedical materials such as stainless steel, titanium, alumina, high density polyethylene (HDPE) and polymethyl methacrylate(PMMA). Such materials are used for hip and knee replacement and for dental implants. The effects of notch angle, notch tip radius and pre-crack length on the stress intensity factor for the mode III have been studied. The model was extended to study the effect of crack and bonding line separation distance on stress intensity factors for specimens made of different homogeneous materials such as stainless steel bonding with epoxy as a filler material. The number of elements along the crack front and crack tip has been varied to determine its effects on the stress intensity factors. It is concluded that the pre-crack must be greater than or equal to 33% of the total crack length and the notch must be a blunt notch in order to obtain the stress intensity factor, K-III, independently, of the crack notch angle. However, the stress intensity factor is independent of the crack and bonding line separation distance when it is less than or equal to 15% of the specimen width. The results for the stress intensity factors, K-III,, are obtained using a linear elastic fracture mechanics (LEFM) approach.
C1 Mansoura Univ, Prod Engn & Mech Design Dept, Fac Engn, Mansoura, Egypt.
RP Hedia, HSM (reprint author), Mansoura Univ, Prod Engn & Mech Design Dept, Fac Engn, Mansoura, Egypt.
RI Hedia, Hassan/I-8289-2012
CR *ANSYS, 1992, ANSYS US MAN VERS 50
   *ASTM, 1983, 399 ASTM E
   *ASTM E, 1995, 647 ASTM E
   CHUNG YL, 1992, ENG FRACT MECH, V4, P321
   DOLAN TJ, 1970, PRECLUDE FAILURE PHI
   Farshad M, 1998, ENG FRACT MECH, V60, P597, DOI 10.1016/S0013-7944(98)00020-4
   Fett T., 1998, STRESS INTENSITY FAC
   FINLAYSON FE, 1998, THESIS
   HE MY, 2001, ENG FRACT MECH, V65, P1
   Hedia HSM, 2002, MATERIALPRUFUNG, V44, P122
   Hedia HSM, 2002, MATERIALPRUFUNG, V44, P117
   Hertzberg W. R., 1996, DEFORMATION FRACTURE
   Stephens R.L., 2001, METAL FATIGUE ENG
   Wearing JL, 1999, ENG ANAL BOUND ELEM, V23, P3, DOI 10.1016/S0955-7997(98)00057-5
   Wong JSS, 2003, ACTA MATER, V51, P4929, DOI 10.1016/S1359-6454(03)00335-5
   Yamauchi T, 2002, J WOOD SCI, V48, P532, DOI 10.1007/BF00766652
   YOUNG MJ, 1993, INT J FRACTURE, V60, P1, DOI 10.1007/BF00034508
NR 17
TC 0
Z9 0
U1 2
U2 7
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0025-5300
J9 MATERIALPRUFUNG
JI Materialprufung
PY 2005
VL 47
IS 10
BP 568
EP 573
DI 10.3139/120.100691
PG 6
WC Materials Science, Characterization & Testing
SC Materials Science
GA 987XO
UT WOS:000233551200003
DA 2018-10-20
ER

PT J
AU Ramanujan, RV
   Yeow, YY
AF Ramanujan, RV
   Yeow, YY
TI Synthesis and characterisation of polymer-coated metallic magnetic
   materials
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE magnetic material; polymer; microsphere; ball milling; coating;
   biomedical applications
AB Polymer-coated magnetic microspheres can be used for bioengineering applications: hence. the synthesis and characterization of such materials was studied. Cobalt and iron powders were ball milled and subsequently characterized by scanning electron microscopy (SEM) and XRD methods. The average size of the ball milled Co powders was 7.4 mum after 1 h of milling; for Fe, the smallest average size was 808 nm after 10 h of milling. These milled powders were then coated, using the solvent evaporation technique with the polymer poly-L-lactic acid (PLLA) to form microspheres. The process parameters to form microspheres with the smallest diameter. spherical morphology and a narrow size distribution was determined. The stirring speed and polymer viscosity were found to control the size and shape of microspheres. The Co and Fe microspheres had an average size of 105 and 125 mum, respectively. The VSM results showed that saturation magnetization decreased with polymer coating thickness. (C) 2004 Elsevier B.V. All rights reserved.
C1 Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
RP Ramanujan, RV (reprint author), Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
EM ramanujan@ntu.edu.sg
RI Ramanujan, Raju/A-2245-2011
CR Carpenter EE, 2001, J MAGN MAGN MATER, V225, P17, DOI 10.1016/S0304-8853(00)01222-1
   Chen C.W., 1977, MAGNETISM METALLURGY
   CHEN JP, 1994, J APPL PHYS, V75, P5876, DOI 10.1063/1.355546
   Craik D., 1995, MAGNETISM PRINCIPLES
   EDELMAN ER, 1985, J BIOMED MATER RES, V19, P67, DOI 10.1002/jbm.820190107
   Hertzog B, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P77
   Jiles D., 1990, INTRO MAGNETISM MAGN
   KOCH CC, 1991, MATERIALS SCI TECHNO, V15, P194
   KRAKHMALEV P, 2001, P 22 RIS INT S MAT S, P301
   Kuznetsov AA, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P379
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   McHenry ME, 2000, ACTA MATER, V48, P223, DOI 10.1016/S1359-6454(99)00296-7
   Murty BS, 1998, INT MATER REV, V43, P101, DOI 10.1179/imr.1998.43.3.101
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   SENYEI A, 1978, J APPL PHYS, V49, P3578, DOI 10.1063/1.325219
   SURYANARAYANA C, 1995, INT MATER REV, V40, P41, DOI 10.1179/imr.1995.40.2.41
NR 16
TC 16
Z9 16
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN
PY 2005
VL 25
IS 1
BP 39
EP 41
DI 10.1016/j.msec.2004.04.001
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 888KH
UT WOS:000226372300006
DA 2018-10-20
ER

PT J
AU Mattioli-Belmonte, M
   Gabbanelli, F
   Marcaccio, M
   Giantomassi, F
   Tarsi, R
   Natali, D
   Callegari, A
   Paolucci, F
   Biagini, G
AF Mattioli-Belmonte, M
   Gabbanelli, F
   Marcaccio, M
   Giantomassi, F
   Tarsi, R
   Natali, D
   Callegari, A
   Paolucci, F
   Biagini, G
TI Bio-characterisation of tosylate-doped polypyrrole films for biomedical
   applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE tosylate-doped polypyrrole; over-oxidation; biomaterial
ID CONDUCTING POLYMER; MECHANICAL-PROPERTIES; GLUCOSE-OXIDASE; ADHESION;
   OVEROXIDATION; BIOMATERIALS; MORPHOLOGY
AB Electroactive polymers such as polypyrrole (PPy) are receiving particular interest because they can combine inherent biological properties that can specifically trigger desired cellular responses for many biological applications. The aim of the present work was to evaluate more efficient solutions, achieved by different oxidisations of tosylate-doped PPy films in different chemico-physical conditions. in view of their long-term biomedical applications. The conductivity and the release of the tosylate ion were assessed. Morpho-functional studies were also performed. A gradual increase in impedance of the oxidised tosylate-doped PPy films soaked in MEM and a reduced conductivity after over-oxidation was found. Scanning electron microscopy (SEM) analysis showed the presence of a hierarchical organisation of the PPy films and a partially different morphology between oxidised and over-oxidised films. Cell behaviour was also randomly affected in relation to the oxidative state of the studied Ppy films. On the basis of the results, growth of these tosylate-doped Ppy films directly in the sol-gel matrix or on the surface of metal alloys could be hypothesised in order to improve bioactive material of potential use in modern regenerative medicine. However, in view of their in vivo application, over-oxidation must be considered as it may represent the degraded material that is likely to form under a biological oxidising environment. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Politecn Marche, Ist Morfol Umana Normale, Fac Med & Chirurg, I-60020 Ancona, Italy.
   Univ Bologna, Dipartimento Chim Ciamician, Bologna, Italy.
   Univ Politecn Marche, Ist Microbiol & Sci Biomed, Ancona, Italy.
RP Mattioli-Belmonte, M (reprint author), Univ Politecn Marche, Ist Morfol Umana Normale, Fac Med & Chirurg, Via Tronto 10-A, I-60020 Ancona, Italy.
EM belmonte@univpm.it
RI Mattioli-Belmonte, Monica/J-5861-2012; Paolucci, Francesco/A-8708-2008
OI Paolucci, Francesco/0000-0003-4614-8740
CR Aoki T, 1996, BIOMATERIALS, V17, P1971, DOI 10.1016/0142-9612(96)00015-4
   BECK F, 1987, BER BUNSEN PHYS CHEM, V91, P967, DOI 10.1002/bbpc.19870910927
   Cen L, 2003, BIOSENS BIOELECTRON, V18, P363, DOI 10.1016/S0956-5663(02)00149-5
   CHEN Y, 2000, ANALYST, V225, P2249
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   DIAZ AF, 1983, IBM J RES DEV, V27, P342, DOI 10.1147/rd.274.0342
   DIAZ AF, 1986, HDB CONDUCTING POLYM, V1, P81
   DUFFITT GL, 1992, J CHEM SOC FARADAY T, V88, P1417, DOI 10.1039/ft9928801417
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   HEINZE J, 2001, ORGANIC ELECTROCHEMI, P1309
   KANATZIDIS MG, 1990, CHEM ENG NEWS, V68, P36, DOI 10.1021/cen-v068n049.p036
   KO JM, 1994, SYNTHETIC MET, V64, P9, DOI 10.1016/0379-6779(94)90267-4
   Lombello CB, 2002, J MATER SCI-MATER M, V13, P867, DOI 10.1023/A:1016552413295
   Long LH, 2001, BIOCHEM BIOPH RES CO, V286, P991, DOI 10.1006/bbrc.2001.5514
   LYONS MEG, 1993, ANALYST, V118, P361, DOI 10.1039/an9931800361
   MATTJOLIBELMONT.M, 2002, 65 NANOMED, V65
   NOFTLE RE, 1987, J ELECTROANAL CHEM, V227, P229, DOI 10.1016/0022-0728(87)80078-5
   PANDE R, 1993, MATER RES SOC SYMP P, V292, P135
   PICKUP PG, 1999, MOD ASPECT ELECTROC, P33
   PREZYNA LA, 1991, MACROMOLECULES, V24, P5283, DOI 10.1021/ma00019a010
   Rodriguez I, 2000, J ELECTROANAL CHEM, V491, P117, DOI 10.1016/S0022-0728(00)00194-7
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Van der Pauw L.J., 1958, Philips Research Reports, V13, P1
   WARREN LF, 1989, J ELECTROCHEM SOC, V136, P2286, DOI 10.1149/1.2097303
   Warriner K, 1997, MAT SCI ENG C-BIOMIM, V5, P81, DOI 10.1016/S0928-4931(97)00026-X
   WYNNE KJ, 1985, MACROMOLECULES, V18, P2361, DOI 10.1021/ma00154a005
   YANG R, 1990, J PHYS CHEM-US, V94, P6117, DOI 10.1021/j100378a087
NR 31
TC 16
Z9 18
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN
PY 2005
VL 25
IS 1
BP 43
EP 49
DI 10.1016/j.msec.2004.04.002
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 888KH
UT WOS:000226372300007
DA 2018-10-20
ER

PT S
AU Kaufman, JD
   Klapperich, CM
AF Kaufman, JD
   Klapperich, CM
BE Viney, C
   Katti, K
   Ulm, FJ
   Hellmich, C
TI Nanomechanical testing of hydrated biornaterials: Sample preparation,
   data validation and analysis
SO Mechanical Properties of Bioinspired and Biological Materials
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Mechanical Properties of Bioinspired and Biological
   Materials held at the 2004 MRS Fall Meeting
CY NOV 29-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc, Hysitron Co
AB Implants, tissue engineering scaffold materials, drug delivery and bio-micro electromechanical systems (BioMEMs) all use polymer or hydrogel materials. These applications require both mechanical performance and successful integration of the material into a biological environment. Mechanical strength, storage and loss moduli, wear resistance and surface adhesion properties are all critical in biomedical device design and can be determined using nanoindentation. The difficulty of obtaining large samples of specialized materials, and the complexity of testing soft materials in traditional materials testing apparatus, make nanoindentation an attractive alternative. Our previous research using nanoindentation to measure the surface mechanical properties of non-hydrated polymers led to improvement in nanoindentation testing protocols. One of the major challenges in using this technique for hydrogels and tissues is maintaining and controlling hydration of the materials during the test. Here we describe the design of a microfluidic platform for nanoindentation that facilitates continuous hydration of hydrogel samples and high throughput nanomechanical testing. Data from creep experiments on synthetic, hydrated poly-2-hydroxyethyl methacrylate (poly-HEMA) are presented. In addition, we show data to validate the materials properties determined from nanomechanical testing by complementary testing. Finally, the data is fitted to a phenomenological model for viscoelastic materials, specifically the three-element standard linear solid model used by Cheng et al. [I].
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Kaufman, JD (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
OI Klapperich, Catherine/0000-0001-6103-849X
CR Cheng L, 2000, J POLYM SCI POL PHYS, V38, P10, DOI 10.1002/(SICI)1099-0488(20000101)38:1<10::AID-POLB2>3.0.CO;2-6
   EBENSTEIN DM, 1996, THESIS U CALIFORNIA
   KLAPPERICH CM, 2004, WORLD BIOM C SYDN AU
   KLAPPERICH CM, 2004, MAT RES SOC P, V823
   OLIVER WC, 1992, J MATER RES, V7, P6
   Tsui TY, 1997, MATER RES SOC SYMP P, V473, P57
   XIA X, 2000, THESIS U MINNESOTA
NR 7
TC 0
Z9 0
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-792-X
J9 MATER RES SOC SYMP P
PY 2005
VL 844
BP 287
EP 292
PG 6
WC Materials Science, Biomaterials; Materials Science, Characterization &
   Testing
SC Materials Science
GA BCF71
UT WOS:000229087800040
DA 2018-10-20
ER

PT J
AU Laborde-Lahoz, P
   Maser, W
   Martinez, T
   Benito, A
   Seeger, T
   Cano, P
   de Villoria, RG
   Miravete, A
AF Laborde-Lahoz, P
   Maser, W
   Martinez, T
   Benito, A
   Seeger, T
   Cano, P
   de Villoria, RG
   Miravete, A
TI Mechanical characterization of carbon nanotube composite materials
SO MECHANICS OF ADVANCED MATERIALS AND STRUCTURES
LA English
DT Article
ID ORGANIC POLYMER; SINGLE; LOAD
AB The unique mechanical, electrical, and electrochemical properties of single-wall carbon nanotubes (SWNTs) and their versatility render these structures potentially promising for a number of structural biomedical applications. Among a series of critical parameters, such as the diameter and structure of the SWNT, its length is considered crucial in attaining the outstanding mechanical properties that this system exhibits at a molecular level. Therefore, long nanotubes are desirable for achieving high stiffness and strength. In this article, SWNTs and SWNT/organic matrix composites have been fabricated and characterized. Their microstructure has been studied via electron microscopy and a series of mechanical tests on these materials have been performed. Additionally, mathematical formulations are used to obtain the stiffness and strength of SWNTs embedded in organic matrices and a theory-experiment correlation study has been carried out. It is shown that the mechanical properties of nanotubes in composite matrix justify their proposed use as electromechanical actuators.
C1 Univ Texas, Hlth Sci Ctr, Houston, TX USA.
   Inst Carboquim, Zaragoza, Spain.
   Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA.
   Univ Zaragoza, Zaragoza, Spain.
   Univ Houston, Houston, TX USA.
RP Miravete, A (reprint author), Composites Engn & Applicat Ctr, 5000 Gulf Freeway,Bldg 3,Rm 152-B, Houston, TX 77024 USA.
EM amiravete@uh.edu
RI Maser, Wolfgang/L-7342-2014; BENITO, ANA/B-2065-2012
OI Maser, Wolfgang/0000-0003-4253-0758; BENITO, ANA/0000-0002-8654-7386;
   Guzman de Villoria, Roberto/0000-0001-6369-5266
CR Aizawa M, 2003, CHEM PHYS LETT, V368, P121, DOI 10.1016/S0009-2614(02)01767-0
   Allaoui A, 2002, COMPOS SCI TECHNOL, V62, P1993, DOI 10.1016/S0266-3538(02)00129-X
   Ando Y, 2002, J CRYST GROWTH, V237, P1926, DOI 10.1016/S0022-0248(01)02248-5
   [Anonymous], 2001, ASM HDB, V21
   Bandyopadhyaya R, 2002, NANO LETT, V2, P25, DOI 10.1021/nl010065f
   CHOI Y, 2000, APPL PHYS LETT, V76, P17
   Coleman JN, 2000, ADV MATER, V12, P213, DOI 10.1002/(SICI)1521-4095(200002)12:3<213::AID-ADMA213>3.0.CO;2-D
   Dalton AB, 2000, J PHYS CHEM B, V104, P10012, DOI 10.1021/jp002857o
   Duclaux L, 2002, CARBON, V40, P1751, DOI 10.1016/S0008-6223(02)00043-X
   Gojny FH, 2003, CHEM PHYS LETT, V370, P820, DOI 10.1016/S0009-2614(03)00187-8
   Gong XY, 2000, CHEM MATER, V12, P1049, DOI 10.1021/cm9906396
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Lau KT, 2002, CARBON, V40, P2965, DOI 10.1016/S0008-6223(02)00245-2
   LI X, 2002, CARBON, V41, P579
   Mehan ML, 2000, COMPOS SCI TECHNOL, V60, P1013, DOI 10.1016/S0266-3538(99)00194-3
   MIRAVETE A, 2001, ANAL COMPOSITE STRUC
   Piggott M. R., 1980, LOAD BEARING FIBRE C
   Pipes RB, 2003, COMPOS SCI TECHNOL, V63, P1349, DOI 10.1016/S0266-3538(03)00020-4
   QUIAN D, 2000, APPL PHYS LETT, V76, P2828
   Schadler LS, 1998, APPL PHYS LETT, V73, P3842, DOI 10.1063/1.122911
   Shaffer MSP, 1998, CARBON, V36, P1603, DOI 10.1016/S0008-6223(98)00130-4
   SHIMODA H, 2002, PHYS REV LETT, V88, DOI DOI 10.1103/PhysRevLett.88.015502
   Yakobson BI, 1997, AM SCI, V85, P324
   Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552
   Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637
   Zhu HW, 2002, SCIENCE, V296, P884, DOI 10.1126/science.1066996
NR 27
TC 30
Z9 30
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1537-6494
J9 MECH ADV MATER STRUC
JI Mech. Adv. Mater. Struct.
PD JAN-FEB
PY 2005
VL 12
IS 1
BP 13
EP 19
DI 10.1080/15376490590491792
PG 7
WC Materials Science, Multidisciplinary; Mechanics; Materials Science,
   Characterization & Testing; Materials Science, Composites
SC Materials Science; Mechanics
GA 886NJ
UT WOS:000226235300002
DA 2018-10-20
ER

PT B
AU Tyber, J
   Gall, K
   Frick, C
   Ortega, A
   Toelle, J
   Steinke, D
   Hardy, E
   Pacaccio, D
AF Tyber, J.
   Gall, K.
   Frick, C.
   Ortega, A.
   Toelle, J.
   Steinke, D.
   Hardy, E.
   Pacaccio, D.
BE Helmus, M
   Medlin, D
TI Improved fracture healing with use of shape memory alloys
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
AB The introduction of shape memory alloys (SMA) as an active implant material has greatly advanced the medical industry. The most heavily utilized SMA in biomedical applications is nickel titanium (NiTiNOL) due to its ability to instantaneously recover large amounts of deformation at a constant stress level. This paper describes the design of a new form of bone plate, utilizing the mechanical properties of NiTiNOL. Also investigated is the biocompatibility of NiTiNOL, demonstrating the potential of NiTiNOL as a biomedical material. The results will be compared to the standard bone plate material, stainless steel (SS).
C1 Univ Colorado, Boulder, CO 80309 USA.
RP Tyber, J (reprint author), Univ Colorado, Boulder, CO 80309 USA.
OI Frick, Carl/0000-0002-8202-924X
CR ALLGOWER M, 1995, MANUAL INTERNAL FIXA, P58
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Gall K, 1999, INT J PLASTICITY, V15, P69, DOI 10.1016/S0749-6419(98)00060-6
   KLIENNULEND J, 1987, BONE MINER, V293, P8
   PILLIAR R, 2003, ASM MAT PROCESSES ME
NR 5
TC 0
Z9 0
U1 1
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 124
EP 127
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900022
DA 2018-10-20
ER

PT B
AU Bradley, D
   Chaney, S
   Fischer, S
AF Bradley, D.
   Chaney, S.
   Fischer, S.
BE Helmus, M
   Medlin, D
TI Characterization of biomedical wire for optimum performance in suture
   needle manufacture and use
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
AB Stabilizing thermomechanical treatments were introduced during suture needle Custom 455 (R) wire stock manufacture to resolve residual stresses. Elongation properties of the material were increased by as much as 133% in final wire form and 8% after precipitation hardening without significant impact to the bend moment and stiffness of the wire. It is hoped that low residual stress wire stock material will improve the attachability of final needle wire forms to suture material. Similar post-draw increases in elongation have been observed in initial evaluation of other needle stock alloys such as Custom 465 (R) and Custom 470 (R).
C1 Ft Wayne Met Res Prod Corp, Ft Wayne, IN USA.
RP Bradley, D (reprint author), Ft Wayne Met Res Prod Corp, Ft Wayne, IN USA.
CR Atienza JM, 2003, MATER STRUCT, V36, P548, DOI 10.1007/BF02480832
   Petzow Gunter, METALLOGRAPHIC ETCHI
NR 2
TC 0
Z9 0
U1 0
U2 1
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 184
EP 188
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900032
DA 2018-10-20
ER

PT B
AU Kurisky, GA
   D'Ambrisi, RP
AF Kurisky, George A.
   D'Ambrisi, Richard P.
BE Helmus, M
   Medlin, D
TI Desirable biocompatible and physical characteristics of selected
   stainless steel alloys and specialty wire materials for use in the
   design and manufacture of implants and medical devices
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
AB The research described in this paper is a technical literature search with additional comments and insight from a wire drawing industry perspective. This paper has two goals. The first goal is to locate relevant citations in literature for alloys 304V, 316LVM, Nitronic (R) 50, Nitronic 60, 25-6M0, 27-7 MO and MP35N (R). This search utilized key words that related to desirable biocompatible and physical characteristics of these alloys. The second goal is to offer future investigators easy access to this information in a concise format that would facilitate their research, product development and subsequent selection of these alloys for medical wire device applications. Our research included several prominent technical metallurgy reference holdings. We focused specific attention to extensive database literature sources offered by our ASM membership. The results of our work confirmed the premise that these alloys have been extensively studied for biomedical applications by previous investigators. Our research uncovered considerable knowledge on the topic. In some cases, selected alloys are used as the standard to validate new materials and technologies. We were able to conclude that these alloys have a very successful and well-documented use in medical devices. It is evident that design and manufacturing professionals can continue to confidently choose these stainless steel wire alloys for medical device applications.
C1 Maryland Specialty Wire, Cockeysville, MD USA.
RP Kurisky, GA (reprint author), Maryland Specialty Wire, Cockeysville, MD USA.
CR Bendel LP, 1997, JMRI-J MAGN RESON IM, V7, P1170, DOI 10.1002/jmri.1880070635
   BHAT SV, 2002, BIOMATERIALS, P26
   *CAN COMM, 2003, ADV MET EXP CAP
   Chen XM, 2004, AM J ROENTGENOL, V182, P1075, DOI 10.2214/ajr.182.4.1821075
   DAVIS JR, 2003, HDB MAT MED DEVICES, P14
   Disegi J A, 2000, Injury, V31 Suppl 4, P2
   FREIHEIT JM, 1953, YALE J BIOL MED, V25, P509
   HELSEN JA, 1999, METALS BIOMATERIALS, pR9
   KAPILA S, 1989, AM J ORTHOD DENTOFAC, V96, P100, DOI 10.1016/0889-5406(89)90251-5
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   VONRECUM AF, 1987, HDB BIOMATERIALS EVA, P15
   Wise D.L., 2000, BIOMATERIALS BIOENGI, P63
NR 12
TC 0
Z9 0
U1 0
U2 2
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 221
EP 224
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900039
DA 2018-10-20
ER

PT B
AU Goodman, SL
   Mengelt, TJ
   Ali, M
   Kostrna, SLP
   Ulfig, RM
   Kelly, TF
AF Goodman, Steven L.
   Mengelt, Terri J.
   Ali, Muhammad
   Kostrna, Stephanie L. P.
   Ulfig, Robert M.
   Kelly, Thomas F.
BE Helmus, M
   Medlin, D
TI Three-dimensional atomic structure and compositional analysis of medical
   devices with the local electrode atom probe
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
ID ALLOY
AB The development of improved implantable biomaterials and the development of ever smaller medical devices for minimally invasive procedures places ever increasing demands on material performance. This ongoing development, in turn, requires greater understanding of material nanostructure. However, existing methods to determine material structure have substantial limitations in that currently used analytical instrumentation is not able to determine structure and composition at sub-manometer levels in three dimensions. The recently introduced Local Electrode Atom Probe microscope (LEAPS) can meet this critical need by providing 3-D atomic structure and composition of medical device materials. LEAP microscopy can readily determine the 3-D bulk and (near) surface nanostructure of biomedical metals and devices with sub-manometer resolution and identify all elements. This is demonstrated herein with three alloys that are widely used in stents, guide wires, orthopedic prosthetics and other device applications. Materials examined include 316L stainless steel, cobalt-chrome-molybdenum, and nitinol. LEAP imaging of these materials, and devices produced from these materials, can provide unique information regarding nanoscale composition, implanted ion distribution, precipitate and grain boundary structure, and elemental distribution across buried interfaces. In development are methods to determine the nanostructure and composition of surface oxides that will utilize the LEAP's intrinsic single atomic layer depth resolution. Such nanostructural information can assist in research, process development, failure analysis, and quality control.
C1 Imago Sci Instruments Corp, Madison, WI USA.
RP Goodman, SL (reprint author), Imago Sci Instruments Corp, Madison, WI USA.
CR GOODMAN SL, 2004, T 7 WORLD BIOM C, P371
   GOODMAN SL, 2004, P MICR MICR S2, V10
   Kelly T. F., 2003, MICROSCOPY TODAY, V11, P8
   Kelly TE, 2004, MICROSC MICROANAL, V10, P373, DOI 10.1017/S1431927604040565
   Kelly TF, 2000, MATER CHARACT, V44, P59, DOI 10.1016/S1044-5803(99)00055-8
   KOSTRNA SLP, 2004, P MICR MICR S2, V10, P206
   RAJAN K, 1984, METALL TRANS A, V15, P1335, DOI 10.1007/BF02648562
   RAJAN K, 1982, METALL TRANS A, V13, P1161, DOI 10.1007/BF02645497
NR 8
TC 0
Z9 0
U1 0
U2 2
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 263
EP 266
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900047
DA 2018-10-20
ER

PT J
AU Repsilber, D
   Ziegler, A
AF Repsilber, D
   Ziegler, A
TI Two-color microarray experiments - Technology and sources of variance
SO METHODS OF INFORMATION IN MEDICINE
LA English
DT Article
DE agilent; chip; comparative hybridization; gene expression; microarray;
   technical variance
ID GENE-EXPRESSION; HYBRIDIZATION; CDNA; ARRAYS
AB Objectives: Microarray gene expression experiments have a complex technical background. Knowledge about certain technical details is inevitable to judge alternatives for both experimental design and analysis. Here, we introduce the necessary details for the so-called two-color microarray experiments and review major sources of technical variance.
   Methods: We follow the sequence of experimental steps during a typical two-color microarray gene expression experiment, stressing decisive points in the choice of technique, experimental handling and biophysical basics. We point out where technical variation is to be expected.
   Results: Tissue storage, RNA extraction techniques, as well as the microarray hybridization represent major components of technical variance to be considered. Depending on the possibilities for access to the biomedical material under investigation, choice of amplification and labeling techniques can also be decisive to avoid additional technical variance. The two-color microarray experimental approach seeks to avoid a group of probe-level technical biases making use of the advantages of an incomplete block-design.
   Conclusions: It is worth to know the major sources of technical variance during the typical experimental sequence, both for choice of experimental design and techniques of molecular biology, as well as for the understanding of quality control and normalization approaches. Here, early investments pay at the level of reduced technical variance, allowing for enhanced detection levels for the effects under investigation.
C1 Univ Lubeck, Inst Med Biometrie & Stat, Lubeck, Germany.
RP Repsilber, D (reprint author), Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, Campus Lubeck,Ratzeburger Allee 160,Haus 4, D-23538 Lubeck, Germany.
EM dirk.repsilber@imbs.uni-luebeck.de
OI Ziegler, Andreas/0000-0002-8386-5397
CR *AG TECHN, 2003, AG SUR PRINT TECHN C
   ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Breit S, 2004, BRIT J HAEMATOL, V126, P231, DOI 10.1111/j.1365-2141.2004.05017.x
   Bretz F, 2005, METHOD INFORM MED, V44, P423
   DeRisi J, 1996, NAT GENET, V14, P457
   Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434
   Eisen MB, 1999, METHOD ENZYMOL, V303, P179
   Ittrich C, 2005, METHOD INFORM MED, V44, P418
   Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552
   Katzer M, 2003, IEEE T NANOBIOSCI, V2, P202, DOI 10.1109/TNB.2003.817023
   Khomyakova EB, 2004, CELL MOL BIOL, V50, P217
   King HC, 2001, JAMA-J AM MED ASSOC, V286, P2280, DOI 10.1001/jama.286.18.2280
   Klur S, 2004, GENOMICS, V83, P508, DOI 10.1016/j.ygeno.2003.09.005
   LANDGREBE J, 2004, SILICO BIOL, V4, P38
   Lipsitt DR, 1999, GEN HOSP PSYCHIAT, V21, P1
   Parmigiani G., 2003, ANAL GENE EXPRESSION
   Rahnenfuhrer J, 2005, METHOD INFORM MED, V44, P405
   Repsilber D, 2005, METHOD INFORM MED, V44, P461
   RISHI AS, 2002, REV PLANT BIOCH BIOT, V1, P81
   Schena M., 2003, MICROARRAY ANAL
   Simon R, 2003, DESIGN ANAL DNA MICR
   SOUTHERN EM, 1992, GENOMICS, V13, P1008, DOI 10.1016/0888-7543(92)90014-J
   SULTMANN H, 2001, CDNA MICROARRAYS GEN
   Tefferi A, 2002, MAYO CLIN PROC, V77, P927
   VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663
   Watson SJ, 2000, BIOL PSYCHIAT, V48, P1147, DOI 10.1016/S0006-3223(00)01080-5
NR 27
TC 9
Z9 9
U1 0
U2 1
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0026-1270
J9 METHOD INFORM MED
JI Methods Inf. Med.
PY 2005
VL 44
IS 3
BP 400
EP 404
PG 5
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 948RY
UT WOS:000230734600008
PM 16113763
DA 2018-10-20
ER

PT J
AU Lindberg, DAB
AF Lindberg, DAB
TI Research opportunities and challenges in 2005
SO METHODS OF INFORMATION IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 49th Annual Conference of the
   German-Society-for-Medical-Informatics-Biometry-and-Epidemiology
CY SEP 26-30, 2004
CL Innsbruck, AUSTRIA
SP German Soc Med Informat Biometry & Epidemiol
DE literature review; medical informatics; computerized patient record;
   population surveillance; cohort studies
ID US; STANDARD; JAPAN; NIH
AB Objectives. Biomedical informatics practice and research have become so brood that I will comment on only three areas. These are the electronic health record; prospective population studies, and interactive publications.
   Methods. Review of the literature, Internet resources and material and reports generated by internal and external research projects.
   Results: Development of an electronic health record continues to be problematic in the U.S. A number of large-scale prospective cohort studies of normal populations are now actively occurring or in planning stages in a number of countries; these present special research opportunities in biomedical informatics. Although there are engineering challenges to the implementation of interactive publications, they have the potential to enhance understanding, learning, and memory of scientific and health concepts.
   Conclusions: Three areas of bio-medical informatics challenge us and offer interesting and worthy research opportunities. These include the electronic health record, prospective cohort studies, and interactive publications.
C1 Natl Lib Med, Bethesda, MD 20894 USA.
RP Lindberg, DAB (reprint author), Natl Lib Med, 8600 Rockville Pike, Bethesda, MD 20894 USA.
EM lindberg@nlm.nih.gov
CR BECKER J, 1998, MANAGING MULTIDIMENS
   Brown PJB, 1998, METHOD INFORM MED, V37, P415
   BULTERMAN D, 2003, WORLD C EL CORP GOV, P2083
   Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628
   Fincke EM, 2005, RADIOLOGY, V234, P319, DOI 10.1148/radiol.2342041680
   FINCKE EM, 2004, RADIOLOGY
   GRAY J, 2000, RULES THUMB DATA ENG
   Hammond WE, 2003, ST HEAL T, V96, P266
   HUMPHREYS BL, 1998, J AM MED INFORM ASSN, V1, P1
   Kaiser J, 2004, SCIENCE, V305, P458
   Kaiser J, 2004, SCIENCE, V305, P764
   Kaiser J, 2002, SCIENCE, V298, P1158, DOI 10.1126/science.298.5596.1158
   LAVEN P, 2003, EBU TECH REV
   LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281
   MARTI V, 1993, ODA BASED CODER DECO, P849
   McDonald CJ, 2003, CLIN CHEM, V49, P624, DOI 10.1373/49.4.624
   Sweeney L, 1997, J LAW MED ETHICS, V25, P98, DOI 10.1111/j.1748-720X.1997.tb01885.x
   Triendl R, 2003, NAT MED, V9, P982, DOI 10.1038/nm0803-982b
   Wang Amy Y, 2002, Proc AMIA Symp, P845
   WATANABE S, 1993, EUR J CANCER, V29A, P2305, DOI 10.1016/0959-8049(93)90226-6
NR 20
TC 8
Z9 8
U1 0
U2 1
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0026-1270
J9 METHOD INFORM MED
JI Methods Inf. Med.
PY 2005
VL 44
IS 4
BP 483
EP 486
PG 4
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 972YQ
UT WOS:000232490100002
PM 16342914
DA 2018-10-20
ER

PT J
AU Ceusters, W
   Smith, B
   Goldberg, L
AF Ceusters, W
   Smith, B
   Goldberg, L
TI A terminological and ontological analysis of the NCI thesaurus
SO METHODS OF INFORMATION IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 49th Annual Conference of the
   German-Society-for-Medical-Informatics-Biometry-and-Epidemiology
CY SEP 26-30, 2004
CL Innsbruck, AUSTRIA
SP German Soc Med Informat Biometry & Epidemiol
DE ontology; medical terminology; standardization; quality control
ID MEDICAL LANGUAGE SYSTEM
AB Objective: The National Cancer Institute Thesaurus is described by its authors as "a biomedical vocabulary that provides consistent, unambiguous codes and definitions for concepts used in cancer research" and which,exhibits ontology-like properties in its construction and use". We performed a qualitative analysis of the Thesaurus in order to assess its conformity with principles of good practice in terminology and ontology design.
   Materials and Methods. We used both the on-line browsable version of the Thesaurus and its OWL-representation (version 04.08b, released on August 2, 2004), measuring each in light of the requirements put forward in relevant ISO terminology standards and in light of ontological principles advanced in the recent literature.
   Results: We found many mistakes and inconsistencies with respect to the term-formation principles used, the underlying knowledge representation system, and missing or inappropriately assigned verbal and formal definitions.
   Conclusion: Version 04.08b of the NCI Thesaurus suffers from the same broad range of problems that have been observed in other biomedical terminologies. For its further development, we recommend the use of a more principled approach that allows the Thesaurus to be tested not just for internal consistency but also for its degree of correspondence to that part of reality which it is designed to represent.
C1 Univ Saarland, European Ctr Ontol Res, D-66041 Saarbrucken, Germany.
   Univ Buffalo, Dept Philosophy, Buffalo, NY USA.
   Univ Saarland, Inst Formal Ontol & Med Informat Sci, D-6600 Saarbrucken, Germany.
   Univ Buffalo, Sch Dent Med, Buffalo, NY USA.
RP Ceusters, W (reprint author), Univ Saarland, European Ctr Ontol Res, Postfach 151150, D-66041 Saarbrucken, Germany.
EM werner.ceusters@ecor.uni-saarland.de
RI Ceusters, Werner/H-2269-2013; Smith, Barry/A-9525-2011
OI Ceusters, Werner/0000-0002-2676-8689; Smith, Barry/0000-0003-1384-116X
CR BODENREIDER O, 2004, P 3 INT C FORM ONT I, P185
   CANTOR MN, 2003, P AMIA S, P125
   Ceusters W, 2004, ST HEAL T, V102, P145
   CEUSTERS W, 2003, P C EL PAT REC TEPR
   CEUSTERS W, 2004, P 11 WORLD C MED INF, P482
   Cimino JJ, 1998, J AM MED INFORM ASSN, V5, P41, DOI 10.1136/jamia.1998.0050041
   *COLL AM PATH, SNOMED CLIN TERMS CO
   de Coronado S, 2004, ST HEAL T, V107, P33
   DECORONADO S, 2004, PROT WORKSH JUL 6 9
   FISCHER DH, CONVERTING THESAURUS
   GAMPER J, P 5 INT C TERM KNOWL
   GOLBECK J, 2003, J WEB SEMANT, V1, P75, DOI DOI 10.1016/J.WEB-SEM.2003.07.007
   Grenon P, 2004, ST HEAL T, V102, P20
   Hahn U, 2003, Pac Symp Biocomput, P577
   HARTEL F, 2004, W3C WORKSH SEM WEB L
   Kumar A, 2003, LECT NOTES ARTIF INT, V2821, P135
   KUMAR A, 2004, MEDINFO 2004 P 11 WO, P1700
   *LAB APPL ONT DOLC, 2005, DESCR ONT LING COGN
   OGDEN CK, 1923, MEANING MEANING
   Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007
   SCHNEIDER L, 16114019 ISSN
   SMITH B, 2004, INT C FORM ONT INF S, P73
   SMITH B, 2003, P AMIA S, P609
   Smith B., 2004, P 11 WORLD C MED INF, P444
   Smith Barry, 2003, AMIA Annu Symp Proc, P609
   SPYNS P, STAR200420
   SWARTZ N, USE MENTION
   *W3C, 2004, RES DESC FRAM RDF CO
   W3C, 2004, OWL WEB ONT LANG REF
   WIELEMAKER J, TRIPLE20 RDF TRIPLE
   WIELEMAKER J, 2003, PRACTICAL ASPECTS DE, P31
NR 31
TC 59
Z9 60
U1 0
U2 1
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0026-1270
J9 METHOD INFORM MED
JI Methods Inf. Med.
PY 2005
VL 44
IS 4
BP 498
EP 507
PG 10
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 972YQ
UT WOS:000232490100004
PM 16342916
DA 2018-10-20
ER

PT S
AU Lee, DS
   Chung, KH
   Yang, HS
   Park, SH
   Kim, SJ
   Pyo, HB
AF Lee, DS
   Chung, KH
   Yang, HS
   Park, SH
   Kim, SJ
   Pyo, HB
BE Chiao, JC
   Jamieson, DN
   Faraone, L
   Dzurak, AS
TI Plastic thermally-controllable platform with integrated thin film
   micro-components
SO Micro- and Nanotechnology: Materials, Processes, Packaging, and Systems
   II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Micro- and Nanotechnology - Materials , Processes,
   Packaging, and Systems II
CY DEC 13-15, 2004
CL Sydney, AUSTRALIA
SP SPIE, Univ New S Wales, Australian Govt Dept Def, Def Sci &Technol Org, Cochlear, Minist Sci & Med Res, Univ Adelaide, Ctr Biomed Engn
DE micro-patterning on polymer; thermal isolation; COC; injection molding
ID MICROFLUIDIC DEVICE; CHIP; ELECTROPHORESIS; DIAGNOSTICS; FABRICATION;
   PCR
AB We present a novel technology for a cyclo-olefin-copolymer (COC) plastic microfluidic platform for heat control With fully semiconductor process-compatible photolithographic 5 mu m-wide metal patterns, for heaters, electrodes., and temperature sensors and a thin membrane structure.
   Through tests of compatibility of some thermoplastic materials with chemical Solutions and temperature tolerance to the semiconductor processes (thin film depositions, photolithography, and etchings), we selected COC as a semiconductor process-compatible plastic material for biomedical applications. For photolithography processes, we manufactured the 5 COC wafer with flat Surface with c.a. 3 nm Surface roughness, employing a novel flame-torched injection-molding method. Furthermore, the part of heating blocks on COC wafers is controlled thickness to the 100 pm. to enhance the heat-ramping speeds through reduction of the thermal mass.
   In order to fabricate the Au thin film micro-patterns for temperature sensors, heaters, and electrodes, Au film (100 nm) was deposited by e-beam evaporator and patterned by using standard photolithography, and wet-etched. The micropatterned Au temperature sensors, heaters, and electrodes was demonstrated For insulating layers, Al2O3 film was deposited by an ALD system, patterned by using the standard photo lithography, and wet-etched.
   Using the COC microfluidic platform, we tested thermal cycling with simple heating and natural cooling on chip with water and. heating rates (5 degrees C/s when heating, 3 degrees C/s when cooling) are obtained. Therefore. the COC microfluidic platform can be applied to,I DNA lab-on-a-chip.
C1 ETRI, BioMEMS Team, Taejon 305350, South Korea.
RP Lee, DS (reprint author), ETRI, BioMEMS Team, Taejon 305350, South Korea.
CR Ahn CH, 2004, P IEEE, V92, P154, DOI 10.1109/JPROC.2003.820548
   Boone T, 2002, ANAL CHEM, V74, p78A, DOI 10.1021/ac021943c
   Buch JS, 2004, ANAL CHEM, V76, P874, DOI 10.1021/ac034913y
   Buchholz BA, 2001, ANAL CHEM, V73, P157, DOI 10.1021/ac001023z
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Kim K, 2004, CHEM COMMUN, P1466, DOI 10.1039/b402914c
   Ko JS, 2003, LAB CHIP, V3, P106, DOI 10.1039/b301794j
   Koh CG, 2003, ANAL CHEM, V75, P4591, DOI 10.1021/ac0343836
   Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046
   Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p
   Lee DS, 2004, LAB CHIP, V4, P401, DOI 10.1039/b313547k
   Lim JW, 2004, ELECTROCHEM SOLID ST, V7, pF45, DOI 10.1149/1.1756541
   Madou M, 2000, CHEM REV, V100, P2679, DOI 10.1021/cr980098o
   Mastrangelo CH, 1998, P IEEE, V86, P1769, DOI 10.1109/5.704282
   Ritala M, 1999, NANOTECHNOLOGY, V10, P19, DOI 10.1088/0957-4484/10/1/005
   Rossier J, 2002, ELECTROPHORESIS, V23, P858, DOI 10.1002/1522-2683(200203)23:6<858::AID-ELPS858>3.0.CO;2-3
   Vilkner T, 2004, ANAL CHEM, V76, P3373, DOI 10.1021/ac040063q
   Wang Z, 2003, J AM CHEM SOC, V125, P15278, DOI 10.1021/ja036581k
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xiang JH, 2004, LANGMUIR, V20, P3278, DOI 10.1021/la036088m
   Yang H, 2004, ANAL CHEM, V76, P1537, DOI 10.1021/ac035270p
NR 21
TC 0
Z9 0
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5610-1
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5650
BP 429
EP 437
DI 10.1117/12.582342
PG 9
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Optics
SC Materials Science; Optics
GA BCD14
UT WOS:000228693800054
DA 2018-10-20
ER

PT S
AU Liu, CG
   Qiu, YF
   Lian, K
AF Liu, CG
   Qiu, YF
   Lian, K
BE Papautsky, I
TI Polymer-based valves with tunable opening pressures for biomedical
   applications
SO Microfluidics, BioMEMS, and Medical Microsystems III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Microfludics, BioMEMS, and Medical Microsystems III
CY JAN 24-26, 2005
CL San Jose, CA
SP SPIE, Semiconduct Equipment and Mat Int, Soild State Technol, Sandia Natl Lab
DE microfluidics; polymer-based valve; PDMS material; injection molding;
   hyper-elastic; simulation
AB A series of polymer-based Polydimethylsiloxanes (PDMS) ball valves with different opening pressures have been developed for biomedical applications. By tuning different weight ratios of the two components (the base and the curing agent) of PDMS, the valves will have different opening pressures because of different stiffness of the PDMS materials. The curing conditions and mechanical properties of the PDMS material with different ratios have been thoroughly studied. The compressive Young's modulus of the material can be tuned from 310 KPa to 2.0 MPa. Such kind valves can be fabricated by injection molding, one of the cheapest fabrication techniques. Also such kind valve has no dead volume and easily to be integrated into micro-total analysis systems (mu TAS).
C1 Louisiana State Univ, Ctr Adv Microstruct & Devices, Baton Rouge, LA 70806 USA.
RP Liu, CG (reprint author), Louisiana State Univ, Ctr Adv Microstruct & Devices, 6980 Jefferson Highway, Baton Rouge, LA 70806 USA.
CR ARMANI D, MEMS 99, P222
   Cooney CG, 2004, SENSOR ACTUAT A-PHYS, V116, P519, DOI 10.1016/j.sna.2004.05.015
   Go JS, 2004, SENSOR ACTUAT A-PHYS, V114, P438, DOI 10.1016/j.sna.2003.12.028
   Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017
   Schotter J, 2002, IEEE T MAGN, V38, P3365, DOI 10.1109/TMAG.2002.802290
   Tamanaha CR, 2002, J MICROMECH MICROENG, V12, pN7, DOI 10.1088/0960-1317/12/2/401
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   YAO TJ, P MEMS 2000 MIY JAP, P624
NR 8
TC 1
Z9 1
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5692-6
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5718
BP 179
EP 185
DI 10.1117/12.590859
PG 7
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BCE50
UT WOS:000228863400024
DA 2018-10-20
ER

PT B
AU Dewidar, MM
   Khalil, KA
   Hassan, MK
   Tag, G
   Seo, DW
   Lim, JK
AF Dewidar, MM
   Khalil, KA
   Hassan, MK
   Tag, G
   Seo, DW
   Lim, JK
BE Sih, GC
   Tu, ST
   Wang, Z
TI Processing and mechanical properties of porous 316L stainless steel for
   artificial hip joints
SO MULTISCALE DAMAGE RELATED TO ENVIRONMENT ASSISTED CRACKING
SE Fracture Mechanics Symposium
LA English
DT Proceedings Paper
CT 3rd Annual Meeting of the Fracture-Mechanics-Group
CY NOV 02-05, 2005
CL Zhengzhou Univ, Zhengzhou, PEOPLES R CHINA
SP E China Univ Sci Technol, Natl Tech Res Ctr Safety Engn Pressure Vessel & Pipelines, Nanjing Univ Technol, Zhengzhou Univ Technol, China Pressure Vessel Inst, Natl Sci Fdn, China, Natl Sci Fdn, US, Boiler & Pressure Vessel Safety Super Bureau China, Henan Dept Sci & Technol, Fracture Mech Grp
HO Zhengzhou Univ
DE 316L stainless steel; porous; artificial hip joints; selective laser
   sintering; processing; mechanical properties
ID TITANIUM; IMPLANTS; BEHAVIOR; MODEL
AB 316L stainless steel is considered as one of the attractive metallic materials for biomedical applications due to its mechanical properties, biocompatibility, and corrosion resistance. It has been demonstrated that 316L stainless steel is well accepted by human tissues. In the present investigation, highly porous 316L stainless steel parts were produced by using a novel powder metallurgy process, which includes the selective laser sintering process and traditional sintering. Porous 316L stainless steel used for medical applications was successfully fabricated in the porosity range from 40 to 50 vol.% by controlling the selective laser sintering parameters and sintering behaviour. Elastic modulus and strength of the 316L stainless steel material was investigated as a function of the selective laser sintering process and the furnace cycle, or in the other words as a function of porosity.
C1 High Inst Energy, Dept Mech Design & Mat, Aswan, Egypt.
RP Dewidar, MM (reprint author), High Inst Energy, Dept Mech Design & Mat, Aswan, Egypt.
EM dewidar5@hotmail.com
CR ANA YB, 2005, MATER LETT, V59, P2178
   Becker BS, 1997, J MATER SCI-MATER M, V8, P793, DOI 10.1023/A:1018525015421
   DENG X, 2005, INT J FATIGUE, P1
   Dewidar M, 2001, ADVANCES IN MANUFACTURING TECHNOLOGY - XV, P181
   German R. M., 1994, POWDER METALLURGY SC
   German R. M., 1998, POWDER METALLURGY IR
   German RM, 1985, LIQUID PHASE SINTERI
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Laptev A, 2004, POWDER METALL, V47, P85, DOI 10.1179/003258904225015536
   LEE WH, 2005, APPL SURF SCI
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MANIATOPOULOS C, 1988, J PROSTHET DENT, V59, P438, DOI 10.1016/0022-3913(88)90039-X
   MANIATOPOULOS C, 1988, J PROSTHET DENT, V59, P662, DOI 10.1016/0022-3913(88)90378-2
   MANIATOPOULOS C, 1986, J BIOMED MATER RES, V20, P1309, DOI 10.1002/jbm.820200907
   MURRAY GAW, 1981, J BONE JOINT SURG BR, V63, P138
   Simmons CA, 1999, J BIOMED MATER RES, V47, P127, DOI 10.1002/(SICI)1097-4636(199911)47:2<127::AID-JBM3>3.0.CO;2-C
   SUN ZM, 2005, ACTA MAT
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   Wegner LD, 2001, INT J MECH SCI, V43, P1061, DOI 10.1016/S0020-7403(00)00035-7
   Xina R, 2005, BIOMATERIALS, V26, P6477
NR 20
TC 0
Z9 0
U1 2
U2 4
PU EAST CHINA UNIV SCIENCE AND TECHNOLOGY PRESS
PI SHANGHAI
PA MEILONG RD, SHANGHAI 200237, PEOPLES R CHINA
BN 7-5628-1804-5
J9 FRACTURE MECH SYMP
PY 2005
BP 43
EP 49
PG 7
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA BDQ87
UT WOS:000234971500006
DA 2018-10-20
ER

PT B
AU Dewidar, MM
   Seo, DW
   Lim, JK
AF Dewidar, MM
   Seo, DW
   Lim, JK
BE Sih, GC
   Tu, ST
   Wang, Z
TI Processing of high porosity Ti-6Al-4V by powder sintering process for
   biomedical applications
SO MULTISCALE DAMAGE RELATED TO ENVIRONMENT ASSISTED CRACKING
SE Fracture Mechanics Symposium
LA English
DT Proceedings Paper
CT 3rd Annual Meeting of the Fracture-Mechanics-Group
CY NOV 02-05, 2005
CL Zhengzhou Univ, Zhengzhou, PEOPLES R CHINA
SP E China Univ Sci Technol, Natl Tech Res Ctr Safety Engn Pressure Vessel & Pipelines, Nanjing Univ Technol, Zhengzhou Univ Technol, China Pressure Vessel Inst, Natl Sci Fdn, China, Natl Sci Fdn, US, Boiler & Pressure Vessel Safety Super Bureau China, Henan Dept Sci & Technol, Fracture Mech Grp
HO Zhengzhou Univ
DE Ti-6Al-4V; porous materials; space-holder; decomposition; sintering
   process; biomedical application
ID BONE CEMENTS; TI
AB Due to their excellent mechanical properties, superior biocompatibility, corrosion resistance titanium and its alloys are currently considered as the most important metallic materials for biomedical applications. In the present study, an effective method of fabricating porous metal was developed. Porous Ti-6Al-4Vusing a space-holder method and powder sintering process for biomedical applications are successfully fabricated in the porosities between 30% and 70%. The results showed that spherical-shaped pores were obtained depending on the shape and size distribution of the space-holder. The porous Ti-6Al-4V parts are characterized by using scanning electron microscopy. The results show that this process is promise to fabricate biomaterials for bone implants.
C1 High Inst Energy, Dept Mech Design & Mat, Aswan, Egypt.
RP Dewidar, MM (reprint author), High Inst Energy, Dept Mech Design & Mat, Aswan, Egypt.
EM dewidar5@hotmail.com
CR Amigo V, 2003, J MATER PROCESS TECH, V141, P117, DOI 10.1016/S0924-0136(03)00243-7
   *ASTM, 1995, 158995 ASTM F
   DAVID CD, 2004, ADV ENG MATER, V6, P369
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   Deb S, 2005, BIOMATERIALS, V26, P3713, DOI 10.1016/j.biomaterials.2004.09.065
   Deb S, 2002, BIOMATERIALS, V23, P3387, DOI 10.1016/S0142-9612(02)00039-X
   Deb S, 1997, J MATER SCI-MATER M, V8, P829, DOI 10.1023/A:1018589302217
   HEEMAN C, 2005, MAT SCI ENG A-STRUCT, V396, P99
   Laptev A, 2004, POWDER METALL, V47, P85, DOI 10.1179/003258904225015536
   Li JP, 2004, J MATER SCI-MATER M, V15, P951, DOI 10.1023/B:JMSM.0000042680.10087.15
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Martin B, 2000, ADV ENG MATER, V2, P196
   MASAYUKI K, 2003, WILEY PERIODICALS, P88
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
NR 16
TC 0
Z9 0
U1 0
U2 1
PU EAST CHINA UNIV SCIENCE AND TECHNOLOGY PRESS
PI SHANGHAI
PA MEILONG RD, SHANGHAI 200237, PEOPLES R CHINA
BN 7-5628-1804-5
J9 FRACTURE MECH SYMP
PY 2005
BP 177
EP 183
PG 7
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA BDQ87
UT WOS:000234971500028
DA 2018-10-20
ER

PT S
AU Rabiei, A
   Thomas, B
AF Rabiei, A
   Thomas, B
BE Laurencin, CT
   Botchwey, EA
TI Processing and development of nano-scale HA coatings for biomedical
   application
SO Nanoscale Materials Science in Biology and Medicine
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoscale Materials Science in Biology and Medicine held at
   the 2004 MRS Fall Meeting
CY NOV 28-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc
AB Functionally graded Hydroxyapatite coating with graded Crystallinity across the thickness of the film has been processed and tested as a more effective orthopedic/ dental implant coating. The present study aims to increase the service-life of an orthopedic/ dental implant by creating materials that form a strong, long lasting, bond with the Ti substrate as well as juxtaposed bone. The health relatedness of the new material is to increase bonding between an implant and juxtaposed bone so that a patient who has received joint or dental replacement surgery may quickly return to a normal active lifestyle. Cross-sectional transmission electron microscopy analysis displayed that the films have a graded crystal structure with the crystalline layer near the substrate and the amorphous layer at the top surface. Compositional analysis was performed using SEM-EDX at the top surface as well as STEM-EDX at the cross section of the film. The average calcium to phosphorous ratio at the surface is 1.46, obtained by SEM-EDX. The Ca/P ratios in the crystalline and amorphous layers of the film are 1.6 to 1.7, close to the ratio of 1.67 for HA.
C1 N Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA.
RP Rabiei, A (reprint author), N Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA.
CR FEDDES B, 2000, SURF COAT TECH, V185, P346
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
NR 2
TC 2
Z9 2
U1 0
U2 3
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-793-8
J9 MATER RES SOC SYMP P
PY 2005
VL 845
BP 193
EP 199
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BCE01
UT WOS:000228804900028
DA 2018-10-20
ER

PT S
AU Newaz, G
   Georgiev, DG
   Mian, A
   Auner, G
   Herfurth, H
   Witte, R
AF Newaz, G
   Georgiev, DG
   Mian, A
   Auner, G
   Herfurth, H
   Witte, R
BE Laurencin, CT
   Botchwey, EA
TI Laser fabrication and characterization of adhesive-free joints for
   encapsulation of biomedical implant devices
SO Nanoscale Materials Science in Biology and Medicine
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoscale Materials Science in Biology and Medicine held at
   the 2004 MRS Fall Meeting
CY NOV 28-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc
ID DIFFUSION; INTERFACE
AB Laser-fabricated joints of sub-millimeter widths between biocompatible, dissimilar materials have the potential for applications as encapsulation of miniature implant biomedical devices. In this work, we briefly describe the laser joining method of a very promising system, polyimide/titanium-coated borosilicate glass, and present and discuss results from characterization of such laser joints by means of mechanical failure (tensile) tests, optical microscopy, X-ray photoelectron spectroscopy (XPS) and Raman spectroscopy. Our results suggest the formation of strong chemical bonds between Ti-containing species and certain polymeric functional groups. Mechanical tensile strength failure test showed that such joint experience only limited, disappearing with time degradation as a result of soaking in physiological solutions.
C1 Wayne State Univ, Coll Engn, Ctr Smart Sensors & Integrated Microsyst, Detroit, MI 48202 USA.
RP Newaz, G (reprint author), Wayne State Univ, Coll Engn, Ctr Smart Sensors & Integrated Microsyst, Detroit, MI 48202 USA.
OI Mian, Ahsan/0000-0002-2033-6738
CR Bauer I, 2004, P SOC PHOTO-OPT INS, V5339, P454, DOI 10.1117/12.530239
   Faupel F, 1997, DEFECT DIFFUS FORUM, V143, P887, DOI 10.4028/www.scientific.net/DDF.143-147.887
   Georgiev DG, 2004, APPL SURF SCI, V236, P71, DOI 10.1016/j.apsusc.2004.03.261
   Girardeaux C, 1996, J ELECTRON SPECTROSC, V77, P209, DOI 10.1016/0368-2048(95)02521-9
   GIRARDEAUX C, 1994, J ELECT SPECTROSC RE, V7, P11
   Marin N, 1997, NUCL INSTRUM METH B, V131, P109, DOI 10.1016/S0168-583X(97)00197-3
   MIAN A, IN PRESS J MAT SCI M
   OHUCHI FS, 1986, J VAC SCI TECHNOL A, V4, P1039, DOI 10.1116/1.573450
NR 8
TC 2
Z9 2
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-793-8
J9 MATER RES SOC SYMP P
PY 2005
VL 845
BP 267
EP 272
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BCE01
UT WOS:000228804900039
DA 2018-10-20
ER

PT S
AU Hai, NH
   Lemoine, R
   Remboldt, S
   Strand, MA
   Wignall, S
   Shield, JE
   Leslie-Pelecky, D
AF Hai, NH
   Lemoine, R
   Remboldt, S
   Strand, MA
   Wignall, S
   Shield, JE
   Leslie-Pelecky, D
BE Laurencin, CT
   Botchwey, EA
TI The stability and oxidation resistance of iron- and cobalt-based
   magnetic nanoparticle fluids fabricated by inert-gas condensation
SO Nanoscale Materials Science in Biology and Medicine
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoscale Materials Science in Biology and Medicine held at
   the 2004 MRS Fall Meeting
CY NOV 28-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc
ID CLUSTER GUN; ANISOTROPY
AB Magnetic nanoparticle fluids have numerous biomedical applications, including magnetic imaging, drug delivery, and hyperthermia treatment for cancer. Ideal magnetic nanoparticle fluids have well-separated, biocompatible nanoparticles with a small size distribution that form a stable colloid. We have combined inert-gas condensation, which produces nanoparticles with low polydispersity, with deposition directly into a surfactant-laden fluid to prevent agglomeration. Iron, cobalt, and iron-nitride nanoparticle fluids fabricated using inert-gas condensation have with mean particle sizes from 5-50 nm and remain stable over long periods of time. Iron and cobalt nanoparticles oxidize on exposure to air, with oxidation rates dependent on surfactant type and concentration. Iron-nitride fluids are more oxidation and corrosion resistant, while retaining the same high degree of colloidal stability. Magnetic properties vary depending on the nanoparticle size and material, but can be varied from superparamagnetic to ferromagnetic with coercivities on the order of 1000 Oe. In addition to future biomedical applications, inert-gas condensation into fluids offers the opportunity to study interparticle interactions over a broad range of intrinsic materials parameters and interparticle separations.
C1 Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA.
RP Hai, NH (reprint author), Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA.
CR Granqvust C., 1976, J APPL PHYS, V47, P220
   GRIMES CA, 2000, J APPL PHYS, V87, P564
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   HAHN H, 1990, J APPL PHYS, V67, P1113, DOI 10.1063/1.345798
   Jack KH, 2000, MATER SCI FORUM, V325-3, P91, DOI 10.4028/www.scientific.net/MSF.325-326.91
   Li D, 2004, J MAGN MAGN MATER, V277, P64, DOI 10.1016/j.jmmm.2003.10.011
   MEIKLEJOHN WH, 1956, PHYS REV, V102, P1413, DOI 10.1103/PhysRev.102.1413
   NAKATANI I, 1990, J MAGN MAGN MATER, V85, P11, DOI 10.1016/0304-8853(90)90006-C
   NGUYEN H, 2005, IN PRESS MAGN MAGN M
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   ROSENZWEIG RE, 1985, FERRHYDRODYNAMICS
   Stoyanov S, 2003, J APPL PHYS, V93, P7592, DOI 10.1063/1.1544503
   Stoyanov S, 2003, J APPL PHYS, V93, P7190, DOI 10.1063/1.1555898
   Wagener M, 1999, J MAGN MAGN MATER, V201, P41, DOI 10.1016/S0304-8853(99)00055-4
NR 14
TC 1
Z9 1
U1 0
U2 4
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-793-8
J9 MATER RES SOC SYMP P
PY 2005
VL 845
BP 351
EP 356
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BCE01
UT WOS:000228804900053
DA 2018-10-20
ER

PT S
AU Nakajima, H
AF Nakajima, H
BE Naka, M
   Yamane, T
TI Fabrication of lotus-type porous metals, intermetallic compounds and
   semiconductors
SO NEW FRONTIERS OF PROCESSING AND ENGINEERING IN ADVANCED MATERIALS
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT International Conference on New Frontiers of Process Science and
   Engineering in Advanced Materials/ 14th Iketani Conference
CY NOV 24-26, 2004
CL Kyoto, JAPAN
SP High Temp Soc Japan, Osaka Univ, Joining & Welding Res Inst, Iketani Sci & Technol Fdn, Murata Sci Fdn
DE porous materials; metals; intermetallic compounds; semiconductors;
   solidification; hydrogen; nitrogen
ID UNIDIRECTIONAL SOLIDIFICATION; SILICON
AB Lotus-type porous materials, whose long cylindrical pores were aligned along the same direction, were fabricated by unidirectional solidification in a pressurized gas atmosphere. The pores were formed in the solidified materials as a result of precipitation due to supersaturated gas during solidification of the liquid material dissolved with gas atoms. The lotus-type porous materials with homogeneous size and porosity of the evolved pores can be obtained by the mould casting method with constant solidification rate for the materials with high thermal conductivity. On the other hand, the novel continuous floating zone melting method was invented to fabricate the porous materials with low thermal conductivity. Recently we succeeded in fabricating lotus-type porous materials such as various metals and alloys, intermetallic compound Ni3Al and NiTi, and semiconductor silicon. The fabrication conditions comprise a pressure up to 3.0 MPa and the use of a mixture gas of hydrogen (or nitrogen) and argon (or helium). Such lotus-type porous materials are expected to be employed in various applications such as machine parts, biomedical materials, etc.
C1 Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.
RP Nakajima, H (reprint author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.
EM nakajima@sanken.osaka-u.ac.jp
CR Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   CULLIS AG, 1991, NATURE, V353, P335, DOI 10.1038/353335a0
   Hyun SK, 2004, J JPN I MET, V68, P39, DOI 10.2320/jinstmet.68.39
   Hyun SK, 2003, MATER LETT, V57, P3149, DOI 10.1016/S0167-577X(03)00012-0
   Nakahata T, 2004, MAT SCI ENG A-STRUCT, V384, P373, DOI 10.1016/j.msea.2004.07.004
   Nakajima H., 2003, CELLULAR METALS MANU, P191
   Nakanishi N, 2000, J OCCUP HEALTH, V42, P1, DOI 10.1539/joh.42.1
NR 7
TC 3
Z9 3
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-980-6
J9 MATER SCI FORUM
PY 2005
VL 502
BP 367
EP 372
DI 10.4028/www.scientific.net/MSF.502.367
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BDL89
UT WOS:000234200300060
DA 2018-10-20
ER

PT S
AU Porjazoska, A
   Yilmaz, OK
   Kayaman-Apohan, N
   Baysal, K
   Cvetkovska, M
   Baysal, BM
AF Porjazoska, A
   Yilmaz, OK
   Kayaman-Apohan, N
   Baysal, K
   Cvetkovska, M
   Baysal, BM
BE KorugicKarasz, LS
   MacKnight, WJ
   Martuscelli, E
TI Synthesis of an ABA triblock copolymer of poly(DL-lactide) and
   poly(ethylene glycol) and blends with poly(epsilon-caprolactone) as a
   promising material for biomedical application
SO NEW POLYMERIC MATERIALS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on New Poymeric Materias
CY OCT 22-25, 2003
CL Capri, ITALY
SP Polymer Chem In, ACS Div
ID DRUG-RELEASE; DEGRADATION; BEHAVIOR; ACID
AB The aim of this work was preparation of blends based on ABA triblock copolymers [A=poly(DL-lactide); B=poly(ethylene glycol)] and poly(epsilon-caprolactone) (PCL), their characterization, hydrolytic degradation study, and evaluation of the possibility to use these materials in tissue engineering. GPC, FTIR, H-1 NMR and DSC analyses were used for block copolymers characterization, and the corresponding blends with PCL, were characterized by FTIP, TGA, DSC and contact angle measurements. Porous films were prepared from triblock copolymers, and corresponding blends using solvent casting particulate-leaching technique. Hydrolytic in vitro degradation was performed in phosphate buffer solution. Preliminary cell growth experiments, using L929 mouse fibroblasts, were performed to observe the attachment and growth of cells on polymer matrices.
C1 Sv Kiril & Metodij Univ, Fac Technol & Met, Skopje 1000, Macedonia.
   TUBITAK, Res Inst Genet Engn & Biotechnol, TR-41470 Gebze, Turkey.
   Marmara Univ, Dept Chem, TR-81040 Istanbul, Turkey.
   Bogazici Univ, Dept Chem Engn, TR-34342 Istanbul, Turkey.
RP Porjazoska, A (reprint author), Sv Kiril & Metodij Univ, Fac Technol & Met, Skopje 1000, Macedonia.
CR BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0
   Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   Dogan M, 1999, J APPL POLYM SCI, V74, P2848, DOI 10.1002/(SICI)1097-4628(19991213)74:12<2848::AID-APP8>3.3.CO;2-W
   Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027
   Hurrell S, 2001, J MATER SCI-MATER M, V12, P811, DOI 10.1023/A:1017925019985
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   John G, 1997, J POLYM SCI POL CHEM, V35, P1901, DOI 10.1002/(SICI)1099-0518(19970730)35:10<1901::AID-POLA4>3.0.CO;2-Q
   Kim CH, 2000, J APPL POLYM SCI, V77, P226, DOI 10.1002/(SICI)1097-4628(20000705)77:1<226::AID-APP29>3.0.CO;2-8
   Lee SH, 2002, J POLYM SCI POL CHEM, V40, P2545, DOI 10.1002/pola.10339
   MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807
   Penco M, 2000, J APPL POLYM SCI, V78, P1721, DOI 10.1002/1097-4628(20001205)78:10<1721::AID-APP20>3.0.CO;2-6
   Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065
   Sheth M, 1997, J APPL POLYM SCI, V66, P1495, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1495::AID-APP10>3.0.CO;2-3
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Wang J, 2002, J CONTROL RELEASE, V82, P289, DOI 10.1016/S0168-3659(02)00137-2
   Xiong XY, 2003, MACROMOLECULES, V36, P9979, DOI 10.1021/ma035292d
NR 19
TC 1
Z9 1
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3928-2
J9 ACS SYM SER
PY 2005
VL 916
BP 119
EP 135
PG 17
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary;
   Polymer Science
SC Chemistry; Materials Science; Polymer Science
GA BDO71
UT WOS:000234566100010
DA 2018-10-20
ER

PT J
AU Konefal, A
   Dybek, M
   Lobodziec, W
   Szczucka, K
AF Konefal, A
   Dybek, M
   Lobodziec, W
   Szczucka, K
TI Thermal and epithermal neutrons in the vicinity of the Primus Siemens
   biomedical accelerator
SO NUKLEONIKA
LA English
DT Article
DE biomedical accelerators; thermal neutrons; epithermal neutrons
ID MEDICAL ACCELERATOR; SPECTRA
AB In this paper, the thermal and epithermal neutron fluence distributions in the vicinity of the Primus Siemens accelerator are presented. The measurements were carried out by the use of the neutron activation method for 15 MV X-rays and electron beams of 18 MeV and 21 MeV. From the radiation safety point of view for the hospital personnel, it is important to know the thermal and epithermal neutron fluence distribution in the vicinity of the accelerator because the neutrons interacting with atoms of a medium by various processes induce the activity of objects (accelerator, other apparatus etc.) and walls in the treatment room. The thermal and epithermal neutron capture, particularly, in high atomic number materials of the accelerator head can be a significant source of gamma radiation and it has to be taken into account for estimation of the work safety of the personnel. Values of the neutron fluence were normalized to the maximum photon (or electron) dose D-max,D-gamma(e) measured at the central axis of therapeutic X-ray (or electron) beam in a water phantom. The thermal neutron fluences measured during the 15 MV X-ray emission varied between 1.1 x 10(5) n (.) cm(-1 .) Gy(-1) and 4.4 x 10(5) n (.) cm(-2) (.) Gy(-1) whereas the epithermal neutron fluences ranged from 0.2 x 10(5) n (.) cm(-2) (.) Gy(-1) to 1.8 x 10(5) n (.) cm(-2) (.) Gy(-1). In the case of electron beams, the neutron fluence measurements were performed only at the isocentre. The obtained thermal and epithermal neutron fluences were 1.2 x 10(4) n (.) cm(-2) (.) Gy(-1) and 0.6 x 10(4) n (.) cm(-2) (.) Gy(-1), respectively, for the 18 MeV electrons. In the the case of the 21 MeV electron beams the thermal neutron fluence was 2.0 x 10(4) n (.) cm(-2) (.) Gy(-1) whereas the epithermal neutron fluence was 0.8 x 10(4) n (.) cm(-2 .) Gy(-1).
C1 Silesian Univ, Inst Phys, PL-40007 Katowice, Poland.
   Hosp Mem St Leszcynski, Dept Radiotherapy, PL-40074 Katowice, Poland.
RP Konefal, A (reprint author), Silesian Univ, Inst Phys, 4 Uniwersytecka Str, PL-40007 Katowice, Poland.
EM akonefal@uranos.cto.us.edu.pl
CR [Anonymous], 1995, ICRP PUBL, V74
   BECKURC K, 1968, NIJTRONNAYA FIZIKA
   Berman BL, 1998, ATOM DATA NUCL DATA, V38, P199
   Carrier JF, 2004, MED PHYS, V31, P484, DOI 10.1118/1.1644532
   Cymerman U, 1984, Nowotwory, V34, P31
   Firestone RB, 1996, TABLE ISOTOPES
   FIRK FWK, 1970, ANN REV NUCL SCI, V20, P39
   Followill David S, 2003, J Appl Clin Med Phys, V4, P189, DOI 10.1120/1.1571671
   Gudowska I., 1996, Nukleonika, V41, P105
   Kase KR, 1998, HEALTH PHYS, V74, P38, DOI 10.1097/00004032-199801000-00005
   KONEFAL A, 2003, PHYS MED, V20, pS147
   KONEFAL A, 2001, POL J MED PHYS ENG, V2, P291
   LEVNGER JS, 1960, NUCL PHOTO DISINTEGR
   MACDONALD N, 1965, NUCL STRUCTURE ELECT
   Macklin RL, 1956, P 1 INT C PEAC US AT, V5, P96
   Mao XS, 1997, HEALTH PHYS, V72, P524, DOI 10.1097/00004032-199704000-00003
   *NBS, 1982, 822543 NBSIR
   *NBS, 1973, NBS SPEC PUBL, V380
   Ongaro C, 2000, PHYS MED BIOL, V45, pL55, DOI 10.1088/0031-9155/45/12/101
   Price WJ, 1964, NUCL RAD DETECTION
   Scott M.B., 1955, PHYS REV, V100, P205
   Wu Raymond K, 2003, J Appl Clin Med Phys, V4, P162, DOI 10.1120/1.1561954
NR 22
TC 15
Z9 15
U1 0
U2 1
PU INST NUCLEAR CHEMISTRY TECHNOLOGY
PI WARSAW
PA DORODNA 16 STR, 03-195 WARSAW, POLAND
SN 0029-5922
J9 NUKLEONIKA
JI Nukleonika
PY 2005
VL 50
IS 2
BP 73
EP 81
PG 9
WC Chemistry, Inorganic & Nuclear; Physics, Nuclear
SC Chemistry; Physics
GA 937VA
UT WOS:000229952800005
DA 2018-10-20
ER

PT J
AU Allan, PS
   Tarverdi, K
AF Allan, PS
   Tarverdi, K
TI Novel articulated support structure for orthopaedic and general
   engineering applications
SO PLASTICS RUBBER AND COMPOSITES
LA English
DT Article; Proceedings Paper
CT Biennial Polymer Process Engineering International Meeting
CY JUL 05-06, 2005
CL Univ Bradford, Bradford, ENGLAND
HO Univ Bradford
DE biomedical; splint; twin-screw extrusion; seating; composite
AB The present paper discusses investigations into the manufacture, testing and application of a highly flexible structure incorporating innovative joints linked together to form a sheet that can be conformed around complex three-dimensional shapes which can be easily 'switched' from a flexible state to a highly stable/rigid one and a process which can be reversed. In the present study, consideration will be given to preparation, characterisation and properties of the manufactured modules. A range of techniques used to characterise these materials will be discussed, including compressive strength, impact and recovery measurements.
C1 Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
RP Tarverdi, K (reprint author), Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
EM Karnik.Tarverdi@brunel.ac.uk
CR BEVIS MJ, 1996, P 20 INT BPF COMP C
   CONEN V, 2001, P 8 ANN INT C COMP E, P143
   Metaxas R, 2000, POWER ENG J, V14, P51, DOI 10.1049/pe:20000206
   Olofinjana A, 2001, INT J MACH TOOL MANU, V41, P209, DOI 10.1016/S0890-6955(00)00060-2
   Pozar D. M., 1998, MICROWAVE ENG
   Thostenson ET, 1999, COMPOS PART A-APPL S, V30, P1055, DOI 10.1016/S1359-835X(99)00020-2
   Tressler JF, 1999, COMPOS PART A-APPL S, V30, P477, DOI 10.1016/S1359-835X(98)00137-7
NR 7
TC 0
Z9 0
U1 0
U2 1
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 1465-8011
J9 PLAST RUBBER COMPOS
JI Plast. Rubber Compos.
PY 2005
VL 34
IS 5-6
BP 283
EP 286
DI 10.1179/174328905X64795
PG 4
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 992GD
UT WOS:000233871500013
DA 2018-10-20
ER

PT J
AU Prowans, P
   El Fray, M
   Jursa, J
AF Prowans, P
   El Fray, M
   Jursa, J
TI Study on degradation and systemic toxicity of multiblock
   poly(aliphatic/aromatic-ester) copolymers
SO POLIMERY
LA English
DT Article
DE multiblock copolyesters; dimer fatty acid; degradation; toxicity test;
   hemolysis; mechanical properties
ID MECHANICAL-BEHAVIOR; PHYSICAL-PROPERTIES; FATTY-ACID; VITAMIN-E;
   POLYANHYDRIDES; ANTIOXIDANT; TEREPHTHALATE); POLYETHYLENE; POLYESTER;
   POLYMERS
AB The series of PED multiblock copolymers were synthesized. They are composed of poly(butylene terephthalate) (PBT) aromatic units (hard segments) and aliphatic sequences of dimer fatty acids (DFA) (soft segments). The composition of hard segments vary in the range from 26 to 70 wt. %. These polymers can be "tailor-made", and therefore, their properties can change along with the composition, from very soft and flexible materials to semi-rigid polymers. Their susceptibility to degradation is a function of hard/soft segment composition. Degradation test (buffer saline solution, pH = 7.4, temp. 37 degreesC, time 5 weeks) as well as in vivo implantation test for 6 months confirm this statement. Polymers containing higher concentrations of soft segments are more susceptible to degradation than the materials with higher concentrations of hard, aromatic segments as demonstrated by GPC and ATR FT-IR. The chloroformic extracts from PED copolymers were analyzed by GC/MS to evaluate the chemical composition of potential extractables, especially from the polymers demonstrating higher susceptibility to degradation. Prepared saline extracts were subjected to the pyrogenicity tests on rabbits. The influence of the polymer composition on skin irritation was also evaluated by the intracutaneous injections of polymer extracts. Additionally, hemolysis test in contact with bulk polymers was performed. Evaluating the nature of local tissue response to PED extracts and the results of hemolysis test, we did not detect any indication of systemic toxicity over the compositional range of PED copolymers. These novel copolymers were shown to be biocompatible and are very promising materials for biomedical applications.
C1 Clin Gen & Hand Surg, Pomeranian Med Acad Szczecin, PL-71344 Szczecin, Poland.
   Tech Univ Szczecin, Polymer Inst, PL-70322 Szczecin, Poland.
   Pomeranian Med Acad Szczecin, Dept Microbiol & Med Immunol, PL-70111 Szczecin, Poland.
   Pomeranian Med Acad Szczecin, Sect Microbiol & Med Immunol, PL-70111 Szczecin, Poland.
RP El Fray, M (reprint author), Clin Gen & Hand Surg, Pomeranian Med Acad Szczecin, Ul Unii Lubelskiej 1, PL-71344 Szczecin, Poland.
EM mirfray@ps.pl
RI Prowans, Piotr/B-5495-2015; El Fray, Miroslawa/J-4128-2016
OI Prowans, Piotr/0000-0002-6102-364X; 
CR Al-Malaika S, 2000, POLYM POLYM COMPOS, V8, P537
   ALMALAIKA S, 1994, J POLYM SCI POL CHEM, V32, P3099, DOI 10.1002/pola.1994.080321610
   Dawids S. G., 1993, TEST PROCEDURES BLOO
   Deschamps AA, 2001, POLYMER, V42, P9335, DOI 10.1016/S0032-3861(01)00453-0
   DOMB AJ, 1993, J POLYM SCI POL CHEM, V31, P1275, DOI 10.1002/pola.1993.080310523
   Domb AJ, 1994, BIOMEDICAL POLYM, P69
   *DSM PROD FOLD, 2002, ARN GEN INF APPL PRO
   El Fray M, 2000, J MATER SCI-MATER M, V11, P757
   El Fray M, 1996, ANGEW MAKROMOL CHEM, V234, P103
   El Fray M, 2000, TAILORED POLYMERS & APPLICATIONS, P133
   ELFRAY M, 2003, MATER ENG, V17, P1
   ELFRAY M, 1998, Patent No. 329794
   FENG Y, 2001, EPOLYMERS
   FOLDES E, 1992, J APPL POLYM SCI, V46, P507, DOI 10.1002/app.1992.070460317
   Hoeschele G K, 1976, Patent No. [US 3954689, 3954689]
   Krasko MY, 2002, POLYM ADVAN TECHNOL, V13, P960, DOI 10.1002/pat.267
   Prowans P, 2002, BIOMATERIALS, V23, P2973, DOI 10.1016/S0142-9612(02)00026-1
   Sakkers RJB, 1998, J MATER SCI-MATER M, V9, P375, DOI 10.1023/A:1013227428530
   Schnabel W., 1981, POLYM DEGRADATION PR
   Schubert MA, 1996, J BIOMED MATER RES, V32, P493, DOI 10.1002/(SICI)1097-4636(199612)32:4<493::AID-JBM1>3.3.CO;2-H
   SHIEH L, 1994, J BIOMED MATER RES, V28, P1465, DOI 10.1002/jbm.820281212
   SITTING M, 1991, HDB TOXIC HAZARDOUS, P659
   Stareczek T, 1999, POLIMERY-W, V44, P218
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   SWANSON JW, 1974, J BIOMED MATER RES, V8, P357, DOI 10.1002/jbm.820080603
   Teomim D, 1999, J POLYM SCI POL CHEM, V37, P3337, DOI 10.1002/(SICI)1099-0518(19990815)37:16<3337::AID-POLA32>3.0.CO;2-S
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WINTERMANTEL E, 2002, MED BIOKOMPATIBLEN W
NR 28
TC 7
Z9 7
U1 0
U2 6
PU INDUSTRIAL CHEMISTRY RESEARCH INST
PI WARSAW
PA 8 RYDYGIERA STR, 01-793 WARSAW, POLAND
SN 0032-2725
J9 POLIMERY-W
JI Polimery
PY 2005
VL 50
IS 2
BP 131
EP 138
PG 8
WC Polymer Science
SC Polymer Science
GA 894IZ
UT WOS:000226786000006
DA 2018-10-20
ER

PT S
AU Chiba, A
   Kumagai, K
   Takeda, H
   Nomura, N
AF Chiba, A
   Kumagai, K
   Takeda, H
   Nomura, N
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Mechanical properties of forged low Ni and C-containing Co-Cr-Mo
   biomedical implant alloy
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE joint prostheses; biomaterial; Co-Cr-Mo alloy; hot-forging; mechanical
   properties; wear
AB In order to examine the influence of variation in grain size and microstructure on mechanical properties of a low Ni and C-containing Co-29Cr-6Mo alloy for biomedical implant materials, the tensile properties and the dry friction wear characteristics of the wrought Co-29Cr-6Mo alloy without addition of Ni and C were investigated. The microstructure of as-forged alloys, consisting of fcc phase mixed with athermal hcp martensite, is found to become finer as the reduction during forging increases. The hot-forging processes for fabricating the fine microstructure with different grain sizes of 43, 11 and 3 pm has been successfully established under the condition that forging temperature of higher than 1273 K is strictly kept during forging. The tensile properties, such as the yield stress, the tensile stress and the elongation, are improved with decreasing the gram size and thereby increasing the volume fraction of the fcc phase in the microstructure. The dry wear resistance against the alumina ball is enhanced by decreasing the grain size.
C1 Iwate Univ, Dept Welfare Engn, Morioka, Iwate 0200801, Japan.
   Iwate Univ, Morioka, Iwate 0200801, Japan.
RP Chiba, A (reprint author), Iwate Univ, Dept Welfare Engn, Morioka, Iwate 0200801, Japan.
EM a.chiba@iwate-u.ac.jp; t5103002@iwate-u.ac.jp; N.Nomura@iwate-u.ac.jp
RI Chiba, Akihiko/D-1326-2011; NOMURA, Naoyuki/L-7149-2017
CR BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x
   CLEMOW AJT, 1980, WEAR, V61, P219, DOI 10.1016/0043-1648(80)90287-2
   HOLLANDER R, 1975, J BIOMED MATER RES, V9, P367, DOI 10.1002/jbm.820090311
   Montero-Ocampo C, 1999, METALL MATER TRANS A, V30, P611, DOI 10.1007/s11661-999-0052-6
   Sage M., 1950, REV MET, V47, P139
NR 5
TC 48
Z9 48
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2317
EP 2321
DI 10.4028/www.scientific.net/MSF.475-479.2317
PN 1-5
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702156
DA 2018-10-20
ER

PT S
AU Inamura, T
   Fukui, Y
   Hosoda, H
   Wakashima, K
   Miyazaki, S
AF Inamura, T
   Fukui, Y
   Hosoda, H
   Wakashima, K
   Miyazaki, S
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Pseudoelastic properties of cold-rolled TiNbAl alloy
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE beta-titanium; biomedical shape memory alloy; superelasticity; texture
ID MECHANICAL-PROPERTIES
AB Microstructures and pseudo-elasticity of as-rolled Ti-24mol%Nb-3mol%Al, a newly developed functional biomedical beta-Ti alloy (bcc), at room temperature were characterized. The material was homogenized at 1273K after arc-melting and quenched into water to obtain single phase of P. Cold-rolling of 99% reduction in thickness was carried out and then, microstructures and pseudo-elastic properties were examined. theta-2 theta XRD measurement revealed that the as-rolled material was consisted with the parent P phase and martensite phase (alpha", C-center orthorhombic). X-ray pole figure measurements revealed that the rolling texture was a mixture of < 110 >(beta){001}(beta)-type and < 112 >(beta){111}(beta)-type textures. Shape recovery strain of 4% appeared along TD without any intermediate annealing after the cold-rolling.
C1 Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.
   Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RP Inamura, T (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.
EM inamura@pi.titech.ac.jp; hosoda@pi.titech.ac.jp;
   wakashim@pi.titech.ac.jp; miyazaki@ims.tsukuba.ac.jp
RI Inamura, Tomonari/E-5712-2014; Miyazaki, Shuichi/A-3113-2012
OI Miyazaki, Shuichi/0000-0003-3849-4176
CR Brooks C. R., 1982, HEAT TREATMENT STRUC, P329
   BROWN ARG, 1964, NATURE, V201, P914, DOI 10.1038/201914a0
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   FUKUI Y, 2003, T MRS J, V28, P623
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   HOSODA H, 2000, INT WORKSH BIOINT MA, P26
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   HOSODA N, 2001, 4 PAC RIM INT C ADV, V2, P1623
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   KURODA D, 1996, IRON STEEL I JPN, V9, P421
   Kuroda K., 2003, T MRS J, V28, P631
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   TADA H, 1998, 3 PAC RIM INT C ADV, V2, P3086
NR 15
TC 18
Z9 18
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2323
EP 2327
DI 10.4028/www.scientific.net/MSF.475-479.2323
PN 1-5
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702157
DA 2018-10-20
ER

PT S
AU Zhentao, Y
   Lian, Z
   Maohong, F
   Sibo, Y
AF Zhentao, Y
   Lian, Z
   Maohong, F
   Sibo, Y
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Investigation on near-beta titanium alloy Ti-5Zr-3Sn-5Mo-15Nb for
   surgical implant materials
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE titanium; near-beta type titanium alloys; surgical implant materials
AB A newly designed near-beta type biomedical Ti alloy Ti-5Zr-3Sn-5Mo-15Nb (TLM) were introduced which are much more suitable for surgical implant and orthopedic materials. The typical mechanical properties and microstructure were studied by means of the alloying elements, process and heat treatment. The alloy possesses excellent biocompatibility, lower elastic modulus, higher strength, finer plasticity and fracture toughness matching by means of solid solution and aging treatment. The better workability of TLM alloy results from the stress-induced martensite transform.
C1 NW Inst Nonferrous Met Res, Xian 710016, Shaanxi, Peoples R China.
   Iowa State Univ, Ctr Sustainable Environm Technol, Ames, IA 50011 USA.
RP Zhentao, Y (reprint author), NW Inst Nonferrous Met Res, Xian 710016, Shaanxi, Peoples R China.
EM ayzt@c-nin.com; Zhoul@c-nin.com; fan@ameslab.gov
CR FROS FH, 1985, J MET, V37, P28
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   STEINEMANN SG, 1993, SEMLITSCH TITANIUM, V92, P2689
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   WARRENDALE MS, 1993, PENNSYLVANIA, P2689
   YU ZT, 2004, RARE METALS LETT, V23, P5
NR 9
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2353
EP 2357
PN 1-5
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702163
DA 2018-10-20
ER

PT B
AU He, CL
   Huang, ZM
   Liu, L
   Han, XJ
AF He, CL
   Huang, ZM
   Liu, L
   Han, XJ
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI Electrospun core-shell PLLA nanofiber and its potential for drug release
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
AB Electrospinning has been developed to fabricate composite nanofibers for biomedical applications such as drug delivery systems and tissue engineering scaffolds. The objective of this study was to evaluate the physical-chemical properties and drug release properties of electrospun core-shell poly (L-lactic acid) (PLLA) fibrous membranes used as a controlled release carriers for tetracycline hydrochloride (TCH). The fibrous membranes were fabricated by coaxial electrospinning in which PLLA (2:1 mixture of chloroform and acetone by weight as a solvent) and TCH/PLLA (2:1 mixture of methanol and chloroform by weight as a solvent) were used as the shell and the core materials, respectively. The electrospun fibers and their membranes were characterized by scanning electron microscope (SEM), transmission electron microscopy (TEM), and differential scanning calorimetry (DSC), whereas the mechanical performances of fibrous membranes were tested through tensile test. The drug release behavior was investigated by UV-VIS spectroscopy. Results indicated that the morphology of fibers and distribution of fiber diameter relied on the processing parameters, and the uniform composite fibers with eminent mechanical properties could be obtained when the core and shell solution concentrations were kept at 5 wt% (0.3 ml.h-1 flow rate) and 8-10 wt% (5.0 ml.h-I flow rate), respectively. TCH could be encapsulated in the PLLA ultrafine fibers and maintain a sustaining release from the fibrous membranes, suggesting that the thus obtained core-shell composite fibrous membranes can be a promising candidate for drug release carrier.
C1 Tongji Univ, Sch Aeronaut Astronaut & Mech, Shanghai 200092, Peoples R China.
RP Huang, ZM (reprint author), Tongji Univ, Sch Aeronaut Astronaut & Mech, Shanghai 200092, Peoples R China.
RI He, Chuanglong/C-2976-2011
OI He, Chuanglong/0000-0001-8330-8542
CR Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
NR 2
TC 0
Z9 0
U1 0
U2 11
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 708
EP 712
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600184
DA 2018-10-20
ER

PT B
AU Sell, SA
   Barnes, CP
   Knapp, DC
   Walpoth, BH
   Bowlin, GL
AF Sell, SA
   Barnes, CP
   Knapp, DC
   Walpoth, BH
   Bowlin, GL
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI The new 'spin' on vascular tissue engineering
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
AB Over the years there has been considerable effort to develop biomedical textiles for applications ranging from tissue engineering scaffolds to vascular grafts to wound dressings and hemostatic bandages. Biomedical textiles used for such applications must meet many criteria, among which are the following: the material must be biocompatible and function without interrupting other physiological processes and the textile production method must be reproducible and allow for a wide range of shapes and sizes such that the morphological and mechanical properties of the textile are sufficient for the intended use. The method of electrospinning is a simple fabrication process that achieves the goals of many biomedical textiles. Our lab has successfully electrospun the biodegradable polymers poly(glycolic acid) (PGA), poly(lactic acid) (PLA), polycaprolactone (PCL), and polydioxanone (PDS) as well as natural polymers including collagen (types I, II, III and IV), elastin, fibrinogen, hemoglobin, and myoglobin. In addition, blends and copolymers of these synthetic and/or natural polymers have also been electrospun to develop novel biomedical textiles, including tissue engineering scaffolds. vascular grafts, wound dressings, and hemostatic bandages (U.S. and International Patents Pending). The majority of these structures are comprised of fibers ranging in diameter from 80 nm to 1.5 microns. The fiber diameters are controllable via electrospinning solution concentration, and the mechanical properties of the scaffolds are controllable via fiber diameter and fiber orientation. With various compositions, fiber dimensions, and fiber orientations, the mechanical properties and degradation rates of the electrospun textiles can be tailored. Cellular/tissue interactions have been shown to be dependent on the characteristics of the electrospun scaffolds with composition and fiber diameter as the dominant variables. The results from all this preliminary work are very promising in that the ideal biomedical textile may be customized for a specific application using this technology leading to the ultimate goal of biomimicking extracellular matrix, in particular for vascular tissue engineering. Data to date regarding our work fabricating and testing electrospun scaffolds for completely tissue engineered blood vessels (in vitro tissue engineering) and bioresorbable vascular grafts (in vivo tissue engineering) will be presented.
C1 Virginia Commonwealth Univ, Richmond, VA 23298 USA.
RP Sell, SA (reprint author), Virginia Commonwealth Univ, Med Coll Virginia Campus, Richmond, VA 23298 USA.
RI Bowlin, Gary/E-8617-2010
OI Sell, Scott/0000-0002-6785-3193
NR 0
TC 0
Z9 0
U1 2
U2 10
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 912
EP 915
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600228
DA 2018-10-20
ER

PT B
AU Li, Z
   Xu, XF
AF Li, Z
   Xu, XF
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI Synthesis, characterization and performance of the biomedical breathable
   polyurethane material
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
DE hydrophilic polyurethane; mechanical property; contact angle; blood
   compatibility
AB A series of thermoplastic polyurethane materials were synthesized based on 4, 4'-diphenylmethane-diisocyanate(MIDI), chain-extender (BDO), polyethylene glycol (PEG) and polytetramethylene-ether glycol (PTMG), stannous octoate by changing proportion of PEG in soft segment. The experiment used Fourier transform infrared spectrum (FTIR) to signify internal structure of material, tested mechanical properties, water contact angles, moisture permeability and blood compatibility of synthetic material. The result indicated that choosing appropriate proportion of PEG in soft segment is advantageous to balance mechanical properties and affinity of new-type synthetic material.
C1 Jiaxing Coll, Sch Garments & Arts Design, Jiaxing 314001, Zhejiang, Peoples R China.
RP Li, Z (reprint author), Jiaxing Coll, Sch Garments & Arts Design, Jiaxing 314001, Zhejiang, Peoples R China.
CR Fu M., 1999, POLYURETHANE ELASTOM
   JOHNSON L, 2000, BREATHABLE TPE FILMS, P30
   Yan R.X., 1998, WATER SOLUBLE POLYM
NR 3
TC 0
Z9 0
U1 0
U2 2
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 963
EP 966
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600240
DA 2018-10-20
ER

PT B
AU Liu, M
   Yu, WD
AF Liu, M
   Yu, WD
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI Investigation on the biocompatibility of keratin membranes
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
DE keratin; membrane; biocompatibility; wool; fiber
ID SPONGE SCAFFOLDS; WOOL KERATIN; FILMS; CULTIVATION
AB Artificial keratin membranes are made frorn the keratin materials Such as wool or other animal hairs through the dissolution with various chemicals at first and then the preparation into the membranes in Filtration and dry, that means there are many extra chemicals which influence the biocompatibility of the compound though keratin is ecological and biocompatible. Therefore, the membranes formed in milder solvents and low damaged treatment frorn wool fibers has been investigated by means of biocompatibility tests, which were conducted through the general methods according to ISO 10993 in order to evaluate the capacity of skin irritation, hemolysis and cell Cultivation. The animal tests show that the keratin membranes prepared by authors are good compatibility and have no significant anaphylaxis because the primary irritation index (PII) is below 0.4. Consequently, the wool keratin membrane is one kind of friendly and most prospective biomaterials for biomedical and histological utilization.
C1 Donghua Univ, Text Mat & Technol Lab, Shanghai 200051, Peoples R China.
RP Yu, WD (reprint author), Donghua Univ, Text Mat & Technol Lab, Shanghai 200051, Peoples R China.
CR EARLAND C, 1959, BIOCHIM BIOPHYS ACTA, V36, P273, DOI 10.1016/0006-3002(59)90104-0
   FEUGHELMAN M, 1985, ENCY POLYM SCI ENG, V8, P566
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Katoh K, 2004, J APPL POLYM SCI, V91, P756, DOI 10.1002/app.13236
   KOGA J, 1989, J APPL POLYM SCI, V37, P2131, DOI 10.1002/app.1989.070370805
   ODONNELL IJ, 1964, AUST J BIOL SCI, V17, P973, DOI 10.1071/BI9640973
   SCHALLER H, 1980, J APPL POLYM SCI, V25, P783
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   WU ZY, 1996, J SU ZHOU I SILK TEX, V16, P71
   Yamauchi K, 1997, COLLOID SURFACE B, V9, P117, DOI 10.1016/S0927-7765(96)01322-7
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   YOSHIMIZU H, 1991, MACROMOLECULES, V24, P862, DOI 10.1021/ma00004a008
   74898 ASTM F
   GBT16886102000
   345630
   1099312003 ISO
NR 18
TC 0
Z9 0
U1 0
U2 3
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 1011
EP 1014
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600252
DA 2018-10-20
ER

PT B
AU Oates, WS
   Smith, RC
AF Oates, William S.
   Smith, Ralph C.
GP ASME
TI Nonlinear open loop optimal tracking using magnetostrictive transducers
SO Proceedings of the ASME Dynamic Systems and Control Division 2005, Pts A
   and B
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 05-11, 2005
CL Orlando, FL
SP ASME, Proc Ind Div, ASME, Rail Transportat Div, ASME, Noise Control & Acoust Div, ASME, Triol Div, ASME, Pressure Vessels & Piping Div, ASME, Bioengn Div, ASME, Mat Div, ASME, Appl Mech Div, ASME, Fluids Engn Div, ASME, Micro Elect Mech Syst Div, ASME, Heat Transfer Div, ASME, Nucl Engn Div, ASME, Power Div, ASME, Solar Energy Div, ASME, Safety Engn & Risk Anal Div, ASME, Technol & Soc Div, ASME, Adv Energy Syst Div, ASME, Aerosp Div, ASME, Comp & Informat Engn Div
ID INVERSE COMPENSATION; HYSTERESIS; SMART
AB The design of high performance smart material devices requires control laws that can achieve stringent performance criteria required in many industrial, automotive, aerospace and biomedical applications. Moderate to high field inputs are often required which introduces nonlinear hysteretic constitutive behavior This often cannot be effectively compensated using linear control theory. In the present work, a nonlinear optimal control methodology is developed for tracking a reference trajectory when nonlinear hysteretic constitutive behavior is significant. For brevity, we focus on open loop control for regimes when disturbances are minimal. The nonlinear control design is investigated on magnetostrictive rod-type actuators by implementing a homogenized energy model. Significant emphasis is place on material behavior at multiple length scales to produce an accurate and efficient model to compensate for nonlinear hysteretic magnetostrictive constitutive behavior.
C1 N Carolina State Univ, Dept Math, Ctr Res Sci Computat, Raleigh, NC 27695 USA.
RP Oates, WS (reprint author), N Carolina State Univ, Dept Math, Ctr Res Sci Computat, Box 8205, Raleigh, NC 27695 USA.
CR Ascher U M, 1995, NUMERICAL SOLUTION B
   BITTANTI S, 1972, PERIODIC OPTIMIZATIO, V2, P183
   Bryson A. E., 1969, APPL OPTIMAL CONTROL
   Dapino MJ, 2000, IEEE T MAGN, V36, P545, DOI 10.1109/20.846217
   DAPRATO G, 1987, SIAM J CONTROL OPTIM, V25, P706, DOI 10.1137/0325039
   Duerig TW, 2002, MRS BULL, V27, P101, DOI 10.1557/mrs2002.44
   Ge P, 1996, IEEE T CONTR SYST T, V4, P209, DOI 10.1109/87.491195
   Grant D, 1997, IEEE CONTR SYST MAG, V17, P80, DOI 10.1109/37.588180
   JILES DC, 1984, J PHYS D APPL PHYS, V17, P1265, DOI 10.1088/0022-3727/17/6/023
   Lewis F. L., 1995, OPTIMAL CONTROL
   NEALIS JM, UNPUB IEEE T CONTROL
   OATES W, UNPUB J INTELL MAT S
   Smith R, 2005, SMART MAT SYSTEMS MO
   SMITH R, 1995, J INTEL MAT SYST STR, V9, P468
   Smith R. C., 1999, Proceedings of the 38th IEEE Conference on Decision and Control (Cat. No.99CH36304), P2875, DOI 10.1109/CDC.1999.831370
   Smith RC, 2001, MATH COMPUT MODEL, V33, P285, DOI 10.1016/S0895-7177(00)00245-4
   Smith RC, 2000, P AMER CONTR CONF, P2750, DOI 10.1109/ACC.2000.878710
   Straub FK, 2004, J INTEL MAT SYST STR, V15, P249, DOI 10.1177/1045389X04042795
   Tao G., 1996, ADAPTIVE CONTROL SYS
NR 19
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4216-4
PY 2005
BP 17
EP 24
PG 8
WC Automation & Control Systems
SC Automation & Control Systems
GA BFY96
UT WOS:000245508100003
DA 2018-10-20
ER

PT B
AU Xu, AP
   Qu, YX
   Wang, JW
   Shaw, LL
AF Xu, AP
   Qu, YX
   Wang, JW
   Shaw, LL
BE Batra, RC
   Qian, LF
   Zhang, YL
   Li, XN
   Tso, SK
TI Design for solid freeform fabrication of dental restoration
SO Proceedings of the International Conference on Mechanical Engineering
   and Mechanics 2005, Vols 1 and 2
LA English
DT Proceedings Paper
CT International Conference on Mechanical Engineering and Mechanics
CY OCT 26-28, 2005
CL Nanjing Univ Sci & Technol, Nanjing, PEOPLES R CHINA
HO Nanjing Univ Sci & Technol
DE bio-CAD; dental restoration; multiple materials; solid freeform
   fabrication
AB Solid freeform fabrication (SFF) has been increasingly used in biomedical applications such as dental restoration, orthopedic implants, scaffolds and drug delivery where complex-shaped objects made of multiple materials or functionally graded materials are typically desired. This paper shows the design process for SFF of the hollow multi-material complex-shaped object such as dental crown during dental restoration, which is covered with a layer of dental porcelain outside, and a layer of noble metal inside; besides, a removable material needs to be used in the hollow cave as the supporting structure. First of all, the design process begins with a 3D surface model in STL format. With the aid of Magics RP (Materialise, Belgium), the surface model will be converted into a solid model, and then the solid model needs to be further processed and divided into three parts to which different materials will be respectively specified in order to meet the requirements of multi-material object. After that, a special process planning needs to be conducted. Finally, the multi-material dental crown can be fabricated via selective slurry extrusion (SSE) based technique of SFF. The case study demonstrates the feasibility of SFF technique for biomedical applications.
C1 Hebei Univ Technol, Sch Mech Engn, Tianjin 300130, Peoples R China.
RP Xu, AP (reprint author), Hebei Univ Technol, Sch Mech Engn, Tianjin 300130, Peoples R China.
CR ANPING XU, COMPUTER AIDED DESIG, V37, P1308
   WANG J, 2004, P 15 SFF S, P816
   COLGATE CORPORATION
NR 3
TC 8
Z9 8
U1 0
U2 1
PU SCIENCE PRESS BEIJING
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100707, PEOPLES R CHINA
BN 1-933100-14-1
PY 2005
BP 1216
EP 1219
PG 4
WC Engineering, Multidisciplinary; Mechanics
SC Engineering; Mechanics
GA BDC76
UT WOS:000232717800250
DA 2018-10-20
ER

PT B
AU Bahar, E
AF Bahar, Ezekiel
BE Hamza, MH
TI Mueller Matrix applied to detection and identification of bio-medical
   materials possessing chirality
SO Proceedings of the Second IASTED International Conference on Antennas,
   Radar, and Wave Propagation
LA English
DT Proceedings Paper
CT 2nd IASTED International Conference on Antennas, Radar, and Wave
   Propagation
CY JUL 19-21, 2005
CL Banff, CANADA
SP Int Assoc Sci & Technol Dev, IASTED Tech Comm Telecommun, IEEE Antennas & Propagat Soc
DE bio-electromagnetics; wave propagation
AB All sixteen Mueller Matrix elements of Bio-Medical Materials measured by an optical polarimetric scatterometer are examined to develop discrimination algorithms. Special attention was given to the eight quasi off diagonal scattering elements of the Mueller Matrix in order to examine the feasibility of bio-medical identification. Since bio-medical materials possess some degree of chirality, the specific impact of chirality on the Mueller Matrix elements is analyzed extensively. It is shown that (to within first order in chirality) only the eight quasi off diagonal elements of the Mueller Matrix are effected by the chiral property of the bio-medical materials. This reinforces the experimental observations from previous scattering experiments that the quasi off diagonal Mueller Matrix elements could provide a basis for bio-medical detection and identification. The analysis provides the specific relationship between the quasi off diagonal elements and the degree of chirality of the biomedical materials, in order to determine whether the chiral effects are sufficiently large to provide the accuracy necessary to conduct species-level discrimination in the presence of spurious (noise) contributions due to surface roughness, etc. The specific dependence of scattering due to chirality upon frequency and angle of incidence is also determined.
C1 Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.
RP Bahar, E (reprint author), Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.
CR BAHAR E, 1972, RADIO SCI, V50
   CRITTENDEN PE, 2002, THESIS U NEBRASKA LI
NR 2
TC 0
Z9 0
U1 0
U2 1
PU ACTA PRESS ANAHEIM
PI ANAHEIM
PA PO BOX 5124, ANAHEIM, CA 92814-5124 USA
BN 0-88986-503-5
PY 2005
BP 207
EP 210
PG 4
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA BEW24
UT WOS:000239789900039
DA 2018-10-20
ER

PT S
AU Noureddine, B
   Mohamed, M
   Lies, D
AF Noureddine, Batel
   Mohamed, Mehenni
   Lies, Dekar
BE Ardil, C
TI Attenuation in Transferred RF Power to a Biomedical Implant due to the
   Misalignment Coils
SO PROCEEDINGS OF WORLD ACADEMY OF SCIENCE, ENGINEERING AND TECHNOLOGY, VOL
   10
SE Proceedings of World Academy of Science Engineering and Technology
LA English
DT Proceedings Paper
CT Conference of the World-Academy-of-Science-Engineering-and-Technology
CY DEC 16-18, 2005
CL Cracow, POLAND
DE Biomedical implant field; misalignment coils; power attenuation;
   transmitter and receiver coils
AB In biomedical implant field, a new formula is given for the study of Radio Frequency power attenuation by simultaneous effects of side and angular misalignment of the supply/data transfer coils. A confrontation with the practical measurements done into a Faraday cage, allowed a checking of the obtained theoretical results. The DC supply systems without material connection and the data transmitters used in the case of biomedical implants, can be well dimensioned by taking into account the possibility of power attenuation by misalignment of transfer coils.
C1 [Noureddine, Batel; Lies, Dekar] Yahia Fares Univ Ctr, Engn Sci Inst, Medea 26001, Algeria.
RP Noureddine, B (reprint author), Yahia Fares Univ Ctr, Engn Sci Inst, Medea 26001, Algeria.
CR CHOSSAT M, 1977, MEMORANDUM MATH
   FLACK FC, 1971, MED BIOL ENG, V9
   JEUTTEUR DC, 1994, MED LIFE SCI ENG, V13, P131
   KO WEN, 1977, MED BIOL ENG COMPUTI
   MEHENNI M, 1992, THESIS NATL SCH POLY
   Mehenni M., 1992, FEEDING EXTERNAL ELE, V14
   Nasar S.A., 1997, INTRO ELECTROMAGNETI
   Soma M., 1987, IEEE T BIOMEDICAL EN, V34
   TAFLOVE A, 1975, IEEE T MICROW THEORY, V23, P623, DOI 10.1109/TMTT.1975.1128640
   Terman F. E., 1943, RADIO ENG HDB
   YAVORSKI B, 1986, MEMORANDUM PHYS
NR 11
TC 3
Z9 3
U1 0
U2 0
PU WORLD ACAD SCI, ENG & TECH-WASET
PI CANAKKALE
PA PO BOX 125, CANAKKALE, 17100, TURKEY
SN 1307-6884
J9 PROC WRLD ACAD SCI E
PY 2005
VL 10
BP 160
EP 164
PG 5
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods
SC Computer Science
GA BIK61
UT WOS:000260416300031
DA 2018-10-20
ER

PT J
AU Stojilovic, N
   Bender, ET
   Ramsier, RD
AF Stojilovic, N
   Bender, ET
   Ramsier, RD
TI Surface chemistry of zirconium
SO PROGRESS IN SURFACE SCIENCE
LA English
DT Review
DE zirconium; oxidation; surface chemistry; subsurface species; diffusion;
   water; oxygen; hydrogen; nuclear materials; alloys; zircaloy
AB This article presents an overview of the surface chemistry of zirconium, focusing on the relationship of what is known from model studies and how this connects to current and future applications of Zr-based materials. The discussion includes the synergistic nature of adsorbate interactions in this system, the role of impurities and alloying elements, and temperature-dependent surface-subsurface transport. Finally, some potential uses of zirconium and its alloys for biomedical and nanolithographic applications are presented. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Akron, Dept Phys, Akron, OH 44325 USA.
   Univ Akron, Dept Chem, Akron, OH 44325 USA.
RP Ramsier, RD (reprint author), Univ Akron, Dept Phys, 250 Buchtel Commons,Ayer Hall 111, Akron, OH 44325 USA.
EM rex@uakron.edu
CR Ankrah S, 2003, J PHYS-CONDENS MAT, V15, P1899, DOI 10.1088/0953-8984/15/12/307
   Ardlin BI, 2002, DENT MATER, V18, P590, DOI 10.1016/S0109-5641(01)00095-1
   Arima T, 2001, J NUCL MATER, V294, P148, DOI 10.1016/S0022-3115(01)00453-6
   Arima T, 1998, J NUCL MATER, V257, P67, DOI 10.1016/S0022-3115(98)00069-5
   ASBURY DA, 1987, SURF SCI, V185, P213, DOI 10.1016/S0039-6028(87)80623-4
   AXELSSON KO, 1985, SURF SCI, V164, P109, DOI 10.1016/0039-6028(85)90702-2
   Baek JH, 2002, J NUCL MATER, V304, P107
   Bai XD, 1998, J NUCL MATER, V254, P266, DOI 10.1016/S0022-3115(97)00346-2
   Barberis P, 1997, J NUCL MATER, V246, P232, DOI 10.1016/S0022-3115(97)00038-X
   Barberis P, 2001, J NUCL MATER, V288, P241, DOI 10.1016/S0022-3115(00)00727-3
   Bastl Z, 2002, SURF INTERFACE ANAL, V34, P477, DOI 10.1002/sia.1342
   BEHM RJ, 1983, J CHEM PHYS, V78, P7486, DOI 10.1063/1.444739
   Bellanger G, 2000, J MATER SCI, V35, P1759, DOI 10.1023/A:1004732703500
   Benezra V, 1999, MATER RES SOC SYMP P, V550, P337
   Bodansky D., 1996, NUCL ENERGY PRINCIPL
   Bottcher A, 1999, PHYS STATUS SOLIDI A, V173, P101, DOI 10.1002/(SICI)1521-396X(199905)173:1<101::AID-PSSA101>3.0.CO;2-R
   Bouvier P, 2002, J NUCL MATER, V300, P118, DOI 10.1016/S0022-3115(01)00756-5
   BRODKIN JS, 1993, THIN SOLID FILMS, V234, P512, DOI 10.1016/0040-6090(93)90320-O
   Buczynski BW, 2003, COLLOID SURFACE B, V30, P167, DOI 10.1016/S0927-7765(03)00068-7
   Cho JH, 1997, PHYS REV B, V56, P9282, DOI 10.1103/PhysRevB.56.9282
   CHOU MY, 1989, PHYS REV B, V39, P5623, DOI 10.1103/PhysRevB.39.5623
   Clarke AH, 1997, SURF INTERFACE ANAL, V25, P948, DOI 10.1002/(SICI)1096-9918(199711)25:12<948::AID-SIA338>3.0.CO;2-K
   Cohen P, 1980, WATER COOLANT TECHNO
   Cox B, 1997, J ALLOY COMPD, V256, pL4, DOI 10.1016/S0925-8388(96)02956-8
   COX B, 1993, J NUCL MATER, V199, P258, DOI 10.1016/0022-3115(93)90147-Q
   COX B, 1995, J NUCL MATER, V218, P261, DOI 10.1016/0022-3115(94)00654-7
   Cox B, 1999, J NUCL MATER, V270, P134, DOI 10.1016/S0022-3115(98)00898-8
   Cox B, 1999, J NUCL MATER, V264, P283, DOI 10.1016/S0022-3115(98)00492-9
   Cox B, 1997, J NUCL MATER, V249, P17, DOI 10.1016/S0022-3115(97)00191-8
   COX B, 1995, J NUCL MATER, V218, P113, DOI 10.1016/0022-3115(94)00651-2
   Cox B., 1976, ADV CORROSION SCI TE, V5
   D'Souza DH, 2002, LETT APPL MICROBIOL, V35, P414, DOI 10.1046/j.1472-765X.2002.01206.x
   DAVIES JA, 1965, J ELECTROCHEM SOC, V112, P675, DOI 10.1149/1.2423662
   DEGONZALEZ CO, 1988, SURF SCI, V193, P305, DOI 10.1016/0039-6028(88)90438-4
   ElMahdy GA, 1996, THIN SOLID FILMS, V286, P289, DOI 10.1016/S0040-6090(95)08503-3
   Elmoselhi MB, 1995, J ALLOY COMPD, V231, P716, DOI 10.1016/0925-8388(95)01759-3
   Farkas N, 2005, J VAC SCI TECHNOL A, V23, P846, DOI 10.1116/1.1864052
   Farkas N, 2005, NANOTECHNOLOGY, V16, P262, DOI 10.1088/0957-4484/16/2/014
   Farkas N, 2004, APPL PHYS LETT, V85, P5691, DOI 10.1063/1.1833569
   Farkas N, 2004, THIN SOLID FILMS, V447, P468, DOI 10.1016/S0040-6090(03)01252-5
   Farkas N, 2004, J VAC SCI TECHNOL A, V22, P1879, DOI 10.1116/1.1723269
   Farkas N, 2003, J VAC SCI TECHNOL A, V21, P1188, DOI 10.1116/1.1560712
   Fehlner F. P., 1970, OXID MET, V2, P59
   Feibelman PJ, 1996, SURF SCI, V360, P297, DOI 10.1016/0039-6028(96)00599-7
   Feibelman PJ, 1996, PHYS REV B, V53, P13740, DOI 10.1103/PhysRevB.53.13740
   Fernandez GE, 2002, J ALLOY COMPD, V330, P483, DOI 10.1016/S0925-8388(01)01622-X
   Fischer H, 2002, DENT MATER, V18, P570, DOI 10.1016/S0109-5641(01)00091-4
   FLINN BJ, 1993, PHYS REV B, V47, P16499, DOI 10.1103/PhysRevB.47.16499
   FOORD JS, 1980, SURF SCI, V94, P339, DOI 10.1016/0039-6028(80)90011-4
   Frank H, 2002, J NUCL MATER, V306, P85, DOI 10.1016/S0022-3115(02)00879-6
   Garcia EA, 1999, J NUCL MATER, V273, P221, DOI 10.1016/S0022-3115(98)00691-6
   GARCIA EA, 1994, J NUCL MATER, V210, P78, DOI 10.1016/0022-3115(94)90225-9
   Grandjean A, 1999, J NUCL MATER, V273, P111, DOI 10.1016/S0022-3115(99)00036-7
   GRIFFITHS K, 1988, J VAC SCI TECHNOL A, V6, P210, DOI 10.1116/1.574982
   HARUO N, 1997, KOGAKU SHUHO KYUSHU, V70, P569
   HOFLUND GB, 1983, J VAC SCI TECHNOL A, V1, P1837, DOI 10.1116/1.572224
   HOFLUND GB, 1987, J VAC SCI TECHNOL A, V5, P112
   HOOD GM, 1994, J NUCL MATER, V210, P1, DOI 10.1016/0022-3115(94)90215-1
   Howlader MMR, 1998, J NUCL MATER, V253, P149, DOI 10.1016/S0022-3115(97)00309-7
   HUANG JH, 1993, MAT SCI ENG A-STRUCT, V161, P247, DOI 10.1016/0921-5093(93)90519-K
   HUI KC, 1985, SOLID STATE COMMUN, V56, P83, DOI 10.1016/0038-1098(85)90539-3
   ILTIS X, 1994, J NUCL MATER, V209, P180, DOI 10.1016/0022-3115(94)90294-1
   Jomard G, 2000, MOL SIMULAT, V24, P111, DOI 10.1080/08927020008024191
   JOMARD G, 2000, APPL SURF SCI, V177, P230
   Jones AC, 2004, J MATER CHEM, V14, P3101, DOI 10.1039/b405525j
   Kang YC, 2002, APPL SURF SCI, V195, P196, DOI 10.1016/S0169-4332(02)00541-X
   Kang YC, 2002, SURF SCI, V519, P229, DOI 10.1016/S0039-6028(02)02210-0
   Kang YC, 2002, J NUCL MATER, V303, P125, DOI 10.1016/S0022-3115(02)00845-0
   Kang YC, 2001, J VAC SCI TECHNOL A, V19, P1996, DOI 10.1116/1.1339020
   Kang YC, 2000, J NUCL MATER, V281, P57, DOI 10.1016/S0022-3115(00)00131-8
   KANG YC, 2002, VACUUM, V64, P113
   Kim HG, 2002, J NUCL MATER, V306, P44, DOI 10.1016/S0022-3115(02)01226-6
   Kim JM, 2004, APPL PHYS LETT, V85, P6368, DOI 10.1063/1.1841470
   Kim W, 1995, SURF COAT TECH, V76-77, P595, DOI 10.1016/0257-8972(95)02576-6
   Kim YS, 1999, J NUCL MATER, V270, P165, DOI 10.1016/S0022-3115(98)00904-0
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Kovar M, 1997, J CHEM PHYS, V106, P4797, DOI 10.1063/1.473478
   KUBO T, 1991, J NUCL SCI TECHNOL, V28, P122, DOI 10.1080/18811248.1991.9731331
   Kurahashi M, 1999, SURF SCI, V420, P259, DOI 10.1016/S0039-6028(98)00838-3
   Kurahashi M, 1997, J VAC SCI TECHNOL A, V15, P2548, DOI 10.1116/1.580768
   LI AJ, 1995, J CHEM PHYS, V103, P7187, DOI 10.1063/1.470347
   Li B, 1997, SURF SCI, V370, P97, DOI 10.1016/S0039-6028(96)00955-7
   Li B, 1997, SURF SCI, V384, P70, DOI 10.1016/S0039-6028(97)00159-3
   LI B, 1995, SURF SCI, V330, P276, DOI 10.1016/0039-6028(95)00052-6
   LI B, 1995, SURF SCI, V322, P373, DOI 10.1016/0039-6028(95)90045-4
   LI YS, 1995, APPL SURF SCI, V89, P263, DOI 10.1016/0169-4332(95)00032-1
   Li YS, 1996, APPL SURF SCI, V103, P389, DOI 10.1016/S0169-4332(96)00535-1
   Li YS, 1995, SURF REV LETT, V2, P759, DOI 10.1142/S0218625X95000686
   LIN JM, 1984, APPL SURF SCI, V18, P315, DOI 10.1016/0378-5963(84)90318-0
   Lin YP, 2000, J NUCL MATER, V277, P11, DOI 10.1016/S0022-3115(99)00153-1
   LOU JR, 1988, CAN J CHEM, V66, P3157, DOI 10.1139/v88-487
   Lyapin A, 2004, SURF SCI, V552, P160, DOI 10.1016/j.susc.2004.01.016
   Maslar JE, 2001, J NUCL MATER, V298, P239, DOI 10.1016/S0022-3115(01)00657-2
   MCINTYRE NS, 1991, SURF INTERFACE ANAL, V17, P757, DOI 10.1002/sia.740171102
   MCINTYRE NS, 1991, J NUCL MATER, V178, P80, DOI 10.1016/0022-3115(91)90458-J
   McNatt JS, 2002, J PHYS D APPL PHYS, V35, P1855, DOI 10.1088/0022-3727/35/15/306
   Meyer G, 1996, J NUCL MATER, V229, P48, DOI 10.1016/0022-3115(95)00228-6
   Michaelis A, 1998, THIN SOLID FILMS, V313, P756, DOI 10.1016/S0040-6090(97)00992-9
   MITCHELL DJ, 1984, J VAC SCI TECHNOL A, V2, P780, DOI 10.1116/1.572571
   Miyagawa Y., 1998, Surface and Coatings Technology, V103-104, P323, DOI 10.1016/S0257-8972(98)00408-3
   Miyake M, 1999, J NUCL MATER, V270, P233, DOI 10.1016/S0022-3115(98)00779-X
   MOORE WT, 1979, J PHYS C SOLID STATE, V12, pL887, DOI 10.1088/0022-3719/12/23/003
   MORANT C, 1989, SURF SCI, V218, P331, DOI 10.1016/0039-6028(89)90156-8
   Morgan JM, 2002, J APPL PHYS, V91, P9375, DOI 10.1063/1.1476079
   Moya JS, 2000, ACTA MATER, V48, P4749, DOI 10.1016/S1359-6454(00)00267-6
   Nagano H, 1996, CORROS SCI, V38, P781, DOI 10.1016/0010-938X(95)00166-H
   NEERGAARDWALTENBURG H, 1994, J PHYS CHEM-US, V98, P12075, DOI 10.1021/j100097a037
   NICHTLPECHER W, 1991, PHYS REV B, V43, P6946, DOI 10.1103/PhysRevB.43.6946
   Nishino Y, 1997, J NUCL MATER, V248, P292, DOI 10.1016/S0022-3115(97)00126-8
   Nishino Y, 1996, J NUCL MATER, V228, P346, DOI 10.1016/0022-3115(95)00194-8
   Ojima K, 2000, APPL SURF SCI, V165, P141, DOI 10.1016/S0169-4332(00)00370-6
   Ojima K, 2000, APPL SURF SCI, V165, P149, DOI 10.1016/S0169-4332(00)00371-8
   Okuyama H, 1998, SURF SCI, V401, P344, DOI 10.1016/S0039-6028(98)00020-X
   Olmedo D, 2002, J MATER SCI-MATER M, V13, P793, DOI 10.1023/A:1016131310025
   Oskarsson M, 2001, J NUCL MATER, V297, P77, DOI 10.1016/S0022-3115(01)00580-3
   Oskarsson M, 2001, J NUCL MATER, V295, P97, DOI 10.1016/S0022-3115(01)00480-9
   PALACIO C, 1987, SURF SCI, V191, P385, DOI 10.1016/S0039-6028(87)81185-8
   Parise M, 1998, J NUCL MATER, V256, P35, DOI 10.1016/S0022-3115(98)00045-2
   Park K, 1999, J NUCL MATER, V270, P154, DOI 10.1016/S0022-3115(98)00903-9
   Patel AM, 1997, BIOMATERIALS, V18, P441, DOI 10.1016/S0142-9612(96)00152-4
   Pecheur D, 2000, J NUCL MATER, V278, P195, DOI 10.1016/S0022-3115(99)00253-6
   PETERSON WJ, 1985, APPL SURF SCI, V24, P121, DOI 10.1016/0169-4332(85)90216-8
   Phadnis SV, 1999, T I MET FINISH, V77, P200, DOI 10.1080/00202967.1999.11871283
   Pichugin AT, 2000, MATER SCI+, V36, P683, DOI 10.1023/A:1011355723821
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Qin Z, 1999, J NUCL MATER, V264, P228, DOI 10.1016/S0022-3115(98)00465-6
   RAMASUBRAMANIAN N, 1990, J NUCL MATER, V175, P237, DOI 10.1016/0022-3115(90)90212-6
   Raspopov SA, 1997, J CHEM SOC FARADAY T, V93, P2113, DOI 10.1039/a608475c
   Ries MD, 2002, J BONE JOINT SURG AM, V84A, P129, DOI 10.2106/00004623-200200002-00018
   Sawicki JA, 1999, J NUCL MATER, V264, P169, DOI 10.1016/S0022-3115(98)00463-2
   Schweinsberg M, 1997, ELECTROCHIM ACTA, V42, P3303, DOI 10.1016/S0013-4686(97)00181-3
   Sergeev VS, 2003, ATOM ENERGY+, V95, P613, DOI 10.1023/B:ATEN.0000007884.41282.34
   Shi LQ, 2002, J VAC SCI TECHNOL A, V20, P1840, DOI 10.1116/1.1506174
   SHIH HD, 1976, SURF SCI, V60, P445, DOI 10.1016/0039-6028(76)90328-9
   Shimizu K, 1998, CAN J CHEM, V76, P1796, DOI 10.1139/cjc-76-12-1796
   Song Z, 2004, J VAC SCI TECHNOL A, V22, P711, DOI 10.1116/1.1690252
   Spector M, 2001, J BONE JOINT SURG AM, V83A, P80, DOI 10.2106/00004623-200100022-00004
   Stojilovic N, 2005, J VAC SCI TECHNOL A, V23, P1013, DOI 10.1116/1.1864054
   Stojilovic N, 2004, J VAC SCI TECHNOL A, V22, P1631, DOI 10.1116/1.1723308
   Stojilovic N, 2004, CHEM PHYS LETT, V399, P53, DOI 10.1016/j.cplett.2004.10.003
   Stojilovic N, 2004, SURF SCI, V565, P243, DOI 10.1016/j.susc.2004.07.015
   Stojilovic N, 2004, SOLID STATE COMMUN, V130, P623, DOI 10.1016/j.ssc.2004.03.023
   Stojilovic N, 2004, SURF SCI, V553, P23, DOI 10.1016/j.susc.2004.02.002
   Stojilovic N, 2003, APPL SURF SCI, V218, P188, DOI 10.1016/S0169-4332(03)00584-1
   Stojilovic N, 2002, SURF INTERFACE ANAL, V33, P945, DOI 10.1002/sia.1475
   STOJILOVIC N, IN PRESS APPL SURF S
   TAKEUCHI H, 1988, J CHEM SOC FARAD T 1, V84, P4235, DOI 10.1039/f19888404235
   TAKEUCHI K, 1995, SURF SCI, V323, P30, DOI 10.1016/0039-6028(94)00621-0
   TANABE T, 1989, SURF SCI, V222, P84, DOI 10.1016/0039-6028(89)90336-1
   TAPPING RL, 1995, INT J MASS SPECTROM, V146, P75, DOI 10.1016/0168-1176(95)04205-Y
   Taylor DF, 2000, J NUCL MATER, V277, P295, DOI 10.1016/S0022-3115(99)00159-2
   Tokash JC, 2005, SURF INTERFACE ANAL, V37, P379, DOI 10.1002/sia.1993
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   Vaillancourt M, 1995, J NUCL MATER, V227, P58, DOI 10.1016/0022-3115(95)00144-1
   Vermoyal JJ, 2001, J NUCL MATER, V298, P297, DOI 10.1016/S0022-3115(01)00648-1
   Vermoyal JJ, 1999, ELECTROCHIM ACTA, V45, P1039, DOI 10.1016/S0013-4686(99)00307-2
   Veshchunov MS, 1998, J NUCL MATER, V255, P250, DOI 10.1016/S0022-3115(98)00018-X
   Vittoz C, 1999, J ADHES SCI TECHNOL, V13, P1045, DOI 10.1163/156856199X00505
   Wang YM, 1997, SURF SCI, V380, P540, DOI 10.1016/S0039-6028(97)00039-3
   WANG YM, 1995, SURF SCI, V343, pL1167, DOI 10.1016/0039-6028(95)00897-7
   WANG YM, 1993, APPL SURF SCI, V72, P237, DOI 10.1016/0169-4332(93)90192-E
   WANG YM, 1995, SURF SCI, V342, P272, DOI 10.1016/0039-6028(95)00807-1
   Watanabe K, 1998, FUSION ENG DES, V39-40, P1055, DOI 10.1016/S0920-3796(98)00161-6
   WEST PE, 1987, J VAC SCI TECHNOL A, V5, P1124, DOI 10.1116/1.574814
   WONG PC, 1995, SURF REV LETT, V2, P165, DOI 10.1142/S0218625X95000170
   WONG PC, 1987, SOLID STATE COMMUN, V62, P293, DOI 10.1016/0038-1098(87)90815-5
   WONG PC, 1987, CAN J PHYS, V65, P464, DOI 10.1139/p87-062
   WONG PC, 1995, APPL SURF SCI, V89, P255, DOI 10.1016/0169-4332(95)00031-3
   WONG PC, 1987, SURF SCI, V187, pL599, DOI 10.1016/0167-2584(87)90854-1
   Yamamoto M, 1997, SURF SCI, V387, P300, DOI 10.1016/S0039-6028(97)00365-8
   Yamamoto M, 1996, PHYS REV B, V54, P14111, DOI 10.1103/PhysRevB.54.14111
   YAMAMOTO M, 1990, J CHEM SOC FARADAY T, V86, P157, DOI 10.1039/ft9908600157
   YAMAMOTO M, 1991, J CHEM SOC FARADAY T, V87, P1591, DOI 10.1039/ft9918701591
   Yamamoto M, 1996, PHYS REV B, V53, P13772, DOI 10.1103/PhysRevB.53.13772
   Yamanaka S, 1997, J NUCL MATER, V247, P315, DOI 10.1016/S0022-3115(97)00101-3
   Yamanaka S, 1995, J ALLOY COMPD, V231, P503, DOI 10.1016/0925-8388(95)01864-6
   YAMOKOSKI EA, 2005, J ASTM INT, V2
   YAU TE, 1983, SCC ZIRCONIUM ITSL A, V39
   YAU TL, 1992, STRESS CORROSION CRA, pCH11
   ZEHRINGER R, 1989, SURF SCI, V215, P501, DOI 10.1016/0039-6028(89)90272-0
   Zhang CS, 1996, SURF SCI, V346, P206, DOI 10.1016/0039-6028(95)00904-3
   ZHANG CS, 1995, J NUCL MATER, V223, P238, DOI 10.1016/0022-3115(95)00030-5
   Zhang CS, 1998, J NUCL MATER, V257, P1, DOI 10.1016/S0022-3115(98)00432-2
   ZHANG CS, 1994, SURF SCI, V313, P308, DOI 10.1016/0039-6028(94)90051-5
   ZHANG CS, 1995, SURF SCI, V338, P157, DOI 10.1016/0039-6028(95)00600-1
   Zhang CS, 2002, J NUCL MATER, V300, P7, DOI 10.1016/S0022-3115(01)00714-0
   ZHANG CS, 1991, SURF SCI, V245, P373, DOI 10.1016/0039-6028(91)90039-U
   ZHANG CS, 1992, J VAC SCI TECHNOL A, V10, P2560, DOI 10.1116/1.578099
   ZHANG CS, 1993, J NUCL MATER, V199, P231
   Zhang CS, 1995, J ALLOY COMPD, V231, P354, DOI 10.1016/0925-8388(95)01847-6
   ZHANG CS, 1991, SURF SCI, V264, P1
   Zhdanov VP, 1996, APPL SURF SCI, V99, P205, DOI 10.1016/0169-4332(96)00098-0
   ZOU H, 1995, APPL SURF SCI, V90, P59, DOI 10.1016/0169-4332(95)00056-9
NR 193
TC 64
Z9 65
U1 2
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6816
J9 PROG SURF SCI
JI Prog. Surf. Sci.
PY 2005
VL 78
IS 3-4
BP 101
EP 184
DI 10.1016/j.progsurf.2005.07.001
PG 84
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 980XN
UT WOS:000233051600002
DA 2018-10-20
ER

PT S
AU Allen, MG
   Cook, DJ
   Decker, BK
   Hensley, JM
   Rosen, DI
   Silva, ML
   Sonnenfroh, DM
   Wainner, RT
AF Allen, MG
   Cook, DJ
   Decker, BK
   Hensley, JM
   Rosen, DI
   Silva, ML
   Sonnenfroh, DM
   Wainner, RT
BE Razeghi, M
   Brown, GJ
TI In-situ and stand-off sensing using QC/IC laser technology from 3-100
   microns
SO Quantum Sensing and Nanophotonic Devices II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Quantum Sensing and Nanophotonic Devices II
CY JAN 23-27, 2005
CL San Jose, CA
SP SPIE
DE quantum cascade laser; LIDAR; cavity enhance spectroscopy; gas
   detection; absorption
ID QUANTUM-CASCADE LASERS; ABSORPTION-MEASUREMENTS; SPECTROSCOPY;
   TEMPERATURE; OPERATION; GAS
AB Recent advances in current-pumped, bandgap-engineered semiconductor lasers have dramatically impacted laser-based sensor concepts for in-situ trace species measurement and standoff sensing applications. These devices allow a common technology platform to access strong fundamental vibrational absorption transitions of many gases., liquids, and solids in the mid-wave and long-wave Ilk, as well as far-Ilk, or THz. The THz wavelength region is particularly interesting for applications related to structure penetrating detection of hidden materials and biomolecular spectroscopy. This presentation will briefly review the important properties of these lasers as they apply to sensor design and present highlights of recent sensor development activity for trace gas analysis in environmental and biomedical applications, remote sensing LIDAR systems, and detection of hidden explosives.
C1 Phys Sci Inc, Andover, MA 01810 USA.
RP Allen, MG (reprint author), Phys Sci Inc, 20 New England Business Ctr, Andover, MA 01810 USA.
CR ALLEN MG, 1995, APPL OPTICS, V34, P3240, DOI 10.1364/AO.34.003240
   Bakhirkin YA, 2004, APPL OPTICS, V43, P2257, DOI 10.1364/AO.43.002257
   Barkan A, 2004, OPT LETT, V29, P575, DOI 10.1364/OL.29.000575
   Capasso F, 2000, IEEE J SEL TOP QUANT, V6, P931, DOI 10.1109/2944.902142
   COOK D, 2004, 535408 SPIE
   COOK D, 2003, S OPT TECHN IND ENV
   Gittins CM, 2000, OPT LETT, V25, P1162, DOI 10.1364/OL.25.001162
   HCNSLCY JM, 2005, OSA OPT TER SCI TECH
   Kohler R, 2002, NATURE, V417, P156, DOI 10.1038/417156a
   KOSTEREV A, APP OPT, V39, P4425
   Kumar S, 2004, APPL PHYS LETT, V84, P2494, DOI 10.1063/1.1695099
   Mahler L, 2004, APPL PHYS LETT, V84, P5446, DOI 10.1063/1.1767957
   Sonnenfroh DM, 2001, APPL OPTICS, V40, P812, DOI 10.1364/AO.40.000812
   Wainner RT, 2002, APPL PHYS B-LASERS O, V75, P249, DOI 10.1007/s00340-002-0984-7
   Yang RQ, 2001, IEEE J QUANTUM ELECT, V37, P282, DOI 10.1109/3.903079
NR 15
TC 3
Z9 3
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5706-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5732
BP 134
EP 143
DI 10.1117/12.598279
PG 10
WC Instruments & Instrumentation; Optics; Spectroscopy
SC Instruments & Instrumentation; Optics; Spectroscopy
GA BCF41
UT WOS:000229036500014
DA 2018-10-20
ER

PT S
AU Elliott, TB
   Knudson, GB
   Shoemaker, MO
   Ledney, GD
AF Elliott, TB
   Knudson, GB
   Shoemaker, MO
   Ledney, GD
BE Gazso, LG
   Ponta, CC
TI Inactivation of biological warfare agent simulants by ionizing radiation
SO Radiation Inactivation of Bioterrorism Agents
SE NATO SCIENCE SERIES, SUB-SERIES I: LIFE AND BEHAVIOURAL SCIENCES
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Radiation Inactivation of
   Bioterrorism Agents
CY MAR 07-09, 2004
CL Frederic Joliot-Curie Natl Res Inst Radiobiol & Radiohygiene, Budapest,
   HUNGARY
SP NATO
HO Frederic Joliot-Curie Natl Res Inst Radiobiol & Radiohygiene
ID BACILLUS-ATROPHAEUS; STRAINS
AB The Armed Forces Radiobiology Research Institute (AFRRI) in the U. S. Department of Defense conducts biomedical research on the effects of ionizing radiation. It has the largest radiobiology program in the United States and is a national resource in the response to nuclear and radiation accidents. Bacterial spores are potential biological weapons because they can be prepared and distributed by aerosol, they endure harsh environmental conditions, and they are infectious. Decontamination procedures for large concentrations of spores must be effective and practical. We determined the dose response of bacterial spores to three qualities, or types, of ionizing radiation.
   Inactivation of dry and hydrated bacterial spores with gamma radiation has been more thoroughly studied than spore inactivation with neutron radiation. Decimalreduction curves were produced at AFRRI for Bacillus atrophaeus (B. subtilis var. niger, B. globigii, '' BG ''), B. pumilus, B. thuringiensis, and B. anthracis Sterne spores, both wet and dry, using doses of 0.3 to 7.2 kGy neutrons delivered at a dose rate of 44 to 49 Gy/min (D-n/D-T = 0.95) in the AFRRI training, research, isotope-producing General Atomic (TRIGA) Mark-F nuclear reactor, and doses of 0.6 to 24.0 kGy gamma rays delivered at dose rates of 112 to 120 Gy/min in the AFRRI cobalt-60 ((CO)-C-60) gamma-photon irradiation facility. Decimal-reduction curves were constructed by plotting the spore survival fraction in terms of colony-forming units vs. radiation dose. All four species showed greater sensitivity to neutron radiation than to gamma radiation, regardless of the state of hydration. Dry spores of all four species were more sensitive to gamma radiation than were hydrated spores. In contrast, the state of hydration, whether dry or hydrated, of spores of B. subtilis and B. pumilus, which were embedded in filter paper strips, did not affect their sensitivity to neutron radiation. Wet B. thuringiensis spores were only slightly more sensitive to neutrons than were B. thuringiensis spores in dry powdered form. Furthermore, the species most resistant to neutron and gamma radiations was a concentrated B. anthracis Sterne spore suspension. When the starting spore concentration, the Bacillus species used, the radiation quality (neutron or gamma), and the state of hydration are known, the radiation decimal-reduction curves generated in these studies can be used to predict bacterial spore survival.
   Electron-beam radiation (e-beam) has been used to inactivate microorganisms in spices, fresh food, medical components, and hazardous waste. AFRRI assessed the efficacy of using an e-beam for decontamination of bulk biological agents and of byproducts of the decontamination procedures such as wipes and aqueous runoff. Biological agent surrogates were tested under controlled conditions to determine the effectiveness of e-beam for decontamination. Using the AFRRI linear accelerator (LINAC) to deliver doses of 2 to 20 kGy at a dose rate of 1 kGy/min, radiation Decimal-reduction curves were constructed for Bacillus atrophaeus spores in a dry powder and B. anthracis Sterne spores in a slurry. Doses of 0.25 to 1.0 kGy were delivered to vegetative Gram-negative bacterial cells of Serratia marcescens. The LINAC produced 13-MeV electrons at 30 pulses/sec with a 4-mu sec pulse width generated through a water scatterer. Spore samples were irradiated in an array of three screw-capped polystyrene tubes. Dosimetry was performed at the beginning of each experimental run with LiF:Ti,Mg thermoluminescent dosimeters (TLDs), product type TLD-100 (Bicrong (R)). TLDs were processed with the Bicron (R)/Harshaw Model 5500 Automatic TLD Reader. The inactivation data for dry B. atraphaeus spores, B. anthracis Sterne spores, and S. marcescens were fitted to a mathematical ton-rula. The e-beam decimal-reduction curves for the bacterial spores were similar to our previously generated gamma-photon radiation curves. The vegetative bacterial cells of S. marcescens were more susceptible to high-speed electrons than were the bacterial spores. These experimental findings support the concept of using a truck-mounted transportable LINAC in the field for decontaminating bulk materials that are contaminated with pathogenic bacteria.
C1 Armed Forces Radiobiol Res Inst, Bethesda, MD 20889 USA.
RP Elliott, TB (reprint author), Armed Forces Radiobiol Res Inst, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.
CR *AM ASS PHYS MED, 1983, MED PHYS, V10, P741
   Carter RE, 1973, 733 ARM FORC RAD RES
   COLE LA, 1988, CLOUBS SECRECY ARMYS
   ELLIOT TB, 1995, INT J RADIAT BIOL, V68, P311, DOI 10.1080/09553009514551241
   Fritze D, 2001, INT J SYST EVOL MICR, V51, P35, DOI 10.1099/00207713-51-1-35
   LEDNEY GD, 1996, 961 ARMED FORCES RAD
   NAKAMURA LK, 1989, INT J SYST BACTERIOL, V39, P295, DOI 10.1099/00207713-39-3-295
NR 7
TC 1
Z9 1
U1 0
U2 5
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1566-7693
BN 1-58603-488-X
J9 NATO SCI SER I LIFE
PY 2005
VL 365
BP 153
EP 160
PG 8
WC Biology; Microbiology; Nuclear Science & Technology; Physics, Applied
SC Life Sciences & Biomedicine - Other Topics; Microbiology; Nuclear
   Science & Technology; Physics
GA BCE05
UT WOS:000228807300017
DA 2018-10-20
ER

PT S
AU Zhang, J
   Chou, C
   Jensen, T
   Gray, J
AF Zhang, J
   Chou, C
   Jensen, T
   Gray, J
BE Thompson, DO
   Chimenti, DE
TI Development of a high-resolution CT system and 3D data visualization
   tools
SO Review of Progress in Quantitative Nondestructive Evaluation, Vols 24A
   and 24B
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 31st Annual Review of Progress in Quantitative Nondestructive Evaluation
CY JUL 25-30, 2004
CL Colorado Sch Mines, Golden, CO
HO Colorado Sch Mines
AB The need for material characterization covers broad areas including new materials development, failure analysis, biomedical applications and process development and characterization. Length scales of 0.1 mu through 500 mu are of key importance to if processes are to be understood and a measure of control on those processes achieved. Computed tomography (CT) imaging of objects is increasingly important in that it can provide 3D information nondestructively about the internal features of interest. We present results from a recently developed mu CT system based cm a 130 kVp microfocus tube, an amorphous Si array detector and a micro-stepped positioner. At present the highest resolutions available are voxel sizes of 2.5 microns with a field of view of 4 mm. The data volumes are several gigabytes and have 1400x1400x500voxels. Larger fields of view can be obtained at lower resolution. In generating these 31) data sets a number of issues need to be addressed including detector noise and artifacts, transfer of data from systems, efficient reconstruction of the large data sets, visualization of the data and finally, extraction of information from the data. Parallel processing for the CT reconstruction is implemented on a 64 node Linux cluster and provides reconstruction of a 3D volume in 12 minutes. A custom 3D visualization tool implements volume rendering on a PC and provides 3D viewing of the objects. Users have various functions such as histogram lookup table, mapping, region of interest clipping, normalization, and transparency to explore and interrogate the data. Examples from the CT scanning system will be presented.
C1 Iowa State Univ, Ctr NDE, Ames, IA 50011 USA.
RP Zhang, J (reprint author), Iowa State Univ, Ctr NDE, 1915 Scholl Rd, Ames, IA 50011 USA.
CR Fan P., 2001, THESIS IOWA STATE U
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   JASIUNIENE E, 2000, P 15 WORLD C NOND TE
   XU JD, 1994, REV PROG Q, V13, P557
   Zhang J., 2003, THESIS IOWA STATE U
NR 5
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0245-0
J9 AIP CONF PROC
PY 2005
VL 760
BP 686
EP 693
PG 8
WC Acoustics; Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Materials Science, Characterization & Testing; Optics
SC Acoustics; Engineering; Materials Science; Optics
GA BCE68
UT WOS:000228893300088
DA 2018-10-20
ER

PT S
AU Oliveira, L
   Lage, A
AF Oliveira, L
   Lage, A
BE Tuchin, VV
TI Monte Carlo simulation for the optical transmittance in biological
   tissues during the action of osmotic agents
SO Saratov Fall Meeting 2004: Optical Technologies in Biophysics and
   Medicine VI
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 2004 Saratov Fall Meeting
CY SEP 21-24, 2004
CL Saratov, RUSSIA
SP Russian Fdn Basic Res, US Civilian Res & Dev Fdn Independent States Former Soviet Union, SPIE Russian Chapter, IEEE MTT, ED, AP, CPMT Saratov Penza Chapter, TECHNOSERV S, Ltd, Almus, Ltd, Saratov State Univ, Res Educ Inst Opt & Biophoton SSU, Russian Acad Sci, Inst Precis Mech & Control, Res Educ Ctr Nonlinear Dynam & Biophys CRDF & Minist Educ & Sci RF, Volga Reg Ctr New Informat Technologies, Russian Acad Nat Sci, Saratov Reg Div, Russian Soc Photobiol, Saratov State Tech Univ, Inst Business & Business Adm
DE Monte Carlo; optical transmittance; biological optical properties
AB Computational methods have been used with great application to biomedical optics. The events created by the interaction of radiation with biological materials can easily be translated to computer languages with the objective of producing simulation techniques to be used prior to physical intervention. The addition of biocompatible and hyper osmotic agents to several types of biological tissues has proven the enhancement of transparency to radiation flux by reduction of material's optical properties. The evolutionary behavior of the agent's action in the tissue samples before saturation has been observed by numerous researchers but has never been described mathematically. In the present work we will describe the application of Monte Carlo simulation to estimate the evolutionary states of optical transparency of biological tissues when immersed in an osmotic solution. We begin our study with typical values for the optical properties of rabbit muscle and proceed by reducing the absorption and scattering coefficients independently and simultaneously. The results show the number of transmitted, absorbed, scattered and reflected photons in different stages of the action of a generic osmotic agent over a small and well defined tissue sample.
C1 Ctr Ciencias & Tecnol Opt, P-4150 Oporto, Portugal.
RP Oliveira, L (reprint author), Ctr Ciencias & Tecnol Opt, Rua Caldas Xavier 38, P-4150 Oporto, Portugal.
RI Oliveira, Luis/B-7198-2017
OI Oliveira, Luis/0000-0003-0667-3428
CR CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354
   Galanzha EI, 2003, J PHYS D APPL PHYS, V36, P1739, DOI 10.1088/0022-3727/36/14/313
   KIN F, 2001, LASER SURG MED, V29, P213
   MEGLINSKI IV, 2001, 4 PAC RIM C, V1, P1
   Prahl S., 1988, THESIS U TEXAS AUSTI
   WANG L., 1995, COMPUTER METHODS PRO, V47
   2002, BIOMEDICAL PHOTONICS, pCH3
   1987, OPTICS EUGENE HECHT
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5752-3
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5771
BP 225
EP 236
DI 10.1117/12.634821
PG 12
WC Biophysics; Engineering, Biomedical; Optics
SC Biophysics; Engineering; Optics
GA BCW59
UT WOS:000231561200028
DA 2018-10-20
ER

PT J
AU Bollen, PJA
   Remie, R
   Kloots, W
   Barfred, L
   Salomon, S
   Ritskes-Hoitinga, M
AF Bollen, PJA
   Remie, R
   Kloots, W
   Barfred, L
   Salomon, S
   Ritskes-Hoitinga, M
TI Post-graduate teaching in microsurgery using a combination of
   alternative non-animal and in vivo methods
SO SCANDINAVIAN JOURNAL OF LABORATORY ANIMAL SCIENCE
LA English
DT Article
ID RAT
AB Over recent years alternative, non-animal methods have been developed for use in microsurgical training courses, for the training of suture techniques, dexterity and hand-eye coordination. Nevertheless, it is still hard to imagine that alternative methods will be able to replace in vivo teaching completely, because properties of biological tissue are different from those of latex or other artificial materials. Also the dynamics of biological processes, such as a pulsating bloodstream, are difficult to simulate in alternative models. However, the number of animals used in microsurgical training courses can be limited by combining non-animal methods with in vivo training. Moreover, individual techniques can be improved greatly by using non-animal methods. In a five-day introductory course in microsurgical and experimental techniques at the Biomedical Laboratory, University of Southern Denmark, we have limited the average number of animals to one rat per day per participant, by using alternative non-animal methods extensively on the first course day. Nearly all participants were able to produce a successful end-to-end anastomosis of the femoral artery during the second or third day of the course. The alternative methods used included a training device for microsurgical anastomosis and the MD PVC-Rat, an artificial rat with life-size latex abdominal vessels.
C1 Univ So Denmark, Biomed Labs, Fac Hlth Sci, DK-5000 Odense, Denmark.
   Vejle Hosp, Velje, Denmark.
   Hosp Fyn Svendborg, Svendborg, Denmark.
RP Bollen, PJA (reprint author), Univ So Denmark, Biomed Labs, Fac Hlth Sci, Winsloewparken 23, DK-5000 Odense, Denmark.
EM pbollen@health.sdu.dk
RI Ritskes-Hoitinga, J./H-8083-2014
CR ACLAND RD, 1977, MICROSURGERY PRACTIC
   Crosby NL, 1995, MICROSURG, V16, P655, DOI 10.1002/micr.1920160913
   Dongen J. J. van, 1996, Animal Technology, V47, P19
   Erel E, 2003, MICROSURG, V23, P147, DOI 10.1002/micr.10106
   Fanua SP, 2001, MICROSURG, V21, P379, DOI 10.1002/micr.21812
   Flecknell P., 1996, LAB ANIMAL ANAESTHES
   KAUFMAN T, 1984, Microsurgery, V5, P57, DOI 10.1002/micr.1920050113
   KLOOTS WJ, 1995, LAB ANIM SCI, V45, P588
   KOHN D, 1997, ANESTHESIA ANALGESIA
   Miko I, 2001, MICROSURG, V21, P121, DOI 10.1002/micr.1021
   Pless J, 1978, Ugeskr Laeger, V140, P850
   POPP MB, 1981, AM J PHYSIOL, V241, P606
   Remie R, 2001, LAB ANIMAL, V30, P48
   Salomon S, 1996, SCAND J LAB ANIM SCI, V23, P73
   VANDONGEN JJ, 1990, MNAUAL MICROSURGERY
NR 15
TC 1
Z9 1
U1 0
U2 7
PU SCANDINAVIAN FEDERATION LABORATORY ANIMAL SCIENCE
PI SOBORG
PA C/O MARGARETA BERTRAM, NATIONAL FOOD AGENCY, MORKHOJ BYGHADE 19, DK-2860
   SOBORG, DENMARK
SN 0901-3393
J9 SCAND J LAB ANIM SCI
JI Scand. J. Lab. Anim. Sci.
PY 2005
VL 32
IS 3
BP 183
EP 187
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 978WK
UT WOS:000232903500005
DA 2018-10-20
ER

PT S
AU Lin, CM
   Yen, SK
AF Lin, CM
   Yen, SK
BE Gupta, M
   Lim, CYH
TI In vitro corrosion behavior and apatite-formation of electrolytic
   nanocrystalline TiO2 coating for biomedical applications
SO Science and Technology of Nanomaterials - ICMAT 2003
SE JOURNAL OF METASTABLE AND NANOCRYSTALLINE MATERIALS SERIES
LA English
DT Proceedings Paper
CT ICMAT Symposium on Science and Technologies of Nanomaterials
CY DEC 07-12, 2003
CL Singapore, SINGAPORE
SP NUS, Mat Engn Initiat, Fac Engn, NUS Nanosci & Nanotechnol Initiat
DE apatite; corrosion; electrolytic; nanocrystalline; TiO2
AB Titanium and titanium alloys are among the most widely used materials in biomedical devices because of their high corrosion resistance and excellent biocompatibility. The excellent tissue response to titanium is believed to relate to the chemical and biochemical properties of surface native titanium oxide. In effect, the surface native titanium oxide consists of nonstoichiometric titanium oxide and display amorphous of low crystallinity. After implantation for a long time, titanium implants cannot bond directly to living bone. A fibrous capsule is normally formed between the titanium implant and natural bone. In the other hand, titanium ions release into the bioliquid is expected. In the metal-tissue interaction studies, it indicated that a high concentration of titanium have been detected both in osseous tissue and surrounding organs after 3 years. Titanium ions release will inhibit apatite formation and may combine with biomolecules induce toxicity and allergy. Cathodic electrolytic deposition is an important method in ceramic processing. In this paper, the nanocrystalline TiO2 coating were prepared by electrolytic deposition process, the TiO2 coated specimens were characterization by XRD, SEM, AFM and dynamic cyclic polarization. According to the XRD results, we can clearly identified that electrolytic deposition titanium hydrate gel annealed at 300 degrees C for 1 hr will form to anatase TiO2, and its grain size about 2.77 nm. From cross-section and dynamic cyclic polarization tests, we can found that dense TiO2 coated exhibited thickness about 1.2 mu m, and effective improved corrosion resistance of Ti substrate than thermally grown oxide. From immersion tests, we can found that anatase TiO2 exhibited excellent bioactive.
C1 Natl Chung Hsing Univ, Dept Mat Engn, Taichung 402, Taiwan.
RP Lin, CM (reprint author), Natl Chung Hsing Univ, Dept Mat Engn, 250,Kuo Kuang Rd, Taichung 402, Taiwan.
CR Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   JACOBLABARRE JT, 1994, J BIOMED MATER RES, V28, P699, DOI 10.1002/jbm.820280607
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Wang JY, 1996, J BIOMED MATER RES, V32, P655, DOI 10.1002/(SICI)1097-4636(199612)32:4<655::AID-JBM19>3.0.CO;2-C
NR 4
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1422-6375
BN 0-87849-953-9
J9 J METASTAB NANOCRYST
PY 2005
VL 23
BP 121
EP 124
DI 10.4028/www.scientific.net/JMNM.23.121
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBZ72
UT WOS:000228398300030
DA 2018-10-20
ER

PT J
AU Al-Qasas, NS
   Rohani, S
AF Al-Qasas, NS
   Rohani, S
TI Synthesis of pure hydroxyapatite and the effect of synthesis conditions
   on its yield, crystallinity, morphology and mean particle size
SO SEPARATION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE hydroxyapatite; purity; mean particle size; precipitation;
   crystallinity; Rietveld refinement
ID AMORPHOUS CALCIUM-PHOSPHATE; PRECIPITATION; CONVERSION; POWDERS
AB Hydroxyapatite (HAP) is a calcium phosphate compound with the chemical formula Ca-5 (PO4 )(3)OH. This compound is especially significant in biomedical applications since it resembles the mineral constituents of the hard tissue in the human body. Its biocompatibility, castability, and sinterability make it a very attractive material for simulating bones and therefore for implantations. The objective of this study was to produce HAP with a high purity and to determine quantitatively the exact percentage of HAP in the synthesized powder. Hydrothermal methods have been used to produce HAP. In the present work, Hydroxyapatite powder was produced using the chemical precipitation method in a batch and semi-batch modes of operation. The effect of temperature, pH, and reactant addition rates on the mean particle size was studied. Results showed a maximum in the mean particle size at pH 9, while a minimum was observed at around 45 degrees C. As the reactant addition rate increased the mean particle size increased as well. The purity of the obtained powder was characterized using both quantitative and qualitative techniques. The quantitative results were performed using the powerful Rietveld refinement method. The quantitative results were obtained for three samples. Results showed that pure HAP was produced at a temperature of 85 degrees C, pH 9 and reactant addition rate of 1.3 mL/min.
C1 Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Rohani, S (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
EM rohani@eng.uwo.ca
CR ALQASAS NS, 2004, THESIS
   Amjad Z., 1998, CALCIUM PHOSPHATES B
   Arifuzzaman SM, 2004, J CRYST GROWTH, V267, P624, DOI 10.1016/j.jcrysgro.2004.04.024
   BOSKEY AL, 1973, J PHYS CHEM-US, V77, P2313, DOI 10.1021/j100638a011
   EANES ED, 1965, NATURE, V208, P365, DOI 10.1038/208365a0
   Elliott J.C., 1994, STUDIES INORGANIC CH
   GENCK WJ, 1972, AICHE S SER 121, V68, P57
   Gomez-Morales J, 2001, CRYST RES TECHNOL, V36, P15, DOI 10.1002/1521-4079(200101)36:1<15::AID-CRAT15>3.3.CO;2-5
   HARRIES JE, 1987, J CRYST GROWTH, V84, P563, DOI 10.1016/0022-0248(87)90046-7
   JENKINS R, 1996, SERIES MONOGRAPHS AN, P138
   KIM WS, 2002, CHEM ENG T, V1, P611
   KING PL, 2004, SHORT COURSE SERIES, V33, P57
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Koumoulidis GC, 2003, NATO SCI SER II MATH, V102, P83
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   MATHEW M, 1988, J CRYST SPECTROSC, V18, P235, DOI 10.1007/BF01194315
   MEYER JL, 1978, CALC TISS RES, V25, P209, DOI 10.1007/BF02010771
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   Riman RE, 2002, SOLID STATE IONICS, V151, P393, DOI 10.1016/S0167-2738(02)00545-3
   Rodriguez-Lorenzo LM, 2000, CHEM MATER, V12, P2460, DOI 10.1021/cm001033g
   Saeri MR, 2003, MATER LETT, V57, P4064, DOI 10.1016/S0167-577X(03)00266-0
   Salahi E, 2001, CFI-CERAM FORUM INT, V78, pE43
   Sarig S, 2002, J CRYST GROWTH, V237, P55, DOI 10.1016/S0022-0248(01)01850-4
   SECKLER MM, 1999, MAT RES, V2, P59
   Shuk P, 2001, J MATER RES, V16, P1231, DOI 10.1557/JMR.2001.0170
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Torrent-Burgues J, 2001, CRYST RES TECHNOL, V36, P1075, DOI 10.1002/1521-4079(200110)36:8/10<1075::AID-CRAT1075>3.0.CO;2-E
   YOUNG RA, 1982, J APPL CRYSTALLOGR, V15, P430, DOI 10.1107/S002188988201231X
NR 29
TC 18
Z9 19
U1 1
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0149-6395
EI 1520-5754
J9 SEP SCI TECHNOL
JI Sep. Sci. Technol.
PY 2005
VL 40
IS 15
BP 3187
EP 3224
DI 10.1080/01496390500385400
PG 38
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 997JV
UT WOS:000234242400010
DA 2018-10-20
ER

PT S
AU Godignon, P
AF Godignon, P
BE Nipoti, R
   Poggi, A
   Scorzoni, A
TI SiC materials and technologies for sensors development
SO SILICON CARBIDE AND RELATED MATERIALS 2004
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 5th European Conference on Silicon Carbide and Related Materials
CY AUG 31-SEP 04, 2004
CL Bologna, ITALY
SP Comune Bologna, Giunta Reg Emilia Romagna, Prov Biologna, Univ Bologna, President Italian Consiglio Nazl Ric
DE SiC sensors; Hall sensors; SiC micromachining; biomedical sensors
ID SILICON-CARBIDE
AB Silicon Carbide has proven its strong interest for power and high frequency devices but it also has superior characteristics for application in the sensors and MEMS fields. The characteristic requirements of the starting material are different from that of power devices since the level of defects is not so critical while the layer stress is important especially in 3C-SiC on Si. The key process for MEMS fabrication is the etching, which is progressing thanks to ICP process improvements. A perfect control of the etching step could allow the obtention of nano-resonators in SiC with fairly superior characteristics to the Si ones. Other electrical sensors for high temperature application such as gas sensors or Hall sensors have been also successfully developed taking profit of the deep etching process improvement and high temperature contact developments.
C1 Ctr Nacl Microelect, Bellaterra 08193, Barcelona, Spain.
RP Godignon, P (reprint author), Ctr Nacl Microelect, Campus UAB, Bellaterra 08193, Barcelona, Spain.
EM philippe.godignon@cnm.es
CR Catellani A, 2000, PHYS REV B, V62, pR4794, DOI 10.1103/PhysRevB.62.R4794
   Galli G, 1999, PHYS REV LETT, V83, P2006, DOI 10.1103/PhysRevLett.83.2006
   GODIGNON P, 2004, P MRS SPRING M SAN F
   Gonzalez P, 2003, BIOMATERIALS, V24, P4827, DOI 10.1016/S0142-9612(03)00405-8
   KROTZ G, 1995, P INT C SIC REL MAT, P829
   Okojie RS, 1997, P TRANSD 97 IEEE, P1407
   ROBERT JL, Patent No. 0011087
   Santavirta S, 1998, ARCH ORTHOP TRAUM SU, V118, P89, DOI 10.1007/s004020050319
   SHOR JS, 1994, IEEE T ELECTRON DEV, V41, P661, DOI 10.1109/16.285013
NR 9
TC 30
Z9 30
U1 1
U2 13
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-963-6
J9 MATER SCI FORUM
PY 2005
VL 483
BP 1009
EP 1014
DI 10.4028/www.scientific.net/MSF.483-485.1009
PG 6
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BCB85
UT WOS:000228549600241
DA 2018-10-20
ER

PT S
AU Fargas, M
   von Busse, A
   Bunte, J
AF Fargas, M
   von Busse, A
   Bunte, J
BE Cane, C
   Chiao, JC
   Verdu, FV
TI Laser material micro-processing of shape memory alloys
SO SMART SENSORS, ACTUATORS, AND MEMS II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference Sensors, Actuators, and MEMS II
CY MAY 09-11, 2005
CL Seville, SPAIN
SP Amer Soc Regional Anesthesia
AB Due to their precise focusing properties and the possibility of an excellent non-tactile energy coupling, lasers represent a suitable machining process for miniaturised components of shape memory alloys (SMAs) in micro-system and biomedical technology. SMAs find increasing application in these fields because of their special properties such as super-elasticity and shape memory effect.
   Current research is concentrated on the development of suitable and economic process strategies for machining microcomponents and -actuators using ultra-short-pulse lasers. The application of this laser type enables the realisation of miniaturised components made of SMAs without damaging the grain structure and therefore maintaining the shape memory effect. The processed miniaturised components are characterised with respect to the achieved geometrical resolution, the surface quality of the processed areas and their mechanical functionality.
   For real production, a reduction of the processing time is necessary. Therefore, different process strategies consisting in different numbers of process cycles (simultaneous material removal and smoothing, material removal and subsequent smoothing) are investigated machining NiTi-components. In this paper, results of the laser based method regarding processing time and surface quality will be presented. In addition, the application of these strategies for the realisation of exemplary actuator or component geometries (e.g. for minimal invasive surgery) will be demonstrated.
C1 Laser Zentrum Hannover eV, D-30419 Hannover, Germany.
RP Fargas, M (reprint author), Laser Zentrum Hannover eV, Hollerithallee 8, D-30419 Hannover, Germany.
EM fa@lzh.de
CR Duerig T., 2002, P SOC PHOTO-OPT INS, V4763, P7
   Haferkamp H, 1999, P SOC PHOTO-OPT INS, V3675, P267, DOI 10.1117/12.352800
   HAKERKAMP H, 2004, P LASE SAN JOS
   Otsuka K, 2002, MRS BULL, V27, P91, DOI 10.1557/mrs2002.43
   Pelton AR, 2000, MATER SCI FORUM, V327-3, P63, DOI 10.4028/www.scientific.net/MSF.327-328.63
   Stockel D., 1995, P SHAP MEM ALL POW S, P1
   Van Humbeeck J, 2001, ADV ENG MATER, V3, P837, DOI 10.1002/1527-2648(200111)3:11<837::AID-ADEM837>3.0.CO;2-0
NR 7
TC 1
Z9 1
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5831-7
J9 PROC SPIE
PY 2005
VL 5836
BP 162
EP 170
DI 10.1117/12.608695
PG 9
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BCX90
UT WOS:000231822100016
DA 2018-10-20
ER

PT S
AU Ocana, JL
   Molpeceres, C
   Lauzurica, S
   Morales, M
AF Ocana, JL
   Molpeceres, C
   Lauzurica, S
   Morales, M
BE Cane, C
   Chiao, JC
   Verdu, FV
TI Advanced 3D micromachining techniques using V-UV laser sources in the
   nanosecond regime
SO Smart Sensors, Actuators, and MEMS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference Sensors, Actuators, and MEMS II
CY MAY 09-11, 2005
CL Seville, SPAIN
SP Amer Soc Regional Anesthesia
DE laser micromachining; laser ablation; laser processing of advanced
   materials
AB Laser micromachining techniques are among the most promising fabrication processes in strategic industrial fields. Although lasers systems have been widely applied last twenty years in semiconductor industry for microfabrication process development, the current availability of new excimer and Diode Pumped Solid State Lasers (DPSS) sources are extending the applications fields of laser microprocessing. Nowadays MEMs, fluidic devices, advanced sensors and biomedical devices and instruments are among the more promising developments of this technology. Nevertheless the fast progress of this technology has brought as a consequence the building up of specific laser based machines for each process of interest (most of them until now strictly 2D), and an important gap has been generated, from the fabrication point of view, in fully 3D potential applications.
   In this work, the conception, design and first results of a fully automatized 3D laser micromachining workstation, based on the main concept of flexibility, is presented. This system integrates two UV laser sources, excimer and DPSS in ns pulse regime, and an advanced positioning system (with six degrees of freedom) for complex parts machining.
   Several examples of first results obtained with this system, including processing of semiconductors for sensoring and photovoltaic applications, organic materials for biomedical devices and metallic materials for different strategic industrial sectors are presented.
C1 Univ Politecn Madrid, Ctr Laser, Madrid 28031, Spain.
RP Ocana, JL (reprint author), Univ Politecn Madrid, Ctr Laser, Crta Valencia Km 7-3, Madrid 28031, Spain.
RI Morales Furio, Miguel/D-5318-2011; LAUZURICA SANTIAGO, SARA/R-8219-2018;
   Molpeceres, Carlos/F-1268-2016; OCANA, JOSE LUIS/I-7475-2012
OI Morales Furio, Miguel/0000-0001-7425-9742; LAUZURICA SANTIAGO,
   SARA/0000-0003-4398-6474; Molpeceres, Carlos/0000-0002-6236-8359; OCANA,
   JOSE LUIS/0000-0001-9263-8404
CR Gower M.C., 2000, OPT EXPRESS, V7, P57
   HOLMES AS, 2001, 2 INT S LAS PREC MIC
   KEIPER B, 1999, P ICLAEO 1999, P1
   METEV SM, 1998, SERIES MAT SCI, V19
   MILLER JC, 1994, PRINCIPLES APPL
   Molpeceres C, 2005, J MICROMECH MICROENG, V15, P1271, DOI 10.1088/0960-1317/15/6/019
   MOMMA C, 1996, APPL PHYS A, V63, P109
   NIE M, 2000, MICROSYST TECHNOL, V6, P184
   Pfleging W, 2000, APPL SURF SCI, V154, P633, DOI 10.1016/S0169-4332(99)00468-7
   STASSENBOHLEN I, 2003, SPIE, V4977, P198
   WOLFF B, 1992, APPL PHYS A, V54, P363
NR 11
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5831-7
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5836
BP 307
EP 317
DI 10.1117/12.608818
PG 11
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BCX90
UT WOS:000231822100031
DA 2018-10-20
ER

PT S
AU Ochoteco, E
   Pomposo, JA
   Grande, H
   Rodriguez, J
AF Ochoteco, E
   Pomposo, JA
   Grande, H
   Rodriguez, J
BE Cane, C
   Chiao, JC
   Verdu, FV
TI A self-supported polypyrrole artificial muscle: design optimization
SO SMART SENSORS, ACTUATORS, AND MEMS II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference Sensors, Actuators, and MEMS II
CY MAY 09-11, 2005
CL Seville, SPAIN
SP Amer Soc Regional Anesthesia
DE conducting polymer; actuator; artificial muscle; simplified device; low
   power consumption device
ID CONDUCTING POLYMERS; ACTUATORS
AB Conducting polymers, due to their property of oxidize and reduce in a reversible way, have largely been studied as adequate materials for constructing actuators. The volume change produced in these processes is used for the stuck of a conducting polymer film on a not-volume-changing layer for the development of artificial muscles. One of the main drawbacks that these multilayer artificial muscles show lies on the fact that they delaminate after several working cycles. In one of our previous works, a simplified, single film, self-supported artificial muscle was developed assembling different polypyrrole structures in the same synthesis process. This produces not only "all-polymeric" but rather "all-conducting-polymer" artificial muscles that are able to move in electrolytic media without showing delamination problems after long cycling times. This new generation of simplified artificial muscles seems to be suitable for biomedical related applications. In the present work, actuator's basement is explained and design configurations analyzed.
C1 CIDETEC Ctr Electrochem Technol, E-20009 Donostia San Sebastian, Spain.
RP Ochoteco, E (reprint author), CIDETEC Ctr Electrochem Technol, Parque Tecnol Miramon,Pa Miramon 196, E-20009 Donostia San Sebastian, Spain.
EM eochoteco@cidetec.es
OI pomposo, jose a./0000-0003-4620-807X; Pomposo, Jose
   A./0000-0001-9458-4200
CR BAUGHMAN RH, 1990, SCI APPL CONDUCTING
   DellaSanta A, 1997, SYNTHETIC MET, V90, P93, DOI 10.1016/S0379-6779(97)81256-8
   HILLMAN AR, 1988, J ELECTROANAL CHEM, V244, P353, DOI 10.1016/0022-0728(88)80120-7
   Lu W, 2004, CHEM MATER, V16, P1615, DOI 10.1021/cm0301591
   Madden JD, 2000, SYNTHETIC MET, V113, P185, DOI 10.1016/S0379-6779(00)00195-8
   MARQUE P, 1990, J PHYS CHEM-US, V94, P8614, DOI 10.1021/j100386a024
   OCHOTECO E, IN PRESS CHEM COMMUN
   OTERO TF, 1992, J ELECTROANAL CHEM, V341, P369, DOI 10.1016/0022-0728(92)80495-P
   OTERO TF, 1993, NATO ADV SCI INST SE, V246, P179
   OTERO TF, 1995, BIOELECTROCH BIOENER, V38, P411, DOI 10.1016/0302-4598(95)01802-L
   Otero TF, 1998, ADV MATER, V10, P491, DOI 10.1002/(SICI)1521-4095(199804)10:6<491::AID-ADMA491>3.0.CO;2-Q
   OTERO TF, 1997, HDB ORGANIC CONDUCTI, V4, P517
   OTERO TF, 1992, Patent No. 9200095
   PEI QB, 1993, SYNTHETIC MET, V57, P3718, DOI 10.1016/0379-6779(93)90503-O
   Qibing Pei, 1993, Smart Materials and Structures, V2, P1, DOI 10.1088/0964-1726/2/1/001
   Sansinena JM, 1997, CHEM COMMUN, P2217, DOI 10.1039/a705341j
   SMELA E, 1995, SCIENCE, V268, P1735, DOI 10.1126/science.268.5218.1735
   SMELA E, 2000, ELECTROCHIM ACTA, V45, P2121
   TAKASHIMA W, 1995, SYNTHETIC MET, V71, P2265, DOI 10.1016/0379-6779(94)03252-2
NR 19
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5831-7
J9 PROC SPIE
PY 2005
VL 5836
BP 649
EP 656
DI 10.1117/12.607922
PG 8
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BCX90
UT WOS:000231822100068
DA 2018-10-20
ER

PT S
AU Fernandez, D
   Moreno, L
   Baselga, J
AF Fernandez, D
   Moreno, L
   Baselga, J
BE Cohen, YB
TI Towards standardization of EAP actuators test procedures
SO Smart Structures and Materials 2005: Electroactive Polymer Actuators and
   Devices( EAPAD)
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
DE EAP characterization; smart materials characterization; artificial
   muscles; digital force generator
AB Since the field of Electroactive Polymers (EAP) actuators is fairly new there are no standard testing processes for such intelligent materials. This drawback can seriously limit the scope of application of EAP actuators, since the targeted industrial sectors (aerospace, biomedical...) demand high reliability and product assurance. As a first iteration two elements are required to define a test standard for an EAP actuator: a Unit Tester, and a Component Specification. In this paper a EAP Unit Tester architecture is presented along with the required classification of measurements to be included in the EAP actuator Component Specification. The proposed EAP Unit Tester allows on-line monitoring and recording of the following properties of the specimen under test: large deformation, small tip displacement, temperature at the electrodes, weight of the specimen, voltage and current driven into the EAP, load being applied to the actuator, output voltage of the EAP in sensing operation and mode of operation (structure / sensor / actuator / smart). The measurements are taken simultaneously, in real-time. The EAP Unit Tester includes a friendly Graphical User Interface. It uses embedded Excel tools to visualize data. In addition, real-time connectivity with MATLAB allows an easy testing of control algorithms.
   A novel methodology to measure the properties of EAP specimens versus a variable load is also presented. To this purpose a force signals generator in the range of mN was developed. The device is based on a DC mini-motor. It generates an opposing force to the movement of the EAP actuator. Since the device constantly opposes the EAP actuator movement it has been named Digital Force Generator (DFG). The DFG design allows simultaneous length and velocity measuring versus different load signals. By including such a device in the EAP Unit Tester the most suitable application for the specimen under test can be easily identified (vibration damper, large deformation actuator, large force actuator, fast actuator...).
C1 EADS Astrium CRISA, Madrid 28760, Spain.
RP Fernandez, D (reprint author), EADS Astrium CRISA, C Torres Quevedo 9,PTM, Madrid 28760, Spain.
OI Moreno, Luis/0000-0002-4450-680X
CR BARCOHEN, 2001, ELECTROACTIVE POLYM
   BARCOHEN J, 2002, P SPIE SMART STRUCT
   BHAT ND, 2003, THESIS TEXAS A M U
   FINNI T, 2001, MUSCLE MECH HUMAN MO
   MEIJER K, 1999, UTILIZATION ELECTROA
   Newbury K.M., 2002, THESIS VIRGINIA POLY
   SHANIPOOR M, 2004, IONIC POLYM CONDUCTO
   WALLACE GG, 2003, CONDUCTING ELECTROAC
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5740-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5759
BP 274
EP 282
DI 10.1117/12.599106
PG 9
WC Instruments & Instrumentation; Materials Science, Composites; Polymer
   Science
SC Instruments & Instrumentation; Materials Science; Polymer Science
GA BCN04
UT WOS:000230111000031
DA 2018-10-20
ER

PT S
AU Lalli, JH
   Claus, RO
   Hill, AB
   Mecham, JB
   Davis, BA
   Subrahmanyan, S
   Goff, RM
AF Lalli, JH
   Claus, RO
   Hill, AB
   Mecham, JB
   Davis, BA
   Subrahmanyan, S
   Goff, RM
BE White, EV
TI Commercial applications of Metal Rubber (TM)
SO SMART STRUCTURES AND MATERIALS 2005: INDUSTRIAL AND COMMERCIAL
   APPLICATIONS OF SMART STRUCTURES TECHNOLOGIES
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
DE electrostatic self-assembly; nanocomposite; Metal Rubber (TM); sensors;
   electrodes; interconnects; flexible; lightweight; electrically
   conductive; elastomer
AB This paper describes the commercial applications of Metal Rubber (TM), the first material of its kind, a self-assembled free-standing electrically conductive elastomer in biomedical, aerospace and microelectronic areas. Metal Rubber (TM) is a novel nanocomposite formed via the self-assembly processing of metal nanoparticles and elastomeric polyectrolytes. This type of processing allows for control over bulk mechanical and electrical properties and requires only ppm quantities of metal to achieve percolation. The use of nanostructured precursors also results in transparent, electrically conductive nanocomposites. Metal Rubber (TM) elastomers are being developed as electrodes, for biomedical applications; flexible interconnects for microelectronics, and sensors to detect fatigue, impact and large strain for aerospace applications. This novel material may be formed as a conformal coating on nearly any substrate or as free standing films.
C1 NanoSon Inc, Blacksburg, VA 24060 USA.
RP Lalli, JH (reprint author), NanoSon Inc, 1485 S Main St, Blacksburg, VA 24060 USA.
EM jlalli@nanosonic.com; roclaus@vt.edu
CR Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   LALLI JH, 2003, P SPIE, V4991
   Liu YJ, 1999, SMART MATER STRUCT, V8, P100, DOI 10.1088/0964-1726/8/1/011
NR 3
TC 3
Z9 3
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5743-4
J9 PROC SPIE
PY 2005
VL 5762
BP 1
EP 7
DI 10.1117/12.606788
PG 7
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BCN14
UT WOS:000230112600001
DA 2018-10-20
ER

PT S
AU Arzberger, SC
   Tupper, ML
   Lake, MS
   Barrett, R
   Mallick, K
   Hazelton, C
   Francis, W
   Keller, PN
   Campbell, D
   Feucht, S
   Codell, D
   Wintergerst, J
   Adams, L
   Mallioux, J
   Denis, R
   White, K
   Long, M
   Munshi, NA
   Gall, K
AF Arzberger, SC
   Tupper, ML
   Lake, MS
   Barrett, R
   Mallick, K
   Hazelton, C
   Francis, W
   Keller, PN
   Campbell, D
   Feucht, S
   Codell, D
   Wintergerst, J
   Adams, L
   Mallioux, J
   Denis, R
   White, K
   Long, M
   Munshi, NA
   Gall, K
BE White, EV
TI Elastic Memory Composites (EMC) for deployable industrial and commercial
   applications
SO Smart Structures and Materials 2005: Industrial and Commercial
   Applications of Smart Structures Technologies
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
DE Elastic Memory Composite (EMC); shape memory polymer; composite;
   thermoset; epoxy; cyanate ester; deployable; smart materials;
   multifunctional components; commercial uses
ID THERMOMECHANICAL PROPERTIES; BIOMEDICAL APPLICATIONS;
   PERCOLATION-THRESHOLD; CARBON NANOTUBES; STRAIN RECOVERY; POLYMER FOAM;
   NANOCOMPOSITES; BEHAVIOR; STRESS; THIN
AB The use of smart materials and multifunctional components has the potential to provide enhanced performance, improved economics, and reduced safety concerns for applications ranging from outer space to subterranean. Elastic Memory Composite (EMC) materials, based on shape memory polymers and used to produce multifunctional components and structures, are being developed and qualified for commercial use as deployable components and structures. EMC materials are sin-filar to traditional fiber-reinforced composites except for the use of a thermoset shape memory resin that enables much higher packaging strains than traditional composites without damage to the fibers or the resin. This unique capability is being exploited in the development of very efficient EMC structural components for deployable spacecraft systems as well as capability enhancing components for use in other industries. The present paper is intended primarily to describe the transition of EMC materials as smart structure technologies into viable industrial and commercial products. Specifically, the paper discusses: 1) TEMBO (R) EMC materials for deployable space/aerospace systems, 2) TEMBO (R) EMC resins for terrestrial applications, 3) future generation EMC materials.
C1 CTD Inc, Lafayette, CO 80026 USA.
RP Arzberger, SC (reprint author), CTD Inc, 2600 Campus Dr,Suite D, Lafayette, CO 80026 USA.
CR Abrahamson ER, 2003, J INTEL MAT SYST STR, V14, P623, DOI 10.1177/104538903036213
   Arzberger SC, 2003, P SOC PHOTO-OPT INS, V5179, P143, DOI 10.1117/12.507157
   *ASTM E, 59584 ASTM E
   BARRAU S, 2002, MACROMOLECULES, V36, P5187
   BEAVERS FL, 2002, 43 AIAA ASME ASCH AH
   CAMBELL D, 2004, ASCE EARTH SPAC 2004
   Chen PC, 1995, ASTR SOC P, V79, P252
   Conley Peter L., 1998, SPACE VEHICLE MECH E
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Francis W, 2004, 45 AIAA ASME ASCE AH
   Francis W, 2003, 44 AIAA ASME ASCE AH
   GALL K, 2003, 44 AIAA ASME ASCE AH
   Hamerton I., 1994, CHEM TECHNOLOGY CYAN, P195
   Hazelton C.S, 2003, 44 AIAA ASME ASCE AH
   Irie M., 1998, SHAPE MEMORY POLYM
   Jeong HM, 2001, EUR POLYM J, V37, P2245, DOI 10.1016/S0014-3057(01)00123-9
   Keller P, 2004, 45 AIAA ASME ASCE AH
   Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059
   LAKE MS, 2004, 2004 IEEE AER C BIG
   LAKE MS, 2000, TM2000210089 NASA
   LAKE MS, 1998, SPAC TECHN APPL INT
   LANGER RS, 2000, Patent No. 6160084
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Li FK, 2000, J APPL POLYM SCI, V75, P68, DOI 10.1002/(SICI)1097-4628(20000103)75:1<68::AID-APP8>3.0.CO;2-I
   Liang C, 1997, J INTEL MAT SYST STR, V8, P380, DOI 10.1177/1045389X9700800411
   Liu CD, 2002, MACROMOLECULES, V35, P9868, DOI 10.1021/ma021141j
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Monkman GJ, 2000, MECHATRONICS, V10, P489, DOI 10.1016/S0957-4158(99)00068-9
   Murphey T. W., 2004, 45 AIAA ASME ASCE AH
   *NASA, 6001 NASA
   Nogales A, 2004, MACROMOLECULES, V37, P7669, DOI 10.1021/ma049440r
   Sandler J, 1999, POLYMER, V40, P5967, DOI 10.1016/S0032-3861(99)00166-4
   Sandler JKW, 2003, POLYMER, V44, P5893, DOI 10.1016/S0032-3861(03)00539-1
   SHRIER LL, 1995, CORROSION METAL ENV
   Tey SJ, 2001, SMART MATER STRUCT, V10, P321, DOI 10.1088/0964-1726/10/2/318
   Tobushi H, 1996, SMART MATER STRUCT, V5, P483, DOI 10.1088/0964-1726/5/4/012
   Tobushi H, 2001, J INTEL MAT SYST STR, V12, P283, DOI 10.1106/FNSX-AP9V-QP1R-NMWV
   WANG Z, 2000, POLYM CLAY NANOCOMPO
   WHITE CV, 2000, SPIE PHOT E OPT MECH
NR 40
TC 15
Z9 17
U1 4
U2 25
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5743-4
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5762
BP 35
EP 47
DI 10.1117/12.600583
PG 13
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BCN14
UT WOS:000230112600005
DA 2018-10-20
ER

PT S
AU McKnight, G
   Momoda, L
   Croft, D
   Lee, DG
   Shin, D
   Carman, G
AF McKnight, G
   Momoda, L
   Croft, D
   Lee, DG
   Shin, D
   Carman, G
BE White, EV
TI Miniature thin film NiTi hydraulic actuator with MEMS microvalves
SO Smart Structures and Materials 2005: Industrial and Commercial
   Applications of Smart Structures Technologies
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
DE shape memory alloy; thin film; microvalve; actuation
AB The implementation of smaller, lighter, and more agile military systems requires new actuation technologies that offer high power density in compact form factors. The Compact Hybrid Actuator Program (CHAP) is pursuing active material based, rectifying actuators to create new actuation solutions for these demanding applications. Our actuator approach is based on thin film NiTi membranes operating in parallel (high intrinsic power density, > 125 kW/kg) combined with liquid rectification, MEMS passive check valves, and commercially available power electronics. Previous results demonstrated 8 micron thick membrane actuation with 150 Hz forced convection response and force output of 100N. This paper focuses on two developments critical in scaling up previous single membrane results to power levels sufficient for military applications. This first is the development of SOI MEMS fabricated microvalve arrays which exhibit high flow rate at high frequencies. The second focus area is the design, fabrication, and assembly of a form factor compact actuator. The initial prototype demonstration of this concept shows great promise for thin film NiTi based actuation both in military technologies and in other areas which demand extremely compact actuation such as embedded fluid delivery for biomedical applications.
C1 Hughes Res Labs, Malibu, CA 90265 USA.
RP McKnight, G (reprint author), Hughes Res Labs, 3011 Malibu Canyon Rd, Malibu, CA 90265 USA.
CR ALSHEHRI Y, 2004, 22 ANN MICR ENG C, P52
   Ho KK, 2000, THIN SOLID FILMS, V370, P18, DOI 10.1016/S0040-6090(00)00947-0
   LAVINE AS, 2000, THERMAL SCI ENG, V8, P13
   Li B, 2005, SENSOR ACTUAT A-PHYS, V117, P325, DOI 10.1016/j.sna.2004.06.029
   Momoda LA, 2003, P SOC PHOTO-OPT INS, V5054, P85, DOI 10.1117/12.483889
NR 5
TC 2
Z9 2
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5743-4
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5762
BP 187
EP 195
DI 10.1117/12.607307
PG 9
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BCN14
UT WOS:000230112600021
DA 2018-10-20
ER

PT S
AU Choi, SH
   Kim, JW
   Chu, SH
   Park, Y
   King, GC
   Lillehei, PT
   Kim, SJ
   Elliott, JR
AF Choi, SH
   Kim, JW
   Chu, SH
   Park, Y
   King, GC
   Lillehei, PT
   Kim, SJ
   Elliott, JR
BE Varadan, VK
TI Ferritin-templated quantum-dots for quantum logic gates
SO SMART STRUCTURES AND MATERIALS 2005: SMART ELECTRONICS, MEMS, BIOMEMS,
   AND NANOTECHNOLOGY
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
ID 2-IMINOTHIOLANE METHYL 4-MERCAPTOBUTYRIMIDATE; BIOMIMETIC SYNTHESIS;
   MAGNETIC PROTEINS; HORSE SPLEEN; MAGNETOFERRITIN; COMPUTATION;
   COMPUTERS; HARDWARE; OXIDE; CAGE
AB Quantum logic gates (QLGs) or other logic systems are based on quantum-dots (QD) with a stringent requirement of size uniformity. The QD are widely known building units for QLGs. The size control of QD is a critical issue in quantum-dot fabrication. The work presented here offers a new method to develop quantum-dots using a bio-template, called ferritin, that ensures QD production in uniform size of nano-scale proportion. This technology is essential for NASA, Dol), and industrial nanotechnology applications such as: ultra-high density data storage, quantum electronic devices, biomedical nanorobots, molecular tagging, terahertz radiation sources, nanoelectromechanical systems (NEMS), etc. The bio-template for uniform yield of QD is based on a ferritin protein that allows reconstitution of core material through the reduction and chelation processes. By either the magnetic or electrical property of reconstituted core materials, the QD can be used for logic gates which are fundamental building blocks for quantum computing. However, QLGs are in an incubation stage and still have many potential obstacles that need to be addressed, such as an error collection, a decoherence, and a hardware architecture. One of the biggest challenges for developing QLG is the requirement of ordered and uniform size of QD for arrays on a substrate with nanometer precision. The other methods known so far, such as self-assembled QD grown in the Stranski-Krastanov mode, are usually randomly organized. The QD development by bio-template includes the electrochentical/chemical reconsitution of ferridris with different core materials, such as iron, cobalt, manganese, platinum, and nickel. The other bio-template method used in our laboratory is dendrimers, precisely defined chemical structures. With ferritin-templated QD, we fabricated the heptagon-shaped patterned array via direct nano manipulation of the ferritin molecules with a tip of atomic force microscope (AFM). We also designed various nanofabrication methods of QD arrays using a wide range manipulation techniques. The precise control of the ferritin-templated QD for a patterned arrangement are offered by various methods, such as a site-specific immobilization of thiolated ferritins through local oxidation using the AFM tip, ferritin arrays induced by gold nanoparticle manipulation, thiolated ferritin positioning by shaving method, etc. In the signal measurements, the current-voltage curve is obtained by measuring the current through the ferritin, between the tip and the substrate for potential sweeping or at constant potential. The measured resistance near zero bias was 1.8 teraohm for single holoferritin and 5.7 teraohm for single apoferritin, respectively.
C1 NASA, Langley Res Ctr, Hampton, VA 23681 USA.
RP Choi, SH (reprint author), NASA, Langley Res Ctr, Hampton, VA 23681 USA.
RI Lillehei, Peter/C-9196-2009; Kim, Jae-Woo/A-8314-2008
OI Lillehei, Peter/0000-0001-8183-9980; 
CR AWSCHALOM DD, 1992, PHYS REV LETT, V68, P3092, DOI 10.1103/PhysRevLett.68.3092
   BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457
   Borgstrom M, 2001, APPL PHYS LETT, V78, P1367, DOI 10.1063/1.1351528
   Darder M, 1999, ANAL CHEM, V71, P5530, DOI 10.1021/ac990759x
   del Barco E, 1999, PHYS REV B, V60, P11898, DOI 10.1103/PhysRevB.60.11898
   Douglas T, 2000, INORG CHEM, V39, P1828, DOI 10.1021/ic991269q
   GIDER S, 1995, SCIENCE, V268, P77, DOI 10.1126/science.7701343
   HARRISON PM, 1996, BIOCHIM BIOPHYS ACTA, V161, P1275
   Hu M, 2002, J VAC SCI TECHNOL A, V20, P589, DOI 10.1116/1.1458941
   JELINSKI L, 1999, BIOL RELATED ASPECTS
   JUE R, 1978, BIOCHEMISTRY-US, V17, P5399, DOI 10.1021/bi00618a013
   Kohmoto S, 1999, APPL PHYS LETT, V75, P3488, DOI 10.1063/1.125364
   LAMBERT JM, 1978, BIOCHEMISTRY-US, V17, P5406, DOI 10.1021/bi00618a014
   Lee H, 2000, J VAC SCI TECHNOL B, V18, P2193, DOI 10.1116/1.1306281
   Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120
   MACKLE P, 1993, J AM CHEM SOC, V115, P8471, DOI 10.1021/ja00071a076
   MELDRUM FC, 1991, NATURE, V349, P684, DOI 10.1038/349684a0
   MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086
   MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B
   NIELSEN M. A, 2000, QUANTUM COMPUTATION
   Ohshima T, 2003, 2ND INTERNATIONAL CONFERENCE ON SEMICONDUCTOR QUANTUM DOTS, P1364, DOI 10.1002/pssc.200303096
   Okuda M, 2003, BIOTECHNOL BIOENG, V84, P187, DOI 10.1002/bit.10748
   Pavlovic E, 2002, J COLLOID INTERF SCI, V254, P200, DOI 10.1006/jcis.2002.8565
   Song HZ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.085303
   Tejada J, 1997, PHYS REV LETT, V79, P1754, DOI 10.1103/PhysRevLett.79.1754
   Tejada J, 2001, POLYHEDRON, V20, P1751, DOI 10.1016/S0277-5387(01)00684-2
   Tejada J, 2001, NANOTECHNOLOGY, V12, P181, DOI 10.1088/0957-4484/12/2/323
   Torres F, 2000, APPL PHYS LETT, V77, P3248, DOI 10.1063/1.1325393
   TREFFRY A, 1978, BIOCHEM J, V171, P313, DOI 10.1042/bj1710313
   Wong KKW, 1998, CHEM MATER, V10, P279, DOI 10.1021/cm970421o
   Wong KKW, 1996, ADV MATER, V8, P928, DOI 10.1002/adma.19960081114
   YAMADA H, 1993, FISH PHYSIOL BIOCHEM, V12, P1, DOI 10.1007/BF00004317
   Zborowski M, 1996, CYTOMETRY, V24, P251, DOI 10.1002/(SICI)1097-0320(19960701)24:3<251::AID-CYTO8>3.0.CO;2-K
   ZHANG B, 2004, INORG CHEM
   Zhao GH, 2001, BIOCHEMISTRY-US, V40, P10832, DOI 10.1021/bi011052j
NR 35
TC 1
Z9 1
U1 1
U2 12
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5744-2
J9 PROC SPIE
PY 2005
VL 5763
BP 213
EP 232
DI 10.1117/12.625319
PG 20
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Materials Science, Multidisciplinary
SC Engineering; Instruments & Instrumentation; Materials Science
GA BCN83
UT WOS:000230338300025
DA 2018-10-20
ER

PT S
AU Berman, M
   Phatak, A
   Lagerstrom, R
AF Berman, M
   Phatak, A
   Lagerstrom, R
BE Bearman, GH
   MahadevanJansen, A
   Leveson, RM
TI ICE: A statistical approach to identifying constituents of biomedical
   hyperspectral images
SO Spectral Imaging: Instrumentation, Applications, and Analysis III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Spectral Imaging - Instrumentation. Applications and
   Analysis III
CY JAN   23, 2005
CL San Jose, CA
SP SPIE, Cambridge Res & Instrumentat Inc, Carl Zeiss Jena
DE convex geometry; endmember; hyperspectral; mixture; simplex
AB A problem of considerable interest in the hyperspectral and chemical imaging communities in recent years has been the automated identification and mapping of the constituent materials ("endmembers") present in a hyperspectral image. Several of the more important endmember-finding algorithms are discussed and some of their shortcomings highlighted. A relatively new algorithm, ICE, which attempts to address these shortcomings, is introduced. Although ICE was originally developed for exploration applications of airborne hyperspectral data, its performance on two biomedical data sets is investigated. Possible future research directions are outlined.
C1 CSIRO, N Ryde, NSW 2113, Australia.
RP Berman, M (reprint author), CSIRO, Macquarie Univ Campus, N Ryde, NSW 2113, Australia.
RI Whitford, Linda/C-2470-2009; Lagerstrom, Ryan/A-3642-2009; Berman,
   Mark/D-3411-2009
CR Berman M, 2004, IEEE T GEOSCI REMOTE, V42, P2085, DOI 10.1109/TGRS.2004.835299
   Berman M., 1999, P 13 INT C APPL GEOL, V1, P222
   BOARDMAN E, 1995, JPL PUBL, V951, P23
   BOARDMAN JW, 1993, JPL PUBLICATION, V9326, P11
   BOX GEP, 1979, ROBUSTNESS STAT, P201, DOI DOI 10.1016/B978-0-12-438150-6.50018-2
   CRAIG MD, 1994, IEEE T GEOSCI REMOTE, V32, P542, DOI 10.1109/36.297973
   de Juan A, 2004, TRAC-TREND ANAL CHEM, V23, P70, DOI 10.1016/S0165-9936(04)00101-3
   *ENVI, 2000, ENV VIS IM US GUID V
   GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001
   Hastie T., 2001, ELEMENTS STAT LEARNI
   HAZEWINKEL M, 1995, ENCY MATH, V5
   LEE JB, 1990, IEEE T GEOSCI REMOTE, V28, P295, DOI 10.1109/36.54356
   Nocedal J., 1999, NUMERICAL OPTIMIZATI
   Press WH, 1992, NUMERICAL RECIPES C
   Weibel E. R, 1980, STEREOLOGICAL METHOD, V2
   Winter M. E., 1999, P 13 INT C APPL GEOL, V2, P337
NR 16
TC 2
Z9 2
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5668-3
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5694
BP 62
EP 73
DI 10.1117/12.600291
PG 12
WC Spectroscopy
SC Spectroscopy
GA BCH87
UT WOS:000229357000008
DA 2018-10-20
ER

PT S
AU Xu, ZQ
   Kumar, A
   Kumar, A
   Sikder, A
AF Xu, ZQ
   Kumar, A
   Kumar, A
   Sikder, A
BE Basu, SN
   Krzanowski, JE
   Patscheider, J
   Gogotsi, Y
TI Synthesis and characterization of nanocrystalline diamond and its
   biomedical application
SO Surface Engineering 2004 - Fundamentals and Applications
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Ultrafast Lasers for Materials Science held at the 2004 MRS
   Fall Meeting
CY NOV 30-DEC 01, 2004
CL Boston, MA
SP MRS
ID FILMS
AB Diamond is known as the material that has excellent mechanical, electrical and chemical properties. Diamond is also an ideal interface that is compatible with microelectronics process and biological environments to work as a biosensor platform with excellent selectivity and stability. In our study, nanocrystalline diamond (NCD) films were grown on Si substrates by the microwave plasma enhanced chemical vapor deposition (MPECVD) method. Parameters such as gas composition, temperature and pressure are investigated to get the best film quality. Scanning electron microscopy (SEM) and Raman spectroscopy were used to characterize the NCD films. Then the NCD films were treated by hydrogen plasma in the CVD chamber to obtain the hydrogen terminated surface. This hydrogenated NCD film is ready for bio-modification and can work as the platform of the biosensors. Fourier Transform Infrared Spectroscopy (FTIR) and Xray Photoelectron Spectroscopy (XPS) were employed to confirm the surface hydrogenation.
C1 Univ S Florida, Dept Mech Engn, Tampa, FL 33620 USA.
RP Xu, ZQ (reprint author), Univ S Florida, Dept Mech Engn, Tampa, FL 33620 USA.
CR Aleksov A, 2004, DIAM RELAT MATER, V13, P233, DOI 10.1016/j.diamond.2003.11.090
   Bhattacharyya S, 2001, APPL PHYS LETT, V79, P1441, DOI 10.1063/1.1400761
   BIRRELL J, 2004, DIAM RELAT MATER, V14, P1588
   Bower C, 2000, APPL PHYS LETT, V77, P830, DOI 10.1063/1.1306658
   Davidson JL, 2003, DIAM RELAT MATER, V12, P429, DOI 10.1016/S0925-9635(03)00041-4
   Deuerler F., 2002, INT J REFRACT MET H, V20, P115
   Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211
   Krainsky IL, 1998, APPL PHYS LETT, V72, P2574, DOI 10.1063/1.121422
   Maier F, 1999, SURF SCI, V443, P177, DOI 10.1016/S0039-6028(99)01010-9
   Qiu DJ, 2004, DIAM RELAT MATER, V13, P419, DOI 10.1016/j.diamond.2003.11.086
   Sharda T, 2001, DIAM RELAT MATER, V10, P1592, DOI 10.1016/S0925-9635(01)00415-0
   THOMS BD, 1994, APPL PHYS LETT, V65, P2957, DOI 10.1063/1.112503
   Wang T, 2004, DIAM RELAT MATER, V13, P6, DOI 10.1016/j.diamond.2003.08.014
   Weide J., 1994, PHYS REV B, V50, P5803
   Yoshikawa H, 2001, DIAM RELAT MATER, V10, P1588, DOI 10.1016/S0925-9635(01)00414-9
   Zhang Q, 1998, J APPL PHYS, V83, P1349, DOI 10.1063/1.367311
NR 16
TC 1
Z9 1
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-791-1
J9 MATER RES SOC SYMP P
PY 2005
VL 843
BP 55
EP 60
PG 6
WC Materials Science, Coatings & Films; Physics, Condensed Matter
SC Materials Science; Physics
GA BCH96
UT WOS:000229372000008
DA 2018-10-20
ER

PT S
AU Hladky-Hennion, AC
   Cochran, JK
   Meyer, R
   Markley, DC
   Newnham, RE
AF Hladky-Hennion, AC
   Cochran, JK
   Meyer, R
   Markley, DC
   Newnham, RE
BE WongNg, W
   Goyal, A
   Guo, R
   Bhalla, AS
TI The wagon wheel transducer as a vector sensor and a directional
   projector
SO SYNTHESIS, PROPERTIES, AND CRYSTAL CHEMISTRY OF PEROVSKITE-BASED
   MATERIALS
SE CERAMIC TRANSACTIONS
LA English
DT Proceedings Paper
CT 106th Annual Meeting of the American-Ceramic-Society
CY APR 18-21, 2004
CL Indianapolis, IN
SP Amer Ceram Soc
AB Traditional flextensional transducers have been used extensively for fish-finding, oil exploration, sonar systems, and low frequency biomedical applications in the 1-100 kHz range. Our goal is to develop a family of small, low-cost, underwater and biomedical transducers based on extrusion technology. Some of these designs resemble traditional Class IV and Class VII flextensional transducers and will expand their useful operating range. Others incorporate features of tonpilz and vector sensor transducers. Miniature versions of these high-power, low frequency transducers are being optimized to produce broadband transmit and receive response, engineered vibration modes,. and optimized acoustic beam patterns. Transducer topologies with various shapes, cross-sections, and symmetries can be fabricated through high volume, low-cost ceramic and metal extrusion processes. Dimensions of the pieces can be as small as one millimeter and as large as 10 cm, which provide resonance frequencies from above 1 MHz to below 10 kHz. The acoustic vibration modes, resonance frequencies and radiation patterns of these transducers are controlled through the symmetry and external shape of the transducer material, poling pattern, the driving and receiving electrode geometries and driving conditions. This is the first in a series of papers devoted to small, multimode flextensional transducers with active shells. The specific aim of this paper is to present a flextensional transducer shaped like a wagon wheel with active shells, which combines the advantages of small size and low-cost manufacturing with control of the shape of the acoustic radiation/receive pattern. The performance of the transducer as a vector sensor and as a directional projector is emphasized.
C1 CNRS, IEMN, UMR 8520, F-59046 Lille, France.
RP Hladky-Hennion, AC (reprint author), CNRS, IEMN, UMR 8520, 41,Blvd Vauban, F-59046 Lille, France.
RI HLADKY-HENNION, Anne-Christine/I-3237-2017
OI HLADKY-HENNION, Anne-Christine/0000-0001-6339-8448
CR Butler S.C., 2000, P MTS IEEE OC 2000 C, V3, P1469
   Ehrlich S. L., 1973, U. S. Patent No, Patent No. [3732535, 3, 732, 535]
   Ehrlich S. L., 1966, U.S. patent, Patent No. [3290646, 3,290,646]
   HLADKYHENNION AC, 1993, J ACOUST SOC AM, V94, P621, DOI 10.1121/1.406878
   HOWARTH TR, 1997, P MTS IEEE OC 1997 C, V2, P1195
   Hurysz KM, 2002, PROCESSSING AND PROPERTIES OF LIGHTWEIGHT CELLULAR METALS AND STRUCTURES, P167
   Hurysz KM, 2003, J EUR CERAM SOC, V23, P2047, DOI 10.1016/S0955-2219(03)00027-X
   HURYSZ KM, 2003, IN PRESS INNOVATIVE, V7
   KO SH, 1974, J ACOUST SOC AM, V56, P1890, DOI 10.1121/1.1903528
   LAN J, 1996, P MTS IEEE OC 1996 C, V2, P763
   OH R, 2003, INNOVATIVE PROCESSES, V7
   RYNNE EF, 1993, INNOVATIVE APPROACHE, P38
   Zhang J, 2001, ULTRASONICS, V39, P91, DOI 10.1016/S0041-624X(00)00055-X
NR 13
TC 0
Z9 0
U1 0
U2 0
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 1042-1122
BN 1-57498-190-0
J9 CERAM TRANS
PY 2005
VL 169
BP 17
EP 37
PG 21
WC Materials Science, Ceramics
SC Materials Science
GA BBR78
UT WOS:000227471800002
DA 2018-10-20
ER

PT S
AU Bellucci, S
   Balasubramanian, C
   Mancia, F
   Marchetti, M
   Regi, M
   Tombolini, F
AF Bellucci, S
   Balasubramanian, C
   Mancia, F
   Marchetti, M
   Regi, M
   Tombolini, F
BE Quan, C
   Chau, FS
   Asundi, A
   Wong, BS
   Lim, CT
TI Composite materials based on Carbon Nanotubes for aerospace applications
SO Third International Conference on Experimental Mechanics and Third
   Conference of the Asian-Committee-on-Experimental-Mechanics, Pts 1and 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Conference on Experimental Mechanics/3rd Conference of
   the Asian-Committee-on-Experimental-Mechanics
CY NOV 29-DEC 01, 2004
CL Singapore, SINGAPORE
SP Asian Comm Expt Mech, Natl Univ Singapore, Dept Mech Engn, Nanyang Technol Univ, Sch Mech & Product Engn, Lee Fdn, USAF Off Sci Res, Asian Off Aerosp Res & Dev, SPIE
DE carbon nanotubes; composite materials; mechanical properties; aerospace
   structuress; anisogrid lattices
ID ARC-DISCHARGE
AB Electrical and mechanical proper-ties of composite materials based on Carbon Nanotubes are considered for aerospace applications. Nanostructured materials gained great importance in the past decade, owing to their wide ranging potential applications in many areas, e.g. mechanical, structural, sensor, biomedical, electronics. Of particular interest are carbon nanotubes, which can be used as a main constituent of composite materials with exceptional mechanical and electrical properties, very suitable for aerospace applications, also due to their light weight, mechanical strength and flexibility. We present results obtained recently in our laboratories concerning the electrical and mechanical properties (including resilience measurement, stress analysis, conductivity) of carbon nanotubes we synthesized by arc discharge and other techniques, embedded in a polymer matrix.
C1 Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy.
RP Bellucci, S (reprint author), Ist Nazl Fis Nucl, Lab Nazl Frascati, Via E Fermi 40, I-00044 Frascati, Italy.
RI Chidambara Thanupillai, Balasubramanian/H-2138-2013; Bellucci,
   Stefano/C-9235-2011
OI Bellucci, Stefano/0000-0003-0326-6368
CR BELLUCCI S, IN PRESS RELATIVISTI
   BELLUCCI S, 2004, IN PRESS PHYS ST JUL
   Lange H, 2003, CARBON, V41, P1617, DOI 10.1016/S0008-6223(03)00111-8
   Lau KT, 2002, COMPOS PART B-ENG, V33, P263
   REGI M, 2004, S SULL TECHN AV SVIL
   REGI M, AEROTECNICA MISSILI, V83
   REGI M, AEROTECNICA MISSILI, V82
   Takikawa H, 1999, J PHYS D APPL PHYS, V32, P2433, DOI 10.1088/0022-3727/32/18/315
   Vasiliev VV, 2001, COMPOS STRUCT, V54, P361, DOI 10.1016/S0263-8223(01)00111-8
   Zeng H, 1998, CARBON, V36, P259, DOI 10.1016/S0008-6223(97)00167-X
   Zhang HY, 2003, PHYSICA B, V325, P224, DOI 10.1016/S0921-4526(02)01528-4
NR 11
TC 3
Z9 3
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5852-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5852
BP 121
EP 126
DI 10.1117/12.621441
PN 1&2
PG 6
WC Instruments & Instrumentation; Materials Science, Biomaterials;
   Materials Science, Characterization & Testing; Optics; Imaging Science &
   Photographic Technology
SC Instruments & Instrumentation; Materials Science; Optics; Imaging
   Science & Photographic Technology
GA BCL69
UT WOS:000229932000019
DA 2018-10-20
ER

PT B
AU Dittmar, A
   Lymberis, A
AF Dittmar, A
   Lymberis, A
GP IEEE
TI Smart clothes and associated wearable devices for biomedical ambulatory
   monitoring
SO TRANSDUCERS '05, DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 13th International Conference on Solid-State Sensors, Actuators and
   Microsystems
CY JUN 05-09, 2005
CL Seoul, SOUTH KOREA
SP Korean Sensors Soc, IEEE Electron Devices Soc, IEEE Robot & Automat Soc, IEE Japan, Sensors & Micromach Soc, Int Federat Automat Control, Inst Control, Automat & Syst Engineers, Inst Elect Engineers Korea, Korean Inst Elect Engineers, Korean Soc Mech Engineers, Korean Soc Precis Engn, Korean Robot Soc
DE smart clothes; WBS (Wearable Biomedical Sensors); non-invasive sensors;
   flexible technology; ambulatory measurement; monitoring; textile-made
   sensors; textile-made electrodes
ID EMOTIONS
AB The world is becoming more and more "health conscious". Society, health policy and patients' needs are all changing dramatically.
   The challenges society is currently facing are related to: The increase in the aging population, changing lifestyles, the need for healthcare cost-containment, the improvement and monitoring of healthcare quality, the prevention approaches rather than treatment.
   In addition, patients and health consumers are waiting for : non invasive, mini invasive... painless methods for diagnosis and treatment, home care, ambulatory methods, short stays in hospital, use of telemedicine, enhancement of rehabilitation, information and involvement in their own treatment.
   Health smart clothes which are in contact with almost all the surface of the skin offer large possibilities for the location of sensors for non invasive measurements. Head band, collar, tee-shirt, socks, shoes, belts for chest, arm, wrist, legs... provide localization with specific purpose taking into account their proximity of an organ or a source of biosignal, and also its ergonomic possibility (user friendly) to fix a sensor, and the associated instrumentations (batteries, amplifiers, signal processing, telecom, alarm, display...).
   Progress in science and technology offers, for the first time, intelligence, speed, miniaturization, sophistication and new materials at low cost. In this new landscape, microtechnologies, information technologies and telecommunications are a key factor. Microsensors : Microtechnologies offer the possibility of small size, but also intelligent, active device, working with low energy, wireless and non invasive or mini invasive. These sensors have to be thin, flexible and compatible with textile, or made using textile technologies, new fibers with specific properties: mechanical, electrical, optical...
   The field of applications is very large, e.g. continuous monitoring on elderly population, professional and military activities, athletes performance and condition, and people with disabilities.
   The research are oriented toward two complementary directions : Improving the relevancy of each sensor and increasing the number of sensors for having a more global synthetic and robust information(1).
C1 Inst Natl Sci Appl, CNRS, LPM, F-69621 Villeurbanne, France.
RP Dittmar, A (reprint author), Inst Natl Sci Appl, CNRS, LPM, Bat L De Vinci,20 Ave Albert Einstein, F-69621 Villeurbanne, France.
EM dittmar@univ-lyon1.fr; andreas.lymberis@cec.eu.int
CR AXISA F, 2005, THESIS INSA LYON
   AXISA F, 2005, UNPUB IEEE T INFORM
   BONFIGLIO A, 2003, NEW GENERATION WEARA, P258
   Collet C, 1997, J AUTONOM NERV SYST, V62, P45, DOI 10.1016/S0165-1838(96)00108-7
   De Rossi D, 2000, 1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS, P587, DOI 10.1109/MMB.2000.893853
   DITTMAR A, Patent No. 0402037
   DITTMAR A, 2003, 25 ANN INT C IEEE EM
   Dittmar A., 2004, STUD HLTH TECHNOL IN, V108, P9
   EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338
   GROSSMAN P, 2003, NEW GENERATION WEARA, P73
   GUILLEMAUD R, 2003, NEW GENERATION WEARA, P209
   HEALEY J, 2003, NEW GENERATION WEARA, P194
   HERZOG RK, 2003, 25 ANN INT C IEEE EM
   JONES M, 2003, NEW GENERATION WEARA, P216
   Khalil S., 2004, P SOC PHOTO-OPT INS, V5270, P38
   KIRSTEIN T, 2003, NEW GENERATION WEARA, P201
   LAUTER J, 2003, 25 ANN INT C IEEE EM
   LEITCH P, 2003, NEW GENERATION WEARA, P54
   LORUSSI F, 2003, NEW GENERATION WEARA, P175
   LUPRANO J, 2003, NEW GENERATION WEARA, P100
   Lymberis A, 2003, TELEMEDICINE J E HLT, V9
   LYMBERIS A, 2003, 25 ANN INT C IEEE EM
   MCADAMS E, 2003, NEW GENERATION WEARA, P115
   MOHAN A, 2004, THESIS MIT
   MOHAN A, 2003, NEW GENERATION WEARA, P291
   MUNRO B, 2003, NEW GENERATION WEARA, P187
   NOURY N, 2004, P 26 ANN INT C IEEE, P3266
   PARADISO R, 2003, 25 ANN INT C IEEE EM
   Park S, 2002, DES AUT CON, P170, DOI 10.1109/DAC.2002.1012614
   Saranummi N, 2002, IEEE T BIO-MED ENG, V49, P1385, DOI 10.1109/TBME.2002.806021
   WALLACE GG, 2003, NEW GENERATION WEARA, P241
   WEBER L, 2003, NEW GENERATION WEARA, P169
NR 32
TC 1
Z9 1
U1 0
U2 12
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8994-8
PY 2005
BP 221
EP 227
PG 7
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Engineering
GA BCZ93
UT WOS:000232189100055
DA 2018-10-20
ER

PT B
AU Lei, KF
   Li, WJ
AF Lei, KF
   Li, WJ
GP IEEE
TI Microfluidic mixing by fluidic discretization
SO TRANSDUCERS '05, DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 13th International Conference on Solid-State Sensors, Actuators and
   Microsystems
CY JUN 05-09, 2005
CL Seoul, SOUTH KOREA
SP Korean Sensors Soc, IEEE Electron Devices Soc, IEEE Robot & Automat Soc, IEE Japan, Sensors & Micromach Soc, Int Federat Automat Control, Inst Control, Automat & Syst Engineers, Inst Elect Engineers Korea, Korean Inst Elect Engineers, Korean Soc Mech Engineers, Korean Soc Precis Engn, Korean Robot Soc
DE microfluidic mixing; micropump; micromixer
AB A new concept of microfluidic mixing based on fluid "discretization" is proposed in this paper. Polymer based micropumps, micromixer and microchannels have been designed and integrated in a single PMMA chip microfluidic system. The optically transparent and biocompatible material used to fabricate the microfluidic system will enable many biomedical and chemical analysis applications. The idea of "discretized" microfluidic mixing is to manipulate fluids as "discretize" volumes by pumping fluids by two micropumps into a microchamber alternatively in order to increasing the interfacial surface area. Hence, the diffusion between fluids can be completed in a shorter time and fluids can be mixed instantly without external energy in the chamber. The design, implementation and experimental results are presented in this paper.
C1 Chinese Univ Hong Kong, Ctr Micro & Nano Syst, Shatin, Hong Kong, Peoples R China.
RP Li, WJ (reprint author), Chinese Univ Hong Kong, Ctr Micro & Nano Syst, Shatin, Hong Kong, Peoples R China.
EM wen@acae.cuhk.edu.hk
RI Li, Wen Jung/A-6153-2010; Li, Wen Jung/M-9995-2013
OI Li, Wen Jung/0000-0001-9616-6213; Li, Wen Jung/0000-0001-9616-6213
CR BRANEBJERG P, 1996, PROC IEEE MICR ELECT, P441
   CHOW WWY, 2004, IN PRESS NANOTECHNOL
   LEI KF, 2005, J MICROMECHANICS MIC
   LEI KF, 2004, J MICROSYSTEM TECHNO
   LEI KF, 2004, 2004 IEEE RSJ INT C
   Lu LH, 2002, J MICROELECTROMECH S, V11, P462, DOI 10.1109/JMEMS.2002.802899
   MIYAKE R, 1993, MICRO ELECTRO MECHANICAL SYSTEMS, PROCEEDINGS, P248
   YAN Z, 2000, IEEE MEMS 2000, P80
NR 8
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8994-8
PY 2005
BP 1537
EP 1540
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Engineering
GA BCZ93
UT WOS:000232189100379
DA 2018-10-20
ER

PT J
AU Patil, GV
   Pokhrel, K
AF Patil, GV
   Pokhrel, K
TI Biomedical solid waste management in an Indian hospital: a case study
SO WASTE MANAGEMENT
LA English
DT Article
AB The objectives of this study were: (i) to assess the waste handling and treatment system of hospital bio-medical solid waste and its mandatory compliance with Regulatory Notifications for Bio-medical Waste (Management and Handling) Rules, 1998, under the Environment (Protection Act 1986), Ministry of Environment and Forestry, Govt. of India, at the chosen KLE Society's J. N. Hospital and Medical Research Center, Belgaum, India and (ii) to quantitatively estimate the amount of non-infectious and infectious waste generated in different wards/sections. During the study, it was observed that: (i) the personnel working under the occupier (who has control over the institution to take all steps to ensure biomedical waste is handled without any adverse effects to human health and the environment) were trained to take adequate precautionary measures in handling these bio-hazardous waste materials, (ii) the process of segregation, collection, transport, storage and final disposal of infectious waste was done in compliance with the Standard Procedures, (iii) the final disposal was by incineration in accordance to EPA Rules 1998, (iv) the non-infectious waste was collected separately in different containers and treated as general waste, and (v) on an average about 520 kg of non-infectious and 101 kg of infectious waste is generated per day (about 2.31 kg per day per bed, gross weight comprising both infectious and noninfectious waste). This hospital also extends its facility to the neighboring clinics and hospitals by treating their produced waste for incineration. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Bundelkhand Univ, Inst Pharm, Jhansi 284128, Uttar Pradesh, India.
   KLE Soc JN Med Coll, Hosp Adm, Belgaum 590010, India.
RP Patil, GV (reprint author), Bundelkhand Univ, Inst Pharm, Jhansi 284128, Uttar Pradesh, India.
EM patilgayathripatil@rediffmail.com
OI Patil, Gayathri/0000-0001-5618-2788
CR Baveja G., 2000, HOSP TODAY, V5, P485
   *CENS IND, 2001, BELG DISTR
   GUPTA SP, 1998, STAT METHODS
   JASWAL PS, 2000, ENV LAW
   Manohar D, 1998, IND J ENV HLTH, V40, P319
   SANDHU TS, 2003, TRIBUNE         0630
   Shah S., 2001, OCCUPATIONAL HLTH HA
NR 7
TC 56
Z9 56
U1 1
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0956-053X
J9 WASTE MANAGE
JI Waste Manage.
PY 2005
VL 25
IS 6
BP 592
EP 599
DI 10.1016/j.wasman.2004.07.011
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 948VB
UT WOS:000230742700007
PM 15993343
DA 2018-10-20
ER

EF